PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mack, PJ; Zhang, Y; Chung, S; Vickerman, V; Kamm, RD; Garcia-Cardena, G				Mack, Peter J.; Zhang, Yuzhi; Chung, Seok; Vickerman, Vernella; Kamm, Roger D.; Garcia-Cardena, Guillermo			Biomechanical Regulation of Endothelium-dependent Events Critical for Adaptive Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE GROWTH-FACTOR; FLUID SHEAR-STRESS; MUSCLE-CELL DIFFERENTIATION; CORONARY-ARTERY-DISEASE; GENE-EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSCRIPTION FACTOR; MOLECULAR REGULATION; VESSEL MATURATION; NITRIC-OXIDE	Alterations in hemodynamic shear stress acting on the vascular endothelium are critical for adaptive arterial remodeling. The molecular mechanisms regulating this process, however, remain largely uncharacterized. Here, we sought to define the responses evoked in endothelial cells exposed to shear stress waveforms characteristic of coronary collateral vessels and the subsequent paracrine effects on smooth muscle cells. A lumped parameter model of the human coronary collateral circulation was used to simulate normal and adaptive remodeling coronary collateral shear stress waveforms. These wave forms were then applied to cultured human endothelial cells ( EC), and the resulting differences in EC gene expression were assessed by genome-wide transcriptional profiling to identify genes distinctly regulated by collateral flow. Analysis of these transcriptional programs identified several genes to be differentially regulated by collateral flow, including genes important for endothelium-smooth muscle interactions. In particular, the transcription factor KLF2 was up- regulated by the adaptive remodeling coronary collateral waveform, and several of its downstream targets displayed the expected modulation, including the down-regulation of connective tissue growth factor. To assess the effect of endothelial KLF2 expression on smooth muscle cell migration, a three-dimensional microfluidic assay was developed. Using this three-dimensional system, we showed that KLF2-expressing EC co-cultured with SMC significantly reduce SMC migration compared with control EC and that this reduction can be rescued by the addition of exogenous connective tissue growth factor. Collectively, these results demonstrate that collateral flow evokes distinct EC gene expression profiles and functional phenotypes that subsequently influence vascular events important for adaptive remodeling.	[Chung, Seok; Garcia-Cardena, Guillermo] MIT, Dept Biol, Cambridge, MA 02139 USA; [Vickerman, Vernella] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Mack, Peter J.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Garcia-Cardena, Guillermo] Harvard Univ, Sch Med, Dept Pathol, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Garcia-Cardena, Guillermo] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kamm, RD (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave,NE47-320, Cambridge, MA 02139 USA.	rdkamm@mit.edu; guillermo_garcia-cardena@hms.harvard.edu	Garcia-Cardena, Guillermo/Q-6649-2019; Kamm, Roger D/I-7630-2012; Chung, Seok/B-1501-2015	/0000-0002-7232-304X	National Institutes of Health; NHLB [RO1-HL7066686, P50-HL56985]; NIBIB [BRP-EB003805]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006348, R01EB003805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLB; NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health, NHLB, Grants RO1-HL7066686 and P50-HL56985 (to G. G.- C.) and National Institutes of Health, NIBIB, Grant BRP-EB003805 (to R. D. K.).	Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; CHAITMAN BR, 1981, CIRCULATION, V64, P360, DOI 10.1161/01.CIR.64.2.360; Chatzizisis YS, 2007, CURR OPIN CARDIOL, V22, P552, DOI 10.1097/HCO.0b013e3282f07548; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Chiu JJ, 2005, ARTERIOSCL THROM VAS, V25, P963, DOI 10.1161/01.ATV.0000159703.43374.19; Cicha I, 2005, ARTERIOSCL THROM VAS, V25, P1008, DOI 10.1161/01.ATV.0000162173.27682.7b; Comander J, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-17; Corriere MA, 2008, J SURG RES, V145, P142, DOI 10.1016/j.jss.2007.03.077; Crean JK, 2004, FASEB J, V18, P1541, DOI 10.1096/fj.04-1546fje; Dai GH, 2004, P NATL ACAD SCI USA, V101, P14871, DOI 10.1073/pnas.0406073101; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Garcia-Cardena G, 2006, Handb Exp Pharmacol, P79; Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007; Heil M, 2004, CORONARY ARTERY DIS, V15, P373, DOI 10.1097/00019501-200411000-00002; Heldt T, 2002, J APPL PHYSIOL, V92, P1239, DOI 10.1152/japplphysiol.00241.2001; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Huddleson JP, 2005, J BIOL CHEM, V280, P23371, DOI 10.1074/jbc.M413839200; Huddleson JP, 2004, BIOL CHEM, V385, P723, DOI 10.1515/BC.2004.088; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jones N, 2000, CANCER METAST REV, V19, P13, DOI 10.1023/A:1026555121511; Korshunov VA, 2007, ARTERIOSCL THROM VAS, V27, P1722, DOI 10.1161/ATVBAHA.106.129254; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; LEE E, 1995, ARTERIOSCL THROM VAS, V15, P2284, DOI 10.1161/01.ATV.15.12.2284; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Limbourg A, 2007, CIRC RES, V100, P363, DOI 10.1161/01.RES.0000258174.77370.2c; Lindahl P, 1998, CURR OPIN LIPIDOL, V9, P407, DOI 10.1097/00041433-199810000-00004; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Mees B, 2007, ARTERIOSCL THROM VAS, V27, P1926, DOI 10.1161/ATVBAHA.107.145375; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Oemar BS, 1997, ARTERIOSCL THROM VAS, V17, P1483, DOI 10.1161/01.ATV.17.8.1483; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Reiss Y, 2007, CIRC RES, V101, P88, DOI 10.1161/CIRCRESAHA.106.143594; Rockstroh J, 2002, CIRCULATION, V105, P168, DOI 10.1161/hc0202.102120; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Sakamoto N, 2006, ANN BIOMED ENG, V34, P408, DOI 10.1007/s10439-005-9043-y; Schaper W, 2003, ARTERIOSCL THROM VAS, V23, P1143, DOI 10.1161/01.ATV.0000069625.11230.96; SCHREINER W, 1990, J BIOMED ENG, V12, P429, DOI 10.1016/0141-5425(90)90029-M; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Song RH, 2000, ARTERIOSCL THROM VAS, V20, P923, DOI 10.1161/01.ATV.20.4.923; Sullivan CC, 2003, P NATL ACAD SCI USA, V100, P12331, DOI 10.1073/pnas.1933740100; Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225; Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f; Vita JA, 2008, CIRCULATION, V117, P3126, DOI 10.1161/CIRCULATIONAHA.108.778472; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Watts KL, 2004, AM J PHYSIOL-LUNG C, V287, pL1323, DOI 10.1152/ajplung.00447.2003; Wolf C, 1998, J MOL CELL CARDIOL, V30, P2291, DOI 10.1006/jmcc.1998.0790; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Zhao XM, 1997, J MATER CHEM, V7, P1069, DOI 10.1039/a700145b	55	38	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8412	8420		10.1074/jbc.M804524200	http://dx.doi.org/10.1074/jbc.M804524200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19047056	hybrid, Green Published			2022-12-25	WOS:000264397800025
J	Venza, I; Cucinotta, M; Visalli, M; De Grazia, G; Oliva, S; Teti, D				Venza, Isabella; Cucinotta, Maria; Visalli, Maria; De Grazia, Giuseppina; Oliva, Sabrina; Teti, Diana			Pseudomonas aeruginosa Induces Interleukin-8 (IL-8) Gene Expression in Human Conjunctiva through the Recruitment of Both RelA and CCAAT/Enhancer-binding Protein beta to the IL-8 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CORNEAL EPITHELIAL-CELLS; CYSTIC-FIBROSIS; TRANSCRIPTION; ACTIVATION; INFECTION; CYTOKINES; RESPONSES; ALPHA; MITOCHONDRIA	The purpose of this study was to identify the Pseudomonas aeruginosa-activated signaling pathway leading to interleukin (IL)-8 gene expression and protein synthesis by human conjunctival epithelium. IL-8 protein and mRNA were determined by enzyme-linked immunosorbent assay and reverse transcription-PCR, respectively. Activation of MAPKs and NF-kappa B was analyzed by Western blotting using phosphospecific antibodies. We used transfection with wild-type or mutated IL-8 promoters and cotransfection with transcription factor overexpressing plasmids or small interfering RNAs. Electrophoretic mobility shift assay and chromatin immunoprecipitation (ChIP) were performed for in vitro and in vivo protein-DNA binding studies, respectively. P. aeruginosa increased IL-8 expression at the transcriptional level by phosphorylating CCAAT/enhancer-binding protein beta (C/EBP beta) via p38MAPK and activating NF-kappa B. The simultaneous involvement of RelA and C/EBP beta and the integrity of the corresponding consensus sites were required, whereas c-Jun was involved only in basal IL-8 expression. Re-ChIP experiments showed that RelA and C/EBP beta act together at the IL-8 promoter level upon P. aeruginosa infection. Taken together, our results suggest that P. aeruginosa induces IL-8 promoter expression and protein production in conjunctival epithelial cells by activating RelA and C/EBP beta and by promoting the cooperative binding of these transcription factors to the IL-8 promoter that in turn activates transcription.	[Venza, Isabella] Univ Messina, Dept Surg Specialties, I-98125 Messina, Italy; [Cucinotta, Maria; Visalli, Maria; De Grazia, Giuseppina; Oliva, Sabrina; Teti, Diana] Univ Messina, Dept Expt Pathol & Microbiol, I-98125 Messina, Italy	University of Messina; University of Messina	Teti, D (corresponding author), Azienda Osped Univ, Dept Expt Pathol & Microbiol, Via Consolare Valeria 1, I-98125 Messina, Italy.	dteti@unime.it	Oliva, Sabrina/G-6809-2012	Oliva, Sabrina/0000-0002-0111-8276				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barie, 2000, Am J Surg, V179, P2, DOI 10.1016/S0002-9610(00)00316-0; BAUM J, 1995, CLIN INFECT DIS, V21, P479, DOI 10.1093/clinids/21.3.479; Brito D. V. D., 2003, Braz J Infect Dis, V7, P234, DOI 10.1590/S1413-86702003000400001; Caristi S, 2005, J BIOL CHEM, V280, P14433, DOI 10.1074/jbc.M410725200; Delgado MA, 2006, INFECT IMMUN, V74, P2975, DOI 10.1128/IAI.74.5.2975-2984.2006; Eifrig CWG, 2003, OPHTHALMOLOGY, V110, P1714, DOI 10.1016/S0161-6420(03)00572-4; Epelman S, 2000, INFECT IMMUN, V68, P4811, DOI 10.1128/IAI.68.8.4811-4814.2000; Foca M, 2000, NEW ENGL J MED, V343, P695, DOI 10.1056/NEJM200009073431004; Gaili H, 2002, ARCH DIS CHILD-FETAL, V86, P204; Garg P, 1999, OPHTHALMOLOGY, V106, P1319, DOI 10.1016/S0161-6420(99)00717-4; Giagounidis AAN, 1997, ANN HEMATOL, V75, P121, DOI 10.1007/s002770050325; Hybiske K, 2004, CELL MICROBIOL, V6, P49, DOI 10.1046/j.1462-5822.2003.00342.x; Jendrossek V, 2001, INFECT IMMUN, V69, P2675, DOI 10.1128/IAI.69.4.2675-2683.2001; Joseph T, 2005, AM J PHYSIOL-LUNG C, V288, pL471, DOI 10.1152/ajplung.00066.2004; Kenzel S, 2006, J IMMUNOL, V176, P3181, DOI 10.4049/jimmunol.176.5.3181; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; KING S, 1998, INFECT CONT HOSP EP, V9, P77; Kojima K, 2008, BRIT J OPHTHALMOL, V92, P411, DOI 10.1136/bjo.2007.128322; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; KUNSCH C, 1994, J IMMUNOL, V153, P153; Lambertini E, 2008, J CELL PHYSIOL, V216, P101, DOI 10.1002/jcp.21379; Lang R, 2003, INVEST OPHTH VIS SCI, V44, P99, DOI 10.1167/iovs.02-0357; Li J, 2007, MOL VIS, V13, P813; Mancuso G, 2002, J IMMUNOL, V169, P1401, DOI 10.4049/jimmunol.169.3.1401; Matsumoto K, 2005, CORNEA, V24, pS43, DOI 10.1097/01.ico.0000178737.35297.d4; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Mori N, 1999, INFECT IMMUN, V67, P3872, DOI 10.1128/IAI.67.8.3872-3878.1999; Mukerjee R, 2007, J CELL BIOCHEM, V100, P1210, DOI 10.1002/jcb.21109; Narayanan S, 2003, INVEST OPHTH VIS SCI, V44, P3795, DOI 10.1167/iovs.02-1301; Oka M, 2006, BRIT J OPHTHALMOL, V90, P612, DOI 10.1136/bjo.2005.084525; Pruitt BA, 1998, WORLD J SURG, V22, P135; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rudner XL, 2000, J IMMUNOL, V164, P6576, DOI 10.4049/jimmunol.164.12.6576; Ruocco MR, 1996, J BIOL CHEM, V271, P22479, DOI 10.1074/jbc.271.37.22479; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Sawa T, 1997, J IMMUNOL, V159, P2858; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; Shah S S, 1999, J Perinatol, V19, P462, DOI 10.1038/sj.jp.7200247; Shah SS, 1998, PEDIATR INFECT DIS J, V17, P97, DOI 10.1097/00006454-199802000-00004; Smit EE, 2003, CORNEA, V22, P332, DOI 10.1097/00003226-200305000-00010; Smulders C, 1999, NETH J MED, V55, P106, DOI 10.1016/S0300-2977(99)00037-6; Talreja J, 2005, INFLAMMATION, V29, P170, DOI 10.1007/s10753-006-9014-y; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tuft SJ, 2000, BRIT J OPHTHALMOL, V84, P687, DOI 10.1136/bjo.84.7.687; van den Berg A, 2005, AM J RESP CELL MOL, V33, P97, DOI 10.1165/rcmb.2005-0022OC; Venza I, 2007, INVEST OPHTH VIS SCI, V48, P270, DOI 10.1167/iovs.06-0081; Wu Q, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-26; Xue ML, 2001, CLIN EXP OPHTHALMOL, V29, P171, DOI 10.1046/j.1442-9071.2001.00410.x; Yu YM, 2003, AM J PHYSIOL-GASTR L, V285, pG282, DOI 10.1152/ajpgi.00503.2002; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zhang J, 2005, CURR EYE RES, V30, P527, DOI 10.1080/02713680590968150	53	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4191	4199		10.1074/jbc.M805429200	http://dx.doi.org/10.1074/jbc.M805429200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19064995	hybrid			2022-12-25	WOS:000263134400016
J	Pedram, A; Razandi, M; Kim, JK; O'Mahony, F; Lee, EYHP; Luderer, U; Levin, ER				Pedram, Ali; Razandi, Mahnaz; Kim, Jin K.; O'Mahony, Fiona; Lee, Eva Y. H. P.; Luderer, Ulrike; Levin, Ellis R.			Developmental Phenotype of a Membrane Only Estrogen Receptor alpha(MOER) Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATION PROVIDES EVIDENCE; ALPHA KNOCKOUT MICE; PLASMA-MEMBRANE; ADIPOSE-TISSUE; IN-VIVO; DIFFERENTIATION; EXPRESSION; INDUCTION; BINDING; GLAND	Estrogen receptors (ERs) alpha and beta exist as nuclear, cytoplasmic, and membrane cellular pools in a wide variety of organs. The relative contributions of each ER alpha pool to in vivo phenotypes resulting from estrogen signaling have not been determined. To address this, we generated a transgenic mouse expressing only a functional E domain of ER alpha at the plasma membrane (MOER). Cells isolated from many organs showed membrane only localized E domain of ER alpha and no other receptor pools. Liver cells from MOER and wild type mice responded to 17-beta-estradiol (E2) with comparable activation of ERK and phosphatidylinositol 3-kinase, not seen in cells from ER alpha KO mice. Mating the MOER female mice with proven male wild type breeders produced no pregnancies because the uterus and vagina of the MOER female mice were extremely atrophic. Ovaries of MOER and homozygous Strasbourg ER alpha KO mice showed multiple hemorrhagic cysts and no corpus luteum, and the mammary gland development in both MOER and ER alpha KO mice was rudimentary. Despite elevated serum E2 levels, serum LH was not suppressed, and prolactin levels were low in MOER mice. MOER and Strasbourg female mice showed plentiful abdominal visceral and other depots of fat and increased body weight compared to wild type mice despite comparable food consumption. These results provide strong evidence that the normal development and adult functions of important organs in female mice requires nuclear ER alpha and is not rescued by membrane ER alpha domain expression alone.	[Levin, Ellis R.] UC Irvine, Vet Affairs Med Ctr, Div Endocrinol, Med Serv I 111, Long Beach, CA 90822 USA; [Pedram, Ali; Razandi, Mahnaz; Kim, Jin K.; O'Mahony, Fiona; Luderer, Ulrike; Levin, Ellis R.] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; [Lee, Eva Y. H. P.; Levin, Ellis R.] Univ Calif Irvine, Dept Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine	Levin, ER (corresponding author), UC Irvine, Vet Affairs Med Ctr, Div Endocrinol, Med Serv I 111, 5901 E 7th St, Long Beach, CA 90822 USA.	ellis.levin@med.va.gov	Levin, Ellis/J-5402-2013		National Institutes of Health Grants [CA-100366, K08HL089066]; Research Service of the Department of Veteran's Affairs; National Biophotonics and Imaging Platform of Ireland; NATIONAL CANCER INSTITUTE [P30CA062203, R01CA100366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089066] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Department of Veteran's Affairs(US Department of Veterans Affairs); National Biophotonics and Imaging Platform of Ireland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-100366(to E. R. L.) and K08HL089066(to J.K.K.). This work was also supported by grants from the Research Service of the Department of Veteran's Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a post-doctoral fellowship grant from the National Biophotonics and Imaging Platform of Ireland.	Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Dupont S, 2000, DEVELOPMENT, V127, P4277; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kousteni S, 2007, MOL CELL BIOL, V27, P1516, DOI 10.1128/MCB.01550-06; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; O'Brien JE, 2006, J BIOL CHEM, V281, P26683, DOI 10.1074/jbc.M601522200; Pedersen SB, 2001, MOL CELL ENDOCRINOL, V182, P27, DOI 10.1016/S0303-7207(01)00557-3; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Quyyumi AA, 2006, J AM COLL CARDIOL, V47, p66S, DOI 10.1016/j.jacc.2004.11.075; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Scully KM, 1997, MOL ENDOCRINOL, V11, P674, DOI 10.1210/me.11.6.674; Simpson ER, 2004, SEMIN REPROD MED, V22, P25; Sinkevicius KW, 2008, ENDOCRINOLOGY, V149, P2970, DOI 10.1210/en.2007-1526; Vasudevan N, 2001, P NATL ACAD SCI USA, V98, P12267, DOI 10.1073/pnas.221449798	21	107	110	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3488	3495		10.1074/jbc.M806249200	http://dx.doi.org/10.1074/jbc.M806249200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19054762	Green Published, hybrid			2022-12-25	WOS:000262872500015
J	Matyash, A; Singh, N; Hanes, SD; Urlaub, H; Jackle, H				Matyash, Alexey; Singh, Navjot; Hanes, Steven D.; Urlaub, Henning; Jaeckle, Herbert			SAP18 Promotes Kruppel-dependent Transcriptional Repression by Enhancer-specific Histone Deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTBP-INDEPENDENT REPRESSION; TRITHORAX GROUP GENES; DROSOPHILA EMBRYO; GAGA FACTOR; POSTERIOR REGION; MODIFIER SCREEN; BINDING-SITE; DNA-BINDING; IN-VIVO; POLYCOMB	Body pattern formation during early embryogenesis of Drosophila melanogaster relies on a zygotic cascade of spatially restricted transcription factor activities. The gap gene Kruppel ranks at the top level of this cascade. It encodes a C2H2 zinc finger protein that interacts directly with cis-acting stripe enhancer elements of pair rule genes, such as even skipped and hairy, at the next level of the gene hierarchy. Kruppel mediates their transcriptional repression by direct association with the corepressor Drosophila C terminus-binding protein (dCtBP). However, for some Kruppel target genes, deletion of the dCtBP-binding sites does not abolish repression, implying a dCtBP-independent mode of repression. We identified Kruppel-binding proteins by mass spectrometry and found that SAP18 can both associate with Kruppel and support Kruppel-dependent repression. Genetic interaction studies combined with pharmacological and biochemical approaches suggest a site-specific mechanism of Kruppel-dependent gene silencing. The results suggest that Kruppel tethers the SAP18 bound histone deacetylase complex 1 at distinct enhancer elements, which causes repression via histone H3 deacetylation.	[Matyash, Alexey; Jaeckle, Herbert] Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, D-37077 Gottingen, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Singh, Navjot; Hanes, Steven D.] SUNY Albany, Wadsworth Ctr, New York State Dept Hlth, Albany, NY 12208 USA; [Singh, Navjot; Hanes, Steven D.] SUNY Albany, Dept Biomed Sci, Albany, NY 12208 USA	Max Planck Society; Max Planck Society; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Jackle, H (corresponding author), Fassberg 11, D-37077 Gottingen, Germany.	hjaeckl@gwdg.de			Max-Planck-Gesellschaft; American Cancer Society [RSG-9508506-DDC, 1-FY07-527]	Max-Planck-Gesellschaft(Max Planck Society); American Cancer Society(American Cancer Society)	This work was supported by funds from the Max-Planck-Gesellschaft (to H.J., H.U., and A.M.) and by American Cancer Society Grant RSG-9508506-DDC and March of Dimes Grant 1-FY07-527 (to V.N.S. and S. D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.. S The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1 and S2 and Figs. S1 and S2.	Abrell S, 2000, CHROMOSOMA, V109, P334, DOI 10.1007/s004120000092; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Canudas S, 2005, NUCLEIC ACIDS RES, V33, P4857, DOI 10.1093/nar/gki776; Carrera P, 1998, P NATL ACAD SCI USA, V95, P10779, DOI 10.1073/pnas.95.18.10779; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; CHOU TB, 1992, GENETICS, V131, P643; Chou TB, 1996, GENETICS, V144, P1673; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Espinas ML, 2000, EMBO REP, V1, P253, DOI 10.1093/embo-reports/kvd046; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Faucheux M, 2003, MOL CELL BIOL, V23, P1181, DOI 10.1128/MCB.23.4.1181-1195.2003; Foglietti C, 2006, J BIOL CHEM, V281, P17968, DOI 10.1074/jbc.M511945200; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Gaul U, 1990, Adv Genet, V27, P239; Gildea JJ, 2000, GENETICS, V156, P645; Hartmann C, 1997, EMBO J, V16, P5299, DOI 10.1093/emboj/16.17.5299; HOCH M, 1991, EMBO J, V10, P2267, DOI 10.1002/j.1460-2075.1991.tb07763.x; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; Hoch M, 1998, EMBO J, V17, P5766, DOI 10.1093/emboj/17.19.5766; Huang XJ, 2001, J BIOL CHEM, V276, P12497, DOI 10.1074/jbc.C100034200; JACKLE H, 1992, J CELL SCI, P39; La Rosee-Borggreve A, 1999, MECH DEVELOP, V89, P133, DOI 10.1016/S0925-4773(99)00219-1; LaRosee A, 1997, EMBO J, V16, P4403, DOI 10.1093/emboj/16.14.4403; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; Matyash A, 2004, J BIOL CHEM, V279, P30689, DOI 10.1074/jbc.M403345200; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mottus R, 2000, GENETICS, V154, P657; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Nibu Y, 2003, MOL CELL BIOL, V23, P3990, DOI 10.1128/MCB.23.11.3990-3999.2003; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; PANKRATZ MJ, 1990, TRENDS GENET, V6, P287, DOI 10.1016/0168-9525(90)90234-W; PANKRATZ MJ, 1989, NATURE, V341, P337, DOI 10.1038/341337a0; PANKRATZ MJ, 1990, CELL, V61, P309, DOI 10.1016/0092-8674(90)90811-R; Phippen TM, 2000, J BIOL CHEM, V275, P37628, DOI 10.1074/jbc.M004234200; ROSENBERG UB, 1985, NATURE, V313, P703, DOI 10.1038/313703a0; Ryu JR, 2003, NUCLEIC ACIDS RES, V31, P4654, DOI 10.1093/nar/gkg491; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; SAUER F, 1991, NATURE, V353, P563, DOI 10.1038/353563a0; SAUER F, 1995, NATURE, V375, P162, DOI 10.1038/375162a0; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh N, 2005, DEV BIOL, V278, P242, DOI 10.1016/j.ydbio.2004.11.011; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Song CP, 2006, PLANT MOL BIOL, V60, P241, DOI 10.1007/s11103-005-3880-9; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; STRECKER TR, 1994, BIOTECH HISTOCHEM, V69, P25, DOI 10.3109/10520299409106257; Struffi P, 2005, J BIOL CHEM, V280, P40757, DOI 10.1074/jbc.M506819200; Struffi P, 2004, DEVELOPMENT, V131, P2419, DOI 10.1242/dev.01075; Subramanian T, 2003, FEBS LETT, V540, P255, DOI 10.1016/S0014-5793(03)00275-8; Tie F, 2001, DEVELOPMENT, V128, P275; Tillib S, 1999, MOL CELL BIOL, V19, P5189; Wang L, 2002, GENE, V285, P119, DOI 10.1016/S0378-1119(02)00418-3; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhu WC, 2000, GENE, V245, P329, DOI 10.1016/S0378-1119(00)00048-2; Zhu WC, 2001, DEV GENES EVOL, V211, P109, DOI 10.1007/s004270100135	66	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3012	3020		10.1074/jbc.M806163200	http://dx.doi.org/10.1074/jbc.M806163200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049982	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000262700900045
J	Scheinman, EJ; Avni, O				Scheinman, Eyal J.; Avni, Orly			Transcriptional Regulation of Gata3 in T Helper Cells by the Integrated Activities of Transcription Factors Downstream of the Interleukin-4 Receptor and T Cell Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CYTOKINE GENE-EXPRESSION; IFN-GAMMA PRODUCTION; DEVELOPING TH1 CELLS; IN-VIVO; ENFORCED EXPRESSION; TRANSGENIC MICE; IL-4 RECEPTOR; CUTTING EDGE; HISTONE ACETYLATION	GATA3 is a critical transcription factor for many developmental processes. During T helper (Th) cell differentiation, GATA3 induces the Th2 and suppresses the Th1 pathway. Stimulation of the T cell receptor (TCR) of naive Th cells in the presence of interleukin 4 (IL-4) induces robust expression of GATA3; however, it is unclear where these signals integrate. Gata3 encodes two transcripts that differ in their alternative, untranslated first exons. We show here the involvement of the TCR-inducible transcription factor NFAT1 in the transcriptional regulation of both Gata3 transcripts following TCR stimulation of naive and differentiated Th2 cells. We also show that IL-4 is important for the initiation and establishment of Gata3 transcription in developing Th2 cells, especially from the distal promoter. The early function of IL-4 can be STAT6 dependent or independent. However, the establishment of the activity of the distal promoter is totally dependent on STAT6, whereas it is likely that the proximal promoter has additional activation mechanisms that are STAT6 independent. Our findings suggest that different combinations of transcription factors downstream of the IL-4 receptor (IL-4R) and TCR finely modulate Gata3 gene expression from its two promoters for optimal Th2 differentiation.	[Scheinman, Eyal J.; Avni, Orly] Technion Israel Inst Technol, Dept Immunol, Rappaport Fac Med, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Avni, O (corresponding author), Efron 1 St, IL-31096 Haifa, Israel.	oavni@tx.technion.ac.il			Israel Science Foundation [986/04]; Rappaport Family Institute for Research	Israel Science Foundation(Israel Science Foundation); Rappaport Family Institute for Research	This work was supported by Israel Science Foundation Grant 986/04 and the Rappaport Family Institute for Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Anderson MK, 2002, DEV BIOL, V246, P103, DOI 10.1006/dbio.2002.0674; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Benson RA, 2005, EUR J IMMUNOL, V35, P859, DOI 10.1002/eji.200425562; Bouchard MF, 2005, ENDOCRINOLOGY, V146, P4905, DOI 10.1210/en.2005-0187; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chen CH, 2000, J IMMUNOL, V165, P5597, DOI 10.4049/jimmunol.165.10.5597; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; CORRY DB, 1994, J IMMUNOL, V153, P4142; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Ferber IA, 1999, CLIN IMMUNOL, V91, P134, DOI 10.1006/clim.1999.4718; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Gregoire JM, 1999, J BIOL CHEM, V274, P6567, DOI 10.1074/jbc.274.10.6567; Gulbinas A, 2006, J HISTOCHEM CYTOCHEM, V54, P161, DOI 10.1369/jhc.5A6626.2005; Hasegawa SL, 2007, DEV BIOL, V301, P568, DOI 10.1016/j.ydbio.2006.09.030; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Ho IC, 2007, CELL MOL IMMUNOL, V4, P15; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jacob E, 2008, J BIOL CHEM, V283, P13471, DOI 10.1074/jbc.M709886200; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kim ST, 2007, P NATL ACAD SCI USA, V104, P17052, DOI 10.1073/pnas.0708293104; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kubo M, 1999, J IMMUNOL, V163, P2432; Kurata H, 2002, J IMMUNOL, V168, P4538, DOI 10.4049/jimmunol.168.9.4538; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; LABASTIE MC, 1994, GENOMICS, V21, P1, DOI 10.1006/geno.1994.1217; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Lakshmanan G, 1999, MOL CELL BIOL, V19, P1558; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lieuw KH, 1997, DEV BIOL, V188, P1, DOI 10.1006/dbio.1997.8575; LING PD, 1994, J VIROL, V68, P5375, DOI 10.1128/JVI.68.9.5375-5383.1994; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P5220; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; Nawijn MC, 2001, J IMMUNOL, V167, P724, DOI 10.4049/jimmunol.167.2.724; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; OOSTERWEGEL M, 1992, DEV IMMUNOL, V3, P1, DOI 10.1155/1992/27903; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Palmieri M, 1999, NUCLEIC ACIDS RES, V27, P2785, DOI 10.1093/nar/27.13.2785; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rulifson IC, 1997, J IMMUNOL, V158, P658; Schmitz ML, 2006, CELL DEATH DIFFER, V13, P834, DOI 10.1038/sj.cdd.4401845; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Steenbergen RDM, 2002, AM J PATHOL, V160, P1945, DOI 10.1016/S0002-9440(10)61143-1; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Taghon T, 2001, J IMMUNOL, V167, P4468, DOI 10.4049/jimmunol.167.8.4468; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tsarovina K, 2004, DEVELOPMENT, V131, P4775, DOI 10.1242/dev.01370; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van der Wees J, 2004, NEUROBIOL DIS, V16, P169, DOI 10.1016/j.nbd.2004.02.004; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Wang CD, 2001, BIOL REPROD, V65, P1437, DOI 10.1095/biolreprod65.5.1437; Wang JH, 2001, J IMMUNOL, V167, P289, DOI 10.4049/jimmunol.167.1.289; Yamagata T, 2000, EMBO J, V19, P4676, DOI 10.1093/emboj/19.17.4676; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461	100	63	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3037	3048		10.1074/jbc.M807302200	http://dx.doi.org/10.1074/jbc.M807302200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19056736	hybrid			2022-12-25	WOS:000262700900048
J	Takahata, M; Inoue, Y; Tsuda, H; Imoto, I; Koinuma, D; Hayashi, M; Ichikura, T; Yamori, T; Nagasaki, K; Yoshida, M; Matsuoka, M; Morishita, K; Yuki, K; Hanyu, A; Miyazawa, K; Inazawa, J; Miyazono, K; Imamura, T				Takahata, Mami; Inoue, Yasumichi; Tsuda, Hitoshi; Imoto, Issei; Koinuma, Daizo; Hayashi, Makoto; Ichikura, Takashi; Yamori, Takao; Nagasaki, Koichi; Yoshida, Mika; Matsuoka, Masao; Morishita, Kazuhiro; Yuki, Keiko; Hanyu, Aki; Miyazawa, Keiji; Inazawa, Johji; Miyazono, Kohei; Imamura, Takeshi			SKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-beta Signal in Gastric Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; C-SKI; SMAD PROTEINS; GENE-EXPRESSION; LEUKEMIA-CELLS; ONCOPROTEIN; BINDING; LINES; SNO; DIFFERENTIATION	Chromosomal amplification occurs frequently in solid tumors and is associated with poor prognosis. Several reports demonstrated the cooperative effects of oncogenic factors in the same amplicon during cancer development. However, the functional correlation between the factors remains unclear. Transforming growth factor (TGF)-beta signaling plays important roles in cytostasis and normal epithelium differentiation, and alterations in TGF-beta signaling have been identified in many malignancies. Here, we demonstrated that transcriptional co-repressors of TGF-beta signaling, SKI and MDS1/EVI1-like gene 1 (MEL1), were aberrantly expressed in MKN28 gastric cancer cells by chromosomal co-amplification of 1p36.32. SKI and MEL1 knockdown synergistically restored TGF-beta responsiveness in MKN28 cells and reduced tumor growth in vivo. MEL1 interacted with SKI and inhibited TGF-beta signaling by stabilizing the inactive Smad3-SKI complex on the promoter of TGF-beta target genes. These findings reveal a novel mechanism where distinct transcriptional co-repressors are co-amplified and functionally interact, and provide molecular targets for gastric cancer treatment.	[Takahata, Mami; Inoue, Yasumichi; Koinuma, Daizo; Hayashi, Makoto; Hanyu, Aki; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Div Biochem, Koto Ku, Tokyo 1358550, Japan; [Yamori, Takao] Japanese Fdn Canc Res, Div Mol Pharmacol, Ctr Canc Chemotherapy, Koto Ku, Tokyo 1358550, Japan; [Nagasaki, Koichi] Japanese Fdn Canc Res, Genome Ctr, Koto Ku, Tokyo 1358550, Japan; [Takahata, Mami; Yuki, Keiko; Miyazawa, Keiji; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Tsuda, Hitoshi] Natl Def Med Coll, Dept Basic Pathol, Tokorozawa, Saitama 3598513, Japan; [Ichikura, Takashi] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan; [Imoto, Issei; Inazawa, Johji] Tokyo Med & Dent Univ, Dept Mol Cytogenet, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Imoto, Issei; Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Yoshida, Mika; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Lab Virus Immunol, Sakyo Ku, Kyoto 6068507, Japan; [Morishita, Kazuhiro] Miyazaki Med Coll, Dept Biochem, Kiyotake, Miyazaki 8891692, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; University of Tokyo; National Defense Medical College - Japan; National Defense Medical College - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University; University of Miyazaki	Imamura, T (corresponding author), Japanese Fdn Canc Res, Inst Canc, Div Biochem, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	timamura-ind@umin.ac.jp	imoto, Issei/D-8065-2012; Imoto, Issei/AAD-5799-2020; Koinuma, Daizo/Y-8716-2018; MIYAZAWA, KEIJI/I-9713-2014	Koinuma, Daizo/0000-0001-5611-2122; Matsuoka, Masao/0000-0002-0473-754X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Vehicle Racing Commemorative Foundation, Naito Foundation,; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation, Naito Foundation,; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by KAKENHI grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the Vehicle Racing Commemorative Foundation, Naito Foundation, and Takeda Science Foundation.	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Alliston T, 2005, J BIOL CHEM, V280, P24227, DOI 10.1074/jbc.M414305200; ARIYAMA T, 1995, CANCER GENET CYTOGEN, V81, P20, DOI 10.1016/0165-4608(94)00197-9; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Collins C, 2001, GENOME RES, V11, P1034, DOI 10.1101/gr.GR1743R; Dan S, 2002, CANCER RES, V62, P1139; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Ebisawa T, 1999, J CELL SCI, V112, P3519; Fukuchi M, 2004, INT J CANCER, V108, P818, DOI 10.1002/ijc.11651; FUMAGALLI S, 1993, MELANOMA RES, V3, P23, DOI 10.1097/00008390-199304000-00004; Imoto I, 2001, BIOCHEM BIOPH RES CO, V286, P559, DOI 10.1006/bbrc.2001.5428; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Korchynskyi O, 1999, INT J CANCER, V82, P197, DOI 10.1002/(SICI)1097-0215(19990719)82:2<197::AID-IJC8>3.0.CO;2-V; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Nagata M, 2006, GENES CELLS, V11, P1267, DOI 10.1111/j.1365-2443.2006.01018.x; Nishihara A, 1999, J BIOL CHEM, V274, P28716, DOI 10.1074/jbc.274.40.28716; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; PEARSONWHITE S, 1993, NUCLEIC ACIDS RES, V21, P4632, DOI 10.1093/nar/21.19.4632; PearsonWhite S, 1997, NUCLEIC ACIDS RES, V25, P2930, DOI 10.1093/nar/25.14.2930; Reed JA, 2001, CANCER RES, V61, P8074; Sakakura C, 1999, GENE CHROMOSOME CANC, V24, P299, DOI 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; STAVNEZER E, 1989, MOL CELL BIOL, V9, P4038, DOI 10.1128/MCB.9.9.4038; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Suzuki H, 2004, ONCOGENE, V23, P5068, DOI 10.1038/sj.onc.1207690; Takada H, 2005, CANCER SCI, V96, P100, DOI 10.1111/j.1349-7006.2005.00016.x; Warner DR, 2007, BBA-MOL CELL RES, V1773, P814, DOI 10.1016/j.bbamcr.2007.03.016; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Xiangming C, 2001, CLIN CANCER RES, V7, P277; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Yoshida M, 2004, BLOOD, V103, P2753, DOI 10.1182/blood-2003-07-2482; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	46	63	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3334	3344		10.1074/jbc.M808989200	http://dx.doi.org/10.1074/jbc.M808989200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049980	hybrid			2022-12-25	WOS:000262700900076
J	Vararattanavech, A; Lin, X; Torres, J; Tan, SM				Vararattanavech, Ardcharaporn; Lin, Xin; Torres, Jaume; Tan, Suet-Mien			Disruption of the Integrin alpha L beta 2 Transmembrane Domain Interface by beta 2 Thr-686 Mutation Activates alpha L beta 2 and Promotes Micro-clustering of the alpha L Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE-3; RECEPTOR LATERAL MOBILITY; RESONANCE ENERGY-TRANSFER; EXTENDED CONFORMATIONS; MONOCLONAL-ANTIBODIES; CYTOPLASMIC DOMAINS; SIGNAL-TRANSDUCTION; BETA(2) SUBUNIT; CELL-ADHESION; LFA-1	Integrins are type I heterodimeric cell adhesion molecules that mediate a wide array of biological processes. Integrin bidirectional signaling allows communication between the cell interior with its microenvironment. The integrin transmembrane domains (TMs) are the transducers of activation signal that is relayed from the cytoplasmic domains to the distal ligand binding site located in the ectodomain of the integrin and vice versa. In this study, we showed that the disruption of the alpha L beta 2 TMs by mutation of a key interface residue Thr-686 in the beta 2 TM promoted alpha L beta 2 activation with ICAMs binding properties that are reminiscent of an intermediate affinity receptor. The activated alpha L beta 2 TM mutants, however, showed minimal reactivity with the reporter mAb KIM127 that recognizes a highly extended alpha L beta 2. Two models of alpha L beta 2 TM interaction were proposed previously. One with GXXXG-type interaction, and another that is based on TM cysteine-scanning analyses. Our data are consistent with a GXXXG-type interaction of the alpha L beta 2 TMs. Finally, we observed by FRET analyses that perturbation of the alpha L beta 2 TMs by beta 2 Thr-686 mutation facilitated alpha L microcluster formation. This was diminished by linking the alpha L beta 2 TMs with a disulfide bond, which served to clasp the TMs. These data suggest that disruption of the TM interface changes alpha L beta 2 ligand binding affinity, and it may contribute to alpha L micro-cluster formation.	[Vararattanavech, Ardcharaporn; Lin, Xin; Torres, Jaume; Tan, Suet-Mien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	smtan@ntu.edu.sg	Torres, Jaume/AAJ-4510-2020; Tan, Suet/A-2224-2011; Torres, Jaume/A-2179-2011	Torres, Jaume/0000-0002-1282-9727; Tan, Suet-Mien/0000-0003-2371-8739	Singapore Agency for Science, Technology, and Research (A*STAR) [04/1/22/19/358, 03/1/22/19/238]	Singapore Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by Singapore Agency for Science, Technology, and Research (A*STAR) BMRC Grant 04/1/22/19/358. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by A*STAR BMRC Grant 03/1/22/19/238.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Al-Shamkhani A, 1998, EUR J IMMUNOL, V28, P3291, DOI 10.1002/(SICI)1521-4141(199810)28:10<3291::AID-IMMU3291>3.0.CO;2-E; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Barclay A. N., 1997, LEUCOCYTE ANTIGEN FA, V2nd; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Cairo CW, 2008, BIOPOLYMERS, V89, P409, DOI 10.1002/bip.20898; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fu G, 2006, BIOCHEM BIOPH RES CO, V351, P847, DOI 10.1016/j.bbrc.2006.10.127; Gottschalk KE, 2005, STRUCTURE, V13, P703, DOI 10.1016/j.str.2005.02.014; Gottschalk KE, 2002, PROTEIN SCI, V11, P1800, DOI 10.1110/ps.4120102; HILDRETH JEK, 1985, J IMMUNOL, V134, P3272; Huang CC, 1997, P NATL ACAD SCI USA, V94, P3162, DOI 10.1073/pnas.94.7.3162; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Li YF, 2007, J BIOL CHEM, V282, P24310, DOI 10.1074/jbc.M701860200; Lin X, 2006, PROTEINS, V65, P274, DOI 10.1002/prot.21072; Liu SC, 2000, J CELL SCI, V113, P3563; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Nurmi SM, 2007, J BIOL CHEM, V282, P968, DOI 10.1074/jbc.M608524200; Parthasarathy K, 2008, PROTEIN SCI, V17, P930, DOI 10.1110/ps.073234208; Poloni F, 2001, EUR J IMMUNOL, V31, P57, DOI 10.1002/1521-4141(200101)31:1<57::AID-IMMU57>3.0.CO;2-9; Reichardt P, 2007, IMMUNOL REV, V218, P165, DOI 10.1111/j.1600-065X.2007.00526.x; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Shi ML, 2007, J BIOL CHEM, V282, P30198, DOI 10.1074/jbc.M701670200; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Stephens P, 1995, CELL ADHES COMMUN, V3, P375, DOI 10.3109/15419069509081292; Suzuki J, 2007, BLOOD, V109, P168, DOI 10.1182/blood-2005-12-020164; Tan SM, 2000, J IMMUNOL, V165, P2574, DOI 10.4049/jimmunol.165.5.2574; Tang ML, 2006, BIOCHEM BIOPH RES CO, V348, P1184, DOI 10.1016/j.bbrc.2006.07.179; Tang RH, 2005, J BIOL CHEM, V280, P29208, DOI 10.1074/jbc.M503239200; Tang XY, 2008, J IMMUNOL, V180, P4793, DOI 10.4049/jimmunol.180.7.4793; Vararattanavech A, 2008, BIOCHEM J, V410, P495, DOI 10.1042/BJ20071218; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; Xu Y, 2002, MOL BIOL CELL, V13, P3493, DOI 10.1091/mbc.E02-01-0004; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	61	14	14	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3239	3249		10.1074/jbc.M802782200	http://dx.doi.org/10.1074/jbc.M802782200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029120	hybrid			2022-12-25	WOS:000262700900067
J	Ludwig, M; Schubert, T; Zebger, I; Wisitruangsakul, N; Saggu, M; Strack, A; Lenz, O; Hildebrandt, P; Friedrich, B				Ludwig, Marcus; Schubert, Torsten; Zebger, Ingo; Wisitruangsakul, Nattawadee; Saggu, Miguel; Strack, Angelika; Lenz, Oliver; Hildebrandt, Peter; Friedrich, Baerbel			Concerted Action of Two Novel Auxiliary Proteins in Assembly of the Active Site in a Membrane-bound [NiFe] Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RALSTONIA-EUTROPHA H16; IRON-SULFUR CLUSTERS; HYP GENE-PRODUCTS; ALCALIGENES-EUTROPHUS; ESCHERICHIA-COLI; CARBON-MONOXIDE; FE HYDROGENASE; THIOCAPSA-ROSEOPERSICINA; RHIZOBIUM-LEGUMINOSARUM; BINDING PROTEIN	[NiFe] hydrogenases catalyze the reversible conversion of H-2 into protons and electrons. The reaction takes place at the active site, which is composed of a nickel and an iron atom and three diatomic ligands, two cyanides and one carbon monoxide, bound to the iron. The NiFe(CN-)(2)CO cofactor is synthesized by an intricate posttranslational maturation process, which is mediated by a set of six conserved Hyp proteins. Depending on the cellular location and the physiological function, additional auxiliary proteins are involved in hydrogenase biosynthesis. Here we present evidence that the auxiliary proteins HoxL and HoxV assist in assembly of the Fe(CN-)(2)CO moiety. This unit was identified as a cofactor intermediate of the oxygen-tolerant membrane-bound [NiFe] hydrogenase (MBH) in the beta-proteobacterium Ralstonia eutropha H16. Both HoxL and HoxV proved to be essential for H-2-oxidizing activity and MBH-driven growth on H-2. Copurification studies revealed that HoxL and HoxV directly interact with the hydrogenase apoprotein. HoxV forms complexes with HoxL and HypC, a HoxL paralogue that is essential for cofactor assembly. These observations suggest that HoxL acts as a specific chaperone assisting the transfer of the Fe(CN-)(2)CO cofactor intermediate from the Hyp machinery to the MBH. This shuttle also involves the scaffold protein HoxV. Indeed, infrared spectroscopy and metal analysis identified for the first time a non-redox-active Fe(CN-)(2)CO intermediate coordinated to HoxV.	[Ludwig, Marcus; Schubert, Torsten; Strack, Angelika; Lenz, Oliver; Friedrich, Baerbel] Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany; [Zebger, Ingo; Wisitruangsakul, Nattawadee; Saggu, Miguel; Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany	Humboldt University of Berlin; Technical University of Berlin	Friedrich, B (corresponding author), Humboldt Univ, Inst Biol Mikrobiol, Chausseestr 117, D-10115 Berlin, Germany.	baerbel.friedrich@cms.hu-berlin.de	Lenz, Oliver/N-5130-2019; Hildebrandt, Peter/J-5658-2014; Lenz, Oliver/C-1582-2019; Saggu, Miguel/B-1224-2009; Schubert, Torsten/ABG-5468-2020; Schubert, Torsten/N-2457-2016	Lenz, Oliver/0000-0003-4550-5128; Hildebrandt, Peter/0000-0003-1030-5900; Lenz, Oliver/0000-0003-4550-5128; Schubert, Torsten/0000-0002-6569-1194; Schubert, Torsten/0000-0002-6569-1194	Deutsche Forschungsgemeinschaft [Sfb498]; Cluster of Excellence; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant Sfb498 and the Cluster of Excellence "Unifying Concepts in Catalysis" and the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; Bernhard M, 1996, J BACTERIOL, V178, P4522, DOI 10.1128/jb.178.15.4522-4529.1996; Blokesch M, 2001, J BACTERIOL, V183, P2817, DOI 10.1128/JB.183.9.2817-2822.2001; Blokesch M, 2002, J MOL BIOL, V324, P287, DOI 10.1016/S0022-2836(02)01070-7; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buhrke T, 2005, J BIOL CHEM, V280, P19488, DOI 10.1074/jbc.M500601200; Buhrke T, 2001, J BACTERIOL, V183, P7087, DOI 10.1128/JB.183.24.7087-7093.2001; Cammack R., 2001, HYDROGEN FUEL LEARNI; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; DeLacey AL, 2003, J BIOL INORG CHEM, V8, P129, DOI 10.1007/s00775-002-0397-4; Dernedde J, 1996, EUR J BIOCHEM, V235, P351, DOI 10.1111/j.1432-1033.1996.00351.x; Fichtner C, 2006, BIOCHEMISTRY-US, V45, P9706, DOI 10.1021/bi0602462; Fodor BD, 2004, APPL ENVIRON MICROB, V70, P712, DOI 10.1128/AEM.70.2.712-721.2004; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; FRIEDRICH B, 1993, ANNU REV MICROBIOL, V47, P351, DOI 10.1146/annurev.mi.47.100193.002031; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; HENNESSY DJ, 1984, CAN J CHEM, V62, P721, DOI 10.1139/v84-121; IMPERIAL J, 1993, MOL MICROBIOL, V9, P1305, DOI 10.1111/j.1365-2958.1993.tb01260.x; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Kennedy DC, 2007, J AM CHEM SOC, V129, P16, DOI 10.1021/ja066958x; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Kleihues L, 2000, J BACTERIOL, V182, P2716, DOI 10.1128/JB.182.10.2716-2724.2000; KNUTTEL K, 1994, B POL ACAD SCI-CHEM, V42, P495; KORTLUKE C, 1992, J BACTERIOL, V174, P6277; Kovacs AT, 2005, J BACTERIOL, V187, P2618, DOI 10.1128/JB.187.8.2618-2627.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leach MR, 2007, CURR OPIN CHEM BIOL, V11, P159, DOI 10.1016/j.cbpa.2007.01.011; Lenz O, 2002, J MOL MICROB BIOTECH, V4, P255; LENZ O, 1994, J BACTERIOL, V176, P4385, DOI 10.1128/jb.176.14.4385-4393.1994; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Liaw WF, 2002, J AM CHEM SOC, V124, P1680, DOI 10.1021/ja011504f; Loscher S, 2005, FEBS LETT, V579, P4287, DOI 10.1016/j.febslet.2005.06.063; Magalon A, 2000, J BIOL CHEM, V275, P21114, DOI 10.1074/jbc.M000987200; Maier T, 1996, BIOCHEMISTRY-US, V35, P10089, DOI 10.1021/bi960567l; Maroti G, 2003, EUR J BIOCHEM, V270, P2218, DOI 10.1046/j.1432-1033.2003.03589.x; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; Miller J.H., 1972, EXPT MOL GENETICS; Olson JW, 2000, J BACTERIOL, V182, P1702, DOI 10.1128/JB.182.6.1702-1705.2000; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; REY L, 1994, J BACTERIOL, V176, P6066, DOI 10.1128/jb.176.19.6066-6073.1994; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; SCHNEIDER K, 1983, BIOCHIM BIOPHYS ACTA, V748, P353, DOI 10.1016/0167-4838(83)90179-6; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; Schwartz E, 2003, J MOL BIOL, V332, P369, DOI 10.1016/S0022-2836(03)00894-5; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Soboh B, 2006, J BIOL CHEM, V281, P36701, DOI 10.1074/jbc.M606820200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Winter G, 2004, ARCH MICROBIOL, V182, P138, DOI 10.1007/s00203-004-0680-6; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	68	43	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2159	2168		10.1074/jbc.M808488200	http://dx.doi.org/10.1074/jbc.M808488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017638	hybrid			2022-12-25	WOS:000262545600025
J	Rhode, S; Grurl, R; Brameshuber, M; Hermetter, A; Schutz, GJ				Rhode, Sebastian; Grurl, Reinhard; Brameshuber, Mario; Hermetter, Albin; Schuetz, Gerhard J.			Plasma Membrane Fluidity Affects Transient Immobilization of Oxidized Phospholipids in Endocytotic Sites for Subsequent Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR CLASS-B; SCAVENGER RECEPTOR; SR-BI; SELECTIVE UPTAKE; LIPID-BILAYERS; CELLS; CHOLESTEROL; IDENTIFICATION; LIPOPROTEINS; ACTIVATION	Oxidized phospholipids in serum initiate severe pathophysiological responses during the process of atherogenesis. On the cellular level it is known that these lipids induce apoptosis; however, the uptake mechanism remains enigmatic. We investigated here the behavior of the fluorescent oxidized phospholipid 1-palmitoyl-2-glutaroyl-sn-glycero-3-phospho-N-Alexa647-ethanolamine (PGPE-Alexa647) in the plasma membrane of various cell lines. The probe was taken up by the cells unspecifically via caveolae or clathrin-coated pits. Interestingly, we found the uptake to be facilitated by the overexpression of the scavenger receptor class B type I. Ultra-sensitive microscopy allowed us to follow the uptake process at the single molecule level; we observed rapid diffusion of PGPE-Alexa647 in the plasma membrane, interrupted by transient halts with duration of similar to 0.9 s at endocytotic sites. Scavenger receptor class B type I overexpression yielded a pronounced increase in the single molecule mobility, and in consequence an increased frequency of immobilization. Alternatively, the plasma membrane fluidity could also be increased by treating cells with high levels of the unlabeled oxidized phospholipid 1- palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine; also in this case, the immobilization frequency of PGPE-Alexa647 was concomitantly increased. The data demonstrate the relevance of plasma membrane properties for uptake of oxidized phospholipids, and indicate a novel indirect mechanism for the control of endocytosis.	[Rhode, Sebastian; Grurl, Reinhard; Brameshuber, Mario; Schuetz, Gerhard J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Hermetter, Albin] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	Johannes Kepler University Linz; Graz University of Technology	Schutz, GJ (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	gerhard.schuetz@jku.at	Schuetz, Gerhard/B-1243-2008	Schuetz, Gerhard/0000-0003-1542-1089; Brameshuber, Mario/0000-0001-8672-2255	Austrian Research Funds [P15053, Y250-B10, P14714-PHA, F30-B05]; Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF) [F 3006, Y 250] Funding Source: researchfish	Austrian Research Funds(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Research Funds Project Numbers P15053, Y250-B10, P14714-PHA, and F30-B05 (SFB-Lipotox) and by the GEN-AU Project of the Austrian Federal Ministry for Science and Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Burns AR, 2005, BIOPHYS J, V89, P1081, DOI 10.1529/biophysj.105.060327; Calvo D, 1998, J LIPID RES, V39, P777; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; Deigner HP, 2008, CURR OPIN LIPIDOL, V19, P289, DOI 10.1097/MOL.0b013e3282fe1d0e; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Frank PG, 2002, BIOCHEMISTRY-US, V41, P11931, DOI 10.1021/bi0257078; Fureder-Kitzmuller E, 2005, CHEM PHYS LETT, V404, P13, DOI 10.1016/j.cplett.2005.01.053; GALLA HJ, 1979, J MEMBRANE BIOL, V48, P215, DOI 10.1007/BF01872892; Ghosh PK, 2002, NAT CELL BIOL, V4, P894, DOI 10.1038/ncb873; Graf GA, 1999, J BIOL CHEM, V274, P12043, DOI 10.1074/jbc.274.17.12043; Graf GA, 1999, TRENDS CARDIOVAS MED, V9, P221, DOI 10.1016/S1050-1738(00)00031-1; Grunfelder CG, 2003, MOL BIOL CELL, V14, P2029, DOI 10.1091/mbc.E02-10-0640; Hazen SL, 2002, P NATL ACAD SCI USA, V99, P12515, DOI 10.1073/pnas.212532799; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kogure K, 2003, CHEM PHYS LIPIDS, V126, P29, DOI 10.1016/S0009-3084(03)00091-4; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Krieger M, 1998, P NATL ACAD SCI USA, V95, P4077, DOI 10.1073/pnas.95.8.4077; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Liu CH, 1997, BIOPHYS J, V73, P2580, DOI 10.1016/S0006-3495(97)78287-0; Loidl A, 2004, BBA-MOL BASIS DIS, V1690, P150, DOI 10.1016/j.bbadis.2004.06.003; Loidl A, 2003, J BIOL CHEM, V278, P32921, DOI 10.1074/jbc.M306088200; Matveev S, 1999, J LIPID RES, V40, P1647; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mortelmaier M, 2002, SINGLE MOL, V3, P225, DOI 10.1002/1438-5171(200208)3:4<225::AID-SIMO225>3.0.CO;2-K; Moumtzi A, 2007, J LIPID RES, V48, P565, DOI 10.1194/jlr.M600394-JLR200; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Parathath S, 2004, J BIOL CHEM, V279, P41310, DOI 10.1074/jbc.M404952200; Sampaio JL, 2005, BIOPHYS J, V88, P4064, DOI 10.1529/biophysj.104.054007; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stangl H, 1999, J BIOL CHEM, V274, P32692, DOI 10.1074/jbc.274.46.32692; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Subbanagounder G, 2000, FREE RADICAL BIO MED, V28, P1751, DOI 10.1016/S0891-5849(00)00233-1; Swarnakar S, 1999, J BIOL CHEM, V274, P29733, DOI 10.1074/jbc.274.42.29733; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; WATSON AD, 1995, J CLIN INVEST, V95, P774, DOI 10.1172/JCI117726; Williams DL, 2002, J LIPID RES, V43, P544	44	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2258	2265		10.1074/jbc.M807591200	http://dx.doi.org/10.1074/jbc.M807591200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19043088	hybrid			2022-12-25	WOS:000262545600035
J	Li, YJ; Lu, J; Prochownik, EV				Li, Youjun; Lu, Jie; Prochownik, Edward V.			Modularity of the Oncoprotein-like Properties of Platelet Glycoprotein Ib alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; VON-WILLEBRAND-FACTOR; IX-V COMPLEX; C-MYC TARGET; GENOMIC INSTABILITY; PLASMA-MEMBRANE; GPIB-ALPHA; EXPRESSION; PROLIFERATION; FILAMIN	Glycoprotein Ib alpha(GpIb alpha), a trans-membrane glycoprotein, is expressed on the surface of megakaryocytes and platelets, where, in association with glycoprotein Ib beta, glycoprotein V, and glycoprotein IX, it normally forms the von Willebrand factor receptor (vWFR). A fully functional vWFR is necessary for platelet attachment, aggregation, and activation and has also been shown to regulate megakaryocyte ploidy. We have recently shown that the gene encoding GpIb alpha is a transcriptional target for the c-Myc oncoprotein and is more widely expressed than previously thought, with particularly high levels occurring in transformed cells. Indeed, GpIb alpha can substitute for c-Myc in promoting growth, transformation, and genomic instability. In the current work, we have demonstrated that, despite the promiscuous expression of GpIb alpha, other vWFR subunits remain largely restricted to megakaryocytes. We have characterized a panel of GpIb alpha mutants and shown that some regions of the protein essential for vWFR activity are not necessary for c-Myc-like functions. Specifically, the six C-terminal amino acids of the cytoplasmic domain, which mediate vWFR signaling, are entirely dispensible for the c-Myc-like functions of GpIb alpha. Instead, these require a more membrane-proximal filamin-binding domain. Also important is the GpIb alpha signal peptide, which, in the absence of other vWFR subunits, directs GpIb alpha to the endoplasmic reticulum rather than the membrane. Together, these results provide strong evidence that the domains of GpIb alpha mediating c-Myc-like functions are modular, genetically distinct, and independent of those involved in vWFR signaling.	[Prochownik, Edward V.] Childrens Hosp Pittsburgh, Hematol Oncol Sect, Rangos Res Ctr, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Childrens Hosp Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Ctr Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), Childrens Hosp Pittsburgh, Hematol Oncol Sect, Rangos Res Ctr, Rm 8125,3460 5th Ave, Pittsburgh, PA 15213 USA.	procev@chp.edu			National Institutes of Health [CA105033, CA078259]; Children's Hospital of Pittsburgh Research Advisory Committee; NATIONAL CANCER INSTITUTE [R01CA078259, R01CA105033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh Research Advisory Committee; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105033 and CA078259 (to E.V.P.). This work was also supported by a postdoctoral fellowship award from the Children's Hospital of Pittsburgh Research Advisory Committee (to Y.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beckman RA, 2005, SEMIN CANCER BIOL, V15, P423, DOI 10.1016/j.semcancer.2005.06.007; Berndt MC, 2001, THROMB HAEMOSTASIS, V86, P178; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Canobbio H, 2004, CELL SIGNAL, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Dai KS, 2005, BLOOD, V106, P1975, DOI 10.1182/blood-2005-01-0440; Dong JF, 1998, J BIOL CHEM, V273, P31449, DOI 10.1074/jbc.273.47.31449; Feng S, 1999, BLOOD, V93, P4256, DOI 10.1182/blood.V93.12.4256.412k33_4256_4263; Feng SJ, 2005, J BIOL CHEM, V280, P6709, DOI 10.1074/jbc.M413590200; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Geddis AE, 2001, J BIOL CHEM, V276, P34473, DOI 10.1074/jbc.M105178200; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; HUNZIKER W, 1992, FEBS LETT, V307, P93, DOI 10.1016/0014-5793(92)80908-Y; Kanaji T, 2004, BLOOD, V104, P3161, DOI 10.1182/blood-2004-03-0893; KONKLE BA, 1990, J BIOL CHEM, V265, P19833; Li Y, 2008, ONCOGENE, V27, P1599, DOI 10.1038/sj.onc.1210794; Li YJ, 2007, P NATL ACAD SCI USA, V104, P3490, DOI 10.1073/pnas.0610163104; LOPEZ JA, 1992, J BIOL CHEM, V267, P12851; LOPEZ JA, 1994, BLOOD COAGUL FIBRIN, V5, P97; LOPEZ JA, 1992, J BIOL CHEM, V267, P10055; Luo SZ, 2007, BLOOD, V109, P603, DOI 10.1182/blood-2006-05-024091; Miyazawa KEISUKE, 2000, Hematology, V5, P233; Mo X, 2006, J BIOL CHEM, V281, P23050, DOI 10.1074/jbc.M600924200; Monteiro MR, 1999, J INVEST DERMATOL, V113, P272, DOI 10.1046/j.1523-1747.1999.00665.x; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Oleksowicz L, 1997, EXP CELL RES, V237, P110, DOI 10.1006/excr.1997.3784; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Rogulski KR, 2005, P NATL ACAD SCI USA, V102, P18968, DOI 10.1073/pnas.0507902102; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Strassel C, 2003, BIOCHEMISTRY-US, V42, P4452, DOI 10.1021/bi026213d; Ulsemer P, 2001, BIOCHEM J, V358, P295, DOI 10.1042/0264-6021:3580295; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wu Y, 2003, BLOOD, V101, P3469, DOI 10.1182/blood-2002-03-0806; Yin H, 2008, BLOOD, V111, P658, DOI 10.1182/blood-2007-04-085514; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200; Yin XY, 2001, CANCER RES, V61, P6487; Yin XY, 2001, ONCOGENE, V20, P4650, DOI 10.1038/sj.onc.1204606	44	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1410	1418		10.1074/jbc.M806222200	http://dx.doi.org/10.1074/jbc.M806222200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017648	Green Published, hybrid			2022-12-25	WOS:000262330100008
J	Schottkowski, M; Gkalympoudis, S; Tzekova, N; Stelljes, C; Schunemann, D; Ankele, E; Nickelsen, J				Schottkowski, Marco; Gkalympoudis, Stephanie; Tzekova, Nevena; Stelljes, Christian; Schuenemann, Danja; Ankele, Elisabeth; Nickelsen, Joerg			Interaction of the Periplasmic PratA Factor and the PsbA (D1) Protein during Biogenesis of Photosystem II in Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; TERMINAL EXTENSION; CRYSTAL-STRUCTURE; MEMBRANE; COMPLEXES; PRECURSOR; REPAIR; ACCUMULATION; PCC-6803; HOMOLOG	The biogenesis of photosynthetic complexes is assisted by a growing number of trans-acting factors in both chloroplasts and cyanobacteria. We have previously shown that the periplasmic PratA factor from Synechocystis sp. PCC 6803 (Synechocystis 6803) is required for adequate C-terminal processing of the PsbA (D1) subunit of photosystem II (PSII) supporting the idea that the early steps of PSII assembly occur at the plasma membrane. Here we report on the molecular analysis of the interaction between PratA and the D1 protein. Both yeast two-hybrid and glutathione S-transferase pull-down assays revealed that PratA binds to the soluble forms of both mature and precursor D1 C-terminal regions. In agreement with that finding, the binding region was mapped to amino acid positions 314-328 of D1 by applying a peptide-scanning approach. Approximately 10-20% of the soluble PratA factor was found to be associated with membranes in a D1-dependent manner. Sucrose density gradient centrifugations allowed the identification of a specific membrane subfraction that contains both PratA and D1 and which might represent a transfer and/or connecting region between plasma and thylakoid membrane. Imaging data obtained with enhanced cyan fluorescent protein-labeled D1 protein in wild-type and pratA mutant backgrounds further supported this notion.	[Schottkowski, Marco; Gkalympoudis, Stephanie; Tzekova, Nevena; Stelljes, Christian; Ankele, Elisabeth; Nickelsen, Joerg] Biozentrum LMU Munchen, D-82152 Planegg Martinsried, Germany; [Schuenemann, Danja] Ruhr Univ Bochum, LS Allgemeine & Mol Bot, D-44780 Bochum, Germany	University of Munich; Ruhr University Bochum	Nickelsen, J (corresponding author), Biozentrum LMU Munchen, Univ Str 150, D-82152 Planegg Martinsried, Germany.	joerg.nickelsen@lrz.uni-muenchen.de	Nickelsen, Jörg/J-8896-2014	Schuenemann, Danja/0000-0001-8894-7685; Nickelsen, Joerg/0000-0003-4184-4560				Bergantino E, 2003, J BIOL CHEM, V278, P41820, DOI 10.1074/jbc.M303096200; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; Duhring U, 2006, BBA-BIOENERGETICS, V1757, P3, DOI 10.1016/j.bbabio.2005.11.001; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Inagaki N, 2001, FEBS LETT, V509, P197, DOI 10.1016/S0014-5793(01)03180-5; Ivleva NB, 2000, PLANT PHYSIOL, V124, P1403, DOI 10.1104/pp.124.3.1403; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Keren N, 2005, PLANT CELL, V17, P2768, DOI 10.1105/tpc.105.035048; Keren N, 2005, J BIOL CHEM, V280, P6548, DOI 10.1074/jbc.M410218200; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Komenda J, 2005, PLANT CELL PHYSIOL, V46, P1477, DOI 10.1093/pcp/pci159; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Komenda J, 2007, BBA-BIOENERGETICS, V1767, P829, DOI 10.1016/j.bbabio.2007.01.005; Kuvikova S, 2005, PHOTOCH PHOTOBIO SCI, V4, P1044, DOI 10.1039/b506059a; Liberton M, 2006, PROTOPLASMA, V227, P129, DOI 10.1007/s00709-006-0145-7; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; Nickelsen Jorg, 2007, V68, P57, DOI 10.1007/978-3-540-36832-8_3; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10589; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Ossenbuhl F, 2006, PLANT CELL, V18, P2236, DOI 10.1105/tpc.106.043646; Pasch JC, 2005, APPL MICROBIOL BIOT, V69, P440, DOI 10.1007/s00253-005-0029-3; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; Reineke U, 1999, CURR TOP MICROBIOL, V243, P23; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Srivastava R, 2006, ARCH MICROBIOL, V185, P238, DOI 10.1007/s00203-006-0086-8; Uniacke J, 2007, PLANT CELL, V19, P3640, DOI 10.1105/tpc.107.054882; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zinchenko VV, 1999, RUSS J GENET+, V35, P228; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	36	55	58	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1813	1819		10.1074/jbc.M806116200	http://dx.doi.org/10.1074/jbc.M806116200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017636	hybrid			2022-12-25	WOS:000262330100052
J	Schroder, R; Merten, N; Mathiesen, JM; Martini, L; Kruljac-Letunic, A; Krop, F; Blaukat, A; Fang, Y; Tran, E; Ulven, T; Drewke, C; Whistler, J; Pardo, L; Gomeza, J; Kostenis, E				Schroeder, Ralf; Merten, Nicole; Mathiesen, Jesper Mosolff; Martini, Lene; Kruljac-Letunic, Anamarija; Krop, Friederike; Blaukat, Andree; Fang, Ye; Tran, Elizabeth; Ulven, Trond; Drewke, Christel; Whistler, Jennifer; Pardo, Leonardo; Gomeza, Jesus; Kostenis, Evi			The C-terminal Tail of CRTH2 Is a Key Molecular Determinant That Constrains G alpha(i) and Downstream Signaling Cascade Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; PROSTAGLANDIN D-2; ALLERGIC INFLAMMATION; AIRWAY INFLAMMATION; CRYSTAL-STRUCTURE; BETA-ARRESTINS; BETA(1)-ADRENERGIC RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; BRADYKININ RECEPTOR	Prostaglandin D-2 activation of the seven-transmembrane receptor CRTH2 regulates numerous cell functions that are important in inflammatory diseases, such as asthma. Despite its disease implication, no studies to date aimed at identifying receptor domains governing signaling and surface expression of human CRTH2. We tested the hypothesis that CRTH2 may take advantage of its C-tail to silence its own signaling and that this mechanism may explain the poor functional responses observed with CRTH2 in heterologous expression systems. Although the C terminus is a critical determinant for retention of CRTH2 at the plasma membrane, the presence of this domain confers a signaling-compromised conformation onto the receptor. Indeed, a mutant receptor lacking the major portion of its C-terminal tail displays paradoxically enhanced G alpha(i) and ERK1/2 activation despite enhanced constitutive and agonist-mediated internalization. Enhanced activation of G alpha(i) proteins and downstream signaling cascades is probably due to the inability of the tail-truncated receptor to recruit beta-arrestin2 and undergo homologous desensitization. Unexpectedly, CRTH2 is not phosphorylated upon agonist-stimulation, a primary mechanism by which GPCR activity is regulated. Dynamic mass redistribution assays, which allow label-free monitoring of all major G protein pathways in real time, confirm that the C terminus inhibits G alpha(i) signaling of CRTH2 but does not encode G protein specificity determinants. We propose that intrinsic CRTH2 inhibition by its C terminus may represent a rather unappreciated strategy employed by a GPCR to specify the extent of G protein activation and that this mechanism may compensate for the absence of the classical phosphorylation-dependent signal attenuation.	[Kostenis, Evi] Univ Bonn, Dept Mol Cellular & Pharmacobiol, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Mathiesen, Jesper Mosolff] Zealand Pharma AS, Dept Mol Pharmacol, DK-2600 Glostrup, Denmark; [Martini, Lene; Whistler, Jennifer] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Kruljac-Letunic, Anamarija; Krop, Friederike; Blaukat, Andree] Merck KGaA, Merck Serono Res, TA Oncol, D-64293 Darmstadt, Germany; [Fang, Ye; Tran, Elizabeth] Corning Inc, Div Sci & Technol, Biochem Technol, New York, NY 14831 USA; [Schroeder, Ralf; Merten, Nicole; Ulven, Trond] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense, Denmark; [Pardo, Leonardo] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Spain	University of Bonn; Zealand Pharma A/S; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Merck KGaA; EMD Serono Inc.; Corning Inc; State University of New York (SUNY) System; SUNY Community College; University of Southern Denmark; Autonomous University of Barcelona	Kostenis, E (corresponding author), Univ Bonn, Dept Mol Cellular & Pharmacobiol, Inst Pharmaceut Biol, Nussallee 6, D-53115 Bonn, Germany.	kostenis@uni-bonn.de	/B-1341-2009; Ulven, Trond/H-5500-2015	Ulven, Trond/0000-0002-8135-1755; Fang, Ye/0000-0002-1322-7365; Pardo, Leonardo/0000-0003-1778-7420; Mathiesen, Jesper Mosolff/0000-0003-4251-4416				Almishri W, 2005, J PHARMACOL EXP THER, V313, P64, DOI 10.1124/jpet.104.079079; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blaukat A, 1996, J BIOL CHEM, V271, P32366, DOI 10.1074/jbc.271.50.32366; Blaukat A, 2001, J BIOL CHEM, V276, P40431, DOI 10.1074/jbc.M107024200; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Bohm E, 2004, J BIOL CHEM, V279, P7663, DOI 10.1074/jbc.M310270200; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Budd DC, 2003, J BIOL CHEM, V278, P19565, DOI 10.1074/jbc.M211670200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Estall JL, 2005, J BIOL CHEM, V280, P22124, DOI 10.1074/jbc.M500078200; Fang Y, 2005, ANAL CHEM, V77, P5720, DOI 10.1021/ac050887n; Fang Y, 2008, COMB CHEM HIGH T SCR, V11, P357, DOI 10.2174/138620708784534789; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Hata AN, 2005, J BIOL CHEM, V280, P32442, DOI 10.1074/jbc.M502563200; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hirai K, 2001, CURR TOP MICROBIOL, V255, P261; Hoare S, 1999, J BIOL CHEM, V274, P28682, DOI 10.1074/jbc.274.40.28682; Hosoi T, 2002, J BIOL CHEM, V277, P31459, DOI 10.1074/jbc.M203194200; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kalatskaya I, 2004, J BIOL CHEM, V279, P31268, DOI 10.1074/jbc.M401796200; Kang DS, 2002, MOL PHARMACOL, V62, P281, DOI 10.1124/mol.62.2.281; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kostenis E, 2005, J PHARMACOL EXP THER, V313, P78, DOI 10.1124/jpet.104.080424; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; Kruljac-Letunic A, 2003, J BIOL CHEM, V278, P29560, DOI 10.1074/jbc.M302278200; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; Lee CJ, 2008, J THROMB HAEMOST, V6, P83; Lee KB, 2000, J BIOL CHEM, V275, P9284, DOI 10.1074/jbc.275.13.9284; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Lukacs NW, 2008, AM J PHYSIOL-LUNG C, V295, pL767, DOI 10.1152/ajplung.90351.2008; Mathiesen JM, 2006, MOL PHARMACOL, V69, P1441, DOI 10.1124/mol.105.017681; Mathiesen JM, 2005, MOL PHARMACOL, V68, P393, DOI 10.1124/mol.104.010520; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Monneret G, 2003, J PHARMACOL EXP THER, V304, P349, DOI 10.1124/jpet.102.042937; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Royer JF, 2007, ALLERGY, V62, P1401, DOI 10.1111/j.1398-9995.2007.01452.x; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; Satoh T, 2006, J IMMUNOL, V177, P2621, DOI 10.4049/jimmunol.177.4.2621; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Shichijo M, 2003, J PHARMACOL EXP THER, V307, P518, DOI 10.1124/jpet.103.055442; Shiraishi Y, 2008, J IMMUNOL, V180, P541, DOI 10.4049/jimmunol.180.1.541; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Spik I, 2005, J IMMUNOL, V174, P3703, DOI 10.4049/jimmunol.174.6.3703; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Takeshita K, 2004, INT IMMUNOL, V16, P947, DOI 10.1093/intimm/dxh096; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Uller L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-16; Ulven T, 2007, BIOORG MED CHEM LETT, V17, P5924, DOI 10.1016/j.bmcl.2007.07.080; Verzijl D, 2006, J BIOL CHEM, V281, P35327, DOI 10.1074/jbc.M606877200; WANG J, 2008, MOL BIOL RE IN PRESS; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; WESS J, 1990, MOL PHARMACOL, V38, P872; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yamamoto M, 2009, INT ARCH ALLERGY IMM, V148, P127, DOI 10.1159/000155743; Yoshimura-Uchiyama C, 2004, CLIN EXP ALLERGY, V34, P1283, DOI 10.1111/j.1365-2222.2004.02027.x	78	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1324	1336		10.1074/jbc.M806867200	http://dx.doi.org/10.1074/jbc.M806867200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010788	hybrid			2022-12-25	WOS:000262122900067
J	Schneider, H; Valk, E; Leung, R; Rudd, CE				Schneider, Helga; Valk, Elke; Leung, Rufina; Rudd, Christopher E.			CTLA-4 Activation of Phosphatidylinositol 3-Kinase (PI 3-K) and Protein Kinase B (PKB/AKT) Sustains T-Cell Anergy without Cell Death	PLOS ONE			English	Article								The balance of T-cell proliferation, anergy and apoptosis is central to immune function. In this regard, co-receptor CTLA-4 is needed for the induction of anergy and tolerance. One central question concerns the mechanism by which CTLA-4 can induce T-cell non-responsiveness without a concurrent induction of antigen induced cell death (AICD). In this study, we show that CTLA-4 activation of the phosphatidylinositol 3-kinase (PI 3-K) and protein kinase B (PKB/AKT) sustains T-cell anergy without cell death. CTLA-4 ligation induced PI 3K activation as evidenced by the phosphorylation of PKB/AKT that in turn inactivated GSK-3. The level of activation was similar to that observed with CD28. CTLA-4 induced PI 3K and AKT activation also led to phosphorylation of the pro-apoptotic factor BAD as well as the up-regulation of BcL-XL. In keeping with this, CD3/CTLA-4 co-ligation prevented apoptosis under the same conditions where T-cell non-responsiveness was induced. This effect was PI 3K and PKB/AKT dependent since inhibition of these enzymes under conditions of anti-CD3/CTLA-4 co-ligation resulted in cell death. Our findings therefore define a mechanism by which CTLA-4 can induce anergy (and possibly peripheral tolerance) by preventing the induction of cell death.	[Schneider, Helga; Valk, Elke; Rudd, Christopher E.] Univ Cambridge, Dept Pathol, Cell Signalling Sect, Cambridge CB2 1QP, England; [Schneider, Helga; Valk, Elke; Leung, Rufina; Rudd, Christopher E.] Imperial Coll London, Hammersmith Hosp, Fac Med, Div Investigative Sci, Mol Immunol Sect, London, England; [Rudd, Christopher E.] Cambridge Inst Med Res, Cambridge, England	University of Cambridge; Imperial College London; University of Cambridge	Schneider, H (corresponding author), Univ Cambridge, Dept Pathol, Cell Signalling Sect, Tennis Court Rd, Cambridge CB2 1QP, England.	cer51@cam.ac.uk	Rudd, Christopher E/GOH-2021-2022; Rudd, Christopher E/ABF-7259-2021	Rudd, Christopher E/0000-0001-5295-9019; 	Wellcome Trust; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Wellcome Trust, BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no competing financial interests.	Abbas AK, 2004, AUTOIMMUN REV, V3, P471, DOI 10.1016/j.autrev.2004.07.004; Abbas AK, 2003, AUTOIMMUN REV, V2, P115, DOI 10.1016/S1568-9972(03)00028-4; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; Bauer B, 2002, MOL IMMUNOL, V38, P1087, DOI 10.1016/S0161-5890(02)00011-1; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dias SD, 2001, BLOOD, V97, P1134, DOI 10.1182/blood.V97.4.1134; Fecteau S, 2001, NAT IMMUNOL, V2, P58, DOI 10.1038/83175; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Janssen O, 2000, INT ARCH ALLERGY IMM, V121, P183, DOI 10.1159/000024316; Kato T, 2000, J IMMUNOL, V164, P3554, DOI 10.4049/jimmunol.164.7.3554; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lin SS, 2006, J BIOL CHEM, V281, P23003, DOI 10.1074/jbc.M602648200; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1995, J EXP MED, V182, P289, DOI 10.1084/jem.182.2.289; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Pandiyan P, 2004, J EXP MED, V199, P831, DOI 10.1084/jem.20031058; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Schneider H, 2002, J IMMUNOL, V169, P3475, DOI 10.4049/jimmunol.169.7.3475; Schneider H, 1999, J IMMUNOL, V163, P1868; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zheng XG, 1998, TRANSPL P, V30, P2146, DOI 10.1016/S0041-1345(98)00568-5	36	56	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3842	10.1371/journal.pone.0003842	http://dx.doi.org/10.1371/journal.pone.0003842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052636	Green Submitted, Green Published, gold			2022-12-25	WOS:000265452200002
J	Meyer, RD; Sacks, DB; Rahimi, N				Meyer, Rosana D.; Sacks, David B.; Rahimi, Nader			IQGAP1-Dependent Signaling Pathway Regulates Endothelial Cell Proliferation and Angiogenesis	PLOS ONE			English	Article								Background: Vascular endothelial growth factor receptor-2 (VEGFR-2) signaling is an obligate requirement for normal development and pathological angiogenesis such as cancer and age-related macular degeneration. Although autophosphorylation of tyrosine 1173 (Y1173) of VEGFR-2 is considered a focal point for its angiogenic signal relay, however, the mechanism of phosphorylation of Y1173, signaling proteins that are recruited to this residue and their role in angiogenesis is not fully understood. Methodology/Principal Findings: In this study we demonstrate that c-Src kinase directly through its Src homology 2 (SH2) domain and indirectly via c-Cbl binds to phospho-Y1057 of VEGFR-2. Activation of c-Src kinase by a positive feedback mechanism phosphorylates VEGFR-2 at multi-docking site, Y1173. c-Src also catalyzes tyrosine phosphorylation of IQGAP1 and acts as an adaptor to bridge IQGAP1 to VEGFR-2. In turn, IQGAP1 activates b-Raf and mediates proliferation of endothelial cells. Silencing expression of IQGAP1 and b-Raf revealed that their activity is essential for VEGF to stimulate angiogenesis in an in vivo angiogenesis model of chicken chorioallantoic membrane (CAM). Conclusions/Significance: Angiogenesis contributes to the pathology of numerous human diseases ranging from cancer to age-related macular degeneration. Determining molecular mechanism of tyrosine phosphorylation of VEGFR-2 and identification of molecules that are relaying its angiogenic signaling may identify novel targets for therapeutic intervention against angiogenesis-associated diseases. Our study shows that recruitment and activation of c-Src by VEGFR-2 plays a pivotal role in relaying angiogenic signaling of VEGFR-2; it phosphorylates VEGFR-2 at Y1173, facilitates association and activation of IQGAP1 and other signaling proteins to VEGFR-2. IQGAP1-dependent signaling, in part, is critically required for endothelial cell proliferation, a key step in angiogenesis. Thus, Y1057 of VEGFR-2 serves to regulate VEGFR-2 function in a combinatorial manner by supporting both diversity of recruitment of angiogenic signaling proteins to VEGFR-2, and its ability to promote angiogenesis.	[Meyer, Rosana D.; Rahimi, Nader] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Sacks, David B.] Harvard Univ, Sch Med, Boston, MA USA; [Sacks, David B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA	Boston University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Meyer, RD (corresponding author), Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA.	nrahimi@bu.edu		Rahimi, Nader/0000-0002-6745-1725; Sacks, David/0000-0003-3100-0735	National Institutes of Health; Massachusetts Lions Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Foundation	This study was supported in part by grants from the National Institutes of Health (NR and DBS) and Massachusetts Lions Foundation grant to the Department of Ophthalmology.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Igarashi K, 1998, BIOCHEM BIOPH RES CO, V251, P77, DOI 10.1006/bbrc.1998.9442; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; Meyer RD, 2004, ONCOGENE, V23, P5523, DOI 10.1038/sj.onc.1207712; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; Meyer RD, 2002, J BIOL CHEM, V277, P27081, DOI 10.1074/jbc.M110544200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Ratcliffe KE, 2002, ONCOGENE, V21, P6307, DOI 10.1038/sj.onc.1205781; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sanjay A, 2006, FEBS J, V273, P5442, DOI 10.1111/j.1742-4658.2006.05535.x; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Singh AJ, 2005, MOL BIOL CELL, V16, P2106, DOI 10.1091/mbc.E04-08-0749; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Warner AJ, 2000, BIOCHEM J, V347, P501, DOI 10.1042/0264-6021:3470501; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200	33	72	77	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3848	10.1371/journal.pone.0003848	http://dx.doi.org/10.1371/journal.pone.0003848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050761	Green Published, Green Submitted, gold			2022-12-25	WOS:000265452100007
J	Petkova, VI; Ehrsson, HH				Petkova, Valeria I.; Ehrsson, H. Henrik			If I Were You: Perceptual Illusion of Body Swapping	PLOS ONE			English	Article							RUBBER HAND ILLUSION; MULTISENSORY INTEGRATION; PHYSIOLOGICAL CONDITION; PARIETAL CORTEX; REPRESENTATION; FEEL; SPACE; SENSE; INTEROCEPTION; MECHANISMS	The concept of an individual swapping his or her body with that of another person has captured the imagination of writers and artists for decades. Although this topic has not been the subject of investigation in science, it exemplifies the fundamental question of why we have an ongoing experience of being located inside our bodies. Here we report a perceptual illusion of body-swapping that addresses directly this issue. Manipulation of the visual perspective, in combination with the receipt of correlated multisensory information from the body was sufficient to trigger the illusion that another person's body or an artificial body was one's own. This effect was so strong that people could experience being in another person's body when facing their own body and shaking hands with it. Our results are of fundamental importance because they identify the perceptual processes that produce the feeling of ownership of one's body.	[Petkova, Valeria I.; Ehrsson, H. Henrik] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet	Petkova, VI (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	Valeria.Petkova@ki.se			Swedish Medical Research Council; Swedish Foundation for Strategic Research; Human Frontier Science Programme; European Research Council; KI-NIH [PhD fellowship]; European Union	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Human Frontier Science Programme(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); KI-NIH; European Union(European Commission)	This work was supported by grants from the Swedish Medical Research Council, the Swedish Foundation for Strategic Research, the Human Frontier Science Programme, and the European Research Council. V.I.P was supported by a PhD fellowship from the KI-NIH graduate programme. The study was conducted as part of Stockholm Brain Institute, a consortium for Cognitive and Computational Neuroscience in Stockholm, and PRESENCCIA (Presence: Research Encompassing Sensory Enhancement,Neuroscience, Cerebral-Computer Interfaces, and Applications) project, a European Union-funded project under the Information Society Technologies program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler EL, 2007, PERCEPTION, V36, P632, DOI 10.1068/p5730; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick M, 2004, SCIENCE, V305, P782, DOI 10.1126/science.1101836; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Churchland PS, 2002, SCIENCE, V296, P308, DOI 10.1126/science.1070564; Cole J, 2000, TRENDS COGN SCI, V4, P167, DOI 10.1016/S1364-6613(00)01459-5; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley M., 1953, PARIETAL LOBES; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Gibson JJ, 1979, ECOLOGICAL APPROACH; GRAZIANO M, 2002, COMMON MECH PERCEPTI; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; JAMES W, 1890, PRINICPLES PSYCHOL; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lenggenhager B, 2006, REV NEUROSCIENCE, V17, P643; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Levelt W., 1965, BINOCULAR RIVALRY; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Meador KJ, 2000, NEUROLOGY, V55, P816, DOI 10.1212/WNL.55.6.816; Merleau-Ponty M, 1945, PHENOMENOLOGIE PERCE; METZINGER T, 2003, BEING ONE SELF MODEL; MINSKY M, 1980, OMNI, V45; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; SLATER M, 2008, FRONTIERS HUMAN NEUR; Slater M, 2007, IEEE COMPUT GRAPH, V27, P90, DOI 10.1109/MCG.2007.93; Stratton GM, 1899, MIND, V8, P492, DOI DOI 10.1093/MINDNIII.4.492; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; WELCH RB, 1986, HDB PERCEPTION HUMAN; Wolpert DM, 2007, HUM MOVEMENT SCI, V26, P511, DOI 10.1016/j.humov.2007.05.005	52	536	544	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3832	10.1371/journal.pone.0003832	http://dx.doi.org/10.1371/journal.pone.0003832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436YN	19050755	Green Submitted, Green Published, gold			2022-12-25	WOS:000265452100002
J	Seitsonen, SP; Onkamo, P; Peng, G; Xiong, MM; Tommila, PV; Ranta, PH; Holopainen, JM; Moilanen, JA; Palosaari, T; Kaarniranta, K; Meri, S; Immonen, IR; Jarvela, IE				Seitsonen, Sanna P.; Onkamo, Paivi; Peng, Gang; Xiong, Momiao; Tommila, Petri V.; Ranta, Paivi H.; Holopainen, Juha M.; Moilanen, Jukka A.; Palosaari, Tapani; Kaarniranta, Kai; Meri, Seppo; Immonen, Ilkka R.; Jarvela, Irma E.			Multifactor Effects and Evidence of Potential Interaction between Complement Factor H Y402H and LOC387715 A69S in Age-Related Macular Degeneration	PLOS ONE			English	Article							HTRA1 PROMOTER POLYMORPHISM; CIGARETTE-SMOKING; GEOGRAPHIC ATROPHY; VARIANT INCREASES; 3RD COMPONENT; IN-VITRO; RISK; GENE; SUSCEPTIBILITY; ASSOCIATION	Background: Variants in the complement cascade genes and the LOC387715/HTRA1, have been widely reported to associate with age-related macular degeneration (AMD), the most common cause of visual impairment in industrialized countries. Methods/Principal Findings: We investigated the association between the LOC387715 A69S and complement component C3 R102G risk alleles in the Finnish case-control material and found a significant association with both variants (OR 2.98, p = 3.75x10(-9); non-AMD controls and OR 2.79, p = 2.78x10(-19), blood donor controls and OR 1.83, p = 0.008; non-AMD controls and OR 1.39, p = 0.039; blood donor controls), respectively. Previously, we have shown a strong association between complement factor H (CFH) Y402H and AMD in the Finnish population. A carrier of at least one risk allele in each of the three susceptibility loci (LOC387715, C3, CFH) had an 18-fold risk of AMD when compared to a non-carrier homozygote in all three loci. A tentative gene-gene interaction between the two major AMD-associated loci, LOC387715 and CFH, was found in this study using a multiplicative (logistic regression) model, a synergy index (departure-from-additivity model) and the mutual information method (MI), suggesting that a common causative pathway may exist for these genes. Smoking (ever vs. never) exerted an extra risk for AMD, but somewhat surprisingly, only in connection with other factors such as sex and the C3 genotype. Population attributable risks (PAR) for the CFH, LOC387715 and C3 variants were 58.2%, 51.4% and 5.8%, respectively, the summary PAR for the three variants being 65.4%. Conclusions/Significance: Evidence for gene-gene interaction between two major AMD associated loci CFH and LOC387715 was obtained using three methods, logistic regression, a synergy index and the mutual information (MI) index.	[Seitsonen, Sanna P.; Tommila, Petri V.; Ranta, Paivi H.; Holopainen, Juha M.; Moilanen, Jukka A.; Meri, Seppo; Immonen, Ilkka R.] Univ Helsinki, Dept Ophthalmol, Helsinki, Finland; [Seitsonen, Sanna P.; Jarvela, Irma E.] Univ Helsinki, Haartman Inst, Dept Med Genet, FIN-00014 Helsinki, Finland; [Onkamo, Paivi] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Peng, Gang; Xiong, Momiao] Fudan Univ, Sch Life Sci, Fudan, Peoples R China; [Xiong, Momiao] Univ Texas, Sch Publ Hlth, Human Genet Ctr, Houston, TX USA; [Palosaari, Tapani] Univ Oulu, Dept Ophthalmol, Helsinki, Finland; [Kaarniranta, Kai] Univ Kuopio, Dept Ophthalmol, FIN-70211 Kuopio, Finland; Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Jarvela, Irma E.] Univ Helsinki, Cent Hosp, Lab Mol Genet, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Fudan University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Oulu; University of Eastern Finland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Seitsonen, SP (corresponding author), Univ Helsinki, Dept Ophthalmol, Helsinki, Finland.	sanna.seitsonen@hus.fi	Jarvela, Irma E/L-5836-2013; Peng, Gang/AAN-5355-2020	Jarvela, Irma E/0000-0002-1770-6187; Peng, Gang/0000-0003-0307-9351; Kaarniranta, Kai/0000-0003-2600-8679; Meri, Seppo/0000-0001-9142-501X	Eye Foundation, Helsinki, Finland; The Evald and Hilda Nissi Foundation, Vaasa, Finland; The Academy of Finland, Hel-sinki, Finland; Helsinki University Central Hospital Research Funds, Helsinki, Finland [TYH5117, TYH6233]; National Institutes of Health [EY11515]; NATIONAL EYE INSTITUTE [R01EY011515] Funding Source: NIH RePORTER	Eye Foundation, Helsinki, Finland; The Evald and Hilda Nissi Foundation, Vaasa, Finland; The Academy of Finland, Hel-sinki, Finland(Academy of Finland); Helsinki University Central Hospital Research Funds, Helsinki, Finland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by grants from the Paivikki and Sakari Sohlberg Foundation, Hel-sinki, Finland; The Mary and Georg Ehrnrooth Foundation, Helsinki, Finland; The Eye and Tissue Bank Foundation, Helsinki, Finland; The Eye Foundation, Helsinki, Finland; The Evald and Hilda Nissi Foundation, Vaasa, Finland; The Academy of Finland, Hel-sinki, Finland; Helsinki University Central Hospital Research Funds (TYH5117, TYH6233), Helsinki, Finland; and National Institutes of Health (EY11515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors do not have any financial interests to disclose.	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Baird PN, 2008, HUM MOL GENET, V17, P1299, DOI 10.1093/hmg/ddn018; Baird PN, 2006, INVEST OPHTH VIS SCI, V47, P4194, DOI 10.1167/iovs.05-1285; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Cameron DJ, 2007, CELL CYCLE, V6, P1122, DOI 10.4161/cc.6.9.4157; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Cover TM, 1991, ELEMENTS INFORM THEO; DeAngelis MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P49, DOI 10.1001/archopht.125.1.49; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Francis PJ, 2008, MOL VIS, V14, P1395; Francis PJ, 2007, HUM HERED, V63, P212, DOI 10.1159/000100046; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; GICLAS PC, 1979, J IMMUNOL, V122, P146; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2007, PLOS MED, V4, P1993, DOI 10.1371/journal.pmed.0040355; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Jakobsdottir J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002199; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; KEW RR, 1985, J CLIN INVEST, V75, P1000, DOI 10.1172/JCI111760; KEW RR, 1987, CLIN IMMUNOL IMMUNOP, V44, P248, DOI 10.1016/0090-1229(87)90069-9; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Liew G, 2007, OPHTHALMOLOGY, V114, P1793, DOI 10.1016/j.ophtha.2007.04.036; Lu F, 2007, VISION RES, V47, P3120, DOI 10.1016/j.visres.2007.08.010; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mori K, 2007, J HUM GENET, V52, P636, DOI 10.1007/s10038-007-0162-1; Narayanan R, 2007, OPHTHALMOLOGY, V114, P1327, DOI 10.1016/j.ophtha.2006.10.035; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; North BV, 2005, HUM HERED, V59, P79, DOI 10.1159/000085222; Postel EA, 2006, OPHTHALMOLOGY, V113, P1504, DOI 10.1016/j.ophtha.2006.02.049; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; ROBBINS RA, 1991, AM J PHYSIOL, V260, pL254, DOI 10.1152/ajplung.1991.260.4.L254; Ross RJ, 2007, INVEST OPHTH VIS SCI, V48, P1128, DOI 10.1167/iovs.06-0999; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Scott WK, 2007, OPHTHALMOLOGY, V114, P1151, DOI 10.1016/j.ophtha.2006.08.054; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seitsonen S, 2006, MOL VIS, V12, P796; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Simonelli F, 2006, BRIT J OPHTHALMOL, V90, P1142, DOI 10.1136/bjo.2006.096487; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Souied EH, 2005, MOL VIS, V11, P1135; Tanimoto S, 2007, NEUROSCI LETT, V414, P71, DOI 10.1016/j.neulet.2006.12.011; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; TUO J, 2008, OPHTHALMOLO IN PRESS; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Weger M, 2007, MOL VIS, V13, P1274; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yoshida T, 2007, MOL VIS, V13, P545; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571	62	58	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3833	10.1371/journal.pone.0003833	http://dx.doi.org/10.1371/journal.pone.0003833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048105	Green Submitted, Green Published, gold			2022-12-25	WOS:000265452000006
J	Ma, JG; Xin, XL; Meng, LH; Tong, LJ; Lin, LP; Geng, MY; Ding, J				Ma, Jingui; Xin, Xianliang; Meng, Linghua; Tong, Linjiang; Lin, Liping; Geng, Meiyu; Ding, Jian			The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; CELL LUNG-CANCER; CATALYTIC DOMAIN; ACQUIRED-RESISTANCE; MUTATION; GEFITINIB; SUNITINIB; IMATINIB; THERAPY; DESIGN	Despite the emerging success of multi-targeted protein tyrosine kinase (PTK) inhibitors in cancer therapy, significant side effects and resistance concerns seems to be avoided unlikely. The aim of the present study was to identify novel multi-targeting PTK inhibitors. The kinase enzymatic activities were measured by enzyme-linked immunosorbent assay (ELISA). The antiproliferative activities in human microvascular endothelial cells (HMECs) were evaluated by sulforhodamine (SRB) assay. The phosphorylation of kinases and their downstream molecules was probed by western blot analysis. The binding mode between MdOS and PTKs was profiled by surface plasmon resonance (SPR) approach and molecular simulation. Tube formation assay, rat aortic ring method and chicken chorioallantoic membrane assay were combined to illustrate the in vitro and in vivo anti-angiogenic effects. Results indicated that MdOS, a novel marine-derived oligosaccharide sulfate, exhibited a broad-spectrum PTK inhibitory action. At an enzymatic level, MdOS inhibited HER2, EGFR, VEGFR, PDGFR, c-Kit, FGFR1 and c-Src, with little impact on FGFR2. In cellular settings, MdOS inhibited phosphorylation of PTKs, exemplified by HER2, EGFR and VEGFR2, and downstream molecules of Erk1/2 and AKT. Further studies demonstrated that MdOS acted as an ATP-competitive inhibitor via directly binding to the residues of entrance rather than those of the ATP-binding pocket. Furthermore, MdOS inhibited proliferation and tube formation of HMECs, arrested microvessel outgrowth of rat aortic rings and hindered the neovascularization of chick allantoic membrane. Taken together, results presented here indicated that MdOS exhibited anti-angiogenic activity in a PTK-dependent manner and make it a promising agent for further evaluation in PTK-associated cancer therapy.	[Ma, Jingui; Xin, Xianliang; Meng, Linghua; Tong, Linjiang; Lin, Liping; Geng, Meiyu; Ding, Jian] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Div Antitumor Pharmacol,State Key Lab Drug Res, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS	Ma, JG (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Div Antitumor Pharmacol,State Key Lab Drug Res, Shanghai 200031, Peoples R China.	mygeng@mail.shcnc.ac.cn; suozhang@mail.shcnc.ac.cn	meng, linghua/Y-8110-2019; lin, liping/HGE-0871-2022		Science Foundation of China; Natural Science Foundation of China [30725046, 30721005]; Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-YW-R-25]; Science and Technology Commission of Shanghai [07dz05906]; National Basic Research Program [2003CB716400]	Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); National Basic Research Program(National Basic Research Program of China)	National Basic Research Program Grant (2003CB716400) of China, Natural Science Foundation of China for Distinguished Young Scholars (30725046) and Natural Science Foundation of China for Innovation Research Group (30721005). Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-YW-R-25), Science and Technology Commission of Shanghai Municipality Grant 07dz05906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga C, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016/S0093-7754(03)00185-4; Baselga J, 2004, NAT MED, V10, P786, DOI 10.1038/nm0804-786; Baselga J, 2001, ANN ONCOL, V12, P35, DOI 10.1023/A:1011163824080; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Blencke S, 2003, J BIOL CHEM, V278, P15435, DOI 10.1074/jbc.M211158200; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Ciardiello F, 2003, CLIN CANCER RES, V9, P1546; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Cole CL, 2008, EXPERT OPIN BIOL TH, V8, P351, DOI 10.1517/14712598.8.3.351 ; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Goodman VL, 2007, CLIN CANCER RES, V13, P1367, DOI 10.1158/1078-0432.CCR-06-2328; Guo XN, 2004, BBA-GEN SUBJECTS, V1673, P186, DOI 10.1016/j.bbagen.2004.04.015; Herbst RS, 2004, NAT REV CANCER, V4, P956, DOI 10.1038/nrc1506; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Klein S, 2007, ADV CANCER RES, V97, P295, DOI 10.1016/S0065-230X(06)97013-4; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; LAZARO I, 1991, ANAL BIOCHEM, V192, P257, DOI 10.1016/0003-2697(91)90533-Y; LI F, 2002, CHEM RES CHINESE U, V9, P1704; Lin LG, 2008, J MED CHEM, V51, P4419, DOI 10.1021/jm701501x; Madhusudan S, 2004, CLIN BIOCHEM, V37, P618, DOI 10.1016/j.clinbiochem.2004.05.006; Maione P, 2006, ONCOLOGIST, V11, P274, DOI 10.1634/theoncologist.11-3-274; Miao BC, 2005, MOL PHARMACOL, V68, P1716, DOI 10.1124/mol.105.015412; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Rock EP, 2007, ONCOLOGIST, V12, P107, DOI 10.1634/theoncologist.12-1-107; Sawyers CL, 2001, SCIENCE, V294, P1834; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Sosman JA, 2007, CLIN CANCER RES, V13, p764S, DOI 10.1158/1078-0432.CCR-06-1975; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhang XH, 2007, BBA-GEN SUBJECTS, V1770, P1490, DOI 10.1016/j.bbagen.2007.06.017; Zhang YX, 2005, ANTI-CANCER DRUG, V16, P515, DOI 10.1097/00001813-200506000-00007; Zhong L, 2005, BBA-GEN SUBJECTS, V1722, P254, DOI 10.1016/j.bbagen.2004.12.015	39	31	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3774	10.1371/journal.pone.0003774	http://dx.doi.org/10.1371/journal.pone.0003774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020661	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448600007
J	Vogt, A; D'Angelo, C; Oswald, F; Denzel, A; Mazel, CH; Matz, MV; Ivanchenko, S; Nienhaus, GU; Wiedenmann, J				Vogt, Alexander; D'Angelo, Cecilia; Oswald, Franz; Denzel, Andrea; Mazel, Charles H.; Matz, Mikhail V.; Ivanchenko, Sergey; Nienhaus, G. Ulrich; Wiedenmann, Joerg			A Green Fluorescent Protein with Photoswitchable Emission from the Deep Sea	PLOS ONE			English	Article							GFP-LIKE PROTEINS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MONOMERIC RED; ANTHOZOA; CORAL; MICROSCOPY; ORANGE; MARKER; COLOR	A colorful variety of fluorescent proteins (FPs) from marine invertebrates are utilized as genetically encoded markers for live cell imaging. The increased demand for advanced imaging techniques drives a continuous search for FPs with new and improved properties. Many useful FPs have been isolated from species adapted to sun-flooded habitats such as tropical coral reefs. It has yet remained unknown if species expressing green fluorescent protein (GFP)-like proteins also exist in the darkness of the deep sea. Using a submarine-based and -operated fluorescence detection system in the Gulf of Mexico, we discovered ceriantharians emitting bright green fluorescence in depths between 500 and 600 m and identified a GFP, named cerFP505, with bright fluorescence emission peaking at 505 nm. Spectroscopic studies showed that similar to 15% of the protein bulk feature reversible ON/OFF photo switching that can be induced by alternating irradiation with blue und near-UV light. Despite being derived from an animal adapted to essentially complete darkness and low temperatures, cerFP505 maturation in living mammalian cells at 37 degrees C, its brightness and photostability are comparable to those of EGFP and cmFP512 from shallow water species. Therefore, our findings disclose the deep sea as a potential source of GFP-like molecular marker proteins.	[Vogt, Alexander; D'Angelo, Cecilia; Denzel, Andrea; Wiedenmann, Joerg] Univ Ulm, Inst Gen Zool & Endocrinol, Ulm, Germany; [Oswald, Franz] Univ Ulm, Dept Internal Med 1, D-89069 Ulm, Germany; [Mazel, Charles H.] NightSea, Andover, MA USA; [Matz, Mikhail V.] Univ Texas, Austin, TX USA; [Ivanchenko, Sergey; Nienhaus, G. Ulrich] Univ Ulm, Inst Biophys, D-89069 Ulm, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL USA; [Wiedenmann, Joerg] Univ Southampton, Natl Oceanography Ctr, Southampton SO9 5NH, Hants, England	Ulm University; Ulm University; University of Texas System; University of Texas Austin; Ulm University; University of Illinois System; University of Illinois Urbana-Champaign; NERC National Oceanography Centre; University of Southampton	Vogt, A (corresponding author), Univ Ulm, Inst Gen Zool & Endocrinol, Ulm, Germany.	J.Wiedenmann@soton.ac.uk	Oswald, Franz/AAO-9584-2020; Matz, Mikhail V/K-4392-2017; Nienhaus, Gerd Ulrich/G-8698-2012	Matz, Mikhail V/0000-0001-5453-9819; Nienhaus, Gerd Ulrich/0000-0002-5027-3192	Deutsche Forschungsgemeinschaft [Wi1990/2-1, SFB 497/B9, SFB518/A18, SFB 497/D2]; NOAA Ocean Exploration Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NOAA Ocean Exploration Program(National Oceanic Atmospheric Admin (NOAA) - USA)	The work was supported by the Deutsche Forschungsgemeinschaft (Wi1990/2-1 to JW, SFB 497/B9 and SFB518/A18 to FO, SFB 497/D2 to GUN) and NOAA Ocean Exploration Program ("Operation Deep Scope" to MVM and CHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CARLGREN OSKAR, 1952, PUBL INST MARINE SCI UNIV TEXAS [PORT ARANSAS], V2, P141; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; D'Angelo C, 2008, MAR ECOL PROG SER, V364, P97, DOI 10.3354/meps07588; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; den Hartog J. C., 1977, Zoologische Meded Leiden, V51, P211; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Flors C, 2007, J AM CHEM SOC, V129, P13970, DOI 10.1021/ja074704l; Griesbeck O, 2004, CURR OPIN NEUROBIOL, V14, P636, DOI 10.1016/j.conb.2004.08.002; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Habuchi S, 2006, PHOTOCH PHOTOBIO SCI, V5, P567, DOI 10.1039/b516339k; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Ip DTM, 2007, MAR BIOTECHNOL, V9, P469, DOI 10.1007/s10126-007-9005-5; Ip DTM, 2004, ACTA CRYSTALLOGR D, V60, P340, DOI 10.1107/S0907444903027100; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Kawaguti S., 1969, Micronesica, V5, P313; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kredel S, 2008, CHEM BIOL, V15, P224, DOI 10.1016/j.chembiol.2008.02.008; Leutenegger A, 2007, J EXP MAR BIOL ECOL, V353, P221, DOI 10.1016/j.jembe.2007.09.013; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyawaki A, 2002, CELL STRUCT FUNCT, V27, P343, DOI 10.1247/csf.27.343; Mocz G, 2007, MAR BIOTECHNOL, V9, P305, DOI 10.1007/s10126-006-7145-7; Molodtsova T.N., 2003, Zoologische Verhandelingen (Leiden), V345, P249; Molodtsova TN, 2004, HYDROBIOLOGIA, V530, P261, DOI 10.1007/s10750-004-2671-7; Nienhaus K, 2006, BIOPHYS J, V91, P4210, DOI 10.1529/biophysj.106.087411; Nienhaus K, 2006, BIOCHEMISTRY-US, V45, P12942, DOI 10.1021/bi060885c; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; SCHNITZLER CE, 2008, MAR BIOTECHNOL; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; SHEPARD AN, 1986, FISH B-NOAA, V84, P625; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Stiel AC, 2007, BIOCHEM J, V402, P35, DOI 10.1042/BJ20061401; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Verkhusha VV, 2004, CHEM BIOL, V11, P845, DOI 10.1016/j.chembiol.2004.04.007; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Ward WW, 2006, METHOD BIOCHEM ANAL, V47, P39; Wiedenmann J, 2000, P NATL ACAD SCI USA, V97, P14091, DOI 10.1073/pnas.97.26.14091; Wiedenmann J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854680; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wiedenmann J, 2000, OPHELIA, V52, P57, DOI 10.1080/00785236.1999.10409419; Wiedenmann J, 2004, MAR BIOTECHNOL, V6, P270, DOI 10.1007/s10126-004-3006-4; Wiedenmann J., 1997, (sulcata) Pennant, (Cnidaria, Anthozoa, Actinaria) in Gentechnologie und Molekularbiologie, Offenlegungsschrift DE, Patent No. [197 18 640 A1, 19718640]; Wiedenmann J, 1999, VERHANDLUNGEN GESELL, V29, P497; Wiedenmann J, 2006, EXPERT REV PROTEOMIC, V3, P361, DOI 10.1586/14789450.3.3.361; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462	81	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3766	10.1371/journal.pone.0003766	http://dx.doi.org/10.1371/journal.pone.0003766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018285	gold, Green Published, Green Submitted			2022-12-25	WOS:000265448500013
J	Molla-Herman, A; Boularan, C; Ghossoub, R; Scott, MGH; Burtey, A; Zarka, M; Saunier, S; Concordet, JP; Marullo, S; Benmerah, A				Molla-Herman, Anahi; Boularan, Cedric; Ghossoub, Rania; Scott, Mark G. H.; Burtey, Anne; Zarka, Marion; Saunier, Sophie; Concordet, Jean-Paul; Marullo, Stefano; Benmerah, Alexandre			Targeting of beta-Arrestin2 to the Centrosome and Primary Cilium: Role in Cell Proliferation Control	PLOS ONE			English	Article								Background: The primary cilium is a sensory organelle generated from the centrosome in quiescent cells and found at the surface of most cell types, from where it controls important physiological processes. Specific sets of membrane proteins involved in sensing the extracellular milieu are concentrated within cilia, including G protein coupled receptors (GPCRs). Most GPCRs are regulated by beta-arrestins, beta arr1 and beta arr2, which control both their signalling and endocytosis, suggesting that beta arrs may also function at primary cilium. Methodology/Principal Findings: In cycling cells, beta arr2 was observed at the centrosome, at the proximal region of the centrioles, in a microtubule independent manner. However, beta arr2 did not appear to be involved in classical centrosome-associated functions. In quiescent cells, both in vitro and in vivo, beta arr2 was found at the basal body and axoneme of primary cilia. Interestingly, beta arr2 was found to interact and colocalize with 14-3-3 proteins and Kif3A, two proteins known to be involved in ciliogenesis and intraciliary transport. In addition, as suggested for other centrosome or cilia-associated proteins, beta arrs appear to control cell cycle progression. Indeed, cells lacking beta arr2 were unable to properly respond to serum starvation and formed less primary cilia in these conditions. Conclusions/Significance: Our results show that beta arr2 is localized to the centrosome in cycling cells and to the primary cilium in quiescent cells, a feature shared with other proteins known to be involved in ciliogenesis or primary cilium function. Within cilia, beta arr2 may participate in the signaling of cilia-associated GPCRs and, therefore, in the sensory functions of this cell "antenna".	[Molla-Herman, Anahi; Boularan, Cedric; Ghossoub, Rania; Scott, Mark G. H.; Burtey, Anne; Zarka, Marion; Concordet, Jean-Paul; Marullo, Stefano; Benmerah, Alexandre] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France; [Molla-Herman, Anahi; Boularan, Cedric; Ghossoub, Rania; Scott, Mark G. H.; Burtey, Anne; Zarka, Marion; Concordet, Jean-Paul; Marullo, Stefano; Benmerah, Alexandre] INSERM, U567, Paris, France; [Saunier, Sophie] Hop Necker Enfants Malad, INSERM, U574, Paris, France; [Saunier, Sophie] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Molla-Herman, A (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France.	alexandre.benmerah@inserm.fr	concordet, jean-paul/C-3417-2015; benmerah, alexandre/H-3742-2017; Scott, Mark/R-3521-2019; Saunier, Sophie/G-6044-2015; Ghossoub, Rania/AAO-9580-2020; Marullo, Stefano/C-6142-2008	benmerah, alexandre/0000-0003-0188-8016; Saunier, Sophie/0000-0002-1069-0047; Marullo, Stefano/0000-0001-9604-9973; Scott, Mark G.H./0000-0002-1557-1856; Burtey, Anne/0000-0003-4548-8807; Ghossoub, Rania/0000-0003-1886-343X; Concordet, Jean-Paul/0000-0001-8924-4316	Association pour la recherche contre le cancer [36-91, 3925]; Ligue nationale contre le cancer; Agence nationale de la recherche [BLAN07-3-187842]	Association pour la recherche contre le cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue nationale contre le cancer(Ligue nationale contre le cancer); Agence nationale de la recherche(French National Research Agency (ANR))	This work was supported by grants from the "Association pour la recherche contre le cancer" (ARC, 36-91, AB; 3925 JPC) and from the " Ligue nationale contre le cancer" and "Agence nationale de la recherche" ("ANR" BLAN07-3-187842, SM). Anne Burtey was supported by a doctoral fellowship from ARC.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Benmerah A, 2003, TRAFFIC, V4, P503, DOI 10.1034/j.1600-0854.2003.00102.x; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Borck G, 2008, HUM MUTAT, V29, P966, DOI 10.1002/humu.20531; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Christensen ST, 2007, TRAFFIC, V8, P97, DOI 10.1111/j.1600-0854.2006.00516.x; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Ge H, 2006, CHEM SENSES, V31, P49, DOI 10.1093/chemse/bjj005; GERDES J, 1984, J IMMUNOL, V133, P1710; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Menco BPM, 2005, J NEUROCYTOL, V34, P11, DOI 10.1007/s11068-005-5045-9; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Peterson JJ, 2003, EXP EYE RES, V76, P553, DOI 10.1016/S0014-4835(03)00032-0; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Piu F, 2006, ONCOGENE, V25, P218, DOI 10.1038/sj.onc.1209024; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; REID DM, 1987, EXP EYE RES, V45, P731, DOI 10.1016/S0014-4835(87)80121-5; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; VANVEEN T, 1986, EXP BIOL, V45, P15; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; WHEATLEY DN, 1969, J ANAT, V105, P351; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215	65	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3728	10.1371/journal.pone.0003728	http://dx.doi.org/10.1371/journal.pone.0003728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19008961	Green Submitted, Green Published, gold			2022-12-25	WOS:000265166400006
J	Rodriguez-Galan, O; Galindo, A; Hervas-Aguilar, A; Arst, HN; Penalva, MA				Rodriguez-Galan, Olga; Galindo, Antonio; Hervas-Aguilar, America; Arst, Herbert N., Jr.; Penalva, Miguel A.			Physiological Involvement in pH Signaling of Vps24-mediated Recruitment of Aspergillus PalB Cysteine Protease to ESCRT-III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER TRANSCRIPTION FACTOR; YEAST YARROWIA-LIPOLYTICA; AMBIENT PH; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; STRUCTURAL BASIS; PLASMA-MEMBRANE; RIM101 PATHWAY; UBIQUITIN ISOPEPTIDASE; ALKALINE PH	Activation of the Aspergillus nidulans transcription factor PacC, which mediates ambient pH regulation of gene expression and is recruited to ESCRT-III by the Vps32-interacting scaffold PalA, involves its ambient pH-dependent C-terminal proteolysis. This reaction is almost certainly catalyzed by the PalB calpain-like protease. Here we show that PalB associates with membranes and interacts specifically and directly with ESCRT-III Vps24. The PalB N-terminal MIT domain and the Vps24 C-terminal MIM motif are necessary and sufficient for this interaction. PalB(Delta MIT), a mutant PalB lacking the MIT domain is inefficiently recruited to membranes and impaired in PacC proteolytic processing. Notably, membrane recruitment is promoted and PacC processing largely restored by covalent attachment of Vps24 to mutant PalB(Delta MIT). This is the first reported evidence that calpain-like recruitment to ESCRT-III lattices plays a physiological role. It unambiguously positions the calpain-like protease PalB within the ESCRT-III-associated pH signaling complex, underlines the positive role of ESCRT-III in ambient pH signal transduction, and suggests a possible mechanism for PalB activation.	[Rodriguez-Galan, Olga; Galindo, Antonio; Hervas-Aguilar, America; Penalva, Miguel A.] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Arst, Herbert N., Jr.] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, London SW7 2AZ, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Imperial College London	Penalva, MA (corresponding author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain.	penalva@cib.csic.es	Rodríguez-Galán, Olga/K-5580-2015; Galindo, Antonio/A-9991-2018; Penalva, Miguel A/G-2295-2015	Rodríguez-Galán, Olga/0000-0002-3137-8554; Galindo, Antonio/0000-0002-1108-652X; Penalva, Miguel A/0000-0002-3102-2806	DGICYT; Comunidad de Madrid [BIO2005-0556, S2006/SAL-024]; Wellcome Trust [067878, 084660]; BBSRC [BB/F01189X/1]	DGICYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by DGICYT and Comunidad de Madrid Grants BIO2005-0556 and S2006/SAL-024, respectively, (to M.A.P.) and by Wellcome Trust Grants 067878 and 084660 and BBSRC grant BB/F01189X/1 (to H.N.A.).	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; Arst HN, 2003, TRENDS GENET, V19, P224, DOI 10.1016/S0168-9525(03)00052-0; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Blanchin-Roland S, 2005, MICROBIOL-SGM, V151, P3627, DOI 10.1099/mic.0.28196-0; Blanchin-Roland S, 2008, MICROBIOL-SGM, V154, P1668, DOI 10.1099/mic.0.2008/017046-0; Boysen JH, 2006, MOL BIOL CELL, V17, P1344, DOI 10.1091/mbc.e05-10-0949; Calcagno-Pizarelli AM, 2007, EUKARYOT CELL, V6, P2365, DOI 10.1128/EC.00275-07; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cornet M, 2005, INFECT IMMUN, V73, P7977, DOI 10.1128/IAI.73.12.7977-7987.2005; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; DENISON SH, 1995, J BIOL CHEM, V270, P28519, DOI 10.1074/jbc.270.48.28519; Denison SH, 1998, MOL MICROBIOL, V30, P259, DOI 10.1046/j.1365-2958.1998.01058.x; Diez E, 2002, EMBO J, V21, P1350, DOI 10.1093/emboj/21.6.1350; Espeso EA, 1997, J MOL BIOL, V274, P466, DOI 10.1006/jmbi.1997.1428; Espeso EA, 2000, MOL CELL BIOL, V20, P3355, DOI 10.1128/MCB.20.10.3355-3363.2000; Espeso EA, 1996, J BIOL CHEM, V271, P28825, DOI 10.1074/jbc.271.46.28825; Futai E, 1999, MOL GEN GENET, V260, P559, DOI 10.1007/s004380050929; Futai E, 2001, BBA-GENE STRUCT EXPR, V1517, P316, DOI 10.1016/S0167-4781(00)00256-6; Galindo A, 2007, TRAFFIC, V8, P1346, DOI 10.1111/j.1600-0854.2007.00620.x; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hervas-Aguilar A, 2007, J BIOL CHEM, V282, P34735, DOI 10.1074/jbc.M706723200; Howard TL, 2001, J CELL SCI, V114, P2395; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kullas AL, 2004, EUKARYOT CELL, V3, P1609, DOI 10.1128/EC.3.6.1609-1618.2004; Kyuuma M, 2006, CELL STRUCT FUNCT, V31, P159, DOI 10.1247/csf.06023; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Li WS, 1997, GENETICS, V145, P63; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mingot JM, 1999, MOL CELL BIOL, V19, P1390; Mitchell AP, 2008, P NATL ACAD SCI USA, V105, P7111, DOI 10.1073/pnas.0803384105; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Negrete-Urtasun S, 1999, MOL MICROBIOL, V33, P994, DOI 10.1046/j.1365-2958.1999.01540.x; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; OREJAS M, 1995, GENE DEV, V9, P1622, DOI 10.1101/gad.9.13.1622; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; OSMANI SA, 1988, CELL, V52, P241, DOI 10.1016/0092-8674(88)90513-2; Penalva MA, 2004, ANNU REV MICROBIOL, V58, P425, DOI 10.1146/annurev.micro.58.030603.123715; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Penas MM, 2007, EUKARYOT CELL, V6, P960, DOI 10.1128/EC.00047-07; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; RIEDER SE, 2001, CURR PROTOC CELL BIO; Rothfels K, 2005, MOL CELL BIOL, V25, P6772, DOI 10.1128/MCB.25.15.6772-6788.2005; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tatsumi A, 2007, BIOCHEM BIOPH RES CO, V362, P474, DOI 10.1016/j.bbrc.2007.08.027; Tatsumi A, 2006, BIOCHEM BIOPH RES CO, V347, P970, DOI 10.1016/j.bbrc.2006.06.183; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Tompa P, 2001, BIOCHEM BIOPH RES CO, V280, P1333, DOI 10.1006/bbrc.2001.4279; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Yorikawa C, 2008, J BIOCHEM, V143, P731, DOI 10.1093/jb/mvn030	74	46	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4404	4412		10.1074/jbc.M808645200	http://dx.doi.org/10.1074/jbc.M808645200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19056728	Green Published, hybrid			2022-12-25	WOS:000263134400040
J	Tutter, AV; Kowalski, MP; Baltus, GA; Iourgenko, V; Labow, M; Li, E; Kadam, S				Tutter, Antonin V.; Kowalski, Michael P.; Baltus, Gretchen A.; Iourgenko, Vadim; Labow, Mark; Li, En; Kadam, Shilpa			Role for Med12 in Regulation of Nanog and Nanog Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; MEDIATOR COMPLEX; SELF-RENEWAL; TRANSCRIPTION; PLURIPOTENCY; DIFFERENTIATION; NETWORK; SUBUNITS; MUTATION	Nanog, Oct4, and Sox2 form the core of a transcription factor network that maintains embryonic stem cells in the pluripotent state in both humans and mice. These critical factors have been implicated as both positive and negative regulators of transcription, varying by promoter and differentiation state of the cell. The Mediator complex, a ubiquitous conserved complex of similar to 30 subunits, facilitates transcription by coordinating RNA polymerase II binding to target promoters via gene-specific activators and can be divided into several functional subcomplexes. Med12 is part of a subcomplex of four proteins associated with the core Mediator complex and has been found to function both in repressing and activating transcription when recruited to target promoters. We identified an interaction between Med12 and Nanog and present evidence of involvement of Med12 in regulation of Nanog function. Gene expression analysis of embryonic stem cells knocked down for Med12 showed a similarity to Nanog knockdown, with increased expression of Nanog-repressed targets and decreased expression of Nanog-activated targets. Using chromatin immunoprecipitation, we found that Med12 and Nanog co-occupied Nanog target promoters in embryonic stem cells and that Med12 dissociated from target promoters upon differentiation with kinetics similar to Nanog. Our results indicate that Nanog and Med12 function in concert to regulate Nanog target genes and	[Tutter, Antonin V.; Baltus, Gretchen A.; Li, En; Kadam, Shilpa] Novartis Inst Biomed Res, Epigenet, Cambridge, MA 02139 USA; [Kowalski, Michael P.; Iourgenko, Vadim; Labow, Mark] Novartis Inst Biomed Res, Dev & Mol Pathways, Cambridge, MA 02139 USA	Novartis; Novartis	Kadam, S (corresponding author), Novartis Inst Biomed Res, Epigenet, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	shilpa.kadam@novartis.com						Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Kamachi Y, 1999, MOL CELL BIOL, V19, P107; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Pan GJ, 2003, CELL RES, V13, P499, DOI 10.1038/sj.cr.7290193; Philiber RA, 2007, PHARMACOGENOMICS, V8, P909, DOI 10.2217/14622416.8.8.909; Rau MJ, 2006, DEV BIOL, V296, P83, DOI 10.1016/j.ydbio.2006.04.437; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Rohwedel J, 1999, CELLS TISSUES ORGANS, V165, P190, DOI 10.1159/000016699; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Shin CH, 2008, DEV BIOL, V317, P467, DOI 10.1016/j.ydbio.2008.02.031; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yoda A, 2005, DEVELOPMENT, V132, P1885, DOI 10.1242/dev.01776; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	31	50	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3709	3718		10.1074/jbc.M805677200	http://dx.doi.org/10.1074/jbc.M805677200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19036726	hybrid			2022-12-25	WOS:000262872500039
J	Lahsnig, C; Mikula, M; Petz, M; Zulehner, G; Schneller, D; van Zijl, F; Huber, H; Csiszar, A; Beug, H; Mikulits, W				Lahsnig, C.; Mikula, M.; Petz, M.; Zulehner, G.; Schneller, D.; van Zijl, F.; Huber, H.; Csiszar, A.; Beug, H.; Mikulits, W.			ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression	ONCOGENE			English	Article						hepatocyte; ILEI; epithelial to mesenchymal transition; HCC; tumor progression	HUMAN HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR-BETA; TGF-BETA; SIGNAL TRANSDUCERS; TUMOR-SUPPRESSOR; CANCER; CELLS; HEPATOCARCINOGENESIS; METASTASIS; ACTIVATION	In human hepatocellular carcinoma (HCC), epithelial to mesenchymal transition (EMT) correlates with aggressiveness of tumors and poor survival. We employed a model of EMT based on immortalized p19(ARF) null hepatocytes (MIM), which display tumor growth upon expression of oncogenic Ras and undergo EMT through the synergism of Ras and transforming growth factor (TGF)-beta. Here, we show that the interleukin-related protein interleukin-like EMT inducer (ILEI), a novel EMT-, tumor-and metastasis-inducing protein, cooperates with oncogenic Ras to cause TGF-beta-independent EMT. Ras-transformed MIM hepatocytes overexpressing ILEI showed cytoplasmic E-cadherin, loss of ZO-1 and induction of a-smooth muscle actin as well as platelet-derived growth factor (PDGF)/PDGF-R isoforms. As shown by dominant-negative PDGF-R expression in these cells, ILEI-induced PDGF signaling was required for enhanced cell migration, nuclear accumulation of beta-catenin, nuclear pY-Stat3 and accelerated growth of lung metastases. In MIM hepatocytes expressing the Ras mutant V12-C40, ILEI collaborated with PI3K signaling resulting in tumor formation without EMT. Clinically, human HCC samples showed granular or cytoplasmic localization of ILEI correlating with well and poorly differentiated tumors, respectively. In conclusion, these data indicate that ILEI requires cooperation with oncogenic Ras to govern hepatocellular EMT through mechanisms involving PDGF-R/beta-catenin and PDGF-R/Stat3 signaling.	[Lahsnig, C.; Zulehner, G.; Schneller, D.; van Zijl, F.; Huber, H.; Mikulits, W.] Med Univ Vienna, Dept Med 1, Div Inst Canc Res, A-1090 Vienna, Austria; [Mikula, M.; Petz, M.; Csiszar, A.; Beug, H.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Medical University of Vienna; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Mikulits, W (corresponding author), Med Univ Vienna, Dept Med 1, Div Inst Canc Res, Borschke Gasse 8A, A-1090 Vienna, Austria.	wolfgang.mikulits@meduniwien.ac.at	Csiszar, Agnes/I-2747-2019; Mikulits, Wolfgang/AAH-4043-2021	Csiszar, Agnes/0000-0001-7911-3427; Petz, Michaela/0000-0002-6854-9919; Mikula, Mario/0000-0001-5782-0681; Mikulits, Wolfgang/0000-0003-4612-7106	Austrian Science Fund, FWF [SFBF28, P19598-B13]	Austrian Science Fund, FWF(Austrian Science Fund (FWF))	We thank ORIDIS Biomed for providing HCC tissue arrays and immunohistochemical staining. This work was supported by grants from the Austrian Science Fund, FWF, Grant number SFBF28 and P19598-B13.	Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Campbell JS, 2007, DIFFERENTIATION, V75, P843, DOI 10.1111/j.1432-0436.2007.00235.x; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fischer ANM, 2007, ONCOGENE, V26, P3395, DOI 10.1038/sj.onc.1210121; Fischer ANM, 2005, CARCINOGENESIS, V26, P931, DOI 10.1093/carcin/bgi043; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Giebel B, 2006, CURR BIOL, V16, pR91, DOI 10.1016/j.cub.2006.01.022; Gotzmann J, 2006, ONCOGENE, V25, P3170, DOI 10.1038/sj.onc.1209083; Gotzmann J, 2002, J CELL SCI, V115, P1189; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Kensler TW, 2003, NAT REV CANCER, V3, P321, DOI 10.1038/nrc1076; Kondoh N, 2001, INT J ONCOL, V18, P1271; Lacher MD, 2006, CANCER RES, V66, P1648, DOI 10.1158/0008-5472.CAN-05-2328; Lee HC, 2006, FRONT BIOSCI-LANDMRK, V11, P1901, DOI 10.2741/1933; Lee TK, 2006, CANCER RES, V66, P9948, DOI 10.1158/0008-5472.CAN-06-1092; Macheiner D, 2006, J HEPATOL, V45, P81, DOI 10.1016/j.jhep.2005.12.017; Mikula M, 2004, HEPATOLOGY, V39, P628, DOI 10.1002/hep.20084; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; Ogata H, 2006, GASTROENTEROLOGY, V131, P179, DOI 10.1053/j.gastro.2006.04.025; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Rossmanith W, 2001, MICROSC RES TECHNIQ, V52, P430, DOI 10.1002/1097-0029(20010215)52:4<430::AID-JEMT1028>3.0.CO;2-3; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Tannapfel A, 2001, ONCOGENE, V20, P7104, DOI 10.1038/sj.onc.1204902; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang SF, 2007, J CLIN PATHOL, V60, P642, DOI 10.1136/jcp.2006.036970; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Zhou L, 2007, WORLD J SURG, V31, P1782, DOI 10.1007/s00268-007-9029-z	41	73	77	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					638	650		10.1038/onc.2008.418	http://dx.doi.org/10.1038/onc.2008.418			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	19015638	Bronze, Green Accepted			2022-12-25	WOS:000263076400002
J	Hou, ZJ; Matherly, LH				Hou, Zhanjun; Matherly, Larry H.			Oligomeric Structure of the Human Reduced Folate Carrier IDENTIFICATION OF HOMO-OLIGOMERS AND DOMINANT-NEGATIVE EFFECTS ON CARRIER EXPRESSION AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; ESCHERICHIA-COLI; TRANSMEMBRANE DOMAINS; METHOTREXATE SENSITIVITY; SEROTONIN TRANSPORTER; QUATERNARY STRUCTURE; CROSS-LINKING; CELLS; MEMBRANE; LOCALIZATION	The ubiquitously expressed reduced folate carrier (RFC) is the major transport system for folate cofactors in mammalian cells and tissues. Previous considerations of RFC structure and mechanism were based on the notion that RFC monomers were sufficient to mediate transport of folate and antifolate substrates. The present study examines the possibility that human RFC (hRFC) exists as higher order homo-oligomers. By chemical cross-linking, transiently expressed hRFC in hRFC-null HeLa (R5) cells with the homobifunctional cross-linker 1,3-propanediyl bis-methanethiosulfonate and Western blotting, hRFC species with molecular masses of hRFC homo-oligomers were identified. Hemagglutinin- and Myc epitope-tagged hRFC proteins expressed in R5 cells were co-immunoprecipitated from both membrane particulate and surface-enriched membrane fractions, indicating that oligomeric hRFC is expressed at the cell surface. By co-expression of wild type and inactive mutant S138C hRFCs, combined with surface biotinylation and confocal microscopy, a dominant-negative phenotype was demonstrated involving greatly decreased cell surface expression of both mutant and wild type carrier caused by impaired intracellular trafficking. For another hRFC mutant (R373A), expression of oligomeric wild type-mutant hRFC was accompanied by a significant and disproportionate loss of wild type activity unrelated to the level of surface carrier. Collectively, our results demonstrate the existence of hRFC homo-oligomers. They also establish the likely importance of these higher order hRFC structures to intracellular trafficking and carrier function.	[Hou, Zhanjun; Matherly, Larry H.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dev Therapeut Program, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Canc Biol Grad Program, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University	Matherly, LH (corresponding author), 110 E Warren Ave, Detroit, MI 48201 USA.	matherly@kci.wayne.edu	/S-1117-2019		National Institutes of Health [CA53535]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant CA53535. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; AMBUDKAR SV, 1990, J BIOL CHEM, V265, P12287; Balamurugan K, 2006, AM J PHYSIOL-CELL PH, V291, pC189, DOI 10.1152/ajpcell.00594.2005; Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; Dahl NK, 2003, J BIOL CHEM, V278, P44949, DOI 10.1074/jbc.M308660200; Deng YJ, 2008, MOL PHARMACOL, V73, P1274, DOI 10.1124/mol.107.043190; DIXON KH, 1994, J BIOL CHEM, V269, P17; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; FRY DW, 1982, J BIOL CHEM, V257, P1890; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; HICKMAN RK, 1988, J BACTERIOL, V170, P1715, DOI 10.1128/jb.170.4.1715-1720.1988; Horschitz S, 2008, NEUROCHEM INT, V52, P770, DOI 10.1016/j.neuint.2007.09.005; Hou ZJ, 2006, J BIOL CHEM, V281, P33588, DOI 10.1074/jbc.M607049200; Hou ZJ, 2005, J BIOL CHEM, V280, P36206, DOI 10.1074/jbc.M507295200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Kneuer C, 2005, CELL TISSUE RES, V320, P517, DOI 10.1007/s00441-005-1092-x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matherly LH, 2008, VITAM HORM, V79, P145, DOI 10.1016/S0083-6729(08)00405-6; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; Matherly Larry H., 2004, Current Pharmacogenomics, V2, P287, DOI 10.2174/1570160043377547; MATHERLY LH, 1991, CANCER RES, V51, P3420; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Payton SG, 2007, BBA-GENE STRUCT EXPR, V1769, P131, DOI 10.1016/j.bbaexp.2006.12.006; Regeer RR, 2007, INT J BIOCHEM CELL B, V39, P2240, DOI 10.1016/j.biocel.2007.06.015; Sadlish H, 2002, J BIOL CHEM, V277, P42105, DOI 10.1074/jbc.M206459200; Sharina IG, 2001, MOL PHARMACOL, V59, P1022, DOI 10.1124/mol.59.5.1022; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Sitte HH, 2003, EUR J PHARMACOL, V479, P229, DOI 10.1016/j.ejphar.2003.08.072; Spector R, 2006, PHARM RES-DORDR, V23, P2515, DOI 10.1007/s11095-006-9091-5; Stokstad ELR, 1990, FOLIC ACID METABOLIS, P1; SWEIRY JH, 1985, BIOCHIM BIOPHYS ACTA, V821, P497, DOI 10.1016/0005-2736(85)90055-0; Taylor AM, 2001, BIOCHEM J, V359, P661, DOI 10.1042/0264-6021:3590661; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; Veenhoff LM, 2001, EMBO J, V20, P3056, DOI 10.1093/emboj/20.12.3056; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Witt TL, 2004, J BIOL CHEM, V279, P46755, DOI 10.1074/jbc.M408696200; WONG SC, 1995, J BIOL CHEM, V270, P17468, DOI 10.1074/jbc.270.29.17468; Wong SC, 1998, BBA-BIOMEMBRANES, V1375, P6, DOI 10.1016/S0005-2736(98)00118-7; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044; Yin CC, 2000, MOL MICROBIOL, V38, P482, DOI 10.1046/j.1365-2958.2000.02149.x; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2003, ONCOGENE, V22, P7431, DOI 10.1038/sj.onc.1206946; Zhao RB, 2007, CANCER METAST REV, V26, P129, DOI 10.1007/s10555-007-9047-1; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	48	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3285	3293		10.1074/jbc.M807206200	http://dx.doi.org/10.1074/jbc.M807206200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19019821	Green Published, hybrid			2022-12-25	WOS:000262700900071
J	Zhang, Z; Xing, JP; Ma, L; Gong, RJ; Chin, YE; Zhuang, SG				Zhang, Zhu; Xing, Jingping; Ma, Li; Gong, Rujun; Chin, Y. Eugene; Zhuang, Shougang			Transglutaminase-1 Regulates Renal Epithelial Cell Proliferation through Activation of Stat-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; KINASE-ACTIVITY; GROWTH; PHOSPHORYLATION; EXPRESSION; STRESS; CANCER; INHIBITION; SUBSTRATE; PATHWAY	Transglutaminase-1 (TGase-1) is a Ca2+-dependent enzyme capable of cross-linking a variety of proteins and promoting wound healing in the skin. In this study, we examined the role of TGase-1 in proliferation of renal proximal tubular cells (RPTC). TGase-1, but not TGase-2, -5, and -7, was expressed in RPTC. Treatment with monodansylcadarevine (MDC), a selective TGase inhibitor or down-regulation of TGase-1 with small interfering RNA (siRNA) decreased RPTC proliferation. Proliferation of RPTC was accompanied by activation of Akt and Stat-3 (signal transducer and activator of transcription-3). Treatment with MDC or TGase-1 siRNA decreased Stat-3 but not Akt phosphorylation. Further studies showed that the Janus-activated kinase 2 (JAK2) mediates phosphorylation of Stat-3, and knockdown of either JAK2 or Stat-3 by siRNA decreased RPTC proliferation. However, inhibition of TGase-1 decreased phosphorylation of Stat-3 but not JAK2. Overexpression of Stat-3, JAK2, and/or TGase-1 in RPTC revealed that JAK2 is indispensable for TGase-1 to induce Stat-3 phosphorylation and TGase-1 potentiates JAK2-induced Stat-3 phosphorylation. Consistent with these observations, we found that inhibition of TGase-1 and the JAK2-Stat-3 signaling pathway decreased the transcriptional activity of Stat-3 and expression of the Stat-3-targeted genes, cyclin D1 and cyclin E. Conversely, overexpresssion of TGase-1 enhanced the JAK2-dependent transcriptional activity of Stat-3. Finally, TGase-1 was found to interact with JAK2, and this interaction was inhibited by MDC. These results demonstrate that TGase-1 plays an important role in regulation of renal epithelial cell proliferation through the JAK2-Stat-3 signaling pathway.	[Zhang, Zhu; Xing, Jingping; Gong, Rujun; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Med, Providence, RI 02903 USA; [Ma, Li; Chin, Y. Eugene] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Zhuang, SG (corresponding author), Brown Univ, Rhode Isl Hosp, Sch Med, Dept Med, Middle House 301,593 Eddy St, Providence, RI 02903 USA.	szhuang@lifespan.org	Zhang, Zhu/A-2575-2012		National Institutes of Health [DK-071997]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-071997. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arany I, 2006, KIDNEY INT, V70, P669, DOI 10.1038/sj.ki.5001604; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Colman H, 2006, AM J SURG PATHOL, V30, P657, DOI 10.1097/01.pas.0000202048.28203.25; ERNEST S, 1995, AM J PHYSIOL-CELL PH, V269, pC323, DOI 10.1152/ajpcell.1995.269.2.C323; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Hiiragi T, 1999, J BIOL CHEM, V274, P34148, DOI 10.1074/jbc.274.48.34148; Ientile R, 2007, AMINO ACIDS, V33, P385, DOI 10.1007/s00726-007-0517-0; Inada R, 2000, AM J PATHOL, V157, P1875, DOI 10.1016/S0002-9440(10)64826-2; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; KIM SY, 1995, J BIOL CHEM, V270, P18026, DOI 10.1074/jbc.270.30.18026; Klampfer L, 2008, FRONT BIOSCI-LANDMRK, V13, P2888, DOI 10.2741/2893; Kwon DS, 2006, EUR J CELL BIOL, V85, P1189, DOI 10.1016/j.ejcb.2006.06.001; Lee YM, 2006, CELL CYCLE, V5, P2110, DOI 10.4161/cc.5.18.3218; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Martinet N, 2003, AM J RESP CELL MOL, V28, P428, DOI 10.1165/rcmb.2002-0114OC; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Mishra S, 2006, J BIOL CHEM, V281, P5532, DOI 10.1074/jbc.M506864200; Mishra S, 2006, BIOCHEM BIOPH RES CO, V339, P726, DOI 10.1016/j.bbrc.2005.11.071; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Nony PA, 2003, J PHARMACOL EXP THER, V304, P905, DOI 10.1124/jpet.102.035022; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Odajima J, 2000, J BIOL CHEM, V275, P24096, DOI 10.1074/jbc.M001606200; PERRY MJM, 1995, NEUROSCIENCE, V65, P1063, DOI 10.1016/0306-4522(94)00556-K; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shetty S, 2006, AM J PHYSIOL-LUNG C, V291, pL772, DOI 10.1152/ajplung.00476.2005; Shin DM, 2004, J BIOL CHEM, V279, P15032, DOI 10.1074/jbc.M308734200; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Stephanou A, 2005, GROWTH FACTORS, V23, P177, DOI 10.1080/08977190500178745; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Xing JP, 2008, AM J PHYSIOL-RENAL, V295, pF145, DOI 10.1152/ajprenal.00092.2008; Zhuang SG, 2004, AM J PHYSIOL-RENAL, V287, pF365, DOI 10.1152/ajprenal.00035.2004; Zhuang S, 2008, AM J PHYSIOL-RENAL, V294, pF459, DOI 10.1152/ajprenal.00473.2007	43	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3345	3353		10.1074/jbc.M808396200	http://dx.doi.org/10.1074/jbc.M808396200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049964	hybrid, Green Published			2022-12-25	WOS:000262700900077
J	Bakker, H; Oka, T; Ashikov, A; Yadav, A; Berger, M; Rana, NA; Bai, XM; Jigami, Y; Haltiwanger, RS; Esko, JD; Gerardy-Schahn, R				Bakker, Hans; Oka, Takuji; Ashikov, Angel; Yadav, Ajit; Berger, Monika; Rana, Nadia A.; Bai, Xiaomei; Jigami, Yoshifumi; Haltiwanger, Robert S.; Esko, Jeffrey D.; Gerardy-Schahn, Rita			Functional UDP-xylose Transport across the Endoplasmic Reticulum/Golgi Membrane in a Chinese Hamster Ovary Cell Mutant Defective in UDP-xylose Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-LIKE; GLUCURONIC ACID DECARBOXYLASE; NUCLEOTIDE-SUGAR TRANSPORTER; FUNGUS CRYPTOCOCCUS-NEOFORMANS; HEPARAN-SULFATE BIOSYNTHESIS; PROTEOGLYCAN CORE PROTEIN; SUBSTRATE-SPECIFICITY; XT-II; N-ACETYLGLUCOSAMINYLTRANSFERASE; SUBCELLULAR-LOCALIZATION	In mammals, xylose is found as the first sugar residue of the tetrasaccharide GlcA beta 1-3Gal beta 1-3Gal beta 1-4Xyl beta 1-O-Ser, initiating the formation of the glycosaminoglycans heparin/heparan sulfate and chondroitin/dermatan sulfate. It is also found in the trisaccharide Xyl alpha 1-3Xyl alpha 1-3Glc beta 1-O-Ser on epidermal growth factor repeats of proteins, such as Notch. UDP-xylose synthase (UXS), which catalyzes the formation of the UDP-xylose substrate for the different xylosyltransferases through decarboxylation of UDP-glucuronic acid, resides in the endoplasmic reticulum and/or Golgi lumen. Since xylosylation takes place in these organelles, no obvious requirement exists for membrane transport of UDP-xylose. However, UDP-xylose transport across isolated Golgi membranes has been documented, and we recently succeeded with the cloning of a human UDP-xylose transporter (SLC25B4). Here we provide new evidence for a functional role of UDP-xylose transport by characterization of a new Chinese hamster ovary cell mutant, designated pgsI-208, that lacks UXS activity. The mutant fails to initiate glycosaminoglycan synthesis and is not capable of xylosylating Notch. Complementation was achieved by expression of a cytoplasmic variant of UXS, which proves the existence of a functional Golgi UDP-xylose transporter. A similar to 200 fold increase of UDP-glucuronic acid occurred in pgsI-208 cells, demonstrating a lack of UDP-xylose-mediated control of the cytoplasmically localized UDP-glucose dehydrogenase in the mutant. The data presented in this study suggest the bidirectional transport of UDP-xylose across endoplasmic reticulum/Golgi membranes and its role in controlling homeostasis of UDP-glucuronic acid and UDP-xylose production.	[Bakker, Hans; Ashikov, Angel; Yadav, Ajit; Berger, Monika; Gerardy-Schahn, Rita] Hannover Med Sch, Zentrum Biochem, D-30625 Hannover, Germany; [Oka, Takuji; Jigami, Yoshifumi] Natl Inst Adv Ind Sci & Technol, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan; [Rana, Nadia A.; Haltiwanger, Robert S.] SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Bai, Xiaomei; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Hannover Medical School; National Institute of Advanced Industrial Science & Technology (AIST); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego	Bakker, H (corresponding author), Hannover Med Sch, Zentrum Biochem, Zellulare Chem OE 4330,Carl Neuberg Str 1, D-30625 Hannover, Germany.	bakker.hans@mh-hannover.de	Bakker, Hans/A-1787-2017; Ashikov, Angel/N-7714-2015; Bakker, Hans/AAA-1623-2020	Bakker, Hans/0000-0002-1364-9154; Ashikov, Angel/0000-0001-9679-7955; Bakker, Hans/0000-0002-1364-9154; Oka, Takuji/0000-0002-5691-654X	National Institutes of Health [GM33063, GM61126]; Deutsche Forschungsgemeinschaft (DFG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063, R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33063 (to J. D. E.) and GM61126 (to R. S. H.). This work was also supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) for the Junior Research Group "Glycomics" established under the roof of REBIRTH, a DFG cluster of Excellence (to R. G.- S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bakker H, 1999, BIOCHEM BIOPH RES CO, V261, P829, DOI 10.1006/bbrc.1999.1117; BAME KJ, 1989, J BIOL CHEM, V264, P8059; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Bossuyt X, 2001, J HEPATOL, V34, P210, DOI 10.1016/S0168-8278(00)00083-0; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; ELBEIN AD, 2003, Patent No. 20030166012; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1992, ADV EXP MED BIOL, V313, P97; ESKO JD, 1989, METHOD CELL BIOL, V32, P387; FAYE L, 1993, ANAL BIOCHEM, V209, P104, DOI 10.1006/abio.1993.1088; GEETHAHABIB M, 1984, J BIOL CHEM, V259, P7300; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; HASE S, 1988, J BIOCHEM-TOKYO, V104, P867, DOI 10.1093/oxfordjournals.jbchem.a122571; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; Ishimizu T, 2007, J BIOCHEM, V141, P593, DOI 10.1093/jb/mvm064; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; KEARNS AE, 1993, J BIOL CHEM, V268, P11097; Kobayashi M, 2002, PLANT CELL PHYSIOL, V43, P1259, DOI 10.1093/pcp/pcf157; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Minamida S, 1996, J BIOCHEM-TOKYO, V120, P1002; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moriarity JL, 2002, J BIOL CHEM, V277, P16968, DOI 10.1074/jbc.M109316200; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; NEUFELD EF, 1965, BIOCHEM BIOPH RES CO, V19, P456, DOI 10.1016/0006-291X(65)90146-4; Nita-Lazar A, 2006, METHOD ENZYMOL, V417, P93, DOI 10.1016/S0076-6879(06)17008-1; NUWAYHID N, 1986, J BIOL CHEM, V261, P2936; Oka T, 2006, FEBS J, V273, P2645, DOI 10.1111/j.1742-4658.2006.05281.x; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Omichi K, 1997, EUR J BIOCHEM, V245, P143, DOI 10.1111/j.1432-1033.1997.00143.x; Ponighaus C, 2007, J BIOL CHEM, V282, P5201, DOI 10.1074/jbc.M611665200; RODEN L, 1966, J BIOL CHEM, V241, P65; Schon S, 2006, J BIOL CHEM, V281, P14224, DOI 10.1074/jbc.M510690200; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; SIMINOVITCH L, 1976, CELL, V7, P1, DOI 10.1016/0092-8674(76)90249-X; Strasser R, 2000, FEBS LETT, V472, P105, DOI 10.1016/S0014-5793(00)01443-5; ten Dam GB, 2003, J HISTOCHEM CYTOCHEM, V51, P727; Voglmeir J, 2007, J BIOL CHEM, V282, P5984, DOI 10.1074/jbc.M608087200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Zhang LJ, 2001, J BIOL CHEM, V276, P42311, DOI 10.1074/jbc.M101441200	52	42	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2576	2583		10.1074/jbc.M804394200	http://dx.doi.org/10.1074/jbc.M804394200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028698	Green Published, hybrid			2022-12-25	WOS:000262545600062
J	Blanco-Garcia, N; Asensio-Juan, E; de la Cruz, X; Martinez-Balbas, MA				Blanco-Garcia, Noemi; Asensio-Juan, Elena; de la Cruz, Xavier; Martinez-Balbas, Marian A.			Autoacetylation Regulates P/CAF Nuclear Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; FUNCTION IN-VIVO; DNA-DAMAGE; PCAF CONTROLS; ACETYLATION; P53; APOPTOSIS; TRANSCRIPTION; PHOSPHORYLATION; P300	Acetylation is a posttranslational modification that alters the biological activities of proteins by affecting their association with other proteins or DNA, their catalytic activities, or their subcellular distribution. The acetyltransferase P/CAF is autoacetylated and acetylated by p300 in vivo. P/CAF autoacetylation is an intramolecular or intermolecular event. Intramolecular acetylation targets five lysines within the nuclear localization signal at the P/CAF C terminus. We analyzed how the subcellular distribution of P/CAF is regulated by intramolecular autoacetylation and found that a P/CAF mutant lacking histone acetyltransferase activity accumulated primarily in the cytoplasm. This cytoplasmic fraction of P/CAF is enriched for nonautoacetylated P/CAF. In addition, P/CAF deacetylation by HDAC3 and in a minor degree by HDAC1, HDAC2, or HDAC4 leads to cytoplasmic accumulation of P/CAF. Importantly, our data show that P/CAF accumulates in the cytoplasm during apoptosis. These results reveal the molecular mechanism of autoacetylation control of P/CAF nuclear translocation and suggest a novel pathway by which P/CAF activity is controlled in vivo.	[Blanco-Garcia, Noemi; Asensio-Juan, Elena; Martinez-Balbas, Marian A.] CSIC, Inst Mol Biol, E-08028 Barcelona, Spain; [de la Cruz, Xavier] Inst Catala Recerca & Estudis Avancats, E-08018 Barcelona, Spain; [de la Cruz, Xavier] IRB, Inst Mol Biol, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Martinez-Balbas, MA (corresponding author), CSIC, Inst Mol Biol, Baldiri & Reixac 15-21,Parc Cient Barcelona, E-08028 Barcelona, Spain.	mmbbmc@ibmb.csic.es		De la Cruz Montserrat, Fco. Xavier/0000-0002-9738-8472; Martinez-Balbas, Marian/0000-0003-0173-0964	Spanish Ministry of Education and Science [Gen2003-20642, SAF2005-01285, BFU2006-01493, CSD2006-00049, BIO2006-15557]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported by Spanish Ministry of Education and Science Grants Gen2003-20642, SAF2005-01285, BFU2006-01493, CSD2006-00049,and BIO2006-15557. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Boix-Chornet M, 2006, J BIOL CHEM, V281, P13540, DOI 10.1074/jbc.M601136200; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Candau R, 1997, EMBO J, V16, P555, DOI 10.1093/emboj/16.3.555; Chan HM, 2001, J CELL SCI, V114, P2363; Chao C, 2006, MOL CELL BIOL, V26, P6859, DOI 10.1128/MCB.00062-06; Chen CJ, 2001, MOL CELL BIOL, V21, P476, DOI 10.1128/MCB.21.2.476-487.2001; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; di Bari MG, 2006, EMBO REP, V7, P727, DOI 10.1038/sj.embor.7400700; Escaffit F, 2007, MOL CELL BIOL, V27, P554, DOI 10.1128/MCB.00869-06; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gay F, 2003, GENE DEV, V17, P717, DOI 10.1101/gad.1042403; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Kratzmeier M, 2000, J BIOL CHEM, V275, P30478, DOI 10.1074/jbc.M003956200; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Madison DL, 2002, J BIOL CHEM, V277, P38755, DOI 10.1074/jbc.M207512200; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McLaughlin F, 2004, BIOCHEM PHARMACOL, V68, P1139, DOI 10.1016/j.bcp.2004.05.034; Mimnaugh EG, 2001, CELL DEATH DIFFER, V8, P1182, DOI 10.1038/sj.cdd.4400924; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Reid JL, 1998, EMBO J, V17, P4469, DOI 10.1093/emboj/17.15.4469; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; Thevenet L, 2004, EMBO J, V23, P3336, DOI 10.1038/sj.emboj.7600352; Valls E, 2005, J BIOL CHEM, V280, P42592, DOI 10.1074/jbc.M507407200; Valls E, 2003, NUCLEIC ACIDS RES, V31, P3114, DOI 10.1093/nar/gkg418; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; Wong DS, 2004, J BIOL CHEM, V279, P55667, DOI 10.1074/jbc.M408174200; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamagoe S, 2003, MOL CELL BIOL, V23, P1025, DOI 10.1128/MCB.23.3.1025-1033.2003; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yuan LW, 2002, BBA-MOL CELL RES, V1592, P205, DOI 10.1016/S0167-4889(02)00327-0; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200; Zhao LY, 2003, ONCOGENE, V22, P8316, DOI 10.1038/sj.onc.1206916	59	53	54	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1343	1352		10.1074/jbc.M806075200	http://dx.doi.org/10.1074/jbc.M806075200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015268	Green Submitted, hybrid			2022-12-25	WOS:000262330100002
J	Watanabe, T; Kubota, N; Ohsugi, M; Kubota, T; Takamoto, I; Iwabu, M; Awazawa, M; Katsuyama, H; Hasegawa, C; Tokuyama, K; Moroi, M; Sugi, K; Yamauchi, T; Noda, T; Nagai, R; Terauchi, Y; Tobe, K; Ueki, K; Kadowaki, T				Watanabe, Taku; Kubota, Naoto; Ohsugi, Mitsuru; Kubota, Tetsuya; Takamoto, Iseki; Iwabu, Masato; Awazawa, Motoharu; Katsuyama, Hisayuki; Hasegawa, Chiaki; Tokuyama, Kumpei; Moroi, Masao; Sugi, Kaoru; Yamauchi, Toshimasa; Noda, Tetsuo; Nagai, Ryozo; Terauchi, Yasuo; Tobe, Kazuyuki; Ueki, Kohjiro; Kadowaki, Takashi			Rimonabant Ameliorates Insulin Resistance via both Adiponectin-dependent and Adiponectin-independent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CB1 RECEPTOR ANTAGONIST; ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; ENDOGENOUS CANNABINOID SYSTEM; NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; RISK-FACTORS; OVERWEIGHT PATIENTS; HEPATIC STEATOSIS; WEIGHT-LOSS	Rimonabant has been shown to not only decrease the food intake and body weight but also to increase serum adiponectin levels. This increase of the serum adiponectin levels has been hypothesized to be related to the rimonabant-induced amelioration of insulin resistance linked to obesity, although experimental evidence to support this hypothesis is lacking. To test this hypothesis experimentally, we generated adiponectin knock-out (adipo(-/-)) ob/ob mice. After 21 days of 30 mg/kg rimonabant, the body weight and food intake decreased to similar degrees in the ob/ob and adipo(-/-)ob/ob mice. Significant improvement of insulin resistance was observed in the ob/ob mice following rimonabant treatment, associated with significant up-regulation of the plasma adiponectin levels, in particular, of high molecular weight adiponectin. Amelioration of insulin resistance in the ob/ob mice was attributed to the decrease of glucose production and activation of AMP-activated protein kinase (AMPK) in the liver induced by rimonabant but not to increased glucose uptake by the skeletal muscle. Interestingly, the rimonabant-treated adipo(-/-) ob/ob mice also exhibited significant amelioration of insulin resistance, although the degree of improvement was significantly lower as compared with that in the ob/ob mice. The effects of rimonabant on the liver metabolism, namely decrease of glucose production and activation of AMPK, were also less pronounced in the adipo(-/-)ob/ob mice. Thus, it was concluded that rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways.	[Kadowaki, Takashi] Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Nagai, Ryozo] Univ Tokyo, Dept Cardiovasc Dis, Grad Sch Med, Tokyo 1138655, Japan; [Watanabe, Taku] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 0608648, Japan; [Kubota, Naoto; Awazawa, Motoharu; Katsuyama, Hisayuki; Kadowaki, Takashi] Natl Inst Hlth & Nutr, Div Appl Nutr, Tokyo 1628636, Japan; [Kubota, Tetsuya; Moroi, Masao; Sugi, Kaoru] Toho Univ, Ohashi Hosp, Div Cardiovasc Med, Tokyo 1538515, Japan; [Hasegawa, Chiaki; Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3050006, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 1358550, Japan; [Terauchi, Yasuo] Yokohama City Univ, Sch Med, Dept Diabet & Endocrinol, Kanagawa 2360004, Japan; [Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Fac Med, Toyama 9300194, Japan	University of Tokyo; University of Tokyo; Hokkaido University; National Institute of Health & Nutrition - Japan; Toho University; University of Tsukuba; Japanese Foundation for Cancer Research; Yokohama City University; University of Toyama	Kadowaki, T (corresponding author), Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kadowaki-3im@h.u-tokyo.ac.jp	Noda, Tetsuo/B-1667-2016; Terauchi, Yasuo/AAO-4347-2020; Kubota, Naoto/N-7892-2015; Watanabe, Taku/H-2083-2012	Watanabe, Taku/0000-0002-3195-2413	Ministry of Education, Culture, Sports, Science and Technology of Japan [16209030, 18209033]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( for the Translational Systems Biology and Medicine Initiative), Grant-in-Aid for Scientific Research in Priority Areas (A) 16209030 and (A) 18209033 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Addy C, 2008, CELL METAB, V7, P68, DOI 10.1016/j.cmet.2007.11.012; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Chin ML, 2008, ANESTH ANALG, V107, P4, DOI 10.1213/ane.0b013e3181788ca3; Costa B, 2007, BRIT J PHARMACOL, V150, P535, DOI 10.1038/sj.bjp.0707139; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cota D, 2003, INT J OBESITY, V27, P289, DOI 10.1038/sj.ijo.0802250; Croci T, 2003, BRIT J PHARMACOL, V140, P115, DOI 10.1038/sj.bjp.0705412; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gary-Bobo M, 2006, MOL PHARMACOL, V69, P471, DOI 10.1124/mol.105.015040; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Hada Y, 2007, BIOCHEM BIOPH RES CO, V356, P487, DOI 10.1016/j.bbrc.2007.03.004; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hosking RD, 2008, BRIT J ANAESTH, V101, P59, DOI 10.1093/bja/aen119; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Hurley RW, 2008, ANESTH ANALG, V107, P309, DOI 10.1213/01.ane.0b013e31816ba437; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Schafers M, 2003, EUR J NEUROSCI, V17, P791, DOI 10.1046/j.1460-9568.2003.02504.x; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Xie S, 2007, J CLIN PHARM THER, V32, P209, DOI 10.1111/j.1365-2710.2007.00817.x; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	52	40	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1803	1812		10.1074/jbc.M807120200	http://dx.doi.org/10.1074/jbc.M807120200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19008231	hybrid			2022-12-25	WOS:000262330100051
J	Lewkowich, IP; Lajoie, S; Clark, JR; Herman, NS; Sproles, AA; Wills-Karp, M				Lewkowich, Ian P.; Lajoie, Stephane; Clark, Jennifer R.; Herman, Nancy S.; Sproles, Alyssa A.; Wills-Karp, Marsha			Allergen Uptake, Activation, and IL-23 Production by Pulmonary Myeloid DCs Drives Airway Hyperresponsiveness in Asthma-Susceptible Mice	PLOS ONE			English	Article								Maladaptive, Th2-polarized inflammatory responses are integral to the pathogenesis of allergic asthma. As regulators of T cell activation, dendritic cells (DCs) are important mediators of allergic asthma, yet the precise signals which render endogenous DCs "pro-asthmatic'', and the extent to which these signals are regulated by the pulmonary environment and host genetics, remains unclear. Comparative phenotypic and functional analysis of pulmonary DC populations in mice susceptible (A/J), or resistant (C3H) to experimental asthma, revealed that susceptibility to airway hyperresponsiveness is associated with preferential myeloid DC (mDC) allergen uptake, and production of Th17-skewing cytokines (IL-6, IL-23), whereas resistance is associated with increased allergen uptake by plasmacytoid DCs. Surprisingly, adoptive transfer of syngeneic HDM-pulsed bone marrow derived mDCs (BMDCs) to the lungs of C3H mice markedly enhanced lung IL-17A production, and rendered them susceptible to allergen-driven airway hyperresponsiveness. Characterization of these BMDCs revealed levels of antigen uptake, and Th17 promoting cytokine production similar to that observed in pulmonary mDCs from susceptible A/J mice. Collectively these data demonstrate that the lung environment present in asthma-resistant mice promotes robust pDC allergen uptake, activation, and limits Th17-skewing cytokine production responsible for driving pathologic T cell responses central to the development of allergen-induced airway hyperresponsiveness.	[Lewkowich, Ian P.; Lajoie, Stephane; Clark, Jennifer R.; Herman, Nancy S.; Sproles, Alyssa A.; Wills-Karp, Marsha] Univ Cincinnati, Med Ctr, Coll Med, Cincinnati Childrens Hosp,Div Immunobiol, Cincinnati, OH 45267 USA; [Wills-Karp, Marsha] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Lewkowich, IP (corresponding author), Univ Cincinnati, Med Ctr, Coll Med, Cincinnati Childrens Hosp,Div Immunobiol, Cincinnati, OH 45267 USA.	wildc7@cchmc.org		Lajoie, Stephane/0000-0002-0514-1801	NHLBI [HL67736, HL076383]; NIH [AR47363]; American Lung Association [Senior Research Training Fellowship]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067736, P01HL076383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NHLBI grants HL67736 and HL076383 to MWK, and NIH grant AR47363 to support the flow cytometry core at Cincinnati Children's Hospital Medical Center. IPL is the recipient of a Senior Research Training Fellowship from the American Lung Association. The authors have no conflicting financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 1997, CELL IMMUNOL, V181, P86, DOI 10.1006/cimm.1997.1180; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Betti M, 2006, ANN ONCOL, V17, P235; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Cates EC, 2003, J ALLERGY CLIN IMMUN, V111, P1076, DOI 10.1067/mai.2003.1460; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Deurloo DT, 2003, CLIN EXP ALLERGY, V33, P1297, DOI 10.1046/j.1365-2222.2003.01757.x; Ebner S, 2002, J IMMUNOL, V168, P6199, DOI 10.4049/jimmunol.168.12.6199; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Faith A, 2005, J ALLERGY CLIN IMMUN, V116, P1136, DOI 10.1016/j.jaci.2005.08.002; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Finkelman FD, 2005, J IMMUNOL, V174, P4630, DOI 10.4049/jimmunol.174.8.4630; FUKUSHIMA A, 2006, BR J OPHTHALMOL; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Graffi SJ, 2002, CLIN IMMUNOL, V103, P176, DOI 10.1006/clim.2002.5190; Hashimoto T, 2005, INT ARCH ALLERGY IMM, V137, P51, DOI 10.1159/000085432; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hewitt CRA, 1997, CLIN EXP ALLERGY, V27, P201, DOI 10.1111/j.1365-2222.1997.tb00694.x; Holt Patrick G, 2005, Proc Am Thorac Soc, V2, P116, DOI 10.1513/pats.200502-017AW; HOLT PG, 1988, J EXP MED, V167, P262, DOI 10.1084/jem.167.2.262; Hoshino A, 2003, EUR J IMMUNOL, V33, P861, DOI 10.1002/eji.200323455; Huh JC, 2003, J EXP MED, V198, P19, DOI 10.1084/jem.20021328; Ito T, 2004, J IMMUNOL, V172, P4253, DOI 10.4049/jimmunol.172.7.4253; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; KATAMURA K, 1995, J IMMUNOL, V155, P4604; Keane-Myers A, 1998, J IMMUNOL, V161, P919; Keane-Myers AM, 1998, J IMMUNOL, V160, P1036; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Lambrecht BN, 2000, CLIN EXP ALLERGY, V30, P214; Lambrecht BN, 2000, J IMMUNOL, V164, P2937, DOI 10.4049/jimmunol.164.6.2937; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Matsumoto K, 2004, J IMMUNOL, V172, P2530, DOI 10.4049/jimmunol.172.4.2530; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Oflazoglu E, 2004, EUR J IMMUNOL, V34, P3326, DOI 10.1002/eji.200425197; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Piconi S, 2007, J IMMUNOL, V178, P1931, DOI 10.4049/jimmunol.178.3.1931; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Ritz SA, 2002, AM J RESP CELL MOL, V27, P428, DOI 10.1165/rcmb.4824; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schulz O, 1997, EUR J IMMUNOL, V27, P584, DOI 10.1002/eji.1830270303; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Sung SSJ, 2001, J IMMUNOL, V166, P1261, DOI 10.4049/jimmunol.166.2.1261; Tokita D, 2008, TRANSPLANTATION, V85, P369, DOI 10.1097/TP.0b013e3181612ded; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wan H, 2000, CLIN EXP ALLERGY, V30, P685, DOI 10.1046/j.1365-2222.2000.00820.x; Wang YL, 2006, LIVER TRANSPLANT, V12, P1850, DOI 10.1002/lt.20919; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258	76	79	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3879	10.1371/journal.pone.0003879	http://dx.doi.org/10.1371/journal.pone.0003879			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060952	Green Published, Green Submitted, gold			2022-12-25	WOS:000265455100004
J	Montag, C; Schubert, F; Heinz, A; Gallinat, J				Montag, Christiane; Schubert, Florian; Heinz, Andreas; Gallinat, Juergen			Prefrontal Cortex Glutamate Correlates with Mental Perspective-Taking	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MRS; INDIVIDUAL-DIFFERENCES; SCHIZOPHRENIA; EMPATHY; HIPPOCAMPAL; AUTISM; MIND; STIMULATION; REGIONS	Background: Dysfunctions in theory of mind and empathic abilities have been suggested as core symptoms in major psychiatric disorders including schizophrenia and autism. Since self monitoring, perspective taking and empathy have been linked to prefrontal (PFC) and anterior cingulate cortex (ACC) function, neurotransmitter variations in these areas may account for normal and pathological variations of these functions. Converging evidence indicates an essential role of glutamatergic neurotransmission in psychiatric diseases with pronounced deficits in empathy. However, the role of the glutamate system for different dimensions of empathy has not been investigated so far. Methodology/Principal Findings: Absolute concentrations of cerebral glutamate in the ACC, left dorsolateral PFC and left hippocampus were determined by 3-tesla proton magnetic resonance spectroscopy (1H-MRS) in 17 healthy individuals. Three dimensions of empathy were estimated by a self-rating questionnaire, the Interpersonal Reactivity Index (IRI). Linear regression analysis showed that dorsolateral PFC glutamate concentration was predicted by IRI factor "perspective taking'' (T = 22.710, p = 0.018; adjusted alpha-level of 0.017, Bonferroni) but not by "empathic concern'' or "personal distress''. No significant relationship between IRI subscores and the glutamate levels in the ACC or left hippocampus was detected. Conclusions/Significance: This is the first study to investigate the role of the glutamate system for dimensions of theory of mind and empathy. Results are in line with recent concepts that executive top-down control of behavior is mediated by prefrontal glutamatergic projections. This is a preliminary finding that needs a replication in an independent sample.	[Heinz, Andreas; Gallinat, Juergen] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Schubert, Florian] Phys Tech Bundesanstalt Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Physikalisch-Technische Bundesanstalt (PTB)	Montag, C (corresponding author), Charite, Dept Psychiat & Psychotherapy, Campus Mitte, D-13353 Berlin, Germany.	christiane.montag@charite.de	Heinz, Andreas/ABB-7736-2020	Heinz, Andreas/0000-0001-5405-9065; Montag, Christiane/0000-0002-3307-276X	German Federal Ministry of Education and Research [01G00208]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Support from the German Federal Ministry of Education and Research (BMBF, Project Berlin Neuroimaging Center, No. 01G00208), is gratefully acknowledged. The German Federal Ministry of Education and Research had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Blasi G, 2006, EUR J NEUROSCI, V23, P1658, DOI 10.1111/j.1460-9568.2006.04680.x; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Brunet-Gouet E, 2006, PSYCHIAT RES-NEUROIM, V148, P75, DOI 10.1016/j.pscychresns.2006.05.001; Carlson SM, 2004, J EXP CHILD PSYCHOL, V87, P299, DOI 10.1016/j.jecp.2004.01.002; Castner SA, 2007, BRAIN COGNITION, V63, P94, DOI 10.1016/j.bandc.2006.11.002; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Deakin JFW, 2008, ARCH GEN PSYCHIAT, V65, P154, DOI 10.1001/archgenpsychiatry.2007.37; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Elster C, 2005, MAGN RESON MED, V53, P1288, DOI 10.1002/mrm.20500; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallinat J, 2007, NEUROIMAGE, V34, P671, DOI 10.1016/j.neuroimage.2006.10.004; Gallinat J, 2006, PSYCHOPHARMACOLOGY, V187, P103, DOI 10.1007/s00213-006-0397-0; Harich S, 2007, PSYCHOPHARMACOLOGY, V192, P511, DOI 10.1007/s00213-007-0742-y; Janssen I, 2003, ACTA PSYCHIAT SCAND, V108, P110, DOI 10.1034/j.1600-0447.2003.00092.x; Langdon R, 2004, PSYCHIAT RES, V125, P9, DOI 10.1016/j.psychres.2003.10.005; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Luborzewski A, 2007, J PSYCHIATR RES, V41, P606, DOI 10.1016/j.jpsychires.2006.02.003; McDougle CJ, 2005, J CLIN PSYCHIAT, V66, P9; Melendez RI, 2004, NEUROPSYCHOPHARMACOL, V29, P1980, DOI 10.1038/sj.npp.1300507; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Ohrmann P, 2007, J PSYCHIATR RES, V41, P625, DOI 10.1016/j.jpsychires.2006.07.002; Page LA, 2006, AM J PSYCHIAT, V163, P2189, DOI 10.1176/appi.ajp.163.12.2189; PAULUS C, 1992, EMPATHIE KOMPETENZ A; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Sanacora G, 2003, ANN NY ACAD SCI, V1003, P292, DOI 10.1196/annals.1300.018; Schubert F, 2004, NEUROIMAGE, V21, P1762, DOI 10.1016/j.neuroimage.2003.11.014; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Seitz RJ, 2006, NEUROPSYCHOLOGY, V20, P743, DOI 10.1037/0894-4105.20.6.743; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shinohe A, 2006, PROG NEURO-PSYCHOPH, V30, P1472, DOI 10.1016/j.pnpbp.2006.06.013; Theberge J, 2003, AM J PSYCHIAT, V160, P2231, DOI 10.1176/appi.ajp.160.12.2231; Theberge J, 2002, AM J PSYCHIAT, V159, P1944, DOI 10.1176/appi.ajp.159.11.1944; Tibbo P, 2004, AM J PSYCHIAT, V161, P1116, DOI 10.1176/appi.ajp.161.6.1116; van Elst LT, 2005, BIOL PSYCHIAT, V58, P724, DOI 10.1016/j.biopsych.2005.04.041	36	38	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3890	10.1371/journal.pone.0003890	http://dx.doi.org/10.1371/journal.pone.0003890			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZO	19060949	Green Submitted, Green Published, gold			2022-12-25	WOS:000265455100009
J	Terzibasi, E; Valenzano, DR; Benedetti, M; Roncaglia, P; Cattaneo, A; Domenici, L; Cellerino, A				Terzibasi, Eva; Valenzano, Dario Riccardo; Benedetti, Mauro; Roncaglia, Paola; Cattaneo, Antonino; Domenici, Luciano; Cellerino, Alessandro			Large Differences in Aging Phenotype between Strains of the Short-Lived Annual Fish Nothobranchius furzeri	PLOS ONE			English	Article							LIFE-SPAN; EXTRINSIC MORTALITY; SENESCENCE; EVOLUTION; AGE; MODEL; CYPRINODONTIFORMES; GENETICS	Background: A laboratory inbred strain of the annual fish Nothobranchius furzeri shows exceptionally short life expectancy and accelerated expression of age markers. In this study, we analyze new wild-derived lines of this short-lived species. Methodology/Principal Findings: We characterized captive survival and age-related traits in F1 and F2 offspring of wild-caught N. furzeri. Wild-derived N. furzeri lines showed expression of lipofuscin and neurodegeneration at age 21 weeks. Median lifespan in the laboratory varied from to 20 to 23 weeks and maximum lifespan from 25 to 32 weeks. These data demonstrate that rapid age-dependent decline and short lifespan are natural characteristics of this species. The N. furzeri distribution range overlaps with gradients in altitude and aridity. Fish from more arid habitats are expected to experience a shorter survival window in the wild. We tested whether captive lines stemming from semi-arid and sub-humid habitats differ in longevity and expression of age-related traits. We detected a clear difference in age-dependent cognitive decline and a slight difference in lifespan (16% for median, 15% for maximum lifespan) between these lines. Finally, we observed shorter lifespan and accelerated expression of age-related markers in the inbred laboratory strain compared to these wild-derived lines. Conclusions/Significance: Owing to large differences in aging phenotypes in different lines, N. furzeri could represent a model system for studying the genetic control of life-history traits in natural populations.	[Domenici, Luciano] CNR, Ist Neurosci, I-56100 Pisa, Italy; [Terzibasi, Eva; Cellerino, Alessandro] Leibniz Inst, Fritz Lipmann Inst Age Res, Jena, Germany; [Valenzano, Dario Riccardo; Cellerino, Alessandro] Scuola Normale Superiore, Pisa, Italy; [Valenzano, Dario Riccardo] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Benedetti, Mauro; Roncaglia, Paola; Cattaneo, Antonino] Int Sch Advanced Stud, Trieste, Italy; [Cattaneo, Antonino] European Brain Res Inst, Rome, Italy; [Domenici, Luciano] Univ LAquila, Sch Med, Laquila, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; Stanford University; International School for Advanced Studies (SISSA); University of L'Aquila	Terzibasi, E (corresponding author), CNR, Ist Neurosci, I-56100 Pisa, Italy.	acellerino@fli-leibniz.de	Cattaneo, Antonino/AAA-7252-2019; Cellerino, Alessandro/AAJ-7453-2020; Tozzini, Eva Terzibasi/J-9466-2016; Cattaneo, Antonino/K-4471-2016; Cellerino, Alessandro/M-9380-2013; terzibasi tozzini, eva/AEA-0204-2022; Cellerino, Alessandro/AAB-4398-2020	Cellerino, Alessandro/0000-0003-3834-0097; Tozzini, Eva Terzibasi/0000-0003-3317-1538; Cattaneo, Antonino/0000-0002-6975-8923; Cellerino, Alessandro/0000-0003-3834-0097; terzibasi tozzini, eva/0000-0003-3317-1538; Cellerino, Alessandro/0000-0003-3834-0097; Valenzano, Dario Riccardo/0000-0002-8761-8289; Domenici, Luciano/0000-0003-2923-9421; Roncaglia, Paola/0000-0002-2825-0621	LayLineGenomics S.p.A.; Scuola Normale Superiore; Leibniz Gemeinschaft	LayLineGenomics S.p.A.; Scuola Normale Superiore; Leibniz Gemeinschaft	This work was supported by LayLineGenomics S.p.A., Scuola Normale Superiore, and the Leibniz Gemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ABRAMS PA, 1991, EVOL ECOL, V5, P343, DOI 10.1007/BF02214152; Austad SN, 2004, J GERONTOL A-BIOL, V59, P99; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Blanco MA, 2005, MECH AGEING DEV, V126, P794, DOI 10.1016/j.mad.2005.02.006; BRUNK UT, 1992, MUTAT RES, V275, P395, DOI 10.1016/0921-8734(92)90042-N; Caswell H, 2007, TRENDS ECOL EVOL, V22, P173, DOI 10.1016/j.tree.2007.01.006; Foersch W, 1975, J AM GROWTH DEV AGIN, V8, P315; Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x; Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hendry AP, 2004, P ROY SOC B-BIOL SCI, V271, P259, DOI 10.1098/rspb.2003.2600; Hoback WW, 2000, J COMP PHYSIOL B, V170, P307, DOI 10.1007/s003600000104; Horiuchi J, 2005, AGEING RES REV, V4, P83, DOI 10.1016/j.arr.2004.10.001; JUBB R A, 1971, Journal of the American Killifish Association, V8, P12; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; LEVELS PJ, 1986, COMP BIOCHEM PHYS A, V84, P767, DOI 10.1016/0300-9629(86)90403-2; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Medawar P B., 1952, UNSOLVED PROBLEM BIO; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; Murphy WJ, 1997, MOL BIOL EVOL, V14, P790, DOI 10.1093/oxfordjournals.molbev.a025819; Podrabsky JE, 1999, J EXP BIOL, V202, P2567; Promislow DEL, 1998, GENETICA, V102-3, P299, DOI 10.1023/A:1017047212008; REICHARD M, 2008, J FISH BIOL IN PRESS; Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SGRO CM, 2000, AM NATUR, V156; SITNIKOVA T, 1995, MOL BIOL EVOL, V12, P319; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; Strauss RE, 1999, GROWTH DEVELOP AGING, V63, P151; Swindell WR, 2006, GENETICS, V172, P317, DOI 10.1534/genetics.105.045740; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TERZIBASI E, 2006, EXP GERONTOL; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048; Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2006, TRENDS ECOL EVOL, V21, P458, DOI 10.1016/j.tree.2006.05.008; WOOD T, 2000, BKA KILLI NEWS, V419, P105; Yu LL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000014	43	119	120	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3866	10.1371/journal.pone.0003866	http://dx.doi.org/10.1371/journal.pone.0003866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052641	Green Published, Green Submitted, gold			2022-12-25	WOS:000265452200012
J	Perron, GG; Quessy, S; Bell, G				Perron, Gabriel G.; Quessy, Sylvain; Bell, Graham			A Reservoir of Drug-Resistant Pathogenic Bacteria in Asymptomatic Hosts	PLOS ONE			English	Article							SEROTYPE TYPHIMURIUM DT104; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; UNITED-STATES; ANTIBACTERIAL RESISTANCE; MULTIDRUG-RESISTANCE; ADAPTIVE RADIATION; DNA POLYMORPHISM; SALMONELLA	The population genetics of pathogenic bacteria has been intensively studied in order to understand the spread of disease and the evolution of virulence and drug resistance. However, much less attention has been paid to bacterial carriage populations, which inhabit hosts without producing disease. Since new virulent strains that cause disease can be recruited from the carriage population of bacteria, our understanding of infectious disease is seriously incomplete without knowledge on the population structure of pathogenic bacteria living in an asymptomatic host. We report the first extensive survey of the abundance and diversity of a human pathogen in asymptomatic animal hosts. We have found that asymptomatic swine from livestock productions frequently carry populations of Salmonella enterica with a broad range of drug-resistant strains and genetic diversity greatly exceeding that previously described. This study shows how agricultural practice and human intervention may lead and influence the evolution of a hidden reservoir of pathogens, with important implications for human health.	[Perron, Gabriel G.; Bell, Graham] McGill Univ, Dept Biol, Montreal, PQ H3A 2T5, Canada; [Quessy, Sylvain] Univ Montreal, Fac Med Vet, Dept Pathol Microbiol, Montreal, PQ H3C 3J7, Canada	McGill University; Universite de Montreal	Perron, GG (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	gabriel.guimond-perron@zoo.ox.ac.uk			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was supported by NSERC to G. Bell. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaska JM, 2008, VET MICROBIOL, V128, P90, DOI 10.1016/j.vetmic.2007.08.033; Amar CFL, 2008, MICROB DRUG RESIST, V14, P79, DOI 10.1089/mdr.2008.0812; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Baggesen DL, 2000, J CLIN MICROBIOL, V38, P1581, DOI 10.1128/JCM.38.4.1581-1586.2000; Bahnson PB, 2005, J FOOD PROTECT, V68, P246, DOI 10.4315/0362-028X-68.2.246; Baquero F, 2001, DRUG RESIST UPDATE, V4, P93, DOI 10.1054/drup.2001.0196; Bell G, 2008, SELECTION: THE MECHANISM OF EVOLUTION, 2ND EDITION, P1; Beloeil PA, 2004, PREV VET MED, V63, P103, DOI 10.1016/j.prevetmed.2004.01.010; Botteldoorn N, 2003, J APPL MICROBIOL, V95, P891, DOI 10.1046/j.1365-2672.2003.02042.x; Brown EW, 2003, P NATL ACAD SCI USA, V100, P15676, DOI 10.1073/pnas.2634406100; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Chopra I, 2003, DRUG RESIST UPDATE, V6, P137, DOI 10.1016/S1368-7646(03)00041-4; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Day NPJ, 2001, SCIENCE, V292, P114, DOI 10.1126/science.1056495; Day T, 2003, TRENDS ECOL EVOL, V18, P113, DOI 10.1016/S0169-5347(02)00049-6; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Frank SA, 2008, J EVOLUTION BIOL, V21, P396, DOI 10.1111/j.1420-9101.2007.01480.x; Fu YX, 1997, GENETICS, V147, P915; Gebreyes WA, 2004, J ANTIMICROB CHEMOTH, V53, P997, DOI 10.1093/jac/dkh247; Gupta S, 2001, TRENDS MICROBIOL, V9, P181, DOI 10.1016/S0966-842X(01)01986-2; Hauser AR, 2007, ANTIBIOTICS BASICS C; Hopkins KL, 2007, J ANTIMICROB CHEMOTH, V59, P1071, DOI 10.1093/jac/dkm081; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Khachatryan AR, 2008, APPL ENVIRON MICROB, V74, P391, DOI 10.1128/AEM.01534-07; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Lawson AJ, 2004, CLIN MICROBIOL INFEC, V10, P143, DOI 10.1111/j.1469-0691.2004.00754.x; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; MacLean RC, 2003, P ROY SOC B-BIOL SCI, V270, P1645, DOI 10.1098/rspb.2003.2408; McVean G, 2002, GENETICS, V160, P1231; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Murphy TM, 2001, EPIDEMIOL INFECT, V126, P3, DOI 10.1017/S0950268801005143; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Perron GG, 2008, FEMS MICROBIOL LETT, V281, P17, DOI 10.1111/j.1574-6968.2007.01045.x; Perron GG, 2007, INFECT GENET EVOL, V7, P223, DOI 10.1016/j.meegid.2006.09.003; Poppe C, 2005, APPL ENVIRON MICROB, V71, P1184, DOI 10.1128/AEM.71.3.1184-1192.2005; Poppe C, 2002, MICROB DRUG RESIST, V8, P107, DOI 10.1089/107662902760190653; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Randall LP, 2004, J ANTIMICROB CHEMOTH, V53, P208, DOI 10.1093/jac/dkh070; Ribot EM, 2002, EMERG INFECT DIS, V8, P387, DOI 10.3201/eid0804.010202; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Singer RS, 2006, NAT REV MICROBIOL, V4, P943, DOI 10.1038/nrmicro1553; Smith JM, 2000, BIOESSAYS, V22, P1115, DOI 10.1002/1521-1878(200012)22:12&lt;1115::AID-BIES9&gt;3.0.CO;2-R; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; TAJIMA F, 1989, GENETICS, V123, P585; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Witte W, 2000, INT J ANTIMICROB AG, V16, pS19, DOI 10.1016/S0924-8579(00)00301-0; Zhao S, 2006, J FOOD PROTECT, V69, P500, DOI 10.4315/0362-028X-69.3.500	58	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3749	10.1371/journal.pone.0003749	http://dx.doi.org/10.1371/journal.pone.0003749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015729	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448400006
J	Frobisch, J				Frobisch, Jorg			Global Taxonomic Diversity of Anomodonts (Tetrapoda, Therapsida) and the Terrestrial Rock Record Across the Permian-Triassic Boundary	PLOS ONE			English	Article							MASS EXTINCTION; KAROO BASIN; FOSSIL RECORD; BIODIVERSITY; ORIGINATION; VERTEBRATES; AGE; STANDARDIZATION; DICYNODONT; COMPONENTS	The end-Permian biotic crisis (similar to 252.5 Ma) represents the most severe extinction event in Earth's history. This paper investigates diversity patterns in Anomodontia, an extinct group of therapsid synapsids ('mammal-like reptiles'), through time and in particular across this event. As herbivores and the dominant terrestrial tetrapods of their time, anomodonts play a central role in assessing the impact of the end-Permian extinction on terrestrial ecosystems. Taxonomic diversity analysis reveals that anomodonts experienced three distinct phases of diversification interrupted by the same number of extinctions, i.e. an end-Guadalupian, an end-Permian, and a mid-Triassic extinction. A positive correlation between the number of taxa and the number of formations per time interval shows that anomodont diversity is biased by the Permian-Triassic terrestrial rock record. Normalized diversity curves indicate that anomodont richness continuously declines from the Middle Permian to the Late Triassic, but also reveals all three extinction events. Taxonomic rates ( origination and extinction) indicate that the end-Guadalupian and end-Permian extinctions were driven by increased rates of extinction as well as low origination rates. However, this pattern is not evident at the final decline of anomodont diversity during the Middle Triassic. Therefore, it remains unclear whether the Middle Triassic extinction represents a gradual or abrupt event that is unique to anomodonts or more common among terrestrial tetrapods. The end-Permian extinction represents the most distinct event in terms of decline in anomodont richness and turnover rates.	[Frobisch, Jorg] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Frobisch, J (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	jorg.frobisch@utoronto.ca			Full Doctoral Scholarship of the Government of Canada Awards Program; Doctoral Scholarship of the German Academic Exchange Service (Deutscher Akademischer Austauschdienst)	Full Doctoral Scholarship of the Government of Canada Awards Program; Doctoral Scholarship of the German Academic Exchange Service (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD))	Full Doctoral Scholarship of the Government of Canada Awards Program and a Doctoral Scholarship of the German Academic Exchange Service (Deutscher Akademischer Austauschdienst). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 1998, BIODIVERSITY DYNAMICS, P232; Alroy J, 2003, PALEOBIOLOGY, V29, P26, DOI 10.1666/0094-8373(2003)029<0026:GDWYRM>2.0.CO;2; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Bakker R.T., 1977, PATTERNS EVOLUTION I, P439; BARRY JC, 1995, PALAEOGEOGR PALAEOCL, V115, P209, DOI 10.1016/0031-0182(94)00112-L; Battail B, 1993, NEW MEXICO MUSEUM NA, V3, P31; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Benton M. J., 2003, WHEN LIFE NEARLY DIE; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Benton MJ, 1998, ADEQUACY OF THE FOSSIL RECORD, P269; BENTON MJ, 1985, SP PAP PALAEONTOL, P185; BENTON MJ, 1989, PHILOS T ROY SOC B, V325, P369, DOI 10.1098/rstb.1989.0094; BENTON MJ, 1985, NATURE, V316, P811, DOI 10.1038/316811a0; Botha J, 2006, J AFR EARTH SCI, V45, P502, DOI 10.1016/j.jafrearsci.2006.04.006; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; Erwin D. H., 2006, EXTINCTION LIFE EART; Fitzgerald PC, 2006, PALEOBIOLOGY, V32, P367, DOI 10.1666/05029.1; Foote M, 2003, J GEOL, V111, P125, DOI 10.1086/345841; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; FROBISCH J, 2008, THESIS U TORONTO TOR; Frobisch J, 2007, ZOOL J LINN SOC-LOND, V150, P117, DOI 10.1111/j.1096-3642.2007.00285.x; Frobisch J, 2008, J VERTEBR PALEONTOL, V28, P770, DOI 10.1671/0272-4634(2008)28[770:ANSOES]2.0.CO;2; Furin S, 2006, GEOLOGY, V34, P1009, DOI 10.1130/G22967A.1; GOLUBEV VK, 2005, NEW MEXICO MUSEUM NA, V30, P95; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Grine Frederick E., 2006, P432; Hancox PJ, 2001, J AFR EARTH SCI, V33, P563, DOI 10.1016/S0899-5362(01)00081-1; Harper Charles W. Jr, 1996, Historical Biology, V11, P267; IVAKHNENKO MF, 1994, PALEONTOL J, V28, P96; Jaanusson V., 1976, P301; Kent DV, 1999, J GEOPHYS RES-SOL EA, V104, P12831, DOI 10.1029/1999JB900076; Keyser AW., 1993, GEOL SURV S AFR MEM, V82, P1; KING AW, 1991, LANDSCAPE ECOL, V5, P239, DOI 10.1007/BF00141438; KING G M, 1990, Palaeontologia Africana, V27, P31; King G. M., 1990, S HAUGHTON MEMORIAL, V3, P17; King Gillian M., 1993, Annals of the South African Museum, V102, P303; King GM, 1997, PALAEONTOLOGY, V40, P149; KING GM, 1993, ZOOL J LINN SOC-LOND, V107, P131, DOI 10.1111/j.1096-3642.1993.tb00218.x; King GM., 1988, ANOMODONTIA; KURKIN AA, 2000, PALEONTOL J, V34, P203; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; [刘俊 Liu Shun], 2004, [古脊椎动物学报, Vertebrata Palasiatica], V42, P77; Lu PJ, 2006, P NATL ACAD SCI USA, V103, P2736, DOI 10.1073/pnas.0511083103; Lucas S. G., 2007, NEW MEXICO MUSEUM NA, V41, P229; Lucas S.G., 1999, ZENTRALBLATT GEOLO 1, P497; Lucas SG, 1998, PALAEOGEOGR PALAEOCL, V143, P345; Lucas SG, 2003, GREAT RIFT VALLEYS OF PANGEA IN EASTERN NORTH AMERICA, VOL 2, P143; LUCAS SG, 2005, NEW MEXICO MUSEUM NA, V30, P197; LUCAS SG, 1995, ALBERTIANA, V16, P33; Lucas Spencer G., 2002, Canadian Society of Petroleum Geologists Memoir, V19, P479; Lucas Spencer G., 1994, Canadian Society of Petroleum Geologists Memoir, V17, P869; Lucas Spencer G., 2006, V265, P1, DOI 10.1144/GSL.SP.2006.265.01.01; MacLeod KG, 2000, GEOLOGY, V28, P227, DOI 10.1130/0091-7613(2000)28<227:TOMREA>2.0.CO;2; Maisch MW, 2002, PALAEONTOLOGY, V45, P343, DOI 10.1111/1475-4983.00240; Marshall CR, 1998, ADEQUACY OF THE FOSSIL RECORD, P23; MAXWELL WD, 1992, PALAEONTOLOGY, V35, P571; McElwain JC, 2007, TRENDS ECOL EVOL, V22, P548, DOI 10.1016/j.tree.2007.09.003; Modesto S, 1999, P ROY SOC B-BIOL SCI, V266, P331, DOI 10.1098/rspb.1999.0642; Mundil R, 2004, SCIENCE, V305, P1760, DOI 10.1126/science.1101012; Norell Mark A., 1992, P89; OGG JG, 2008, CONCISE GEOLOGIC TIM, P95; Olson E.C., 1989, Historical Biology, V2, P17; OLSON EC, 1982, GEOLOGICAL SOC AM SP, V190, P501; Padian K., 1985, P41; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; PITRAT CW, 1973, PALAEOGEOGR PALAEOCL, V14, P249, DOI 10.1016/0031-0182(73)90011-4; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; Renaut A.J., 2000, THESIS U WITWATERSRA; Retallack GJ, 2006, GEOL SOC AM BULL, V118, P1398, DOI 10.1130/B26011.1; Riggs NR, 2003, GEOL SOC AM BULL, V115, P1315, DOI 10.1130/B25254.1; Roopnarine PD, 2007, P ROY SOC B-BIOL SCI, V274, P2077, DOI 10.1098/rspb.2007.0515; Rubidge B.S., 1995, GEOLOGICAL SURVEY S, V1, P1; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; Schultz, 1982, GEOLOGICAL SOC AM SP, V190, P291, DOI DOI 10.1130/SPE190-P291; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Smith AB, 2005, BIOL LETT-UK, V1, P443, DOI 10.1098/rsbl.2005.0345; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Smith R, 2005, CR PALEVOL, V4, P623, DOI 10.1016/j.crpv.2005.07.005; Smith RMH, 2001, GEOLOGY, V29, P1147, DOI 10.1130/0091-7613(2001)029<1147:POVEAA>2.0.CO;2; Steiner M. B., 2006, GEOLOGICAL SOC LONDO, V265, P15, DOI DOI 10.1144/GSL.SP.2006.265.01.02; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; VANVALEN LM, 1984, NATURE, V307, P50, DOI 10.1038/307050a0; Vermeij GJ, 2003, PALEOBIOLOGY, V29, P3, DOI 10.1666/0094-8373(2003)029<0003:DGDMA>2.0.CO;2; Wagner PJ, 2007, P ROY SOC B-BIOL SCI, V274, P439, DOI 10.1098/rspb.2006.3742; Ward PD, 2005, SCIENCE, V307, P709, DOI 10.1126/science.1107068	87	100	102	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3733	10.1371/journal.pone.0003733	http://dx.doi.org/10.1371/journal.pone.0003733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011684	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448300001
J	Manirarora, JN; Kosiewicz, MM; Parnell, SA; Alard, P				Manirarora, Jean N.; Kosiewicz, Michele M.; Parnell, Sarah A.; Alard, Pascale			APC Activation Restores Functional CD4(+)CD25(+) Regulatory T Cells in NOD Mice that Can Prevent Diabetes Development	PLOS ONE			English	Article							COMPLETE FREUND ADJUVANT; DENDRITIC CELLS; CUTTING EDGE; TGF-BETA; TOLERANCE; DEFECTS; CD25(+); MOUSE; FOXP3; ONSET	Background: Defects in APC and regulatory cells are associated with diabetes development in NOD mice. We have shown previously that NOD APC are not effective at stimulating CD4(+)CD25(+) regulatory cell function in vitro. We hypothesize that failure of NOD APC to properly activate CD4(+)CD25(+) regulatory cells in vivo could compromise their ability to control pathogenic cells, and activation of NOD APC could restore this defect, thereby preventing disease. Methodology/Principal Findings: To test these hypotheses, we used the well-documented ability of complete Freund's adjuvant (CFA), an APC activator, to prevent disease in NOD mice. Phenotype and function of CD4(+)CD25(+) regulatory cells from untreated and CFA-treated NOD mice were determined by FACS, and in vitro and in vivo assays. APC from these mice were also evaluated for their ability to activate regulatory cells in vitro. We have found that sick NOD CD4(+)CD25(+) cells expressed Foxp3 at the same percentages, but decreased levels per cell, compared to young NOD or non-NOD controls. Treatment with CFA increased Foxp3 expression in NOD cells, and also increased the percentages of CD4(+)CD25(+)Foxp3+ cells infiltrating the pancreas compared to untreated NOD mice. Moreover, CD4(+)CD25(+) cells from pancreatic LN of CFA-treated, but not untreated, NOD mice transferred protection from diabetes. Finally, APC isolated from CFA-treated mice increased Foxp3 and granzyme B expression as well as regulatory function by NOD CD4(+)CD25(+) cells in vitro compared to APC from untreated NOD mice. Conclusions/Significance: These data suggest that regulatory T cell function and ability to control pathogenic cells can be enhanced in NOD mice by activating NOD APC.	[Manirarora, Jean N.; Kosiewicz, Michele M.; Parnell, Sarah A.; Alard, Pascale] Univ Louisville, Hlth Sci Ctr, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Manirarora, Jean N.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA	University of Louisville; St Jude Children's Research Hospital	Manirarora, JN (corresponding author), Univ Louisville, Hlth Sci Ctr, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	p0alar01@gwise.louisville.edu			American Diabetes Association [Junior Faculty Award]; University of Louisville School of Medicine; Ruth L. Kirschstein NRSA	American Diabetes Association(American Diabetes Association); University of Louisville School of Medicine; Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a Junior Faculty Award (Pascale Alard) from the American Diabetes Association, and in part by a grant from the University of Louisville School of Medicine. Jean N. Manirarora was supported by a Ruth L. Kirschstein NRSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alard P, 2006, DIABETES, V55, P2098, DOI 10.2337/db05-0810; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Dahlen E, 2000, J IMMUNOL, V164, P2444, DOI 10.4049/jimmunol.164.5.2444; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Garg A, 2008, EUR J IMMUNOL, V38, P459, DOI 10.1002/eji.200737268; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gregg RK, 2004, J IMMUNOL, V173, P7308, DOI 10.4049/jimmunol.173.12.7308; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horwitz DA, 2008, EUR J IMMUNOL, V38, P912, DOI 10.1002/eji.200738109; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Lee IF, 2004, J IMMUNOL, V172, P937, DOI 10.4049/jimmunol.172.2.937; Lee M, 2000, J KOREAN MED SCI, V15, P217, DOI 10.3346/jkms.2000.15.2.217; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; MANIRARORA JN, 2008, FASEB J, V22; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Piganelli JD, 1998, DIABETES, V47, P1212, DOI 10.2337/diabetes.47.8.1212; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; QIN HY, 1993, J IMMUNOL, V150, P2072; Rosignoli F, 2006, ANN NY ACAD SCI, V1070, P525, DOI 10.1196/annals.1317.073; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SERREZE DV, 1988, J IMMUNOL, V140, P3801; SERREZE DV, 1993, J IMMUNOL, V150, P2534; Stephens GL, 2007, J IMMUNOL, V178, P6901, DOI 10.4049/jimmunol.178.11.6901; Takahashi K, 1998, J IMMUNOL, V161, P2629; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	43	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3739	10.1371/journal.pone.0003739	http://dx.doi.org/10.1371/journal.pone.0003739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011680	gold, Green Submitted, Green Published			2022-12-25	WOS:000265448300007
J	Cortese, K; Sahores, M; Madsen, CD; Tacchetti, C; Blasi, F				Cortese, Katia; Sahores, Macarena; Madsen, Chris D.; Tacchetti, Carlo; Blasi, Francesco			Clathrin and LRP-1-Independent Constitutive Endocytosis and Recycling of uPAR	PLOS ONE			English	Article							RECEPTOR-RELATED-PROTEIN; PLASMINOGEN-ACTIVATOR RECEPTOR; MEDIATED ENDOCYTOSIS; UROKINASE; MACROPINOCYTOSIS; INTERNALIZATION; BINDING; PATHWAYS; LOCALIZATION; DYNAMICS	Background: The urokinase receptor (uPAR/CD87) is highly expressed in malignant tumours. uPAR, as a GPI anchored protein, is preferentially located at the cell surface, where it interacts with its ligands urokinase (uPA) and the extracellular matrix protein vitronectin, thus promoting plasmin generation, cell-matrix interactions and intracellular signalling events. Interaction with a complex formed by uPA and its inhibitor PAI-1 induces cell surface down regulation and recycling of the receptor via the clathrin-coated pathway, a process dependent on the association to LRP-1. Methodology/Principal Findings: In this study, we have found that along with the ligand-induced down-regulation, uPAR also internalizes and recycles constitutively through a second pathway that is independent of LRP-1 and clathrin but shares some properties with macropinocytosis. The ligand-independent route is amiloride-sensitive, does not require uPAR partitioning into lipid rafts, is independent of the activity of small GTPases RhoA, Rac1 and Cdc42, and does not require PI3K activity. Constitutively endocytosed uPAR is found in EEA1 positive early/recycling endosomes but does not reach lysosomes in the absence of ligands. Electron microscopy analysis reveals the presence of uPAR in ruffling domains at the cell surface, in macropinosome-like vesicles and in endosomal compartments. Conclusions/Significance: These results indicate that, in addition to the ligand-induced endocytosis of uPAR, efficient surface expression and membrane trafficking might also be driven by an uncommon macropinocytic mechanism coupled with rapid recycling to the cell surface.	[Cortese, Katia; Tacchetti, Carlo] Univ Genoa, Dipartimento Med Sperimentale, Sez Anat Umana, FIRC Inst Mol Oncol,Ctr Ric MicroSCoBio IFOM, Genoa, Italy; [Sahores, Macarena; Madsen, Chris D.; Blasi, Francesco] FIRC Inst Mol Oncol, IFOM, Univ Vita Salute San Raffaele, Mol Genet Unit, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IFOM - FIRC Institute of Molecular Oncology; Vita-Salute San Raffaele University	Cortese, K (corresponding author), Univ Genoa, Dipartimento Med Sperimentale, Sez Anat Umana, FIRC Inst Mol Oncol,Ctr Ric MicroSCoBio IFOM, Genoa, Italy.	Carlo.Tacchetti@unige.it; Francesco.Blasi@hsr.it	Cortese, Katia/AAC-2990-2021	Cortese, Katia/0000-0001-9218-8933; Blasi, Francesco/0000-0001-9406-1784; TACCHETTI, CARLO/0000-0003-4602-000X; Madsen, Chris D/0000-0001-6838-2103	AIRC Italian Association for Cancer Research; ISS Istituto Superiore di Sanita	AIRC Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); ISS Istituto Superiore di Sanita	AIRC (Italian Association for Cancer Research) to FB, ISS (Istituto Superiore di Sanita) Special Project on Oncology, to FB	Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BRETSCHER MS, 1980, P NATL ACAD SCI-BIOL, V77, P4156, DOI 10.1073/pnas.77.7.4156; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; CUBELLIS MV, 1989, P NATL ACAD SCI USA, V86, P4828, DOI 10.1073/pnas.86.13.4828; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Degryse B, 1999, BLOOD, V94, P649, DOI 10.1182/blood.V94.2.649.414k34_649_662; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Fretz M, 2006, J CONTROL RELEASE, V116, P247, DOI 10.1016/j.jconrel.2006.07.009; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; GECKLE M, 1999, J PHYSL, V520, P709; GECKLE M, 2001, J PHYSL, V560, P267; HASEGAWA T, 1993, J CELL BIOL, V120, P1439, DOI 10.1083/jcb.120.6.1439; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Masilamani M, 2008, TRAFFIC, V9, P1019, DOI 10.1111/j.1600-0854.2008.00738.x; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Sahores M, 2008, BBA-BIOMEMBRANES, V1778, P250, DOI 10.1016/j.bbamem.2007.09.030; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Vilhardt F, 1999, MOL BIOL CELL, V10, P179, DOI 10.1091/mbc.10.1.179; Watarai M, 2002, CELL MICROBIOL, V4, P341, DOI 10.1046/j.1462-5822.2002.00195.x; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731	43	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3730	10.1371/journal.pone.0003730	http://dx.doi.org/10.1371/journal.pone.0003730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19008962	Green Published, Green Submitted, gold			2022-12-25	WOS:000265166400008
J	Sun, J; Ramnath, RD; Tamizhselvi, R; Bhatia, M				Sun, Jia; Ramnath, Raina Devi; Tamizhselvi, Ramasamy; Bhatia, Madhav			Role of protein kinase C and phosphoinositide 3-kinase-Akt in substance P-induced proinflammatory pathways in mouse macrophages	FASEB JOURNAL			English	Article						neuroimmunoregulation; neuropeptides; leukocytes; inflammation; signaling kinases	NF-KAPPA-B; OXIDE SYNTHASE EXPRESSION; PANCREATIC ACINAR-CELLS; NITRIC-OXIDE; LUNG INJURY; PKC-DELTA; POLYMICROBIAL SEPSIS; NEGATIVE REGULATION; PHOSPHATIDYLINOSITOL 3-KINASE; ALVEOLAR MACROPHAGES	Neuropeptide modulation of immune cell function is an important mechanism of neuroimmune intersystem crosstalk. Substance P (SP) is one such key neuropeptide involved. In this study, we investigated the yet unexplored cellular mechanisms of SP-mediated inflammatory responses in macrophages using a mouse macrophage-like cell line RAW 264.7 and isolated peritoneal macrophages. We found that the conventional PKC alpha and novel PKC delta and epsilon were selectively activated by SP via its primary neurokinin-1 receptor (NK-1R) on the cells. Activation of these PKC isoforms mediated the activation of downstream extracellular signal-regulated kinase-1/2 (ERK1/2) and the transcription factor NF-kappa B, which drove the transcription of inducible chemokines in macrophages. Additionally, phosphoinositide 3-kinase (PI3K)-Akt was also activated by SP/NK-1R in macrophages. Inhibition of PI3K-Akt pathway attenuated ERK1/2 and NF-kappa B activation, suggesting it also played a part in SP-induced cellular inflammatory response. Kinetic analysis indicated that PKC isoforms induced early ERK1/2 activation, while PI3K-Akt contributed to the pathway at later time points. It was further demonstrated that PKC and PI3K-Akt were activated independent of each other. Collectively, our results suggest that SP/NK-1R activates two convergent proinflammatory signaling pathways, PKCs and PI3K-Akt, resulting in ERK1/2 and NF-kappa B activation and chemokine production in mouse macrophages.-Sun, J., Ramnath, R. D., Tamizhselvi, R., Bhatia, M. Role of protein kinase C and phosphoinositide 3-kinase-Akt in substance P-induced proinflammatory pathways in mouse macrophages. FASEB J. 23, 997-1010 (2009)	[Bhatia, Madhav] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol,Cardiovasc Biol Res Grp, Cardiovasc Biol Res Programme,Ctr Life Sci, Singapore 117456, Singapore	National University of Singapore	Bhatia, M (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol,Cardiovasc Biol Res Grp, Cardiovasc Biol Res Programme,Ctr Life Sci, 28 Med Dr, Singapore 117456, Singapore.	mbhatia@nus.edu.sg	Ramnath, Raina/AAO-1180-2020	Ramnath, Raina/0000-0001-8472-5081; Ramasamy, Tamizhselvi/0000-0002-8945-6308	National Medical Research Council [R-184-000-156213]; Life Sciences Institute of National University [R-184-000-074-712]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Life Sciences Institute of National University	This work was supported by National Medical Research Council grant R-184-000-156213 and Life Sciences Institute of National University of Singapore Cardiovascular Biology Program grant R-184-000-074-712. We thank Mr. Akhil Kumar Hegde Rama for reading and commenting on the manuscript. We also thank Ms. Mei Leng Shoon for technical support.	Bardelli C, 2005, BRIT J PHARMACOL, V145, P385, DOI 10.1038/sj.bjp.0706198; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Bhatia M, 2006, AM J PHYSIOL-LUNG C, V291, pL896, DOI 10.1152/ajplung.00053.2006; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Cao Y, 2007, AM J PATHOL, V170, P1521, DOI 10.2353/ajpath.2007.061149; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Diaz-Guerra MJM, 1999, J IMMUNOL, V162, P6184; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Grimsholm O, 2007, ANN NY ACAD SCI, V1110, P525, DOI 10.1196/annals.1423.056; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hegde A, 2007, J LEUKOCYTE BIOL, V82, P678, DOI 10.1189/jlb.0407217; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Kanchanapoo J, 2007, AM J PHYSIOL-CELL PH, V293, pC1851, DOI 10.1152/ajpcell.00194.2007; Kao SJ, 2005, IMMUNOLOGY, V115, P366, DOI 10.1111/j.1365-2567.2005.02160.x; Karimi K, 2004, EUR J PHARMACOL, V489, P49, DOI 10.1016/j.ejphar.2004.03.003; Koon HW, 2005, J PHARMACOL EXP THER, V314, P1393, DOI 10.1124/jpet.105.088013; Lau HY, 2005, BIOCHEM BIOPH RES CO, V327, P509, DOI 10.1016/j.bbrc.2004.12.030; Lee MC, 2008, J LEUKOCYTE BIOL, V84, P835, DOI 10.1189/jlb.1007691; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Ng SW, 2008, J LEUKOCYTE BIOL, V83, P288, DOI 10.1189/jlb.0807575; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Ohno S, 2002, J BIOCHEM, V132, P509, DOI 10.1093/oxfordjournals.jbchem.a003249; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Pengal RA, 2006, MOL IMMUNOL, V43, P1557, DOI 10.1016/j.molimm.2005.09.022; Puneet P, 2006, J IMMUNOL, V176, P3813, DOI 10.4049/jimmunol.176.6.3813; Ramnath RD, 2008, AM J PHYSIOL-CELL PH, V294, pC683, DOI 10.1152/ajpcell.00360.2007; Sapna S, 2007, CELL BIOL INT, V31, P856, DOI 10.1016/j.cellbi.2007.01.031; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Schechtman D, 2002, METHOD ENZYMOL, V345, P470; Sebastian C, 2008, J IMMUNOL, V180, P5898, DOI 10.4049/jimmunol.180.9.5898; Smith MV, 2007, J BONE JOINT SURG AM, V89A, P1019, DOI 10.2106/JBJS.F.00615; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Sud N, 2008, AM J PHYSIOL-LUNG C, V294, pL582, DOI 10.1152/ajplung.00353.2007; Sun J, 2008, AM J PHYSIOL-CELL PH, V294, pC1586, DOI 10.1152/ajpcell.00129.2008; Sun J, 2007, AM J PHYSIOL-CELL PH, V293, pC696, DOI 10.1152/ajpcell.00060.2007; Sun J, 2007, AM J PHYSIOL-GASTR L, V292, pG143, DOI 10.1152/ajpgi.00271.2006; Thrower EC, 2008, AM J PHYSIOL-GASTR L, V294, pG1344, DOI 10.1152/ajpgi.00020.2008; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; Tsukamoto K, 2008, J IMMUNOL, V180, P2054, DOI 10.4049/jimmunol.180.4.2054; Ward SG, 2003, CURR OPIN PHARMACOL, V3, P426, DOI 10.1016/S1471-4892(03)00078-X; Xu J, 2008, AM J PHYSIOL-LUNG C, V295, pL162, DOI 10.1152/ajplung.00282.2007; Yaraee R, 2007, INT IMMUNOPHARMACOL, V7, P135, DOI 10.1016/j.intimp.2006.09.001; Yoo JK, 2005, J IMMUNOL, V175, P8280, DOI 10.4049/jimmunol.175.12.8280; Zhang H, 2008, AM J RESP CELL MOL, V38, P483, DOI 10.1165/rcmb.2007-0260OC; Zhang HL, 2007, J IMMUNOL, V179, P4153, DOI 10.4049/jimmunol.179.6.4153; Zhang Y, 2006, CURR DRUG TARGETS, V7, P1011, DOI 10.2174/138945006778019363	52	40	41	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					997	1010		10.1096/fj.08-121756	http://dx.doi.org/10.1096/fj.08-121756			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19029199				2022-12-25	WOS:000266651600004
J	Blouse, GE; Botkjaer, KA; Deryugina, E; Byszuk, AA; Jensen, JM; Mortensen, KK; Quigley, JP; Andreasen, PA				Blouse, Grant E.; Botkjaer, Kenneth A.; Deryugina, Elena; Byszuk, Aleksandra A.; Jensen, Janni M.; Mortensen, Kim K.; Quigley, James P.; Andreasen, Peter A.			A Novel Mode of Intervention with Serine Protease Activity TARGETING ZYMOGEN ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR; IN-VIVO; UROKINASE RECEPTOR; MONOCLONAL-ANTIBODIES; FIBROSARCOMA CELLS; ALLOSTERIC SITE; DOWN-REGULATION; INHIBITORS; SUBSTRATE; PROUROKINASE	Serine proteases are secreted from cells as single-chain zymogens, typically having activities orders of magnitude lower than those of the mature two-chain enzymes. Activation occurs by a conformational change initiated by cleavage of a specific peptide bond. We have derived a monoclonal antibody (mAb-112) which binds with subnanomolar affinity to pro-uPA, the zymogen form of urokinase-type plasminogen activator (uPA). We mapped the epitope of the antibody to the autolysis loop, one of the structural elements known to change conformation during zymogen activation. A mechanistic evaluation with biophysical methods elucidated a novel bifunctional inhibitory mechanism whereby mAb-112 not only delays the proteolytic conversion of single-chain pro-uPA into the two-chain form but also subsequently averts the conformational transition to a mature protease by sequestering the two-chain form in a zymogen-like, noncatalytic state. Functional studies employing two variants of human HT-1080 cells, exhibiting high and low levels of dissemination in a chorioallantoic membrane assay, demonstrate that mAb-112 is an effective inhibitor of tumor cell intravasation. These findings show that pharmacological interference with zymogen activation is a plausible and robust means to regulate uPA activity and the downstream effects of plasminogen activation in the spread of cancer and other processes of pathological tissue remodeling. A strategy that targets regions related to pro-enzyme activation likely provide a unique inhibitor-protease interaction surface and is, thus, expected to enhance the chances of engineering high inhibitor specificity. Our results provide new information about the structural flexibility underlying the equilibrium between active and inactive forms of serine proteases.	[Blouse, Grant E.; Botkjaer, Kenneth A.; Byszuk, Aleksandra A.; Jensen, Janni M.; Mortensen, Kim K.; Andreasen, Peter A.] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Deryugina, Elena; Quigley, James P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Aarhus University; Scripps Research Institute	Andreasen, PA (corresponding author), Univ Aarhus, Dept Mol Biol, 10C Gustav Wieds Vej, DK-8000 Aarhus C, Denmark.	pa@mb.au.dk			National Institutes of Health [CA55852, CA105412]; Danish Cancer Society; Danish Cancer Research Foundation; Danish Research Agency; Carlsberg Foundation; Novo-Nordisk Foundation; European Union FP6 [LSHC-CT-2003 h503297]; Danish Heart Association; NATIONAL CANCER INSTITUTE [R01CA105412, R01CA055852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; Danish Research Agency; Carlsberg Foundation(Carlsberg Foundation); Novo-Nordisk Foundation(Novo Nordisk Foundation); European Union FP6(European Commission); Danish Heart Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA55852 and CA105412 (to J.P.Q.). This work was also supported by grants from the Danish Cancer Society, the Danish Cancer Research Foundation, the Danish Research Agency, the Carlsberg Foundation, the Novo-Nordisk Foundation, European Union FP6 Contract LSHC-CT-2003 h503297 (the Cancer Degradome) (to P. A. A.), and the Danish Heart Association (to G. E. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAMOWITZ N, 1967, BIOCHEM BIOPH RES CO, V29, P862, DOI 10.1016/0006-291X(67)90299-9; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Behrendt N, 2003, BIOCHEM J, V371, P277, DOI 10.1042/BJ20021508; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Creighton T. E., 1993, PROTEINS STRUCTURES, P419; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Egelund R, 2001, EUR J BIOCHEM, V268, P673, DOI 10.1046/j.1432-1327.2001.01921.x; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; JESPERSEN MH, 1993, SCAND J CLIN LAB INV, V53, P639; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Knoop A, 1998, BRIT J CANCER, V77, P932, DOI 10.1038/bjc.1998.154; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; List K, 2000, BIOCHEMISTRY-US, V39, P508, DOI 10.1021/bi991701f; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lund IK, 2008, J BIOL CHEM, V283, P32506, DOI 10.1074/jbc.M801924200; LUND LR, 1988, MOL CELL ENDOCRINOL, V60, P43, DOI 10.1016/0303-7207(88)90118-9; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; Madsen MA, 2006, J BIOL CHEM, V281, P15997, DOI 10.1074/jbc.M601223200; Moran P, 2006, J BIOL CHEM, V281, P30439, DOI 10.1074/jbc.M605440200; NIELSEN LS, 1986, THROMB HAEMOSTASIS, V55, P206; OSSOWSKI L, 1980, CANCER RES, V40, P2300; OSSOWSKI L, 1988, J CELL BIOL, V107, P2437, DOI 10.1083/jcb.107.6.2437; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Pasternak A, 1998, BIOCHEMISTRY-US, V37, P16201, DOI 10.1021/bi980951d; Petersen HH, 2001, EUR J BIOCHEM, V268, P4430, DOI 10.1046/j.1432-1327.2001.02365.x; PICONE R, 1989, J CELL BIOL, V108, P693, DOI 10.1083/jcb.108.2.693; Rockway TW, 2002, CURR PHARM DESIGN, V8, P2541, DOI 10.2174/1381612023392676; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; SPRAGGON G, 1995, STRUCTURE, V3, P681, DOI 10.1016/S0969-2126(01)00203-9; Stoppelli M. Patrizia, 2008, P721, DOI 10.1007/978-0-387-69057-5_35	37	34	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4647	4657		10.1074/jbc.M804922200	http://dx.doi.org/10.1074/jbc.M804922200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19047064	Green Published, hybrid			2022-12-25	WOS:000263134400064
J	Taleux, N; Guigas, B; Dubouchaud, H; Moreno, M; Weitzel, JM; Goglia, F; Favier, R; Leverve, XM				Taleux, Nellie; Guigas, Bruno; Dubouchaud, Herve; Moreno, Maria; Weitzel, Joachim M.; Goglia, Fernando; Favier, Roland; Leverve, Xavier M.			High Expression of Thyroid Hormone Receptors and Mitochondrial Glycerol-3-phosphate Dehydrogenase in the Liver Is Linked to Enhanced Fatty Acid Oxidation in Lou/C, a Rat Strain Resistant to Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL-PHOSPHATE DEHYDROGENASE; AGE-RELATED-CHANGES; MACRONUTRIENT INTAKE; PARENCHYMAL-CELLS; GENE-EXPRESSION; WISTAR RATS; METABOLISM; EXERCISE; MODEL; GLUCONEOGENESIS	Besides its well recognized role in lipid and carbohydrate metabolisms, glycerol is involved in the regulation of cellular energy homeostasis via glycerol-3-phosphate, a key metabolite in the translocation of reducing power across the mitochondrial inner membrane with mitochondrial glycerol-3-phosphate dehydrogenase. Here, we report a high rate of gluconeogenesis from glycerol and fatty acid oxidation in hepatocytes from Lou/C, a peculiar rat strain derived from Wistar, which is resistant to age- and diet-related obesity. This feature, associated with elevated cellular respiration and cytosolic ATP/ADP and NAD(+)/NADH ratios, was linked to a high expression and activity of mitochondrial glycerol-3-phosphate dehydrogenase. Interestingly, this strain exhibited high expression and protein content of thyroid hormone receptor, whereas circulating thyroid hormone levels were slightly decreased and hepatic thyroid hormone carrier MCT-8 mRNA levels were not modified. We propose that an enhanced liver thyroid hormone receptor in Lou/C may explain its unique resistance to obesity by increasing fatty acid oxidation and lowering liver oxidative phosphorylation stoichiometry at the translocation of reducing power into mitochondria.	[Taleux, Nellie; Dubouchaud, Herve; Favier, Roland; Leverve, Xavier M.] Univ Grenoble 1, INSERM, Bioenerget Fondamentale & Appl U884, F-38041 Grenoble 9, France; [Guigas, Bruno] Univ Catholique Louvain, Hormone & Metab Res Unit, B-1200 Brussels, Belgium; [Moreno, Maria; Goglia, Fernando] Univ Sannio, Dipartimento Sci Biol & Ambientali, I-82100 Benevento, Italy; [Weitzel, Joachim M.] Charite Univ Med Berlin, Inst Expt Endocrinol, D-10117 Berlin, Germany; [Guigas, Bruno] Inst Cellular Pathol, B-1200 Brussels, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Catholique Louvain; University of Sannio; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Leverve, XM (corresponding author), Univ Grenoble 1, INSERM, Bioenerget Fondamentale & Appl U884, BP 53X, F-38041 Grenoble 9, France.	xavier.leverve@ujf-grenoble.fr	Guigas, Bruno/M-2515-2015	Guigas, Bruno/0000-0002-8856-5799; Weitzel, Joachim/0000-0002-4073-6691; MORENO, Maria/0000-0002-6218-5501; GOGLIA, Fernando/0000-0003-0468-9645	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by a grant from INSERM. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alliot J, 2002, J GERONTOL A-BIOL, V57, pB312, DOI 10.1093/gerona/57.8.B312; BAZIN H, 1990, RAT HYBRIDOMAS RAT M, P43; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN; BERRY MN, 1973, EUR J BIOCHEM, V33, P407, DOI 10.1111/j.1432-1033.1973.tb02697.x; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Boghossian S, 2000, PHYSIOL BEHAV, V69, P231, DOI 10.1016/S0031-9384(99)00233-4; Brown LJ, 2002, J BIOL CHEM, V277, P32899, DOI 10.1074/jbc.M202409200; Couturier K, 2004, INT J OBESITY, V28, P972, DOI 10.1038/sj.ijo.0802717; Couturier K, 2002, OBES RES, V10, P188, DOI 10.1038/oby.2002.29; DEBEER LJ, 1974, EUR J BIOCHEM, V47, P591, DOI 10.1111/j.1432-1033.1974.tb03730.x; ESTABROOK RW, 1958, J BIOL CHEM, V233, P1014; Garait B, 2005, FREE RADICAL BIO MED, V39, P1249, DOI 10.1016/j.freeradbiomed.2005.06.026; GROEN AK, 1983, J BIOL CHEM, V258, P4346; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; KLINGENBERG M, 1970, EUR J BIOCHEM, V13, P247, DOI 10.1111/j.1432-1033.1970.tb00924.x; KLINGENBERG M, 1959, BIOCHEM Z, V331, P486; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Kuriyama H, 2002, DIABETES, V51, P2915, DOI 10.2337/diabetes.51.10.2915; Lacraz G, 2008, INT J OBESITY, V32, P629, DOI 10.1038/sj.ijo.0803779; LEE YP, 1965, J BIOL CHEM, V240, P1427; LEVERVE XM, 1986, EUR J BIOCHEM, V155, P551, DOI 10.1111/j.1432-1033.1986.tb09523.x; Leverve XM, 2001, IUBMB LIFE, V52, P221; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mitchell SE, 2006, J ENDOCRINOL, V190, P571, DOI 10.1677/joe.1.06576; NEWBY FD, 1990, AM J PHYSIOL, V259, pR1117, DOI 10.1152/ajpregu.1990.259.6.R1117; Nguyen NHT, 2003, J NEUROCHEM, V85, P831, DOI 10.1046/j.1471-4159.2003.01762.x; Nogueira V, 2001, J BIOL CHEM, V276, P46104, DOI 10.1074/jbc.M107425200; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Rauchova H, 2003, ACTA BIOCHIM POL, V50, P405; ROBBINS BL, 1991, LIFE SCI, V48, P1075, DOI 10.1016/0024-3205(91)90509-A; RUTTER GA, 1992, BIOCHIM BIOPHYS ACTA, V1175, P107, DOI 10.1016/0167-4889(92)90016-5; Servais S, 2003, FREE RADICAL BIO MED, V35, P24, DOI 10.1016/S0891-5849(03)00177-1; Sibille B, 2001, BIOCHEM J, V355, P231, DOI 10.1042/0264-6021:3550231; SIBILLE B, 1995, EUR J BIOCHEM, V231, P498, DOI 10.1111/j.1432-1033.1995.tb20724.x; STIRLING JL, 1968, NATURE, V220, P801, DOI 10.1038/220801a0; STOCK MJ, 1978, J APPL PHYSIOL, V45, P350, DOI 10.1152/jappl.1978.45.3.350; TALEUX N, 2007, INT J OBES LOND, V32, P639; VANDERMEER R, 1976, FEBS LETT, V67, P36, DOI 10.1016/0014-5793(76)80865-4; Veyrat-Durebex C, 1998, MECH AGEING DEV, V103, P223, DOI 10.1016/S0047-6374(98)00013-X; Veyrat-Durebex C, 1997, PHYSIOL BEHAV, V62, P1273, DOI 10.1016/S0031-9384(97)00304-1; Weitzel JM, 2001, EUR J BIOCHEM, V268, P4095, DOI 10.1046/j.1432-1327.2001.02332.x; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Zuurendonk P F, 1979, Methods Enzymol, V56, P207	44	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4308	4316		10.1074/jbc.M806187200	http://dx.doi.org/10.1074/jbc.M806187200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19049970	hybrid			2022-12-25	WOS:000263134400029
J	Ren, L; Hong, SH; Cassavaugh, J; Osborne, T; Chou, AJ; Kim, SY; Gorlick, R; Hewitt, SM; Khanna, C				Ren, L.; Hong, S. H.; Cassavaugh, J.; Osborne, T.; Chou, A. J.; Kim, S. Y.; Gorlick, R.; Hewitt, S. M.; Khanna, C.			The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC	ONCOGENE			English	Article						ezrin; ERM; PKC; tumor metastasis	EZRIN/RADIXIN/MOESIN ERM PROTEINS; KINASE-C; PLASMA-MEMBRANE; EPITHELIAL-CELLS; CARCINOMA-CELLS; T-LYMPHOCYTES; CRUCIAL ROLE; PHOSPHORYLATION; EXPRESSION; MOESIN	Ezrin is a member of the ERM (ezrin, radixin, moesin) protein family and links F-actin to the cell membrane following phosphorylation. Ezrin has been associated with tumor progression and metastasis in several cancers including the pediatric solid tumors, osteosarcoma and rhabdomyosarcoma. In this study, we were surprised to find that ezrin was not constitutively phosphorylated but rather was dynamically regulated during metastatic progression in osteosarcoma. Metastatic osteosarcoma cells expressed phosphorylated ERM early after their arrival in the lung, and then late in progression, only at the invasive front of larger metastatic lesions. To pursue mechanisms for this regulation, we found that inhibitors of PKC (protein kinase C) blocked phosphorylation of ezrin, and that ezrin coimmunoprecipitated in cells with PKC alpha, PKC iota and PKC gamma. Furthermore, phosphorylated forms of ezrin and PKC had identical expression patterns at the invasive front of pulmonary metastatic lesions in murine and human patient samples. Finally, we showed that the promigratory effects of PKC were linked to ezrin phosphorylation. These data are the first to suggest a dynamic regulation of ezrin phosphorylation during metastasis and to connect the PKC family members with this regulation.	[Khanna, C.] NCI, Tumor & Metastasis Biol Sect, Pediat Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Chou, A. J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Gorlick, R.] Childrens Hosp Montefiore, Albert Einstein Coll Med, Dept Pediat, Bronx, NY USA; [Hewitt, S. M.] NCI, Tissue Array Res Program, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Khanna, C (corresponding author), NCI, Tumor & Metastasis Biol Sect, Pediat Oncol Branch, Ctr Canc Res, 37 Convent Dr,Rm 2144, Bethesda, MD 20892 USA.	khannac@mail.nih.gov		Hewitt, Stephen/0000-0001-8283-1788; GORLICK, RICHARD/0000-0001-8995-2929; Chou, Alexander/0000-0002-7926-3326	Intramural NIH HHS [Z01 BC010566] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIGBC010931, Z01BC010931, Z01BC010566, ZIABC011024, Z01BC011024, ZIABC010566] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERRYMAN M, 1993, J CELL SCI, V105, P1025; BLOBE GC, 1994, CANCER METAST REV, V13, P411, DOI 10.1007/BF00666107; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bretscher A, 1997, J CELL SCI, V110, P3011; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Dard N, 2004, DEV BIOL, V271, P87, DOI 10.1016/j.ydbio.2004.03.024; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Forte E, 2008, BBA-MOL CELL RES, V1783, P334, DOI 10.1016/j.bbamcr.2007.11.004; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; HERBERT JM, 1993, BIOCHEM PHARMACOL, V45, P527, DOI 10.1016/0006-2952(93)90123-E; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Ilmonen S, 2005, MODERN PATHOL, V18, P503, DOI 10.1038/modpathol.3800300; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Khanna C, 2001, CANCER RES, V61, P3750; Kivela T, 2000, CELL TISSUE RES, V301, P217, DOI 10.1007/s004410000225; Kobel M, 2006, INT J GYNECOL PATHOL, V25, P121, DOI 10.1097/01.pgp.0000185410.39050.ac; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; KRIEG J, 1992, J BIOL CHEM, V267, P19258; Krishnan K, 2006, CLIN EXP METASTAS, V23, P227, DOI 10.1007/s10585-006-9033-y; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P2442; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Musashi M, 2000, INT J HEMATOL, V72, P12; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Ohtani K, 1999, CANCER LETT, V147, P31, DOI 10.1016/S0304-3835(99)00272-4; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pang ST, 2004, UROLOGY, V63, P609, DOI 10.1016/j.urology.2003.09.068; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Polesello C, 2004, TRENDS CELL BIOL, V14, P294, DOI 10.1016/j.tcb.2004.04.003; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Sullivan RM, 2000, MOL PHARMACOL, V58, P729, DOI 10.1124/mol.58.4.729; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Wald FA, 2008, J CELL SCI, V121, P644, DOI 10.1242/jcs.016246; Weng WH, 2005, CLIN CANCER RES, V11, P6198, DOI 10.1158/1078-0432.CCR-05-0548; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007	51	99	111	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					792	802		10.1038/onc.2008.437	http://dx.doi.org/10.1038/onc.2008.437			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19060919	Green Accepted			2022-12-25	WOS:000263320000002
J	Kos, V; Cuthbertson, L; Whitfield, C				Kos, Veronica; Cuthbertson, Leslie; Whitfield, Chris			The Klebsiella pneumoniae O2a Antigen Defines a Second Mechanism for O Antigen ATP-binding Cassette Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; O1K2 NCTC-5055 LIPOPOLYSACCHARIDE; GRAM-NEGATIVE BACTERIA; VIBRIO-CHOLERAE O1; RFB GENE-CLUSTER; D-GALACTAN-I; OUTER-MEMBRANE; POLYSIALIC ACID; POLYSACCHARIDE EXPORT; CAMPYLOBACTER-JEJUNI	An ATP-binding cassette (ABC) transporter-dependent mechanism is responsible for the biosynthesis of polysaccharide O antigens in the lipopolysaccharides of many Gram-negative bacteria. In the Escherichia coli O9a prototype, addition of a non-reducing terminal modification regulates chain length. The terminal residue is an export signal recognized by the nucleotide-binding domain component of the cognate ABC transporter. The Klebsiella pneumoniae O2a antigen lacks a capping residue, and the corresponding nucleotide-binding protein does not contain a separate substrate-binding domain. Unlike the O9a transporter, the O2a transporter can export heterologous O antigens. Export of the O2a antigen is obligatorily coupled to chain elongation, and the O2a transporter is essential for establishing O antigen chain length. The E. coli O9a transporter operates after chain length has been determined. Furthermore biosynthesis and export can be uncoupled. O antigen chain length is a critical element in the ability of lipopolysaccharides to confer resistance to complement-mediated killing. This study establishes that two distinctly different approaches are available for the regulation of O antigen chain length and export via an ABC transporter.	[Kos, Veronica; Cuthbertson, Leslie; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca			Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research (CIHR) (to C. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Bliss JM, 1996, MOL MICROBIOL, V21, P221, DOI 10.1046/j.1365-2958.1996.6461357.x; Bliss JM, 1996, GLYCOBIOLOGY, V6, P445, DOI 10.1093/glycob/6.4.445; BRONNER D, 1994, MOL MICROBIOL, V14, P505, DOI 10.1111/j.1365-2958.1994.tb02185.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CLARKE BR, 1995, J BACTERIOL, V177, P5411, DOI 10.1128/jb.177.19.5411-5418.1995; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cronan JE, 2006, PLASMID, V55, P152, DOI 10.1016/j.plasmid.2005.07.001; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; FITZGERA.DK, 1971, EUR J BIOCHEM, V24, P222, DOI 10.1111/j.1432-1033.1971.tb19674.x; Guan S, 2001, J BACTERIOL, V183, P3318, DOI 10.1128/JB.183.11.3318-3327.2001; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hisatsune K, 1996, MICROBIOL IMMUNOL, V40, P621, DOI 10.1111/j.1348-0421.1996.tb01119.x; HISATSUNE K, 1993, BIOCHEM BIOPH RES CO, V190, P302, DOI 10.1006/bbrc.1993.1046; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; JANSSON PE, 1985, CARBOHYD RES, V145, P59, DOI 10.1016/S0008-6215(00)90412-9; KELLY RF, 1993, MOL MICROBIOL, V10, P615, DOI 10.1111/j.1365-2958.1993.tb00933.x; Kelly RF, 1996, J BACTERIOL, V178, P5205, DOI 10.1128/jb.178.17.5205-5214.1996; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; KOL O, 1992, CARBOHYD RES, V236, P339, DOI 10.1016/0008-6215(92)85028-X; KOL O, 1991, CARBOHYD RES, V217, P117, DOI 10.1016/0008-6215(91)84122-U; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; Lo RYC, 2001, INFECT IMMUN, V69, P4458, DOI 10.1128/IAI.69.7.4458-4464.2001; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; MEIERDIETER U, 1992, J BIOL CHEM, V267, P746; Miller J. H., 1972, EXPT MOL GENETICS, P431; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rick P, 1996, ESCHERICHIA COLI SAL, P104; RICK PD, 1994, J BACTERIOL, V176, P2877, DOI 10.1128/JB.176.10.2877-2884.1994; Rocchetta HL, 1997, J BACTERIOL, V179, P4713, DOI 10.1128/jb.179.15.4713-4724.1997; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Sambrook J., 1989, MOL CLONING LAB MANU; SCHNAITMAN CA, 1990, J BACTERIOL, V172, P5511, DOI 10.1128/jb.172.9.5511-5513.1990; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Steenbergen SM, 2008, MOL MICROBIOL, V68, P1252, DOI 10.1111/j.1365-2958.2008.06231.x; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; STORM DR, 1973, J BIOL CHEM, V248, P3940; STROEHER UH, 1992, P NATL ACAD SCI USA, V89, P2566, DOI 10.1073/pnas.89.7.2566; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; WHITFIELD C, 1992, J BACTERIOL, V174, P4913, DOI 10.1128/JB.174.15.4913-4919.1992; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WHTIFIELD C, 1989, J GEN MICROBIOL, V135, P2589; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; ZHANG LJ, 1993, MOL MICROBIOL, V9, P309, DOI 10.1111/j.1365-2958.1993.tb01692.x	59	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2947	2956		10.1074/jbc.M807213200	http://dx.doi.org/10.1074/jbc.M807213200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19036729	hybrid			2022-12-25	WOS:000262700900039
J	Placanica, L; Tarassishin, L; Yang, G; Peethumnongsin, E; Kim, SH; Zheng, H; Sisodia, SS; Li, YM				Placanica, Lisa; Tarassishin, Leonid; Yang, Guangli; Peethumnongsin, Erica; Kim, Seong-Hun; Zheng, Hui; Sisodia, Sangram S.; Li, Yue-Ming			Pen2 and Presenilin-1 Modulate the Dynamic Equilibrium of Presenilin-1 and Presenilin-2 gamma-Secretase Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; AMYLOID PATHOLOGY; TALKING POINT; IN-VITRO; APH-1; NICASTRIN; MUTATIONS; INHIBITORS; SUBSTRATE; STATE	gamma-Secretase is known to play a pivotal role in the pathogenesis of Alzheimer disease through production of amyloidogenic A beta 42 peptides. Early onset familial Alzheimer disease mutations in presenilin (PS), the catalytic core of gamma-secretase, invariably increase the A beta 42:A beta 40 ratio. However, the mechanism by which these mutations affect gamma-secretase complex formation and cleavage specificity is poorly understood. We show that our in vitro assay system recapitulates the effect of PS1 mutations on the A beta 42:A beta 40 ratio observed in cell and animal models. We have developed a series of small molecule affinity probes that allow us to characterize active gamma-secretase complexes. Furthermore we reveal that the equilibrium of PS1- and PS2-containing active complexes is dynamic and altered by overexpression of Pen2 or PS1 mutants and that formation of PS2 complexes is positively correlated with increased A beta 42:A beta 40 ratios. These data suggest that perturbations to gamma-secretase complex equilibrium can have a profound effect on enzyme activity and that increased PS2 complexes along with mutated PS1 complexes contribute to an increased A beta 42:A beta 40 ratio.	[Placanica, Lisa; Tarassishin, Leonid; Yang, Guangli; Li, Yue-Ming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Placanica, Lisa; Li, Yue-Ming] Cornell Univ, Sch Med Sci, Weill Grad Sch, Dept Pharmacol, New York, NY 10065 USA; [Peethumnongsin, Erica; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Huffington Ctr Aging, Houston, TX 77030 USA; [Kim, Seong-Hun; Sisodia, Sangram S.] Univ Chicago, Ctr Mol Neurobiol, Chicago, IL 60637 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Baylor College of Medicine; University of Chicago	Li, YM (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10065 USA.	liy2@mskcc.org	LI, Yue/GRS-8071-2022	Tarassishin, Leonid/0000-0002-2649-5465	National Institutes of Health [R01-AG026660, R01-AG20670]; Institutional Training [T32 GM073546-01A1]; Ruth L. Kirschstein National Research Service [T32 CA062948-11A1]; William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; William Randolph Hearst Fund in Experimental Therapeutics; American Health Assistance Foundation; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020670, R01AG026660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Training; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; William Randolph Hearst Fund in Experimental Therapeutics; American Health Assistance Foundation(BrightFocus Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG026660 (to Y.M.L.) and R01-AG20670 (to H.Z.), Institutional Training Grant T32 GM073546-01A1 (to L. P.), and Ruth L. Kirschstein National Research Service Award T32 CA062948-11A1 (to L. P.). This work was also supported by William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center, the William Randolph Hearst Fund in Experimental Therapeutics, and the American Health Assistance Foundation (to Y. M. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Nadin A, 2001, TETRAHEDRON, V57, P1861, DOI 10.1016/S0040-4020(00)01167-4; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Vetrivel KS, 2008, J BIOL CHEM, V283, P19489, DOI 10.1074/jbc.M801037200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; YANG G, 2009, BIOORG MED IN PRESS; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	44	47	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2967	2977		10.1074/jbc.M807269200	http://dx.doi.org/10.1074/jbc.M807269200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19036728	hybrid, Green Published			2022-12-25	WOS:000262700900041
J	Barroso-Gonzalez, J; Machado, JD; Garcia-Exposito, L; Valenzuela-Fernandez, A				Barroso-Gonzalez, Jonathan; Machado, Jose-David; Garcia-Exposito, Laura; Valenzuela-Fernandez, Agustin			Moesin Regulates the Trafficking of Nascent Clathrin-coated Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNTINGTIN-INTERACTING PROTEIN-1; AGONIST-INDUCED ENDOCYTOSIS; ACTIN CYTOSKELETON; N-WASP; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MEDIATED ENDOCYTOSIS; HIP1-RELATED PROTEIN; CHEMOKINE RECEPTORS; IMAGING ACTIN; ERM PROTEINS	Clathrin-coated vesicles are responsible for the trafficking of several internalized biological cargos. We have observed that the endogenous F-actin-linker moesin co-distributes with constitutive components of clathrin-coated structures. Total internal reflection fluorescence microscopy studies have shown that short interference RNA of moesin enhances the lateral movement of clathrin-coated structures and provokes their abnormal clustering. The aggregation of clathrin-coated structures has also been observed in cells overexpressing N-moesin, a dominant-negative construct unable to bind to F-actin. Only overexpressed moesin constructs with an intact phosphatidylinositol 4,5-bisphosphate-binding domain co-distribute with clathrin-coated structures. Hence, this N-terminal domain is mostly responsible for moesin/clathrin-coated structure association. Biochemical endosome fractioning together with total internal reflection fluorescence microscopy comparative studies, between intact cells and plasma-membrane sheets, indicate that moesin knockdown provokes the accumulation of endocytic rab5-clathrin-coated vesicles carrying the transferrin receptor. The altered trafficking of these endocytic rab5-clathrin- coated vesicles accounts for a transferrin receptor recycling defect that reduces cell-surface expression of the transferrin receptor and increases the amount of sequestered transferrin ligand. Therefore, we propose that moesin is a clathrin-coated vesicle linker that drives cargo trafficking and acts on nascent rab5clathrin-coated vesicles by simultaneously binding to clathrin-coated vesicle-associated phosphatidylinositol 4,5-bisphosphate and actin cytoskeleton. Hence, functional alterations of moesin may be involved in pathological disorders associated with clathrin-mediated internalization or receptor recycling.	[Barroso-Gonzalez, Jonathan; Garcia-Exposito, Laura; Valenzuela-Fernandez, Agustin] Univ La Laguna, Lab Inmunol Celular & Viral, Fac Med, Inst Tecnol Biomed,Dept Med Fis & Farmacol, Tenerife 38071, Spain; [Machado, Jose-David] Univ La Laguna, Lab Neurosecrec, Fac Med, Inst Tecnol Biomed,Dept Med Fis & Farmacol, Tenerife 38071, Spain; [Barroso-Gonzalez, Jonathan; Machado, Jose-David; Garcia-Exposito, Laura; Valenzuela-Fernandez, Agustin] Univ La Laguna, Unidad Farmacol, Fac Med, Inst Tecnol Biomed,Dept Med Fis & Farmacol, Tenerife 38071, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna	Valenzuela-Fernandez, A (corresponding author), Univ La Laguna, Lab Inmunol Celular & Viral, Fac Med, Inst Tecnol Biomed,Dept Med Fis & Farmacol, Campus Ofra S-N, Tenerife 38071, Spain.	avalenzu@ull.es	Barroso, Jonathan/T-9295-2017; Machado, José David/N-5210-2014; Valenzuela-Fernández, Agustín/B-6219-2014; Valenzuela-Fernández, Agustín/P-1638-2019	Barroso, Jonathan/0000-0001-9167-6660; Machado, José David/0000-0003-3531-7051; Valenzuela-Fernández, Agustín/0000-0002-2585-8703; Valenzuela-Fernández, Agustín/0000-0002-2585-8703; Garcia Exposito, Laura/0000-0002-8172-7986	Instituto de Salud Carlos III; Ministeriode Sanidad y Consumo, Spain [FIS-PI050995]; Fundacion para la Investigacion y Prevencio n del SIDA en Espana [FIPSE-24508/05, FIPSE-24661/07]; Consejeria de Industria; Comercio y Nuevas Tecnologias del Gobierno Auto nomo de Canarias, Spain [IDT-TF-06/066]; Universidad de La Laguna, Tenerife, Spain [ULL-06-1500]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministeriode Sanidad y Consumo, Spain; Fundacion para la Investigacion y Prevencio n del SIDA en Espana; Consejeria de Industria; Comercio y Nuevas Tecnologias del Gobierno Auto nomo de Canarias, Spain; Universidad de La Laguna, Tenerife, Spain	This work was supported in part by the Instituto de Salud Carlos III, Ministeriode Sanidad y Consumo, Spain (Grant FIS-PI050995), by the Fundacion para la Investigacion y Prevencio n del SIDA en Espana (Grants FIPSE-24508/05 and FIPSE-24661/07), by the Consejeria de Industria, Comercio y Nuevas Tecnologias del Gobierno Auto nomo de Canarias, Spain (Grant IDT-TF-06/066), and by the Universidad de La Laguna, Tenerife, Spain(Grant ULL-06-1500). The authors declare that they have no competing financial interests. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; Amieva MR, 1999, J CELL SCI, V112, P111; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Burns Alan R., 2008, V440, P235, DOI 10.1007/978-1-59745-178-9_18; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chen CY, 2005, J BIOL CHEM, V280, P6109, DOI 10.1074/jbc.M408454200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Connor JR, 2004, NEUROLOGY, V62, P1563, DOI 10.1212/01.WNL.0000123251.60485.AC; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; FRANCK Z, 1993, J CELL SCI, V105, P219; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Haffner C, 1997, FEBS LETT, V419, P175, DOI 10.1016/S0014-5793(97)01451-8; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Hirasawa A, 1998, BRIT J PHARMACOL, V124, P55, DOI 10.1038/sj.bjp.0701795; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 2002, CELL, V109, P413, DOI 10.1016/S0092-8674(02)00751-1; Knuehl C, 2006, TRAFFIC, V7, P1688, DOI 10.1111/j.1600-0854.2006.00499.x; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Laroche G, 2005, J BIOL CHEM, V280, P23215, DOI 10.1074/jbc.M414071200; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Clainche C, 2007, EMBO J, V26, P1199, DOI 10.1038/sj.emboj.7601576; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Lindsay AJ, 2004, J CELL SCI, V117, P4365, DOI 10.1242/jcs.01280; Lunn JA, 2000, AM J PHYSIOL-CELL PH, V279, pC2019, DOI 10.1152/ajpcell.2000.279.6.C2019; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Marin-Vicente C, 2005, MOL BIOL CELL, V16, P2848, DOI 10.1091/mbc.E05-01-0067; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; McPherson PS, 2002, TRENDS CELL BIOL, V12, P312, DOI 10.1016/S0962-8924(02)02309-7; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Musacchio A, 1999, MOL CELL, V3, P761, DOI 10.1016/S1097-2765(01)80008-3; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rappoport J, 2004, TRAFFIC, V5, P327, DOI 10.1111/j.1600-0854.2004.00187.x; Rappoport JZ, 2005, TRAFFIC, V6, P539, DOI 10.1111/j.1600-0854.2005.00280.x; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Scott MGH, 2002, J BIOL CHEM, V277, P3552, DOI 10.1074/jbc.M106586200; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wallace DME, 2002, BIOCHEM BIOPH RES CO, V299, P770, DOI 10.1016/S0006-291X(02)02720-1; Wilbur JD, 2008, J BIOL CHEM, V283, P32870, DOI 10.1074/jbc.M802863200; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708; Zaslaver A, 2001, J IMMUNOL, V166, P1272, DOI 10.4049/jimmunol.166.2.1272; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	92	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2419	2434		10.1074/jbc.M805311200	http://dx.doi.org/10.1074/jbc.M805311200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047065	hybrid			2022-12-25	WOS:000262545600050
J	Ko, MH; Puglielli, L				Ko, Mi Hee; Puglielli, Luigi			Two Endoplasmic Reticulum (ER)/ER Golgi Intermediate Compartment-based Lysine Acetyltransferases Post-translationally Regulate BACE1 Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-CLEAVING ENZYME-1; ALZHEIMERS-DISEASE; QUALITY-CONTROL; ACETYLATION; CERAMIDE; IDENTIFICATION; PURIFICATION; METABOLISM; GENERATION; DOMAIN	We have recently identified a novel form of post-translational regulation of BACE1(beta-site amyloid precursor protein-cleaving enzyme 1), a membrane protein that acts as the rate-limiting enzyme in the generation of the Alzheimer disease amyloid beta-peptide. Specifically, nascent BACE1 is transiently acetylated in seven lysine residues clustered in a highly disordered region of the protein that faces the lumen of the endoplasmic reticulum (ER)/ER Golgi intermediate compartment (ER/ERGIC). The acetylation protects the nascent protein from degradation by PCSK9/NARC-1 in the ERGIC and allows it to reach the Golgi apparatus. Here we report the identification of two ER/ERGIC-based acetyltransferases, ATase1 and ATase2. Both proteins display acetyl-CoA: lysine acetyltransferase activity, can interact with and acetylate BACE1, and display an ER/ERGIC localization with the catalytic site facing the lumen of the organelle. Both ATase1 and ATase2 regulate the steady-state levels of BACE1 and the rate of amyloid beta-peptide generation. Finally, their transcripts are up-regulated by ceramide treatment. In conclusion, our studies have identified two new enzymes that may be involved in the pathogenesis of late-onset Alzheimer disease. The biochemical characterization of the above events could lead to the identification of novel pharmacological strategies for the prevention of this form of dementia.	[Ko, Mi Hee; Puglielli, Luigi] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Puglielli, Luigi] Vet Affairs Med Ctr, Ctr Geriatr Res Educ Clin, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Puglielli, L (corresponding author), Univ Wisconsin, Dept Med, VAH GRECC 11G,2500 Overlook Terrace, Madison, WI 53705 USA.	lp1@medicine.wisc.edu			National Institutes of Health; NATIONAL INSTITUTE ON AGING [R01AG028569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by a National Institutes of Health grant (to L. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; CAREY DJ, 1981, J BIOL CHEM, V256, P989; Costantini C, 2005, BIOCHEM J, V391, P59, DOI 10.1042/BJ20050700; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Costantini C, 2006, EMBO J, V25, P1997, DOI 10.1038/sj.emboj.7601062; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dempski RE, 2002, CURR OPIN CHEM BIOL, V6, P844, DOI 10.1016/S1367-5931(02)00390-3; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Ko MH, 2007, J BIOL CHEM, V282, P19742, DOI 10.1074/jbc.M611426200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Popsueva AE, 2001, DEV BIOL, V234, P483, DOI 10.1006/dbio.2001.0261; Puglielli L, 1999, J BIOL CHEM, V274, P12665, DOI 10.1074/jbc.274.18.12665; Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Tissenbaum HA, 2002, DEV CELL, V2, P9, DOI 10.1016/S1534-5807(01)00098-3; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Yang XJ, 2007, EMBO REP, V8, P556, DOI 10.1038/sj.embor.7400977; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	37	88	93	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2482	2492		10.1074/jbc.M804901200	http://dx.doi.org/10.1074/jbc.M804901200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19011241	Green Published, hybrid			2022-12-25	WOS:000262545600055
J	Watanabe, N; Sekine, T; Takagi, M; Iwasaki, J; Imamoto, N; Kawasaki, H; Osada, H				Watanabe, Nobumoto; Sekine, Tomomi; Takagi, Masatoshi; Iwasaki, Jun-ichi; Imamoto, Naoko; Kawasaki, Hisashi; Osada, Hiroyuki			Deficiency in Chromosome Congression by the Inhibition of Plk1 Polo Box Domain-dependent Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-CHECKPOINT PROTEINS; SMALL-MOLECULE INHIBITOR; SOMATIC WEE1; CENP-E; KINASE; PHOSPHORYLATION; KINETOCHORE; METAPHASE; BINDING; ROLES	Polo-like kinase 1 (Plk1) is one of the key regulators of mitotic cell division. In addition to an N-terminal protein kinase catalytic domain, Plk1 possesses a phosphopeptide binding domain named polo box domain (PBD) at its C terminus. PBD is postulated to be essential for Plk1 localization and substrate targeting. Here, we developed a high-throughput screening system to identify inhibitors of PBD-dependent binding and screened a chemical library. Weisolated a benzotropolone-containing natural compound derived from nutgalls (purpurogallin (PPG)) that inhibited PBD-dependent binding in vitro and in vivo. PPG not only delayed the onset of mitosis but also prolonged the progression of mitosis in HeLa cells. Although apparently normal bipolar spindles were formed even in the presence of PPG, the perturbation of chromosome alignment at metaphase plates activated the spindle assembly checkpoint pathway. These results demonstrate the predominant role of PBD-dependent binding on smooth chromosome congression at metaphase.	[Watanabe, Nobumoto; Osada, Hiroyuki] RIKEN, Dept Biol Chem, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Watanabe, Nobumoto; Sekine, Tomomi; Iwasaki, Jun-ichi; Osada, Hiroyuki] RIKEN, Antibiot Lab, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Takagi, Masatoshi; Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Sekine, Tomomi; Kawasaki, Hisashi] Tokyo Denki Univ, Dept Environm Mat Sci, Chiyoda Ku, Tokyo 1018457, Japan	RIKEN; RIKEN; RIKEN; Tokyo Denki University	Watanabe, N (corresponding author), RIKEN, Dept Biol Chem, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nwatanab@riken.jp	Osada, Hiroyuki/N-4305-2014; Imamoto, Naoko/A-7458-2015; Osada, Hiroyuki/AAY-6254-2020; Watanabe, Nobumoto/N-6959-2015; 川崎, 寿/AAY-1352-2021	Imamoto, Naoko/0000-0002-2886-3022; Watanabe, Nobumoto/0000-0002-2130-1334; Kawasaki, Hisashi/0000-0001-6662-9301	Ministry of Education, Science, Technology, Sports, and Culture of Japan	Ministry of Education, Science, Technology, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science, Technology, Sports, and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abou-Karam M, 1999, PHYTOTHER RES, V13, P337, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;337::AID-PTR451&gt;3.0.CO;2-J; Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Farnet CM, 1998, ANTIMICROB AGENTS CH, V42, P2245, DOI 10.1128/AAC.42.9.2245; Fung KP, 1996, CHEMOTHERAPY, V42, P199, DOI 10.1159/000239442; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Inamori Y, 1997, BIOSCI BIOTECH BIOCH, V61, P890, DOI 10.1271/bbb.61.890; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Ma S, 2003, MOL CANCER RES, V1, P376; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Nishino M, 2006, CURR BIOL, V16, P1414, DOI 10.1016/j.cub.2006.05.052; Peters U, 2006, NAT CHEM BIOL, V2, P618, DOI 10.1038/nchembio826; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tomiki T, 2006, J COMPUT AIDED CHEM, V7, P157; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Wong OK, 2007, J CELL BIOL, V179, P611, DOI 10.1083/jcb.200708044; Wong OK, 2005, J CELL BIOL, V170, P709, DOI 10.1083/jcb.200502163; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	52	96	100	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2344	2353		10.1074/jbc.M805308200	http://dx.doi.org/10.1074/jbc.M805308200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19033445	hybrid			2022-12-25	WOS:000262545600043
J	Mukherjee, S; Shields, D				Mukherjee, Shaeri; Shields, Dennis			Nuclear Import Is Required for the Pro-apoptotic Function of the Golgi Protein p115	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-MEDIATED CLEAVAGE; VESICLE-TETHERING PROTEIN; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS; SECRETORY PATHWAY; TRANSPORT; FRAGMENTATION; APPARATUS; COMPLEX; GM130	During apoptosis the Golgi apparatus undergoes irreversible fragmentation. In part, this results from caspase-mediated cleavage of several high molecular weight coiled-coil proteins, termed golgins. These include GM130, golgin 160, and the Golgi vesicle tethering protein p115, whose caspase cleavage generates a C-terminal fragment (CTF) of 205 residues. Here we demonstrate that early during apoptosis, following the rapid cleavage of p115, endogenous CTF translocated to the cell nucleus and its nuclear import was required to enhance the apoptotic response. Expression of a series of deletion constructs identified a putative alpha-helical region of 26 amino acids, whose expression alone was sufficient to induce apoptosis; deletion of these 26 residues from the CTF diminished its proapoptotic activity. This region contains several potential SUMOylation sites and co-expression of SUMO together with the SUMO ligase, UBC9, resulted in SUMOylation of the p115 CTF. Significantly, when cells were treated with drugs that induce apoptosis, SUMOylation enhanced the efficiency of p115 cleavage and the kinetics of apoptosis. A construct in which a nuclear export signal was fused to the N terminus of p115 CTF accumulated in the cytoplasm and surprisingly, its expression did not induce apoptosis. In contrast, treatment of cells expressing this chimera with the antibiotic leptomycin induced its translocation into the nucleus and resulted in the concomitant induction of apoptosis. These results demonstrate that nuclear import of the p115 CTF is required for it to stimulate the apoptotic response and suggest that its mode of action is confined to the nucleus.	[Mukherjee, Shaeri; Shields, Dennis] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Shields, Dennis] Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Mukherjee, S (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, 333 Cedar St, New Haven, CT 06536 USA.	smukherj@aecom.yu.edu			National Institutes of Health [DK21860]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021860, R37DK021860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK21860 (to D. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Alvarez C, 1999, J CELL BIOL, V147, P1205, DOI 10.1083/jcb.147.6.1205; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Besnault-Mascard L, 2005, ONCOGENE, V24, P3268, DOI 10.1038/sj.onc.1208448; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Haga N, 2003, ONCOGENE, V22, P5579, DOI 10.1038/sj.onc.1206576; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lowe M, 2004, J CELL SCI, V117, P1139, DOI 10.1242/jcs.00950; Maag RS, 2005, MOL BIOL CELL, V16, P3019, DOI 10.1091/mbc.E04-11-0971; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Mukherjee S, 2007, TRAFFIC, V8, P369, DOI 10.1111/j.1600-0854.2007.00542.x; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Sesso A, 1999, TISSUE CELL, V31, P357, DOI 10.1054/tice.1999.0042; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sohda M, 2005, BIOCHEM BIOPH RES CO, V338, P1268, DOI 10.1016/j.bbrc.2005.10.084; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Walker A, 2004, BIOCHEM BIOPH RES CO, V316, P6, DOI 10.1016/j.bbrc.2004.02.015; Warren G, 1998, CURR OPIN CELL BIOL, V10, P493, DOI 10.1016/S0955-0674(98)80064-1	38	25	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1709	1717		10.1074/jbc.M807263200	http://dx.doi.org/10.1074/jbc.M807263200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028683	Green Published, hybrid			2022-12-25	WOS:000262330100040
J	Whittaker, E; Gordon, A; Kampmann, B				Whittaker, Elizabeth; Gordon, Andrea; Kampmann, Beate			Is IP-10 a Better Biomarker for Active and Latent Tuberculosis in Children than IFN gamma?	PLOS ONE			English	Article								Background: The blood based interferon-gamma release assays (IGRA) for the diagnosis of tuberculosis do not discriminate between active TB disease and latent TB infection (LTBI). The search for distinguishing biomarkers therefore continues, as the accurate diagnosis of tuberculosis is particularly challenging in children. IFN-gamma-inducible protein 10 (IP-10/CXCL10) has recently been evaluated as a marker for active TB in adults with promising results. Aim: To investigate this new biomarker for active TB and LTBI in paediatrics. Method: We measured IP-10 levels using ELISA in supernatants of whole blood samples stimulated with TB-specific-antigens and negative control antigen. Results: IP-10 is produced in high levels following mycobacterial antigen stimulation in active TB (n = 17) and LTBI (n = 16) compared to controls (n = 16) and to IFN-gamma. The baseline levels of IP-10 are increased in active TB and in LTBI, but there is no significant difference of stimulated levels of IP-10 between active TB and LTBI. Conclusions: IP-10 is a biomarker for tuberculosis in children. However like IFN gamma, IP-10 also does not distinguish between active TB and LTBI.	[Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England; [Gordon, Andrea; Kampmann, Beate] Imperial Coll London, Wellcome Ctr Clin Trop Med, London, England	Imperial College London; Imperial College London	Whittaker, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England.	e.whittaker@imperial.ac.uk		Whittaker, Elizabeth/0000-0002-7944-8793	Peel Foundation; European Society for Paediatric Infectious Diseases (ESPID); Wellcome Trust [GR 077273]; Biomedical Research Centre at Imperial College; National Institute for Health Research [ACF-2006-21-031] Funding Source: researchfish	Peel Foundation; European Society for Paediatric Infectious Diseases (ESPID); Wellcome Trust(Wellcome TrustEuropean Commission); Biomedical Research Centre at Imperial College; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was facilitated by consumable grants from the Peel Foundation and the European Society for Paediatric Infectious Diseases (ESPID). BK is funded by the Wellcome Trust (GR 077273). LW and BK are supported by the Biomedical Research Centre at Imperial College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Alessandri AL, 2006, INFLAMM RES, V55, P528, DOI 10.1007/s00011-006-5136-9; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Ferrero E, 2003, IMMUNOLOGY, V108, P365, DOI 10.1046/j.1365-2567.2003.01600.x; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Juffermans NP, 1999, INFECT IMMUN, V67, P4295, DOI 10.1128/IAI.67.8.4295-4297.1999; KAPLAN G, 1987, J EXP MED, V166, P1098, DOI 10.1084/jem.166.4.1098; Kawamura A, 2003, CIRC J, V67, P851, DOI 10.1253/circj.67.851; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lalvani A, 2007, CURR OPIN INFECT DIS, V20, P264, DOI 10.1097/QCO.0b013e32813e3fd8; Lit LCW, 2006, ANN RHEUM DIS, V65, P209, DOI 10.1136/ard.2005.038315; Loetscher M, 1998, EUR J IMMUNOL, V28, P3696, DOI 10.1002/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Marais BJ, 2007, J INFECT DIS, V196, pS76, DOI 10.1086/518659; Marais BJ, 2006, PEDIATRICS, V118, pE1350, DOI 10.1542/peds.2006-0519; Okamoto M, 2005, J LAB CLIN MED, V145, P88, DOI 10.1016/j.lab.2004.11.013; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Peters W, 2003, MICROBES INFECT, V5, P151, DOI 10.1016/S1286-4579(02)00082-5; Romagnani P, 2002, AM J PATHOL, V161, P195, DOI 10.1016/S0002-9440(10)64171-5; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Tan JQ, 2000, J IMMUNOL, V165, P1548, DOI 10.4049/jimmunol.165.3.1548	25	106	107	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3901	10.1371/journal.pone.0003901	http://dx.doi.org/10.1371/journal.pone.0003901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065267	gold, Green Published, Green Submitted			2022-12-25	WOS:000265455200013
J	Kinameri, E; Inoue, T; Aruga, J; Imayoshi, I; Kageyama, R; Shimogori, T; Moore, AW				Kinameri, Emi; Inoue, Takashi; Aruga, Jun; Imayoshi, Itaru; Kageyama, Ryoichiro; Shimogori, Tomomi; Moore, Adrian W.			Prdm Proto-Oncogene Transcription Factor Family Expression and Interaction with the Notch-Hes Pathway in Mouse Neurogenesis	PLOS ONE			English	Article								Background: Establishment and maintenance of a functional central nervous system (CNS) requires a highly orchestrated process of neural progenitor cell proliferation, cell cycle exit, and differentiation. An evolutionary conserved program consisting of Notch signalling mediated by basic Helix-Loop-Helix (bHLH) transcription factor activity is necessary for both the maintenance of neural progenitor cell character and the progression of neurogenesis; however, additional players in mammalian CNS neural specification remain largely unknown. In Drosophila we recently characterized Hamlet, a transcription factor that mediates Notch signalling and neural cell fate. Methodology/Principal Findings: Hamlet is a member of the Prdm (PRDI-BF1 and RIZ homology domain containing) protooncogene transcription factor family, and in this study we report that multiple genes in the Prdm family (Prdm6, 8, 12, 13 and 16) are expressed in the developing mouse CNS in a spatially and temporally restricted manner. In developing spinal cord Prdm8, 12 and 13 are expressed in precise neuronal progenitor zones suggesting that they may specify discrete neuronal subtypes. In developing telencephalon Prdm12 and 16 are expressed in the ventricular zone in a lateral to medial graded manner, and Prdm8 is expressed in a complementary domain in postmitotic neurons. In postnatal brain Prdm8 additionally shows restricted expression in cortical layers 2/3 and 4, the hippocampus, and the amygdala. To further elucidate roles of Prdm8 and 16 in the developing telencephalon we analyzed the relationship between these factors and the bHLH Hes (Hairy and enhancer of split homolog) effectors of Notch signalling. In Hes null telencephalon neural differentiation is enhanced, Prdm8 expression is upregulated, and Prdm16 expression is downregulated; conversely in utero electroporation of Hes1 into the developing telencephalon upregulates Prdm16 expression. Conclusions/Significance: Our data demonstrate that Prdm genes are regulated by the Notch-Hes pathway and represent strong candidates to control neural class specification and the sequential progression of mammalian CNS neurogenesis.	[Kinameri, Emi; Moore, Adrian W.] RIKEN, Brain Sci Inst, Mol Neuropathol Grp, Wako, Saitama, Japan; [Inoue, Takashi; Aruga, Jun] RIKEN Brain Sci Inst, Lab Behavioral & Dev Disorders, Wako, Saitama, Japan; [Imayoshi, Itaru; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kyoto, Japan; [Shimogori, Tomomi] RIKEN Brain Sci Inst, Shimogori Res Unit, Wako, Saitama, Japan	RIKEN; RIKEN; Kyoto University; RIKEN	Kinameri, E (corresponding author), RIKEN, Brain Sci Inst, Mol Neuropathol Grp, Wako, Saitama, Japan.	tshimogori@brain.riken.jp; adrianm@brain.riken.jp	Shimogori, Tomomi/L-2893-2013; Aruga, Jun/H-5837-2011; Moore, Adrian Walton/AAN-5656-2021; Moore, Adrian W/A-3339-2013	Shimogori, Tomomi/0000-0002-6931-5401; Aruga, Jun/0000-0001-7936-1375; Moore, Adrian Walton/0000-0002-8242-301X; Moore, Adrian W/0000-0002-8242-301X	RIKEN Brain Science Institute	RIKEN Brain Science Institute	Funding provided by the RIKEN Brain Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxendale S, 2004, NAT GENET, V36, P88, DOI 10.1038/ng1280; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; CATTANEO F, 2008, J CELL BIOCH; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Cornell RA, 2002, DEVELOPMENT, V129, P2639; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; GARRIGA G, 1993, GENE DEV, V7, P2097, DOI 10.1101/gad.7.11.2097; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grove EA, 1998, DEVELOPMENT, V125, P2315; Guillemot F, 2006, EUR J NEUROSCI, V23, P857, DOI 10.1111/j.1460-9568.2006.04626.x; Hazourli S, 2006, GENE CHROMOSOME CANC, V45, P1072, DOI 10.1002/gcc.20370; Hernandez-Lagunas L, 2005, DEV BIOL, V278, P347, DOI 10.1016/j.ydbio.2004.11.014; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Hwang BJ, 2007, DEVELOPMENT, V134, P669, DOI 10.1242/dev.02769; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; JAN YN, 1994, ANNU REV GENET, V28, P373, DOI 10.1146/annurev.ge.28.120194.002105; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kendall SE, 2003, DEV BRAIN RES, V144, P151, DOI 10.1016/S0165-3806(03)00166-4; MODLICH U, 2008, LEUKEMIA; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Moore AW, 2004, GENE DEV, V18, P623, DOI 10.1101/gad.1170904; Morishita K, 2007, INT J HEMATOL, V85, P279, DOI 10.1532/IJH97.06174; MUCENSKI ML, 1988, MOL CELL BIOL, V8, P301, DOI 10.1128/MCB.8.1.301; Ng T, 2006, DEV GENES EVOL, V216, P243, DOI 10.1007/s00427-005-0044-5; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; Nishikawa N, 2007, CANCER RES, V67, P9649, DOI 10.1158/0008-5472.CAN-06-4111; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; PERKINS AS, 1991, DEVELOPMENT, V111, P479; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Reid AG, 2004, LEUKEMIA, V18, P178, DOI 10.1038/sj.leu.2403162; Rimann I, 2007, DEV BIOL, V308, P187, DOI 10.1016/j.ydbio.2007.05.023; Roy S, 2004, CURR BIOL, V14, P1772, DOI 10.1016/j.cub.2004.09.046; Santiago AC, 2004, J COMP NEUROL, V471, P314, DOI 10.1002/cne.20028; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; SHIMOGORI T, 2008, DEV GROWTH DIFFER; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Tam W, 2006, BLOOD, V107, P4090, DOI 10.1182/blood-2005-09-3778; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zeltser LM, 2001, NAT NEUROSCI, V4, P683, DOI 10.1038/89455; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	59	87	89	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3859	10.1371/journal.pone.0003859	http://dx.doi.org/10.1371/journal.pone.0003859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050759	gold, Green Published, Green Submitted			2022-12-25	WOS:000265452100010
J	Pi, M; Chen, L; Huang, MZ; Zhu, WY; Ringhofer, B; Luo, JM; Christenson, L; Li, BY; Zhang, JH; Jackson, PD; Faber, P; Brunden, KR; Harrington, JJ; Quarles, LD				Pi, Min; Chen, Ling; Huang, Min-Zhao; Zhu, Wenyu; Ringhofer, Brian; Luo, Junming; Christenson, Lane; Li, Benyi; Zhang, Jianghong; Jackson, P. David; Faber, Pieter; Brunden, Kurt R.; Harrington, John J.; Quarles, L. Darryl			GPRC6A Null Mice Exhibit Osteopenia, Feminization and Metabolic Syndrome	PLOS ONE			English	Article								Background: GPRC6A is a widely expressed orphan G-protein coupled receptor that senses extracellular amino acids, osteocalcin and divalent cations in vitro. The physiological functions of GPRC6A are unknown. Methods/Principal Findings: In this study, we created and characterized the phenotype of GPRC6A(-/-) mice. We observed complex metabolic abnormalities in GPRC6A(-/-) mice involving multiple organ systems that express GPRC6A, including bone, kidney, testes, and liver. GPRC6A(-/-) mice exhibited hepatic steatosis, hyperglycemia, glucose intolerance, and insulin resistance. In addition, we observed high expression of GPRC6A in Leydig cells in the testis. Ablation of GPRC6A resulted in feminization of male GPRC6A(-/-) mice in association with decreased lean body mass, increased fat mass, increased circulating levels of estradiol, and reduced levels of testosterone. GPRC6A was also highly expressed in kidney proximal and distal tubules, and GPRC6A(-/-) mice exhibited increments in urine Ca/Cr and PO4/Cr ratios as well as low molecular weight proteinuria. Finally, GPRC6A(-/-) mice exhibited a decrease in bone mineral density (BMD) in association with impaired mineralization of bone. Conclusions/Significance: GPRC6A(-/-) mice have a metabolic syndrome characterized by defective osteoblast-mediated bone mineralization, abnormal renal handling of calcium and phosphorus, fatty liver, glucose intolerance and disordered steroidogenesis. These findings suggest the overall function of GPRC6A may be to coordinate the anabolic responses of multiple tissues through the sensing of extracellular amino acids, osteocalcin and divalent cations.	[Pi, Min; Chen, Ling; Huang, Min-Zhao; Zhu, Wenyu; Ringhofer, Brian; Luo, Junming; Quarles, L. Darryl] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA; [Christenson, Lane; Li, Benyi] Univ Kansas, Med Ctr, Dept Mol & Integrative Physiol, Kansas City, KS USA; [Zhang, Jianghong] Vanderbilt Univ, Ctr Bone Biol, Nashville, TN USA; [Jackson, P. David; Faber, Pieter; Brunden, Kurt R.; Harrington, John J.] Athersys Inc, Cleveland, OH USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Vanderbilt University	Pi, M (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA.	dquarles@kumc.edu	Christenson, Lane K/G-6435-2013; Brunden, Kurt/D-1994-2009	Quarles, L. Darryl/0000-0002-5082-7896; Pi, Min/0000-0002-0319-8003	NIH [R01-AR37308]; COBRE [P20 RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037308] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH R01-AR37308 (L. D. Q.) and COBRE grant P20 RR017686 (M. P.).	Auchus RJ, 2004, SEMIN REPROD MED, V22, P281, DOI 10.1055/s-2004-861545; Bodine PVN, 1999, BONE, V25, P535, DOI 10.1016/S8756-3282(99)00213-6; Carreau Serge, 2003, Reprod Biol Endocrinol, V1, P35, DOI 10.1186/1477-7827-1-35; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Cohen A, 2002, CURR OPIN PHARMACOL, V2, P734, DOI 10.1016/S1471-4892(02)00210-2; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; FOLKERS K, 1986, P NATL ACAD SCI USA, V83, P1070, DOI 10.1073/pnas.83.4.1070; GASPAR ML, 1991, P NATL ACAD SCI USA, V88, P8606, DOI 10.1073/pnas.88.19.8606; Giannini S, 2005, CRIT REV CL LAB SCI, V42, P229, DOI 10.1080/10408360590913533; HE WW, 1991, NUCLEIC ACIDS RES, V19, P2373, DOI 10.1093/nar/19.9.2373; Hiroi H, 2004, MOL ENDOCRINOL, V18, P791, DOI 10.1210/me.2003-0305; Hu JX, 2002, J BIOL CHEM, V277, P46622, DOI 10.1074/jbc.M207100200; Hug BA, 1996, MOL CELL BIOL, V16, P2906; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Perlemuter G, 2007, NAT CLIN PRACT ENDOC, V3, P458, DOI 10.1038/ncpendmet0505; Petrel C, 2004, J BIOL CHEM, V279, P18990, DOI 10.1074/jbc.M400724200; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2004, J BONE MINER RES, V19, P862, DOI 10.1359/JBMR.040114; Pi M, 2000, J BIOL CHEM, V275, P3256, DOI 10.1074/jbc.275.5.3256; QUARLES LD, 1988, J CLIN INVEST, V81, P1056, DOI 10.1172/JCI113417; Reim NS, 2008, J BONE MINER RES, V23, P694, DOI 10.1359/JBMR.080202; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tabata T, 2004, P NATL ACAD SCI USA, V101, P16952, DOI 10.1073/pnas.0405387101; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Tong MH, 2004, ENDOCRINOLOGY, V145, P2487, DOI 10.1210/en.2003-1237; Tu QS, 2003, J CLIN INVEST, V111, P1029, DOI 10.1172/JCI200317054; Ulloa-Aguirre A, 1990, Gac Med Mex, V126, P297; ULLOAAGUIRRE A, 1990, GAC MED MEX, V126, P304; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; WELLENDORPH P, 2007, GENE; Xiao ZS, 2003, J CELL BIOCHEM, V88, P493, DOI 10.1002/jcb.10375; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; ZAIDI M, 1995, J CLIN INVEST, V96, P1582, DOI 10.1172/JCI118197; ZERWEKH JE, 1992, OSTEOPOROSIS INT, V2, P128, DOI 10.1007/BF01623819	40	182	197	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3858	10.1371/journal.pone.0003858	http://dx.doi.org/10.1371/journal.pone.0003858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050760	Green Published, Green Submitted, gold			2022-12-25	WOS:000265452100009
J	Maeda, YT; Inose, J; Matsuo, MY; Iwaya, S; Sano, M				Maeda, Yusuke T.; Inose, Junya; Matsuo, Miki Y.; Iwaya, Suguru; Sano, Masaki			Ordered Patterns of Cell Shape and Orientational Correlation during Spontaneous Cell Migration	PLOS ONE			English	Article								Background: In the absence of stimuli, most motile eukaryotic cells move by spontaneously coordinating cell deformation with cell movement in the absence of stimuli. Yet little is known about how cells change their own shape and how cells coordinate the deformation and movement. Here, we investigated the mechanism of spontaneous cell migration by using computational analyses. Methodology: We observed spontaneously migrating Dictyostelium cells in both a vegetative state ( round cell shape and slow motion) and starved one ( elongated cell shape and fast motion). We then extracted regular patterns of morphological dynamics and the pattern-dependent systematic coordination with filamentous actin (F-actin) and cell movement by statistical dynamic analyses. Conclusions/Significance: We found that Dictyostelium cells in both vegetative and starved states commonly organize their own shape into three ordered patterns, elongation, rotation, and oscillation, in the absence of external stimuli. Further, cells inactivated for PI3-kinase (PI3K) and/or PTEN did not show ordered patterns due to the lack of spatial control in pseudopodial formation in both the vegetative and starved states. We also found that spontaneous polarization was achieved in starved cells by asymmetric localization of PTEN and F-actin. This breaking of the symmetry of protein localization maintained the leading edge and considerably enhanced the persistence of directed migration, and overall random exploration was ensured by switching among the different ordered patterns. Our findings suggest that Dictyostelium cells spontaneously create the ordered patterns of cell shape mediated by PI3K/PTEN/F-actin and control the direction of cell movement by coordination with these patterns even in the absence of external stimuli.	[Maeda, Yusuke T.; Inose, Junya; Matsuo, Miki Y.; Iwaya, Suguru; Sano, Masaki] Univ Tokyo, Grad Sch Sci, Dept, Phys, Tokyo, Japan	University of Tokyo	Maeda, YT (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	ymaeda@rockefeller.edu	Sano, Masaki/E-4434-2012	Sano, Masaki/0000-0002-6262-9635	Japanese Society for Promotion of Science [fellowship]	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the fellowship DC1 (YTM) and the postdoctoral fellowship (YTM and MYM) from Japanese Society for Promotion of Science.	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; KILLICH T, 1993, J CELL SCI, V106, P1005; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee E, 2003, EUKARYOT CELL, V2, P474, DOI 10.1128/EC.2.3.474-485.2003; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; PARTIN AW, 1989, P NATL ACAD SCI USA, V86, P1254, DOI 10.1073/pnas.86.4.1254; Rieu JP, 2000, BIOPHYS J, V79, P1903, DOI 10.1016/S0006-3495(00)76440-X; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Somesh BP, 2006, EUKARYOT CELL, V5, P1648, DOI 10.1128/EC.00221-06; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vicker MG, 2002, FEBS LETT, V510, P5, DOI 10.1016/S0014-5793(01)03207-0; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Wessels D, 2007, J CELL SCI, V120, P2517, DOI 10.1242/jcs.010876	32	95	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3734	10.1371/journal.pone.0003734	http://dx.doi.org/10.1371/journal.pone.0003734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011688	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448300002
J	Cheng, Q; Sandalova, T; Lindqvist, Y; Arner, ESJ				Cheng, Qing; Sandalova, Tatyana; Lindqvist, Ylva; Arner, Elias S. J.			Crystal Structure and Catalysis of the Selenoprotein Thioredoxin Reductase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN THIOREDOXIN; GLUTATHIONE-REDUCTASE; ACTIVE-SITE; RECOMBINANT PROTEINS; ESCHERICHIA-COLI; HUMAN PLACENTA; CELL-DEATH; SELENOCYSTEINE; SELENIUM; MECHANISM	Selenoproteins contain a highly reactive 21st amino acid selenocysteine (Sec) encoded by recoding of a predefined UGA codon. Because of a lack of selenoprotein supply, high chemical reactivity of Sec, and intricate translation machineries, selenoprotein crystal structures are difficult to obtain. Structural prerequisites for Sec involvement in enzyme catalysis are therefore sparsely known. Here we present the crystal structure of catalytically active rat thioredoxin reductase 1 (TrxR1), revealing surprises at the C-terminal Sec-containing active site in view of previous literature. The oxidized enzyme presents a selenenyl-sulfide motif in trans-configuration, with the selenium atom of Sec-498 positioned beneath the side chain of Tyr-116, thereby located far from the redox active moieties proposed to be involved in electron transport to the Sec-containing active site. Upon reduction to a selenolthiol motif, the Sec residue moved toward solvent exposure, consistent with its presumed role in reduction of TrxR1 substrates or as target of electrophilic agents inhibiting the enzyme. A Y116I mutation lowered catalytic efficiency in reduction of thioredoxin, but surprisingly increased turnover using 5-hydroxy-1,4-naphthoquinone (juglone) as substrate. The same mutation also decreased sensitivity to inhibition by cisplatin. The results suggest that Tyr-116 plays an important role for catalysis of TrxR1 by interacting with the selenenylsulfide of oxidized TrxR1, thereby facilitating its reduction in the reductive half reaction of the enzyme. The interaction of a selenenylsulfide with the phenyl ring of a tyrosine, affecting turnover, switch of substrate specificity, and modulation of sensitivity to electrophilic agents, gives important clues into the mechanism of TrxR1, which is a selenoprotein that plays a major role for mammalian cell fate and function. The results also demonstrate that a recombinant selenoprotein TrxR can be produced in high amount and sufficient purity to enable crystal structure determination, which suggests that additional structural studies of these types of proteins are feasible.	[Cheng, Qing; Arner, Elias S. J.] Karolinska Inst, Med Nobel Inst Biochem, Div Biochem, SE-17177 Stockholm, Sweden; [Sandalova, Tatyana; Lindqvist, Ylva] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Struct Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Arner, ESJ (corresponding author), Karolinska Inst, Med Nobel Inst Biochem, Div Biochem, SE-17177 Stockholm, Sweden.	Elias.Arner@ki.se	Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019; Lindqvist, Ylva/F-9009-2010	Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114; Cheng, Qing/0000-0002-3170-9333; Sandalova, Tatyana/0000-0002-7694-6420; Lindqvist, Ylva/0000-0003-3162-8661	Karolinska Institutet; The Swedish Research Council (Medicine); The Swedish Cancer Society, Hedlunds Stiftelse; Knutoch Alice Wallenbergs Stiftelse	Karolinska Institutet(Karolinska Institutet); The Swedish Research Council (Medicine)(Swedish Research Council); The Swedish Cancer Society, Hedlunds Stiftelse(Swedish Cancer Society); Knutoch Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation)	This work was supported by the Karolinska Institutet, The Swedish Research Council (Medicine), The Swedish Cancer Society, Hedlunds Stiftelse, and Knutoch Alice Wallenbergs Stiftelse. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Allamand V, 2006, EMBO REP, V7, P450, DOI 10.1038/sj.embor.7400648; Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Anestal K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001846; ARNE RESJ, 2000, CURRENT PROTOCOLS TO; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 2001, FREE RADICAL BIO MED, V31, P1170, DOI 10.1016/S0891-5849(01)00698-0; Arscott LD, 1997, P NATL ACAD SCI USA, V94, P3621, DOI 10.1073/pnas.94.8.3621; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biterova EI, 2005, P NATL ACAD SCI USA, V102, P15018, DOI 10.1073/pnas.0504218102; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Brandt W, 2005, CHEMBIOCHEM, V6, P386, DOI 10.1002/cbic.200400276; Cenas N, 2006, J BIOL CHEM, V281, P5593, DOI 10.1074/jbc.M511972200; Cenas N, 2004, J BIOL CHEM, V279, P2583, DOI 10.1074/jbc.M310292200; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; Cheng Q, 2006, CHEMBIOCHEM, V7, P1976, DOI 10.1002/cbic.200600326; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Eckenroth B, 2006, BIOCHEMISTRY-US, V45, P5158, DOI 10.1021/bi0517887; Eckenroth BE, 2007, BIOCHEMISTRY-US, V46, P9472, DOI 10.1021/bi7004812; Eckenroth BE, 2007, BIOCHEMISTRY-US, V46, P4694, DOI 10.1021/bi602394p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; Flohe L, 2000, IUBMB LIFE, V49, P411; Fritz-Wolf K, 2007, J MOL BIOL, V370, P116, DOI 10.1016/j.jmb.2007.04.044; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Gromer S, 2003, P NATL ACAD SCI USA, V100, P12618, DOI 10.1073/pnas.2134510100; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Gromer S, 2006, CHEMBIOCHEM, V7, P1649, DOI 10.1002/cbic.200600080; Grundner-Culemann E, 2001, J MOL BIOL, V310, P699, DOI 10.1006/jmbi.2001.4809; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Huttenhofer A, 1998, COLD SPRING HARBOR M, P603; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Johansson L, 2006, FREE RADICAL BIO MED, V41, P649, DOI 10.1016/j.freeradbiomed.2006.05.005; Krauth-Siegel RL, 1998, BIOCHEMISTRY-US, V37, P13968, DOI 10.1021/bi980637j; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Moroder L, 2005, J PEPT SCI, V11, P187, DOI 10.1002/psc.654; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordstrand K, 2000, J MOL BIOL, V303, P423, DOI 10.1006/jmbi.2000.4145; PAI EF, 1983, J BIOL CHEM, V258, P1752; Ren B, 1997, J MOL BIOL, V268, P869, DOI 10.1006/jmbi.1997.1005; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; Tormay P, 1997, J BACTERIOL, V179, P576, DOI 10.1128/jb.179.3.576-582.1997; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wessjohann LA, 2007, BIOL CHEM, V388, P997, DOI 10.1515/BC.2007.138; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; Witte AB, 2005, FREE RADICAL BIO MED, V39, P696, DOI 10.1016/j.freeradbiomed.2005.04.025; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Zhang JX, 1997, PROTEIN SCI, V6, P1549, DOI 10.1002/pro.5560060719; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000095; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	70	149	152	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3998	4008		10.1074/jbc.M807068200	http://dx.doi.org/10.1074/jbc.M807068200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19054767	hybrid			2022-12-25	WOS:000262872500068
J	Halbach, A; Rucktaschel, R; Rottensteiner, H; Erdmann, R				Halbach, Andre; Rucktaeschel, Robert; Rottensteiner, Hanspeter; Erdmann, Ralf			The N-domain of Pex22p Can Functionally Replace the Pex3p N-domain in Targeting and Peroxisome Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT RECEPTOR PEX5P; MEMBRANE-PROTEINS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; BIOGENESIS; YEAST; PEX19P; UBIQUITINATION; IDENTIFICATION; ASSOCIATION	Pex3p is a central component of the import machinery for peroxisomal membrane proteins (PMPs) that can reach peroxisomes via the endoplasmic reticulum (ER) and even trigger de novo peroxisome formation from the ER. Pex19p is the import receptor for type I PMPs, whereas targeting of type II PMPs, of which Pex3p so far represents the only species, does not require Pex19p. Pex3p possesses two domains with distinct function: a short N-terminal domain, which harbors the information for peroxisomal (and ER) targeting, and a C-terminal domain, which faces the cytosol and serves as a docking site for Pex19p, thereby delivering newly synthesized PMPs to the peroxisome. Here we show that the N-terminal domain of Pex3p can be functionally replaced by the N-terminal peroxisomal membrane targeting signal (mPTS) of Pex22p, a supposedly unrelated component of the import machinery for peroxisomal matrix proteins. An exchange of the mPTS of Pex22p by that of Pex3p likewise fully preserved the function of Pex22p. Neither of the two mPTS interacted with Pex19p, and in the absence of Pex19p, colocalization of Pex3p and Pex22p was observed, indicating that also Pex22p is targeted to peroxisomes by a type II mPTS. When a type I mPTS was hooked to the C-terminal domains of Pex22p and Pex3p, function was retained in the case of Pex22p and in part even for Pex3p. The C-terminal domain of Pex3p thus contains the relevant information required for de novo peroxisome formation, thereby challenging the concept of the N terminus of Pex3p being key in that process.	[Halbach, Andre; Rucktaeschel, Robert; Rottensteiner, Hanspeter; Erdmann, Ralf] Ruhr Univ Bochum, Abt Syst Biochem, Inst Physiol Chem, D-44780 Bochum, Germany	Ruhr University Bochum	Rottensteiner, H (corresponding author), Ruhr Univ Bochum, Abt Syst Biochem, Inst Physiol Chem, D-44780 Bochum, Germany.	Hanspeter.Rottensteiner@rub.de			Deutsche Forschungsgemeinschaft [178/2-4]; FP6 European Union Project Peroxisome [LHSG-CT-2004-512018]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FP6 European Union Project Peroxisome(European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant 178/2-4, by FP6 European Union Project Peroxisome Grant LHSG-CT-2004-512018, and by the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Bascom RA, 2003, MOL BIOL CELL, V14, P939, DOI 10.1091/mbc.E02-10-0633; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; DECKERS M, 2007, THESIS RUHR U BOCHUM; Eckert JH, 2003, REV PHYSIOL BIOCH P, V147, P75, DOI 10.1007/s10254-003-0007-z; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Faber KN, 2002, J BIOL CHEM, V277, P11026, DOI 10.1074/jbc.M112347200; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Ghaedi K, 2000, MOL BIOL CELL, V11, P2085, DOI 10.1091/mbc.11.6.2085; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Haan GJ, 2006, FEMS YEAST RES, V6, P186, DOI 10.1111/j.1567-1364.2006.00037.x; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; HOHFELD J, 1991, J CELL BIOL, V114, P1167, DOI 10.1083/jcb.114.6.1167; Honsho M, 2002, J BIOL CHEM, V277, P44513, DOI 10.1074/jbc.M206139200; Hunt JE, 2004, BIOCHEM BIOPH RES CO, V314, P586, DOI 10.1016/j.bbrc.2003.12.123; James P, 1996, GENETICS, V144, P1425; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; Kragt A, 2005, J BIOL CHEM, V280, P34350, DOI 10.1074/jbc.M505432200; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Lazarow PB, 2003, CURR OPIN CELL BIOL, V15, P489, DOI 10.1016/S0955-0674(03)00082-6; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Pause B, 1997, FEBS LETT, V414, P95, DOI 10.1016/S0014-5793(97)00975-7; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Soukupova M, 1999, EUR J CELL BIOL, V78, P357, DOI 10.1016/S0171-9335(99)80078-8; South ST, 2000, J CELL BIOL, V149, P1345, DOI 10.1083/jcb.149.7.1345; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; South ST, 2001, P NATL ACAD SCI USA, V98, P12027, DOI 10.1073/pnas.221289498; Stein K, 2002, MOL CELL BIOL, V22, P6056, DOI 10.1128/MCB.22.17.6056-6069.2002; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; Tabak HF, 2006, BBA-MOL CELL RES, V1763, P1647, DOI 10.1016/j.bbamcr.2006.08.045; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	48	32	33	5	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3906	3916		10.1074/jbc.M806950200	http://dx.doi.org/10.1074/jbc.M806950200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19017643	hybrid			2022-12-25	WOS:000262872500059
J	Gresko, E; Ritterhoff, S; Sevilla-Perez, J; Roscic, A; Frobius, K; Kotevic, I; Vichalkovski, A; Hess, D; Hemmings, BA; Schmitz, ML				Gresko, E.; Ritterhoff, S.; Sevilla-Perez, J.; Roscic, A.; Froebius, K.; Kotevic, I.; Vichalkovski, A.; Hess, D.; Hemmings, B. A.; Schmitz, M. L.			PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage	ONCOGENE			English	Article						HIPK2; PML; phosphorylation; cell death	ACUTE PROMYELOCYTIC LEUKEMIA; HOMEODOMAIN-INTERACTING PROTEIN-KINASE-2; NUCLEAR-BODIES; RAR-ALPHA; PROTEIN KINASE-2; P53 ACTIVITY; CELL-DEATH; HIPK2; TRANSCRIPTION; APOPTOSIS	The promyelocytic leukemia (PML) tumor suppressor protein, a central regulator of cell proliferation and apoptosis, is frequently fused to the retinoic acid receptor-alpha (RAR alpha) in acute PML. Here we show the interaction of PML with another tumor suppressor protein, the serine/threonine kinase homeodomain-interacting protein kinase (HIPK2). In response to DNA damage, HIPK2 phosphorylates PML at serines 8 and 38. Although HIPK2-mediated phosphorylation of PML occurs early during the DNA damage response, the oncogenic PML-RAR alpha fusion protein is phosphorylated with significantly delayed kinetics. DNA damage or HIPK2 expression leads to the stabilization of PML and PML-RARa proteins. The N-terminal phosphorylation sites contribute to the DNA damage-induced PML SUMOylation and are required for the ability of PML to cooperate with HIPK2 for the induction of cell death.	[Ritterhoff, S.; Sevilla-Perez, J.; Roscic, A.; Froebius, K.; Schmitz, M. L.] Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; [Gresko, E.] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Gresko, E.; Vichalkovski, A.; Hess, D.; Hemmings, B. A.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Roscic, A.] Novartis Pharma AG, Basel, Switzerland; [Kotevic, I.] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Kotevic, I.] ETH, Zurich, Switzerland	Justus Liebig University Giessen; University of Bern; Friedrich Miescher Institute for Biomedical Research; Novartis; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schmitz, ML (corresponding author), Univ Giessen, Inst Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	lienhard.schmitz@biochemie.med.uni-giessen.de	Schmitz, M. Lienhard/D-9328-2017	Schmitz, M. Lienhard/0000-0002-6984-7192	Deutsche Forschungsgemeinschaft [SCHM 1417/4-1, SCHM 1417/5-1, SFB 547]; ECCPS-Excellence Cluster Cardio-Pulmonary System; Swiss Cancer League [OCS 01667-02-2005]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ECCPS-Excellence Cluster Cardio-Pulmonary System(German Research Foundation (DFG)); Swiss Cancer League	We are grateful to Drs Giannino Del Sal (Trieste, Italy) and Myung K Kim (NIH, USA) for generously providing expression vectors. The study from our laboratory was supported by grants from the Deutsche Forschungsgemeinschaft projects SCHM 1417/4-1, SCHM 1417/5-1, SFB 547 and the ECCPS-Excellence Cluster Cardio-Pulmonary System. FMI is a part of Novartis Research Foundation and EG was supported by the Swiss Cancer League Grant OCS 01667-02-2005.	Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Boisvert FM, 2000, J CELL BIOL, V148, P283, DOI 10.1083/jcb.148.2.283; Borden KLB, 2008, BBA-MOL CELL RES, V1783, P2145, DOI 10.1016/j.bbamcr.2008.06.005; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dellaire G, 2006, J CELL BIOL, V175, P55, DOI 10.1083/jcb.200604009; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Hess D, 2008, J BIOL CHEM, V283, P7354, DOI 10.1074/jbc.M710251200; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kramer OH, 2008, FASEB J, V22, P1369, DOI 10.1096/fj.06-8050com; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li XL, 2007, ONCOGENE, V26, P7231, DOI 10.1038/sj.onc.1210523; Link N, 2007, J CELL BIOL, V178, P567, DOI 10.1083/jcb.200702125; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Moller A, 2003, CANCER RES, V63, P4310; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Tagata Y, 2008, LEUKEMIA, V22, P273, DOI 10.1038/sj.leu.2405024; Takahashi Y, 2004, ONCOGENE, V23, P2819, DOI 10.1038/sj.onc.1207533; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869	39	33	37	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					698	708		10.1038/onc.2008.420	http://dx.doi.org/10.1038/onc.2008.420			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	19015637	Bronze			2022-12-25	WOS:000263076400007
J	Li, DD; Wang, L; Deng, R; Tang, J; Shen, Y; Guo, JF; Wang, Y; Xia, LP; Feng, GK; Liu, QQ; Huang, WL; Zeng, YX; Zhu, XF				Li, D-D; Wang, L-L; Deng, R.; Tang, J.; Shen, Y.; Guo, J-F; Wang, Y.; Xia, L-P; Feng, G-K; Liu, Q. Q.; Huang, W-L; Zeng, Y-X; Zhu, X-F			The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells	ONCOGENE			English	Article						c-Jun NH2-terminal kinase (JNK); autophagy; ceramide; Beclin 1	PROTEIN-KINASE; CERAMIDE; DEATH; MACROAUTOPHAGY; PATHWAY; INHIBITION; SURVIVAL; DEGRADATION; MECHANISMS; INDUCTION	The c-Jun NH2-terminal kinase (JNK) pathway represents one subgroup of MAP kinases that are activated primarily by cytokines and exposure to environmental stress. Autophagy is a protein-degradation system characterized by the formation of double-membrane vacuoles termed autophagosomes. Autophagy-related gene beclin 1 plays a key role in autophagosome formation. However, the relationships between activation of JNK pathway, autophagy induction and Beclin 1 expression remain elusive. In this study, we used human cancer cell lines CNE2 and Hep3B to investigate the role of JNK-mediated Beclin 1 expression in ceramide-induced autophagic cell death. Ceramide-treated cells exhibited the characteristics of autophagy (that is, acidic vesicular organelle formation and the LC3-II generation). JNK was activated in these two cell lines exposed to ceramide and the phosphorylation of c-Jun also increased. In the meantime, we found that ceramide upregulated Beclin 1 expression in cancer cells. The upregulation of Beclin 1 expression could be blocked by SP600125 (a specific inhibitor of JNK) or a small interfering RNA (siRNA) directed against JNK1/2 or c-Jun. Chromatin immunoprecipitation and luciferase reporter analysis revealed that c-Jun was involved in the regulation of beclin 1 transcription in response to ceramide treatment. In addition, inhibition of JNK activity by SP600125 could inhibit autophagy induction by ceramide. Furthermore, Beclin 1 knockdown by siRNA also inhibited ceramide-mediated autophagic cell death. JNK-mediated Beclin 1 expression was also observed in topotecan-induced autophagy. These data suggest that activation of JNK pathway can mediate Beclin 1 expression, which plays a key role in autophagic cell death in cancer cells.	[Li, D-D; Wang, L-L; Deng, R.; Tang, J.; Shen, Y.; Guo, J-F; Wang, Y.; Xia, L-P; Feng, G-K; Liu, Q. Q.; Huang, W-L; Zeng, Y-X; Zhu, X-F] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University	Zhu, XF (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, 651 Dongfeng Rd E, Guangzhou 510060, Guangdong, Peoples R China.	zhuxfeng@mail.sysu.edu.cn	huang, wen/GXW-0661-2022		National Nature Science Foundation of China [30572363, 30873085]; 863 programme [2006AA02A404]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 programme(National High Technology Research and Development Program of China)	This study was supported by grants from the National Nature Science Foundation of China (30572363, 30873085) and 863 programme (2006AA02A404).	Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Bergamini E, 2003, BIOMED PHARMACOTHER, V57, P203, DOI 10.1016/S0753-3322(03)00048-9; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Cao Q, 2008, INT J BIOCHEM CELL B, V40, P272, DOI 10.1016/j.biocel.2007.07.020; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Deng R, 2006, ONCOGENE, V25, P7070, DOI 10.1038/sj.onc.1209686; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gewies A, 2000, LAB INVEST, V80, P671, DOI 10.1038/labinvest.3780070; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hamdi M, 2005, ONCOGENE, V24, P7135, DOI 10.1038/sj.onc.1208875; Huwiler A, 2004, BBA-MOL CELL BIOL L, V1636, P159, DOI 10.1016/j.bbalip.2003.08.010; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; KIM MY, 1991, J BIOL CHEM, V266, P484; Kim WH, 2005, NEUROCHEM RES, V30, P969, DOI 10.1007/s11064-005-6223-y; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Liu JN, 2007, LEUKEMIA, V21, P1300, DOI 10.1038/sj.leu.2404652; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mengubas K, 1999, ONCOGENE, V18, P2499, DOI 10.1038/sj.onc.1202622; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mochizuki T, 2002, J BIOL CHEM, V277, P2790, DOI 10.1074/jbc.M106361200; Nishino Ichizo, 2003, Curr Neurol Neurosci Rep, V3, P64, DOI 10.1007/s11910-003-0040-y; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Saftig P, 2001, TRENDS MOL MED, V7, P37, DOI 10.1016/S1471-4914(00)01868-2; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang ZH, 2007, GYNECOL ONCOL, V107, P107, DOI 10.1016/j.ygyno.2007.05.034; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang PS, 1996, J NEUROSCI RES, V46, P114, DOI 10.1002/(SICI)1097-4547(19961001)46:1<114::AID-JNR14>3.0.CO;2-5; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zhou JM, 2006, ONCOGENE, V25, P503, DOI 10.1038/sj.onc.1209067; Zhu XF, 2005, MOL PHARMACOL, V67, P1444, DOI 10.1124/mol.104.009894	58	210	220	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					886	898		10.1038/onc.2008.441	http://dx.doi.org/10.1038/onc.2008.441			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19060920				2022-12-25	WOS:000263320000011
J	Al Sorkhy, M; Craig, R; Market, B; Ard, R; Porter, LA				Al Sorkhy, Mohammad; Craig, Ryan; Market, Brenna; Ard, Ryan; Porter, Lisa A.			The Cyclin-dependent Kinase Activator, Spy1A, Is Targeted for Degradation by the Ubiquitin Ligase NEDD4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL DIVERSITY; THERAPEUTIC TARGET; PROTEIN LIGASES; BREAST-CANCER; DNA-DAMAGE; EXPRESSION; FAMILY; GROWTH; CELLS; PHOSPHORYLATION	Spy1A is a cyclin-like protein required for progression through the G(1)/S phase of the cell cycle. Elevated Spy1A protein levels have been implicated in tumorigenesis and are attributed to overriding the DNA damage response and enhancing cell proliferation. Understanding how Spy1A is produced and degraded is essential in resolving how it contributes to normal and abnormal growth processes. Herein, we demonstrate that Spy1A is degraded in a cell cycle-dependent manner during mitosis via the ubiquitin-proteasome system. We have resolved the E3 ligase and essential phosphorylation sites mediating Spy1A degradation. Furthermore, we have determined that non-degradable forms of Spy1A do not trigger cell cycle arrest but, rather, contribute to uncontrolled cell growth. Further investigation into the regulation of Spy1A may reveal novel strategies for understanding the etiology and progression of specific growth disorders.	[Al Sorkhy, Mohammad; Craig, Ryan; Ard, Ryan; Porter, Lisa A.] Univ Windsor, Windsor, ON N9B 3P4, Canada; [Market, Brenna] Univ Western Ontario, London, ON N6A 5C1, Canada	University of Windsor; Western University (University of Western Ontario)	Porter, LA (corresponding author), 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lporter@uwindsor.ca	, Lisa/AAA-3185-2020	, Lisa/0000-0002-9234-1712; Ard, Ryan/0000-0002-9070-9747; , Brenna/0000-0001-8266-4203	Canadian Institutes of Health Research and the Canadian Breast Cancer Research Alliance [151092]; University of Windsor; Ontario Graduate Scholarship in Science and Technology; Natural Science and Engineering Research Council PGD2; Natural Science and Engineering Research Council Canada Graduate Scholarship-Masters; Canadian Institutes of Health Research New Investigator Program	Canadian Institutes of Health Research and the Canadian Breast Cancer Research Alliance(Canadian Institutes of Health Research (CIHR)); University of Windsor; Ontario Graduate Scholarship in Science and Technology; Natural Science and Engineering Research Council PGD2(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science and Engineering Research Council Canada Graduate Scholarship-Masters(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research New Investigator Program(Canadian Institutes of Health Research (CIHR))	This work was supported by operating funds from a partnership between the Canadian Institutes of Health Research and the Canadian Breast Cancer Research Alliance Grant 151092. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; 1 Supported by the University of Windsor, the Ontario Graduate Scholarship in Science and Technology, and a Natural Science and Engineering Research Council PGD2.; 2 Supported by a Natural Science and Engineering Research Council Canada Graduate Scholarship-Masters.; 3 Supported by the Canadian Institutes of Health Research New Investigator Program.	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Barnes EA, 2003, CANCER RES, V63, P3701; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chen C, 2006, MOL CANCER RES, V4, P695, DOI 10.1158/1541-7786.MCR-06-0182; Cheng A, 2005, CELL CYCLE, V4, P155, DOI 10.4161/cc.4.1.1347; Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479; Gastwirt RF, 2006, J BIOL CHEM, V281, P35425, DOI 10.1074/jbc.M604720200; Giatromanolaki A, 2007, EUR J CLIN INVEST, V37, P878, DOI 10.1111/j.1365-2362.2007.01866.x; Golipour A, 2008, CANCER RES, V68, P3591, DOI 10.1158/0008-5472.CAN-07-6453; Gutierrez GJ, 2006, NAT CELL BIOL, V8, P1084, DOI 10.1038/ncb1472; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Karaiskou A, 2001, J BIOL CHEM, V276, P36028, DOI 10.1074/jbc.M104722200; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; McAndrew CW, 2007, CELL CYCLE, V6, P1937, DOI 10.4161/cc.6.15.4520; Miller BS, 2005, CANCER RES, V65, P10123, DOI 10.1158/0008-5472.CAN-05-2752; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Murillas R, 2002, J BIOL CHEM, V277, P2897, DOI 10.1074/jbc.M110047200; Nurse PM, 2002, BIOSCIENCE REP, V22, P487, DOI 10.1023/A:1022017701871; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Porter LA, 2003, MOL BIOL CELL, V14, P3664, DOI 10.1091/mbc.E02-12-0820; Porter LA, 2002, J CELL BIOL, V157, P357, DOI 10.1083/jcb.200109045; Puputti M, 2006, MOL CANCER RES, V4, P927, DOI 10.1158/1541-7786.MCR-06-0085; Robinson PA, 2004, J CELL SCI, V117, P5191, DOI 10.1242/jcs.01539; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Ryden L, 2003, BREAST CANCER RES TR, V82, P147, DOI 10.1023/B:BREA.0000004357.92232.cb; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	33	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2617	2627		10.1074/jbc.M804847200	http://dx.doi.org/10.1074/jbc.M804847200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054764	Green Submitted, hybrid			2022-12-25	WOS:000262700900004
J	Cordier, F; Grubisha, O; Traincard, F; Veron, M; Delepierre, M; Agou, F				Cordier, Florence; Grubisha, Olivera; Traincard, Francois; Veron, Michel; Delepierre, Muriel; Agou, Fabrice			The Zinc Finger of NEMO Is a Functional Ubiquitin-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANHIDROTIC ECTODERMAL DYSPLASIA; GAMMA IKK-GAMMA; GENOTOXIC STRESS; COMPLEX ACTIVITY; POINT MUTATION; ACTIVATION; KINASE; PROTEIN; SITE	NEMO (NF-kappa B essential modulator) is a regulatory protein essential to the canonical NF-kappa B signaling pathway, notably involved in immune and inflammatory responses, apoptosis, and oncogenesis. Here, we report that the zinc finger (ZF) motif, located in the regulatory C-terminal half of NEMO, forms a specific complex with ubiquitin. We have investigated the NEMO ZF-ubiquitin interaction and proposed a structural model of the complex based on NMR, fluorescence, and mutagenesis data and on the sequence homology with the polymerase eta ubiquitin-binding zinc finger involved in DNA repair. Functional complementation assays and in vivo pull-down experiments further show that ZF residues involved in ubiquitin binding are functionally important and required for NF-kappa B signaling in response to tumor necrosis factor-alpha. Thus, our findings indicate that NEMO ZF is a bona fide ubiquitin-binding domain of the ubiquitin-binding zinc finger type.	[Cordier, Florence; Delepierre, Muriel] CNRS, URA 2185, Unite Resonance Magnet Nucl Biomol, F-75015 Paris, France; [Grubisha, Olivera; Traincard, Francois; Veron, Michel; Agou, Fabrice] CNRS, URA 2185, Unite Biochim Struct & Cellulaire, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Grubisha, O (corresponding author), CNRS, URA 2185, Unite Resonance Magnet Nucl Biomol, 25-28 Rue Dr Roux, F-75015 Paris, France.	fcordier@pasteur.fr; fagou@pasteur.fr	, AGOU/GXA-2760-2022	Cordier, Florence/0000-0002-5963-7773; Grubisha, Olivera/0000-0003-1067-1230	Canceropole Ile-de-France; Banque Nationale de Paris Paribas Foundation; Pasteur Foundation	Canceropole Ile-de-France(Region Ile-de-France); Banque Nationale de Paris Paribas Foundation; Pasteur Foundation	This work was supported by grants from the Canceropole Ile-de-France, the Banque Nationale de Paris Paribas Foundation, and the Pasteur Foundation. The costs of publication of this article were defrayed in part by the payment of pagecharges. This article must there fore be hereby marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; DevilleBonne D, 1996, BIOCHEMISTRY-US, V35, P14643, DOI 10.1021/bi960945m; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fontan E, 2007, FEBS J, V274, P2540, DOI 10.1111/j.1742-4658.2007.05788.x; Fusco F, 2008, HUM MUTAT, V29, P595, DOI 10.1002/humu.20739; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; NENCI A, 2006, NF KAPPAB 20 YEARS R, P84; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Smahi A, 2000, NATURE, V405, P466; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Temmerman ST, 2006, BLOOD, V108, P2324, DOI 10.1182/blood-2006-04-017210; Vinolo E, 2006, J BIOL CHEM, V281, P6334, DOI 10.1074/jbc.M510118200; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9; Yang F, 2004, J IMMUNOL, V172, P2446, DOI 10.4049/jimmunol.172.4.2446; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	31	64	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2902	2907		10.1074/jbc.M806655200	http://dx.doi.org/10.1074/jbc.M806655200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19033441	Green Accepted, hybrid			2022-12-25	WOS:000262700900034
J	Lee, AY; Chiang, CM				Lee, A-Young; Chiang, Cheng-Ming			Chromatin Adaptor Brd4 Modulates E2 Transcription Activity and Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PAPILLOMAVIRUS E2; P-TEFB; MITOTIC CHROMOSOMES; E6 PROMOTER; BINDING; ACTIVATION; DNA; DEGRADATION; COMPLEX	Brd4 is a chromatin adaptor containing tandem bromodomains binding to acetylated histone H3 and H4. Although Brd4 has been implicated in the transcriptional control of papilloma-virus-encoded E2 protein, it is unclear how Brd4 regulates E2 function and whether the involvement of Brd4 in transactivation and transrepression is common to different types of E2 proteins. Using DNase I footprinting performed with in vitro reconstituted human papillomavirus (HPV) chromatin and nucleosome-free DNA templates, we found that Brd4 facilitates E2 binding to its cognate sequences in chromatin depending on bromodomains and the E2-interacting region of Brd4. Moreover, the coactivator and corepressor function of Brd4 requires at least one intact bromodomain and is mediated by its direct association with E2 proteins encoded by cancer-inducing high risk HPV-16 and HPV-18, wart-causing low risk HPV-11, and bovine papillomavirus type 1, in part through enhancing the protein stability of E2 that is normally degraded via the ubiquitin dependent proteasome pathway. Our findings indicate that a chromatin adaptor can bridge and enhance the binding of a sequence-specific transcription factor to chromatin and further promote the stability of a labile transcription factor via direct protein-protein interaction.	[Lee, A-Young; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chiang, CM (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Bldg ND2-210H,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	cheng-ming.chiang@utsouthwestern.edu			National Institutes of Health [CA103867, CA124760]; University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center [CSCN 041]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA103867 and CA124760. This work is report CSCN 041 from the University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Bellanger S, 2001, J VIROL, V75, P7244, DOI 10.1128/JVI.75.16.7244-7251.2001; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; CHIANG CM, 1993, EMBO J, V12, P2749, DOI 10.1002/j.1460-2075.1993.tb05936.x; CHIANG CM, 1993, PEPTIDE RES, V6, P62; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Dao LD, 2006, J VIROL, V80, P4792, DOI 10.1128/JVI.80.10.4792-4800.2006; Demeret C, 1997, J VIROL, V71, P9343, DOI 10.1128/JVI.71.12.9343-9349.1997; DONG G, 1994, J VIROL, V68, P1115, DOI 10.1128/JVI.68.2.1115-1127.1994; DOSTATNI N, 1991, GENE DEV, V5, P1657, DOI 10.1101/gad.5.9.1657; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; HIROCHIKA H, 1988, GENE DEV, V2, P54, DOI 10.1101/gad.2.1.54; Hou SY, 2002, J BIOL CHEM, V277, P45619, DOI 10.1074/jbc.M206829200; Hou SY, 2000, MOL CELL BIOL, V20, P113, DOI 10.1128/MCB.20.1.113-125.2000; Ilves I, 2006, J VIROL, V80, P3660, DOI 10.1128/JVI.80.7.3660-3665.2006; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kovelman R, 1996, J VIROL, V70, P7549, DOI 10.1128/JVI.70.11.7549-7560.1996; LI R, 1989, GENE DEV, V3, P510, DOI 10.1101/gad.3.4.510; McPhillips MG, 2006, J VIROL, V80, P9530, DOI 10.1128/JVI.01105-06; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Parish JL, 2006, MOL CELL, V24, P867, DOI 10.1016/j.molcel.2006.11.005; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; Schweiger MR, 2006, J VIROL, V80, P4276, DOI 10.1128/JVI.80.9.4276-4285.2006; Senechal H, 2007, VIROLOGY, V358, P10, DOI 10.1016/j.virol.2006.08.035; TAN SH, 1994, J VIROL, V68, P6411, DOI 10.1128/JVI.68.10.6411-6420.1994; THIERRY F, 1990, MOL CELL BIOL, V10, P4431, DOI 10.1128/MCB.10.8.4431; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Wang WM, 2008, PROTEIN EXPRES PURIF, V59, P144, DOI 10.1016/j.pep.2008.01.016; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wu SY, 1999, J BIOL CHEM, V274, P23480, DOI 10.1074/jbc.274.33.23480; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7	35	55	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2778	2786		10.1074/jbc.M805835200	http://dx.doi.org/10.1074/jbc.M805835200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19038968	hybrid, Green Published			2022-12-25	WOS:000262700900020
J	Schnizler, MK; Schnizler, K; Zha, XM; Hall, DD; Wemmie, JA; Hell, JW; Welsh, MJ				Schnizler, Mikael K.; Schnizler, Katrin; Zha, Xiang-Ming; Hall, Duane D.; Wemmie, John A.; Hell, Johannes W.; Welsh, Michael J.			The Cytoskeletal Protein alpha-Actinin Regulates Acid-sensing Ion Channel 1a through a C-terminal Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; ACTIVATED CURRENTS; SODIUM-CHANNEL; NMDA RECEPTOR; KINASE-II; SUBUNIT; CALCIUM; EXPRESSION	The acid-sensing ion channel 1a (ASIC1a) is widely expressed in central and peripheral neurons where it generates transient cation currents when extracellular pH falls. ASIC1a confers pH-dependent modulation on postsynaptic dendritic spines and has critical effects in neurological diseases associated with a reduced pH. However, knowledge of the proteins that interact with ASIC1a and influence its function is limited. Here, we show that alpha-actinin, which links membrane proteins to the actin cytoskeleton, associates with ASIC1a in brain and in cultured cells. The interaction depended on an alpha-actinin-binding site in the ASIC1a C terminus that was specific for ASIC1a versus other ASICs and for alpha-actinin-1 and -4. Co-expressing alpha-actinin-4 altered ASIC1a current density, pH sensitivity, desensitization rate, and recovery from desensitization. Moreover, reducing alpha-actinin expression altered acid-activated currents in hippocampal neurons. These findings suggest that alpha-actinins may link ASIC1a to a macromolecular complex in the postsynaptic membrane where it regulates ASIC1a activity.	[Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, EMRB 500, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Schnizler, Mikael K.; Zha, Xiang-Ming; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Schnizler, Katrin; Hall, Duane D.; Hell, Johannes W.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Wemmie, John A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Wemmie, John A.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Welsh, MJ (corresponding author), Univ Iowa, Howard Hughes Med Inst, EMRB 500, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	Hall, Duane/ACD-6815-2022; Hell, Johannes W./P-5085-2019	Hall, Duane/0000-0003-2228-0966; Wemmie, John/0000-0001-7531-9065; Welsh, Michael/0000-0002-1646-6206; Zha, Xiangming/0000-0001-9490-2731	National Institutes of Health [AG017502]; Deutsche Forschungsgemeinschaft DFG Forschungsstipendium Schn [740/2-1]; American Heart Association [0535235N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL061234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG017502, R01AG017502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft DFG Forschungsstipendium Schn(German Research Foundation (DFG)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG017502 (to J. W. H.). This work was also supported in part by Deutsche Forschungsgemeinschaft DFG Forschungsstipendium Schn 740/2-1 (to M. K. S.) and American Heart Association Grant 0535235N (to D. D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allison DW, 1998, J NEUROSCI, V18, P2423; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bhatt A, 2002, J CELL SCI, V115, P3415; Celli L, 2006, J IMMUNOL, V177, P4113, DOI 10.4049/jimmunol.177.6.4113; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Donier E, 2005, J BIOL CHEM, V280, P38666, DOI 10.1074/jbc.M505981200; Duggan A, 2002, J BIOL CHEM, V277, P5203, DOI 10.1074/jbc.M104748200; FLOOD G, 1995, J MOL BIOL, V252, P227, DOI 10.1006/jmbi.1995.0490; Fraley TS, 2005, J BIOL CHEM, V280, P15479, DOI 10.1074/jbc.M500631200; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Leonard AS, 2003, P NATL ACAD SCI USA, V100, P2029, DOI 10.1073/pnas.252782799; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; Li Q, 2007, J NEUROCHEM, V103, P2391, DOI 10.1111/j.1471-4159.2007.04940.x; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Maruoka ND, 2000, FEBS LETT, V473, P188, DOI 10.1016/S0014-5793(00)01521-0; Mazzochi C, 2006, AM J PHYSIOL-RENAL, V291, pF1113, DOI 10.1152/ajprenal.00195.2006; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Nuriya M, 2005, J NEUROCHEM, V95, P544, DOI 10.1111/j.1471-4159.2005.03410.x; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Rao A, 1998, J NEUROSCI, V18, P1217; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sadeghi A, 2002, AM J PHYSIOL-CELL PH, V282, pC1502, DOI 10.1152/ajpcell.00435.2001; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zuckerman JB, 1999, J BIOL CHEM, V274, P23286, DOI 10.1074/jbc.274.33.23286	63	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2697	2705		10.1074/jbc.M805110200	http://dx.doi.org/10.1074/jbc.M805110200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19028690	Green Published, hybrid			2022-12-25	WOS:000262700900012
J	Kang, X; Chen, W; Kim, RH; Kang, MK; Park, NH				Kang, X.; Chen, W.; Kim, R. H.; Kang, M. K.; Park, N-H			Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells	ONCOGENE			English	Article						hTERT; telomerase; GRHL2; hnRNPs; MSH2; oral cancer	TELOMERASE-REVERSE-TRANSCRIPTASE; CATALYTIC SUBUNIT; GENE; EXPRESSION; BINDING; PROTEIN; CANCER; KERATINOCYTES; SP1; CARCINOGENESIS	Higher expression of human telomerase reverse transcriptase (hTERT) and subsequent activation of telomerase occur during cellular immortalization and are maintained in cancer cells. To understand the mode of hTERT expression in cancer cells, we identified cancer-specific trans-regulatory proteins that interact with the hTERT promoter, using the promoter magnetic precipitation assay coupled with mass spectrometry. The identified proteins include MutS homolog 2(MSH2), heterogeneous nuclear ribonucleoprotein (hnRNP) D, hnRNP K and grainyhead-like 2(GRHL2). We noticed a higher expression of these proteins in human oral squamous cell carcinoma (OSCC) cells than in normal cells, which do not exhibit telomerase activity. Knockdown of MSH2, hnRNP D and GRHL2 resulted in a notable reduction of the hTERT promoter activity in tested cancer cells. Silencing of the above genes resulted in a significant reduction of the telomerase activity in OSCC cells. Interestingly, among the four identified genes, silencing of GRHL2 was essential in reducing telomerase activity and viability of tested cancer cells. These results suggest a possible role of GRHL2 in telomerase activation during cellular immortalization.	[Kang, X.; Chen, W.; Kim, R. H.; Kang, M. K.; Park, N-H] Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Los Angeles, CA 90095 USA; [Kim, R. H.; Kang, M. K.; Park, N-H] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90095 USA; [Kim, R. H.; Kang, M. K.; Park, N-H] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Park, N-H] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kang, MK (corresponding author), Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Room 43-009,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	mkang@dentistry.ucla.edu; nhpark@dentistry.ucla.edu			NIDCR [K22DE15316, R01DE18295, K02DE18959]; NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K02DE018959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018295, R01DE014147, K22DE015316] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr JC Barrett (NIEHS/NIH) for providing the pGL3B-TRTP vector. This study was supported in part by the Grants (K22DE15316, R01DE18295, and K02DE18959 to MKK and R01DE14147 to N-HP) from NIDCR/NIH.	Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; Campbell MR, 2006, ONCOGENE, V25, P2531, DOI 10.1038/sj.onc.1209277; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; Deng WG, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M610579200; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; Fujiki T, 2007, ONCOGENE, V26, P5258, DOI 10.1038/sj.onc.1210331; He C, 2006, EMBO J, V25, P3823, DOI 10.1038/sj.emboj.7601264; Isenmann S, 2007, J BONE MINER RES, V22, P897, DOI 10.1359/JBMR.070308; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Kang MK, 2004, J CELL PHYSIOL, V199, P364, DOI 10.1002/jcp.10410; Kang MK, 1998, CELL GROWTH DIFFER, V9, P85; Kiledjian M, 1997, MOL CELL BIOL, V17, P4870, DOI 10.1128/MCB.17.8.4870; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim RH, 2007, EXP CELL RES, V313, P462, DOI 10.1016/j.yexcr.2006.10.025; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lebel R, 2007, BIOCHEMISTRY-US, V46, P10279, DOI 10.1021/bi700076m; Lou F, 2007, MOL CANCER RES, V5, P793, DOI 10.1158/1541-7786.MCR-07-0065; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Ostrowski J, 2004, J BIOL CHEM, V279, P54599, DOI 10.1074/jbc.M406753200; PARK NH, 1991, CARCINOGENESIS, V12, P1627, DOI 10.1093/carcin/12.9.1627; Poole JC, 2001, GENE, V269, P1, DOI 10.1016/S0378-1119(01)00440-1; Rizki A, 2001, NATURE, V411, P713, DOI 10.1038/35079641; Roychoudhury P, 2007, BRIT J CANCER, V97, P574, DOI 10.1038/sj.bjc.6603911; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Stramer B, 2005, CURR BIOL, V15, pR425, DOI 10.1016/j.cub.2005.05.034; Suzuki T, 2003, J BIOL CHEM, V278, P28758, DOI 10.1074/jbc.M302228200; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Yan P, 2001, J PATHOL, V193, P21, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH728>3.0.CO;2-G; Zhu QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001446	33	75	86	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					565	574		10.1038/onc.2008.404	http://dx.doi.org/10.1038/onc.2008.404			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	19015635	Green Accepted			2022-12-25	WOS:000262866500010
J	Elias, BC; Suzuki, T; Seth, A; Giorgianni, F; Kale, G; Shen, L; Turner, JR; Naren, A; Desiderio, DM; Rao, R				Elias, Bertha C.; Suzuki, Takuya; Seth, Ankur; Giorgianni, Francesco; Kale, Gautam; Shen, Le; Turner, Jerrold R.; Naren, Anjaparavanda; Desiderio, Dominic M.; Rao, Radhakrishna			Phosphorylation of Tyr-398 and Tyr-402 in Occludin Prevents Its Interaction with ZO-1 and Destabilizes Its Assembly at the Tight Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; INTESTINAL EPITHELIAL BARRIER; STRESS-INDUCED DISRUPTION; POSSIBLE INVOLVEMENT; BINDING; EXPRESSION; LOCALIZATION; COMPLEXES; CALCIUM; DOMAIN	Occludin is phosphorylated on tyrosine residues during the oxidative stress-induced disruption of tight junction, and in vitro phosphorylation of occludin by c-Src attenuates its binding to ZO-1. In the present study mass spectrometric analyses of C-terminal domain of occludin identified Tyr-379 and Tyr-383 in chicken occludin as the phosphorylation sites, which are located in a highly conserved sequence of occludin, YETDYTT; Tyr-398 and Tyr-402 are the corresponding residues in human occludin. Deletion of YETDYTT motif abolished the c-Src-mediated phosphorylation of occludin and the regulation of ZO-1 binding. Y398A and Y402A mutations in human occludin also abolished the c-Src-mediated phosphorylation and regulation of ZO-1 binding. Y398D/Y402D mutation resulted in a dramatic reduction in ZO-1 binding even in the absence of c-Src. Similar to wild type occludin, its Y398A/Y402A mutant was localized at the plasma membrane and cell-cell contact sites in Rat-1 cells. However, Y398D/Y402D mutants of occludin failed to localize at the cell-cell contacts. Calcium-induced reassembly of Y398D/Y402D mutant occludin in Madin-Darby canine kidney cells was significantly delayed compared with that of wild type occludin or its T398A/T402A mutant. Furthermore, expression of Y398D/Y402D mutant of occludin sensitized MDCK cells for hydrogen peroxide-induced barrier disruption. This study reveals a unique motif in the occludin sequence that is involved in the regulation of ZO-1 binding by reversible phosphorylation of specific Tyr residues.	[Elias, Bertha C.; Suzuki, Takuya; Seth, Ankur; Kale, Gautam; Naren, Anjaparavanda; Rao, Radhakrishna] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Giorgianni, Francesco; Desiderio, Dominic M.] Univ Tennessee, Hlth Sci Ctr, Charles B Stout Neurosci Mass Spectrometry Lab, Memphis, TN 38163 USA; [Shen, Le; Turner, Jerrold R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Chicago	Rao, R (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rkrao@physio1.utmem.edu	Shen, Le/E-7866-2010; Turner, Jerrold R/A-6895-2009; Seth, Ankur/AAE-1800-2020; Suzuki, Takuya/H-3750-2019; Turner, Jerrold/H-1502-2019	Turner, Jerrold R/0000-0003-0627-9455; Suzuki, Takuya/0000-0003-3709-543X; Seth, Ankur/0000-0003-0140-4691	National Institutes of Health [R01-DK55532, R01-AA12307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK55532 and R01-AA12307. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AndoAkatsuka Y, 1996, J CELL BIOL, V133, P43, DOI 10.1083/jcb.133.1.43; Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; Atkinson KJ, 2001, AM J PHYSIOL-GASTR L, V280, pG1280, DOI 10.1152/ajpgi.2001.280.6.G1280; Balkovetz DF, 2006, AM J PHYSIOL-RENAL, V290, pF572, DOI 10.1152/ajprenal.00135.2005; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; Kale G, 2003, BIOCHEM BIOPH RES CO, V302, P324, DOI 10.1016/S0006-291X(03)00167-0; Keon BH, 1996, J CELL BIOL, V134, P1003, DOI 10.1083/jcb.134.4.1003; Laukoetter MG, 2006, CURR OPIN GASTROEN, V22, P85, DOI 10.1097/01.mog.0000203864.48255.4f; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Nusrat A, 2000, J BIOL CHEM, V275, P29816, DOI 10.1074/jbc.M002450200; Rao R, 1999, BIOCHEM PHARMACOL, V57, P685, DOI 10.1016/S0006-2952(98)00333-5; Rao R, 2008, FRONT BIOSCI-LANDMRK, V13, P7210, DOI 10.2741/3223; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Sheth P, 2003, J BIOL CHEM, V278, P49239, DOI 10.1074/jbc.M305654200; STEVENS C, 1992, DIGEST DIS SCI, V37, P818, DOI 10.1007/BF01300378; STUART RO, 1994, J CELL PHYSIOL, V159, P423, DOI 10.1002/jcp.1041590306; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; ZHONG Y, 1993, J CELL BIOL, V120, P477, DOI 10.1083/jcb.120.2.477	40	142	151	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1559	1569		10.1074/jbc.M804783200	http://dx.doi.org/10.1074/jbc.M804783200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017651	Green Published, hybrid			2022-12-25	WOS:000262330100024
J	Tapryal, N; Mukhopadhyay, C; Das, D; Fox, PL; Mukhopadhyay, CK				Tapryal, Nisha; Mukhopadhyay, Chaitali; Das, Dola; Fox, Paul L.; Mukhopadhyay, Chinmay K.			Reactive Oxygen Species Regulate Ceruloplasmin by a Novel mRNA Decay Mechanism Involving Its 3 '-Untranslated Region IMPLICATIONS IN NEURODEGENERATIVE DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-I; OXIDATIVE STRESS; FERROXIDASE ACTIVITY; IRON UPTAKE; GENE-EXPRESSION; DOWN-REGULATION; CELLS; ACTIVATION; HYPOXIA; COPPER	Ceruloplasmin (Cp), a copper-containing protein, plays a significant role in body iron homeostasis as aceruloplasminemia patients and Cp knock-out mice exhibit iron overload in several tissues including liver and brain. Several other functions as oxidant, as antioxidant, and in nitric oxide metabolism are also attributed to Cp. Despite its role in iron oxidation and other biological oxidation reactions the regulation of Cp by reactive oxygen species (ROS) remains unexplored. Cp is synthesized in liver as a secretory protein and predominantly as a glycosylphosphatidylinositol-anchored membrane-bound form in astroglia. In this study we demonstrated that Cp expression is decreased by an mRNA decay mechanism in response to extracellular (H2O2) or intracellular oxidative stress (by mitochondrial chain blockers rotenone or antimycin A) in both hepatic and astroglial cells. The promotion of Cp mRNA decay is conferred by its 3'- untranslated region (UTR). When chloramphenicol acetyltransferase (CAT) gene was transfected as a chimera with Cp 3'- UTR in hepatic or astroglial cells, in response to either H2O2, rotenone, or antimycin A, the expression of CAT transcript was decreased, whereas expression of a 3'-UTR-less CAT transcript remained unaffected. RNA gel shift assay showed significant reduction in 3'-UTR-binding protein complex by ROS in both cell types that was reversed by the antioxidant N-acetylcysteine suggesting that ROS affects RNA-protein complex formation to promote Cp mRNA decay. Our finding is not only the first demonstration of regulation of Cp by ROS by a novel post-transcriptional mechanism but also provides a mechanism of iron deposition in neurodegenerative diseases.	[Tapryal, Nisha; Mukhopadhyay, Chaitali; Das, Dola; Mukhopadhyay, Chinmay K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India; [Fox, Paul L.] Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Jawaharlal Nehru University, New Delhi; Cleveland Clinic Foundation	Mukhopadhyay, CK (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	ckm2300@mail.jnu.ac.in	Das, Dola/I-1802-2014		Department of Biotechnology and Council of Scientific and Industrial Research, India; Council of Scientific and Industrial Research, India	Department of Biotechnology and Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported in part by research grants from the Department of Biotechnology and Council of Scientific and Industrial Research, India ( to C. K. M.), and by a fellowship from the Council of Scientific and Industrial Research, India ( to N.T. and D. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Attieh ZK, 1999, J BIOL CHEM, V274, P1116, DOI 10.1074/jbc.274.2.1116; Biswas S, 2007, AM J PHYSIOL-HEART C, V292, pH758, DOI 10.1152/ajpheart.00718.2006; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; Caltagirone A, 2001, J BIOL CHEM, V276, P19738, DOI 10.1074/jbc.M100245200; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Das D, 2007, BIOCHEM J, V402, P135, DOI 10.1042/BJ20060963; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; FLEMING RE, 1991, AM J PHYSIOL, V260, pL68, DOI 10.1152/ajplung.1991.260.2.L68; Fox PL, 2000, FREE RADICAL BIO MED, V28, P1735, DOI 10.1016/S0891-5849(00)00231-8; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GITLIN JD, 1988, J BIOL CHEM, V263, P6281; GOLDSTEIN IM, 1979, J BIOL CHEM, V254, P4040; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; Harris ZL, 2004, BLOOD, V103, P4672, DOI 10.1182/blood-2003-11-4060; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; He Y, 2003, FREE RADICAL BIO MED, V35, P540, DOI 10.1016/S0891-5849(03)00385-X; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Jones RJ, 2000, J HEPATOL, V32, P703, DOI 10.1016/S0168-8278(00)80234-2; Kaneko K, 2008, NEUROSCI LETT, V446, P56, DOI 10.1016/j.neulet.2008.08.089; Ke Y, 2006, J CELL BIOCHEM, V98, P912, DOI 10.1002/jcb.20740; Klomp LWJ, 1996, HUM MOL GENET, V5, P1989, DOI 10.1093/hmg/5.12.1989; Kohgo Y, 2007, WORLD J GASTROENTERO, V13, P4699, DOI 10.3748/wjg.v13.i35.4699; KOSCHINSKY ML, 1986, P NATL ACAD SCI USA, V83, P5086, DOI 10.1073/pnas.83.14.5086; Kowdley KV, 2004, GASTROENTEROLOGY, V127, pS79, DOI 10.1016/j.gastro.2004.09.019; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; MIYAJIMA H, 1987, NEUROLOGY, V37, P761, DOI 10.1212/WNL.37.5.761; Morel Y, 1998, J BIOL CHEM, V273, P26969, DOI 10.1074/jbc.273.41.26969; Mueller S, 2001, J BIOL CHEM, V276, P23192, DOI 10.1074/jbc.M100654200; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; Mukhopadhyay CK, 1998, SCIENCE, V279, P714, DOI 10.1126/science.279.5351.714; Mukhopadhyay CK, 1996, J BIOL CHEM, V271, P14773, DOI 10.1074/jbc.271.25.14773; Mukhopadhyay CK, 1997, P NATL ACAD SCI USA, V94, P11546, DOI 10.1073/pnas.94.21.11546; OSAKI S, 1969, J BIOL CHEM, V244, P5757; OSAKI S, 1966, J BIOL CHEM, V241, P5053; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Patel BN, 2002, J NEUROSCI, V22, P6578; RAGAN HA, 1969, AM J PHYSIOL, V217, P1320, DOI 10.1152/ajplegacy.1969.217.5.1320; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Sen P, 2005, FEBS LETT, V579, P4402, DOI 10.1016/j.febslet.2005.06.081; Seshadri V, 2002, J BIOL CHEM, V277, P27903, DOI 10.1074/jbc.M203610200; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; TAETLE R, 1987, BLOOD, V70, P852; Vassiliev V, 2005, BRAIN RES REV, V49, P633, DOI 10.1016/j.brainresrev.2005.03.003; Xie JX, 2002, MOL BRAIN RES, V99, P12, DOI 10.1016/S0169-328X(01)00336-9	54	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1873	1883		10.1074/jbc.M804079200	http://dx.doi.org/10.1074/jbc.M804079200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19019832	hybrid			2022-12-25	WOS:000262330100058
J	Poynard, T; Ingiliz, P; Elkrief, L; Munteanu, M; Lebray, P; Morra, R; Messous, D; Bismut, FI; Roulot, D; Benhamou, Y; Thabut, D; Ratziu, V				Poynard, Thierry; Ingiliz, Patrick; Elkrief, Laure; Munteanu, Mona; Lebray, Pascal; Morra, Rachel; Messous, Djamila; Bismut, Francoise Imbert; Roulot, Dominique; Benhamou, Yves; Thabut, Dominique; Ratziu, Vlad			Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis Markers	PLOS ONE			English	Article							OPERATING CHARACTERISTIC CURVES; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; BIOCHEMICAL MARKERS; DIAGNOSTIC EVALUATION; HEPATITIS-C; FIBROTEST; STIFFNESS; VARIABILITY; BIOMARKERS	Background: Assessing liver fibrosis is traditionally performed by biopsy, an imperfect gold standard. Non-invasive techniques, liver stiffness measurements (LSM) and biomarkers [FibroTest (R) (FT)], are widely used in countries where they are available. The aim was to identify factors associated with LSM accuracy using FT as a non-invasive endpoint and vice versa. Methods: The proof of concept was taken using the manufacturers recommendations for excluding patients at high risk of false negative/positive. The hypothesis was that the concordance between LSM and FT, would be improved by excluding high-risk patients. Thereafter, the impact of potential variability factors was assessed by the same methods. Liver biopsy and independent endpoints were used to validate the results. Results: Applying manufacturers' recommendations in 2,004 patients increased the strength of concordance between LSM and FT (P<0.00001). Among the 1,338 patients satisfying recommendations, the methodology identified a significant LSM operator effect (P = 0.001) and the following variability factors (all P<0.01), related to LSM: male gender, older age, and NAFLD as a cause of liver disease. Biopsy confirmed in 391 patients these results. Conclusion: This study has validated the concept of using the strength of concordance between non-invasive estimates of liver fibrosis for the identification of factors associated with variability and precautions of use.	[Poynard, Thierry; Ingiliz, Patrick; Elkrief, Laure; Lebray, Pascal; Morra, Rachel; Messous, Djamila; Bismut, Francoise Imbert; Benhamou, Yves; Thabut, Dominique; Ratziu, Vlad] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, CNRS UMR, Paris, France; [Munteanu, Mona] Biopredictive, Paris, France; [Roulot, Dominique] APHP Hop Avicennes, Bobigny, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Poynard, T (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, CNRS UMR, Paris, France.	tpoynard@teaser.fr	Poynard, Thierry/C-1355-2010; Elkrief, Laure/AAC-9142-2022; Roulot, Dominique/U-1732-2018	Poynard, Thierry/0000-0002-3726-7230; Elkrief, Laure/0000-0003-2843-1710; Roulot, Dominique/0000-0003-0926-3563; Poynard, Thierry/0000-0002-2050-640X; Munteanu, Mona/0000-0003-4517-2757	Association de Recherche sur les Maladies Virales et Hepatiques	Association de Recherche sur les Maladies Virales et Hepatiques	The study has funding support from the Association de Recherche sur les Maladies Virales et Hepatiques providing part of secretary assistance and biochemical kits. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2007, J HEPATOL, V46, P528, DOI 10.1016/j.jhep.2006.12.002; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Corpechot C, 2006, HEPATOLOGY, V44, P513, DOI 10.1002/hep.21306; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; *HAS FRANC, HAS REC MAN CHRON HE; HINTZE JL, 2007, NCSS 2007 USER GUIDE, P200; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; Imbert-Bismut F, 2004, CLIN CHEM LAB MED, V42, P323, DOI 10.1515/CCLM.2004.058; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kettaneh A, 2007, J HEPATOL, V46, P628, DOI 10.1016/j.jhep.2006.11.010; Kim KM, 2007, J GASTROENTEROL, V42, P382, DOI 10.1007/s00535-007-2016-1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin L, 2007, J BIOPHARM STAT, V17, P629, DOI 10.1080/10543400701376498; Lucidarme D, 2007, HEPATOLOGY, V46, p318A; MUNTEANU M, 2006, GASTROENTEROLOGY, V130, P195; Ngo Y, 2006, CLIN CHEM, V52, P1887, DOI 10.1373/clinchem.2006.070961; Pouillot R, 2002, PREV VET MED, V53, P67, DOI 10.1016/S0167-5877(01)00272-0; Poynard T, 2007, ALIMENT PHARM THER, V25, P733, DOI 10.1111/j.1365-2036.2007.03252.x; Poynard T, 2005, GASTROENTEROLOGY, V128, P1146, DOI 10.1053/j.gastro.2005.02.056; Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; Poynard Thierry, 2004, Comp Hepatol, V3, P8, DOI 10.1186/1476-5926-3-8; Ratziu V, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-6; Ratziu V, 2005, J HEPATOL, V42, P12, DOI 10.1016/j.jhep.2004.11.027; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682; ZHOU X, 2002, STAT METHODS DIAGNOS, P235; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	36	69	75	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3857	10.1371/journal.pone.0003857	http://dx.doi.org/10.1371/journal.pone.0003857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052646	gold, Green Published, Green Submitted			2022-12-25	WOS:000265452200009
J	Brown, JN; Kohler, JJ; Coberley, CR; Sleasman, JW; Goodenow, MM				Brown, Joseph N.; Kohler, James J.; Coberley, Carter R.; Sleasman, John W.; Goodenow, Maureen M.			HIV-1 Activates Macrophages Independent of Toll-Like Receptors	PLOS ONE			English	Article								Background: Macrophages provide an interface between innate and adaptive immunity and are important long-lived reservoirs for Human Immunodeficiency Virus Type-1 (HIV-1). Multiple genetic networks involved in regulating signal transduction cascades and immune responses in macrophages are coordinately modulated by HIV-1 infection. Methodology/Principal Findings: To evaluate complex interrelated processes and to assemble an integrated view of activated signaling networks, a systems biology strategy was applied to genomic and proteomic responses by primary human macrophages over the course of HIV-1 infection. Macrophage responses, including cell cycle, calcium, apoptosis, mitogen-activated protein kinases (MAPK), and cytokines/chemokines, to HIV-1 were temporally regulated, in the absence of cell proliferation. In contrast, Toll-like receptor (TLR) pathways remained unaltered by HIV-1, although TLRs 3, 4, 7, and 8 were expressed and responded to ligand stimulation in macrophages. HIV-1 failed to activate phosphorylation of IRAK-1 or IRF-3, modulate intracellular protein levels of Mx1, an interferon-stimulated gene, or stimulate secretion of TNF, IL-1 beta, or IL-6. Activation of pathways other than TLR was inadequate to stimulate, via cross-talk mechanisms through molecular hubs, the production of proinflammatory cytokines typical of a TLR response. HIV-1 sensitized macrophage responses to TLR ligands, and the magnitude of viral priming was related to virus replication. Conclusions/Significance: HIV-1 induced a primed, proinflammatory state, M1(HIV), which increased the responsiveness of macrophages to TLR ligands. HIV-1 might passively evade pattern recognition, actively inhibit or suppress recognition and signaling, or require dynamic interactions between macrophages and other cells, such as lymphocytes or endothelial cells. HIV-1 evasion of TLR recognition and simultaneous priming of macrophages may represent a strategy for viral survival, contribute to immune pathogenesis, and provide important targets for therapeutic approaches.	[Brown, Joseph N.; Kohler, James J.; Coberley, Carter R.; Goodenow, Maureen M.] Univ Florida, Coll Med, Lab Med, & Pediat, Dept Pathol, Immunol, Div Rheumatol, Immunol & Inf, Gainesville, FL 32611 USA; [Sleasman, John W.] Univ S Florida, Coll Med, All Childrens Hosp, Dept Pediat, Div Allergy, Immunol & Rheumatol, St Petersburg, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of South Florida	Brown, JN (corresponding author), Pacific NW Natl Lab, Richland, WA USA.	goodenow@pathology.ufl.edu			Laura McClamma Fellowship; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research;  [HD032259];  [AI047723];  [AI065265];  [AR07603];  [CA09126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032259] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047723, R01AI065265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007603] Funding Source: NIH RePORTER	Laura McClamma Fellowship; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research was supported in part by PHS R01 awards HD032259, AI047723, and AI065265; T32 awards AR07603 and CA09126; the Laura McClamma Fellowship; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; Aderem A, 2004, SEMIN IMMUNOL, V16, P55, DOI 10.1016/j.smim.2003.10.002; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Arthos J, 2000, J VIROL, V74, P6418, DOI 10.1128/JVI.74.14.6418-6424.2000; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Baur Andreas, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P309, DOI 10.2174/1568008043339749; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Bennasser Y, 2002, VIROLOGY, V303, P174, DOI 10.1006/viro.2002.1676; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Coberley CR, 2004, J VIROL, V78, P11477, DOI 10.1128/JVI.78.21.11477-11486.2004; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; DeFilippis VR, 2007, ADV EXP MED BIOL, V598, P309; Del Corno M, 2001, BLOOD, V98, P2909, DOI 10.1182/blood.V98.10.2909; Douek Daniel, 2007, Top HIV Med, V15, P114; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Franchin G, 2000, J IMMUNOL, V164, P2592, DOI 10.4049/jimmunol.164.5.2592; Freedman BD, 2006, CRIT REV IMMUNOL, V26, P97, DOI 10.1615/CritRevImmunol.v26.i2.10; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Ghaffari G, 2001, CLIN DIAGN LAB IMMUN, V8, P880, DOI 10.1128/CDLI.8.5.880-883.2001; Ghaffari G, 2005, J VIROL, V79, P13250, DOI 10.1128/JVI.79.21.13250-13261.2005; Giri MS, 2006, J LEUKOCYTE BIOL, V80, P1031, DOI 10.1189/jlb.0306157; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Goodenow MM, 2003, J LEUKOCYTE BIOL, V74, P657, DOI 10.1189/jlb.0403186; Gorry PR, 2005, CURR HIV RES, V3, P53, DOI 10.2174/1570162052772951; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Gu YM, 2006, FEBS LETT, V580, P305, DOI 10.1016/j.febslet.2005.12.024; Guntermann C, 1999, BIOCHEM BIOPH RES CO, V256, P429, DOI 10.1006/bbrc.1999.0333; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hamilton T.A., 2002, MACROPHAGE, V2, P73; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Ho W Z, 1994, Immunol Ser, V60, P569; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Janket ML, 2004, BIOCHEM BIOPH RES CO, V314, P1126, DOI 10.1016/j.bbrc.2004.01.008; Khati M, 2001, ARCH IMMUNOL THER EX, V49, P367; Kim WK, 2005, NEUROTOX RES, V8, P107, DOI 10.1007/BF03033823; Kitaya K, 2007, INT J MOL MED, V20, P689; Kohler JJ, 2003, J LEUKOCYTE BIOL, V73, P407, DOI 10.1189/jlb.0702358; Kootstra NA, 1998, AIDS RES HUM RETROV, V14, P339, DOI 10.1089/aid.1998.14.339; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Lee C, 2005, J LEUKOCYTE BIOL, V78, P1016, DOI 10.1189/jlb.0105056; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; Lee SK, 2007, BIOCHEM BIOPH RES CO, V352, P756, DOI 10.1016/j.bbrc.2006.11.098; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; LLEONART R, 1990, BIO-TECHNOL, V8, P1263, DOI 10.1038/nbt1290-1263; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Muthumani K, 2004, AIDS, V18, P739, DOI 10.1097/00002030-200403260-00004; Olivetta E, 2006, EXP CELL RES, V312, P890, DOI 10.1016/j.yexcr.2005.12.003; Ortutay C, 2007, IMMUNOGENETICS, V59, P333, DOI 10.1007/s00251-007-0191-0; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Percario Z, 2003, J LEUKOCYTE BIOL, V74, P821, DOI 10.1189/jlb.0403161; Popik W, 2000, VIROLOGY, V276, P1, DOI 10.1006/viro.2000.0581; Popik W, 1998, VIROLOGY, V252, P210, DOI 10.1006/viro.1998.9466; Salemi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000950; SCHUITEMAKER H, 1994, J LEUKOCYTE BIOL, V56, P218, DOI 10.1002/jlb.56.3.218; SCHUITEMAKER H, 1994, EMBO J, V13, P5929, DOI 10.1002/j.1460-2075.1994.tb06938.x; Shapiro L, 1998, P NATL ACAD SCI USA, V95, P7422, DOI 10.1073/pnas.95.13.7422; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; Tomkowicz B, 2006, BLOOD, V108, P1145, DOI 10.1182/blood-2005-12-012815; Tuttle DL, 1998, J VIROL, V72, P4962, DOI 10.1128/JVI.72.6.4962-4969.1998; Tuttle DL, 2002, AIDS RES HUM RETROV, V18, P353, DOI 10.1089/088922202753519133; Vazquez N, 2005, J VIROL, V79, P4479, DOI 10.1128/JVI.79.7.4479-4491.2005; Verani A, 2002, J IMMUNOL, V168, P6388, DOI 10.4049/jimmunol.168.12.6388; Verani A, 1997, J EXP MED, V185, P805, DOI 10.1084/jem.185.5.805; Wang XP, 2001, J LEUKOCYTE BIOL, V69, P405; Wang XZ, 2004, J BIOL CHEM, V279, P49460, DOI 10.1074/jbc.M406059200; Weber F, 2004, VIRAL IMMUNOL, V17, P498, DOI 10.1089/vim.2004.17.498; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Zybarth G, 1999, J IMMUNOL, V162, P400	78	78	80	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3664	10.1371/journal.pone.0003664	http://dx.doi.org/10.1371/journal.pone.0003664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048100	Green Submitted, gold, Green Published			2022-12-25	WOS:000265452000001
J	Schneider, A; Spitkovsky, D; Riess, P; Molcanyi, M; Kamisetti, N; Maegele, M; Hescheler, J; Schaefer, U				Schneider, Annette; Spitkovsky, Dimitry; Riess, Peter; Molcanyi, Marek; Kamisetti, Naidu; Maegele, Marc; Hescheler, Juergen; Schaefer, Ute			"The Good into the Pot, the Bad into the Crop!" - A New Technology to Free Stem Cells from Feeder Cells	PLOS ONE			English	Article							SERUM-FREE; CONDITIONED MEDIUM; STROMAL CELLS; FREE CULTURE; GROWTH; DIFFERENTIATION; SUPPORT; REPLACEMENT; PROPAGATION; EXPRESSION	A variety of embryonic and adult stem cell lines require an intial co-culturing with feeder cells for non-differentiated growth, self renewal and maintenance of pluripotency. However for many downstream ES cell applications the feeder cells have to be considered contaminations that might interfere not just with the analysis of experimental data but also with clinical application and tissue engineering approaches. Here we introduce a novel technique that allows for the selection of pure feeder-freed stem cells, following stem cell proliferation on feeder cell layers. Complete and reproducible separation of feeder and embryonic stem cells was accomplished by adaptation of an automated cell selection system that resulted in the aspiration of distinct cell colonies or fraction of colonies according to predefined physical parameters. Analyzing neuronal differentiation we demonstrated feeder-freed stem cells to exhibit differentiation potentials comparable to embryonic stem cells differentiated under standard conditions. However, embryoid body growth as well as differentiation of stem cells into cardiomyocytes was significantly enhanced in feeder-freed cells, indicating a feeder cell dependent modulation of lineage differentiation during early embryoid body development. These findings underline the necessity to separate stem and feeder cells before the initiation of in vitro differentiation. The complete separation of stem and feeder cells by this new technology results in pure stem cell populations for translational approaches. Furthermore, a more detailed analysis of the effect of feeder cells on stem cell differentiation is now possible, that might facilitate the identification and development of new optimized human or genetically modified feeder cell lines.	[Schneider, Annette] Univ Witten Herdecke, Inst Res Operat Med IFOM, Fac Med, Witten, Germany; [Spitkovsky, Dimitry; Kamisetti, Naidu; Hescheler, Juergen] Univ Cologne, Fac Med, Inst Neurophysiol, Ctr Physiol, D-5000 Cologne, Germany; [Riess, Peter; Maegele, Marc] Univ Witten Herdecke, Hosp Merheim, Fac Med, Dept Trauma & Orthoped Surg, Cologne, Germany; [Molcanyi, Marek] Univ Cologne, Fac Med, Dept Neurophysiol 2, Clin Neurosurg, D-5000 Cologne, Germany; [Schaefer, Ute] Med Univ Graz, Dept Expt Neurotraumatol, Graz, Austria	Witten Herdecke University; University of Cologne; University of Cologne; Witten Herdecke University; University of Cologne; Medical University of Graz	Schneider, A (corresponding author), Univ Witten Herdecke, Inst Res Operat Med IFOM, Fac Med, Witten, Germany.	ute.schaefer@meduni-graz.at	Spitkovsky, Dimitry/ABA-1605-2020					Amit M, 2006, METHOD ENZYMOL, V420, P37, DOI 10.1016/S0076-6879(06)20003-X; Bentz K, 2007, J NEUROSCI RES, V85, P1057, DOI 10.1002/jnr.21219; Bentz K, 2006, CELL PHYSIOL BIOCHEM, V18, P275, DOI 10.1159/000097674; Bigdeli N, 2008, J BIOTECHNOL, V133, P146, DOI 10.1016/j.jbiotec.2007.08.045; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Choo A, 2006, J BIOTECHNOL, V122, P130, DOI 10.1016/j.jbiotec.2005.09.008; Djordjevic B, 2006, ACTA ONCOL, V45, P412, DOI 10.1080/02841860500520743; Dravid G, 2006, METH MOL B, V331, P91; EHMANN UK, 1992, EXP CELL RES, V199, P314, DOI 10.1016/0014-4827(92)90440-J; Fujimoto N, 2007, BIOMATERIALS, V28, P4795, DOI 10.1016/j.biomaterials.2007.07.033; Gottschling S, 2007, STEM CELLS, V25, P798, DOI 10.1634/stemcells.2006-0513; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; He J, 2007, J BIOMED SCI, V14, P617, DOI 10.1007/s11373-007-9185-z; Hiroyama T, 2008, CELL BIOL INT, V32, P1, DOI 10.1016/j.cellbi.2007.08.001; Huettner JE, 2006, STEM CELLS, V24, P1654, DOI 10.1634/stemcells.2005-0003; Kang SK, 2003, DEV BRAIN RES, V145, P141, DOI 10.1016/S0165-3806(03)00224-4; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Lee JB, 2004, REPRODUCTION, V128, P727, DOI 10.1530/rep.1.00415; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li FF, 2007, CELLS TISSUES ORGANS, V186, P221, DOI 10.1159/000107637; Lim JWE, 2002, PROTEOMICS, V2, P1187, DOI 10.1002/1615-9861(200209)2:9<1187::AID-PROT1187>3.0.CO;2-T; Lorincz Matthew T., 2006, V330, P55; Mangel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001591; Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127; Michelini M, 2006, CELL PROLIFERAT, V39, P217, DOI 10.1111/j.1365-2184.2006.00381.x; Moore H, 2006, NAT BIOTECHNOL, V24, P160, DOI 10.1038/nbt0206-160; Nichols Jennifer, 2006, V329, P91; Peterkin T, 2003, EMBO J, V22, P4260, DOI 10.1093/emboj/cdg400; Richards M, 2006, METH MOL B, V331, P23; SAXENA S, 2008, MOL REPROD DEV; Skottman H, 2006, STEM CELLS, V24, P151, DOI 10.1634/stemcells.2004-0189; Steinschneider R, 1996, DEV BRAIN RES, V95, P15, DOI 10.1016/0165-3806(96)00052-1; Weitzer G, 2006, HANDB EXP PHARM, V174, P21; Xie CQ, 2005, CELL BIOL INT, V29, P623, DOI 10.1016/j.cellbi.2005.03.015; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yoo SJ, 2005, EXP MOL MED, V37, P399, DOI 10.1038/emm.2005.50	36	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3788	10.1371/journal.pone.0003788	http://dx.doi.org/10.1371/journal.pone.0003788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023443	Green Submitted, Green Published, gold			2022-12-25	WOS:000265448800009
J	Fernando, C; Karishma, KK; Szathmary, E				Fernando, Chrisantha; Karishma, K. K.; Szathmary, Eoers			Copying and Evolution of Neuronal Topology	PLOS ONE			English	Article							DEPENDENT SYNAPTIC PLASTICITY; ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; THALAMOCORTICAL CIRCUITRY; MEMORY CONSOLIDATION; CEREBELLAR CORTEX; AUDITORY-CORTEX; NEURAL-NETWORKS; DENTATE GYRUS; D1 RECEPTORS	We propose a mechanism for copying of neuronal networks that is of considerable interest for neuroscience for it suggests a neuronal basis for causal inference, function copying, and natural selection within the human brain. To date, no model of neuronal topology copying exists. We present three increasingly sophisticated mechanisms to demonstrate how topographic map formation coupled with Spike-Time Dependent Plasticity (STDP) can copy neuronal topology motifs. Fidelity is improved by error correction and activity-reverberation limitation. The high-fidelity topology-copying operator is used to evolve neuronal topologies. Possible roles for neuronal natural selection are discussed.	[Fernando, Chrisantha; Karishma, K. K.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Fernando, Chrisantha; Szathmary, Eoers] Inst Advanced Study, Budapest, Hungary; [Szathmary, Eoers] Parmenides Fdn, Munich, Germany; [Szathmary, Eoers] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary	MRC National Institute for Medical Research; Eotvos Lorand University	Fernando, C (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	ctf20@sussex.ac.uk	Szathmáry, Eörs/A-5007-2011; Szathmary, Eors/AAS-1202-2021	Szathmary, Eors/0000-0001-5227-2997	MRC National Institute for Medical Research, Mill Hill, London; Marie Curie; Hungarian National Office for Research and Technology [NAP 2005/KCKHA005]; Regional Knowledge Centre of Eotvos University [RET2.4/2005]; MRC [MC_U117573805] Funding Source: UKRI; Medical Research Council [MC_U117573805] Funding Source: researchfish	MRC National Institute for Medical Research, Mill Hill, London; Marie Curie(European Commission); Hungarian National Office for Research and Technology(National Office for Research and Technology); Regional Knowledge Centre of Eotvos University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Thanks to a Career Development Fellowship at the MRC National Institute for Medical Research, Mill Hill, London, and to a Marie Curie Inter-European Grant to work at Collegium Budapest, Hungary. Partial support of this work has generously been provided by the Hungarian National Office for Research and Technology (NAP 2005/KCKHA005) and by the Regional Knowledge Centre of Eotvos University (National Office for Research and Technology grant No. RET2.4/2005).	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Adams P, 2002, PHILOS T ROY SOC B, V357, P1767, DOI 10.1098/rstb.2002.1164; Adams P, 1998, J THEOR BIOL, V195, P419, DOI 10.1006/jtbi.1997.0620; Aunger R., 2002, ELECT MEME NEW THEOR; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; BEYER HG, 2001, THEORY EVOLUTION; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Blaisdell AP, 2006, SCIENCE, V311, P1020, DOI 10.1126/science.1121872; Calvin W. H., 1996, CEREBRAL CODE; CALVIN WH, 1987, NATURE, V330, P33, DOI 10.1038/330033a0; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Changeux J.-P., 1985, NEURONAL MAN BIOL MI; CHANGEUX JP, 1973, P NATL ACAD SCI USA, V70, P2974, DOI 10.1073/pnas.70.10.2974; Chialvo DR, 1999, NEUROSCIENCE, V90, P1137, DOI 10.1016/S0306-4522(98)00472-2; Chronicle EP, 2004, J EXP PSYCHOL LEARN, V30, P14, DOI 10.1037/0278-7393.30.1.14; Churchland PatriciaS., 2002, BRAIN WISE STUDIES N; CRICK F, 1990, TRENDS NEUROSCI, V13, P13, DOI 10.1016/0166-2236(90)90055-F; CRICK F, 1995, BEHAV BRAIN RES, V69, P147, DOI 10.1016/0166-4328(95)00006-F; CRICK F, 1989, TRENDS NEUROSCI, V12, P240, DOI 10.1016/0166-2236(89)90019-2; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; DAWKINS R, 1971, NATURE, V229, P118, DOI 10.1038/229118a0; Dayan P., 2001, THEORETICAL NEUROSCI; Dayan P., 1995, NEURAL COMPUT, V7, P1022, DOI [10.1162/neco.1995.7.5.889, DOI 10.1162/NECO.1995.7.5.889]; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; DEHAENE S, 1987, P NATL ACAD SCI USA, V84, P2727, DOI 10.1073/pnas.84.9.2727; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; DENK W, PLOS BIOL, V2, pE329; Dennett Daniel, 1969, CONTENT CONSCIOUSNES; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; Eckardt LH, 2002, NATURE, V420, P286, DOI 10.1038/420286a; EDELMAN GM, 1994, GENETICS, V138, P975; Edelman GM, 1987, NEURAL DARWINISM THE; Elliott T, 2002, TRENDS COGN SCI, V6, P147, DOI 10.1016/S1364-6613(02)01886-7; FERNANDO C, 2009, NEURONAL RE IN PRESS; FISCHER TM, 1993, J NEUROSCI, V13, P1302; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Frankland PW, 2006, P NATL ACAD SCI USA, V103, P509, DOI 10.1073/pnas.0510133103; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Ganti T., 2003, PRINCIPLES LIFE; Gerstner W, 2002, BIOL CYBERN, V87, P404, DOI 10.1007/s00422-002-0353-y; Gisiger T, 2000, CURR OPIN NEUROBIOL, V10, P250, DOI 10.1016/S0959-4388(00)00075-1; Glymour C, 2003, TRENDS COGN SCI, V7, P43, DOI 10.1016/S1364-6613(02)00009-8; Goldberg AdeleE., 1995, CONSTRUCTIONS CONSTR; Gopnik A, 2004, TRENDS COGN SCI, V8, P371, DOI 10.1016/j.tics.2004.06.005; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; James W., 1890, PRINCIPLES PSYCHOL; Kandel E., 2000, PRINCIPLES NEURAL SC; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Krichmar JL, 2005, ARTIF LIFE, V11, P63, DOI 10.1162/1064546053278946; Lagnado D.A., 2007, CAUSAL LEARNING PSYC, P154, DOI DOI 10.1093/ACPROF:OSO/9780195176803.003.0011; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; LEE R, 2001, HIPPOCAMPUS, V11, P707; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Marr D, 1983, VISION COMPUTATIONAL; Maynard Smith J., 1986, PROBLEMS BIOL; Medina JH, 2008, BEHAV BRAIN RES, V192, P61, DOI 10.1016/j.bbr.2008.02.006; MEL BW, 1994, NEURAL COMPUT, V6, P1031, DOI 10.1162/neco.1994.6.6.1031; Michod R. E., 1988, EVOLUTION, V43, P694, DOI DOI 10.1111/J.1558-5646.1989.TB04268.X; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell, 1996, INTRO GENETIC ALGORI; MULLER HJ, 1966, AM NAT, V100, P493, DOI 10.1086/282445; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nadel Lynn, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/90472; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Orban G, 2008, P NATL ACAD SCI USA, V105, P2745, DOI 10.1073/pnas.0708424105; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Rekkas PV, 2005, J COGNITIVE NEUROSCI, V17, P1950, DOI 10.1162/089892905775008652; Rougier NP, 2005, P NATL ACAD SCI USA, V102, P7338, DOI 10.1073/pnas.0502455102; SCHELER G, 2003, PRESYNAPTIC MODULATI; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Sirota Anton, 2005, Thalamus & Related Systems, V3, P245, DOI 10.1017/S1472928807000258; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2002, NEURAL NETWORKS, V15, P761, DOI 10.1016/S0893-6080(02)00062-X; Steels L, 2006, TRENDS COGN SCI, V10, P347, DOI 10.1016/j.tics.2006.06.002; Steinvorth S, 2005, NEUROPSYCHOLOGIA, V43, P479, DOI 10.1016/j.neuropsychologia.2005.01.001; STERIADE M, 2007, GATING NEURONAL NETW; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Szathmary E, 1995, MAJOR TRANSITIONS EV; Takayanagi M, 2006, NEUROSCIENCE, V142, P769, DOI 10.1016/j.neuroscience.2006.06.048; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Thiel CM, 2002, NEURON, V35, P567, DOI 10.1016/S0896-6273(02)00801-2; Thivierge JP, 2007, TRENDS NEUROSCI, V30, P251, DOI 10.1016/j.tins.2007.04.004; Toussaint M, 2003, EVOLUTION GENETIC RE; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Young JM, 2007, NAT NEUROSCI, V10, P887, DOI 10.1038/nn1913	127	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3775	10.1371/journal.pone.0003775	http://dx.doi.org/10.1371/journal.pone.0003775			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020662	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000265448600008
J	Woodland, HR; Fry, AM				Woodland, Hugh R.; Fry, Andrew M.			Pix Proteins and the Evolution of Centrioles	PLOS ONE			English	Article								We have made a wide phylogenetic survey of Pix proteins, which are constituents of vertebrate centrioles in most eukaryotes. We have also surveyed the presence and structure of flagella or cilia and centrioles in these organisms, as far as is possible from published information. We find that Pix proteins are present in a vast range of eukaryotes, but not all. Where centrioles are absent so are Pix proteins. If one considers the maintenance of Pix proteins over evolutionary time scales, our analysis would suggest that their key function is to make cilia and flagella, and the same is true of centrioles. Moreover, this survey raises the possibility that Pix proteins are only maintained to make cilia and flagella that undulate, and even then only when they are constructed by transporting ciliary constituents up the cilium using the intraflagellar transport (IFT) system. We also find that Pix proteins have become generally divergent within Ecdysozoa and between this group and other taxa. This correlates with a simplification of centrioles within Ecdysozoa and a loss or divergence of cilia/flagella. Thus Pix proteins act as a weathervane to indicate changes in centriole function, whose core activity is to make cilia and flagella.	[Woodland, Hugh R.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Fry, Andrew M.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Warwick; University of Leicester	Woodland, HR (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	h.r.woodland@warwick.ac.uk			Wellcome Trust; Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/F010702/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F010702/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Wellcome Trust (HRW) and The Biotechnology and Biological Sciences Research Council (BBSRC)(AMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzelius BA, 1999, INT J DEV BIOL, V43, P283; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Dutcher SK, 2001, CURR BIOL, V11, pR419, DOI 10.1016/S0960-9822(01)00250-0; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; Feldman JL, 2004, CURR BIOL, V14, pR659, DOI 10.1016/j.cub.2004.08.019; GARBARY DJ, 1993, PLANT SYST EVOL, V188, P237; Gonzalez C, 1998, J CELL SCI, V111, P2697; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Harnes RS, 2008, EXP CELL RES, V314, P574, DOI 10.1016/j.yexcr.2007.10.019; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Machado RJ, 2005, DEV BIOL, V287, P289, DOI 10.1016/j.ydbio.2005.08.044; Marshall WF, 2007, J CELL BIOCHEM, V100, P916, DOI 10.1002/jcb.21117; Marshall WF, 2000, CURR OPIN CELL BIOL, V12, P119, DOI 10.1016/S0955-0674(99)00065-4; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Montsant A, 2007, J PHYCOL, V43, P585, DOI 10.1111/j.1529-8817.2007.00342.x; Nielsen MG, 2001, CURR BIOL, V11, P529, DOI 10.1016/S0960-9822(01)00150-6; PITNICK S, 1995, NATURE, V375, P109, DOI 10.1038/375109a0; Popodi EM, 2008, CELL MOTIL CYTOSKEL, V65, P216, DOI 10.1002/cm.20256; Renzaglia KS, 1999, INT J PLANT SCI, V160, P14, DOI 10.1086/314103; Renzaglia KS, 2000, MICROSC RES TECHNIQ, V49, P496, DOI 10.1002/(SICI)1097-0029(20000601)49:5<496::AID-JEMT12>3.0.CO;2-H; Rodrigues-Martins A, 2008, CELL CYCLE, V7, P11, DOI 10.4161/cc.7.1.5226; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schmidt-Rhaesa A, 1998, J MORPHOL, V238, P263, DOI 10.1002/(SICI)1097-4687(199812)238:3<263::AID-JMOR1>3.0.CO;2-L; SINDEN RE, 1976, PROC R SOC SER B-BIO, V193, P55, DOI 10.1098/rspb.1976.0031; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V124, P479, DOI 10.1007/BF00335253; Valentine JW, 2000, EVOL DEV, V2, P152, DOI 10.1046/j.1525-142x.2000.00043.x; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9	44	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3778	10.1371/journal.pone.0003778	http://dx.doi.org/10.1371/journal.pone.0003778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020665	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448600011
J	Dubin-Thaler, BJ; Hofman, JM; Cai, YF; Xenias, H; Spielman, I; Shneidman, AV; David, LA; Dobereiner, HG; Wiggins, CH; Sheetz, MP				Dubin-Thaler, Benjamin J.; Hofman, Jake M.; Cai, Yunfei; Xenias, Harry; Spielman, Ingrid; Shneidman, Anna V.; David, Lawrence A.; Doebereiner, Hans-Guenther; Wiggins, Chris H.; Sheetz, Michael P.			Quantification of Cell Edge Velocities and Traction Forces Reveals Distinct Motility Modules during Cell Spreading	PLOS ONE			English	Article								Actin-based cell motility and force generation are central to immune response, tissue development, and cancer metastasis, and understanding actin cytoskeleton regulation is a major goal of cell biologists. Cell spreading is a commonly used model system for motility experiments-spreading fibroblasts exhibit stereotypic, spatially-isotropic edge dynamics during a reproducible sequence of functional phases: 1) During early spreading, cells form initial contacts with the surface. 2) The middle spreading phase exhibits rapidly increasing attachment area. 3) Late spreading is characterized by periodic contractions and stable adhesions formation. While differences in cytoskeletal regulation between phases are known, a global analysis of the spatial and temporal coordination of motility and force generation is missing. Implementing improved algorithms for analyzing edge dynamics over the entire cell periphery, we observed that a single domain of homogeneous cytoskeletal dynamics dominated each of the three phases of spreading. These domains exhibited a unique combination of biophysical and biochemical parameters-a motility module. Biophysical characterization of the motility modules revealed that the early phase was dominated by periodic, rapid membrane blebbing; the middle phase exhibited continuous protrusion with very low traction force generation; and the late phase was characterized by global periodic contractions and high force generation. Biochemically, each motility module exhibited a different distribution of the actin-related protein VASP, while inhibition of actin polymerization revealed different dependencies on barbed-end polymerization. In addition, our whole-cell analysis revealed that many cells exhibited heterogeneous combinations of motility modules in neighboring regions of the cell edge. Together, these observations support a model of motility in which regions of the cell edge exhibit one of a limited number of motility modules that, together, determine the overall motility function. Our data and algorithms are publicly available to encourage further exploration.	[Dubin-Thaler, Benjamin J.; Cai, Yunfei; Xenias, Harry; Spielman, Ingrid; Shneidman, Anna V.; Doebereiner, Hans-Guenther; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Dubin-Thaler, Benjamin J.] Cell Motion Lab Inc, New York, NY USA; [Hofman, Jake M.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Hofman, Jake M.; Wiggins, Chris H.] Columbia Univ, Dept Applied Phys & Applied Math, New York, NY 10027 USA; [David, Lawrence A.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Doebereiner, Hans-Guenther] Univ Bremen, Inst Biophys, D-2800 Bremen, Germany	Columbia University; Columbia University; Columbia University; Columbia University; University of Bremen	Dubin-Thaler, BJ (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ben@cellmotion.org	David, Lawrence/B-1044-2010; Döbereiner, Hans-Günther/F-7302-2012; David, Lawrence Anthony/HCJ-0062-2022	David, Lawrence/0000-0002-3570-4767; Döbereiner, Hans-Günther/0000-0003-1691-634X; David, Lawrence Anthony/0000-0002-3570-4767	National Institutes of Health [PN2 EY016586]; Training Program in Molecular Biophysics [GM008281]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Molecular Biophysics; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded from the National Institutes of Health through the NIH Roadmap for Medical Research (PN2 EY016586) and the Training Program in Molecular Biophysics, GM008281 (BJD).	Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Adamsky K, 2001, ONCOGENE, V20, P609, DOI 10.1038/sj.onc.1204119; AXELROD D, 1983, J MICROSC-OXFORD, V129, P19, DOI 10.1111/j.1365-2818.1983.tb04158.x; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bailly M, 1998, MICROSC RES TECHNIQ, V43, P433, DOI 10.1002/(SICI)1097-0029(19981201)43:5<433::AID-JEMT9>3.0.CO;2-2; BARDSLEY WG, 1983, J CELL SCI, V61, P365; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Baum B, 2004, CURR BIOL, V14, pR716, DOI 10.1016/j.cub.2004.08.047; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BEREITERHAHN J, 1990, J CELL SCI, V96, P171; Betz T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098103; BLIOKH ZL, 1977, BIOFIZIKA+, V22, P281; BOSS J, 1955, EXP CELL RES, V8, P181, DOI 10.1016/0014-4827(55)90055-0; CAI Y, 2006, BIOPHYS J; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Chamaraux F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158102; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; CHURCH GM, 2005, MOL SYST BIOL; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Dobereiner HG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108105; Dobereiner HG, 2005, J APPL PHYSIOL, V98, P1542, DOI 10.1152/japplphysiol.01181.2004; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Dustin ML, 2001, TRENDS IMMUNOL, V22, P192, DOI 10.1016/S1471-4906(01)01872-5; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; FUJINAMI N, 1975, J CELL SCI, V19, P169; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; HASTIE T, 2001, ELEMENTS STAT LEARNI, V16, P533; Heo WD, 2003, CELL, V113, P315; KAGEYAMA T, 1977, DEV GROWTH DIFFER, V19, P103; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Keller HU, 1996, CELL MOTIL CYTOSKEL, V33, P241, DOI 10.1002/(SICI)1097-0169(1996)33:4<241::AID-CM1>3.0.CO;2-C; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; Ninov N, 2007, DEVELOPMENT, V134, P367, DOI 10.1242/dev.02728; POGGIO T, 1985, NATURE, V317, P314, DOI 10.1038/317314a0; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shlomovitz R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.168103; Silva HS, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041903; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; VASILIEV JM, 1982, PHILOS T ROY SOC B, V299, P159, DOI 10.1098/rstb.1982.0122; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang WG, 2007, CANCER RES, V67, P3505, DOI 10.1158/0008-5472.CAN-06-3714; WEISS Y, 2000, OPHTHALMOLOGY VISUAL, V795, pS795; WINKLBAUER R, 1992, DEV BIOL, V150, P335, DOI 10.1016/0012-1606(92)90246-D; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; ZHANG X, 2008, NAT CELL BIOL	68	95	97	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3735	10.1371/journal.pone.0003735	http://dx.doi.org/10.1371/journal.pone.0003735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011687	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448300003
J	Mayers, JR; Iliff, BW; Swoap, SJ				Mayers, Jared R.; Iliff, Benjamin W.; Swoap, Steven J.			Resveratrol treatment in mice does not elicit the bradycardia and hypothermia associated with calorie restriction	FASEB JOURNAL			English	Article						obesity; dieting; body temperature; heart rate	SMALL-MOLECULE ACTIVATORS; CEREVISIAE LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; HEART-RATE; DIETARY RESTRICTION; BODY-TEMPERATURE; SIRT1; DISEASE; LEPTIN; EXPRESSION	Dietary supplementation with resveratrol may produce calorie restriction-like effects on metabolic and longevity endpoints in mice. In this study, we sought to determine whether resveratrol treatment elicited other hallmark changes associated with calorie restriction, namely bradycardia and decreased body temperature. We found that during short-term treatment, wild-type mice on a calorie-restricted diet experienced significant decreases in both heart rate and body temperature after only 1 day whereas those receiving resveratrol exhibited no such change after 1 wk. We also used ob/ob mice to study the effects of long-term treatment because previous studies had indicated the therapeutic value of resveratrol against the linked morbidities of obesity and diabetes. After 12 wk, resveratrol treatment had produced no changes in either heart rate or body temperature. Strikingly, and in contrast to previous findings, we found that resveratrol-treated mice had significantly reduced endurance in a treadmill test. Quantitative reverse transcriptase-polymerase chain reaction suggested that a proposed target of resveratrol, Sirt1, was activated in resveratrol-treated ob/ob mice. Thus, we conclude that the bradycardia and hypothermia associated with calorie restriction occur through mechanisms unaffected by the actions of resveratrol and that further studies are needed to examine the differential effects of resveratrol in a leptin-deficient background.-Mayers, J. R., Iliff, B. W., Swoap, S. J. Resveratrol treatment in mice does not elicit the bradycardia and hypothermia associated with calorie restriction. FASEB J. 23, 1032-1040 (2009)	[Mayers, Jared R.; Iliff, Benjamin W.; Swoap, Steven J.] Williams Coll, Dept Biol, Williamstown, MA 01267 USA	Williams College	Swoap, SJ (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	sswoap@williams.edu		Mayers, Jared/0000-0002-8607-1787	U.S. National Institutes of Health [R15 HL081101-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL081101] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health grant R15 HL081101-01 to S.J.S.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; Chen WP, 2007, EUR J PHARMACOL, V568, P269, DOI 10.1016/j.ejphar.2007.04.062; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 2006, NATURE, V444, P280, DOI 10.1038/nature05308; Kakuma T, 2000, ENDOCRINOLOGY, V141, P4576, DOI 10.1210/en.141.12.4576; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lane MA, 1999, TOXICOL SCI, V52, P41, DOI 10.1093/toxsci/52.suppl_1.41; Lane MA, 1996, P NATL ACAD SCI USA, V93, P4159, DOI 10.1073/pnas.93.9.4159; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; Pagano C, 2008, NUTR METAB CARDIOVAS, V18, P189, DOI 10.1016/j.numecd.2006.05.009; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Rikke BA, 2003, MECH AGEING DEV, V124, P663, DOI 10.1016/S0047-6374(03)00003-4; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sowden GL, 2007, AM J PHYSIOL-REG I, V292, pR962, DOI 10.1152/ajpregu.00405.2006; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Swoap SJ, 2008, AM J PHYSIOL-HEART C, V294, pH1581, DOI 10.1152/ajpheart.01000.2007; Swoap SJ, 2004, AM J PHYSIOL-REG I, V286, pR108, DOI 10.1152/ajpregu.00405.2003; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wolf G, 2006, NUTR REV, V64, P89, DOI [10.1111/j.1753-4887.2006.tb00192.x, 10.1301/nr.2006.feb.89-92]; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	53	31	33	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1032	1040		10.1096/fj.08-115923	http://dx.doi.org/10.1096/fj.08-115923			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19056839	Green Published			2022-12-25	WOS:000266651600007
J	Guo, P; Dong, XY; Zhang, XH; Zhao, KW; Sun, XD; Li, QN; Dong, JT				Guo, Peng; Dong, Xue-Yuan; Zhang, Xiaohui; Zhao, Ke-Wen; Sun, Xiaodong; Li, Qunna; Dong, Jin-Tang			Pro-proliferative Factor KLF5 Becomes Anti-proliferative in Epithelial Homeostasis upon Signaling-mediated Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CDK INHIBITOR P15(INK4B); HUMAN PROSTATE-CANCER; KRUPPEL-LIKE FACTOR-5; TRANSCRIPTION FACTOR; TGF-BETA; STEM-CELLS; TUMOR PROGRESSION; HUMAN SKIN; PROMOTER	During epithelial homeostasis, stem cells divide to produce progenitor cells, which not only proliferate to generate the cell mass but also respond to cellular signaling to transition from a proliferative state to a differentiation state. Such a transition involves functional alterations of transcriptional factors, yet the underlying molecular mechanisms are poorly understood. Recent studies have implicated Kruppel-like factors (KLFs) including KLF5 in the renewal and maintenance of stem/progenitor cells. Here we demonstrate that the pro-proliferative factor KLF5 becomes anti-proliferative upon TGF beta-mediated acetylation in an in vitro model of epithelial homeostasis. In the HaCaT epidermal cell line treated with or without TGF beta, we found that KLF5 was not only essential for cell proliferation, it was also indispensable for TGF beta-induced anti-proliferation in these cells. KLF5 inhibited the expression of p15 (CDKN2B), a cell cycle inhibitor, without TGF beta, but became a coactivator in TGF beta-induced p15 expression in the same cells. Mechanistically, TGF beta recruited acetylase p300 to acetylate KLF5, and acetylation in turn altered the binding of KLF5 to p15 promoter, resulting in the reversal of KLF5 function. These studies not only demonstrate that a basic transcription factor can be both pro-proliferation and anti-proliferation in epithelial homeostasis, they also present a unique mechanism for how transcriptional regulation changes during the transition from proliferation to inhibition of proliferation. Furthermore, they establish KLF5 as an essential cofactor for TGF beta signaling.	[Guo, Peng; Dong, Xue-Yuan; Zhang, Xiaohui; Zhao, Ke-Wen; Sun, Xiaodong; Li, Qunna; Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University	Dong, JT (corresponding author), 1365-C Clifton Rd, Atlanta, GA 30322 USA.	jdong2@emory.edu	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022	Guo, Peng/0000-0002-4575-8443; Dong, Jin-Tang/0000-0003-2349-5782	NCI [Grant R01CA87921]; National Institutes of Health; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [R01CA087921] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Grant R01CA87921 from the NCI, National Institutes of Health. This work was also supported by the Georgia Cancer Coalition.	Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Chanchevalap S, 2004, FEBS LETT, V578, P99, DOI 10.1016/j.febslet.2004.10.079; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Grabbe J, 1996, J INVEST DERMATOL, V107, P219, DOI 10.1111/1523-1747.ep12329664; Greiff AH, 2002, CLIN EXP METASTAS, V19, P727, DOI 10.1023/A:1021304700234; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Lemaitre G, 2005, PROTEOMICS, V5, P3637, DOI 10.1002/pmic.200401224; LI JM, 1995, J BIOL CHEM, V270, P26750, DOI 10.1074/jbc.270.45.26750; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park BJ, 2000, CANCER RES, V60, P3031; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Roberts A, 2005, ONCOGENE, V24, P5667, DOI 10.1038/sj.onc.1208915; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sandhu C, 1997, MOL CELL BIOL, V17, P2458, DOI 10.1128/MCB.17.5.2458; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shi HP, 1999, NUCLEIC ACIDS RES, V27, P4807, DOI 10.1093/nar/27.24.4807; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sur I, 2002, EUR J CELL BIOL, V81, P323, DOI 10.1078/0171-9335-00257; Sur I, 2006, J CELL SCI, V119, P3593, DOI 10.1242/jcs.03070; Wakefield LM, 2007, CANCER CELL, V12, P293, DOI 10.1016/j.ccr.2007.10.002; Wan H, 2007, STEM CELLS, V25, P1286, DOI 10.1634/stemcells.2006-0304; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310	40	62	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6071	6078		10.1074/jbc.M806270200	http://dx.doi.org/10.1074/jbc.M806270200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19056724	Green Published, hybrid			2022-12-25	WOS:000263742700009
J	Fiume, R; Ramazzotti, G; Teti, G; Chiarini, F; Faenza, I; Mazzotti, G; Billi, AM; Cocco, L				Fiume, Roberta; Ramazzotti, Giulia; Teti, Gabriella; Chiarini, Francesca; Faenza, Irene; Mazzotti, Giovanni; Billi, Anna Maria; Cocco, Lucio			Involvement of nuclear PLC beta 1 in lamin B1 phosphorylation and G(2)/M cell cycle progression	FASEB JOURNAL			English	Article						JNK; PKC alpha; nucleus; inositide signaling	PROTEIN-KINASE-C; GROWTH-FACTOR-I; PHOSPHOLIPASE-C; ERYTHROLEUKEMIA-CELLS; SWISS 3T3-CELLS; HL-60 CELLS; ACTIVATION; IDENTIFICATION; TRANSCRIPTION; ORGANIZATION	Inositide-specific phospholipase C beta 1 (PLC beta 1) signaling in cell proliferation has been investigated thoroughly in the G(1) cell cycle phase. However, little is known about its involvement in G(2)/M progression. We used murine erythroleukemia cells to investigate the role of PLC beta 1 in G(2)/M cell cycle progression and screened a number of candidate intermediate players, particularly mitogen-activated protein kinase (MAPK) and protein kinase C (PKC), which can, potentially, transduce serum mitogenic stimulus and induce lamin B1 phosphorylation, leading to G(2)/M progression. We report that PLC beta 1 colocalizes and physically interacts with lamin B1. Studies of the effects of inhibitors and selective si-RNA mediated silencing showed a role of JNK, PKC alpha, PKC beta I, and the beta 1 isoform of PI-PLC in cell accumulation in G(2)/M [as observed by fluorescence-activated cell sorter (FACS)]. To shed light on the mechanism, we considered that the final signaling target was lamin B1 phosphorylation. When JNK, PKC alpha, or PLC beta 1 were silenced, lamin B1 exhibited a lower extent of phosphorylation, as compared to control. The salient features to emerge from these studies are a common pathway in which JNK is likely to represent a link between mitogenic stimulus and activation of PLC beta 1, and, foremost, the finding that the PLC beta 1-mediated pathway represents a functional nuclear inositide signaling in the G(2)/M transition.-Fiume, R., Ramazzotti, G., Teti, G., Chiarini, F., Faenza, I., Mazzotti, G., Billi, A. M., Cocco, L., Involvement of nuclear PLC beta 1 in lamin B1 phosphorylation and G(2)/M cell cycle progression. FASEB J. 23, 957-966 (2009)	[Fiume, Roberta; Ramazzotti, Giulia; Teti, Gabriella; Chiarini, Francesca; Faenza, Irene; Mazzotti, Giovanni; Billi, Anna Maria; Cocco, Lucio] Univ Bologna, Cellular Signaling Lab, Dept Human Anat Sci, I-40126 Bologna, Italy	University of Bologna	Cocco, L (corresponding author), Univ Bologna, Cellular Signaling Lab, Dept Human Anat Sci, Via Irnerio 48, I-40126 Bologna, Italy.	lucio.cocco@unibo.it	Cocco, Lucio/AAI-2206-2020; RAMAZZOTTI, GIULIA/AGZ-9499-2022; Ramazzotti, Giulia/AAC-4597-2022; Faenza, Irene/AAC-4606-2022	Cocco, Lucio/0000-0002-9206-8277; RAMAZZOTTI, GIULIA/0000-0001-9684-714X; Faenza, Irene/0000-0002-5227-3567; FIUME, ROBERTA/0000-0001-7757-4000; teti, gabriella/0000-0001-9817-8437	Italian MIUR-FIRB (Human Proteome Net); MIUR-COFIN; Carisbo Foundation	Italian MIUR-FIRB (Human Proteome Net)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); MIUR-COFIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Carisbo Foundation(Fondazione Carisbo)	This work was supported by Italian MIUR-FIRB (Human Proteome Net), MIUR-COFIN, and the Carisbo Foundation.	Avazeri N, 2000, MOL BIOL CELL, V11, P4369, DOI 10.1091/mbc.11.12.4369; Bavelloni A, 2006, PROTEOMICS, V6, P5725, DOI 10.1002/pmic.200600318; Clarke JH, 2001, BIOCHEM J, V357, P905, DOI 10.1042/0264-6021:3570905; Cocco L, 1996, ADV ENZYME REGUL, V36, P101, DOI 10.1016/0065-2571(95)00007-0; Cocco L, 2001, BBA-MOL CELL BIOL L, V1530, P1, DOI 10.1016/S1388-1981(00)00169-4; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; Faenza I, 2000, J BIOL CHEM, V275, P30520, DOI 10.1074/jbc.M004630200; Fukuda T, 2005, GENES CELLS, V10, P655, DOI 10.1111/j.1365-2443.2005.00866.x; GOSS VL, 1994, J BIOL CHEM, V269, P19074; HOCEVAR BA, 1993, J BIOL CHEM, V268, P7545; Horne MM, 2003, J CELL BIOL, V161, P1021, DOI 10.1083/jcb.200304144; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lukinovic-Skudar V, 2005, BBA-MOL CELL BIOL L, V1733, P148, DOI 10.1016/j.bbalip.2004.12.009; Lukinovic-Skudar V, 2007, BBA-MOL CELL BIOL L, V1771, P514, DOI 10.1016/j.bbalip.2007.02.002; Manzoli L, 2005, PROG LIPID RES, V44, P185, DOI 10.1016/j.plipres.2005.04.003; MARTELLI AM, 1994, CANCER RES, V54, P2536; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; Neri LM, 1999, J CELL BIOCHEM, V75, P36, DOI 10.1002/(SICI)1097-4644(19991001)75:1<36::AID-JCB4>3.0.CO;2-R; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Sun B, 1997, J BIOL CHEM, V272, P26313, DOI 10.1074/jbc.272.42.26313; Tabellini G, 2002, CELL SIGNAL, V14, P819, DOI 10.1016/S0898-6568(02)00021-9; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Xu AM, 2001, MOL CELL BIOL, V21, P2981, DOI 10.1128/MCB.21.9.2981-2990.2001; Xu AM, 2001, J BIOL CHEM, V276, P14980, DOI 10.1074/jbc.M009144200	28	45	51	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2009	23	3					957	966		10.1096/fj.08-121244	http://dx.doi.org/10.1096/fj.08-121244			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19028838				2022-12-25	WOS:000265506300031
J	Preveral, S; Gayet, L; Moldes, C; Hoffmann, J; Mounicou, S; Gruet, A; Reynaud, F; Lobinski, R; Verbavatz, JM; Vavasseur, A; Forestier, C				Preveral, Sandra; Gayet, Landry; Moldes, Cristina; Hoffmann, Jonathan; Mounicou, Sandra; Gruet, Antoine; Reynaud, Florie; Lobinski, Ryszard; Verbavatz, Jean-Marc; Vavasseur, Alain; Forestier, Cyrille			A Common Highly Conserved Cadmium Detoxification Mechanism from Bacteria to Humans HEAVY METAL TOLERANCE CONFERRED BY THE ATP-BINDING CASSETTE (ABC) TRANSPORTER SpHMT1 REQUIRES GLUTATHIONE BUT NOT METAL-CHELATING PHYTOCHELATIN PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; SACCHAROMYCES-CEREVISIAE; SYNTHASE; FAMILY; PLANTS; GENES; REDOX	Cadmium poses a significant threat to human health due to its toxicity. In mammals and in bakers' yeast, cadmium is detoxified by ATP-binding cassette transporters after conjugation to glutathione. In fission yeast, phytochelatins constitute the co-substrate with cadmium for the transporter SpHMT1. In plants, a detoxification mechanism similar to the one in fission yeast is supposed, but the molecular nature of the transporter is still lacking. To investigate further the relationship between SpHMT1 and its co-substrate, we overexpressed the transporter in a Schizosaccharomyces pombe strain deleted for the phytochelatin synthase gene and heterologously in Saccharomyces cerevisiae and in Escherichia coli. In all organisms, overexpression of SpHMT1 conferred a markedly enhanced tolerance to cadmium but not to Sb(III), AgNO3, As(III), As(V), CuSO4, or HgCl2. Abolishment of the catalytic activity by expression of SpHMT1(K623M) mutant suppressed the cadmium tolerance phenotype independently of the presence of phytochelatins. Depletion of the glutathione pool inhibited the SpHMT1 activity but not that of AtHMA4, a P-type ATPase, indicating that GSH is necessary for the SpHMT1-mediated cadmium resistance. In E. coli, SpHMT1 was targeted to the periplasmic membrane and led to an increased amount of cadmium in the periplasm. These results demonstrate that SpHMT1 confers cadmium tolerance in the absence of phytochelatins but depending on the presence of GSH and ATP. Our results challenge the dogma of the two separate cadmium detoxification pathways and demonstrate that a common highly conserved mechanism has been selected during the evolution from bacteria to humans.	[Preveral, Sandra; Gayet, Landry; Moldes, Cristina; Hoffmann, Jonathan; Gruet, Antoine; Reynaud, Florie; Vavasseur, Alain; Forestier, Cyrille] Aix Marseille Univ, F-13108 St Paul Les Durance, France; [Mounicou, Sandra; Lobinski, Ryszard] CNRS, UMR 5034, Equipe Chim Analyt Bioinorgan, F-64053 Pau 9, France; [Verbavatz, Jean-Marc] CEA Saclay, DSV, Inst Biol & Technol Saclay, SB2SM, F-91191 Gif Sur Yvette, France; [Preveral, Sandra; Gayet, Landry; Moldes, Cristina; Hoffmann, Jonathan; Gruet, Antoine; Reynaud, Florie; Vavasseur, Alain; Forestier, Cyrille] CEA Cadarache, CNRS,Serv Biol Vegetale & Microbiol Environm, DSV,LEMS, IBEB,UMR Biol Vegetale & Microbiol Environm, F-13108 St Paul Les Durance, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Forestier, C (corresponding author), CEA Aix Marseille II, CNRS, DSV,CEA Cadarache,LEMS, IBEB,UMR 6191, F-13108 St Paul Les Durance, France.	cforestier@cea.fr	Prévéral, sandra/ABE-7177-2021; FORESTIER, Cyrille/AAX-8921-2021; FORESTIER, Cyrille/B-9684-2009; Gayet, Landry/M-7851-2014	FORESTIER, Cyrille/0000-0003-2141-1303; SANDRA, PREVERAL/0000-0002-0372-6099; HOFFMANN, JONATHAN/0000-0002-2400-8862; Reynaud, Florie/0000-0002-1653-7377; Lobinski, Ryszard/0000-0003-1908-2029; Verbavatz, Jean-Marc/0000-0002-4654-1174				AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Clemens S, 2006, J PLANT PHYSIOL, V163, P319, DOI 10.1016/j.jplph.2005.11.010; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Cobbett CS, 1999, TRENDS PLANT SCI, V4, P335, DOI 10.1016/S1360-1385(99)01465-X; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Henkel G, 2004, CHEM REV, V104, P801, DOI 10.1021/cr020620d; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; KONDO N, 1984, TETRAHEDRON LETT, V25, P3869, DOI 10.1016/S0040-4039(01)91190-6; LEBRUN M, 1994, J BACTERIOL, V176, P3040, DOI 10.1128/JB.176.10.3040-3048.1994; Lee SH, 2003, BIOCHEM BIOPH RES CO, V306, P644, DOI 10.1016/S0006-291X(03)01029-5; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Meyer AJ, 2008, J PLANT PHYSIOL, V165, P1390, DOI 10.1016/j.jplph.2007.10.015; MORENO S, 1991, METHOD ENZYMOL, V194, P795; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Preveral S, 2006, BIOCHIMIE, V88, P1651, DOI 10.1016/j.biochi.2006.05.016; Rea PA, 2006, P NATL ACAD SCI USA, V103, P507, DOI 10.1073/pnas.0509971102; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Suga M, 2001, YEAST, V18, P1015, DOI 10.1002/yea.753; Tamas MJ, 2006, TOP CURR GENET, V14, P395; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Vivares D, 2005, P NATL ACAD SCI USA, V102, P18848, DOI 10.1073/pnas.0505833102; Wunschmann J, 2007, FEBS LETT, V581, P1681, DOI 10.1016/j.febslet.2007.03.039	29	77	81	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4936	4943		10.1074/jbc.M808130200	http://dx.doi.org/10.1074/jbc.M808130200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19054771	hybrid			2022-12-25	WOS:000263416600023
J	Durr, KL; Tavraz, NN; Dempski, RE; Bamberg, E; Friedrich, T				Duerr, Katharina L.; Tavraz, Neslihan N.; Dempski, Robert E.; Bamberg, Ernst; Friedrich, Thomas			Functional Significance of E-2 State Stabilization by Specific alpha/beta-Subunit Interactions of Na,K- and H,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE-CLAMP FLUOROMETRY; NA,K-ATPASE BETA-SUBUNIT; ATP-ADP EXCHANGE; P-TYPE ATPASES; NA+/K+-ATPASE; INTRACELLULAR-TRANSPORT; GASTRIC H+,K+-ATPASE; XENOPUS OOCYTES; ACID-SECRETION; SODIUM-IONS	The beta-subunits of Na,K-ATPase and H,K-ATPase have important functions in maturation and plasma membrane targeting of the catalytic alpha-subunit but also modulate the transport activity of the holoenzymes. In this study, we show that tryptophan replacement of two highly conserved tyrosines in the transmembrane domain of both Na,K- and gastric H,K-ATPase beta-subunits resulted in considerable shifts of the voltage-dependent E1P/E2P distributions toward the E1P state as inferred from presteady-state current and voltage clamp fluorometric measurements of tetramethylrhodamine-6-maleimide-labeled ATPases. The shifts in conformational equilibria were accompanied by significant decreases in the apparent affinities for extracellular K+ that were moderate for the Na,K-ATPase beta-(Y39W,Y43W) mutation but much more pronounced for the corresponding H,K-ATPase beta-(Y44W,Y48W) variant. Moreover in the Na,K-ATPase beta-(Y39W,Y43W) mutant, the apparent rate constant for reverse binding of extracellular Na+ and the subsequent E2P-E1P conversion, as determined from transient current kinetics, was significantly accelerated, resulting in enhanced Na+ competition for extracellular K+ binding especially at extremely negative potentials. Analogously the reverse binding of extracellular protons and subsequent E2P-E1P conversion was accelerated by the H,K-ATPase beta-(Y44W,Y48W) mutation, and H+ secretion was strongly impaired. Remarkably tryptophan replacements of residues in the M7 segment of Na, K- and H,K-ATPase alpha-subunits, which are at interacting distance to the beta-tyrosines, resulted in similar E-1 shifts, indicating their participation in stabilization of E-2. Thus, interactions between selected residues within the transmembrane regions of alpha- and beta-subunits of P-2C-type ATPases exert an E-2-stabilizing effect, which is of particular importance for efficient H+ pumping by H,K-ATPase under in vivo conditions.	[Duerr, Katharina L.; Tavraz, Neslihan N.; Friedrich, Thomas] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Dempski, Robert E.; Bamberg, Ernst] Max Planck Inst Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany; [Bamberg, Ernst] Goethe Univ Frankfurt, Chem & Pharmaceut Sci Dept, D-60439 Frankfurt, Germany	Technical University of Berlin; Max Planck Society; Goethe University Frankfurt	Durr, KL (corresponding author), Tech Univ Berlin, Inst Chem, PC 14,Str 17 Juni 135, D-10623 Berlin, Germany.	Katharina.Duerr@TU-Berlin.DE	Friedrich, Thomas/AAA-3418-2022; Duerr, Katharina/A-6975-2015	Duerr, Katharina/0000-0002-3245-4088	Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V; Deutsche Forschungsgemeinschaft [SFB 472, SFB 740]; Cluster of Excellence	Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence	This work was supported by the Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. and the Deutsche Forschungsgemeinschaft (Grants SFB 472 and SFB 740 and Cluster of Excellence "Unifying Concepts in Catalysis"). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abriel H, 1999, BBA-BIOMEMBRANES, V1418, P85, DOI 10.1016/S0005-2736(99)00025-5; Altendorf K, 1998, ACTA PHYSIOL SCAND, V163, P137; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; CHOW DC, 1993, AM J PHYSIOL, V265, pC1562, DOI 10.1152/ajpcell.1993.265.6.C1562; CHOW DC, 1992, AM J PHYSIOL, V263, pC39, DOI 10.1152/ajpcell.1992.263.1.C39; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Dempski RE, 2005, J GEN PHYSIOL, V125, P505, DOI 10.1085/jgp.200409186; Durr KL, 2008, BIOCHEMISTRY-US, V47, P4288, DOI 10.1021/bi800092k; EAKLE KA, 1994, J BIOL CHEM, V269, P6550; EAKLE KA, 1992, P NATL ACAD SCI USA, V89, P2834, DOI 10.1073/pnas.89.7.2834; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; Geibel S, 2003, ANN NY ACAD SCI, V986, P31, DOI 10.1111/j.1749-6632.2003.tb07136.x; Geibel S, 2003, P NATL ACAD SCI USA, V100, P964, DOI 10.1073/pnas.0337336100; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; Hasler U, 2000, J BIOL CHEM, V275, P29011, DOI 10.1074/jbc.M002867200; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; HELMICHDEJONG ML, 1985, BIOCHIM BIOPHYS ACTA, V821, P377, DOI 10.1016/0005-2736(85)90041-0; HORISBERGER JD, 1991, J BIOL CHEM, V266, P19131; Hu YK, 2000, J BIOL CHEM, V275, P19185, DOI 10.1074/jbc.M000641200; JAISSER F, 1994, J GEN PHYSIOL, V103, P605, DOI 10.1085/jgp.103.4.605; JAISSER F, 1993, J CELL BIOL, V123, P1421, DOI 10.1083/jcb.123.6.1421; JAUNIN P, 1993, J CELL BIOL, V123, P1751, DOI 10.1083/jcb.123.6.1751; Kamsteeg EJ, 2000, AM J PHYSIOL-RENAL, V279, pF778, DOI 10.1152/ajprenal.2000.279.4.F778; Kamsteeg EJ, 2001, BIOCHEM BIOPH RES CO, V282, P683, DOI 10.1006/bbrc.2001.4629; KAPLAN JH, 1982, J GEN PHYSIOL, V80, P915, DOI 10.1085/jgp.80.6.915; KAPLAN JH, 1980, NATURE, V288, P587, DOI 10.1038/288587a0; KAWAMURA M, 1985, BIOCHIM BIOPHYS ACTA, V821, P115, DOI 10.1016/0005-2736(85)90161-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORENTZON P, 1985, BIOCHIM BIOPHYS ACTA, V817, P25, DOI 10.1016/0005-2736(85)90064-1; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; NOGUCHI S, 1987, FEBS LETT, V225, P27, DOI 10.1016/0014-5793(87)81125-0; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; POLVANI C, 1989, J BIOL CHEM, V264, P17854; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; RABON EC, 1990, J BIOL CHEM, V265, P19594; RAKOWSKI RF, 1993, J GEN PHYSIOL, V101, P117, DOI 10.1085/jgp.101.1.117; RAY TK, 1985, FEBS LETT, V185, P24, DOI 10.1016/0014-5793(85)80733-X; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; SAGAR A, 1994, J GEN PHYSIOL, V103, P869, DOI 10.1085/jgp.103.5.869; SHULL GE, 1986, J BIOL CHEM, V261, P6788; SWARTS HGP, 1995, J BIOL CHEM, V270, P7890, DOI 10.1074/jbc.270.14.7890; TUCHSEN E, 1987, BIOCHEMISTRY-US, V26, P1918, DOI 10.1021/bi00381a020; WALLMARK B, 1987, J BIOL CHEM, V262, P2077	53	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3842	3854		10.1074/jbc.M808101200	http://dx.doi.org/10.1074/jbc.M808101200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19064992	hybrid			2022-12-25	WOS:000262872500053
J	Karuri, NW; Lin, Z; Rye, HS; Schwarzbauer, JE				Karuri, Nancy W.; Lin, Zong; Rye, Hays S.; Schwarzbauer, Jean E.			Probing the Conformation of the Fibronectin III1-2 Domain by Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-ASSOCIATION; BINDING-SITE; MATRIX; PROTEIN; DYNAMICS; MODULES; GFP	Fibronectin (FN) matrix is crucial for cell and tissue functions during embryonic development, wound healing, and oncogenesis. Assembly of FN matrix fibrils requires FN domains that mediate interactions with integrin receptors and with other FN molecules. In addition, regulation of FN matrix assembly depends on the first two FN type III modules, III1 and III2, which harbor FN-binding sites. We propose that interactions between these two modules sequester FN-binding sites in soluble FN and that these sites become exposed by FN conformational changes during assembly. To test the idea that III1-2 has a compact conformation, we constructed CIIIY, a conformational sensor of III1-2 based on fluorescent resonance energy transfer between cyan and yellow fluorescent proteins conjugated at its N and C termini. We demonstrate energy transfer in CIIIY and show that fluorescent resonance energy transfer was eliminated by proteolysis and by treatment with mild denaturants that disrupted intramolecular interactions between the two modules. We also show that mutations of key charged residues resulted in conformational changes that exposed binding sites for the N-terminal 70-kDa FN fragment. Collectively, these results support a conformation-dependent mechanism for the regulation of FN matrix assembly by III1-2.	[Karuri, Nancy W.; Lin, Zong; Rye, Hays S.; Schwarzbauer, Jean E.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Schwarzbauer, JE (corresponding author), Princeton Univ, Dept Mol Biol, 315 Schultz Lab, Princeton, NJ 08544 USA.	jschwarz@princeton.edu		Schwarzbauer, Jean/0000-0003-1012-7593; Rye, Hays/0000-0002-9420-3137	National Institutes of Health Grants [CA044627, GM065421]; New Jersey Center for Biomaterials [T32EB005583]; NATIONAL CANCER INSTITUTE [R01CA044627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Center for Biomaterials; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA044627 (to J.E.S.) and GM065421 (to H. S. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the New Jersey Center for Biomaterials through NIBIB Training Program Grant T32EB005583 from the National Institutes of Health.	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; ARGOS P, 1990, J MOL BIOL, V211, P943, DOI 10.1016/0022-2836(90)90085-Z; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; CAMPBELL ID, 1994, STRUCTURE, V2, P333, DOI 10.1016/S0969-2126(00)00034-4; CHERNOUSOV MA, 1987, FEBS LETT, V217, P124, DOI 10.1016/0014-5793(87)81255-3; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; EPE B, 1983, P NATL ACAD SCI-BIOL, V80, P2579, DOI 10.1073/pnas.80.9.2579; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Ghosh K, 2006, TISSUE ENG, V12, P601, DOI 10.1089/ten.2006.12.601; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Honest H, 2002, BMJ-BRIT MED J, V325, P301, DOI 10.1136/bmj.325.7359.301; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; KHAN MY, 1990, BIOCHEM J, V270, P33, DOI 10.1042/bj2700033; Lakowicz J, 2006, PRINCIPLES FLUORESCE, DOI [DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4]; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Miyawaki A, 2003, NAT CELL BIOL, pS1, DOI 10.1038/ncb1031; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Prescott M, 1999, ANAL BIOCHEM, V273, P305, DOI 10.1006/abio.1999.4235; Santimaria M, 2003, CLIN CANCER RES, V9, P571; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsumoto K, 2003, BIOCHEM BIOPH RES CO, V312, P1383, DOI 10.1016/j.bbrc.2003.11.055; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Visser NV, 2002, FEBS LETT, V521, P31, DOI 10.1016/S0014-5793(02)02808-9; Zhang B, 2004, BIOCHEM BIOPH RES CO, V323, P674, DOI 10.1016/j.bbrc.2004.08.143; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	32	21	21	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3445	3452		10.1074/jbc.M805025200	http://dx.doi.org/10.1074/jbc.M805025200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19064996	Green Published, hybrid			2022-12-25	WOS:000262872500010
J	Connors, SK; Balusu, R; Kundu, CN; Jaiswal, AS; Gairola, CG; Narayan, S				Connors, S. K.; Balusu, R.; Kundu, C. N.; Jaiswal, A. S.; Gairola, C. G.; Narayan, S.			C/EBP beta-mediated transcriptional regulation of bcl-xl gene expression in human breast epithelial cells in response to cigarette smoke condensate	ONCOGENE			English	Article						cigarette smoke condensate; bcl-xl; C/EBP beta; gene regulation; breast carcinogenesis	MOUSE MAMMARY-GLAND; CANCER-CELLS; TOBACCO-SMOKE; NULL ASSOCIATION; ACTIVE SMOKING; PROTEIN; APOPTOSIS; BCL-X(L); RISK; OVEREXPRESSION	In earlier studies, we have shown that cigarette smoke condensate (CSC), a surrogate for cigarette smoke, is capable of transforming the spontaneously immortalized human breast epithelial cell line, MCF10A. These transformed cells displayed upregulation of the antiapoptotic gene, bcl-xl. Upregulation of this gene may impede the apoptotic pathway and allow the accumulation of DNA damage that can lead to cell transformation and carcinogenesis. In the present study, we have determined the mechanism of CSC-mediated transcriptional upregulation of bcl-xl gene expression in MCF10A cells. We cloned the human bcl-xl promoter (pBcl-xLP) and identified putative transcription factor binding sites. Sequential deletion constructs that removed the putative cis-elements were constructed and transfected into MCF10A cells to determine the CSC-responsive cis-element(s) on the pBcl-xLP. Gel-shift, super-shift and chromatin immunoprecipitation analysis confirmed that CCAAT/enhancer-binding protein (C/EBP beta) specifically bound to a C/EBP-binding site on the pBcl-xLP in vitro and in vivo. Additionally, overexpression of C/EBP beta-LAP2 stimulated pBcl-xLP activity and Bcl-xL protein levels, which mimicked the conditions of CSC treatment. Our results indicate that C/EBP beta regulates bcl-xl gene expression in MCF10A cells in response to CSC treatment; therefore, making it a potential target for chemotherapeutic intervention of cigarette smoke-induced breast carcinogenesis.	[Connors, S. K.; Balusu, R.; Kundu, C. N.; Jaiswal, A. S.; Narayan, S.] Univ Florida, UF Shands Canc Ctr, Gainesville, FL 32610 USA; [Connors, S. K.; Balusu, R.; Kundu, C. N.; Jaiswal, A. S.; Narayan, S.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Gairola, C. G.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Kentucky	Narayan, S (corresponding author), Univ Florida, UF Shands Canc Ctr, Canc & Genet Res Complex,Room 255,POB 103633,1376, Gainesville, FL 32610 USA.	snarayan@ufl.edu		Kundu, Chanakya/0000-0003-0297-1030	NCI-NIH [CA-100247]; Flight Attendant Medical Research Institute; University Florida Shands Cancer Center; NATIONAL CANCER INSTITUTE [R01CA100247] Funding Source: NIH RePORTER	NCI-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Flight Attendant Medical Research Institute; University Florida Shands Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Michael Kilberg from the University of Florida for the gift of the C/EBP beta overexpression constructs. The financial support for these studies was provided by the Grants from NCI-NIH (CA-100247) and Flight Attendant Medical Research Institute to Satya Narayan, and T32-Training Grant in Cancer Biology from University Florida Shands Cancer Center to Shahnjayla K Connors.	Bennett WP, 1999, JNCI-J NATL CANCER I, V91, P2009, DOI 10.1093/jnci/91.23.2009; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bundy L, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-43; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; CherbonnelLasserre C, 1996, ONCOGENE, V13, P1489; DATTA R, 1995, CELL GROWTH DIFFER, V6, P363; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; ELBAYOUMY K, 1995, CARCINOGENESIS, V16, P431, DOI 10.1093/carcin/16.2.431; Espana L, 2004, BREAST CANCER RES TR, V87, P33, DOI 10.1023/B:BREA.0000041579.51902.89; Feng G, 2001, CANCER RES, V61, P7999; Fernandez Y, 2002, INT J CANCER, V101, P317, DOI 10.1002/ijc.10628; Fink AK, 2003, CANCER CAUSE CONTROL, V14, P497, DOI 10.1023/A:1024922824237; Gigliotti AP, 2003, EXP BIOL MED, V228, P278, DOI 10.1177/153537020322800306; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hecht SS, 2002, ENVIRON MOL MUTAGEN, V39, P119, DOI 10.1002/em.10071; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; HSU TC, 1991, MUTAT RES, V259, P67, DOI 10.1016/0165-1218(91)90110-8; Jaiswal AS, 2006, CARCINOGENESIS, V27, P252, DOI 10.1093/carcin/bgi225; Johnson KC, 2005, INT J CANCER, V117, P619, DOI 10.1002/ijc.21150; KUMAR R, 1990, ONCOGENE, V5, P1271; Kundu CN, 2007, ONCOGENE, V26, P1428, DOI 10.1038/sj.onc.1209925; Lash TL, 2002, BREAST CANCER RES TR, V75, P181, DOI 10.1023/A:1019625102365; Mendez O, 2005, CLIN EXP METASTAS, V22, P297, DOI 10.1007/s10585-005-8751-x; Mendez O, 2001, BREAST CANCER RES TR, V65, P171, DOI 10.1023/A:1006490622103; Mendez O, 2006, CARCINOGENESIS, V27, P1169, DOI 10.1093/carcin/bgi363; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; Nagata C, 2006, JPN J CLIN ONCOL, V36, P387, DOI 10.1093/jjco/hyl031; Narayan S, 1997, J BIOL CHEM, V272, P30619, DOI 10.1074/jbc.272.49.30619; Narayan S, 2004, ONCOGENE, V23, P5880, DOI 10.1038/sj.onc.1207792; Olopade OI, 1997, CANCER J SCI AM, V3, P230; PERERA FP, 1995, CANCER EPIDEM BIOMAR, V4, P233; PETRAKIS NL, 1978, SCIENCE, V199, P303, DOI 10.1126/science.619458; Reynolds P, 2004, JNCI-J NATL CANCER I, V96, P29, DOI 10.1093/jnci/djh002; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Rubio N, 2001, LAB INVEST, V81, P725, DOI 10.1038/labinvest.3780281; Sabatakos G, 1998, BIOCHEM J, V334, P205, DOI 10.1042/bj3340205; SCHOTT AF, 1995, ONCOGENE, V11, P1389; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sevilla L, 1999, MOL CELL BIOL, V19, P2624; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Simonian PL, 1997, BLOOD, V90, P1208, DOI 10.1182/blood.V90.3.1208.1208_1208_1216; SOULE HD, 1990, CANCER RES, V50, P6075; Stabbert R, 2003, J APPL TOXICOL, V23, P329, DOI 10.1002/jat.924; TAIT L, 1990, CANCER RES, V50, P6087; WELLS AJ, 2000, J WOMENS CANC, V2, P55; Zahnow CA, 2002, BREAST CANCER RES, V4, P109, DOI 10.1186/bcr428; [No title captured]; [No title captured]	51	13	13	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					921	932		10.1038/onc.2008.429	http://dx.doi.org/10.1038/onc.2008.429			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19043455	Green Accepted			2022-12-25	WOS:000263320000014
J	Hoyos, JM; Ferraro, A; Sacchetti, S; Keller, S; De Martino, I; Borbone, E; Pallante, P; Fedele, M; Montanaro, D; Esposito, F; Cserjesi, P; Chiariotti, L; Troncone, G; Fusco, A				Hoyos, J. Martinez; Ferraro, A.; Sacchetti, S.; Keller, S.; De Martino, I.; Borbone, E.; Pallante, P.; Fedele, M.; Montanaro, D.; Esposito, F.; Cserjesi, P.; Chiariotti, L.; Troncone, G.; Fusco, A.			HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas	ONCOGENE			English	Article						HMGA1; HAND1; knockout mice; ES cells; thyroid carcinomas	TRANSCRIPTION FACTOR; HMGA1 PROTEINS; IDENTIFICATION; CANCERS; REQUIRES; MICE	HMGA1 proteins exert their major physiological function during embryonic development and play a critical role in neoplastic transformation. Here, we show that Hand1 gene, which codes for a transcription factor crucial for differentiation of trophoblast giant cells and heart development, is upregulated in hmga1 minus embryonic stem cells. We demonstrate that HMGA1 proteins bind directly to Hand1 promoter both in vitro and in vivo and inhibit Hand1 promoter activity. We have also investigated HAND1 expression in human thyroid carcinoma cell lines and tissues, in which HMGA proteins are overexpressed, with respect to normal thyroid; an inverse correlation between HMGA1 and HAND1 expression was found in all thyroid tumor histotypes. A correlation between HAND1 gene repression and promoter hypermethylation was found in anaplastic carcinomas but not in other thyroid tumor histotypes. Therefore, we can hypothesize that HMGA1 overexpression plays a key role on HAND1 silencing in differentiated thyroid carcinomas and that promoter hypermethylation occurs in later stages of thyroid tumor progression. Finally, the restoration of the HAND1 gene expression reduces the clonogenic ability of two human thyroid carcinoma-derived cell lines, suggesting that HAND1 downregulation may have a role in the process of thyroid carcinogenesis.	[Hoyos, J. Martinez; Keller, S.; De Martino, I.; Fedele, M.; Esposito, F.; Chiariotti, L.; Fusco, A.] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Ist Endocrinol & Oncol Sperimentale, CNR,Fac Med & Chirurg Napoli, I-80131 Naples, Italy; [Hoyos, J. Martinez; Ferraro, A.; Sacchetti, S.; Keller, S.; De Martino, I.; Borbone, E.; Pallante, P.; Montanaro, D.; Chiariotti, L.; Fusco, A.] CEINGE Biotecn Avanzate, NOGEC, Naples, Italy; [Cserjesi, P.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Troncone, G.] Univ Naples Federico II, Dipartimento Anat Patol & Citopatol, Fac Med & Chirurg, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; CEINGE Biotecnologie Avanzate; Tulane University; University of Naples Federico II	Fusco, A (corresponding author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Ist Endocrinol & Oncol Sperimentale, CNR,Fac Med & Chirurg Napoli, Via Pansini 5, I-80131 Naples, Italy.	afusco@napoli.com	ESPOSITO, FRANCESCO/AAX-2044-2020; Ferraro, Angelo/A-4172-2014; Fedele, Monica/C-1417-2015; Chiariotti, Lorenzo/AAC-5262-2022; Esposito, Francesco/J-9136-2016; Ferraro, Angelo/H-3193-2019; Pallante, Pierlorenzo/AAX-8758-2020	Ferraro, Angelo/0000-0002-2044-7569; Fedele, Monica/0000-0002-9171-1312; Esposito, Francesco/0000-0002-7709-5736; Ferraro, Angelo/0000-0002-2044-7569; CHIARIOTTI, Lorenzo/0000-0001-6097-4171; Fusco, Alfredo/0000-0003-3332-5197; Martinez Hoyos, Josefina/0000-0002-6909-8259	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MIUR); NOGEC-Naples Oncogenomic Center; Associazione Partenopea per le Ricerche Oncologiche (APRO)	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MIUR)(Ministry of Education, Universities and Research (MIUR)); NOGEC-Naples Oncogenomic Center; Associazione Partenopea per le Ricerche Oncologiche (APRO)	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC), and the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MIUR). This work was supported from NOGEC-Naples Oncogenomic Center. We thank the Associazione Partenopea per le Ricerche Oncologiche (APRO) for its support. We thank Gabriella Sole, INN-CNR of Cagliari, for statistical analysis.	Baldassarre G, 2001, P NATL ACAD SCI USA, V98, P7970, DOI 10.1073/pnas.141224998; Battista S, 2003, FASEB J, V17, P1496, DOI 10.1096/fj.02-0977fje; Berlingieri MT, 2002, ONCOGENE, V21, P2971, DOI 10.1038/sj.onc.1205368; Chiappetta G, 1996, ONCOGENE, V13, P2439; CROSS JC, 1995, DEVELOPMENT, V121, P2513; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; Donato G, 2004, ONCOL REP, V11, P1209; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Fedele M, 2001, CARCINOGENESIS, V22, P1583, DOI 10.1093/carcin/22.10.1583; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Hagihara A, 2004, ONCOGENE, V23, P8705, DOI 10.1038/sj.onc.1207783; Hoyos JM, 2004, CANCER RES, V64, P5728, DOI 10.1158/0008-5472.CAN-04-1410; Kaneda A, 2002, CANCER RES, V62, P6645; Knofler M, 2002, BIOCHEM J, V361, P641, DOI 10.1042/0264-6021:3610641; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Ritter O, 1999, J CELL BIOCHEM, V74, P551, DOI 10.1002/(SICI)1097-4644(19990915)74:4<551::AID-JCB5>3.3.CO;2-0; Takada T, 2004, CANCER SCI, V95, P741, DOI 10.1111/j.1349-7006.2004.tb03255.x; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1	21	17	17	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					876	885		10.1038/onc.2008.438	http://dx.doi.org/10.1038/onc.2008.438			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19060921				2022-12-25	WOS:000263320000010
J	Dhawan, P; Weider, R; Christakos, S				Dhawan, Puneet; Weider, Robert; Christakos, Sylvia			CCAAT Enhancer-binding Protein alpha Is a Molecular Target of 1,25-Dihydroxyvitamin D-3 in MCF-7 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; C/EBP-ALPHA; D ANALOG; IN-VIVO; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; DOWN-REGULATION; REGULATORY ROLE; ONCOGENIC RAS; PROLIFERATION	Numerous studies have shown that the active form of vitamin D, 1,25(OH)(2)D-3, can exert growth inhibitory effects on human breast cancer cells and mammary tumor growth. However, the molecular mechanisms remain to be fully delineated. This study demonstrates for the first time that CCAAT enhancer-binding protein alpha(C/EBP alpha), a member of the C/EBP family of transcription factors, is induced by 1,25(OH)(2)D-3 and is a potent enhancer of VDR transcription in MCF-7 breast cancer cells. 1,25(OH)(2)D-3 was found to induce C/EBP alpha as well as VDR expression in MCF-7 cells. C/EBP alpha was not detected in MDA-MB-231 cells that are poorly responsive to 1,25(OH)(2)D-3. Antiproliferative effects of 1,25(OH)(2)D-3 and induction of VDR were observed in MDA-MB-231 cells transfected with C/EBP alpha, and knockdown of C/EBP alpha suppressed VDR and antiproliferative effects of 1,25(OH)(2)D-3 in MCF-7 cells. Transfection of C/EBP alpha in MCF-7 cells resulted in a dose-dependent enhancement of hVDR transcription. Our studies show that C/EBP alpha can bind to Brahma (Brm), an ATPase that is a component of the SWI/SNF complex, and cooperate with Brm in the regulation of hVDR transcription in MCF-7 cells. Because the levels of VDR in MCF-7 breast cancer cells correlate with the antiproliferative effects of 1,25(OH)(2)D-3 and because C/EBP alpha has been suggested as a potential tumor suppressor in breast cancer, these findings provide important mechanisms whereby 1,25(OH)(2)D-3 may act to inhibit growth of breast cancer cells. These findings also identify C/EBP alpha as a 1,25(OH)(2)D-3 target in breast cancer cells and provide evidence for C/EBP alpha as a candidate for breast cancer treatment.	[Dhawan, Puneet; Christakos, Sylvia] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Weider, Robert] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Christakos, S (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, 185 S Orange Ave, Newark, NJ 07103 USA.	christak@umdnj.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038961] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 38961, R01 DK038961-22, R01 DK038961] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABE J, 1991, ENDOCRINOLOGY, V129, P832, DOI 10.1210/endo-129-2-832; ANZANO MA, 1994, CANCER RES, V54, P1653; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng JW, 2007, J BIOL CHEM, V282, P30535, DOI 10.1074/jbc.M704829200; CHOUVET C, 1986, J STEROID BIOCHEM, V24, P373, DOI 10.1016/0022-4731(86)90085-3; Christakos S, 2003, J CELL BIOCHEM, V88, P695, DOI 10.1002/jcb.10423; COLSTON KW, 1992, BIOCHEM PHARMACOL, V44, P2273, DOI 10.1016/0006-2952(92)90669-A; COLSTON KW, 1989, LANCET, V1, P188; COLSTON KW, 1992, BIOCHEM PHARMACOL, V44, P693, DOI 10.1016/0006-2952(92)90405-8; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Dhawan P, 2005, MOL CELL BIOL, V25, P472, DOI 10.1128/MCB.25.1.472-487.2005; ELSTNER E, 1995, CANCER RES, V55, P2822; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Gery S, 2005, CLIN CANCER RES, V11, P3184, DOI 10.1158/1078-0432.CCR-04-2625; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Halmos B, 2002, CANCER RES, V62, P528; Hanson RW, 1998, J BIOL CHEM, V273, P28543, DOI 10.1074/jbc.273.44.28543; Huening M, 2002, MOL ENDOCRINOL, V16, P2052, DOI 10.1210/me.2001-0260; JACOBSON EA, 1989, CANCER RES, V49, P6300; JAMES SY, 1994, J ENDOCRINOL, V141, P555, DOI 10.1677/joe.0.1410555; Janowsky EC, 1999, PUBLIC HEALTH NUTR, V2, P283, DOI 10.1017/S1368980099000385; Kim JW, 2007, BIOCHEM BIOPH RES CO, V354, P517, DOI 10.1016/j.bbrc.2007.01.008; Lee TH, 2001, PHYSIOL GENOMICS, V7, P187, DOI 10.1152/physiolgenomics.00046.2001; Liu Y, 2005, J BONE MINER RES, V20, P1680, DOI 10.1359/JBMR.050410; Maurer U, 2001, J BIOL CHEM, V276, P3727, DOI 10.1074/jbc.M005292200; Mawer EB, 1997, J CLIN ENDOCR METAB, V82, P118, DOI 10.1210/jc.82.1.118; Mehta R, 2000, JNCI-J NATL CANCER I, V92, P1836, DOI 10.1093/jnci/92.22.1836; Menendez-Hurtado A, 2000, ENDOCRINOLOGY, V141, P4164, DOI 10.1210/en.141.11.4164; Miyamoto K, 1997, MOL ENDOCRINOL, V11, P1165, DOI 10.1210/me.11.8.1165; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ramos RA, 1996, MOL CELL BIOL, V16, P5288; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Shim M, 2005, CANCER RES, V65, P861; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; Stoica A, 1999, J CELL BIOCHEM, V75, P640, DOI 10.1002/(SICI)1097-4644(19991215)75:4<640::AID-JCB10>3.3.CO;2-#; Swami S, 2003, BREAST CANCER RES TR, V80, P49, DOI 10.1023/A:1024487118457; Swami S, 2000, CLIN CANCER RES, V6, P3371; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wang Q, 2000, CANCER RES, V60, P2040; Wang Q, 2001, BREAST CANCER RES TR, V67, P157, DOI 10.1023/A:1010643323268; Welsh JE, 2003, J NUTR, V133, p2425S, DOI 10.1093/jn/133.7.2425S; Wietzke JA, 2005, MOL CELL ENDOCRINOL, V230, P59, DOI 10.1016/j.mce.2004.11.001; Wilson HL, 2002, MOL CELL ENDOCRINOL, V188, P15, DOI 10.1016/S0303-7207(01)00754-7; Xu L, 2001, CANCER RES, V61, P3176; Zella LA, 2007, J STEROID BIOCHEM, V103, P435, DOI 10.1016/j.jsbmb.2006.12.019; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhong Y, 2006, J BONE MINER RES, V21, pS120; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zierold C, 2007, ARCH BIOCHEM BIOPHYS, V460, P233, DOI 10.1016/j.abb.2006.11.028; Zinser GM, 2005, J STEROID BIOCHEM, V97, P153, DOI 10.1016/j.jsbmb.2005.06.024; Zinser GM, 2003, MOL CELL ENDOCRINOL, V200, P67, DOI 10.1016/S0303-7207(02)00416-1	65	29	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3086	3095		10.1074/jbc.M803602200	http://dx.doi.org/10.1074/jbc.M803602200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054766	hybrid, Green Published			2022-12-25	WOS:000262700900053
J	Gimenez-Cassina, A; Lim, F; Cerrato, T; Palomo, GM; Diaz-Nido, J				Gimenez-Cassina, Alfredo; Lim, Filip; Cerrato, Toni; Palomo, Gloria M.; Diaz-Nido, Javier			Mitochondrial Hexokinase II Promotes Neuronal Survival and Acts Downstream of Glycogen Synthase Kinase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; APOPTOTIC CELL-DEATH; PARKINSONS-DISEASE; ENERGY-METABOLISM; GLUCOSE-METABOLISM; ROTENONE MODELS; MELANOMA-CELLS; GENE-TRANSFER; COMPLEX-I; LITHIUM	Mitochondrial alterations are detected in most neurodegenerative disorders and may contribute to the dysfunction and demise of neuronal cells. Because glycogen synthase kinase-3 (GSK-3) is considered to be a critical factor in regulating neuronal cell survival and death, we studied the effects of modulating GSK-3 activity in cultured neurons treated with the mitochondrial inhibitor, rotenone. Interestingly, chronic inhibition of GSK-3 protects against rotenone-induced apoptosis in cultured neuronal cells. In an attempt to elucidate the molecular mechanisms underlying this neuroprotection, we demonstrated that chronic inhibition of GSK-3 reprograms the metabolism of neuronal cells, leading to an enhancement of glycolysis. This effect was accompanied by the induction and accumulation of hexokinase II (HKII) in the mitochondria. Interfering with either the mitochondrial binding of HKII or HKII expression significantly diminished the neuroprotection evoked by GSK-3 inhibition, and importantly, HKII overexpression is sufficient to protect against rotenone-induced cell death. Thus, mitochondrial HKII is a promoter of neuronal survival under the regulation of GSK-3. Furthermore, the neuroprotective effect of HKII may be relevant to neurodegenerative diseases in which glucose hypometabolism and mitochondrial dysfunction are prominent features.	[Gimenez-Cassina, Alfredo; Lim, Filip; Cerrato, Toni; Palomo, Gloria M.; Diaz-Nido, Javier] Univ Autonoma Madrid, CSIC, Dept Biol Mol, E-28049 Madrid, Spain; [Gimenez-Cassina, Alfredo; Lim, Filip; Cerrato, Toni; Palomo, Gloria M.; Diaz-Nido, Javier] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Diaz-Nido, J (corresponding author), Univ Autonoma Madrid, CSIC, Dept Biol Mol, Campus Cantoblanco, E-28049 Madrid, Spain.	javier.diaznido@uam.es	Gimenez-Cassina, Alfredo/AAA-6550-2019; Lim, Filip/C-7412-2011; Avila, Jesus/I-2610-2015; Diaz-Nido, Javier/L-2371-2013	Lim, Filip/0000-0001-6570-1017; Avila, Jesus/0000-0002-6288-0571; Diaz-Nido, Javier/0000-0002-0927-7925; Gimenez-Cassina, Alfredo/0000-0002-2768-2350	Spanish Ministry of Education and Science [SAF 2003-06782, SAF2006-12782-C03-02]; Autonomous Government of Madrid (Comunidad Autonoma de Madrid, CAM) [S-SAL-0202-2006]; Instituto de Salud Carlos III	Spanish Ministry of Education and Science(Spanish Government); Autonomous Government of Madrid (Comunidad Autonoma de Madrid, CAM)(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported in part by the Spanish Ministry of Education and Science (Grants SAF 2003-06782 and SAF2006-12782-C03-02) and the Autonomous Government of Madrid (Comunidad Autonoma de Madrid, CAM) through the NEURODEGMODELS project S-SAL-0202-2006. The Centre for Biomedical Research on Rare Diseases (Centro de Investigacion Biomedica en Red sobre Enfermedades Raras) is an initiative supported by the Instituto de Salud Carlos III. The authors declare no conflicts of interest. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; ADAMS V, 1988, BIOCHIM BIOPHYS ACTA, V932, P195, DOI 10.1016/0005-2728(88)90156-9; Alvarez G, 1999, FEBS LETT, V453, P260, DOI 10.1016/S0014-5793(99)00685-7; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Basselin M, 2006, PSYCHOPHARMACOLOGY, V187, P303, DOI 10.1007/s00213-006-0425-0; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; BLASS JP, 1988, REV NEUROL, V144, P543; Bovia F, 2003, BLOOD, V101, P1727, DOI 10.1182/blood-2001-12-0249; BUTTERFIELD PG, 1993, NEUROLOGY, V43, P1150, DOI 10.1212/WNL.43.6.1150; CHI MMY, 1987, ANAL BIOCHEM, V161, P508, DOI 10.1016/0003-2697(87)90481-7; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Facci L, 2003, NEUROREPORT, V14, P1467, DOI 10.1097/00001756-200308060-00012; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GELLER AI, 1988, SCIENCE, V241, P1667, DOI 10.1126/science.2843986; Giasson BI, 2000, NAT NEUROSCI, V3, P1227, DOI 10.1038/81737; Gimenez-Cassina A, 2007, NEUROCHEM INT, V50, P181, DOI 10.1016/j.neuint.2006.08.003; Gimenez-Cassina A, 2006, J NEUROSCI RES, V84, P755, DOI 10.1002/jnr.20976; GolshaniHebroni SG, 1997, J BIOENERG BIOMEMBR, V29, P331, DOI 10.1023/A:1022442629543; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; IWANGOFF P, 1980, MECH AGEING DEV, V14, P203, DOI 10.1016/0047-6374(80)90120-7; King TD, 2001, BRAIN RES, V919, P106, DOI 10.1016/S0006-8993(01)03005-0; King TD, 2005, NEUROREPORT, V16, P597, DOI 10.1097/00001756-200504250-00016; Kivell BM, 2000, DEV BRAIN RES, V120, P199, DOI 10.1016/S0165-3806(00)00010-9; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Li J, 2005, J NEUROCHEM, V92, P462, DOI 10.1111/j.1471-4159.2004.02872.x; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; LIGURI G, 1990, NEUROSCI LETT, V112, P338, DOI 10.1016/0304-3940(90)90227-Z; Lim F, 1996, BIOTECHNIQUES, V20, P460; Lim F, 1997, Methods Mol Biol, V62, P223; Lim F, 2007, MOL THER, V15, P1072, DOI 10.1038/sj.mt.6300143; LINDAHL PE, 1961, EXP CELL RES, V23, P228, DOI 10.1016/0014-4827(61)90033-7; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Merlo-Pich M, 2004, EXP GERONTOL, V39, P277, DOI 10.1016/j.exger.2003.11.014; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Munoz-Montano Juan Ramon, 1999, J Alzheimers Dis, V1, P361; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Penso J, 2003, MOL GENET METAB, V78, P74, DOI 10.1016/S1096-7192(02)00203-2; Penso J, 1998, EUR J PHARMACOL, V342, P113, DOI 10.1016/S0014-2999(97)01507-0; Perez M, 2003, BIOCHEM J, V372, P129, DOI 10.1042/BJ20021596; PLENGE P, 1976, INT PHARMACOPSYCHIAT, V11, P84, DOI 10.1159/000468216; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Sanchez S, 2001, J NEUROCHEM, V78, P468, DOI 10.1046/j.1471-4159.2001.00453.x; Saravanan KS, 2005, BRAIN RES, V1049, P147, DOI 10.1016/j.brainres.2005.04.051; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; ZHAN QM, 1994, ONCOGENE, V9, P3743; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	70	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3001	3011		10.1074/jbc.M808698200	http://dx.doi.org/10.1074/jbc.M808698200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19033437	hybrid			2022-12-25	WOS:000262700900044
J	Seefeldt, T; Zhao, Y; Chen, W; Raza, AS; Carlson, L; Herman, J; Stoebner, A; Hanson, S; Foll, R; Guan, XM				Seefeldt, Teresa; Zhao, Yong; Chen, Wei; Raza, Ashraf S.; Carlson, Laura; Herman, Jocqueline; Stoebner, Adam; Hanson, Sarah; Foll, Ryan; Guan, Xiangming			Characterization of a Novel Dithiocarbamate Glutathione Reductase Inhibitor and Its Use as a Tool to Modulate Intracellular Glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL REDOX STATE; OXIDATIVE STRESS; IN-VITRO; CRYSTALLOGRAPHIC ANALYSIS; SECONDARY ALCOHOLS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; PROTEIN-THIOLS; ACID; CELL	Thiol redox state (TRS) is an important parameter to reflect intracellular oxidative stress and is associated with various normal and abnormal biochemical processes. Agents that can be used to increase intracellular TRS will be valuable tools in TRS-related research. Glutathione reductase (GR) is a critical enzyme in the homeostasis of TRS. The enzyme catalyzes the reduction of GSSG to GSH to maintain a high GSH: GSSG ratio. Inhibition of the enzyme can be used to increase TRS. Despite the reports of various GR inhibitors, N,N-bis(2-chloroethyl)-N-nitrosourea, an anticancer drug with IC50 = 647 mu M against yeast GR, remains the most commonly used GR inhibitor in the literature. However, the toxicity caused by nonspecific interactions, as well as inhibition of DNA synthesis, complicates the use of N,N-bis(2-chloroethyl)-N-nitrosourea as a GR inhibitor. We report 2-acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylthiocarbonylamino)phenylthio-carbamoylsulfanyl]propionic acid (2-AAPA) as a novel irreversible GR inhibitor. 2-AAPA was prepared by one-step synthesis from commercially available reagents. The K-i and k(inact) of 2-AAPA against yeast GR were determined to be 56 mu M and 0.1 min(-1), respectively. At the concentration that produced >80% yeast GR inhibition, 2-APAA showed no inhibition against glutamylcysteine synthetase, glutathione synthetase, catalase, and superoxide dismutase, but minimal inhibition against glutathione S-transferase and glutathione peroxidase. In CV-1 cells, 2-AAPA (0.1 mM) produced 97% GR inhibition, 25% GSH reduction, and a 5-fold increase in GSSG in 20 min. The compound can be a useful tool in TRS-related research.	[Seefeldt, Teresa; Zhao, Yong; Chen, Wei; Carlson, Laura; Herman, Jocqueline; Stoebner, Adam; Hanson, Sarah; Foll, Ryan; Guan, Xiangming] S Dakota State Univ, Coll Pharm, Dept Pharmaceut Sci, Brookings, SD 57007 USA; [Raza, Ashraf S.] Covance Bioanalyt Serv LLC, Indianapolis, IN 46214 USA	South Dakota State University; Covance	Guan, XM (corresponding author), S Dakota State Univ, Coll Pharm, Dept Pharmaceut Sci, Box 2202C, Brookings, SD 57007 USA.	Xiangming.Guan@sdstate.edu	Raza, Faisal/AAG-4567-2021	Raza, Faisal/0000-0001-5569-3535; Zhao, Yong/0000-0003-3423-2718	National Institutes of Health [CA098810-01, CA120062-01]; American Foundation for Pharmaceutical Education Kappa Epsilon Nellie Wakeman first year graduate mentorship; F. Nelson undergraduate research mentorship awards; NATIONAL CANCER INSTITUTE [R15CA098810, R15CA120062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Pharmaceutical Education Kappa Epsilon Nellie Wakeman first year graduate mentorship; F. Nelson undergraduate research mentorship awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA098810-01 and CA120062-01. This work was also supported by 2005 Governor Rounds' individual research seed grant awards, an American Foundation for Pharmaceutical Education Kappa Epsilon Nellie Wakeman first year graduate mentorship (to T. S.), Joseph F. Nelson undergraduate research mentorship awards (to S. H., L. C., and A. S.), and a South Dakota EPSCoR Rushmore undergraduate research fellowship (to J.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arscott LD, 2000, BIOCHEMISTRY-US, V39, P4711, DOI 10.1021/bi9926431; Asmis R, 2005, FASEB J, V19, P1866, DOI 10.1096/fj.04-2991fje; Bauer H, 2006, J AM CHEM SOC, V128, P10784, DOI 10.1021/ja061155v; BECKER K, 1995, EUR J BIOCHEM, V234, P472, DOI 10.1111/j.1432-1033.1995.472_b.x; BECKER K, 1990, BIOCHEM PHARMACOL, V39, P59, DOI 10.1016/0006-2952(90)90648-5; Biot C, 2004, J MED CHEM, V47, P5972, DOI 10.1021/jm0497545; Bishop GM, 2007, FREE RADICAL BIO MED, V42, P1222, DOI 10.1016/j.freeradbiomed.2007.01.022; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Bizzozero OA, 2006, J NEUROSCI RES, V83, P656, DOI 10.1002/jnr.20771; Boese M, 1997, J BIOL CHEM, V272, P21767, DOI 10.1074/jbc.272.35.21767; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURRELL CJ, 1989, BRIT HEART J, V61, P4; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Cesaratto L, 2005, FREE RADICAL RES, V39, P255, DOI 10.1080/10715760400029603; Davioud-Charvet E, 2001, J MED CHEM, V44, P4268, DOI 10.1021/jm010268g; Deponte M, 2005, J BIOL CHEM, V280, P20628, DOI 10.1074/jbc.M412519200; Dursun E, 2005, J DIABETES COMPLICAT, V19, P142, DOI 10.1016/j.jdiacomp.2004.11.001; Erlemann KR, 2004, J BIOL CHEM, V279, P40376, DOI 10.1074/jbc.M401294200; Farber PM, 1998, FEBS LETT, V422, P311, DOI 10.1016/S0014-5793(98)00031-3; FERRARI R, 1990, CIRCULATION, V81, P201, DOI 10.1161/01.CIR.81.1.201; FITZGERALD GB, 1991, BIOCHEM PHARMACOL, V41, P185, DOI 10.1016/0006-2952(91)90475-K; Gallwitz H, 1999, J MED CHEM, V42, P364, DOI 10.1021/jm980471k; Ghezzi P, 2005, ANTIOXID REDOX SIGN, V7, P964, DOI 10.1089/ars.2005.7.964; Ghezzi P, 2005, BIOCHEM SOC T, V33, P1378, DOI 10.1042/BST0331378; Go YM, 2005, CIRCULATION, V111, P2973, DOI 10.1161/CIRCULATIONAHA.104.515155; Guan XM, 2002, DRUG METAB DISPOS, V30, P331, DOI 10.1124/dmd.30.3.331; Guan XM, 2003, J PHARMACEUT BIOMED, V31, P251, DOI 10.1016/S0731-7085(02)00594-0; Guan XM, 1999, CHEM RES TOXICOL, V12, P1138, DOI 10.1021/tx990086d; Han D, 2006, FREE RADICAL BIO MED, V41, P627, DOI 10.1016/j.freeradbiomed.2006.05.002; HINCHMAN CA, 1990, BIOCHEM PHARMACOL, V40, P1131, DOI 10.1016/0006-2952(90)90503-D; JOCHHEIM CM, 1994, BIOCHEM PHARMACOL, V47, P1197, DOI 10.1016/0006-2952(94)90392-1; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; KANN HE, 1980, CANCER RES, V40, P50; KARPLUS PA, 1988, EUR J BIOCHEM, V171, P193, DOI 10.1111/j.1432-1033.1988.tb13775.x; KASSAHUN K, 1994, BIOCHEM PHARMACOL, V48, P587, DOI 10.1016/0006-2952(94)90290-9; KITZ R, 1962, J BIOL CHEM, V237, P3245; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Linetsky M, 2003, INVEST OPHTH VIS SCI, V44, P3920, DOI 10.1167/iovs.03-0390; NARDI G, 1990, J CHROMATOGR-BIOMED, V530, P122, DOI 10.1016/S0378-4347(00)82310-5; Patsoukis N, 2005, ANAL BIOANAL CHEM, V383, P923, DOI 10.1007/s00216-005-0095-5; Patsoukis N, 2005, NEUROSCI LETT, V376, P24, DOI 10.1016/j.neulet.2004.11.019; Patsoukis N, 2004, ANAL BIOANAL CHEM, V378, P1783, DOI 10.1007/s00216-004-2525-1; Pullela PK, 2006, ANAL BIOCHEM, V352, P265, DOI 10.1016/j.ab.2006.01.047; REGLINSKI J, 1992, J MED CHEM, V35, P2134, DOI 10.1021/jm00089a026; Rigobello MP, 2005, ARCH BIOCHEM BIOPHYS, V441, P112, DOI 10.1016/j.abb.2005.07.007; Savvides SN, 1996, J BIOL CHEM, V271, P8101, DOI 10.1074/jbc.271.14.8101; Schirmer R. H., 1989, GLUTATHIONE CHEM B A, P553; SchonlebenJanas A, 1996, J MED CHEM, V39, P1549, DOI 10.1021/jm950511+; Seefeldt T, 2005, J MED CHEM, V48, P5224, DOI 10.1021/jm050030i; TSUNODA T, 1995, TETRAHEDRON LETT, V36, P2529, DOI 10.1016/0040-4039(95)00299-R; Tsunoda T, 1999, TETRAHEDRON LETT, V40, P7355, DOI 10.1016/S0040-4039(99)01509-9; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P1283, DOI 10.1161/ATVBAHA.107.144659; Yu J, 2007, PROTEINS, V68, P972, DOI 10.1002/prot.21354	54	44	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2729	2737		10.1074/jbc.M802683200	http://dx.doi.org/10.1074/jbc.M802683200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049979	hybrid, Green Published			2022-12-25	WOS:000262700900015
J	Vincke, C; Loris, R; Saerens, D; Martinez-Rodriguez, S; Muyldermans, S; Conrath, K				Vincke, Cecile; Loris, Remy; Saerens, Dirk; Martinez-Rodriguez, Sergio; Muyldermans, Serge; Conrath, Katja			General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-H DOMAIN; HEAVY-CHAIN ANTIBODIES; CRYSTAL-STRUCTURE; ANTIGEN-BINDING; PROTEIN STABILITY; VARIABLE DOMAINS; LIGHT-CHAINS; IN-VITRO; FRAGMENTS; VHH	Nanobodies, single-domain antigen-binding fragments of camelid-specific heavy-chain only antibodies offer special advantages in therapy over classic antibody fragments because of their smaller size, robustness, and preference to target unique epitopes. A Nanobody differs from a human heavy chain variable domain in about ten amino acids spread all over its surface, four hallmark Nanobody-specific amino acids in the framework-2 region ( positions 42, 49, 50, and 52), and a longer third antigen-binding loop (H3) folding over this area. For therapeutic applications the camelid-specific amino acid sequences in the framework have to be mutated to their human heavy chain variable domain equivalent, i.e. humanized. We performed this humanization exercise with Nanobodies of the subfamily that represents close to 80% of all dromedary-derived Nanobodies and investigated the effects on antigen affinity, solubility, expression yield, and stability. It is demonstrated that the humanization of Nanobody-specific residues outside framework-2 are neutral to the Nanobody properties. Surprisingly, the Glu-49 -> Gly and Arg-50 -> Leu humanization of hallmark amino acids generates a single domain that is more stable though probably less soluble. The other framework-2 substitutions, Phe-42 -> Val and Gly/Ala-52 -> Trp, are detrimental for antigen affinity, due to a repositioning of the H3 loop as shown by their crystal structures. These insights were used to identify a soluble, stable, well expressed universal humanized Nanobody scaffold that allows grafts of antigen-binding loops from other Nanobodies with transfer of the antigen specificity and affinity.	[Vincke, Cecile; Saerens, Dirk; Muyldermans, Serge; Conrath, Katja] Vrije Univ Brussel, Cellular & Mol Immunol Lab, B-1050 Brussels, Belgium; [Loris, Remy; Martinez-Rodriguez, Sergio] Vrije Univ Brussel, Ultrastrutture Lab, B-1050 Brussels, Belgium; [Vincke, Cecile; Loris, Remy; Saerens, Dirk; Martinez-Rodriguez, Sergio; Muyldermans, Serge; Conrath, Katja] Vlaams Inst Biotechnol, Dept Mol & Cellular Interact, Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Muyldermans, S (corresponding author), Vrije Univ Brussel, Cellular & Mol Immunol Lab, Pl Laan 2, B-1050 Brussels, Belgium.	svmuylde@vub.ac.be	Muyldermans, Serge V/C-6418-2016; Muyldermans, Serge/AAC-7374-2019; MARTINEZ-RODRIGUEZ, SERGIO/H-3448-2015; Saerens, Dirk/B-9162-2008; Loris, Remy/GPG-0894-2022; Vincke, Cecile/C-6590-2016	Muyldermans, Serge V/0000-0002-3678-3575; Muyldermans, Serge/0000-0002-3678-3575; MARTINEZ-RODRIGUEZ, SERGIO/0000-0001-6675-1550; Saerens, Dirk/0000-0001-8894-8039; Loris, Remy/0000-0002-8862-3338; Vincke, Cecile/0000-0003-0681-7444				Achour I, 2008, J IMMUNOL, V181, P2001, DOI 10.4049/jimmunol.181.3.2001; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen ZD, 1998, NUCLEIC ACIDS RES, V26, P1126, DOI 10.1093/nar/26.4.1126; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; da Silva FA, 2004, J MOL BIOL, V340, P525, DOI 10.1016/j.jmb.2004.04.062; Davies J, 1996, PROTEIN ENG, V9, P531, DOI 10.1093/protein/9.6.531; DAVIES J, 1994, FEBS LETT, V339, P285, DOI 10.1016/0014-5793(94)80432-X; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Huang L, 2005, BIOSENS BIOELECTRON, V21, P483, DOI 10.1016/j.bios.2004.11.016; Huang SC, 1996, MOL IMMUNOL, V33, P553, DOI 10.1016/0161-5890(95)00162-X; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; Jung S, 2001, J MOL BIOL, V309, P701, DOI 10.1006/jmbi.2001.4665; KELLIS JT, 1989, BIOCHEMISTRY-US, V28, P4914, DOI 10.1021/bi00437a058; Martin F, 1997, PROTEIN ENG, V10, P607, DOI 10.1093/protein/10.5.607; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Ohlin M, 1996, MOL IMMUNOL, V33, P583, DOI 10.1016/0161-5890(96)00018-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C N, 1986, Methods Enzymol, V131, P266; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; PADLAN EA, 1991, MOL IMMUNOL, V28, P489, DOI 10.1016/0161-5890(91)90163-E; Riechmann L, 1996, J MOL BIOL, V259, P957, DOI 10.1006/jmbi.1996.0373; ROGUSKA MA, 1994, P NATL ACAD SCI USA, V91, P969, DOI 10.1073/pnas.91.3.969; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; ROUSSEL A, 1989, SILICON GRAPHIC GEOM, P71; Royer C A, 1995, Methods Mol Biol, V40, P65; Saerens D, 2005, ANAL CHEM, V77, P7547, DOI 10.1021/ac051092j; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tanha J, 2002, J IMMUNOL METHODS, V263, P97, DOI 10.1016/S0022-1759(02)00027-3; Tanha J, 2001, J BIOL CHEM, V276, P24774, DOI 10.1074/jbc.M100770200; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7; Voordijk S, 2000, J MOL BIOL, V300, P963, DOI 10.1006/jmbi.2000.3890; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0	58	308	404	11	137	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3273	3284		10.1074/jbc.M806889200	http://dx.doi.org/10.1074/jbc.M806889200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19010777	hybrid			2022-12-25	WOS:000262700900070
J	Xu, LS; Komatsu, M				Xu, Lusheng; Komatsu, Masanobu			Promoter Cloning and Characterization of the Anti-vascular Proliferation Gene, R-ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETS TRANSCRIPTION FACTOR; GA-BINDING PROTEIN; ZINC-FINGER GENE; GROWTH-FACTOR; INTEGRIN ACTIVATION; SP1; EXPRESSION; ANGIOGENESIS; FAMILY; CELLS	The R-ras gene encodes a small GTPase of the ras family that is closely related to H-ras and K-ras. Unlike the prototypic ras genes, the disruption of the R-ras gene in mice results in enhanced angiogenesis in tumor implants and sustained neointimal hyperplasia in response to arterial injury, indicating the in vivo role of R-ras as a negative regulator of vascular proliferation. R-ras is abundantly expressed in normal mature blood vessels but significantly down-regulated in pathologically regenerating vasculature. In this study, we investigated the roles of cis-acting elements in the transcription of the human R-ras gene, as well as the transcription factors that interact with these sequences in cultured endothelial cells and arterial smooth muscle cells. The findings from vascular cells were then compared with findings from epithelial tumor cells that aberrantly express R-ras. Deletion analyses on 5 kb of 5'-flanking DNA of the human R-ras gene revealed the functional importance of the region between -727/-476, which contains two Ets and one Sp1 consensus binding motifs. Mutation analyses of various consensus binding motifs within this region suggest both cell type-dependent and -independent regulatory mechanisms for the R-ras gene transcription. Electrophoretic mobility shift and antibody disruption assays demonstrated that an Ets transcription factor family protein, GA-binding protein (GABP), binds to the R-ras-derived sequence. Chromatin immunoprecipitation analyses determined the association of endogenous GABP as well as Sp3 proteins with the -727/-476 region of the R-ras promoter in intact cells grown in culture. Forced expression of GABP significantly enhanced R-ras mRNA expression level in endothelial cells. These results map the functional elements in the R-ras promoter sequence and suggest that the GABP may be critical for transcription of R-ras and for maintenance of normal blood vessel functions through the regulation of this gene.	[Xu, Lusheng; Komatsu, Masanobu] Univ Alabama Birmingham, Div Mol & Cellular Pathol, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Komatsu, M (corresponding author), Burnham Inst Med Res Lake Nona, 8669 Commod Circle, Orlando, FL 32819 USA.	mkomatsu@burnham.org	Komatsu, Masanobu/AAV-3013-2020	Komatsu, Masanobu/0000-0001-7548-137X	American Heart Association [0665251B]; Department of Pathology, University of Alabama	American Heart Association(American Heart Association); Department of Pathology, University of Alabama	This work was supported by American Heart Association Grant 0665251B and departmental start-up funds provided by the Department of Pathology, University of Alabama at Birmingham. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; BOTTINGER EP, 1994, MOL CELL BIOL, V14, P2604; Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000; Chen ZQ, 1997, CANCER RES, V57, P2013; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; DENNIG J, 1995, J BIOL CHEM, V270, P12737, DOI 10.1074/jbc.270.21.12737; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Fromm L, 1998, J PHYSIOLOGY-PARIS, V92, P173, DOI 10.1016/S0928-4257(98)80005-3; Galvagni F, 2001, J MOL BIOL, V306, P985, DOI 10.1006/jmbi.2000.4335; Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223; Gyrd-Hansen M, 2002, J NEUROL SCI, V197, P27, DOI 10.1016/S0022-510X(02)00038-2; Hashiya N, 2004, CIRCULATION, V109, P3035, DOI 10.1161/01.CIR.0000130643.41587.DB; Hata Y, 1998, J BIOL CHEM, V273, P19294, DOI 10.1074/jbc.273.30.19294; HROMAS R, 1991, J BIOL CHEM, V266, P14183; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Iwasaka C, 1996, J CELL PHYSIOL, V169, P522, DOI 10.1002/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.3.CO;2-Q; Jiang P, 2002, J BIOL CHEM, V277, P8989, DOI 10.1074/jbc.M105682200; Juven-Gershon T, 2006, BIOCHEM SOC T, V34, P1047, DOI 10.1042/BST0341047; Kappel A, 2000, BLOOD, V96, P3078; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; Kappert K, 2001, BASIC RES CARDIOL, V96, P42, DOI 10.1007/s003950170076; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; LIU XW, 1993, NUCLEIC ACIDS RES, V21, P4954, DOI 10.1093/nar/21.21.4954; LOWE DG, 1987, CELL, V48, P137, DOI 10.1016/0092-8674(87)90364-3; LOWE DG, 1987, MOL CELL BIOL, V7, P2845, DOI 10.1128/MCB.7.8.2845; MORRIS JF, 1995, BLOOD, V86, P3640; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nickel J, 1995, NUCLEIC ACIDS RES, V23, P4785, DOI 10.1093/nar/23.23.4785; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; Nuchprayoon I, 1997, BLOOD, V89, P4546, DOI 10.1182/blood.V89.12.4546; Oertli B, 2000, ONCOGENE, V19, P4961, DOI 10.1038/sj.onc.1203876; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; Rao MK, 2002, J BIOL CHEM, V277, P26036, DOI 10.1074/jbc.M203374200; ROSEN GD, 1994, J BIOL CHEM, V269, P15652; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; ROSMARIN AG, 1995, J BIOL CHEM, V270, P23627, DOI 10.1074/jbc.270.40.23627; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; SADASIVAN E, 1994, J BIOL CHEM, V269, P4725; Sassa Y, 2004, DIABETES, V53, P1222, DOI 10.2337/diabetes.53.5.1222; Sato Y, 2001, ANN NY ACAD SCI, V947, P117; Sawa C, 1996, NUCLEIC ACIDS RES, V24, P4954, DOI 10.1093/nar/24.24.4954; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Sethi T, 1999, MOL BIOL CELL, V10, P1799, DOI 10.1091/mbc.10.6.1799; Sjottem E, 1996, J VIROL, V70, P188; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suzuki J, 1998, FEBS LETT, V437, P112, DOI 10.1016/S0014-5793(98)01213-7; Suzuki J, 2000, ONCOGENE, V19, P1138, DOI 10.1038/sj.onc.1203402; Tomita N, 2003, CIRCULATION, V107, P1411, DOI 10.1161/01.CIR.0000055331.41937.AA; WERNERT N, 1992, AM J PATHOL, V140, P119; Yasuda M, 1998, LIFE SCI, V64, P249, DOI 10.1016/S0024-3205(98)00560-8; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	55	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2706	2718		10.1074/jbc.M808184200	http://dx.doi.org/10.1074/jbc.M808184200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19011236	hybrid			2022-12-25	WOS:000262700900013
J	Zhang, Y; Hassan, MQ; Xie, RL; Hawse, JR; Spelsberg, TC; Montecino, M; Stein, JL; Lian, JB; van Wijnen, AJ; Stein, GS				Zhang, Ying; Hassan, Mohammad Q.; Xie, Rong-Lin; Hawse, John R.; Spelsberg, Thomas C.; Montecino, Martin; Stein, Janet L.; Lian, Jane B.; van Wijnen, Andre J.; Stein, Gary S.			Co-stimulation of the Bone-related Runx2 P1 Promoter in Mesenchymal Cells by SP1 and ETS Transcription Factors at Polymorphic Purine-rich DNA Sequences (Y-repeats)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; EMBRYONIC-DEVELOPMENT; REGULATED EXPRESSION; GENE-TRANSCRIPTION; CBFA1; DOMAIN; IDENTIFICATION; ACTIVATION	Transcriptional control of Runx2 gene expression through two alternative promoters (P1 and P2) is critical for the execution of its function as an osteogenic cell fate determining factor. In all vertebrates examined to date, the bone related P1 promoter contains a purine-rich region (-303 to -128 bp in the rat) that separates two regulatory domains. The length of this region differs dramatically between species even within the same order. Using deletion analysis, we show that part of this purine-rich region (-200 to -128) containing a duplicated element (Y-repeat) positively regulates Runx2 P1 transcription. Electrophoretic mobility assays and chromatin immunoprecipitations reveal that Y- repeat binds at least two different classes of transcription factors related to GC box binding proteins ( e. g. SP1 and SP7/Osterix) and ETS-like factors ( e. g. ETS1 and ELK1). Forced expression of SP1 increases Runx2 P1 promoter activity through the Y- repeats, and small interfering RNA depletion of SP1 decreases Runx2 expression. Similarly, exogenous expression of wild type ELK1, but not a defective mutant that cannot be phosphorylated, enhances Runx2 gene expression. SP1 is most abundant in proliferating cells, and ELK1 is most abundant in postconfluent cells; during MC3T3-E1 osteoblast differentiation, both proteins are transiently co-expressed when Runx2 expression is enhanced. Taken together, our data suggest that basal Runx2 gene transcription is regulated by dynamic interactions between SP1 and ETS-like factors during progression of osteogenesis.	[Zhang, Ying; Hassan, Mohammad Q.; Xie, Rong-Lin; Stein, Janet L.; Lian, Jane B.; van Wijnen, Andre J.; Stein, Gary S.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Zhang, Ying; Hassan, Mohammad Q.; Xie, Rong-Lin; Stein, Janet L.; Lian, Jane B.; van Wijnen, Andre J.; Stein, Gary S.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Hawse, John R.; Spelsberg, Thomas C.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Montecino, Martin] Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Mayo Clinic; Universidad de Concepcion	Stein, GS (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.	gary.stein@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019; Hassan, Mohammad/GZA-7507-2022; Zhang, Ying/B-5470-2010	van Wijnen, Andre J./0000-0002-4458-0946; Hassan, Mohammad/0000-0002-1712-0004; 	National Institutes of Health [R01 AR39588]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR39588. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aronson BD, 1997, MOL CELL BIOL, V17, P5581, DOI 10.1128/MCB.17.9.5581; Bae JS, 2007, J CELL BIOCHEM, V100, P434, DOI 10.1002/jcb.21039; Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Drissi H, 2002, J CELL BIOCHEM, V86, P403, DOI 10.1002/jcb.10238; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; Frank RN, 2003, INVEST OPHTH VIS SCI, V44, P1; Fujiwara M, 1999, BBA-GENE STRUCT EXPR, V1446, P265, DOI 10.1016/S0167-4781(99)00113-X; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ghozi MC, 1996, P NATL ACAD SCI USA, V93, P1935, DOI 10.1073/pnas.93.5.1935; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hovhannisyan H, 2004, J BONE MINER RES, V19, pS78; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Kahler RA, 2006, J CELL BIOCHEM, V97, P969, DOI 10.1002/jcb.20702; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kim YJ, 2006, GENE, V366, P145, DOI 10.1016/j.gene.2005.08.021; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; LOU Y, 2008, HUM MOL GEN IN PRESS; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Rini D, 2001, GENE, V273, P13, DOI 10.1016/S0378-1119(01)00579-0; Santiago FS, 2004, CIRC RES, V95, P479, DOI 10.1161/01.RES.0000141135.36279.67; Sato T, 2007, J BIOL CHEM, V282, P27702, DOI 10.1074/jbc.M611862200; Sears KE, 2007, EVOL DEV, V9, P555, DOI 10.1111/j.1525-142X.2007.00196.x; Stains JP, 2003, J BIOL CHEM, V278, P24377, DOI 10.1074/jbc.M212554200; Stewart M, 1997, P NATL ACAD SCI USA, V94, P8646, DOI 10.1073/pnas.94.16.8646; van Wijnen AJ, 2004, ONCOGENE, V23, P4209, DOI 10.1038/sj.onc.1207758; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Zambotti A, 2002, J BIOL CHEM, V277, P41497, DOI 10.1074/jbc.M204271200; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746	50	63	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3125	3135		10.1074/jbc.M807466200	http://dx.doi.org/10.1074/jbc.M807466200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19017640	Green Published, hybrid			2022-12-25	WOS:000262700900057
J	Carland, JE; Cooper, MA; Sugiharto, S; Jeong, HJ; Lewis, TM; Barry, PH; Peters, JA; Lambert, JJ; Moorhouse, AJ				Carland, Jane E.; Cooper, Michelle A.; Sugiharto, Silas; Jeong, Hyo-Jin; Lewis, Trevor M.; Barry, Peter H.; Peters, John A.; Lambert, Jeremy J.; Moorhouse, Andrew J.			Characterization of the Effects of Charged Residues in the Intracellular Loop on Ion Permeation in alpha 1 Glycine Receptor Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LARGE CYTOPLASMIC LOOP; 5-HT3 RECEPTOR; 5-HYDROXYTRYPTAMINE TYPE-3; ANGSTROM RESOLUTION; GATING MECHANISM; CONDUCTANCE; SUBUNIT; DETERMINANTS; SELECTIVITY	The Cys loop receptor channels mediate fast synaptic transmission in the nervous system. The M2-demarcated transmembrane pore is an important determinant of their ion permeation properties. Portals within the intracellular domain are also part of the permeation pathway in cationic Cys loop receptors, with charged residues in a helical MA stretch partially lining these openings profoundly affecting channel conductance. It is unknown whether analogous portals contribute to the permeation pathway in anionic Cys loop receptors. We therefore investigated the influence of charged residues within the proposed MA stretch on functional properties of the homomeric glycine alpha 1 receptor. Up to eight basic residues in the MA stretch were concurrently mutated to a negatively charged glutamate, and wild-type and mutant subunits were expressed in HEK-293 cells. Mutation of all eight residues produced a non-functional receptor. The greatest reduction in conductance at negative membrane potentials (from 92.2 +/- 2.8 to 60.0 +/- 2.2 picosiemens) was observed with glutamate present at the 377, 378, 385, and 386 positions (the 4E subunit). Inclusion of additional glutamate residues within this subunit did not decrease conductance further. Neutralizing these residues (the 4A subunit) caused a modest decrease in conductance (80.5 +/- 2.3 picosiemens). Outward conductance at positive potentials was not markedly affected. Anion to cation selectivity and concentration-response relationships were unaffected by the 4A or 4E mutations. Our results identify basic residues affecting conductance in the glycine receptor, suggesting that portals are part of the extended permeation pathway but that the M2-demarcated channel pore is the dominant determinant of permeation properties in glycine receptors.	[Carland, Jane E.; Cooper, Michelle A.; Peters, John A.; Lambert, Jeremy J.] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Neurosci, Div Mol & Translat Med, Dundee DD1 9SY, Scotland; [Carland, Jane E.; Sugiharto, Silas; Jeong, Hyo-Jin; Lewis, Trevor M.; Barry, Peter H.; Moorhouse, Andrew J.] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia	University of Dundee; University of New South Wales Sydney	Lambert, JJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Ctr Neurosci, Div Mol & Translat Med, Dundee DD1 9SY, Scotland.	j.j.lambert@dundee.ac.uk; moorhouse@unsw.edu.au	Moorhouse, Andrew J/B-8526-2011; Lewis, Trevor/A-2939-2011	Moorhouse, Andrew J/0000-0001-7957-2498; Lewis, Trevor/0000-0003-1864-6806; Carland, Jane/0000-0002-1456-876X	Wellcome Trust, Tenovus Scotland; Anonymous Trust; University of New South Wales (UNSW) Faculty Research	Wellcome Trust, Tenovus Scotland(Wellcome Trust); Anonymous Trust; University of New South Wales (UNSW) Faculty Research	This work was supported by grants from the Wellcome Trust, Tenovus Scotland, and the Anonymous Trust ( to J.A.P. and J.J.L.), and University of New South Wales (UNSW) Faculty Research Grants (A.J.M.).	Barry PH, 2005, IEEE T NANOBIOSCI, V4, P70, DOI 10.1109/TNB.2004.842497; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Brown AM, 1998, J PHYSIOL-LONDON, V507, P653, DOI 10.1111/j.1469-7793.1998.653bs.x; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; Gee VJ, 2007, BRIT J PHARMACOL, V152, P501, DOI 10.1038/sj.bjp.0707429; GRENNINGLOH G, 1987, NATURE, V330, P25, DOI 10.1038/330025b0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Kuo YP, 2005, J PHARMACOL EXP THER, V314, P455, DOI 10.1124/jpet.105.084954; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Moorhouse AJ, 2002, J GEN PHYSIOL, V119, P411, DOI 10.1085/jgp.20028553; Peters JA, 2006, BIOCHEM SOC T, V34, P882, DOI 10.1042/BST0340882; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; ROBINSON RA, 1965, ACTIVITY COEFFICIENT, P492; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 2000, J GEN PHYSIOL, V116, P449, DOI 10.1085/jgp.116.3.449; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	28	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2023	2030		10.1074/jbc.M806618200	http://dx.doi.org/10.1074/jbc.M806618200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19049967	hybrid			2022-12-25	WOS:000262545600009
J	Davydova, EK; Kaganman, I; Kazmierczak, KM; Rothman-Denes, LB				Davydova, Elena K.; Kaganman, Irene; Kazmierczak, Krystyna M.; Rothman-Denes, Lucia B.			Identification of Bacteriophage N4 Virion RNA Polymerase-Nucleic Acid Interactions in Transcription Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; PROMOTER RECOGNITION; ELONGATION COMPLEX; STRUCTURAL BASIS; INITIATION; HAIRPIN; PROCESSIVITY; DOMAIN	Bacteriophage N4 mini-virion RNA polymerase (mini-vRNAP), the 1106-amino acid transcriptionally active domain of vRNAP, recognizes single-stranded DNA template-containing promoters composed of conserved sequences and a 3-base loop-5-base pair stem hairpin structure. The major promoter recognition determinants are a purine located at the center of the hairpin loop (-11G) and a base at the hairpin stem (-8G). Mini-vRNAP is an evolutionarily highly diverged member of the T7 family of RNAPs. A two-plasmid system was developed to measure the in vivo activity of mutant mini-vRNAP enzymes. Five mini-vRNAP derivatives, each containing a pair of cysteine residues separated by similar to 100 amino acids and single cysteine-containing enzymes, were generated. These reagents were used to determine the smallest catalytically active polypeptide and to map promoter, substrate, and RNA-DNA hybrid contact sites to single amino acid residues in the enzyme by using end-labeled 5-iododeoxyuridine- and azidophenacyl-substituted oligonucleotides, cross-linkable derivatives of the initiating nucleotide, and RNA products with 5-iodouridine incorporated at specific positions. Localization of functionally important amino acid residues in the recently determined crystal structures of apo-mini-vRNAP and the mini-vRNAP-promoter complex and comparison with the crystal structures of the T7 RNAP initiation and elongation complexes allowed us to predict major rearrangements in mini-vRNAP in the transition from transcription initiation to elongation similar to those observed in T7 RNAP, a task otherwise precluded by the lack of sequence homology between N4 mini-vRNAP and T7 RNAP.	[Davydova, Elena K.; Kaganman, Irene; Kazmierczak, Krystyna M.; Rothman-Denes, Lucia B.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago	Rothman-Denes, LB (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St,CLSC 613, Chicago, IL 60637 USA.	lbrd@uchicago.edu			National Institutes of Health [AI12575]; United States Public Health Service [T32 GM07197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI012575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI12575 ( to L. B. R.-D.). This work was also supported in part by United States Public Health Service Grant T32 GM07197 ( to K. M. K.).	Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Choi KH, 2008, J MOL BIOL, V378, P726, DOI 10.1016/j.jmb.2008.02.059; Davydova EK, 2003, METHOD ENZYMOL, V370, P83; Davydova EK, 2003, P NATL ACAD SCI USA, V100, P9250, DOI 10.1073/pnas.1133325100; Davydova EK, 2007, P NATL ACAD SCI USA, V104, P7033, DOI 10.1073/pnas.0610627104; Gardner LP, 1997, BIOCHEMISTRY-US, V36, P2908, DOI 10.1021/bi962397i; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; GLUCKSMANN MA, 1992, CELL, V70, P491, DOI 10.1016/0092-8674(92)90173-A; GlucksmannKuis MA, 1996, CELL, V84, P147, DOI 10.1016/S0092-8674(00)81001-6; HAYNES LL, 1985, CELL, V41, P597, DOI 10.1016/S0092-8674(85)80032-5; Imburgio D, 2002, J MOL BIOL, V319, P37, DOI 10.1016/S0022-2836(02)00261-9; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kazmierczak KM, 2002, EMBO J, V21, P5815, DOI 10.1093/emboj/cdf584; Kennedy WP, 2007, J MOL BIOL, V370, P256, DOI 10.1016/j.jmb.2007.03.041; MAKSIMOVA TG, 1991, EUR J BIOCHEM, V195, P841, DOI 10.1111/j.1432-1033.1991.tb15773.x; MARKIEWICZ P, 1992, GENE DEV, V6, P2010, DOI 10.1101/gad.6.10.2010; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; MAYER AN, 1995, GENE, V153, P1, DOI 10.1016/0378-1119(94)00752-E; MOOKHTIAR KA, 1991, BIOCHEMISTRY-US, V30, P6305, DOI 10.1021/bi00239a032; Murakami KS, 2008, P NATL ACAD SCI USA, V105, P5046, DOI 10.1073/pnas.0712325105; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	23	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					1962	1970		10.1074/jbc.M807785200	http://dx.doi.org/10.1074/jbc.M807785200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19015264	Green Published, hybrid			2022-12-25	WOS:000262545600003
J	Gordon, LI; Burke, MA; Singh, ATK; Prachand, S; Lieberman, ED; Sun, L; Naik, TJ; Prasad, SVN; Ardehali, H				Gordon, Leo I.; Burke, Michael A.; Singh, Amareshwar T. K.; Prachand, Sheila; Lieberman, Elliot D.; Sun, Lin; Naik, Tejaswitha Jairaj; Prasad, Sathyamangla V. Naga; Ardehali, Hossein			Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; DILATED CARDIOMYOPATHY; TYROSINE KINASES; ACTIVATION; ONCOGENE; PROTEIN; DYSFUNCTION; INHIBITION; EXPRESSION; ALPHA	Overexpression of the receptor tyrosine kinase erbB2 (Her2 in humans) is correlated with a poor prognosis in breast and ovarian cancers. Treatment with trastuzumab ( a monoclonal antibody against erbB2) improves survival; however, it also causes cardiomyopathy. We hypothesized that blockade of the erbB2 receptor induces cardiomyocyte death through a mitochondrial pathway that is dependent on the production of reactive oxygen species (ROS). We first showed that levels of erbB2 receptor are significantly decreased in an animal model of ischemic heart disease and in human ischemic cardiomyopathy. We treated neonatal rat cardiomyocytes with an inhibitory erbB2 antibody to study the mechanism behind the deleterious effects of erbB2 blockade. These cells displayed a dose-dependent increase in ROS production and cell death compared with control IgG-treated cells; these processes were reversed by the antioxidant, N-acetylcysteine. The effects of erbB2 antibody on both cell death and ROS production were also reversed by cyclosporine A and diazoxide, chemicals that regulate the pro- and anti-apoptotic channels in the mitochondria, respectively. Furthermore, mouse embryonic fibroblasts lacking Bax and Bak ( proteins that mediate cell death through a mitochondrial pathway) were resistant to the deleterious effects of erbB2 antibody. These effects of erbB2 blockade appear to occur through a pathway involving AKT and PKC-alpha. Our results suggest that erbB2 plays a role in cardiomyocyte survival, and that the deleterious effects of trastuzumab on the heart occur through a mitochondrial pathway and is mediated by ROS production. Manipulation of redox signaling may be beneficial in cancer patients receiving trastuzumab.	[Gordon, Leo I.; Singh, Amareshwar T. K.; Prachand, Sheila; Lieberman, Elliot D.; Ardehali, Hossein] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA; [Burke, Michael A.; Sun, Lin; Naik, Tejaswitha Jairaj] Northwestern Univ, Div Cardiol, Dept Med, Chicago, IL 60611 USA; [Gordon, Leo I.; Singh, Amareshwar T. K.; Prachand, Sheila; Ardehali, Hossein] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Prasad, Sathyamangla V. Naga] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Cleveland Clinic Foundation	Ardehali, H (corresponding author), Tarry 12-725,303 E Chicago Ave, Chicago, IL 60611 USA.	h-ardehali@northwestern.edu	Burke, Michael/GSN-3331-2022	Burke, Michael/0000-0003-1491-1131; Gordon, Leo/0000-0003-1666-7064	National Institutes of Health [K08 HL079387, R01 HL087149]; Schweppe Foundation; American Heart Association; American Cancer Society, Illinois; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087149, K08HL079387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schweppe Foundation; American Heart Association(American Heart Association); American Cancer Society, Illinois(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 HL079387 and R01 HL087149. This work was also supported by the Schweppe Foundation, American Heart Association, and a grant from the American Cancer Society, Illinois Chapter ( to H. A.).	Ardehali H, 2005, CIRC RES, V97, P740, DOI 10.1161/01.RES.0000186277.12336.11; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; Di Carlo E, 1999, LAB INVEST, V79, P1261; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Grazette LP, 2004, J AM COLL CARDIOL, V44, P2231, DOI 10.1016/j.jacc.2004.08.066; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Keefe DL, 2002, CANCER-AM CANCER SOC, V95, P1592, DOI 10.1002/cncr.10854; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Timolati F, 2006, J MOL CELL CARDIOL, V41, P845, DOI 10.1016/j.yjmcc.2006.08.002; TOIKKANEN S, 1992, J CLIN ONCOL, V10, P1044, DOI 10.1200/JCO.1992.10.7.1044; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	22	134	140	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2080	2087		10.1074/jbc.M804570200	http://dx.doi.org/10.1074/jbc.M804570200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017630	hybrid, Green Published			2022-12-25	WOS:000262545600016
J	Martin, B; Brenneman, R; Golden, E; Walent, T; Becker, KG; Prabhu, VV; Wood, W; Ladenheim, B; Cadet, JL; Maudsley, S				Martin, Bronwen; Brenneman, Randall; Golden, Erin; Walent, Tom; Becker, Kevin G.; Prabhu, Vinayakumar V.; Wood, William, III; Ladenheim, Bruce; Cadet, Jean-Lud; Maudsley, Stuart			Growth Factor Signals in Neural Cells COHERENT PATTERNS OF INTERACTION CONTROL MULTIPLE LEVELS OF MOLECULAR AND PHENOTYPIC RESPONSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE SET ENRICHMENT; ALPHA-B-CRYSTALLIN; PHEOCHROMOCYTOMA CELLS; KINASE; ACTIVATION; EXPRESSION; SHC; SCAFFOLD; DIFFERENTIATION; PROTEINS	Individual neurons express receptors for several different growth factors that influence the survival, growth, neurotransmitter phenotype, and other properties of the cell. Although there has been considerable progress in elucidating the molecular signal transduction pathways and physiological responses of neurons and other cells to individual growth factors, little is known about if and how signals from different growth factors are integrated within a neuron. In this study, we determined the interactive effects of nerve growth factor, insulin-like growth factor 1, and epidermal growth factor on the activation status of downstream kinase cascades and transcription factors, cell survival, and neurotransmitter production in neural cells that express receptors for all three growth factors. We document considerable differences in the quality and quantity of intracellular signaling and eventual phenotypic responses that are dependent on whether cells are exposed to a single or multiple growth factors. Dual stimulations that generated the greatest antagonistic or synergistic actions, compared with a theoretically neutral summation of their two activities, yielded the largest eventual change of neuronal phenotype indicated by the ability of the cell to produce norepinephrine or resist oxidative stress. Combined activation of insulin-like growth factor 1 and epidermal growth factor receptors was particularly notable for antagonistic interactions at some levels of signal transduction and norepinephrine production, but potentiation at other levels of signaling and cytoprotection. Our findings suggest that in true physiological settings where multiple growth factors are present, activation of one receptor type may result in molecular and phenotypic responses that are different from that observed in typical experimental paradigms in which cells are exposed to only a single growth factor at a time.	[Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Neurosci Lab, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Ladenheim, Bruce; Cadet, Jean-Lud] Natl Inst Drug Abuse, Mol Psychiat Branch, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Maudsley, S (corresponding author), NIA, Receptor Pharmacol Unit, Neurosci Lab, Intramural Res Program,NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	maudsleyst@mail.nih.gov	Maudsley, Stuart/Q-4782-2019; Maudsley, Stuart/AAV-9929-2021	Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925; Becker, Kevin/0000-0002-6794-6656	National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000325, ZIAAG000318, ZIAAG000917, ZICAG000616, Z01AG000318, ZIAAG000916, Z01AG000616, Z01AG000325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000494, ZIADA000494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health (Intramural Research Program of the NIA). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blanquet PR, 1998, NEUROSCIENCE, V86, P739, DOI 10.1016/S0306-4522(98)00087-6; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Chao CC, 2006, NEUROBIOL AGING, V27, P105, DOI 10.1016/j.neurobiolaging.2005.01.009; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Che Y, 2001, J NEUROSCI RES, V65, P425, DOI 10.1002/jnr.1170; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Freeman RS, 2004, PROG BRAIN RES, V146, P111, DOI 10.1016/S0079-6123(03)46008-1; GARBER SS, 1989, J NEUROSCI, V9, P3976; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Groot M, 2000, EUR J CELL BIOL, V79, P924, DOI 10.1078/0171-9335-00126; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Kim SA, 2008, FEBS LETT, V582, P734, DOI 10.1016/j.febslet.2008.01.053; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; KRASNOVA IN, 1999, KLIN LAB DIAGN, V7, P11; Lee JH, 2004, J PHARMACOL EXP THER, V308, P896, DOI 10.1124/jpet.103.061853; LIU XQ, 1994, RECENT PROG HORM RES, V49, P149; Masilamoni JG, 2005, BRAIN RES BULL, V67, P235, DOI 10.1016/j.brainresbull.2005.07.002; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Maudsley S, 2007, MOL ENDOCRINOL, V21, P1216, DOI 10.1210/me.2006-0053; Maudsley S, 2007, CURR ALZHEIMER RES, V4, P3, DOI 10.2174/156720507779939850; Maudsley S, 2006, NEUROENDOCRINOLOGY, V84, P285, DOI 10.1159/000098402; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Park SY, 2000, J BIOL CHEM, V275, P19768, DOI 10.1074/jbc.M909932199; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1355, DOI 10.1210/en.138.3.1355; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pelicci G, 1996, ONCOGENE, V13, P633; PELICCI G, 1995, ONCOGENE, V11, P899; Peng H, 1998, J CEREBR BLOOD F MET, V18, P349, DOI 10.1097/00004647-199804000-00002; Qureshi FG, 1997, J SURG RES, V69, P354, DOI 10.1006/jsre.1997.5080; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SAMPATH D, 1994, J NEUROCHEM, V62, P2476; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shinoda S, 2003, EUR J NEUROSCI, V17, P2065, DOI 10.1046/j.1460-9568.2003.02655.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung U, 2003, J NEUROSCI, V23, P1697; Tapon N, 1998, EMBO J, V17, P1395, DOI 10.1093/emboj/17.5.1395; TISCHLER AS, 1983, CELL TISSUE RES, V228, P641; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Whitney LW, 1999, ANN NEUROL, V46, P425; Willoughby EA, 2005, J BIOL CHEM, V280, P25651, DOI 10.1074/jbc.M501926200; Xiong WC, 2003, FRONT BIOSCI, V8, pS676, DOI 10.2741/1116; Yamada M, 1997, PROG NEUROBIOL, V51, P19, DOI 10.1016/S0301-0082(96)00046-9; Ying X, 2008, J MOL NEUROSCI, V35, P253, DOI 10.1007/s12031-007-9010-1; YING Z, 1993, J CEREBR BLOOD F MET, V13, P378, DOI 10.1038/jcbfm.1993.51	58	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2493	2511		10.1074/jbc.M804545200	http://dx.doi.org/10.1074/jbc.M804545200			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19038969	Green Published, hybrid			2022-12-25	WOS:000262545600056
J	Liu, RH; Lu, PH; Chu, JWK; Sharom, FJ				Liu, Ronghua; Lu, Peihua; Chu, Joseph W. K.; Sharom, Frances J.			Characterization of Fluorescent Sterol Binding to Purified Human NPC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIEMANN-PICK C1; INTESTINAL CHOLESTEROL ABSORPTION; TRANS-GOLGI NETWORK; SENSING DOMAIN; NUCLEOTIDE-BINDING; PROTEIN-DEFICIENT; C2 DISEASE; MODEL MEMBRANES; LIPID TRANSPORT; P-GLYCOPROTEIN	Mutations in the NPC1 gene cause Niemann-Pick type C disease, which appears to result from a defect in intracellular cholesterol trafficking. NPC1 is a member of the resistance-nodulation-cell division (RND) permease superfamily and contains a sterol-sensing domain, yet its cellular function and the identity of its substrates remain unknown. FLAG-tagged human NPC1 was purified from NPC1-expressing Chinese hamster ovary cells by solubilization in 3-[(3-cholamidopropyl) dimethylammonio]1-propanesulfonic acid (CHAPS), followed by affinity chromatography. Purified NPC1 in detergent solution appeared to be oligomeric as determined by gel filtration fast protein liquid chromatography and was photolabeled by an azido-cholesterol derivative. Fluorescent cholesterol analogs, including dehydroergosterol, cholestatrienol, and 22-(N-(7-nitrobenz-2-oxa-1,3-diazol4-yl)amino)-23,24-bisnor-5- cholen-3 beta-ol (NBD-cholesterol), displayed enhanced fluorescence upon binding to NPC1 and also resulted in saturable, concentration-dependent quenching of NPC1 intrinsic Trp fluorescence. The apparent binding affinity for these three sterols was in the 0.5-6 mu M range. Binding of NBD-cholesterol to NPC1 at low detergent concentration (2 mM CHAPS) was of high apparent affinity(0.5-0.6 mu M) and occurred rapidly (< 1 min). However, binding of a BODIPY-labeled cholesterol derivative was very slow, requiring similar to 3 h to reach equilibrium. The apparent NBD-cholesterol binding affinity was greatly reduced at higher detergent concentration. The stoichiometry of NBD-cholesterol binding to NPC1 was similar to 1. Various sterols, including native cholesterol and 25-hydroxycholesterol, inhibited NBD-cholesterol binding, suggesting that they compete for binding to the protein. Dynamic quenching studies showed that bound NBD-cholesterol was almost completely shielded from the aqueous medium, suggesting that it is buried in a deep hydrophobic pocket in NPC1. The use of fluorescent cholesterol analogs provides novel information on the molecular properties of the sterol-binding site in the full-length NPC1 protein.	[Liu, Ronghua; Lu, Peihua; Chu, Joseph W. K.; Sharom, Frances J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Sharom, FJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex Rm 2255, Guelph, ON N1G 2W1, Canada.	fsharom@uoguelph.ca	Sharom, Frances/A-1613-2010	Sharom, Frances/0000-0002-9521-5367	Ara Parseghian Medical Research Foundation	Ara Parseghian Medical Research Foundation	This work was supported by a research grant from the Ara Parseghian Medical Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Avdulov NA, 1999, BBA-MOL CELL BIOL L, V1437, P37, DOI 10.1016/S0005-2760(98)00178-7; Avdulov NA, 1997, J NEUROCHEM, V69, P1746; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dixit SS, 2007, BIOCHEM J, V408, P1, DOI 10.1042/BJ20071167; Dixon M., 1979, ENZYMES, Vthird; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Gong YP, 2006, J PHARMACOL EXP THER, V316, P242, DOI 10.1124/jpet.105.089482; HABERLAND ME, 1973, P NATL ACAD SCI USA, V70, P2313, DOI 10.1073/pnas.70.8.2313; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P976, DOI 10.1021/bi051978h; Haugland R.P., 2002, HDB FLUORESCENT PROB; Higaki K, 2001, J BIOCHEM-TOKYO, V129, P875, DOI 10.1093/oxfordjournals.jbchem.a002932; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15336, DOI 10.1021/bi981094g; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Ioannou YA, 2005, TRENDS BIOCHEM SCI, V30, P498, DOI 10.1016/j.tibs.2005.07.007; Ioannou YA, 2000, MOL GENET METAB, V71, P175, DOI 10.1006/mgme.2000.3061; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P1; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 1998, CURR OPIN STRUC BIOL, V8, P435, DOI 10.1016/S0959-440X(98)80119-X; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Liou HL, 2006, J BIOL CHEM, V281, P36710, DOI 10.1074/jbc.M608743200; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; LOE DW, 1994, BBA-BIOMEMBRANES, V1190, P72, DOI 10.1016/0005-2736(94)90035-3; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Mintzer EA, 2002, FEBS LETT, V510, P181, DOI 10.1016/S0014-5793(01)03271-9; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Ory DS, 2000, BBA-MOL CELL BIOL L, V1529, P331, DOI 10.1016/S1388-1981(00)00158-X; Parker C. A., 1968, PHOTOLUMINESCENCE SO, P220; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Petrescu AD, 2001, J BIOL CHEM, V276, P36970, DOI 10.1074/jbc.M101939200; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Sugimoto Y, 2001, P NATL ACAD SCI USA, V98, P12391, DOI 10.1073/pnas.221181998; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; Vanier MT, 2004, BBA-MOL CELL BIOL L, V1685, P14, DOI 10.1016/j.bbalip.2004.08.007; Watari H, 1999, J BIOL CHEM, V274, P21861, DOI 10.1074/jbc.274.31.21861; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7	57	51	53	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1840	1852		10.1074/jbc.M803741200	http://dx.doi.org/10.1074/jbc.M803741200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19029290	hybrid			2022-12-25	WOS:000262330100055
J	Mace, C; Seyer, D; Chemani, C; Cosette, P; Di-Martino, P; Guery, B; Filloux, A; Fontaine, M; Molle, V; Junter, GA; Jouenne, T				Mace, Camille; Seyer, Damien; Chemani, Chanez; Cosette, Pascal; Di-Martino, Patrick; Guery, Benoit; Filloux, Alain; Fontaine, Marc; Molle, Virginie; Junter, Guy-Alain; Jouenne, Thierry			Identification of Biofilm-Associated Cluster (bac) in Pseudomonas aeruginosa Involved in Biofilm Formation and Virulence	PLOS ONE			English	Article								Biofilms are prevalent in diseases caused by Pseudomonas aeruginosa, an opportunistic and nosocomial pathogen. By a proteomic approach, we previously identified a hypothetical protein of P. aeruginosa (coded by the gene pA3731) that was accumulated by biofilm cells. We report here that a Delta pA3731 mutant is highly biofilm-defective as compared with the wildtype strain. Using a mouse model of lung infection, we show that the mutation also induces a defect in bacterial growth during the acute phase of infection and an attenuation of the virulence. The pA3731 gene is found to control positively the ability to swarm and to produce extracellular rhamnolipids, and belongs to a cluster of 4 genes (pA3729-pA3732) not previously described in P. aeruginosa. Though the protein PA3731 has a predicted secondary structure similar to that of the Phage Shock Protein, some obvious differences are observed compared to already described psp systems, e. g., this unknown cluster is monocistronic and no homology is found between the other proteins constituting this locus and psp proteins. As E. coli PspA, the amount of the protein PA3731 is enlarged by an osmotic shock, however, not affected by a heat shock. We consequently named this locus bac for biofilm-associated cluster.	[Cosette, Pascal; Junter, Guy-Alain; Jouenne, Thierry] Univ Rouen, Lab Polymeres Biopolymeres Surfaces, CNRS, Plate Forme Prote IFRMP 23,FRE 3101, Mont St Aignan, France; [Seyer, Damien; Di-Martino, Patrick] Univ Cergy Pontoise, Lab ERRMECe, EA1391, Pontoise, France; [Chemani, Chanez; Guery, Benoit] Univ Lille 2, Lab Detresses Resp Circulat Physiopathol, Mecan, F-59800 Lille, France; [Filloux, Alain] Imperial Coll London, Fac Nat Sci, Ctr Mol Microbiol & Infect, London, England; [Fontaine, Marc] Univ Rouen, EA 4130, F-76821 Mont St Aignan, France; [Molle, Virginie] Inst Biol Chim Proteines, CNRS, UMR 5086, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rouen Normandie; CY Cergy Paris Universite; Universite de Lille - ISITE; Universite de Lille; Imperial College London; Universite de Rouen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Mace, C (corresponding author), Univ Rouen, Lab Polymeres Biopolymeres Surfaces, CNRS, Plate Forme Prote IFRMP 23,FRE 3101, Mont St Aignan, France.	thierry.jouenne@univ-rouen.fr	Guery, Benoit/D-8089-2017; Guery, Benoit/AAP-2046-2021; MOLLE, Virginie/D-4050-2019	Guery, Benoit/0000-0002-6526-0714; MOLLE, Virginie/0000-0002-6573-3411; jouenne, thierry/0000-0003-0994-9944; Cosette, Pascal/0000-0002-7588-0167; Seyer, Damien/0000-0001-7510-0573; DI MARTINO, Patrick/0000-0001-5450-2733	French Cystic Fibrosis Foundation; French Research and Technology Ministry	French Cystic Fibrosis Foundation; French Research and Technology Ministry	The authors thank the French Cystic Fibrosis Foundation (VLM) for its financial support. CM is supported by the French Research and Technology Ministry.	Bailey J, 2002, NAT BIOTECHNOL, V20, P839, DOI 10.1038/nbt715; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Chandrasekaran EV, 1980, METHODS CARBOHYDRATE, P89; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Darwin AJ, 1999, MOL MICROBIOL, V32, P51, DOI 10.1046/j.1365-2958.1999.01324.x; Darwin AJ, 2001, MOL MICROBIOL, V39, P429, DOI 10.1046/j.1365-2958.2001.02235.x; de Bentzmann S, 2006, J BACTERIOL, V188, P4851, DOI 10.1128/JB.00345-06; Di Martino P, 2002, MICROBES INFECT, V4, P613, DOI 10.1016/S1286-4579(02)01579-4; Dworkin J, 2000, J BACTERIOL, V182, P311, DOI 10.1128/JB.182.2.311-319.2000; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883; Green RC, 2004, J BACTERIOL, V186, P4910, DOI 10.1128/JB.186.15.4910-4920.2004; Jovanovic G, 1996, J BACTERIOL, V178, P1936, DOI 10.1128/jb.178.7.1936-1945.1996; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x; KOCH A, 1991, J BACTERIOL, V17, P4212; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Robriquet L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-41; Ruer S, 2007, J BACTERIOL, V189, P3547, DOI 10.1128/JB.00093-07; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sharma M, 2002, CURR SCI INDIA, V83, P707; Thompson LS, 2003, FEMS MICROBIOL LETT, V220, P187, DOI 10.1016/S0378-1097(03)00097-1; Tummler B, 1999, MOL MED TODAY, V5, P351, DOI 10.1016/S1357-4310(99)01506-3; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Vilain S, 2004, ANAL BIOCHEM, V329, P120, DOI 10.1016/j.ab.2004.02.014; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627	35	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3897	10.1371/journal.pone.0003897	http://dx.doi.org/10.1371/journal.pone.0003897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065261	Green Published, gold, Green Submitted			2022-12-25	WOS:000265455200010
J	Zeng, YA; Rahnama, M; Wang, S; Lee, W; Verheyen, EM				Zeng, Yi Arial; Rahnama, Maryam; Wang, Simon; Lee, Wendy; Verheyen, Esther M.			Inhibition of Drosophila Wg Signaling Involves Competition between Mad and Armadillo/beta-Catenin for dTcf Binding	PLOS ONE			English	Article								Precisely regulated signal transduction pathways are crucial for the regulation of developmental events and prevention of tumorigenesis. Both the Transforming Growth Factor beta (TGF beta)/Bone morphogenetic protein (BMP) and Wnt/Wingless (Wg) pathways play essential roles in organismal patterning and growth, and their deregulation can lead to cancers. We describe a mechanism of interaction between Drosophila Wg and BMP signaling in which Wg target gene expression is antagonized by BMP signaling. In vivo, high levels of both an activated BMP receptor and the BMP effector Mad can inhibit the expression of Wg target genes. Conversely, loss of mad can induce Wg target gene expression. In addition, we find that ectopic expression in vivo of the Wg transcription factor dTcf is able to suppress the inhibitory effect caused by ectopic Mad. In vitro binding studies revealed competition for dTcf binding between Mad and the Wnt effector beta-catenin/Armadillo (Arm). Our in vivo genetic analyses and target gene studies support a mechanism consistent with the in vitro binding and competition studies, namely that BMP pathway components can repress Wg target gene expression by influencing the binding of Arm and dTcf.	[Zeng, Yi Arial; Rahnama, Maryam; Wang, Simon; Lee, Wendy; Verheyen, Esther M.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Zeng, YA (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	everheye@sfu.ca		Verheyen, Esther/0000-0002-9795-5094; Wang, Simon/0000-0003-0624-5482; Lee, Wendy/0000-0002-8807-0550	MacMillan-Bloedel Graduate Scholarship; CIHR [Doctoral Research Award]	MacMillan-Bloedel Graduate Scholarship; CIHR(Canadian Institutes of Health Research (CIHR))	Y.A.Z. was supported by a MacMillan-Bloedel Graduate Scholarship. M. R. is supported by a CIHR Doctoral Research Award. This work was supported by an operating grant from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Bennett D, 2002, NAT GENET, V31, P419, DOI 10.1038/ng938; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Campbell G, 1998, DEVELOPMENT, V125, P4483; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COUSO JP, 1994, DEVELOPMENT, V120, P621; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; Estella C, 2008, DEV CELL, V14, P86, DOI 10.1016/j.devcel.2007.11.002; Giraldez AJ, 2003, DEVELOPMENT, V130, P6533, DOI 10.1242/dev.00904; Glise B, 2002, DEV BIOL, V248, P93, DOI 10.1006/dbio.2002.0720; Hussein SM, 2003, J BIOL CHEM, V278, P48805, DOI 10.1074/jbc.M305472200; Ito K, 1997, DEVELOPMENT, V124, P761; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Lim SK, 2006, P NATL ACAD SCI USA, V103, P18580, DOI 10.1073/pnas.0604773103; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marquez RM, 2001, GENETICS, V157, P1639; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Morimura S, 1996, DEV BIOL, V177, P136, DOI 10.1006/dbio.1996.0151; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Newfeld SJ, 2002, GENETICS, V161, P685; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Pai LM, 1997, DEVELOPMENT, V124, P2255; Parker DS, 2002, DEVELOPMENT, V129, P2565; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; SEKELSKY JJ, 1995, GENETICS, V139, P1347; STAEHLINGHAMPTON K, 1994, DEV BIOL, V164, P502, DOI 10.1006/dbio.1994.1219; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; TAKAESU NT, 2005, DEVELOPMENT; Theil T, 2002, DEVELOPMENT, V129, P3045; Theisen H, 1996, DEVELOPMENT, V122, P3939; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Willert K, 1999, DEVELOPMENT, V126, P4165; Yang X, 2000, DEVELOPMENT, V127, P3695; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu X, 1996, DEVELOPMENT, V122, P849; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177; Zhang J, 1998, DEVELOPMENT, V125, P3075	52	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3893	10.1371/journal.pone.0003893	http://dx.doi.org/10.1371/journal.pone.0003893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065265	Green Published, gold, Green Submitted			2022-12-25	WOS:000265455200008
J	Young, ME; Norman, GR; Humphreys, KR				Young, Meredith E.; Norman, Geoffrey R.; Humphreys, Karin R.			The Role of Medical Language in Changing Public Perceptions of Illness	PLOS ONE			English	Article							FEMALE SEXUAL DYSFUNCTION; DISEASE; DEFINITIONS; NONDISEASE; JUDGMENTS; IMPACT	This study was designed to investigate the impact of medical terminology on perceptions of disease. Specifically, we look at the changing public perceptions of newly medicalized disorders with accompanying newly medicalized terms (e. g. impotence has become erectile dysfunction disorder). Does using "medicalese'' to label a recently medicalized disorder lead to a change in the perception of that condition? Undergraduate students (n = 52) rated either the medical or lay label for recently medicalized disorders (such as erectile dysfunction disorder vs. impotence) and established medical conditions (such as a myocardial infarction vs. heart attack) for their perceived seriousness, disease representativeness and prevalence. Students considered the medical label of the recently medicalized disease to be more serious (mean = 4.95 (SE = .27) vs. mean = 3.77 (SE = .24) on a ten point scale), more representative of a disease (mean = 2.47 (SE = .09) vs. mean = 1.83 (SE = .09) on a four point scale), and have lower prevalence (mean = 68 (SE = 12.6) vs. mean = 122 (SE = 18.1) out of 1,000) than the same disease described using common language. A similar pattern was not seen in the established medical conditions, even when controlled for severity. This study demonstrates that the use of medical language in communication can induce bias in perception; a simple switch in terminology results in a disease being perceived as more serious, more likely to be a disease, and more likely to be a rare condition. These findings regarding the conceptualization of disease have implications for many areas, including medical communication with the public, advertising, and public policy.	[Humphreys, Karin R.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Norman, Geoffrey R.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Young, ME (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	youngme2@mcmaster.ca			Natural Science and Engineering Research Council (NSERC) of Canada	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was conducted with the assistance from the Natural Science and Engineering Research Council (NSERC) of Canada to the second and third authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACESAVILA FS, 2004, BEST PRACT RES CLIN, V18, P155; Applbaum K, 2006, PLOS MED, V3, P445, DOI 10.1371/journal.pmed.0030189; CAMPBELL EJM, 1979, BMJ-BRIT MED J, V2, P757, DOI 10.1136/bmj.2.6193.757; Chan DJ, 2005, INT J STD AIDS, V16, P91, DOI 10.1258/0956462053057657; Cooper Y, 2008, INT J NUMBER THEORY, V4, P1, DOI 10.1142/S1793042108001171; COTTERILL JA, 2002, DERMATOL PSYCHOSOM, V3, P60; CRIXER G, 2005, GENERATION RX PRESCR; DITTO PH, 1987, RARITY EVALUAT UNPUB; Eva KW, 2001, ACAD MED, V76, pS11, DOI 10.1097/00001888-200110001-00005; Flower R, 2004, TRENDS PHARMACOL SCI, V25, P182, DOI 10.1016/j.tips.2004.02.006; Frewer LJ, 2002, RISK ANAL, V22, P701, DOI 10.1111/0272-4332.00062; Jason LA, 2002, AM J COMMUN PSYCHOL, V30, P133, DOI 10.1023/A:1014328319297; JEMMOTT JB, 1988, HEALTH PSYCHOL, V7, P55, DOI 10.1037/0278-6133.7.1.55; Jones MP, 2003, AM J GASTROENTEROL, V98, P2813; Lexchin J, 2006, PLOS MED, V3, P429, DOI 10.1371/journal.pmed.0030132; Melton LJ, 2003, BONE, V32, P327, DOI 10.1016/S8756-3282(03)00022-X; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2003, BRIT MED J, V326, P45, DOI 10.1136/bmj.326.7379.45; Norman GR, 2003, ACAD MED, V78, pS82, DOI 10.1097/00001888-200310001-00026; Payer L., 1992, DIS MONGERS DOCTORS; Scully JL, 2004, EMBO REP, V5, P650, DOI 10.1038/sj.embor.7400195; Smith R, 2002, BRIT MED J, V324, P883, DOI 10.1136/bmj.324.7342.883; Tiefer L, 2006, PLOS MED, V3, P436, DOI 10.1371/journal.pmed.0030178; Wessely S, 2002, BRIT MED J, V324, P912, DOI 10.1136/bmj.324.7342.912; Young M, 2007, MED EDUC, V41, P1146, DOI 10.1111/j.1365-2923.2007.02913.x; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552	26	28	28	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3875	10.1371/journal.pone.0003875	http://dx.doi.org/10.1371/journal.pone.0003875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZO	19060953	gold, Green Published, Green Submitted			2022-12-25	WOS:000265455100003
J	Sevillano, D; Aguilar, L; Alou, L; Gimenez, MJ; Gonzalez, N; Torrico, M; Cafini, F; Coronel, P; Prieto, J				Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Gimenez, Maria-Jose; Gonzalez, Natalia; Torrico, Martha; Cafini, Fabio; Coronel, Pilar; Prieto, Jose			beta-Lactam Effects on Mixed Cultures of Common Respiratory Isolates as an Approach to Treatment Effects on Nasopharyngeal Bacterial Population Dynamics	PLOS ONE			English	Article								Background: Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae are bacteria present in the nasopharynx as part of normal flora. The ecological equilibrium in the nasopharynx can be disrupted by the presence of antibiotics. Methodology/Principal Findings: A computerized two-compartment pharmacodynamic model was used to explore beta-lactam effects on the evolution over time of a bacterial load containing common pharyngeal isolates by simulating free serum concentrations obtained with amoxicillin (AMX) 875 mg tid, amoxicillin/clavulanic acid (AMC) 875/125 mg tid and cefditoren (CDN) 400 mg bid regimens over 24 h. Strains and MICs (mu g/ml) of AMX, AMC and CDN were: S. pyogenes (0.03, 0.03 and 0.015), S. pneumoniae (2, 2 and 0.25), a beta-lactamase positive H. influenzae (BL(+); >16, 2 and 0.06) and a beta-lactamase positive AMC-resistant H. influenzae (BLPACR, >16, 8 and 0.06). Mixture of identical 1:1:1:1 volumes of each bacterial suspension were prepared yielding an inocula of approximate to 4 x 10(6) cfu/ml. Antibiotic concentrations were measured both in bacterial and in bacteria-free antibiotic simulations. beta-lactamase production decreased AMX concentrations and fT(>MIC) against S. pneumoniae (from 43.2% to 17.7%) or S. pyogenes (from 99.9% to 24.9%), and eradication was precluded. The presence of clavulanic acid countered this effect of co-pathogenicity, and S. pyogenes (but not BL(+) and S. pneumoniae) was eradicated. Resistance of CDN to TEM b-lactamase avoided this co-pathogenicity effect, and CDN eradicated S. pyogenes and H. influenzae strains (fT(>MIC) >58%), and reduced in 94% S. pneumoniae counts (fT(>MIC) approximate to 25%). Conclusions/Significance: Co-pathogenicity seems to be gradual since clavulanic acid countered this effect for strains very susceptible to AMX as S. pyogenes but not for strains with AMX MIC values in the limit of susceptibility as S. pneumoniae. There is a potential therapeutic advantage for beta-lactamase resistant cephalosporins with high activity against streptococci.	[Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Gimenez, Maria-Jose; Gonzalez, Natalia; Torrico, Martha; Cafini, Fabio; Prieto, Jose] Univ Complutense, Dept Microbiol, Sch Med, E-28040 Madrid, Spain; [Coronel, Pilar] Tedec Meiji Farma SA, Sci Dept, Madrid, Spain	Complutense University of Madrid	Sevillano, D (corresponding author), Univ Complutense, Dept Microbiol, Sch Med, E-28040 Madrid, Spain.	laguilar@med.ucm.es	Prieto, José/G-5644-2010; Cafini, Fabio/AAA-7938-2020; Hidalgo, Natalia González/X-6840-2018; Sevillano, David/G-5661-2010; Alou, Luis/B-8170-2011; Gimenez, Maria Jose/GXF-2237-2022	Cafini, Fabio/0000-0002-5442-1674; Hidalgo, Natalia González/0000-0002-6874-954X; Alou, Luis/0000-0002-0859-008X; Gimenez, Maria Jose/0000-0003-0830-4095; Sevillano Fernandez, David/0000-0003-0212-2194	Tedec-Meiji Farma S.A., Madrid, Spain	Tedec-Meiji Farma S.A., Madrid, Spain	This study was supported in part by an unrestricted grant from Tedec-Meiji Farma S.A., Madrid, Spain. The sponsor had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrews J.M., 1999, CLIN ANTIMICROBIAL A, P35; [Anonymous], PRINCIPLES PRACTICE; Ball P, 2002, J ANTIMICROB CHEMOTH, V49, P31, DOI 10.1093/jac/49.1.31; Baquero F, 2005, INT MICROBIOL, V8, P81; Bisno AL, 2004, CLIN INFECT DIS, V38, P1535, DOI 10.1086/392520; Brook I, 2005, ARCH OTOLARYNGOL, V131, P509, DOI 10.1001/archotol.131.6.509; Brook I, 2001, INT J ANTIMICROB AG, V17, P439, DOI 10.1016/S0924-8579(01)00321-1; Brook I, 2005, ANTIMICROB AGENTS CH, V49, P4787, DOI 10.1128/AAC.49.11.4787-4788.2005; Brook I, 2006, J MED MICROBIOL, V55, P989, DOI 10.1099/jmm.0.46325-0; Brook I, 2006, J MED MICROBIOL, V55, P1741, DOI 10.1099/jmm.0.46796-0; Cafini F, 2008, MICROB DRUG RESIST, V14, P13, DOI 10.1089/mdr.2008.0783; Casey JR, 2007, DIAGN MICR INFEC DIS, V57, p39S, DOI 10.1016/j.diagmicrobio.2006.12.020; Dabernat H, 2002, ANTIMICROB AGENTS CH, V46, P2208, DOI 10.1128/AAC.46.7.2208-2218.2002; Ekdahl K, 1997, CLIN INFECT DIS, V25, P1113, DOI 10.1086/516103; Garcia-Cobos S, 2007, ANTIMICROB AGENTS CH, V51, P2564, DOI 10.1128/AAC.00354-07; Gillespie SH, 2002, MICROB DRUG RESIST, V8, P79, DOI 10.1089/107662902760190617; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Martin JM, 2004, PEDIATRICS, V114, P1212, DOI 10.1542/peds.2004-0133; Martin M, 1997, J ANTIMICROB CHEMOTH, V39, P290, DOI 10.1093/jac/39.2.290; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; MURTHY TF, 2005, MANDELL DOUGLAS BENN, P2661; Musher DM, 2005, MANDELL DOUGLAS BENN, P2362; National Committee for Clinical Laboratory Standards, 2003, METH DIL ANT SUSC TE; Nuermberger EL, 2004, CLIN INFECT DIS, V38, pS363, DOI 10.1086/382696; Perez-Trallero E, 2005, ANTIMICROB AGENTS CH, V49, P1965, DOI 10.1128/AAC.49.5.1965-1972.2005; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Pichichero ME, 2000, PEDIATR INFECT DIS J, V19, P917, DOI 10.1097/00006454-200009000-00035; Prieto J, 1998, ANTIMICROB AGENTS CH, V42, P1574, DOI 10.1128/AAC.42.7.1574; Rozen DE, 2007, ANTIMICROB AGENTS CH, V51, P412, DOI 10.1128/AAC.01161-06; Sa-Leado R, 2008, J CLIN MICROBIOL, V46, P225, DOI 10.1128/JCM.01551-07; Sa-Leao R, 2002, J CLIN MICROBIOL, V40, P3577, DOI 10.1128/JCM.40.10.3577-3585.2002; SCRIVER SR, 1994, ANTIMICROB AGENTS CH, V38, P1678, DOI 10.1128/AAC.38.7.1678; Sevillano D, 2006, J ANTIMICROB CHEMOTH, V58, P794, DOI 10.1093/jac/dkl307; Sevillano D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002717; Shulman ST, 2004, PEDIATRICS, V113, P1816, DOI 10.1542/peds.113.6.1816; SmithVaughan HC, 1996, EPIDEMIOL INFECT, V116, P177, DOI 10.1017/S0950268800052419; Stjernquist-Desatnik A, 1999, ACTA OTO-LARYNGOL, V119, P102; Torrico M, 2007, ANTIMICROB AGENTS CH, V51, P3699, DOI 10.1128/AAC.01530-06; AUGMENTIN PACKAGE IN; CEFDITOREN PACKAGE I	40	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3846	10.1371/journal.pone.0003846	http://dx.doi.org/10.1371/journal.pone.0003846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052648	Green Published, Green Submitted, gold			2022-12-25	WOS:000265452200003
J	Eswarappa, SM; Janice, J; Nagarajan, AG; Balasundaram, SV; Karnam, G; Dixit, NM; Chakravortty, D				Eswarappa, Sandeepa M.; Janice, Jessin; Nagarajan, Arvindhan G.; Balasundaram, Sudhagar V.; Karnam, Guruswamy; Dixit, Narendra M.; Chakravortty, Dipshikha			Differentially Evolved Genes of Salmonella Pathogenicity Islands: Insights into the Mechanism of Host Specificity in Salmonella	PLOS ONE			English	Article								Background: The species Salmonella enterica (S. enterica) includes many serovars that cause disease in avian and mammalian hosts. These serovars differ greatly in their host range and their degree of host adaptation. The host specificity of S. enterica serovars appears to be a complex phenomenon governed by multiple factors acting at different stages of the infection process, which makes identification of the cause/s of host specificity solely by experimental methods difficult. Methodology/Principal Findings: In this study, we have employed a molecular evolution and phylogenetics based approach to identify genes that might play important roles in conferring host specificity to different serovars of S. enterica. These genes are 'differentially evolved' in different S. enterica serovars. This list of 'differentially evolved' genes includes genes that encode translocon proteins (SipD, SseC and SseD) of both Salmonella pathogenicity islands 1 and 2 encoded type three secretion systems, sptP, which encodes an effector protein that inhibits the mitogen-activated protein kinase pathway of the host cell, and genes which encode effector proteins (SseF and SifA) that are important in placing the Salmonella-containing vacuole in a juxtanuclear position. Conclusions/Significance: Analysis of known functions of these 'differentially evolved genes' indicates that the products of these genes directly interact with the host cell and manipulate its functions and thereby confer host specificity, at least in part, to different serovars of S. enterica that are considered in this study.	[Eswarappa, Sandeepa M.; Janice, Jessin; Nagarajan, Arvindhan G.; Balasundaram, Sudhagar V.; Karnam, Guruswamy; Chakravortty, Dipshikha] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India; [Dixit, Narendra M.] Indian Inst Sci, Ctr Infect Dis Res, Dept Chem Engn, Biosafety Lab, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Eswarappa, SM (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	Chakravortty, Dipshikha/AAI-4448-2020; chakravortty, dipshikha/A-9492-2009; Eswarappa, Sandeep/AFG-1997-2022	Muthanegere Eswarappa, Sandeepa/0000-0003-4479-5354; Chakravortty, Dipshikha/0000-0002-7838-5145; Eswarappa, Sandeep/0000-0002-7903-5198; Janice, Jessin/0000-0001-9991-6315	Department of Biotechnology [DBTO/197]; Department of Atomic Energy [DAEO/119]; Government of India; Indian Institute of Science [191/MCB]; ICMR; DBT	Department of Biotechnology; Department of Atomic Energy(Department of Atomic Energy (DAE)); Government of India; Indian Institute of Science; ICMR(Indian Council of Medical Research (ICMR)); DBT(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology (DBTO/197) and Department of Atomic Energy (DAEO/119), Government of India, the director of Indian Institute of Science [Provision (2A) Tenth Plan (191/MCB)], ICMR center for Medical Microbiology and DBT program support on Basic Biology of Microbial Pathogens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, TRAFFIC, V7, P950, DOI 10.1111/j.1600-0854.2006.00454.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARROW PA, 1994, INFECT IMMUN, V62, P4602, DOI 10.1128/IAI.62.10.4602-4610.1994; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Collazo CM, 1997, GENE, V192, P51, DOI 10.1016/S0378-1119(96)00825-6; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Darwin KH, 1999, CLIN MICROBIOL REV, V12, P405, DOI 10.1128/CMR.12.3.405; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Elewaut D, 1999, J IMMUNOL, V163, P1457; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Hansen-Wester I, 2004, INFECT IMMUN, V72, P2879, DOI 10.1128/IAI.72.5.2879-2888.2004; Hansen-Wester I, 2002, INFECT IMMUN, V70, P1403, DOI 10.1128/IAI.70.3.1403-1409.2002; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; KANIGA K, 1995, J BACTERIOL, V177, P7078, DOI 10.1128/jb.177.24.7078-7085.1995; Klein JR, 2001, INFECT IMMUN, V69, P737, DOI 10.1128/IAI.69.2.737-743.2001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Lin SL, 2003, CELL MICROBIOL, V5, P267, DOI 10.1046/j.1462-5822.2003.t01-1-00274.x; MCCORMICK BA, 1995, INFECT IMMUN, V63, P2302, DOI 10.1128/IAI.63.6.2302-2309.1995; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Murli S, 2001, CELL MICROBIOL, V3, P795, DOI 10.1046/j.1462-5822.2001.00158.x; Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PASCOPELLA L, 1995, INFECT IMMUN, V63, P4329, DOI 10.1128/IAI.63.11.4329-4335.1995; Paulin SM, 2002, INFECT IMMUN, V70, P6788, DOI 10.1128/IAI.70.12.6788-6797.2002; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Pier GB, 1998, NATURE, V393, P79, DOI 10.1038/30006; Raffatellu M, 2005, INFECT IMMUN, V73, P3367, DOI 10.1128/IAI.73.6.3367-3374.2005; REEVES MW, 1989, J CLIN MICROBIOL, V27, P313, DOI 10.1128/JCM.27.2.313-320.1989; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schwan WR, 2000, INFECT IMMUN, V68, P1005, DOI 10.1128/IAI.68.3.1005-1013.2000; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Tracz DM, 2006, J CLIN MICROBIOL, V44, P2007, DOI 10.1128/JCM.02630-05; Uzzau S, 2001, INFECT IMMUN, V69, P3092, DOI 10.1128/IAI.69.5.3092-3099.2001; Weinstein DL, 1998, INFECT IMMUN, V66, P2310, DOI 10.1128/IAI.66.5.2310-2318.1998; Wood MW, 1998, MOL MICROBIOL, V29, P883, DOI 10.1046/j.1365-2958.1998.00984.x; Zhang SP, 2003, INFECT IMMUN, V71, P1, DOI 10.1128/IAI.71.1.1-12.2003	59	42	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3829	10.1371/journal.pone.0003829	http://dx.doi.org/10.1371/journal.pone.0003829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050757	Green Submitted, Green Published, gold			2022-12-25	WOS:000265452100001
J	Clements, A; Gaboriaud, F; Duval, JFL; Farn, JL; Jenney, AW; Lithgow, T; Wijburg, OLC; Hartland, EL; Strugnell, RA				Clements, Abigail; Gaboriaud, Fabien; Duval, Jerome F. L.; Farn, Jacinta L.; Jenney, Adam W.; Lithgow, Trevor; Wijburg, Odilia L. C.; Hartland, Elizabeth L.; Strugnell, Richard A.			The Major Surface-Associated Saccharides of Klebsiella pneumoniae Contribute to Host Cell Association	PLOS ONE			English	Article								Analysing the pathogenic mechanisms of a bacterium requires an understanding of the composition of the bacterial cell surface. The bacterial surface provides the first barrier against innate immune mechanisms as well as mediating attachment to cells/surfaces to resist clearance. We utilised a series of Klebsiella pneumoniae mutants in which the two major polysaccharide layers, capsule and lipopolysaccharide (LPS), were absent or truncated, to investigate the ability of these layers to protect against innate immune mechanisms and to associate with eukaryotic cells. The capsule alone was found to be essential for resistance to complement mediated killing while both capsule and LPS were involved in cell-association, albeit through different mechanisms. The capsule impeded cell-association while the LPS saccharides increased cell-association in a non-specific manner. The electrohydrodynamic characteristics of the strains suggested the differing interaction of each bacterial strain with eukaryotic cells could be partly explained by the charge density displayed by the outermost polysaccharide layer. This highlights the importance of considering not only specific adhesin: ligand interactions commonly studied in adherence assays but also the initial non-specific interactions governed largely by the electrostatic interaction forces.	[Clements, Abigail; Farn, Jacinta L.; Jenney, Adam W.; Wijburg, Odilia L. C.; Hartland, Elizabeth L.; Strugnell, Richard A.] Univ Melbourne, Australian Bacterial Pathogenesis Program, Parkville, Vic 3052, Australia; [Clements, Abigail; Farn, Jacinta L.; Jenney, Adam W.; Wijburg, Odilia L. C.; Hartland, Elizabeth L.; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Co operative Res Ctr Vaccine Technol, Parkville, Vic 3052, Australia; [Gaboriaud, Fabien] Univ Nancy, CNRS, Lab Phys Chem & Microbiol Environm, F-54013 Nancy, France; [Duval, Jerome F. L.] Univ Nancy, CNRS, Lab Environm & Mineral Processing, F-54013 Nancy, France; [Lithgow, Trevor] Univ Melbourne, Bio21 Inst, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Melbourne	Clements, A (corresponding author), Univ Melbourne, Australian Bacterial Pathogenesis Program, Parkville, Vic 3052, Australia.	abigailc@unimelb.edu.au	Lithgow, Trevor J/H-5925-2017; Jerome, Duval/H-6421-2011; Hartland, Elizabeth/O-2569-2014	Lithgow, Trevor J/0000-0002-0102-7884; Jerome, Duval/0000-0002-5458-3761; Strugnell, Richard/0000-0003-0614-5641; Clements, Abigail/0000-0003-2285-777X; Hartland, Elizabeth/0000-0003-4254-2863	NHMRC; Co-operative Research Centre for Vaccine Technology	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Co-operative Research Centre for Vaccine Technology(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	NHMRC Australian Bacterial Pathogenesis Program Grant 2003 2008, Co-operative Research Centre for Vaccine Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER B, 1983, PATHOLOGY, V15, P247, DOI 10.3109/00313028309083501; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; AMAKO K, 1988, J BACTERIOL, V170, P4960, DOI 10.1128/jb.170.10.4960-4962.1988; BELANGER M, 1990, INFECT IMMUN, V58, P3523; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Burks GA, 2003, LANGMUIR, V19, P2366, DOI 10.1021/la026375a; Clements A, 2007, J BIOL CHEM, V282, P15569, DOI 10.1074/jbc.M701454200; Corsaro MM, 2005, CARBOHYD RES, V340, P2212, DOI 10.1016/j.carres.2005.07.006; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Couto RC, 2007, AM J INFECT CONTROL, V35, P183, DOI 10.1016/j.ajic.2006.06.013; Dague E, 2006, BIOPHYS J, V90, P2612, DOI 10.1529/biophysj.105.068205; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Domenico P, 1999, INFECT IMMUN, V67, P664, DOI 10.1128/IAI.67.2.664-669.1999; Duval JFL, 2006, LANGMUIR, V22, P3533, DOI 10.1021/la0528293; Duval JFL, 2005, LANGMUIR, V21, P11268, DOI 10.1021/la051735q; FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973; Fresno S, 2007, J BACTERIOL, V189, P1128, DOI 10.1128/JB.01489-06; Frirdich E, 2005, J BIOL CHEM, V280, P27604, DOI 10.1074/jbc.M504987200; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Gaboriaud F, 2008, LANGMUIR, V24, P10988, DOI 10.1021/la800258n; Hanberger H, 1999, JAMA-J AM MED ASSOC, V281, P67, DOI 10.1001/jama.281.1.67; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Jenney AW, 2006, J CLIN MICROBIOL, V44, P102, DOI 10.1128/JCM.44.1.102-107.2006; JOHANSON WG, 1969, NEW ENGL J MED, V281, P1137, DOI 10.1056/NEJM196911202812101; KABHA K, 1995, INFECT IMMUN, V63, P847, DOI 10.1128/IAI.63.3.847-852.1995; KASTOWSKY M, 1992, J BACTERIOL, V174, P4798, DOI 10.1128/JB.174.14.4798-4806.1992; Kostina E, 2005, INFECT IMMUN, V73, P8282, DOI 10.1128/IAI.73.12.8282-8290.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Maneval WE, 1941, STAIN TECHNOL, V16, P13, DOI 10.3109/10520294109106189; MERINO S, 1992, INFECT IMMUN, V60, P2529, DOI 10.1128/IAI.60.6.2529-2535.1992; Moses AE, 1997, INFECT IMMUN, V65, P64, DOI 10.1128/IAI.65.1.64-71.1997; Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885; Okamoto S, 2004, INFECT IMMUN, V72, P6068, DOI 10.1128/IAI.72.10.6068-6075.2004; OPHIR T, 1994, APPL ENVIRON MICROB, V60, P740, DOI 10.1128/AEM.60.2.740-745.1994; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Regue M, 2005, J BACTERIOL, V187, P4198, DOI 10.1128/JB.187.12.4198-4206.2005; RIED G, 1990, J BACTERIOL, V172, P6048, DOI 10.1128/jb.172.10.6048-6053.1990; ROSENTHAL S, 1975, ANN INTERN MED, V83, P355, DOI 10.7326/0003-4819-83-3-355; Rotureau E, 2007, LANGMUIR, V23, P8460, DOI 10.1021/la700427p; Sahly H, 2000, INFECT IMMUN, V68, P6744, DOI 10.1128/IAI.68.12.6744-6749.2000; Schembri MA, 2005, INFECT IMMUN, V73, P4626, DOI 10.1128/IAI.73.8.4626-4633.2005; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; TOMAS JM, 1986, INFECT IMMUN, V54, P85; Trautmann M, 2004, VACCINE, V22, P818, DOI 10.1016/j.vaccine.2003.11.026; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Walker SL, 2004, LANGMUIR, V20, P7736, DOI 10.1021/la049511f; Waters V, 2004, CLIN INFECT DIS, V38, P1682, DOI 10.1086/386331; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x	56	60	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3817	10.1371/journal.pone.0003817	http://dx.doi.org/10.1371/journal.pone.0003817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043570	gold, Green Published			2022-12-25	WOS:000265451400009
J	Thibonnier, M; Thiberge, JM; De Reuse, H				Thibonnier, Marie; Thiberge, Jean-Michel; De Reuse, Hilde			Trans-Translation in Helicobacter pylori: Essentiality of Ribosome Rescue and Requirement of Protein Tagging for Stress Resistance and Competence	PLOS ONE			English	Article								Background: The ubiquitous bacterial trans-translation is one of the most studied quality control mechanisms. Trans-translation requires two specific factors, a small RNA SsrA (tmRNA) and a protein co-factor SmpB, to promote the release of ribosomes stalled on defective mRNAs and to add a specific tag sequence to aberrant polypeptides to direct them to degradation pathways. Helicobacter pylori is a pathogen persistently colonizing a hostile niche, the stomach of humans. Principal Findings: We investigated the role of trans-translation in this bacterium well fitted to resist stressful conditions and found that both smpB and ssrA were essential genes. Five mutant versions of ssrA were generated in H. pylori in order to investigate the function of trans-translation in this organism. Mutation of the resume codon that allows the switch of template of the ribosome required for its release was essential in vivo, however a mutant in which this codon was followed by stop codons interrupting the tag sequence was viable. Therefore one round of translation is sufficient to promote the rescue of stalled ribosomes. A mutant expressing a truncated SsrA tag was viable in H. pylori, but affected in competence and tolerance to both oxidative and antibiotic stresses. This demonstrates that control of protein degradation through trans-translation is by itself central in the management of stress conditions and of competence and supports a regulatory role of trans-translation-dependent protein tagging. In addition, the expression of smpB and ssrA was found to be induced upon acid exposure of H. pylori. Conclusions: We conclude to a central role of trans-translation in H. pylori both for ribosome rescue possibly due to more severe stalling and for protein degradation to recover from stress conditions frequently encountered in the gastric environment. Finally, the essential trans-translation machinery of H. pylori is an excellent specific target for the development of novel antibiotics.	[Thibonnier, Marie; Thiberge, Jean-Michel; De Reuse, Hilde] Inst Pasteur, Unite Postulante Pathogenese Helicobacter, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Thibonnier, M (corresponding author), Inst Pasteur, Unite Postulante Pathogenese Helicobacter, Paris, France.	hdereuse@pasteur.fr		DE REUSE, Hilde/0000-0002-0100-4826	FRM	FRM(Fondation pour la Recherche Medicale)	MT was supported by a FRM grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2002, GENES CELLS, V7, P629, DOI 10.1046/j.1365-2443.2002.00549.x; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boneca IG, 2008, APPL ENVIRON MICROB, V74, P2095, DOI 10.1128/AEM.01348-07; Braud S, 2006, ARCH MICROBIOL, V184, P343, DOI 10.1007/s00203-005-0051-y; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; Bury-Mone S, 2001, MOL MICROBIOL, V42, P1021, DOI 10.1046/j.1365-2958.2001.02689.x; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; de la Cruz J, 2001, RNA, V7, P1708; Dong QJ, 2007, ANTON LEEUW INT J G, V92, P301, DOI 10.1007/s10482-007-9152-8; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; EBELING S, 1991, J BACTERIOL, V173, P6373, DOI 10.1128/jb.173.20.6373-6382.1991; Ermak TH, 1998, J EXP MED, V188, P2277, DOI 10.1084/jem.188.12.2277; Falnes Pal O, 2005, RNA Biol, V2, P14, DOI 10.4161/rna.2.1.1602; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hallier M, 2004, J BIOL CHEM, V279, P25978, DOI 10.1074/jbc.M314086200; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Hanawa-Suetsugu K, 2001, NUCLEIC ACIDS RES, V29, P4663, DOI 10.1093/nar/29.22.4663; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Hong SJ, 2007, P NATL ACAD SCI USA, V104, P17128, DOI 10.1073/pnas.0707671104; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Ivanova N, 2005, J MOL BIOL, V350, P897, DOI 10.1016/j.jmb.2005.05.033; Julio SM, 2000, J BACTERIOL, V182, P1558, DOI 10.1128/JB.182.6.1558-1563.2000; Kaakoush NO, 2007, FEMS IMMUNOL MED MIC, V50, P177, DOI 10.1111/j.1574-695X.2007.00259.x; Karnholz A, 2006, J BACTERIOL, V188, P882, DOI 10.1128/JB.188.3.882-893.2006; Keiler KC, 2000, P NATL ACAD SCI USA, V97, P7778, DOI 10.1073/pnas.97.14.7778; Keiler KC, 2003, J BACTERIOL, V185, P1825, DOI 10.1128/JB.185.6.1825-1830.2003; Keiler KC, 2003, J BACTERIOL, V185, P573, DOI 10.1128/JB.185.2.573-580.2003; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; Keiler KC, 2007, CURR OPIN MICROBIOL, V10, P169, DOI 10.1016/j.mib.2007.03.014; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Lessner FH, 2007, J BACTERIOL, V189, P272, DOI 10.1128/JB.01387-06; Luidalepp Hannes, 2005, RNA Biol, V2, P70, DOI 10.4161/rna.2.2.2020; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Muto A, 2000, GENES CELLS, V5, P627, DOI 10.1046/j.1365-2443.2000.00356.x; OH BK, 1991, MOL GEN GENET, V229, P52, DOI 10.1007/BF00264212; Okan Nihal A., 2006, PLoS Pathogens, V2, P50; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Sambrook J, 2001, MOL CLONING LAB MANU; Skouloubris S, 2001, MOL MICROBIOL, V40, P596, DOI 10.1046/j.1365-2958.2001.02400.x; STINGL K, 2008, MOL CELL PR IN PRESS; Stingl K, 2007, EMBO J, V26, P232, DOI 10.1038/sj.emboj.7601471; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TU GF, 1995, J BIOL CHEM, V270, P9322, DOI 10.1074/jbc.270.16.9322; van Amsterdam K, 2006, FEMS MICROBIOL REV, V30, P131, DOI 10.1111/j.1574-6976.2005.00006.x; Vioque A, 2003, FEMS MICROBIOL LETT, V218, P9, DOI 10.1016/S0378-1097(02)01110-2; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x	57	54	57	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3810	10.1371/journal.pone.0003810	http://dx.doi.org/10.1371/journal.pone.0003810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043582	Green Submitted, Green Published, gold			2022-12-25	WOS:000265451400002
J	Hacker, KE; Lee, CM; Rathmell, WK				Hacker, Kathryn E.; Lee, Caroline Martz; Rathmell, W. Kimryn			VHL Type 2B Mutations Retain VBC Complex Form and Function	PLOS ONE			English	Article							HIPPEL-LINDAU-DISEASE; TUMOR-SUPPRESSOR PROTEIN; RENAL-CELL CARCINOMA; UBIQUITIN LIGASE; GERMLINE MUTATIONS; GENE ALTERATIONS; ELONGIN-C; BINDING; PVHL; IDENTIFICATION	Background: von Hippel-Lindau disease is characterized by a spectrum of hypervascular tumors, including renal cell carcinoma, hemangioblastoma, and pheochromocytoma, which occur with VHL genotype-specific differences in penetrance. VHL loss causes a failure to regulate the hypoxia inducible factors (HIF-1 alpha and HIF-2 alpha), resulting in accumulation of both factors to high levels. Although HIF dysregulation is critical to VHL disease-associated renal tumorigenesis, increasing evidence points toward gradations of HIF dysregulation contributing to the degree of predisposition to renal cell carcinoma and other manifestations of the disease. Methodology/Principal Findings: This investigation examined the ability of disease-specific VHL missense mutations to support the assembly of the VBC complex and to promote the ubiquitylation of HIF. Our interaction analysis supported previous observations that VHL Type 2B mutations disrupt the interaction between pVHL and Elongin C but maintain partial regulation of HIF. We additionally demonstrated that Type 2B mutant pVHL forms a remnant VBC complex containing the active members ROC1 and Cullin-2 which retains the ability to ubiquitylate HIF-1 alpha. Conclusions: Our results suggest that subtypes of VHL mutations support an intermediate level of HIF regulation via a remnant VBC complex. These findings provide a mechanism for the graded HIF dysregulation and genetic predisposition for cancer development in VHL disease.	[Hacker, Kathryn E.; Lee, Caroline Martz; Rathmell, W. Kimryn] Univ N Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Dept Med, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Hacker, KE (corresponding author), Univ N Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Dept Med, Durham, NC USA.	Rathmell@med.unc.edu			VHL Family Alliance;  [F30 ES015248];  [R01 CA121781];  [K08 CA098410]; NATIONAL CANCER INSTITUTE [R01CA121781, K08CA098410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES015248] Funding Source: NIH RePORTER	VHL Family Alliance; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work has been supported by F30 ES015248 (CML), R01 CA121781 (WKR, KEH), K08 CA098410 (WKR), and the VHL Family Alliance (WKR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; CROSSEY PA, 1994, HUM MOL GENET, V3, P1303; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Hansen WJ, 2002, MOL CELL BIOL, V22, P1947, DOI 10.1128/MCB.22.6.1947-1960.2002; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Megumi Y, 2005, GENES CELLS, V10, P679, DOI 10.1111/j.1365-2443.2005.00869.x; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pastore YD, 2003, BLOOD, V101, P1591, DOI 10.1182/blood-2002-06-1843; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Rathmell WK, 2008, EXPERT REV ANTICANC, V8, P63, DOI 10.1586/14737140.8.1.63; Rathmell WK, 2004, CANCER RES, V64, P8595, DOI 10.1158/0008-5472.CAN-04-1430; Rathmell WK, 2005, J THROMB HAEMOST, V3, P2627, DOI 10.1111/j.1538-7836.2005.01441.x; Ritter MM, 1996, J CLIN ENDOCR METAB, V81, P1035, DOI 10.1210/jc.81.3.1035; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3	30	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2008	3	11							e3801	10.1371/journal.pone.0003801	http://dx.doi.org/10.1371/journal.pone.0003801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YD	19030229	gold, Green Published, Green Submitted			2022-12-25	WOS:000265451100001
J	de Bruyn, PJN; Bastos, ADS; Eadie, C; Tosh, CA; Bester, MN				de Bruyn, P. J. Nico; Bastos, Armanda D. S.; Eadie, Candice; Tosh, Cheryl A.; Bester, Marthan N.			Mass Mortality of Adult Male Subantarctic Fur Seals: Are Alien Mice the Culprits?	PLOS ONE			English	Article							ENCEPHALOMYOCARDITIS-VIRUS; HOUSE MICE; IDENTIFICATION; ARCTOCEPHALUS; LEPTOSPIRA; PATTERNS; SUSCEPTIBILITY; ELEPHANTS; DISEASE; BIOLOGY	Background: Mass mortalities of marine mammals due to infectious agents are increasingly reported. However, in contrast to previous die-offs, which were indiscriminate with respect to sex and age, here we report a land-based mass mortality of Subantarctic fur seals with apparent exclusivity to adult males. An infectious agent with a male-predilection is the most plausible explanation for this die-off. Although pathogens with gender-biased transmission and pathologies are unusual, rodents are known sources of male-biased infectious agents and the invasive Mus musculus house mouse, occurs in seal rookeries. Methodology/Principal Findings: Molecular screening for male-biased pathogens in this potential rodent reservoir host revealed the absence of Cardiovirus and Leptospirosis genomes in heart and kidney samples, respectively, but identified a novel Streptococcus species with 30% prevalence in mouse kidneys. Conclusions/Significance: Inter-species transmission through environmental contamination with this novel bacterium, whose congenerics display male-bias and have links to infirmity in seals and terrestrial mammals (including humans), highlights the need to further evaluate disease risks posed by alien invasive mice to native species, on this and other islands.	[de Bruyn, P. J. Nico; Bastos, Armanda D. S.; Eadie, Candice; Tosh, Cheryl A.; Bester, Marthan N.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	University of Pretoria	de Bruyn, PJN (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	pjndebruyn@zoology.up.ac.za	Tosh, Cheryl/D-5623-2016; De Bruyn, P.J.N./E-4176-2010; Bastos, Armanda/B-6357-2009; Bester, Marthán N/E-5387-2010	Tosh, Cheryl/0000-0003-0243-5422; De Bruyn, P.J.N./0000-0002-9114-9569; Bastos, Armanda/0000-0002-9223-4204; 	Department of Science and Technology, through the National Research Foundation (South Africa)	Department of Science and Technology, through the National Research Foundation (South Africa)(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	The Department of Science and Technology, through the National Research Foundation (South Africa), provided financial support.	Avenant NL, 2003, POLAR BIOL, V26, P129, DOI 10.1007/s00300-002-0464-x; Bastos ADS, 1998, ONDERSTEPOORT J VET, V65, P37; Baumann CD, 2001, J WILDLIFE DIS, V37, P661, DOI 10.7589/0090-3558-37.4.661; BESTER MN, 1990, J ZOOL, V222, P177, DOI 10.1111/j.1469-7998.1990.tb05670.x; BESTER MN, 1994, S AFR J ZOOL, V29, P168; BESTER MN, 1977, THESIS U PRETORIA; Cameron CE, 2008, J CLIN MICROBIOL, V46, P1728, DOI 10.1128/JCM.02022-07; CONDY PR, 1978, S AFR J WILDL RES, V8, P159; Fenwick SG, 2004, J WILDLIFE DIS, V40, P566, DOI 10.7589/0090-3558-40.3.566; FRIEDMAN SB, 1972, INFECT IMMUN, V5, P637, DOI 10.1128/IAI.5.5.637-644.1972; GROBLER DG, 1995, ONDERSTEPOORT J VET, V62, P97; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harwood J, 1998, NATURE, V393, P17, DOI 10.1038/29877; HEIDEJORGENSEN MP, 1992, J APPL ECOL, V29, P99, DOI 10.2307/2404353; Hofmeyr GJG, 2006, S AFR J WILDL RES, V36, P55; Hofmeyr GJG, 2007, S AFR J WILDL RES, V37, P1, DOI 10.3957/0379-4369-37.1.1; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; Hunter P, 1998, VACCINE, V16, P55, DOI 10.1016/S0264-410X(97)00158-8; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; Kerley G.J.H., 1987, NOAA Technical Report NMFS, V51, P61; KERLEY GIH, 1983, S AFR J WILDL RES, V13, P71; Kirkman SP, 2002, AFR ZOOL, V37, P13; Knox G. A., 2007, BIOL SO OCEAN; KYU B, 1992, CIRCULATION, V86, P522, DOI 10.1161/01.CIR.86.2.522; La Scola B, 2006, FEMS MICROBIOL LETT, V263, P142, DOI 10.1111/j.1574-6968.2006.00377.x; MATTHEWSON DC, 1994, S AFR J ZOOL, V29, P99; Matthias MA, 2005, AM J TROP MED HYG, V73, P964, DOI 10.4269/ajtmh.2005.73.964; MILLER E H, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P170; MILLER EH, 1975, BEHAVIOUR, V53, P268, DOI 10.1163/156853975X00227; Nikkari S, 2002, EMERG INFECT DIS, V8, P188, DOI 10.3201/eid0802.010150; OSHEA TJ, 1999, BIOL MARINE MAMMALS; Shin GY, 2005, HEART, V91, DOI 10.1136/hrt.2004.056762; Smith VR, 2002, POLAR BIOL, V25, P703, DOI 10.1007/s00300-002-0405-8; Smith VR, 2002, CLIMATIC CHANGE, V52, P345, DOI 10.1023/A:1013718617277; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMSON GR, 2001, INFECT DIS WILD MAMM, P124; van Vuuren BJ, 2007, POLAR BIOL, V30, P327, DOI 10.1007/s00300-006-0188-4; Vanderhallen H, 1998, J CLIN MICROBIOL, V36, P3463, DOI 10.1128/JCM.36.12.3463-3467.1998; Wickens P, 1997, MAR MAMMAL SCI, V13, P241, DOI 10.1111/j.1748-7692.1997.tb00631.x; WILLOUGHBY DS, 1964, J BACTERIOL, V87, P1457, DOI 10.1128/JB.87.6.1457-1461.1964	40	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3757	10.1371/journal.pone.0003757	http://dx.doi.org/10.1371/journal.pone.0003757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018284	gold, Green Published			2022-12-25	WOS:000265448500004
J	Krintel, C; Osmark, P; Larsen, MR; Resjo, S; Logan, DT; Holm, C				Krintel, Christian; Osmark, Peter; Larsen, Martin R.; Resjo, Svante; Logan, Derek T.; Holm, Cecilia			Ser649 and Ser650 Are the Major Determinants of Protein Kinase A-Mediated Activation of Human Hormone-Sensitive Lipase against Lipid Substrates	PLOS ONE			English	Article								Background: Hormone-sensitive lipase (HSL) is a key enzyme in the mobilization of fatty acids from stored triacylglycerols. Its activity is regulated by reversible protein phosphorylation. In rat HSL Ser563, Ser659 and Ser660 have been shown to be phosphorylated by protein kinase A (PKA) in vitro as well as in vivo. Methodology/Principal Findings: In this study we employed site-directed mutagenesis, in vitro phosphorylation and mass spectrometry to show that in vitro phosphorylation of human HSL by PKA occurs primarily on Ser649 and Ser650 (Ser659 and Ser660 in rat HSL). The wild type enzyme and four mutants were expressed in C-terminally His-tagged form in Sf9 insect cells and purified to homogeneity. HSL variants in which Ser552 and/or Ser554 were mutated to Ala or Glu retained both lipolytic and non-lipolytic activity and were phosphorylated by PKA and activated to a similar extent as the wild type enzyme. (32)P-labeling studies revealed that the bulk of the phosphorylation was on the Ser649/Ser650 site, with only a minor phosphorylation of Ser552 and Ser554. MS/MS analysis demonstrated that the peptide containing Ser649 and Ser650 was primarily phosphorylated on Ser650. The mutant lacking all four serines had severely reduced lipolytic activity, but a lesser reduction in non-lipolytic activity, had S(0.5) values for p-nitrophenol butyrate and triolein comparable to those of wild type HSL and was not phosphorylated by PKA. PKA phosphorylation of the wild type enzyme resulted in an increase in both the maximum turnover and S(0,5) using the TO substrate. Conclusions: Our results demonstrate that PKA activates human HSL against lipid substrates in vitro primarily through phosphorylation of Ser649 and Ser650. In addition the results suggest that Ser649 and Ser650 are located in the vicinity of a lipid binding region and that PKA phosphorylation controls the accessibility of this region.			Krintel, C (corresponding author), Lund Univ, Dept Expt Med Sci, Div Diabet Metab & Endocrinol, Lund, Sweden.	cecilia.holm@med.lu.se	Logan, Derek T/A-1114-2011; Logan, Derek/O-2497-2019; Larsen, Martin Rossel/F-1411-2015	Logan, Derek T/0000-0002-0098-8560; Logan, Derek/0000-0002-0098-8560; krintel, christian/0000-0001-5925-5639; Larsen, Martin Rossel/0000-0001-6203-0123				Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; BELFRAGE P, 1984, ADV CYCLIC NUCL PROT, V17, P351; Ben Ali Y, 2004, BIOCHEMISTRY-US, V43, P9298, DOI 10.1021/bi049479o; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chahinian H, 2005, BBA-MOL CELL BIOL L, V1738, P29, DOI 10.1016/j.bbalip.2005.11.003; Contreras JA, 1998, PROTEIN EXPRES PURIF, V12, P93, DOI 10.1006/prep.1997.0821; COOK KG, 1982, EUR J BIOCHEM, V125, P245, DOI 10.1111/j.1432-1033.1982.tb06675.x; COOK KG, 1983, BIOCHIM BIOPHYS ACTA, V752, P46, DOI 10.1016/0005-2760(83)90231-X; FELLER G, 1991, DNA CELL BIOL, V10, P381, DOI 10.1089/dna.1991.10.381; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; GARTON AJ, 1990, EUR J BIOCHEM, V191, P245, DOI 10.1111/j.1432-1033.1990.tb19116.x; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; HOLM C, 1994, PROTEIN ENG, V7, P537, DOI 10.1093/protein/7.4.537; Holm C, 1997, METHOD ENZYMOL, V284, P272; Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254; Kjellstrom S, 2004, ANAL CHEM, V76, P5109, DOI 10.1021/ac0400257; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; NILSSON NO, 1980, FEBS LETT, V111, P125, DOI 10.1016/0014-5793(80)80776-9; Osterlund T, 1999, J BIOL CHEM, V274, P15382, DOI 10.1074/jbc.274.22.15382; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shen WJ, 1998, BIOCHEMISTRY-US, V37, P8973, DOI 10.1021/bi980545u; STRALFORS P, 1983, J BIOL CHEM, V258, P5146; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Talanian JL, 2006, AM J PHYSIOL-REG I, V291, pR1094, DOI 10.1152/ajpregu.00130.2006; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; TORNQVIST H, 1978, J LIPID RES, V19, P654; TORNQVIST H, 1972, J LIPID RES, V13, P424; Wang J, 2005, BIOCHEMISTRY-US, V44, P1953, DOI 10.1021/bi049206t; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Watt MJ, 2003, J PHYSIOL-LONDON, V547, P301, DOI 10.1113/jphysiol.2002.034595	33	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3756	10.1371/journal.pone.0003756	http://dx.doi.org/10.1371/journal.pone.0003756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018281	Green Submitted, gold, Green Published			2022-12-25	WOS:000265448500003
J	Sundelacruz, S; Levin, M; Kaplan, DL				Sundelacruz, Sarah; Levin, Michael; Kaplan, David L.			Membrane Potential Controls Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article								Background: Control of stem cell behavior is a crucial aspect of developmental biology and regenerative medicine. While the functional role of electrophysiology in stem cell biology is poorly understood, it has become clear that endogenous ion flows represent a powerful set of signals by means of which cell proliferation, differentiation, and migration can be controlled in regeneration and embryonic morphogenesis. Methodology/Principal Findings: We examined the membrane potential (Vmem) changes exhibited by human mesenchymal stem cells (hMSCs) undergoing adipogenic ( AD) and osteogenic ( OS) differentiation, and uncovered a characteristic hyperpolarization of differentiated cells versus undifferentiated cells. Reversal of the progressive polarization via pharmacological modulation of transmembrane potential revealed that depolarization of hMSCs prevents differentiation. In contrast, treatment with hyperpolarizing reagents upregulated osteogenic markers. Conclusions/Significance: Taken together, these data suggest that the endogenous hyperpolarization is a functional determinant of hMSC differentiation and is a tractable control point for modulating stem cell function.	[Sundelacruz, Sarah; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Levin, Michael] Tufts Univ, Tufts Ctr Regenerat & Dev Biol, Dept Biol, Medford, MA 02155 USA	Tufts University; Tufts University	Sundelacruz, S (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Levin, Michael/A-5918-2011	Levin, Michael/0000-0001-7292-8084	NIH [P41 EB002520]; NHTSA [DTNH22-06-G-00001]; DARPA [W911NF-07-1-0572]; NSF; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHTSA; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We gratefully acknowledge support from NIH through the Tissue Engineering Resource Center (P41 EB002520) (D.K.), from NHTSA (DTNH22-06-G-00001) (M.L.), from DARPA (W911NF-07-1-0572) (M.L. and D.K.), and from NSF through the Graduate Research Fellowship Program (S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; Altizer AM, 2002, J EXP ZOOL, V293, P467, DOI 10.1002/jez.10141; Altizer AM, 2001, DEV DYNAM, V221, P391, DOI 10.1002/dvdy.1158; Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje; Arcangeli A, 1999, J NEUROBIOL, V40, P214; Arcangeli A, 1997, EUR J NEUROSCI, V9, P2596, DOI 10.1111/j.1460-9568.1997.tb01689.x; AUWERX J, 1992, CRIT REV CL LAB SCI, V29, P243, DOI 10.3109/10408369209114602; Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022; BECKER RO, 1972, B NEW YORK ACAD MED, V48, P627; Biagiotti T, 2006, STEM CELLS, V24, P443, DOI 10.1634/stemcells.2004-0264; BINGGELI R, 1986, J THEOR BIOL, V123, P377, DOI 10.1016/S0022-5193(86)80209-0; BORGENS RB, 1977, J EXP ZOOL, V200, P403, DOI 10.1002/jez.1402000310; BORGENS RB, 1979, J EXP ZOOL, V209, P377, DOI 10.1002/jez.1402090304; BORGENS RB, 1977, P NATL ACAD SCI USA, V74, P4528, DOI 10.1073/pnas.74.10.4528; BORGENS RB, 1987, J EXP ZOOL, V244, P203, DOI 10.1002/jez.1402440204; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; CONE C D JR, 1970, Oncology (Basel), V24, P438; CONE CD, 1971, J THEOR BIOL, V30, P151, DOI 10.1016/0022-5193(71)90042-7; CONE CD, 1971, ONCOLOGY-BASEL, V25, P168; Erdogan A, 2005, J VASC RES, V42, P368, DOI 10.1159/000087159; ERSKINE L, 1995, DEV BIOL, V171, P330, DOI 10.1006/dbio.1995.1285; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; FISHER LW, 1990, J BIOL CHEM, V265, P2347; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Heubach JF, 2004, J PHYSIOL-LONDON, V554, P659, DOI 10.1113/jphysiol.2003.055806; Hoenicke EM, 2001, J HEART LUNG TRANSPL, V20, P1106, DOI 10.1016/S1053-2498(01)00307-2; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Jenkins LS, 1996, DEV BIOL, V178, P251, DOI 10.1006/dbio.1996.0216; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Korsgaard MPG, 2001, PFLUG ARCH EUR J PHY, V443, P18, DOI 10.1007/s004240100625; Lawson K, 2000, KIDNEY INT, V57, P838, DOI 10.1046/j.1523-1755.2000.00923.x; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; Liu JH, 1998, J PHYSIOL-LONDON, V510, P467, DOI 10.1111/j.1469-7793.1998.467bk.x; Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCaig CD, 2000, DEV DYNAM, V217, P299, DOI 10.1002/(SICI)1097-0177(200003)217:3<299::AID-DVDY8>3.0.CO;2-G; MCCAIG CD, 1996, NERVE GROWTH GUIDANC, P151; Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010; Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021; NielsenKudsk JE, 1996, DAN MED BULL, V43, P429; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Nuccitelli R, 2003, RADIAT PROT DOSIM, V106, P375, DOI 10.1093/oxfordjournals.rpd.a006375; Olivotto M, 1996, BIOESSAYS, V18, P495, DOI 10.1002/bies.950180612; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; SMITH SD, 1974, ANN NY ACAD SCI, V238, P500, DOI 10.1111/j.1749-6632.1974.tb26816.x; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; STEWART R, 1995, DEV BIOL, V171, P340, DOI 10.1006/dbio.1995.1286; Sun W, 2005, STEM CELLS, V23, P931, DOI 10.1634/stemcells.2004-0316; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; van Kempen MJA, 2003, CELL PHYSIOL BIOCHEM, V13, P263, DOI 10.1159/000074541; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Xiong YM, 1995, SKIN PHARMACOL, V8, P309, DOI 10.1159/000211362; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x	63	177	184	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3737	10.1371/journal.pone.0003737	http://dx.doi.org/10.1371/journal.pone.0003737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011685	Green Submitted, Green Published, gold			2022-12-25	WOS:000265448300005
J	Huggins, A; Paschalidis, N; Flower, RJ; Perretti, M; D'Acquisto, F				Huggins, Anthony; Paschalidis, Nikolaos; Flower, Roderick J.; Perretti, Mauro; D'Acquisto, Fulvio			Annexin-1-deficient dendritic cells acquire a mature phenotype during differentiation	FASEB JOURNAL			English	Article						inflammation; antigen presenting cells; formyl peptide receptor ligand	NF-KAPPA-B; FORMYL PEPTIDE RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; LIPOXIN A(4) RECEPTOR; TOLL-LIKE RECEPTORS; CD4(+) T-CELLS; IN-VIVO; TRANSLATING INNATE; ADAPTIVE IMMUNITY; SIGNALING MODULE	Dendritic cells play a key role in the adaptive immune system by influencing T-cell differentiation. Annexin-1 (Anx-A1) has recently been shown to modulate the adaptive immune response by regulating T-cell activation and differentiation. Here we investigated the role of endogenous Anx-A1 in dendritic cells as major cellular counterpart of T-cell-driven immune response. We found that Anx-A1(-/-) bone marrow-derived dendritic cells show an increased number of CD11c(+) cells expressing high levels of some maturation markers, such as CD40, CD54, and CD80, coupled to a decreased capacity to take up antigen compared to control Anx-A1(+/+) cells. However, analysis of LPS-treated dendritic cells from Anx-A1(-/-) mice demonstrated a diminished up-regulation of maturation markers, a decreased migratory activity in vivo, and an attenuated production of the inflammatory cytokines interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha, and IL-12. This defect was also accompanied by impaired nuclear factor (NF)-kappa B/DNA-binding activity and lack of Anx-A1 signaling, as demonstrated by the reduced activation of extracellular-signal regulated kinase (ERK)1/2 and Akt compared to cells from control littermates. As a consequence of this phenotype, Anx-A1(-/-) dendritic cells showed an impaired capacity to stimulate T-cell proliferation and differentiation in mixed leukocyte reaction. Together, these findings suggest that inhibition of Anx-A1 expression or function in dendritic cells might represent a useful way to modulate the adaptive immune response and pathogen-induced T-cell-driven immune diseases.-Huggins, A., Paschalidis, N., Flower, R. J., Perretti, M., D'Acquisto, F. Annexin-1-deficient dendritic cells acquire a mature phenotype during differentiation. FASEB J. 23, 985-996 (2009)	[Huggins, Anthony; Paschalidis, Nikolaos; Flower, Roderick J.; Perretti, Mauro; D'Acquisto, Fulvio] Barts & London Med Sch, William Harvey Res Inst, London EC1M 6BQ, England	University of London; Queen Mary University London	D'Acquisto, F (corresponding author), Barts & London Med Sch, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	f.dacquisto@qmul.ac.uk	D'Acquisto, Fulvio/E-7204-2018	D'Acquisto, Fulvio/0000-0002-4513-1608; Paschalidis, Nikolaos/0000-0001-6278-4144	St. Bartholomew's and The Royal London Charitable foundation [RAB05/PJ/10]; Arthritis Research Campaign studentship [16125]; Medical Research Council UK; Medical Research Council [G0400327] Funding Source: researchfish; MRC [G0400327] Funding Source: UKRI	St. Bartholomew's and The Royal London Charitable foundation; Arthritis Research Campaign studentship(Versus Arthritis); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dr. Magali Perederzoli- Ribeil and Dr. Andre Sampaio for their scientific support. F. D. is supported by a New Investigator Award fellowship of the Medical Research Council UK. A. H. is supported by a studentship of the St. Bartholomew's and The Royal London Charitable foundation (RAB05/PJ/10). N. P. is supported by an Arthritis Research Campaign studentship (16125). Experimental work was supported by the St. Bartholomew's and The Royal London Charitable foundation (RAB05/PJ/10).	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bouma G, 2007, BLOOD, V110, P4278, DOI 10.1182/blood-2007-06-096875; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Clark GJ, 2000, MICROBES INFECT, V2, P257, DOI 10.1016/S1286-4579(00)00302-6; D'Acquisto F, 2008, RHEUMATOLOGY, V47, P636, DOI 10.1093/rheumatology/ken062; D'Acquisto F, 2007, EUR J IMMUNOL, V37, P3131, DOI 10.1002/eji.200636792; D'Acquisto F, 2007, BLOOD, V109, P1095, DOI 10.1182/blood-2006-05-022798; Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Gavins FNE, 2005, PROSTAG LEUKOTR ESS, V73, P211, DOI 10.1016/j.plefa.2005.05.008; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gripentrog JM, 2005, CELL SIGNAL, V17, P1300, DOI 10.1016/j.cellsig.2005.01.006; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Langenkamp A, 2002, EUR J IMMUNOL, V32, P2046, DOI 10.1002/1521-4141(200207)32:7<2046::AID-IMMU2046>3.0.CO;2-M; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Le YY, 2002, INT IMMUNOPHARMACOL, V2, P1, DOI 10.1016/S1567-5769(01)00150-3; Lindner I, 2007, ADV EXP MED BIOL, V590, P1; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Perretti M, 2003, TRENDS PHARMACOL SCI, V24, P574, DOI 10.1016/j.tips.2003.09.010; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rescher U, 2006, BBA-MOL CELL RES, V1763, P1320, DOI 10.1016/j.bbamcr.2006.08.041; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Sousa CRE, 2001, IMMUNITY, V14, P495; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; van Duivenvoorde LM, 2006, IMMUNOBIOLOGY, V211, P627, DOI 10.1016/j.imbio.2006.05.014; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wang ZG, 2002, GENE, V299, P57, DOI 10.1016/S0378-1119(02)01012-0; Yang D, 2002, J LEUKOCYTE BIOL, V72, P598; Yoshimura S, 2001, INT IMMUNOL, V13, P675, DOI 10.1093/intimm/13.5.675; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	52	36	38	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2009	23	4					985	996		10.1096/fj.08-119040	http://dx.doi.org/10.1096/fj.08-119040			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19029200				2022-12-25	WOS:000266651600003
J	Guhaniyogi, J; Sohar, I; Das, K; Stock, AM; Lobel, P				Guhaniyogi, Jayita; Sohar, Istvan; Das, Kalyan; Stock, Ann M.; Lobel, Peter			Crystal Structure and Autoactivation Pathway of the Precursor Form of Human Tripeptidyl-peptidase 1, the Enzyme Deficient in Late Infantile Ceroid Lipofuscinosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-CARBOXYL PEPTIDASE; HUMAN CLN2 PROTEIN; I IN-VITRO; X-RAY DATA; KUMAMOLISIN-AS; MOUSE MODEL; MACROMOLECULAR STRUCTURES; CATALYTIC-ACTIVITY; GENE-TRANSFER; ACTIVE-SITE	Late infantile neuronal ceroid lipofuscinosis is a fatal childhood neurological disorder caused by a deficiency in the lysosomal protease tripeptidyl-peptidase 1 (TPP1). TPP1 represents the only known mammalian member of the S53 family of serine proteases, a group characterized by a subtilisin-like fold, a Ser-Glu-Asp catalytic triad, and an acidic pH optimum. TPP1 is synthesized as an inactive proenzyme (pro-TPP1) that is proteolytically processed into the active enzyme after exposure to low pH in vitro or targeting to the lysosome in vivo. In this study, we describe an endoglycosidase H-deglycosylated form of TPP1 containing four Asn-linked N-acetylglucosamines that is indistinguishable from fully glycosylated TPP1 in terms of autocatalytic processing of the proform and enzymatic properties of the mature protease. The crystal structure of deglycosylated pro-TPP1 was determined at 1.85 angstrom resolution. A large 151-residue C-shaped prodomain makes extensive contacts as it wraps around the surface of the catalytic domain with the two domains connected by a 24-residue flexible linker that passes through the substrate-binding groove. The proenzyme structure reveals suboptimal catalytic triad geometry with its propiece linker partially blocking the substrate-binding site, which together serve to prevent premature activation of the protease. Finally, we have identified numerous processing intermediates and propose a structural model that explains the pathway for TPP1 activation in vitro. These data provide new insights into TPP1 function and represent a valuable resource for constructing improved TPP1 variants for treatment of late infantile neuronal ceroid lipofuscinosis.	[Guhaniyogi, Jayita; Sohar, Istvan; Das, Kalyan; Stock, Ann M.; Lobel, Peter] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Guhaniyogi, Jayita; Stock, Ann M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Sohar, Istvan; Lobel, Peter] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Das, Kalyan] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Stock, Ann M.] Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Howard Hughes Medical Institute	Lobel, P (corresponding author), 679 Hoes Lane, Piscataway, NJ 08854 USA.	stock@cabm.rutgers.edu; lobel@cabm.rutgers.edu	Das, Kalyan/O-9224-2019; Das, Kalyan/B-2967-2018	Das, Kalyan/0000-0002-8897-324X; Das, Kalyan/0000-0002-8897-324X; Stock, Ann/0000-0002-0446-8079	National Institutes of Health [NS037918]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017992, S10RR020932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS037918 (to P.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabrera-Salazar MA, 2007, MOL THER, V15, P1782, DOI 10.1038/sj.mt.6300249; Chang M, 2008, MOL THER, V16, P649, DOI 10.1038/mt.2008.9; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Comellas-Bigler M, 2004, STRUCTURE, V12, P1313, DOI 10.1016/j.str.2004.04.013; Comellas-Bigler M, 2002, STRUCTURE, V10, P865, DOI 10.1016/S0969-2126(02)00772-4; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Dauter Z, 2001, ACTA CRYSTALLOGR D, V57, P239, DOI 10.1107/S0907444900015249; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diemand AV, 2004, NUCLEIC ACIDS RES, V32, pW512, DOI 10.1093/nar/gkh403; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezaki J, 2000, BIOCHEM BIOPH RES CO, V268, P904, DOI 10.1006/bbrc.2000.2207; FERSHT A, 1999, STRUCTURE MECH PROTE, P144; Golabek AA, 2005, J BIOL CHEM, V280, P7550, DOI 10.1074/jbc.M412047200; Golabek AA, 2004, J BIOL CHEM, V279, P31058, DOI 10.1074/jbc.M400700200; Golabek AA, 2003, J BIOL CHEM, V278, P7135, DOI 10.1074/jbc.M211872200; Golabek AA, 2008, J BIOL CHEM, V283, P16497, DOI 10.1074/jbc.M800458200; Golabek AA, 2006, BIOL CHEM, V387, P1091, DOI 10.1515/BC.2006.135; Guo HB, 2006, BIOCHEMISTRY-US, V45, P9129, DOI 10.1021/bi060461i; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Junaid MA, 2000, J NEUROCHEM, V74, P287, DOI 10.1046/j.1471-4159.2000.0740287.x; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Khan AR, 1998, PROTEIN SCI, V7, P815; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Lin L, 2001, BIOCHEM J, V357, P49, DOI 10.1042/0264-6021:3570049; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MENARD R, 1992, BIOL CHEM H-S, V373, P393, DOI 10.1515/bchm3.1992.373.2.393; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okubo A, 2006, FEBS J, V273, P2563, DOI 10.1111/j.1742-4658.2006.05266.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAGE AE, 1993, ARCH BIOCHEM BIOPHYS, V306, P354, DOI 10.1006/abbi.1993.1523; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; PAL A, 2009, J BIOL CHEM IN PRESS, V264; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Passini MA, 2006, J NEUROSCI, V26, P1334, DOI 10.1523/JNEUROSCI.2676-05.2006; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rawlings ND, 1999, BBA-PROTEIN STRUCT M, V1429, P496, DOI 10.1016/S0167-4838(98)00238-6; REYNOLDS C, 2008, BIOINFORMATICS OXF; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sleat D E, 2001, Eur J Paediatr Neurol, V5 Suppl A, P57, DOI 10.1053/ejpn.2000.0436; Sleat DE, 1999, AM J HUM GENET, V64, P1511, DOI 10.1086/302427; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sohar I, 2000, CLIN CHEM, V46, P1005; SOHAR I, 2004, HDB PROTEOLYTIC ENZY, P1893; Sondhi D, 2008, EXP NEUROL, V213, P18, DOI 10.1016/j.expneurol.2008.04.022; Sondhi D, 2007, MOL THER, V15, P481, DOI 10.1038/sj.mt.6300049; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tian Y, 2006, J BIOL CHEM, V281, P6559, DOI 10.1074/jbc.M507336200; Tsiakas K, 2004, GLYCOBIOLOGY, V14, p1C, DOI 10.1093/glycob/cwh054; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walus M, 2005, FEBS LETT, V579, P1383, DOI 10.1016/j.febslet.2005.01.035; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Wlodawer A, 2004, J BIOL CHEM, V279, P21500, DOI 10.1074/jbc.M401141200; Wlodawer A, 2004, BIOCHEM BIOPH RES CO, V314, P638, DOI 10.1016/j.bbrc.2003.12.130; Wlodawer A, 2003, ACTA BIOCHIM POL, V50, P81; Wlodawer A, 2001, BIOCHEMISTRY-US, V40, P15602, DOI 10.1021/bi011817n; Wlodawer A, 2001, NAT STRUCT BIOL, V8, P442, DOI 10.1038/87610; Wlodawer Alexander, 2003, BMC Struct Biol, V3, P8, DOI 10.1186/1472-6807-3-8; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Wujek P, 2004, J BIOL CHEM, V279, P12827, DOI 10.1074/jbc.M313173200; Xu Q, 2007, BIOCHEMISTRY-US, V46, P3784, DOI 10.1021/bi061737p	81	40	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3985	3997		10.1074/jbc.M806943200	http://dx.doi.org/10.1074/jbc.M806943200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19038967	Green Published, hybrid			2022-12-25	WOS:000262872500067
J	Yanagimoto, S; Tatsuno, K; Okugawa, S; Kitazawa, T; Tsukada, K; Koike, K; Kodama, T; Kimura, S; Shibasaki, Y; Ota, Y				Yanagimoto, Shintaro; Tatsuno, Keita; Okugawa, Shu; Kitazawa, Takatoshi; Tsukada, Kunihisa; Koike, Kazuhiko; Kodama, Tatsuhiko; Kimura, Satoshi; Shibasaki, Yoshikazu; Ota, Yasuo			A Single Amino Acid of Toll-like Receptor 4 That Is Pivotal for Its Signal Transduction and Subcellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; ENDOPLASMIC-RETICULUM; CONTAINING ADAPTER; CUTTING EDGE; TLR4; MD-2; MOLECULE; PROTEIN; MUTATIONS; CD14	Toll-like receptor 4 (TLR4) is essential for recognizing a Gram-negative bacterial component, lipopolysaccharide (LPS). A single amino acid mutation at position 712 of murine TLR4 leads to hyporesponsiveness to LPS. In this study we determined that an amino acid, a leucine at position 815 of human TLR4, is also pivotal for LPS responsiveness and subcellular distribution. By replacing the leucine with alanine, the mutant TLR4 lost responsiveness to LPS and did not localize on the plasma membrane. In addition, it does not coprecipitate with myeloid differentiation-2, an accessory protein that is necessary for TLR4 to recognize LPS. These results suggest that the leucine at position 815 is required for the normal maturation of TLR4 and for formation of the TLR4.MD-2 complex.	[Ota, Yasuo] Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, Tokyo 1738605, Japan; [Yanagimoto, Shintaro; Shibasaki, Yoshikazu] Univ Tokyo, Grad Sch Arts & Sci, Ctr Structuring Life Sci, Meguro Ku, Tokyo 1538903, Japan; [Yanagimoto, Shintaro; Tatsuno, Keita; Okugawa, Shu; Kitazawa, Takatoshi; Tsukada, Kunihisa; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Infect Dis, Bunkyo Ku, Tokyo 1138655, Japan; [Yanagimoto, Shintaro; Kodama, Tatsuhiko] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Kimura, Satoshi] Tokyo Teishin Hosp, Chiyoda Ku, Tokyo 1028798, Japan	Teikyo University; University of Tokyo; University of Tokyo; University of Tokyo	Ota, Y (corresponding author), Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	yasuota-tky@umin.ac.jp		Okugawa, Shu/0000-0003-3455-8291	National Institute of Biomedical Innovation; New Energy and Industrial Technology Development Organization; Special Coordination Fund for Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology; Ministry of Education, Culture, Sports, Science and Technology	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Special Coordination Fund for Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by the Program of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, by the Focus 21 project of the New Energy and Industrial Technology Development Organization, and by the Special Coordination Fund for Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology. This study was also partly supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (to Y.O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Akashi S, 2000, BIOCHEM BIOPH RES CO, V268, P172, DOI 10.1006/bbrc.2000.2089; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Espevik T, 2003, SCAND J INFECT DIS, V35, P660, DOI 10.1080/00365540310016493; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Konno K, 2006, BIOCHEM BIOPH RES CO, V339, P1076, DOI 10.1016/j.bbrc.2005.11.123; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Muta T, 2001, EUR J BIOCHEM, V268, P4580, DOI 10.1046/j.1432-1327.2001.02385.x; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nishitani C, 2006, J BIOL CHEM, V281, P38322, DOI 10.1074/jbc.M606904200; Nishitania C, 2005, BIOCHEM BIOPH RES CO, V328, P586, DOI 10.1016/j.bbrc.2005.01.021; Nufer O, 2003, CURR BIOL, V13, pR391, DOI 10.1016/S0960-9822(03)00318-X; Ohnishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P405, DOI 10.1128/CDLI.10.3.405-410.2003; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Wakabayashi Y, 2006, J IMMUNOL, V177, P1772, DOI 10.4049/jimmunol.177.3.1772; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	33	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3513	3520		10.1074/jbc.M803086200	http://dx.doi.org/10.1074/jbc.M803086200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19064998	hybrid			2022-12-25	WOS:000262872500018
J	Thorner, AR; Hoadley, KA; Parker, JS; Winkel, S; Millikan, RC; Perou, CM				Thorner, A. R.; Hoadley, K. A.; Parker, J. S.; Winkel, S.; Millikan, R. C.; Perou, C. M.			In vitro and in vivo analysis of B-Myb in basal-like breast cancer	ONCOGENE			English	Article						B-Myb; MYBL2; breast cancer; basal-like	RETINOBLASTOMA TUMOR-SUPPRESSOR; CENTRAL-NERVOUS-SYSTEM; C-MYB; CELL-CYCLE; A-MYB; EXPRESSION SIGNATURE; MOLECULAR PORTRAITS; GENE; TRANSCRIPTION; SUBTYPES	A defining feature of basal-like breast cancer, a breast cancer subtype with poor clinical prognosis, is the high expression of 'proliferation signature' genes. We identified B-Myb, a MYB family transcription factor that is often amplified and overexpressed in many tumor types, as being highly expressed in the proliferation signature. However, the roles of B-Myb in disease progression, and its mammary-specific transcriptional targets, are poorly understood. Here, we showed that B-Myb expression is a significant predictor of survival and pathological complete response to neoadjuvant chemotherapy in breast cancer patients. We also identified a significant association between the G/G genotype of a nonsynonymous B-Myb germline variant (rs2070235, S427G) and an increased risk of basal-like breast cancer [OR 2.0, 95% CI (1.1-3.8)]. In immortalized, human mammary epithelial cell lines, but not in basal-like tumor lines, cells ectopically expressing wild-type B-Myb or the S427G variant showed increased sensitivity to two DNA topoisomerase II alpha inhibitors, but not to other chemotherapeutics. In addition, microarray analyses identified many G2/M genes as being induced in B-Myb overexpressing cells. These results confirm that B-Myb is involved in cell cycle control, and that its dysregulation may contribute to increased sensitivity to a specific class of chemotherapeutic agents. These data provide insight into the influence of B-Myb in human breast cancer, which is of potential clinical importance for determining disease risk and for guiding treatment.	[Perou, C. M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Thorner, A. R.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Winkel, S.; Millikan, R. C.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Perou, C. M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Perou, CM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, 450 West Dr, Chapel Hill, NC 27599 USA.	cperou@med.unc.edu	Perou, Charles M/H-9934-2014; Parker, Joel/AAG-1108-2019	Perou, Charles M/0000-0001-9827-2247; Hoadley, Katherine/0000-0002-1216-477X	NCI Breast SPORE [P50-CA5822309A1, RO1-CA-101227-01]; Breast Cancer Research Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA101227, P50CA058223] Funding Source: NIH RePORTER	NCI Breast SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Melissa A Troester and William K Kaufmann for comments and discussion. This work was supported by funds from the NCI Breast SPORE program (P50-CA5822309A1), by RO1-CA-101227-01, by the Breast Cancer Research Foundation and the V Foundation for Cancer Research.	Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Davidson CJ, 2005, GENETICS, V169, P215, DOI 10.1534/genetics.104.034132; Derenzini M, 2008, CLIN CANCER RES, V14, P2199, DOI 10.1158/1078-0432.CCR-07-2065; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hu ZY, 2005, BIOTECHNIQUES, V38, P121, DOI 10.2144/05381MT02; Ito M, 2001, PLANT CELL, V13, P1891, DOI 10.1105/tpc.13.8.1891; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Millikan R, 2003, BREAST CANCER RES TR, V79, P355, DOI 10.1023/A:1024068525763; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Ness SA, 2003, BLOOD CELL MOL DIS, V31, P192, DOI 10.1016/S1079-9796(03)00151-7; NEWMAN B, 1995, BREAST CANCER RES TR, V35, P51, DOI 10.1007/BF00694745; NOMURA N, 1988, NUCLEIC ACIDS RES, V16, P11075, DOI 10.1093/nar/16.23.11075; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Schwab R, 2008, ONCOGENE, V27, P2929, DOI 10.1038/sj.onc.1210947; SMITH PJ, 1994, BRIT J CANCER, V70, P914, DOI 10.1038/bjc.1994.420; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; TRAUTH K, 1994, EMBO J, V13, P5994, DOI 10.1002/j.1460-2075.1994.tb06945.x; Troester MA, 2004, CANCER RES, V64, P4218, DOI 10.1158/0008-5472.CAN-04-0107; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; VANEWIJK PH, 1993, ECOTOX ENVIRON SAFE, V25, P25, DOI 10.1006/eesa.1993.1003; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	44	73	74	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					742	751		10.1038/onc.2008.430	http://dx.doi.org/10.1038/onc.2008.430			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	19043454	Green Submitted, Green Accepted			2022-12-25	WOS:000263076400011
J	Picozzi, P; Wang, FX; Cronk, K; Ryan, K				Picozzi, Paola; Wang, Fengxiang; Cronk, Kevin; Ryan, Kenneth			Eomesodermin Requires Transforming Growth Factor-beta/Activin Signaling and Binds Smad2 to Activate Mesodermal Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-EOMESODERMIN; EXPRESSION; MOUSE; EFFECTOR; SPECIFICATION; INDUCTION; BRACHYURY	The T-box gene Eomesodermin (Eomes) is required for early embryonic mesoderm differentiation in mouse, frog (Xenopus laevis), and zebrafish, is important in late cardiac development in Xenopus, and for CD8(+) T effector cell function in mouse. Eomes can ectopically activate many mesodermal genes. However, the mechanism by which Eomes activates transcription of these genes is poorly understood. We report that Eomes protein interacts with Smad2 and is capable of working in a non-cell autonomous manner via transfer of Eomes protein between adjacent embryonic cells. Blocking of Eomes protein transfer using a farnesylated red fluorescent protein (CherryF) also prevents Eomes nuclear accumulation. Transfer of Eomes protein between cells is mediated by the Eomes carboxyl terminus (456-692). A carbohydrate binding domain within the Eomes carboxyl-terminal region is sufficient for transfer and important for gene activation. We propose a novel mechanism by which Eomes helps effect a cellular response to a morphogen gradient.	Childrens Hosp Philadelphia, Dept Pediat, Div Cardiol, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Ryan, K (corresponding author), 3615 Civ Ctr Blvd,Abramson Res Ctr,Rm 710A, Philadelphia, PA 19104 USA.	ryank@email.chop.edu			National Institutes of Health [HL070168, HL74731]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074731, R01HL070168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070168 and HL74731. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Ataliotis P, 2005, DEV DYNAM, V232, P979, DOI 10.1002/dvdy.20276; Bjornson CRR, 2005, DEV CELL, V9, P523, DOI 10.1016/j.devcel.2005.08.010; Bruce AEE, 2005, DEV DYNAM, V233, P105, DOI 10.1002/dvdy.20305; Bruce AEE, 2003, DEVELOPMENT, V130, P5503, DOI 10.1242/dev.00763; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Ciruna BG, 1999, MECH DEVELOP, V81, P199, DOI 10.1016/S0925-4773(98)00243-3; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Derynck R, 1996, CELL, V87, P173, DOI 10.1016/S0092-8674(00)81335-5; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Messenger NJ, 2005, DEV CELL, V8, P599, DOI 10.1016/j.devcel.2005.03.001; Newfeld SJ, 1996, DEVELOPMENT, V122, P2099; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ryan K, 2000, MECH DEVELOP, V94, P133, DOI 10.1016/S0925-4773(00)00300-2; Ryan K, 2004, HUM GENE THER, V15, P842, DOI 10.1089/hum.2004.15.842; Ryan K, 1998, MECH DEVELOP, V75, P155, DOI 10.1016/S0925-4773(98)00084-7; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Ryan Kenneth, 2003, Birth Defects Research, V69, P25, DOI 10.1002/bdrc.10001; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Spemann H, 2001, INT J DEV BIOL, V45, P13; Standley HJ, 2002, INT J DEV BIOL, V46, P993; Standley HJ, 2002, INT J DEV BIOL, V46, P279; Stennard F, 1999, MECH DEVELOP, V86, P87, DOI 10.1016/S0925-4773(99)00119-7; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tada M, 1997, DEVELOPMENT, V124, P2225; Wilson V, 2002, GENOME BIOL, V3, P30081, DOI [10.1186/gb-2002-3-6-reviews3008, DOI 10.1186/GB-2002-3-6-REVIEWS3008]	43	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2397	2408		10.1074/jbc.M808704200	http://dx.doi.org/10.1074/jbc.M808704200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19036723	Green Published, hybrid			2022-12-25	WOS:000262545600048
J	Yagi, H; Kajiwara, N; Iwabuchi, T; Izumi, K; Yoshida, M; Akutsu, H				Yagi, Hiromasa; Kajiwara, Nobumoto; Iwabuchi, Tomoyuki; Izumi, Kenya; Yoshida, Masasuke; Akutsu, Hideo			Stepwise Propagation of the ATP-induced Conformational Change of the F-1-ATPase beta Subunit Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOPHILIC BACILLUS PS3; ESCHERICHIA-COLI F-1-ATPASE; BOVINE HEART-MITOCHONDRIA; GLYCINE-RICH SEQUENCE; 3 CATALYTIC SITES; H+-ATPASE; NUCLEOTIDE-BINDING; DIPOLAR COUPLINGS; F1-ATPASE; SYNTHASE	The rotation of F1-ATPase (F1) is driven by the open/close bending motion of the beta subunit. The mechanism underlying the bending motion was investigated for the F-1 beta monomer from thermophilic Bacillus PS3 (TF1 beta) in solution, using mutagenesis and NMR. The hydrogen bond networks involving the side chains of Lys-164 (numbering forTF(1)beta; 162 for mitochondrial F-1 beta in parentheses), Thr-165(163), Arg-191(189), Asp-252(256), Asp-311(315), and Arg-333(337) in the catalytic region are significantly different for the ligand-bound and free beta subunits in the crystal structures of mitochondrial F1. The role of each amino acid residue was examined by Ala substitution. beta(K164A) reduced the affinity constant for 5'-adenyl-beta,gamma-imidodiphosphate by 20-fold and abolished the conformational change associated with nucleotide binding and the ATPase activity of alpha(3)beta(K164A)(3)gamma.beta(T165A) and beta(D252A) exhibited no effect on the binding affinity but abolished the conformational change and the ATPase activity. The chemical shift perturbation of backbone amide signals of the segmentally labeled beta(mutant)s indicated stepwise propagation of the open/close conversion on ligand binding. The key action in the conversion is the switching of the hydrogen-bonding partner of Asp-252 from Lys164 to Thr-165. Residual dipolar coupling analysis revealed that the closed conformation of the beta monomer was more closed than that in the crystal structure and was different for MgATP-and MgADP-bound beta subunits. Actually, MgATP induced a conformational change around Tyr-307 (311 for MF1 beta), whereas MgADP did not. The significance of these findings is discussed in connection with the catalytic rotation of F1-ATPase.	[Yagi, Hiromasa; Kajiwara, Nobumoto; Izumi, Kenya; Akutsu, Hideo] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Iwabuchi, Tomoyuki] Yokohama Natl Univ, Fac Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Yoshida, Masasuke] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan	Osaka University; Yokohama National University; Tokyo Institute of Technology	Akutsu, H (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	akutsu@protein.osaka-u.ac.jp	Yagi, Hiromasa/H-9253-2017	Akutsu, Hideo/0000-0001-7236-5285	Scientific research on priority areas; Ministry of Education, Science, Technology, Sport, and Culture of Japan; Japan Science and Technology Agency	Scientific research on priority areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Science, Technology, Sport, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by grants-in-aid for scientific research on priority areas (to H. A.) and grants-in-aid for young scientists (B) (to H. Y.) from the Ministry of Education, Science, Technology, Sport, and Culture of Japan and grants from the Japan Science and Technology Agency (Target Protein Program (to H. A. and M. Y.) and ERATO (to M. Y.)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Aggeler R, 1997, J BIOL CHEM, V272, P19621, DOI 10.1074/jbc.272.31.19621; Ahmad Z, 2004, J BIOL CHEM, V279, P31505, DOI 10.1074/jbc.M404621200; Bandyopadhyay S, 2002, BIOCHEMISTRY-US, V41, P14421, DOI 10.1021/bi026243g; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Dou C, 1998, BIOCHEMISTRY-US, V37, P16757, DOI 10.1021/bi981717q; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; Masaike T, 2002, J BIOL CHEM, V277, P21643, DOI 10.1074/jbc.M110297200; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; MIWA K, 1989, P NATL ACAD SCI USA, V86, P6484, DOI 10.1073/pnas.86.17.6484; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P7670, DOI 10.1021/bi990663x; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; ODAKA M, 1994, J BIOCHEM-TOKYO, V115, P789, DOI 10.1093/oxfordjournals.jbchem.a124410; ODAKA M, 1993, FEBS LETT, V336, P231, DOI 10.1016/0014-5793(93)80809-9; OMOTE H, 1992, J BIOL CHEM, V267, P20571; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PARK MY, 1994, J BIOCHEM-TOKYO, V116, P1139, DOI 10.1093/oxfordjournals.jbchem.a124640; Ren HM, 2000, J BIOL CHEM, V275, P10057, DOI 10.1074/jbc.275.14.10057; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; SENIOR AE, 1993, J BIOL CHEM, V268, P6989; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; TAKEYAMA M, 1990, J BIOL CHEM, V265, P21279; Tolman JR, 1997, NAT STRUCT BIOL, V4, P292, DOI 10.1038/nsb0497-292; TOZAWA K, 1992, J BIOL CHEM, V267, P16484; Tozawa K, 2001, J BIOCHEM, V130, P527, DOI 10.1093/oxfordjournals.jbchem.a003015; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEBER J, 1993, J BIOL CHEM, V268, P20126; Yagi H, 2004, J AM CHEM SOC, V126, P16632, DOI 10.1021/ja045279o; Yagi H, 1999, BIOPHYS J, V77, P2175, DOI 10.1016/S0006-3495(99)77057-8; Yamazaki T, 1998, J AM CHEM SOC, V120, P5591, DOI 10.1021/ja980776o; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 2003, P NATL ACAD SCI USA, V100, P9314, DOI 10.1073/pnas.1637860100; YOHDA M, 1988, BIOCHIM BIOPHYS ACTA, V933, P156, DOI 10.1016/0005-2728(88)90065-5; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; YOSHIDA M, 1990, J BIOL CHEM, V265, P2483	46	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2374	2382		10.1074/jbc.M808212200	http://dx.doi.org/10.1074/jbc.M808212200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028677	hybrid			2022-12-25	WOS:000262545600046
J	Kumar, D; Ray, A; Ray, BK				Kumar, Deepak; Ray, Alpana; Ray, Bimal K.			Transcriptional Synergy Mediated by SAF-1 and AP-1 CRITICAL ROLE OF N-TERMINAL POLYALANINE AND TWO ZINC FINGER DOMAINS OF SAF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-ACTIVATING FACTOR; PROTEIN-KINASE-A; C-FOS/C-JUN; GENE-EXPRESSION; MONOCYTE/MACROPHAGE CELLS; MATRIX METALLOPROTEINASES; FUNCTIONAL COOPERATION; SIGNALING PATHWAY; SYNOVIOCYTE CELLS; DNA ELEMENTS	Previously we determined that inflammation responsive transcription factors AP-1 and SAF-1 synergistically regulate transcriptional induction of the MMP-1 gene. The present study investigated the underlying molecular mechanism of cooperativity between these two different groups of transcription factors. We present evidence that knockdown of SAF-1 by small interfering RNAs inhibits AP-1-mediated increase of human MMP-1 expression. The two key members of the AP-1 family of proteins, c-Fos and c-Jun, and SAF-1 form a ternary protein complex, which has markedly higher DNA binding activity than either a SAF-1 homodimer or a c-Fos/c-Jun heterodimer. The increased DNA binding activity of the ternary complex is translated into a striking enhancement of their transcriptional activity by which synergistic transcriptional induction of MMP-1 expression is achieved. The SAF-1.c-Fos.c-Jun ternary complex efficiently promotes transcription from both SAF-1 and AP-1 sites of human MMP-1 promoter. The physical interaction between SAF-1 and AP-1 was demonstrated both in vitro by Far-Western and antibody pulldown assays with recombinant proteins and in vivo by chromatin immunoprecipitation (ChIP), re-ChIP, and co-immunoprecipitation analyses. Two distinct but adjacent domains in SAF-1 are involved in protein-protein contact with c-Fos and c-Jun; one domain resides within two N-terminal polyalanine tracts, and the other is present within the first two zinc finger motifs. Together these findings delineate the mechanism of synergy and the essential role of SAF-1 and AP-1 in up-regulating human MMP-1 expression under various inflammatory conditions.	[Kumar, Deepak; Ray, Alpana; Ray, Bimal K.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Ray, A (corresponding author), Univ Missouri, Dept Vet Pathobiol, 126 Connaway Hall, Columbia, MO 65211 USA.	rayal@missouri.edu; rayb@missouri.edu						ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; BASSUK AG, 1995, IMMUNITY, V3, P223, DOI 10.1016/1074-7613(95)90092-6; Basuyaux JP, 1997, J BIOL CHEM, V272, P26188, DOI 10.1074/jbc.272.42.26188; Berend KR, 1998, J BONE JOINT SURG AM, V80A, P11, DOI 10.2106/00004623-199801000-00004; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; BLANAR MA, 1992, SCIENCE, V256, P1014, DOI 10.1126/science.1589769; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; EHRLICH MG, 1985, J ORTHOP RES, V3, P170, DOI 10.1002/jor.1100030206; Ferguson HA, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.20.e98; Fry CJ, 1999, J BIOL CHEM, V274, P29583, DOI 10.1074/jbc.274.42.29583; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; GUTMAN A, 1991, TRENDS GENET, V7, P49, DOI 10.1016/0168-9525(91)90231-E; Hancock JM, 2005, GENE, V345, P113, DOI 10.1016/j.gene.2004.11.023; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Kampfer S, 1998, EMBO J, V17, P4046, DOI 10.1093/emboj/17.14.4046; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; Ray A, 1999, J BIOL CHEM, V274, P4300, DOI 10.1074/jbc.274.7.4300; Ray A, 2005, BBA-GENE STRUCT EXPR, V1732, P53, DOI 10.1016/j.bbaexp.2005.11.004; RAY A, 1995, J BIOL CHEM, V270, P7365, DOI 10.1074/jbc.270.13.7365; Ray A, 2005, J IMMUNOL, V175, P4039, DOI 10.4049/jimmunol.175.6.4039; Ray A, 1998, MOL CELL BIOL, V18, P7327, DOI 10.1128/MCB.18.12.7327; Ray A, 2003, ARTHRITIS RHEUM, V48, P134, DOI 10.1002/art.10706; Ray A, 2003, J BIOL CHEM, V278, P22586, DOI 10.1074/jbc.M300705200; Ray A, 2002, MOL CELL BIOL, V22, P1027, DOI 10.1128/MCB.22.4.1027-1035.2002; Ray A, 1996, MOL CELL BIOL, V16, P1584; Ray A, 2000, J BIOL CHEM, V275, P39727, DOI 10.1074/jbc.M007907200; Ray BK, 1999, DNA CELL BIOL, V18, P65, DOI 10.1089/104454999315637; Ray BK, 2001, J IMMUNOL, V167, P2343, DOI 10.4049/jimmunol.167.4.2343; Ray BK, 1997, BIOCHEMISTRY-US, V36, P4662, DOI 10.1021/bi9624595; Sambrook J, 2001, MOL CLONING LAB MANU; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Utsch B, 2002, HUM GENET, V110, P488, DOI 10.1007/s00439-002-0712-8; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	44	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1853	1862		10.1074/jbc.M806289200	http://dx.doi.org/10.1074/jbc.M806289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028685	hybrid			2022-12-25	WOS:000262330100056
J	Le Clech, M				Le Clech, Mikael			Role of CAP350 in Centriolar Tubule Stability and Centriole Assembly	PLOS ONE			English	Article								Background: Centrioles are microtubule-based cylindrical structures composed of nine triplet tubules and are required for the formation of the centrosome, flagella and cilia. Despite theirs importance, centriole biogenesis is poorly understood. Centrosome duplication is initiated at the G1/S transition by the sequential recruitment of a set of conserved proteins under the control of the kinase Plk4. Subsequently, the procentriole is assembled by the polymerization of centriolar tubules via an unknown mechanism involving several tubulin paralogs. Methodology/Principal Findings: Here, we developed a cellular assay to study centrosome duplication and procentriole stability based on its sensitivity to the microtubule-depolymerizing drug nocodazole. By using RNA interference experiments, we show that the stability of growing procentrioles is regulated by the microtubule-stabilizing protein CAP350, independently of hSAS-6 and CPAP which initiate procentriole growth. Furthermore, our analysis reveals the critical role of centriolar tubule stability for an efficient procentriole growth. Conclusions/Significance: CAP350 belongs to a new class of proteins which associate and stabilize centriolar tubules to control centriole duplication.			Le Clech, M (corresponding author), CNRS, Inst Genet Humaine, UPR 1142, Montpellier, France.	mikael.leclech@igh.cnrs.fr			Max Planck society [postdoctoral fellowship]	Max Planck society(Max Planck Society)	This work was supported by the Max Planck society. M Le CLech was a recipient of a postdoctoral fellowship from the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.0.CO;2-7; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Dupuis-Williams P, 2002, J CELL BIOL, V158, P1183, DOI 10.1083/jcb.200205028; Dutcher SK, 2002, MOL BIOL CELL, V13, P3859, DOI 10.1091/mbc.E02-04-0205; Hoppeler-Lebel A, 2007, J CELL SCI, V120, P3299, DOI 10.1242/jcs.013102; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; KURIYAMA R, 1982, J CELL SCI, V53, P155; Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lohret TA, 1998, MOL BIOL CELL, V9, P1195, DOI 10.1091/mbc.9.5.1195; Marshall WF, 2003, CURR BIOL, V13, pR55, DOI 10.1016/S0960-9822(02)01427-6; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Regnard C, 1999, J CELL SCI, V112, P4281; ROBBINS E, 1968, J CELL BIOL, V36, P329, DOI 10.1083/jcb.36.2.329; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Tachibana KEK, 2005, EMBO REP, V6, P1052, DOI 10.1038/sj.embor.7400527; Uetake Y, 2007, CURR BIOL, V17, P2081, DOI 10.1016/j.cub.2007.10.065; WENDELL KL, 1993, J CELL SCI, V104, P261; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3855	10.1371/journal.pone.0003855	http://dx.doi.org/10.1371/journal.pone.0003855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052644	Green Published, gold			2022-12-25	WOS:000265452200007
J	Luo, HW; Shi, J; Arndt, W; Tang, JJ; Friedman, R				Luo, Haiwei; Shi, Jian; Arndt, William; Tang, Jijun; Friedman, Robert			Gene Order Phylogeny of the Genus Prochlorococcus	PLOS ONE			English	Article							RECONSTRUCTION; ECOTYPES; TREE	Background: Using gene order as a phylogenetic character has the potential to resolve previously unresolved species relationships. This character was used to resolve the evolutionary history within the genus Prochlorococcus, a group of marine cyanobacteria. Methodology/Principal Findings: Orthologous gene sets and their genomic positions were identified from 12 species of Prochlorococcus and 1 outgroup species of Synechococcus. From this data, inversion and breakpoint distance-based phylogenetic trees were computed by GRAPPA and FastME. Statistical support of the resulting topology was obtained by application of a 50% jackknife resampling technique. The result was consistent and congruent with nucleotide sequence-based and gene-content based trees. Also, a previously unresolved clade was resolved, that of MIT9211 and SS120. Conclusions/Significance: This is the first study to use gene order data to resolve a bacterial phylogeny at the genus level. It suggests that the technique is useful in resolving the Tree of Life.	[Luo, Haiwei; Friedman, Robert] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Shi, Jian; Arndt, William; Tang, Jijun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Luo, HW (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	bobf@biol.sc.edu	Luo, Haiwei/AAE-1958-2021; Tang, Jijun/ABH-6528-2020	Luo, Haiwei/0000-0001-8452-6066; Friedman, Robert/0000-0002-1061-4909	National Institutes of Health [GM078991, GM43940]; University of South Carolina; NSF [CNS 0708391]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043940, R01GM078991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants GM078991 and GM43940 from the National Institutes of Health; University of South Carolina startup funds; and NSF grant CNS 0708391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bapteste E, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-33; Bapteste E, 2004, TRENDS MICROBIOL, V12, P406, DOI 10.1016/j.tim.2004.07.002; Belda E, 2005, MOL BIOL EVOL, V22, P1456, DOI 10.1093/molbev/msi134; Blanchette M, 1999, J MOL EVOL, V49, P193, DOI 10.1007/PL00006542; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; FELSENSTEIN J, 1989, PHYLIP PHYLOGENY INF, V5, P164; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Moret B M, 2001, Bioinformatics, V17 Suppl 1, pS165; Moret BME, 2002, J COMPUT SYST SCI, V65, P508, DOI 10.1016/S0022-0000(02)00007-7; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Palmer Jeffrey D., 1992, P99; RAUBESON LA, 1992, SCIENCE, V255, P1697, DOI 10.1126/science.255.5052.1697; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang LS, 2006, J MOL EVOL, V63, P473, DOI 10.1007/s00239-005-0216-y	26	22	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3837	10.1371/journal.pone.0003837	http://dx.doi.org/10.1371/journal.pone.0003837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050756	Green Published, gold, Green Submitted			2022-12-25	WOS:000265452100003
J	Mazzaccara, C; Labruna, G; Cito, G; Scarfo, M; De Felice, M; Pastore, L; Sacchetti, L				Mazzaccara, Cristina; Labruna, Giuseppe; Cito, Gennaro; Scarfo, Marzia; De Felice, Mario; Pastore, Lucio; Sacchetti, Lucia			Age-Related Reference Intervals of the Main Biochemical and Hematological Parameters in C57BL/6J, 129SV/EV and C3H/HeJ Mouse Strains	PLOS ONE			English	Article								Background: Although the mouse is the animal model most widely used to study the pathogenesis and treatment of human diseases, reference values for biochemical parameters are scanty or lacking for the most frequently used strains. We therefore evaluated these parameters in the C57BL/6J, 129SV/EV and C3H/HeJ mice. Methodology/Principal Findings: We measured by dry chemistry 26 analytes relative to electrolyte balance, lipoprotein metabolism, and muscle/heart, liver, kidney and pancreas functions, and by automated blood counter 5 hematological parameters in 30 animals (15 male and 15 female) of each mouse strain at three age ranges: 1-2 months, 3-8 months and 9 12 months. Whole blood was collected from the retro-orbital sinus. We used quality control procedures to investigate analytical imprecision and inaccuracy. Reference values were calculated by non parametric methods (median and 2.5(th) and 97.5(th) percentiles). The Mann-Whitney and Kruskal-Wallis tests were used for between-group comparisons. Median levels of GLU, LDH, Chol and BUN were higher, and LPS, AST, ALP and CHE were lower in males than in females (p range: 0.05-0.001). Inter-strain differences were observed for: (1) GLU, t-Bil, K(+), Ca(++), PO(4)(-) (p<0.05) and for TAG, Chol, AST, Fe(++) (p<0.001) in 4-8 month-old animals; (2) for CK, Crea, Mg(++), Na(++), K(+), Cl(-) (p<0.05) and BUN (p<0.001) in 2-and in 10-12 month-old mice; and (3) for WBC, RBC, HGB, HCT and PLT (p<0.05) during the 1 year life span. Conclusion/Significance: Our results indicate that metabolic variations in C57BL/6J, 129SV/EV and C3H/HeJ mice after therapeutic intervention should be evaluated against gender-and age-dependent reference intervals.	[Mazzaccara, Cristina; Labruna, Giuseppe; Pastore, Lucio; Sacchetti, Lucia] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, Naples, Italy; [Cito, Gennaro; Scarfo, Marzia; De Felice, Mario] Biogem SCaRL, Naples, Italy	University of Naples Federico II	Mazzaccara, C (corresponding author), Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, Naples, Italy.	sacchetti@dbbm.unina.it	Pastore, Lucio/F-4668-2010; Pastore, Lucio/AAF-3487-2019; Labruna, Giuseppe/K-6670-2016; Mazzaccara, Cristina/AAC-5361-2022	Pastore, Lucio/0000-0001-6894-9317; Labruna, Giuseppe/0000-0002-4436-846X; Mazzaccara, Cristina/0000-0001-7774-2799	Centro di Eccellenza MIUR; Centro di ricerca per lo studio di malattie genetiche dell'uomo e loro modelli cellulari e animali; CEINGE-Regione Campania; Ministero Salute	Centro di Eccellenza MIUR; Centro di ricerca per lo studio di malattie genetiche dell'uomo e loro modelli cellulari e animali; CEINGE-Regione Campania; Ministero Salute(Ministry of Health, Italy)	This work was supported by grants from Centro di Eccellenza MIUR ex. D.M. 11/2000, Centro di ricerca per lo studio di malattie genetiche dell'uomo e loro modelli cellulari e animali. Grants from CEINGE-Regione Campania (Convenzione del G.R. 29/12/2007), from MUR art. 5.2 and from Ministero Salute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehm O, 2007, BIOL CHEM, V388, P547, DOI 10.1515/BC.2007.061; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; CRAIGEN WJ, 2001, METABOLIC MOL BASES, P379; HARRISON SD, 1978, CANCER RES, V38, P2636; Kile BT, 2003, MAMM GENOME, V14, P81, DOI 10.1007/s00335-002-2160-0; *MOUS PHEN, MOUS PHEN DAT; *NAT RES COUNC, 1985, GUID CAR US LAB AN; Schnell MA, 2002, HUM GENE THER, V13, P155, DOI 10.1089/10430340152712700; Zhou XH, 2004, COMPARATIVE MED, V54, P176	9	71	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3772	10.1371/journal.pone.0003772	http://dx.doi.org/10.1371/journal.pone.0003772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020657	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448600005
J	Harja, E; Chang, JS; Lu, Y; Leitges, M; Zou, YS; Schmidt, AM; Yan, SF				Harja, Evis; Chang, Jong Sun; Lu, Yan; Leitges, Michael; Zou, Yu Shan; Schmidt, Ann Marie; Yan, Shi-Fang			Mice deficient in PKC beta and apolipoprotein E display decreased atherosclerosis	FASEB JOURNAL			English	Article						signal transduction; MMP-2; JNK; Egr-1	KINASE-C-BETA; LOW-DENSITY-LIPOPROTEIN; NH2-TERMINAL PROTEIN-KINASES; EARLY GROWTH RESPONSE-1; SMOOTH-MUSCLE-CELLS; GLUCOSE-TRANSPORT; RETINAL HEMODYNAMICS; INCREASED EXPRESSION; MESANGIAL CELLS; DIABETIC-RATS	Endothelial activation is a central initiating event in atheroma formation. Evidence from our laboratory and others has demonstrated links between activation of early growth response-1 (Egr-1) and atherosclerosis and also has demonstrated that activated protein kinase C (PKC) beta II is a critical upstream regulator of Egr-1 in response to vascular stress. We tested the role of PKC beta in regulating key events linked to atherosclerosis and show that the aortas of apoE(-/-) mice display an age-dependent increase in PKC beta II antigen in membranous fractions vs. C57BL/6 animals with a similar to 2-fold increase at age 6 wk and a similar to 4.5-fold increase at age 24 wk. Consistent with important roles for PKC beta in atherosclerosis, a significant decrease in atherosclerotic lesion area was evident in PKC beta(-/-)/apoE(-/-) vs. apoE(-/-) mice by similar to 5-fold, in parallel with significantly reduced vascular transcripts for Egr-1 and matrix metalloproteinase (MMP)-2 antigen and activity vs. apoE(-/-) mice. Significant reduction in atherosclerosis of similar to 2-fold was observed in apoE(-/-) mice fed ruboxistaurin chow (PKC beta inhibitor) vs. vehicle. In primary murine and human aortic endothelial cells, the PKC beta-JNK mitogen-activated protein kinase pathway importantly contributes to oxLDL-mediated induction of MMP2 expression. Blockade of PKC beta may be beneficial in mitigating endothelial perturbation and atherosclerosis.-Harja, E., Chang, J. S., Lu, Y., Leitges, M., Zou, Y. S., Schmidt, A. M., Yan, S.-F. Mice deficient in PKC beta and apolipoprotein E display decreased atherosclerosis. FASEB J. 23, 1081-1091 (2009)	[Yan, Shi-Fang] Columbia Univ, Dept Surg, Coll Phys & Surg, Div Surg Sci, New York, NY 10032 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway	Columbia University; University of Oslo	Yan, SF (corresponding author), Columbia Univ, Dept Surg, Coll Phys & Surg, Div Surg Sci, 630 W 168th St,BB1705, New York, NY 10032 USA.	sy18@columbia.edu	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995	LeDucq Foundation; Surgical Research Fund of Columbia University; National Heart, Lung, and Blood Institute [RO1 HL073325, HL60901]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060901, R01HL073325] Funding Source: NIH RePORTER	LeDucq Foundation(Leducq Foundation); Surgical Research Fund of Columbia University; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge grant support provided by the LeDucq Foundation, the Surgical Research Fund of Columbia University, and National Heart, Lung, and Blood Institute grants (RO1 HL073325) and (HL60901). We are grateful to L. Woods for her expert assistance in preparation of the manuscript.	ADLER V, 1995, CELL GROWTH DIFFER, V6, P1437; Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; Beckman JA, 2002, CIRC RES, V90, P107, DOI 10.1161/hh0102.102359; Braiman L, 1999, DIABETES, V48, P1922, DOI 10.2337/diabetes.48.10.1922; Bursell SE, 1997, INVEST OPHTH VIS SCI, V38, P2711; Chait A, 1992, CURR OPIN LIPIDOL, V3, P389; Danis RP, 1998, INVEST OPHTH VIS SCI, V39, P171; Erl W, 1998, ATHEROSCLEROSIS, V136, P297, DOI 10.1016/S0021-9150(97)00223-2; Fischer B, 2002, J IMMUNOL, V168, P2828, DOI 10.4049/jimmunol.168.6.2828; Fujita T, 2004, J CLIN INVEST, V113, P1615, DOI 10.1172/JCI200419225; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Griendling KK, 1997, CIRCULATION, V96, P3264; Hamada K, 1998, J BIOL CHEM, V273, P6334, DOI 10.1074/jbc.273.11.6334; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Hein TW, 2000, AM J PHYSIOL-HEART C, V278, pH175, DOI 10.1152/ajpheart.2000.278.1.H175; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Hu YH, 1997, J BIOL CHEM, V272, P9113; Idris I, 2001, DIABETOLOGIA, V44, P659, DOI 10.1007/s001250051675; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Kalra VK, 1996, AM J PHYSIOL-HEART C, V271, pH2025, DOI 10.1152/ajpheart.1996.271.5.H2025; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Koya D, 2000, FASEB J, V14, P439, DOI 10.1096/fasebj.14.3.439; Kreuzer J, 1996, J MOL MED-JMM, V74, P161; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; Metzler B, 2000, AM J PATHOL, V156, P1875, DOI 10.1016/S0002-9440(10)65061-4; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; MOREL DW, 1983, J LIPID RES, V24, P1070; Nakamura J, 1999, DIABETES, V48, P2090, DOI 10.2337/diabetes.48.10.2090; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Nishio H, 2001, HISTOCHEM J, V33, P167, DOI 10.1023/A:1017952310800; Park CW, 2000, DIABETOLOGIA, V43, P1544, DOI 10.1007/s001250051567; Park JY, 2000, DIABETES, V49, P1239, DOI 10.2337/diabetes.49.7.1239; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Reusch HP, 1997, BIOCHEM BIOPH RES CO, V237, P239, DOI 10.1006/bbrc.1997.7121; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Seguin CA, 2008, SPINE, V33, P356, DOI 10.1097/BRS.0b013e3181642a5e; SHARMA K, 1995, BIOCHEM BIOPH RES CO, V207, P80, DOI 10.1006/bbrc.1995.1156; Standaert ML, 1999, ENDOCRINOLOGY, V140, P4470, DOI 10.1210/en.140.10.4470; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Takagi C, 1996, INVEST OPHTH VIS SCI, V37, P2504; Yan SF, 2000, J BIOL CHEM, V275, P11921, DOI 10.1074/jbc.275.16.11921; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; YUE TL, 1980, EUR J PHARMACOL, V345, P61	49	64	65	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1081	1091		10.1096/fj.08-120345	http://dx.doi.org/10.1096/fj.08-120345			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19036858	Green Published			2022-12-25	WOS:000266651600012
J	Zong, HH; Bastie, CC; Xu, J; Fassler, R; Campbell, KP; Kurland, IJ; Pessin, JE				Zong, Haihong; Bastie, Claire C.; Xu, Jun; Fassler, Reinhard; Campbell, Kevin P.; Kurland, Irwin J.; Pessin, Jeffrey E.			Insulin Resistance in Striated Muscle-specific Integrin Receptor beta 1-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; HUMAN SKELETAL-MUSCLE; PROTEIN-KINASE; LINKED KINASE; GLYCOGEN-SYNTHASE; SUBSTRATE-1 PHOSPHORYLATION; CELL-ADHESION; BETA-1-INTEGRIN; ACTIVATION	Integrin receptor plays key roles in mediating both inside-out and outside-in signaling between cells and the extracellular matrix. We have observed that the tissue-specific loss of the integrin beta 1 subunit in striated muscle results in a near complete loss of integrin beta 1 subunit protein expression concomitant with a loss of talin and to a lesser extent, a reduction in F-actin content. Muscle-specific integrin beta 1-deficient mice had no significant difference in food intake, weight gain, fasting glucose, and insulin levels with their littermate controls. However, dynamic analysis of glucose homeostasis using euglycemic- hyperinsulinemic clamps demonstrated a 44 and 48% reduction of insulin-stimulated glucose infusion rate and glucose clearance, respectively. The whole body insulin resistance resulted from a specific inhibition of skeletal muscle glucose uptake and glycogen synthesis without any significant effect on the insulin suppression of hepatic glucose output or insulin-stimulated glucose uptake in adipose tissue. The reduction in skeletal muscle insulin responsiveness occurred without any change in GLUT4 protein expression levels but was associated with an impairment of the insulin-stimulated protein kinase B/Akt serine 473 phosphorylation but not threonine 308. The inhibition of insulin-stimulated serine 473 phosphorylation occurred concomitantly with a decrease in integrin-linked kinase expression but with no change in the mTOR.Rictor.LST8 complex (mTORC2). These data demonstrate an in vivo crucial role of integrin beta 1 signaling events in mediating cross-talk to that of insulin action.	[Zong, Haihong; Bastie, Claire C.; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Zong, Haihong; Bastie, Claire C.; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Xu, Jun; Kurland, Irwin J.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Fassler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82151 Martinsried, Germany; [Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Max Planck Society; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Pessin, JE (corresponding author), Albert Einstein Coll Med, Dept Med, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	jpessin@aecom.yu.edu		Campbell, Kevin/0000-0003-2066-5889; Bastie, Claire/0000-0001-8178-4748	National Institutes of Health [DK55811, DK33823, DK20541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055811, P30DK020541, R01DK058132, P60DK020541, R37DK033823, R01DK033823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK55811, DK33823, and DK20541. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama S K, 1996, Hum Cell, V9, P181; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bjornholm M, 1997, DIABETES, V46, P524, DOI 10.2337/diabetes.46.3.524; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; CARO JF, 1987, J CLIN INVEST, V79, P1330, DOI 10.1172/JCI112958; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007/BF00405082; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dormond O, 2007, J BIOL CHEM, V282, P23679, DOI 10.1074/jbc.M700563200; Gary DS, 2001, J NEUROCHEM, V76, P1485, DOI 10.1046/j.1471-4159.2001.00173.x; Gauthier R, 2001, AM J PHYSIOL-CELL PH, V280, pC1540, DOI 10.1152/ajpcell.2001.280.6.C1540; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GINSBERG MH, 1983, J CELL BIOL, V97, P571, DOI 10.1083/jcb.97.2.571; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang DS, 2006, ENDOCRINOLOGY, V147, P3333, DOI 10.1210/en.2005-0382; Huang DS, 2002, J BIOL CHEM, V277, P18151, DOI 10.1074/jbc.M104252200; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; JOHNSON AB, 1991, METABOLISM, V40, P252, DOI 10.1016/0026-0495(91)90106-7; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kim JK, 1996, DIABETES, V45, P651, DOI 10.2337/diabetes.45.5.651; Kim YB, 2005, MOL CELL BIOL, V25, P9713, DOI 10.1128/MCB.25.21.9713-9723.2005; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kuppuswamy D, 2002, CIRC RES, V90, P1240, DOI 10.1161/01.RES.0000025080.78636.23; Li FG, 1999, J CELL SCI, V112, P4589; Mandarino LJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE463, DOI 10.1152/ajpendo.1996.270.3.E463; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; OHSHIMA K, 1984, AM J PHYSIOL, V246, pE193, DOI 10.1152/ajpendo.1984.246.2.E193; Oshikawa J, 2004, P NATL ACAD SCI USA, V101, P12670, DOI 10.1073/pnas.0402053101; Pasquet JM, 2002, THROMB HAEMOSTASIS, V88, P115; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pencek RR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1124, DOI 10.1152/ajpendo.00598.2004; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Ren JH, 1997, BIOCHEMISTRY-US, V36, P10213, DOI 10.1021/bi9709295; Ryder JW, 2001, FRONT BIOSCI-LANDMRK, V6, pD154, DOI 10.2741/Ryder; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Shai SY, 2002, GENET ENG P, V24, P87; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tai YT, 2003, CANCER RES, V63, P5850; Tomas E, 2002, ANN NY ACAD SCI, V967, P43; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang HV, 2008, J CELL BIOL, V180, P1037, DOI 10.1083/jcb.200707175; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamaji S, 2002, BIOCHEM BIOPH RES CO, V297, P1324, DOI 10.1016/S0006-291X(02)02381-1; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Yujiri T, 2003, J BIOL CHEM, V278, P3846, DOI 10.1074/jbc.M206087200; Zierath JR, 1998, MOL CELL BIOCHEM, V182, P153, DOI 10.1023/A:1006861628496; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	66	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4679	4688		10.1074/jbc.M807408200	http://dx.doi.org/10.1074/jbc.M807408200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19064993	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000263134400067
J	Yang, G; Lim, C; Li, C; Xiao, X; Radda, GK; Li, C; Cao, X; Han, W				Yang, Guoqing; Lim, Chun-Yan; Li, Chao; Xiao, Xiaoqiu; Radda, George K.; Li, Cai; Cao, Xinmin; Han, Weiping			FoxO1 Inhibits Leptin Regulation of Pro-opiomelanocortin Promoter Activity by Blocking STAT3 Interaction with Specificity Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; GENE-EXPRESSION; ENERGY HOMEOSTASIS; SIGNAL TRANSDUCER; SKELETAL-MUSCLE; ARCUATE NUCLEUS; MESSENGER-RNA; GROWTH-FACTOR; BODY-WEIGHT; FOOD-INTAKE	Leptin controls food intake and energy expenditure by regulating hypothalamic neuron activities. Leptin exerts its actions through complex signaling pathways including STAT3 phosphorylation, nuclear translocation, and binding to target gene promoter/cofactor complexes. Deficient or defective leptin signaling leads to obesity, which may be caused by insufficient leptin levels and/or resistance to leptin signaling. To understand the molecular mechanisms of leptin resistance, we studied the regulation of pro-opiomelanocortin (POMC) gene expression by leptin. We show that phospho-STAT3 activates POMC promoter in response to leptin signaling through a mechanism that requires an SP1-binding site in the POMC promoter. Furthermore, FoxO1 binds to STAT3 and prevents STAT3 from interacting with the SP1.POMC promoter complex, and consequently, inhibits STAT3-mediated leptin action. Our study suggests that leptin action could be inhibited at a step downstream of STAT3 phosphorylation and nuclear translocation, and provides a potential mechanism of leptin resistance in which an increased FoxO1 antagonizes STAT3-mediated leptin signaling.	[Yang, Guoqing; Lim, Chun-Yan; Li, Chao; Xiao, Xiaoqiu; Radda, George K.; Han, Weiping] ASTAR, Singapore Bioimaging Consortium, Lab Metab Med, Singapore 138667, Singapore; [Li, Cai] Merck Res Labs, Rahway, NJ 07065 USA; [Cao, Xinmin] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Cao, Xinmin; Han, Weiping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Merck & Company; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Han, W (corresponding author), ASTAR, Singapore Bioimaging Consortium, Lab Metab Med, 02-02 Helios,11 Biopolis Way, Singapore 138667, Singapore.	weiping_han@sbic.a-star.edu.sg	Xiao, Xiaoqiu/K-7672-2019	Xiao, Xiaoqiu/0000-0002-4568-8772	Agency for Science, Technology and Research Biomedical Research Council	Agency for Science, Technology and Research Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by an intramural funding from Agency for Science, Technology and Research Biomedical Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Ge HF, 2002, J BIOL CHEM, V277, P45898, DOI 10.1074/jbc.M205825200; Gong L, 2008, ENDOCRINOLOGY, V149, P3346, DOI 10.1210/en.2007-0945; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Huang XF, 2004, DIABETES OBES METAB, V6, P35, DOI 10.1111/j.1463-1326.2004.00312.x; JEANNOTTE L, 1987, MOL CELL BIOL, V7, P4058, DOI 10.1128/MCB.7.11.4058; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Li H, 2007, MOL CELL BIOL, V27, P2676, DOI 10.1128/MCB.01748-06; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Xiao XQ, 2004, ENDOCRINOLOGY, V145, P5344, DOI 10.1210/en.2004-0721; Zhang T, 2000, MOL CELL BIOL, V20, P7132, DOI 10.1128/MCB.20.19.7132-7139.2000; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	34	69	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3719	3727		10.1074/jbc.M804965200	http://dx.doi.org/10.1074/jbc.M804965200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19049975	hybrid			2022-12-25	WOS:000262872500040
J	Ristriani, T; Fournane, S; Orfanoudakis, G; Trave, G; Masson, M				Ristriani, T.; Fournane, S.; Orfanoudakis, G.; Trave, G.; Masson, M.			A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells	ONCOGENE			English	Article						human papillomavirus; cervical cancer; E6 oncoprotein; senescence; p53 protein	HUMAN-PAPILLOMAVIRUS TYPE-16; CARCINOMA-CELLS; BIOPHYSICAL CHARACTERIZATION; GENE-EXPRESSION; PROTEIN; DEGRADATION; APOPTOSIS; DOMAIN; P53; DNA	High-risk mucosal human papillomaviruses (HPV), mainly HPV16 and HPV18, are implicated in cervical carcinogenesis. HPV16 E6 oncoprotein binds and often targets for degradation numerous cell proteins, including the tumor suppressor p53 and several PDZ domain proteins. Here, we show that a single-point mutation, F47R, is sufficient to convert the HPV16 E6 oncoprotein into a suppressor of HPV-positive HeLa cervical cancer cells proliferation. The E6 F47R mutant is defective for polyubiquitination and subsequent degradation of p53. When expressed in HPV-positive cervical cancer cells, E6 F47R acts as a dominant negative mutant by counteracting the p53 degradation activity of endogenous E6 and restoring high p53 protein levels. Moreover, the prolonged expression of E6 F47R leads to suppression of HeLa cells proliferation through the induction of premature senescence. This phenotype is independent on the PDZ-binding activity of E6. F47R-senescent HeLa cells exhibit a sustained expression of p53, hMDM2 and p21CIP proteins and a reduced expression of endogenous HPV18 E6 protein. Finally, small interfering RNAs directed against p53 counteract the effect of E6 F47R expression, indicating that E6 F47R-induced cellular senescence is strongly dependent on p53 signaling pathway.	[Ristriani, T.; Fournane, S.; Orfanoudakis, G.; Trave, G.; Masson, M.] CNRS, ESBS, Equipe Oncoprot, UMR 7175, F-67412 Illkirch Graffenstaden, Bas Rhin, France	Centre National de la Recherche Scientifique (CNRS)	Masson, M (corresponding author), CNRS, ESBS, Equipe Oncoprot, UMR 7175, Blvd Sebastien Brant,BP10413, F-67412 Illkirch Graffenstaden, Bas Rhin, France.	gtrave@titus.u-strasbg.fr; masson@esbs.u-strasbg.fr	TRAVE, Gilles/P-8577-2016	Orfanoudakis, Georges/0000-0002-0064-1305	University of Strasbourg; CNRS; Association de Recherche contre le Cancer (ARC); Ligue Nationale Contre le Cancer; Canceropole Grand-EST (INCA)	University of Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS)); Association de Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Canceropole Grand-EST (INCA)(Institut National du Cancer (INCA) France)	We thank F Hoppe-Seyler for providing HeLa cells, H Zentgraf for the antibody 18E7C, G de Murcia for the PARP antibody and Arbor Vita Corp. (USA) for the HPV18 E6 antibody. We thank E Weiss, A-P Sibler, A-S Rinaldi and B Chatton for helpful discussions. This study was supported by the University of Strasbourg, CNRS, Association de Recherche contre le Cancer (ARC), Ligue Nationale Contre le Cancer. TR and SF were supported by the Canceropole Grand-EST (INCA).	Bernard B, 2003, BIOL CELL, V95, P17, DOI 10.1016/S0248-4900(02)01220-0; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Courtete J, 2007, MOL CANCER THER, V6, P1728, DOI 10.1158/1535-7163.MCT-06-0808; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Griffin H, 2006, J MOL BIOL, V355, P360, DOI 10.1016/j.jmb.2005.10.077; Hall AHS, 2003, J VIROL, V77, P6066, DOI 10.1128/JVI.77.10.6066-6069.2003; Horner SM, 2004, J VIROL, V78, P4063, DOI 10.1128/JVI.78.8.4063-4073.2004; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Johung K, 2007, J VIROL, V81, P2102, DOI 10.1128/JVI.02348-06; Lagrange M, 2007, BIOCHEM BIOPH RES CO, V361, P487, DOI 10.1016/j.bbrc.2007.07.040; Lee CJ, 2002, EXP CELL RES, V277, P173, DOI 10.1006/excr.2002.5554; Lipari F, 2001, BIOCHEMISTRY-US, V40, P1196, DOI 10.1021/bi001837+; Liu Y, 1999, J VIROL, V73, P7297, DOI 10.1128/JVI.73.9.7297-7307.1999; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massimi P, 2004, ONCOGENE, V23, P8033, DOI 10.1038/sj.onc.1207977; Masson M, 2003, J GEN VIROL, V84, P2099, DOI 10.1099/vir.0.18961-0; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Nomine Y, 2003, BIOCHEMISTRY-US, V42, P4909, DOI 10.1021/bi026980c; Nomine Y, 2001, PROTEIN EXPRES PURIF, V23, P22, DOI 10.1006/prep.2001.1451; Nomine Y, 2001, PROTEIN ENG, V14, P297, DOI 10.1093/protein/14.4.297; Ristriani T, 2000, J MOL BIOL, V296, P1189, DOI 10.1006/jmbi.2000.3527; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Stewart D, 2004, J GEN VIROL, V85, P1419, DOI 10.1099/vir.0.19679-0; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Tang S, 2006, J VIROL, V80, P4249, DOI 10.1128/JVI.80.9.4249-4263.2006; Topffer S, 2007, J GEN VIROL, V88, P2956, DOI 10.1099/vir.0.83123-0; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; VOUSDEN K, 1993, FASEB J, V7, P872, DOI 10.1096/fasebj.7.10.8393818; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; Zanier K, 2007, PROTEIN EXPRES PURIF, V51, P59, DOI 10.1016/j.pep.2006.07.029; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	31	31	35	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					762	772		10.1038/onc.2008.422	http://dx.doi.org/10.1038/onc.2008.422			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	19015633				2022-12-25	WOS:000263076400013
J	Wincent, E; Amini, N; Luecke, S; Glatt, H; Bergman, J; Crescenzi, C; Rannug, A; Rannug, U				Wincent, Emma; Amini, Nahid; Luecke, Sandra; Glatt, Hansruedi; Bergman, Jan; Crescenzi, Carlo; Rannug, Agneta; Rannug, Ulf			The Suggested Physiologic Aryl Hydrocarbon Receptor Activator and Cytochrome P4501 Substrate 6-Formylindolo[3,2-b]carbazole Is Present in Humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AH RECEPTOR; DIOXIN RECEPTOR; HIGH-AFFINITY; INDUCTION; IDENTIFICATION; TRANSCRIPTION; SULFOTRANSFERASES; SULT1A3; TARGET; GENE	Dioxins and other polycyclic aromatic compounds formed during the combustion of waste and fossil fuels represent a risk to human health, as well as to the well being of our environment. Compounds of this nature exert carcinogenic and endocrine-disrupting effects in experimental animals by binding to the orphan aryl hydrocarbon receptor (AhR). Understanding the mechanism of action of these pollutants, as well as the physiological role(s) of the AhR, requires identification of the endogenous ligand(s) of this receptor. We reported earlier that activation of AhR by ultraviolet radiation is mediated by the chromophoric amino acid tryptophan (Trp), and we suggested that a new class of compounds derived from Trp, in particular 6-formylindolo[3,2-b]carbazole (FICZ), acts as natural high affinity ligands for this receptor. Here we describe seven new FICZ-derived indolo[3,2-b]carbazole-6-carboxylic acid metabolites and two sulfoconjugates, and we demonstrate the following. (i) FICZ is formed efficiently by photolysis of Trp upon exposure to visible light. (ii) FICZ is an exceptionally good substrate for cytochromes P450 (CYP) 1A1, 1A2, and 1B1, and its hydroxylated metabolites are remarkably good substrates for the sulfotransferases (SULTs) 1A1, 1A2, 1B1, and 1E1. Finally, (iii) sulfoconjugates of phenolic metabolites of FICZ are present in human urine. Our findings indicate that formylindolo[3,2-b]carbazols are the most potent naturally occurring activators of the AhR signaling pathway and may be the key substrates of the CYP1 and SULT1 families of enzymes. These conclusions contradict the widespread view that xenobiotic compounds are the major AhR ligands and CYP1 substrates.	[Rannug, Ulf] Stockholm Univ, Arrhenius Labs 16E, Dept Genet Microbiol & Toxicol, SE-10691 Stockholm, Sweden; [Amini, Nahid; Crescenzi, Carlo] Stockholm Univ, Dept Analyt Chem, SE-10691 Stockholm, Sweden; [Luecke, Sandra; Rannug, Agneta] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Glatt, Hansruedi] German Inst Human Nutr Potsdam Rehbrucke, Dept Toxicol, D-14558 Nuthetal, Germany; [Bergman, Jan] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden	Stockholm University; Stockholm University; Karolinska Institutet; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Karolinska Institutet	Rannug, U (corresponding author), Stockholm Univ, Arrhenius Labs 16E, Dept Genet Microbiol & Toxicol, SE-10691 Stockholm, Sweden.	Ulf.Rannug@gmt.su.se	Rannug, Ulf/B-1867-2016; CRESCENZI, CARLO/C-4946-2008; Rannug, Ulf/K-2799-2019	CRESCENZI, CARLO/0000-0001-6950-1506; Rannug, John Ulf/0000-0003-1045-376X; Wincent, Emma/0000-0003-1637-654X; Glatt, Hansruedi/0000-0001-6053-0562; Lucke-Johansson, Sandra/0000-0002-9737-9111	Swedish Research Council ( Formas); Swedish Radiation Safety Authority; Karolinska Institutet; Sven and Lily Lawskis Fund	Swedish Research Council ( Formas)(Swedish Research CouncilSwedish Research Council Formas); Swedish Radiation Safety Authority; Karolinska Institutet(Karolinska Institutet); Sven and Lily Lawskis Fund	This work was supported by Swedish Research Council ( Formas), the Swedish Radiation Safety Authority, Karolinska Institutet, and the Sven and Lily Lawskis Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baba T, 2005, MOL CELL BIOL, V25, P10040, DOI 10.1128/MCB.25.22.10040-10051.2005; Badawi AF, 2001, METABOLISM, V50, P1001, DOI 10.1053/meta.2001.25592; Bergander L, 2004, CHEM-BIOL INTERACT, V149, P151, DOI 10.1016/j.cbi.2004.08.005; BERGHARD A, 1993, MOL CELL BIOL, V13, P677, DOI 10.1128/MCB.13.1.677; Brix LA, 1999, BIOCHEMISTRY-US, V38, P10474, DOI 10.1021/bi990795q; BURKE MD, 1974, DRUG METAB DISPOS, V2, P583; Chang CY, 1998, MOL CELL BIOL, V18, P525, DOI 10.1128/MCB.18.1.525; Dajani R, 1999, PROTEIN EXPRES PURIF, V16, P11, DOI 10.1006/prep.1999.1030; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Elferink CJ, 2001, MOL PHARMACOL, V59, P664, DOI 10.1124/mol.59.4.664; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Fersht A., 1999, STRUCTURE MECH PROTE, P164; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Fujita K, 1999, BIOL PHARM BULL, V22, P446; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Guengerich FP, 1996, METHOD ENZYMOL, V272, P35, DOI 10.1016/S0076-6879(96)72006-2; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; HANKINSON O, 1985, J BIOL CHEM, V260, P1790; Ikuta T, 2006, EXP CELL RES, V312, P3585, DOI 10.1016/j.yexcr.2006.08.002; Katiyar SK, 2000, J INVEST DERMATOL, V114, P328, DOI 10.1046/j.1523-1747.2000.00876.x; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Matsumoto Y, 2007, ENVIRON SCI TECHNOL, V41, P3775, DOI 10.1021/es062793g; Meinl W, 2002, PHARMACOGENETICS, V12, P677, DOI 10.1097/00008571-200212000-00002; Nebert DW, 2008, J BIOL CHEM, V283, P36061, DOI 10.1074/jbc.R800053200; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; OMURA T, 1964, J BIOL CHEM, V239, P2370; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; RANNUG A, 1987, J BIOL CHEM, V262, P15422; Rannug U, 1995, CHEM BIOL, V2, P841, DOI 10.1016/1074-5521(95)90090-X; Shi LZ, 2007, J IMMUNOL, V179, P6952, DOI 10.4049/jimmunol.179.10.6952; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wahlstrom N, 2004, EUR J ORG CHEM, V2004, P2593, DOI 10.1002/ejoc.200400087; Wei YD, 2000, ARCH BIOCHEM BIOPHYS, V383, P99, DOI 10.1006/abbi.2000.2037; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	41	210	218	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2690	2696		10.1074/jbc.M808321200	http://dx.doi.org/10.1074/jbc.M808321200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054769	hybrid			2022-12-25	WOS:000262700900011
J	Colon, E; Shytuhina, A; Cowman, MK; Band, PA; Sanggaard, KW; Enghild, JJ; Wisniewski, HG				Colon, Elisa; Shytuhina, Anastasia; Cowman, Mary K.; Band, Philip A.; Sanggaard, Kristian W.; Enghild, Jan J.; Wisniewski, Hans-Georg			Transfer of Inter-alpha-inhibitor Heavy Chains to Hyaluronan by Surface-linked Hyaluronan-TSG-6 Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; T-CELL EXTRAVASATION; TRYPSIN-INHIBITOR; STIMULATED GENE-6; EXTRACELLULAR-MATRIX; BINDING PROTEIN; TSG-6 PROTEIN; RHEUMATOID-ARTHRITIS; FOLLICULAR-FLUID; PRIMARY ADHESION	Inter-alpha-inhibitor, TSG-6, and hyaluronan have important functions in fertility and inflammation. Two subunits of inter-alpha-inhibitor, the heavy chains, form covalent bonds with TSG-6 or hyaluronan in vitro. TSG-6-heavy chain complexes serve as intermediates in the transfer of heavy chains from inter-alpha-inhibitor to hyaluronan. In vivo, in addition to these complexes, stable ternary complexes of hyaluronan with both TSG-6 and heavy chains have been demonstrated in the ovulatory cumulus oophorus. In our ongoing efforts to characterize the multiple interactions between hyaluronan, TSG-6 and inter-alpha-inhibitor, we recently characterized the formation of highly stable complexes of TSG-6 with hyaluronan that had been tethered to a solid surface. Here we show that these hyaluronan-TSG-6 complexes are functionally active and transfer heavy chain subunits from inter-alpha-inhibitor to either free or surfacebound hyaluronan. Transitional hyaluronan-TSG-6-heavy chain complexes do not accumulate in vitro. Our data show the capability for heavy chain transfer by both free TSG-6 and preformed hyaluronan-TSG-6 complexes, suggesting that both might contribute to hyaluronan modification in vivo. Transfer of heavy chains to surface-tethered hyaluronan by either free TSG-6 or surface-tethered hyaluronan-TSG-6 complexes did not affect the CD 44-mediated binding of BW 5147 cells in vitro. We show how TSG-6 and hyaluronan together can deplete inter-alpha-inhibitor and generate bikunin, as has been observed in sepsis, and discuss the role of TSG-6 in the generation of hyaluronan-heavy chain complexes associated with ovulation, arthritis, and sepsis.	[Colon, Elisa; Wisniewski, Hans-Georg] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Band, Philip A.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Shytuhina, Anastasia; Cowman, Mary K.] NYU, Polytech Inst, Dept Chem & Biol Sci, Brooklyn, NY 11201 USA; [Sanggaard, Kristian W.; Enghild, Jan J.] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark	New York University; New York University; New York University; New York University Tandon School of Engineering; Aarhus University	Wisniewski, HG (corresponding author), NYU, Sch Med, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA.	hans-georg.wisniewski@med.nyu.edu		Enghild, Jan Johannes/0000-0001-9292-9172	The Vilcek Foundation; Polytechnic Institute of NewYork University	The Vilcek Foundation; Polytechnic Institute of NewYork University	This work was supported by a research grant from The Vilcek Foundation and by the Othmer Institute for Interdisciplinary Studies at the Polytechnic Institute of NewYork University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baek YW, 2003, J PEDIATR-US, V143, P11, DOI 10.1016/S0022-3476(03)00190-2; Balduyck M, 2000, J LAB CLIN MED, V135, P188, DOI 10.1067/mlc.2000.104462; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; BECKER A, 1971, ARTHRITIS RHEUM, V14, P764, DOI 10.1002/art.1780140613; Bonder CS, 2006, BLOOD, V107, P4798, DOI 10.1182/blood-2005-09-3581; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; DeGrendele HC, 1997, J IMMUNOL, V159, P2549; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Frost GI, 1997, ANAL BIOCHEM, V251, P263, DOI 10.1006/abio.1997.2262; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; HAYNES BF, 1989, IMMUNOL TODAY, V10, P423, DOI 10.1016/0167-5699(89)90040-6; HUANG L, 1993, J BIOL CHEM, V268, P26725; Jessen TE, 2004, OSTEOARTHR CARTILAGE, V12, P142, DOI 10.1016/j.joca.2003.10.004; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Kida D, 1999, J RHEUMATOL, V26, P1230; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; LESLEY J, 1990, EXP CELL RES, V187, P224, DOI 10.1016/0014-4827(90)90085-O; Lim YP, 2003, J INFECT DIS, V188, P919, DOI 10.1086/377642; Maier R, 1996, ARTHRITIS RHEUM, V39, P552, DOI 10.1002/art.1780390403; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; MIKECZ K, 1995, NAT MED, V1, P558, DOI 10.1038/nm0695-558; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Odum L, 2002, REPRODUCTION, V124, P249, DOI 10.1530/reprod/124.2.249; Opal SM, 2007, CRIT CARE MED, V35, P387, DOI 10.1097/01.CCM.0000253810.08230.83; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; POWERS RW, 1995, AM J PHYSIOL-ENDOC M, V269, pE290, DOI 10.1152/ajpendo.1995.269.2.E290; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Salier JP, 1996, BIOCHEM J, V315, P1, DOI 10.1042/bj3150001; Sandson J, 1965, Trans Assoc Am Physicians, V78, P304; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Shen L, 2006, HEPATOL RES, V34, P178, DOI 10.1016/j.hepres.2005.12.008; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Wisniewski HG, 2005, ANAL BIOCHEM, V347, P42, DOI 10.1016/j.ab.2005.09.038; Wisniewski HG, 2005, J BIOL CHEM, V280, P14476, DOI 10.1074/jbc.M411734200; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Wu RQ, 2004, CRIT CARE MED, V32, P1747, DOI 10.1097/01.CCM.0000132903.14121.0E; Yang SL, 2002, CRIT CARE MED, V30, P617, DOI 10.1097/00003246-200203000-00021; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	60	19	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2320	2331		10.1074/jbc.M807183200	http://dx.doi.org/10.1074/jbc.M807183200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19033448	hybrid			2022-12-25	WOS:000262545600041
J	Izaguirre, G; Rezaie, AR; Olson, ST				Izaguirre, Gonzalo; Rezaie, Alireza R.; Olson, Steven T.			Engineering Functional Antithrombin Exosites in alpha(1)-Proteinase Inhibitor That Specifically Promote the Inhibition of Factor Xa and Factor IXa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-ACTIVATED ANTITHROMBIN; AUTOLYSIS LOOP; ALPHA-1-PROTEINASE INHIBITOR; COAGULATION PROTEASES; PLASMINOGEN-ACTIVATOR; ALLOSTERIC MECHANISM; SERINE PROTEINASES; RAPID INHIBITION; TERNARY COMPLEX; BASIC RESIDUES	We have previously shown that residues Tyr-253 and Glu-255 in the serpin antithrombin function as exosites to promote the inhibition of factor Xa and factor IXa when the serpin is conformationally activated by heparin. Here we show that functional exosites can be engineered at homologous positions in a P1 Arg variant of the serpin alpha(1)-proteinase inhibitor (alpha 1PI) that does not require heparin for activation. The combined effect of the two exosites increased the association rate constant for the reactions of alpha 1PI with factors Xa and IXa 11-14-fold, comparable with their rate-enhancing effects on the reactions of heparin-activated antithrombin with these proteases. The effects of the engineered exosites were specific, alpha 1PI inhibitor reactions with trypsin and thrombin being unaffected. Mutation of Arg-150 in factor Xa, which interacts with the exosite residues in heparin-activated antithrombin, abrogated the ability of the engineered exosites in alpha 1PI to promote factor Xa inhibition. Binding studies showed that the exosites enhance the Michaelis complex interaction of alpha 1PI with S195A factor Xa as they do with the heparin-activated antithrombin interaction. Replacement of the P4-P2 AIP reactive loop residues in the alpha 1PI exosite variant with a preferred IEG substrate sequence for factor Xa modestly enhanced the reactivity of the exosite mutant inhibitor with factor Xa by similar to 2-fold but greatly increased the selectivity of alpha 1PI for inhibiting factor Xa over thrombin by similar to 1000-fold. Together, these results show that a specific and selective inhibitor of factor Xa can be engineered by incorporating factor Xa exosite and reactive site recognition determinants in a serpin.	[Izaguirre, Gonzalo] Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Rezaie, Alireza R.] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Saint Louis University	Izaguirre, G (corresponding author), Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, 801 S Paulina St,Rm 530C, Chicago, IL 60612 USA.	goniza@uic.edu			National Institutes of Health [HL39888, HL62565]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL39888 (to S.T.O.) and HL62565 (to A.R.R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AKO H, 1972, BIOCHEM BIOPH RES CO, V47, P1402, DOI 10.1016/0006-291X(72)90228-8; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; KWON KS, 1995, BBA-PROTEIN STRUCT M, V1247, P179, DOI 10.1016/0167-4838(94)00224-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langdown J, 2004, J BIOL CHEM, V279, P47288, DOI 10.1074/jbc.M408961200; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; OLSON ST, 1995, J BIOL CHEM, V270, P30007; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P331, DOI 10.1016/S1050-1738(02)00183-4; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PANNELL R, 1974, BIOCHEMISTRY-US, V13, P5439, DOI 10.1021/bi00723a031; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P5324, DOI 10.1021/bi060056r; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; Stratikos E, 1998, J BIOL CHEM, V273, P15582, DOI 10.1074/jbc.273.25.15582; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; TRAVIS J, 1986, BIOL CHEM H-S, V367, P853, DOI 10.1515/bchm3.1986.367.2.853; Yang LK, 2003, J BIOL CHEM, V278, P25032, DOI 10.1074/jbc.M302174200; Yang LK, 2004, BLOOD, V104, P1753, DOI 10.1182/blood-2004-03-1092; YUNG BY, 1975, BIOCHEM BIOPH RES CO, V65, P927, DOI 10.1016/S0006-291X(75)80474-8	38	14	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1550	1558		10.1074/jbc.M807340200	http://dx.doi.org/10.1074/jbc.M807340200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19010776	Green Published, hybrid			2022-12-25	WOS:000262330100023
J	Makharashvili, N; Mi, T; Koroleva, O; Korolev, S				Makharashvili, Nodar; Mi, Tian; Koroleva, Olga; Korolev, Sergey			RecR-mediated Modulation of RecF Dimer Specificity for Single- and Double-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RECF; ARRESTED REPLICATION FORKS; ATP-BINDING; HOMOLOGOUS RECOMBINATION; GENETIC-RECOMBINATION; CRYSTAL-STRUCTURE; ACTIVE-SITE; GAPPED DNA; ABC ATPASE; PROTEIN	RecF pathway proteins play an important role in the restart of stalled replication and DNA repair in prokaryotes. Following DNA damage, RecF, RecR, and RecO initiate homologous recombination ( HR) by loading of the RecA recombinase on single-stranded ( ss) DNA, protected by ssDNA-binding protein. The specific role of RecF in this process is not well understood. Previous studies have proposed that RecF directs the RecOR complex to boundaries of damaged DNA regions by recognizing single-stranded/double-stranded ( ss/ds) DNA junctions. RecF belongs to ABC-type ATPases, which function through an ATP-dependent dimerization. Here, we demonstrate that the RecF of Deinococcus radio-durans interacts with DNA as an ATP-dependent dimer, and that the DNA binding and ATPase activity of RecF depend on both the structure of DNA substrate, and the presence of RecR. We found that RecR interacts as a tetramer with the RecF dimer. RecR increases the RecF affinity to dsDNA without stimulating ATP hydrolysis but destabilizes RecF binding to ssDNA and dimerization, likely due to increasing the ATPase rate. The DNA-dependent binding of RecR to the RecF-DNA complex occurs through specific protein-protein interactions without significant contributions from RecR-DNA interactions. Finally, RecF neither alone nor in complex with RecR preferentially binds to the ss/dsDNA junction. Our data suggest that the specificity of the RecFOR complex toward the boundaries of DNA damaged regions may result from a network of protein-protein and DNA-protein interactions, rather than a simple recognition of the ss/dsDNA junction by RecF.	[Makharashvili, Nodar; Mi, Tian; Koroleva, Olga; Korolev, Sergey] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Korolev, S (corresponding author), DRC 551,1100 S Grand Blvd, St Louis, MO 63104 USA.	korolevs@slu.edu	Korolev, Sergey/ABA-7517-2020	Korolev, Sergey/0000-0001-9313-7126	National Institutes of Health [GM073837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073837. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ASAI T, 1994, J BACTERIOL, V176, P7113, DOI 10.1128/JB.176.22.7113-7114.1994; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bidnenko V, 1999, MOL MICROBIOL, V33, P846, DOI 10.1046/j.1365-2958.1999.01532.x; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Chow KH, 2004, J BIOL CHEM, V279, P3492, DOI 10.1074/jbc.M311012200; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Courcelle J, 2001, P NATL ACAD SCI USA, V98, P8196, DOI 10.1073/pnas.121008898; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Harvey SH, 2002, GENOME BIOL, V3; Hegde SP, 1996, P NATL ACAD SCI USA, V93, P14468, DOI 10.1073/pnas.93.25.14468; Hegde SP, 1996, J BACTERIOL, V178, P184, DOI 10.1128/jb.178.1.184-190.1996; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Honda M, 2008, NUCLEIC ACIDS RES, V36, P5013, DOI 10.1093/nar/gkn471; Honda M, 2006, J BIOL CHEM, V281, P18549, DOI 10.1074/jbc.M512658200; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; Ivancic-Bace I, 2003, GENETICS, V163, P485; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; KOLODNER R, 1985, J BACTERIOL, V163, P1060, DOI 10.1128/JB.163.3.1060-1066.1985; Koroleva O, 2007, EMBO J, V26, P867, DOI 10.1038/sj.emboj.7601537; Kowalczykowski SC, 2005, NATURE, V433, P591, DOI 10.1038/433591a; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, GENE DEV, V13, P345, DOI 10.1101/gad.13.3.345; Lee BI, 2004, EMBO J, V23, P2029, DOI 10.1038/sj.emboj.7600222; Liu YH, 1998, J BACTERIOL, V180, P1766, DOI 10.1128/JB.180.7.1766-1770.1998; Lowe J, 2001, J MOL BIOL, V306, P25, DOI 10.1006/jmbi.2000.4379; Lusetti SL, 2006, MOL CELL, V21, P41, DOI 10.1016/j.molcel.2005.11.011; MADIRAJU MVVS, 1992, J BACTERIOL, V174, P7705, DOI 10.1128/JB.174.23.7705-7710.1992; MAHDI AA, 1989, MOL GEN GENET, V216, P503, DOI 10.1007/BF00334397; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Mohaghegh P, 2001, HUM MOL GENET, V10, P741, DOI 10.1093/hmg/10.7.741; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; SANDLER SJ, 1994, J BACTERIOL, V176, P3661, DOI 10.1128/JB.176.12.3661-3672.1994; SANDLER SJ, 1992, NUCLEIC ACIDS RES, V20, P839, DOI 10.1093/nar/20.4.839; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; SMITH GR, 1988, MICROBIOL REV, V52, P1; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Timmins J, 2007, EMBO J, V26, P3260, DOI 10.1038/sj.emboj.7601760; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; WANG TCV, 1993, MUTAT RES, V294, P157, DOI 10.1016/0921-8777(93)90024-B; WANG TCV, 1984, J BACTERIOL, V158, P727, DOI 10.1128/JB.158.2.727-729.1984; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; Webb BL, 1999, J BIOL CHEM, V274, P15367, DOI 10.1074/jbc.274.22.15367; Webb BL, 1995, J BIOL CHEM, V270, P31397, DOI 10.1074/jbc.270.52.31397; Xu GZ, 2008, J BACTERIOL, V190, P2624, DOI 10.1128/JB.01851-07; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200	61	17	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1425	1434		10.1074/jbc.M806378200	http://dx.doi.org/10.1074/jbc.M806378200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017635	hybrid, Green Published			2022-12-25	WOS:000262330100010
J	Virtanen, C; Paris, J; Takahashi, M				Virtanen, Carl; Paris, James; Takahashi, Mark			Identification and Characterization of a Novel Gene, dapr, Involved in Skeletal Muscle Differentiation and Protein Kinase B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLAYS; GSK3; AKT	The phosphatidylinositol 3-kinase (PI3K) signaling pathway has been associated with a variety of cellular functions ranging from cell cycle regulation to tissue development. Although years of research have extensively characterized this signaling pathway, little is known as to how specific cellular events are coordinated by its activation. Here we demonstrate that Dapr (differentiation-associated protein), a novel protein, appears to focus one aspect of this pathway by acting as a putative scaffold protein during skeletal muscle differentiation. We present for the first time a description of this protein using in silico analysis. dapr was discovered through a previous study employing chromatin immunoprecipitation and CpG microarray analysis experiments as being regulated by myocyte-enhancing factor 2, a key transcription factor involved in the differentiation of skeletal muscle tissue. In this study we show that during the course of differentiation, Dapr binds to the PI3K signaling pathway member protein kinase B (PKB). In C2C12 myoblast cells before differentiation Dapr is localized to the cytosol, migrating with PKB to the membrane after initiation of muscle differentiation. Knockdown of Dapr by RNAi resulted in inhibition of myotube formation. Our findings indicate that Dapr is a key component required by myoblasts for orchestrating their differentiation during myogenesis. Furthermore, it appears that Dapr is involved in the PI3K signaling cascade, potentially acting as a scaffold protein for PKB	[Virtanen, Carl; Paris, James; Takahashi, Mark] Univ Hlth Network Microarray Ctr, Toronto, ON M5G 1L7, Canada	University of Toronto; University Health Network Toronto	Takahashi, M (corresponding author), MaRS Ctr, Univ Hlth Microarray Ctr 21, Toronto Med Discovery Tower,101 Coll St 9-301, Toronto, ON M5G 1L7, Canada.	markt@uhnresearch.ca			Genome Canada and the Ontario Research Fund	Genome Canada and the Ontario Research Fund	This work was funded in part by Genome Canada and the Ontario Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Coffer PJ, 1998, BIOCHEM J, V335, P1; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Galvin CD, 2003, MOL CELL ENDOCRINOL, V200, P19, DOI 10.1016/S0303-7207(02)00420-3; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Kaneko S, 2002, J BIOL CHEM, V277, P23230, DOI 10.1074/jbc.M201733200; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Paris J, 2004, PHYSIOL GENOMICS, V20, P143, DOI 10.1152/physiolgenomics.00149.2004; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Tamir Y, 2000, J BIOL CHEM, V275, P34424, DOI 10.1074/jbc.M005815200; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; Vandromme M, 2001, J BIOL CHEM, V276, P8173, DOI 10.1074/jbc.M005587200; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158	27	3	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1636	1643		10.1074/jbc.M807000200	http://dx.doi.org/10.1074/jbc.M807000200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028694	hybrid			2022-12-25	WOS:000262330100032
J	Yu, Q; Kuzmiak, H; Zou, YF; Olsen, L; Defossez, PA; Bi, X				Yu, Qun; Kuzmiak, Holly; Zou, Yanfei; Olsen, Lars; Defossez, Pierre-Antoine; Bi, Xin			Saccharomyces cerevisiae Linker Histone Hho1p Functionally Interacts with Core Histone H4 and Negatively Regulates the Establishment of Transcriptionally Silent Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; TELOMERIC HETEROCHROMATIN; DNA-REPLICATION; GENE ACTIVATION; HOMOLOG HHO1P; YEAST; H1; RECOMBINATION; INHERITANCE; EXPRESSION	Saccharomyces cerevisiae linker histone Hho1p is not essential for cell viability, and very little is known about its function in vivo. We show that deletion of HHO1 (hho1 Delta) suppresses the defect in transcriptional silencing caused by a mutation in the globular domain of histone H4. hho1 Delta also suppresses the reduction in HML silencing by the deletion of SIR1 that is involved in the establishment of silent chromatin at HML. We further show that hho1 Delta suppresses changes in silent chromatin structure caused by the histone H4 mutation and sir1 Delta. These results suggest that HHO1 plays a negative role in transcriptionally silent chromatin. We also provide evidence that Hho1p hinders the de novo establishment of silent chromatin but does not affect the stability of preexistent silent chromatin. Unlike canonical linker histones in higher eukaryotes that have a single conserved globular domain, Hho1p possesses two globular domains. We show that the carboxyl-terminal globular domain of Hho1p is dispensable for its function, suggesting that the mode of Hho1p action is similar to that of canonical linker histones.	[Yu, Qun; Kuzmiak, Holly; Zou, Yanfei; Olsen, Lars; Bi, Xin] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Defossez, Pierre-Antoine] CNRS, UMR218, Inst Curie, Sect Rech, F-75248 Paris, France	University of Rochester; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Bi, X (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	xinbi@mail.rochester.edu		Defossez, Pierre-Antoine/0000-0002-6463-9263	National Institutes of Health [GM62484]; Centre National de la Recherche Scientifique Programme Action Thematique et Incitative sur Programme; Fondation pour la Recherche Medicale; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique Programme Action Thematique et Incitative sur Programme(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62484 ( to X. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by Centre National de la Recherche Scientifique Programme Action Thematique et Incitative sur Programme and by Fondation pour la Recherche Medicale.	Ali T, 2004, J MOL BIOL, V338, P139, DOI 10.1016/j.jmb.2004.02.046; Ali T, 2004, J MOL BIOL, V337, P1123, DOI 10.1016/j.jmb.2004.02.029; Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; Chiu YH, 2003, GENETICS, V165, P115; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Escher D, 1997, MOL GEN GENET, V256, P456, DOI 10.1007/s004380050589; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Freidkin I, 2001, NUCLEIC ACIDS RES, V29, P4043, DOI 10.1093/nar/29.19.4043; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1842; HANNON R, 1984, J MOL BIOL, V180, P131, DOI 10.1016/0022-2836(84)90434-0; Harvey AC, 2004, MOL MICROBIOL, V53, P771, DOI 10.1111/j.1365-2958.2004.04195.x; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hellauer K, 2001, J BIOL CHEM, V276, P13587, DOI 10.1074/jbc.M011196200; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Landsman D, 1996, TRENDS BIOCHEM SCI, V21, P287, DOI 10.1016/S0968-0004(96)30030-3; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Li CH, 2008, MOL MICROBIOL, V67, P906, DOI 10.1111/j.1365-2958.2007.06101.x; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Ono K, 2003, NUCLEIC ACIDS RES, V31, P7199, DOI 10.1093/nar/gkg931; Patterton HG, 1998, J BIOL CHEM, V273, P7268, DOI 10.1074/jbc.273.13.7268; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; RODRIGUEZCAMPOS A, 1989, J MOL BIOL, V209, P135, DOI 10.1016/0022-2836(89)90177-0; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Santisteban MS, 1997, EMBO J, V16, P2493, DOI 10.1093/emboj/16.9.2493; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Ushinsky SC, 1997, YEAST, V13, P151, DOI 10.1002/(SICI)1097-0061(199702)13:2<151::AID-YEA94>3.0.CO;2-5; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Veron M, 2006, GENETICS, V173, P579, DOI 10.1534/genetics.105.050195; VOLKERT FC, 1986, CELL, V46, P541, DOI 10.1016/0092-8674(86)90879-2; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Xu EY, 2005, MOL CELL BIOL, V25, P1846, DOI 10.1128/MCB.25.5.1846-1859.2005; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Zou YF, 2008, NUCLEIC ACIDS RES, V36, P5189, DOI 10.1093/nar/gkn465; Zou YF, 2006, GENETICS, V174, P203, DOI 10.1534/genetics.106.055525	49	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					740	750		10.1074/jbc.M806274200	http://dx.doi.org/10.1074/jbc.M806274200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19017647	Green Published, hybrid			2022-12-25	WOS:000262122900007
J	Kagaayi, J; Gray, RH; Brahmbhatt, H; Kigozi, G; Nalugoda, F; Wabwire-Mangen, F; Serwadda, D; Sewankambo, N; Ddungu, V; Ssebagala, D; Sekasanvu, J; Kigozi, G; Makumbi, F; Kiwanuka, N; Lutalo, T; Reynolds, SJ; Wawer, MJ				Kagaayi, Joseph; Gray, Ronald H.; Brahmbhatt, Heena; Kigozi, Godfrey; Nalugoda, Fred; Wabwire-Mangen, Fred; Serwadda, David; Sewankambo, Nelson; Ddungu, Veronica; Ssebagala, Darix; Sekasanvu, Joseph; Kigozi, Grace; Makumbi, Fredrick; Kiwanuka, Noah; Lutalo, Tom; Reynolds, Steven J.; Wawer, Maria J.			Survival of Infants Born to HIV-Positive Mothers, by Feeding Modality, in Rakai, Uganda	PLOS ONE			English	Article								Background: Data comparing survival of formula-fed to breast-fed infants in programmatic settings are limited. We compared mortality and HIV-free of breast and formula-fed infants born to HIV-positive mothers in a program in rural, Rakai District Uganda. Methodology/Principal Findings: One hundred eighty two infants born to HIV-positive mothers were followed at one, six and twelve months postpartum. Mothers were given infant-feeding counseling and allowed to make informed choices as to whether to formula-feed or breast-feed. Eligible mothers and infants received antiretroviral therapy (ART) if indicated. Mothers and their newborns received prophylaxis for prevention of mother-to-child HIV transmission (pMTCT) if they were not receiving ART. Infant HIV infection was detected by PCR (Roche Amplicor 1.5) during the follow-up visits. Kaplan Meier time-to-event methods were used to compare mortality and HIV-free survival. The adjusted hazard ratio (Adjusted HR) of infant HIV-free survival was estimated by Cox regression. Seventy-five infants (41%) were formula-fed while 107 (59%) were breast-fed. Exclusive breast-feeding was practiced by only 25% of breast-feeding women at one month postpartum. The cumulative 12-month probability of infant mortality was 18% (95% CI = 11%-29%) among the formula-fed compared to 3% (95% CI = 1%-9%) among the breast-fed infants (unadjusted hazard ratio (HR) = 6.1(95% CI = 1.7-21.4, P-value<0.01). There were no statistically significant differentials in HIV-free survival by feeding choice (86% in the formula-fed compared to 96% in breast-fed group (Adjusted RH = 2.8[ 95% CI = 0.67-11.7, P-value = 0.16] Conclusions/Significance: Formula-feeding was associated with a higher risk of infant mortality than breastfeeding in this rural population. Our findings suggest that formula-feeding should be discouraged in similar African settings.	[Kigozi, Godfrey; Nalugoda, Fred; Ddungu, Veronica] Rakai Hlth Sci Program, Dept Clin Res Studies, Entebbe, Uganda; [Gray, Ronald H.; Brahmbhatt, Heena; Wawer, Maria J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat, Family & Reproduct Hlth, Baltimore, MD 21218 USA; [Wabwire-Mangen, Fred; Makumbi, Fredrick; Kiwanuka, Noah] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Dept Dis Control, Kampala, Uganda; [Sewankambo, Nelson] Makerere Univ, Sch Med, Dept Med, Clin Epidemiol Unit, Kampala, Uganda; [Ssebagala, Darix; Sekasanvu, Joseph; Lutalo, Tom] Rakai Hlth Sci Program, Dept Biostat & Data Management, Entebbe, Uganda; [Kigozi, Grace] Rakai Hlth Sci Program, Dept Quality Control & Quality Assurance, Entebbe, Uganda; [Reynolds, Steven J.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21218 USA; [Reynolds, Steven J.] NIAID, NIH, Div Intramural Res, Lab Immunoregulat, Bethesda, MD USA	Rakai Health Sciences Program; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Makerere University; Makerere University; Rakai Health Sciences Program; Rakai Health Sciences Program; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kagaayi, J (corresponding author), Rakai Hlth Sci Program, Dept Clin Res Studies, Entebbe, Uganda.	jkagayi@rhsp.org		Sewankambo, Nelson/0000-0001-9362-053X; Kagaayi, Joseph/0000-0003-4101-3038; Reynolds, Steven/0000-0002-5403-2759	National Institute of Child Health and Human Development(NICHD); Presidential Emergency Plan for AIDS Relief(PEPFAR)	National Institute of Child Health and Human Development(NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Presidential Emergency Plan for AIDS Relief(PEPFAR)	National Institute of Child Health and Human Development(NICHD). Presidential Emergency Plan for AIDS Relief(PEPFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquet R, 2007, PLOS MED, V4, P139, DOI 10.1371/journal.pmed.0040017; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Bobat R, 1997, AIDS, V11, P1627, DOI 10.1097/00002030-199713000-00012; Coovadia HM, 2007, AIDS, V21, P1837, DOI 10.1097/QAD.0b013e32826fb731; Coutsoudis A, 2003, ACTA PAEDIATR, V92, P890, DOI 10.1080/08035250310004261; Coutsoudis A, 2008, B WORLD HEALTH ORGAN, V86, P210, DOI 10.2471/BLT.07.041673; COX DR, 1968, J ROY STAT SOC B, V30, P248, DOI 10.1111/j.2517-6161.1968.tb00724.x; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Kagaayi J, 2005, JAIDS-J ACQ IMM DEF, V39, P121, DOI 10.1097/01.qai.0000148530.66587.7c; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Mbori-Ngacha D, 2001, JAMA-J AM MED ASSOC, V286, P2413, DOI 10.1001/jama.286.19.2413; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; WHO, 2006, ANT DRUGS TREAT PREG; *WHO, 2007, HIV INF FEED NEW EV; *WHO, 2006, WHO HIV INF FEED TEC	18	58	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3877	10.1371/journal.pone.0003877	http://dx.doi.org/10.1371/journal.pone.0003877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065270	Green Submitted, gold, Green Published			2022-12-25	WOS:000265455200003
J	McNamara, A; Buccino, G; Menz, MM; Glascher, J; Wolbers, T; Baumgartner, A; Binkofski, F				McNamara, Adam; Buccino, Giovanni; Menz, Mareike M.; Glaescher, Jan; Wolbers, Thomas; Baumgaertner, Annette; Binkofski, Ferdinand			Neural Dynamics of Learning Sound - Action Associations	PLOS ONE			English	Article							TEMPORAL CORTEX; BROCAS AREA; ACTION REPRESENTATION; OBJECT MANIPULATION; ACTION RECOGNITION; SPEECH; FMRI; LANGUAGE; MOTOR; HAND	A motor component is pre-requisite to any communicative act as one must inherently move to communicate. To learn to make a communicative act, the brain must be able to dynamically associate arbitrary percepts to the neural substrate underlying the pre-requisite motor activity. We aimed to investigate whether brain regions involved in complex gestures (ventral pre-motor cortex, Brodmann Area 44) were involved in mediating association between novel abstract auditory stimuli and novel gestural movements. In a functional resonance imaging (fMRI) study we asked participants to learn associations between previously unrelated novel sounds and meaningless gestures inside the scanner. We use functional connectivity analysis to eliminate the often present confound of 'strategic covert naming' when dealing with BA44 and to rule out effects of non-specific reductions in signal. Brodmann Area 44, a region incorporating Broca's region showed strong, bilateral, negative correlation of BOLD (blood oxygen level dependent) response with learning of sound-action associations during data acquisition. Left-inferior-parietal-lobule (l-IPL) and bilateral loci in and around visual area V5, right-orbital-frontal-gyrus, right-hippocampus, left-para-hippocampus, right-head-of-caudate, right-insula and left-lingual-gyrus also showed decreases in BOLD response with learning. Concurrent with these decreases in BOLD response, an increasing connectivity between areas of the imaged network as well as the right-middle-frontal-gyrus with rising learning performance was revealed by a psychophysiological interaction (PPI) analysis. The increasing connectivity therefore occurs within an increasingly energy efficient network as learning proceeds. Strongest learning related connectivity between regions was found when analysing BA44 and l-IPL seeds. The results clearly show that BA44 and l-IPL is dynamically involved in linking gesture and sound and therefore provides evidence that one of the mechanisms required for the evolution of human communication is found within these motor regions.	[McNamara, Adam; Menz, Mareike M.; Binkofski, Ferdinand] UKSH, Dept Neurol, Lubeck, Germany; [McNamara, Adam] Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England; [Buccino, Giovanni] Univ Degli Studi Parma, Dept Neurosci, Parma, Italy; [Menz, Mareike M.; Glaescher, Jan; Wolbers, Thomas; Baumgaertner, Annette] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, NeuroImage Nord, Hamburg, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Surrey; University of Parma; University of Hamburg; University Medical Center Hamburg-Eppendorf	McNamara, A (corresponding author), UKSH, Dept Neurol, Lubeck, Germany.	a.mcnamara@surrey.ac.uk	Binkofski, Ferdinand/S-6997-2017; Gläscher, Jan/H-2930-2019; Buccino, Giovanni/AAC-4503-2022	Binkofski, Ferdinand/0000-0002-6750-943X; Gläscher, Jan/0000-0002-1020-7115; Buccino, Giovanni/0000-0001-5432-1756; Wolbers, Thomas/0000-0003-2943-8949	Volkswagenstiftung [I/79006]; BMBF [01GW0571, 01GO0207]; DFG	Volkswagenstiftung(Volkswagen); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	AM and FB were funded by the Volkswagenstiftung (I/79006). MM and FB were supported by BMBF (01GW0571). NeuroImage Nord is supported by the BMBF (01GO0207) and the DFG.	Amunts K, 2004, NEUROIMAGE, V22, P42, DOI 10.1016/j.neuroimage.2003.12.031; Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Aziz-Zadeh L, 2005, J COGNITIVE NEUROSCI, V17, P928, DOI 10.1162/0898929054021157; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Binkofski F, 1999, EXP BRAIN RES, V128, P210, DOI 10.1007/s002210050838; Binkofski Ferdinand, 2004, Cortex, V40, P159, DOI 10.1016/S0010-9452(08)70933-X; BLAKE RW, 1992, EFFICIENCY EC ANIMAL; BROWN MW, 1987, BRAIN RES, V409, P158, DOI 10.1016/0006-8993(87)90753-0; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Corina DP, 2006, CORTEX, V42, P529, DOI 10.1016/S0010-9452(08)70393-9; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Fadiga L, 2004, J CLIN NEUROPHYSIOL, V21, P157, DOI 10.1097/00004691-200405000-00004; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gandour J, 2003, BRAIN LANG, V84, P318, DOI 10.1016/S0093-934X(02)00505-9; Gandour J, 2002, J COGNITIVE NEUROSCI, V14, P1076, DOI 10.1162/089892902320474526; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Golestani N, 2004, NEUROIMAGE, V21, P494, DOI 10.1016/j.neuroimage.2003.09.071; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Gron G, 2001, LEARN MEMORY, V8, P336, DOI 10.1101/lm.42901; Hurford JR, 2004, VIENNA S THEOR BIOL, P297; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kaplan Jonas T, 2007, Cogn Process, V8, P103, DOI 10.1007/s10339-007-0165-z; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Lindenberg R, 2007, BRAIN LANG, V102, P22, DOI 10.1016/j.bandl.2006.11.012; Makuuchi M, 2005, CEREB CORTEX, V15, P563, DOI 10.1093/cercor/bhh157; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; MATELLI M, 1991, J COMP NEUROL, V311, P445, DOI 10.1002/cne.903110402; McNamara A, 2007, NEUROIMAGE, V35, P1211, DOI 10.1016/j.neuroimage.2007.01.009; Menz MM, 2006, NEUROIMAGE, V32, P1185, DOI 10.1016/j.neuroimage.2006.06.003; MEYER M, 2006, INVOLVEMENT LEFT RIG; Muller RA, 2004, BRAIN LANG, V89, P329, DOI 10.1016/S0093-934X(03)00346-8; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; Puce A, 1998, J NEUROSCI, V18, P2188; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005	63	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3845	10.1371/journal.pone.0003845	http://dx.doi.org/10.1371/journal.pone.0003845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436YN	19050764	gold, Green Published			2022-12-25	WOS:000265452100006
J	Kulick, S; Moccia, C; Didelot, X; Falush, D; Kraft, C; Suerbaum, S				Kulick, Stefan; Moccia, Claudia; Didelot, Xavier; Falush, Daniel; Kraft, Christian; Suerbaum, Sebastian			Mosaic DNA Imports with Interspersions of Recipient Sequence after Natural Transformation of Helicobacter pylori	PLOS ONE			English	Article								Helicobacter pylori colonizes the gastric mucosa of half of the human population, causing gastritis, ulcers, and cancer. H. pylori is naturally competent for transformation by exogenous DNA, and recombination during mixed infections of one stomach with multiple H. pylori strains generates extensive allelic diversity. We developed an in vitro transformation protocol to study genomic imports after natural transformation of H. pylori. The mean length of imported fragments was dependent on the combination of donor and recipient strain and varied between 1294 bp and 3853 bp. In about 10% of recombinant clones, the imported fragments of donor DNA were interrupted by short interspersed sequences of the recipient (ISR) with a mean length of 82 bp. 18 candidate genes were inactivated in order to identify genes involved in the control of import length and generation of ISR. Inactivation of the antimutator glycosylase MutY increased the length of imports, but did not have a significant effect on ISR frequency. Overexpression of mutY strongly increased the frequency of ISR, indicating that MutY, while not indispensable for ISR formation, is part of at least one ISR-generating pathway. The formation of ISR in H. pylori increases allelic diversity, and contributes to the uniquely low linkage disequilibrium characteristic of this pathogen.	[Kulick, Stefan; Moccia, Claudia; Kraft, Christian; Suerbaum, Sebastian] Hannover Med Sch, Inst Med Microbiol, D-3000 Hannover, Germany; [Didelot, Xavier] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Falush, Daniel] Univ Coll Cork, Environm Res Inst, Cork, Ireland	Hannover Medical School; University of Warwick; University College Cork	Kulick, S (corresponding author), Hannover Med Sch, Inst Med Microbiol, D-3000 Hannover, Germany.	suerbaum.sebastian@mh-hannover.de	Didelot, Xavier/H-1608-2013; Didelot, Xavier/P-4282-2019	Didelot, Xavier/0000-0003-1885-500X; Didelot, Xavier/0000-0003-1885-500X	European Union, project INCA [LSHC-CT-2005-018704]; German Research Foundation (DFG); German Academic Exchange Service (DAAD); Wilhelm Hirte Foundation	European Union, project INCA; German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Wilhelm Hirte Foundation	This work was supported by funding under the Sixth Research Framework Programme of the European Union, project INCA (LSHC-CT-2005-018704). S.K. received a Ph.D. stipend from Research Training Group GRK745 funded by the German Research Foundation (DFG). C.M. received a Ph.D. stipend from the German Academic Exchange Service (DAAD) and the Wilhelm Hirte Foundation.	ABASTADO JP, 1984, P NATL ACAD SCI-BIOL, V81, P5792, DOI 10.1073/pnas.81.18.5792; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; CAMI B, 1984, P NATL ACAD SCI-BIOL, V81, P503, DOI 10.1073/pnas.81.2.503; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Eutsey R, 2007, DNA REPAIR, V6, P19, DOI 10.1016/j.dnarep.2006.08.006; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Fearnbead P, 2005, J MOL EVOL, V61, P333, DOI 10.1007/s00239-004-0316-0; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; FORNILI SL, 1977, J MOL BIOL, V113, P181, DOI 10.1016/0022-2836(77)90048-1; Furuta T, 2007, J GASTROEN HEPATOL, V22, P1810, DOI 10.1111/j.1440-1746.2007.04919.x; GE ZM, 1995, MOL MICROBIOL, V15, P97, DOI 10.1111/j.1365-2958.1995.tb02224.x; Go MF, 1996, J BACTERIOL, V178, P3934, DOI 10.1128/jb.178.13.3934-3938.1996; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; GUILD WR, 1968, COLD SPRING HARB SYM, V33, P643, DOI 10.1101/SQB.1968.033.01.072; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hofreuter D, 1998, MOL MICROBIOL, V28, P1027, DOI 10.1046/j.1365-2958.1998.00879.x; Hofreuter D, 2001, MOL MICROBIOL, V41, P379, DOI 10.1046/j.1365-2958.2001.02502.x; Huang S, 2006, J BACTERIOL, V188, P6224, DOI 10.1128/JB.00477-06; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kulick S, 2008, ARCH MICROBIOL, V189, P263, DOI 10.1007/s00203-007-0315-9; LABIGNEROUSSEL A, 1988, J BACTERIOL, V170, P1704, DOI 10.1128/jb.170.4.1704-1708.1988; Mathieu A, 2006, J BACTERIOL, V188, P7464, DOI 10.1128/JB.00851-06; MCKANE M, 1995, GENETICS, V139, P35; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Pinto AV, 2005, MOL CELL, V17, P113, DOI 10.1016/j.molcel.2004.11.035; Sambrook J., 2004, MOL CLONING LAB MANU; Samrakandi MM, 2000, J BACTERIOL, V182, P3353, DOI 10.1128/JB.182.12.3353-3360.2000; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483	40	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3797	10.1371/journal.pone.0003797	http://dx.doi.org/10.1371/journal.pone.0003797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030104	gold, Green Submitted, Green Published			2022-12-25	WOS:000265450800007
J	Labalette, C; Nouet, Y; Levillayer, F; Armengol, C; Renard, CA; Soubigou, G; Xia, T; Buendia, MA; Wei, Y				Labalette, Charlotte; Nouet, Yann; Levillayer, Florence; Armengol, Carolina; Renard, Claire-Angelique; Soubigou, Guillaume; Xia, Tian; Buendia, Marie-Annick; Wei, Yu			The LIM-Only Protein FHL2 Mediates Ras-Induced Transformation through Cyclin D1 and p53 Pathways	PLOS ONE			English	Article								Background: Four and a half LIM-only protein 2 (FHL2) has been implicated in multiple signaling pathways that regulate cell growth and tissue homeostasis. We reported previously that FHL2 regulates cyclin D1 expression and that immortalized FHL2-null mouse embryo fibroblasts (MEFs) display reduced levels of cyclin D1 and low proliferative activity. Methodology/Principal Findings: Here we address the contribution of FHL2 in cell transformation by investigating the effects of oncogenic Ras in FHL2-null context. We show that H-RasV12 provokes cell cycle arrest accompanied by accumulation of p53 and p16(INK4a) in immortalized FHL2(-/-) MEFs. These features contrast sharply with Ras transforming activity in wild type cell lines. We further show that establishment of FHL2-null cell lines differs from conventional immortalization scheme by retaining functional p19(ARF)/p53 checkpoint that is required for cell cycle arrest imposed by Ras. However, after serial passages of Ras-expressing FHL2(-/-) cells, dramatic increase in the levels of D-type cyclins and Rb phosphorylation correlates with the onset of cell proliferation and transformation without disrupting the p19(ARF)/p53 pathway. Interestingly, primary FHL2-null cells overexpressing cyclin D1 undergo a classical immortalization process leading to loss of the p19(ARF)/p53 checkpoint and susceptibility to Ras transformation. Conclusions/Significance: Our findings uncover a novel aspect of cellular responses to mitogenic stimulation and illustrate a critical role of FHL2 in the signalling network that implicates Ras, cyclin D1 and p53.			Labalette, C (corresponding author), Inst Pasteur, Unite Oncogenese & Virol Mol, Paris, France.	yu.wei@pasteur.fr	XIA, Tian/A-5392-2015; Wei, Yu/A-7289-2016; Armengol, Carol/D-5253-2014	XIA, Tian/0000-0002-9665-5858; Armengol, Carol/0000-0002-3723-7760; ARMENGOL, CAROLINA/0000-0002-4690-4027				Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; Blagosklonny MV, 2003, EMBO REP, V4, P358, DOI 10.1038/sj.embor.embor806; Chen DH, 2003, CANCER RES, V63, P6626; Chu PH, 2000, MOL CELL BIOL, V20, P7460, DOI 10.1128/MCB.20.20.7460-7462.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Gabriel B, 2004, ANTICANCER RES, V24, P921; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Heemers HV, 2007, CANCER RES, V67, P10592, DOI 10.1158/0008-5472.CAN-07-1917; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kong YF, 2001, CIRCULATION, V103, P2731; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Martin BT, 2007, CELL CYCLE, V6, P1779, DOI 10.4161/cc.6.14.4448; McLoughlin P, 2002, J BIOL CHEM, V277, P37045, DOI 10.1074/jbc.M203336200; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ongusaha PP, 2003, ONCOGENE, V22, P3749, DOI 10.1038/sj.onc.1206439; PARK J, 2008, FASEB J; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; SCHUERMANN M, 1990, NUCLEIC ACIDS RES, V18, P4945, DOI 10.1093/nar/18.16.4945; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang JD, 2007, GASTROENTEROLOGY, V132, P1066, DOI 10.1053/j.gastro.2006.12.004; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Wu Q, 2002, J BIOL CHEM, V277, P36329, DOI 10.1074/jbc.M204962200; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yu QY, 2005, ONCOGENE, V24, P7114, DOI 10.1038/sj.onc.1208853	49	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3761	10.1371/journal.pone.0003761	http://dx.doi.org/10.1371/journal.pone.0003761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018287	Green Submitted, gold, Green Published			2022-12-25	WOS:000265448500008
J	Gee, EPS; Ingber, DE; Stultz, CM				Gee, Elaine P. S.; Ingber, Donald E.; Stultz, Collin M.			Fibronectin Unfolding Revisited: Modeling Cell Traction-Mediated Unfolding of the Tenth Type-III Repeat	PLOS ONE			English	Article								Fibronectin polymerization is essential for the development and repair of the extracellular matrix. Consequently, deciphering the mechanism of fibronectin fibril formation is of immense interest. Fibronectin fibrillogenesis is driven by cell-traction forces that mechanically unfold particular modules within fibronectin. Previously, mechanical unfolding of fibronectin has been modeled by applying tensile forces at the N- and C-termini of fibronectin domains; however, physiological loading is likely focused on the solvent-exposed RGD loop in the 10(th) type-III repeat of fibronectin (10FNIII), which mediates binding to cell-surface integrin receptors. In this work we used steered molecular dynamics to study the mechanical unfolding of 10FNIII under tensile force applied at this RGD site. We demonstrate that mechanically unfolding 10FNIII by pulling at the RGD site requires less work than unfolding by pulling at the N- and C-termini. Moreover, pulling at the N- and C-termini leads to 10FNIII unfolding along several pathways while pulling on the RGD site leads to a single exclusive unfolding pathway that includes a partially unfolded intermediate with exposed hydrophobic N- terminal beta-strands - residues that may facilitate fibronectin self-association. Additional mechanical unfolding triggers an essential arginine residue, which is required for high affinity binding to integrins, to move to a position far from the integrin binding site. This cell traction-induced conformational change may promote cell detachment after important partially unfolded kinetic intermediates are formed. These data suggest a novel mechanism that explains how cell-mediated forces promote fibronectin fibrillogenesis and how cell surface integrins detach from newly forming fibrils. This process enables cells to bind and unfold additional fibronectin modules - a method that propagates matrix assembly.	[Gee, Elaine P. S.; Ingber, Donald E.; Stultz, Collin M.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Ingber, Donald E.] Harvard Med Sch, Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA USA; [Ingber, Donald E.] Harvard Med Sch, Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA USA; [Stultz, Collin M.] MIT, Department of Elect Engn & Comp Sci, Harvard MIT Div Hlth Sci & Technol, Rese Lab Elect, Cambridge, MA USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	Gee, EPS (corresponding author), Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA.	cmstultz@csail.mit.edu	Ingber, Donald E/AAC-5894-2019		NIH [T32 GM008313, CA45548]; Keck Foundation; NATIONAL CANCER INSTITUTE [P01CA045548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (NIH/NIGMS Molecular Biophysics Training Grant T32 GM008313 and NIH CA45548) as well as the Keck Foundation (NAKFI Nano 06). No funding agency was directly involved in the collection, analysis, interpretation of the data, or in preparation, review or approval of the manuscript.	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; AOTA S, 1994, J BIOL CHEM, V269, P24756; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Craig D, 2004, STRUCTURE, V12, P21, DOI 10.1016/j.str.2003.11.024; Craig D, 2001, P NATL ACAD SCI USA, V98, P5590, DOI 10.1073/pnas.101582198; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Kauf ACW, 2001, BIOCHEMISTRY-US, V40, P9159, DOI 10.1021/bi010503x; Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Li PC, 2004, J CHEM PHYS, V121, P4826, DOI 10.1063/1.1778152; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Ng SP, 2007, J MOL BIOL, V371, P851, DOI 10.1016/j.jmb.2007.06.015; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALGANICOFF L, 1985, AM J PHYSIOL, V249, pC279, DOI 10.1152/ajpcell.1985.249.3.C279; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Sottile J, 1998, J CELL SCI, V111, P2933; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Toofanny RD, 2006, J MOL GRAPH MODEL, V24, P396, DOI 10.1016/j.jmgm.2005.09.005; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Zanotti G, 2003, FEBS LETT, V534, P7, DOI 10.1016/S0014-5793(02)03853-X; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	56	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2373	10.1371/journal.pone.0002373	http://dx.doi.org/10.1371/journal.pone.0002373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	19020673	Green Published, Green Submitted, gold			2022-12-25	WOS:000263248800014
J	Bessac, BF; Sivula, M; von Hehn, CA; Caceres, AI; Escalera, J; Jordt, SE				Bessac, Bret F.; Sivula, Michael; von Hehn, Christian A.; Caceres, Ana I.; Escalera, Jasmine; Jordt, Sven-Eric			Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases	FASEB JOURNAL			English	Article						sensory neurons; pain; nociception; analgesia; TRP channels	ION-CHANNEL TRPA1; DYSFUNCTION SYNDROME RADS; RIOT CONTROL AGENTS; TOLUENE DIISOCYANATE; SENSORY IRRITATION; METHYL ISOCYANATE; CIGARETTE-SMOKE; ACTIVATION; RESPONSES; PAIN	The release of methyl isocyanate in Bhopal, India, caused the worst industrial accident in history. Exposures to industrial isocyanates induce lacrimation, pain, airway irritation, and edema. Similar responses are elicited by chemicals used as tear gases. Despite frequent exposures, the biological targets of isocyanates and tear gases in vivo have not been identified, precluding the development of effective countermeasures. We use Ca2+ imaging and electrophysiology to show that the noxious effects of isocyanates and those of all major tear gas agents are caused by activation of Ca2+ influx and membrane currents in mustard oil-sensitive sensory neurons. These responses are mediated by transient receptor potential ankyrin 1 (TRPA1), an ion channel serving as a detector for reactive chemicals. In mice, genetic ablation or pharmacological inhibition of TRPA1 dramatically reduces isocyanate-and tear gas-induced nocifensive behavior after both ocular and cutaneous exposures. We conclude that isocyanates and tear gas agents target the same neuronal receptor, TRPA1. Treatment with TRPA1 antagonists may prevent and alleviate chemical irritation of the eyes, skin, and airways and reduce the adverse health effects of exposures to a wide range of toxic noxious chemicals.-Bessac, B. F., Sivula, M., von Hehn, C. A., Caceres, A. I., Escalera, J., Jordt, S.-E. Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases. FASEB J. 23, 1102-1114 (2009)	[Bessac, Bret F.; Sivula, Michael; von Hehn, Christian A.; Caceres, Ana I.; Escalera, Jasmine; Jordt, Sven-Eric] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Jordt, SE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	sven.jordt@yale.edu	Caceres, Ana I/E-5542-2012; Jordt, Sven-Eric/ABE-6517-2020; Bessac, Bret/AAZ-1550-2020	Caceres, Ana I/0000-0001-7219-8851; Jordt, Sven-Eric/0000-0001-6171-5622; Bessac, Brett/0000-0002-0522-4455	National Institutes of Health Counter-ACT (Countermeasures Against Chemical Threats); National Institute of Environmental Health Sciences (NIEHS) [F31ES015932]; ONES (Outstanding New Environmental Scientists) [U01 ES015674, R01 ES015056]; Spanish Foundation for Science and Technology [2007-0480]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES017218, R01ES015056, U01ES015674, F31ES015932] Funding Source: NIH RePORTER	National Institutes of Health Counter-ACT (Countermeasures Against Chemical Threats)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ONES (Outstanding New Environmental Scientists); Spanish Foundation for Science and Technology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Carrie Redlich for scientific advice. This work was funded by the National Institutes of Health Counter-ACT (Countermeasures Against Chemical Threats) and National Institute of Environmental Health Sciences (NIEHS) ONES (Outstanding New Environmental Scientists) programs (awards U01 ES015674 and R01 ES015056 to S.-E. J. from NIEHS), a NIEHS predoctoral fellowship to J.E. (F31ES015932), and a Ministry of Education and Science/Fulbright fellowship from the Spanish Foundation for Science and Technology to A. C. (2007-0480). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the federal government. S.J. serves on the Scientific Advisory Board of Hydra Biosciences, a biotech startup company in Cambridge, MA, USA. Hydra Biosciences provided the TRPA1 antagonist HC-030031 used in this study. We are grateful to Aiwei Sui and Marian Brackmann for technical support.	ALARIE Y, 1973, TOXICOL APPL PHARM, V24, P279, DOI 10.1016/0041-008X(73)90148-8; ALARIE Y, 1987, ENVIRON HEALTH PERSP, V72, P159, DOI 10.2307/3430291; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bessac BF, 2007, J PHYSIOL-LONDON, V582, P1073, DOI 10.1113/jphysiol.2007.130534; Blain Peter G., 2003, Toxicological Reviews, V22, P103, DOI 10.2165/00139709-200322020-00005; Brone B, 2008, TOXICOL APPL PHARM, V231, P150, DOI 10.1016/j.taap.2008.04.005; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CONE JE, 1994, CHEST, V106, P500, DOI 10.1378/chest.106.2.500; CULLEN MR, 1987, OCCUP MED, V2, P655; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; DETORRES JP, 2006, RESP MED EXTRA, V2, P13; Dhara VR, 2002, ARCH ENVIRON HEALTH, V57, P391, DOI 10.1080/00039890209601427; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Escalera J, 2008, J BIOL CHEM, V283, P24136, DOI 10.1074/jbc.M710280200; FERGUSON JS, 1991, TOXICOL APPL PHARM, V107, P253, DOI 10.1016/0041-008X(91)90207-U; Gerhold KA, 2008, J PHYSIOL-LONDON, V586, P3303, DOI 10.1113/jphysiol.2008.158030; GOLDMAN LR, 1987, WESTERN J MED, V147, P95; GORDON T, 1985, AM REV RESPIR DIS, V132, P1106; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUPTA BN, 1987, ENVIRON HEALTH PERSP, V72, P105, DOI 10.2307/3430282; Herrick CA, 2002, J ALLERGY CLIN IMMUN, V109, P873, DOI 10.1067/mai.2002.123533; Hill AR, 2000, MEDICINE, V79, P234, DOI 10.1097/00005792-200007000-00004; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; HU H, 1989, JAMA-J AM MED ASSOC, V262, P660; Jordt S. E., 2007, V45, P253; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; Karagama YG, 2003, J ROY SOC MED, V96, P172, DOI 10.1258/jrsm.96.4.172; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Koehler G A, 1993, Prehosp Disaster Med, V8, P359; Lee SP, 2008, BRIT J PHARMACOL, V153, P1739, DOI 10.1038/bjp.2008.85; Lu SG, 2006, J PHYSIOL-LONDON, V577, P169, DOI 10.1113/jphysiol.2006.116418; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; MAPP CE, 1991, EUR J PHARMACOL, V200, P73, DOI 10.1016/0014-2999(91)90667-F; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Millqvist E, 1998, ALLERGY, V53, P1208, DOI 10.1111/j.1398-9995.1998.tb03843.x; Morris JB, 2005, TOXICOL SCI, V83, P380, DOI 10.1093/toxsci/kfi038; Morris JB, 1999, J APPL PHYSIOL, V87, P1877, DOI 10.1152/jappl.1999.87.5.1877; Mutch J R, 1944, Br J Ophthalmol, V28, P317, DOI 10.1136/bjo.28.7.317; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Olajos EJ, 2001, J APPL TOXICOL, V21, P355, DOI 10.1002/jat.767; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Prezant DJ, 2008, MT SINAI J MED, V75, P89, DOI 10.1002/msj.20028; Pruett SB, 2001, J TOXICOL ENV HEAL B, V4, P207, DOI 10.1080/109374001300339818; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; SANGHA GK, 1979, TOXICOL APPL PHARM, V50, P533, DOI 10.1016/0041-008X(79)90408-3; Sartori M., 1939, WAR GASES CHEM ANAL, V118, pe19; Shakeri MS, 2008, OCCUP MED-OXFORD, V58, P205, DOI 10.1093/occmed/kqn013; Simon SA, 2008, J CLIN INVEST, V118, P2383, DOI 10.1172/JCI36111; Taylor-Clark TE, 2008, J PHYSIOL-LONDON, V586, P3447, DOI 10.1113/jphysiol.2008.153585; Thomas RJ, 2002, MIL MED, V167, P136, DOI 10.1093/milmed/167.2.136; THOMPSON JE, 1987, AM REV RESPIR DIS, V136, P43, DOI 10.1164/ajrccm/136.1.43; Treudler R, 1999, BRIT J DERMATOL, V140, P531; Vaca FE, 1996, AM J EMERG MED, V14, P402, DOI 10.1016/S0735-6757(96)90060-1; VARMA DR, 1993, J TOXICOL ENV HEALTH, V40, P513, DOI 10.1080/15287399309531816; Varma S, 2001, CLIN EXP DERMATOL, V26, P248, DOI 10.1046/j.1365-2230.2001.00806.x; Vaughan RP, 2006, TOXICOL SCI, V93, P411, DOI 10.1093/toxsci/kfl061; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Warden CR, 2005, CRIT CARE CLIN, V21, P719, DOI 10.1016/j.ccc.2005.05.008; Wisnewski AV, 2008, CLIN EXP ALLERGY, V38, P957, DOI 10.1111/j.1365-2222.2008.02982.x; Wisnewski AV, 2001, CURR OPIN ALLERGY CL, V1, P169, DOI 10.1097/00130832-200104000-00009; WOOLRICH PF, 1982, AM IND HYG ASSOC J, V43, P89, DOI 10.1080/15298668291409415; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843; 1991, MMWR MORB MORTAL WKL, V40, P825; 1991, MMWR MORB MORTAL WKL, V40, P833; 2004, MMWR MORB MORTAL WKL, V53, P740	78	116	119	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1102	1114		10.1096/fj.08-117812	http://dx.doi.org/10.1096/fj.08-117812			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19036859	Green Published			2022-12-25	WOS:000266651600014
J	Liang, D; Nunes-Tavares, N; Xie, HQ; Carvalho, S; Bon, S; Massoulie, J				Liang, Dong; Nunes-Tavares, Nilson; Xie, Heidi Q.; Carvalho, Stephanie; Bon, Suzanne; Massoulie, Jean			Protein CutA Undergoes an Unusual Transfer into the Secretory Pathway and Affects the Folding, Oligomerization, and Secretion of Acetylcholinesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL T-PEPTIDE; BOVINE CAUDATE-NUCLEUS; QUATERNARY ASSOCIATIONS; MEMBRANE ANCHOR; MOLECULAR-FORMS; COLLAGEN TAIL; HELA-CELLS; X-RAY; DEGRADATION; SUBUNIT	The mammalian protein CutA was first discovered in a search for the membrane anchor of mammalian brain acetylcholinesterase (AChE). It was co-purified with AChE, but it is distinct from the real transmembrane anchor protein, PRiMA. CutA is a ubiquitous trimeric protein, homologous to the bacterial CutA1 protein that belongs to an operon involved in resistance to divalent ions ("copper tolerance A"). The function of this protein in plants and animals is unknown, and several hypotheses concerning its subcellular localization have been proposed. We analyzed the expression and the subcellular localization of mouse CutA variants, starting at three in-frame ATG codons, in transfected COS cells. We show that CutA produces 20-kDa (H) and 15-kDa (L) components. The H component is transferred into the secretory pathway and secreted, without cleavage of a signal peptide, whereas the L component is mostly cytosolic. We show that expression of the longer CutA variant reduces the level of AChE, that this effect depends on the AChE C-terminal peptides, and probably results from misfolding. Surprisingly, CutA increased the secretion of a mutant possessing a KDEL motif at its C terminus; it also increased the formation of AChE homotetramers. We found no evidence for a direct interaction between CutA and AChE. The longer CutA variant seems to affect the processing and trafficking of secretory proteins, whereas the shorter one may have a distinct function in the cytoplasm.	[Liang, Dong; Nunes-Tavares, Nilson; Xie, Heidi Q.; Carvalho, Stephanie; Bon, Suzanne; Massoulie, Jean] CNRS, Ecole Normale Super, UMR 8544, Neurobiol Lab, F-75005 Paris, France; [Liang, Dong] E China Normal Univ, Shanghai Inst Brain Funct Genom, Minist Educ & Sci & Technol Commiss Shanghai Muni, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China; [Nunes-Tavares, Nilson] Ctr Univ Zona Oeste UEZO, BR-21941590 Rio De Janeiro, Brazil; [Xie, Heidi Q.] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); East China Normal University; Centro Universitario Estadual da Zona Oeste; Hong Kong University of Science & Technology	Massoulie, J (corresponding author), CNRS, Ecole Normale Super, UMR 8544, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	jean.massoulie@biologie.ens.fr			CNRS; Ecole Normale Superieure; Association Francais Contre les Myopathies; Direction Generale de l'Armement; Defense Threat Reduction Agency	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure; Association Francais Contre les Myopathies(Association Francaise contre les Myopathies); Direction Generale de l'Armement; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by grants from CNRS, Ecole Normale Superieure, Association Francais Contre les Myopathies, Direction Generale de l'Armement, and Defense Threat Reduction Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arnesano F, 2003, J BIOL CHEM, V278, P45999, DOI 10.1074/jbc.M304398200; Belbeoc'h S, 2004, EUR J BIOCHEM, V271, P1476, DOI 10.1111/j.1432-1033.2004.04052.x; Belbeoc'h S, 2003, EMBO J, V22, P3536, DOI 10.1093/emboj/cdg360; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Falasca C, 2005, J BIOL CHEM, V280, P878, DOI 10.1074/jbc.M409201200; FONG ST, 1995, MOL MICROBIOL, V15, P1127, DOI 10.1111/j.1365-2958.1995.tb02286.x; GENNARI K, 1987, J NEUROCHEM, V49, P12, DOI 10.1111/j.1471-4159.1987.tb03386.x; GRASSI J, 1982, J NEUROCHEM, V38, P457, DOI 10.1111/j.1471-4159.1982.tb08651.x; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; Lin CH, 2006, ACTA CRYSTALLOGR F, V62, P1113, DOI 10.1107/S1744309106039832; Massoulie J, 2008, CHEM-BIOL INTERACT, V175, P30, DOI 10.1016/j.cbi.2008.04.039; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Navaratnam DS, 2000, J NEUROCHEM, V74, P2146, DOI 10.1046/j.1471-4159.2000.0742146.x; Noureddine H, 2008, J BIOL CHEM, V283, P20722, DOI 10.1074/jbc.M801364200; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Savchenko A, 2004, PROTEINS, V54, P162, DOI 10.1002/prot.10585; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; TAKAYUKI N, 1993, Patent No. 1994056895; Tanaka Y, 2004, FEBS LETT, V556, P167, DOI 10.1016/S0014-5793(03)01402-9; Xu YB, 2001, EUR J BIOCHEM, V268, P2028, DOI 10.1046/j.1432-1327.2001.02074.x; Yang JC, 2008, ACTA BIOCHIM POL, V55, P411, DOI 10.18388/abp.2008_3089; Yang JC, 2009, MOL BIOL REP, V36, P63, DOI 10.1007/s11033-007-9152-9	31	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5195	5207		10.1074/jbc.M806260200	http://dx.doi.org/10.1074/jbc.M806260200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19049969	hybrid			2022-12-25	WOS:000263416600050
J	Katona, BW; Anant, S; Covey, DF; Stenson, WF				Katona, Bryson W.; Anant, Shrikant; Covey, Douglas F.; Stenson, William F.			Characterization of Enantiomeric Bile Acid-induced Apoptosis in Colon Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-INDUCED APOPTOSIS; ELECTRON-TRANSPORT CHAIN; DEOXYCHOLIC-ACID; HEPATOCYTE APOPTOSIS; PERMEABILITY TRANSITION; CASPASE-8 ACTIVATION; HEPATIC MITOCHONDRIA; INDUCED CYTOTOXICITY; LIVER-MITOCHONDRIA; OXIDATIVE STRESS	Bile acids are steroid detergents that are toxic to mammalian cells at high concentrations; increased exposure to these steroids is pertinent in the pathogenesis of cholestatic disease and colon cancer. Understanding the mechanisms of bile acid toxicity and apoptosis, which could include nonspecific detergent effects and/or specific receptor activation, has potential therapeutic significance. In this report we investigate the ability of synthetic enantiomers of lithocholic acid (ent-LCA), chenodeoxycholic acid (ent-CDCA), and deoxycholic acid (ent-DCA) to induce toxicity and apoptosis in HT-29 and HCT-116 cells. Natural bile acids were found to induce more apoptotic nuclear morphology, cause increased cellular detachment, and lead to greater capase-3 and -9 cleavage compared with enantiomeric bile acids in both cell lines. In contrast, natural and enantiomeric bile acids showed similar effects on cellular proliferation. These data show that bile acid-induced apoptosisin HT29 and HCT-116 cells is enantiospecific, hence correlated with the absolute configuration of the bile steroid rather than its detergent properties. The mechanism of LCA- and ent-LCA-induced apoptosis was also investigated in HT29 and HCT-116 cells. These bile acids differentially activate initiator caspases-2 and -8 and induce cleavage of full-length Bid. LCA and ent-LCA mediated apoptosis was inhibited by both pan-caspase and selective caspase-8 inhibitors, whereas a selective caspase-2 inhibitor provided no protection. LCA also induced increased CD95 localization to the plasma membrane and generated increased reactive oxygen species compared with ent-LCA. This suggests that LCA/ent-LCA induce apoptosis enantioselectively through CD95 activation, likely because of increased reactive oxygen species generation, with resulting procaspase-8 cleavage.	[Stenson, William F.] Washington Univ, Sch Med, Div Gastroenterol, Dept Med, St Louis, MO 63110 USA; [Katona, Bryson W.; Covey, Douglas F.] Washington Univ, Sch Med, Div Gastroenterol, Dept Dev Biol, St Louis, MO 63110 USA; [Anant, Shrikant] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA	Washington University (WUSTL); Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center	Stenson, WF (corresponding author), Washington Univ, Sch Med, Div Gastroenterol, Dept Med, Campus Box 8124,660 S Euclid Ave, St Louis, MO 63110 USA.	wstenson@im.wustl.edu	Anant, Shrikant/AAF-8020-2020	Katona, Bryson/0000-0001-8186-9119	National Institutes of Health [GM47969, 5-T32-HL07275, CA109269, DK33165]; NATIONAL CANCER INSTITUTE [R01CA109269] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033165, R37DK033165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM47969 ( to D. F. C.), 5-T32-HL07275 ( to B. W. K.), CA109269 ( to S. A.), and DK33165 ( to W. F. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alakoskela JM, 2008, LANGMUIR, V24, P830, DOI 10.1021/la702909q; Alakoskela JM, 2007, BBA-BIOMEMBRANES, V1768, P131, DOI 10.1016/j.bbamem.2006.07.011; Becker S, 2007, BIOL CHEM, V388, P185, DOI 10.1515/BC.2007.021; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Biellmann JF, 2003, CHEM REV, V103, P2019, DOI 10.1021/cr020071b; CHOW SC, 1995, FEBS LETT, V364, P134, DOI 10.1016/0014-5793(95)00370-O; Debruyne PR, 2001, MUTAT RES-FUND MOL M, V480, P359, DOI 10.1016/S0027-5107(01)00195-6; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; FEARNHEAD HO, 1995, FEBS LETT, V375, P283, DOI 10.1016/0014-5793(95)01228-7; Goncalves A, 2000, BIOCHEM PHARMACOL, V60, P1579, DOI 10.1016/S0006-2952(00)00481-0; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Green PS, 2001, ENDOCRINOLOGY, V142, P400, DOI 10.1210/en.142.1.400; Gregoli PA, 1999, J CELL PHYSIOL, V178, P133, DOI 10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.3.CO;2-X; HAGUE A, 1995, INT J CANCER, V60, P400, DOI 10.1002/ijc.2910600322; Haza AI, 2000, NUTR CANCER, V36, P79, DOI 10.1207/S15327914NC3601_12; HEUMAN DM, 1995, ITAL J GASTROENTEROL, V27, P372; Higuchi H, 2003, AM J PHYSIOL-GASTR L, V284, pG734, DOI 10.1152/ajpgi.00491.2002; Higuchi H, 2001, J BIOL CHEM, V276, P38610, DOI 10.1074/jbc.M105300200; Iizaka Toru, 2007, Toxicology, V241, P146, DOI 10.1016/j.tox.2007.08.095; Jean-Louis S, 2006, J BIOL CHEM, V281, P14948, DOI 10.1074/jbc.M506710200; Katona BW, 2008, EUR J MED CHEM, V43, P107, DOI 10.1016/j.ejmech.2007.02.017; Katona BW, 2007, J ORG CHEM, V72, P9298, DOI 10.1021/jo701559q; Katona BW, 2007, J MED CHEM, V50, P6048, DOI 10.1021/jm0707931; Khosravi-Far R, 2004, CANCER BIOL THER, V3, P1051, DOI 10.4161/cbt.3.11.1173; KRAHENBUHL S, 1992, HEPATOLOGY, V15, P1160, DOI 10.1002/hep.1840150630; KRAHENBUHL S, 1994, HEPATOLOGY, V19, P471, DOI 10.1016/0270-9139(94)90027-2; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Milovic V, 2002, EUR J CLIN INVEST, V32, P29, DOI 10.1046/j.0014-2972.2001.00938.x; Oh SH, 2003, ARCH TOXICOL, V77, P110, DOI 10.1007/s00204-002-0415-x; Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001; Park SE, 2004, INT J ONCOL, V25, P231; Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139; Payne CM, 2005, CELL BIOL TOXICOL, V21, P215, DOI 10.1007/s10565-005-0166-6; Powell AA, 2001, BIOCHEM J, V356, P481, DOI 10.1042/0264-6021:3560481; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; REDDY BS, 1975, CANCER, V36, P2401, DOI 10.1002/1097-0142(197512)36:6<2401::AID-CNCR2820360619>3.0.CO;2-O; REDDY BS, 1992, LIPIDS, V27, P807, DOI 10.1007/BF02535855; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Reinehr R, 2004, GASTROENTEROLOGY, V127, P1540, DOI 10.1053/j.gastro.2004.08.056; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Richter RK, 2004, BIOORG MED CHEM LETT, V14, P115, DOI 10.1016/j.bmcl.2003.10.018; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rolo AP, 2004, TOXICOL SCI, V79, P196, DOI 10.1093/toxsci/kfh078; Rolo AP, 2003, MITOCHONDRION, V2, P305, DOI 10.1016/S1567-7249(03)00007-2; SAGAWA H, 1993, AM J PHYSIOL, V264, pG835, DOI 10.1152/ajpgi.1993.264.5.G835; Schlottmann K, 2000, CANCER RES, V60, P4270; Scotti E, 2007, CELL MOL LIFE SCI, V64, P2477, DOI 10.1007/s00018-007-7280-y; Shiraki K, 2005, INT J MOL MED, V16, P729; Sodeman T, 2000, AM J PHYSIOL-GASTR L, V278, pG992, DOI 10.1152/ajpgi.2000.278.6.G992; Sokol RJ, 2001, PEDIATR RES, V49, P519, DOI 10.1203/00006450-200104000-00014; Sokol RJ, 2006, J PEDIATR GASTR NUTR, V43, pS4, DOI 10.1097/01.mpg.0000226384.71859.16; Sokol TJ, 2005, J PEDIATR GASTR NUTR, V41, P235, DOI 10.1097/01.MPG.0000170600.80640.88; Sola S, 2002, CLIN SCI, V103, P475, DOI 10.1042/CS20020196; Strupp W, 2000, J MEMBRANE BIOL, V175, P181, DOI 10.1007/s002320001066; Takizawa T, 1999, MICROBIOL IMMUNOL, V43, P245, DOI 10.1111/j.1348-0421.1999.tb02400.x; Tan KP, 2007, MOL PHARMACOL, V72, P1380, DOI 10.1124/mol.107.039370; Thomas C, 2008, THYROID, V18, P167, DOI 10.1089/thy.2007.0255; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015; Wachs FP, 2005, INT J COLORECTAL DIS, V20, P103, DOI 10.1007/s00384-004-0616-2; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200; Yang JI, 2007, BIOCHEM BIOPH RES CO, V361, P156, DOI 10.1016/j.bbrc.2007.07.001; Yi KD, 2008, J PHARMACOL EXP THER, V324, P1188, DOI 10.1124/jpet.107.132308; Yui S, 2005, J BIOCHEM, V138, P151, DOI 10.1093/jb/mvi106	66	52	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3354	3364		10.1074/jbc.M805804200	http://dx.doi.org/10.1074/jbc.M805804200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054763	Green Published, hybrid			2022-12-25	WOS:000262700900078
J	Maity, P; Bindu, S; Dey, S; Goyal, M; Alam, A; Pal, C; Mitra, K; Bandyopadhyay, U				Maity, Pallab; Bindu, Samik; Dey, Sumanta; Goyal, Manish; Alam, Athar; Pal, Chinmay; Mitra, Kalyan; Bandyopadhyay, Uday			Indomethacin, a Non-steroidal Anti-inflammatory Drug, Develops Gastropathy by Inducing Reactive Oxygen Species-mediated Mitochondrial Pathology and Associated Apoptosis in Gastric Mucosa A NOVEL ROLE OF MITOCHONDRIAL ACONITASE OXIDATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; COMPLEX-III; IN-VITRO; INJURY; SUPEROXIDE; STRESS; PROLIFERATION; INVOLVEMENT; ACTIVATION; ISCHEMIA	We have investigated the role of mitochondria on the development of indomethacin (a non-steroidal anti-inflammatory drug)-induced gastric mucosal apoptosis and associated gas-tropathy in rat. Transmission electron microscopic studies indicate that indomethacin damages mitochondrial ultrastructure and causes mitochondrial dysfunction as evident from decreased stage-3 respiration, dehydrogenase activity, and transmembrane potential (Delta psi(m)). Mitochondrial pathology is associated with increased generation of intra-mitochondrial-reactive oxygen species, such as O-2(center dot-), H2O2 and center dot OH, leading to oxidative stress. O-2(center dot-) is the most effective to damage mitochondrial aconitase, leading to the release of iron from its iron-sulfur cluster. The released iron, by interacting with intra-mitochondrial H2O2, forms center dot OH. Immunoprecipitation of mitochondrial aconitase and subsequent Western immunoblotting indicate carbonylation of aconitase along with the loss of activity in vivo after indomethacin treatment. The release of iron has been documented by fluorescence imaging of mucosal cells by using Phen Green SK, a specific probe for chelatable iron. Interestingly, intra-mitochondrial center dot OH generation is crucial for the development of mitochondrial pathology and activation of mitochondrial death pathway by indomethacin. Scavenging of center dot OH by dimethyl sulfoxide or alpha-phenyl-n-tert-butylnitrone, a spin-trap, prevents indomethacin-induced mitochondrial ultrastructural changes, oxidative stress, collapse of Delta psi(m), and mitochondrial dysfunction. The scavengers also restore indomethacin-induced activation of caspase-9 and caspase-3 to block mitochondrial pathway of apoptosis and gastric mucosal damage. This study, thus, reveals the critical role of O-2(center dot-)-mediated mitochondrial aconitase inactivation to release intra-mitochondrial iron, which by generating center dot OH promotes gastric mucosal cell apoptosis and gastropathy during indomethacin treatment.	[Maity, Pallab; Bindu, Samik; Dey, Sumanta; Goyal, Manish; Alam, Athar; Pal, Chinmay; Bandyopadhyay, Uday] Indian Inst Chem Biol, Dept Infect Dis & Immunol, Kolkata 700032, W Bengal, India; [Mitra, Kalyan] Cent Drug Res Inst, Electron Microscopy Unit, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Bandyopadhyay, U (corresponding author), Indian Inst Chem Biol, Dept Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com	Maity, Pallab/L-3896-2017; Goyal, Manish/O-2183-2015; Alam, Athar/B-3642-2010	Maity, Pallab/0000-0001-9769-3533; Goyal, Manish/0000-0003-2383-5409; Bindu, Samik/0000-0003-1416-2003	Council of Scientific and Industrial Research, New Delhi [SIP 0007]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi for providing funds through Suprainstitutional Project SIP 0007. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aggarwal S, 2000, NEOPLASIA, V2, P346, DOI 10.1038/sj.neo.7900097; Andersson U, 1998, BIOCHEM BIOPH RES CO, V249, P512, DOI 10.1006/bbrc.1998.9171; BABBS CF, 1990, METHOD ENZYMOL, V186, P137; Bandyopadhyay U, 2002, LIFE SCI, V71, P2845, DOI 10.1016/S0024-3205(02)02143-4; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Cecarini V, 2007, BBA-MOL CELL RES, V1773, P93, DOI 10.1016/j.bbamcr.2006.08.039; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Chan JM, 2006, HEMATOL ONCOL CLIN N, V20, P797, DOI 10.1016/j.hoc.2006.03.002; Chang JK, 2006, TOXICOLOGY, V228, P111, DOI 10.1016/j.tox.2006.08.028; Chattopadhyay I, 2006, FREE RADICAL BIO MED, V40, P1397, DOI 10.1016/j.freeradbiomed.2005.12.016; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CHEVION M, 1993, P NATL ACAD SCI USA, V90, P1102, DOI 10.1073/pnas.90.3.1102; Chiou SK, 2005, GASTROENTEROLOGY, V128, P63, DOI 10.1053/j.gastro.2004.10.008; *CTR PUBL HLTH PRE, 2005, GRAD STUD EP RESP PR, P6; de Groot DJA, 2005, BRIT J CANCER, V92, P1459, DOI 10.1038/sj.bjc.6602516; Eli Y, 2001, BIOCHEM PHARMACOL, V61, P565, DOI 10.1016/S0006-2952(00)00578-5; Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7; Fujii Y, 2000, P SOC EXP BIOL MED, V224, P102, DOI 10.1046/j.1525-1373.2000.22407.x; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gu Q, 2005, CARCINOGENESIS, V26, P541, DOI 10.1093/carcin/bgh345; Guha M, 2007, J PINEAL RES, V43, P372, DOI 10.1111/j.1600-079X.2007.00488.x; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Gulbins E, 2003, EXP PHYSIOL, V88, P85, DOI 10.1113/eph8802503; GUTTERIDGE JMC, 1985, FEBS LETT, V185, P19, DOI 10.1016/0014-5793(85)80732-8; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; INSEL PA, 1991, GOODMAN GILMANS PHAR, P638; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; KADIISKA MB, 1995, J CLIN INVEST, V96, P1653, DOI 10.1172/JCI118205; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; LARKAI EN, 1987, AM J GASTROENTEROL, V82, P1153; Maity P, 2008, J BIOL CHEM, V283, P14391, DOI 10.1074/jbc.M800414200; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Naito Y, 2006, REDOX REP, V11, P243, DOI 10.1179/135100006X155021; Ong MMK, 2006, FREE RADICAL BIO MED, V40, P420, DOI 10.1016/j.freeradbiomed.2005.08.038; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; PARKE DV, 1983, VET RES COMMUN, V7, P285, DOI 10.1007/BF02228636; PERRY MA, 1986, GASTROENTEROLOGY, V90, P362, DOI 10.1016/0016-5085(86)90933-9; PORTER DJT, 1987, J BIOL CHEM, V262, P6552; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Redlak MJ, 2005, AM J PHYSIOL-GASTR L, V289, pG731, DOI 10.1152/ajpgi.00150.2005; Regula J, 2006, AM J GASTROENTEROL, V101, P1747, DOI 10.1111/j.1572-0241.2006.00686.x; Ricci C, 2008, AM J PHYSIOL-CELL PH, V294, pC413, DOI 10.1152/ajpcell.00362.2007; Rousou AJ, 2004, AM J PHYSIOL-HEART C, V287, pH1967, DOI 10.1152/ajpheart.00338.2004; Scatena R, 2007, AM J PHYSIOL-CELL PH, V293, pC12, DOI 10.1152/ajpcell.00314.2006; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC; SWIFT GL, 1992, DIGESTION, V53, P88, DOI 10.1159/000200975; TAKEUCHI Y, 1991, ARCH BIOCHEM BIOPHYS, V289, P33, DOI 10.1016/0003-9861(91)90438-O; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; TERANO A, 1982, GASTROENTEROLOGY, V83, P1280; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; Wallace JL, 2001, BEST PRACT RES CL GA, V15, P691, DOI 10.1053/bega.2001.0229; YOSHIKAWA T, 1993, GUT, V34, P732, DOI 10.1136/gut.34.6.732; Zhang GS, 2000, LEUKEMIA RES, V24, P385, DOI 10.1016/S0145-2126(99)00198-8; Zheng W, 1998, BRAIN RES, V799, P334, DOI 10.1016/S0006-8993(98)00481-8; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	58	87	89	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3058	3068		10.1074/jbc.M805329200	http://dx.doi.org/10.1074/jbc.M805329200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049974	hybrid			2022-12-25	WOS:000262700900050
J	Pimkina, J; Humbey, O; Zilfou, JT; Jarnik, M; Murphy, ME				Pimkina, Julia; Humbey, Olivier; Zilfou, Jack T.; Jarnik, Michal; Murphy, Maureen E.			ARF Induces Autophagy by Virtue of Interaction with Bcl-xl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P19(ARF) TUMOR-SUPPRESSOR; P53-INDEPENDENT APOPTOSIS; MITOCHONDRIAL P-32; BECLIN-1; P53; PROTEIN; DOMAIN; GENE; TUMORIGENESIS; INHIBITION	The ARF tumor suppressor controls a well-described p53/Mdm2-dependent oncogenic stress checkpoint. In addition, ARF has recently been shown to localize to mitochondria, and to induce autophagy; however, this has never before been demonstrated for endogenous ARF, and the molecular basis for this activity of ARF has not been elucidated. Using an unbiased mass spectrometry-based approach, we show that mitochondrial ARF interacts with the Bcl2 family member Bcl-xl, which normally protects cells from autophagy by inhibiting the Beclin-1/Vps34 complex, which is essential for autophagy. We find that increased expression of ARF decreases Beclin-1/Bcl-xl complexes in cells, thereby providing a basis for ARF-induced autophagy. Our data also indicate that silencing p53 leads to high levels of ARF and increased autophagy, thereby providing a possible basis for the finding by others that p53 inhibits autophagy. The combined data support the premise that ARF induces autophagy in a p53-independent manner in part by virtue of its interaction with Bcl-xl.	[Pimkina, Julia; Humbey, Olivier; Murphy, Maureen E.] Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA; [Pimkina, Julia] Fox Chase Canc Ctr, Smolensk State Med Acad Grad Program, Philadelphia, PA 19111 USA; [Jarnik, Michal] Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA 19111 USA; [Zilfou, Jack T.] Zilfou Therapeut Inc, Allentown, PA 18104 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Murphy, ME (corresponding author), Fox Chase Canc Ctr, Div Med Sci, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Maureen.Murphy@FCCC.edu		Murphy, Maureen/0000-0001-7644-7296	National Institutes of Health [R01 CA080854, R01 CA150002]; Philippe Foundation; NATIONAL CANCER INSTITUTE [R01CA139319, R01CA080854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philippe Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health R01 CA080854 (to M. M.) and R01 CA150002 (to M. M.). This work was also supported by the Philippe Foundation (to O. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Criollo A, 2007, AUTOPHAGY, V3, P350, DOI 10.4161/auto.4077; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Humbey O, 2008, CANCER RES, V68, P9608, DOI 10.1158/0008-5472.CAN-08-2263; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Ku B, 2008, AUTOPHAGY, V4, P519, DOI 10.4161/auto.5846; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Matsuoka M, 2003, BIOCHEM BIOPH RES CO, V301, P1000, DOI 10.1016/S0006-291X(03)00080-9; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Paliwal S, 2006, MOL CELL BIOL, V26, P2360, DOI 10.1128/MCB.26.6.2360-2372.2006; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pietsch EC, 2007, CANCER BIOL THER, V6, P1576, DOI 10.4161/cbt.6.10.4719; Reef S, 2007, ONCOGENE, V26, P6677, DOI 10.1038/sj.onc.1210485; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	35	79	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2803	2810		10.1074/jbc.M804705200	http://dx.doi.org/10.1074/jbc.M804705200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049976	Green Published, hybrid			2022-12-25	WOS:000262700900023
J	Tan, YW; Hanson, JA; Yang, H				Tan, Yan-Wen; Hanson, Jeffrey A.; Yang, Haw			Direct Mg2+ Binding Activates Adenylate Kinase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE MONOPHOSPHATE KINASES; CHRONIC HEMOLYTIC-ANEMIA; CONFORMATIONAL DYNAMICS; SUBSTRATE-INHIBITION; MOLECULAR EVOLUTION; POTASSIUM CHANNELS; CATALYTIC ACTIVITY; CRYSTAL-STRUCTURES; FREE MAGNESIUM; ENERGY-CHARGE	We report evidence that adenylate kinase (AK) from Escherichia coli can be activated by the direct binding of a magnesium ion to the enzyme, in addition to ATP-complexed Mg2+. By systematically varying the concentrations of AMP, ATP, and magnesium in kinetic experiments, we found that the apparent substrate inhibition of AK, formerly attributed to AMP, was suppressed at low magnesium concentrations and enhanced at high magnesium concentrations. This previously unreported magnesium dependence can be accounted for by a modified random bi-bi model in which Mg2+ can bind to AK directly prior to AMP binding. A new kinetic model is proposed to replace the conventional random bi-bi mechanism with substrate inhibition and is able to describe the kinetic data over a physiologically relevant range of magnesium concentrations. According to this model, the magnesium-activated AK exhibits a 23- +/- 3-fold increase in its forward reaction rate compared with the unactivated form. The findings imply that Mg2+ could be an important affecter in the energy signaling network in cells.	[Tan, Yan-Wen; Hanson, Jeffrey A.; Yang, Haw] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Yang, Haw] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Yang, H (corresponding author), Univ Calif Berkeley, Dept Chem, D46 Hildebrand Hall, Berkeley, CA 94720 USA.	hawyang@berkeley.edu	Yang, Haw/AHD-0857-2022; Tan, Yan-Wen/GQZ-0713-2022	Yang, Haw/0000-0003-0268-6352; Tan, Yan-Wen/0000-0002-5522-7996	National Science Foundation; A. P. Sloan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069937] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); A. P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the National Science Foundation and by the A. P. Sloan Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Aden J, 2007, J AM CHEM SOC, V129, P14003, DOI 10.1021/ja075055g; AINSWORTH S, 1973, BIOCHEM J, V131, P223, DOI 10.1042/bj1310223; ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; BERRY MB, 1994, PROTEINS, V19, P183, DOI 10.1002/prot.340190304; Berry MB, 1998, PROTEINS, V32, P276, DOI 10.1002/(SICI)1097-0134(19980815)32:3<276::AID-PROT3>3.0.CO;2-G; Bianchi P, 1999, BRIT J HAEMATOL, V105, P75, DOI 10.1111/j.1365-2141.1999.01297.x; Bilderback T, 1996, BIOCHEMISTRY-US, V35, P6100, DOI 10.1021/bi951833i; BLAIR JM, 1970, EUR J BIOCHEM, V13, P384, DOI 10.1111/j.1432-1033.1970.tb00940.x; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; Chu JW, 2007, BIOPHYS J, V93, P3860, DOI 10.1529/biophysj.107.112060; Corrons JLV, 2003, BLOOD, V102, P353, DOI 10.1182/blood-2002-07-2288; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; Dzeja PP, 2007, J BIOL CHEM, V282, P31366, DOI 10.1074/jbc.M705268200; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Elamrani S, 1996, PROTEINS, V25, P79, DOI 10.1002/(SICI)1097-0134(199605)25:1<79::AID-PROT6>3.3.CO;2-Z; FukamiKobayashi K, 1996, FEBS LETT, V385, P214, DOI 10.1016/0014-5793(96)00367-5; GILLES AM, 1986, P NATL ACAD SCI USA, V83, P5798, DOI 10.1073/pnas.83.16.5798; GILLES AM, 1988, J BIOL CHEM, V263, P8204; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hibino T, 2005, J BIOL CHEM, V280, P30671, DOI 10.1074/jbc.M412601200; HSIEH LS, 1991, J BACTERIOL, V173, P3914, DOI 10.1128/JB.173.12.3914-3917.1991; Huang C Y, 1979, Methods Enzymol, V63, P54; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Igamberdiev AU, 2006, J EXP BOT, V57, P2133, DOI 10.1093/jxb/erl006; Igamberdiev AU, 2001, BIOCHEM J, V360, P225, DOI 10.1042/0264-6021:3600225; JAMES F, 1975, COMPUT PHYS COMMUN, V10, P343, DOI 10.1016/0010-4655(75)90039-9; JENSEN PR, 1995, J BACTERIOL, V177, P3420, DOI 10.1128/jb.177.12.3420-3426.1995; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; LACHANT NA, 1991, BLOOD, V77, P2774; Lasko DR, 1996, BIOTECHNOL BIOENG, V52, P364, DOI 10.1002/(SICI)1097-0290(19961105)52:3<364::AID-BIT2>3.0.CO;2-I; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; LIANG P, 1991, PROTEINS, V9, P28, DOI 10.1002/prot.340090105; Lu Q, 2008, J AM CHEM SOC, V130, P4772, DOI 10.1021/ja0780481; Marco-Marin C, 2005, J MOL BIOL, V352, P438, DOI 10.1016/j.jmb.2005.07.045; MATSUURA S, 1989, J BIOL CHEM, V264, P10148; MILNE JA, 1979, BIOCHEMISTRY-US, V18, P3604, DOI 10.1021/bi00583a026; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Munier-Lehmann H, 1999, PROTEINS, V36, P238, DOI 10.1002/(SICI)1097-0134(19990801)36:2<238::AID-PROT9>3.0.CO;2-K; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; Noda L., 1970, ADENYLATE KINASE; Ostermann N, 2000, STRUCTURE, V8, P629, DOI 10.1016/S0969-2126(00)00149-0; PRADET A, 1983, ANNU REV PLANT PHYS, V34, P199, DOI 10.1146/annurev.pp.34.060183.001215; Pucar D, 2000, J BIOL CHEM, V275, P41424, DOI 10.1074/jbc.M007903200; Qualtieri A, 1997, BRIT J HAEMATOL, V99, P770, DOI 10.1046/j.1365-2141.1997.4953299.x; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7440, DOI 10.1021/bi00484a013; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; Romani A, 2007, ARCH BIOCHEM BIOPHYS, V458, P90, DOI 10.1016/j.abb.2006.07.012; Saks V, 2006, J PHYSIOL-LONDON, V571, P253, DOI 10.1113/jphysiol.2005.101444; SEGEL IH, 1993, ENZYME KINETICS BEHA, P503; Shapiro YE, 2002, BIOCHEMISTRY-US, V41, P6271, DOI 10.1021/bi012132q; Shapiro YE, 2000, BIOCHEMISTRY-US, V39, P6634, DOI 10.1021/bi992076h; Sheng XR, 1999, J BIOL CHEM, V274, P22238, DOI 10.1074/jbc.274.32.22238; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Sinev MA, 1996, BIOCHEMISTRY-US, V35, P6425, DOI 10.1021/bi952687j; Sinev MA, 1996, FEBS LETT, V397, P273, DOI 10.1016/S0014-5793(96)01195-7; Temiz NA, 2004, PROTEINS, V57, P468, DOI 10.1002/prot.20226; THOMAS AP, 1986, BIOCHEM J, V238, P83, DOI 10.1042/bj2380083; Touyz RM, 1996, J BIOL CHEM, V271, P24353, DOI 10.1074/jbc.271.40.24353; vanWorkum M, 1996, MOL MICROBIOL, V20, P351; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; Yde CW, 2005, J MOL BIOL, V347, P399, DOI 10.1016/j.jmb.2005.01.003; YOUNIS HM, 1983, BIOCHEMISTRY-US, V22, P2505, DOI 10.1021/bi00279a030; Zhang WQ, 1997, ANAL BIOCHEM, V251, P246, DOI 10.1006/abio.1997.2238	71	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3306	3313		10.1074/jbc.M803658200	http://dx.doi.org/10.1074/jbc.M803658200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029291	Green Published, hybrid			2022-12-25	WOS:000262700900073
J	Wegierski, T; Lewandrowski, U; Muller, B; Sickmann, A; Walz, G				Wegierski, Tomasz; Lewandrowski, Urs; Mueller, Barbara; Sickmann, Albert; Walz, Gerd			Tyrosine Phosphorylation Modulates the Activity of TRPV4 in Response to Defined Stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION CHANNEL TRPV4; RECEPTOR POTENTIAL VANILLOID-4; HEAT-EVOKED ACTIVATION; MICE LACKING TRPV4; INFLAMMATORY MEDIATORS; ION-CHANNEL; SRC KINASE; CA2+ ENTRY; PROTEIN; EXPRESSION	Src family tyrosine kinases (SFKs) regulate the function of several transient receptor potential (TRP) family members, yet their role in the regulation of the vanilloid subfamily member 4 protein (TRPV4) remains controversial. TRPV4 is a calcium-permeable channel activated by numerous physical and chemical stimuli. Here we show that SFKs mediate tyrosine phosphorylation of TRPV4 in different cell lines. Using mass spectrometric analysis, we identified two novel phosphorylation sites in the cytosolic N- and C-terminal tails of TRPV4. Substitution of either tyrosine with phenylalanine led to a substantial reduction in the overall tyrosine phosphorylation level of TRPV4, suggesting that these two tyrosines constitute major phosphorylation sites. Both mutants efficiently localized to the plasma membrane, indicating that neither tyrosine is required for trafficking of TRPV4 in the secretory pathway. Analysis of the channel function demonstrated a crucial role of the N-terminal tyrosine residue in the activation of TRPV4 by heat, mechanical (shear) stress, hypotonic cell swelling, and phorbol 12-myristate 13-acetate, but not in the activation by synthetic ligand 4 alpha-phorbol 12,13-didecanoate. Furthermore, the response of TRPV4 to phorbol 12-myristate 13-acetate was SFK-dependent. Because the SFK-mediated phosphorylation of the N-terminal tyrosine occurred before TRPV4 activation, tyrosine phosphorylation appears to sensitize rather than activate this channel. Reactive oxygen species, known to mediate inflammatory pain, strongly up-regulated TRPV4 phosphorylation in the presence of SFKs. Our findings indicate that tyrosine phosphorylation of TRPV4 represents an important modulatory mechanism, which may underlie the recently described function of TRPV4 in inflammatory hyperalgesia.	[Wegierski, Tomasz; Mueller, Barbara; Walz, Gerd] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; [Lewandrowski, Urs; Sickmann, Albert] Univ Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany	University of Freiburg; German Research Foundation (DFG); University of Wurzburg	Walz, G (corresponding author), Univ Hosp Freiburg, Div Renal, Hugstetter Str 55, D-79106 Freiburg, Germany.	gerd.walz@uniklinik-freiburg.de	Wegierski, Tomasz/AAG-3284-2020; Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265; Wegierski, Tomasz/0000-0003-2635-8580	Deutsche Forschungsgemeinschaft [FZT-82]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants (to G. W. and to A. S. (FZT-82)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Chung JM, 2004, MOL INTERV, V4, P248, DOI 10.1124/mi.4.5.3; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; DRAY A, 1995, BRIT J ANAESTH, V75, P125, DOI 10.1093/bja/75.2.125; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guler AD, 2002, J NEUROSCI, V22, P6408; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Jin XC, 2004, AM J PHYSIOL-CELL PH, V287, pC558, DOI 10.1152/ajpcell.00113.2004; Kawasaki BT, 2006, P NATL ACAD SCI USA, V103, P335, DOI 10.1073/pnas.0508030102; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2006, J ENDOCRINOL, V191, P515, DOI 10.1677/joe.1.07000; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Schindler J, 2008, J PROTEOME RES, V7, P432, DOI 10.1021/pr0704736; Sidhaye VK, 2006, P NATL ACAD SCI USA, V103, P4747, DOI 10.1073/pnas.0511211103; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Tian W, 2004, AM J PHYSIOL-RENAL, V287, pF17, DOI 10.1152/ajprenal.00397.2003; Todaka H, 2004, J BIOL CHEM, V279, P35133, DOI 10.1074/jbc.M406260200; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443; Xu HS, 2003, J BIOL CHEM, V278, P11520, DOI 10.1074/jbc.M211061200; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhougang SG, 2004, AM J PHYSIOL-RENAL, V286, pF858, DOI 10.1152/ajprenal.00282.2003	51	67	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2923	2933		10.1074/jbc.M805357200	http://dx.doi.org/10.1074/jbc.M805357200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19033444	hybrid			2022-12-25	WOS:000262700900037
J	Espinosa, A; Garcia, A; Hartel, S; Hidalgo, C; Jaimovich, E				Espinosa, Alejandra; Garcia, Alejandra; Haertel, Steffen; Hidalgo, Cecilia; Jaimovich, Enrique			NADPH Oxidase and Hydrogen Peroxide Mediate Insulin-induced Calcium Increase in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL GENE-EXPRESSION; PROTEIN-KINASE; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; NAD(P)H OXIDASE; GLUCOSE-UPTAKE; ACTIVATION; DEPOLARIZATION; GENERATION; PHOSPHORYLATION	Skeletal muscle is one of the main physiological targets of insulin, a hormone that triggers a complex signaling cascade and that enhances the production of reactive oxygen species (ROS) in different cell types. ROS, currently considered second messengers, produce redox modifications in proteins such as ion channels that induce changes in their functional properties. In myotubes, insulin also enhances calcium release from intracellular stores. In this work, we studied in myotubes whether insulin stimulated ROS production and investigated the mechanisms underlying the insulin-dependent calcium increase: in particular, whether the late phase of the Ca2+ increase induced by insulin required ROS. We found that insulin stimulated ROS production, as detected with the probe 2', 7'-dichlorofluorescein diacetate (CM-H(2)DCFDA). We used the translocation of p47(phox) from the cytoplasm to the plasma membrane as a marker of the activation of NADPH oxidase. Insulin-stimulated ROS generation was suppressed by the NADPH oxidase inhibitor apocynin and by small interfering RNA against p47(phox), a regulatory NADPH oxidase subunit. Additionally, both protein kinase C and phosphatidylinositol 3-kinase are presumably involved in insulin-induced ROS generation because bisindolylmaleimide, a nonspecific protein kinase C inhibitor, and LY290042, an inhibitor of phosphatidylinositol 3-kinase, inhibited this increase. Bisindolylmaleimide, LY290042, apocynin, small interfering RNA against p47(phox), and two drugs that interfere with inositol 1,4,5-trisphosphate-mediated Ca2+ release, xestospongin C and U73122, inhibited the intracellular Ca2+ increase produced by insulin. These combined results strongly suggest that insulin induces ROS generation trough NADPH activation and that this ROS increase is required for the intracellular Ca2+ rise mediated by inositol 1,4,5-trisphosphate receptors.	[Hidalgo, Cecilia; Jaimovich, Enrique] Univ Chile, Fac Med, ICBM, Programa Biol Mol & Celular, Santiago 7, Chile; [Espinosa, Alejandra] Univ Chile, Fac Med, Escuela Tecnol Med, Santiago 7, Chile; [Garcia, Alejandra; Hidalgo, Cecilia; Jaimovich, Enrique] Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago 7, Chile; [Haertel, Steffen] Univ Chile, Fac Med, Inst Ciencias Biomed, Program Anat & Biol Desarrollo, Santiago 7, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Jaimovich, E (corresponding author), Univ Chile, Fac Med, ICBM, Programa Biol Mol & Celular, Casilla 70005, Santiago 7, Chile.	ejaimovi@med.uchile.cl	Härtel, Steffen/AAA-2336-2020; Jaimovich, Enrique/AAY-7632-2020; HIDALGO, Cecilia/H-7107-2013	Härtel, Steffen/0000-0002-8913-1757; 	Fondo Nacional de Investigacion en Areas Prioritarias (FONDAP) [15010006]; Fondecyt [1060890, 1071001]; PBCT [ACT47]	Fondo Nacional de Investigacion en Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PBCT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT)	This work was supported by Fondo Nacional de Investigacion en Areas Prioritarias (FONDAP) Grant 15010006. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by Fondecyt Grants 1060890, 1071001, and PBCT ACT47.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730; Carrasco MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1438, DOI 10.1152/ajpcell.00117.2002; CHOE CU, 2006, SCI STKE, pRE15; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Espinosa A, 2006, J CELL PHYSIOL, V209, P379, DOI 10.1002/jcp.20745; Feng W, 2000, J BIOL CHEM, V275, P35902, DOI 10.1074/jbc.C000523200; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; Goldstein BJ, 2005, ANTIOXID REDOX SIGN, V7, P1021, DOI 10.1089/ars.2005.7.1021; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Hutchinson DS, 2007, CELL SIGNAL, V19, P1610, DOI 10.1016/j.cellsig.2007.02.006; Jaimovich E, 2004, BIOL RES, V37, P625; Joseph SK, 2006, BIOCHEM J, V393, P575, DOI 10.1042/BJ20050889; Juretic N, 2007, J CELL PHYSIOL, V210, P819, DOI 10.1002/jcp.20902; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; KAPLIN AI, 1994, J BIOL CHEM, V269, P28972; Lanner JT, 2006, DIABETES, V55, P2077, DOI 10.2337/db05-1613; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; MANDERS EMM, 1993, J MICROSCOPY    0303, P375; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Powell JA, 2001, J CELL SCI, V114, P3673; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanchez G, 2008, CARDIOVASC RES, V77, P380, DOI 10.1093/cvr/cvm011; Talior I, 2005, AM J PHYSIOL-ENDOC M, V288, pE405, DOI 10.1152/ajpendo.00378.2004	29	77	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2568	2575		10.1074/jbc.M804249200	http://dx.doi.org/10.1074/jbc.M804249200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028699	hybrid			2022-12-25	WOS:000262545600061
J	Rybin, VO; Guo, JF; Steinberg, SF				Rybin, Vitalyi O.; Guo, Jianfen; Steinberg, Susan F.			Protein Kinase D1 Autophosphorylation via Distinct Mechanisms at Ser(744)/Ser(748) and Ser(916)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION LOOP PHOSPHORYLATION; ELEMENT-BINDING PROTEIN; D-DEPENDENT ACTIVATION; CARDIAC TROPONIN-I; C-MU; G(Q)-COUPLED RECEPTORS; KAPPA-B; PKC-MU; VIVO; LOCALIZATION	Protein kinase D1 (PKD1) is a physiologically important signaling enzyme that is activated via protein kinase C-dependent trans-phosphorylation of the activation loop at Ser(744) and Ser(748) followed by PKD1 autophosphorylation at Ser(916). Although PKD-Ser(916) autophosphorylation is widely used to track cellular PKD activity, this study exposes conditions leading to increased PKD-Ser(P)(916) immunoreactivity without an associated increase in PKD activity in cardiomyocytes that heterologously overexpress catalytically inactive PKD1 and in cardiomyocytes treated with Go6976 (a PKD inhibitor that competes with ATP). In each case, PKD1 is detected as a Ser(916)-phosphorylated enzyme that lacks kinase activity. In vitro kinase assays reconcile these seemingly discrepant findings by demonstrating that PKD1-Ser(916) autophosphorylation can proceed via either an intermolecular reaction or an intramolecular autophosphorylation that requires only very low ATP concentrations that do not support target substrate phosphorylation. Additional studies show that Ser(744) and Ser(748) are targets for a protein kinase C-independent autocatalytic phosphorylation and that the PKD1-S744A/S748A mutant is a Ser(916)-phosphorylated enzyme that is not active toward heterologous substrates. In contrast, PKD1-S916A is an active kinase that autophosphorylates at Ser(744). However, the S916A substitution leads to a Ser(748) phosphorylation defect and a prolonged cellular PKD1 signaling response. Collectively, these results implicate PKD1-Ser(744) phosphorylation in the phorbol 12-myristate 13-acetate-dependent mechanism that increases PKD1 activity toward physiologically relevant substrates. We show that PKD1-Ser(916) autophosphorylation does not necessarily correlate with PKD1 activity. Rather, autophosphorylation at Ser(916) is required for subsequent autophosphorylation at Ser(748). Finally, this study exposes a novel role for Ser(916) and/or Ser(748) autophosphorylation to terminate the cellular PKD1 signaling response.	[Steinberg, Susan F.] Columbia Univ, Dept Pharmacol, Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Steinberg, SF (corresponding author), Columbia Univ, Dept Pharmacol, Coll Phys & Surg, 630 West,168th St, New York, NY 10032 USA.	sfs1@columbia.edu			National Institutes of Health [77860]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 77860 (USPHS NHLBI). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Feng H, 2007, J BIOL CHEM, V282, P31273, DOI 10.1074/jbc.M701532200; Feng H, 2006, J BIOL CHEM, V281, P17801, DOI 10.1074/jbc.M511899200; Feng H, 2006, J BIOL CHEM, V281, P17815, DOI 10.1074/jbc.M511898200; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Nishikawa K, 1998, J BIOL CHEM, V273, P23126, DOI 10.1074/jbc.273.36.23126; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200	31	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2332	2343		10.1074/jbc.M806381200	http://dx.doi.org/10.1074/jbc.M806381200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19029298	hybrid, Green Published			2022-12-25	WOS:000262545600042
J	Serebrov, V; Beran, RKF; Pyle, AM				Serebrov, Victor; Beran, Rudolf K. F.; Pyle, Anna Marie			Establishing a Mechanistic Basis for the Large Kinetic Steps of the NS3 Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; CRYSTAL-STRUCTURE; RNA HELICASE; UNWINDING ACTIVITY; UVRD HELICASE; DNA HELICASE; IN-VITRO; PROTEIN; TRANSLOCATION; DOMAIN	The NS3 helicase from hepatitis C virus is a prototypical DEx(H/D) RNA helicase. NS3 has been shown to unwind RNA in a discontinuous manner, pausing after long apparent steps of unwinding. We systematically examined the effects of duplex stability and ionic conditions on the periodicity of the NS3 unwinding cycle. The kinetic step size for NS3 unwinding was examined on diverse substrate sequences. The kinetic step size (16 bp/step) was found to be independent of RNA duplex stability and composition, but it exhibited strong dependence on monovalent salt concentration, decreasing to similar to 11 bp/step at low [NaCl]. We addressed this behavior by analyzing the oligomeric state of NS3 at various salt concentrations. Whereas only NS3 oligomers are capable of processive unwinding, we found that monomeric NS3 is an active helicase that unwinds with low processivity. We demonstrate that low salt conditions enhance unwinding by monomeric NS3, which is likely to account for the reduction in apparent step size under low salt conditions. Based on results reported here, as well as available structural and single molecule data, we present an unwinding mechanism that addresses the apparent periodicity of NS3 unwinding, the magnitude of the step size, and that integrates the various stepwise motions observed for NS3. We propose that the large kinetic step size of NS3 unwinding reflects a delayed, periodic release of the separated RNA product strand from a secondary binding site that is located in the NTPase domain (Domain II) of NS3. These findings suggest that the mechanism of product release represents an important and unexplored feature of helicase mechanism.	[Serebrov, Victor; Beran, Rudolf K. F.; Pyle, Anna Marie] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Pyle, AM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	anna.pyle@yale.edu		Serebrov, Victor/0000-0002-5800-3103	National Institutes of Health [GM60620, 32 GM071120-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060620, F32GM071120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60620 (to A. M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant F32 GM071120-01A1 (Ruth Kirschstein postdoctoral fellowship).	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Beran RKF, 2006, J MOL BIOL, V358, P974, DOI 10.1016/j.jmb.2006.02.078; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Cho HS, 1998, J BIOL CHEM, V273, P15045, DOI 10.1074/jbc.273.24.15045; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jankowsky E, 2000, NUCLEIC ACIDS RES, V28, P333, DOI 10.1093/nar/28.1.333; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Jennings TA, 2008, BIOCHEMISTRY-US, V47, P1126, DOI 10.1021/bi701048a; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Levin MK, 2002, J BIOL CHEM, V277, P29377, DOI 10.1074/jbc.M112315200; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463	37	40	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2512	2521		10.1074/jbc.M805460200	http://dx.doi.org/10.1074/jbc.M805460200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19010782	Green Published, hybrid			2022-12-25	WOS:000262545600057
J	Yu, JK; Hai, Y; Liu, GD; Fang, TL; Kung, SKP; Xie, JY				Yu, Jiankun; Hai, Yan; Liu, Guodong; Fang, Tielan; Kung, Sam K. P.; Xie, Jiuyong			The Heterogeneous Nuclear Ribonucleoprotein L Is an Essential Component in the Ca2+/Calmodulin-dependent Protein Kinase IV-regulated Alternative Splicing through Cytidine-Adenosine Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRACT-BINDING-PROTEIN; HNRNP-L; RNA-BINDING; EXON; GENE; EXPRESSION; PHOSPHORYLATION; RECEPTOR; ELEMENT; DEPOLARIZATION	The regulation of gene expression through alternative pre-mRNA splicing is common in metazoans and is often controlled by intracellular signaling pathways that are important in cell physiology. We have shown that the alternative splicing of a number of genes is controlled by membrane depolarization and Ca2+/calmodulin-dependent protein kinase IV (CaMKIV) through CaMKIV-responsive RNA elements (CaRRE1 and CaRRE2); however, the trans-acting factors remain unknown. Here we show that the heterogeneous nuclear ribonucleoprotein (hnRNP) L is a CaRRE1 binding factor in nuclear extracts. An hnRNP L high affinity CA (cytidine-adenosine) repeat element is sufficient to mediate CaMKIV and hnRNP L repression of splicing in a location (3'-splice site proximity)-dependent way. Depletion of hnRNP L by RNA interference followed by rescue with coexpressed exogenous hnRNP L demonstrates that hnRNP L mediates the CaMKIV-regulated splicing through CA repeats in heterologous contexts. Depletion of hnRNP L also led to increased inclusion of the stress axis-regulated exon and aCA repeat-harboring exon under depolarization or with activated CaMKIV. Moreover, hnRNP L binding to CaRRE1 was increased by CaMKIV and, conversely, was reduced by pretreatments with protein phosphatases. Therefore, hnRNP L is an essential component of CaMKIV-regulated alternative splicing through CA repeats, with its phosphorylation likely playing a critical role.	[Yu, Jiankun; Hai, Yan; Liu, Guodong; Xie, Jiuyong] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB R3E 0J9, Canada	University of Manitoba	Xie, JY (corresponding author), 439 BMSB,745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	xiej@cc.umanitoba.ca	Xie, Jiuyong/D-2899-2013	Xie, Jiuyong/0000-0003-2909-1033; Yu, Jiankun/0000-0001-9916-1012	Canadian Institutes of Health Research [MOP68919]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP68919 (to J.X.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	An DS, 2001, J VIROL, V75, P3547, DOI 10.1128/JVI.75.8.3547-3555.2001; An P, 2007, PLOS BIOL, V5, P263, DOI 10.1371/journal.pbio.0050036; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Black DL, 1998, PRACT APPROACH SER, V192, P109; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Cheli Y, 2006, BLOOD, V107, P4391, DOI 10.1182/blood-2005-12-4822; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Forgacs E, 1998, ONCOGENE, V17, P1557, DOI 10.1038/sj.onc.1202070; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Griffith BN, 2006, BBA-GENE STRUCT EXPR, V1759, P552, DOI 10.1016/j.bbaexp.2006.10.001; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Hai Y, 2008, NUCLEIC ACIDS RES, V36, P3320, DOI 10.1093/nar/gkn207; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hui JY, 2003, RNA, V9, P931, DOI 10.1261/rna.5660803; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; LIU XD, 1995, GENE DEV, V9, P1766, DOI 10.1101/gad.9.14.1766; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mckee AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r159; Melton AA, 2007, MOL CELL BIOL, V27, P6972, DOI 10.1128/MCB.00419-07; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Perucho M, 1996, BIOL CHEM, V377, P675; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Radu CG, 2004, P NATL ACAD SCI USA, V101, P245, DOI 10.1073/pnas.2536801100; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Stamm S, 2002, HUM MOL GENET, V11, P2409, DOI 10.1093/hmg/11.20.2409; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443	58	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1505	1513		10.1074/jbc.M805113200	http://dx.doi.org/10.1074/jbc.M805113200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017650	Green Accepted, hybrid			2022-12-25	WOS:000262330100018
J	Chen, SJ; Ko, CY; Yen, CW; Wang, CC				Chen, Shun-Jia; Ko, Chou-Yuan; Yen, Chih-Wei; Wang, Chien-Chia			Translational Efficiency of Redundant ACG Initiator Codons Is Enhanced by a Favorable Sequence Context and Remedial Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; NON-AUG INITIATION; SACCHAROMYCES-CEREVISIAE; STRUCTURAL FEATURES; RIBOSOMAL-SUBUNIT; GENE ENCODES; IN-VIVO; YEAST; MITOCHONDRIAL; PROTEIN	Earlier studies showed that the redundancy of ACG initiation codons enhanced the efficiency of translation initiation by 3- to 6-fold. Evidence presented here shows that this "redundancy effect" can be attributed to a favorable sequence context and, to a lesser extent, remedial initiation. In the case of redundant ACG initiator codons, the second ACG not only acts as a remedial initiation site for scanning ribosomes that skip the first ACG but also enhances the activity of the preceding initiator by providing a preferable "A" at its relative +4 position. Hence, non-successive ACG codons can be as effective as successive ACG codons in initiation, if positioned within a similar context. In contrast, redundant GUG initiation codons (GUG/GUG) bear an unfavorable "G" nucleotide at both the +4 and -3 positions relative to the first and second GUGs, respectively, such that redundant GUG codons act more poorly as translation initiation sites than does a single GUG with a favorable "A" nucleotide in the +4 position (similar to 2.5-fold). Thus, the sequence context plays a much more important role than remedial initiation in modulating the efficiency of translational initiation from redundant non-AUG codons.	[Chen, Shun-Jia; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Jhongli 320, Taiwan; [Ko, Chou-Yuan] Armed Forces Taoyuan Gen Hosp, Lung Tan 325, Taiwan; [Yen, Chih-Wei] Cathay Gen Hosp, Taipei 106, Taiwan	National Central University; Cathay General Hospital	Wang, CC (corresponding author), Natl Cent Univ, Dept Life Sci, Jhongli 320, Taiwan.	dukewang@cc.ncu.edu.tw		Chen, Shun-Jia/0000-0002-5489-4930	National Science Council ( Taiwan) [NSC96-2311-B-008-002, NSC96-2311-B-008-003]; CGH-NCU Joint Research Foundation (Taiwan) [CNJRF-96CGH-NCU-B4]; Armed Forces Taoyuan General Hospital (Taiwan)	National Science Council ( Taiwan)(Ministry of Science and Technology, Taiwan); CGH-NCU Joint Research Foundation (Taiwan); Armed Forces Taoyuan General Hospital (Taiwan)	This work was supported by the National Science Council ( Taiwan) ( Grants NSC96-2311-B-008-002 and NSC96-2311-B-008-003 to C.- C. W.), by the CGH-NCU Joint Research Foundation ( Taiwan) (Grant CNJRF-96CGH-NCU-B4 to C.- C. W. and C.- W. Y.), and by a grant from Armed Forces Taoyuan General Hospital ( Taiwan) ( to C.- Y. K. and C.- C. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramczyk D, 2003, YEAST, V20, P1045, DOI 10.1002/yea.1020; ACLAND P, 1990, NATURE, V343, P662, DOI 10.1038/343662a0; BAIM SB, 1988, MOL CELL BIOL, V8, P1591, DOI 10.1128/MCB.8.4.1591; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang KJ, 2006, J BIOL CHEM, V281, P7775, DOI 10.1074/jbc.M511265200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; Chen SP, 2002, ARCH BIOCHEM BIOPHYS, V398, P87, DOI 10.1006/abbi.2001.2675; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; CIGAN AM, 1987, GENE, V59, P1; CIGAN AM, 1988, MOL CELL BIOL, V8, P2964, DOI 10.1128/MCB.8.7.2964; CLEMENTS JM, 1988, MOL CELL BIOL, V8, P4533, DOI 10.1128/MCB.8.10.4533; DIETRICH A, 1992, ANNU REV CELL BIOL, V8, P115, DOI 10.1146/annurev.cb.08.110192.000555; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; HANN SR, 1992, GENE DEV, V6, P1229, DOI 10.1101/gad.6.7.1229; Huang HY, 2006, J BIOL CHEM, V281, P31430, DOI 10.1074/jbc.M601869200; Huang HY, 2006, MOL MICROBIOL, V60, P189, DOI 10.1111/j.1365-2958.2006.05083.x; HUANG S, 1987, BIOCHEMISTRY-US, V26, P8242, DOI 10.1021/bi00399a033; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1991, J BIOL CHEM, V266, P19867; MARTINIS SA, 1996, ESCHERICHIA COLI SAL, P887; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Pelchat M, 1999, BIOCHEM CELL BIOL, V77, P343, DOI 10.1139/bcb-77-4-343; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Riechmann JL, 1999, MOL CELL BIOL, V19, P8505; Sadler R, 1999, J VIROL, V73, P5722, DOI 10.1128/JVI.73.7.5722-5730.1999; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; SHERMAN F, 1980, CELL, V20, P215, DOI 10.1016/0092-8674(80)90249-4; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c; WOLFE CL, 1994, J BIOL CHEM, V269, P13361; YOON H, 1992, MOL MICROBIOL, V6, P1413, DOI 10.1111/j.1365-2958.1992.tb00861.x; ZITOMER RS, 1984, MOL CELL BIOL, V4, P1191, DOI 10.1128/MCB.4.7.1191	44	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					818	827		10.1074/jbc.M804378200	http://dx.doi.org/10.1074/jbc.M804378200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010786	hybrid			2022-12-25	WOS:000262122900016
J	Lewerenz, J; Maher, P				Lewerenz, Jan; Maher, Pamela			Basal Levels of eIF2 alpha Phosphorylation Determine Cellular Antioxidant Status by Regulating ATF4 and xCT Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; EUKARYOTIC INITIATION FACTOR-2-ALPHA; OXIDATIVE GLUTAMATE TOXICITY; AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; TRANSLATIONAL CONTROL; IN-VIVO; NEURONAL DEGENERATION; TRANSCRIPTION FACTOR	eIF2 alpha is part of a multimeric complex that regulates cap-dependent translation. Phosphorylation of eIF2 alpha (phospho-eIF2 alpha) is induced by various forms of cell stress, resulting in changes to the proteome of the cell with two diametrically opposed consequences, adaptation to stress or initiation of programmed cell death. In contrast to the robust eIF2 alpha phosphorylation seen in response to acute insults, less is known about the functional role of basal levels of eIF2 alpha phosphorylation. Here we show that mouse embryonic fibroblasts expressing a nonphosphorylatable eIF2 alpha have enhanced sensitivity to diverse toxic insults, including amyloid beta-(1-42) peptide (A beta), a key factor in the pathogenesis of Alzheimer disease. This correlates with impaired glutathione metabolism because of down-regulation of the light chain, xCT, of the cystine/glutamate antiporter system X-c(-). The mechanistic link between the absence of phospho-eIF2 alpha and xCT expression is nuclear factor ATF4. Consistent with these findings, long term activation of the phospho-eIF2 alpha/ATF4/xCT signaling module by the specific eIF2 alpha phosphatase inhibitor, salubrinal, induces resistance against oxidative glutamate toxicity in the hippocampal cell line HT22 and primary cortical neurons. Furthermore, in PC12 cells selected for resistance against A beta, increased activity of the phospho-eIF2 alpha/ATF4/xCT module contributes to the resistant phenotype. In wild-type PC12 cells, activation of this module by salubrinal ameliorates the response to A beta. Furthermore, in human brains, ATF4 and phospho-eIF2 alpha levels are tightly correlated and upregulated in Alzheimer disease, most probably representing an adaptive response against disease-related cellular stress rather than a correlate of neurodegeneration.	[Lewerenz, Jan; Maher, Pamela] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Maher, P (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pmaher@salk.edu			National Institutes of Health [AG025337]; NATIONAL INSTITUTE ON AGING [R01AG025337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG025337 (to P. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe K, 1996, J NEUROCHEM, V67, P2074; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; BANNAI S, 1986, J BIOL CHEM, V261, P2256; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Burdo J, 2006, J HISTOCHEM CYTOCHEM, V54, P549, DOI 10.1369/jhc.5A6840.2006; Burdo J, 2008, BRAIN RES, V1189, P12, DOI 10.1016/j.brainres.2007.10.077; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x; Cordey M, 2006, J NEUROCHEM, V96, P204, DOI 10.1111/j.1471-4159.2005.03545.x; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; DeGracia DJ, 2002, J CEREBR BLOOD F MET, V22, P127, DOI 10.1097/00004647-200202000-00001; Eriksen JL, 2007, BEHAV GENET, V37, P79, DOI 10.1007/s10519-006-9118-z; Fogal B, 2007, J NEUROSCI, V27, P10094, DOI 10.1523/JNEUROSCI.2459-07.2007; Gietzen DW, 2004, J NUTR, V134, P717, DOI 10.1093/jn/134.4.717; Grallert B, 2007, CELL CYCLE, V6, P2768, DOI 10.4161/cc.6.22.4933; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; Hussain SG, 2007, BIOCHEM BIOPH RES CO, V355, P365, DOI 10.1016/j.bbrc.2007.01.156; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Kanai Y, 2004, PFLUG ARCH EUR J PHY, V447, P469, DOI 10.1007/s00424-003-1146-4; KHAN TK, 2008, NEUROBIOL A IN PRESS; Kim HS, 2007, J NEUROSCI RES, V85, P1528, DOI 10.1002/jnr.21267; Kudo T, 2002, ANN NY ACAD SCI, V977, P349, DOI 10.1111/j.1749-6632.2002.tb04837.x; La Bella V, 2007, NEUROCHEM RES, V32, P1081, DOI 10.1007/s11064-006-9277-6; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Leclerc GM, 2000, BIOTECHNIQUES, V29, P590, DOI 10.2144/00293rr02; Lewerenz J, 2003, J NEUROCHEM, V87, P522, DOI 10.1046/j.1471-4159.2003.02019.x; Lewerenz J, 2006, J NEUROCHEM, V98, P916, DOI 10.1111/j.1471-4159.2006.03921.x; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu YB, 1997, J NEUROCHEM, V69, P2285; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Maher P, 2005, AGEING RES REV, V4, P288, DOI 10.1016/j.arr.2005.02.005; Maher P, 2008, J NEUROCHEM, V107, P690, DOI 10.1111/j.1471-4159.2008.05620.x; MATSUOKA HC, 2002, BLOOD, V99, P736; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Page G, 2006, NEUROSCIENCE, V139, P1343, DOI 10.1016/j.neuroscience.2006.01.047; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; RAVINDRANATH V, 1990, BIOCHEM BIOPH RES CO, V169, P1075, DOI 10.1016/0006-291X(90)92004-J; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Sagara Y, 1996, J NEUROSCI, V16, P497; Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schubert D, 2001, J NEUROSCI, V21, P7455, DOI 10.1523/JNEUROSCI.21-19-07455.2001; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sonnen JA, 2008, FREE RADICAL BIO MED, V45, P219, DOI 10.1016/j.freeradbiomed.2008.04.022; Sontheimer H, 2003, TRENDS NEUROSCI, V26, P543, DOI 10.1016/j.tins.2003.08.007; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Suen KC, 2003, J BIOL CHEM, V278, P49819, DOI 10.1074/jbc.M306503200; Tan S, 2001, J CELL BIOL, V152, P997, DOI 10.1083/jcb.152.5.997; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zhu Y, 2008, J NEUROSCI, V28, P2168, DOI 10.1523/JNEUROSCI.5232-07.2008	71	145	152	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1106	1115		10.1074/jbc.M807325200	http://dx.doi.org/10.1074/jbc.M807325200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19017641	Green Published, hybrid			2022-12-25	WOS:000262122900047
J	Gonzalez-Barroso, MM; Giurgea, I; Bouillaud, F; Anedda, A; Bellanne-Chantelot, C; Hubert, L; de Keyzer, Y; de Lonlay, P; Ricquier, D				Gonzalez-Barroso, M. Mar; Giurgea, Irina; Bouillaud, Frederic; Anedda, Andrea; Bellanne-Chantelot, Christine; Hubert, Laurence; de Keyzer, Yves; de Lonlay, Pascale; Ricquier, Daniel			Mutations in UCP2 in Congenital Hyperinsulinism Reveal a Role for Regulation of Insulin Secretion	PLOS ONE			English	Article							MITOCHONDRIAL PROTON LEAK; BETA-CELL DYSFUNCTION; UNCOUPLING PROTEIN-2; FAMILIAL HYPERINSULINISM; COMMON POLYMORPHISM; GLUCOSE-HOMEOSTASIS; HYPOGLYCEMIA; OBESITY; EXPRESSION; GENE	Although the most common mechanism underlying congenital hyperinsulinism is dysfunction of the pancreatic ATP-sensitive potassium channel, the pathogenesis and genetic origins of this disease remains largely unexplained in more than half of all patients. UCP2 knockout mice exhibit an hyperinsulinemic hypoglycemia, suggesting an involment of UCP2 in insulin secretion. However, a possible pathogenic role for UCP2 protein in the development of human congenital hyperinsulinism or of any human disease has not yet been investigated. We studied ten children exhibiting congenital hyperinsulinism, without detectable mutations in the known congenital hyperinsulinism-causing genes. Parental-inherited heterozygous UCP2 variants encoding amino-acid changes were found in two unrelated children with congenital hyperinsulinism. Functional assays in yeast and in insulin-secreting cells revealed an impaired activity of UCP2 mutants. Therefore, we report the finding of UCP2 coding variants in human congenital hyperinsulinism, which reveals a role for this gene in the regulation of insulin secretion and glucose metabolism in humans. Our results show for the first time a direct association between UCP2 amino acid alteration and human disease and highlight a role for mitochondria in hormone secretion.	[Bouillaud, Frederic; Ricquier, Daniel] Univ Paris Descartes Site Necker Enfants Malad, CNRS, UPR 9078, BIOTRAM, Paris, France; [Giurgea, Irina; Hubert, Laurence; de Keyzer, Yves; de Lonlay, Pascale] AP HP, Hop Necker Enfants Malades, Dept Pediat, Paris, France; [Giurgea, Irina; Hubert, Laurence; de Keyzer, Yves; de Lonlay, Pascale] Univ Paris Descartes Site Necker enfants Malades, INSERM U781, Paris, France; [Gonzalez-Barroso, M. Mar; Anedda, Andrea] CSIC, Ctr Investigac Biol, Madrid, Spain; [Bellanne-Chantelot, Christine] AP HP, Grp Hosp Pitie Salpetriere, Dept Genet, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Consejo Superior de Investigaciones Cientificas (CSIC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gonzalez-Barroso, MM (corresponding author), Univ Paris Descartes Site Necker Enfants Malad, CNRS, UPR 9078, BIOTRAM, Paris, France.	ricquier@necker.fr	Giurgea, Irina/AGX-6879-2022; Bouillaud, Frédéric R/L-3238-2017	Giurgea, Irina/0000-0002-5035-2958; Bouillaud, Frédéric R/0000-0002-7518-9237; GONZALEZ BARROSO, MARIA DEL MAR/0000-0002-0278-8298	Centre National de la Recherche Scientifique; European Union	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission)	Academic support was obtained from the Centre National de la Recherche Scientifique and from the European Union (FP6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFOURTIT C, 2007, NOVART FDN SYMP, V28, P70; Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; ARECHAGA I, 1993, BIOCHEM J, V296, P693, DOI 10.1042/bj2960693; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Averet N, 1998, MOL CELL BIOCHEM, V184, P67, DOI 10.1023/A:1006830810440; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brown JEP, 2002, FEBS LETT, V513, P189, DOI 10.1016/S0014-5793(02)02296-2; BRUNELLE F, 1989, PEDIATR RADIOL, V19, P100, DOI 10.1007/BF02387895; Chan CB, 2006, BIOCHEM SOC T, V34, P802, DOI 10.1042/BST0340802; Chan CB, 2006, CURR DIABETES REV, V2, P271, DOI 10.2174/157339906777950660; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Clayton PT, 2001, J CLIN INVEST, V108, P457; De Leon DD, 2007, NAT CLIN PRACT ENDOC, V3, P57, DOI 10.1038/ncpendmet0368; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Glaser B, 2000, ARCH DIS CHILD-FETAL, V82, pF79, DOI 10.1136/fn.82.2.F79; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Graier WF, 2008, CELL CALCIUM, V44, P36, DOI 10.1016/j.ceca.2008.01.001; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hojlund K, 2004, DIABETES, V53, P1592, DOI 10.2337/diabetes.53.6.1592; Huopio H, 2000, J CLIN INVEST, V106, P897, DOI 10.1172/JCI9804; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Krempler F, 2002, DIABETES, V51, P3331, DOI 10.2337/diabetes.51.11.3331; LOCKE RM, 1982, EUR J BIOCHEM, V129, P381, DOI 10.1111/j.1432-1033.1982.tb07061.x; Magge SN, 2004, J CLIN ENDOCR METAB, V89, P4450, DOI 10.1210/jc.2004-0441; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; Nestorowicz A, 1997, DIABETES, V46, P1743, DOI 10.2337/diabetes.46.11.1743; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Otonkoski T, 2007, AM J HUM GENET, V81, P467, DOI 10.1086/520960; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Pearson ER, 2007, PLOS MED, V4, P760, DOI 10.1371/journal.pmed.0040118; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Produit-Zengaffinen N, 2007, DIABETOLOGIA, V50, P84, DOI 10.1007/s00125-006-0499-6; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Saleh MC, 2006, J ENDOCRINOL, V190, P659, DOI 10.1677/joe.1.06715; Sempoux C, 1998, J CLIN ENDOCR METAB, V83, P1455, DOI 10.1210/jc.83.5.1455; Sesti G, 2003, DIABETES, V52, P1280, DOI 10.2337/diabetes.52.5.1280; Sheets AR, 2008, AM J PHYSIOL-GASTR L, V294, pG1017, DOI 10.1152/ajpgi.00016.2008; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Thomas PM, 1996, P ASSOC AM PHYSICIAN, V108, P14; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	51	78	81	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3850	10.1371/journal.pone.0003850	http://dx.doi.org/10.1371/journal.pone.0003850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065272	Green Published, gold			2022-12-25	WOS:000265455200002
J	Phimpraphi, W; Paul, R; Witoonpanich, B; Turbpaiboon, C; Peerapittayamongkol, C; Louicharoen, C; Casademont, I; Tungpradabkul, S; Krudsood, S; Kaewkunwal, J; Sura, T; Looareesuwan, S; Singhasivanon, P; Sakuntabhai, A				Phimpraphi, Waraphon; Paul, Richard; Witoonpanich, Bhee; Turbpaiboon, Chairat; Peerapittayamongkol, Chayanon; Louicharoen, Chalisa; Casademont, Isabelle; Tungpradabkul, Sumalee; Krudsood, Srivicha; Kaewkunwal, Jaranit; Sura, Thanyachai; Looareesuwan, Sornchai; Singhasivanon, Pratap; Sakuntabhai, Anavaj			Heritability of P. falciparum and P. vivax Malaria in a Karen Population in Thailand	PLOS ONE			English	Article								The majority of studies concerning malaria host genetics have focused on individual genes that confer protection against rather than susceptibility to malaria. Establishing the relative impact of genetic versus non-genetic factors on malaria infection and disease is essential to focus effort on key determinant factors. This relative contribution has rarely been evaluated for Plasmodium falciparum and almost never for Plasmodium vivax. We conducted a longitudinal cohort study in a Karen population of 3,484 individuals in a region of mesoendemic malaria, Thailand from 1998 to 2005. The number of P. falciparum and P. vivax clinical cases and the parasite density per person were determined. Statistical analyses were performed to account for the influence of environmental factors and the genetic heritability of the phenotypes was calculated using the pedigree-based variance components model. The genetic contribution to the number of clinical episodes resulting from P. falciparum and P. vivax were 10% and 19% respectively. There was also moderate genetic contribution to the maximum and overall parasite trophozoite density phenotypes for both P. falciparum (16%&16%) and P. vivax (15%&13%). These values, for P. falciparum, were similar to those previously observed in a region of much higher transmission intensity in Senegal, West Africa. Although environmental factors play an important role in acquiring an infection, genetics plays a determinant role in the outcome of an infection with either malaria parasite species prior to the development of immunity.	[Phimpraphi, Waraphon; Paul, Richard; Witoonpanich, Bhee; Turbpaiboon, Chairat; Peerapittayamongkol, Chayanon; Louicharoen, Chalisa; Casademont, Isabelle; Sakuntabhai, Anavaj] Inst Pasteur, Lab Genet Reponse Infect Chez Homme, Paris, France; [Phimpraphi, Waraphon; Krudsood, Srivicha; Kaewkunwal, Jaranit; Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Dept Trop Hygiene, Bangkok 10700, Thailand; [Witoonpanich, Bhee; Turbpaiboon, Chairat; Tungpradabkul, Sumalee] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10700, Thailand; [Sura, Thanyachai; Sakuntabhai, Anavaj] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10700, Thailand; [Looareesuwan, Sornchai] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok 10700, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Phimpraphi, W (corresponding author), Inst Pasteur, Lab Genet Reponse Infect Chez Homme, Paris, France.	anavaj@pasteur.fr	Peerapittayamongkol, Chayanon/K-7965-2019; Peerapittayamongkol, Chayanon/B-4920-2010	Singhasivanon, Pratap/0000-0002-9759-1702	BIOTEC [BT-B06-MG-14-4507]; Thailand Research Fund [BRG/16/2544]; Mahidol University [OR-9123]; Institut Pasteur; Inserm [post-doctoral fellowship]; Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand [post-doctoral fellowship]; Royal Golden Jubilee Program; French Embassy in Thailand; Medical Scholar Program, Mahidol University	BIOTEC; Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; Royal Golden Jubilee Program; French Embassy in Thailand; Medical Scholar Program, Mahidol University	This work was funded in part by grants from BIOTEC (BT-B06-MG-14-4507), the Thailand Research Fund (BRG/16/2544), Mahidol University grant (OR-9123) and the Institut Pasteur to AS. Microsatellite genotyping was performed at Centre National de Genotypage, Evry, France. CP was supported by post-doctoral fellowships from Inserm and from the Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand. CT, WP and CL were supported by the Royal Golden Jubilee Program, the Thailand Research Fund and the French Embassy in Thailand. BW was supported by the Medical Scholar Program, Mahidol University and the French Embassy in Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ABEL L, 1992, AM J HUM GENET, V50, P1308; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Boyd M. F., 1937, American Journal of Tropical Medicine, V17, P855; BOYD MARK F., 1938, AMER JOUR TROP MED, V18, P505; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Bruce MC, 2002, CURR OPIN MICROBIOL, V5, P431, DOI 10.1016/S1369-5274(02)00348-X; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; Garcia A, 1998, AM J TROP MED HYG, V58, P705, DOI 10.4269/ajtmh.1998.58.705; Gilmour A. R., ASREML USER GUIDE RE; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Haldane J.B.S., 1949, HEREDITAS, V35, P267; JEPSON AP, 1995, J INFECT DIS, V172, P316, DOI 10.1093/infdis/172.1.316; Kasehagen LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000336; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LOOAREESUWAN S, 1987, LANCET, V2, P1052, DOI 10.1016/S0140-6736(87)91479-6; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; Mackinnon MJ, 2000, P NATL ACAD SCI USA, V97, P12661, DOI 10.1073/pnas.220267997; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Maitland K, 1997, PARASITOL TODAY, V13, P227, DOI 10.1016/S0169-4758(97)01061-2; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; NAGEL RL, 1989, BLOOD, V74, P1213; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Rihet P, 1998, GENET EPIDEMIOL, V15, P435, DOI 10.1002/(SICI)1098-2272(1998)15:5<435::AID-GEPI1>3.0.CO;2-#; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stirnadel HA, 1999, GENET EPIDEMIOL, V17, P16, DOI 10.1002/(SICI)1098-2272(1999)17:1<16::AID-GEPI2>3.0.CO;2-7; Stirnadel HA, 2000, EPIDEMIOL INFECT, V124, P153, DOI 10.1017/S0950268899003325; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; WARD RH, 1975, AM J HUM GENET, V27, P1; WEATHERALL DJ, 1987, ANN TROP MED PARASIT, V81, P539, DOI 10.1080/00034983.1987.11812155; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3887	10.1371/journal.pone.0003887	http://dx.doi.org/10.1371/journal.pone.0003887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060954	Green Published, gold, Green Submitted			2022-12-25	WOS:000265455100007
J	Seelow, D; Schwarz, JM; Schuelke, M				Seelow, Dominik; Schwarz, Jana Marie; Schuelke, Markus			GeneDistiller-Distilling Candidate Genes from Linkage Intervals	PLOS ONE			English	Article								Background: Linkage studies often yield intervals containing several hundred positional candidate genes. Different manual or automatic approaches exist for the determination of the gene most likely to cause the disease. While the manual search is very flexible and takes advantage of the researchers' background knowledge and intuition, it may be very cumbersome to collect and study the relevant data. Automatic solutions on the other hand usually focus on certain models, remain "black boxes'' and do not offer the same degree of flexibility. Methodology: We have developed a web-based application that combines the advantages of both approaches. Information from various data sources such as gene-phenotype associations, gene expression patterns and protein-protein interactions was integrated into a central database. Researchers can select which information for the genes within a candidate interval or for single genes shall be displayed. Genes can also interactively be filtered, sorted and prioritised according to criteria derived from the background knowledge and preconception of the disease under scrutiny. Conclusions: GeneDistiller provides knowledge-driven, fully interactive and intuitive access to multiple data sources. It displays maximum relevant information, while saving the user from drowning in the flood of data. A typical query takes less than two seconds, thus allowing an interactive and explorative approach to the hunt for the candidate gene. Access: GeneDistiller can be freely accessed at http://www.genedistiller.org	[Seelow, Dominik; Schwarz, Jana Marie; Schuelke, Markus] Charite, Dept Neuropaediat, Berlin, Germany; [Schuelke, Markus] Charite, Sch Med, NeuroCure Clin Res Ctr, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Seelow, D (corresponding author), Charite, Dept Neuropaediat, Berlin, Germany.	markus.schuelke@charite.de	Schwarz, Jana Marie/AAZ-7833-2021; Seelow, Dominik/HGB-3124-2022	Schwarz, Jana Marie/0000-0002-7048-208X; Seelow, Dominik/0000-0002-9746-4412; Schuelke, Markus/0000-0003-2824-3891	NeuroCure Clinical Research Centre of the Charite Berlin; Deutsche Forschungsgemeinschaft [SFB665]	NeuroCure Clinical Research Centre of the Charite Berlin; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work has been supported by funds of the NeuroCure Clinical Research Centre of the Charite Berlin, and by the Deutsche Forschungsgemeinschaft (SFB665 TP A6 to M.S.)	Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Chaurasia G, 2007, NUCLEIC ACIDS RES, V35, pD590, DOI 10.1093/nar/gkl817; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Martin PT, 2006, NAT CLIN PRACT NEURO, V2, P222, DOI 10.1038/ncpneuro0155; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nakayama J, 2006, EPILEPSY RES, V70, pS190, DOI 10.1016/j.eplepyres.2005.11.023; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Safran M, 2003, NUCLEIC ACIDS RES, V31, P142, DOI 10.1093/nar/gkg050; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thornblad TA, 2007, TWIN RES HUM GENET, V10, P861, DOI 10.1375/twin.10.6.861; van Driel MA, 2005, NUCLEIC ACIDS RES, V33, pW758, DOI 10.1093/nar/gki435; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000	33	88	90	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3874	10.1371/journal.pone.0003874	http://dx.doi.org/10.1371/journal.pone.0003874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057649	gold, Green Submitted, Green Published			2022-12-25	WOS:000265452300010
J	Santi, I; Pezzicoli, A; Bosello, M; Berti, F; Mariani, M; Telford, JL; Grandi, G; Soriani, M				Santi, Isabella; Pezzicoli, Alfredo; Bosello, Mattia; Berti, Francesco; Mariani, Massimo; Telford, John L.; Grandi, Guido; Soriani, Marco			Functional Characterization of a Newly Identified Group B Streptococcus Pullulanase Eliciting Antibodies Able to Prevent Alpha-Glucans Degradation	PLOS ONE			English	Article								Streptococcal pullulanases have been recently proposed as key components of the metabolic machinery involved in bacterial adaptation to host niches. By sequence analysis of the Group B Streptococcus (GBS) genome we found a novel putative surface exposed protein with pullulanase activity. We named such a protein SAP. The sap gene is highly conserved among GBS strains and homologous genes, such as PulA and SpuA, have been described in other pathogenic streptococci. The SAP protein contains two N-terminal carbohydrate-binding motifs, followed by a catalytic domain and a C-terminal LPXTG cell wall-anchoring domain. In vitro analysis revealed that the recombinant form of SAP is able to degrade alpha-glucan polysaccharides, such as pullulan, glycogen and starch. Moreover, NMR analysis showed that SAP acts as a type I pullulanase. Studies performed on whole bacteria indicated that the presence of alpha-glucan polysaccharides in culture medium up-regulated the expression of SAP on bacterial surface as confirmed by FACS analysis and confocal imaging. Deletion of the sap gene resulted in a reduced capacity of bacteria to grow in medium containing pullulan or glycogen, but not glucose or maltose, confirming the pivotal role of SAP in GBS metabolism of alpha-glucans. As reported for other streptococcal pullulanases, we found specific anti-SAP antibodies in human sera from healthy volunteers. Investigation of the functional role of anti-SAP antibodies revealed that incubation of GBS in the presence of sera from animals immunized with SAP reduced the capacity of the bacterium to degrade pullulan. Of interest, anti-SAP sera, although to a lower extent, also inhibited Group A Streptococcus pullulanase activity. These data open new perspectives on the possibility to use SAP as a potential vaccine component inducing functional cross-reacting antibodies interfering with streptococcal infections.	[Santi, Isabella; Pezzicoli, Alfredo; Bosello, Mattia; Berti, Francesco; Mariani, Massimo; Telford, John L.; Grandi, Guido; Soriani, Marco] Novartis Vaccines & Diagnost Srl, Siena, Italy	Novartis	Santi, I (corresponding author), Novartis Vaccines & Diagnost Srl, Siena, Italy.	Marco.Soriani@novartis.com	Telford, John Laird/ABG-8144-2020	SORIANI, Marco/0000-0002-9752-5844; Grandi, Guido/0000-0001-9724-2185	Novartis Vaccines & Diagnostic	Novartis Vaccines & Diagnostic	This work was supported by internal funding from Novartis Vaccines & Diagnostic.	ADAM MN, 1994, PATHOL BIOL, V42, P544; ANDERSON IH, 1981, NEW ENGL J MED, V304, P891, DOI 10.1056/NEJM198104093041507; ARNOSTI C, 1994, APPL ENVIRON MICROB, V60, P840, DOI 10.1128/AEM.60.3.840-846.1994; Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Baron MJ, 2007, J BIOL CHEM, V282, P10526, DOI 10.1074/jbc.M608279200; Bertoldo C, 1999, APPL ENVIRON MICROB, V65, P2084; Bertoldo C, 2004, APPL ENVIRON MICROB, V70, P3407, DOI 10.1128/AEM.70.6.3407-3416.2004; Bongaerts RJM, 2000, INFECT IMMUN, V68, P7141, DOI 10.1128/IAI.68.12.7141-7143.2000; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Doman-Pytka M, 2004, CRIT REV MICROBIOL, V30, P107, DOI 10.1080/10408410490435115; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Glinel K, 2000, CARBOHYD RES, V328, P343, DOI 10.1016/S0008-6215(00)00120-8; Graham MR, 2006, AM J PATHOL, V169, P927, DOI 10.2353/ajpath.2006.060112; GREGOIRE AT, 1971, FERTIL STERIL, V22, P64; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Hytonen J, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-18; Hytonen J, 2003, INFECT IMMUN, V71, P784, DOI 10.1128/IAI.71.2.784-793.2003; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; MILLER G, 1959, ANAL CHEM, V31; PAAVONEN J, 1983, SCAND J INFECT DIS, P31; Reid SD, 2002, J BACTERIOL, V184, P6316, DOI 10.1128/JB.184.22.6316-6324.2002; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shelburne SA, 2006, INFECT IMMUN, V74, P4605, DOI 10.1128/IAI.00477-06; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Bueren AL, 2007, J MOL BIOL, V365, P555, DOI 10.1016/j.jmb.2006.10.018; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; Wu CY, 2002, ARCH BIOCHEM BIOPHYS, V406, P21, DOI 10.1016/S0003-9861(02)00412-5; Zysk G, 2000, INFECT IMMUN, V68, P3740, DOI 10.1128/IAI.68.6.3740-3743.2000	37	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3787	10.1371/journal.pone.0003787	http://dx.doi.org/10.1371/journal.pone.0003787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023424	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448800008
J	Robertson, AJ; Coluccio, A; Knowlton, P; Dickey-Sims, C; Coffman, JA				Robertson, Anthony J.; Coluccio, Alison; Knowlton, Peter; Dickey-Sims, Carrie; Coffman, James A.			Runx Expression Is Mitogenic and Mutually Linked to Wnt Activity in Blastula-Stage Sea Urchin Embryos	PLOS ONE			English	Article							TGF-BETA SUPERFAMILY; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; EPITHELIAL-CELLS; GROWTH; GENE; DIFFERENTIATION; CATENIN; PHOSPHORYLATION; UBIQUITINATION	Background: The Runt homology domain (Runx) defines a metazoan family of sequence-specific transcriptional regulatory proteins that are critical for animal development and causally associated with a variety of mammalian cancers. The sea urchin Runx gene SpRunt-1 is expressed throughout the blastula stage embryo, and is required globally during embryogenesis for cell survival and differentiation. Methodology/Principal Findings: Depletion of SpRunt-1 by morpholino antisense-mediated knockdown causes a blastula stage deficit in cell proliferation, as shown by bromodeoxyuridine (BrdU) incorporation and direct cell counts. Reverse transcription coupled polymerase chain reaction (RT-PCR) studies show that the cell proliferation deficit is presaged by a deficit in the expression of several zygotic wnt genes, including wnt8, a key regulator of endomesoderm development. In addition, SpRunt-1-depleted blastulae underexpress cyclinD, an effector of mitogenic Wnt signaling. Blastula stage cell proliferation is also impeded by knockdown of either wnt8 or cyclinD. Chromatin immunoprecipitation (ChIP) indicates that Runx target sites within 59 sequences flanking cyclinD, wnt6 and wnt8 are directly bound by SpRunt-1 protein at late blastula stage. Furthermore, experiments using a green fluorescent protein (GFP) reporter transgene show that the blastulastage operation of a cis-regulatory module previously shown to be required for wnt8 expression (Minokawa et al., Dev. Biol. 288: 545-558, 2005) is dependent on its direct sequence-specific interaction with SpRunt-1. Finally, inhibitor studies and immunoblot analysis show that SpRunt-1 protein levels are negatively regulated by glycogen synthase kinase (GSK)-3. Conclusions/Significance: These results suggest that Runx expression and Wnt signaling are mutually linked in a feedback circuit that controls cell proliferation during development.	[Robertson, Anthony J.; Coluccio, Alison; Knowlton, Peter; Coffman, James A.] Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA; [Dickey-Sims, Carrie] Stowers Inst Med Res, Kansas City, MO USA	Mount Desert Island Biological Laboratory; Stowers Institute for Medical Research	Robertson, AJ (corresponding author), Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA.	jcoffman@mdibl.org			NIH [GM070840]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070840] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the NIH (GM070840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 2004, DEV BIOL, V270, P76, DOI 10.1016/j.ydbio.2004.02.012; Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Cameron ER, 2003, BLOOD CELL MOL DIS, V30, P194, DOI 10.1016/S1079-9796(03)00031-7; Cameron RA, 2004, GENE EXPR PATTERNS, V4, P205, DOI 10.1016/j.modgep.2003.08.007; Cheers MS, 2004, METHOD CELL BIOL, V74, P287; Coffman JA, 2003, CELL BIOL INT, V27, P315, DOI 10.1016/S1065-6995(03)00018-0; Coffman JA, 1996, DEV BIOL, V174, P43, DOI 10.1006/dbio.1996.0050; Coffman JA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-6; Croce JC, 2006, DEV BIOL, V300, P121, DOI 10.1016/j.ydbio.2006.08.045; Davidson EH, 2006, REG GEN GEN REG; Dickey-Sims C, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-18; Fernandez-Guerra A, 2006, DEV BIOL, V300, P238, DOI 10.1016/j.ydbio.2006.09.012; Fukamachi H, 2004, ONCOGENE, V23, P4330, DOI 10.1038/sj.onc.1207121; GOODE N, 1992, J BIOL CHEM, V267, P16878; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Ichikawa M, 2004, CELL CYCLE, V3, P722; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Kagoshima H, 2005, DEV BIOL, V287, P262, DOI 10.1016/j.ydbio.2005.08.034; Kagoshima H, 2007, J CELL BIOCHEM, V100, P1119, DOI 10.1002/jcb.21174; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; KNOWLTON P, 2007, MDIBL B, V46, P65; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li J, 2004, J CLIN PATHOL, V57, P294, DOI 10.1136/jcp.2003.013011; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; Mikesch JH, 2007, LEUKEMIA, V21, P1638, DOI 10.1038/sj.leu.2404732; Minokawa T, 2005, DEV BIOL, V288, P545, DOI 10.1016/j.ydbio.2005.09.047; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Moore JC, 2002, MOL CELL BIOL, V22, P4863, DOI 10.1128/MCB.22.13.4863-4875.2002; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Nimmo R, 2008, DEV BIOL, V313, P492, DOI 10.1016/j.ydbio.2007.11.002; Peterson LF, 2005, MOL CELL BIOL, V25, P10205, DOI 10.1128/MCB.25.23.10205-10219.2005; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Raveh E, 2006, MECH DEVELOP, V123, P842, DOI 10.1016/j.mod.2006.08.002; Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Robertson AJ, 2002, MECH DEVELOP, V117, P327, DOI 10.1016/S0925-4773(02)00201-0; Robertson AJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-4; Selvamurugan N, 2004, J BIOL CHEM, V279, P27764, DOI 10.1074/jbc.M312870200; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; SMITH J, 2007, DEV BIOL; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Sun LX, 2004, ONCOGENE, V23, P4722, DOI 10.1038/sj.onc.1207589; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Vilimek D, 2006, BIOCHEM CELL BIOL, V84, P20, DOI 10.1139/O05-154; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Westendorf JJ, 1999, J CELL BIOCHEM, P51; Wheeler JC, 2000, SEMIN CELL DEV BIOL, V11, P369, DOI 10.1006/scdb.2000.0184; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045; Wotton S, 2002, CANCER RES, V62, P7181; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332	59	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3770	10.1371/journal.pone.0003770	http://dx.doi.org/10.1371/journal.pone.0003770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020668	gold, Green Published, Green Submitted			2022-12-25	WOS:000265448600003
J	Caiado, F; Real, C; Carvalho, T; Dias, S				Caiado, Francisco; Real, Carla; Carvalho, Tania; Dias, Sergio			Notch Pathway Modulation on Bone Marrow-Derived Vascular Precursor Cells Regulates Their Angiogenic and Wound Healing Potential	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MOBILIZATION; STEM; ARTERIAL; REPAIR; DIFFERENTIATION; TRANSPLANTATION; RECRUITMENT; HYPOXIA	Bone marrow (BM) derived vascular precursor cells (BM-PC, endothelial progenitors) are involved in normal and malignant angiogenesis, in ischemia and in wound healing. However, the mechanisms by which BM-PC stimulate the pre-existing endothelial cells at sites of vascular remodelling/recovery, and their contribution towards the formation of new blood vessels are still undisclosed. In the present report, we exploited the possibility that members of the Notch signalling pathway, expressed by BM-PC during endothelial differentiation, might regulate their pro-angiogenic or pro-wound healing properties. We demonstrate that Notch pathway modulates the adhesion of BM-PC to extracellular matrix (ECM) in vitro via regulation of integrin alpha3beta1; and that Notch pathway inhibition on BM-PC impairs their capacity to stimulate endothelial cell tube formation on matrigel and to promote endothelial monolayer recovery following wounding in vitro. Moreover, we show that activation of Notch pathway on BM-PC improved wound healing in vivo through angiogenesis induction. Conversely, inoculation of BM-PC pre-treated with a gamma secretase inhibitor (GSI) into wounded mice failed to induce angiogenesis at the wound site and did not promote wound healing, presumably due to a lower frequency of BM-PC at the wound area. Our data suggests that Notch pathway regulates BM-PC adhesion to ECM at sites of vascular repair and that it also regulates the capacity of BM-PC to stimulate angiogenesis and to promote wound healing. Drug targeting of the Notch pathway on BM-PC may thus represent a novel strategy to modulate neo-angiogenesis and vessel repair.	[Caiado, Francisco; Real, Carla; Carvalho, Tania; Dias, Sergio] Portuguese Inst Oncol, CIPM, Angiogenesis Lab, Lisbon, Portugal; [Caiado, Francisco; Real, Carla; Carvalho, Tania; Dias, Sergio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Dias, Sergio] Inst Med Mol, Lisbon, Portugal	Universidade de Coimbra; Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Caiado, F (corresponding author), Portuguese Inst Oncol, CIPM, Angiogenesis Lab, Lisbon, Portugal.	sergidias@ipolisboa.min-saude.pt	Carvalho, Tânia/X-2873-2019; Dias, Sergio/L-1250-2014; Carvalho, Tânia/GNM-6203-2022; Real, Carla/D-5444-2009	Carvalho, Tânia/0000-0002-5283-5013; Dias, Sergio/0000-0002-7603-4616; Real, Carla/0000-0001-8067-2023; Caiado, Francisco/0000-0003-4096-4448	Fundacao para a Ciencia e Tecnologia fellowships [SFRH/BD/31381/2006, SFRH/BPD/17479/2004, SFRH/BPD/41378/2007]; Crioestaminal; Gulbenkian Foundation	Fundacao para a Ciencia e Tecnologia fellowships; Crioestaminal; Gulbenkian Foundation	Francisco Caiado, Carla Real and Tania Carvalho are supported by Fundacao para a Ciencia e Tecnologia fellowships (SFRH/BD/31381/2006, SFRH/BPD/17479/2004 and SFRH/BPD/41378/2007). This work was supported by Crioestaminal and by the Gulbenkian Foundation.	Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chigurupati S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001167; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Igreja C, 2008, EXP HEMATOL, V36, P193, DOI 10.1016/j.exphem.2007.09.001; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Karsan A, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.12pe2; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lanner F, 2007, ARTERIOSCL THROM VAS, V27, P487, DOI 10.1161/01.ATV.0000255990.91805.6d; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Nakajima M, 2003, MECH DEVELOP, V120, P657, DOI 10.1016/S0925-4773(03)00064-9; O'Neill TJ, 2005, CIRC RES, V97, P1027, DOI 10.1161/01.RES.0000189259.69645.25; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; ROGERS LC, 2008, INT WOUND J, P520; Silvestre JS, 2008, DIABETES METAB, V34, pS33, DOI 10.1016/S1262-3636(08)70101-0; Sivan-Loukianova E, 2003, J VASC RES, V40, P368, DOI 10.1159/000072701; Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Wilson Joyce A, 2004, Adv Skin Wound Care, V17, P426, DOI 10.1097/00129334-200410000-00013; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50	39	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3752	10.1371/journal.pone.0003752	http://dx.doi.org/10.1371/journal.pone.0003752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015735	Green Submitted, Green Published, gold			2022-12-25	WOS:000265448400009
J	Schmid, K; Yang, ZH				Schmid, Karl; Yang, Ziheng			The Trouble with Sliding Windows and the Selective Pressure in BRCA1	PLOS ONE			English	Article								Sliding-window analysis has widely been used to uncover synonymous (silent, d(S)) and nonsynonymous (replacement, d(N)) rate variation along the protein sequence and to detect regions of a protein under selective constraint (indicated by d(N)<d(S)) or positive selection (indicated by d(N)>d(S)). The approach compares two or more protein-coding genes and plots estimates <(d)over cap>(S) and (d) over cap (N) from each sliding window along the sequence. Here we demonstrate that the approach produces artifactual trends of synonymous and nonsynonymous rate variation, with greater variation in (d) over cap (S) than in (d) over cap (N). Such trends are generated even if the true dS and dN are constant along the whole protein and different codons are evolving independently. Many published tests of negative and positive selection using sliding windows that we have examined appear to be invalid because they fail to correct for multiple testing. Instead, likelihood ratio tests provide a more rigorous framework for detecting signals of natural selection affecting protein evolution. We demonstrate that a previous finding that a particular region of the BRCA1 gene experienced a synonymous rate reduction driven by purifying selection is likely an artifact of the sliding window analysis. We evaluate various sliding-window analyses in molecular evolution, population genetics, and comparative genomics, and argue that the approach is not generally valid if it is not known a priori that a trend exists and if no correction for multiple testing is applied.	[Schmid, Karl] Swedish Univ Agr Sci SLU, Dept Plant Biol & Forest Genet, Uppsala, Sweden; [Yang, Ziheng] UCL, Dept Biol, London WC1E 6BT, England	Swedish University of Agricultural Sciences; University of London; University College London	Schmid, K (corresponding author), Swedish Univ Agr Sci SLU, Dept Plant Biol & Forest Genet, Uppsala, Sweden.	z.yang@ucl.ac.uk						Andolfatto P, 1999, GENETICS, V153, P1297; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Ardell DH, 2004, BIOINFORMATICS, V20, P1986, DOI 10.1093/bioinformatics/bth187; Barbash DA, 2004, PLOS BIOL, V2, P839, DOI 10.1371/journal.pbio.0020142; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; Fares MA, 2004, BIOINFORMATICS, V20, P2867, DOI 10.1093/bioinformatics/bth303; Fares MA, 2002, J MOL EVOL, V55, P509, DOI 10.1007/s00239-002-2346-9; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Grassly NC, 1997, MOL BIOL EVOL, V14, P239, DOI 10.1093/oxfordjournals.molbev.a025760; Hurst LD, 2001, TRENDS GENET, V17, P62, DOI 10.1016/S0168-9525(00)02173-9; Huttley GA, 2000, NAT GENET, V25, P410, DOI 10.1038/78092; Kawabe A, 2000, GENETICS, V156, P1339; Ladoukakis ED, 2001, MOL BIOL EVOL, V18, P2127, DOI 10.1093/oxfordjournals.molbev.a003755; Llopart A, 1999, GENETICS, V152, P269; Makova KD, 2001, GENETICS, V158, P1253; Malik HS, 2001, GENETICS, V157, P1293; Mathias RA, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-38; McClellan DA, 2000, J MOL EVOL, V50, P131, DOI 10.1007/s002399910015; Nielsen R, 1998, GENETICS, V148, P929; Peek AS, 2001, J MOL EVOL, V52, P193, DOI 10.1007/s002390010148; Polley SD, 2001, GENETICS, V158, P1505; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Simon AL, 2002, P NATL ACAD SCI USA, V99, P2912, DOI 10.1073/pnas.042692299; TAJIMA F, 1991, J MOL EVOL, V33, P470, DOI 10.1007/BF02103140; Talbert Paul B, 2004, J Biol, V3, P18, DOI 10.1186/jbiol11; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan Z, 2002, PROTEINS, V48, P566, DOI 10.1002/prot.10176	39	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3746	10.1371/journal.pone.0003746	http://dx.doi.org/10.1371/journal.pone.0003746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015730	Green Published, gold			2022-12-25	WOS:000265448400003
J	Noel, F; Mehta, S; Zhu, YW; Rouzier, PD; Marcelin, A; Shi, JR; Nolte, C; Severe, L; Deschamps, MM; Fitzgerald, DW; Johnson, WD; Wright, PF; Pape, JW				Noel, Francine; Mehta, Sapna; Zhu, Yuwei; Rouzier, Patricia De Matteis; Marcelin, Abdias; Shi, Jian R.; Nolte, Claudine; Severe, Linda; Deschamps, Marie Marcelle; Fitzgerald, Daniel W.; Johnson, Warren D.; Wright, Peter F.; Pape, Jean W.			Improving Outcomes in Infants of HIV-Infected Women in a Developing Country Setting	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; BREAST-FED CHILDREN; ANTIRETROVIRAL THERAPY; ORAL ZIDOVUDINE; COTE-DIVOIRE; PREVENTION; MORTALITY; COTRIMOXAZOLE; PROPHYLAXIS; MOTHERS	Background: Since 1999 GHESKIO, a large voluntary counseling and HIV testing center in Port-au-Prince, Haiti, has had an ongoing collaboration with the Haitian Ministry of Health to reduce the rate of mother to child HIV transmission. There are limited data on the ability to administer complex regimens for reducing mother to child transmission and on risk factors for continued transmission and infant mortality within programmatic settings in developing countries. Methods and Findings: We analyzed data from 551 infants born to HIV-infected mothers seen at GHESKIO, between 1999 and 2005. HIV-infected mothers and their infants were given "short-course" monotherapy with antiretrovirals for prophylaxis; and, since 2003, highly active antiretroviral therapy (HAART) when clinical or laboratory indications were met. Infected women seen in the pre-treatment era had 27% transmission rates, falling to 10% in this cohort of 551 infants, and to only 1.9% in infants of women on HAART. Mortality rate after HAART introduction (0.12 per year of follow-up [0.08-0.16]) was significantly lower than the period before the availability of such therapy (0.23 [0.16-0.30], P<0.0001). The effects of maternal health, infant feeding, completeness of prophylaxis, and birth weight on mortality and transmission were determined using univariate and multivariate analysis. Infant HIV-1 infection and low birth weight were associated with infant mortality in less than 15 month olds in multivariate analysis. Conclusions: Our findings demonstrate success in prevention of mother-to-child HIV transmission and mortality in a highly resource constrained setting. Elements contributing to programmatic success include provision of HAART in the context of a comprehensive program with pre and postnatal care for both mother and infant.	[Noel, Francine; Rouzier, Patricia De Matteis; Marcelin, Abdias; Nolte, Claudine; Severe, Linda; Deschamps, Marie Marcelle; Pape, Jean W.] Ctr GHESKIO, Port Au Prince, Haiti; [Mehta, Sapna; Shi, Jian R.; Wright, Peter F.] Vanderbilt Univ, Sch Med, Nashville, TN USA; [Zhu, Yuwei] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Fitzgerald, Daniel W.; Johnson, Warren D.; Pape, Jean W.] Cornell Univ, Weill Med Coll, Div Infect Dis & Int Hlth, Dept Med, New York, NY USA; [Wright, Peter F.] Dartmouth Coll, Dartmouth Med Sch, Div Infect Dis & Int Med, Lebanon, NH USA	Vanderbilt University; Vanderbilt University; Cornell University; Dartmouth College	Noel, F (corresponding author), Ctr GHESKIO, Port Au Prince, Haiti.	peter.f.wright@dartmouth.edu	Marcelin, Anne-Genevieve/D-8272-2014	Marcelin, Anne-Genevieve/0000-0003-4808-8999	NIAID for the Latin American region of the International Epidemiology Databases to Evaluate AIDS (IeDEA) program [1 U01 AI069923-01]; Global fund; United Nations Population Fund (UNFPA); The Elizabeth Glaser Foundation; BioMeriux foundation; Norwegian Church; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069923] Funding Source: NIH RePORTER	NIAID for the Latin American region of the International Epidemiology Databases to Evaluate AIDS (IeDEA) program; Global fund; United Nations Population Fund (UNFPA); The Elizabeth Glaser Foundation; BioMeriux foundation; Norwegian Church; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by a PEPFAR supplement to cooperative agreement 1 U01 AI069923-01 from NIAID for the Latin American region of the International Epidemiology Databases to Evaluate AIDS (IeDEA) program, by the Global fund and United Nations Population Fund (UNFPA), The Elizabeth Glaser Foundation, BioMeriux foundation and the Norwegian Church. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brahmbhatt H, 2006, JAIDS-J ACQ IMM DEF, V41, P504, DOI 10.1097/01.qai.0000188122.15493.0a; CAYEMITTES M, 2005, ENQUETE MORTALITE MO; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; CONNOR EM, 1995, PEDIATR INFECT DIS J, V14, P536, DOI 10.1097/00006454-199506000-00012; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; Dao H, 2007, AM J OBSTET GYNECOL, V197, pS42, DOI 10.1016/j.ajog.2007.03.001; DESCHAMPS MM, REV PANAMER IN PRESS, P1; EKOUEVI DKT, 2008, ANRS DITRAME PLUS CO; George E, 2007, J CLIN MICROBIOL, V45, P3416, DOI 10.1128/JCM.01314-07; George E, 2007, J INFECT DIS, V195, P1411, DOI 10.1086/514823; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Jean SS, 1999, PEDIATR INFECT DIS J, V18, P58, DOI 10.1097/00006454-199901000-00014; Kourtis AP, 2007, AM J OBSTET GYNECOL, V197, pS113, DOI 10.1016/j.ajog.2007.03.003; Lipsitz SR, 1998, J ROY STAT SOC B, V60, P127, DOI 10.1111/1467-9868.00113; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; Magder LS, 2005, JAIDS-J ACQ IMM DEF, V38, P87, DOI 10.1097/00126334-200501010-00016; Mofenson LM, 2003, J INFECT DIS, V187, P721, DOI 10.1086/367905; Mofenson Lynne M, 2002, MMWR Recomm Rep, V51, P1; Morris K, 1998, LANCET, V351, P651, DOI 10.1016/S0140-6736(05)78436-1; MURPHY JMH, 2004, 15 INT AIDS CBANGK T; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Noel F, 2006, JAIDS-J ACQ IMM DEF, V43, P313, DOI 10.1097/01.qai.0000242463.73817.c6; Peck R, 2003, JAIDS-J ACQ IMM DEF, V33, P470, DOI 10.1097/00126334-200308010-00007; Respess RA, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200104003-00007; Ryan M, 2008, AIDS, V22, P749, DOI 10.1097/QAD.0b013e3282f43519; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Stringer JSA, 2003, LANCET, V362, P667, DOI 10.1016/S0140-6736(03)14172-4; Taha TE, 1999, PEDIATR INFECT DIS J, V18, P689, DOI 10.1097/00006454-199908000-00007; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/00002030-200305230-00016; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; *UNAID WHO, 2000, US COTR PROPH AD CHI; *UNAIDS WHO, 2007, AIDS EP UPD; Wei RL, 2004, PEDIATR INFECT DIS J, V23, P530, DOI 10.1097/01.inf.0000129691.42964.eb; *WHO, 2004, GENEVA; WHO, 2006, ANT DRUGS TREAT PREG; *WHO UNICEF UNU, 2001, IR DEF AN; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; World Health Organization Occupational and Environmental Health Team, 2006, WORLD HEAL ORGAN FOO, DOI DOI 10.1016/0004-6981(88)90109-6; 1998, MMWR MORB MORTAL WKL, V47, P151; 1985, MMWR MORB MORTAL WKL, V55, P592	44	14	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3723	10.1371/journal.pone.0003723	http://dx.doi.org/10.1371/journal.pone.0003723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19009021	Green Published, gold, Green Submitted			2022-12-25	WOS:000265166400002
J	Chen, J; Lu, YY; Meng, SX; Han, MH; Lin, CY; Wang, XZ				Chen, Jian; Lu, Yanyan; Meng, Shuxia; Han, Meng-Hsuan; Lin, Chengyi; Wang, Xiaozhong			alpha- and gamma-Protocadherins Negatively Regulate PYK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; SRC FAMILY KINASES; GENE-CLUSTER; TYROSINE PHOSPHORYLATION; COMBINATORIAL EXPRESSION; CEREBRAL-ISCHEMIA; CELL-ADHESION; NEURONS; CADHERINS; ORGANIZATION	Genetic studies demonstrate that gamma-protocadherins (PCDH-gamma) are required for the survival and synaptic connectivity in neuronal subpopulations of the central nervous system. However, the intracellular signaling mechanisms for PCDH-gamma are poorly understood. Here, we show that PCDH-gamma binds two tyrosine kinases, PYK2 and focal adhesion kinase (FAK), and interaction with PCDH-gamma inhibits kinase activity. Consistent with this, PYK2 activity is abnormally up-regulated in the Pcdh-gamma-deficient neurons. Overexpression of PYK2 induces apoptosis in the chicken spinal cord. Thus, negative regulation of PYK2 activity by PCDH could contribute to the survival of subsets of neurons. Surprisingly, we found that PCDH-alpha interacts similarly with PYK2 and FAK despite containing a distinct cytoplasmic domain. In neural tissue, PCDH-gamma, together with PCDH-alpha, forms functional complexes with PYK2 and/or FAK. Therefore, the identification of common intracellular effectors for PCDH-gamma and PCDH-alpha suggests that dozens of protocadherins generated by Pcdh-alpha and Pcdh-gamma gene clusters can converge different extracellular signals into common intracellular pathways.	[Chen, Jian; Lu, Yanyan; Meng, Shuxia; Han, Meng-Hsuan; Lin, Chengyi; Wang, Xiaozhong] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Wang, XZ (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	awang@northwestern.edu			National Institutes of Health [5R01NS051253]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01NS051253 (to X. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Bonn S, 2007, MOL CELL BIOL, V27, P4121, DOI 10.1128/MCB.01708-06; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Emond MR, 2008, DEV BIOL, V321, P175, DOI 10.1016/j.ydbio.2008.06.011; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Frank M, 2005, MOL CELL NEUROSCI, V29, P603, DOI 10.1016/j.mcn.2005.05.001; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Murata Y, 2004, J BIOL CHEM, V279, P49508, DOI 10.1074/jbc.M408771200; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; OBATA S, 1995, J CELL SCI, V108, P3765; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Phillips GR, 2003, J NEUROSCI, V23, P5096; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Tian DH, 2000, J NEUROSCI, V20, P6478, DOI 10.1523/JNEUROSCI.20-17-06478.2000; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Xiong WC, 1997, J CELL BIOL, V139, P529, DOI 10.1083/jcb.139.2.529; Yagi T, 2000, GENE DEV, V14, P1169; Zou C, 2007, NEUROSCIENCE, V144, P579, DOI 10.1016/j.neuroscience.2006.10.011	50	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2880	2890		10.1074/jbc.M807417200	http://dx.doi.org/10.1074/jbc.M807417200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047047	Green Published, hybrid			2022-12-25	WOS:000262700900032
J	Kruse, JP; Gu, W				Kruse, Jan-Philipp; Gu, Wei			MSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; NUCLEAR EXPORT; TRANSCRIPTIONAL ACTIVATION; P53-DEPENDENT APOPTOSIS; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; UBIQUITIN LIGASE; TERMINAL DOMAIN; PROTEIN; MDM2	Although it was originally thought of as a passive way to block the nuclear function of p53, accumulating evidence suggests that cytoplasmic localization of p53 plays an active role in p53-mediated functions such as apoptosis and autophagy. Previous studies by us and others demonstrated that Mdm2-mediated p53 ubiquitination induces both degradation and cytoplasmic localization. Here we describe MSL2, a novel E3 ligase for p53 that promotes ubiquitin-dependent cytoplasmic p53 localization. Unlike Mdm2 or most other p53 E3 ligases, MSL2-mediated p53 ubiquitination does not affect the stability of p53. Moreover, the MSL2-mediated effect on p53 is Mdm2-independent. Thus, our study identifies an important ubiquitin-ligase for modulating p53 subcellular localization.	[Kruse, Jan-Philipp; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Kruse, Jan-Philipp; Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu			National Institutes of Health; NCI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants from NCI ( to W. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Brooks CL, 2007, J BIOL CHEM, V282, P22804, DOI 10.1074/jbc.M700961200; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2004, CELL CYCLE, V3, P429; Clegg HV, 2008, CELL CYCLE, V7, P287, DOI 10.4161/cc.7.3.5358; Dornan D, 2004, CANCER RES, V64, P7226, DOI 10.1158/0008-5472.CAN-04-2601; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Fang S, 2003, SEMIN CANCER BIOL, V13, P5, DOI 10.1016/S1044-579X(02)00095-0; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gilman CP, 2003, NEUROMOL MED, V3, P159, DOI 10.1385/NMM:3:3:159; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Lu WJ, 2006, CELL DEATH DIFFER, V13, P909, DOI 10.1038/sj.cdd.4401922; LUNA RMD, 1995, NATURE, V378, P203; Manfredi JJ, 2003, MOL CELL, V11, P552, DOI 10.1016/S1097-2765(03)00106-0; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Marin I, 2003, J MOL EVOL, V56, P527, DOI 10.1007/s00239-002-2422-1; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Mendjan S, 2007, CHROMOSOMA, V116, P95, DOI 10.1007/s00412-006-0089-x; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Murphy ME, 2004, CELL CYCLE, V3, P836; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175	67	77	81	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3250	3263		10.1074/jbc.M805658200	http://dx.doi.org/10.1074/jbc.M805658200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19033443	hybrid, Green Published			2022-12-25	WOS:000262700900068
J	Xiao, LP; Liu, P; Li, XF; Doetschman, T; Coffin, JD; Drissi, H; Hurley, MM				Xiao, Liping; Liu, Peng; Li, Xiaofeng; Doetschman, Thomas; Coffin, J. Douglas; Drissi, Hicham; Hurley, Marja M.			Exported 18-kDa Isoform of Fibroblast Growth Factor-2 Is a Critical Determinant of Bone Mass in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRIZZLED-RELATED PROTEIN-1; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; TRABECULAR BONE; GENE; CBFA1; EXPRESSION; OSTEOPENIA; MINERALIZATION; DISRUPTION	The role of the 18-kDa isoform of fibroblast growth factor-2 (FGF2) in the maintenance of bone mass was examined in Col3.6-18-kDa FGF2-IRES-GFPsaph transgenic (18-kDa TgFGF2) mice in which a 3.6-kb fragment of the type I collagen 5'-regulatory region (Col3.6) drives the expression of only the 18-kDa isoform of FGF2 with green fluorescent protein-sapphire (GFPsaph). Vector only transgenic mice (Col3.6-IRES-GFPsaph, VTg) were also developed as a control, and mice specifically deficient in 18-kDa FGF2 (FGF2(lmw-/-)) were also examined. Bone mineral density, femoral bone volume, trabecular thickness, and cortical bone area and thickness were significantly increased in 18-kDa TgFGF2 mice compared with VTg. Bone marrow cultures (BMSC) from 18-kDa TgFGF2 mice produced more mineralized nodules than VTg. Increased bone formation was associated with reduced expression of the Wnt antagonist secreted frizzled receptor 1 (sFRP-1). In contrast to 18-kDa TgFGF2 mice, FGF2(lmw-/-) mice have significantly reduced bone mineral density and fewer mineralized nodules, coincident with increased expression of sFRP-1 in bones and BMSC. Moreover, silencing of sFRP-1 in BMSC from FGF2(lmw-/-) mice reversed the decrease in beta-catenin and Runx2 mRNA. Assay of Wnt/beta-catenin-mediated transcription showed increased and decreased TCF-luciferase activity in BMSC from 18-kDa TgFGF2 and FGF2(lmw-/-) mice, respectively. Collectively, these results demonstrate that the 18-kDa FGF2 isoform is a critical determinant of bone mass in mice by modulation of the Wnt signaling pathway.	[Hurley, Marja M.] Univ Connecticut, Sch Med, Div Endocrinol & Metab, Ctr Hlth,Dept Med, Farmington, CT 06030 USA; [Liu, Peng] Univ Connecticut, Dept Reconstruct Sci, Farmington, CT 06030 USA; [Li, Xiaofeng] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Doetschman, Thomas] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA; [Coffin, J. Douglas] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Drissi, Hicham] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA; Univ Arizona, Inst BIO5, Tucson, AZ 85724 USA	University of Connecticut; University of Connecticut; Yale University; University of Arizona; University of Montana System; University of Montana; University of Connecticut; University of Arizona	Hurley, MM (corresponding author), Univ Connecticut, Sch Med, Div Endocrinol & Metab, Ctr Hlth,Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA.	hurley@exchange.uchc.edu	Liu, Peng/AAH-5688-2020	drissi, hicham/0000-0002-3322-281X	National Institutes of Health [AG021189-05A1]; NATIONAL INSTITUTE ON AGING [R01AG021189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021189-05A1 ( to M. M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Church VL, 2002, INT J DEV BIOL, V46, P927; COTTIN JDG, 1995, MOL BIOL CELL, V6, P1861; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Dougall WC, 2006, CANCER METAST REV, V25, P541, DOI 10.1007/s10555-006-9021-3; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; FLORKIEWICZ RZ, 1991, ANN NY ACAD SCI, V638, P109, DOI 10.1111/j.1749-6632.1991.tb49022.x; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; Friedenstein A., 1990, BONE MINERAL RES, P243, DOI DOI 10.1016/B978-0-444-81371-8.50012-1; Garmy-Susini B, 2004, CIRC RES, V94, P1301, DOI 10.1161/01.RES.0000127719.13255.81; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; HURLEY MM, 2002, PRINCIPLES BONE BIOL, P825; Iseki S, 1999, DEVELOPMENT, V126, P5611; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; MAZUE G, 1993, TOXICOL PATHOL, V21, P490, DOI 10.1177/019262339302100508; Millar JBA, 2002, GENOME BIOL, V3; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Naganawa T, 2006, BIOCHEM BIOPH RES CO, V339, P490, DOI 10.1016/j.bbrc.2005.10.215; Nakagawa N, 1999, BIOCHEM BIOPH RES CO, V265, P158, DOI 10.1006/bbrc.1999.1601; NAKAMURA T, 1995, ENDOCRINOLOGY, V136, P1276, DOI 10.1210/en.136.3.1276; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096; Patel MS, 2002, NEW ENGL J MED, V346, P1572, DOI 10.1056/NEJM200205163462011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; Sobue T, 2005, J CELL BIOCHEM, V95, P83, DOI 10.1002/jcb.20389; STACHOWIAK MK, 1994, J CELL BIOL, V127, P203, DOI 10.1083/jcb.127.1.203; Valverde-Franco G, 2004, HUM MOL GENET, V13, P271, DOI 10.1093/hmg/ddh034; Wamsley HL, 2005, TOXICOL PATHOL, V33, P577, DOI 10.1080/01926230500243060; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao L, 2003, J CELL BIOCHEM, V89, P1291, DOI 10.1002/jcb.10589; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; ZHANG X, 2005, BIOCHEM BIOPH RES CO, V290, P526; Zhong XT, 2007, J BIOL CHEM, V282, P20523, DOI 10.1074/jbc.M609096200	49	49	52	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3170	3182		10.1074/jbc.M804900200	http://dx.doi.org/10.1074/jbc.M804900200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19056741	Green Published, hybrid			2022-12-25	WOS:000262700900061
J	Wang, H; Lindsey, S; Konieczna, I; Bei, L; Horvath, E; Huang, WQ; Saberwal, G; Eklund, EA				Wang, Hao; Lindsey, Stephan; Konieczna, Iwona; Bei, Ling; Horvath, Elizabeth; Huang, Weiqi; Saberwal, Gurveen; Eklund, Elizabeth A.			Constitutively Active SHP2 Cooperates with HoxA10 Overexpression to Induce Acute Myeloid Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-CELLS; GENE; EXPRESSION; MUTATIONS; PTPN11; TRANSCRIPTION; PROGENITORS; PHOSPHATASE; ACTIVATION; LINEAGE	The homeodomain transcription factor HoxA10 is maximally expressed in myeloid progenitor cells. Sustained HoxA10 expression during differentiation has been described in poor prognosis human acute myeloid leukemia (AML). Consistent with this, engineered overexpression of HoxA10 in murine bone marrow induces a myeloproliferative disorder that progresses to AML over time. This murine model suggests that HoxA10 overexpression is sufficient for myeloproliferation but that differentiation block, and therefore AML, requires acquisition of additional mutations. In myeloid progenitor cells, HoxA10 represses transcription of genes that encode phagocyte effector proteins such as gp91(PHOX) and p67(PHOX). Tyrosine phosphorylation of HoxA10 during myelopoiesis decreases binding to these target genes. In immature myeloid cells, HoxA10 also activates transcription of the DUSP4 gene that encodes Mkp2, an antiapoptotic protein. HoxA10 binding to the DUSP4 promoter decreases during myelopoiesis. Therefore, both myeloid-specific gene repression and DUSP4 activation by HoxA10 decrease during myelopoiesis. This results in phenotypic differentiation and facilitates apoptosis as differentiation proceeds. HoxA10 is de-phosphorylated by SHP2 protein-tyrosine phosphatase in myeloid progenitors. This mechanism maintains HoxA10 in a nonphosphorylated state in immature, but not differentiating, myeloid cells. Constitutively active SHP2 mutants have been described in human AML, which dephosphorylate HoxA10 throughout myelopoiesis. In this study, we hypothesize that constitutive SHP2 activation synergizes with HoxA10 overexpression to accelerate progression to AML. Because both HoxA10 overexpression and constitutive SHP2 activation are found in poor prognosis human AML, these studies contribute to understanding biochemical aspects of disease progression in myeloid malignancy.	[Wang, Hao; Lindsey, Stephan; Konieczna, Iwona; Bei, Ling; Horvath, Elizabeth; Huang, Weiqi; Saberwal, Gurveen; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Wang, Hao; Lindsey, Stephan; Konieczna, Iwona; Bei, Ling; Horvath, Elizabeth; Huang, Weiqi; Saberwal, Gurveen; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Horvath, Elizabeth; Saberwal, Gurveen; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 710 N Fairbanks Ct,Olson Pavilion Rm 8524, Chicago, IL 60611 USA.	e-eklund@northwestern.edu	Lindsey, Stephan/E-4358-2012	Wang, Hao/0000-0003-2131-0377	National Institutes of Health [HL87717]; Veterans Affairs Merit Review and a Leukemia and Lymphoma Society Translational Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review and a Leukemia and Lymphoma Society Translational Research Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 01 HL87717 (to E. A. E.). This work was also supported by a Veterans Affairs Merit Review and a Leukemia and Lymphoma Society Translational Research Award (to E. A. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Christiansen DH, 2007, GENE CHROMOSOME CANC, V46, P517, DOI 10.1002/gcc.20426; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Eisterer W, 2005, LEUKEMIA, V19, P435, DOI 10.1038/sj.leu.2403649; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Eklund EA, 2000, J BIOL CHEM, V39, P36878; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Ferrando AA, 2003, BLOOD, V102, P262, DOI 10.1182/blood-2002-10-3221; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; KhannaGupta A, 1997, BLOOD, V90, P2784, DOI 10.1182/blood.V90.7.2784.2784_2784_2795; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; LARRICK JW, 1980, J IMMUNOL, V125, P6; LAWRENCE HJ, 1995, EXP HEMATOL, V23, P1160; Lawson ND, 1998, BLOOD, V91, P2517, DOI 10.1182/blood.V91.7.2517.2517_2517_2524; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Lindsey S, 2007, J BIOL CHEM, V282, P2237, DOI 10.1074/jbc.M608642200; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Schnabel CA, 2000, ONCOGENE, V19, P608, DOI 10.1038/sj.onc.1203371; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	34	36	43	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2549	2567		10.1074/jbc.M804704200	http://dx.doi.org/10.1074/jbc.M804704200			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19022774	hybrid, Green Published			2022-12-25	WOS:000262545600060
J	Zhang, L; Zhao, H; Qiu, Y; Loh, HH; Law, PY				Zhang, Lei; Zhao, Hui; Qiu, Yu; Loh, Horace H.; Law, Ping-Yee			Src Phosphorylation of mu-Receptor Is Responsible for the Receptor Switching from an Inhibitory to a Stimulatory Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-OPIOID RECEPTOR; ADENYLYL-CYCLASE SUPERACTIVATION; PROTEIN-COUPLED RECEPTORS; NG108-15 HYBRID-CELLS; N-TERMINAL KINASES; TYROSINE KINASE; BETA-ARRESTINS; C-SRC; MUSCARINIC RECEPTORS; MOLECULAR-MECHANISMS	Recent studies have revealed that in Gprotein-coupled receptor signalings switching between G protein-and beta-arrestin (beta Arr)-dependent pathways occurs. In the case of opioid receptors, the signal is switched from the initial inhibition of adenylyl cyclase (AC) to an increase in AC activity (AC activation) during prolonged agonist treatment. The mechanism of such AC activation has been suggested to involve the switching of G proteins activated by the receptor, phosphorylation of signaling molecules, or receptor-dependent recruitment of cellular proteins. Using protein kinase inhibitors, dominant negative mutant studies and mouse embryonic fibroblast cells isolated from Src kinase knock-out mice, we demonstrated that mu-opioid receptor (OPRM1)-mediated AC activation requires direct association and activation of Src kinase by lipid raft-located OPRM1. Such Src activation was independent of beta Arr as indicated by the ability of OPRM1 to activate Src and AC after prolonged agonist treatment in mouse embryonic fibroblast cells lacking both beta Arr-1 and -2. Instead the switching of OPRM1 signals was dependent on the heterotrimeric G protein, specifically G(i2) alpha-subunit. Among the Src kinase substrates, OPRM1 was phosphorylated at Tyr(336) within NPXXY motif by Src during AC activation. Mutation of this Tyr residue, together with mutation of Tyr(166) within the DRY motif to Phe, resulted in the complete blunting of AC activation. Thus, the recruitment and activation of Src kinase by OPRM1 during chronic agonist treatment, which eventually results in the receptor tyrosine phosphorylation, is the key for switching the opioid receptor signals from its initial AC inhibition to subsequent AC activation.	[Zhang, Lei; Zhao, Hui; Qiu, Yu; Loh, Horace H.; Law, Ping-Yee] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Zhao, Hui] Fudan Univ, Dept Chinese & Western Med, Shanghai 200032, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Fudan University	Zhang, L (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	Zhang247@umn.edu		Law, Ping-Yee/0000-0002-5364-1093	National Institutes of Health [DA007339, DA016674, DA000564, DA011806, K05-DA70544, K05-DA00513]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA000564, P50DA011806, K05DA000513, R56DA000564, R01DA007339, R01DA016674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA007339, DA016674, DA000564, DA011806, K05-DA70544 ( to H. H. L.), and K05-DA00513 ( to P.-Y.L.).	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Audet N, 2005, J BIOL CHEM, V280, P7808, DOI 10.1074/jbc.M411695200; AvidorReiss T, 1996, J BIOL CHEM, V271, P21309, DOI 10.1074/jbc.271.35.21309; AvidorReiss T, 1997, J BIOL CHEM, V272, P5040, DOI 10.1074/jbc.272.8.5040; Bahia DS, 1998, BIOCHEMISTRY-US, V37, P11555, DOI 10.1021/bi980284o; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Cavalli A, 2000, J BIOL CHEM, V275, P23693, DOI 10.1074/jbc.M910395199; Chakrabarti S, 1998, MOL PHARMACOL, V54, P949, DOI 10.1124/mol.54.6.949; Chakrabarti S, 2001, P NATL ACAD SCI USA, V98, P4209, DOI 10.1073/pnas.071031798; CHENG HC, 1992, J BIOL CHEM, V267, P9248; Fan GF, 2001, J BIOL CHEM, V276, P13240, DOI 10.1074/jbc.M011578200; Favre N, 2005, BIOCHEMISTRY-US, V44, P9990, DOI 10.1021/bi0509853; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Fischer JA, 2002, BIOCHEM SOC T, V30, P455, DOI 10.1042/bst0300455; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Garzon J, 2005, NEUROPHARMACOLOGY, V48, P853, DOI 10.1016/j.neuropharm.2005.01.004; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Kalatskaya I, 2004, J BIOL CHEM, V279, P31268, DOI 10.1074/jbc.M401796200; Kam AYF, 2004, J PHARMACOL EXP THER, V310, P301, DOI 10.1124/jpet.104.065078; Kam AYF, 2003, J NEUROCHEM, V84, P503, DOI 10.1046/j.1471-4159.2003.01535.x; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Kramer HK, 2000, MOL BRAIN RES, V79, P55, DOI 10.1016/S0169-328X(00)00097-8; Kramer HK, 2000, BIOCHEM PHARMACOL, V60, P781, DOI 10.1016/S0006-2952(00)00400-7; LAW PY, 1982, MOL PHARMACOL, V22, P1; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; LAW PY, 1983, MOL PHARMACOL, V24, P413; Law PY, 1999, BIOPOLYMERS, V51, P440, DOI 10.1002/(SICI)1097-0282(1999)51:6<440::AID-BIP6>3.0.CO;2-T; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li J, 2001, MOL PHARMACOL, V60, P1064, DOI 10.1124/mol.60.5.1064; Li LY, 1996, MOL PHARMACOL, V50, P599; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Linseman DA, 2001, J BIOL CHEM, V276, P5622, DOI 10.1074/jbc.M006812200; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Narita M, 2006, NEUROREPORT, V17, P115, DOI 10.1097/01.wnr.0000198950.92820.c7; Nguyen QD, 2002, FASEB J, V16, P565, DOI 10.1096/fj.01-0525com; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Pineyro G, 2007, CELL SIGNAL, V19, P8, DOI 10.1016/j.cellsig.2006.05.026; Qiu Y, 2003, J BIOL CHEM, V278, P36733, DOI 10.1074/jbc.M305857200; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Sarnago S, 1999, J BIOL CHEM, V274, P34411, DOI 10.1074/jbc.274.48.34411; Schallmach E, 2006, J MOL NEUROSCI, V29, P115, DOI 10.1385/JMN:29:2:115; Schindelholz B, 1997, J NEUROSCI, V17, P8391; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; SHARMA SK, 1977, P NATL ACAD SCI USA, V74, P3365, DOI 10.1073/pnas.74.8.3365; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Singer CA, 2002, AM J PHYSIOL-GASTR L, V282, pG61, DOI 10.1152/ajpgi.00100.2002; Smith NJ, 2006, HYPERTENSION, V48, P173, DOI 10.1161/01.HYP.0000232641.84521.92; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Szucs M, 2004, J PHARMACOL EXP THER, V310, P256, DOI 10.1124/jpet.104.066837; Varga EV, 2002, EUR J PHARMACOL, V451, P101, DOI 10.1016/S0014-2999(02)02220-3; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Walwyn W, 2007, J NEUROSCI, V27, P5092, DOI 10.1523/JNEUROSCI.1157-07.2007; WONG YH, 1992, SCIENCE, V255, P339, DOI 10.1126/science.1347957; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang L, 2006, MOL PHARMACOL, V69, P1810, DOI 10.1124/mol.105.021352; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024	69	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					1990	2000		10.1074/jbc.M807971200	http://dx.doi.org/10.1074/jbc.M807971200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19029294	Green Published, hybrid			2022-12-25	WOS:000262545600006
J	Hansen, JL; Hansen, JT; Speerschneider, T; Lyngso, C; Erikstrup, N; Burstein, ES; Weiner, DM; Walther, T; Makita, N; Iiri, T; Merten, N; Kostenis, E; Sheikh, SP				Hansen, Jakob L.; Hansen, Jonas T.; Speerschneider, Tobias; Lyngso, Christina; Erikstrup, Niels; Burstein, Ethan S.; Weiner, David M.; Walther, Thomas; Makita, Noriko; Iiri, Taroh; Merten, Nicole; Kostenis, Evi; Sheikh, Soren P.			Lack of Evidence for AT(1)R/B2R Heterodimerization in COS-7, HEK293, and NIH3T3 Cells HOW COMMON IS THE AT(1)R/B2R HETERODIMER?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II TYPE-1 RECEPTOR; ENERGY-TRANSFER BRET; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; CARDIAC MYOCYTES; WILD-TYPE; ANGIOTENSIN; BRADYKININ; ACTIVATION; OLIGOMERIZATION	It has been suggested previously (AbdAlla, S., Lother, H., and Quitterer, U. (2000) Nature 407, 94-98) that the angiotensin II type 1 receptor (AT(1)R) and the bradykinin B2 receptor (B2R)form constitutive heterodimers. Furthermore they demonstrate that AT(1)R signaling significantly increases in the presence of the B2R. These findings suggest that heterodimerization and potentiation of AT(1)R signaling is a universal phenomenon that occurs as a natural consequence of simultaneous expression of the two receptors. Hence this potential interaction is of great pharmacological and biological interest that adds an additional layer of complexity to the understanding of the cross-talk between the renin-angiotensin and kallikrein-kinin systems. Given the remarkable significance of this finding, scientists from four independent research groups have set out to reproduce and further examine the potential AT(1)R/B2R interaction. We have investigated functional potentiation by the B2R of AT(1)R signaling in three different cell lines using multiple assays including phosphoinositide hydrolysis, ERK activation, beta-arrestin recruitment, and receptor selection and amplification technology, and we have examined dimerization using bioluminescence resonance energy transfer and regulated secretion/aggregation technology. However, although both the AT(1)Rs and B2Rs were functional in our systems and the systems were fine tuned to detect small changes in receptor function, we failed to detect any functional modulation by or physical interaction between the two receptor proteins. In contrast to the previous observations, our data collectively suggest that AT(1)R/B2R heterodimerization does not occur as a natural consequence of their simultaneous expression in the same cell nor does the B2R influence the AT(1)R signaling.	[Hansen, Jakob L.; Hansen, Jonas T.; Speerschneider, Tobias; Lyngso, Christina; Erikstrup, Niels] Univ Copenhagen, Mol Cardiol Lab, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Hansen, Jakob L.; Hansen, Jonas T.; Speerschneider, Tobias; Lyngso, Christina; Erikstrup, Niels] Univ Copenhagen Hosp, Rigshosp, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Mol Cardiol Lab,Heart Ctr, DK-2100 Copenhagen, Denmark; [Burstein, Ethan S.; Weiner, David M.] ACADIA Pharmaceut Inc, San Diego, CA 92121 USA; [Walther, Thomas] Univ Hull, Dept Biomed Sci, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Makita, Noriko; Iiri, Taroh] Univ Tokyo, Sch Med, Dept Endocrinol & Nephrol, Bunkyo Ku, Tokyo 1138655, Japan; [Merten, Nicole; Kostenis, Evi] Univ Bonn, Dept Mol Cellular & Pharmacobiol, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Sheikh, Soren P.] Odense Univ Hosp, Dept Biochem Pharmacol & Genet, DK-5000 Odense, Denmark	Danmarks Grundforskningsfond; University of Copenhagen; Danmarks Grundforskningsfond; Rigshospitalet; University of Copenhagen; University of Hull; University of York - UK; University of Tokyo; University of Bonn; University of Southern Denmark; Odense University Hospital	Hansen, JL (corresponding author), Univ Copenhagen, Mol Cardiol Lab, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Dept Neurosci & Pharmacol, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	jlhansen@sund.ku.dk; sheikh@dadlnet.dk	Makita, Noriko/GQY-8175-2022					Abadir PM, 2006, HYPERTENSION, V48, P316, DOI 10.1161/01.HYP.0000228997.88162.a8; AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; AbdAlla S, 2005, J MOL NEUROSCI, V26, P185, DOI 10.1385/JMN:26:2-3:185; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P296, DOI 10.1111/j.1742-7843.2007.00064.x; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P289, DOI 10.1111/j.1742-7843.2007.00063.x; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Brauner-Osborne H, 1996, EUR J PHARMACOL, V295, P93, DOI 10.1016/0014-2999(95)00639-7; Burstein ES, 2006, CURR PHARM DESIGN, V12, P1717, DOI 10.2174/138161206776873662; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Hansen JL, 2008, EUR J PHARMACOL, V590, P255, DOI 10.1016/j.ejphar.2008.05.010; Hansen JL, 2000, CIRC RES, V87, P753, DOI 10.1161/01.RES.87.9.753; Hansen JL, 2004, EUR J PHARM SCI, V23, P301, DOI 10.1016/j.ejps.2004.08.004; Hansen JL, 2004, J BIOL CHEM, V279, P24108, DOI 10.1074/jbc.M400092200; Hansen JL, 2004, MOL PHARMACOL, V65, P770, DOI 10.1124/mol.65.3.770; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; Hu K, 1998, CARDIOVASC RES, V39, P401, DOI 10.1016/S0008-6363(98)00090-X; Isbell DC, 2007, AM J PHYSIOL-HEART C, V293, pH3372, DOI 10.1152/ajpheart.00997.2007; Jensen AA, 2002, EUR J BIOCHEM, V269, P5076, DOI 10.1046/j.1432-1033.2002.03218.x; Karip E, 2007, NEUROCHEM INT, V51, P261, DOI 10.1016/j.neuint.2007.05.018; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; LYNGSO C, 2008, MOL CELL EN IN PRESS; MCEACHERN AE, 1991, P NATL ACAD SCI USA, V88, P7724, DOI 10.1073/pnas.88.17.7724; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Milligan G, 2006, DRUG DISCOV TODAY, V11, P541, DOI 10.1016/j.drudis.2006.04.007; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Santos EL, 2007, REGUL PEPTIDES, V141, P159, DOI 10.1016/j.regpep.2006.12.030; Sato M, 2000, CIRCULATION, V102, P346; Shen B, 2007, J AM SOC NEPHROL, V18, P1140, DOI 10.1681/ASN.2006101127; Tan Y, 2004, AM J PHYSIOL-HEART C, V286, pH926, DOI 10.1152/ajpheart.00757.2003; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Weiner DM, 2001, J PHARMACOL EXP THER, V299, P268; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zeng CY, 2003, HYPERTENSION, V42, P787, DOI 10.1161/01.HYP.0000085334.34963.4E; Zeng CY, 2003, HYPERTENSION, V41, P724, DOI 10.1161/01.HYP.0000047880.78462.0E; Zhu PL, 1999, J CARDIOVASC PHARM, V33, P785, DOI 10.1097/00005344-199905000-00016	44	46	48	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1831	1839		10.1074/jbc.M804607200	http://dx.doi.org/10.1074/jbc.M804607200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017652	hybrid			2022-12-25	WOS:000262330100054
J	Karamysheva, Z; Diaz-Martinez, LA; Crow, SE; Li, B; Yu, HT				Karamysheva, Zemfira; Diaz-Martinez, Laura A.; Crow, Sara E.; Li, Bing; Yu, Hongtao			Multiple Anaphase-promoting Complex/Cyclosome Degrons Mediate the Degradation of Human Sgo1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; PROTEIN PHOSPHATASE 2A; SPINDLE-CHECKPOINT; HUMAN SHUGOSHIN; HUMAN-CELLS; KEN-BOX; CHROMOSOME; MITOSIS; LOCALIZATION; CYTOKINESIS	Shugoshin 1 (Sgo1) protects centromeric sister-chromatid cohesion in early mitosis and, thus, prevents premature sister-chromatid separation. The protein level of Sgo1 is regulated during the cell cycle; it peaks in mitosis and is down-regulated in G(1)/S. Here we show that Sgo1 is degraded during the exit from mitosis, and its degradation depends on the anaphase-promoting complex/cyclosome (APC/C). Overexpression of Cdh1 reduces the protein levels of ectopically expressed Sgo1 in human cells. Sgo1 is ubiquitinated by APC/C bound to Cdh1 (APC/CCdh1) in vitro. We have further identified two functional degradation motifs in Sgo1; that is, aKEN (Lys-Glu-Asn) box and a destruction box (D box). Although removal of either motif is not sufficient to stabilize Sgo1, Sgo1 with both KEN box and D box deleted is stable in cells. Surprisingly, mitosis progresses normally in the presence of non-degradable Sgo1, indicating that degradation of Sgo1 is not required for sister-chromatid separation or mitotic exit. Finally, we show that the spindle checkpoint kinase Bub1 contributes to the maintenance of Sgo1 steady-state protein levels in an APC/C-independent mechanism.	[Karamysheva, Zemfira; Diaz-Martinez, Laura A.; Crow, Sara E.; Li, Bing; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, HT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu	Díaz-Martínez, Laura/A-5357-2010	Diaz-Martinez, Laura/0000-0002-7226-7068; Yu, Hongtao/0000-0002-8861-049X	National Institutes of Health [GM76481]; March of Dimes Foundation; Welch Foundation; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Welch Foundation(The Welch Foundation); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM76481. This work was also supported by the March of Dimes Foundation, the Welch Foundation, and the Leukemia and Lymphoma Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fu GS, 2007, BIOCHEM BIOPH RES CO, V357, P672, DOI 10.1016/j.bbrc.2007.03.204; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1561, DOI 10.4161/cc.4.11.2146; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; LOSADA A, 2002, ANNU REV CELL DEV BI, V24, P105; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Qi W, 2007, J BIOL CHEM, V282, P3672, DOI 10.1074/jbc.M609376200; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Suzuki H, 2006, CELL CYCLE, V5, P1094, DOI 10.4161/cc.5.10.2747; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tang Zhanyun, 2004, Methods Mol Biol, V281, P227; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Wang XX, 2006, CELL CYCLE, V5, P635; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	30	36	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1772	1780		10.1074/jbc.M807083200	http://dx.doi.org/10.1074/jbc.M807083200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015261	hybrid, Green Published			2022-12-25	WOS:000262330100048
J	Rudolph, V; Schopfer, FJ; Khoo, NKH; Rudolph, TK; Cole, MP; Woodcock, SR; Bonacci, G; Groeger, AL; Golin-Bisello, F; Chen, CS; Baker, PRS; Freeman, BA				Rudolph, Volker; Schopfer, Francisco J.; Khoo, Nicholas K. H.; Rudolph, Tanja K.; Cole, Marsha P.; Woodcock, Steven R.; Bonacci, Gustavo; Groeger, Alison L.; Golin-Bisello, Franca; Chen, Chen-Shan; Baker, Paul R. S.; Freeman, Bruce A.			Nitro-fatty Acid Metabolome: Saturation, Desaturation, beta-Oxidation, and Protein Adduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN OXIDATION; OXIDIZED LIPID DERIVATIVES; HUMAN BLOOD-PLASMA; OLD YELLOW ENZYME; NITROLINOLEIC ACID; METHYL LINOLEATE; OXIDE INHIBITION; POTENTIAL ROLE; CELL-FUNCTION; TRANSDUCTION	Nitrated derivatives of fatty acids (NO2-FA) are pluripotent cell-signaling mediators that display anti-inflammatory properties. Current understanding of NO2-FA signal transduction lacks insight into how or if NO2-FA are modified or metabolized upon formation or administration in vivo. Here the disposition and metabolism of nitro-9-cis- octadecenoic (18:1-NO2) acid was investigated in plasma and liver after intravenous injection in mice. High performance liquid chromatography-tandem mass spectrometry analysis showed that no 18:1-NO2 or metabolites were detected under basal conditions, whereas administered 18:1-NO2 is rapidly adducted to plasma thiol-containing proteins and glutathione. NO2-FA are also metabolized via beta-oxidation, with high performance liquid chromatography-tandem mass spectrometry analysis of liver lipid extracts of treated mice revealing nitro-7-cis-hexadecenoic acid, nitro-5-cis-tetradecenoic acid, and nitro-3-cis-dodecenoic acid and corresponding coenzyme A derivatives of 18:1-NO2 as metabolites. Additionally, a significant proportion of 18:1-NO2 and its metabolites are converted to nitroalkane derivatives by saturation of the double bond, and to a lesser extent are desaturated to diene derivatives. There was no evidence of the formation of nitrohydroxyl or conjugated ketone derivatives in organs of interest, metabolites expected upon 18:1-NO2 hydration or nitric oxide ((NO)-N-center dot) release. Plasma samples from treated mice had significant extents of protein-adducted 18:1-NO2 detected by exchange to added beta-mercaptoethanol. This, coupled with the observation of 18:1-NO2 release from glutathione-18:1-NO2 adducts, supports that reversible and exchangeable NO2-FA-thiol adducts occur under biological conditions. After administration of [H-3] 18:1-NO2, 64% of net radiolabel was recovered 90 min later in plasma (0.2%), liver (18%), kidney (2%), adipose tissue (2%), muscle (31%), urine (6%), and other tissue compartments, and may include metabolites not yet identified. In aggregate, these findings show that electrophilic FA nitroalkene derivatives (a) acquire an extended half-life by undergoing reversible and exchangeable electrophilic reactions with nucleophilic targets and (b) are metabolized predominantly via saturation of the double bond and beta-oxidation reactions that terminate at the site of acyl-chain nitration.	[Rudolph, Volker; Schopfer, Francisco J.; Khoo, Nicholas K. H.; Rudolph, Tanja K.; Cole, Marsha P.; Woodcock, Steven R.; Bonacci, Gustavo; Groeger, Alison L.; Golin-Bisello, Franca; Chen, Chen-Shan; Baker, Paul R. S.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Rudolph, Volker; Rudolph, Tanja K.] Univ Heart Ctr Hamburg, Dept Cardiol, D-20246 Hamburg, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hamburg; University Medical Center Hamburg-Eppendorf	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, E1340 Thomas E Starzl Biomed Sci Tower,200 Lothro, Pittsburgh, PA 15213 USA.	freerad@pitt.edu	Schopfer, Francisco/AAW-6505-2021; Schopfer, Francisco Jose/AAE-8125-2020; Freeman, Bruce A/H-9342-2012; Woodcock, Steven/AAE-9199-2020	Schopfer, Francisco Jose/0000-0001-9526-695X; 	National Institutes of Health [R01 HL58115, R01 HL64937]; American Diabetes Association [7-08-JF-52, 7-06-JF-06]; American Heart Association [0665418U]; Deutsche Herzstiftung; Deutsche Forschungsgemeinschaft; Complexa, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, R01HL064937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Deutsche Herzstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Complexa, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL58115 and R01 HL64937. This work was also supported by American Diabetes Association Grants 7-08-JF-52 (to F.J.S.) and 7-06-JF-06 (to P.R.S.B.), American Heart Association Grant 0665418U (to F.J.S.), the Deutsche Herzstiftung (to V.R.), and the Deutsche Forschungsgemeinschaft (to T.R.). B.A.F. acknowledges financial interest in Complexa, LLC.	Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Balazy M, 2001, J PHARMACOL EXP THER, V299, P611; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Calder PC, 1997, ADV ENZYME REGUL, V37, P197, DOI 10.1016/S0065-2571(96)00004-0; CASTUMA JC, 1972, J LIPID RES, V13, P783; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; FINLAYSONPITTS BJ, 1987, TOXICOL APPL PHARM, V89, P438, DOI 10.1016/0041-008X(87)90163-3; Fox JEM, 2003, METABOLISM, V52, P1313, DOI 10.1016/S0026-0495(03)00199-9; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; GALLON AA, 1993, LIPIDS, V28, P125, DOI 10.1007/BF02535776; GALLON AA, 1994, LIPIDS, V29, P171, DOI 10.1007/BF02536725; Hanley PJ, 2005, J PHYSIOL-LONDON, V562, P307, DOI 10.1113/jphysiol.2004.073932; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; HOGG N, 1993, FEBS LETT, V334, P170, DOI 10.1016/0014-5793(93)81706-6; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; Leonarduzzi G, 2004, FREE RADICAL BIO MED, V37, P1694, DOI 10.1016/j.freeradbiomed.2004.08.027; Lim DG, 2002, P NATL ACAD SCI USA, V99, P15941, DOI 10.1073/pnas.232409599; Lima ES, 2005, FREE RADICAL BIO MED, V39, P532, DOI 10.1016/j.freeradbiomed.2005.04.005; Lima ES, 2003, J LIPID RES, V44, P1660, DOI 10.1194/jlr.M200467-JLR200; Lima ES, 2002, BIOCHEMISTRY-US, V41, P10717, DOI 10.1021/bi025504j; Magnes C, 2005, ANAL CHEM, V77, P2889, DOI 10.1021/ac048314i; Meah Y, 2000, P NATL ACAD SCI USA, V97, P10733, DOI 10.1073/pnas.190345597; Musiek ES, 2005, BRAIN PATHOL, V15, P149; Napolitano A, 2002, J ORG CHEM, V67, P1125, DOI 10.1021/jo015973b; Napolitano A, 2000, J ORG CHEM, V65, P4853, DOI 10.1021/jo000090q; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; O'Donnell VB, 2001, CIRC RES, V88, P12, DOI 10.1161/01.RES.88.1.12; ODonnell VB, 1997, BIOCHEMISTRY-US, V36, P15216, DOI 10.1021/bi971891z; Riedel MJ, 2005, DIABETES, V54, P2070, DOI 10.2337/diabetes.54.7.2070; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Rubbo H, 1995, ARCH BIOCHEM BIOPHYS, V324, P15, DOI 10.1006/abbi.1995.9935; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6; Trostchansky A, 2008, FREE RADICAL BIO MED, V44, P1887, DOI 10.1016/j.freeradbiomed.2008.03.006; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Wong HL, 2008, CHEM RES TOXICOL, V21, P796, DOI 10.1021/tx700433m; Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103	44	96	106	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1461	1473		10.1074/jbc.M802298200	http://dx.doi.org/10.1074/jbc.M802298200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015269	hybrid, Green Published			2022-12-25	WOS:000262330100014
J	Terziyska, N; Grumbt, B; Kozany, C; Hell, K				Terziyska, Nadia; Grumbt, Barbara; Kozany, Christian; Hell, Kai			Structural and Functional Roles of the Conserved Cysteine Residues of the Redox-regulated Import Receptor Mia40 in the Intermembrane Space of Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; SULFHYDRYL OXIDASE; RESPIRATORY-CHAIN; CYTOCHROME-C; PATHWAY; ERV1; TIM10; BIOGENESIS	Oxidative folding drives the import of proteins containing twin CXnC motifs into the intermembrane space of mitochondria. This import pathway employs a disulfide relay system whose key components are the redox-regulated import receptor Mia40 and the thiol oxidase Erv1. Mia40 contains six cysteine residues in a CPC-CX9C-CX9C arrangement in a highly conserved domain. We show that this domain is sufficient for the function of Mia40. By analysis of Mia40 cysteine mutants we demonstrate that the cysteine residues have distinct roles and are not equally important for Mia40 function. The second cysteine residue is essential for viability of yeast cells. It is required for the interaction of Mia40 with Erv1 in a disulfide intermediate and forms a redox-sensitive disulfide bond with the first cysteine residue. Both cysteine residues are required for the oxidation of the substrate, Tim10, in a reconstituted system comprised of Mia40 and Erv1. Mutants with amino acid exchanges in the third and sixth cysteine residues have severe defects in growth and in the import of intermembrane space proteins. These Mia40 variants are not tightly folded. We conclude that the cysteine residues of the twin CX9C motif have a structural role and stabilize Mia40. In particular, the disulfide bond formed by the third and sixth cysteine residues apparently supports a conformation crucial for the function of Mia40. Furthermore, the disulfide bond in the CPC segment mediates the redox reactions with the thiol oxidase Erv1 and substrate proteins in mitochondria.	[Terziyska, Nadia; Grumbt, Barbara; Kozany, Christian; Hell, Kai] Univ Munich, Adolf Butenandt Inst Physiol Chem, D-81377 Munich, Germany	University of Munich	Hell, K (corresponding author), Univ Munich, Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	hell@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [SFB 594, He 2803/2-4]; Elite Netzwerk Bayern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elite Netzwerk Bayern	This work was supported in part by Grants SFB 594 (B13) and He 2803/2-4, from the Deutsche Forschungsgemeinschaft (to K.H.) and by a predoctoral fellowship from the Elite Netzwerk Bayern (to B.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Allen S, 2003, J BIOL CHEM, V278, P38505, DOI 10.1074/jbc.M306027200; Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chacinska A, 2008, J BIOL CHEM, V283, P29723, DOI 10.1074/jbc.M805356200; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; Grumbt B, 2007, J BIOL CHEM, V282, P37461, DOI 10.1074/jbc.M707439200; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lu H, 2005, J MOL BIOL, V353, P897, DOI 10.1016/j.jmb.2005.09.002; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Lu H, 2004, J BIOL CHEM, V279, P18959, DOI 10.1074/jbc.M313046200; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Mesecke N, 2008, EMBO REP, V9, P1107, DOI 10.1038/embor.2008.173; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Stojanovski D, 2008, BBA-MOL CELL RES, V1783, P610, DOI 10.1016/j.bbamcr.2007.10.004; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010	33	65	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1353	1363		10.1074/jbc.M805035200	http://dx.doi.org/10.1074/jbc.M805035200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19011240	hybrid			2022-12-25	WOS:000262330100003
J	Zhao, YS; Min, CY; Vora, SR; Trackman, PC; Sonenshein, GE; Kirsch, KH				Zhao, Yingshe; Min, Chengyin; Vora, Siddharth R.; Trackman, Philip C.; Sonenshein, Gail E.; Kirsch, Kathrin H.			The Lysyl Oxidase Pro-peptide Attenuates Fibronectin-mediated Activation of Focal Adhesion Kinase and p130(Cas) in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR ACTIVITY; INVASIVE PHENOTYPE; H-RAS; EXPRESSION; GENE; LOX; CARCINOMA; MIGRATION; REVERSION; PRECURSOR	The lysyl oxidase (LOX) gene encodes an enzyme (LOX) critical for extracellular matrix maturation. The LOX gene has also been shown to inhibit the transforming activity of Ras oncogene signaling. In particular, the pro-peptide domain (LOX-PP) released from the secreted precursor protein (Pro-LOX) was found to inhibit the transformed phenotype of breast, lung, and pancreatic cancer cells. However, the mechanisms of action of LOX-PP remained to be determined. Here, the ability of LOX-PP to attenuate the integrin signaling pathway, which leads to phosphorylation of focal adhesion kinase (FAK), and the activation of its downstream target p130(Cas), was determined. In NF639 breast cancer cells driven by Her-2/neu, which signals via Ras, ectopic Pro-LOX and LOX-PP expression inhibited fibronectin-stimulated protein tyrosine phosphorylation. Importantly, phosphorylation of FAK on Tyr-397 and Tyr-576, and p130(Cas) were substantially reduced. The amount of endogenous p130(Cas) in the Triton X-100-insoluble protein fraction, and fibronectin-activated haptotaxis were decreased. Interestingly, expression of mature LOX enzyme enhanced fibronectin-stimulated integrin signaling. Of note, treatment with recombinant LOX-PP selectively reduced fibronectin-mediated haptotaxis of NF639, MDA-MB-231, and Hs578T breast cancer cells. Thus, evidence is provided that one mechanism of action of LOX-PP tumor suppression is to block fibronectin-stimulated signaling and cell migration.	[Zhao, Yingshe; Min, Chengyin; Sonenshein, Gail E.; Kirsch, Kathrin H.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Vora, Siddharth R.; Trackman, Philip C.] Boston Univ, Goldman Sch Dent Med, Div Oral Biol, Boston, MA 02118 USA	Boston University; Boston University	Kirsch, KH (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	kirschk@bu.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Kirsch, Kathrin/0000-0003-1532-1715	National Institute of Health [CA82742, CA106468]; Dept. of the Army [DAMD 05-1-0286, 08-1-0349]; NATIONAL CANCER INSTITUTE [R01CA082742, R01CA106468] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of the Army; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institute of Health Grants CA82742 and CA106468 and by Grants DAMD 05-1-0286 and 08-1-0349 from the Dept. of the Army. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASSOIAN RK, 1989, ANAL BIOCHEM, V177, P95, DOI 10.1016/0003-2697(89)90020-1; AZZOPARI JG, 1974, CANCER, V33, P174, DOI 10.1002/1097-0142(197401)33:1<174::AID-CNCR2820330126>3.0.CO;2-X; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Eto T, 1996, CANCER, V77, P646, DOI 10.1002/(SICI)1097-0142(19960215)77:4<646::AID-CNCR10>3.0.CO;2-0; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; HOWLETT A, 1999, METHODS MOL BIOL, V129; Hsia DA, 2005, MOL CELL BIOL, V25, P9700, DOI 10.1128/MCB.25.21.9700-9712.2005; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; KAGAN HM, 1995, J CELL BIOCHEM, V59, P329, DOI 10.1002/jcb.240590305; KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898; Kirsch KH, 1998, J BIOL CHEM, V273, P25673, DOI 10.1074/jbc.273.40.25673; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; KRAUS MH, 1984, P NATL ACAD SCI-BIOL, V81, P5384, DOI 10.1073/pnas.81.17.5384; Laczko R, 2007, NEUROPATH APPL NEURO, V33, P631, DOI 10.1111/j.1365-2990.2007.00858.x; Lark AL, 2005, MODERN PATHOL, V18, P1289, DOI 10.1038/modpathol.3800424; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; Peyrol S, 1997, AM J PATHOL, V150, P497; Rodriguez C, 2002, ARTERIOSCL THROM VAS, V22, P1409, DOI 10.1161/01.ATV.0000033818.21748.99; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; Seve S, 2002, CONNECT TISSUE RES, V43, P613, DOI 10.1080/03008200290001348; Sibon I, 2005, HEART, V91, DOI 10.1136/hrt.2004.053074; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Watermann DO, 2005, BRIT J CANCER, V93, P694, DOI 10.1038/sj.bjc.6602744; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776	41	55	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1385	1393		10.1074/jbc.M802612200	http://dx.doi.org/10.1074/jbc.M802612200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19029090	Green Published, hybrid			2022-12-25	WOS:000262330100006
J	Shirato, H; Ogawa, S; Nakajima, K; Inagawa, M; Kojima, M; Tachibana, M; Shinkai, Y; Takeuchi, T				Shirato, Haruki; Ogawa, Satoko; Nakajima, Kuniko; Inagawa, Masayo; Kojima, Mizuyo; Tachibana, Makoto; Shinkai, Yoichi; Takeuchi, Takashi			A Jumonji (Jarid2) Protein Complex Represses cyclin D1 Expression by Methylation of Histone H3-K9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COREPRESSOR; LYSINE METHYLATION; EPIGENETIC CODE; HAIRLESS GENE; G9A; METHYLTRANSFERASE; FAMILY; TRANSCRIPTION; ROLES; JMJC	Covalent modifications of histone tails have critical roles in regulating gene expression. Previously, we identified the jumonji (jmj, Jarid2) gene, the jmjC domain, and a Jmj family. Recently, many Jmj family proteins have been shown to be histone demethylases, and jmjC is the catalytic domain. However, Jmj does not have histone demethylase activity because the jmjC domain lacks conserved residues for binding to cofactors. Independently of these studies, we previously showed that Jmj binds to the cyclin D1 promoter and represses the transcription of cyclin D1. Here, we show the mechanisms by which Jmj represses the transcription of cyclin D1. We found that a protein complex of Jmj had histone methyltransferase activity toward histone H3 lysine 9 (H3-K9). We also found that Jmj bound to the H3-K9 methyltransferases G9a and GLP. Expression of Jmj recruited G9a and GLP to the cyclin D1 promoter and increased H3-K9 methylation. Inactivation of both G9a and GLP, but not of only G9a, inhibited the methylation of H3-K9 in the cyclin D1 promoter and repression of cyclin D1 expression by Jmj. These results suggest that Jmj methylates H3-K9 and represses cyclin D1 expression through G9a and GLP, and that Jmj family proteins can regulate gene expression by not only histone demethylation but also other histone modification.	[Shirato, Haruki; Ogawa, Satoko; Nakajima, Kuniko; Inagawa, Masayo; Kojima, Mizuyo; Takeuchi, Takashi] Kyoto Univ, Mitsubishi Kagaku Inst Life Sci, Kyoto 6068507, Japan; [Tachibana, Makoto; Shinkai, Yoichi] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Takeuchi, Takashi] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	Kyoto University; Kyoto University; Yokohama National University	Takeuchi, T (corresponding author), 11 Minamiooya, Tokyo 1948511, Japan.	take@mitils.jp	Shinkai, Yoichi/N-3909-2014	Shinkai, Yoichi/0000-0002-6051-2484	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Balciunas D, 2000, TRENDS BIOCHEM SCI, V25, P274, DOI 10.1016/S0968-0004(00)01593-0; CACHONGONZALEZ MB, 1994, P NATL ACAD SCI USA, V91, P7717, DOI 10.1073/pnas.91.16.7717; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Hsieh JC, 2003, J BIOL CHEM, V278, P38665, DOI 10.1074/jbc.M304886200; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Moraitis AN, 2002, MOL CELL BIOL, V22, P6831, DOI 10.1128/MCB.22.19.6831-6841.2002; Motoyama J, 1997, MECH DEVELOP, V66, P27, DOI 10.1016/S0925-4773(97)00082-8; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Potter GB, 2001, GENE DEV, V15, P2687, DOI 10.1101/gad.916701; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Takahashi M, 2007, DEV BIOL, V303, P549, DOI 10.1016/j.ydbio.2006.11.031; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Toyoda M, 2000, BIOCHEM BIOPH RES CO, V274, P332, DOI 10.1006/bbrc.2000.3138; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2	29	59	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					733	739		10.1074/jbc.M804994200	http://dx.doi.org/10.1074/jbc.M804994200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010785	hybrid			2022-12-25	WOS:000262122900006
J	Blinder, P; Cove, J; Foox, M; Baranes, D				Blinder, Pablo; Cove, Joshua; Foox, Maytal; Baranes, Danny			Convergence among Non-Sister Dendritic Branches: An Activity-Controlled Mean to Strengthen Network Connectivity	PLOS ONE			English	Article							HIPPOCAMPAL MOSSY FIBER; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; WIRING OPTIMIZATION; NEURONS; MODEL; ELECTROPHYSIOLOGY; RAT; ORGANELLES; MORPHOLOGY	The manner by which axons distribute synaptic connections along dendrites remains a fundamental unresolved issue in neuronal development and physiology. We found in vitro and in vivo indications that dendrites determine the density, location and strength of their synaptic inputs by controlling the distance of their branches from those of their neighbors. Such control occurs through collective branch convergence, a behavior promoted by AMPA and NMDA glutamate receptor activity. At hubs of convergence sites, the incidence of axo-dendritic contacts as well as clustering levels, pre- and postsynaptic protein content and secretion capacity of synaptic connections are higher than found elsewhere. This coupling between synaptic distribution and the pattern of dendritic overlapping results in 'Economical Small World Network', a network configuration that enables single axons to innervate multiple and remote dendrites using short wiring lengths. Thus, activity-mediated regulation of the proximity among dendritic branches serves to pattern and strengthen neuronal connectivity.	[Blinder, Pablo; Cove, Joshua; Foox, Maytal; Baranes, Danny] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Baranes, Danny] Ariel Univ, Ctr Samaria, Ariel, Israel	Ben Gurion University; Ariel University	Blinder, P (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dbaranes@bgu.ac.il	Blinder, Pablo/AAX-7980-2020; Blinder, Pablo/GQI-2237-2022	Blinder, Pablo/0000-0002-4042-214X; 	Canada Foundation of Innovation; Kreitman and Horowitz foundations	Canada Foundation of Innovation(Canada Foundation for Innovation); Kreitman and Horowitz foundations	Canada Foundation of Innovation, The Kreitman and Horowitz foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranes D, 1996, P NATL ACAD SCI USA, V93, P4706, DOI 10.1073/pnas.93.10.4706; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Bortolotto ZA, 2005, NEUROTOXICOLOGY, V26, P769, DOI 10.1016/j.neuro.2005.02.004; Chauvet GA, 2002, HIPPOCAMPUS, V12, P698, DOI 10.1002/hipo.10106; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Criado R, 2005, J MATH MODELLING ALG, V4, P307, DOI DOI 10.1007/S10852-005-9006-1; Dudoit S, 2003, BIOINFORMATICS, V19, P1090, DOI 10.1093/bioinformatics/btg038; Furtado LS, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011907; Grebenyuk SE, 2004, NEUROSCI LETT, V361, P60, DOI 10.1016/j.neulet.2004.02.040; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Hasegawa H, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066107; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kohrmann M, 1999, J NEUROSCI RES, V58, P831; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Krichmar JL, 2002, BRAIN RES, V941, P11, DOI 10.1016/S0006-8993(02)02488-5; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LopezGarcia JC, 1996, P NATL ACAD SCI USA, V93, P4712, DOI 10.1073/pnas.93.10.4712; Lovmar L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-35; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6803; MASON A, 1990, J NEUROSCI, V10, P1415; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; Migliore M, 1995, J COMPUT NEUROSCI, V2, P335, DOI 10.1007/BF00961444; OLSON CF, 1995, PARALLEL COMPUT, V21, P1313, DOI 10.1016/0167-8191(95)00017-I; OSTLING A, 2000, SCIENCE, V290, P627; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Sargent PB, 2005, J NEUROSCI, V25, P8173, DOI 10.1523/JNEUROSCI.2051-05.2005; Shefi O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021905; Skoglund TS, 2004, NEUROSCI RES, V50, P189, DOI 10.1016/j.neures.2004.06.017; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; van Ooyen A, 2002, NETWORK-COMP NEURAL, V13, P311, DOI 10.1088/0954-898X/13/3/304; vanPelt J, 1997, J THEOR BIOL, V186, P17, DOI 10.1006/jtbi.1996.0341; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Washington SD, 2000, NEUROCOMPUTING, V32, P261, DOI 10.1016/S0925-2312(00)00173-9; Wen Q, 2005, PLOS COMPUT BIOL, V1, P617, DOI 10.1371/journal.pcbi.0010078; Zheng JQ, 1996, J NEUROSCI, V16, P1140	48	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3782	10.1371/journal.pone.0003782	http://dx.doi.org/10.1371/journal.pone.0003782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023423	Green Submitted, Green Published, gold			2022-12-25	WOS:000265448800003
J	Sun, H; Skogerbo, G; Wang, Z; Liu, W; Li, YX				Sun, Hong; Skogerbo, Geir; Wang, Zhen; Liu, Wei; Li, Yixue			Structural Relationships between Highly Conserved Elements and Genes in Vertebrate Genomes	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; NONCODING ELEMENTS; SEGMENTAL DUPLICATIONS; MOUSE; IDENTIFICATION; EXPRESSION; SEQUENCES; DELETION; REGIONS; LOCUS	Large numbers of sequence elements have been identified to be highly conserved among vertebrate genomes. These highly conserved elements (HCEs) are often located in or around genes that are involved in transcription regulation and early development. They have been shown to be involved in cis-regulatory activities through both in vivo and additional computational studies. We have investigated the structural relationships between such elements and genes in six vertebrate genomes human, mouse, rat, chicken, zebrafish and tetraodon and detected several thousand cases of conserved HCE-gene associations, and also cases of HCEs with no common target genes. A few examples underscore the potential significance of our findings about several individual genes. We found that the conserved association between HCE/HCEs and gene/genes are not restricted to elements by their absolute distance on the genome. Notably, long-range associations were identified and the molecular functions of the associated genes do not show any particular overrepresentation of the functional categories previously reported. HCEs in close proximity are found to be linked with different set of gene/genes. The results reflect the highly complex correlation between HCEs and their putative target genes.	[Sun, Hong; Wang, Zhen; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Sun, Hong; Liu, Wei] Wyeth Res, Cambridge, MA USA; [Sun, Hong; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Skogerbo, Geir] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Bioinformat Lab, Beijing 100864, Peoples R China; [Sun, Hong] Zhongxin Biotechnol Shanghai Co Ltd, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Pfizer; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS	Sun, H (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	wliu@wyeth.com; yxli@sibs.ac.cn			Wyeth-Zhongxin Joint postdoctoral program; National High-Tech R&D Program [2006AA02Z334, 2007AA02Z330]; National Basic Research Program of China [2006CB910700, 2003CB715901]; Key Research Program [KSCX2-YW-R-112]; Shanghai Committee of Science and Technology [07JC14048]	Wyeth-Zhongxin Joint postdoctoral program; National High-Tech R&D Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Key Research Program; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	Hong Sun is supported by Wyeth-Zhongxin Joint postdoctoral program. This work is supported by grants National High-Tech R&D Program (863) (2006AA02Z334, 2007AA02Z330), National Basic Research Program of China (2006CB910700, 2003CB715901), Key Research Program (CAS) KSCX2-YW-R-112 and the Shanghai Committee of Science and Technology (07JC14048).	Ahituv N, 2005, HUM MOL GENET, V14, P3057, DOI 10.1093/hmg/ddi338; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Bachman NJ, 1999, MAMM GENOME, V10, P506, DOI 10.1007/s003359901031; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Bonferroni C., 1936, PUBBL R 1 SUPER SCI, V8, P3; Bourque G, 2005, GENOME RES, V15, P98, DOI 10.1101/gr.3002305; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Dirksen WP, 2000, J BIOL CHEM, V275, P29170, DOI 10.1074/jbc.M001126200; Dubourg O, 2006, NEUROMOL MED, V8, P75, DOI 10.1385/NMM:8:1:75; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kikuchi M, 2000, ONCOGENE, V19, P4941, DOI 10.1038/sj.onc.1203864; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kim SY, 2007, PLOS GENET, V3, P1572, DOI 10.1371/journal.pgen.0030147; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lin CJ, 2001, J IMMUNOL, V166, P6134, DOI 10.4049/jimmunol.166.10.6134; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; Nagase T, 2000, DNA RES, V7, P143, DOI 10.1093/dnares/7.2.143; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stephen S, 2008, MOL BIOL EVOL, V25, P402, DOI 10.1093/molbev/msm268; Sun H, 2006, HUM MOL GENET, V15, P2911, DOI 10.1093/hmg/ddl232; Varon R, 2003, NAT GENET, V35, P185, DOI 10.1038/ng1243; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Veeramachaneni V, 2004, GENOME RES, V14, P280, DOI 10.1101/gr.1590904; WILLIAMS T, 1986, NATURE, V322, P275, DOI 10.1038/322275a0; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	39	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3727	10.1371/journal.pone.0003727	http://dx.doi.org/10.1371/journal.pone.0003727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19008958	gold, Green Published, Green Submitted			2022-12-25	WOS:000265166400005
J	Arnold, T; Zeth, K; Linke, D				Arnold, Thomas; Zeth, Kornelius; Linke, Dirk			Structure and Function of Colicin S4, a Colicin with a Duplicated Receptor-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING COLICINS; MEMBRANE PROTEIN OMPW; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSLOCATION DOMAIN; CELL ENTRY; MODEL; MECHANISM; INSERTION; RECRUITMENT	Colicins are plasmid-encoded toxic proteins produced by Escherichia coli strains to kill other E. coli strains that lack the corresponding immunity protein. Colicins intrude into the host cell by exploiting existing transport, diffusion, or efflux systems. We have traced the way colicin S4 takes to execute its function and show that it interacts specifically with OmpW, OmpF, and the Tol system before it inserts its pore-forming domain into the cytoplasmic membrane. The common structural architecture of colicins comprises a translocation, a receptor-binding, and an activity domain. We have solved the crystal structure of colicin S4 to a resolution of 2.5 A, which shows a remarkably compact domain arrangement of four independent domains, including a unique domain duplication of the receptor-binding domain. Finally, we have determined the residues responsible for binding to the receptor OmpW by mutating exposed charged residues in one or both receptor-binding domains.	[Arnold, Thomas; Zeth, Kornelius; Linke, Dirk] Max Planck Inst Dev Biol, Dept 1, D-72076 Tubingen, Germany	Max Planck Society	Zeth, K (corresponding author), Max Planck Inst Dev Biol, Dept 1, Spemannstr 35, D-72076 Tubingen, Germany.	kornelius.zeth@tuebingen.mpg.de; dirk.linke@tuebingen.mpg.de	Linke, Dirk/F-9147-2010	Linke, Dirk/0000-0003-3150-6752	Max Planck Society; German Science Foundation [SFB766/B4]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation(German Research Foundation (DFG))	This work was supported by the Max Planck Society and by German Science Foundation Grant SFB766/B4. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albrecht R, 2006, ACTA CRYSTALLOGR F, V62, P415, DOI 10.1107/S1744309106010190; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Braun V, 2006, ACS CHEM BIOL, V1, P352, DOI 10.1021/cb600256k; Cao Z, 2002, BIOCHIMIE, V84, P399, DOI 10.1016/S0300-9084(02)01455-4; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CAVARD D, 1991, J BACTERIOL, V173, P191, DOI 10.1128/jb.173.1.191-196.1991; CAVARD D, 1990, J BACTERIOL, V172, P648, DOI 10.1128/jb.172.2.648-652.1990; Cheng YS, 2006, J MOL BIOL, V356, P22, DOI 10.1016/j.jmb.2005.11.056; Clavel T, 1998, MOL MICROBIOL, V29, P359, DOI 10.1046/j.1365-2958.1998.00945.x; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; COLLARINI M, 1987, EUR BIOPHYS J BIOPHY, V14, P147, DOI 10.1007/BF00253839; Collins ES, 2002, J MOL BIOL, V318, P787, DOI 10.1016/S0022-2836(02)00036-0; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIDSON VL, 1984, J MEMBRANE BIOL, V79, P105, DOI 10.1007/BF01872115; de Zamaroczy M, 2002, BIOCHIMIE, V84, P423, DOI 10.1016/S0300-9084(02)01426-8; Delcour AH, 2003, FRONT BIOSCI-LANDMRK, V8, pD1055, DOI 10.2741/1132; Deprez C, 2002, BIOCHEMISTRY-US, V41, P2589, DOI 10.1021/bi0157262; Duche D, 2002, BIOCHIMIE, V84, P455, DOI 10.1016/S0300-9084(02)01424-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gillor O, 2008, MICROBIOL-SGM, V154, P1783, DOI 10.1099/mic.0.2007/016139-0; Gratia A, 1925, CR SOC BIOL, V93, P1040; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kienker PK, 1997, J MEMBRANE BIOL, V157, P27, DOI 10.1007/s002329900213; Kleanthous C, 1998, MOL MICROBIOL, V28, P227, DOI 10.1046/j.1365-2958.1998.00811.x; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; Lakey JH, 2001, CURR TOP MICROBIOL, V257, P131; Lazzaroni JC, 2002, BIOCHIMIE, V84, P391, DOI 10.1016/S0300-9084(02)01419-0; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; Loftus SR, 2006, P NATL ACAD SCI USA, V103, P12353, DOI 10.1073/pnas.0603433103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pilsl H, 1999, J BACTERIOL, V181, P3578, DOI 10.1128/JB.181.11.3578-3581.1999; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; RILEY MA, 1993, MOL BIOL EVOL, V10, P1048; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; SONG HY, 1991, J BACTERIOL, V173, P2927, DOI 10.1128/JB.173.9.2927-2934.1991; SUN TP, 1986, J BACTERIOL, V165, P107, DOI 10.1128/jb.165.1.107-115.1986; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vetter IR, 1998, STRUCTURE, V6, P863, DOI 10.1016/S0969-2126(98)00088-4; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zakharov SD, 2004, BIOPHYS J, V87, P3901, DOI 10.1529/biophysj.104.046151; Zakharov SD, 2004, FRONT BIOSCI-LANDMRK, V9, P1311, DOI 10.2741/1334; Zakharov SD, 2002, BBA-BIOMEMBRANES, V1565, P333, DOI 10.1016/S0005-2736(02)00579-5; Zakharov SD, 2002, BIOCHIMIE, V84, P465, DOI 10.1016/S0300-9084(02)01453-0; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200	58	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6403	6413		10.1074/jbc.M808504200	http://dx.doi.org/10.1074/jbc.M808504200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19056731	Green Published, hybrid			2022-12-25	WOS:000263742700043
J	Sarg, B; Chwatal, S; Talasz, H; Lindner, HH				Sarg, Bettina; Chwatal, Sabine; Talasz, Heribert; Lindner, Herbert H.			Testis-specific Linker Histone H1t Is Multiply Phosphorylated during Spermatogenesis IDENTIFICATION OF PHOSPHORYLATION SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; AGE-DEPENDENT DEAMIDATION; SPERMATIDAL PROTEIN TP2; CELL-SPECIFIC VARIANT; C-TERMINAL DOMAIN; DNA CONDENSATION; RAT TESTIS; CAPILLARY ELECTROPHORESIS; MAMMALIAN SPERMIOGENESIS; MOUSE SPERMATOGENESIS	During normal spermatogenesis, the testis-specific linker histone H1t appears at pachytene stage becomes phosphorylated in early spermatids and disappears in late spermatids. Using reversed-phase and hydrophilic interaction liquid chromatography, H1t from rat and mouse testes was isolated, subjected to enzymatic digestion, and analyzed by mass spectrometry. We observed different phosphorylated states of H1t (mono-, di-, and triphosphorylated) as well as the unphosphorylated protein. Tandem mass spectrometry and immobilized metal ion affinity chromatography experiments with MS/MS/MS and multistage activation were utilized to identify five phosphorylation sites on H1t from rats. Phosphorylation occurs on both serine and threonine residues, whereas only two of these sites were located on peptides containing the CDK consensus motif (S/T) PXZ. Rat H1t phosphorylation starts first by phosphorylation of the non-consensus motif SPKS in the COOH-terminal domain, namely at Ser-140 and to a smaller degree at a further nonconsensus motif at Ser-186. This is followed by phosphorylation of Ser-177 and Thr-155, both located in CDK consensus motifs. A single phosphorylation site at Ser-8 in the NH2-terminal tail was also found. Mouse H1t lacks Ser-186 and is phosphorylated at up to four sites. In contrast to somatic linker histones, no strict order of increasing phosphorylation could be detected in H1t. Thus, it appears that not the order of up-phosphorylation but the number of the phosphate groups is necessary for regulated chromatin decondensation, thus facilitating the substitution of H1t by transition proteins and protamines.	[Sarg, Bettina; Chwatal, Sabine; Talasz, Heribert; Lindner, Herbert H.] Innsbruck Med Univ, Div Clin Biochem, Bioctr, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Lindner, HH (corresponding author), Innsbruck Med Univ, Div Clin Biochem, Bioctr, Fritz Pregl Str 3, A-6020 Innsbruck, Austria.	herbert.lindner@i-med.ac.at			European Science Foundation EUROCORES Programme EuroDYNA; Austrian Science Foundation [I23-B03]	European Science Foundation EUROCORES Programme EuroDYNA(European Science Foundation (ESF)); Austrian Science Foundation(Austrian Science Fund (FWF))	This work, as part of the European Science Foundation EUROCORES Programme EuroDYNA, was supported by funds from Austrian Science Foundation Project I23-B03. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adham IM, 2001, MOL HUM REPROD, V7, P513, DOI 10.1093/molehr/7.6.513; BABA T, 1994, J BIOL CHEM, V269, P10133; CHIRAT F, 1991, EUR J BIOCHEM, V198, P13, DOI 10.1111/j.1432-1033.1991.tb15980.x; CHIRAT F, 1993, BIOCHIM BIOPHYS ACTA, V1203, P109, DOI 10.1016/0167-4838(93)90043-Q; Cobb J, 1999, CHROMOSOMA, V108, P412, DOI 10.1007/s004120050393; COLE KD, 1986, J BIOL CHEM, V261, P7178; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; DELUCIA F, 1994, BIOCHEM BIOPH RES CO, V198, P32, DOI 10.1006/bbrc.1994.1005; Doenecke D, 1997, HISTOCHEM CELL BIOL, V107, P1, DOI 10.1007/s004180050083; Drabent B, 2000, HISTOCHEM CELL BIOL, V113, P433; DRABENT B, 1993, BIOCHIM BIOPHYS ACTA, V1216, P311, DOI 10.1016/0167-4781(93)90162-7; Fantz DA, 2001, BIOL REPROD, V64, P425, DOI 10.1095/biolreprod64.2.425; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; GREEN GR, 1994, MOL REPROD DEV, V37, P255, DOI 10.1002/mrd.1080370303; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; KISTLER WS, 1987, ANN NY ACAD SCI, V513, P102, DOI 10.1111/j.1749-6632.1987.tb25001.x; Krishnamoorthy T, 2006, GENE DEV, V20, P2580, DOI 10.1101/gad.1457006; LEBLOND CP, 1952, ANN NY ACAD SCI, V55, P548, DOI 10.1111/j.1749-6632.1952.tb26576.x; LENNOX RW, 1984, DEV BIOL, V103, P80, DOI 10.1016/0012-1606(84)90009-5; Lin QC, 2000, MOL CELL BIOL, V20, P2122, DOI 10.1128/MCB.20.6.2122-2128.2000; LINDNER H, 1986, J CHROMATOGR, V357, P301, DOI 10.1016/S0021-9673(01)95832-7; Lindner H, 1996, J CHROMATOGR A, V743, P137, DOI 10.1016/0021-9673(96)00131-8; LINDNER H, 1992, BIOCHEM J, V283, P467, DOI 10.1042/bj2830467; Lindner H, 1997, J CHROMATOGR A, V782, P55, DOI 10.1016/S0021-9673(97)00468-8; LINDNER H, 1986, ANAL BIOCHEM, V158, P424, DOI 10.1016/0003-2697(86)90570-1; LINDNER H, 1990, CHROMATOGRAPHIA, V30, P518, DOI 10.1007/BF02269797; LINDNER H, 1990, BIOCHEM J, V269, P359, DOI 10.1042/bj2690359; Lindner H, 1999, J CANCER RES CLIN, V125, P182, DOI 10.1007/s004320050261; LINDNER H, 1993, ELECTROPHORESIS, V14, P480, DOI 10.1002/elps.1150140174; Lindner H, 1998, J BIOL CHEM, V273, P13324, DOI 10.1074/jbc.273.21.13324; LINDNER H, 1995, ELECTROPHORESIS, V16, P604, DOI 10.1002/elps.1150160197; Lindner Herbert, 2003, J Capill Electrophor Microchip Technol, V8, P59; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; MARUSHIGE Y, 1975, J BIOL CHEM, V250, P39; Meetei AR, 2002, BIOCHEMISTRY-US, V41, P185, DOI 10.1021/bi0117652; MEISTRICH ML, 1992, MOL REPROD DEV, V31, P170, DOI 10.1002/mrd.1080310303; MEISTRICH ML, 1994, BIOL REPROD, V51, P334, DOI 10.1095/biolreprod51.2.334; MEISTRICH ML, 1985, DEV BIOL, V112, P230, DOI 10.1016/0012-1606(85)90137-X; MEISTRICH ML, 1978, FED PROC, V37, P2522; MEISTRICH ML, 1989, HISTONES OTHER BASIC; Nayernia K, 2005, MOL REPROD DEV, V70, P406, DOI 10.1002/mrd.20227; Nayernia K, 2003, CYTOGENET GENOME RES, V103, P314, DOI 10.1159/000076819; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rabini S, 2000, EXP CELL RES, V255, P114, DOI 10.1006/excr.1999.4767; Rathke C, 2007, J CELL SCI, V120, P1689, DOI 10.1242/jcs.004663; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roque A, 2008, NUCLEIC ACIDS RES, V36, P4719, DOI 10.1093/nar/gkn440; Rousseaux S, 2005, GENE, V345, P139, DOI 10.1016/j.gene.2004.12.004; Sarg B, 2006, J BIOL CHEM, V281, P6573, DOI 10.1074/jbc.M508957200; Sarg B, 2004, J BIOL CHEM, V279, P53458, DOI 10.1074/jbc.M409099200; Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200; Sarg B, 1999, ARCH BIOCHEM BIOPHYS, V372, P333, DOI 10.1006/abbi.1999.1503; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SHIRES A, 1976, J BIOL CHEM, V251, P4155; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; TROSTLEWEIGE PK, 1982, J BIOL CHEM, V257, P5560; TROSTLEWEIGE PK, 1984, J BIOL CHEM, V259, P8769; Ullas KS, 2003, J BIOL CHEM, V278, P52673, DOI 10.1074/jbc.M308365200; Vila R, 2001, J BIOL CHEM, V276, P46429, DOI 10.1074/jbc.M106952200; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Yan W, 2003, P NATL ACAD SCI USA, V100, P10546, DOI 10.1073/pnas.1837812100; Zhu DH, 1997, DEVELOPMENT, V124, P3007	70	26	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3610	3618		10.1074/jbc.M805925200	http://dx.doi.org/10.1074/jbc.M805925200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19043117	hybrid			2022-12-25	WOS:000262872500029
J	Ter-Avetisyan, G; Tuennemann, G; Nowak, D; Nitschke, M; Herrmann, A; Drab, M; Cardoso, MC				Ter-Avetisyan, Gohar; Tuennemann, Gisela; Nowak, Danny; Nitschke, Matthias; Herrmann, Andreas; Drab, Marek; Cardoso, M. Cristina			Cell Entry of Arginine-rich Peptides Is Independent of Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAT-FUSION PROTEINS; CLATHRIN-DEPENDENT ENDOCYTOSIS; HUMAN IMMUNODEFICIENCY VIRUS; PENETRATING PEPTIDES; IN-VIVO; MAMMALIAN-CELLS; LOW-TEMPERATURE; CARGO DELIVERY; DRUG-DELIVERY; COATED PITS	Arginine-rich peptides are a subclass of cell-penetrating peptides that are taken up by living cells and can be detected freely diffusing inside the cytoplasm and nucleoplasm. This phenomenon has been attributed to either an endocytic mode of uptake and a subsequent release from vesicles or to direct membrane penetration (transduction). To distinguish between both possibilities, we have blocked endocytic pathways suggested to be involved in uptake of cell-penetrating peptides. We have then monitored by confocal microscopy the uptake and distribution of the cell-penetrating transactivator of transcription (TAT) peptide into living mammalian cells over time. To prevent side effects of chemical inhibitors, we used genetically engineered cells as well as different temperature. We found that a knock-down of clathrin-mediated endocytosis and a knock-out of caveolin-mediated endocytosis did not affect the ability of TAT to enter cells. In addition, the TAT peptide showed the same intracellular distribution throughout the cytoplasm and nucleus as in control cells. Even incubation of cells at 4 degrees C did not abrogate TAT uptake nor change its intracellular distribution. We therefore conclude that this distribution results from TAT peptide that directly penetrated (transduced) the plasma membrane. The formation of nonselective pores is unlikely, because simultaneously added fluorophores were not taken up together with the TAT peptide. In summary, although the frequency and kinetics of TAT transduction varied between cell types, it was independent of endocytosis.	[Ter-Avetisyan, Gohar; Tuennemann, Gisela; Nowak, Danny; Cardoso, M. Cristina] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Nitschke, Matthias; Herrmann, Andreas] Humboldt Univ, Dept Biol Biophys, D-10115 Berlin, Germany; [Drab, Marek] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, D-64287 Darmstadt, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Max Planck Society; Technical University of Darmstadt	Cardoso, MC (corresponding author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.	Cardoso@bio.tu-darmstadt.de	Drab, Marek/J-5196-2013; Drab, Marek/AAQ-1892-2020; Cardoso, M. Cristina/F-5215-2011	Drab, Marek/0000-0002-2771-1692; Ter-Avetisyan, Gohar/0000-0003-2751-1938; Lattig, Gisela/0000-0001-6485-1136	Deutsche Forschungsgemeinschaft; Volkswagen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Volkswagen Foundation (to M. C. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Astriab-Fisher A, 2002, PHARMACEUT RES, V19, P744, DOI 10.1023/A:1016136328329; Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790; Dietz Gunnar P. H., 2007, V399, P181, DOI 10.1007/978-1-59745-504-6_13; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Ho A, 2001, CANCER RES, V61, P474; Iversen TG, 2003, P NATL ACAD SCI USA, V100, P5175, DOI 10.1073/pnas.0534231100; Iwasa A, 2006, BBA-BIOMEMBRANES, V1758, P713, DOI 10.1016/j.bbamem.2006.04.015; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kawamura KS, 2006, BIOCHEMISTRY-US, V45, P1116, DOI 10.1021/bi051338e; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MARSHAK DR, 1985, BIOCHEMISTRY-US, V24, P144, DOI 10.1021/bi00322a020; Martin-Acebes MA, 2007, VIROLOGY, V369, P105, DOI 10.1016/j.virol.2007.07.021; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Nitschke M, 2008, VIROLOGY, V377, P248, DOI 10.1016/j.virol.2008.04.041; Nori A, 2003, BIOCONJUGATE CHEM, V14, P44, DOI 10.1021/bc0255900; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rothbard JB, 2002, J MED CHEM, V45, P3612, DOI 10.1021/jm0105676; Saalik P, 2004, BIOCONJUGATE CHEM, V15, P1246, DOI 10.1021/bc049938y; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Seeman P, 2002, CAN J PSYCHIAT, V47, P27, DOI 10.1177/070674370204700106; Shibagaki N, 2002, J IMMUNOL, V168, P2393, DOI 10.4049/jimmunol.168.5.2393; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Torchilin VP, 2001, P NATL ACAD SCI USA, V98, P8786, DOI 10.1073/pnas.151247498; Torgersen ML, 2001, J CELL SCI, V114, P3737; Tuunnemann G, 2008, J PEPT SCI, V14, P469, DOI 10.1002/psc.968; Tunnemann G, 2007, J MOL MED-JMM, V85, P1405, DOI 10.1007/s00109-007-0238-6; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	53	175	179	2	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3370	3378		10.1074/jbc.M805550200	http://dx.doi.org/10.1074/jbc.M805550200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19047062	Green Published, hybrid			2022-12-25	WOS:000262872500002
J	Fischer, A; Baljuls, A; Reinders, J; Nekhoroshkova, E; Sibilski, C; Metz, R; Albert, S; Rajalingam, K; Hekman, M; Rapp, UR				Fischer, Andreas; Baljuls, Angela; Reinders, Joerg; Nekhoroshkova, Elena; Sibilski, Claudia; Metz, Renate; Albert, Stefan; Rajalingam, Krishnaraj; Hekman, Mirko; Rapp, Ulf R.			Regulation of RAF Activity by 14-3-3 Proteins RAF KINASES ASSOCIATE FUNCTIONALLY WITH BOTH HOMO- AND HETERODIMERIC FORMS OF 14-3-3 PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; B-RAF; C-RAF; PHOSPHORYLATION SITES; IN-VIVO; A-RAF; POLYACRYLAMIDE-GELS; BIOLOGICAL-ACTIVITY; BINDING-SITES; CAUSE NOONAN	Mammalian 14-3-3 proteins play a crucial role in the activation process of RAF kinases. However, little is known about the selectivity of the mammalian 14-3-3 isoforms with respect to RAF association and activation. Using mass spectrometry, we analyzed the composition of the 14-3-3 isoforms attached to RAF kinases and found that B-RAF associates in vivo with 14-3-3 at much higher diversity than A- and C-RAF. We also examined in vitro binding of purified mammalian 14-3-3 proteins to RAF kinases using surface plasmon resonance techniques. While B- and C-RAF exhibited binding to all seven 14-3-3 isoforms, A- RAF bound with considerably lower affinities to epsilon, tau, and sigma 14-3-3. These findings indicate that 14-3-3 proteins associate with RAF isoforms in a pronounced isoform-specific manner. Because 14-3-3 proteins appear in dimeric forms, we addressed the question of whether both homo-and heterodimeric forms of 14-3-3 proteins participate in RAF signaling. For that purpose, the budding yeast Saccharomyces cerevisiae, possessing only two 14-3-3 isoforms (BMH1 and BMH2), served as testing system. By deletion of the single BMH2 gene, we found that both homo-and heterodimeric forms of 14-3-3 can participate in RAF activation. Furthermore, we show that A-, B-, and C-RAF activity is differentially regulated by its C-terminal and internal 14-3-3 binding domain. Finally, prohibitin, a scaffold protein that affects C-RAF activation in a stimulatory manner, proved to interfere with the internal 14-3-3 binding site in C-RAF. Together, our results shed more light on the complex mechanism of RAF activation, particularly with respect to activation steps that are mediated by 14-3-3 proteins and prohibitin.	[Fischer, Andreas; Baljuls, Angela; Nekhoroshkova, Elena; Sibilski, Claudia; Metz, Renate; Albert, Stefan; Hekman, Mirko; Rapp, Ulf R.] Univ Wurzburg, Bayer Krebsforschungszentrum, D-97078 Wurzburg, Germany; [Reinders, Joerg] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Rajalingam, Krishnaraj] Univ Frankfurt, Sch Med, Inst Biochem 2, Deutsch Forsch Gemeinschaft,Emmy Noether Grp, D-60596 Frankfurt, Germany	University of Wurzburg; University of Regensburg; Goethe University Frankfurt	Rapp, UR (corresponding author), Univ Wurzburg, Bayer Krebsforschungszentrum, Versbacherstr 5, D-97078 Wurzburg, Germany.	rappur@mail.uni-wuerzburg.de	Rajalingam, krishnaraj/D-3081-2011	Reinders, Joerg/0000-0003-1025-7849	Deutsche Forschungsgemeinschaft [487, C3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487, project C3. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Baljuls A, 2008, J BIOL CHEM, V283, P27239, DOI 10.1074/jbc.M801782200; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; Brummer T, 2006, ONCOGENE, V25, P6262, DOI 10.1038/sj.onc.1209640; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2005, FEBS LETT, V579, P464, DOI 10.1016/j.febslet.2004.11.105; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; LUO ZJ, 1995, J BIOL CHEM, V270, P23681, DOI 10.1074/jbc.270.40.23681; MARTIN H, 1993, FEBS LETT, V331, P296, DOI 10.1016/0014-5793(93)80356-Y; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STEPHENS RM, 1992, MOL CELL BIOL, V12, P3733, DOI 10.1128/MCB.12.9.3733; SUEN KL, 1995, ONCOGENE, V11, P825; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Williams JG, 2000, J BIOL CHEM, V275, P22172, DOI 10.1074/jbc.M000397200; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	55	64	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3183	3194		10.1074/jbc.M804795200	http://dx.doi.org/10.1074/jbc.M804795200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049963	hybrid			2022-12-25	WOS:000262700900062
J	Rust, C; Wild, N; Bernt, C; Vennegeerts, T; Wimmer, R; Beuers, U				Rust, Christian; Wild, Nadine; Bernt, Carina; Vennegeerts, Timo; Wimmer, Ralf; Beuers, Ulrich			Bile Acid-induced Apoptosis in Hepatocytes Is Caspase-6-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED APOPTOSIS; SALT-INDUCED APOPTOSIS; GROWTH-FACTOR RECEPTOR; URSODEOXYCHOLIC ACID; RAT HEPATOCYTES; HEPATOMA-CELLS; FAS; ACTIVATION; LIVER; CD95	Apoptosis induced by hydrophobic bile acids is thought to contribute to liver injury during cholestasis. Caspase-6 is an executioner caspase that also appears to have regulatory functions in hematopoetic cell lines. We aimed to elucidate the role of caspase-6 in bile acid-induced apoptosis. The major human hydrophobic bile acid, glycochenodeoxycholic acid (GCDCA, 75 mu mol/liter), rapidly induced caspase-6 cleavage in HepG2-Ntcp human hepatoma cells. GCDCA-induced, but not tumor necrosis factor alpha-or etoposide-induced activation of effector caspases-3 and -7 was significantly reduced by 50% in caspase-6-deficient HepG2-Ntcp cells as well as in primary rat hepatocytes pretreated with a caspase-6 inhibitor. Inhibition of caspase-9 reduced GCDCA-induced activation of caspase-6, whereas inhibition of caspase-6 reduced activation of caspase-8 placing caspase-6 between caspase-9 and caspase-8. GCDCA also induced apoptosis in Fas-deficient Hep3B-Ntcp and HuH7-Ntcp hepatoma cells. In addition, GCDCA-induced apoptosis was reduced by 50% in FADD-deficient HepG2-Ntcp cells, whereas apoptosis induced by tumor necrosis factor alpha was reduced by 90%. Collectively, these observations suggest that GCDCA can induce hepatocyte apoptosis in the absence of death receptor signaling, presumably by a compensatory mitochondrial pathway. In conclusion, caspase-6 appears to play an important regulatory role in the promotion of bile acid-induced apoptosis as part of a feedback loop.	[Rust, Christian; Wild, Nadine; Bernt, Carina; Vennegeerts, Timo; Wimmer, Ralf] Univ Munich, Dept Med 2, D-81377 Munich, Germany; [Bernt, Carina] Eugenex Biotechnol, CH-8274 Traegerwilen, Switzerland; [Beuers, Ulrich] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 Amsterdam, Netherlands	University of Munich; University of Amsterdam	Beuers, U (corresponding author), Marchioninistr 15, D-81377 Munich, Germany.	christian.rust@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [Ru 743/3-1, Be 1242/5-5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Ru 743/3-1 (to C. R.) and Be 1242/5-5 (to U. B.). Parts of the data were presented at the Annual Meeting of the European Association for the Study of Liver Disease, Vienna, Austria, 2006 (J. Hepatol. 44, S116) and at the Biannual International Bile Acid Meeting, Freiburg, October 7, 2006. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bajt ML, 2000, TOXICOL SCI, V58, P109, DOI 10.1093/toxsci/58.1.109; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bernhard D, 2000, CELL DEATH DIFFER, V7, P834, DOI 10.1038/sj.cdd.4400719; Bernt C, 2006, BIOCHEM BIOPH RES CO, V340, P800, DOI 10.1016/j.bbrc.2005.12.081; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Glasova H, 2002, EUR J CLIN INVEST, V32, P437, DOI 10.1046/j.1365-2362.2002.01002.x; Higuchi H, 2001, J BIOL CHEM, V276, P38610, DOI 10.1074/jbc.M105300200; Hofmann AF, 2002, LIVER, V22, P14, DOI 10.1034/j.1600-0676.2002.00002.x; Jian S, 1999, HEPATOLOGY, V29, P101, DOI 10.1002/hep.510290102; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Loegering DA, 2006, CELL DEATH DIFFER, V13, P346, DOI 10.1038/sj.cdd.4401791; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Reinehr R, 2004, J BIOL CHEM, V279, P23977, DOI 10.1074/jbc.M401519200; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Rodrigues CMP, 1999, CELL DEATH DIFFER, V6, P842, DOI 10.1038/sj.cdd.4400560; Rust C, 2000, J BIOL CHEM, V275, P20210, DOI 10.1074/jbc.M909992199; Rust C, 2006, GUT, V55, P719, DOI 10.1136/gut.2005.077461; Rust C, 2005, CLIN REV ALLERG IMMU, V28, P135, DOI 10.1385/CRIAI:28:2:135; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SCHMUCKER DL, 1990, HEPATOLOGY, V12, P1216, DOI 10.1002/hep.1840120523; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Sokol TJ, 2005, J PEDIATR GASTR NUTR, V41, P235, DOI 10.1097/01.MPG.0000170600.80640.88; Sola S, 2002, CLIN SCI, V103, P475, DOI 10.1042/CS20020196; Sola S, 2007, CURR ISSUES MOL BIOL, V9, P123; Tourneur Lea, 2005, Med Immunol, V4, P1, DOI 10.1186/1476-9433-4-1; Yoon JH, 2002, J HEPATOL, V37, P400, DOI 10.1016/S0168-8278(02)00209-X	34	68	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2908	2916		10.1074/jbc.M804585200	http://dx.doi.org/10.1074/jbc.M804585200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19017654	hybrid			2022-12-25	WOS:000262700900035
J	Zou, J; Chang, SC; Marjanovic, J; Majerus, PW				Zou, Jun; Chang, Shao-Chun; Marjanovic, Jasna; Majerus, Philip W.			MTMR9 Increases MTMR6 Enzyme Activity, Stability, and Role in Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOTUBULARIN-RELATED PROTEIN-2; MARIE-TOOTH-DISEASE; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CAENORHABDITIS-ELEGANS; PHOSPHATASE; FAMILY; GENE; IDENTIFICATION; SPECIFICITY; MYOPATHY	Myotubularin-related protein 6 (MTMR6) is a catalytically active member of the myotubularin (MTM) family, which is composed of 14 proteins. Catalytically active myotubularins possess 3-phosphatase activity dephosphorylating phosphatidylinositol-3-phoshate and phosphatidylinositol-3,5-bisphosphate, and some members have been shown to form homomers or heteromeric complexes with catalytically inactive myotubularins. We demonstrate that human MTMR6 forms a heteromer with an enzymatically inactive member myotubularin-related protein 9 (MTMR9), both in vitro and in cells. MTMR9 increased the binding of MTMR6 to phospholipids without changing the lipid binding profile. MTMR9 increased the 3-phosphatase activity of MTMR6 up to 6-fold. We determined that MTMR6 is activated up to 28-fold in the presence of phosphatidylserine liposomes. Together, MTMR6 activity in the presence of MTMR9 and assayed in phosphatidylserine liposomes increased 84-fold. Moreover, the formation of this heteromer in cells resulted in increased protein levels of both MTMR6 and MTMR9, probably due to the inhibition of degradation of both proteins. Furthermore, co-expression of MTMR6 and MTMR9 decreased etoposide-induced apoptosis, whereas decreasing both MTMR6 and MTMR9 by RNA interference led to increased cell death in response to etoposide treatment when compared with that seen with RNA interference of MTMR6 alone. Thus, MTMR9 greatly enhances the functions of MTMR6.	[Majerus, Philip W.] Washington Univ, Sch Med, Dept Internal Med, Div Hematol, St Louis, MO 63110 USA; [Chang, Shao-Chun] Eli Lilly & Co, Indianapolis, IN 46825 USA	Washington University (WUSTL); Eli Lilly	Majerus, PW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Hematol, 660 S Euclid Ave,Campus Box 8125, St Louis, MO 63110 USA.	phil@dom.wustl.edu			National Institutes of Health [HL 016634]; American Heart Association [0475014N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016634, R37HL016634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 016634( to P. W. M.). This work was also supported by the American Heart Association Grant 0475014N ( to S. C. C.).	Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Berger P, 2006, HUM MOL GENET, V15, P569, DOI 10.1093/hmg/ddi473; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Biro E, 2005, J THROMB HAEMOST, V3, P2754, DOI 10.1111/j.1538-7836.2005.01646.x; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; CALDWELL KK, 1991, J BIOL CHEM, V266, P18378; Choudhury P, 2006, J BIOL CHEM, V281, P31762, DOI 10.1074/jbc.M606344200; Clague MJ, 2005, TRAFFIC, V6, P1063, DOI 10.1111/j.1600-0854.2005.00338.x; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; Kim SA, 2002, J BIOL CHEM, V277, P4526, DOI 10.1074/jbc.M111087200; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 1998, HUM MOL GENET, V7, P1703, DOI 10.1093/hmg/7.11.1703; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lorenzo O, 2005, J CELL SCI, V118, P2005, DOI 10.1242/jcs.02325; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Nandurkar HH, 2001, P NATL ACAD SCI USA, V98, P9499, DOI 10.1073/pnas.171306098; Robinson FL, 2005, J BIOL CHEM, V280, P31699, DOI 10.1074/jbc.M505159200; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Srivastava S, 2005, MOL CELL BIOL, V25, P3630, DOI 10.1128/MCB.25.9.3630-3638.2005; Srivastava S, 2006, MOL CELL BIOL, V26, P5595, DOI 10.1128/MCB.00352-06; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Taylor GS, 2003, METHOD ENZYMOL, V366, P43; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; Vallat L, 2003, BLOOD, V101, P4598, DOI 10.1182/blood-2002-06-1743; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Verbsky JW, 2005, J BIOL CHEM, V280, P1911, DOI 10.1074/jbc.M411528200; Xue YZ, 2003, J BIOL CHEM, V278, P34380, DOI 10.1074/jbc.M303259200; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zou J, 2007, P NATL ACAD SCI USA, V104, P16834, DOI 10.1073/pnas.0708189104	35	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2064	2071		10.1074/jbc.M804292200	http://dx.doi.org/10.1074/jbc.M804292200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19038970	Green Published, hybrid			2022-12-25	WOS:000262545600014
J	Chen, M; Sinha, M; Luxon, BA; Bresnick, AR; O'Connor, KL				Chen, Min; Sinha, Mala; Luxon, Bruce A.; Bresnick, Anne R.; O'Connor, Kathleen L.			Integrin alpha 6 beta 4 Controls the Expression of Genes Associated with Cell Motility, Invasion, and Metastasis, Including S100A4/Metastasin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; CHEMOTACTIC MIGRATION; LAMELLAE FORMATION; CALCIUM-BINDING; MAMMARY-TUMORS; MTS1 GENE; S100A4; PROGRESSION	The integrin alpha 6 beta 4 is associated with carcinoma progression by contributing to apoptosis resistance, invasion, and metastasis, due in part to the activation of select transcription factors. To identify genes regulated by the alpha 6 beta 4 integrin, we compared gene expression profiles of MDA-MB-435 cells that stably express integrin alpha 6 beta 4 (MDA/beta 4) and vector-only-transfected cells (MDA/mock) using Affymetrix GeneChip (R) analysis. Our results show that integrin alpha 6 beta 4 altered the expression of 538 genes (p < 0.01). Of these genes, 36 are associated with pathways implicated in cell motility and metastasis, including S100A4/metastasin. S100A4 expression correlated well with integrin alpha 6 beta 4 expression in established cell lines. Suppression of S100A4 by small interference RNA resulted in a reduced capacity of alpha 6 beta 4-expressing cells to invade a reconstituted basement membrane in response to lysophosphatidic acid. Using small interference RNA, promoter analysis, and chromatin immuno-precipitation, we demonstrate that S100A4 is regulated by NFAT5, thus identifying the first target of NFAT5 in cancer. In addition, several genes that are known to be regulated by DNA methylation were up-regulated dramatically by integrin alpha 6 beta 4 expression, including S100A4, FST, PDLIM4, CAPG, and Nkx2.2. Notably, inhibition of DNA methyltransferases stimulated expression of these genes in cells lacking the alpha 6 beta 4 integrin, whereas demethylase inhibitors suppressed expression in alpha 6 beta 4 integrin-expressing cells. Alterations in DNA methylation were confirmed by bisulfate sequencing, thus suggesting that integrin alpha 6 beta 4 signaling can lead to the demethylation of select promoters. In summary, our data suggest that integrin alpha 6 beta 4 confers a motile and invasive phenotype to breast carcinoma cells by regulating proinvasive and prometastatic gene expression.	[Chen, Min; O'Connor, Kathleen L.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Sinha, Mala; Luxon, Bruce A.; O'Connor, Kathleen L.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Chen, Min; O'Connor, Kathleen L.] Univ Texas Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; [Bresnick, Anne R.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Yeshiva University; Albert Einstein College of Medicine	O'Connor, KL (corresponding author), Univ Texas Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.	kloconno@utmb.edu	Luxon, Bruce A/C-9140-2012; O'Connor, Kathleen L/H-2569-2013	O'Connor, Kathleen L/0000-0002-1088-9734	National Institutes of Health [R01-CA109136]; University of Texas Medical Branch Gastrointestinal Research Interdisciplinary Research Program; Center for Interdisciplinary Research in Women's Health; Sealy and Smith Foundation; NATIONAL CANCER INSTITUTE [R01CA109136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Medical Branch Gastrointestinal Research Interdisciplinary Research Program; Center for Interdisciplinary Research in Women's Health; Sealy and Smith Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA109136. This work was also supported by the University of Texas Medical Branch Gastrointestinal Research Interdisciplinary Research Program, the Center for Interdisciplinary Research in Women's Health, and the Sealy and Smith Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambartsumian NS, 1996, ONCOGENE, V13, P1621; Bahassi EM, 2004, CLIN EXP METASTAS, V21, P293, DOI 10.1023/B:CLIN.0000046132.46946.dd; Bao X, 2008, VIROLOGY, V374, P114, DOI 10.1016/j.virol.2007.12.024; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; Bonaccorsi L, 2000, ENDOCRINOLOGY, V141, P3172, DOI 10.1210/en.141.9.3172; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Chung J, 2004, J BIOL CHEM, V279, P32287, DOI 10.1074/jbc.M403809200; Cruz-Monserrate Z, 2007, MODERN PATHOL, V20, P656, DOI 10.1038/modpathol.3800782; Davies MPA, 1996, ONCOGENE, V13, P1631; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; FRIEDRICHS K, 1995, CANCER RES, V55, P901; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Grigorian M, 1996, INT J CANCER, V67, P831, DOI 10.1002/(SICI)1097-0215(19960917)67:6<831::AID-IJC13>3.0.CO;2-4; Grossman HB, 2000, ONCOL REP, V7, P13; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hernan R, 2003, CANCER RES, V63, P140; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jenkinson SR, 2004, BRIT J CANCER, V90, P253, DOI 10.1038/sj.bjc.6601483; Jones JL, 1997, EXP CELL RES, V235, P325, DOI 10.1006/excr.1997.3662; Kim EJ, 2003, J BIOL CHEM, V278, P30063, DOI 10.1074/jbc.M304909200; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Liang GN, 2000, CANCER RES, V60, P4907; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Lipscomb EA, 2003, CLIN EXP METASTAS, V20, P569, DOI 10.1023/A:1025819521707; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; Mukhopadhyay R, 1999, CLIN EXP METASTAS, V17, P325; Nakamura N, 1998, CLIN EXP METASTAS, V16, P471; Noh JH, 2006, MOL CELL BIOCHEM, V288, P91, DOI 10.1007/s11010-006-9124-8; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; PRICE JE, 1990, CANCER RES, V50, P717; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Raymond K, 2007, MOL BIOL CELL, V18, P4210, DOI 10.1091/mbc.E06-08-0720; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Ruse M, 2001, BIOCHEMISTRY-US, V40, P3167, DOI 10.1021/bi0019747; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Tagliabue E, 1998, CLIN CANCER RES, V4, P407; TENNENBAUM T, 1993, CANCER RES, V53, P4803; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; TULCHINSKY E, 1992, P NATL ACAD SCI USA, V89, P9146, DOI 10.1073/pnas.89.19.9146; Vanaja DK, 2006, CLIN CANCER RES, V12, P1128, DOI 10.1158/1078-0432.CCR-05-2072; Wade PA, 2001, ONCOGENE, V20, P3166, DOI 10.1038/sj.onc.1204340; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Xue CS, 2003, CANCER RES, V63, P3386; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Yoon SO, 2006, CANCER RES, V66, P6288, DOI 10.1158/0008-5472.CAN-06-0826; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023	58	122	124	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1484	1494		10.1074/jbc.M803997200	http://dx.doi.org/10.1074/jbc.M803997200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19011242	hybrid, Green Published			2022-12-25	WOS:000262330100016
J	Hnia, K; Notarnicola, C; de Santa Barbara, P; Hugon, G; Rivier, F; Laoudj-Chenibvesse, D; Mornet, D				Hnia, Karim; Notarnicola, Cecile; de Santa Barbara, Pascal; Hugon, Gerald; Rivier, Francois; Laoudj-Chenibvesse, Dalila; Mornet, Dominique			Biochemical Properties of Gastrokine-1 Purified from Chicken Gizzard Smooth Muscle	PLOS ONE			English	Article								The potential role and function of gastrokine-1 (GNK1) in smooth muscle cells is investigated in this work by first establishing a preparative protocol to obtain this native protein from freshly dissected chicken gizzard. Some unexpected biochemical properties of gastrokine-1 were deduced by producing specific polyclonal antibody against the purified protein. We focused on the F-actin interaction with gastrokine-1 and the potential role and function in smooth muscle contractile properties. Background: GNK1 is thought to provide mucosal protection in the superficial gastric epithelium. However, the actual role of gastrokine-1 with regards to its known decreased expression in gastric cancer is still unknown. Recently, trefoil factors (TFF) were reported to have important roles in gastric epithelial regeneration and cell turnover, and could be involved in GNK1 interactions. The aim of this study was to evaluate the role and function of GNK1 in smooth muscle cells. Methodology/Principal Findings: From fresh chicken gizzard smooth muscle, an original purification procedure was used to purify a heat soluble 20 kDa protein that was sequenced and found to correspond to the gastrokine-1 protein sequence containing one BRICHOS domain and at least two or possibly three transmembrane regions. The purified protein was used to produce polyclonal antibody and highlighted the smooth muscle cell distribution and F-actin association of GNK1 through a few different methods. Conclusion/Significance: Altogether our data illustrate a broader distribution of gastrokine-1 in smooth muscle than only in the gastrointestinal epithelium, and the specific interaction with F-actin highlights and suggests a new role and function of GNK1 within smooth muscle cells. A potential role via TFF interaction in cell-cell adhesion and assembly of actin stress fibres is discussed.	[Hnia, Karim; Notarnicola, Cecile; de Santa Barbara, Pascal; Hugon, Gerald; Rivier, Francois; Laoudj-Chenibvesse, Dalila; Mornet, Dominique] Univ Montpellier 1, CHU Arnaud de Villeneuve, INSERM, ERI Muscle & Pathol 25,EA 4202, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Hnia, K (corresponding author), Univ Montpellier 1, CHU Arnaud de Villeneuve, INSERM, ERI Muscle & Pathol 25,EA 4202, Montpellier, France.	mornet@montp.inserm.fr	Notarnicola, Cecile/N-9032-2018; de Santa Barbara, Pascal/AAO-5969-2021; de Santa Barbara, Pascal/N-6426-2015; Laoudj-Chenivesse, dalila/N-7097-2018	Notarnicola, Cecile/0000-0001-8363-1614; de Santa Barbara, Pascal/0000-0001-9040-2481; de Santa Barbara, Pascal/0000-0001-9040-2481; HNIA, karim/0000-0001-5298-3000; Laoudj-Chenivesse, dalila/0000-0003-4356-9187	INSERM; University Montpellier1	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Montpellier1	The funders (INSERM and University Montpellier1)have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara PD, 2005, DEV DYNAM, V234, P312, DOI 10.1002/dvdy.20554; BRETSCHER A, 1984, J BIOL CHEM, V259, P2873; Chazalette D, 2005, FEBS LETT, V579, P1079, DOI 10.1016/j.febslet.2004.12.081; DALLALIBERA L, 1990, BIOCHEM BIOPH RES CO, V167, P1249; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; HALLIDAY DC, 2008, GENE EXPR PATTERNS; IKEBE M, 1978, J BIOCHEM, V83, P1643, DOI 10.1093/oxfordjournals.jbchem.a132077; LEVINE BA, 1988, EUR J BIOCHEM, V172, P389, DOI 10.1111/j.1432-1033.1988.tb13899.x; Martin TE, 2003, AM J PHYSIOL-GASTR L, V285, pG332, DOI 10.1152/ajpgi.00453.2002; MORNET D, 1988, BIOCHEM BIOPH RES CO, V154, P564, DOI 10.1016/0006-291X(88)90177-5; MORNET D, 1981, NATURE, V292, P301, DOI 10.1038/292301a0; Moss SF, 2008, CLIN CANCER RES, V14, P4161, DOI 10.1158/1078-0432.CCR-07-4381; Nardone G, 2007, DIGEST LIVER DIS, V39, P122, DOI 10.1016/j.dld.2006.09.017; Oien KA, 2004, J PATHOL, V203, P789, DOI 10.1002/path.1583; Punta M, 2007, METHODS, V41, P460, DOI 10.1016/j.ymeth.2006.07.026; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Shiozaki K, 2001, INT J ONCOL, V19, P701; SOBIESZEK A, 1975, EUR J BIOCHEM, V55, P49, DOI 10.1111/j.1432-1033.1975.tb02137.x; SOBUE K, 1983, P NATL ACAD SCI-BIOL, V80, P6868, DOI 10.1073/pnas.80.22.6868; Sutoh K, 1985, Tanpakushitsu Kakusan Koso, V30, P1290; SUTOH K, 1986, BIOCHEMISTRY-US, V25, P435, DOI 10.1021/bi00350a024; SUTOH K, 1983, BIOCHEMISTRY-US, V22, P1579, DOI 10.1021/bi00276a009; SUTOH K, 1984, BIOCHEMISTRY-US, V23, P1942, DOI 10.1021/bi00304a009; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Toback FG, 2003, AM J PHYSIOL-GASTR L, V285, pG344, DOI 10.1152/ajpgi.00455.2002; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Walsh-Reitz MM, 2005, AM J PHYSIOL-GASTR L, V289, pG163, DOI 10.1152/ajpgi.00013.2005; Yoshihara T, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-75; Yoshikawa Y, 2000, JPN J CANCER RES, V91, P459, DOI 10.1111/j.1349-7006.2000.tb00967.x	29	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3854	10.1371/journal.pone.0003854	http://dx.doi.org/10.1371/journal.pone.0003854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057650	gold, Green Submitted, Green Published			2022-12-25	WOS:000265452300003
J	Kobayashi, T; Morone, N; Kashiyama, T; Oyamada, H; Kurebayashi, N; Murayama, T				Kobayashi, Takuya; Morone, Nobuhiro; Kashiyama, Taku; Oyamada, Hideto; Kurebayashi, Nagomi; Murayama, Takashi			Engineering a Novel Multifunctional Green Fluorescent Protein Tag for a Wide Variety of Protein Research	PLOS ONE			English	Article								Background: Genetically encoded tag is a powerful tool for protein research. Various kinds of tags have been developed: fluorescent proteins for live-cell imaging, affinity tags for protein isolation, and epitope tags for immunological detections. One of the major problems concerning the protein tagging is that many constructs with different tags have to be made for different applications, which is time- and resource-consuming. Methodology/Principal Findings: Here we report a novel multifunctional green fluorescent protein (mfGFP) tag which was engineered by inserting multiple peptide tags, i.e., octa-histidine (86His), streptavidin-binding peptide (SBP), and c-Myc tag, in tandem into a loop of GFP. When fused to various proteins, mfGFP monitored their localization in living cells. Streptavidin agarose column chromatography with the SBP tag successfully isolated the protein complexes in a native form with a high purity. Tandem affinity purification (TAP) with 8xHis and SBP tags in mfGFP further purified the protein complexes. mfGFP was clearly detected by c-Myc-specific antibody both in immunofluorescence and immuno-electron microscopy (EM). These findings indicate that mfGFP works well as a multifunctional tag in mammalian cells. The tag insertion was also successful in other fluorescent protein, mCherry. Conclusions and Significance: The multifunctional fluorescent protein tag is a useful tool for a wide variety of protein research, and may have the advantage over other multiple tag systems in its higher expandability and compatibility with existing and future tag technologies.	[Kobayashi, Takuya; Kashiyama, Taku; Kurebayashi, Nagomi; Murayama, Takashi] Juntendo Univ, Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo 113, Japan; [Morone, Nobuhiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan; [Oyamada, Hideto] Showa Univ, Sch Med, Dept Pharmacol, Tokyo, Japan	Juntendo University; National Center for Neurology & Psychiatry - Japan; Showa University	Kobayashi, T (corresponding author), Juntendo Univ, Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo 113, Japan.	takashim@juntendo.ac.jp		Morone, Nobuhiro/0000-0002-7672-158X	Japan Science and Technology Agency (SENTAN); Japan Society for Promotion of Science [Grants-in-Aid]; Health Labor Sciences Research [NANO-001]	Japan Science and Technology Agency (SENTAN)(Japan Science & Technology Agency (JST)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labor Sciences Research	This work was supported in part by grants from the Japan Science and Technology Agency (SENTAN), Grants-in-Aid for Scientific Research, Japan Society for Promotion of Science, and a Health Labor Sciences Research Grant (NANO-001).	Abedi MR, 1998, NUCLEIC ACIDS RES, V26, P623, DOI 10.1093/nar/26.2.623; Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Fritze CE, 2000, METHOD ENZYMOL, V327, P3, DOI 10.1016/S0076-6879(00)27263-7; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Giraldez T, 2005, J GEN PHYSIOL, V126, P429, DOI 10.1085/jgp.200509368; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Hamilton SL, 2005, CELL CALCIUM, V38, P253, DOI 10.1016/j.ceca.2005.06.037; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Los GV, 2007, METH MOL B, V356, P195; Miyawaki A, 2005, ADV BIOCHEM ENG BIOT, V95, P1, DOI 10.1007/b102208; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Paramban RI, 2004, BIOTECHNOL BIOENG, V86, P687, DOI 10.1002/bit.20077; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Prasad K, 1995, J BIOL CHEM, V270, P30551, DOI 10.1074/jbc.270.51.30551; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Wu CF, 2000, APPL MICROBIOL BIOT, V54, P78, DOI 10.1007/s002539900286; Zhong JQ, 2004, BIOMOL ENG, V21, P67, DOI 10.1016/j.bioeng.2003.10.004	25	35	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3822	10.1371/journal.pone.0003822	http://dx.doi.org/10.1371/journal.pone.0003822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048102	Green Submitted, gold, Green Published			2022-12-25	WOS:000265452000003
J	Tamai, SI; Sanada, K; Fukada, Y				Tamai, So-ichi; Sanada, Kamon; Fukada, Yoshitaka			Time-of-Day-Dependent Enhancement of Adult Neurogenesis in the Hippocampus	PLOS ONE			English	Article								Background: Adult neurogenesis occurs in specific regions of the mammalian brain such as the dentate gyrus of the hippocampus. In the neurogenic region, neural progenitor cells continuously divide and give birth to new neurons. Although biological properties of neurons and glia in the hippocampus have been demonstrated to fluctuate depending on specific times of the day, it is unclear if neural progenitors and neurogenesis in the adult brain are temporally controlled within the day. Methodology/Principal Findings: Here we demonstrate that in the dentate gyrus of the adult mouse hippocampus, the number of M-phase cells shows a day/night variation throughout the day, with a significant increase during the nighttime. The M-phase cell number is constant throughout the day in the subventricular zone of the forebrain, another site of adult neurogenesis, indicating the daily rhythm of progenitor mitosis is region-specific. Importantly, the nighttime enhancement of hippocampal progenitor mitosis is accompanied by a nighttime increase of newborn neurons. Conclusions/Significance: These results indicate that neurogenesis in the adult hippocampus occurs in a time-of-day-dependent fashion, which may dictate daily modifications of dentate gyrus physiology.	[Tamai, So-ichi; Fukada, Yoshitaka] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan; [Sanada, Kamon] Osaka Univ, Grad Sch Med, Dept Dev Neurosci, Suita, Osaka 565, Japan; [Sanada, Kamon] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	University of Tokyo; Osaka University; Japan Science & Technology Agency (JST)	Tamai, SI (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan.	kamon_sanada@neuro.med.osaka-u.ac.jp; sfukada@mail.ecc.u-tokyo.ac.jp	SANADA, YOSHIKADO/G-5014-2014; 吉孝, 深田/G-5090-2014	Sanada, Kamon/0000-0002-0280-8957	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [Grants-in-Aid]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research and for Young Scientist from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Global COE Program "Integrative Life Science Based on the Study of Biosignaling Mechanisms", MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bjarnason GA, 1999, AM J PATHOL, V154, P613, DOI 10.1016/S0002-9440(10)65306-0; Bjarnason GA, 2002, CHRONOBIOL INT, V19, P129, DOI 10.1081/CBI-120002595; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kochman LJ, 2006, NEUROSCI LETT, V406, P256, DOI 10.1016/j.neulet.2006.07.058; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; SCHEVING LE, 1978, ANAT REC, V191, P479, DOI 10.1002/ar.1091910407; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Valentinuzzi VS, 2004, J BIOL RHYTHM, V19, P312, DOI 10.1177/0748730404265688; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368	30	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3835	10.1371/journal.pone.0003835	http://dx.doi.org/10.1371/journal.pone.0003835			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048107	Green Published, gold, Green Submitted			2022-12-25	WOS:000265452000008
J	Bem, T; Meyrand, P; Branchereau, P; Hallam, J				Bem, Tiaza; Meyrand, Pierre; Branchereau, Pascal; Hallam, John			Multi-Stability and Pattern-Selection in Oscillatory Networks with Fast Inhibition and Electrical Synapses	PLOS ONE			English	Article								A model or hybrid network consisting of oscillatory cells interconnected by inhibitory and electrical synapses may express different stable activity patterns without any change of network topology or parameters, and switching between the patterns can be induced by specific transient signals. However, little is known of properties of such signals. In the present study, we employ numerical simulations of neural networks of different size composed of relaxation oscillators, to investigate switching between in-phase (IP) and anti-phase (AP) activity patterns. We show that the time windows of susceptibility to switching between the patterns are similar in 2-, 4- and 6-cell fully-connected networks. Moreover, in a network (N = 4, 6) expressing a given AP pattern, a stimulus with a given profile consisting of depolarizing and hyperpolarizing signals sent to different subpopulations of cells can evoke switching to another AP pattern. Interestingly, the resulting pattern encodes the profile of the switching stimulus. These results can be extended to different network architectures. Indeed, relaxation oscillators are not only models of cellular pacemakers, bursting or spiking, but are also analogous to firing-rate models of neural activity. We show that rules of switching similar to those found for relaxation oscillators apply to oscillating circuits of excitatory cells interconnected by electrical synapses and cross-inhibition. Our results suggest that incoming information, arriving in a proper time window, may be stored in an oscillatory network in the form of a specific spatio-temporal activity pattern which is expressed until new pertinent information arrives.	[Bem, Tiaza] Polish Acad Sci, Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Meyrand, Pierre; Branchereau, Pascal] Univ Bordeaux 1, CNRS, UMR 5228, Ctr Neurosci Integratives Cognitives, F-33405 Talence, France; [Hallam, John] Univ So Denmark, Maersk Mc Kinney Moller Inst, Odense, Denmark	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Southern Denmark	Bem, T (corresponding author), Polish Acad Sci, Inst Biocybernet & Biomed Engn, Warsaw, Poland.	tiaza.bem@ibib.waw.pl	Branchereau, Pascal/B-9206-2011; Bem, Tiaza/N-1841-2016	Branchereau, Pascal/0000-0003-3972-8229; 	MNiSW; Danish Agency for Science, Technology and Innovation [274-06-0292]; Conseil Regional d'Aquitaine	MNiSW(Ministry of Science and Higher Education, Poland); Danish Agency for Science, Technology and Innovation; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This study was supported by MNiSW (status grant 18/st, TB), Danish Agency for Science, Technology and Innovation" (TB and JH grant number 274-06-0292), Conseil Regional d'Aquitaine (PM and PB).	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Aramaki Y, 2006, CEREB CORTEX, V16, P1338, DOI 10.1093/cercor/bhj075; Bem T, 2005, EUR J NEUROSCI, V22, P2661, DOI 10.1111/j.1460-9568.2005.04405.x; Bem T, 2004, J NEUROPHYSIOL, V91, P693, DOI 10.1152/jn.00783.2003; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Durstewitz D, 2006, NEUROSCIENCE, V139, P119, DOI 10.1016/j.neuroscience.2005.06.094; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hultborn H, 2004, PROG BRAIN RES, V143, P77, DOI 10.1016/S0079-6123(03)43008-2; Jirsa VK, 1998, NEURAL COMPUT, V10, P2019, DOI 10.1162/089976698300016954; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Merriam EB, 2005, J NEUROSCI, V25, P6175, DOI 10.1523/JNEUROSCI.0512-05.2005; Meyer-Lindenberg A, 2002, P NATL ACAD SCI USA, V99, P10948, DOI 10.1073/pnas.162114799; MEYRAND P, 1991, NATURE, V351, P60, DOI 10.1038/351060a0; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; ROWAT PF, 1993, J NEUROPHYSIOL, V70, P1030, DOI 10.1152/jn.1993.70.3.1030; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Shpiro A, 2007, J NEUROPHYSIOL, V97, P462, DOI 10.1152/jn.00604.2006; Tabak J, 2006, J COMPUT NEUROSCI, V21, P307, DOI 10.1007/s10827-006-8862-7; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Zhang K, 1996, J NEUROSCI, V16, P2112	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3830	10.1371/journal.pone.0003830	http://dx.doi.org/10.1371/journal.pone.0003830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043586	Green Published, gold			2022-12-25	WOS:000265451500009
J	Bartolazzi, A; D'Alessandria, C; Parisella, MG; Signore, A; Del Prete, F; Lavra, L; Braesch-Andersen, S; Massari, R; Trotta, C; Soluri, A; Sciacchitano, S; Scopinaro, F				Bartolazzi, Armando; D'Alessandria, Calogero; Parisella, Maria Gemma; Signore, Alberto; Del Prete, Fabrizio; Lavra, Luca; Braesch-Andersen, Sten; Massari, Roberto; Trotta, Carlo; Soluri, Alessandro; Sciacchitano, Salvatore; Scopinaro, Francesco			Thyroid Cancer Imaging In Vivo by Targeting the Anti-Apoptotic Molecule Galectin-3	PLOS ONE			English	Article							ANTIAPOPTOTIC MOLECULE; CARCINOMA; NODULES; INHIBITION; EXPRESSION; CYTOLOGY; MARKERS; TUMORS; P53	Background: The prevalence of thyroid nodules increases with age, average 4-7% for the U. S. A. adult population, but it is much higher (19-67%) when sub-clinical nodules are considered. About 90% of these lesions are benign and a reliable approach to their preoperative characterization is necessary. Unfortunately conventional thyroid scintigraphy does not allow the distinction among benign and malignant thyroid proliferations but it provides only functional information (cold or hot nodules). The expression of the anti-apoptotic molecule galectin-3 is restricted to cancer cells and this feature has potential diagnostic and therapeutic implications. We show here the possibility to obtain thyroid cancer imaging in vivo by targeting galectin-3. Methods: The galectin-3 based thyroid immuno-scintigraphy uses as radiotracer a specific 99m Tc-radiolabeled mAb. A position-sensitive high-resolution mini-gamma camera was used as imaging capture device. Human galectin-3 positive thyroid cancer xenografts (ARO) and galectin-3 knockout tumors were used as targets in different experiments in vivo. 38 mice with tumor mass of about 1 gm were injected in the tail vein with 100 mu Ci of Tc-99m-labeled mAb to galectin-3 (30 mu g protein/in 100 mu l saline solution). Tumor images were acquired at 1 hr, 3 hrs, 6 hrs, 9 hrs and 24 hrs post injection by using the mini-gamma camera. Findings: Results from different consecutive experiments show an optimal visualization of thyroid cancer xenografts between 6 and 9 hours from injection of the radiotracer. Galectin-3 negative tumors were not detected at all. At 6 hrs post-injection galectin-3 expressing tumors were correctly visualized, while the whole-body activity had essentially cleared. Conclusions: These results demonstrate the possibility to distinguish preoperatively benign from malignant thyroid nodules by using a specific galectin-3 radio-immunotargeting. In vivo imaging of thyroid cancer may allow a better selection of patients referred to surgery. The possibility to apply this method for imaging and treatment of other galectin-3 expressing tumors is also discussed.	[Bartolazzi, Armando; Del Prete, Fabrizio] Karolinska Hosp, Cellular & Mol Tumor Pathol Lab, Canc Ctr Karolinska, S-10401 Stockholm, Sweden; [Bartolazzi, Armando; Del Prete, Fabrizio] St Andrea Univ Hosp, Pathol Res Lab, Rome, Italy; [D'Alessandria, Calogero; Parisella, Maria Gemma; Signore, Alberto; Scopinaro, Francesco] Univ Roma La Sapienza, St Andrea Univ Hosp, Lab Nuclear Med, Rome, Italy; [Lavra, Luca; Sciacchitano, Salvatore] Assoc Fatebenefratelli Ricerca AfaR, S Pietro Fatebenefratelli Hosp, Rome, Italy; [Lavra, Luca; Sciacchitano, Salvatore] Univ Roma La Sapienza, Fac Med 2, Dept Expt Med & Pathol, Rome, Italy; [Braesch-Andersen, Sten] Mabtech Res Lab, Nacka, Sweden; [Massari, Roberto; Trotta, Carlo; Soluri, Alessandro] Natl Council Res, ISIB, Rome, Italy	Karolinska Institutet; Karolinska University Hospital; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR)	Bartolazzi, A (corresponding author), Karolinska Hosp, Cellular & Mol Tumor Pathol Lab, Canc Ctr Karolinska, S-10401 Stockholm, Sweden.	Armando.Bartolazzi@ki.se; Francesco.Scopinaro@uniroma1.it	Signore, Alberto/E-5812-2010; Massari, Roberto/H-7579-2015; Sciacchitano, Salvatore/AAM-5895-2020; Bartolazzi, Armando/K-9708-2016	Signore, Alberto/0000-0001-8923-648X; Massari, Roberto/0000-0001-9266-8910; Sciacchitano, Salvatore/0000-0003-1492-5365; SOLURI, ALESSANDRO/0000-0002-1600-8790; Scopinaro, Francesco/0000-0003-1924-3005; Bartolazzi, Armando/0000-0001-7820-5127	AIRC (Italian Association for Cancer Research)	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro)	Supported by AIRC (Italian Association for Cancer Research). No other sponsors played a role in this paper.	Akahani S, 1997, CANCER RES, V57, P5272; Bartolazzi A, 2000, LANCET, V355, P1661, DOI 10.1016/S0140-6736(00)02233-9; Bartolazzi A, 2001, LANCET, V357, P1644, DOI 10.1016/S0140-6736(00)04817-0; Bartolazzi A, 2008, LANCET ONCOL, V9, P543, DOI 10.1016/S1470-2045(08)70132-3; Becker D, 1996, J NUCL MED, V37, P1264; Carpi A, 2006, BRIT J CANCER, V95, P204, DOI 10.1038/sj.bjc.6603232; Cecchinelli B, 2006, MOL CELL BIOL, V26, P4746, DOI 10.1128/MCB.00959-05; Dalessandria C, 2007, Q J NUCL MED MOL IM, V51, P334; DIVIGI CR, 1996, ONCOLOGY HUNTINGTON, V10, P939; Johnson KD, 2007, NEOPLASIA, V9, P662, DOI 10.1593/neo.07433; Kim HRC, 1999, CANCER RES, V59, P4148; Kumar SR, 2008, J NUCL MED, V49, P796, DOI 10.2967/jnumed.107.048751; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; MATHER SJ, 1990, J NUCL MED, V31, P692; Moiseeva EV, 2005, BREAST CANCER RES TR, V91, P227, DOI 10.1007/s10549-005-0289-8; Moretti F, 1997, ONCOGENE, V14, P729, DOI 10.1038/sj.onc.1200887; Papotti M, 2005, MODERN PATHOL, V18, P541, DOI 10.1038/modpathol.3800321; Prieto VG, 2006, CLIN CANCER RES, V12, P6709, DOI 10.1158/1078-0432.CCR-06-0758; Rosai J., 1992, ATLAS TUMOR PATHOL, P1; Saggiorato E, 2005, ENDOCR-RELAT CANCER, V12, P305, DOI 10.1677/erc.1.00944; Saggiorato E, 2001, J CLIN ENDOCR METAB, V86, P5152, DOI 10.1210/jc.86.11.5152; SCHWEPPE RE, 2008, J CLIN ENDOCRIN 0819; Scopinaro F, 2007, Q J NUCL MED MOL IM, V51, P204; SHI Y, 1993, J CLIN INVEST, V91, P179; Shi YH, 2007, INT J CANCER, V121, P1175, DOI 10.1002/ijc.22848; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Takenaka Y, 2003, CANCER LETT, V195, P111, DOI 10.1016/S0304-3835(03)00056-9; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; The American Thyroid Association, 2003, THYROID, V13, P80; Trotta C, 2007, NUCL INSTRUM METH A, V577, P604, DOI 10.1016/j.nima.2007.03.037; Yoshii T, 2001, INT J ONCOL, V18, P787	31	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3768	10.1371/journal.pone.0003768	http://dx.doi.org/10.1371/journal.pone.0003768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020658	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448600001
J	Skerritt, MR; Campbell, DL				Skerritt, Matthew R.; Campbell, Donald L.			Non-Native R1 Substitution in the S4 Domain Uniquely Alters Kv4.3 Channel Gating	PLOS ONE			English	Article							CLOSED-STATE INACTIVATION; POTASSIUM CHANNEL; VOLTAGE SENSOR; ELECTRIC-FIELD; AMINO-ACID; CHARGE; RESIDUES; PATHWAY; TIME	The S4 transmembrane domain in Shaker (Kv1) voltage-sensitive potassium channels has four basic residues (R1-R4) that are responsible for carrying the majority of gating charge. In Kv4 channels, however, R1 is replaced by a neutral valine at position 287. Among other differences, Kv4 channels display prominent closed state inactivation, a mechanism which is minimal in Shaker. To determine if the absence of R1 is responsible for important variation in gating characteristics between the two channel types, we introduced the V287R mutant into Kv4.3 and analyzed its effects on several voltage sensitive gating transitions. We found that the mutant increased the voltage sensitivity of steady-state activation and altered the kinetics of activation and deactivation processes. Although the kinetics of macroscopic inactivation were minimally affected, the characteristics of closed-state inactivation and recovery from open and closed inactivated states were significantly altered. The absence of R1 can only partially account for differences in the effective voltage sensitivity of gating between Shaker and Kv4.3. These results suggest that the S4 domain serves an important functional role in Kv4 channel activation and deactivation processes, and also those of closed-state inactivation and recovery.	[Skerritt, Matthew R.; Campbell, Donald L.] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Skerritt, MR (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14260 USA.	dc25@buffalo.edu			American Heart Association [Predoctoral Fellowship]; Department of Physiology and Biophysics	American Heart Association(American Heart Association); Department of Physiology and Biophysics	American Heart Association Predoctoral Fellowship (MRS) and Department of Physiology and Biophysics (DLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Aldrich RW, 2001, NATURE, V411, P643, DOI 10.1038/35079705; Amadi CC, 2007, CHANNELS, V1, P305, DOI 10.4161/chan.5017; Asamoah OK, 2003, NEURON, V37, P85, DOI 10.1016/S0896-6273(02)01126-1; Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; Bezanilla F, 2005, IEEE T NANOBIOSCI, V4, P34, DOI 10.1109/TNB.2004.842463; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Chanda B, 2008, NEURON, V57, P345, DOI 10.1016/j.neuron.2008.01.015; Claydon TW, 2008, CHANNELS, V2, P139, DOI 10.4161/chan.2.2.6231; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; HILLE B, 2001, ION CHANNELS EXCITAB, P603; JACKSON MB, 2006, MOL CELLULAR BIOPHYS, P1; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; Patel SP, 2002, J PHYSIOL-LONDON, V539, P649, DOI 10.1113/jphysiol.2001.015156; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Rasmusson RL, 1998, CIRC RES, V82, P739, DOI 10.1161/01.RES.82.7.739; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SKERITT MR, 2008, BIOCH BIOPH IN PRESS; Skerritt MR, 2007, AM J PHYSIOL-CELL PH, V293, pC906, DOI 10.1152/ajpcell.00167.2007; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Wang SM, 2005, BIOPHYS J, V89, P3026, DOI 10.1529/biophysj.105.059378; Wang SM, 2004, J PHYSIOL-LONDON, V557, P705, DOI 10.1113/jphysiol.2003.058578; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZAMYATNIN AA, 1984, ANNU REV BIOPHYS BIO, V13, P145, DOI 10.1146/annurev.bb.13.060184.001045; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	40	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3773	10.1371/journal.pone.0003773	http://dx.doi.org/10.1371/journal.pone.0003773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020667	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448600006
J	Kirk, U				Kirk, Ulrich			The Neural Basis of Object-Context Relationships on Aesthetic Judgment	PLOS ONE			English	Article							HUMAN ORBITOFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; EVENT-RELATED FMRI; EMOTIONAL RESPONSES; BRAIN MECHANISMS; TARGET DETECTION; PARIETAL CORTEX; VISUAL TARGET; PERCEPTION; REWARD	The relationship between contextual information and object perception has received considerable attention in neuroimaging studies. In the work reported here, we used functional magnetic resonance imaging ( \fMRI) to investigate the relationship between aesthetic judgment and images of objects in their normal contextual setting versus images of objects in abnormal contextual settings and the underlying brain activity. When object-context relationships are violated changes in visual perception and aesthetic judgment emerges that exposes the contribution of vision to interpretations shaped by previous experience. We found that effects of context on aesthetic judgment modulates different memory subsystems, while aesthetic judgment regardless of context recruit medial and lateral aspects of the orbitofrontal cortex, consistent with previous findings. Visual cortical areas traditionally associated with the processing of visual features are recruited in normal contexts, irrespective of aesthetic ratings, while prefrontal areas are significantly more engaged when objects are viewed in unaccustomed settings.			Kirk, U (corresponding author), Baylor Coll Med, Human Neuroimaging Lab, Houston, TX 77030 USA.	ulrich.kirk@uclmail.net		kirk, ulrich/0000-0002-2121-2016	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; [Anonymous], 1974, STUDIES NEW EXPT AES; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; BERLYNE DE, 1970, PERCEPT PSYCHOPHYS, V8, P279, DOI 10.3758/BF03212593; BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; BOYCE SJ, 1992, J EXP PSYCHOL LEARN, V18, P531, DOI 10.1037/0278-7393.18.3.531; BOYCE SJ, 1989, J EXP PSYCHOL HUMAN, V15, P556, DOI 10.1037/0096-1523.15.3.556; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; Cunningham WA, 2004, J COGNITIVE NEUROSCI, V16, P1717, DOI 10.1162/0898929042947919; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fenske MJ, 2006, PROG BRAIN RES, V155, P3, DOI 10.1016/S0079-6123(06)55001-0; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; FRIEDMAN A, 1979, J EXP PSYCHOL GEN, V108, P316, DOI 10.1037/0096-3445.108.3.316; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; German TP, 2004, J COGNITIVE NEUROSCI, V16, P1805, DOI 10.1162/0898929042947892; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; Grezes J, 2004, J NEUROSCI, V24, P5500, DOI 10.1523/JNEUROSCI.0219-04.2004; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Gronau N, 2008, J COGNITIVE NEUROSCI, V20, P371, DOI 10.1162/jocn.2008.20.3.371; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; KNIGHT RT, 1989, BRAIN RES, V502, P109, DOI 10.1016/0006-8993(89)90466-6; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Mellet E, 2000, NEUROIMAGE, V12, P588, DOI 10.1006/nimg.2000.0648; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Mobbs D, 2006, SOC COGN AFFECT NEUR, V1, P95, DOI 10.1093/scan/nsl014; Mummery CJ, 2000, ANN NEUROL, V47, P36; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Stevens AA, 2000, MAGN RESON IMAGING, V18, P495, DOI 10.1016/S0730-725X(00)00128-4; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002180	61	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3754	10.1371/journal.pone.0003754	http://dx.doi.org/10.1371/journal.pone.0003754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436XD	19018279	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448500002
J	De Miranda, J; Yaddanapudi, K; Hornig, M; Lipkin, WI				De Miranda, Joari; Yaddanapudi, Kavitha; Hornig, Mady; Lipkin, W. Ian			Astrocytes recognize intracellular polyinosinic-polycytidylic acid via MDA-5	FASEB JOURNAL			English	Article						ds-RNA; TLR-3; RIG-I; CNS; innate immunity	DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; RIG-I; CUTTING EDGE; ADAPTER; ROLES; ACTIVATION; MICROGLIA; RESPONSES	RNA virus replication results in expression of double-stranded RNA (ds-RNA) molecules that trigger innate immune responses through interactions with both intracellular and extracellular receptors. We investigated the contributions of the extracellular and intracellular pathways to innate immunity in murine astrocyte primary cultures using polyinosinic-polycytidylic acid (poly I:C), a synthetic ds-RNA molecule designed to mimic RNA virus infection. Whereas extracellular poly I:C (naked poly I:C) mainly induced the expression of regulated on activation normal T-cell expressed and secreted (RANTES), interleukin-8 (IL-8), and tumor necrosis factor alpha (TNF-alpha), intracellular delivery of poly I:C (complexed poly I:C) chiefly induced expression of IFN-beta and IL-6. Experiments with astrocytes from Toll-like receptor 3 (TLR-3) knockout mice indicated that naked poly I:C signals via a TLR-3-dependent NF-kappa B pathway. Complexed poly I:C induced the expression of the intracellular ds-RNA sensor proteins, retinoic acid inducible gene I (RIG-I), and melanoma differentiation-associated gene 5 (MDA-5). However, transfection of astrocytes with dominant negative forms of the helicases implicated MDA-5, but not RIG-I, as the intracellular sensor of poly I:C. Complexed poly I:C-mediated MDA-5 stimulation transmitted "downstream" signals, resulting in activation of the transcription factors NF-kappa B and IRF-3. Our results illustrate the intricacy of extracellular and intracellular ds-RNA recognition in viral infections of the central nervous system and indicate the importance of MDA-5 helicase as an intracellular ds-RNA sensor in astrocytes. De Miranda, J., Yaddanapudi, K., Hornig, M., Lipkin, W. I. Astrocytes recognize intracellular polyinosinic-polycytidylic acid via MDA-5. FASEB J. 23, 1064-1071 (2009)	[De Miranda, Joari; Yaddanapudi, Kavitha; Hornig, Mady; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10032 USA	Columbia University	Lipkin, WI (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, 722 W 168th St,Rm 1801, New York, NY 10032 USA.	wil2001@columbia.edu	Hornig, Mady/AAE-8431-2020; Lipkin, W. Ian/ABE-6216-2020	Hornig, Mady/0000-0001-7572-3092; Lipkin, W. Ian/0000-0002-8768-9386	U.S. National Institutes of Health [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Vishal Kapoor for technical assistance and Robert Serge for help with statistical analysis. This work was supported by a grant from the U.S. National Institutes of Health (Northeast Biodefense Center U54-AI057158-Lipkin).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Carpentier PA, 2007, GLIA, V55, P239, DOI 10.1002/glia.20450; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; GIULIAN D, 1995, J NEUROSCI, V15, P7712; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Park C, 2006, GLIA, V53, P248, DOI 10.1002/glia.20278; Scumpia PO, 2005, GLIA, V52, P153, DOI 10.1002/glia.20234; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Town T, 2006, J IMMUNOL, V176, P3804, DOI 10.4049/jimmunol.176.6.3804; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	20	43	43	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1064	1071		10.1096/fj.08-121434	http://dx.doi.org/10.1096/fj.08-121434			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19036857	Green Published			2022-12-25	WOS:000266651600010
J	Holtje, M; Djalali, S; Hofmann, F; Munster-Wandowski, A; Hendrix, S; Boato, F; Dreger, SC; Grosse, G; Henneberger, C; Grantyn, R; Just, I; Ahnert-Hilger, G				Hoeltje, Markus; Djalali, Susann; Hofmann, Fred; Muenster-Wandowski, Agnieszka; Hendrix, Sven; Boato, Francesco; Dreger, Stefanie C.; Grosse, Gisela; Henneberger, Christian; Grantyn, Rosemarie; Just, Ingo; Ahnert-Hilger, Gudrun			A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation	FASEB JOURNAL			English	Article						regeneration; hippocampus; axon	RHO-GTPASES; NEUROTROPHIC FACTOR; SYNAPTOTAGMIN-I; NEURITE GROWTH; REGENERATION; INHIBITION; ASTROCYTES; EXPRESSION; RELEASE; NERVE	Small GTPases of the Rho family play versatile roles in the formation and development of axons and dendrites, effects often studied by the Rho-inactivating C3 transferase (C3bot) from Clostridium botulinum. Recently, we reported that transferase-deficient C3bot also exerted axonotrophic activity. Using overlapping peptides from the C3bot sequence, we identified a small peptide of 29 amino acids (covering residues 154-182) from the C-terminal region of C3bot that promotes both axonal and dendritic growth, as well as branching of hippocampal neurons, at sub-micromolar concentrations. Several C3bot constructs, including the short peptide, enhanced the number of axonal segments from mid-to higher-order segments. C3bot(154-182) also increased the number of synaptophysin-expressing terminals, up-regulated various synaptic proteins, and functionally increased the glutamate uptake. Staining against the vesicular glutamate and GABA transporters further revealed that the effect was attributable to a higher number of glutamatergic and GABAergic inputs on proximal dendrites of enhanced green fluorescent protein (EGFP)-transfected neurons. Using organotypical slice cultures, we also detected trophic effects of C3bot(154-182) on length and density of outgrowing fibers from the entorhinal cortex that were comparable to the effects elicited by full-length C3bot. In addition, an enhanced reinnervation was observed in a hippocampal-entorhinal lesion model. In summary, the neurotrophic effect of C3bot is executed by a C-terminal peptide fragment covering aa 154-182 of C3; it triggers dendritic and axonal growth and branching as well as increased synaptic connectivity. In contrast to full-length C3, this C3 peptide selectively acts on neurons but not on glial cells. Holtje, M., Djalali, S., Hofmann, F., Munster-Wandowski, A., Hendrix, S., Boato, F., Dreger, S. C., Grosse, G., Henneberger, C., Grantyn, R., Just, I., Ahnert-Hilger, G. A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation. FASEB J. 23, 1115-1126 (2009)	[Hoeltje, Markus] Charite, Inst Integrat Neuroanat, Ctr Anat, AG Funkt Zellbiol, D-10115 Berlin, Germany; [Hendrix, Sven; Boato, Francesco] Charite, Ctr Anat, Inst Zell & Neurobiol, D-10115 Berlin, Germany; [Henneberger, Christian; Grantyn, Rosemarie] Charite, Johannes Muller Inst Neurophysiol, AG Entwicklungsphysiol, D-10115 Berlin, Germany; [Hofmann, Fred; Dreger, Stefanie C.; Just, Ingo] Hannover Med Sch, Inst Toxikol, D-30623 Hannover, Germany; [Hendrix, Sven] Hasselt Univ, Dept Morphol, Hasselt, Belgium; [Hendrix, Sven] Hasselt Univ, Biomed Res Inst, Hasselt, Belgium	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; Hasselt University; Hasselt University	Holtje, M (corresponding author), Charite, Inst Integrat Neuroanat, Ctr Anat, AG Funkt Zellbiol, Philippstr 12, D-10115 Berlin, Germany.	markus.hoeltje@charite.de	Henneberger, Christian/C-1557-2008; Hendrix, Sven/F-4059-2010; Münster-Wandowski, Agnieszka/Q-5690-2016	Henneberger, Christian/0000-0002-5391-7387; Hendrix, Sven/0000-0003-2344-7369; Münster-Wandowski, Agnieszka/0000-0002-5401-0218; Holtje, Markus/0000-0003-3193-4140; Boato, Francesco/0000-0001-9741-8021	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors are indebted to Ursel Tofote, Birgit Metze, and Sandra Hagemann for their engaged and skillfull technical assistance. Work was supported by a grant from the Deutsche Forschungsgemeinschaft to G. A. H. and I.J. F.B. is a member of the CORTEX network [Marie Curie Early Stage Training (EST) Programme].	Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Barth H, 1999, J BIOL CHEM, V274, P27407, DOI 10.1074/jbc.274.39.27407; Bertrand J, 2007, NEUROBIOL DIS, V25, P65, DOI 10.1016/j.nbd.2006.08.008; Bertrand J, 2005, J NEUROSCI, V25, P1113, DOI 10.1523/JNEUROSCI.3931-04.2005; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Chan CCM, 2007, GLIA, V55, P369, DOI 10.1002/glia.20466; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; FROTSCHER M, 1993, P NATL ACAD SCI USA, V90, P10400, DOI 10.1073/pnas.90.21.10400; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hechler D, 2006, BRAIN RES REV, V52, P160, DOI 10.1016/j.brainresrev.2006.01.005; Henneberger C, 2005, NEUROSCIENCE, V135, P749, DOI 10.1016/j.neuroscience.2005.06.044; Holtje M, 2008, J BIOL CHEM, V283, P9289, DOI 10.1074/jbc.M706499200; Hoffmann A, 2008, GLIA, V56, P1162, DOI 10.1002/glia.20687; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Hu Y, 2007, MOL CELL NEUROSCI, V34, P88, DOI 10.1016/j.mcn.2006.10.005; Jaffe AB, 2004, MOL CELL BIOL, V24, P1736, DOI 10.1128/MCB.24.4.1736-1746.2004; Jokic N, 2006, EMBO REP, V7, P1162, DOI 10.1038/sj.embor.7400826; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Neiiendam JL, 2004, J NEUROCHEM, V91, P920, DOI 10.1111/j.1471-4159.2004.02779.x; Prang P, 2001, EXP NEUROL, V169, P135, DOI 10.1006/exnr.2001.7648; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rind HB, 2005, J NEUROSCI, V25, P539, DOI 10.1523/JNEUROSCI.4322-04.2005; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Schmitt KRL, 2007, NEUROSCI RES, V59, P68, DOI 10.1016/j.neures.2007.05.011; Singh B, 2006, J NEUROSCI, V26, P7189, DOI 10.1523/JNEUROSCI.5474-05.2006; Steup A, 2000, MOL CELL NEUROSCI, V15, P141, DOI 10.1006/mcne.1999.0818; Sun JJ, 2004, NAT STRUCT MOL BIOL, V11, P868, DOI 10.1038/nsmb818; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006	36	43	46	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1115	1126		10.1096/fj.08-116855	http://dx.doi.org/10.1096/fj.08-116855			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19047066				2022-12-25	WOS:000266651600015
J	Madison, BB; McKenna, LB; Dolson, D; Epstein, DJ; Kaestner, KH				Madison, Blair B.; McKenna, Lindsay B.; Dolson, Diane; Epstein, Douglas J.; Kaestner, Klaus H.			FoxF1 and FoxL1 Link Hedgehog Signaling and the Control of Epithelial Proliferation in the Developing Stomach and Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD BOX F1; GASTROINTESTINAL DEVELOPMENT; EXPRESSION; GENE; GUT; MORPHOGENESIS; BETA; MICE; GLI3; DIFFERENTIATION	The hedgehog (Hh) signaling pathway is a key component of cross-talk during vertebrate gut development, involving endodermally secreted Sonic (Shh) and Indian hedgehog (Ihh) proteins that directly signal to adjacent mesoderm. Here we show that the closely linked mesenchymal forkhead transcription factors Foxf1 and Foxl1 are part of this signaling cascade. Analysis of conserved non-coding sequences surrounding Foxf1 and Foxl1 identified seven Gli binding sites, with two sites near Foxl1 being identical among mammalian, bird, fish, and amphibian species. In vitro experiments indicate that Gli2 binds to these Gli sites, several of which are critical for Gli2-mediated activation of a luciferase reporter in 293 cells. In addition, we demonstrate occupancy of one of these elements by Gli proteins in the intestine in vivo using chromatin immunoprecipitation. Furthermore, expression of both Foxf1 and Foxl1 is reduced in the Gli2/Gli3 mutant gut. These results provide compelling evidence that Foxf1 and Foxl1 are mediators of the Hh (endoderm) to mesoderm signaling pathway.	[Madison, Blair B.; McKenna, Lindsay B.; Dolson, Diane; Epstein, Douglas J.; Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Kaestner, KH (corresponding author), 752B Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	kaestner@mail.med.upenn.edu			National Institutes of Health [DK-053839]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK053839, R37DK053839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-053839 through the NIDDK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Batts LE, 2006, DEV DYNAM, V235, P1563, DOI 10.1002/dvdy.20741; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fukuda K, 2003, DEV BIOL, V255, P278, DOI 10.1016/S0012-1606(02)00088-X; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Kaestner KH, 1996, DEVELOPMENT, V122, P1751; Kaestner KH, 1997, GENE DEV, V11, P1583, DOI 10.1101/gad.11.12.1583; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Kim IM, 2005, J BIOL CHEM, V280, P37908, DOI 10.1074/jbc.M506531200; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Malin D, 2007, MOL CELL BIOL, V27, P2486, DOI 10.1128/MCB.01736-06; Mo R, 1997, DEVELOPMENT, V124, P113; Motoyama J, 1998, MECH DEVELOP, V78, P81, DOI 10.1016/S0925-4773(98)00149-X; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Perreault N, 2005, GENE DEV, V19, P311, DOI 10.1101/gad.1260605; Perreault N, 2001, J BIOL CHEM, V276, P43328, DOI 10.1074/jbc.M104366200; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Rubins NE, 2005, MOL CELL BIOL, V25, P7069, DOI 10.1128/MCB.25.16.7069-7077.2005; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang LC, 2002, GASTROENTEROLOGY, V122, P469, DOI 10.1053/gast.2002.31102; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005	37	103	105	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5936	5944		10.1074/jbc.M808103200	http://dx.doi.org/10.1074/jbc.M808103200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19049965	Green Published, hybrid			2022-12-25	WOS:000263560600057
J	Bertoli, C; Copetti, T; Lam, EWF; Demarchi, F; Schneider, C				Bertoli, C.; Copetti, T.; Lam, E. W-F; Demarchi, F.; Schneider, C.			Calpain small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A	ONCOGENE			English	Article						CAPNS-1; FoxO3A; apoptosis; PP2A; B56; Akt	PROTEIN PHOSPHATASE 2A; FORKHEAD TRANSCRIPTION FACTORS; CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; KINASE-B; MAMMALIAN-CELLS; AKT; DEATH; CANCER; SURVIVAL	Here, we show that FoxO3A transcription factor is upregulated upon calpain small-1 (CAPNS1) depletion both in mouse embryonic. broblasts (MEFs) and in the human mammary carcinoma cell line MCF-7. On starvation, CAPNS1 depletion is associated with a higher rate of FoxO3A dephosphorylation and translocation to the nucleus and to a sharper increase in the levels of p27Kip1 and Bim, the products of two FoxO target genes. Notably, FoxO3A depletion in CAPNS1(-/-) MEFs reduces both the induction of Bim and apoptosis. Both okadaic acid treatment and silencing of the protein phosphatase 2A (PP2A) catalytic subunit can partially reduce starvation-induced FoxO3A activation and apoptosis in CAPNS1(-/-). broblasts. PP2A associates more tightly with Akt in CAPNS1 knockout cells, indicating that PP2A is involved in calpain-mediated FoxO regulation. Finally, we show that PP2A regulatory subunits B56 alpha and gamma are in vitro substrates of calpain, and calpain regulates B56 alpha stability in vivo, suggesting a direct role of calpain in the regulation of PP2A function. In conclusion, for the fist time we report that CAPNS1 interferes with PP2A-Akt interaction consequently affecting FoxO3A-dependent cell death. Calpain inhibition might therefore be exploited as a tool to induce apoptosis in tumors sensitive to FoxO activation.	[Bertoli, C.; Copetti, T.; Demarchi, F.; Schneider, C.] LNCIB, I-34012 Trieste, Italy; [Lam, E. W-F] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Oncol, Canc Res United Kingdom Labs, London, England; [Schneider, C.] Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy	Cancer Research UK; Imperial College London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Demarchi, F (corresponding author), LNCIB, AREA Sci Pk,Padriciano 99, I-34012 Trieste, Italy.	francesca.demarchi@lncib.it; schneide@lncib.it	Lam, Eric W-F/AAW-8566-2020	Lam, Eric W-F/0000-0003-1274-3576; Demarchi, Francesca/0000-0003-1565-3162	FIRC (Fondazione italiana per la ricerca sul cancro); PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale) [2006-prot. 2006053543_003]; TRANSFOG (Translational and Functinal Onco-Genomics) EU [503438]; AIRC (Associazione italiana per la ricerca sul cancro) Grant proposal 2007 [Cod. 4752]; Progetto FAR CT cod. MIUR prog [10036]	FIRC (Fondazione italiana per la ricerca sul cancro)(Fondazione AIRC per la ricerca sul cancro); PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); TRANSFOG (Translational and Functinal Onco-Genomics) EU(European Commission); AIRC (Associazione italiana per la ricerca sul cancro) Grant proposal 2007(Fondazione AIRC per la ricerca sul cancro); Progetto FAR CT cod. MIUR prog(Ministry of Education, Universities and Research (MIUR))	We acknowledge Silvano Piazza for help in statistics. CB was a recipient of an FIRC (Fondazione italiana per la ricerca sul cancro) fellowship. This study was supported by PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale) 2006-prot. 2006053543_003, and TRANSFOG (Translational and Functinal Onco-Genomics) EU Contract 503438, AIRC (Associazione italiana per la ricerca sul cancro) Grant proposal 2007 Cod. 4752, and Progetto FAR CT cod. MIUR prog. 10036.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Darnell GA, 2007, J BIOL CHEM, V282, P37492, DOI 10.1074/jbc.M706860200; Demarchi F, 2005, CELL DEATH DIFFER, V12, P512, DOI 10.1038/sj.cdd.4401592; Demarchi F, 2007, AUTOPHAGY, V3, P235, DOI 10.4161/auto.3661; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guan N, 2006, INT J ONCOL, V29, P655; Harriman JF, 2002, CELL DEATH DIFFER, V9, P734, DOI 10.1038/sj.cdd.4401029; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Libertini SJ, 2005, CANCER RES, V65, P10700, DOI 10.1158/0008-5472.CAN-05-1666; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Reagan-Shaw S, 2006, CANCER RES, V66, P1062, DOI 10.1158/0008-5472.CAN-05-1018; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Xu LJ, 2006, J BIOL CHEM, V281, P35567, DOI 10.1074/jbc.M607702200; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Yin KJ, 2006, J NEUROSCI, V26, P2290, DOI 10.1523/JNEUROSCI.5103-05.2006; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	49	42	43	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					721	733		10.1038/onc.2008.425	http://dx.doi.org/10.1038/onc.2008.425			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	19029949				2022-12-25	WOS:000263076400009
J	Burns, KE; Liu, WT; Boshoff, HIM; Dorrestein, PC; Barry, CE				Burns, Kristin E.; Liu, Wei-Ting; Boshoff, Helena I. M.; Dorrestein, Pieter C.; Barry, Clifton E.			Proteasomal Protein Degradation in Mycobacteria Is Dependent upon a Prokaryotic Ubiquitin-like Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBERCULOSIS PROTEASOME; 20S PROTEASOME; FAMILY; GENES; IDENTIFICATION; COMPLEX	The striking identification of an apparent proteasome core in Mycobacteria and allied actinomycetes suggested that additional elements of this otherwise strictly eukaryotic system for regulated protein degradation might be conserved. The genes encoding this prokaryotic proteasome are clustered in an operon with a short open reading frame that encodes a small protein of 64 amino acids resembling ubiquitin with a carboxyl-terminal di-glycine-glutamine motif ( herein called Pup for prokaryotic ubiquitin-like protein). Expression of a polyhistidine-tagged Pup followed by pulldown revealed that a broad spectrum of proteins were post-translationally modified by Pup. Two-dimensional gel electrophoresis allowed us to conclusively identify two targets of this modification as myoinositol-1-phosphate synthase and superoxide dismutase. Deletion of the penultimate di-glycine motif or the terminal glutamine completely abrogated modification of cellular proteins with Pup. Further mass spectral analysis demonstrated that Pup was attached to a lysine residue on its target protein via the carboxyl-terminal glutamine with deamidation of this residue. Finally, we showed that cell lysates of wild type ( but not a proteasome mutant) efficiently degraded Pup-modified proteins. These data therefore establish that, despite differences in both sequence and target linkage, Pup plays an analogous role to ubiquitin in targeting proteins to the proteasome for degradation.	[Burns, Kristin E.; Boshoff, Helena I. M.; Barry, Clifton E.] NIAID, TB Res Sect, NIH, Bethesda, MD 20892 USA; [Liu, Wei-Ting; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA; [Liu, Wei-Ting; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Chem & Biochem, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Diego; University of California System; University of California San Diego	Barry, CE (corresponding author), NIAID, TB Res Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cbarry@mail.nih.gov	Dorrestein, Pieter/ABF-2930-2020; Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020; Dorrestein, Pieter/D-5012-2012	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; 	National Institutes of Health; Intramural Research Program, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health, Intramural Research Program, NIAID. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAHLMANN B, 1989, FEBS LETT, V251, P125, DOI 10.1016/0014-5793(89)81441-3; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Dorrestein PC, 2006, NAT PROD REP, V23, P893, DOI 10.1039/b511400b; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Knipfer N, 1997, MOL MICROBIOL, V25, P375, DOI 10.1046/j.1365-2958.1997.4721837.x; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; Lin G, 2008, J BIOL CHEM, V283, P34423, DOI 10.1074/jbc.M805324200; LUND PK, 1985, J BIOL CHEM, V260, P7609; LUPAS A, 1994, TRENDS BIOCHEM SCI, V19, P533, DOI 10.1016/0968-0004(94)90054-X; Nagy I, 1998, J BACTERIOL, V180, P5448, DOI 10.1128/JB.180.20.5448-5453.1998; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; TAMURA T, 1995, CURR BIOL, V5, P766, DOI 10.1016/S0960-9822(95)00153-9; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589; Zwickl P, 1999, PHILOS T R SOC B, V354, P1501, DOI 10.1098/rstb.1999.0494	29	112	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3069	3075		10.1074/jbc.M808032200	http://dx.doi.org/10.1074/jbc.M808032200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19028679	Green Published, hybrid			2022-12-25	WOS:000262700900051
J	Willoughby, JA; Sundar, SN; Cheung, M; Tin, AS; Modiano, J; Firestone, GL				Willoughby, Jamin A., Sr.; Sundar, Shyam N.; Cheung, Mark; Tin, Antony S.; Modiano, Jaime; Firestone, Gary L.			Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELLS; PROTEIN; ANTIMALARIAL; ANGIOGENESIS; ACTIVATION; CASTRATION; ARTESUNATE; STABILITY; CARCINOMA; SURVIVAL	Artemisinin, a naturally occurring component of Artemisia annua, or sweet wormwood, is a potent anti-malaria compound that has recently been shown to have anti-proliferative effects on a number of human cancer cell types, although little is know about the molecular mechanisms of this response. We have observed that artemisinin treatment triggers a stringent G(1) cell cycle arrest of LNCaP (lymph node carcinoma of the prostate) human prostate cancer cells that is accompanied by a rapid down-regulation of CDK2 and CDK4 protein and transcript levels. Transient transfection with promoter-linked luciferase reporter plasmids revealed that artemisinin strongly inhibits CDK2 and CDK4 promoter activity. Deletion analysis of the CDK4 promoter revealed a 231-bp artemisinin-responsive region between -1737 and -1506. Site-specific mutations revealed that the Sp1 site at -1531 was necessary for artemisinin responsiveness in the context of the CDK4 promoter. DNA binding assays as well as chromatin immunoprecipitation assays demonstrated that this Sp1-binding site in the CDK4 promoter forms a specific artemisinin-responsive DNA-protein complex that contains the Sp1 transcription factor. Artemisinin reduced phosphorylation of Sp1, and when dephosphorylation of Sp1 was inhibited by treatment of cells with the phosphatase inhibitor okadaic acid, the ability of artemisinin to down-regulate Sp1 interactions with the CDK4 promoter was ablated, rendering the CDK4 promoter unresponsive to artemisinin. Finally, overexpression of Sp1 mostly reversed the artemisinin down-regulation of CDK4 promoter activity and partially reversed the cell cycle arrest. Taken together, our results demonstrate that a key event in the artemisinin anti-proliferative effects in prostate cancer cells is the transcriptional down-regulation of CDK4 expression by disruption of Sp1 interactions with the CDK4 promoter.	[Willoughby, Jamin A., Sr.; Sundar, Shyam N.; Cheung, Mark; Tin, Antony S.; Firestone, Gary L.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Willoughby, Jamin A., Sr.; Sundar, Shyam N.; Cheung, Mark; Tin, Antony S.; Firestone, Gary L.] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Modiano, Jaime] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Modiano, Jaime] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Firestone, GL (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 591 LSA, Berkeley, CA 94720 USA.	glfire@berkeley.edu	MODIANO, JAIME/K-3583-2019	MODIANO, JAIME/0000-0001-6398-7648	National Institutes of Health [CA102360]; NCI; NATIONAL CANCER INSTITUTE [R01CA102360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA102360 from NCI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beekman AC, 1997, J PHARM PHARMACOL, V49, P1254, DOI 10.1111/j.2042-7158.1997.tb06080.x; Chen HH, 2004, PHARMACOLOGY, V71, P1, DOI 10.1159/000076256; Chen HH, 2003, PHARMACOL RES, V48, P231, DOI 10.1016/S1043-6618(03)00107-5; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Cram EJ, 2001, J BIOL CHEM, V276, P22332, DOI 10.1074/jbc.M010539200; Dalrymple SL, 2007, PROSTATE, V67, P790, DOI 10.1002/pros.20573; Duffy PE, 2004, LANCET, V363, P3, DOI 10.1016/S0140-6736(03)15230-0; Efferth T, 2001, INT J ONCOL, V18, P767; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Garcia HH, 2005, J BIOL CHEM, V280, P8756, DOI 10.1074/jbc.M407957200; Halabi S, 2003, J CLIN ONCOL, V21, P1232, DOI 10.1200/JCO.2003.06.100; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; Hong CB, 2002, CARCINOGENESIS, V23, P1297, DOI 10.1093/carcin/23.8.1297; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; LABRIE F, 1989, BRIT J UROL, V63, P634, DOI 10.1111/j.1464-410X.1989.tb05260.x; Lynch J H, 2001, Rev Urol, V3 Suppl 2, pS39; MACKINTOSH C, 1994, TRENDS BIOCHEM SCI, V19, P444, DOI 10.1016/0968-0004(94)90127-9; Paik IH, 2006, J MED CHEM, V49, P2731, DOI 10.1021/jm058288w; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; REIZENSTEIN P, 1991, MED ONCOL TUMOR PHAR, V8, P229; Sadava D, 2002, CANCER LETT, V179, P151, DOI 10.1016/S0304-3835(02)00005-8; Samson SLA, 2002, J MOL ENDOCRINOL, V29, P265, DOI 10.1677/jme.0.0290265; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Smaletz O, 2002, J CLIN ONCOL, V20, P3972, DOI 10.1200/JCO.2002.11.021; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yamachika E, 2004, ANTICANCER RES, V24, P2153; Yokota T, 2007, CANCER SCI, V98, P1447, DOI 10.1111/j.1349-7006.2007.00560.x	27	111	123	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2203	2213		10.1074/jbc.M804491200	http://dx.doi.org/10.1074/jbc.M804491200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017637	Green Published, hybrid			2022-12-25	WOS:000262545600030
J	Tasaki, T; Zakrzewska, A; Dudgeon, DD; Jiang, YH; Lazo, JS; Kwon, YT				Tasaki, Takafumi; Zakrzewska, Adriana; Dudgeon, Drew D.; Jiang, Yonghua; Lazo, John S.; Kwon, Yong Tae			The Substrate Recognition Domains of the N-end Rule Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASES; MICE LACKING; CARDIOVASCULAR DEVELOPMENT; PROTEIN; DEGRADATION; COMPONENT; ARABIDOPSIS; UBR1; APOPTOSIS; AMIDASE	The N-end rule pathway is a ubiquitin-dependent system where E3 ligases called N-recognins, including UBR1 and UBR2, recognize type-1 (basic) and type-2 (bulky hydrophobic) N-terminal residues as part of N-degrons. We have recently reported an E3 family (termed UBR1 through UBR7) characterized by the 70-residue UBR box, among which UBR1, UBR2, UBR4, and UBR5 were captured during affinity-based proteomics with synthetic degrons. Here we characterized substrate binding specificity and recognition domains of UBR proteins. Pull-down assays with recombinant UBR proteins suggest that 570-kDa UBR4 and 300-kDa UBR5 bind N-degron, whereas UBR3, UBR6, and UBR7 do not. Binding assays with 24 UBR1 deletion mutants and 31 site-directed UBR1 mutations narrow down the degron-binding activity to a 72-residue UBR box-only fragment that recognizes type-1 but not type-2 residues. A surface plasmon-resonance assay shows that the UBR box binds to the type-1 substrate Arg-peptide with K-d of similar to 3.4 mu M. Downstream from the UBR box, we identify a second substrate recognition domain, termed the N-domain, required for type-2 substrate recognition. The similar to 80-residue N-domain shows structural and functional similarity to 106-residue Escherichia coli ClpS, a bacterial N-recognin. We propose a model where the 70-residue UBRbox functions as a common structural element essential for binding to all known destabilizing N-terminal residues, whereas specific residues localized in the UBR box (for type 1) or the N-domain (for type 2) provide substrate selectivity through interaction with the side group of an N-terminal amino acid. Our work provides new insights into substrate recognition in the N-end rule pathway.	[Zakrzewska, Adriana; Jiang, Yonghua; Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Tasaki, Takafumi; Zakrzewska, Adriana; Jiang, Yonghua; Kwon, Yong Tae] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Dudgeon, Drew D.; Lazo, John S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh Mol Lib Screening Ctr, Pittsburgh, PA 15260 USA; [Zakrzewska, Adriana; Lazo, John S.] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kwon, YT (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, 3501 Terrace St, Pittsburgh, PA 15261 USA.	yok5@pitt.edu			National Institutes of Health [GM69482, GM074000, HL083365, CA078039]; American Heart Association; Hartwell Foundation; NATIONAL CANCER INSTITUTE [P01CA078039] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069482, R01GM074000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Hartwell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM69482, GM074000, HL083365 ( to Y.T.K.), and CA078039 ( to J.S.L.). This work was also supported by grants from the American Heart Association ( to Y.T.K.) and the Hartwell Foundation ( to J. S. L. and D. D. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Balogh SA, 2000, LEARN MEMORY, V7, P279, DOI 10.1101/lm.33500; Balogh SA, 2001, BRAIN RES, V892, P336, DOI 10.1016/S0006-8993(00)03268-6; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Grigoryev S, 1996, J BIOL CHEM, V271, P28521, DOI 10.1074/jbc.271.45.28521; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann Michael, 2004, Biotechnol Annu Rev, V10, P1, DOI 10.1016/S1387-2656(04)10001-X; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; JOHANSON A, 1971, J PEDIATR-US, V79, P982, DOI 10.1016/S0022-3476(71)80194-4; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Kwon YT, 1999, J BIOL CHEM, V274, P18135, DOI 10.1074/jbc.274.25.18135; Lecker SH, 1999, J CLIN INVEST, V104, P1411, DOI 10.1172/JCI7300; Lee MJ, 2008, P NATL ACAD SCI USA, V105, P100, DOI 10.1073/pnas.0708465105; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lloyd AG, 2007, VIROLOGY, V360, P129, DOI 10.1016/j.virol.2006.10.007; Lupas AN, 2003, J STRUCT BIOL, V141, P77, DOI 10.1016/S1047-8477(02)00582-8; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Potuschak T, 1998, P NATL ACAD SCI USA, V95, P7904, DOI 10.1073/pnas.95.14.7904; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Stary S, 2003, PLANT PHYSIOL, V133, P1360, DOI 10.1104/pp.103.029272; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Yan OY, 2006, MUTAT RES-FUND MOL M, V596, P64, DOI 10.1016/j.mrfmmm.2005.12.016; Yoshida S, 2002, PLANT J, V32, P129, DOI 10.1046/j.1365-313X.2002.01407.x; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	45	91	95	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1884	1895		10.1074/jbc.M803641200	http://dx.doi.org/10.1074/jbc.M803641200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19008229	Green Published, hybrid			2022-12-25	WOS:000262330100059
J	Palacios, C; Zettler, E; Amils, R; Amaral-Zettler, L				Palacios, Carmen; Zettler, Erik; Amils, Ricardo; Amaral-Zettler, Linda			Contrasting Microbial Community Assembly Hypotheses: A Reconciling Tale from the Rio Tinto	PLOS ONE			English	Article							EXTREME ACIDIC ENVIRONMENT; DIVERSITY; ECOLOGY; RIVER; SEQUENCES; CHANCE; UNITS	Background: The Rio Tinto (RT) is distinguished from other acid mine drainage systems by its natural and ancient origins. Microbial life from all three domains flourishes in this ecosystem, but bacteria dominate metabolic processes that perpetuate environmental extremes. While the patchy geochemistry of the RT likely influences the dynamics of bacterial populations, demonstrating which environmental variables shape microbial diversity and unveiling the mechanisms underlying observed patterns, remain major challenges in microbial ecology whose answers rely upon detailed assessments of community structures coupled with fine-scale measurements of physico-chemical parameters. Methodology/Principal Findings: By using high-throughput environmental tag sequencing we achieved saturation of richness estimators for the first time in the RT. We found that environmental factors dictate the distribution of the most abundant taxa in this system, but stochastic niche differentiation processes, such as mutation and dispersal, also contribute to observed diversity patterns. Conclusions/Significance: We predict that studies providing clues to the evolutionary and ecological processes underlying microbial distributions will reconcile the ongoing debate between the Baas Becking vs. Hubbell community assembly hypotheses.	[Palacios, Carmen; Amaral-Zettler, Linda] Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA USA; [Palacios, Carmen; Amaral-Zettler, Linda] NASA Astrobiol Inst, Marine Biol Lab, Woods Hole, MA USA; [Zettler, Erik; Amils, Ricardo] Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain; [Zettler, Erik] Sea Educ Assoc, Woods Hole, MA USA; [Amils, Ricardo] INTA CSIC, Ctr Astrobiol, Torrejon de Ardoz, Spain	Marine Biological Laboratory - Woods Hole; Marine Biological Laboratory - Woods Hole; National Aeronautics & Space Administration (NASA); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Palacios, C (corresponding author), Univ Perpignan Via Domitia, CNRS EPHE UPVD, UMR 5244, Ctr Biol & Ecol Trop & Mediterraneenne,Equipe Par, Perpignan, France.	amaral@mbl.edu	Amils, Ricardo/X-2706-2019	Zettler, Erik/0000-0002-9266-1142	NASA Astrobiology Institute [NC-1054 LAZ]; Ministry of Science and Education [CGL2006/02534/BOS RA]; Spanish Centro de Astrobiologia	NASA Astrobiology Institute; Ministry of Science and Education; Spanish Centro de Astrobiologia	This work was supported by grants from NASA Astrobiology Institute (NC-1054 LAZ) and from the Ministry of Science and Education (CGL2006/02534/BOS RA) and support to CP by the Spanish Centro de Astrobiologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Aguilera A, 2006, APPL ENVIRON MICROB, V72, P5325, DOI 10.1128/AEM.00513-06; Amaral Zettler Linda A., 2002, Nature (London), V417, P137, DOI 10.1038/417137a; Amils R, 2007, PLANET SPACE SCI, V55, P370, DOI 10.1016/j.pss.2006.02.006; Baker BJ, 2003, APPL ENVIRON MICROB, V69, P5512, DOI 10.1128/AEM.69.9.5512-5518.2003; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Cilia V, 1996, MOL BIOL EVOL, V13, P451, DOI 10.1093/oxfordjournals.molbev.a025606; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; COLE JR, 2005, NUCLEIC ACIDS RES, V33, P1362, DOI DOI 10.1093/NAR/GKI254; Colwell RK, 2013, ESTIMATES STAT ESTIM; de Visser JAGM, 2006, GENETICS, V172, P2093, DOI 10.1534/genetics.105.052373; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Dobyns JR, 1997, ENVIRON ENTOMOL, V26, P150, DOI 10.1093/ee/26.2.150; DYSZYNSKI G, RDPQUERY JAVA PROGRA; Falkowski PG, 2008, PHILOS T R SOC B, V363, P2705, DOI 10.1098/rstb.2008.0054; Fernandez-Remolar D, 2004, PLANET SPACE SCI, V52, P239, DOI 10.1016/j.pss.2003.08.027; Gonzalez-Toril E, 2003, APPL ENVIRON MICROB, V69, P4853, DOI 10.1128/AEM.69.8.4853-4865.2003; Green BD, 2006, CURR OPIN BIOTECH, V17, P236, DOI 10.1016/j.copbio.2006.05.004; Hallberg KB, 2006, APPL ENVIRON MICROB, V72, P2022, DOI 10.1128/AEM.72.3.2022-2030.2006; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Hubbell Stephen P., 2001, V32, pi; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; HURTT GC, 1995, J THEOR BIOL, V176, P1, DOI 10.1006/jtbi.1995.0170; Karavaiko GI, 2003, INT J SYST EVOL MICR, V53, P113, DOI 10.1099/ijs.0.02319-0; Klepac-Ceraj V, 2004, ENVIRON MICROBIOL, V6, P686, DOI 10.1111/j.1462-2920.2004.00600.x; Klepac-Ceraj V., 2006, ONLINE J BIOINFORM, V7, P15; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Kysela DT, 2005, ENVIRON MICROBIOL, V7, P356, DOI 10.1111/j.1462-2920.2004.00712.x; LEGENDRE P, 1998, NUMERICAL ECOLOGY, P445; Lopez-Archilla AI, 2001, MICROB ECOL, V41, P20; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Magurran A.E, 2004, MEASURING BIOL DIVER; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; PALACIOS C, 2006, P OC BIOD INF INT C; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Pommier T, 2005, AQUAT MICROB ECOL, V41, P79, DOI 10.3354/ame041079; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SLAYMAN CL, 1985, BIOSCIENCE, V35, P16, DOI 10.2307/1310077; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	52	30	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3853	10.1371/journal.pone.0003853	http://dx.doi.org/10.1371/journal.pone.0003853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052647	Green Published, gold			2022-12-25	WOS:000265452200006
J	Martinovic, J; Gruber, T; Muller, MM				Martinovic, Jasna; Gruber, Thomas; Mueller, Matthias M.			Coding of Visual Object Features and Feature Conjunctions in the Human Brain	PLOS ONE			English	Article							GAMMA BAND RESPONSES; REPETITION PRIMING TASK; TIME-COURSE; NEUROPHYSIOLOGICAL EVIDENCE; BIOELECTRIC EVENTS; EVOKED-POTENTIALS; RECOGNITION; COLOR; EEG; REPRESENTATIONS	Object recognition is achieved through neural mechanisms reliant on the activity of distributed coordinated neural assemblies. In the initial steps of this process, an object's features are thought to be coded very rapidly in distinct neural assemblies. These features play different functional roles in the recognition process - while colour facilitates recognition, additional contours and edges delay it. Here, we selectively varied the amount and role of object features in an entry-level categorization paradigm and related them to the electrical activity of the human brain. We found that early synchronizations (approx. 100 ms) increased quantitatively when more image features had to be coded, without reflecting their qualitative contribution to the recognition process. Later activity (approx. 200-400 ms) was modulated by the representational role of object features. These findings demonstrate that although early synchronizations may be sufficient for relatively crude discrimination of objects in visual scenes, they cannot support entry-level categorization. This was subserved by later processes of object model selection, which utilized the representational value of object features such as colour or edges to select the appropriate model and achieve identification.	[Martinovic, Jasna] Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England; [Gruber, Thomas] Univ Osnabruck, Inst Psychol, D-4500 Osnabruck, Germany; [Mueller, Matthias M.] Univ Leipzig, Inst Psychol I, Leipzig, Germany	University of Liverpool; University Osnabruck; Leipzig University	Martinovic, J (corresponding author), Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England.	m.mueller@rz.uni-leipzig.de	Martinovic, Jasna/C-7633-2009; martinovic, jasna/AAH-9926-2019	Martinovic, Jasna/0000-0001-9141-2577; martinovic, jasna/0000-0001-9141-2577; Lauwereyns, Jan/0000-0003-0551-2550	Deutsche Forschungsgemeinschaft; DAAD; ESRC; ESRC [ES/G006180/1] Funding Source: UKRI; Economic and Social Research Council [ES/G006180/1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Deutsche Forschungsgemeinschaft supported this research. J.M. was supported by the DAAD and the ESRC.	Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; BERTRAND O, 1994, NATO ADV SCI INST SE, V271, P231; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Brincat SL, 2006, NEURON, V49, P17, DOI 10.1016/j.neuron.2005.11.026; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Busch NA, 2006, NEUROIMAGE, V33, P1169, DOI 10.1016/j.neuroimage.2006.07.034; Conrad N, 2007, NEUROSCI LETT, V429, P126, DOI 10.1016/j.neulet.2007.09.065; David O, 2005, NEUROIMAGE, V25, P756, DOI 10.1016/j.neuroimage.2004.12.030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doniger GM, 2000, J COGNITIVE NEUROSCI, V12, P615, DOI 10.1162/089892900562372; Eckhorn R, 1990, NEURAL COMPUT, V2, P293, DOI 10.1162/neco.1990.2.3.293; Ellis AW, 1998, J EXP PSYCHOL LEARN, V24, P515, DOI 10.1037/0278-7393.24.2.515; ENGBERT R, 2006, FUNDAMENTALS VISION, P177; Fiebach CJ, 2005, J NEUROSCI, V25, P3414, DOI 10.1523/JNEUROSCI.4107-04.2005; Fize D, 2005, BRAIN COGNITION, V59, P145, DOI 10.1016/j.bandc.2005.06.002; Frund I, 2007, VISION RES, V47, P2086, DOI 10.1016/j.visres.2007.03.022; Frund I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001675; Funnell E, 2006, Q J EXP PSYCHOL, V59, P268, DOI 10.1080/02724980443000674; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Gruber T, 2004, EUR J NEUROSCI, V19, P1073, DOI 10.1111/j.0953-816X.2004.03176.x; Gruber T, 2002, COGNITIVE BRAIN RES, V13, P377, DOI 10.1016/S0926-6410(01)00130-6; Herrmann CS, 1999, CLIN NEUROPHYSIOL, V110, P636, DOI 10.1016/S1388-2457(99)00002-4; Herrmann CS, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-13; Johnson JS, 2003, J VISION, V3, P499, DOI 10.1167/3.7.4; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Karakas S, 1998, INT J PSYCHOPHYSIOL, V31, P13, DOI 10.1016/S0167-8760(98)00030-0; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Martinovic J, 2008, BRAIN RES, V1198, P93, DOI 10.1016/j.brainres.2007.12.050; Martinovic J, 2007, J COGNITIVE NEUROSCI, V19, P921, DOI 10.1162/jocn.2007.19.6.921; Muller MM, 2004, J COGNITIVE NEUROSCI, V16, P503, DOI 10.1162/089892904322926827; Naor-Raz G, 2003, PERCEPTION, V32, P667, DOI 10.1068/p5050; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Regan D., 1989, HUMAN BRAIN ELECTROP; Reis A, 2006, BRAIN COGNITION, V60, P49, DOI 10.1016/j.bandc.2005.09.012; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Rousselet GA, 2007, J COGNITIVE NEUROSCI, V19, P1241, DOI 10.1162/jocn.2007.19.8.1241; Schendan HE, 2007, J COGNITIVE NEUROSCI, V19, P734, DOI 10.1162/jocn.2007.19.5.734; Schendan HE, 2003, J COGNITIVE NEUROSCI, V15, P111, DOI 10.1162/089892903321107864; Schendan HE, 2002, NEUROPSYCHOLOGIA, V40, P931, DOI 10.1016/S0028-3932(01)00176-2; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tanaka J, 2001, TRENDS COGN SCI, V5, P211, DOI 10.1016/S1364-6613(00)01626-0; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Ullman S, 2007, TRENDS COGN SCI, V11, P58, DOI 10.1016/j.tics.2006.11.009; van Schie HT, 2003, BRAIN LANG, V86, P300, DOI 10.1016/S0093-934X(02)00546-1; VANRIJN AC, 1991, MED BIOL ENG COMPUT, V29, P433, DOI 10.1007/BF02441666; VANRIJN ACM, 1990, MED BIOL ENG COMPUT, V28, P389, DOI 10.1007/BF02441961; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Yip AW, 2002, PERCEPTION, V31, P995, DOI 10.1068/p3376; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	55	55	56	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3781	10.1371/journal.pone.0003781	http://dx.doi.org/10.1371/journal.pone.0003781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436XG	19023428	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448800002
J	Yang, CY; Cao, GC; Li, Y; Zhang, XJ; Ren, HY; Wang, X; Feng, JH; Zhao, LP; Xu, P				Yang, Chunyu; Cao, Guangchun; Li, Yang; Zhang, Xiaojun; Ren, Hongyan; Wang, Xia; Feng, Jinhui; Zhao, Liping; Xu, Ping			A Constructed Alkaline Consortium and Its Dynamics in Treating Alkaline Black Liquor with Very High Pollution Load	PLOS ONE			English	Article							MILL WASTE-WATER; PULP-MILL; MICROBIAL DIVERSITY; POPULATION-DYNAMICS; COMMUNITY DYNAMICS; WHEAT-STRAW; LIGNIN; REACTOR; DECOLORIZATION; EFFLUENTS	Background: Paper pulp wastewater resulting from alkaline extraction of wheat straw, known as black liquor, is very difficult to be treated and causes serious environmental problems due to its high pH value and chemical oxygen demand (COD) pollution load. Lignin, semicellulose and cellulose are the main contributors to the high COD values in black liquor. Very few microorganisms can survive in such harsh environments of the alkaline wheat straw black liquor. A naturally developed microbial community was found accidentally in a black liquor storing pool in a paper pulp mill of China. The community was effective in pH decreasing, color and COD removing from the high alkaline and high COD black liquor. Findings: Thirty-eight strains of bacteria were isolated from the black liquor storing pool, and were grouped as eleven operational taxonomy units (OTUs) using random amplified polymorphic DNA-PCR profiles (RAPD). Eleven representative strains of each OTU, which were identified as genera of Halomonas and Bacillus, were used to construct a consortium to treat black liquor with a high pH value of 11.0 and very high COD pollution load of 142,600 mg l(-1). After treatment by the constructed consortium, about 35.4% of color and 39,000 mg l(-1) (27.3%) CODcr were removed and the pH decreased to 7.8. 16S rRNA gene polymerase chain reaction denaturant gradient gel electrophoresis (PCR-DGGE) and gas chromatography/mass spectrometry (GC/MS) analysis suggested a two-stage treatment mechanism to elucidate the interspecies collaboration: Halomonas isolates were important in the first stage to produce organic acids that contributed to the pH decline, while Bacillus isolates were involved in the degradation of lignin derivatives in the second stage under lower pH conditions. Conclusions/Significance: Tolerance to the high alkaline environment and good controllability of the simple consortium suggested that the constructed consortium has good potential for black liquor treatment. Facilitating the treatment process by the constructed consortium would provide a promising opportunity to reduce the pollution, as well as to save forest resources and add value to a waste product.	[Yang, Chunyu; Cao, Guangchun; Li, Yang; Wang, Xia; Feng, Jinhui; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zhang, Xiaojun; Ren, Hongyan; Zhao, Liping; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Minist Ed, Key Lab Microbial Metabolism, Shanghai, Peoples R China	Shandong University; Shanghai Jiao Tong University	Yang, CY (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	pingxu@sdu.edu.cn	Zhang, Xiaojun/AAH-2256-2019; Zhang, Xiaojun/E-9521-2016; Liu, Wenjun/L-5256-2016	Zhang, Xiaojun/0000-0002-4559-0177; Zhang, Xiaojun/0000-0002-4559-0177; Liu, Wenjun/0000-0001-9380-2990	Ministry of Science and Technology of China; National Basic Research Program of China [2007CB707803]; Chinese National Programs for High Technology Research and Development [2006AA020101, 2006AA02Z244]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); Chinese National Programs for High Technology Research and Development(National High Technology Research and Development Program of China)	The work was partially supported by the grants from the Ministry of Science and Technology of China, National Basic Research Program of China (2007CB707803) and Chinese National Programs for High Technology Research and Development (2006AA020101 and 2006AA02Z244).	BAJPAI P, 1993, PROCESS BIOCHEM, V28, P377, DOI 10.1016/0032-9592(93)80024-B; Buzzini AP, 2006, PROCESS BIOCHEM, V41, P168, DOI 10.1016/j.procbio.2005.06.009; Buzzini AP, 2005, CHEMOSPHERE, V59, P55, DOI 10.1016/j.chemosphere.2004.09.102; Camarero S, 2001, J ANAL APPL PYROL, V58, P413, DOI 10.1016/S0165-2370(00)00115-7; Carrero-Colon M, 2006, FEMS MICROBIOL ECOL, V57, P1, DOI 10.1111/j.1574-6941.2006.00095.x; CPPA, 1974, TECHN SECT STAND MET; Dafinov A, 2005, DESALINATION, V173, P83, DOI 10.1016/j.desal.2004.07.044; Fenning TM, 2002, TRENDS BIOTECHNOL, V20, P291, DOI 10.1016/S0167-7799(02)01983-2; Font X, 2003, J CHEM TECHNOL BIOT, V78, P548, DOI 10.1002/jctb.834; Ganjidoust H, 1997, WATER SCI TECHNOL, V35, P291, DOI 10.2166/wst.1997.0541; Garg SK, 1999, CRIT REV BIOTECHNOL, V19, P85, DOI 10.1080/0738-859991229206; Greenberg A.E., 1992, STANDARD METHODS EXA, V18; Grover R, 2001, J CHEM TECHNOL BIOT, V76, P251, DOI 10.1002/jctb.371; Gupta VK, 2001, J CHEM TECHNOL BIOT, V76, P547, DOI 10.1002/jctb.417.abs; Harris AT, 2008, J CLEAN PROD, V16, P1971, DOI 10.1016/j.jclepro.2008.02.005; Huang GL, 2007, BIORESOURCE TECHNOL, V98, P2829, DOI 10.1016/j.biortech.2006.09.029; Jain Neeraj, 1997, Indian Journal of Experimental Biology, V35, P139; KAAL EEJ, 1995, BIORESOURCE TECHNOL, V53, P133, DOI 10.1016/0960-8524(95)00066-N; Ko CH, 2007, BIORESOURCE TECHNOL, V98, P2727, DOI 10.1016/j.biortech.2006.09.034; Konopka A, 2007, ENVIRON MICROBIOL, V9, P1584, DOI 10.1111/j.1462-2920.2007.01326.x; Kumar Lokesh, 2001, Indian Journal of Experimental Biology, V39, P584; Lara MA, 2003, INT BIODETER BIODEGR, V52, P167, DOI 10.1016/S0964-8305(03)00055-6; Lim JM, 2004, INT J SYST EVOL MICR, V54, P2037, DOI 10.1099/ijs.0.63194-0; Liu BB, 2006, FEMS MICROBIOL ECOL, V55, P274, DOI 10.1111/j.1574-6941.2005.00033.x; Liu GL, 2004, DESALINATION, V160, P131, DOI 10.1016/S0011-9164(04)90003-3; Lozada M, 2006, ENVIRON MICROBIOL, V8, P625, DOI 10.1111/j.1462-2920.2005.00939.x; Meroth CB, 2003, APPL ENVIRON MICROB, V69, P475, DOI 10.1128/AEM.69.1.475-482.2003; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Pokhrel D, 2004, SCI TOTAL ENVIRON, V333, P37, DOI 10.1016/j.scitotenv.2004.05.017; REN X, 1998, J CLEAN PROD, V6, P349, DOI DOI 10.1016/S0959-6526(98)00023-7; Roncero MB, 2003, BIORESOURCE TECHNOL, V87, P305, DOI 10.1016/S0960-8524(02)00224-9; Sambrook J., 1989, MOL CLONING LAB MANU; Stougaard P, 2002, ENVIRON MICROBIOL, V4, P487, DOI 10.1046/j.1462-2920.2002.00327.x; SUTHERLAND JB, 1983, CAN J MICROBIOL, V29, P1253, DOI 10.1139/m83-195; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tiago I, 2004, APPL ENVIRON MICROB, V70, P7378, DOI 10.1128/AEM.70.12.7378-7387.2004; Tresse O, 2005, J APPL MICROBIOL, V98, P440, DOI 10.1111/j.1365-2672.2004.02475.x; Wu J, 2005, BIORESOURCE TECHNOL, V96, P1357, DOI 10.1016/j.biortech.2004.11.019; Xiong Z, 2007, J BIOSCI BIOENG, V104, P446, DOI 10.1263/jbb.104.446; Zhang QL, 2001, ADV ENVIRON RES, V5, P251, DOI 10.1016/S1093-0191(00)00059-9	41	28	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3777	10.1371/journal.pone.0003777	http://dx.doi.org/10.1371/journal.pone.0003777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020664	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448600010
J	Iliopoulos, D; Malizos, KN; Oikonomou, P; Tsezou, A				Iliopoulos, Dimitrios; Malizos, Konstantinos N.; Oikonomou, Pagona; Tsezou, Aspasia			Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory Networks	PLOS ONE			English	Article								Background: Osteoarthritis is a multifactorial disease characterized by destruction of the articular cartilage due to genetic, mechanical and environmental components affecting more than 100 million individuals all over the world. Despite the high prevalence of the disease, the absence of large-scale molecular studies limits our ability to understand the molecular pathobiology of osteoathritis and identify targets for drug development. Methodology/Principal Findings: In this study we integrated genetic, bioinformatic and proteomic approaches in order to identify new genes and their collaborative networks involved in osteoarthritis pathogenesis. MicroRNA profiling of patient-derived osteoarthritic cartilage in comparison to normal cartilage, revealed a 16 microRNA osteoarthritis gene signature. Using reverse-phase protein arrays in the same tissues we detected 76 differentially expressed proteins between osteoarthritic and normal chondrocytes. Proteins such as SOX11, FGF23, KLF6, WWOX and GDF15 not implicated previously in the genesis of osteoarthritis were identified. Integration of microRNA and proteomic data with microRNA gene-target prediction algorithms, generated a potential "interactome'' network consisting of 11 microRNAs and 58 proteins linked by 414 potential functional associations. Comparison of the molecular and clinical data, revealed specific microRNAs (miR-22, miR-103) and proteins (PPARA, BMP7, IL1B) to be highly correlated with Body Mass Index (BMI). Experimental validation revealed that miR-22 regulated PPARA and BMP7 expression and its inhibition blocked inflammatory and catabolic changes in osteoarthritic chondrocytes. Conclusions/Significance: Our findings indicate that obesity and inflammation are related to osteoarthritis, a metabolic disease affected by microRNA deregulation. Gene network approaches provide new insights for elucidating the complexity of diseases such as osteoarthritis. The integration of microRNA, proteomic and clinical data provides a detailed picture of how a network state is correlated with disease and furthermore leads to the development of new treatments. This strategy will help to improve the understanding of the pathogenesis of multifactorial diseases such as osteoarthritis and provide possible novel therapeutic targets.	[Iliopoulos, Dimitrios; Malizos, Konstantinos N.; Oikonomou, Pagona; Tsezou, Aspasia] Inst Biomed Res & Technol, Larisa, Greece; [Malizos, Konstantinos N.] Univ Thessaly, Sch Med, Dept Orthopaed, Larisa, Greece; [Tsezou, Aspasia] Univ Thessaly, Univ Hosp, Sch Med, Lab Cytogenet & Mol Genet, Larisa, Greece; [Tsezou, Aspasia] Univ Thessaly, Sch Med, Dept Biol, Larisa, Greece	University of Thessaly; General University Hospital of Larissa; University of Patras; University of Thessaly; University of Thessaly	Iliopoulos, D (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	atsezou@med.uth.gr	Iliopoulos, Dimitrios/AAE-9106-2019		Hellenic Association of Orthopaedic Surgery and Traumatology	Hellenic Association of Orthopaedic Surgery and Traumatology	Funding support was provided from Hellenic Association of Orthopaedic Surgery and Traumatology. Funding organizations did not have any role in study design, data collection, interpretation of the results, decision to publish, or preparation of the manuscript.	AQEILAN RI, 2008, J BIOL CHEM, V16; Aspden RM, 2001, LANCET, V357, P1118, DOI 10.1016/S0140-6736(00)04264-1; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chowdhury TT, 2006, BIOMECH MODEL MECHAN, V5, P192, DOI 10.1007/s10237-006-0032-3; Cuzzocrea S, 2006, J LEUKOCYTE BIOL, V79, P999, DOI 10.1189/jlb.0605341; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gulmann C, 2005, CLIN CANCER RES, V11, P5847, DOI 10.1158/1078-0432.CCR-05-0637; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; HUBER J, 2008, J CLIN ENDOCRINOL ME, V20; Iliopoulos D, 2007, ANN RHEUM DIS, V66, P1616, DOI 10.1136/ard.2007.069377; Im HJ, 2003, J BIOL CHEM, V278, P25386, DOI 10.1074/jbc.M302048200; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lementowski Peter W, 2008, Am J Orthop (Belle Mead NJ), V37, P148; LOHMANDER LS, 2008, ANN RHEUM DIS, V8; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MARCH LM, 2008, AM J ORTHOPSYCHIAT, V37, P148; Marks R, 2007, OBESITY, V15, P1867, DOI 10.1038/oby.2007.221; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Ostalowska A, 2006, OSTEOARTHR CARTILAGE, V14, P139, DOI 10.1016/j.joca.2005.08.009; SELBACH M, 2008, NATURE          0730; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Simopoulou T, 2007, OSTEOARTHR CARTILAGE, V15, P872, DOI 10.1016/j.joca.2007.01.018; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Spector T. D., 2004, Osteoarthritis and Cartilage, V12, P39, DOI 10.1016/j.joca.2003.09.005; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tongbai R, 2008, AM J PATHOL, V172, P495, DOI 10.2353/ajpath.2008.061079; VanMeter A, 2007, EXPERT REV MOL DIAGN, V7, P625, DOI 10.1586/14737159.7.5.625; Vincourt JB, 2006, MOL CELL PROTEOMICS, V5, P1984, DOI 10.1074/mcp.T600007-MCP200; Watters JW, 2007, ARTHRITIS RHEUM, V56, P2999, DOI 10.1002/art.22836; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; Yeh LCC, 2004, BIOCHEM BIOPH RES CO, V323, P223, DOI 10.1016/j.bbrc.2004.08.080	40	397	428	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3740	10.1371/journal.pone.0003740	http://dx.doi.org/10.1371/journal.pone.0003740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011694	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448300008
J	Lopes, PC; Sucena, E; Santos, ME; Magalhaes, S				Lopes, Patricia C.; Sucena, Elio; Santos, M. Emilia; Magalhaes, Sara			Rapid Experimental Evolution of Pesticide Resistance in C. elegans Entails No Costs and Affects the Mating System	PLOS ONE			English	Article								Pesticide resistance is a major concern in natural populations and a model trait to study adaptation. Despite the importance of this trait, the dynamics of its evolution and of its ecological consequences remain largely unstudied. To fill this gap, we performed experimental evolution with replicated populations of Caenorhabditis elegans exposed to the pesticide Levamisole during 20 generations. Exposure to Levamisole resulted in decreased survival, fecundity and male frequency, which declined from 30% to zero. This was not due to differential susceptibility of males. Rather, the drug affected mobility, resulting in fewer encounters, probably leading to reduced outcrossing rates. Adaptation, i.e., increased survival and fecundity, occurred within 10 and 20 generations, respectively. Male frequency also increased by generation 20. Adaptation costs were undetected in the ancestral environment and in presence of Ivermectin, another widely-used pesticide with an opposite physiological effect. Our results demonstrate that pesticide resistance can evolve at an extremely rapid pace. Furthermore, we unravel the effects of behaviour on life-history traits and test the environmental dependence of adaptation costs. This study establishes experimental evolution as a powerful tool to tackle pesticide resistance, and paves the way to further investigations manipulating environmental and/or genetic factors underlying adaptation to pesticides.	[Lopes, Patricia C.] Univ Porto, Programa Grad Areas Biol Basica & Aplicada GABBA, Fac Med, P-4100 Oporto, Portugal; [Lopes, Patricia C.; Sucena, Elio; Santos, M. Emilia; Magalhaes, Sara] Inst Gulbenkian Ciencias, Ctr Biol Desenvolvimento, Oeiras, Portugal; [Magalhaes, Sara] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1699 Lisbon, Portugal	Universidade do Porto; Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Lopes, PC (corresponding author), Univ Porto, Programa Grad Areas Biol Basica & Aplicada GABBA, Fac Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	smagalhaes@igc.gulbenkian.pt	S., Magalhaes/B-9673-2012; Sucena, Élio/M-1753-2015; Sucena, Élio/ABF-6684-2020; Lopes, Patricia C./AFK-9377-2022	S., Magalhaes/0000-0002-8609-7768; Sucena, Élio/0000-0001-8810-870X; Sucena, Élio/0000-0001-8810-870X; Santos, M. Emilia/0000-0003-3158-7935; Soares Castro Lopes, Patricia/0000-0001-5170-3230	Marie Curie [36589]; Fundacao para a Ciencia e Tecnologia (Portugal) [POCTI/BSE/48402/2002]	Marie Curie(European Commission); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology)	Marie Curie Reintegration grant (36589 - EVOL HET and ENV) and POCTI/BSE/48402/2002 grant from Fundacao para a Ciencia e Tecnologia (Portugal)	Anderson JB, 2003, GENETICS, V163, P1287; Arnaud L, 2005, FUNCT ECOL, V19, P1032, DOI 10.1111/j.1365-2435.2005.01055.x; Arnaud L, 2002, EVOLUTION, V56, P2435, DOI 10.1111/j.0014-3820.2002.tb00169.x; Asser-Kaiser S, 2007, SCIENCE, V317, P1916, DOI 10.1126/science.1146542; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Bird LJ, 2007, BIOL CONTROL, V40, P196, DOI 10.1016/j.biocontrol.2006.11.004; Bull JJ, 2001, ANNU REV ECOL SYST, V32, P183, DOI 10.1146/annurev.ecolsys.32.081501.114020; CARRIERE Y, 1994, P ROY SOC B-BIOL SCI, V258, P35, DOI 10.1098/rspb.1994.0138; Casida JE, 1998, ANNU REV ENTOMOL, V43, P1, DOI 10.1146/annurev.ento.43.1.1; CHARLESWORTH D, 1984, BIOL J LINN SOC, V22, P333, DOI 10.1111/j.1095-8312.1984.tb01683.x; Coustau C, 2000, TRENDS ECOL EVOL, V15, P378, DOI 10.1016/S0169-5347(00)01929-7; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Cutter AD, 2005, J EVOLUTION BIOL, V18, P27, DOI 10.1111/j.1420-9101.2004.00804.x; DELAGUERIE P, 1991, EVOL ECOL, V5, P361, DOI 10.1007/BF02214153; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Ffrench-Constant RH, 2007, TRENDS GENET, V23, P1, DOI 10.1016/j.tig.2006.11.006; Fleming JT, 1997, J NEUROSCI, V17, P5843; Foster SP, 2007, ANIM BEHAV, V74, P621, DOI 10.1016/j.anbehav.2006.12.018; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; Hedrick PW, 2006, ANNU REV ECOL EVOL S, V37, P67, DOI 10.1146/annurev.ecolsys.37.091305.110132; Jasmin JN, 2007, ECOL LETT, V10, P272, DOI 10.1111/j.1461-0248.2007.01021.x; Kim J, 2001, GENETICS, V157, P1599; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; LaMunyon CW, 1998, P ROY SOC B-BIOL SCI, V265, P1997, DOI 10.1098/rspb.1998.0531; LEJAMBRE LF, 1995, INT J PARASITOL, V25, P691, DOI 10.1016/0020-7519(94)00200-8; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu YS, 2007, J NEUROSCI, V27, P1411, DOI 10.1523/JNEUROSCI.4320-06.2007; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8; Manoel D, 2007, P ROY SOC B-BIOL SCI, V274, P417, DOI 10.1098/rspb.2006.3739; McCart C, 2005, CURR BIOL, V15, pR587, DOI 10.1016/j.cub.2005.07.054; McKenzie JA, 1998, PHILOS T ROY SOC B, V353, P1729, DOI 10.1098/rstb.1998.0325; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; Pannell JR, 2002, ANNU REV ECOL SYST, V33, P397, DOI 10.1146/annurev.ecolsys.33.010802.150419; Raymond M, 1998, PHILOS T R SOC B, V353, P1707, DOI 10.1098/rstb.1998.0322; Sokal RR, 1995, BIOMETRY; Stewart AD, 2002, GENETICS, V160, P975; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Tietjen WJ, 2006, J ARACHNOL, V34, P285, DOI 10.1636/S04-50.1; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547	44	50	51	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3741	10.1371/journal.pone.0003741	http://dx.doi.org/10.1371/journal.pone.0003741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011681	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448300009
J	Shih, MYS; Kane, MA; Zhou, P; Yen, CLE; Streeper, RS; Napoli, JL; Farese, RV				Shih, Michelle Y. S.; Kane, Maureen A.; Zhou, Ping; Yen, C. L. Eric; Streeper, Ryan S.; Napoli, Joseph L.; Farese, Robert V., Jr.			Retinol Esterification by DGAT1 Is Essential for Retinoid Homeostasis in Murine Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-GLAND; BINDING-PROTEINS; ACYLTRANSFERASE GENE; ACID; HAIR; LECITHIN; MICE; EXPRESSION; ENZYMES; MECHANISMS	Retinoic acid (RA) is a potent signaling molecule that is essential for many biological processes, and its levels are tightly regulated by mechanisms that are only partially understood. The synthesis of RA from its precursor retinol (vitamin A) is an important regulatory mechanism. Therefore, the esterification of retinol with fatty acyl moieties to generate retinyl esters, the main storage form of retinol, may also regulate RA levels. Here we show that the neutral lipid synthesis enzyme acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) functions as the major acyl-CoA: retinol acyltransferase (ARAT) in murine skin. When dietary retinol is abundant, DGAT1 deficiency results in elevated levels of RA in skin and cyclical hair loss; both are prevented by dietary retinol deprivation. Further, DGAT1-deficient skin exhibits enhanced sensitivity to topically administered retinol. Deletion of the enzyme specifically in the epidermis causes alopecia, indicating that the regulation of RA homeostasis by DGAT1 is autonomous in the epidermis. These findings show that DGAT1 functions as an ARAT in the skin, where it acts to maintain retinoid homeostasis and prevent retinoid toxicity. Our findings may have implications for human skin or hair disorders treated with agents that modulate RA signaling.	[Shih, Michelle Y. S.; Zhou, Ping; Yen, C. L. Eric; Streeper, Ryan S.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94158 USA; [Shih, Michelle Y. S.; Farese, Robert V., Jr.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA; [Kane, Maureen A.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Farese, RV (corresponding author), J David Gladstone Inst, 1650 Owens St, San Francisco, CA 94158 USA.	bfarese@gladstone.ucsf.edu			National Institutes of Health [DK-056084, DK36870]; National Center for Research Resources extramural research facilities Grant [C06 RR018928]; J. David Gladstone Institutes; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056084, R01DK056084, R01DK036870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources extramural research facilities Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); J. David Gladstone Institutes(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-056084 (to R. F.) and DK36870 (to J. L. N.). This work was also supported by National Center for Research Resources extramural research facilities Grant C06 RR018928 and by the J. David Gladstone Institutes. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Azais-Braesco V, 2000, AM J CLIN NUTR, V71, p1325S, DOI 10.1093/ajcn/71.5.1325s; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BAZZANO G, 1993, J INVEST DERMATOL, V101, pS138, DOI 10.1111/1523-1747.ep12363264; BAZZANO GS, 1986, J AM ACAD DERMATOL, V15, P880, DOI 10.1016/S0190-9622(86)80024-X; BERTHJONES J, 1995, BRIT J DERMATOL, V132, P367, DOI 10.1111/j.1365-2133.1995.tb08669.x; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Cases S, 2004, DEVELOPMENT, V131, P3047, DOI 10.1242/dev.01158; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Clarke SB, 2007, DERMATOL CLIN, V25, P137, DOI 10.1016/j.det.2007.01.004; Dassule HR, 2000, DEVELOPMENT, V127, P4775; ELIAS PM, 1986, J AM ACAD DERMATOL, V15, P797, DOI 10.1016/S0190-9622(86)70236-3; Everts HB, 2004, J INVEST DERMATOL, V123, P258, DOI 10.1111/j.0022-202X.2004.23223.x; Everts HB, 2007, J INVEST DERMATOL, V127, P1593, DOI 10.1038/sj.jid.5700753; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Foitzik K, 2005, J INVEST DERMATOL, V124, P1119, DOI 10.1111/j.0022-202X.2005.23686.x; Gritli-Linde A, 2007, DEV CELL, V12, P99, DOI 10.1016/j.devcel.2006.12.006; Hanakawa Y, 2002, J INVEST DERMATOL, V119, P27, DOI 10.1046/j.1523-1747.2002.01780.x; Hansen LA, 2000, CARCINOGENESIS, V21, P1271, DOI 10.1093/carcin/21.7.1271; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Kurlandsky SB, 1996, J BIOL CHEM, V271, P15346, DOI 10.1074/jbc.271.26.15346; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; LOOK J, 1995, AM J PHYSIOL-ENDOC M, V269, pE91, DOI 10.1152/ajpendo.1995.269.1.E91; MACDONALD PN, 1988, J BIOL CHEM, V263, P12478; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Matsuda D, 2007, CURR OPIN INVEST DR, V8, P836; Meiner V, 1997, J LIPID RES, V38, P1928; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; ONG DE, 1987, J BIOL CHEM, V262, P2729; Orland MD, 2005, BBA-MOL CELL BIOL L, V1737, P76, DOI 10.1016/j.bbalip.2005.09.003; Randolph RK, 1997, J LIPID RES, V38, P1374; RANDOLPH RK, 1991, ARCH BIOCHEM BIOPHYS, V288, P500, DOI 10.1016/0003-9861(91)90227-A; RANDOLPH RK, 1993, J BIOL CHEM, V268, P9198; Reichrath J, 2007, HORM METAB RES, V39, P71, DOI 10.1055/s-2007-958715; ROSS AC, 1982, J LIPID RES, V23, P133; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; TORMA H, 1987, J INVEST DERMATOL, V88, P398, DOI 10.1111/1523-1747.ep12469726; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; Zouboulis CC, 2001, SKIN PHARMACOL APPL, V14, P303, DOI 10.1159/000056361	49	68	71	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4292	4299		10.1074/jbc.M807503200	http://dx.doi.org/10.1074/jbc.M807503200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19028692	Green Published, hybrid			2022-12-25	WOS:000263134400027
J	Popp, MW; Artavanis-Tsakonas, K; Ploegh, HL				Popp, Maximilian W.; Artavanis-Tsakonas, Katerina; Ploegh, Hidde L.			Substrate Filtering by the Active Site Crossover Loop in UCHL3 Revealed by Sortagging and Gain-of-function Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL HYDROLASES; DEUBIQUITINATING ENZYMES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; UBIQUITIN; SPECIFICITY; UCH-L3; MEMBRANE; PROTEINS; A20	Determining how deubiquitinating enzymes discriminate between ubiquitin-conjugated substrates is critical to understand their function. Through application of a novel protein cleavage and tagging technique, sortagging, we show that human UCHL3 and the Plasmodium falciparum homologue, members of the ubiquitin C-terminal hydrolase family, use a unique active site crossover loop to restrict access of bulky ubiquitin adducts to the active site. Although it provides connectivity for critical active site residues in UCHL3, physical integrity of the crossover loop is dispensable for catalysis. By enlarging the active site crossover loop, we have constructed gain-of-function mutants that can accept substrates that the parent enzyme cannot, including ubiquitin chains of various linkages.	[Popp, Maximilian W.; Artavanis-Tsakonas, Katerina; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Popp, Maximilian W.; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by grants from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Frickel EM, 2007, CELL MICROBIOL, V9, P1601, DOI 10.1111/j.1462-5822.2007.00896.x; Hassiepen U, 2007, ANAL BIOCHEM, V371, P201, DOI 10.1016/j.ab.2007.07.034; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Skehel JJ, 2001, BIOCHEM SOC T, V29, P623, DOI 10.1042/BST0290623; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	26	48	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3593	3602		10.1074/jbc.M807172200	http://dx.doi.org/10.1074/jbc.M807172200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19047059	Green Published, hybrid			2022-12-25	WOS:000262872500027
J	Veuger, SJ; Hunter, JE; Durkacz, BW				Veuger, S. J.; Hunter, J. E.; Durkacz, B. W.			Ionizing radiation-induced NF-kappa B activation requires PARP-1 function to confer radioresistance	ONCOGENE			English	Article						NF-kappa B; PARP-1; ionizing radiation	ADP-RIBOSE POLYMERASE-1; APOPTOSIS PROTEIN XIAP; BREAST-CANCER CELLS; X-LINKED INHIBITOR; POLY(ADP-RIBOSE) POLYMERASE-1; TRANSCRIPTION FACTORS; THERAPEUTIC TARGET; BINDING-ACTIVITY; GENE-EXPRESSION; TUMOR-CELLS	Recent reports implicate poly(ADP-ribose) polymerase-1 (PARP-1) in the activation of nuclear factor kappaB (NF-kappa B). We investigated the role of PARP-1 in the NF-kappa B signalling cascade induced by ionizing radiation (IR). AG14361, a potent PARP-1 inhibitor, was used in two breast cancer cell lines expressing different levels of constitutively activated NF-kappa B, as well as mouse embryonic fibroblasts (MEFs) proficient or deficient for PARP-1 or NF-kappa B p65. In the breast cancer cell lines, AG14361 had no effect on IR-induced degradation of I kappa B alpha or nuclear translocation of p50 or p65. However, AG14361 inhibited IR-induced NF-kappa B-dependent transcription of a luciferase reporter gene. Similarly, in PARP-1(-/-) MEFs, IR-induced nuclear translocation of p50 and p65 was normal, but kappa B binding and transcriptional activation did not occur. AG14361 sensitized both breast cancer cell lines to IR-induced cell killing, inhibited IR-induced XIAP expression and increased caspase-3 activity. However, AG14361 failed to increase IR-induced caspase activity when p65 was knocked down by siRNA. Consistent with this, AG14361 sensitized p65(+/+) but not p65(-/-) MEFs to IR. We conclude that PARP-1 activity is essential in the upstream regulation of IR-induced NF-kappa B activation. These data indicate that potentiation of IR-induced cytotoxicity by AG14361 is mediated solely by inhibition of NF-kappa B activation.	[Veuger, S. J.; Hunter, J. E.; Durkacz, B. W.] Univ Newcastle, No Inst Canc Res, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Durkacz, BW (corresponding author), Newcastle Univ, No Inst Canc Res, Sch Med, Paul OGorman Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	b.w.durkacz@newcastle.ac.uk			Breast Cancer Campaign, UK; Cancer Research UK	Breast Cancer Campaign, UK; Cancer Research UK(Cancer Research UK)	This work was supported by the Breast Cancer Campaign, UK and Cancer Research UK.	ALTHAUS FR, 1994, MOL CELL BIOCHEM, V138, P53, DOI 10.1007/BF00928443; Andela VB, 2000, CANCER RES, V60, P6557; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Biswas DK, 2001, P NATL ACAD SCI USA, V98, P10386, DOI 10.1073/pnas.151257998; BRACH MA, 1991, J CLIN INVEST, V88, P691, DOI 10.1172/JCI115354; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Cardoso SM, 2003, FREE RADICAL RES, V37, P967, DOI 10.1080/10715760310001595757; Carrillo A, 2004, NUCLEIC ACIDS RES, V32, P757, DOI 10.1093/nar/gkh239; Chalmers A, 2004, INT J RADIAT ONCOL, V58, P410, DOI 10.1016/j.ijrobp.2003.09.053; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Concin N, 2003, BREAST CANCER RES TR, V79, P37, DOI 10.1023/A:1023351717408; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Ferreira CG, 2001, ANN ONCOL, V12, P799, DOI 10.1023/A:1011167113067; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GRUBE K, 1991, ANAL BIOCHEM, V193, P236, DOI 10.1016/0003-2697(91)90015-L; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Jung M, 2001, SEMIN RADIAT ONCOL, V11, P346, DOI 10.1053/srao.2001.26034; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Martin-Oliva D, 2006, CANCER RES, V66, P5744, DOI 10.1158/0008-5472.CAN-05-3050; Nakajima H, 2004, J BIOL CHEM, V279, P42774, DOI 10.1074/jbc.M407923200; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pande V, 2005, CURR MED CHEM, V12, P357, DOI 10.2174/0929867053363180; Patel NM, 2000, ONCOGENE, V19, P4159, DOI 10.1038/sj.onc.1203768; Penolazzi L, 2003, BIOCHEM PHARMACOL, V66, P1189, DOI 10.1016/S0006-2952(03)00470-2; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pratt MAC, 2003, MOL CELL BIOL, V23, P6887, DOI 10.1128/MCB.23.19.6887-6900.2003; Raju U, 1998, INT J RADIAT BIOL, V74, P617, DOI 10.1080/095530098141195; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Russo SM, 2001, INT J RADIAT ONCOL, V50, P183, DOI 10.1016/S0360-3016(01)01446-8; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Skalitzky DJ, 2003, J MED CHEM, V46, P210, DOI 10.1021/jm0255769; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Veuger SJ, 2003, CANCER RES, V63, P6008; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Xiao CW, 2001, ENDOCRINOLOGY, V142, P557, DOI 10.1210/en.142.2.557; Yang L, 2003, CANCER RES, V63, P6815; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006	52	99	108	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					832	842		10.1038/onc.2008.439	http://dx.doi.org/10.1038/onc.2008.439			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19060926	Green Accepted			2022-12-25	WOS:000263320000006
J	Becker, D; Krayl, M; Strub, A; Li, Y; Mayer, MP; Voos, W				Becker, Dorothea; Krayl, Martin; Strub, Andreas; Li, Yanfeng; Mayer, Matthias P.; Voos, Wolfgang			Impaired Interdomain Communication in Mitochondrial Hsp70 Results in the Loss of Inward-directed Translocation Force	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT MOTOR; SUBSTRATE-BINDING; MOLECULAR CHAPERONES; CONFORMATIONAL-CHANGES; ALLOSTERIC REGULATION; STRUCTURAL BASIS; COCHAPERONE; PREPROTEINS; MECHANISM; COMPLEX	The essential mitochondrial Hsp70 (mtHsp70) is required for the import of mitochondrial preproteins into the matrix compartment. The translocation-specific activity of mtHsp70 is coordinated by its interaction with specific partner proteins, forming the import motor complex that provides the energy for unfolding and complete translocation of precursor polypeptide chains. A major biochemical characteristic of Hsp70-type chaperones is their nucleotide-regulated affinity to polypeptide substrates. To study the role of this allosteric regulation in the course of preprotein translocation, we have generated specific mtHsp70 mutations located within or close to the interface between the nucleotide-binding and the substrate-binding domains. Mitochondria isolated from the mtHsp70 mutants displayed severely reduced import efficiencies in vitro. Two of the mutants exhibited strong growth defects in vivo and were significantly impaired in the generation of an inward-directed, ATP-dependent import force on precursor proteins in transit. The biochemical properties of these two mutant proteins were consistent with defects in the transfer of conformational signals to the substrate-binding domain, resulting in a prolonged and enhanced interaction with imported substrate proteins. Furthermore, interference with the allosteric mechanism resulted in defects of translocation-specific partner protein interaction. We conclude that even a partial disruption of the interdomain communication in the mtHsp70 chaperone results in an almost complete breakdown of its translocation-driving properties.	[Becker, Dorothea; Voos, Wolfgang] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Becker, Dorothea; Krayl, Martin; Strub, Andreas; Li, Yanfeng] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Mayer, Matthias P.] Heidelberg Univ, ZMBH, D-69120 Heidelberg, Germany	University of Bonn; University of Freiburg; Ruprecht Karls University Heidelberg	Voos, W (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	wolfgang.voos@uni-bonn.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112	Deutsche Forschungsgemeinschaft [SFB 388]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 388, Teilprojekt A11 (to W. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bomer U, 1998, EMBO J, V17, P4226, DOI 10.1093/emboj/17.15.4226; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Erbse A, 2004, BIOCHEM SOC T, V32, P617, DOI 10.1042/BST0320617; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Kelley WL, 1999, CURR BIOL, V9, pR305, DOI 10.1016/S0960-9822(99)80185-7; Krayl M, 2007, MOL CELL BIOL, V27, P411, DOI 10.1128/MCB.01391-06; LALORAYA S, 1995, MOL CELL BIOL, V15, P7098; Lim JH, 2001, EMBO J, V20, P941, DOI 10.1093/emboj/20.5.941; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Merlin A, 1999, J CELL BIOL, V145, P961, DOI 10.1083/jcb.145.5.961; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Revington M, 2005, J MOL BIOL, V349, P163, DOI 10.1016/j.jmb.2005.03.033; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Ryan MT, 2002, ADV PROTEIN CHEM, V59, P223; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Schmidt S, 2001, J MOL BIOL, V313, P13, DOI 10.1006/jmbi.2001.5013; Schneider HC, 1996, EMBO J, V15, P5796, DOI 10.1002/j.1460-2075.1996.tb00966.x; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Sousa R, 2006, TRAFFIC, V7, P1596, DOI 10.1111/j.1600-0854.2006.00497.x; Strub A, 2000, BIOL CHEM, V381, P943, DOI 10.1515/BC.2000.115; Strub A, 2002, EMBO J, V21, P2626, DOI 10.1093/emboj/21.11.2626; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Tomkiewicz D, 2007, FEBS LETT, V581, P2820, DOI 10.1016/j.febslet.2007.04.015; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Ungermann C, 1996, EMBO J, V15, P735, DOI 10.1002/j.1460-2075.1996.tb00409.x; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; VOOS W, 1994, MOL CELL BIOL, V14, P6627, DOI 10.1128/MCB.14.10.6627; Voos W, 1996, EMBO J, V15, P2668, DOI 10.1002/j.1460-2075.1996.tb00627.x; VOOS W, 1993, J CELL BIOL, V123, P119, DOI 10.1083/jcb.123.1.119; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; WAGGONER A, 1976, J MEMBRANE BIOL, V27, P317, DOI 10.1007/BF01869143; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x; Westermann B, 1996, MOL CELL BIOL, V16, P7063; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang YB, 2004, P NATL ACAD SCI USA, V101, P10272, DOI 10.1073/pnas.0401313101; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	64	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2934	2946		10.1074/jbc.M803557200	http://dx.doi.org/10.1074/jbc.M803557200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19036727	hybrid			2022-12-25	WOS:000262700900038
J	Chen, RS; Song, YM; Zhou, ZY; Tong, T; Li, Y; Fu, M; Guo, XL; Dong, LJ; He, X; Qiao, HX; Zhan, QM; Li, W				Chen, R-S; Song, Y-M; Zhou, Z-Y; Tong, T.; Li, Y.; Fu, M.; Guo, X-L; Dong, L-J; He, X.; Qiao, H-X; Zhan, Q-M; Li, W.			Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway	ONCOGENE			English	Article						xCT/SLC7A11; cancer; metastasis; caveolin-1; beta-catenin; oxidative stress	BETA-CATENIN; DOWN-REGULATION; PREMATURE SENESCENCE; TYROSINE KINASES; OXIDATIVE STRESS; PLASMA-MEMBRANE; CYSTINE UPTAKE; E-CADHERIN; CAVEOLIN-1; PROTEIN	xCT, the functional subunit of the cystine/glutamate transporter xc- system, plays a critical role in the maintenance of intracellular glutathione and redox balance. Disruption of xCT significantly inhibits the growth of a variety of carcinomas, including lymphoma, glioma, prostate and breast cancer. However, the role of xCT in tumor metastasis remains largely unknown. In this study, both xCT(+/+) and xCT(-/-) melanocytes were used to evaluate the role of xCT in adhesion. xCT activity was suppressed by an inhibitor, sulfasalazine (SASP), or by xCT siRNA in an esophageal cancer cell line, KYSE150. We found that disruption of xCT enhanced homotypic cell-cell adhesion and attenuated cell-extracellular matrix adhesion. SASP significantly inhibited both cell invasion of KYSE150 in vitro and its experimental metastasis in nude mice. Caveolin-1 was upregulated and beta-catenin was recruited to the plasma membrane when xCT was deficient, which were followed by the inhibition of beta-catenin transcriptional activity. Further study revealed that the upregulation of caveolin-1 and inhibition of tumor cell invasion were mediated by reactive oxygen species-induced p38 MAPK activation. These results first establish the role of xCT in tumor metastasis and implicate a potential target for cancer therapy.	[Chen, R-S; Zhou, Z-Y; Li, Y.; Guo, X-L; He, X.; Qiao, H-X; Li, W.] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Chen, R-S; Li, Y.; Guo, X-L] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China; [Chen, R-S] Fujian Acad Agr Sci, Ctr Biotechnol, Fuzhou, Fujian, Peoples R China; [Song, Y-M; Tong, T.; Fu, M.; Dong, L-J; Zhan, Q-M] Peking Union Med Coll, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Song, Y-M; Tong, T.; Fu, M.; Dong, L-J; Zhan, Q-M] Chinese Acad Med Sci, Beijing 100037, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fujian Academy of Agricultural Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Li, W (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Datun Rd, Beijing 100101, Peoples R China.	zhanqimin@pumc.edu.cn; wli@genetics.ac.cn	Guo, Xiaoli/O-3906-2014		National Basic Research Program of China [2006CB504100, 2006CB500700, 2007CB947200]; National Natural Science Foundation of China [30525007, 30730049]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr Richard T Swank and Dr Edward K Novak for their invaluable comments on this paper. This study was supported in part by National Basic Research Program of China (2006CB504100, 2006CB500700 and 2007CB947200), grants from National Natural Science Foundation of China (30525007 and 30730049) (to WL or XH).	Chintala S, 2005, P NATL ACAD SCI USA, V102, P10964, DOI 10.1073/pnas.0502856102; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Doxsee DW, 2007, PROSTATE, V67, P162, DOI 10.1002/pros.20508; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Ji J, 2007, ONCOGENE, V26, P6396, DOI 10.1038/sj.onc.1210469; Kim JY, 2001, BBA-BIOMEMBRANES, V1512, P335, DOI 10.1016/S0005-2736(01)00338-8; Lastro M, 2008, CELL SIGNAL, V20, P390, DOI 10.1016/j.cellsig.2007.10.030; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lehrbach Dárcio Matenhauer, 2003, Arq. Gastroenterol., V40, P256, DOI 10.1590/S0004-28032003000400011; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Liu H, 2007, ONCOGENE, V26, P5900, DOI 10.1038/sj.onc.1210400; Lu ZM, 2004, CELL CYCLE, V3, P571; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Narang VS, 2003, ANTICANCER RES, V23, P4571; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Peifer M, 1997, SCIENCE, V275, P1752, DOI 10.1126/science.275.5307.1752; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Qiao HX, 2008, BIOCHEM BIOPH RES CO, V370, P584, DOI 10.1016/j.bbrc.2008.03.134; Roberson B, 2006, ECON THEOR, V29, P1, DOI 10.1007/s00199-005-0071-5; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Stoner GD, 2001, CARCINOGENESIS, V22, P1737, DOI 10.1093/carcin/22.11.1737; Tominaga J, 2008, GENES CELLS, V13, P67, DOI 10.1111/j.1365-2443.2007.01149.x; Torres VA, 2007, MOL CELL BIOL, V27, P7703, DOI 10.1128/MCB.01991-06; Volonte D, 1999, FEBS LETT, V445, P431, DOI 10.1016/S0014-5793(99)00164-7; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X	44	113	121	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					599	609		10.1038/onc.2008.414	http://dx.doi.org/10.1038/onc.2008.414			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	19015640				2022-12-25	WOS:000262866500013
J	Meyer, D; Seth, S; Albrecht, J; Maier, MK; du Pasquier, L; Ravens, I; Dreyer, L; Burger, R; Gramatzki, M; Schwinzer, R; Kremmer, E; Foerster, R; Bernhardt, G				Meyer, Dorothee; Seth, Sebastian; Albrecht, Jana; Maier, Michael K.; du Pasquier, Louis; Ravens, Inga; Dreyer, Lutz; Burger, Renate; Gramatzki, Martin; Schwinzer, Reinhard; Kremmer, Elisabeth; Foerster, Reinhold; Bernhardt, Guenter			CD96 Interaction with CD155 via Its First Ig-like Domain Is Modulated by Alternative Splicing or Mutations in Distal Ig-like Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; CELL-ADHESION; IMMUNOGLOBULIN SUPERFAMILY; POLIOVIRUS RECEPTOR; MOLECULAR-CLONING; IDENTIFICATION; MEMBER; EXPRESSION; MIGRATION	The adhesion receptor CD96 (TACTILE) is a transmembrane glycoprotein possessing three extracellular immunoglobulin-like domains. Among peripheral blood cells, CD96 is expressed on T cells as well as NK cells and a subpopulation of B cells. A possible function of this receptor in NK cell-mediated killing activities was suggested recently. Moreover, CD96 was described as a tumor marker for T-cell acute lymphoblastic leukemia and acute myeloid leukemia. CD96 binds to CD155 (poliovirus receptor) and nectin-1, an adhesion receptor related to CD155. Here we report that human but not mouse CD96 is expressed in two splice variants possessing either an I-like (variant 1) or V-like (variant 2) second domain. With the notable exception of an AML tumor sample, variant 2 predominates in all the CD96-expressing cell types and tissues examined. Using chimeric human/murine CD96 receptors, we show that the interaction with its ligands is mediated via the outermost V-like domain. In contrast to mouse, however, the binding of human CD96 to CD155 is sensitive to the characteristics of the two downstream domains. This is illustrated by a significantly weaker CD96/CD155 interaction mediated by variant 1 when compared with variant 2. Moreover, recent evidence suggested that mutations in human CD96 correlate with the occurrence of a rare form of trigonocephaly. One such mutation causing a single amino acid exchange in the third domain of human CD96 decreased the capacity of both variants to bind to CD155 considerably, suggesting that a CD96-driven adhesion to CD155 may be crucial in developmental processes.	[Meyer, Dorothee; Seth, Sebastian; Albrecht, Jana; Maier, Michael K.; Ravens, Inga; Dreyer, Lutz; Foerster, Reinhold; Bernhardt, Guenter] Hannover Med Sch, Inst Immunol, Dept Visceral & Transplantat Surg, D-30625 Hannover, Germany; [Schwinzer, Reinhard] Hannover Med Sch, Transplantat Lab, Dept Visceral & Transplantat Surg, D-30625 Hannover, Germany; [du Pasquier, Louis] Univ Basel, Inst Zool & Evolutionary Biol, CH-4051 Basel, Switzerland; [Burger, Renate; Gramatzki, Martin] Univ Med Ctr SH Campus Kiel, Div Stem Cell Transplantat & Immunotherapy, Dept Med 2, D-24105 Kiel, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	Hannover Medical School; Hannover Medical School; University of Basel; University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Bernhardt, G (corresponding author), Hannover Med Sch, Inst Immunol, Dept Visceral & Transplantat Surg, Carl Neuberg Str 1, D-30625 Hannover, Germany.	bernhardt.guenter@mh-hannover.de	Bernhardt, Günter/F-6946-2012; Gramatzki, Martin/A-9533-2010; Burger, Renate/A-9615-2010; Förster, Reinhold/D-6770-2011	Bernhardt, Günter/0000-0002-0510-2853; Forster, Reinhold/0000-0001-6190-7923; Dreyer, Lutz/0000-0003-4380-890X	Deutsche Forschungsgemeinschaft [BE1886/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft Grant BE1886/2-1 (to G. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BERNHARDT G, 1994, VIROLOGY, V203, P344, DOI 10.1006/viro.1994.1493; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Cannon JP, 2004, CURR BIOL, V14, pR465, DOI 10.1016/j.cub.2004.06.009; Cario G, 2007, J CLIN ONCOL, V25, P4813, DOI 10.1200/JCO.2007.11.8166; Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Du Pasquier L, 2004, IMMUNOL REV, V198, P233, DOI 10.1111/j.0105-2896.2004.00122.x; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Gramatzki M, 1998, EXP HEMATOL, V26, P1209; Hollyoake M, 2005, MOL BIOL EVOL, V22, P1661, DOI 10.1093/molbev/msi162; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Inagaki M, 2005, DEVELOPMENT, V132, P1525, DOI 10.1242/dev.01697; Kaname T, 2007, AM J HUM GENET, V81, P835, DOI 10.1086/522014; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Neville MJ, 1999, J IMMUNOL, V162, P4745; NOBIS P, 1985, J GEN VIROL, V66, P2563, DOI 10.1099/0022-1317-66-12-2563; Ravens I, 2003, BIOCHEM BIOPH RES CO, V312, P1364, DOI 10.1016/j.bbrc.2003.11.067; Rozsnyay Z, 1999, IMMUNOL LETT, V68, P101, DOI 10.1016/S0165-2478(99)00037-1; Seth S, 2007, BIOCHEM BIOPH RES CO, V364, P959, DOI 10.1016/j.bbrc.2007.10.102; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; WANG PL, 1992, J IMMUNOL, V148, P2600; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887	26	52	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2235	2244		10.1074/jbc.M807698200	http://dx.doi.org/10.1074/jbc.M807698200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19056733	hybrid			2022-12-25	WOS:000262545600033
J	Porcelli, AM; Angelin, A; Ghelli, A; Mariani, E; Martinuzzi, A; Carelli, V; Petronilli, V; Bernardi, P; Rugolo, M				Porcelli, Anna Maria; Angelin, Alessia; Ghelli, Anna; Mariani, Elisa; Martinuzzi, Andrea; Carelli, Valerio; Petronilli, Valeria; Bernardi, Paolo; Rugolo, Michela			Respiratory Complex I Dysfunction Due to Mitochondrial DNA Mutations Shifts the Voltage Threshold for Opening of the Permeability Transition Pore toward Resting Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY-OPTIC-NEUROPATHY; UBIQUINONE OXIDOREDUCTASE DEFICIENCY; CONGENITAL MUSCULAR-DYSTROPHY; CYTOCHROME-C RELEASE; CYCLOSPORINE-A; OXIDATIVE-PHOSPHORYLATION; CELL-DEATH; CA2+ HOMEOSTASIS; INDUCED APOPTOSIS; GALACTOSE MEDIUM	We have studied mitochondrial bioenergetics in HL180 cells ( a cybrid line harboring the T14484C/ND6 and G14279A/ND6 mtDNA mutations of Leber hereditary optic neuropathy, leading to an similar to 50% decrease of ATP synthesis) and XTC.UC1 cells ( derived from a thyroid oncocytoma bearing a disruptive frame-shift mutation in MT-ND1, which impairs complex I assembly). The addition of rotenone to HL180 cells and of antimycin A to XTC.UC1 cells caused fast mitochondrial membrane depolarization that was prevented by treatment with cyclosporin A, intracellular Ca2+ chelators, and antioxidant. Both cell lines also displayed an anomalous response to oligomycin, with rapid onset of depolarization that was prevented by cyclosporin A and by overexpression of Bcl-2. These findings indicate that depolarization by respiratory chain inhibitors and oligomycin was due to opening of the mitochondrial permeability transition pore (PTP). A shift of the threshold voltage for PTP opening close to the resting potential may therefore be the underlying cause facilitating cell death in diseases affecting complex I activity. This study provides a unifying reading frame for previous observations on mitochondrial dysfunction, bioenergetic defects, and Ca2+ deregulation in mitochondrial diseases. Therapeutic strategies aimed at normalizing the PTP voltage threshold may be instrumental in ameliorating the course of complex I-dependent mitochondrial diseases.	[Angelin, Alessia; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Angelin, Alessia; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Consiglio Nazl Ric Inst Neurosci, I-35121 Padua, Italy; [Porcelli, Anna Maria; Ghelli, Anna; Mariani, Elisa; Rugolo, Michela] Univ Bologna, Dept Evolut & Expt Biol, I-40126 Bologna, Italy; [Carelli, Valerio] Univ Bologna, Dept Neurol Sci, I-40126 Bologna, Italy; [Martinuzzi, Andrea] Ist Ricovero & Cura Carattere Sci E Medea, I-31015 Conegliano, Italy	University of Padua; University of Padua; University of Bologna; University of Bologna; IRCCS Eugenio Medea	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	bernardi@bio.unipd.it	Rugolo, Michela/AAY-8640-2020; Petronilli, Valeria/C-3558-2015; Martinuzzi, Andrea/K-3887-2016; Bernardi, Paolo/C-3656-2008	Petronilli, Valeria/0000-0003-4026-6404; Martinuzzi, Andrea/0000-0002-0319-3579; GHELLI, ANNA MARIA/0000-0003-0830-0000; Porcelli, Anna Maria/0000-0002-6209-0692; CARELLI, VALERIO/0000-0003-4923-6404; Bernardi, Paolo/0000-0001-9187-3736; Rugolo, Michela/0000-0002-4597-0452	Associazione Italiana per la Ricerca sul Cancro and Ministero della Universita e Ricerca; Fondazione Cariparo Progetti di Eccellenza; Telethon [GGP06233]	Associazione Italiana per la Ricerca sul Cancro and Ministero della Universita e Ricerca(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariparo Progetti di Eccellenza(Fondazione Cariparo); Telethon(Fondazione Telethon)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro and Ministero della Universita e Ricerca ( to M. R. and P. B.), Fondazione Cariparo Progetti di Eccellenza ( to P. B.) and Telethon Grant GGP06233 ( to V. C.).	Angelin A, 2008, BBA-BIOENERGETICS, V1777, P893, DOI 10.1016/j.bbabio.2008.03.026; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Battisti C, 2004, J NEUROL NEUROSUR PS, V75, P1731, DOI 10.1136/jnnp.2003.024372; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; Brini M, 1997, MOL BIOL CELL, V8, P129, DOI 10.1091/mbc.8.1.129; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; BYRNE E, 1991, ACTA NEUROPATHOL, V81, P318, DOI 10.1007/BF00305874; Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2; Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Haroon MF, 2007, NEUROBIOL DIS, V28, P237, DOI 10.1016/j.nbd.2007.07.021; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Jun AS, 1996, MOL CELL BIOL, V16, P771; Kaasik A, 2003, FASEB J, V17, DOI 10.1096/fj.02-0684fje; Koopman WJH, 2008, BBA-BIOENERGETICS, V1777, P853, DOI 10.1016/j.bbabio.2008.03.028; Koopman WJH, 2007, AM J PHYSIOL-CELL PH, V293, pC22, DOI 10.1152/ajpcell.00194.2006; Kowaltowski A, 2000, CELL DEATH DIFFER, V7, P903, DOI 10.1038/sj.cdd.4400722; Kubota M, 2006, J NEUROSCI, V26, P12314, DOI 10.1523/JNEUROSCI.3933-06.2006; Manfredi G, 2003, J BIOL CHEM, V278, P5639, DOI 10.1074/jbc.M203080200; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Milanesi E, 2006, J BIOL CHEM, V281, P10066, DOI 10.1074/jbc.M513708200; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Mott JL, 2004, BIOCHEM BIOPH RES CO, V319, P1210, DOI 10.1016/j.bbrc.2004.05.104; Mott JL, 2006, BBA-BIOENERGETICS, V1757, P596, DOI 10.1016/j.bbabio.2006.04.014; MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; PETRONILLI V, 1993, J BIOL CHEM, V268, P21939; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Qi XP, 2003, INVEST OPHTH VIS SCI, V44, P1088, DOI 10.1167/iovs.02-0864; Ricci C, 2008, AM J PHYSIOL-CELL PH, V294, pC413, DOI 10.1152/ajpcell.00362.2007; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; SRERE PA, 1969, ARCH BIOCHEM BIOPHYS, V129, P708, DOI 10.1016/0003-9861(69)90231-8; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; von Kleist-Retzow JC, 2007, EXP CELL RES, V313, P3076, DOI 10.1016/j.yexcr.2007.04.015; Willems PHGM, 2008, CELL CALCIUM, V44, P123, DOI 10.1016/j.ceca.2008.01.002; Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431; Wong A, 1997, BIOCHEM BIOPH RES CO, V239, P139, DOI 10.1006/bbrc.1997.7443; Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989; Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; Zhadanov SI, 2005, BIOCHEM BIOPH RES CO, V332, P1115, DOI 10.1016/j.bbrc.2005.05.059; Zielke A, 1998, THYROID, V8, P475, DOI 10.1089/thy.1998.8.475	73	81	82	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2045	2052		10.1074/jbc.M807321200	http://dx.doi.org/10.1074/jbc.M807321200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047048	hybrid			2022-12-25	WOS:000262545600012
J	Wilson, SR; Peters, C; Saftig, P; Bromme, D				Wilson, Susan R.; Peters, Christoph; Saftig, Paul; Broemme, Dieter			Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone Resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN TYPE-I; MATRIX METALLOPROTEINASES; INTEGRIN ALPHA-V-BETA-3; VITRONECTIN RECEPTOR; RAT OSTEOCLASTS; VINYL SULFONES; DEFICIENT MICE; SEALING ZONE; PROTEINASES; EXPRESSION	Cathepsin K is responsible for the degradation of type I collagen in osteoclast-mediated bone resorption. Collagen fragments are known to be biologically active in a number of cell types. Here, we investigate their potential to regulate osteoclast activity. Mature murine osteoclasts were seeded on type I collagen for actin ring assays or dentine discs for resorption assays. Cells were treated with cathepsins K-, L-, or MMP-1-predigested type I collagen or soluble bone fragments for 24 h. The presence of actin rings was determined fluorescently by staining for actin. We found that the percentage of osteoclasts displaying actin rings and the area of resorbed dentine decreased significantly on addition of cathepsin K-digested type I collagen or bone fragments, but not with cathepsin L or MMP-1 digests. Counterintuitively, actin ring formation was found to decrease in the presence of the cysteine proteinase inhibitor LHVS and in cathepsin K-deficient osteoclasts. However, cathepsin L deficiency or the general MMP inhibitor GM6001 had no effect on the presence of actin rings. Predigestion of the collagen matrix with cathepsin K, but not by cathepsin L or MMP-1 resulted in an increased actin ring presence in cathepsin K-deficient osteoclasts. These studies suggest that cathepsin K interaction with type I collagen is required for 1) the release of cryptic Arg-Gly-Asp motifs during the initial attachment of osteoclasts and 2) termination of resorption via the creation of autocrine signals originating from type I collagen degradation.	[Wilson, Susan R.; Broemme, Dieter] Univ British Columbia, Fac Dent, Vancouver, BC V6T 1Z3, Canada; [Wilson, Susan R.; Broemme, Dieter] Univ British Columbia, UBC Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Peters, Christoph] Univ Freiburg, Inst Mol Med & Zellforsch, D-79104 Freiburg, Germany; [Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany	University of British Columbia; University of British Columbia; University of Freiburg; University of Kiel	Bromme, D (corresponding author), Univ British Columbia, Fac Dent, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	dbromme@interchange.ubc.ca	Saftig, Paul/A-7966-2010		National Institutes of Health [AR48669, DK072070]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR48669 and DK072070. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALBINI A, 1985, EUR J CELL BIOL, V36, P104; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Chellaiah MA, 2006, EUR J CELL BIOL, V85, P311, DOI 10.1016/j.ejcb.2006.01.008; DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; Everts V, 2003, CALCIFIED TISSUE INT, V73, P380, DOI 10.1007/s00223-002-2092-4; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; FITZSIMMONS CM, 1986, THROMB HAEMOSTASIS, V56, P95; Flores ME, 1996, EXP CELL RES, V227, P40, DOI 10.1006/excr.1996.0247; FLORES ME, 1992, EXP CELL RES, V201, P526, DOI 10.1016/0014-4827(92)90305-R; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Goto T, 2003, J ELECTRON MICROSC, V52, P551, DOI 10.1093/jmicro/52.6.551; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Graebert KS, 1997, EXP CELL RES, V231, P214, DOI 10.1006/excr.1996.3456; Helfrich MH, 1996, BONE, V19, P317, DOI 10.1016/S8756-3282(96)00223-2; Hoebertz A, 2003, METH MOLEC MED, V80, P53; Holliday LS, 2003, CALCIFIED TISSUE INT, V72, P206, DOI 10.1007/s00223-002-1008-7; HORTON MA, 1991, EXP CELL RES, V195, P368, DOI 10.1016/0014-4827(91)90386-9; HYNES RO, 1992, COLD SPRING HARB SYM, V57, P249, DOI 10.1101/SQB.1992.057.01.030; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; Inui T, 1997, J BIOL CHEM, V272, P8109, DOI 10.1074/jbc.272.13.8109; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; KING KL, 1994, J BONE MINER RES, V9, P381; Kiviranta R, 2005, BONE, V36, P159, DOI 10.1016/j.bone.2004.09.020; Laitala-Leinonen T, 2006, MATRIX BIOL, V25, P149, DOI 10.1016/j.matbio.2005.10.005; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; MALONE JD, 1991, MATRIX, V11, P289; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; Marneros AG, 2001, MATRIX BIOL, V20, P337, DOI 10.1016/S0945-053X(01)00151-2; Masarachia P, 1998, ENDOCRINOLOGY, V139, P1401, DOI 10.1210/en.139.3.1401; MOONGA BS, 1990, J PHYSIOL-LONDON, V429, P29, DOI 10.1113/jphysiol.1990.sp018242; Nakagawa H, 2003, BONE, V33, P443, DOI 10.1016/S8756-3282(03)00201-1; Nakamura I, 1999, J CELL SCI, V112, P3985; Nakamura I, 1998, ENDOCRINOLOGY, V139, P5182, DOI 10.1210/en.139.12.5182; NESBITT S, 1993, J BIOL CHEM, V268, P16737; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pfaff M, 2001, J CELL SCI, V114, P2775; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sato T, 1998, J BONE MINER RES, V13, P59, DOI 10.1359/jbmr.1998.13.1.59; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Sharan K, 2008, INDIAN J MED RES, V127, P274; Takahashi N, 2007, ODONTOLOGY, V95, P1, DOI 10.1007/s10266-007-0071-y; VANDERPLUIJM G, 1994, J BONE MINER RES, V9, P1021; Xia LH, 1999, BIOL CHEM, V380, P679, DOI 10.1515/BC.1999.084	55	160	170	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2584	2592		10.1074/jbc.M805280200	http://dx.doi.org/10.1074/jbc.M805280200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028686	hybrid, Green Published			2022-12-25	WOS:000262545600063
J	Kent, J; Meredith, AL				Kent, Jack; Meredith, Andrea L.			BK Channels Regulate Spontaneous Action Potential Rhythmicity in the Suprachiasmatic Nucleus	PLOS ONE			English	Article								Background: Circadian (similar to 24 hr) rhythms are generated by the central pacemaker localized to the suprachiasmatic nucleus (SCN) of the hypothalamus. Although the basis for intrinsic rhythmicity is generally understood to rely on transcription factors encoded by "clock genes'', less is known about the daily regulation of SCN neuronal activity patterns that communicate a circadian time signal to downstream behaviors and physiological systems. Action potentials in the SCN are necessary for the circadian timing of behavior, and individual SCN neurons modulate their spontaneous firing rate (SFR) over the daily cycle, suggesting that the circadian patterning of neuronal activity is necessary for normal behavioral rhythm expression. The BK K(+) channel plays an important role in suppressing spontaneous firing at night in SCN neurons. Deletion of the Kcnma1 gene, encoding the BK channel, causes degradation of circadian behavioral and physiological rhythms. Methodology/Principal Findings: To test the hypothesis that loss of robust behavioral rhythmicity in Kcnma1(-/-) mice is due to the disruption of SFR rhythms in the SCN, we used multi-electrode arrays to record extracellular action potentials from acute wild-type (WT) and Kcnma1(-/-) slices. Patterns of activity in the SCN were tracked simultaneously for up to 3 days, and the phase, period, and synchronization of SFR rhythms were examined. Loss of BK channels increased arrhythmicity but also altered the amplitude and period of rhythmic activity. Unexpectedly, Kcnma1(-/-) SCNs showed increased variability in the timing of the daily SFR peak. Conclusions/Significance: These results suggest that BK channels regulate multiple aspects of the circadian patterning of neuronal activity in the SCN. In addition, these data illustrate the characteristics of a disrupted SCN rhythm downstream of clock gene-mediated timekeeping and its relationship to behavioral rhythms.	[Meredith, Andrea L.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Kent, J (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	ameredith@som.umaryland.edu		Meredith, Andrea/0000-0003-1061-2302	University of Maryland School of Medicine [Seed funds]	University of Maryland School of Medicine	This work was funded by University of Maryland School of Medicine Seed funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Brown TM, 2006, J NEUROSCI METH, V156, P173, DOI 10.1016/j.jneumeth.2006.02.024; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cloues RK, 2003, J NEUROSCI, V23, P1593; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; GILLETTE MU, 1986, BRAIN RES, V379, P176, DOI 10.1016/0006-8993(86)90273-8; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hodge JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002274; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Mistlberger RE, 2000, AM J PHYSIOL-REG I, V279, pR813, DOI 10.1152/ajpregu.2000.279.3.R813; Mrugala M, 2000, AM J PHYSIOL-REG I, V278, pR987, DOI 10.1152/ajpregu.2000.278.4.R987; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Pitts GR, 2006, BRAIN RES, V1071, P54, DOI 10.1016/j.brainres.2005.11.078; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Yamazaki S, 1998, J NEUROSCI, V18, P10709	33	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3884	10.1371/journal.pone.0003884	http://dx.doi.org/10.1371/journal.pone.0003884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060951	gold, Green Published			2022-12-25	WOS:000265455100006
J	Chikayama, E; Suto, M; Nishihara, T; Shinozaki, K; Hirayama, T; Kikuchi, J				Chikayama, Eisuke; Suto, Michitaka; Nishihara, Takashi; Shinozaki, Kazuo; Hirayama, Takashi; Kikuchi, Jun			Systematic NMR Analysis of Stable Isotope Labeled Metabolite Mixtures in Plant and Animal Systems: Coarse Grained Views of Metabolic Pathways	PLOS ONE			English	Article								Background: Metabolic phenotyping has become an important 'bird's-eye-view' technology which can be applied to higher organisms, such as model plant and animal systems in the post-genomics and proteomics era. Although genotyping technology has expanded greatly over the past decade, metabolic phenotyping has languished due to the difficulty of 'top-down' chemical analyses. Here, we describe a systematic NMR methodology for stable isotope-labeling and analysis of metabolite mixtures in plant and animal systems. Methodology/Principal Findings: The analysis method includes a stable isotope labeling technique for use in living organisms; a systematic method for simultaneously identifying a large number of metabolites by using a newly developed HSQC-based metabolite chemical shift database combined with heteronuclear multidimensional NMR spectroscopy; Principal Components Analysis; and a visualization method using a coarse-grained overview of the metabolic system. The database contains more than 1000 (1)H and (13)C chemical shifts corresponding to 142 metabolites measured under identical physicochemical conditions. Using the stable isotope labeling technique in Arabidopsis T87 cultured cells and Bombyx mori, we systematically detected >450 HSQC peaks in each (13)C-HSQC spectrum derived from model plant, Arabidopsis T87 cultured cells and the invertebrate animal model Bombyx mori. Furthermore, for the first time, efficient (13)C labeling has allowed reliable signal assignment using analytical separation techniques such as 3D HCCH-COSY spectra in higher organism extracts. Conclusions/Significance: Overall physiological changes could be detected and categorized in relation to a critical developmental phase change in B. mori by coarse-grained representations in which the organization of metabolic pathways related to a specific developmental phase was visualized on the basis of constituent changes of 56 identified metabolites. Based on the observed intensities of (13)C atoms of given metabolites on development-dependent changes in the 56 identified (13)C-HSQC signals, we have determined the changes in metabolic networks that are associated with energy and nitrogen metabolism.	[Chikayama, Eisuke; Shinozaki, Kazuo; Hirayama, Takashi; Kikuchi, Jun] RIKEN, Plant Sci Ctr, Kanagawa, Japan; [Suto, Michitaka; Nishihara, Takashi; Hirayama, Takashi; Kikuchi, Jun] Yokohama City Univ, Yokohama, Kanagawa, Japan; [Kikuchi, Jun] Nagoya Univ, Nagoya, Aichi, Japan	RIKEN; Yokohama City University; Nagoya University	Chikayama, E (corresponding author), RIKEN, Plant Sci Ctr, Kanagawa, Japan.	kikuchi@psc.riken.jp	Shinozaki, Kazuo/AAB-4945-2019; HIRAYAMA, Takashi/B-2496-2011; Kikuchi, Jun/M-5512-2015; Shinozaki, Kazuo/G-4202-2013; Kikuchi, Jun/O-4725-2019	Shinozaki, Kazuo/0000-0002-6317-9867; HIRAYAMA, Takashi/0000-0002-3868-2380; Kikuchi, Jun/0000-0002-6809-394X; Shinozaki, Kazuo/0000-0002-6317-9867; Kikuchi, Jun/0000-0002-6809-394X	RIKEN; Japan Science and Technology Agency; Bio-oriented Technology Advancement Institution; Ministry of Education, Culture, Sports, Science and Technology of Japan [17710191]	RIKEN; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Bio-oriented Technology Advancement Institution; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	J.K. and T.H. were supported in part by grants from RIKEN (the President's Special Research Grant), the Japan Science and Technology Agency (CREST to J.K.), Bio-oriented Technology Advancement Institution (BRAIN to J.K.) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 17710191 to J.K.).	AKIYAMA K, 2008, SILICO BIOL, V8; [Anonymous], 1969, GEN SYSTEM THEORY FD; AXELOS M, 1992, PLANT PHYSIOL BIOCH, V30, P123; Bhavsar AP, 2006, NAT BIOTECHNOL, V24, P1098, DOI 10.1038/nbt0906-1098; Blaise BJ, 2007, P NATL ACAD SCI USA, V104, P19808, DOI 10.1073/pnas.0707393104; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Bundy JG, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-25; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; de Graaf RA, 2004, P NATL ACAD SCI USA, V101, P12700, DOI 10.1073/pnas.0405065101; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Garrahan JP, 2003, P NATL ACAD SCI USA, V100, P9710, DOI 10.1073/pnas.1233719100; Golman K, 2006, P NATL ACAD SCI USA, V103, P11270, DOI 10.1073/pnas.0601319103; Graca G, 2007, ANAL CHEM, V79, P8367, DOI 10.1021/ac071278d; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Hirayama C, 2002, BBA-GEN SUBJECTS, V1571, P131, DOI 10.1016/S0304-4165(02)00207-6; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Huang JTJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000756; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; JUE T, 1989, P NATL ACAD SCI USA, V86, P4489, DOI 10.1073/pnas.86.12.4489; KALDERON B, 1989, P NATL ACAD SCI USA, V86, P4690, DOI 10.1073/pnas.86.12.4690; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; KAY LE, 1990, J AM CHEM SOC, V112, P888, DOI 10.1021/ja00158a070; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; Kikuchi Jun, 2007, V358, P273, DOI 10.1007/978-1-59745-244-1_15; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kuznetsov VA, 2002, GENETICS, V161, P1321; Lane AN, 2008, METHOD CELL BIOL, V84, P541, DOI 10.1016/S0091-679X(07)84018-0; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Lewis IA, 2007, ANAL CHEM, V79, P9385, DOI 10.1021/ac071583z; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Novak BA, 2006, BIOINFORMATICS, V22, P233, DOI 10.1093/bioinformatics/bti764; Oliver SG, 2006, PHILOS T R SOC B, V361, P477, DOI 10.1098/rstb.2005.1805; Orihara Y, 2008, J GEN VIROL, V89, P188, DOI 10.1099/vir.0.83208-0; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Rabani E, 2003, NATURE, V426, P271, DOI 10.1038/nature02087; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ratcliffe RG, 2006, PLANT J, V45, P490, DOI 10.1111/j.1365-313X.2005.02649.x; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Russell R, 2002, P NATL ACAD SCI USA, V99, P4266, DOI 10.1073/pnas.072589599; Ryan RO, 2000, ANNU REV ENTOMOL, V45, P233, DOI 10.1146/annurev.ento.45.1.233; Sakellariou D, 2007, NATURE, V447, P694, DOI 10.1038/nature05897; Saric J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000254; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; Schmeisser C, 2007, APPL MICROBIOL BIOT, V75, P955, DOI 10.1007/s00253-007-0945-5; Segalat L, 2007, ACS CHEM BIOL, V2, P231, DOI 10.1021/cb700009m; Sekiyama Y, 2007, PHYTOCHEMISTRY, V68, P2320, DOI 10.1016/j.phytochem.2007.04.011; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shanaiah N, 2007, P NATL ACAD SCI USA, V104, P11540, DOI 10.1073/pnas.0704449104; Sobolev AP, 2005, MAGN RESON CHEM, V43, P625, DOI 10.1002/mrc.1618; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Steinbeck C, 2004, PHYTOCHEMISTRY, V65, P2711, DOI 10.1016/j.phytochem.2004.08.027; Tadmor AD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000038; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P3765, DOI 10.1073/pnas.0306244101; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; WISHART DS, 2008, J CHROMATOGR B; WYATT GR, 1956, J GEN PHYSIOL, V39, P853, DOI 10.1085/jgp.39.6.853	84	65	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2008	3	11							e3805	10.1371/journal.pone.0003805	http://dx.doi.org/10.1371/journal.pone.0003805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YD	19030231	Green Submitted, gold, Green Published			2022-12-25	WOS:000265451100005
J	Lietha, D; Eck, MJ				Lietha, Daniel; Eck, Michael J.			Crystal Structures of the FAK Kinase in Complex with TAE226 and Related Bis-Anilino Pyrimidine Inhibitors Reveal a Helical DFG Conformation	PLOS ONE			English	Article								Focal Adhesion Kinase (FAK) is a non-receptor tyrosine kinase required for cell migration, proliferation and survival. FAK overexpression has been documented in diverse human cancers and is associated with a poor clinical outcome. Recently, a novel bis-anilino pyrimidine inhibitor, TAE226, was reported to efficiently inhibit FAK signaling, arrest tumor growth and invasion and prolong the life of mice with glioma or ovarian tumor implants. Here we describe the crystal structures of the FAK kinase bound to TAE226 and three related bis-anilino pyrimidine compounds. TAE226 induces a conformation of the N-terminal portion of the kinase activation loop that is only observed in FAK, but is distinct from the conformation in both the active and inactive states of the kinase. This conformation appears to require a glycine immediately N-terminal to the "DFG motif", which adopts a helical conformation stabilized by interactions with TAE226. The presence of a glycine residue in this position contributes to the specificity of TAE226 and related compounds for FAK. Our work highlights the fact that kinases can access conformational space that is not necessarily utilized for their native catalytic regulation, and that such conformations can explain and be exploited for inhibitor specificity.	[Lietha, Daniel; Eck, Michael J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lietha, Daniel; Eck, Michael J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Lietha, D (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	eck@red.dfci.harvard.edu	Lietha, Daniel/AAD-1952-2022; Lietha, Daniel/L-8041-2014	Lietha, Daniel/0000-0002-6133-6486; Lietha, Daniel/0000-0002-6133-6486	NIH [HL048675, CA080942]; Leukemia and Lymphoma Society; NCI [5T32CA09361]; NATIONAL CANCER INSTITUTE [T32CA009361, R01CA080942] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The research was supported in part by NIH grants HL048675 and CA080942 (MJE). MJE is the recipient of a Scholar Award from the Leukemia and Lymphoma Society. DL was supported by an institutional training grant from the NCI (5T32CA09361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIADES HN, 1992, INT J CANCER, V50, P215, DOI 10.1002/ijc.2910500210; Beattie JF, 2003, BIOORG MED CHEM LETT, V13, P2955, DOI 10.1016/S0960-894X(03)00202-6; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Del Valle L, 2002, CLIN CANCER RES, V8, P1822; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOLUBOVSKAYA VM, 2007, MOL CARCINOG; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Han NM, 1997, ANN SURG ONCOL, V4, P264, DOI 10.1007/BF02306620; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jones G, 2001, CANCER RES, V61, P5688; Lamers MBAC, 1999, J MOL BIOL, V285, P713, DOI 10.1006/jmbi.1998.2369; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476; Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Natarajan M, 2003, CANCER J, V9, P126, DOI 10.1097/00130404-200303000-00008; Nowakowski J, 2002, STRUCTURE, V10, P1659, DOI 10.1016/S0969-2126(02)00907-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tremblay L, 1996, INT J CANCER, V68, P164, DOI 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6	38	73	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3800	10.1371/journal.pone.0003800	http://dx.doi.org/10.1371/journal.pone.0003800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030106	Green Published, Green Submitted, gold			2022-12-25	WOS:000265450800010
J	Malavige, GN; Jones, L; Kamaladasa, SD; Wijewickrama, A; Seneviratne, SL; Black, AP; Ogg, GS				Malavige, Gathsaurie Neelika; Jones, Louise; Kamaladasa, S. D.; Wijewickrama, A.; Seneviratne, S. L.; Black, Antony P.; Ogg, Graham S.			Viral Load, Clinical Disease Severity and Cellular Immune Responses in Primary Varicella Zoster Virus Infection in Sri Lanka	PLOS ONE			English	Article								Background: In Sri Lanka, varicella zoster virus (VZV) is typically acquired during adulthood with significant associated disease morbidity and mortality. T cells are believed to be important in the control of VZV replication and in the prevention of reactivation. The relationship between viral load, disease severity and cellular immune responses in primary VZV infection has not been well studied. Methodology: We used IFN gamma ELISpot assays and MHC class II tetramers based on VZV gE and IE63 epitopes, together with quantitative real time PCR assays to compare the frequency and phenotype of specific T cells with virological and clinical outcomes in 34 adult Sri Lankan individuals with primary VZV infection. Principal Findings: Viral loads were found to be significantly higher in patients with moderate to severe infection compared to those with mild infection (p < 0.001) and were significantly higher in those over 25 years of age (P < 0.01). A significant inverse correlation was seen between the viral loads and the ex vivo IFN gamma ELISpot responses of patients (P < 0.001, r = -0.85). VZV-specific CD4+ T cells expressed markers of intermediate differentiation and activation. Conclusions: Overall, these data show that increased clinical severity in Sri Lankan adults with primary VZV infection associates with higher viral load and reduced viral specific T cell responses.	[Malavige, Gathsaurie Neelika; Jones, Louise; Black, Antony P.; Ogg, Graham S.] John Radcliffe Hosp, Oxford Biomed Res Ctr, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Kamaladasa, S. D.] Univ Sri Jayewardenepura, Fac Med Sci, Dept Med, Nugegoda, Sri Lanka; [Wijewickrama, A.] Infect Dis Hosp, Colombo, Sri Lanka; [Seneviratne, S. L.] Imperial Coll AHSC, St Marys Hosp, Dept Clin Immunol, London, England; [Malavige, Gathsaurie Neelika] Univ Sri Jayewardenepura, Fac Med Sci, Dept Microbiol, Nugegoda, Sri Lanka; [Ogg, Graham S.] Churchill Hosp, Dept Dermatol, Oxford, England	University of Oxford; University Sri Jayewardenepura; Imperial College London; University Sri Jayewardenepura; University of Oxford	Malavige, GN (corresponding author), John Radcliffe Hosp, Oxford Biomed Res Ctr, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	graham.ogg@ndm.ox.ac.uk	; Malavige, Gathsaurie/J-5483-2015	Ogg, Graham/0000-0002-3097-045X; Malavige, Gathsaurie/0000-0001-9201-0449	NIHR Biomedical Research Centre Programme; MRC; Commonwealth Commission; Medical Research Council [MC_U137881017, G116/150] Funding Source: researchfish; MRC [G116/150, MC_U137881017] Funding Source: UKRI	NIHR Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Commonwealth Commission; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by NIHR Biomedical Research Centre Programme, MRC and Commonwealth Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth A, 2001, J VIROL, V75, P6183, DOI 10.1128/JVI.75.13.6183-6192.2001; ARVIN AM, 1986, J INFECT DIS, V154, P422, DOI 10.1093/infdis/154.3.422; Asanuma H, 2000, J INFECT DIS, V181, P859, DOI 10.1086/315347; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; de Jong MD, 2000, J CLIN MICROBIOL, V38, P2568, DOI 10.1128/JCM.38.7.2568-2573.2000; de Melker H, 2006, VACCINE, V24, P3946, DOI 10.1016/j.vaccine.2006.02.017; Eisfeld AJ, 2007, J VIROL, V81, P9034, DOI 10.1128/JVI.00711-07; Galil K, 2002, PEDIATR INFECT DIS J, V21, P931, DOI 10.1097/00006454-200210000-00009; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; GARNETT GP, 1993, EPIDEMIOL INFECT, V110, P361, DOI 10.1017/S0950268800068308; GERSHON AA, 1979, INFECT IMMUN, V25, P170, DOI 10.1128/IAI.25.1.170-174.1979; GERSHON AA, 1979, INFECT IMMUN, V25, P164, DOI 10.1128/IAI.25.1.164-169.1979; Ito Y, 2001, MICROBIOL IMMUNOL, V45, P267, DOI 10.1111/j.1348-0421.2001.tb02617.x; Jones L, 2007, EUR J IMMUNOL, V37, P3393, DOI 10.1002/eji.200737648; Jones L, 2006, J VIROL, V80, P9772, DOI 10.1128/JVI.00564-06; Kasprowicz V, 2006, J VIROL, V80, P11209, DOI 10.1128/JVI.01173-06; Khoshnood B, 2006, PEDIATR INFECT DIS J, V25, P41, DOI 10.1097/01.inf.0000195636.43584.bb; Kimura H, 2000, J CLIN MICROBIOL, V38, P2447; Konig A, 2003, MICROBES INFECT, V5, P879, DOI 10.1016/S1286-4579(03)00177-1; Ku CC, 2005, J VIROL, V79, P2651, DOI 10.1128/JVI.79.5.2651-2658.2005; Ku CC, 2004, J EXP MED, V200, P917, DOI 10.1084/jem.20040634; Ku CC, 2002, J VIROL, V76, P11425, DOI 10.1128/JVI.76.22.11425-11433.2002; Lavreys L, 2002, CLIN INFECT DIS, V35, P77, DOI 10.1086/340862; LEIBOVITZ E, 1993, PEDIATRICS, V92, P838; Liyanage N P M, 2007, Indian J Med Sci, V61, P128; Lokeshwar M R, 2000, Indian Pediatr, V37, P714; Lucas M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000649; Mainka C, 1998, J MED VIROL, V56, P91, DOI 10.1002/(SICI)1096-9071(199809)56:1<91::AID-JMV15>3.0.CO;2-Z; Malavige GN, 2008, CLIN EXP IMMUNOL, V152, P522, DOI 10.1111/j.1365-2249.2008.03633.x; Malavige GN, 2007, J INFECT DIS, V195, P660, DOI 10.1086/511274; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; MILONE G, 1992, ANN HEMATOL, V64, P155, DOI 10.1007/BF01697404; MOFFAT JF, 1995, J VIROL, V69, P5236, DOI 10.1128/JVI.69.9.5236-5242.1995; Mohsen AH, 2001, THORAX, V56, P796, DOI 10.1136/thorax.56.10.796; PATEL PA, 1979, J PEDIATR-US, V94, P223, DOI 10.1016/S0022-3476(79)80828-8; Pevenstein SR, 1999, J VIROL, V73, P10514, DOI 10.1128/JVI.73.12.10514-10518.1999; Quinlivan ML, 2007, J CLIN MICROBIOL, V45, P3909, DOI 10.1128/JCM.00874-07; Rentenaar RJ, 2000, J CLIN INVEST, V105, P541, DOI 10.1172/JCI8229; SCREATON G, 2006, NOVART FDN SYMP, V277, P251; SCREATON G, 2006, NOVART FDN SYMP, V277, P177; Screaton Gavin, 2006, Novartis Found Symp, V277, P164, DOI 10.1002/0470058005.ch12; Simpson DM, 2002, AIDS, V16, P407, DOI 10.1097/00002030-200202150-00012; Smith JG, 2001, CLIN DIAGN LAB IMMUN, V8, P871, DOI 10.1128/CDLI.8.5.871-879.2001; Ulsenheimer A, 2006, J VIRAL HEPATITIS, V13, P708, DOI 10.1111/j.1365-2893.2006.00747.x; VADOUDSEYEDI R, 1993, DERMATOLOGY, V187, P47, DOI 10.1159/000247197; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; VENKITARAMAN AR, 1984, INT J EPIDEMIOL, V13, P502, DOI 10.1093/ije/13.4.502; Vyse AJ, 2004, EPIDEMIOL INFECT, V132, P1129, DOI 10.1017/S0950268804003140; Welgama U., 2003, Ceylon Medical Journal, V48, P119	50	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3789	10.1371/journal.pone.0003789	http://dx.doi.org/10.1371/journal.pone.0003789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023425	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448800010
J	Stover, J; Fidzani, B; Molomo, BC; Moeti, T; Musuka, G				Stover, John; Fidzani, Boga; Molomo, Batho Chris; Moeti, Themba; Musuka, Godfrey			Estimated HIV Trends and Program Effects in Botswana	PLOS ONE			English	Article							MORTALITY	Background: This study uses surveillance, survey and program data to estimate past trends and current levels of HIV in Botswana and the effects of treatment and prevention programs. Methods/Principal Findings: Data from sentinel surveillance at antenatal clinics and a national population survey were used to estimate the trend of adult HIV prevalence from 1980 to 2007. Using the prevalence trend we estimated the number of new adult infections, the transmission from mothers to children, the need for treatment and the effects of antiretroviral therapy (ART) and adult and child deaths. Prevalence has declined slowly in urban areas since 2000 and has remained stable in rural areas. National prevalence is estimated at 26% (25-27%) in 2007. About 330,000 (318,000-335,000) people are infected with HIV including 20,000 children. The number of new adult infections has been stable for several years at about 20,000 annually (12,000-26,000). The number of new child infections has declined from 4600 in 1999 to about 890 (810-980) today due to nearly complete coverage of an effective program to prevent mother-to-child transmission (PMTCT). The annual number of adult deaths has declined from a peak of over 15,500 in 2003 to under 7400 (5000-11,000) today due to coverage of ART that reaches over 80% in need. The need for ART will increase by 60% by 2016. Conclusions: Botswana's PMTCT and treatment programs have achieved significant results in preventing new child infections and deaths among adults and children. The number of new adult infections continues at a high level. More effective prevention efforts are urgently needed.	[Stover, John] Futures Inst, Glastonbury, CT USA; [Fidzani, Boga; Molomo, Batho Chris] Natl AIDS Coordinating Agcy, Gaborone, Botswana; [Fidzani, Boga; Moeti, Themba; Musuka, Godfrey] African Comprehensive HIV AIDS Partnership, Gaborone, Botswana		Stover, J (corresponding author), Futures Inst, Glastonbury, CT USA.	JStover@FuturesInstitute.org			Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded by the Bill and Melinda Gates Foundation through the African Comprehensive HIV/AIDS Partnership. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	*ABT ASS S AFR INC, 2000, IMP ASS HIV AIDS CUR; Brown T, 2006, SEX TRANSM INFECT, V82, pIII34, DOI 10.1136/sti.2006.020230; Dorrington R. E., 2006, DEMOGRAPHIC IMPACT H; Marston M, 2005, JAIDS-J ACQ IMM DEF, V38, P219, DOI 10.1097/00126334-200502010-00015; *MIN HLTH, 2005, BOTSW 2 GEN HIV AIDS; *NACA CSO OTH DEV, 2005, BOSTSW AIDS IMP SURV, V2; *NAT AIDS COORD AG, 2008, OCT DEC 2007 NAT AID; *NAT AIDS COORD AG, 2007, 2008 PROGR REP NAT R; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; STOVER J, 2008, AIM COMPUTER PROGRAM; TLALE J, 2008, INT AIDS C MEX CIT A; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; UNAIDS/WHO, 2006, 2006 REP GLOB AIDS E	13	51	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3729	10.1371/journal.pone.0003729	http://dx.doi.org/10.1371/journal.pone.0003729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19008957	gold, Green Published, Green Submitted			2022-12-25	WOS:000265166400007
J	Dubeykovskaya, Z; Dubeykovskiy, A; Solal-Cohen, J; Wang, TC				Dubeykovskaya, Zinaida; Dubeykovskiy, Alexander; Solal-Cohen, Joel; Wang, Timothy C.			Secreted Trefoil Factor 2 Activates the CXCR4 Receptor in Epithelial and Lymphocytic Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; PANCREATIC SPASMOLYTIC POLYPEPTIDE; SIGNAL-REGULATED KINASES-1/2; INDUCED GASTRIC INJURY; CHEMOKINE RECEPTOR; FACTOR-I; BREAST-CANCER; EXPERIMENTAL COLITIS; FUNCTIONAL CXCR4; IMMUNE-RESPONSE	The secreted trefoil factor family 2 (TFF2) protein contributes to the protection of the gastrointestinal mucosa from injury by strengthening and stabilizing mucin gels, stimulating epithelial restitution, and restraining the associated inflammation. Although trefoil factors have been shown to activate signaling pathways, no cell surface receptor has been directly linked to trefoil peptide signaling. Here we demonstrate the ability of TFF2 peptide to activate signaling via the CXCR4 chemokine receptor in cancer cell lines. We found that both mouse and human TFF2 proteins (at similar to 0.5 mu M) activate Ca2+ signaling in lymphoblastic Jurkat cells that could be abrogated by receptor desensitization (with SDF-1 alpha) or pretreatment with the specific antagonist AMD3100 or an anti-CXCR4 antibody. TFF2 pretreatment of Jurkat cells decreased Ca2+ rise and chemotactic response to SDF-1 alpha. In addition, the CXCR4-negative gastric epithelial cell line AGS became highly responsive to TFF2 treatment upon expression of the CXCR4 receptor. TFF2-induced activation of mitogen-activated protein kinases in gastric and pancreatic cancer cells, KATO III and AsPC-1, respectively, was also dependent on the presence of the CXCR4 receptor. Finally we demonstrate a distinct proliferative effect of TFF2 protein on an AGS gastric cancer cell line that expresses CXCR4. Overall these data identify CXCR4 as a bona fide signaling receptor for TFF2 and suggest a mechanism through which TFF2 may modulate immune and tumorigenic responses in vivo.	[Dubeykovskaya, Zinaida; Dubeykovskiy, Alexander; Wang, Timothy C.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Solal-Cohen, Joel] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University; Columbia University	Wang, TC (corresponding author), Columbia Univ, Med Ctr, Dept Med, 1130 St Nicholas Ave,Rm 925, New York, NY 10032 USA.	tcw21@columbia.edu		Wang, Timothy/0000-0001-5730-3019	National Institutes of Health [2RO1DK060758]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2RO1DK060758 (to T. C. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akimoto M, 2002, CLIN SCI, V103, p450S, DOI 10.1042/CS103S450S; ALISON MR, 1995, J PATHOL, V175, P405, DOI 10.1002/path.1711750408; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P489, DOI 10.1053/gast.1996.v110.pm8566596; Bajetto A, 2001, J NEUROCHEM, V77, P1226, DOI 10.1046/j.1471-4159.2001.00350.x; Bajetto A, 2006, NEUROCHEM INT, V49, P423, DOI 10.1016/j.neuint.2006.03.003; Banisadr G, 2000, J NEUROIMMUNOL, V110, P151, DOI 10.1016/S0165-5728(00)00338-6; Barbero S, 2003, CANCER RES, V63, P1969; Baus-Loncar M, 2005, CELL MOL LIFE SCI, V62, P2947, DOI 10.1007/s00018-005-5483-7; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Blades MC, 2002, ARTHRITIS RHEUM, V46, P824, DOI 10.1002/art.10102; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; CARR MD, 1994, P NATL ACAD SCI USA, V91, P2206, DOI 10.1073/pnas.91.6.2206; Cherla RP, 2001, J IMMUNOL, V166, P3067, DOI 10.4049/jimmunol.166.5.3067; CHINERY R, 1995, PEPTIDES, V16, P749, DOI 10.1016/0196-9781(95)00045-L; Christine R, 2005, CANCER RES, V65, P195; Cook GA, 1998, J GASTROEN HEPATOL, V13, P363, DOI 10.1111/j.1440-1746.1998.tb00647.x; Cook GA, 1999, FEBS LETT, V456, P155, DOI 10.1016/S0014-5793(99)00940-0; DE A, 1994, P NATL ACAD SCI USA, V91, P1084, DOI 10.1073/pnas.91.3.1084; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Dwinell MB, 1999, GASTROENTEROLOGY, V117, P359, DOI 10.1053/gast.1999.0029900359; Eddleston J, 2002, J IMMUNOL, V169, P6445, DOI 10.4049/jimmunol.169.11.6445; Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019; Farrell JJ, 2002, J CLIN INVEST, V109, P193, DOI 10.1172/JCI200212529; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Forster R, 1998, J IMMUNOL, V160, P1522; Fox JG, 2007, AM J PATHOL, V171, P1520, DOI 10.2353/ajpath.2007.070249; FRANDSEN EK, 1988, REGUL PEPTIDES, V20, P45, DOI 10.1016/0167-0115(88)90056-0; FRANDSEN EK, 1986, REGUL PEPTIDES, V16, P291, DOI 10.1016/0167-0115(86)90028-5; Graness A, 2002, J BIOL CHEM, V277, P18440, DOI 10.1074/jbc.M200468200; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hoffmann W, 2002, INT REV CYTOL, V213, P147; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; JEFFREY GP, 1994, GASTROENTEROLOGY, V106, P336, DOI 10.1016/0016-5085(94)90590-8; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Jordan NJ, 1999, J CLIN INVEST, V104, P1061, DOI 10.1172/JCI6685; Kalinkovich A, 2006, CANCER RES, V66, P11013, DOI 10.1158/0008-5472.CAN-06-2006; Kanbe K, 2002, ARTHRITIS RHEUM-US, V46, P130, DOI 10.1002/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D; Kjellev S, 2007, PEPTIDES, V28, P1197, DOI 10.1016/j.peptides.2007.03.016; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Kurt-Jones EA, 2007, INFECT IMMUN, V75, P471, DOI 10.1128/IAI.02039-05; Lalani EN, 1999, LAB INVEST, V79, P537; Liu D, 1997, LAB INVEST, V77, P557; LOETSCHER M, 1994, J BIOL CHEM, V269, P232; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Majka M, 2000, EUR J HAEMATOL, V64, P164, DOI 10.1034/j.1600-0609.2000.90112.x; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; May FEB, 2004, PEPTIDES, V25, P865, DOI 10.1016/j.peptides.2003.12.024; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Norsett KG, 2005, PHYSIOL GENOMICS, V22, P24, DOI 10.1152/physiolgenomics.00245.2004; Oertel M, 2001, AM J RESP CELL MOL, V25, P418, DOI 10.1165/ajrcmb.25.4.4429; Otto WR, 2006, PROTEOMICS, V6, P4235, DOI 10.1002/pmic.200500911; Pannequin J, 2004, J ENDOCRINOL, V181, P315, DOI 10.1677/joe.0.1810315; Petty JM, 2007, J IMMUNOL, V178, P8148, DOI 10.4049/jimmunol.178.12.8148; PLAYFORD RJ, 1995, GASTROENTEROLOGY, V108, P92, DOI 10.1016/0016-5085(95)90012-8; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Poulsen SS, 2005, REGUL PEPTIDES, V126, P163, DOI 10.1016/j.regpep.2004.09.007; Poulsen SS, 2003, REGUL PEPTIDES, V115, P91, DOI 10.1016/S0167-0115(03)00145-9; Poulsen SS, 1998, GUT, V43, P240, DOI 10.1136/gut.43.2.240; Quintana A, 2005, PFLUG ARCH EUR J PHY, V450, P1, DOI 10.1007/s00424-004-1364-4; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Soriano-Izquierdo A, 2004, J LEUKOCYTE BIOL, V75, P214, DOI 10.1189/jlb.0803396; Storesund T, 2008, EUR J ORAL SCI, V116, P135, DOI 10.1111/j.1600-0722.2007.00516.x; Tan XD, 1997, BIOCHEM BIOPH RES CO, V237, P673, DOI 10.1006/bbrc.1997.7144; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Thim L, 2000, REGUL PEPTIDES, V90, P61, DOI 10.1016/S0167-0115(00)00110-5; Tran CP, 1999, GUT, V44, P636, DOI 10.1136/gut.44.5.636; Tu SP, 2007, AM J PHYSIOL-GASTR L, V292, pG1726, DOI 10.1152/ajpgi.00348.2006; Ueda Y, 2006, CANCER RES, V66, P5665, DOI 10.1158/0008-5472.CAN-05-3579; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Weber KSC, 2001, MOL BIOL CELL, V12, P3074, DOI 10.1091/mbc.12.10.3074; Zhao M, 2008, BREAST CANCER RES TR, V110, P211, DOI 10.1007/s10549-007-9712-7	76	69	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3650	3662		10.1074/jbc.M804935200	http://dx.doi.org/10.1074/jbc.M804935200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19064997	Green Published, hybrid			2022-12-25	WOS:000262872500033
J	Ding, N; Tomomori-Sato, C; Sato, S; Conaway, RC; Conaway, JW; Boyer, TG				Ding, Ning; Tomomori-Sato, Chieri; Sato, Shigeo; Conaway, Ronald C.; Conaway, Joan W.; Boyer, Thomas G.			MED19 and MED26 Are Synergistic Functional Targets of the RE1 Silencing Transcription Factor in Epigenetic Silencing of Neuronal Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MEDIATOR COMPLEX; LINKED MENTAL-RETARDATION; HISTONE DEACETYLASE; NUCLEAR RECEPTORS; IN-VIVO; NEURAL INDUCTION; STEM-CELLS; REST; REPRESSOR; COACTIVATOR	A key hub for the orchestration of epigenetic modifications necessary to restrict neuronal gene expression to the nervous system is the RE1 silencing transcription factor (REST; also known as neuron restrictive silencer factor, NRSF). REST suppresses the nonspecific and premature expression of neuronal genes in non-neuronal and neural progenitor cells, respectively, via recruitment of enzymatically diverse corepressors, including G9a histone methyltransferase (HMTase) that catalyzes di-methylation of histone 3-lysine 9 (H3K9me2). Recently, we identified the RNA polymerase II transcriptional Mediator to be an essential link between RE1-bound REST and G9a in epigenetic suppression of neuronal genes in non-neuronal cells. However, the means by which REST recruits Mediator to facilitate G9a-dependent extra-neuronal gene silencing remains to be elucidated. Here, we identify the MED19 and MED26 subunits in Mediator as direct physical and synergistic functional targets of REST. We show that although REST independently binds to both MED19 and MED26 in isolation, combined depletion of both subunits is required to disrupt the association of REST with Mediator. Furthermore, combined, but not individual, depletion of MED19/MED26 impairs REST-directed recruitment to RE1 elements of Mediator and G9a, leading to a reversal of G9a-dependent H3K9me2 and de-repression of REST-target gene expression. Together, these findings identify MED19/MED26 as a probable composite REST interface in Mediator and further clarify the mechanistic basis by which Mediator facilitates REST-imposed epigenetic restrictions on neuronal gene expression.	[Ding, Ning; Boyer, Thomas G.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA; [Ding, Ning; Boyer, Thomas G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA; [Tomomori-Sato, Chieri; Sato, Shigeo; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Boyer, TG (corresponding author), 19715 Lambda Dr, San Antonio, TX 78245 USA.	boyer@uthscsa.edu	Ding, Ning/B-4072-2012	Conaway, Joan/0000-0002-2786-0663; Tomomori-Sato, Chieri/0000-0002-2543-293X	NCI [CA-0908301]; National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085320] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by Public Health Service Grant CA-0908301 from NCI, National Institutes of Health (to T. G. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Asada S, 2002, P NATL ACAD SCI USA, V99, P12747, DOI 10.1073/pnas.202162199; Baidoobonso SM, 2007, J BIOL CHEM, V282, P5551, DOI 10.1074/jbc.M609484200; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; Bingham AJ, 2007, MOL CELL BIOL, V27, P4082, DOI 10.1128/MCB.00269-07; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Calderone A, 2003, J NEUROSCI, V23, P2112; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Coulson JM, 2000, CANCER RES, V60, P1840; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Drane P, 1997, ONCOGENE, V15, P3013, DOI 10.1038/sj.onc.1201492; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fuller GN, 2005, MOL CANCER THER, V4, P343; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gonzalez D, 2007, MOL CELL BIOL, V27, P5306, DOI 10.1128/MCB.01912-06; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Gwack Y, 2003, MOL CELL BIOL, V23, P2055, DOI 10.1128/MCB.23.6.2055-2067.2003; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ito M, 2002, EMBO J, V21, P3464, DOI 10.1093/emboj/cdf348; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kallunki P, 1997, J CELL BIOL, V138, P1343, DOI 10.1083/jcb.138.6.1343; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Kim TW, 2004, P NATL ACAD SCI USA, V101, P12153, DOI 10.1073/pnas.0401985101; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; Lau JF, 2003, MOL CELL BIOL, V23, P620, DOI 10.1128/MCB.23.2.620-628.2003; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lee HK, 2007, EMBO J, V26, P3545, DOI 10.1038/sj.emboj.7601797; Lee JE, 2005, J BIOL CHEM, V280, P8819, DOI 10.1074/jbc.M413184200; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Mittler G, 2003, EMBO J, V22, P6494, DOI 10.1093/emboj/cdg619; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Palm K, 1998, J NEUROSCI, V18, P1280; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Sasai Y, 1998, NEURON, V21, P455, DOI 10.1016/S0896-6273(00)80554-1; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sato S, 2003, J BIOL CHEM, V278, P49671, DOI 10.1074/jbc.C300444200; Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Tomomori-Sato C, 2004, J BIOL CHEM, V279, P5846, DOI 10.1074/jbc.M312523200; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; Yang W, 2000, MOL CELL BIOL, V20, P8008, DOI 10.1128/MCB.20.21.8008-8017.2000; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06; Zhou RJ, 2002, NUCLEIC ACIDS RES, V30, P3245, DOI 10.1093/nar/gkf443; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	82	57	67	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2648	2656		10.1074/jbc.M806514200	http://dx.doi.org/10.1074/jbc.M806514200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049968	hybrid, Green Published			2022-12-25	WOS:000262700900007
J	Sun, QX; Collins, R; Huang, SF; Holmberg-Schiavone, L; Anand, GS; Tan, CH; Van-Den-Berg, S; Deng, LW; Moore, PK; Karlberg, T; Sivaraman, J				Sun, Qingxiang; Collins, Ruairi; Huang, Shufen; Holmberg-Schiavone, Lovisa; Anand, Ganesh S.; Tan, Choon-Hong; van-den-Berg, Susanne; Deng, Lih-Wen; Moore, Philip K.; Karlberg, Tobias; Sivaraman, J.			Structural Basis for the Inhibition Mechanism of Human Cystathionine gamma-Lyase, an Enzyme Responsible for the Production of H2S	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE DATABASE; HYDROGEN-SULFIDE; CRYSTAL-STRUCTURE; THREONINE SYNTHASE; VASORELAXANT; SPECIFICITY; METABOLISM; SEARCH; MICE; RAT	Impairment of the formation or action of hydrogen sulfide (H2S), an endogenous gasotransmitter, is associated with various diseases, such as hypertension, diabetes mellitus, septic and hemorrhagic shock, and pancreatitis. Cystathionine beta-synthase and cystathionine gamma-lyase (CSE) are two pyridoxal-5'-phosphate ( PLP)-dependent enzymes largely responsible for the production of H2S in mammals. Inhibition of CSE by DL-propargylglycine (PAG) has been shown to alleviate disease symptoms. Here we report crystal structures of human CSE (hCSE), in apo form, and in complex with PLP and PLP (.) PAG. Structural characterization, combined with biophysical and biochemical studies, provides new insights into the inhibition mechanism of hCSE-mediated production of H2S. Transition from the open form of apo-hCSE to the closed PLP-bound form reveals large conformational changes hitherto not reported. In addition, PAG binds hCSE via a unique binding mode, not observed in PAG-enzyme complexes previously. The interaction of PAG-hCSE was not predicted based on existing information from known PAG complexes. The structure of hCSE (.) PLP (.) PAG complex highlights the particular importance of Tyr(114) in hCSE and the mechanism of PAG-dependent inhibition of hCSE. These results provide significant insights, which will facilitate the structure-based design of novel inhibitors of hCSE to aid in the development of therapies for diseases involving disorders of sulfur metabolism.	[Collins, Ruairi; Holmberg-Schiavone, Lovisa; van-den-Berg, Susanne; Karlberg, Tobias] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, SE-17177 Stockholm, Sweden; [Sun, Qingxiang; Anand, Ganesh S.; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Huang, Shufen; Tan, Choon-Hong] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Deng, Lih-Wen] Natl Univ Singapore, Dept Biochem, Singapore 117543, Singapore; [Moore, Philip K.] Univ London, Univ London Kings Coll, Div Pharmaceut Sci, London SW3 6LX, England	Karolinska Institutet; National University of Singapore; National University of Singapore; National University of Singapore; University of London; King's College London	Karlberg, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, SE-17177 Stockholm, Sweden.	tobias.karlberg@ki.se; dbsjayar@nus.edu.sg	Sivaraman, J/H-8028-2012	Deng, Lih-Wen/0000-0002-4985-7844; J, Sivaraman/0000-0001-9781-5326				Bruger AT, 1998, ACTA CRYSTALLOGR D, V54, P905; Clausen T, 1998, EMBO J, V17, P6827, DOI 10.1093/emboj/17.23.6827; Collin M, 2005, BRIT J PHARMACOL, V146, P498, DOI 10.1038/sj.bjp.0706367; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giles K, 2004, RAPID COMMUN MASS SP, V18, P2401, DOI 10.1002/rcm.1641; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Karsten WE, 2002, METHOD ENZYMOL, V354, P223; Li L, 2008, TRENDS PHARMACOL SCI, V29, P84, DOI 10.1016/j.tips.2007.11.003; Li L, 2006, CURR OPIN PHARMACOL, V6, P125, DOI 10.1016/j.coph.2005.10.007; Mas-Droux C, 2006, J BIOL CHEM, V281, P5188, DOI 10.1074/jbc.M509798200; Messerschmidt A, 2003, BIOL CHEM, V384, P373, DOI 10.1515/BC.2003.043; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ruotolo BT, 2006, CURR OPIN CHEM BIOL, V10, P402, DOI 10.1016/j.cbpa.2006.08.020; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Steegborn C, 1999, J BIOL CHEM, V274, P12675, DOI 10.1074/jbc.274.18.12675; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tang Chaoshu, 2006, Current Vascular Pharmacology, V4, P17; Thomazeau K, 2001, PROTEIN SCI, V10, P638, DOI 10.1110/ps.44301; Tokoro M, 2003, J BIOL CHEM, V278, P42717, DOI 10.1074/jbc.M212414200; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; UREN JR, 1978, BIOCHEM PHARMACOL, V27, P2807, DOI 10.1016/0006-2952(78)90194-6; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang JM, 2006, NUCLEIC ACIDS RES, V34, P3646, DOI 10.1093/nar/gkl395; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhu WD, 2008, BIOCHEMISTRY-US, V47, P6226, DOI 10.1021/bi800351a	34	135	144	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3076	3085		10.1074/jbc.M805459200	http://dx.doi.org/10.1074/jbc.M805459200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19019829	hybrid			2022-12-25	WOS:000262700900052
J	Topol, LL; Chen, W; Song, H; Day, TF; Yang, YZ				Topol, Lilia; Chen, Wen; Song, Hai; Day, Timothy F.; Yang, Yingzi			Sox9 Inhibits Wnt Signaling by Promoting beta-Catenin Phosphorylation in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL SEX REVERSAL; F-BOX PROTEIN; I-KAPPA-B; GLYCOGEN-SYNTHASE KINASE-3; SYNOVIAL JOINT FORMATION; COLON-CARCINOMA CELLS; CRANIAL NEURAL CREST; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; CHONDROCYTE DIFFERENTIATION	Chondrocyte fate determination and maintenance requires Sox9, an intrinsic transcription factor, but is inhibited by Wnt/beta-catenin signaling activated by extrinsic Wnt ligands. Here we explored the underlying molecular mechanism by which Sox9 antagonizes the Wnt/beta-catenin signaling in chondrocyte differentiation. We found that Sox9 employed two distinct mechanisms to inhibit Wnt/beta-catenin signaling: the Sox9 N terminus is necessary and sufficient to promote beta-catenin degradation, whereas the C terminus is required to inhibit beta-catenin transcriptional activity without affecting its stability. Sox9 binds to beta-catenin and components of the beta-catenin "destruction complex," glycogen synthase kinase 3 and beta-transducin repeat containing protein, to promote their nuclear localization. Independent of its DNA binding ability, nuclear localization of Sox9 is both necessary and sufficient to enhance beta-catenin phosphorylation and its subsequent degradation. Thus, one mechanism whereby Sox9 regulates chondrogenesis is to promote efficient beta-catenin phosphorylation in the nucleus. This mechanism may be broadly employed by other intrinsic cell fate determining transcription factors to promptly turn off extrinsic inhibitory Wnt signaling mediated by beta-catenin.	[Topol, Lilia; Chen, Wen; Song, Hai; Day, Timothy F.; Yang, Yingzi] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Yang, YZ (corresponding author), 49 Convent Dr,MSC 4472, Bethesda, MD 20892 USA.	yingzi@mail.nih.gov		Day, Timothy/0000-0002-3786-2152	National Institutes of Health; NHGRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000187, Z01HG000187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by the National Institutes of Health, NHGRI intramural research program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Amati B, 2007, NAT CELL BIOL, V9, P729, DOI 10.1038/ncb0707-729; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; HARLEY VR, 1994, MOL REPROD DEV, V39, P184, DOI 10.1002/mrd.1080390211; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lagna G, 1999, MECH DEVELOP, V80, P101, DOI 10.1016/S0925-4773(98)00208-1; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; McDowall S, 1999, J BIOL CHEM, V274, P24023, DOI 10.1074/jbc.274.34.24023; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Primot A, 2000, PROTEIN EXPRES PURIF, V20, P394, DOI 10.1006/prep.2000.1321; Reinhardt J, 2007, PROTEIN EXPRES PURIF, V54, P101, DOI 10.1016/j.pep.2007.02.020; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Spokony RF, 2002, DEVELOPMENT, V129, P421; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vyas DR, 2002, AM J PHYSIOL-CELL PH, V283, pC545, DOI 10.1152/ajpcell.00049.2002; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	61	165	180	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3323	3333		10.1074/jbc.M808048200	http://dx.doi.org/10.1074/jbc.M808048200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047045	hybrid, Green Published			2022-12-25	WOS:000262700900075
J	Aguilar, HC; Ataman, ZA; Aspericueta, V; Fang, AQ; Stroud, M; Negrete, OA; Kammerer, RA; Lee, B				Aguilar, Hector C.; Ataman, Zeynep Akyol; Aspericueta, Vanessa; Fang, Angela Q.; Stroud, Matthew; Negrete, Oscar A.; Kammerer, Richard A.; Lee, Benhur			A Novel Receptor-induced Activation Site in the Nipah Virus Attachment Glycoprotein (G) Involved in Triggering the Fusion Glycoprotein (F)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMAGGLUTININ-NEURAMINIDASE PROTEIN; MEMBRANE-FUSION; HENDRA-VIRUS; HN PROTEIN; CELL-FUSION; STRUCTURAL BASIS; PARAMYXOVIRUS FUSION; MEASLES-VIRUS; STALK DOMAIN; BINDING-SITE	Cellular entry of paramyxoviruses requires the coordinated action of both the attachment (G/H/HN) and fusion (F) glycoproteins, but how receptor binding activates G to trigger F-mediated fusion during viral entry is not known. Here, we identify a receptor (ephrinB2)-induced allosteric activation site in Nipahvirus(NiV) G involved in triggering F-mediated fusion. We first generated a conformational monoclonal antibody (monoclonal antibody 45 (Mab45)) whose binding to NiV-G was enhanced upon NiV-GephrinB2 binding. However, Mab45 also inhibited viral entry, and its receptor binding-enhanced (RBE) epitope was temperature-dependent, suggesting that the Mab45 RBE epitope on G may be involved in triggering F. The Mab45 RBE epitope was mapped to the base of the globular domain (beta 6S4/beta 1H1). Alanine scan mutants within this region that did not exhibit this RBE epitope were also nonfusogenic despite their ability to bind ephrinB2, oligomerize, and associate with Fat wild-type (WT) levels. Although circular dichroism revealed conformational changes in the soluble ectodomain of WT NiV-G upon ephrinB2 addition, no such changes were detected with soluble RBE epitope mutants or short-stalk G mutants. Additionally, WTG, but not a RBE epitope mutant, could dissociate from F upon ephrinB2 engagement. Finally, using a biotinylated HR2 peptide to detect pre-hairpin intermediate formation, a cardinal feature of F-triggering, we showed that ephrinB2 binding to WT G, but not the RBE-epitope mutants, could trigger F. In sum, we implicate the coordinated interaction between the base of NiV-Gglobular head domain and the stalk domain in mediating receptor-induced F triggering during viral entry.	[Aguilar, Hector C.; Ataman, Zeynep Akyol; Aspericueta, Vanessa; Fang, Angela Q.; Negrete, Oscar A.; Lee, Benhur] Univ Calif Los Angeles, Dept MIMG, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lee, Benhur] Univ Calif Los Angeles, Dept Pathol & Lab Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lee, Benhur] Univ Calif Los Angeles, AIDS Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Stroud, Matthew; Kammerer, Richard A.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Manchester	Lee, B (corresponding author), Univ Calif Los Angeles, Dept MIMG, David Geffen Sch Med, 257 BSRB,615 Charles E Young Dr E, Los Angeles, CA 90095 USA.	bleebhL@ucla.edu	Lee, Benhur/A-8554-2016; Aguilar, Hector/AAD-6663-2022	Lee, Benhur/0000-0003-0760-1709; Stroud, Matthew/0000-0003-0451-3367; Stroud, Matthew John/0000-0002-3337-6851; Kammerer, Richard/0000-0003-4570-5197	National Institutes of Health [AI070495, AI060694, AI069317]; Rockefeller Brothers Fund; Burroughs Welcome Fund Career Development Award; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069317, R01AI060694, U01AI070495, P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller Brothers Fund; Burroughs Welcome Fund Career Development Award(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070495, AI060694, and AI069317 (to B. L.). Additional support was provided by a Charles E. Culpepper Medical Scholarship from the Rockefeller Brothers Fund and a Burroughs Welcome Fund Career Development Award. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked 'advertisement'in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguilar HC, 2007, J VIROL, V81, P4520, DOI 10.1128/JVI.02205-06; Aguilar HC, 2006, J VIROL, V80, P4878, DOI 10.1128/JVI.80.10.4878-4889.2006; Bishop KA, 2008, J VIROL, V82, P11398, DOI 10.1128/JVI.02654-07; Bishop KA, 2007, J VIROL, V81, P5893, DOI 10.1128/JVI.02022-06; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bossart KN, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-57; BOUSSE T, 1994, VIROLOGY, V204, P506, DOI 10.1006/viro.1994.1564; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Connolly SA, 2006, VIROLOGY, V355, P203, DOI 10.1016/j.virol.2006.07.021; Corey EA, 2007, J VIROL, V81, P9900, DOI 10.1128/JVI.00909-07; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; DENG RT, 1994, VIROLOGY, V204, P17, DOI 10.1006/viro.1994.1506; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; Finnegan C., 2006, Infectious Disorders - Drug Targets, V6, P355, DOI 10.2174/187152606779025851; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Lawrence MC, 2004, J MOL BIOL, V335, P1343, DOI 10.1016/j.jmb.2003.11.032; Lee B, 2008, NAT STRUCT MOL BIOL, V15, P540, DOI 10.1038/nsmb0608-540; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413; Lorio RM, 2008, TRENDS MICROBIOL, V16, P135, DOI 10.1016/j.tim.2008.01.006; MCCUBBIN WD, 1974, BIOCHEMISTRY-US, V13, P2689, DOI 10.1021/bi00710a005; MCGINNES L, 1993, VIROLOGY, V196, P101, DOI 10.1006/viro.1993.1458; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Melanson VR, 2004, J VIROL, V78, P13053, DOI 10.1128/JVI.78.23.13053-13061.2004; MIRZA AM, 1994, J VIROL, V68, P5093, DOI 10.1128/JVI.68.8.5093-5099.1994; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete OA, 2007, J VIROL, V81, P10804, DOI 10.1128/JVI.00999-07; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; Plemper RK, 2002, J VIROL, V76, P5051, DOI 10.1128/JVI.76.10.5051-5061.2002; Porotto M, 2003, J VIROL, V77, P3647, DOI 10.1128/JVI.77.6.3647-3654.2003; Porotto M, 2007, J VIROL, V81, P3216, DOI 10.1128/JVI.02617-06; Russell CJ, 2006, TRENDS MICROBIOL, V14, P243, DOI 10.1016/j.tim.2006.04.004; Russell CJ, 2003, J CELL BIOL, V163, P363, DOI 10.1083/jcb.200305130; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; SERGEL T, 1993, VIROLOGY, V193, P717, DOI 10.1006/viro.1993.1180; Stone-Hulslander J, 1999, J VIROL, V73, P3630, DOI 10.1128/JVI.73.5.3630-3637.1999; TSURUDOME M, 1995, VIROLOGY, V213, P190, DOI 10.1006/viro.1995.1559; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WILD TF, 2008, PATHOL BIOL IN PRESS; Xu K, 2008, P NATL ACAD SCI USA, V105, P9953, DOI 10.1073/pnas.0804797105; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; YUASA T, 1995, VIROLOGY, V206, P1117, DOI 10.1006/viro.1995.1035; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004	45	70	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1628	1635		10.1074/jbc.M807469200	http://dx.doi.org/10.1074/jbc.M807469200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19019819	hybrid, Green Published			2022-12-25	WOS:000262330100031
J	Melle, C; Ernst, G; Schimmel, B; Bleul, A; von Eggeling, F				Melle, Christian; Ernst, Guenther; Schimmel, Bettina; Bleul, Annett; von Eggeling, Ferdinand			Colon-Derived Liver Metastasis, Colorectal Carcinoma, and Hepatocellular Carcinoma Can Be Discriminated by the Ca2+-Binding Proteins S100A6 and S100A11	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MOLECULAR-DETECTION; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; IDENTIFICATION; CANCER; DISCOVERY; MARKERS; BIOMARKERS; FAMILY	Background: It is unknown, on the proteomic level, whether the protein patterns of tumors change during metastasis or whether markers are present that allow metastases to be allocated to a specific tumor entity. The latter is of clinical interest if the primary tumor is not known. Methodology/Principal Findings: In this study, tissue from colon-derived liver metastases (n = 17) were classified, laser-microdissected, and analysed by ProteinChip arrays (SELDI). The resulting spectra were compared with data for primary colorectal (CRC) and hepatocellular carcinomas (HCC) from our former studies. Of 49 signals differentially expressed in primary HCC, primary CRC, and liver metastases, two were identified by immunodepletion as S100A6 and S100A11. Both proteins were precisely localized immunohistochemically in cells. S100A6 and S100A11 can discriminate significantly between the two primary tumor entities, CRC and HCC, whereas S100A6 allows the discrimination of metastases and HCC. Conclusions: Both identified proteins can be used to discriminate different tumor entities. Specific markers or proteomic patterns for the metastases of different primary cancers will allow us to determine the biological characteristics of metastasis in general. It is unknown how the protein patterns of tumors change during metastasis or whether markers are present that allow metastases to be allocated to a specific tumor entity. The latter is of clinical interest if the primary tumor is not known.	[Melle, Christian; Ernst, Guenther; Schimmel, Bettina; Bleul, Annett; von Eggeling, Ferdinand] Univ Jena, Fac Med, Core Unit Chip Applicat, Inst Human Genet & Anthropol, Jena, Germany	Friedrich Schiller University of Jena	Melle, C (corresponding author), Univ Jena, Fac Med, Core Unit Chip Applicat, Inst Human Genet & Anthropol, Jena, Germany.	fegg@mti.uni-jena.de	von Eggeling, Ferdinand/AAC-8349-2022; von Eggeling, Ferdinand/B-4033-2014	von Eggeling, Ferdinand/0000-0002-8062-6999; von Eggeling, Ferdinand/0000-0002-8062-6999; Melle, Christian/0000-0002-1870-9419	German Federal Ministry of Education and Research (BMBF); Interdisciplinary Center for Clinical Research (ICCR), Jena	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Center for Clinical Research (ICCR), Jena	This work was supported by a grant from the German Federal Ministry of Education and Research (BMBF) and the Interdisciplinary Center for Clinical Research (ICCR), Jena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung PK, 2004, CANCER RES, V64, P5929, DOI 10.1158/0008-5472.CAN-04-1216; Conzelmann M, 2005, INT J COLORECTAL DIS, V20, P137, DOI 10.1007/s00384-004-0640-2; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Drake RR, 2006, MOL CELL PROTEOMICS, V5, P1957, DOI 10.1074/mcp.M600176-MCP200; FINKELSTEIN SD, 1993, CANCER, V71, P3827, DOI 10.1002/1097-0142(19930615)71:12<3827::AID-CNCR2820711207>3.0.CO;2-N; Guedj N, 2006, LAB INVEST, V86, P951, DOI 10.1038/labinvest.3700450; Helmberger TK, 2002, EUR RADIOL, V12, P62, DOI 10.1007/s003300101122; Jiang DF, 2003, PROTEOMICS, V3, P724, DOI 10.1002/pmic.200300411; Khan ZAJ, 2000, CLIN CANCER RES, V6, P3499; Komatsu K, 2002, ONCOLOGY-BASEL, V63, P192, DOI 10.1159/000063812; Komatsu K, 2000, BRIT J CANCER, V83, P769, DOI 10.1054/bjoc.2000.1356; Kreunin Paweena, 2007, Cancer Genomics & Proteomics, V4, P329; Li YT, 2006, PROTEOMICS, V6, P3426, DOI 10.1002/pmic.200500472; Maelandsmo GM, 1997, INT J CANCER, V74, P464, DOI 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9; MC DS, 1999, CLIN EXP METASTAS, V17, P341; Melle C, 2006, INT J ONCOL, V28, P195; Melle C, 2004, CANCER RES, V64, P4099, DOI 10.1158/0008-5472.CAN-03-3807; Melle C, 2003, MOL CELL PROTEOMICS, V2, P443, DOI 10.1074/mcp.M300033-MCP200; Melle C, 2005, GASTROENTEROLOGY, V129, P66, DOI 10.1053/j.gastro.2005.05.014; Melle C, 2007, J PROTEOME RES, V6, P306, DOI 10.1021/pr060439b; Nakamura S, 1997, WORLD J SURG, V21, P741, DOI 10.1007/s002689900300; Pan S, 2005, MOL CELL PROTEOMICS, V4, P182, DOI 10.1074/mcp.M400161-MCP200; Paradis V, 2005, HEPATOLOGY, V41, P40, DOI 10.1002/hep.20505; Raslich MA, 2007, BIOCHEM MEDICA, V17, P151; Ridley A, 2000, NATURE, V406, P466, DOI 10.1038/35020170; Sanchez-Cespedes M, 1999, CLIN CANCER RES, V5, P2450; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Schutze K, 2007, METHOD CELL BIOL, V82, P649, DOI 10.1016/S0091-679X(06)82023-6; Schutze K, 1998, NAT BIOTECHNOL, V16, P737, DOI 10.1038/nbt0898-737; Tang N, 2004, MASS SPECTROM REV, V23, P34, DOI 10.1002/mas.10066; Tzimas GN, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-149; Ueda J, 2007, PATHOBIOLOGY, V74, P32, DOI 10.1159/000101049; von Eggeling F, 2007, PROTEOMICS, V7, P2729, DOI 10.1002/pmic.200700079; Ward DG, 2006, BRIT J CANCER, V94, P1898, DOI 10.1038/sj.bjc.6603188; Weiss L, 2000, CANCER METAST REV, V19, P381, DOI 10.1023/A:1010623111204; Yao R, 2007, HISTOL HISTOPATHOL, V22, P1025, DOI 10.14670/HH-22.1025; Zhen Cai, 2004, Genomics Proteomics & Bioinformatics, V2, P152	37	36	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3767	10.1371/journal.pone.0003767	http://dx.doi.org/10.1371/journal.pone.0003767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048101	gold, Green Published, Green Submitted			2022-12-25	WOS:000265452000002
J	Paulson, TG; Galipeau, PC; Xu, LJ; Kissel, HD; Li, XH; Blount, PL; Sanchez, CA; Odze, RD; Reid, BJ				Paulson, Thomas G.; Galipeau, Patricia C.; Xu, Lianjun; Kissel, Heather D.; Li, Xiaohong; Blount, Patricia L.; Sanchez, Carissa A.; Odze, Robert D.; Reid, Brian J.			p16 Mutation Spectrum in the Premalignant Condition Barrett's Esophagus	PLOS ONE			English	Article								Background: Mutation, promoter hypermethylation and loss of heterozygosity involving the tumor suppressor gene p16 (CDKN2a/INK4a) have been detected in a wide variety of human cancers, but much less is known concerning the frequency and spectrum of p16 mutations in premalignant conditions. Methods and Findings: We have determined the p16 mutation spectrum for a cohort of 304 patients with Barrett's esophagus, a premalignant condition that predisposes to the development of esophageal adenocarcinoma. Forty seven mutations were detected by sequencing of p16 exon 2 in 44 BE patients (14.5%) with a mutation spectrum consistent with that caused by oxidative damage and chronic inflammation. The percentage of patients with p16 mutations increased with increasing histologic grade. In addition, samples from 3 out of 19 patients (15.8%) who underwent esophagectomy were found to have mutations. Conclusions: The results of this study suggest the environment of the esophagus in BE patients can both generate and select for clones with p16 mutations.	[Paulson, Thomas G.; Galipeau, Patricia C.; Kissel, Heather D.; Li, Xiaohong; Blount, Patricia L.; Sanchez, Carissa A.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Paulson, Thomas G.; Galipeau, Patricia C.; Kissel, Heather D.; Li, Xiaohong; Blount, Patricia L.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA; [Xu, Lianjun] Oregon Hlth & Sci Univ, Dept Gen Surg, Portland, OR USA; [Blount, Patricia L.; Reid, Brian J.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Reid, Brian J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Odze, Robert D.] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital	Paulson, TG (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	tpaulson@fhcrc.org	Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X; Galipeau, Patricia/0000-0001-7961-7430	NIH [K07CA089147, R01CA78828, R01CA61202, PO1CA91955]; Ryan Hill Foundation; Fred Hutchinson Cancer Research Center; NATIONAL CANCER INSTITUTE [P01CA091955, K07CA089147, R01CA078828, R01CA061202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ryan Hill Foundation; Fred Hutchinson Cancer Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NIH K07CA089147, R01CA78828, R01CA61202, PO1CA91955, the Ryan Hill Foundation (TGP) and The Fred Hutchinson Cancer Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett MT, 1996, ONCOGENE, V13, P1867; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; BLOUNT PL, 1993, P NATL ACAD SCI USA, V90, P3221, DOI 10.1073/pnas.90.8.3221; BLOUNT PL, 1994, CANCER RES, V54, P2292; Brown Linda Morris, 2002, Surg Oncol Clin N Am, V11, P235, DOI 10.1016/S1055-3207(02)00002-9; CAMERON AJ, 1992, GASTROENTEROLOGY, V103, P1241, DOI 10.1016/0016-5085(92)91510-B; Dvorak K, 2006, DIS ESOPHAGUS, V19, P366, DOI 10.1111/j.1442-2050.2006.00596.x; Esteve A, 1996, INT J CANCER, V66, P301; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Foulkes WD, 1997, MOL MED, V3, P5, DOI 10.1007/BF03401664; Galipeau PC, 2007, PLOS MED, V4, P342, DOI 10.1371/jourmal.pmed.0040067; Galipeau PC, 1999, J NATL CANCER I, V91, P2087, DOI 10.1093/jnci/91.24.2087; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Gamieldien W, 1998, INT J CANCER, V78, P544, DOI 10.1002/(SICI)1097-0215(19981123)78:5<544::AID-IJC3>3.3.CO;2-K; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Giroux MA, 2002, EUR J GASTROEN HEPAT, V14, P15, DOI 10.1097/00042737-200201000-00004; Gonzalez MV, 1997, J CLIN PATHOL, V50, P212, DOI 10.1136/jcp.50.3.212; Greenblatt MS, 2003, ONCOGENE, V22, P1150, DOI 10.1038/sj.onc.1206101; Hardie JJ, 2005, CANCER LETT, V217, P221, DOI 10.1016/j.canlet.2004.06.025; Hiroyasu M, 2002, AM J PATHOL, V160, P419, DOI 10.1016/S0002-9440(10)64860-2; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEVINE DS, 1993, GASTROENTEROLOGY, V105, P40, DOI 10.1016/0016-5085(93)90008-Z; Lin J, 2004, SEMIN ONCOL, V31, P476, DOI 10.1053/j.seminoncol.2004.04.019; Liu L, 2003, ALIMENT PHARM THER, V18, P693, DOI 10.1046/j.1365-2036.2003.01734.x; Murphy JA, 2004, HUM MUTAT, V24, P296, DOI 10.1002/humu.20083; Muzeau F, 1997, BRIT J CANCER, V75, P1336, DOI 10.1038/bjc.1997.226; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; Paulson TG, 1999, GENOME RES, V9, P482; PHILLIPS RW, 1991, GASTROENTEROL CLIN N, V20, P791; Pho L, 2006, CURR OPIN ONCOL, V18, P173, DOI 10.1097/01.cco.0000208791.22442.09; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Prevo LJ, 1999, CANCER RES, V59, P4784; REID BJ, 1988, GASTROENTEROLOGY, V94, P81, DOI 10.1016/0016-5085(88)90613-0; REID BJ, 1993, GASTROENTEROLOGY, V105, P119, DOI 10.1016/0016-5085(93)90017-7; Reid BJ, 2000, AM J GASTROENTEROL, V95, P3089, DOI 10.1111/j.1572-0241.2000.03182.x; Reid Brian J, 2003, Gastrointest Endosc Clin N Am, V13, P369, DOI 10.1016/S1052-5157(03)00006-0; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Roncalli M, 1998, LAB INVEST, V78, P1049; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Smeds J, 2002, CARCINOGENESIS, V23, P645, DOI 10.1093/carcin/23.4.645; Tanaka T, 1999, ONCOGENE, V18, P3793, DOI 10.1038/sj.onc.1202707; Turker MS, 1999, CANCER RES, V59, P1837; Turner DR, 2003, MUTAT RES-FUND MOL M, V522, P21, DOI 10.1016/S0027-5107(02)00194-X; Vieth M, 2004, VIRCHOWS ARCH, V445, P135, DOI 10.1007/s00428-004-1042-0; Wetscher G J, 1997, Dis Esophagus, V10, P29; Wetscher GJ, 1997, DIS ESOPHAGUS, V10, P33; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wong DJ, 2001, CANCER RES, V61, P8284; Yarbrough WG, 1999, J NATL CANCER I, V91, P1569, DOI 10.1093/jnci/91.18.1569; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; ZHOU XL, 1994, ONCOGENE, V9, P3737	54	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3809	10.1371/journal.pone.0003809	http://dx.doi.org/10.1371/journal.pone.0003809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043591	Green Published, Green Submitted, gold			2022-12-25	WOS:000265451500002
J	Manich, M; Knapp, O; Gibert, M; Maier, E; Jolivet-Reynaud, C; Geny, B; Benz, R; Popoff, MR				Manich, Maria; Knapp, Oliver; Gibert, Maryse; Maier, Elke; Jolivet-Reynaud, Colette; Geny, Blandine; Benz, Roland; Popoff, Michel R.			Clostridium perfringens Delta Toxin Is Sequence Related to Beta Toxin, NetB, and Staphylococcus Pore-Forming Toxins, but Shows Functional Differences	PLOS ONE			English	Article								Clostridium perfringens produces numerous toxins, which are responsible for severe diseases in man and animals. Delta toxin is one of the three hemolysins released by a number of C. perfringens type C and possibly type B strains. Delta toxin was characterized to be cytotoxic for cells expressing the ganglioside G(M2) in their membrane. Here we report the genetic characterization of Delta toxin and its pore forming activity in lipid bilayers. Delta toxin consists of 318 amino acids, its 28 N-terminal amino acids corresponding to a signal peptide. The secreted Delta toxin (290 amino acids; 32619 Da) is a basic protein (pI 9.1) which shows a significant homology with C. perfringens Beta toxin (43% identity), with C. perfringens NetB (40% identity) and, to a lesser extent, with Staphylococcus aureus alpha toxin and leukotoxins. Recombinant Delta toxin showed a preference for binding to G(M2), in contrast to Beta toxin, which did not bind to gangliosides. It is hemolytic for sheep red blood cells and cytotoxic for HeLa cells. In artificial diphytanoyl phosphatidylcholine membranes, Delta and Beta toxin formed channels. Conductance of the channels formed by Delta toxin, with a value of about 100 pS to more than 1 nS in 1 M KCl and a membrane potential of 20 mV, was higher than those formed by Beta toxin and their distribution was broader. The results of zero-current membrane potential measurements and single channel experiments suggest that Delta toxin forms slightly anion-selective channels, whereas the Beta toxin channels showed a preference for cations under the same conditions. C. perfringens Delta toxin shows a significant sequence homolgy with C. perfringens Beta and NetB toxins, as well as with S. aureus alpha hemolysin and leukotoxins, but exhibits different channel properties in lipid bilayers. In contrast to Beta toxin, Delta toxin recognizes G(M2) as receptor and forms anion-selective channels.	[Manich, Maria; Knapp, Oliver; Gibert, Maryse; Geny, Blandine; Popoff, Michel R.] Inst Pasteur, Paris, France; [Knapp, Oliver; Maier, Elke; Benz, Roland] Univ Wurzburg, Theodor Boveri Inst Biozentrum, Lehrstuhl Biotechnol, D-97070 Wurzburg, Germany; [Jolivet-Reynaud, Colette] BioMerieux, Dept Nouveaux Marqueurs, Marcy Letoile, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Wurzburg; bioMerieux	Manich, M (corresponding author), Inst Pasteur, Paris, France.	mpopoff@pasteur.fr		Benz, Roland/0000-0002-9510-9265	IP; Deutsche Forschungsgemeinschaft [SFB 487]; Funds of the Chemical Industry	IP; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Funds of the Chemical Industry	This work was financially supported by IP funding, the Deutsche Forschungsgemeinschaft (project A5 of the SFB 487), and the Funds of the Chemical Industry (to RB).	ALOUF JE, 1981, INFECT IMMUN, V31, P536, DOI 10.1128/IAI.31.2.536-546.1981; Alouf JE, 2000, INT J MED MICROBIOL, V290, P351; BALLARD J, 1993, MOL MICROBIOL, V10, P627, DOI 10.1111/j.1365-2958.1993.tb00934.x; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; CAVAILLON JM, 1986, J LEUKOCYTE BIOL, V40, P65, DOI 10.1002/jlb.40.1.65; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Freer JH., 2006, COMPREHENSIVE SOURCE, P590, DOI 10.1016/B978-012088445-2/50037-8; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Gibert M, 1997, GENE, V203, P65, DOI 10.1016/S0378-1119(97)00493-9; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; HUNTER SEC, 1993, INFECT IMMUN, V61, P3958, DOI 10.1128/IAI.61.9.3958-3965.1993; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; JOLIVETREYNAUD C, 1982, INFECT IMMUN, V38, P860, DOI 10.1128/IAI.38.3.860-864.1982; JOLIVETREYNAUD C, 1993, ANTI-CANCER DRUG, V4, P65, DOI 10.1097/00001813-199302000-00009; JOLIVETREYNAUD C, 1988, ARCH BIOCHEM BIOPHYS, V262, P59, DOI 10.1016/0003-9861(88)90168-3; JOLIVETREYNAUD C, 1983, J BIOL CHEM, V258, P1871; JOLIVETREYNAUD C, 1989, TOXICON, V27, P1113, DOI 10.1016/0041-0101(89)90005-6; JOLIVETREYNAUD C, 1986, ZBL BAKTERIOL S, V15, P145; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; KRASILNIKOV OV, 1992, FEMS MICROBIOL IMMUN, V105, P93; Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200; Michelet N., 2006, COMPREHENSIVE SOURCE, P779; Nablo BJ, 2008, BIOPHYS J, V95, P1157, DOI 10.1529/biophysj.107.121715; Nagahama M, 1999, BBA-MOL BASIS DIS, V1454, P97, DOI 10.1016/S0925-4439(99)00026-5; Nagahama M, 2003, J BIOL CHEM, V278, P36934, DOI 10.1074/jbc.M306562200; Palmer M, 2001, TOXICON, V39, P1681, DOI 10.1016/S0041-0101(01)00155-6; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Popoff Michel R., 2005, P323; POPOFF MR, 1991, INFECT IMMUN, V59, P3673, DOI 10.1128/IAI.59.10.3673-3679.1991; Prevost G, 2001, CURR TOP MICROBIOL, V257, P53; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; SAKURAI J, 1978, INFECT IMMUN, V21, P678, DOI 10.1128/IAI.21.2.678-680.1978; SAKURAI J, 1987, TOXICON, V25, P1301, DOI 10.1016/0041-0101(87)90008-0; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMID A, 1994, J BIOL CHEM, V269, P16706; SELLMAN BR, 1997, MOL MICROBIOL, V23, P531; Shatursky O, 2000, INFECT IMMUN, V68, P5546, DOI 10.1128/IAI.68.10.5546-5551.2000; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; SHERRER R, 1971, J BACTERIOL, V107, P718; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Smedley JG, 2007, INFECT IMMUN, V75, P2381, DOI 10.1128/IAI.01737-06; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Songer J. Glenn, 2005, P527; Steinthorsdottir V, 1998, FEMS MICROBIOL LETT, V158, P17, DOI 10.1016/S0378-1097(97)00470-9; Stiles BG, 2002, BIOCHEM J, V367, P801, DOI 10.1042/BJ20020566; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; VANDERGOOT FG, 1993, BIOCHEMISTRY-US, V32, P2636, DOI 10.1021/bi00061a023; VONHEIJNE G, 1989, FEBS LETT, V244, P439, DOI 10.1016/0014-5793(89)80579-4; [No title captured]	55	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3764	10.1371/journal.pone.0003764	http://dx.doi.org/10.1371/journal.pone.0003764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018299	gold, Green Published, Green Submitted			2022-12-25	WOS:000265448500011
J	Lenselink, CH; Melchers, WJG; Quint, WGV; Hoebers, AMJ; Hendriks, JCM; Massuger, LFAG; Bekkers, RLM				Lenselink, Charlotte H.; Melchers, Willem J. G.; Quint, Wim G. V.; Hoebers, Annelies M. J.; Hendriks, Jan C. M.; Massuger, Leon F. A. G.; Bekkers, Ruud L. M.			Sexual Behaviour and HPV Infections in 18 to 29 Year Old Women in the Pre-Vaccine Era in the Netherlands	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; ONCOGENIC HUMAN-PAPILLOMAVIRUS; LINE PROBE ASSAY; RISK-FACTORS; YOUNG-WOMEN; CLINICAL-EVALUATION; CONDOM USE; PREVALENCE; HISTORY; BRITAIN		[Lenselink, Charlotte H.; Massuger, Leon F. A. G.; Bekkers, Ruud L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Melchers, Willem J. G.; Hoebers, Annelies M. J.] Univ Nijmegen, Ctr Infect Dis, Dept Med Microbiol, Nijmegen, Netherlands; [Quint, Wim G. V.] DDL Diagnost Lab, Voorburg, Netherlands; [Hendriks, Jan C. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; DDL Diagnostic Laboratory; Radboud University Nijmegen	Lenselink, CH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands.	c.lenselink@obgyn.umcn.nl	Hendriks, J.C.M./L-4363-2015; Melchers, Willem/C-8819-2015; Bekkers, Ruud/AAU-5319-2020; Bekkers, Ruud/M-3866-2014; Massuger, Leon F.A.G./H-8072-2014	Melchers, Willem/0000-0002-5446-2230; Bekkers, Ruud/0000-0002-4577-8495; 	GlaxoSmithKline [2702-HPV-109932]	GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline (GSK 2702-HPV-109932 to R.L.B, L.F.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; BRABIN L, 2008, BMJ; Burchell AN, 2006, AM J EPIDEMIOL, V163, P534, DOI 10.1093/aje/kwj077; COUPE VM, 2008, BR J CANC; Dempsey AF, 2008, VACCINE, V26, P1111, DOI 10.1016/j.vaccine.2007.11.088; Fenton KA, 2005, J INFECT DIS, V191, pS127, DOI 10.1086/425286; Fenton KA, 2003, CLIN MED, V3, P199; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Jonsson M, 1997, INT J STD AIDS, V8, P501, DOI 10.1258/0956462971920659; KARLSSON R, 1995, SEX TRANSM DIS, V22, P119, DOI 10.1097/00007435-199503000-00008; Kjaer SK, 1997, CANCER EPIDEM BIOMAR, V6, P799; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Manhart LE, 2006, SEX TRANSM DIS, V33, P502, DOI 10.1097/01.olq.0000204545.89516.0a; Melchers WJG, 1999, AM J PATHOL, V155, P1473, DOI 10.1016/S0002-9440(10)65462-4; Stewart DE, 2007, J OBSTET GYNAECOL CA, V29, P817, DOI 10.1016/S1701-2163(16)32636-6; Tabora N, 2005, AM J TROP MED HYG, V73, P50, DOI 10.4269/ajtmh.2005.73.1.0730050; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P326, DOI 10.1158/1055-9965.EPI-05-0577; van Ham MAPC, 2005, J CLIN MICROBIOL, V43, P2662, DOI 10.1128/JCM.43.6.2662-2667.2005; van Hamont D, 2006, J CLIN MICROBIOL, V44, P3122, DOI 10.1128/JCM.00517-06; Wiley DJ, 2006, CANCER EPIDEM BIOMAR, V15, P915, DOI 10.1158/1055-9965.EPI-05-0963; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180	24	61	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3743	10.1371/journal.pone.0003743	http://dx.doi.org/10.1371/journal.pone.0003743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011683	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448300011
J	Thakur, JK; Arthanari, H; Yang, FJ; Chau, KH; Wagner, G; Naar, AM				Thakur, Jitendra K.; Arthanari, Haribabu; Yang, Fajun; Chau, Katherine H.; Wagner, Gerhard; Naeaer, Anders M.			Mediator Subunit Gal11p/MED15 Is Required for Fatty Acid-dependent Gene Activation by Yeast Transcription Factor Oaf1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODING PEROXISOMAL PROTEINS; NUCLEAR RECEPTOR SUPERFAMILY; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; BETA-OXIDATION; TRANSACTIVATION DOMAIN; X-RECEPTOR; METABOLISM; INDUCTION; COMPLEX	The yeast zinc cluster transcription factor Oaf1p activates transcription of target genes in response to direct binding of fatty acids in a manner analogous to the vertebrate nuclear receptor peroxisome proliferator-activated receptor alpha(PPAR alpha). PPARs and other metazoan nuclear receptors productively engage several distinct LXXLL motif-containing co-activators, including p160 family members and the TRAP220/MED1 subunit of the Mediator coactivator, to promote ligand-dependent gene activation. Yeast, however, does not appear to harbor LXXLL motif co-activators, and the mechanism of fatty acid-dependent gene activation by the yeast PPAR alpha analog Oaf1p is unknown. Here we show that the yeast Mediator subunit Gal11p/MED15 and its activator-targeted KIX domain plays a critical role in fatty acid-dependent transcriptional regulation of fatty acid beta-oxidation and peroxisomal genes by Oaf1p and for the ability of yeast to utilize fatty acids as a sole carbon source. Moreover, structural studies by NMR spectroscopy reveal that the Oaf1p activation domain interacts with the Gal11p/MED15 KIX domain in a manner similar to the yeast zinc cluster family member and xenobiotic receptor Pdr1p, revealing that the Gal11p/MED15 KIX domain is a key target of several ligand-dependent transcription factors in yeast. Together with previous work showing that the Caenorhabditis elegans Gal11p/MED15 homolog MDT-15 plays a critical role in regulation of fatty acid metabolism by the nematode PPAR-like nuclear receptor NHR-49, the findings presented here provide evidence for an ancient and essential role of a Mediator co-activator subunit in regulation of fatty acid metabolism by nuclear receptor-like transcription factors in eukaryotes.	[Thakur, Jitendra K.; Yang, Fajun; Naeaer, Anders M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Thakur, Jitendra K.; Yang, Fajun; Naeaer, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Charlestown, MA 02129 USA; [Arthanari, Haribabu; Chau, Katherine H.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School	Naar, AM (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Rm 7407,Bldg 149,13th St, Charlestown, MA 02129 USA.	naar@helix.mgh.harvard.edu	Thakur, Jitendra/AAN-8674-2021	Thakur, Jitendra Kumar/0000-0001-7874-1923; Arthanari, Haribabu/0000-0002-7281-1289	NCI NIH HHS [R01 CA127990] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baumgartner U, 1999, J BIOL CHEM, V274, P22208, DOI 10.1074/jbc.274.32.22208; Bertrand W, 2004, MOL BIOL EVOL, V21, P1923, DOI 10.1093/molbev/msh200; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Escriva H, 2004, ESSAYS BIOCHEM, V40, P11, DOI 10.1042/bse0400011; Escriva H, 2000, BIOESSAYS, V22, P717; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Glass CK, 2000, GENE DEV, V14, P121; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Handschin C, 2005, ARCH BIOCHEM BIOPHYS, V433, P387, DOI 10.1016/j.abb.2004.08.030; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Karpichev IV, 1997, MOL CELL BIOL, V17, P69, DOI 10.1128/MCB.17.1.69; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	33	73	76	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4422	4428		10.1074/jbc.M808263200	http://dx.doi.org/10.1074/jbc.M808263200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19056732	Green Published, hybrid			2022-12-25	WOS:000263134400042
J	Atanassov, II; Pittman, JK; Turner, SR				Atanassov, Ivan I.; Pittman, Jon K.; Turner, Simon R.			Elucidating the Mechanisms of Assembly and Subunit Interaction of the Cellulose Synthase Complex of Arabidopsis Secondary Cell Walls	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNITS; PROTEIN COMPLEXES; PLASMA-MEMBRANE; BIOSYNTHESIS; PURIFICATION; TAG; DEPOSITION; DEFICIENT; ROSETTES; MUTANTS	Cellulose is the most abundant biopolymer in nature; however, questions relating to the biochemistry of its synthesis including the structure of the cellulose synthase complex (CSC) can only be answered by the purification of a fully functional complex. Despite its importance, this goal remains elusive. The work described here utilizes epitope tagging of cellulose synthase A (CESA) proteins that are known components of the CSC. To avoid problems associated with preferential purification of CESA monomers, we developed a strategy based on dual epitope tagging of the CESA7 protein to select for CESA multimers. With this approach, we used a two-step purification that preferentially selected for larger CESA oligomers. These preparations consisted solely of the three known secondary cell wall CESA proteins CESA4, CESA7, and CESA8. No additional CESA isoforms or other proteins were identified. The data are consistent with a model in which CESA protein homodimerization occurs prior to formation of larger CESA oligomers. This suggests that the three different CESA proteins undergo dimerization independently, but the presence of all three subunits is required for higher order oligomerization. Analysis of purified CESA complex and crude extracts suggests that disulfide bonds and noncovalent interactions contribute to the stability of the CESA subunit interactions. These results demonstrate that this approach will provide an excellent framework for future detailed analysis of the CSC.	[Atanassov, Ivan I.; Pittman, Jon K.; Turner, Simon R.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Turner, SR (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	simon.turner@manchester.ac.uk	Turner, Simon/K-7580-2012	Atanassov, Ivan/0000-0002-7771-3629; Pittman, Jon/0000-0001-7197-1494; Turner, Simon/0000-0003-4859-1068	Biotechnology and Biological Sciences Research Council [P19340]; Biotechnology and Biological Sciences Research Council [BB/C511064/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant P19340. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Cano-Delgado AI, 2000, DEVELOPMENT, V127, P3395; Chang IF, 2006, PROTEOMICS, V6, P6158, DOI 10.1002/pmic.200600225; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; HAIGLER CH, 1986, PROTOPLASMA, V134, P111, DOI 10.1007/BF01275709; Joshi CP, 2007, CURR OPIN PLANT BIOL, V10, P220, DOI 10.1016/j.pbi.2007.04.013; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Kudlicka K, 1997, PLANT PHYSIOL, V115, P643, DOI 10.1104/pp.115.2.643; Kurek I, 2002, P NATL ACAD SCI USA, V99, P11109, DOI 10.1073/pnas.162077099; Lai-Kee-Him J, 2002, J BIOL CHEM, V277, P36931, DOI 10.1074/jbc.M203530200; MUELLER SC, 1980, J CELL BIOL, V84, P315, DOI 10.1083/jcb.84.2.315; Mutwil M, 2008, CURR OPIN PLANT BIOL, V11, P252, DOI 10.1016/j.pbi.2008.03.007; Nomura E, 2004, J MASS SPECTROM, V39, P202, DOI 10.1002/jms.578; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; Schafer PH, 1998, J IMMUNOL, V161, P2307; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; SCHNEIDER B, 1986, PROTOPLASMA, V131, P142, DOI 10.1007/BF01285036; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Taylor NG, 2008, NEW PHYTOL, V178, P239, DOI 10.1111/j.1469-8137.2008.02385.x; Taylor NG, 2004, CELLULOSE, V11, P329, DOI 10.1023/B:CELL.0000046405.11326.a8; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; Wang J, 2008, J EXP BOT, V59, P2627, DOI 10.1093/jxb/ern125; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zolotarjova NI, 2001, J BIOL CHEM, V276, P17063, DOI 10.1074/jbc.M009627200	41	87	95	6	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3833	3841		10.1074/jbc.M807456200	http://dx.doi.org/10.1074/jbc.M807456200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19056734	hybrid			2022-12-25	WOS:000262872500052
J	Bovenschen, N; Quadir, R; van den Berg, AL; Brenkman, AB; Vandenberghe, I; Devreese, B; Joore, J; Kummer, JA				Bovenschen, Niels; Quadir, Razi; van den Berg, A. Lotte; Brenkman, Arjan B.; Vandenberghe, Isabel; Devreese, Bart; Joore, Jos; Kummer, J. Alain			Granzyme K Displays Highly Restricted Substrate Specificity That Only Partially Overlaps with Granzyme A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY PROTEIN SET; HNRNP-K; LYMPHOCYTE PROTEASE; CRYSTAL-STRUCTURE; SERINE PROTEASES; POTENTIAL TARGET; ALPHA-TUBULIN; A-DEFICIENT; IDENTIFICATION; CYTOTOXICITY	Granzymes are serine proteases stored in cytolytic granules of cytotoxic lymphocytes that eliminate virus-infected and tumor cells. Little is known about the molecular mechanism and function of granzyme (Gr) K. GrK is similar to GrA in that they are the only granzymes that display tryptase-like activity. Both granzymes induce cell death by single-stranded nicking of the chromosomal DNA by cleaving the same components of the endoplasmic reticulum-associated SET complex. Therefore, GrK may provide a backup and failsafe mechanism for GrA with redundant specificity. In the present study, we addressed the question of whether GrK displays identical substrate specificity as GrA. In peptide- and protease-proteomic screens, GrK and GrA displayed highly restricted substrate specificities that overlapped only partially. Whereas GrK and GrA cleave SET with similar efficiencies likely at the same sites, both granzymes cleaved the pre-mRNA-binding protein heterogeneous ribonuclear protein K with different kinetics at distinct sites. GrK was markedly more efficient in cleaving heterogeneous ribonuclear protein K than GrA. GrK, but not GrA, cleaved the microtubule network protein beta-tubulin after two distinct Arg residues. Neither GrK cleavage sites in beta-tubulin nor a peptidebased proteomic screen revealed a clear GrK consensus sequence around the P1 residue, suggesting that GrK specificity depends on electrostatic interactions between exosites of the substrate and the enzyme. We hypothesize that GrK not only constitutes a redundant functional backup mechanism that assists GrA-induced cell death but that it also displays a unique function by cleaving its own specific substrates.	[Bovenschen, Niels; Quadir, Razi; van den Berg, A. Lotte; Kummer, J. Alain] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [Brenkman, Arjan B.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, NL-3584 CX Utrecht, Netherlands; [Vandenberghe, Isabel; Devreese, Bart] Univ Ghent, Dept Biochem Physiol & Microbiol, Lab Prot Biochem & Biomol Engn, B-9000 Ghent, Belgium; [Joore, Jos] Pepscan, NL-8219 PK Lelystad, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Ghent University	Bovenschen, N (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	n.bovenschen@umcutrecht.nl	Devreese, Bart/B-2011-2009; Devreese, Bart/K-2841-2019	Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581; Joore, Jos/0000-0002-2744-4862	Netherlands Organization for Scientific Research Grant [916.66.044]; Dutch Cancer Society Grant [UMCU-2004-3047]	Netherlands Organization for Scientific Research Grant(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society Grant(KWF Kankerbestrijding)	This work was supported by Netherlands Organization for Scientific Research Grant 916.66.044 (to N. B.) and Dutch Cancer Society Grant UMCU-2004-3047 (to J.A.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adrain C, 2006, J BIOL CHEM, V281, P8118, DOI 10.1074/jbc.M509361200; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Bell JK, 2003, NAT STRUCT BIOL, V10, P527, DOI 10.1038/nsb944; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bovenschen N, 2008, J IMMUNOL, V180, P8184, DOI 10.4049/jimmunol.180.12.8184; Carter CRD, 1996, CELL IMMUNOL, V172, P235, DOI 10.1006/cimm.1996.0238; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Davis JE, 2001, EUR J IMMUNOL, V31, P39, DOI 10.1002/1521-4141(200101)31:1<39::AID-IMMU39>3.0.CO;2-1; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Goping IS, 2006, J CELL SCI, V119, P858, DOI 10.1242/jcs.02791; Hink-Schauer C, 2003, NAT STRUCT BIOL, V10, P535, DOI 10.1038/nsb945; Hink-Schauer C, 2002, J BIOL CHEM, V277, P50923, DOI 10.1074/jbc.M207962200; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Jackson DS, 1998, J MED CHEM, V41, P2289, DOI 10.1021/jm970543s; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kam CM, 2000, BBA-PROTEIN STRUCT M, V1477, P307, DOI 10.1016/S0167-4838(99)00282-4; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Mahrus S, 2005, CHEM BIOL, V12, P567, DOI 10.1016/j.chembiol.2005.03.006; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Ng LFP, 2005, PLOS MED, V2, P673, DOI 10.1371/journal.pmed.0020163; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; Shresta S, 1997, J BIOL CHEM, V272, P20236, DOI 10.1074/jbc.272.32.20236; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Zhao T, 2007, CELL DEATH DIFFER, V14, P489, DOI 10.1038/sj.cdd.4402040; Zhao TB, 2007, J BIOL CHEM, V282, P12104, DOI 10.1074/jbc.M611006200; Zhu PC, 2006, EMBO REP, V7, P431, DOI 10.1038/sj.embor.7400622	34	68	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3504	3512		10.1074/jbc.M806716200	http://dx.doi.org/10.1074/jbc.M806716200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19059912	hybrid			2022-12-25	WOS:000262872500017
J	Inoue, H; Kobayashi, T; Nozoye, T; Takahashi, M; Kakei, Y; Suzuki, K; Nakazono, M; Nakanishi, H; Mori, S; Nishizawa, NK				Inoue, Haruhiko; Kobayashi, Takanori; Nozoye, Tomoko; Takahashi, Michiko; Kakei, Yusuke; Suzuki, Kazumasa; Nakazono, Mikio; Nakanishi, Hiromi; Mori, Satoshi; Nishizawa, Naoko K.			Rice OsYSL15 Is an Iron-regulated Iron(III)-Deoxymugineic Acid Transporter Expressed in the Roots and Is Essential for Iron Uptake in Early Growth of the Seedlings	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTIANAMINE SYNTHASE GENES; FERRIC-CHELATE REDUCTASE; TRANSCRIPTION FACTOR; PHYTOSIDEROPHORE SYNTHESIS; MEMBRANE TRANSPORTER; YELLOW STRIPE1; CLONING; BARLEY; MAIZE; HOMEOSTASIS	Graminaceous plants take up iron through YS1 (yellow stripe 1) and YS1-like (YSL) transporters using iron-chelating compounds known as mugineic acid family phytosiderophores. We examined the expression of 18 rice (Oryza sativa L.) YSL genes (OsYSL1-18) in the epidermis/exodermis, cortex, and stele of rice roots. Expression of OsYSL15 in root epidermis and stele was induced by iron deficiency and showed daily fluctuation. OsYSL15 restored a yeast mutant defective in iron uptake when supplied with iron(III)-deoxymugineic acid and transported iron(III)-deoxymugineic acid in Xenopus laevis oocytes. An OsYSL15-green fluorescent protein fusion was localized to the plasma membrane when transiently expressed in onion epidermal cells. OsYSL15 promoter-beta-glucuronidase analysis revealed that OsYSL15 expression in roots was dominant in the epidermis/exodermis and phloem cells under conditions of iron deficiency and was detected only in phloem under iron sufficiency. These results strongly suggest that OsYSL15 is the dominant iron(III)-deoxymugineic acid transporter responsible for iron uptake from the rhizosphere and is also responsible for phloem transport of iron. OsYSL15 was also expressed in flowers, developing seeds, and in the embryonic scutellar epithelial cells during seed germination. OsYSL15 knockdown seedlings showed severe arrest in germination and early growth and were rescued by high iron supply. These results demonstrate that rice OsYSL15 plays a crucial role in iron homeostasis during the early stages of growth.	[Inoue, Haruhiko; Kobayashi, Takanori; Nozoye, Tomoko; Takahashi, Michiko; Kakei, Yusuke; Suzuki, Kazumasa; Nakazono, Mikio; Nakanishi, Hiromi; Mori, Satoshi; Nishizawa, Naoko K.] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Nishizawa, NK (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Kakei, Yusuke/AAF-7408-2020; Nakanishi, Hiromi/C-6461-2015	Nakanishi, Hiromi/0000-0001-5556-5058	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bagnaresi P, 1999, BIOCHEM J, V338, P499, DOI 10.1042/0264-6021:3380499; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; BRUNE M, 1992, J NUTR, V122, P442, DOI 10.1093/jn/122.3.442; Cheng LJ, 2007, PLANT PHYSIOL, V145, P1647, DOI 10.1104/pp.107.107912; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; DiDonato RJ, 2004, PLANT J, V39, P403, DOI 10.1111/j.1365-313X.2004.02128.x; DIX DR, 1994, J BIOL CHEM, V269, P26092; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Gendre D, 2007, PLANT J, V49, P1, DOI 10.1111/j.1365-313X.2006.02937.x; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Harada E, 2007, FEBS LETT, V581, P4298, DOI 10.1016/j.febslet.2007.08.011; Herbik A, 1999, EUR J BIOCHEM, V265, P231, DOI 10.1046/j.1432-1327.1999.00717.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Higuchi K, 2001, PLANT J, V25, P159, DOI 10.1046/j.1365-313x.2001.00951.x; HOSHIKAWA K, 1989, GROWING RICE PLANT, P28; Inoue H, 2004, SOIL SCI PLANT NUTR, V50, P1133, DOI 10.1080/00380768.2004.10408586; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Inoue H, 2008, PLANT MOL BIOL, V66, P193, DOI 10.1007/s11103-007-9262-8; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; JACOBSEN T, 1983, CEREAL CHEM, V60, P392; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kobayashi T, 2003, PLANT J, V36, P780, DOI 10.1046/j.1365-313X.2003.01920.x; Kobayashi T, 2007, P NATL ACAD SCI USA, V104, P19150, DOI 10.1073/pnas.0707010104; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Le Jean M, 2005, PLANT J, V44, P769, DOI 10.1111/j.1365-313X.2005.02569.x; Lott JNA., 1984, SEED PHYSL, P139; Ma JF, 1999, PLANTA, V207, P590, DOI 10.1007/s004250050522; MA JF, 1993, PLANT PHYSIOL, V102, P373, DOI 10.1104/pp.102.2.373; Marschner H., 1995, MINERAL NUTR HIGHER, P313, DOI DOI 10.1016/B978-012473542-2/50011-0; MASON JB, 2001, MICRONUTRIENT REPORT, P1; Michael TP, 2002, PLANT PHYSIOL, V130, P627, DOI 10.1104/pp.004929; Mihashi S., 1989, Biology of Metals, V2, P146, DOI 10.1007/BF01142553; Mizuno D, 2003, PLANT PHYSIOL, V132, P1989, DOI 10.1104/pp.102.019869; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; MORI S, 1991, PLANT SOIL, V130, P143, DOI 10.1007/BF00011869; MORRIS ER, 1976, J NUTR, V106, P753, DOI 10.1093/jn/106.6.753; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Nagasaka S, 2009, PLANT MOL BIOL, V69, P621, DOI 10.1007/s11103-008-9443-0; Nakazono M, 2003, PLANT CELL, V15, P583, DOI 10.1105/tpc.008102; Nozoye T, 2004, SOIL SCI PLANT NUTR, V50, P1125, DOI 10.1080/00380768.2004.10408585; Nozoye T, 2007, PLANT MOL BIOL, V64, P35, DOI 10.1007/s11103-007-9132-4; Ogo Y, 2008, J BIOL CHEM, V283, P13407, DOI 10.1074/jbc.M708732200; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; Raboy V, 1997, ADV CELL MOL BIOL PL, V4, P441; Roberts LA, 2004, PLANT PHYSIOL, V135, P112, DOI 10.1104/pp.103.037572; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; SASAMOTO H, 2005, ABSTR PLANT NUTR FOO, P1116; Schaaf G, 2005, PLANT CELL PHYSIOL, V46, P762, DOI 10.1093/pcp/pci081; Schaaf G, 2004, J BIOL CHEM, V279, P9091, DOI 10.1074/jbc.M311799200; SCHMIDKE I, 1995, PHYSIOL PLANTARUM, V95, P147, DOI 10.1111/j.1399-3054.1995.tb00821.x; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; Suzuki M, 2008, PLANT MOL BIOL, V66, P609, DOI 10.1007/s11103-008-9292-x; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; VONWIREN N, 1994, PLANT PHYSIOL, V106, P71, DOI 10.1104/pp.106.1.71; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586	68	324	349	6	72	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3470	3479		10.1074/jbc.M806042200	http://dx.doi.org/10.1074/jbc.M806042200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19049971	hybrid			2022-12-25	WOS:000262872500013
J	Bach, C; Mueller, D; Buhl, S; Garcia-Cuellar, MP; Slany, RK				Bach, C.; Mueller, D.; Buhl, S.; Garcia-Cuellar, M. P.; Slany, R. K.			Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2	ONCOGENE			English	Article						CxxC domain; MLL; MLL2; transformation	HISTONE METHYLTRANSFERASE COMPLEX; DROSOPHILA-TRITHORAX; REPRESSION DOMAIN; BINDING PROTEIN; HRX-ENL; MLL; GENE; DNA; TRANSFORMATION; MENIN	The mixed-lineage leukemia (MLL) family of histone methyltransferases has become notorious for the participation of the founding member, MLL, in fusion proteins that cause acute leukemia. Despite structural conservation, no other MLL homolog has so far been found in a similar arrangement. Here, we show that fusion proteins based on Mll2, the closest relative of MLL, are incapable of transforming hematopoietic cells. Elaborate swap experiments identified the small CxxC zinc-binding region of Mll2 and an adjacent 'post-CxxC' stretch of basic amino acids as the essential determinants for the observed difference. Gel shift experiments indicated that the combined CxxC and post-CxxC domains of MLL and Mll2 possess almost indistinguishable DNA-binding properties in vitro. Within the cellular environment, however, these motifs guided MLL and Mll2 to a largely nonoverlapping target gene repertoire, as evidenced by nuclear localization, reporter assays, and measurements of homeobox gene levels in primary cells expressing MLL and Mll2 fusion proteins. Therefore, the CxxC domain appears to be a promising target for therapies aimed at MLL fusion proteins without affecting the general function of other MLL family members.	[Bach, C.; Mueller, D.; Buhl, S.; Garcia-Cuellar, M. P.; Slany, R. K.] Univ Erlangen Nurnberg, Dept Genet, D-91058 Erlangen, Bavaria, Germany	University of Erlangen Nuremberg	Slany, RK (corresponding author), Univ Erlangen Nurnberg, Dept Genet, Staudtstr 5,Bldg A2, D-91058 Erlangen, Bavaria, Germany.	rslany@biologie.uni-erlangen.de		Bach, Christian/0000-0003-4675-7896	DFG [SL27/6-2, SFB473/D2]; Jose-Carerras-Stiftung; Curt-Bohnewald-Fond	DFG(German Research Foundation (DFG)); Jose-Carerras-Stiftung; Curt-Bohnewald-Fond	We thank Bernd Zeisig and Silvio Scheel for help in early stages of this work. Technical support of Renate Zimmermann and sharing of reagents by Francis Stewart, Boris Fehse and Carol Stocking is gratefully acknowledged. RKS was supported by DFG Grant SL27/6-2 and in part by SFB473/D2. Equipment funding came from Jose-Carerras-Stiftung and Curt-Bohnewald-Fond.	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; FitzGerald KT, 1999, GENOMICS, V59, P187, DOI 10.1006/geno.1999.5860; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schreiner SA, 1999, LEUKEMIA, V13, P1525, DOI 10.1038/sj.leu.2401534; Slany RK, 1998, MOL CELL BIOL, V18, P122, DOI 10.1128/MCB.18.1.122; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; ZELEZNIKLE NJ, 1994, P NATL ACAD SCI USA, V91, P10610, DOI 10.1073/pnas.91.22.10610	29	62	62	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					815	823		10.1038/onc.2008.443	http://dx.doi.org/10.1038/onc.2008.443			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19060922				2022-12-25	WOS:000263320000004
J	Bar, J; Feniger-Barish, R; Lukashchuk, N; Shaham, H; Moskovits, N; Goldfinger, N; Simansky, D; Perlman, M; Papa, M; Yosepovich, A; Rechavi, G; Rotter, V; Oren, M				Bar, J.; Feniger-Barish, R.; Lukashchuk, N.; Shaham, H.; Moskovits, N.; Goldfinger, N.; Simansky, D.; Perlman, M.; Papa, M.; Yosepovich, A.; Rechavi, G.; Rotter, V.; Oren, M.			Cancer cells suppress p53 in adjacent fibroblasts	ONCOGENE			English	Article						p53; stroma; tumor suppression; CAFs; genotoxic stress	STROMAL CELLS; TUMOR-SUPPRESSOR; CARCINOMA; GROWTH; TP53; MUTATIONS	The p53 tumor suppressor serves as a crucial barrier against cancer development. In tumor cells and their progenitors, p53 suppresses cancer in a cell-autonomous manner. However, p53 also possesses non-cell-autonomous activities. For example, p53 of stromal fibroblasts can modulate the spectrum of proteins secreted by these cells, rendering their microenvironment less supportive of the survival and spread of adjacent tumor cells. We now report that epithelial tumor cells can suppress p53 induction in neighboring fibroblasts, an effect reproducible by tumor cell-conditioned medium. The ability to suppress fibroblast p53 activation is acquired by epithelial cells in the course of neoplastic transformation. Specifically, stable transduction of immortalized epithelial cells by mutant H-Ras and p53-specific short inhibitory RNA endows them with the ability to quench fibroblast p53 induction. Importantly, human cancer-associated fibroblasts are more susceptible to this suppression than normal fibroblasts. These findings underscore a mechanism whereby epithelial cancer cells may overcome the non-cell-autonomous tumor suppressor function of p53 in stromal fibroblasts.	[Bar, J.] Chaim Sheba Med Ctr, Canc Res Ctr, Dept Oncol, IL-52621 Tel Hashomer, Israel; [Bar, J.; Rechavi, G.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Lukashchuk, N.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Shaham, H.; Moskovits, N.; Goldfinger, N.; Rotter, V.; Oren, M.] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Simansky, D.] Chaim Sheba Med Ctr, Dept Thorac Surg, IL-52621 Tel Hashomer, Israel; [Perlman, M.; Yosepovich, A.] Chaim Sheba Med Ctr, Inst Pathol, IL-52621 Tel Hashomer, Israel; [Papa, M.] Chaim Sheba Med Ctr, Dept Surg C, IL-52621 Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Beatson Institute; Weizmann Institute of Science; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Bar, J (corresponding author), Ottawa Hosp Canc Ctr, Div Med Oncol, Gen Campus,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	bar.jair@gmail.com	Bar, Jair/AAS-5743-2021	Bar, Jair/0000-0002-1224-3646; Oren, Moshe/0000-0003-4311-7172	Flight Attendant Medical Research Institute (FAMRI); National Cancer Institute [R37 CA40099]; Koschitzky family; Tel Aviv University Cancer Biology Research Center; NATIONAL CANCER INSTITUTE [R37CA040099] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute (FAMRI); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Koschitzky family; Tel Aviv University Cancer Biology Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr J Schachter and Dr B Kaufman for helpful discussions. This work was supported in part by a Center of Excellence grant from the Flight Attendant Medical Research Institute (FAMRI), and by grant R37 CA40099 from the National Cancer Institute. JB was supported also by the Koschitzky family donation to the breast cancer unit of CSMC, and by a Van Bates grant from the Tel Aviv University Cancer Biology Research Center.	Bar J, 2004, ONCOGENE, V23, P2128, DOI 10.1038/sj.onc.1207325; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Campbell IG, 2008, NEW ENGL J MED, V358, P1634, DOI 10.1056/NEJMc086024; Dudley AC, 2008, BRIT J CANCER, V99, P118, DOI 10.1038/sj.bjc.6604465; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Hawsawi NM, 2008, CANCER RES, V68, P2717, DOI 10.1158/0008-5472.CAN-08-0192; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Komarova EA, 1998, ONCOGENE, V17, P1089, DOI 10.1038/sj.onc.1202303; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Logunov DY, 2008, ONCOGENE, V27, P4521, DOI 10.1038/onc.2008.103; Milyavsky M, 2003, CANCER RES, V63, P7147; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Olumi AF, 1999, CANCER RES, V59, P5002; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Radisky D, 2001, SEMIN CANCER BIOL, V11, P87, DOI 10.1006/scbi.2000.0360; Roukos DH, 2008, NEW ENGL J MED, V358, P1636; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Tlsty TD, 2001, SEMIN CANCER BIOL, V11, P97, DOI 10.1006/scbi.2000.0361; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wernert N, 2001, ANTICANCER RES, V21, P2259	22	51	51	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					933	936		10.1038/onc.2008.445	http://dx.doi.org/10.1038/onc.2008.445			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19060923	Green Accepted			2022-12-25	WOS:000263320000015
J	Ballabeni, A; Zamponi, R; Caprara, G; Melixetian, M; Bossi, S; Masiero, L; Helin, K				Ballabeni, Andrea; Zamponi, Raffaella; Caprara, Greta; Melixetian, Marina; Bossi, Sergio; Masiero, Laura; Helin, Kristian			Human CDT1 Associates with CDC7 and Recruits CDC45 to Chromatin during S Phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; XENOPUS EGG EXTRACTS; ORIGIN RECOGNITION COMPLEX; KINASE REGULATORY SUBUNIT; HUMAN CDC7-RELATED KINASE; CYCLIN-DEPENDENT KINASES; LICENSING FACTOR CDT1; CELL-CYCLE; MAMMALIAN-CELLS; PROTEIN-KINASE	The initiation of DNA replication is a tightly controlled process that involves the formation of distinct complexes at origins of DNA replication at specific periods of the cell cycle. Pre-replicative complexes are formed during telophase and early G(1). They rearrange at the start of S phase to form pre-initiation complexes, which are a prerequisite for DNA replication. The CDT1 protein is required for the formation of the pre-replicative complexes. Here we show that human CDT1 associates with the CDC7 kinase and recruits CDC45 to chromatin. Moreover, we show that the amount of CDT1 bound to chromatin is regulated by CDC7. We propose a model in which chromatin-bound CDT1 is first stabilized and subsequently displaced by CDC7 activity, thereby ensuring the timely execution of DNA replication.	[Ballabeni, Andrea; Zamponi, Raffaella; Caprara, Greta; Melixetian, Marina; Bossi, Sergio; Masiero, Laura; Helin, Kristian] European Inst Oncol, Dept Expt Oncol, I-20135 Milan, Italy; [Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark	IRCCS European Institute of Oncology (IEO); University of Copenhagen; University of Copenhagen	Helin, K (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20135 Milan, Italy.	kristian.helin@bric.dk	Caprara, Greta/AAM-8110-2020; Melixetian, Marine/AAR-1524-2020; Helin, Kristian/K-2526-2019; Zamponi, Raffaella/V-5683-2018; Helin, Kristian/HDM-8306-2022	Caprara, Greta/0000-0001-9975-4395; Melixetian, Marine/0000-0002-8454-8262; Helin, Kristian/0000-0003-1975-6097; Zamponi, Raffaella/0000-0002-3313-1387	Associazione Italiana per la Ricerca sul Cancro; Fondazione Italiana per la Ricerca sul Cancro; Danish Cancer Society; European Union	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Danish Cancer Society(Danish Cancer Society); European Union(European Commission)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro, Fondazione Italiana per la Ricerca sul Cancro, the Danish Cancer Society and the European Union. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; DOWELL SJ, 1994, SCIENCE, V265, P1243, DOI 10.1126/science.8066465; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; HEREFORD LM, 1974, J MOL BIOL, V84, P445, DOI 10.1016/0022-2836(74)90451-3; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Jares P, 2000, GENE DEV, V14, P1528; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Kulartz M, 2004, J BIOL CHEM, V279, P41686, DOI 10.1074/jbc.M405798200; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Lau E, 2006, EMBO REP, V7, P425, DOI 10.1038/sj.embor.7400624; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lei M, 2001, J CELL SCI, V114, P1447; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Maiorano D, 2005, CURR BIOL, V15, P146, DOI 10.1016/j.cub.2004.12.002; Maiorano D, 2004, EXP CELL RES, V295, P138, DOI 10.1016/j.yexcr.2003.11.018; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Masai H, 2005, IUBMB LIFE, V57, P323, DOI 10.1080/15216540500092419; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Owens JC, 1997, P NATL ACAD SCI USA, V94, P12521, DOI 10.1073/pnas.94.23.12521; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shechter D, 2004, J BIOL CHEM, V279, P45586, DOI 10.1074/jbc.M407772200; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000; Zou L, 1997, MOL CELL BIOL, V17, P553, DOI 10.1128/MCB.17.2.553	61	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3028	3036		10.1074/jbc.M803609200	http://dx.doi.org/10.1074/jbc.M803609200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054765	hybrid			2022-12-25	WOS:000262700900047
J	Wang, CH; Liu, ML; Riojas, RA; Xin, XB; Gao, ZG; Zeng, R; Wu, JR; Dong, LQ; Liu, F				Wang, Changhua; Liu, Meilian; Riojas, Ramon A.; Xin, Xiaoban; Gao, Zhanguo; Zeng, Rong; Wu, Jiarui; Dong, Lily Q.; Liu, Feng			Protein Kinase C theta (PKC theta)-dependent Phosphorylation of PDK1 at Ser(504) and Ser(532) Contributes to Palmitate-induced Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACID; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; SKELETAL-MUSCLE CELLS; PKC-THETA; RECEPTOR SUBSTRATE-1; SIGNALING CASCADE; ACTIVATION; INHIBITION; EXPRESSION; LOCALIZATION	Clinical, epidemiological, and biochemical studies have highlighted the role of obesity-induced insulin resistance in various metabolic diseases. However, the underlying molecular mechanisms remain to be established. In the present study, we show that palmitate-induced serine phosphorylation of phosphoinositide-dependent protein kinase-1 (PDK1) negatively regulates insulin signaling. PDK1-mediated Akt phosphorylation at Thr(308) in the activation loop is reduced in C2C12 myotubes treated with palmitate or overexpressing protein kinase C theta (PKC theta), a kinase that has been implicated in hyperlipidemia-induced insulin resistance. Palmitate treatment also inhibited platelet-derived growth factor-stimulated Akt phosphorylation, suggesting that the inhibition could occur at a site independent of IRS1/2. The inhibitory effect of palmitate on PDK1 and Akt was diminished in PKC theta-deficient mouse embryonic fibroblasts (MEFs) by treating C2C12 myotubes with PKC theta pseudosubstrates. In vivo labeling studies revealed that PDK1 undergoes palmitate-induced phosphorylation at two novel sites, Ser(504) and Ser(532). Replacing Ser(504/532) with alanine disrupted PKC theta-catalyzed PDK1 phosphorylation in vitro and palmitate-induced PDK1 phosphorylation in cells. PDK1-deficient MEFs transiently expressing PDK1(S504A/S532A) but not PDK1(S504E/S532D) showed increased basal and insulin-stimulated Akt phosphorylation at Thr308 when compared with MEFs expressing wild-type PDK1. Taken together, our results identify PDK1 as a novel target in free fatty acid-induced insulin resistance and PKC theta as the kinase mediating the negative regulation.	[Wang, Changhua; Liu, Meilian; Dong, Lily Q.; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Riojas, Ramon A.; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Xin, Xiaoban; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA; [Gao, Zhanguo] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Zeng, Rong; Wu, Jiarui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Beijing 100864, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Liu, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	liuf@uthscsa.edu	Xin, Xiaoban/D-2338-2012; Liu, Feng/CAG-8962-2022		American Diabetes Association; American Heart Association, Texas Affiliate [0355076Y]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056166, R01DK069930, R01DK080344] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); American Heart Association, Texas Affiliate(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a research award from the American Diabetes Association ( to F. L.) and Grant 0355076Y from the American Heart Association, Texas Affiliate ( to L. Q. D.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bell KS, 2000, AM J PHYSIOL-ENDOC M, V279, pE1196, DOI 10.1152/ajpendo.2000.279.5.E1196; BERTI L, 1994, J BIOL CHEM, V269, P3381; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chalfant CE, 2000, ENDOCRINOLOGY, V141, P2773, DOI 10.1210/en.141.8.2773; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Donnelly R, 1998, CLIN EXP PHARMACOL P, V25, P79, DOI 10.1111/j.1440-1681.1998.tb02181.x; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Frayn Keith N., 1993, Current Opinion in Lipidology, V4, P197, DOI 10.1097/00041433-199306000-00004; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haasch D, 2006, BIOCHEM BIOPH RES CO, V343, P361, DOI 10.1016/j.bbrc.2006.02.177; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Kenchappa P, 2004, J NEUROSCI RES, V76, P466, DOI 10.1002/jnr.20081; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kondo T, 2004, J BIOL CHEM, V279, P37997, DOI 10.1074/jbc.M401339200; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Nakamura K, 2008, J BIOL CHEM, V283, P17702, DOI 10.1074/jbc.M802589200; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; STEINER G, 1980, DIABETES, V29, P899, DOI 10.2337/diabetes.29.11.899; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Wick MJ, 2002, J BIOL CHEM, V277, P16632, DOI 10.1074/jbc.M112402200; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	35	37	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2038	2044		10.1074/jbc.M806336200	http://dx.doi.org/10.1074/jbc.M806336200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047061	hybrid			2022-12-25	WOS:000262545600011
J	Ozawa, D; Yagi, H; Ban, T; Kameda, A; Kawakami, T; Naiki, H; Goto, Y				Ozawa, Daisaku; Yagi, Hisashi; Ban, Tadato; Kameda, Atsushi; Kawakami, Toru; Naiki, Hironobu; Goto, Yuji			Destruction of Amyloid Fibrils of a beta(2)-Microglobulin Fragment by Laser Beam Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOFLAVIN-T; PROTEIN; BINDING; GROWTH; PROPAGATION; MATURATION; SUGGESTS; FORM	To understand the mechanism by which amyloid fibrils form, we have been making real-time observations of the growth of individual fibrils, using total internal fluorescence microscopy combined with an amyloid-specific fluorescence dye, thioflavin T (ThT). At neutral pH, irradiation at 442 nm with a laser beam to excite ThT inhibited the fibril growth of beta(2)-microglobulin (beta(2)-m), a major component of amyloid fibrils deposited in patients with dialysis-related amyloidosis. Examination with a 22-residue K3 fragment of beta(2)-m showed that the inhibition of fibril growth and moreover the destruction of preformed fibrils were coupled with the excitation of ThT. Several pieces of evidence suggest that the excited ThT transfers energy to ground state molecular oxygen, producing active oxygen, which causes various types of chemical modifications. The results imply a novel strategy for preventing the deposition of amyloid fibrils and for destroying preformed amyloid deposits.	[Ozawa, Daisaku; Yagi, Hisashi; Kameda, Atsushi; Kawakami, Toru; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Ozawa, Daisaku; Yagi, Hisashi; Kameda, Atsushi; Kawakami, Toru; Goto, Yuji] Japan Sci & Technol Agcy, CREST, Suita, Osaka 5650871, Japan; [Ban, Tadato] Natl Inst Adv Ind Sci & Technol, Osaka 5638577, Japan; [Naiki, Hironobu] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Fukui 9101193, Japan; [Naiki, Hironobu] Japan Sci & Technol Agcy, CREST, Fukui 9101193, Japan	Osaka University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); University of Fukui; Japan Science & Technology Agency (JST)	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Naiki, Hironobu/G-5599-2014		Takeda Science Foundation; Japanese Ministry of Education, Culture, Sports, Science and Technology on Priority Areas [40153770]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Ministry of Education, Culture, Sports, Science and Technology on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Takeda Science Foundation and by Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology on Priority Areas (No. 40153770). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agon VV, 2006, FREE RADICAL BIO MED, V40, P698, DOI 10.1016/j.freeradbiomed.2005.09.039; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, J BIOL CHEM, V281, P33677, DOI 10.1074/jbc.M606072200; Ban T, 2006, ACCOUNTS CHEM RES, V39, P663, DOI 10.1021/ar050074l; Bieschke J, 2006, ACCOUNTS CHEM RES, V39, P611, DOI 10.1021/ar0500766; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Calabrese MF, 2007, J MOL BIOL, V367, P1, DOI 10.1016/j.jmb.2006.12.034; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Giuliano EA, 2007, VET OPHTHALMOL, V10, P337, DOI 10.1111/j.1463-5224.2007.00578.x; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; Maskevich AA, 2007, J PROTEOME RES, V6, P1392, DOI 10.1021/pr0605567; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ohhashi Y, 2004, J BIOL CHEM, V279, P10814, DOI 10.1074/jbc.M310334200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yamamoto K, 2008, J MOL BIOL, V376, P258, DOI 10.1016/j.jmb.2007.12.002; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	40	40	41	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1009	1017		10.1074/jbc.M805118200	http://dx.doi.org/10.1074/jbc.M805118200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010783	Green Published, hybrid			2022-12-25	WOS:000262122900037
J	Wimmer, B; Raja, M; Hinterdorfer, P; Gruber, HJ; Kinne, RKH				Wimmer, Barbara; Raja, Mobeen; Hinterdorfer, Peter; Gruber, Hermann J.; Kinne, Rolf K. -H.			C-terminal Loop 13 of Na+/Glucose Cotransporter 1 Contains Both Stereospecific and Non-stereospecific Sugar Interaction Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANES; GLUCOSE COTRANSPORTER; COMPETITIVE INHIBITION; FORCE MICROSCOPY; RAT KIDNEY; SGLT1; BINDING; PHLORHIZIN; TRANSPORT; SODIUM	To investigate whether the C-terminal loop 13 of rabbit sodium/glucose cotransporter SGLT1 is involved in the recognition of the substrate D-glucose, isolated loop 13 (amino acids (aa) 541-638) was immobilized to a lipid bilayer. Interactions were investigated by surface plasmon resonance spectroscopy using an antibody directed against the late part of the loop (aa 606 631) or the glucoside transport inhibitor phlorizin. Specific binding of the antibody to the loop could be detected. The number of bound antibodies decreased upon the addition of D-glucose but not upon the addition of L-glucose. Phlorizin also significantly lowered the number of bound antibodies. Binding of phlorizin to the loop could also be demonstrated directly. Binding of phlorizin was, however, reduced to a similar extent upon the addition of either D-glucose or L-glucose, indicating their unspecific competition with the inhibitor's sugar moiety. Thus, the presence of a stereospecific glucose interaction site in the late part of the loop and a second, but non-stereospecific, sugar binding site on the same loop was assumed. To investigate whether the early part of loop 13 contains this non-stereospecific sugar binding site, peptides containing aa 541-598 were expressed in Escherichia coli and purified. Both D-glucose and L-glucose quenched the peptides tryptophan fluorescence and reduced the Trp accessibility to acrylamide to a similar degree. In view of the recently proposed transmembrane orientation of loop 13, the two binding sites may be part of the extracellular (stereospecific) and intracellular (non-stereospecific) sugar interaction sites of SGLT1.	[Wimmer, Barbara; Raja, Mobeen; Kinne, Rolf K. -H.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Wimmer, Barbara; Raja, Mobeen; Hinterdorfer, Peter; Gruber, Hermann J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria	Max Planck Society; Johannes Kepler University Linz	Kinne, RKH (corresponding author), Max Planck Inst Mol Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	barbara.wimmer@mymail.unisa.edu.au; rolf.kinne@mpi-dortmund.mpg.de	Gruber, Hermann J./C-4234-2013; Hinterdorfer, Peter/C-4235-2013	Hinterdorfer, Peter/0000-0003-2583-1305	Austrian Science Fund [FWF 0350300]; Max Planck Society	Austrian Science Fund(Austrian Science Fund (FWF)); Max Planck Society(Max Planck Society)	This work was supported by Austrian Science Fund Project FWF 0350300 and the Max Planck Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARFUSS DW, 1981, AM J PHYSIOL, V241, pF322, DOI 10.1152/ajprenal.1981.241.3.F322; BAUMANN K, 1969, PFLUG ARCH EUR J PHY, V305, P155, DOI 10.1007/BF00585842; Berteloot A, 2003, J MEMBRANE BIOL, V192, P89, DOI 10.1007/s00232-002-1066-9; DIEDRICH DF, 1966, ARCH BIOCHEM BIOPHYS, V117, P248, DOI 10.1016/0003-9861(66)90409-7; Diez-Sampedro A, 2004, BIOCHEMISTRY-US, V43, P13175, DOI 10.1021/bi048652d; Erb EM, 2000, ANAL BIOCHEM, V280, P29, DOI 10.1006/abio.1999.4469; Firnges MA, 2001, J MEMBRANE BIOL, V179, P143, DOI 10.1007/s002320010044; FRASCH W, 1970, PFLUG ARCH EUR J PHY, V320, P265, DOI 10.1007/BF00587458; GLOSSMANN H, 1972, J BIOL CHEM, V247, P7779; Holzl M, 2007, LANGMUIR, V23, P5571, DOI 10.1021/la0627664; Kipp H, 1996, BBA-BIOMEMBRANES, V1282, P124, DOI 10.1016/0005-2736(96)00049-1; Kipp H, 1997, AM J PHYSIOL-REG I, V273, pR134, DOI 10.1152/ajpregu.1997.273.1.R134; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lin JT, 1999, J MEMBRANE BIOL, V170, P243, DOI 10.1007/s002329900553; LOWRY OH, 1951, J BIOL CHEM, V193, P25; Mizuma T, 1998, BBA-GEN SUBJECTS, V1381, P340, DOI 10.1016/S0304-4165(98)00061-0; Novakova R, 2001, J MEMBRANE BIOL, V184, P55, DOI 10.1007/s00232-001-0073-6; PANAYOTOVAHEIERMANN M, 1994, J BIOL CHEM, V269, P21016; PanayotovaHeiermann M, 1997, J BIOL CHEM, V272, P20324, DOI 10.1074/jbc.272.33.20324; PanayotovaHeiermann M, 1996, J BIOL CHEM, V271, P10029, DOI 10.1074/jbc.271.17.10029; Puntheeranurak T, 2007, BIOCHEMISTRY-US, V46, P2797, DOI 10.1021/bi061917z; Puntheeranurak T, 2006, J CELL SCI, V119, P2960, DOI 10.1242/jcs.03035; Raja MM, 2005, BIOCHEMISTRY-US, V44, P9123, DOI 10.1021/bi050323d; Raja MM, 2003, J BIOL CHEM, V278, P49154, DOI 10.1074/jbc.M306881200; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; TURNER RJ, 1977, P NATL ACAD SCI USA, V74, P2825, DOI 10.1073/pnas.74.7.2825; Tyagi NK, 2007, BIOCHEMISTRY-US, V46, P13616, DOI 10.1021/bi701193x; Vayro S, 1999, AM J PHYSIOL-CELL PH, V276, pC1053, DOI 10.1152/ajpcell.1999.276.5.C1053; Wielert-Badt S, 2000, J MED CHEM, V43, P1692, DOI 10.1021/jm9905460; Wielert-Badt S, 2002, BIOPHYS J, V82, P2767, DOI 10.1016/S0006-3495(02)75617-8; WIMMER B, 2005, THESIS J KEPLER U LI; Xia XB, 2003, BIOCHEMISTRY-US, V42, P6115, DOI 10.1021/bi020695b	32	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					983	991		10.1074/jbc.M805082200	http://dx.doi.org/10.1074/jbc.M805082200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010790	hybrid			2022-12-25	WOS:000262122900034
J	Malone, JH; Fontenot, BE				Malone, John H.; Fontenot, Brian E.			Patterns of Reproductive Isolation in Toads	PLOS ONE			English	Article							FROG RANA-RUGOSA; HALDANES RULE; POSTZYGOTIC ISOLATION; HYBRID INVIABILITY; CHARACTER DISPLACEMENT; HETEROGAMETIC SEX; GENE-EXPRESSION; MOLECULAR SYSTEMATICS; CENTRARCHID FISHES; DARWINS COROLLARY	Understanding the general features of speciation is an important goal in evolutionary biology, and despite significant progress, several unresolved questions remain. We analyzed an extensive comparative dataset consisting of more than 1900 crosses between 92 species of toads to infer patterns of reproductive isolation. This unique dataset provides an opportunity to examine the strength of reproductive isolation, the development and sex ratios of hybrid offspring, patterns of fertility and infertility, and polyploidization in hybrids all in the context of genetic divergence between parental species. We found that the strength of intrinsic postzygotic isolation increases with genetic divergence, but relatively high levels of divergence are necessary before reproductive isolation is complete in toads. Fertilization rates were not correlated to genetic divergence, but hatching success, the number of larvae produced, and the percentage of tadpoles reaching metamorphosis were all inversely related with genetic divergence. Hybrids between species with lower levels of divergence developed to metamorphosis, while hybrids with higher levels of divergence stopped developing in gastrula and larval stages. Sex ratios of hybrid offspring were biased towards males in 70% of crosses and biased towards females in 30% of crosses. Hybrid females from crosses between closely related species were completely fertile, while approximately half (53%) of hybrid males were sterile, with sterility predicted by genetic divergence. The degree of abnormal ploidy in hybrids was positively related to genetic divergence between parental species, but surprisingly, polyploidization had no effect on patterns of asymmetrical inviability. We discuss explanations for these patterns, including the role of Haldane's rule in toads and anurans in general, and suggest mechanisms generating patterns of reproductive isolation in anurans.	[Malone, John H.; Fontenot, Brian E.] Univ Texas, Dept Biol, Arlington, TX USA	University of Texas System; University of Texas Arlington	Malone, JH (corresponding author), NIDDKD, Cellular & Dev Biol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	malonej@niddk.nih.gov						Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold Michael L., 2006, P399; Blair AP, 1941, GENETICS, V26, P398; BLAIR AP, 1942, BIOL S, V6, P235; Blair W. F., 1956, Texas Journal of Science, V8, P87; BLAIR W. F, 1972, EVOLUTION GENUS BUFO; BLAIR W. FRANK, 1959, TEXAS JOUR SCI, V11, P427; BLAIR W. FRANK, 1963, TEXAS JOUR SCI, V15, P15; BLAIR W. FRANK, 1961, TEXAS JOUR SCI, V13, P163; BLAIR WF, 1964, Q REV BIOL, V39, P333, DOI 10.1086/404323; BLAIR WF, 1963, EVOLUTION, V17, P1, DOI 10.2307/2406331; BLAIR WF, 1966, TEX J SCI, V18, P333; BLAIR WF, 1955, EVOLUTION, V9, P469, DOI 10.2307/2405481; Bogart J.P., 1972, EVOLUTION GENUS BUFO, P171; Bolnick DI, 2008, GENETICS, V178, P1037, DOI 10.1534/genetics.107.081364; Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; BRIGGS RW, 1959, J EXP ZOOL, V111, P255; Christianson SJ, 2005, EVOLUTION, V59, P849, DOI 10.1554/04-291; Coyne J.A., 1989, P180; COYNE JA, 1989, EVOLUTION, V43, P362, DOI 10.1111/j.1558-5646.1989.tb04233.x; Coyne JA, 1997, EVOLUTION, V51, P295, DOI 10.1111/j.1558-5646.1997.tb02412.x; Coyne JA, 2004, SPECIATION, V37; Cunningham M, 2004, MOL PHYLOGENET EVOL, V32, P671, DOI 10.1016/j.ympev.2004.03.003; Demuth JP, 2007, EVOLUTION, V61, P694, DOI 10.1111/j.1558-5646.2007.00049.x; ENGEL W, 1981, CYTOGENET CELL GENET, V30, P130, DOI 10.1159/000131600; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fitzpatrick BM, 2006, EVOLUTION, V60, P601; Fitzpatrick BM, 2004, EVOLUTION, V58, P1865; FOUQUETTE MJ, 1975, SYST ZOOL, V24, P16, DOI 10.2307/2412694; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; GERHARDT HC, 1994, ANIM BEHAV, V47, P959, DOI 10.1006/anbe.1994.1127; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Herrmann Matthias, 2006, Front Zool, V3, P14, DOI 10.1186/1742-9994-3-14; HILLIS DM, 1990, J EVOLUTION BIOL, V3, P49, DOI 10.1046/j.1420-9101.1990.3010049.x; Johnson Norman A., 2000, P197; Johnson Norman A., 2006, P374; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOBEL HR, 1985, S AFR J SCI, V81, P205; KOBEL HR, 1996, BIOL XENOPUS, P391; Le Gac M, 2007, EVOLUTION, V61, P15, DOI 10.1111/j.1558-5646.2007.00002.x; Leary CJ, 2001, ANIM BEHAV, V61, P431, DOI 10.1006/anbe.2000.1597; Lijtmaer DA, 2003, EVOLUTION, V57, P1411, DOI 10.1111/j.0014-3820.2003.tb00348.x; Malone JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000781; Malone JH, 2008, SCIENCE, V319, P59, DOI 10.1126/science.1148231; Malone JH, 2006, J MOL EVOL, V63, P427, DOI 10.1007/s00239-005-0263-4; Malone JH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-82; Masta SE, 2002, MOL PHYLOGENET EVOL, V24, P302, DOI 10.1016/S1055-7903(02)00216-6; Mendelson TC, 2004, EVOLUTION, V58, P1424; Mendelson TC, 2003, EVOLUTION, V57, P317; Miura I, 1998, MOL BIOL EVOL, V15, P1612, DOI 10.1093/oxfordjournals.molbev.a025889; MOORE JA, 1955, ADV GENET, V7, P139, DOI 10.1016/S0065-2660(08)60095-4; Moyle LC, 2004, EVOLUTION, V58, P1195, DOI 10.1111/j.0014-3820.2004.tb01700.x; Nishioka Midori, 1994, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V13, P35; Ogata M, 2003, GENETICS, V164, P613; Ohtani H, 2000, J EXP ZOOL, V286, P313, DOI 10.1002/(SICI)1097-010X(20000215)286:3<313::AID-JEZ10>3.3.CO;2-2; Orr HA, 2007, J HERED, V98, P103, DOI 10.1093/jhered/esl060; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Pauly GB, 2004, EVOLUTION, V58, P2517; Petrini S, 1998, J EXP ZOOL, V280, P245, DOI 10.1002/(SICI)1097-010X(19980215)280:3<245::AID-JEZ6>3.0.CO;2-N; Pfennig KS, 2002, EVOLUTION, V56, P1840; PONSE KITTY, 1941, REV SUISSE ZOOL, V48, P541; Pramuk JB, 2006, ZOOL J LINN SOC-LOND, V146, P407, DOI 10.1111/j.1096-3642.2006.00212.x; Pramuk JB, 2008, GLOBAL ECOL BIOGEOGR, V17, P72, DOI 10.1111/j.1466-8238.2007.00348.x; Presgraves DC, 1998, SCIENCE, V282, P952, DOI 10.1126/science.282.5390.952; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Price TD, 2002, EVOLUTION, V56, P2083; RAMBAUT A, 2006, SE AL SEQUENCE ALIGN; Russell ST, 2003, ANN ZOOL FENN, V40, P321; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Sawamura K, 1996, GENETICS, V143, P609; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SCHMID M, 2001, GENES MECH VERTEBRAT, P143; Scopece G, 2007, EVOLUTION, V61, P2623, DOI 10.1111/j.1558-5646.2007.00231.x; Slotman M, 2005, EVOLUTION, V59, P1016, DOI 10.1111/j.0014-3820.2005.tb01040.x; Sokal RR, 1995, BIOMETRY; Stock M, 2006, MOL PHYLOGENET EVOL, V41, P663, DOI 10.1016/j.ympev.2006.05.026; SWOFFORD D, 2001, PAUP 4 0 BETA PHYLOG; THORNTON WA, 1955, AM MID NAT, V71, P232; Tubaro PL, 2002, BIOL J LINN SOC, V77, P193, DOI 10.1046/j.1095-8312.2002.00096.x; TURELLI M, 1995, GENETICS, V140, P389; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; VOLPE EP, 1955, AM NAT, V89, P303, DOI 10.1086/281895; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; WU CI, 1992, EVOLUTION, V46, P1584, DOI 10.1111/j.1558-5646.1992.tb01152.x; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; ZOUROS E, 1973, EVOLUTION, V27, P601, DOI 10.1111/j.1558-5646.1973.tb00709.x	89	78	79	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3900	10.1371/journal.pone.0003900	http://dx.doi.org/10.1371/journal.pone.0003900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065271	Green Published, Green Submitted, gold			2022-12-25	WOS:000265455200012
J	Doheny, JG; Mottus, R; Grigliatti, TA				Doheny, J. Greg; Mottus, Randy; Grigliatti, Thomas A.			Telomeric Position Effect-A Third Silencing Mechanism in Eukaryotes	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; HETEROCHROMATIN PROTEIN-1 HP1; ORIGIN RECOGNITION COMPLEX; DROSOPHILA-MELANOGASTER; EFFECT VARIEGATION; CHROMATIN-STRUCTURE; POLYCOMB-GROUP; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; POLYTENE CHROMOSOMES	Eukaryotic chromosomes terminate in telomeres, complex nucleoprotein structures that are required for chromosome integrity that are implicated in cellular senescence and cancer. The chromatin at the telomere is unique with characteristics of both heterochromatin and euchromatin. The end of the chromosome is capped by a structure that protects the end and is required for maintaining proper chromosome length. Immediately proximal to the cap are the telomere associated satellite-like (TAS) sequences. Genes inserted into the TAS sequences are silenced indicating the chromatin environment is incompatible with transcription. This silencing phenomenon is called telomeric position effect (TPE). Two other silencing mechanisms have been identified in eukaryotes, suppressors position effect variegation [Su(var) s, greater than 30 members] and Polycomb group proteins (PcG, approximately 15 members). We tested a large number of each group for their ability to suppress TPE [Su(TPE)]. Our results showed that only three Su(var) s and only one PcG member are involved in TPE, suggesting silencing in the TAS sequences occurs via a novel silencing mechanism. Since, prior to this study, only five genes have been identified that are Su(TPE) s, we conducted a candidate screen for Su(TPE) in Drosophila by testing point mutations in, and deficiencies for, proteins involved in chromatin metabolism. Screening with point mutations identified seven new Su(TPE) s and the deficiencies identified 19 regions of the Drosophila genome that harbor suppressor mutations. Chromatin immunoprecipitation experiments on a subset of the new Su(TPE) s confirm they act directly on the gene inserted into the telomere. Since the Su(TPE) s do not overlap significantly with either PcGs or Su(var) s, and the candidates were selected because they are involved generally in chromatin metabolism and act at a wide variety of sites within the genome, we propose that the Su(TPE) represent a third, widely used, silencing mechanism in the eukaryotic genome.	[Doheny, J. Greg; Mottus, Randy; Grigliatti, Thomas A.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia	Grigliatti, TA (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	grigliat@zoology.ubc.ca			Natural Sciences and Engineering Research Council of Canada 3005	Natural Sciences and Engineering Research Council of Canada 3005	Natural Sciences and Engineering Research Council of Canada 3005 to TAG. This is a public granting agency. Therefore, there are no commercial or competing interests.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Andreyeva EN, 2005, J CELL SCI, V118, P5465, DOI 10.1242/jcs.02654; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Aulner N, 2002, MOL CELL BIOL, V22, P1218, DOI 10.1128/MCB.22.4.1218-1232.2002; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Baur Joseph A, 2004, Methods Mol Biol, V287, P121; Berloco M, 2001, P NATL ACAD SCI USA, V98, P12126, DOI 10.1073/pnas.211428798; Biessmann H, 2005, BIOCHEM CELL BIOL, V83, P477, DOI 10.1139/O05-053; BIESSMANN H, 2005, 2 DISTINCT DOMAINS D; Boivin A, 2003, GENETICS, V164, P195; Brock HW, 2005, DEV DYNAM, V232, P633, DOI 10.1002/dvdy.20298; BRUNK BP, 1991, NUCLEIC ACIDS RES, V19, P3149, DOI 10.1093/nar/19.11.3149; Buscaino A, 2003, MOL CELL, V11, P1265, DOI 10.1016/S1097-2765(03)00140-0; Cenci G, 2005, CHROMOSOMA, V114, P135, DOI 10.1007/s00412-005-0005-9; Cenci G, 1997, GENE DEV, V11, P863, DOI 10.1101/gad.11.7.863; Cernilogar FM, 2005, BIOCHEM CELL BIOL, V83, P322, DOI 10.1139/o05-040; Cleard F, 1997, EMBO J, V16, P5280, DOI 10.1093/emboj/16.17.5280; Crabbe L, 2005, CURR MOL MED, V5, P135, DOI 10.2174/1566524053586527; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Cryderman DE, 2005, DEV DYNAM, V232, P767, DOI 10.1002/dvdy.20310; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Cuvier O, 2002, CHROMOSOMA, V110, P519, DOI 10.1007/s00412-001-0181-1; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Daubresse G, 1999, DEVELOPMENT, V126, P1175; DECAMILLIS M, 1992, GENE DEV, V6, P223, DOI 10.1101/gad.6.2.223; Dejardin J, 2005, PROG MOLEC, V38, P31; DeRubertis F, 1996, NATURE, V384, P589; Donaldson KM, 2002, GENETICS, V160, P995; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Eissenberg JC, 2003, PROG NUCLEIC ACID RE, V74, P275, DOI 10.1016/S0079-6603(03)01016-X; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Fujii S, 2008, CANCER SCI, V99, P738, DOI 10.1111/j.1349-7006.2008.00743.x; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; GRIGLIATTI T, 1991, METHOD CELL BIOL, V35, P587; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; HENDERSON DS, 1994, EMBO J, V13, P1450, DOI 10.1002/j.1460-2075.1994.tb06399.x; HENDERSON DS, 1987, MUTAT RES, V177, P83, DOI 10.1016/0027-5107(87)90024-8; HENIKOFF S, 1990, TRENDS GENET, V6, P422, DOI 10.1016/0168-9525(90)90304-O; Henikoff S, 1992, CURR OPIN GENET DEV, V2, P907, DOI 10.1016/S0959-437X(05)80114-5; Hodgson JW, 1997, MECH DEVELOP, V66, P69, DOI 10.1016/S0925-4773(97)00091-9; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; LOCKE J, 1988, GENETICS, V120, P181; Louis EJ, 2005, BIOESSAYS, V27, P685, DOI 10.1002/bies.20259; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mason JM, 2004, GENETICS, V168, P1353, DOI 10.1534/genetics.104.030676; Mason JM, 2000, GENETICA, V109, P61, DOI 10.1023/A:1026548503320; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Mis J, 2006, MOL GENET GENOMICS, V275, P513, DOI 10.1007/s00438-006-0116-x; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; MOORE GD, 1979, NATURE, V282, P312, DOI 10.1038/282312a0; Mottus R, 2000, GENETICS, V154, P657; MOTTUS R, 1979, EFFECT N BUTYRATE N; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ner SS, 2002, GENETICS, V162, P1763; NORRIS D, 1988, SCIENCE, V242, P759, DOI 10.1126/science.2847314; Oikemus SR, 2004, GENE DEV, V18, P1850, DOI 10.1101/gad.1202504; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Pardo PS, 2002, J BIOL CHEM, V277, P50860, DOI 10.1074/jbc.M203839200; Pardue ML, 2008, FLY, V2, P101, DOI 10.4161/fly.6393; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; REUTER G, 1981, MOL GEN GENET, V182, P516, DOI 10.1007/BF00293947; REUTER G, 1987, MOL GEN GENET, V210, P429, DOI 10.1007/BF00327193; REUTER G, 1990, NATURE, V344, P219, DOI 10.1038/344219a0; REUTER G, 1983, CHROMOSOMA, V88, P277, DOI 10.1007/BF00292904; REUTER G, 1982, CHROMOSOMA, V85, P539, DOI 10.1007/BF00327349; SAMAL B, 1981, CELL, V23, P401, DOI 10.1016/0092-8674(81)90135-5; SAUNDERS WS, 1993, J CELL SCI, V104, P573; Savitsky M, 2002, MOL CELL BIOL, V22, P3204, DOI 10.1128/MCB.22.9.3204-3218.2002; Schotta G, 2000, MOL GEN GENET, V262, P916, DOI 10.1007/PL00008659; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; SINCLAIR DA, 1992, GENETICS, V130, P333; SINCLAIR DAR, 1989, MOL GEN GENET, V216, P328, DOI 10.1007/BF00334372; Sinclair DAR, 1998, GENETICS, V148, P211; SINCLAIR DAR, 1983, MOL GEN GENET, V191, P326, DOI 10.1007/BF00334834; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Spofford J., 1976, GENET BIOL DROSOPHIL, VVolume 1, P955; Srinivasan S, 2005, DEVELOPMENT, V132, P1623, DOI 10.1242/dev.01713; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wallrath LL, 2000, GENETICA, V109, P25, DOI 10.1023/A:1026556705137; WALTER MF, 1995, CHROMOSOMA, V104, P229, DOI 10.1007/BF00352254; WU CT, 1995, GENETICS, V140, P139; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989; Zhimulev IF, 2003, J CELL SCI, V116, P169, DOI 10.1242/jcs.00196	104	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3864	10.1371/journal.pone.0003864	http://dx.doi.org/10.1371/journal.pone.0003864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057646	Green Published, Green Submitted, gold			2022-12-25	WOS:000265452300006
J	Cremer, S; Ugelvig, LV; Drijfhout, FP; Schlick-Steiner, BC; Steiner, FM; Seifert, B; Hughes, DP; Schulz, A; Petersen, KS; Konrad, H; Stauffer, C; Kiran, K; Espadaler, X; d'Ettorre, P; Aktac, N; Eilenberg, J; Jones, GR; Nash, DR; Pedersen, JS; Boomsma, JJ				Cremer, Sylvia; Ugelvig, Line V.; Drijfhout, Falko P.; Schlick-Steiner, Birgit C.; Steiner, Florian M.; Seifert, Bernhard; Hughes, David P.; Schulz, Andreas; Petersen, Klaus S.; Konrad, Heino; Stauffer, Christian; Kiran, Kadri; Espadaler, Xavier; d'Ettorre, Patrizia; Aktac, Nihat; Eilenberg, Jorgen; Jones, Graeme R.; Nash, David R.; Pedersen, Jes S.; Boomsma, Jacobus J.			The Evolution of Invasiveness in Garden Ants	PLOS ONE			English	Article							LASIUS-NEGLECTUS HYMENOPTERA; INTRODUCED POPULATIONS; LINEPITHEMA-HUMILE; ARGENTINE ANT; WOLBACHIA INFECTION; SOCIAL INSECTS; FIRE ANTS; FORMICIDAE; EUROPE; SUPERCOLONIES	It is unclear why some species become successful invaders whilst others fail, and whether invasive success depends on pre-adaptations already present in the native range or on characters evolving de-novo after introduction. Ants are among the worst invasive pests, with Lasius neglectus and its rapid spread through Europe and Asia as the most recent example of a pest ant that may become a global problem. Here, we present the first integrated study on behavior, morphology, population genetics, chemical recognition and parasite load of L. neglectus and its non-invasive sister species L. turcicus. We find that L. neglectus expresses the same supercolonial syndrome as other invasive ants, a social system that is characterized by mating without dispersal and large networks of cooperating nests rather than smaller mutually hostile colonies. We conclude that the invasive success of L. neglectus relies on a combination of parasite-release following introduction and pre-adaptations in mating system, body-size, queen number and recognition efficiency that evolved long before introduction. Our results challenge the notion that supercolonial organization is an inevitable consequence of low genetic variation for chemical recognition cues in small invasive founder populations. We infer that low variation and limited volatility in cuticular hydrocarbon profiles already existed in the native range in combination with low dispersal and a highly viscous population structure. Human transport to relatively disturbed urban areas thus became the decisive factor to induce parasite release, a well established general promoter of invasiveness in non-social animals and plants, but understudied in invasive social insects.	[Cremer, Sylvia; Ugelvig, Line V.; Hughes, David P.; Petersen, Klaus S.; d'Ettorre, Patrizia; Nash, David R.; Pedersen, Jes S.; Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark; [Cremer, Sylvia; Ugelvig, Line V.; d'Ettorre, Patrizia] Univ Regensburg, Regensburg, Germany; [Drijfhout, Falko P.; Jones, Graeme R.] Univ Keele, Sch Phys & Geograph Sci, Chem Ecol Grp, Keele, Staffs, England; [Schlick-Steiner, Birgit C.; Steiner, Florian M.] Univ Innsbruck, Inst Ecol, Innsbruck, Austria; [Schlick-Steiner, Birgit C.; Steiner, Florian M.] Univ Nat Resources & Appl Life Sci Vienna, Dept Intergrat Biol & Biodiversit Res, Vienna, Austria; [Schlick-Steiner, Birgit C.; Steiner, Florian M.; Konrad, Heino; Stauffer, Christian] Univ Nat Resources & Appl Life Sci Vienna, Dept Forest & Soil Sci Boku, Vienna, Austria; [Schlick-Steiner, Birgit C.; Steiner, Florian M.] James Cook Univ N Queensland, Sch marine & Trop Biol, Townsville, Qld, Australia; [Seifert, Bernhard] Nat Hist Museum Gorlitz, Gorlitz, Germany; [Hughes, David P.] Univ Oulu, Dept Biol, Oulu, Finland; [Konrad, Heino] Fed Res & Training Ctr Forest Nat Hazards & Landsc, Dept Genet, Vienna, Austria; [Kiran, Kadri; Aktac, Nihat] Trakya Univ, Dept Biol, Edirne, Turkey; [Espadaler, Xavier] Autonomous Univ Barcelona, Dept Anim Biol Plant Biol & Ecol, Bellaterra, Spain; [Eilenberg, Jorgen] Univ Copenhagen, Dept Ecol, Frederiksberg, Denmark	University of Copenhagen; University of Regensburg; Keele University; University of Innsbruck; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; James Cook University; University of Oulu; Trakya University; Autonomous University of Barcelona; University of Copenhagen	Cremer, S (corresponding author), Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark.	sylvia.cremer@biologie.uni-regensburg.de	Eilenberg, Jorgen/F-7444-2014; Ugelvig, Line V./K-5120-2012; Espadaler, Xavier/F-1898-2011; Pedersen, Jes Søe/J-6337-2014; Boomsma, Jacobus J/M-2785-2014; Cremer, Sylvia/B-2199-2013; Kiran, Kadri/X-7064-2019; Nash, David R./B-2916-2009	Eilenberg, Jorgen/0000-0002-9273-5252; Ugelvig, Line V./0000-0003-1832-8883; Espadaler, Xavier/0000-0002-7681-5957; Pedersen, Jes Søe/0000-0002-4439-2638; Boomsma, Jacobus J/0000-0002-3598-1609; Cremer, Sylvia/0000-0002-2193-3868; Kiran, Kadri/0000-0001-7983-0194; Nash, David R./0000-0002-0462-6794; Drijfhout, Falko/0000-0002-3210-8038; Steiner, Florian M./0000-0003-2414-4650; Schlick-Steiner, Birgit/0000-0003-4026-5778; Konrad, Heino/0000-0003-1820-9550	INSECTS; Marie Curie EIF; Alexander-von-Humboldt Foundation; Danish Natural Science Research Council; Danish National Research Foundation; Austrian Science Fund	INSECTS; Marie Curie EIF(European Commission); Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); Austrian Science Fund(Austrian Science Fund (FWF))	Funding was obtained from the European Community: FP5 EU research-training network INSECTS (JJB SC PD FPD DPH) and FP6 Individual Marie Curie EIF grant (SC), the Alexander-von-Humboldt Foundation (Feodor-Lynen postdoctoral stipend to SC), the Danish Natural Science Research Council (JSP), the Danish National Research Foundation (JJB DRN JSP), and the Austrian Science Fund (BCS FMS CS HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Bouwma AM, 2006, INSECT MOL BIOL, V15, P89, DOI 10.1111/j.1365-2583.2006.00614.x; Chapman RE, 2001, ECOL LETT, V4, P650, DOI 10.1046/j.1461-0248.2001.00253.x; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Elias M, 2005, BEHAV ECOL SOCIOBIOL, V57, P339, DOI 10.1007/s00265-004-0864-8; ELMES GW, 1973, J ANIM ECOL, V42, P761, DOI 10.2307/3136; Espadaler X, 2007, INSECT SOC, V54, P293, DOI 10.1007/s00040-007-0944-7; Espadaler X, 2001, INSECT SOC, V48, P159, DOI 10.1007/PL00001760; ESPADALER X, 2005, LASIUS NEGLECTUS POL; Fenollar F, 2003, ANTIMICROB AGENTS CH, V47, P1665, DOI 10.1128/AAC.47.5.1665-1671.2003; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Groden E, 2005, J ECON ENTOMOL, V98, P1774, DOI 10.1603/0022-0493-98.6.1774; Heller NE, 2004, INSECT SOC, V51, P378, DOI 10.1007/s00040-004-0770-0; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Holzer B, 2006, J EVOLUTION BIOL, V19, P2031, DOI 10.1111/j.1420-9101.2006.01133.x; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kummerli R, 2007, MOL ECOL, V16, P4493, DOI 10.1111/j.1365-294X.2007.03514.x; Lambardi D, 2007, BEHAV ECOL SOCIOBIOL, V61, P843, DOI 10.1007/s00265-006-0313-y; Lowe S., 2000, ENCY BIOL INVASIONS; McGlynn TP, 1999, AM NAT, V154, P690, DOI 10.1086/303270; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Novak SJ, 2007, P NATL ACAD SCI USA, V104, P3671, DOI 10.1073/pnas.0700224104; PASSERA L, 1994, WESTV STUD, P23; Pedersen JS, 2006, EVOLUTION, V60, P782, DOI 10.1111/j.0014-3820.2006.tb01156.x; Queller DC, 2000, NATURE, V405, P519, DOI 10.1038/35014705; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Reuter M, 2005, HEREDITY, V94, P364, DOI 10.1038/sj.hdy.6800601; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Schlick-Steiner BC, 2007, TRENDS ECOL EVOL, V22, P391, DOI 10.1016/j.tree.2007.05.004; Schultz Roland, 2005, Myrmecologische Nachrichten, V7, P47; Seifert B, 2000, DEUT ENTOMOL Z, V47, P173; Shoemaker DD, 2000, INSECT MOL BIOL, V9, P661, DOI 10.1046/j.1365-2583.2000.00233.x; Starks PT, 2003, TRENDS ECOL EVOL, V18, P159, DOI 10.1016/S0169-5347(03)00038-7; Steiner FM, 2007, CURR BIOL, V17, P1903, DOI 10.1016/j.cub.2007.09.061; Steiner FM, 2004, INSECT SOC, V51, P24, DOI 10.1007/s00040-003-0699-8; Tartally A., 2000, TISCIA (Szeged), V32, P43; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Tsutsui ND, 2003, MOL ECOL, V12, P3057, DOI 10.1046/j.1365-294X.2003.01979.x; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; van der Hammen T, 2002, HEREDITY, V89, P83, DOI 10.1038/sj.hdy.6800098; VANLOON AJ, 1990, INSECT SOC, V37, P348, DOI 10.1007/BF02225997; Williamson M., 1996, BIOL INVASIONS	47	74	80	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3838	10.1371/journal.pone.0003838	http://dx.doi.org/10.1371/journal.pone.0003838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050762	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000265452100004
J	Tran, H; Chen, HY; Walz, A; Posthumus, JC; Gong, QZ				Tran, Ha; Chen, Huaiyang; Walz, Andreas; Posthumus, Jamie C.; Gong, Qizhi			Influence of Olfactory Epithelium on Mitral/Tufted Cell Dendritic Outgrowth	PLOS ONE			English	Article								Stereotypical connections between olfactory sensory neuron axons and mitral cell dendrites in the olfactory bulb establish the first synaptic relay for olfactory perception. While mechanisms of olfactory sensory axon targeting are reported, molecular regulation of mitral cell dendritic growth and refinement are unclear. During embryonic development, mitral cell dendritic distribution overlaps with olfactory sensory axon terminals in the olfactory bulb. In this study, we investigate whether olfactory sensory neurons in the olfactory epithelium influence mitral cell dendritic outgrowth in vitro. We report a soluble trophic activity in the olfactory epithelium conditioned medium which promotes mitral/tufted cell neurite outgrowth. While the trophic activity is present in both embryonic and postnatal olfactory epithelia, only embryonic but not postnatal mitral/tufted cells respond to this activity. We show that BMP2, 5 and 7 promote mitral/tufted cells neurite outgrowth. However, the BMP antagonist, Noggin, fails to neutralize the olfactory epithelium derived neurite growth promoting activity. We provide evidence that olfactory epithelium derived activity is a protein factor with molecular weight between 50-100 kD. We also observed that Follistatin can effectively neutralize the olfactory epithelium derived activity, suggesting that TGF-beta family proteins are involved to promote mitral/tufted dendritic elaboration.	[Tran, Ha; Chen, Huaiyang; Posthumus, Jamie C.; Gong, Qizhi] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Walz, Andreas] Rockefeller Univ, New York, NY USA	University of California System; University of California Davis; Rockefeller University	Tran, H (corresponding author), Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.	qzgong@ucdavis.edu			National Institutes of Health [DC06015]; National Science Foundation [IBN0324769]; National Center for Research Resources, National Institutes of Health [C06 RR12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	National Institutes of Health DC06015 and National Science Foundation IBN0324769 to QG. This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR12088-01 from the National Center for Research Resources, National Institutes of Health.	Bailey MS, 1999, J COMP NEUROL, V415, P423; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Beck HN, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-12; Binder DK, 1999, J NEUROSCI, V19, P1424; Blanchart A, 2006, J COMP NEUROL, V496, P529, DOI 10.1002/cne.20941; BYRD CA, 1993, J NEUROBIOL, V24, P1229, DOI 10.1002/neu.480240909; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dijkhuizen PA, 2005, PROG BRAIN RES, V147, P17, DOI 10.1016/S0079-6123(04)47002-2; Esquenazi S, 2002, EXP NEUROL, V176, P41, DOI 10.1006/exnr.2002.7906; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; GRAZIADEI PPC, 1992, NEUROSCIENCE, V46, P617, DOI 10.1016/0306-4522(92)90149-V; HINDS JW, 1972, J COMP NEUROL, V146, P233, DOI 10.1002/cne.901460207; HINDS JW, 1973, J COMP NEUROL, V151, P281, DOI 10.1002/cne.901510305; HINDS JW, 1976, J COMP NEUROL, V169, P41, DOI 10.1002/cne.901690104; Hirata T, 1997, J NEUROBIOL, V32, P415, DOI 10.1002/(SICI)1097-4695(199704)32:4<415::AID-NEU5>3.0.CO;2-9; Hocking JC, 2008, MOL CELL NEUROSCI, V37, P247, DOI 10.1016/j.mcn.2007.09.011; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Kobayashi H, 1997, J NEUROSCI, V17, P8339; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Lee W, 2008, J COMP NEUROL, V507, P1076, DOI 10.1002/cne.21569; Lein PJ, 2002, J NEUROSCI, V22, P10377; Leo JMC, 2000, J COMP NEUROL, V417, P325, DOI 10.1002/(SICI)1096-9861(20000214)417:3<325::AID-CNE6>3.0.CO;2-Y; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Lopez-Mascaraque L, 1998, ANN NY ACAD SCI, V855, P83, DOI 10.1111/j.1749-6632.1998.tb10549.x; Lopez-Mascaraque L, 2005, DEV DYNAM, V232, P325, DOI 10.1002/dvdy.20239; Malun D, 1996, J COMP NEUROL, V368, P1, DOI 10.1002/(SICI)1096-9861(19960422)368:1<1::AID-CNE1>3.0.CO;2-7; Matsutani S, 2000, J COMP NEUROL, V418, P402; Matsuura I, 2007, BIOCHEM BIOPH RES CO, V360, P868, DOI 10.1016/j.bbrc.2007.06.157; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; MICHEL U, 1993, MOL CELL ENDOCRINOL, V91, P1, DOI 10.1016/0303-7207(93)90248-I; Mombaerts P, 1996, CURR OPIN NEUROBIOL, V6, P481, DOI 10.1016/S0959-4388(96)80053-5; Nakajima D, 2001, MOL BRAIN RES, V94, P85; NAKAMURA T, 1991, J BIOL CHEM, V266, P19432; Peretto P, 2002, J COMP NEUROL, V451, P267, DOI 10.1002/cne.10343; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rockle I, 2008, DEV NEUROBIOL, V68, P1170, DOI 10.1002/dneu.20649; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Shou JY, 2000, DEVELOPMENT, V127, P5403; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; STOUT RP, 1980, NEUROSCIENCE, V5, P2175, DOI 10.1016/0306-4522(80)90134-7; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Treloar H, 1997, J NEUROBIOL, V32, P643, DOI 10.1002/(SICI)1097-4695(19970620)32:7<643::AID-NEU1>3.0.CO;2-4; Treloar HB, 1999, J COMP NEUROL, V413, P289; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Walz A, 2006, J NEUROBIOL, V66, P835, DOI 10.1002/neu.20266; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9	53	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3816	10.1371/journal.pone.0003816	http://dx.doi.org/10.1371/journal.pone.0003816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043569	Green Submitted, gold, Green Published			2022-12-25	WOS:000265451400008
J	Skinner, MK; Anway, MD; Savenkova, MI; Gore, AC; Crews, D				Skinner, Michael K.; Anway, Matthew D.; Savenkova, Marina I.; Gore, Andrea C.; Crews, David			Transgenerational Epigenetic Programming of the Brain Transcriptome and Anxiety Behavior	PLOS ONE			English	Article								Embryonic exposure to the endocrine disruptor vinclozolin during gonadal sex determination promotes an epigenetic reprogramming of the male germ-line that is associated with transgenerational adult onset disease states. Further analysis of this transgenerational phenotype on the brain demonstrated reproducible changes in the brain transcriptome three generations (F3) removed from the exposure. The transgenerational alterations in the male and female brain transcriptomes were distinct. In the males, the expression of 92 genes in the hippocampus and 276 genes in the amygdala were transgenerationally altered. In the females, the expression of 1,301 genes in the hippocampus and 172 genes in the amygdala were transgenerationally altered. Analysis of specific gene sets demonstrated that several brain signaling pathways were influenced including those involved in axon guidance and long-term potentiation. An investigation of behavior demonstrated that the vinclozolin F3 generation males had a decrease in anxiety-like behavior, while the females had an increase in anxiety-like behavior. These observations demonstrate that an embryonic exposure to an environmental compound appears to promote a reprogramming of brain development that correlates with transgenerational sex-specific alterations in the brain transcriptomes and behavior. Observations are discussed in regards to environmental and transgenerational influences on the etiology of brain disease.	[Skinner, Michael K.; Anway, Matthew D.; Savenkova, Marina I.] Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA; [Gore, Andrea C.] Univ Texas, Div Pharmacol & Toxicol, Austin, TX USA; [Crews, David] Univ Texas, Sect Integrat Biol, Austin, TX USA	Washington State University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Skinner, MK (corresponding author), Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA.	Skinner@mail.wsu.edu	Savenkova, Marina/AAN-9927-2021	Gore, Andrea/0000-0001-5549-6793	National Institute of Environmental Health Sciences, NIEHS	National Institute of Environmental Health Sciences, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by a grant from the National Institute of Environmental Health Sciences, NIEHS to MKS.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; ANWAY MD, 2006, ENDOCRINOLOGY, V147; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; Burwell RD, 2001, J COMP NEUROL, V437, P17, DOI 10.1002/cne.1267; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; Chen JJ, 2004, BIOINFORMATICS, V20, P1436, DOI 10.1093/bioinformatics/bth118; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cloutier S, 2006, TOXICOLOGY, V217, P147, DOI 10.1016/j.tox.2005.09.003; CRAWLEY JN, 1981, PHARMACOL BIOCHEM BE, V15, P695, DOI 10.1016/0091-3057(81)90007-1; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; CREWS D, 2008, FRONTIERS N IN PRESS; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Crews D, 2006, ENDOCRINOLOGY, V147, pS4, DOI 10.1210/en.2005-1122; Cupp AS, 2003, J ANDROL, V24, P736; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; FILE SE, 1993, BEHAV BRAIN RES, V58, P199, DOI 10.1016/0166-4328(93)90103-W; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gomez C, 2002, PHARMACOL BIOCHEM BE, V72, P543, DOI 10.1016/S0091-3057(02)00722-0; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Heindel JJ, 2005, BIRTH DEFECTS RES A, V73, P131, DOI 10.1002/bdra.20119; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Klose R, 2003, SCIENCE, V302, P793, DOI 10.1126/science.1091762; Lawford BR, 2006, EUR PSYCHIAT, V21, P180, DOI 10.1016/j.eurpsy.2005.01.006; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li H, 2005, BRAIN DEV-JPN, V27, P321, DOI 10.1016/j.braindev.2004.08.003; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Newbold RR, 1998, CARCINOGENESIS, V19, P1655, DOI 10.1093/carcin/19.9.1655; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; NILSSON E, 2008, REPRODUCTIO IN PRESS, V135; O'Donovan MC, 2003, HUM MOL GENET, V12, pR125, DOI 10.1093/hmg/ddg302; PIAZZA PV, 1989, BEHAV BRAIN RES, V31, P267, DOI 10.1016/0166-4328(89)90008-9; PICAZO O, 1995, BRAIN RES, V680, P135, DOI 10.1016/0006-8993(95)00254-N; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; SHIMA JE, 2004, BIOL REPROD; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V50, P153, DOI 10.1159/000079107; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V49, P196, DOI 10.1159/000077366; Uzumcu M, 2004, REPROD TOXICOL, V18, P765, DOI 10.1016/j.reprotox.2004.05.008; Walf AA, 2008, NEUROPSYCHOPHARMACOL, V33, P431, DOI 10.1038/sj.npp.1301416; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Zhang HP, 2006, AM J MED GENET B, V141B, P387, DOI 10.1002/ajmg.b.30332; Zhao XY, 2007, EPIGENETICS-US, V2, P126, DOI 10.4161/epi.2.2.4236	53	199	204	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3745	10.1371/journal.pone.0003745	http://dx.doi.org/10.1371/journal.pone.0003745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015723	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448400002
J	Raad, H; Paclet, MH; Boussetta, T; Kroviarski, Y; Morel, F; Quinn, MT; Gougerot-Pocidalo, MA; Dang, PMC; El-Benna, J				Raad, Houssam; Paclet, Marie-Helene; Boussetta, Tarek; Kroviarski, Yolande; Morel, Francoise; Quinn, Mark T.; Gougerot-Pocidalo, Marie-Anne; Dang, Pham My-Chan; El-Benna, Jamel			Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91(phox)/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67(phox), and p47(phox)	FASEB JOURNAL			English	Article						neutrophils; PMN; cytochrome b558; inflammation; innate immunity	RESPIRATORY BURST OXIDASE; CHRONIC GRANULOMATOUS-DISEASE; SITE-DIRECTED MUTAGENESIS; COLONY-STIMULATING FACTOR; CYTOCHROME B(558); HUMAN-NEUTROPHILS; FLAVOCYTOCHROME B(558); COMPONENT P47(PHOX); FLAVOPROTEIN DOMAIN; ACTIVATION	Neutrophils generate microbicidal oxidants through activation of a multicomponent enzyme called NADPH oxidase. During activation, the cytosolic NADPH oxidase components (p47(phox), p67(phox), p40(phox), and Rac2) translocate to the membranes, where they associate with flavocytochrome b(558), which is composed of gp91(phox)/NOX2 and p22(phox), to form the active system. During neutrophil stimulation, p47(phox), p67(phox), p40(phox), and p22(phox) are phosphorylated; however, the phosphorylation of gp91(phox)/NOX2 and its potential role have not been defined. In this study, we show that gp91(phox) is phosphorylated in stimulated neutrophils. The gp91(phox) phosphoprotein is absent in neutrophils from chronic granulomatous disease patients deficient in gp91(phox), which confirms that this phosphoprotein is gp91(phox). The protein kinase C inhibitor GF109203X inhibited phorbol 12-myristate 13-acetate-induced phosphorylation of gp91(phox), and protein kinase C (PKC) phosphorylated the recombinant gp91(phox)-cytosolic carboxy-terminal flavoprotein domain. Two-dimensional tryptic peptide mapping analysis showed that PKC phosphorylated the gp91(phox)-cytosolic tail on the same peptides that were phosphorylated on gp91(phox) in intact cells. In addition, PKC phosphorylation increased diaphorase activity of the gp91(phox) flavoprotein cytosolic domain and its binding to Rac2, p67(phox), and p47(phox). These results demonstrate that gp91(phox) is phosphorylated in human neutrophils by PKC to enhance its catalytic activity and assembly of the complex. Phosphorylation of gp91(phox)/NOX2 is a novel mechanism of NADPH oxidase regulation.-Raad, H., Paclet, M.-H., Boussetta, T., Kroviarski, Y., Morel, F., Quinn, M. T., Gougerot-Pocidalo, M.-A., Dang, P. M.-C., El-Benna, J. Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91(phox)/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67(phox), and p47(phox). FASEB J. 23, 1011-1022 (2009)	[El-Benna, Jamel] Univ Paris 07, INSERM, Fac Med Xavier Bichat, U773,CRB3,UMRS 773, F-75018 Paris, France; [Paclet, Marie-Helene; Morel, Francoise] CHU Grenoble, UMR CNRS 5525, GREPI, TIMC IMAG, F-38043 Grenoble, France; [Kroviarski, Yolande; Gougerot-Pocidalo, Marie-Anne] CHU Xavier Bichat, AP HP, CIB Phenogen, Paris, France; [Quinn, Mark T.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Montana State University System; Montana State University Bozeman	El-Benna, J (corresponding author), Univ Paris 07, INSERM, Fac Med Xavier Bichat, U773,CRB3,UMRS 773, 16 Rue Henri Huchard, F-75018 Paris, France.	jamel.elbenna@inserm.fr	Paclet, Marie-Hélène/AAS-5029-2020	Quinn, Mark/0000-0001-8114-5073	FRM (Fondation pour la Recherche Medicale); ARC (Association pour la Recherche sur le Cancer); Region Rhone-Alpes; CGD Research Trust 2006, UK; "Delegation Regionale de la Recherche Clinique," CHU Grenoble, France; U.S. National Institutes of Health [AR42426, RR020185]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110732] Funding Source: NIH RePORTER	FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); CGD Research Trust 2006, UK; "Delegation Regionale de la Recherche Clinique," CHU Grenoble, France; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this work to the memory of Bernard M. Babior, who is no longer among us. We thank Mary Dinauer (Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Bloomington, IN, USA) and Ulla Knaus (Scripps Research Institute, La Jolla, CA, USA) for the generous gift of NOX2 cDNA and pGex-Rac2 plasmid. H. R. is a recipient of the FRM (Fondation pour la Recherche Medicale) fellowship. This work was supported by ARC (Association pour la Recherche sur le Cancer); the "Region Rhone-Alpes, program Emergence 2003," France; the CGD Research Trust 2006, UK; the "Delegation Regionale de la Recherche Clinique," CHU Grenoble, France; and U.S. National Institutes of Health grants AR42426 and RR020185.	Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BABIOR BM, 1984, BLOOD, V64, P959; Batot G, 1998, BBA-MOL BASIS DIS, V1406, P188, DOI 10.1016/S0925-4439(98)00004-0; BATOT G, 1995, EUR J BIOCHEM, V234, P208, DOI 10.1111/j.1432-1033.1995.208_c.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bouin AP, 1998, J BIOL CHEM, V273, P30097, DOI 10.1074/jbc.273.46.30097; Burritt JB, 2003, J IMMUNOL, V170, P6082, DOI 10.4049/jimmunol.170.12.6082; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; CROSS AR, 1994, J BIOL CHEM, V269, P21448; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Dang PMC, 1999, J BIOL CHEM, V274, P20704, DOI 10.1074/jbc.274.29.20704; Dang PMC, 2001, J IMMUNOL, V166, P1206, DOI 10.4049/jimmunol.166.2.1206; Dang PMC, 2001, P NATL ACAD SCI USA, V98, P3001, DOI 10.1073/pnas.061029698; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; DINAUER MC, 1993, CRIT REV CL LAB SCI, V30, P329, DOI 10.3109/10408369309082591; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; ElBenna J, 1996, J BIOL CHEM, V271, P6374; ELBENNA J, 1994, J BIOL CHEM, V269, P6729; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; ElBenna J, 1997, J BIOL CHEM, V272, P17204, DOI 10.1074/jbc.272.27.17204; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; GARCIA RC, 1988, BIOCHEM J, V252, P901, DOI 10.1042/bj2520901; Gerard B, 2001, Hum Mutat, V18, P163, DOI 10.1002/humu.1166; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Han CH, 2001, J BIOCHEM-TOKYO, V129, P513, DOI 10.1093/oxfordjournals.jbchem.a002885; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Kao YY, 2008, J BIOL CHEM, V283, P12736, DOI 10.1074/jbc.M801010200; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KOSHKIN V, 1993, FEBS LETT, V327, P57, DOI 10.1016/0014-5793(93)81039-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li JR, 1997, BIOCHEMISTRY-US, V36, P5529, DOI 10.1021/bi963013r; Nisimoto Y, 2004, BIOCHEMISTRY-US, V43, P9567, DOI 10.1021/bi0400249; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Paclet MH, 2004, BIOCHEM J, V382, P981, DOI 10.1042/BJ20040954; Paclet MH, 2001, EUR J BIOCHEM, V268, P5197, DOI 10.1046/j.0014-2956.2001.02455.x; QUINN MT, 1993, J BIOL CHEM, V268, P20983; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; Taylor RM, 2003, BBA-BIOMEMBRANES, V1612, P65, DOI 10.1016/S0005-2736(03)00086-5; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wallach TM, 1997, BIOCHEM J, V321, P583, DOI 10.1042/bj3210583; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	53	136	141	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1011	1022		10.1096/fj.08-114553	http://dx.doi.org/10.1096/fj.08-114553			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19028840	Green Published			2022-12-25	WOS:000266651600005
J	Le, DT; Lee, BC; Marino, SM; Zhang, Y; Fomenko, DE; Kaya, A; Hacioglu, E; Kwak, GH; Koc, A; Kim, HY; Gladyshev, VN				Le, Dung Tien; Lee, Byung Cheon; Marino, Stefano M.; Zhang, Yan; Fomenko, Dmitri E.; Kaya, Alaattin; Hacioglu, Elise; Kwak, Geun-Hee; Koc, Ahmet; Kim, Hwa-Young; Gladyshev, Vadim N.			Functional Analysis of Free Methionine-R-sulfoxide Reductase from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CATALYTIC MECHANISM; OXIDATIVE STRESS; GAF DOMAIN; LIFE-SPAN; PROTEINS; MAMMALS; DAMAGE; SITES; MSRA	Methionine sulfoxide reductases (Msrs) are oxidoreductases that catalyze thiol-dependent reduction of oxidized methionines. MsrA and MsrB are the best known Msrs that repair methionine-S-sulfoxide (Met-S-SO) and methionine-R-sulfoxide (Met-R-SO) residues in proteins, respectively. In addition, an Escherichia coli enzyme specific for free Met-R-SO, designated fRMsr, was recently discovered. In this work, we carried out comparative genomic and experimental analyses to examine occurrence, evolution, and function of fRMsr. This protein is present in single copies and two mutually exclusive subtypes in about half of prokaryotes and unicellular eukaryotes but is missing in higher plants and animals. A Saccharomyces cerevisiae fRMsr homolog was found to reduce free Met-R-SO but not free Met-S-SO or dabsyl-Met-R-SO. fRMsr was responsible for growth of yeast cells on Met-R-SO, and the double fRMsr/MsrA mutant could not grow on a mixture of methionine sulfoxides. However, in the presence of methionine, even the triple fRMsr/MsrA/MsrB mutant was viable. In addition, fRMsr deletion strain showed an increased sensitivity to oxidative stress and a decreased life span, whereas overexpression of fRMsr conferred higher resistance to oxidants. Molecular modeling and cysteine residue targeting by thioredoxin pointed to Cys(101) as catalytic and Cys(125) as resolving residues in yeast fRMsr. These residues as well as a third Cys, resolving Cys(91), clustered in the structure, and each was required for the catalytic activity of the enzyme. The data show that fRMsr is the main enzyme responsible for the reduction of free Met-R-SO in S. cerevisiae.	[Le, Dung Tien; Lee, Byung Cheon; Marino, Stefano M.; Zhang, Yan; Fomenko, Dmitri E.; Kaya, Alaattin; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Le, Dung Tien; Lee, Byung Cheon; Marino, Stefano M.; Zhang, Yan; Fomenko, Dmitri E.; Kaya, Alaattin; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Hacioglu, Elise; Koc, Ahmet] Izmir Inst Technol, Dept Mol Biol & Genet, TR-35430 Izmir, Turkey; [Kwak, Geun-Hee; Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Izmir Institute of Technology; Yeungnam University	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/J-6187-2013; KOÇ, AHMET/ABI-3322-2020; Le, Dung Tien/A-7276-2008; Kaya, Alaattin/T-6427-2017; Gladyshev, Vadim N/A-9894-2013	KOÇ, AHMET/0000-0003-3484-2137; Le, Dung Tien/0000-0002-5117-3476; Kaya, Alaattin/0000-0002-6132-5197; Lee, Byung Cheon/0000-0003-1467-1940; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [AG021518, RR017675]; Korea Research Foundation [KRF-2007-331-C00198]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021518 (to V.N.G.). This work was also supported by Korea Research Foundation Grant KRF-2007-331-C00198 ( to H.-Y.K.). The Nebraska Redox Biology Center is supported by National Institutes of Health Grant RR017675.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; BOSCHIMULLER S, 2002, J BIOL CHEM, V17, P35908; Cabreiro F, 2007, BIOCHIMIE, V89, P1388, DOI 10.1016/j.biochi.2007.05.005; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Etienne F, 2003, BIOCHEM BIOPH RES CO, V300, P378, DOI 10.1016/S0006-291X(02)02870-X; Ezraty B, 2004, EMBO J, V23, P1868, DOI 10.1038/sj.emboj.7600172; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Kantorow M, 2004, P NATL ACAD SCI USA, V101, P9654, DOI 10.1073/pnas.0403532101; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Ko JJ, 2005, PROTEINS, V59, P183, DOI 10.1002/prot.20418; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Le DT, 2008, BIOCHEMISTRY-US, V47, P6685, DOI 10.1021/bi800422s; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Picot CR, 2005, FREE RADICAL BIO MED, V39, P1332, DOI 10.1016/j.freeradbiomed.2005.06.017; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Slyshenkov VS, 2002, ACTA BIOCHIM POL, V49, P907; Smetana JHC, 2007, FEBS J, V274, P5891, DOI 10.1111/j.1742-4658.2007.06112.x; Spector D, 2003, BIOCHEM BIOPH RES CO, V302, P284, DOI 10.1016/S0006-291X(03)00163-3; Stadtman ER, 2002, MOL CELL BIOCHEM, V234, P3, DOI 10.1023/A:1015916831583; Tai SL, 2005, J BIOL CHEM, V280, P437, DOI 10.1074/jbc.M410573200; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wei Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-119; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	43	64	69	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4354	4364		10.1074/jbc.M805891200	http://dx.doi.org/10.1074/jbc.M805891200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19049972	Green Published, hybrid			2022-12-25	WOS:000263134400034
J	Masada, N; Ciruela, A; MacDougall, DA; Cooper, DMF				Masada, Nanako; Ciruela, Antonio; MacDougall, David A.; Cooper, Dermot M. F.			Distinct Mechanisms of Regulation by Ca2+/Calmodulin of Type 1 and 8 Adenylyl Cyclases Support Their Different Physiological Roles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CA2+ ENTRY; LIGHT-CHAIN KINASE; CALMODULIN-BINDING DOMAIN; BARREL MAP DEVELOPMENT; NITRIC-OXIDE SYNTHASE; CALCIUM-BINDING; GENETIC-EVIDENCE; MOUSE-BRAIN; CYCLIC-AMP; CELL-LINE	Nine membrane-bound mammalian adenylyl cyclases (ACs) have been identified. Type 1 and 8 ACs (AC1 and AC8), which are both expressed in the brain and are stimulated by Ca2+/calmodulin (CaM), have discrete neuronal functions. Although the Ca2+ sensitivity of AC1 is higher than that of AC8, precisely how these two ACs are regulated by Ca2+/CaM remains elusive, and the basis for their diverse physiological roles is quite unknown. Distinct localization of the CaM binding domains within the two enzymes may be essential to differential regulation of the ACs by Ca2+/CaM. In this study we compare in detail the regulation of AC1 and AC8 by Ca2+/CaM both in vivo and in vitro and explore the different role of each Ca2+-binding lobe of CaM in regulating the two enzymes. We also assess the relative dependence of AC1 and AC8 on capacitative Ca2+ entry. Finally, in real-time fluorescence resonance energy transfer-based imaging experiments, we examine the effects of dynamic Ca2+ events on the production of cAMP in cells expressing AC1 and AC8. Our data demonstrate distinct patterns of regulation and Ca2+ dependence of AC1 and AC8, which seems to emanate from their mode of regulation by CaM. Such distinctive properties may contribute significantly to the divergent physiological roles in which these ACs have been implicated.	[Masada, Nanako; Ciruela, Antonio; MacDougall, David A.; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	dmfc2@cam.ac.uk		MacDougall, David/0000-0003-1811-288X	Wellcome Trust [RG31760]	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported in part by the Wellcome Trust (Grant RG31760).	BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; BOYAJIAN CL, 1991, J BIOL CHEM, V266, P4995; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; Conti AC, 2007, NEUROSCIENCE, V146, P713, DOI 10.1016/j.neuroscience.2007.01.045; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Crossthwaite AJ, 2006, MOL PHARMACOL, V69, P608, DOI 10.1124/mol.105.018275; Crossthwaite AJ, 2005, J BIOL CHEM, V280, P6380, DOI 10.1074/jbc.M411987200; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; EVANS T, 1984, MOL PHARMACOL, V26, P395; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; FINDLAY WA, 1995, BIOCHEMISTRY-US, V34, P2087, DOI 10.1021/bi00007a001; GAO ZH, 1993, J BIOL CHEM, V268, P20096; Gong B, 2007, EUR J NEUROSCI, V26, P275, DOI 10.1111/j.1460-9568.2007.05669.x; Goraya TA, 2008, CELL SIGNAL, V20, P359, DOI 10.1016/j.cellsig.2007.10.024; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu C, 1999, J BIOL CHEM, V274, P8012, DOI 10.1074/jbc.274.12.8012; HELLEVUO K, 1993, BIOCHEM BIOPH RES CO, V192, P311, DOI 10.1006/bbrc.1993.1415; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LEVIN LR, 1995, J BIOL CHEM, V270, P7573, DOI 10.1074/jbc.270.13.7573; LINSE S, 1991, J BIOL CHEM, V266, P8050; LIVINGSTONE MS, 1985, P NATL ACAD SCI USA, V82, P5992, DOI 10.1073/pnas.82.17.5992; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Lu HC, 2006, J NEUROSCI, V26, P2692, DOI 10.1523/JNEUROSCI.3956-05.2006; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Martin ACL, 2006, MOL PHARMACOL, V70, P769, DOI 10.1124/mol.106.025213; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mons N, 1999, CELL MOL LIFE SCI, V55, P525, DOI 10.1007/s000180050311; Moulder KL, 2008, J NEUROSCI, V28, P5159, DOI 10.1523/JNEUROSCI.5317-07.2008; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Nicol X, 2005, J COMP NEUROL, V486, P281, DOI 10.1002/cne.20528; Nicol X, 2006, EUR J NEUROSCI, V24, P3401, DOI 10.1111/j.1460-9568.2006.05227.x; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; OLWIN BB, 1984, J BIOL CHEM, V259, P949; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Persechini A, 1996, J BIOL CHEM, V271, P62, DOI 10.1074/jbc.271.1.62; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Plas DT, 2004, VISION RES, V44, P3357, DOI 10.1016/j.visres.2004.09.036; Ravary A, 2003, J NEUROSCI, V23, P2228; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Shuttleworth TJ, 1999, J BIOL CHEM, V274, P31174, DOI 10.1074/jbc.274.44.31174; Simpson RE, 2006, J BIOL CHEM, V281, P17379, DOI 10.1074/jbc.M510992200; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; TANG WJ, 1991, J BIOL CHEM, V266, P8595; VILLACRES EC, 1995, J BIOL CHEM, V270, P14352, DOI 10.1074/jbc.270.24.14352; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; Wang HS, 2007, J BIOL CHEM, V282, P1507, DOI 10.1074/jbc.M607291200; WAYMAN GA, 1995, J BIOL CHEM, V270, P21480, DOI 10.1074/jbc.270.37.21480; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; WU ZL, 1993, J BIOL CHEM, V268, P23766; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Zhang M, 2008, J NEUROSCI, V28, P4736, DOI 10.1523/JNEUROSCI.1177-08.2008	72	44	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4451	4463		10.1074/jbc.M807359200	http://dx.doi.org/10.1074/jbc.M807359200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19029295	Green Published, hybrid			2022-12-25	WOS:000263134400045
J	Norton, JT; Wang, C; Gjidoda, A; Henry, RW; Huang, S				Norton, John T.; Wang, Chen; Gjidoda, Alison; Henry, R. William; Huang, Sui			The Perinucleolar Compartment Is Directly Associated with DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III TRANSCRIPTS; TRACT-BINDING-PROTEIN; TOPOISOMERASE-II; RNA; CAMPTOTHECIN; INHIBITION; PREVALENCE; DISTAMYCIN; RESISTANT; NETROPSIN	The perinucleolar compartment (PNC) is a nuclear subdomain that is unique to tumor cells, and the percentage of cells in a population containing PNCs ( PNC prevalence) indicates the level of malignancy of that population. Here, we utilize anticancer drugs and other exogenous stimuli to investigate the structure and function of the PNC. Screening of clinically used anti-cancer drugs revealed two types of drugs disassemble PNCs and do so through their specific molecular actions. Transcription inhibitors reduce PNC prevalence in parallel with RNA polymerase III transcription reduction, and a subset of DNA-damaging drugs and stimuli (UV radiation) disassemble the PNC. Inhibition of cellular DNA damage response demonstrated that the DNA damage itself, not the response or polymerase III inhibition, is responsible for PNC disassembly, suggesting that the maintenance of the PNC is dependent upon DNA integrity. Analyses of the types of DNA damage that cause PNC disassembly show that interstrand DNA base pairing, not strand continuity, is important for PNC integrity, indicating that the PNC components are directly interacting with the DNA. Complementary cell biology experiments demonstrated that the number of PNCs per cell increases with the rounds of endoreplication and that PNCs split into doublets during mid S phase, both of which are phenotypes that are typical of a replicating DNA loci. Together, these studies validate PNC disassembly as a screening marker to identify chemical probes and revealed that the PNC is directly nucleated on a DNA locus, suggesting a potential role for the PNC in gene expression regulation.	[Norton, John T.; Wang, Chen; Huang, Sui] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Gjidoda, Alison; Henry, R. William] Michigan State Univ, E Lansing, MI 48824 USA	Northwestern University; Michigan State University	Huang, S (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	s-huang2@northwestern.edu			NCI NIH HHS [T32CA09560] Funding Source: Medline; NIA NIH HHS [T32AG000260] Funding Source: Medline; NIGMS NIH HHS [GM078555-01A1, 1-R01-GM79098] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079098, R01GM078555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000260] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CAMPAIN JA, 1993, J CELL PHYSIOL, V155, P414, DOI 10.1002/jcp.1041550224; Fortune JM, 1998, J BIOL CHEM, V273, P17643, DOI 10.1074/jbc.273.28.17643; Hall MP, 2004, MOL BIOL CELL, V15, P774, DOI 10.1091/mbc.E03-09-0692; Huang S, 1997, J CELL BIOL, V137, P965, DOI 10.1083/jcb.137.5.965; Huang S, 1998, J CELL BIOL, V143, P35, DOI 10.1083/jcb.143.1.35; Huttelmaier S, 2001, J CELL BIOL, V155, P775, DOI 10.1083/jcb.200105044; ISHIDA R, 1991, CANCER RES, V51, P4909; Kamath RV, 2005, CANCER RES, V65, P246; KIM SK, 1993, FEBS LETT, V315, P61, DOI 10.1016/0014-5793(93)81133-K; Kleinhenz B, 2005, FEBS LETT, V579, P4254, DOI 10.1016/j.febslet.2005.07.001; KOPKA ML, 1985, P NATL ACAD SCI USA, V82, P1376, DOI 10.1073/pnas.82.5.1376; Kopp K, 2005, J CELL BIOCHEM, V95, P217, DOI 10.1002/jcb.20403; Laronne A, 2003, MOL BIOL CELL, V14, P3730, DOI 10.1091/mbc.E02-12-0850; LI LH, 1972, CANCER RES, V32, P2643; MATERA AG, 1995, J CELL BIOL, V129, P1181, DOI 10.1083/jcb.129.5.1181; Norton JT, 2008, CANCER-AM CANCER SOC, V113, P861, DOI 10.1002/cncr.23632; PORTUGAL J, 1987, EUR J BIOCHEM, V167, P281, DOI 10.1111/j.1432-1033.1987.tb13334.x; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Urasaki Y, 2001, CANCER RES, V61, P1964; Wang C, 2003, MOL BIOL CELL, V14, P2425, DOI 10.1091/mbc.E02-12-0818; Won JJ, 2006, NAT CHEM BIOL, V2, P369, DOI 10.1038/nchembio800; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	22	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4090	4101		10.1074/jbc.M807255200	http://dx.doi.org/10.1074/jbc.M807255200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19015260	Green Published, hybrid			2022-12-25	WOS:000263134400006
J	Xu, ZQ; Hurchla, MA; Deng, HJ; Uluckan, O; Bu, F; Berdy, A; Eagleton, MC; Heller, EA; Floyd, DH; Dirksen, WP; Shu, S; Tanaka, Y; Fernandez, SA; Rosol, TJ; Weilbaecher, KN				Xu, Zhiqiang; Hurchla, Michelle A.; Deng, Hongju; Uluckan, Oezge; Bu, Fang; Berdy, Andrew; Eagleton, Mark C.; Heller, Emanuela A.; Floyd, Desiree H.; Dirksen, Wessel P.; Shu, Sherry; Tanaka, Yuetsu; Fernandez, Soledad A.; Rosol, Thomas J.; Weilbaecher, Katherine N.			Interferon-gamma Targets Cancer Cells and Osteoclasts to Prevent Tumor-associated Bone Loss and Bone Metastases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; VIRUS TYPE-I; IFN-GAMMA; CARCINOMA-CELLS; INHIBITS GROWTH; DEFICIENT MICE; INDUCTION; APOPTOSIS; ACTIVATION; EXPRESSION	Interferon-gamma (IFN-gamma) has been shown to enhance anti-tumor immunity and inhibit the formation of bone-resorbing osteoclasts. We evaluated the role of IFN-gamma in bone metastases, tumor-associated bone destruction, and hypercalcemia in human T cell lymphotrophic virus type 1-Tax transgenic mice. Compared with Tax(+)IFN-gamma(+/+) mice, Tax(+)IFN-gamma(-/-) mice developed increased osteolytic bone lesions and soft tissue tumors, as well as increased osteoclast formation and activity. In vivo administration of IFN-gamma to tumor-bearing Tax(+)IFN-gamma(-/-) mice prevented new tumor development and resulted in decreased bromodeoxyuridine uptake by established tumors. Invitro, IFN-gamma directly decreased the viability of Tax(+) tumor cells through inhibition of proliferation, suppression of ERK phosphorylation, and induction of apoptosis and caspase 3 cleavage. IFN-gamma also inhibited macrophage colony-stimulating factor-mediated proliferation and survival of osteoclast progenitors in vitro. Administration of IFN-gamma to C57BL/6 mice decreased Tax(+) tumor growth and prevented tumor-associated bone loss and hypercalcemia. In contrast, IFN-gamma treatment failed to protect IFN-gamma R1(-/-) mice from Tax(+) tumor-induced skeletal complications, despite decreasing tumor growth. These data demonstrate that IFN-gamma suppressed tumor-induced bone loss and hypercalcemia in Tax(+) mice by inhibiting both Tax(+) tumor cell growth and host-induced osteolysis. These data suggest a protective role for IFN-gamma in patients with bone metastases and hypercalcemia of malignancy.	[Xu, Zhiqiang; Hurchla, Michelle A.; Deng, Hongju; Uluckan, Oezge; Bu, Fang; Berdy, Andrew; Eagleton, Mark C.; Heller, Emanuela A.; Floyd, Desiree H.; Weilbaecher, Katherine N.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Dirksen, Wessel P.; Shu, Sherry; Rosol, Thomas J.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Tanaka, Yuetsu] Univ Ryukyus, Dept Immunol, Grad Sch, Okinawa 9030213, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Fac Med, Okinawa 9030213, Japan; [Fernandez, Soledad A.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	Washington University (WUSTL); University System of Ohio; Ohio State University; University of the Ryukyus; University of the Ryukyus; University System of Ohio; Ohio State University	Weilbaecher, KN (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, 660 S Euclid Ave,Campus Box 8069, St Louis, MO 63110 USA.	kweilbae@dom.wustl.edu	Uluckan, Ozge/H-6912-2015; Rosol, Thomas/G-9585-2011	Uluckan, Ozge/0000-0001-9468-1211; Rosol, Thomas/0000-0003-3737-1190	National Institutes of Health [CA100730, R01 CA 097250, T32 CA09547, RO1 CA100730]; St. Louis Men's Club Against Cancer; NATIONAL CANCER INSTITUTE [P01CA100730, R01CA097250, P50CA094056, T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Louis Men's Club Against Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants PPG CA100730 and R01 CA 097250 (to Z. X., M. H., H. D., M. C. E., D. H. F., E. A. H., and K. N. W.), Grant T32 CA09547 (cancer biology training grant to O. U. and M. H.), and Grant RO1 CA100730 (to T. J. R. and W. P. D. and NCRR to S. S.), as well as by the St. Louis Men's Club Against Cancer (to K. N. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bakewell SJ, 2003, P NATL ACAD SCI USA, V100, P14205, DOI 10.1073/pnas.2234372100; Chu CQ, 2003, ANN RHEUM DIS, V62, P983, DOI 10.1136/ard.62.10.983; COCHRAN AJ, 1989, ANTICANCER RES, V9, P859; De Klerck B, 2004, ARTHRITIS RES THER, V6, pR220, DOI 10.1186/ar1167; Detjen KM, 2002, INT J ONCOL, V21, P1133; Detjen KM, 2001, GUT, V49, P251, DOI 10.1136/gut.49.2.251; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2005, CANCER RES, V65, P3447, DOI 10.1158/0008-5472.CAN-04-4316; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Fox SW, 2000, BIOCHEM BIOPH RES CO, V276, P868, DOI 10.1006/bbrc.2000.3577; Gao L, 2005, BLOOD, V106, P4294, DOI 10.1182/blood-2005-04-1730; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Hirbe AC, 2007, P NATL ACAD SCI USA, V104, P14062, DOI 10.1073/pnas.0705203104; Hirbe AC, 2007, BLOOD, V109, P3424, DOI 10.1182/blood-2006-09-048686; HOCHMAN N, 1991, CELL IMMUNOL, V137, P14, DOI 10.1016/0008-8749(91)90052-D; Huang W, 2003, ARTHRITIS RES THER, V5, pR49, DOI 10.1186/ar612; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Kakuta S, 2002, IMMUNOLOGY, V105, P92, DOI 10.1046/j.0019-2805.2001.01342.x; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KEY LL, 1995, NEW ENGL J MED, V332, P1594, DOI 10.1056/NEJM199506153322402; Kim EJ, 2002, J CELL BIOCHEM, V85, P369, DOI 10.1002/jcb.10142; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Lee KY, 2008, ONCOGENE, V27, P5267, DOI 10.1038/onc.2008.147; Madyastha PR, 2000, J INTERF CYTOK RES, V20, P645, DOI 10.1089/107999000414826; Merchant MS, 2007, CANCER IMMUNOL IMMUN, V56, P1037, DOI 10.1007/s00262-006-0257-0; Mitra-Kaushik S, 2004, BLOOD, V104, P3305, DOI 10.1182/blood-2004-01-0266; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Natasha T, 2006, AM J PATHOL, V168, P551, DOI 10.2353/ajpath.2006.050480; TAKAHASHI N, 1986, J CLIN INVEST, V78, P894, DOI 10.1172/JCI112677; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; TANAKA Y, 1990, JPN J CANCER RES, V81, P225, DOI 10.1111/j.1349-7006.1990.tb02554.x; Tannir N, 2006, CANCER-AM CANCER SOC, V107, P497, DOI 10.1002/cncr.22038; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tintut Y, 2002, J BIOL CHEM, V277, P14221, DOI 10.1074/jbc.M111551200; Toh ML, 2007, CURR OPIN RHEUMATOL, V19, P284, DOI 10.1097/BOR.0b013e32805e87e0; Tomita M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-22; Vermeire K, 1997, J IMMUNOL, V158, P5507; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Weissglas M, 2007, BJU INT, V99, P1530, DOI 10.1111/j.1464-410X.2007.06862.x; Xaus J, 1999, IMMUNITY, V11, P103, DOI 10.1016/S1074-7613(00)80085-0; Zhao HB, 2005, J BONE MINER RES, V20, P2116, DOI 10.1359/JBMR.050724; ZHU L, 2006, J IMMUNOL, V177, P8844	44	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4658	4666		10.1074/jbc.M804812200	http://dx.doi.org/10.1074/jbc.M804812200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19059914	hybrid, Green Published			2022-12-25	WOS:000263134400065
J	Lallemand, D; Manent, J; Couvelard, A; Watilliaux, A; Siena, M; Chareyre, F; Lampin, A; Niwa-Kawakita, M; Kalamarides, M; Giovannini, M				Lallemand, D.; Manent, J.; Couvelard, A.; Watilliaux, A.; Siena, M.; Chareyre, F.; Lampin, A.; Niwa-Kawakita, M.; Kalamarides, M.; Giovannini, M.			Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas	ONCOGENE			English	Article						neurofibromatosis type 2; growth factor receptors; trafficking; Schwann cells; proliferation; schwannoma	NF2 TUMOR-SUPPRESSOR; GROWTH-FACTOR; NEUROFIBROMATOSIS TYPE-2; CELLULAR SENESCENCE; TYROSINE KINASES; ERBB RECEPTORS; ACTIVATION; TUMORIGENESIS; SURVIVAL; TRANSPORT	The NF2 gene product, merlin/schwannomin, is a cytoskeleton organizer with unique growth-inhibiting activity in specific cell types. A narrow spectrum of tumors is associated with NF2 deficiency, mainly schwannomas and meningiomas, suggesting cell-specific mechanisms of growth control. We have investigated merlin function in mouse Schwann cells (SCs). We found that merlin regulates contact inhibition of proliferation by limiting the delivery of several growth factor receptors at the plasma membrane of primary SCs. Notably, upon cell-to-cell contact, merlin downregulates the membrane levels of ErbB2 and ErbB3, thus inhibiting the activity of the downstream mitogenic signaling pathways protein kinase B and mitogen-activated protein kinase. Consequently, loss of merlin activity is associated with elevated levels of ErbB receptors in primary SCs. We also observed accumulation of growth factor receptors such as ErbB2 and 3, insulin-like growth factor 1 receptor and platelet-derived growth factor receptor in peripheral nerves of Nf2-mutant mice and in human NF2 schwannomas, suggesting that this mechanism could play an important role in tumorigenesis.	[Lallemand, D.; Manent, J.; Watilliaux, A.; Siena, M.; Chareyre, F.; Lampin, A.; Niwa-Kawakita, M.; Kalamarides, M.; Giovannini, M.] INSERM, U674, Paris, France; [Lallemand, D.; Manent, J.; Watilliaux, A.; Siena, M.; Chareyre, F.; Lampin, A.; Niwa-Kawakita, M.; Kalamarides, M.; Giovannini, M.] Univ Paris 07, Inst Univ Hematol, Paris, France; [Couvelard, A.] Hop Beaujon, APHP, Serv Anat & Cytol Pathol, Clichy, France; [Kalamarides, M.] Hop Beaujon, APHP, Serv Neurochirurg, Clichy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Giovannini, M (corresponding author), House Ear Res Inst, Ctr Neural Tumor Res, 2100W 3rd St, Los Angeles, CA 90057 USA.	mgiovannini@hei.org	lallemand, dominique/O-7445-2017	lallemand, dominique/0000-0002-0212-7342; Anne, Couvelard/0000-0002-6316-1210; Kawakita, Michiko/0000-0002-9450-583X; Manent, Jan/0000-0001-9152-5459	US Department of Defense [W81XWH-05-10265]; Association Neurofibromatoses et Recklinghausen; Canceropole Ile-de France; Institut National du Cancer; ANR; INSERM	US Department of Defense(United States Department of Defense); Association Neurofibromatoses et Recklinghausen; Canceropole Ile-de France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank J Lippincott-Schwartz for the kind gift of the VSV-GFP construct, Z-Y Han for assistance with mouse genotyping, all members of the U674 lab for helpful discussions and support, L Goutebroze B Goud and O Hanemann for helpful suggestions, A McClatchey for many stimulating discussions, M Pla (Departement d'Experimentation Animale-Institut Universitaire d'Hematologie) and the Centre de Distribution, Typage et Archivage animal for mouse housing. DL personally thanks F Mechta-Grigoriou for helpful advice and discussions and continuous support and Odette Mariani for careful reading of the manuscript. This work was supported by Grants from the US Department of Defense (W81XWH-05-10265), Association Neurofibromatoses et Recklinghausen, Canceropole Ile-de France, Institut National du Cancer, ANR and INSERM.	Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Buzard GS, 1999, J CANCER RES CLIN, V125, P653, DOI 10.1007/s004320050330; Cheng HL, 2000, MOL CELL ENDOCRINOL, V170, P211, DOI 10.1016/S0303-7207(00)00324-5; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Deretic D, 2004, MOL BIOL CELL, V15, P359, DOI 10.1091/mbc.E03-04-0203; Fernandez-Valle C, 2002, NAT GENET, V31, P354, DOI 10.1038/ng930; Fraenzer JT, 2003, INT J ONCOL, V23, P1493; Giovannini M, 2000, GENE DEV, V14, P1617; Giovannini M, 1999, GENE DEV, V13, P978, DOI 10.1101/gad.13.8.978; Hansen MR, 2004, OTOL NEUROTOL, V25, P155, DOI 10.1097/00129492-200403000-00013; HARDY M, 1992, J NEUROSCI RES, V31, P254, DOI 10.1002/jnr.490310206; Hirokawa Y, 2004, CANCER J, V10, P20, DOI 10.1097/00130404-200401000-00006; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hyun TS, 2004, TRENDS MOL MED, V10, P194, DOI 10.1016/j.molmed.2004.02.003; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Jones KA, 2004, EXP CELL RES, V295, P512, DOI 10.1016/j.yexcr.2004.01.022; Jozwiak J, 2006, INT J CANCER, V118, P1, DOI 10.1002/ijc.21542; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lim JY, 2003, BIOCHEM BIOPH RES CO, V302, P238, DOI 10.1016/S0006-291X(03)00124-4; Lobsiger CS, 2000, GLIA, V30, P290, DOI 10.1002/(SICI)1098-1136(200005)30:3<290::AID-GLIA8>3.0.CO;2-6; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; Manent J, 2003, J NEUROSCI METH, V123, P167, DOI 10.1016/S0165-0270(02)00349-7; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Miyake K, 2001, J CELL SCI, V114, P3487; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; NIKITIN AY, 1991, P NATL ACAD SCI USA, V88, P9939, DOI 10.1073/pnas.88.22.9939; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Rao DS, 2002, J CLIN INVEST, V110, P351, DOI 10.1172/JCI200215529; Sherman L, 1999, ONCOGENE, V18, P6692, DOI 10.1038/sj.onc.1203055; Siskova Z, 2006, MOL CELL NEUROSCI, V33, P150, DOI 10.1016/j.mcn.2006.07.001; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Stonecypher MS, 2006, J NEUROPATH EXP NEUR, V65, P162, DOI 10.1097/01.jnen.0000199575.93794.2f; Syroid DE, 1999, J NEUROSCI, V19, P2059; Tamma G, 2005, J CELL SCI, V118, P3623, DOI 10.1242/jcs.02495	42	95	99	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					854	865		10.1038/onc.2008.427	http://dx.doi.org/10.1038/onc.2008.427			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19029950	Bronze			2022-12-25	WOS:000263320000008
J	Bergo, VB; Sineshchekov, OA; Kralj, JM; Partha, R; Spudich, EN; Rothschild, KJ; Spudich, JL				Bergo, Vladislav B.; Sineshchekov, Oleg A.; Kralj, Joel M.; Partha, Ranga; Spudich, Elena N.; Rothschild, Kenneth J.; Spudich, John L.			His-75 in Proteorhodopsin, a Novel Component in Light-driven Proton Translocation by Primary Pumps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANABAENA SENSORY RHODOPSIN; SCHIFF-BASE COUNTERION; HISTIDINE; SITE; BACTERIORHODOPSIN; SPECTROSCOPY; PHOTOTROPHY; CATALYSIS; PROTEINS; H-1-NMR	Proteorhodopsins (PRs), photoactive retinylidene membrane proteins ubiquitous in marine eubacteria, exhibit light-driven proton transport activity similar to that of the well studied bacteriorhodopsin from halophilic archaea. However, unlike bacteriorhodopsin, PRs have a single highly conserved histidine located near the photoactive site of the protein. Time-resolved Fourier transform IR difference spectroscopy combined with visible absorption spectroscopy, isotope labeling, and electrical measurements of light-induced charge movements reveal participation of His-75 in the proton translocation mechanism of PR. Substitution of His-75 with Ala or Glu perturbed the structure of the photoactive site and resulted in significantly shifted visible absorption spectra. In contrast, His-75 substitution with a positively charged Arg did not shift the visible absorption spectrum of PR. The mutation to Arg also blocks the light-induced proton transfer from the Schiff base to its counterion Asp-97 during the photocycle and the acid-induced protonation of Asp-97 in the dark state of the protein. Isotope labeling of histidine revealed that His-75 undergoes deprotonation during the photocycle in the proton-pumping (high pH) form of PR, a reaction further supported by results from H75E. Finally, all His-75 mutations greatly affect charge movements within the PR and shift its pH dependence to acidic values. A model of the proteorhodopsin proton transport process is proposed as follows: (i) in the dark state His-75 is positively charged (protonated) over a wide pH range and interacts directly with the Schiff base counterion Asp-97; and (ii) photoisomerization-induced transfer of the Schiff base proton to the Asp-97 counterion disrupts its interaction with His-75 and triggers a histidine deprotonation.	[Bergo, Vladislav B.; Kralj, Joel M.; Rothschild, Kenneth J.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Bergo, Vladislav B.; Kralj, Joel M.; Rothschild, Kenneth J.] Boston Univ, Mol Biophys Lab, Photon Ctr, Boston, MA 02215 USA; [Bergo, Vladislav B.; Sineshchekov, Oleg A.; Partha, Ranga; Spudich, Elena N.; Spudich, John L.] Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA	Boston University; Boston University; University of Texas System; University of Texas Health Science Center Houston	Rothschild, KJ (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	kjr@bu.edu; John.L.Spudich@uth.tmc.edu	Rothschild, Kenneth J/P-6177-2018	Rothschild, Kenneth J/0000-0002-2847-6671	National Institutes of Health [R01GM069969, R37GM27750]; United States Department of Energy [DE-FG02-07ER15867]; Robert A. Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069969, R37GM027750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM069969 (to K. J. R.) and R37GM27750 (to J. L. S.). This work was also supported by United States Department of Energy Grant DE-FG02-07ER15867 and The Robert A. Welch Foundation grant (to J. L. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bergo V, 2000, BIOCHEMISTRY-US, V39, P2823, DOI 10.1021/bi991676d; Bergo V, 2004, BIOCHEMISTRY-US, V43, P9075, DOI 10.1021/bi0361968; Bergo V, 2002, PHOTOCHEM PHOTOBIOL, V76, P341, DOI 10.1562/0031-8655(2002)076<0341:AFTISO>2.0.CO;2; Bergo VB, 2006, J BIOL CHEM, V281, P15208, DOI 10.1074/jbc.M600033200; BOUSCHE O, 1992, PHOTOCHEM PHOTOBIOL, V56, P1085, DOI 10.1111/j.1751-1097.1992.tb09732.x; Bruylants G, 2007, CHEMBIOCHEM, V8, P51, DOI 10.1002/cbic.200600433; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Fisher Z, 2005, BIOCHEMISTRY-US, V44, P1097, DOI 10.1021/bi0480279; Friedrich T, 2002, J MOL BIOL, V321, P821, DOI 10.1016/S0022-2836(02)00696-4; Hasegawa K, 2000, J PHYS CHEM B, V104, P4253, DOI 10.1021/jp000157d; Hienerwadel R, 1997, BIOCHEMISTRY-US, V36, P14712, DOI 10.1021/bi971521a; Kraj JM, 2008, BIOCHEMISTRY-US, V47, P3447, DOI 10.1021/bi7018964; Krebs Richard A, 2002, BMC Physiol, V2, P5, DOI 10.1186/1472-6793-2-5; LeBrun LA, 2004, BIOCHEMISTRY-US, V43, P3014, DOI 10.1021/bi036103m; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Mankelow TJ, 2003, PROTOPLASMA, V221, P101, DOI 10.1007/s00709-002-0056-1; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Nie BN, 2005, BIOPHYS J, V88, P2833, DOI 10.1529/biophysj.104.047639; Noguchi T, 1999, BIOCHEMISTRY-US, V38, P10187, DOI 10.1021/bi990631+; Partha R, 2005, BBA-BIOENERGETICS, V1708, P6, DOI 10.1016/j.bbabio.2004.12.009; Rangarajan R, 2007, BIOCHEMISTRY-US, V46, P12679, DOI 10.1021/bi700955x; Rath P, 1996, BIOCHEMISTRY-US, V35, P6690, DOI 10.1021/bi9600355; ROTHSCHILD KJ, 1988, BIOCHEMISTRY-US, V27, P2420, DOI 10.1021/bi00407a026; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Sineshchekov OA, 2004, PHOTOCH PHOTOBIO SCI, V3, P548, DOI 10.1039/b316207a; Sineshchekov OA, 2006, BIOPHYS J, V91, P4519, DOI 10.1529/biophysj.106.093641; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; Venter H, 2002, BIOCHEM J, V363, P243, DOI 10.1042/0264-6021:3630243; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1259, DOI 10.1002/bip.360301310; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200	35	60	62	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2836	2843		10.1074/jbc.M803792200	http://dx.doi.org/10.1074/jbc.M803792200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19015272	hybrid, Green Published			2022-12-25	WOS:000262700900027
J	Forgacs, E; Sakamoto, T; Cartwright, S; Belknap, B; Kovacs, M; Toth, J; Webb, MR; Sellers, JR; White, HD				Forgacs, Eva; Sakamoto, Takeshi; Cartwright, Suzanne; Belknap, Betty; Kovacs, Mihaly; Toth, Judit; Webb, Martin R.; Sellers, James R.; White, Howard D.			Switch 1 Mutation S217A Converts Myosin V into a Low Duty Ratio Motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC MECHANISM; NECK LENGTH; PHOSPHATE; DOMAIN; ADP; PROCESSIVITY; ACTOMYOSIN; ANALOGS; COMPLEX; BINDING	We have determined the kinetic mechanism and motile properties of the switch 1 mutant S217A of myosin Va. Phosphate dissociation from myosin V-ADP-P-i (inorganic phosphate) and actomyosin V-ADP-P-i and the rate of the hydrolysis step ( myosin V-ATP -> myosin V-ADP-P-i) were all similar to 10-fold slower in the S217A mutant than in wild type (WT) myosin V, resulting in a slower steady-state rate of basal and filamentous actin (actin)-activated ATP hydrolysis. Substrate binding and ADP dissociation kinetics were all similar to or slightly faster in S217A than in WT myosin V and mechanochemical gating of the rates of dissociation of ADP between trail and lead heads is maintained. The reduction in the rate constants of the hydrolysis and phosphate dissociation steps reduces the duty ratio from similar to 0.85 in WT myosin V to similar to 0.25 in S217A and produces a motor in which the average run length on actin at physiological concentrations of ATP is reduced 10-fold. Thus we demonstrate that, by mutational perturbation of the switch 1 structure, myosin V can be converted into a low duty ratio motor that is processive only at low substrate concentrations.	[Forgacs, Eva; Cartwright, Suzanne; Belknap, Betty; White, Howard D.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA; [Webb, Martin R.] Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England; [Sakamoto, Takeshi; Kovacs, Mihaly; Toth, Judit; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Toth, Judit] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary	Eastern Virginia Medical School; MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	White, HD (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA.	whitehd@evms.edu	Kovacs, Mihaly/A-6841-2011	Webb, Martin/0000-0002-0134-9621; Kovacs, Mihaly/0000-0002-1200-4741	National Institutes of Health [EB00209]; Medical Research Council [MC_U117512742] Funding Source: researchfish; MRC [MC_U117512742] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant EB00209 ( to H. D. W.).	Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Batra R, 1999, BIOL CHEM, V380, P1017, DOI 10.1515/BC.1999.126; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; FINER JT, 1995, BIOPHYS J, V68, pS291; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Park S, 2000, BIOCHEMISTRY-US, V39, P11732, DOI 10.1021/bi000945t; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Wu XF, 1997, J CELL SCI, V110, P847; Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	37	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2138	2149		10.1074/jbc.M805530200	http://dx.doi.org/10.1074/jbc.M805530200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19008235	Green Published, hybrid			2022-12-25	WOS:000262545600023
J	Soberanes, S; Urich, D; Baker, CM; Burgess, Z; Chiarella, SE; Bell, EL; Ghio, AJ; De Vizcaya-Ruiz, A; Liu, J; Ridge, KM; Kamp, DW; Chandel, NS; Schumacker, PT; Mutlu, GM; Budinger, GRS				Soberanes, Saul; Urich, Daniela; Baker, Christina M.; Burgess, Zach; Chiarella, Sergio E.; Bell, Eric L.; Ghio, Andrew J.; De Vizcaya-Ruiz, Andrea; Liu, Jing; Ridge, Karen M.; Kamp, David W.; Chandel, Navdeep S.; Schumacker, Paul T.; Mutlu, Goekhan M.; Budinger, G. R. Scott			Mitochondrial Complex III-generated Oxidants Activate ASK1 and JNK to Induce Alveolar Epithelial Cell Death following Exposure to Particulate Matter Air Pollution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATING KINASE 1; REDOX GENE-THERAPY; LONG-TERM EXPOSURE; OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; APOPTOSIS; MORTALITY; PHOSPHORYLATION; DYSFUNCTION; SUPEROXIDE	We have previously reported that airborne particulate matter air pollution (PM) activates the intrinsic apoptotic pathway in alveolar epithelial cells through a pathway that requires the mitochondrial generation of reactive oxygen species (ROS) and the activation of p53. We sought to examine the source of mitochondrial oxidant production and the molecular links between ROS generation and the activation of p53 in response to PM exposure. Using a mitochondrially targeted ratiometric sensor (Ro-GFP) in cells lacking mitochondrial DNA (rho(0) cells) and cells stably expressing a small hairpin RNA directed against the Rieske iron-sulfur protein, we show that site III of the mitochondrial electron transport chain is primarily responsible for fine PM (PM2.5)-induced oxidant production. In alveolar epithelial cells, the overexpression of SOD1 prevented the PM2.5-induced ROS generation from the mitochondria and prevented cell death. Infection of mice with an adenovirus encoding SOD1 prevented the PM2.5-induced death of alveolar epithelial cells and the associated increase inalveolar-capillary permeability. Treatment with PM2.5 resulted in the ROS-mediated activation of the oxidant-sensitive kinase ASK1 and its downstream kinase JNK. Murine embryonic fibroblasts from ASK1 knock-out mice, alveolar epithelial cells transfected with dominant negative constructs against ASK1, and pharmacologic inhibition of JNK with SP600125 (25 mu M) prevented the PM2.5-induced phosphorylation of p53 and cell death. We conclude that particulate matter air pollution induces the generation of ROS primarily from site III of the mitochondrial electron transport chain and that these ROS activate the intrinsic apoptotic pathway through ASK1, JNK, and p53.	[Soberanes, Saul; Urich, Daniela; Baker, Christina M.; Chiarella, Sergio E.; Bell, Eric L.; Liu, Jing; Ridge, Karen M.; Kamp, David W.; Chandel, Navdeep S.; Mutlu, Goekhan M.; Budinger, G. R. Scott] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Schumacker, Paul T.] Northwestern Univ, Div Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Ghio, Andrew J.] US EPA, Res Triangle Pk, NC 27709 USA; [De Vizcaya-Ruiz, Andrea] IPN, Ctr Invest & Estudios Avanzados, Secc Externa Toxicol, Mexico City 07360, DF, Mexico	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; United States Environmental Protection Agency; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Budinger, GRS (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, 240 E Huron,McGaw Pavil M300, Chicago, IL 60611 USA.	s-buding@northwestern.edu	Bell, Eric/F-6368-2012	De Vizcaya-Ruiz, Andrea/0000-0002-2097-0464; Schumacker, Paul T/0000-0001-9591-2034; Chiarella, Sergio/0000-0002-0445-4929	National Institutes of Health [HL071643, GM060472, HL067835, ES015024, ES013995]; American Lung Association and the Veterans Affairs Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, K08HL067835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995, R01ES015024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association and the Veterans Affairs Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL071643, GM060472, HL067835, ES015024, and ES013995. This work was also supported by the American Lung Association and the Veterans Affairs Administration. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABBEY DE, 1991, ENVIRON HEALTH PERSP, V94, P43, DOI 10.2307/3431291; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; Budinger GRS, 2002, J BIOL CHEM, V277, P15654, DOI 10.1074/jbc.M109317200; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Cheng WH, 2003, BIOCHEM J, V370, P927, DOI 10.1042/BJ20021870; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dominici F, 2003, ENVIRON HEALTH PERSP, V111, P39, DOI 10.1289/ehp.5181; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Huggins FE, 2000, J HAZARD MATER, V74, P1, DOI 10.1016/S0304-3894(99)00195-8; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Li N, 2000, J IMMUNOL, V165, P3393, DOI 10.4049/jimmunol.165.6.3393; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Mutlu G, 2005, CIRC RES, V96, P999, DOI 10.1161/01.RES.0000164554.21993.AC; Mutlu GM, 2004, CIRC RES, V94, P1091, DOI 10.1161/01.RES.0000125623.56442.20; MUTLU GM, 2006, AM J RESP CELL MOL B; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Soberanes S, 2006, AM J RESP CRIT CARE, V174, P1229, DOI 10.1164/rccm.200602-203OC; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WISE SA, 2007, CERTIFICATE ANAL STA; Xia T, 2004, ENVIRON HEALTH PERSP, V112, P1347, DOI 10.1289/ehp.7167; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zwacka RM, 1998, NAT MED, V4, P698, DOI 10.1038/nm0698-698; Zwacka RM, 1998, HUM GENE THER, V9, P1381, DOI 10.1089/hum.1998.9.9-1381	49	104	108	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2176	2186		10.1074/jbc.M808844200	http://dx.doi.org/10.1074/jbc.M808844200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19033436	Green Published, hybrid			2022-12-25	WOS:000262545600027
J	King, JD; Vinogradov, E; Preston, A; Li, JJ; Maskell, DJ				King, Jerry D.; Vinogradov, Evgeny; Preston, Andrew; Li, Jianjun; Maskell, Duncan J.			Post-assembly Modification of Bordetella bronchiseptica O Polysaccharide by a Novel Periplasmic Enzyme Encoded by wbmE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; VIRULENCE CONTROL-SYSTEM; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; SHIGELLA-FLEXNERI; POLYACRYLAMIDE GELS; RESPIRATORY-TRACT; ANTIGEN; GENE; PROTEINS	Bordetella bronchiseptica is a pathogen of humans and animals that colonizes the respiratory tract. It produces a lipopolysaccharide O antigen that contains a homopolymer of 2,3-dideoxy-2,3-diacetamido-L- galacturonic acid (L-GalNAc3NAcA). Some of these sugars are found in the uronamide form (L-GalNAc3NAcAN), and there is no discernible pattern in the distribution of amides along the chain. A B. bronchiseptica wbmE mutant expresses an O polysaccharide unusually rich in uronamides. The WbmE protein localizes to the periplasm and catalyzes the deamidation of uronamide-rich O chains in lipopolysaccharide purified from the mutant, to attain a wildtype uronamide/uronic acid ratio. WbmE is a member of the papain-like transglutaminase superfamily, and this categorization is consistent with a deamidase role. The periplasmic location of WbmE and its acceptance of complete lipopolysaccharide as substrate indicate that it operates at a late stage in lipopolysaccharide biosynthesis, after polymerization and export of the O chain from the cytoplasm. This is the first report of such a modification of O antigen after assembly. The expression of wbmE is controlled by the Bordetella virulence gene two-component-regulatory system, BvgAS, suggesting that this deamidation is a novel mechanism by which these bacteria modify their cell surface charge in response to environmental stimuli.	[King, Jerry D.; Preston, Andrew] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [King, Jerry D.; Preston, Andrew; Maskell, Duncan J.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Vinogradov, Evgeny; Li, Jianjun] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Guelph; University of Cambridge; National Research Council Canada	King, JD (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jeguel@gmail.com		Vinogradov, Evgeny/0000-0002-5364-1376; Preston, Andrew/0000-0002-1489-280X	Wellcome Trust [054588]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Programme Grant Number 054588 (to D.J.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AKERLEY BJ, 1993, J BACTERIOL, V175, P3468, DOI 10.1128/jb.175.11.3468-3479.1993; AKERLEY BJ, 1992, J BACTERIOL, V174, P980, DOI 10.1128/jb.174.3.980-990.1992; Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; ANTOINE R, 1992, MOL MICROBIOL, V6, P1785, DOI 10.1111/j.1365-2958.1992.tb01351.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Burns VC, 2003, INFECT IMMUN, V71, P86, DOI 10.1128/IAI.71.1.86-94.2003; CHANTER N, 1989, RES VET SCI, V47, P48, DOI 10.1016/S0034-5288(18)31230-X; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; DIFABIO JL, 1992, FEMS MICROBIOL LETT, V97, P275, DOI 10.1111/j.1574-6968.1992.tb05475.x; Feng L, 2004, MICROB PATHOGENESIS, V36, P109, DOI 10.1016/j.micpath.2003.10.003; FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/JB.176.7.1821-1830.1994; Franklin MJ, 2002, J BACTERIOL, V184, P3000, DOI 10.1128/JB.184.11.3000-3007.2002; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; GRINTER NJ, 1989, PLASMID, V22, P203, DOI 10.1016/0147-619X(89)90003-6; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; JOHNSON KG, 1975, CAN J MICROBIOL, V21, P1969, DOI 10.1139/m75-285; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; JUNCKER AS, 2003, LIPOP 1 0 SIGNAL PEP; King JD, 2008, J BACTERIOL, V190, P1671, DOI 10.1128/JB.01708-07; Korres H, 2005, BIOCHEM BIOPH RES CO, V328, P1252, DOI 10.1016/j.bbrc.2005.01.087; Li JJ, 2007, MASS SPECTROM REV, V26, P35, DOI 10.1002/mas.20105; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Luo YN, 2002, FEMS MICROBIOL LETT, V208, P47; Makarova KS, 1999, PROTEIN SCI, V8, P1714, DOI 10.1110/ps.8.8.1714; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; MCGRATH BC, 1991, J BACTERIOL, V173, P649, DOI 10.1128/jb.173.2.649-654.1991; MICHAELIS S, 1983, J BACTERIOL, V154, P366, DOI 10.1128/JB.154.1.366-374.1983; MOXON ER, 1990, CURR TOP MICROBIOL, V150, P65; PEDERSEN LC, 1994, PROTEIN SCI, V3, P1131, DOI 10.1002/pro.5560030720; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Preston A, 2003, MOL MICROBIOL, V48, P725, DOI 10.1046/j.1365-2958.2003.03484.x; Preston A, 1996, J BACTERIOL, V178, P396, DOI 10.1128/jb.178.2.396-402.1996; Preston A, 2006, J BIOL CHEM, V281, P18135, DOI 10.1074/jbc.M513904200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STIBITZ S, 1991, J BACTERIOL, V173, P4288, DOI 10.1128/JB.173.14.4288-4296.1991; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; van den Akker WMR, 1998, MICROBIOL-SGM, V144, P1527, DOI 10.1099/00221287-144-6-1527; Vander Byl C, 2000, J BACTERIOL, V182, P6472, DOI 10.1128/JB.182.22.6472-6481.2000; Vinogradov E, 2004, CARBOHYD RES, V339, P649, DOI 10.1016/j.carres.2003.12.013; Vinogradov E, 2000, EUR J BIOCHEM, V267, P7230, DOI 10.1046/j.1432-1327.2000.01835.x; VINOGRADOV EV, 1991, CARBOHYD RES, V214, P289, DOI 10.1016/0008-6215(91)80036-M; WAGENER JS, 1984, AM J VET RES, V45, P1862; WEISGERBER C, 1982, EUR J BIOCHEM, V127, P165, DOI 10.1111/j.1432-1033.1982.tb06851.x	53	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1474	1483		10.1074/jbc.M807729200	http://dx.doi.org/10.1074/jbc.M807729200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015265	Green Published, hybrid			2022-12-25	WOS:000262330100015
J	Ku, CP; Lio, JCW; Wang, SH; Lin, CN; Syu, WJ				Ku, Chen-Peng; Lio, Joaquim Chan-Wang; Wang, Shao-Hung; Lin, Chin-Nan; Syu, Wan-Jr			Identification of a Third EspA-binding Protein That Forms Part of the Type III Secretion System of Enterohemorrhagic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCYTE EFFACEMENT; PATHOGENICITY ISLAND; SUBCELLULAR-LOCALIZATION; 2ND CHAPERONE; APPARATUS; ATPASE; LOCUS; COMPONENTS; REGULATOR; VIRULENCE	Enterohemorrhagic Escherichia coli utilizes a type III secretion system to deliver virulent effectors into cells. The secretion apparatus comprises a membrane basal body and an external needle complex of which EspA is the major component. An l0050-deletion (Delta L50) mutation was found to impair type III secretion and bacterial adherence. These phenotypes and the localization of the gene product to the inner membrane support the hypothesis that L0050, renamed EscL, forms part of the secretion apparatus. Furthermore, in Delta L50, the amount of EspA present within the cell lysate was found to have diminished, whereas the EspA co-cistron-expressed partner protein EspB remained unaffected. The decreased EspA level appeared to result from instability of the newly synthesized EspA protein in Delta L50 rather than a decrease in EspA mRNA. Using both biochemical co-purification and a bacterial two-hybrid interaction system, we were able to conclude that EscL is a third protein that, in addition to CesAB and CesA2, interacts with EspA and enhances the stability of intracellular EspA.	[Ku, Chen-Peng; Lio, Joaquim Chan-Wang; Wang, Shao-Hung; Lin, Chin-Nan; Syu, Wan-Jr] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University	Syu, WJ (corresponding author), 155 Sec 2,Li Nong St, Taipei 112, Taiwan.	wjsyu@ym.edu.tw	wang, shaohung/E-4017-2015	wang, shaohung/0000-0002-6824-0372; Lio, Jerry/0000-0003-3876-6741	National Science Council [97-2627-M-120-003, 97-2320-B-010-005-MY3]; Department of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Department of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported in part by National Science Council Grants 97-2627-M-120-003 and 97-2320-B-010-005-MY3 and a grant from "A Plan Aim for the Top University" from the Department of Education, Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Chiu HJ, 2005, MICROBIOL-SGM, V151, P3277, DOI 10.1099/mic.0.28115-0; Chiu HJ, 2003, ARCH MICROBIOL, V180, P218, DOI 10.1007/s00203-003-0579-7; Chuang CH, 2001, J BIOMED SCI, V8, P170, DOI 10.1007/BF02256409; Clarke SC, 2003, CLIN MICROBIOL REV, V16, P365, DOI 10.1128/CMR.16.3.365-378.2003; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Creasey EA, 2003, MICROBIOL-SGM, V149, P3639, DOI 10.1099/mic.0.26735-0; Creasey EA, 2003, MICROBIOL-SGM, V149, P2093, DOI 10.1099/mic.0.26355-0; Daniell SJ, 2003, MOL MICROBIOL, V49, P301, DOI 10.1046/j.1365-2958.2003.03555.x; Delahay RM, 1999, J BIOL CHEM, V274, P35969, DOI 10.1074/jbc.274.50.35969; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Deng WY, 2001, INFECT IMMUN, V69, P6323, DOI 10.1128/IAI.69.10.6323-6335.2001; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Hartland EL, 2000, MOL MICROBIOL, V35, P1483, DOI 10.1046/j.1365-2958.2000.01814.x; Hsu SC, 2000, HEPATOLOGY, V32, P1111, DOI 10.1053/jhep.2000.19257; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x; Imai K, 2008, BIOINFORMATION, V2, P417, DOI 10.6026/97320630002417; Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kenny B, 1997, INFECT IMMUN, V65, P2606, DOI 10.1128/IAI.65.7.2606-2612.1997; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lio JCW, 2004, J BIOMED SCI, V11, P855, DOI 10.1159/000081833; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Miller JH., 1972, EXPT MOL GENETICS; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Neves BC, 2003, INFECT IMMUN, V71, P2130, DOI 10.1128/IAI.71.4.2130-2141.2003; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Shaw RK, 2005, INFECT IMMUN, V73, P1243, DOI 10.1128/IAI.73.2.1243-1251.2005; Su MSW, 2008, MICROBIOL-SGM, V154, P1094, DOI 10.1099/mic.0.2007/013946-0; Tsai NP, 2006, BIOCHEM J, V393, P591, DOI 10.1042/BJ20051201; Wainwright LA, 1998, MOL MICROBIOL, V27, P1247, DOI 10.1046/j.1365-2958.1998.00771.x; Wang GH, 2002, J MICROBIOL METH, V51, P119, DOI 10.1016/S0167-7012(02)00041-6; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493	42	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1686	1693		10.1074/jbc.M807478200	http://dx.doi.org/10.1074/jbc.M807478200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028682	hybrid			2022-12-25	WOS:000262330100037
J	MacFarlane, AJ; Perry, CA; Girnary, HH; Gao, D; Allen, RH; Stabler, SP; Shane, B; Stover, PJ				MacFarlane, Amanda J.; Perry, Cheryll A.; Girnary, Hussein H.; Gao, Dacao; Allen, Robert H.; Stabler, Sally P.; Shane, Barry; Stover, Patrick J.			Mthfd1 Is an Essential Gene in Mice and Alters Biomarkers of Impaired One-carbon Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE-METHENYLTETRAHYDROFOLATE-CYCLOHYDROLASE; DEPENDENT METHYLENETETRAHYDROFOLATE DEHYDROGENASE; NEURAL-TUBE DEFECTS; TRIFUNCTIONAL ENZYME; FORMYLTETRAHYDROFOLATE SYNTHETASE; TISSUE DISTRIBUTION; R653Q POLYMORPHISM; RISK-FACTOR; FOLATE; SERINE	Cytoplasmic folate-mediated one carbon (1C) metabolism functions to carry and activate single carbons for the de novo synthesis of purines, thymidylate, and for the remethylation of homocysteine to methionine. C1 tetrahydrofolate (THF) synthase, encoded by Mthfd1, is an entry point of 1Cs into folate metabolism through its formyl-THF synthetase (FTHFS) activity that catalyzes the ATP-dependent conversion of formate and THF to 10-formyl-THF. Disruption of FTHFS activity by the insertion of a gene trap vector into the Mthfd1 gene results in embryonic lethality in mice. Mthfd1(gt/+) mice demonstrated lower hepatic adenosylmethionine levels, which is consistent with formate serving as a source of 1Cs for cellular methylation reactions. Surprisingly, Mthfd1(gt/+) mice exhibited decreased levels of uracil in nuclear DNA, indicating enhanced de novo thymidylate synthesis, and suggesting that serine hydroxymethyltransferase and FTHFS compete for a limiting pool of unsubstituted THF. This study demonstrates the essentiality of the Mthfd1 gene and indicates that formate-derived 1Cs are utilized for de novo purine synthesis and the remethylation of homocysteine in liver. Further, the depletion of cytoplasmic FTHFS activity enhances thymidylate synthesis, affirming the competition between thymidylate synthesis and homocysteine remethylation for THF cofactors.	[MacFarlane, Amanda J.; Perry, Cheryll A.; Girnary, Hussein H.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Gao, Dacao; Shane, Barry] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Hlth Sci Ctr, Div Hematol, Denver, CO 80262 USA	Cornell University; University of California System; University of California Berkeley; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, 127 Savage Hall, Ithaca, NY 14853 USA.	pjs13@cornell.edu			National Institutes of Health [CA105440, DK42033]; NATIONAL CANCER INSTITUTE [R01CA105440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058144, R01DK042033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105440 (to P.J.S. and B. S.) and DK42033 (to B.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Brody LC, 2002, AM J HUM GENET, V71, P1207, DOI 10.1086/344213; CHEEK WD, 1989, ARCH BIOCHEM BIOPHYS, V270, P504, DOI 10.1016/0003-9861(89)90532-8; Christensen KE, 2005, J BIOL CHEM, V280, P7597, DOI 10.1074/jbc.M409380200; CHRISTENSEN KE, 2008, HUM MUTAT IN PRESS; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; De Marco P, 2006, J HUM GENET, V51, P98, DOI 10.1007/s10038-005-0329-6; Di Pietro E, 2002, MOL CELL BIOL, V22, P4158, DOI 10.1128/MCB.22.12.4158-4166.2002; Duthie SJ, 1998, FASEB J, V12, P1491, DOI 10.1096/fasebj.12.14.1491; Elmore CL, 2007, MOL GENET METAB, V91, P85, DOI 10.1016/j.ymgme.2007.02.001; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Hol FA, 1998, CLIN GENET, V53, P119; HUM DW, 1988, J BIOL CHEM, V263, P15946; Kondo M, 2000, J BIOCHEM, V128, P57, DOI 10.1093/oxfordjournals.jbchem.a022730; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MEJIA NR, 1988, BIOCHEM BIOPH RES CO, V155, P1, DOI 10.1016/S0006-291X(88)81040-4; MEJIA NR, 1985, J BIOL CHEM, V260, P4616; MOTOKAWA Y, 1971, ARCH BIOCHEM BIOPHYS, V146, P461, DOI 10.1016/0003-9861(71)90149-4; Parle-McDermott A, 2005, MOL HUM REPROD, V11, P477, DOI 10.1093/molehr/gah204; Parle-McDermott A, 2005, AM J MED GENET A, V132A, P365, DOI 10.1002/ajmg.a.30354; Parle-McDermott A, 2006, EUR J HUM GENET, V14, P768, DOI 10.1038/sj.ejhg.5201603; PELLETIER JN, 1995, BIOCHEMISTRY-US, V34, P12673, DOI 10.1021/bi00039a025; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; STABLER SP, 1993, BLOOD, V81, P3404; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Suh JR, 2000, J BIOL CHEM, V275, P35646, DOI 10.1074/jbc.M005864200; TAN LUL, 1977, J BIOL CHEM, V252, P1117; VANONI MA, 1984, BIOCHEMISTRY-US, V23, P5272, DOI 10.1021/bi00317a027; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	33	60	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1533	1539		10.1074/jbc.M808281200	http://dx.doi.org/10.1074/jbc.M808281200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19033438	hybrid, Green Published			2022-12-25	WOS:000262330100021
J	Spronk, S; Bosch, JL; Ryjewski, C; Rosenblum, J; Kaandorp, GC; White, JV; Hunink, MGM				Spronk, Sandra; Bosch, Johanna L.; Ryjewski, Constance; Rosenblum, Judith; Kaandorp, Guido C.; White, John V.; Hunink, M. G. Myriam			Cost-Effectiveness of New Cardiac and Vascular Rehabilitation Strategies for Patients with Coronary Artery Disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; AORTOILIAC OCCLUSIVE DISEASE; STENT PLACEMENT; MYOCARDIAL-INFARCTION; DECISION-MAKING; INTERMITTENT CLAUDICATION; LOWER-EXTREMITY; BYPASS GRAFTS; LIMB ISCHEMIA	Objective: Peripheral arterial disease (PAD) often hinders the cardiac rehabilitation program. The aim of this study was evaluating the relative cost-effectiveness of new rehabilitation strategies which include the diagnosis and treatment of PAD in patients with coronary artery disease (CAD) undergoing cardiac rehabilitation. Data Sources: Best-available evidence was retrieved from literature and combined with primary data from 231 patients. Methods: We developed a Markov decision model to compare the following treatment strategies: 1. cardiac rehabilitation only; 2. ankle-brachial index (ABI) if cardiac rehabilitation fails followed by diagnostic work-up and revascularization for PAD if needed; 3. ABI prior to cardiac rehabilitation followed by diagnostic work-up and revascularization for PAD if needed. Quality-adjusted-life years (QALYs), life-time costs (US $), incremental cost-effectiveness ratios (ICER), and gain in net health benefits (NHB) in QALY equivalents were calculated. A threshold willingness-to-pay of $ 75 000 was used. Results: ABI if cardiac rehabilitation fails was the most favorable strategy with an ICER of $ 44 251 per QALY gained and an incremental NHB compared to cardiac rehabilitation only of 0.03 QALYs (95% CI: -0.17, 0.29) at a threshold willingness-to-pay of $ 75 000/QALY. After sensitivity analysis, a combined cardiac and vascular rehabilitation program increased the success rate and would dominate the other two strategies with total lifetime costs of $ 30 246 a quality-adjusted life expectancy of 3.84 years, and an incremental NHB of 0.06 QALYs (95% CI: -0.24, 0.46) compared to current practice. The results were robust for other different input parameters. Conclusion: ABI measurement if cardiac rehabilitation fails followed by a diagnostic work-up and revascularization for PAD if needed are potentially cost-effective compared to cardiac rehabilitation only.	[Spronk, Sandra; Bosch, Johanna L.; Kaandorp, Guido C.; Hunink, M. G. Myriam] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Spronk, Sandra; Bosch, Johanna L.; Hunink, M. G. Myriam] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Ryjewski, Constance; Rosenblum, Judith; White, John V.] Advocate Lutheran Gen Hosp, Dept Surg, Chicago, IL USA; [Hunink, M. G. Myriam] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Cambridge, MA 02138 USA; [White, John V.] Univ Illinois, Coll Med, Dept Surg, Chicago, IL 60680 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Spronk, S (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	s.spronk@erasmusmc.nl						Albers M, 2003, J VASC SURG, V37, P1263, DOI 10.1016/S0741-5214(02)75332-9; Azimi NA, 1998, J GEN INTERN MED, V13, P664, DOI 10.1046/j.1525-1497.1998.00201.x; Bergqvist D, 1998, EUR J SURG, V164, P3; Bosch JL, 1999, CIRCULATION, V99, P3155, DOI 10.1161/01.CIR.99.24.3155; Bosch JL, 1998, RADIOLOGY, V208, P641, DOI 10.1148/radiology.208.3.9722840; Bosch JL, 1997, RADIOLOGY, V204, P87, DOI 10.1148/radiology.204.1.9205227; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; Busschbach JJV, 1999, J HEALTH ECON, V18, P551, DOI 10.1016/S0167-6296(99)00008-9; Chang RW, 2008, J VASC SURG, V48, P362, DOI 10.1016/j.jvs.2008.03.042; Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Conrad MF, 2006, J VASC SURG, V44, P762, DOI 10.1016/j.jvs.2006.06.025; Davidovic Lazar, 2004, Vascular, V12, P171; de Vries SO, 2002, RADIOLOGY, V222, P25, DOI 10.1148/radiol.2221001743; DeRubertis BG, 2007, ANN SURG, V246, P415, DOI 10.1097/SLA.0b013e31814699a2; Dugmore LD, 1999, HEART, V81, P359, DOI 10.1136/hrt.81.4.359; Evenson K R, 2000, J Cardiopulm Rehabil, V20, P241, DOI 10.1097/00008483-200007000-00005; FOWKES FGR, 1988, INT J EPIDEMIOL, V17, P248, DOI 10.1093/ije/17.2.248; Gentile AT, 1996, J VASC SURG, V23, P272, DOI 10.1016/S0741-5214(96)70271-9; Glasziou PP, 2001, DECISION MAKING HLTH; Graham JD, 1998, ANNU REV PUBL HEALTH, V19, P125, DOI 10.1146/annurev.publhealth.19.1.125; Green RM, 2000, J VASC SURG, V31, P417, DOI 10.1016/S0741-5214(00)90300-8; HESSEL SJ, 1981, RADIOLOGY, V138, P273, DOI 10.1148/radiology.138.2.7455105; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; HUNINK MGM, 1995, JAMA-J AM MED ASSOC, V274, P165, DOI 10.1001/jama.274.2.165; HUNINK MGM, 1994, MED DECIS MAKING, V14, P71, DOI 10.1177/0272989X9401400109; Jansen RMG, 1998, J VASC SURG, V28, P617, DOI 10.1016/S0741-5214(98)70085-0; Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; MELNYK KAM, 1988, NURS RES, V37, P196; Morgan MBF, 2001, J VASC SURG, V33, P679, DOI 10.1067/mva.2001.112326; Muradin GSR, 2001, RADIOLOGY, V221, P137, DOI 10.1148/radiol.2211010039; Murphy TP, 2004, RADIOLOGY, V231, P243, DOI 10.1148/radiol.2311030408; NorekvOl TM, 2006, EUR J CARDIOVASC NUR; Poredos P, 2007, ANGIOLOGY, V58, P309, DOI 10.1177/0003319707302494; Prager MR, 2003, SURGERY, V134, P80, DOI 10.1067/msy.2003.179; Reed AB, 2003, J VASC SURG, V37, P1219, DOI 10.1016/S0741-5214(02)75179-3; Russell MW, 1998, AM J CARDIOL, V81, P1110, DOI 10.1016/S0002-9149(98)00136-2; Sanderson Bonnie K, 2004, J Cardiopulm Rehabil, V24, P68, DOI 10.1097/00008483-200403000-00002; Schanzer A, 2008, J VASC SURG, V47, P774, DOI 10.1016/j.jvs.2007.11.056; Schweikert B, 2006, HEART, V92, P62, DOI 10.1136/hrt.2004.052787; SCOTT EC, 2008, J VASC SURG; Siegel JE, 1997, PHARMACOECONOMICS, V11, P159, DOI 10.2165/00019053-199711020-00005; SMITH GD, 1990, CIRCULATION, V82, P1925, DOI 10.1161/01.CIR.82.6.1925; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; SPRONK S, 2008, THESIS ERASMUS U ROT; Stefanick ML, 1998, NEW ENGL J MED, V339, P12, DOI 10.1056/NEJM199807023390103; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X9801800209; Suaya JA, 2007, CIRCULATION, V116, P1653, DOI 10.1161/CIRCULATIONAHA.107.701466; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Tetteroo E, 1998, LANCET, V351, P1153, DOI 10.1016/S0140-6736(97)09508-1; TIRRELL BE, 1980, HEART LUNG, V9, P487; TSEVAT J, 1991, MED CARE, V29, P1153, DOI 10.1097/00005650-199111000-00007; WAUGH JR, 1992, RADIOLOGY, V182, P243, DOI 10.1148/radiology.182.1.1727290; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; WITTELS EH, 1990, AM J CARDIOL, V65, P432, DOI 10.1016/0002-9149(90)90806-C; Yu CM, 2004, ARCH PHYS MED REHAB, V85, P1915, DOI 10.1016/j.apmr.2004.05.010; STAT BOL; STAT DNCFH	59	4	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3883	10.1371/journal.pone.0003883	http://dx.doi.org/10.1371/journal.pone.0003883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436ZP	19065259	Green Published, gold, Green Submitted			2022-12-25	WOS:000265455200004
J	Roder, IV; Petersen, Y; Choi, KR; Witzemann, V; Hammer, JA; Rudolf, R				Roeder, Ira Verena; Petersen, Yvonne; Choi, Kyeong Rok; Witzemann, Veit; Hammer, John A., III; Rudolf, Ruediger			Role of Myosin Va in the Plasticity of the Vertebrate Neuromuscular Junction In Vivo	PLOS ONE			English	Article								Background: Myosin Va is a motor protein involved in vesicular transport and its absence leads to movement disorders in humans (Griscelli and Elejalde syndromes) and rodents (e. g. dilute lethal phenotype in mice). We examined the role of myosin Va in the postsynaptic plasticity of the vertebrate neuromuscular junction (NMJ). Methodology/Principal Findings: Dilute lethal mice showed a good correlation between the propensity for seizures, and fragmentation and size reduction of NMJs. In an aneural C2C12 myoblast cell culture, expression of a dominant-negative fragment of myosin Va led to the accumulation of punctate structures containing the NMJ marker protein, rapsyn-GFP, in perinuclear clusters. In mouse hindlimb muscle, endogenous myosin Va co-precipitated with surface-exposed or internalised acetylcholine receptors and was markedly enriched in close proximity to the NMJ upon immunofluorescence. In vivo microscopy of exogenous full length myosin Va as well as a cargo-binding fragment of myosin Va showed localisation to the NMJ in wildtype mouse muscles. Furthermore, local interference with myosin Va function in live wildtype mouse muscles led to fragmentation and size reduction of NMJs, exclusion of rapsyn-GFP from NMJs, reduced persistence of acetylcholine receptors in NMJs and an increased amount of punctate structures bearing internalised NMJ proteins. Conclusions/Significance: In summary, our data show a crucial role of myosin Va for the plasticity of live vertebrate neuromuscular junctions and suggest its involvement in the recycling of internalised acetylcholine receptors back to the postsynaptic membrane.	[Roeder, Ira Verena; Petersen, Yvonne; Choi, Kyeong Rok; Rudolf, Ruediger] Res Ctr Karlsruhe, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Witzemann, Veit] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Hammer, John A., III] NIH, Lab Cell Biol, Bethesda, MD USA	Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; National Institutes of Health (NIH) - USA	Roder, IV (corresponding author), Res Ctr Karlsruhe, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany.	ruediger.rudolf@itg.fzk.de	Rudolf, Rüdiger/A-6476-2009	Rudolf, Rüdiger/0000-0002-0833-1053	DFG [RU923/3-1]; AFM [12056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000514, ZIAHL000514] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); AFM(Association Francaise contre les Myopathies); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	RR was supported by grants from the DFG (RU923/3-1) and AFM (# 12056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P2660; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; BERG DK, 1975, J PHYSIOL-LONDON, V252, P771, DOI 10.1113/jphysiol.1975.sp011169; BLOCH RJ, 1987, J CELL BIOL, V104, P645, DOI 10.1083/jcb.104.3.645; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; Bruneau EG, 2006, DEVELOPMENT, V133, P4485, DOI 10.1242/dev.02619; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; FUMAGALLI G, 1990, NEURON, V4, P563, DOI 10.1016/0896-6273(90)90114-U; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; KENNEDY MJ, 2006, ANN REV NEUROSCI; Koenen M, 2005, EMBO REP, V6, P570, DOI 10.1038/sj.embor.7400429; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CY, 1967, NATURE, V215, P1177, DOI 10.1038/2151177a0; LEVITT TA, 1981, NATURE, V291, P239, DOI 10.1038/291239a0; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marchand S, 2002, J NEUROSCI, V22, P8891; Marchand S, 2002, MOL NEUROBIOL, V26, P117, DOI 10.1385/MN:26:1:117; Marchand S, 2000, J NEUROSCI, V20, P521, DOI 10.1523/JNEUROSCI.20-02-00521.2000; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERCER J, 1990, NATURE, V352, P547; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Provance DW, 1996, P NATL ACAD SCI USA, V93, P14554, DOI 10.1073/pnas.93.25.14554; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Rodriguez OC, 2002, J CELL SCI, V115, P991; Rudolf R, 2006, J CELL BIOL, V173, P187, DOI 10.1083/jcb.200601160; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Rudolf R, 2003, NAT REV MOL CELL BIO, V4, P579, DOI 10.1038/nrm1153; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Sanal O, 2000, J NEUROL, V247, P570, DOI 10.1007/s004150070162; Sandona D, 2004, BIOCHEM J, V381, P105, DOI 10.1042/BJ20031644; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Santos AF, 2003, J NEUROCYTOL, V32, P849, DOI 10.1023/B:NEUR.0000020628.36013.88; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Slater CR, 1997, BRAIN, V120, P1513, DOI 10.1093/brain/120.9.1513; SMITH MM, 1987, J BIOL CHEM, V262, P4367; STEINBACH JH, 1989, ANNU REV PHYSIOL, V51, P353, DOI 10.1146/annurev.physiol.51.1.353; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; Takagishi Y, 2007, DEV NEUROBIOL, V67, P909, DOI 10.1002/dneu.20375; Tothova J, 2006, J CELL SCI, V119, P1604, DOI 10.1242/jcs.02875; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; WEINBERG CB, 1981, J CELL BIOL, V88, P215, DOI 10.1083/jcb.88.1.215; Witzemann V, 1996, P NATL ACAD SCI USA, V93, P13286, DOI 10.1073/pnas.93.23.13286; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XF, 1997, J CELL SCI, V110, P847; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Xu RF, 1997, J NEUROSCI, V17, P8194; Yampolsky P, 2008, MOL CELL NEUROSCI, V37, P634, DOI 10.1016/j.mcn.2007.12.014	60	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3871	10.1371/journal.pone.0003871	http://dx.doi.org/10.1371/journal.pone.0003871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057648	Green Published, Green Submitted, gold			2022-12-25	WOS:000265452300009
J	Wang, CK; Schirra, HJ; Craik, DJ				Wang, Conan K.; Schirra, Horst Joachim; Craik, David J.			NMRDyn: A Program for NMR Relaxation Studies of Protein Association	PLOS ONE			English	Article								Self-association is an important biological phenomenon that is associated with many cellular processes. NMR relaxation measurements provide data about protein molecular dynamics at the atomic level and are sensitive to changes induced by self-association. Thus, measurements and analysis of NMR relaxation data can provide structurally resolved information on self-association that would not be accessible otherwise. Here, we present a computer program, NMRdyn, which analyses relaxation data to provide parameters defining protein self-association. Unlike existing relaxation analysis software, NMRdyn can explicitly model the monomer-oligomer equilibrium while fitting measured relaxation data. Additionally, the program is packaged with a user-friendly interface, which is important because relaxation data can often be large and complex. NMRdyn is available from http://research1t.imb.uq.edu.au/nmr/NMRdyn.	[Wang, Conan K.; Schirra, Horst Joachim; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Wang, CK (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	d.craik@imb.uq.edu.au	Wang, Conan K/D-1481-2010; Schirra, Horst Joachim/B-4210-2009; Craik, David/B-1695-2010	Wang, Conan K/0000-0002-7973-7632; Schirra, Horst Joachim/0000-0002-7541-246X; Craik, David/0000-0003-0007-6796	Australian Research Council	Australian Research Council(Australian Research Council)	Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerud T, 2002, J MOL BIOL, V322, P137, DOI 10.1016/S0022-2836(02)00714-3; Bader R, 2001, J MOL BIOL, V305, P307, DOI 10.1006/jmbi.2000.4264; Bernado P, 2003, J AM CHEM SOC, V125, P916, DOI 10.1021/ja027836h; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; CRAIK DJ, 1983, J CHEM INF COMP SCI, V23, P30, DOI 10.1021/ci00037a006; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; d'Auvergne EJ, 2006, J BIOMOL NMR, V35, P117, DOI 10.1007/s10858-006-9007-z; d'Auvergne EJ, 2003, J BIOMOL NMR, V25, P25, DOI 10.1023/A:1021902006114; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; McPhee F, 1996, P NATL ACAD SCI USA, V93, P11477, DOI 10.1073/pnas.93.21.11477; Nourse A, 2004, J BIOL CHEM, V279, P562, DOI 10.1074/jbc.M306826200; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; WENNERSTROM H, 1972, MOL PHYS, V24, P69, DOI 10.1080/00268977200101261; WOESSNER DE, 1962, J CHEM PHYS, V37, P647, DOI 10.1063/1.1701390	19	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3820	10.1371/journal.pone.0003820	http://dx.doi.org/10.1371/journal.pone.0003820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043572	Green Published, Green Submitted, gold			2022-12-25	WOS:000265451400011
J	Weissman, JR; Kelley, RI; Bauman, ML; Cohen, BH; Murray, KF; Mitchell, RL; Kern, RL; Natowicz, MR				Weissman, Jacqueline R.; Kelley, Richard I.; Bauman, Margaret L.; Cohen, Bruce H.; Murray, Katherine F.; Mitchell, Rebecca L.; Kern, Rebecca L.; Natowicz, Marvin R.			Mitochondrial Disease in Autism Spectrum Disorder Patients: A Cohort Analysis	PLOS ONE			English	Article							RESPIRATORY-CHAIN DISORDERS; MTDNA MUTATIONS; GASTROINTESTINAL SYMPTOMS; DEVELOPMENTAL REGRESSION; DIAGNOSTIC-CRITERIA; DNA MUTATIONS; COMPLEX-I; DYSFUNCTION; PREVALENCE; CHILDREN	Background: Previous reports indicate an association between autism spectrum disorders (ASD) and disorders of mitochondrial oxidative phosphorylation. One study suggested that children with both diagnoses are clinically indistinguishable from children with idiopathic autism. There are, however, no detailed analyses of the clinical and laboratory findings in a large cohort of these children. Therefore, we undertook a comprehensive review of patients with ASD and a mitochondrial disorder. Methodology/Principal Findings: We reviewed medical records of 25 patients with a primary diagnosis of ASD by DSM-IV-TR criteria, later determined to have enzyme- or mutation-defined mitochondrial electron transport chain (ETC) dysfunction. Twenty-four of 25 patients had one or more major clinical abnormalities uncommon in idiopathic autism. Twenty-one patients had histories of significant non-neurological medical problems. Nineteen patients exhibited constitutional symptoms, especially excessive fatigability. Fifteen patients had abnormal neurological findings. Unusual developmental phenotypes included marked delay in early gross motor milestones (32%) and unusual patterns of regression (40%). Levels of blood lactate, plasma alanine, and serum ALT and/or AST were increased at least once in 76%, 36%, and 52% of patients, respectively. The most common ETC disorders were deficiencies of complex I (64%) and complex III (20%). Two patients had rare mtDNA mutations of likely pathogenicity. Conclusions/Significance: Although all patients' initial diagnosis was idiopathic autism, careful clinical and biochemical assessment identified clinical findings that differentiated them from children with idiopathic autism. These and prior data suggest a disturbance of mitochondrial energy production as an underlying pathophysiological mechanism in a subset of individuals with autism.	[Weissman, Jacqueline R.; Natowicz, Marvin R.] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Kelley, Richard I.; Kern, Rebecca L.] Kennedy Krieger Inst, Division of Metabolism, Baltimore, MD USA; [Kelley, Richard I.; Kern, Rebecca L.] Johns Hopkins Univ, Med Ctr, Dept Pediat, Baltimore, MD 21218 USA; [Bauman, Margaret L.; Murray, Katherine F.] Massachusetts Gen Hosp, LADDERS, Dept Pediat, Boston, MA 02114 USA; [Cohen, Bruce H.; Natowicz, Marvin R.] Cleveland Clin, Pediatrics Inst, Neurol Inst, Cleveland, OH USA; [Mitchell, Rebecca L.; Natowicz, Marvin R.] Cleveland Clin, Genom Med Inst, Cleveland, OH USA; [Natowicz, Marvin R.] Cleveland Clin, Lab Med Inst, Cleveland, OH USA	Case Western Reserve University; Cleveland Clinic Foundation; Kennedy Krieger Institute; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Harvard University; Massachusetts General Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Weissman, JR (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	natowim@ccf.org	Warfield, Simon/B-3352-2009	Warfield, Simon/0000-0002-7659-3880; Bauman, Margaret/0000-0002-3229-0458	Solving the Mystery of Autism Foundation, Inc; Green Foundation	Solving the Mystery of Autism Foundation, Inc; Green Foundation	This work was supported in part by a grant from the Solving the Mystery of Autism Foundation, Inc. and from the Green Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Cavelier L, 2001, HEREDITAS, V135, P65, DOI 10.1111/j.1601-5223.2001.00065.x; COLEMAN M, 1985, J AUTISM DEV DISORD, V15, P1, DOI 10.1007/BF01837894; Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6; Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dipchand AI, 2001, PEDIATR CARDIOL, V22, P14, DOI 10.1007/s002460010145; Edmonds JL, 2002, ARCH OTOLARYNGOL, V128, P355, DOI 10.1001/archotol.128.4.355; Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607; Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596; Finnila Saara, 2001, Mutation Research, V458, P31, DOI 10.1016/S1383-5726(01)00012-7; Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; Hallmayer J, 2002, AM J HUM GENET, V71, P941, DOI 10.1086/342990; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066; Hui J, 2006, DEV MED CHILD NEUROL, V48, P132, DOI 10.1017/S0012162206000284; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; LASZLO A, 1994, CLIN CHIM ACTA, V229, P205, DOI 10.1016/0009-8981(94)90243-7; Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282; Li ZB, 2008, BIOCHEM BIOPH RES CO, V367, P906, DOI 10.1016/j.bbrc.2007.12.150; Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M; Lombard J, 1998, MED HYPOTHESES, V50, P497, DOI 10.1016/S0306-9877(98)90270-5; Mackay N, 2007, METHOD CELL BIOL, V80, P173, DOI 10.1016/S0091-679X(06)80008-7; Martorell R, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035320500495563; Ming X, 2008, J CHILD NEUROL, V23, P6, DOI 10.1177/0883073807307102; Ming X, 2007, BRAIN DEV-JPN, V29, P565, DOI 10.1016/j.braindev.2007.03.002; Molloy CA, 2003, AUTISM, V7, P165, DOI 10.1177/1362361303007002004; Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002; Nissenkorn A, 2000, J CHILD NEUROL, V15, P44, DOI 10.1177/088307380001500110; Offit PA, 2008, NEW ENGL J MED, V358, P2089, DOI 10.1056/NEJMp0802904; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Poling JS, 2006, J CHILD NEUROL, V21, P170, DOI 10.1177/08830738060210021401; Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023; Puchowicz MA, 2004, MITOCHONDRION, V4, P377, DOI 10.1016/j.mito.2004.07.004; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12; Rogers SJ, 2004, MENT RETARD DEV D R, V10, P139, DOI 10.1002/mrdd.20027; Rutter M., 2005, HDB AUTISM PERVASIVE, V1, P425; Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Sugarman SD, 2007, NEW ENGL J MED, V357, P1275, DOI 10.1056/NEJMp078168; Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006; Valicenti-McDermott M, 2006, J DEV BEHAV PEDIATR, V27, pS128, DOI 10.1097/00004703-200604002-00011; van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e89; Vanniarajan A, 2006, ACTA NEUROL SCAND, V114, P350, DOI 10.1111/j.1600-0404.2006.00673.x; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8; Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807; Wong LJC, 2002, CLIN CHEM, V48, P1901; Zankl A, 2003, AM J MED GENET A, V121A, P146, DOI 10.1002/ajmg.a.20185; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd; ZHENG XX, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1, DOI 10.1016/0005-2728(90)90118-N	63	168	173	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3815	10.1371/journal.pone.0003815	http://dx.doi.org/10.1371/journal.pone.0003815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436YG	19043581	Green Published, gold, Green Submitted			2022-12-25	WOS:000265451400007
J	Petter, M; Bonow, I; Klinkert, MQ				Petter, Michaela; Bonow, Insa; Klinkert, Mo-Quen			Diverse Expression Patterns of Subgroups of the rif Multigene Family during Plasmodium falciparum Gametocytogenesis	PLOS ONE			English	Article							INFECTED ERYTHROCYTES; TRANSMISSION STAGES; VARIANT PROTEINS; GENE-EXPRESSION; BONE-MARROW; START SITES; MALARIA; SEQUENCE; ADHESION; IDENTIFICATION	Background: The maturation of Plasmodium falciparum gametocytes in the human host takes several days, during which the parasites need to efficiently evade the host immune system. Like asexual stage parasites, immature gametocytes can sequester at various sites in the human body, and only mature sexual stages are found in the circulation. Although the fundamental mechanisms of gametocyte immune evasion are still largely unknown, candidate molecules that may be involved include variant antigens encoded by multigene families in the P. falciparum genome, such as the PfEMP1, STEVOR and RIFIN proteins. While expression of the former two families in sexual stages has been investigated earlier, we report here RIFIN expression during gametocytogenesis. Methodology/Principal Findings: Variants of two previously characterized RIFIN subfamilies (A-and B-type RIFINs) were found to be synthesized in gametocytes. Immunofluorescence experiments showed A-type RIFINs to be accumulated in a crescent-shaped pattern of discrete punctate structures at the infected erythrocyte membrane, while members of the B-type family were associated with the parasite. Transcription analysis demonstrated the existence of diverse transcriptional regulation patterns during sexual differentiation and indicated variant-specific regulation of B-type RIFINs, in contrast to group-specific regulation for A-type RIFINs. Phylogenetic analysis of 5'-upstream regions showed that the rif-gene family falls into five defined clusters, designated rups (rif upstream) A1, A2, AB, B and C. In trophozoites and early gametocytes, rif variants of the rupsA2-type were preferentially expressed. Conclusions/Significance: In this work we demonstrate the expression dynamics of the rif-gene family during sexual differentiation and present indications for subgroup specific regulation patterns. Therefore, our data provide a first foundation and point to new directions for future investigations of the potential role of RIFINs in gametocyte immune evasion.	[Petter, Michaela; Bonow, Insa; Klinkert, Mo-Quen] Bernhard Nocht Inst Trop Med, Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin	Petter, M (corresponding author), Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia.	mpetter@unimelb.edu.au	Petter, Michaela/N-9876-2017	Petter, Michaela/0000-0002-1837-2756	Friends of the Bernhard-Nocht Institute; Chica and Heinz Schaller Foundation	Friends of the Bernhard-Nocht Institute; Chica and Heinz Schaller Foundation	This work received funding from Friends of the Bernhard-Nocht Institute and the Chica and Heinz Schaller Foundation.	Abdel-Latif MS, 2003, INFECT IMMUN, V71, P6229, DOI 10.1128/IAI.71.11.6229-6233.2003; Abdel-Latif MS, 2002, INFECT IMMUN, V70, P7013, DOI 10.1128/IAI.70.12.7013-7021.2002; ALANO P, 1991, MOL BIOCHEM PARASIT, V46, P81, DOI 10.1016/0166-6851(91)90201-G; Alano P, 2007, MOL MICROBIOL, V66, P291, DOI 10.1111/j.1365-2958.2007.05904.x; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; BLYTHE JE, 2008, INFECT IMMUN; CARTER R, 1989, EXP PARASITOL, V69, P140, DOI 10.1016/0014-4894(89)90182-3; Carter R, 1979, Bull World Health Organ, V57 Suppl 1, P37; Day KP, 1998, MOL BIOCHEM PARASIT, V93, P167, DOI 10.1016/S0166-6851(98)00040-1; Dechering KJ, 1999, MOL CELL BIOL, V19, P967; Dzikowski R, 2006, CELL MICROBIOL, V8, P1371, DOI 10.1111/j.1462-5822.2006.00760.x; Eksi S, 2008, MOL BIOCHEM PARASIT, V160, P148, DOI 10.1016/j.molbiopara.2008.04.005; Fernandez V, 1999, J EXP MED, V190, P1393, DOI 10.1084/jem.190.10.1393; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; HELMBY H, 1993, INFECT IMMUN, V61, P284, DOI 10.1128/IAI.61.1.284-288.1993; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Horrocks P, 1996, MOL BIOCHEM PARASIT, V82, P207, DOI 10.1016/0166-6851(96)02737-5; Horrocks P, 1999, MOL BIOCHEM PARASIT, V99, P77, DOI 10.1016/S0166-6851(98)00182-0; Joannin N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-19; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; Khattab A, 2006, TRAFFIC, V7, P1654, DOI 10.1111/j.1600-0854.2006.00494.x; Kim SK, 2005, J IMMUNOL, V174, P8038, DOI 10.4049/jimmunol.174.12.8038; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; KYES SA, 2007, EUKARYOT CELL; Lavazec C, 2006, NUCLEIC ACIDS RES, V34, P6696, DOI 10.1093/nar/gkl942; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lindenthal C, 2002, MOL BIOCHEM PARASIT, V120, P257, DOI 10.1016/S0166-6851(02)00007-5; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; McRobert L, 2004, INFECT IMMUN, V72, P6597, DOI 10.1128/IAI.72.11.6597-6602.2004; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Militello KT, 2004, MOL BIOCHEM PARASIT, V134, P75, DOI 10.1016/j.molbiopara.2003.11.004; Olivieri A, 2008, INT J PARASITOL, V38, P299, DOI 10.1016/j.ijpara.2007.08.014; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Porter ME, 2002, MOL BIOCHEM PARASIT, V122, P9, DOI 10.1016/S0166-6851(02)00064-6; Pradel G, 2007, PARASITOLOGY, V134, P1911, DOI 10.1017/S0031182007003381; Pradel G, 2006, EXP PARASITOL, V112, P263, DOI 10.1016/j.exppara.2005.11.010; Pradel G, 2004, J EXP MED, V199, P1533, DOI 10.1084/jem.20031274; Preiser PR, 2002, SCIENCE, V295, P342, DOI 10.1126/science.1064938; Rogers NJ, 1996, INFECT IMMUN, V64, P1480, DOI 10.1128/IAI.64.4.1480-1483.1996; Rogers NJ, 2000, INFECT IMMUN, V68, P3455, DOI 10.1128/IAI.68.6.3455-3462.2000; Rogers NJ, 1996, INFECT IMMUN, V64, P4261, DOI 10.1128/IAI.64.10.4261-4268.1996; Saeed M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002280; Sauerwein RW, 2007, MICROBES INFECT, V9, P792, DOI 10.1016/j.micinf.2007.02.011; Schreiber N, 2006, MICROBES INFECT, V8, P1269, DOI 10.1016/j.micinf.2005.12.007; Sharp S, 2006, EUKARYOT CELL, V5, P1206, DOI 10.1128/EC.00029-06; SINDEN RE, 1982, PARASITOLOGY, V84, P1, DOI 10.1017/S003118200005160X; SMALLEY ME, 1981, T ROY SOC TROP MED H, V75, P103, DOI 10.1016/0035-9203(81)90019-5; Sutherland CJ, 2001, MOL BIOCHEM PARASIT, V113, P331, DOI 10.1016/S0166-6851(01)00225-0; Tham WH, 2007, INT J PARASITOL, V37, P605, DOI 10.1016/j.ijpara.2006.11.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THOMSON J. G., 1935, TRANS ROY SOC TROP MED AND HYG, V29, P31, DOI 10.1016/S0035-9203(35)90015-3; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UHLEMANN AC, 2000, MACS MORE, V4, P7; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x; Watanabe J, 2002, GENE, V291, P105, DOI 10.1016/S0378-1119(02)00552-8; *WHO, 2005, WORLD MAL REP; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007	68	50	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3779	10.1371/journal.pone.0003779	http://dx.doi.org/10.1371/journal.pone.0003779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020666	Green Published, gold			2022-12-25	WOS:000265448600012
J	Skogsberg, J; Dicker, A; Ryden, M; Astrom, G; Nilsson, R; Bhuiyan, H; Vitols, S; Mairal, A; Langin, D; Alberts, P; Walum, E; Tegner, J; Hamsten, A; Arner, P; Bjorkegren, J				Skogsberg, Josefin; Dicker, Andrea; Ryden, Mikael; Astrom, Gaby; Nilsson, Roland; Bhuiyan, Hasanuzzaman; Vitols, Sigurd; Mairal, Aline; Langin, Dominique; Alberts, Peteris; Walum, Erik; Tegner, Jesper; Hamsten, Anders; Arner, Peter; Bjorkegren, Johan			ApoB100-LDL Acts as a Metabolic Signal from Liver to Peripheral Fat Causing Inhibition of Lipolysis in Adipocytes	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PROTEIN-KINASE-A; ADIPOSE-TISSUE; MICE; APOLIPOPROTEIN; ACTIVATION	Background: Free fatty acids released from adipose tissue affect the synthesis of apolipoprotein B-containing lipoproteins and glucose metabolism in the liver. Whether there also exists a reciprocal metabolic arm affecting energy metabolism in white adipose tissue is unknown. Methods and Findings: We investigated the effects of apoB-containing lipoproteins on catecholamine-induced lipolysis in adipocytes from subcutaneous fat cells of obese but otherwise healthy men, fat pads from mice with plasma lipoproteins containing high or intermediate levels of apoB100 or no apoB100, primary cultured adipocytes, and 3T3-L1 cells. In subcutaneous fat cells, the rate of lipolysis was inversely related to plasma apoB levels. In human primary adipocytes, LDL inhibited lipolysis in a concentration-dependent fashion. In contrast, VLDL had no effect. Lipolysis was increased in fat pads from mice lacking plasma apoB100, reduced in apoB100-only mice, and intermediate in wild-type mice. Mice lacking apoB100 also had higher oxygen consumption and lipid oxidation. In 3T3-L1 cells, apoB100-containing lipoproteins inhibited lipolysis in a dose-dependent fashion, but lipoproteins containing apoB48 had no effect. ApoB100-LDL mediated inhibition of lipolysis was abolished in fat pads of mice deficient in the LDL receptor ( Ldlr(-/-) Apob(100/100)). Conclusions: Our results show that the binding of apoB100-LDL to adipocytes via the LDL receptor inhibits intracellular noradrenaline-induced lipolysis in adipocytes. Thus, apoB100-LDL is a novel signaling molecule from the liver to peripheral fat deposits that may be an important link between atherogenic dyslipidemias and facets of the metabolic syndrome.	[Skogsberg, Josefin; Bjorkegren, Johan] Karolinska Univ Hosp, Karolinska Inst, Computat Med Grp, Stockholm, Sweden; [Dicker, Andrea; Ryden, Mikael; Astrom, Gaby; Arner, Peter] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Huddinge, Sweden; [Nilsson, Roland; Tegner, Jesper] Linkoping Univ, Dept Phys, Computat Biol Unit, S-58183 Linkoping, Sweden; [Bhuiyan, Hasanuzzaman; Vitols, Sigurd] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Div Clin Pharmacol, Stockholm, Sweden; [Mairal, Aline; Langin, Dominique] Inserm, U586, Obesity Res Unit, Toulouse, France; [Alberts, Peteris; Walum, Erik] Biovitrum AB, Stockholm, Sweden; [Hamsten, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Linkoping University; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Swedish Orphan Biovitrum; Karolinska Institutet; Karolinska University Hospital	Skogsberg, J (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Computat Med Grp, Stockholm, Sweden.	josefin.skogsberg@ki.se	Nilsson, Roland/AAJ-3519-2021; tegner, jesper N/R-5095-2017; Alberts, Peteris/AAQ-6327-2021	tegner, jesper N/0000-0002-9568-5588; Alberts, Peteris/0000-0001-9585-9288; Langin, Dominique/0000-0002-2669-7825; Nilsson, Roland/0000-0002-6020-7498; Arner, Peter/0000-0002-6208-6220	Swedish Research Council; Swedish Diabetes Association; Swedish Heart-Lung Foundation; Novo Nordic Foundation; King Gustaf V and Queen Victoria Foundation; European Commission, 6th Framework Program [LSHM-CT-2005-01873]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordic Foundation(Novo Nordisk Foundation); King Gustaf V and Queen Victoria Foundation; European Commission, 6th Framework Program(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the Swedish Research Council (P.Ar. and J.B.), the Swedish Diabetes Association (P.Ar.), the Swedish Heart-Lung Foundation (P.Ar., J.B., and A.H.), the Novo Nordic Foundation (P.Ar.) and the King Gustaf V and Queen Victoria Foundation (P.Ar., J.B.) and the European Commission, 6th Framework Program (contract LSHM-CT-2005-01873). The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Arner P, 1997, CURR OPIN LIPIDOL, V8, P89, DOI 10.1097/00041433-199704000-00006; BJORNTORP P, 1974, METABOLISM, V23, P1091, DOI 10.1016/0026-0495(74)90076-6; Bjorntorp P, 1974, Horm Metab Res, VSuppl 4, P77; Boquist S, 1999, CIRCULATION, V100, P723, DOI 10.1161/01.CIR.100.7.723; CIANFLONE KM, 1990, J CLIN INVEST, V85, P722, DOI 10.1172/JCI114497; Dicker A, 2004, DIABETOLOGIA, V47, P420, DOI 10.1007/s00125-003-1324-0; Farese RV, 1996, P NATL ACAD SCI USA, V93, P6393, DOI 10.1073/pnas.93.13.6393; Frayn KN, 2006, ESSAYS BIOCHEM, V42, P89, DOI 10.1042/bse0420089; Frayn KN, 1998, ADV EXP MED BIOL, V441, P171; Fricke K, 2004, ENDOCRINOLOGY, V145, P4940, DOI 10.1210/en.2004-0803; HELLMER J, 1989, ANAL BIOCHEM, V177, P132, DOI 10.1016/0003-2697(89)90027-4; Herz J, 2000, CURR OPIN LIPIDOL, V11, P161, DOI 10.1097/00041433-200004000-00009; HIRSCH J, 1968, J LIPID RES, V9, P110; Hogberg H, 2006, OBESITY, V14, P673, DOI 10.1038/oby.2006.76; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; KOLACZYNSKI JW, 1994, INT J OBESITY, V18, P161; KRAEMER FB, 1994, AM J PHYSIOL, V266, pE26, DOI 10.1152/ajpendo.1994.266.1.E26; KRIEGER M, 1978, J BIOL CHEM, V253, P4093; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Planas JV, 1999, J BIOL CHEM, V274, P36281, DOI 10.1074/jbc.274.51.36281; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Raben DM, 2005, TRENDS ENDOCRIN MET, V16, P35, DOI 10.1016/j.tem.2005.01.009; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; REYNISDOTTIR S, 1994, J CLIN INVEST, V93, P2590, DOI 10.1172/JCI117271; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Sniderman AD, 2004, CURR OPIN LIPIDOL, V15, P433, DOI 10.1097/01.mol.0000137220.39031.3b; Sniderman AD, 1998, ARTERIOSCL THROM VAS, V18, P147, DOI 10.1161/01.ATV.18.2.147; Sniderman AD, 2000, CURR OPIN LIPIDOL, V11, P291, DOI 10.1097/00041433-200006000-00010; Spalding K.L., 2008, NATURE	31	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3771	10.1371/journal.pone.0003771	http://dx.doi.org/10.1371/journal.pone.0003771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020660	gold, Green Published			2022-12-25	WOS:000265448600004
J	Pereira, PJB; Empadinhas, N; Albuquerque, L; Sa-Moura, B; da Costa, MS; Macedo-Ribeiro, S				Barbosa Pereira, Pedro Jose; Empadinhas, Nuno; Albuquerque, Luciana; Sa-Moura, Bebiana; da Costa, Milton S.; Macedo-Ribeiro, Sandra			Mycobacterium tuberculosis Glucosyl-3-Phosphoglycerate Synthase: Structure of a Key Enzyme in Methylglucose Lipopolysaccharide Biosynthesis	PLOS ONE			English	Article							FATTY-ACID SYNTHETASE; MACROMOLECULAR CRYOCRYSTALLOGRAPHY; METHYLMANNOSE POLYSACCHARIDE; CRYSTAL-STRUCTURE; IDENTIFICATION; PATHWAY; MANNOSYLGLYCERATE; GLUCOSYLGLYCERATE; CRYSTALLIZATION; PROTEINS	Tuberculosis constitutes today a serious threat to human health worldwide, aggravated by the increasing number of identified multi-resistant strains of Mycobacterium tuberculosis, its causative agent, as well as by the lack of development of novel mycobactericidal compounds for the last few decades. The increased resilience of this pathogen is due, to a great extent, to its complex, polysaccharide-rich, and unusually impermeable cell wall. The synthesis of this essential structure is still poorly understood despite the fact that enzymes involved in glycosidic bond synthesis represent more than 1% of all M. tuberculosis ORFs identified to date. One of them is GpgS, a retaining glycosyltransferase (GT) with low sequence homology to any other GTs of known structure, which has been identified in two species of mycobacteria and shown to be essential for the survival of M. tuberculosis. To further understand the biochemical properties of M. tuberculosis GpgS, we determined the three-dimensional structure of the apo enzyme, as well as of its ternary complex with UDP and 3-phosphoglycerate, by X-ray crystallography, to a resolution of 2.5 and 2.7 angstrom, respectively. GpgS, the first enzyme from the newly established GT-81 family to be structurally characterized, displays a dimeric architecture with an overall fold similar to that of other GT-A-type glycosyltransferases. These three-dimensional structures provide a molecular explanation for the enzyme's preference for UDP-containing donor substrates, as well as for its glucose versus mannose discrimination, and uncover the structural determinants for acceptor substrate selectivity. Glycosyltransferases constitute a growing family of enzymes for which structural and mechanistic data urges. The three-dimensional structures of M. tuberculosis GpgS now determined provide such data for a novel enzyme family, clearly establishing the molecular determinants for substrate recognition and catalysis, while providing an experimental scaffold for the structure-based rational design of specific inhibitors, which lay the foundation for the development of novel anti-tuberculosis therapies.	[Barbosa Pereira, Pedro Jose; Sa-Moura, Bebiana; Macedo-Ribeiro, Sandra] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Empadinhas, Nuno; Albuquerque, Luciana] Univ Coimbra, Dept Zool, Ctr Neuroci Biol Celular, P-3000 Coimbra, Portugal; [da Costa, Milton S.] Univ Coimbra, Dept Bioquim, P-3000 Coimbra, Portugal	Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra	Pereira, PJB (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	sribeiro@ibmc.up.pt	Pereira, Pedro/F-8972-2011; Empadinhas, Nuno/G-3118-2011; Macedo-Ribeiro, Sandra/D-9258-2011	Pereira, Pedro/0000-0003-0969-5438; Empadinhas, Nuno/0000-0001-8938-7560; Macedo-Ribeiro, Sandra/0000-0002-7698-1170; Albuquerque, Luciana/0000-0002-6957-4673; Sa-Moura, Bebiana/0000-0003-2943-8818; da Costa, Milton/0000-0003-4027-4412	Fundacao para a Ciencia e a Tecnologia (Portugal) [POCI/BIA-MIC/56511/2004, PTDC/SAU-MII/70634/2006]	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology)	This work had the financial support of grants POCI/BIA-MIC/56511/2004 and PTDC/SAU-MII/70634/2006 from Fundacao para a Ciencia e a Tecnologia (Portugal). The funding body had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANIS RJ, 1977, J BIOL CHEM, V252, P5740; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Costa J, 2006, J BACTERIOL, V188, P1022, DOI 10.1128/JB.188.3.1022-1030.2006; Costa J, 2007, J BACTERIOL, V189, P1648, DOI 10.1128/JB.00841-06; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Empadinhas N, 2001, J BIOL CHEM, V276, P43580, DOI 10.1074/jbc.M108054200; Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON JA, 1970, J BIOL CHEM, V245, P4213; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRAY GR, 1971, J BIOL CHEM, V246, P6835; Hanson BL, 2003, J STRUCT BIOL, V142, P77, DOI 10.1016/S1047-8477(03)00040-6; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; ILTON M, 1971, P NATL ACAD SCI USA, V68, P87, DOI 10.1073/pnas.68.1.87; KAMISANGO K, 1987, J BIOL CHEM, V262, P4580; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAIRSON LL, 2008, ANN REV BIOCH, V77; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE YC, 1964, J BIOL CHEM, V239, P3602; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pflugrath JW, 2004, METHODS, V34, P415, DOI 10.1016/j.ymeth.2004.03.032; POMMIER MT, 1986, J GEN MICROBIOL, V132, P2433; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Sa-Moura B, 2008, ACTA CRYSTALLOGR F, V64, P760, DOI 10.1107/S1744309108021490; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tuffal G, 1998, GLYCOBIOLOGY, V8, P675, DOI 10.1093/glycob/8.7.675; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; WEISMAN LS, 1984, J BIOL CHEM, V259, P3457; WEISMAN LS, 1984, J BIOL CHEM, V259, P3464; Wimmerova M, 2003, BIOCHIMIE, V85, P691, DOI 10.1016/S0300-9084(03)00120-2; YABUSAKI KK, 1978, P NATL ACAD SCI USA, V75, P691, DOI 10.1073/pnas.75.2.691	48	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3748	10.1371/journal.pone.0003748	http://dx.doi.org/10.1371/journal.pone.0003748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015727	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448400005
J	Tzur, G; Levy, A; Meiri, E; Barad, O; Spector, Y; Bentwich, Z; Mizrahi, L; Katzenellenbogen, M; Ben-Shushan, E; Reubinoff, BE; Galun, E				Tzur, Galit; Levy, Asaf; Meiri, Eti; Barad, Omer; Spector, Yael; Bentwich, Zvi; Mizrahi, Lina; Katzenellenbogen, Mark; Ben-Shushan, Etti; Reubinoff, Benjamin E.; Galun, Eithan			MicroRNA Expression Patterns and Function in Endodermal Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article								Background/Aims: microRNAs (miRNAs) are small noncoding RNAs that regulate cognate mRNAs post-transcriptionally. Human embryonic stem cells (hESC), which exhibit the characteristics of pluripotency and self-renewal, may serve as a model to study the role of miRNAs in early human development. We aimed to determine whether endodermally-differentiated hESC demonstrate a unique miRNA expression pattern, and whether overexpression of endoderm-specific miRNA may affect hESC differentiation. Methods: miRNA expression was profiled in undifferentiated and NaButyrate-induced differentiated hESC of two lines, using microarray and quantitative RT-PCR. Then, the effect of lentiviral-based overexpression of liver-specific miR-122 on hESC differentiation was analyzed, using genomewide gene microarrays. Results: The miRNA profiling revealed expression of three novel miRNAs in undifferentiated and differentiated hESC. Upon NaButyrate induction, two of the most upregulated miRNAs common to both cell lines were miR-24 and miR-10a, whose target genes have been shown to inhibit endodermal differentiation. Furthermore, induction of several liver-enriched miRNAs, including miR-122 and miR-192, was observed in parallel to induction of endodermal gene expression. Stable overexpression of miR-122 in hESC was unable to direct spontaneous differentiation towards a clear endodermal fate, but rather, delayed general differentiation of these cells. Conclusions: Our results demonstrate that expression of specific miRNAs correlates with that of specific genes upon differentiation, and highlight the potential role of miRNAs in endodermal differentiation of hESC.	[Tzur, Galit; Mizrahi, Lina; Katzenellenbogen, Mark; Ben-Shushan, Etti; Reubinoff, Benjamin E.; Galun, Eithan] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Levy, Asaf; Meiri, Eti; Barad, Omer; Spector, Yael; Bentwich, Zvi] Rosetta Genom, Rehovot, Israel	Hebrew University of Jerusalem	Tzur, G (corresponding author), Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel.	eithang@hadassah.org.il	Levy, Asaf/ABA-2623-2020; Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702; Reubinoff, Benjamin/0000-0003-0353-1299	Israeli Science Foundation; Israeli Ministry of Science; National Gene Therapy Knowledge Center [LSHB-CT-2004-512034, LSHB-CT-2005-018961, LSHB-CT-2008- 223317]; Horowitz Foundation; Wolfson Foundation	Israeli Science Foundation(Israel Science Foundation); Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); National Gene Therapy Knowledge Center; Horowitz Foundation; Wolfson Foundation	This work is supported by the Israeli Science Foundation, the Israeli Ministry of Science, through a grant from the National Gene Therapy Knowledge Center and through grants LSHB-CT-2004-512034 (MOLEDA), LSHB-CT-2005-018961 (INTHER) and the FP7 program LSHB-CT-2008- 223317 (LIV-ES). Additional support was provided through grants from Lille and Alfy Nathan, Barbara Fox Miller, the Horowitz and the Wolfson Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang J, 2004, RNA BIOL, V1, P17; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COHEN MA, 2007, NEURAL DIFFERENTIATI; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dvash T, 2004, BEST PRACT RES CL OB, V18, P929, DOI 10.1016/j.bpobgyn.2004.06.005; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fuchs O, 2007, FOLIA BIOL-PRAGUE, V53, P97; Fukuda Yoko, 2005, Nucleic Acids Symp Ser (Oxf), P341; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; Gropp M, 2007, CLONING STEM CELLS, V9, P339, DOI 10.1089/clo.2006.0077; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hunter MP, 2007, DEV BIOL, V308, P355, DOI 10.1016/j.ydbio.2007.05.028; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Katzenellenbogen M, 2007, MOL CANCER THER, V6, P1283, DOI 10.1158/1535-7163.MCT-06-0420; Kikuchi Y, 2004, DEV DYNAM, V229, P756, DOI 10.1002/dvdy.10483; KOSAKA M, 1991, EXP CELL RES, V192, P46, DOI 10.1016/0014-4827(91)90155-N; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar BM, 2007, J REPROD DEVELOP, V53, P903, DOI 10.1262/jrd.18180; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LAKSHMIPATHY U, 2007, STEM CELLS DEV; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LAURENT LC, 2008, STEM CELLS; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rambhatla L, 2003, CELL TRANSPLANT, V12, P1, DOI 10.3727/000000003783985179; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Strauss WM, 2006, MAMM GENOME, V17, P833, DOI 10.1007/s00335-006-0025-7; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; TAY YM, 2007, STEM CELLS; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; XANTHOPOULOS KG, 1993, EUR J BIOCHEM, V216, P353, DOI 10.1111/j.1432-1033.1993.tb18152.x; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	62	84	95	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3726	10.1371/journal.pone.0003726	http://dx.doi.org/10.1371/journal.pone.0003726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015728	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448400001
J	Gowen, BB; Smee, DF; Wong, MH; Hall, JO; Jung, KH; Bailey, KW; Stevens, JR; Furuta, Y; Morrey, JD				Gowen, Brian B.; Smee, Donald F.; Wong, Min-Hui; Hall, Jeffery O.; Jung, Kie-Hoon; Bailey, Kevin W.; Stevens, John R.; Furuta, Yousuke; Morrey, John D.			Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin	PLOS ONE			English	Article								A growing number of arenaviruses are known to cause viral hemorrhagic fever (HF), a severe and life-threatening syndrome characterized by fever, malaise, and increased vascular permeability. Ribavirin, the only licensed antiviral indicated for the treatment of certain arenaviral HFs, has had mixed success and significant toxicity. Since severe arenaviral infections initially do not present with distinguishing symptoms and are difficult to clinically diagnose at early stages, it is of utmost importance to identify antiviral therapies effective at later stages of infection. We have previously reported that T-705, a substituted pyrazine derivative currently under development as an anti-influenza drug, is highly active in hamsters infected with Pichinde virus when the drug is administered orally early during the course of infection. Here we demonstrate that T-705 offers significant protection against this lethal arenaviral infection in hamsters when treatment is begun after the animals are ill and the day before the animals begin to succumb to disease. Importantly, this coincides with the time when peak viral loads are present in most organs and considerable tissue damage is evident. We also show that T-705 is as effective as, and less toxic than, ribavirin, as infected T-705-treated hamsters on average maintain their weight better and recover more rapidly than animals treated with ribavirin. Further, there was no added benefit to combination therapy with T-705 and ribavirin. Finally, pharmacokinetic data indicate that plasma T-705 levels following oral administration are markedly reduced during the latter stages of disease, and may contribute to the reduced efficacy seen when treatment is withheld until day 7 of infection. Our findings support further pre-clinical development of T-705 for the treatment of severe arenaviral infections.	[Gowen, Brian B.; Smee, Donald F.; Wong, Min-Hui; Jung, Kie-Hoon; Bailey, Kevin W.; Morrey, John D.] Inst Antiviral Res, Logan, UT USA; [Gowen, Brian B.; Smee, Donald F.; Wong, Min-Hui; Hall, Jeffery O.; Jung, Kie-Hoon; Bailey, Kevin W.; Morrey, John D.] Utah State Univ, Dept Anim, Dairy, & Vet Sci, Logan, UT 84322 USA; [Stevens, John R.] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA; [Furuta, Yousuke] Toyama Chem Co Ltd, Res Lab, Toyama, Japan	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Gowen, BB (corresponding author), Inst Antiviral Res, Logan, UT USA.	brian.gowen@usu.edu			Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health [N01-AI-15435, N01-AI-30048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048, N01AI015435] Funding Source: NIH RePORTER	Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract grants N01-AI-15435 and N01-AI-30048 from the Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Buchmeier MJ, 2001, FIELDS VIROLOGY, P1635; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; ENRIA DA, 1994, ANTIVIR RES, V23, P23, DOI 10.1016/0166-3542(94)90030-2; FOLLEY LS, 1983, J CHROMATOGR, V281, P199, DOI 10.1016/S0021-9673(01)87878-X; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Gowen BB, 2005, ANTIMICROB AGENTS CH, V49, P2378, DOI 10.1128/AAC.49.6.2378-2386.2005; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Gowen Brian B., 2006, Antiviral Chemistry & Chemotherapy, V17, P175; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Gunther S, 2001, J INFECT DIS, V184, P345, DOI 10.1086/322033; Hedstrom L, 1999, CURR MED CHEM, V6, P545; KENYON RH, 1986, J MED VIROL, V20, P207, DOI 10.1002/jmv.1890200303; KENYON RH, 1988, INTERVIROLOGY, V29, P133, DOI 10.1159/000150039; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Kilgore PE, 1997, CLIN INFECT DIS, V24, P718, DOI 10.1093/clind/24.4.718; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; MCKEE KT, 1987, J MED VIROL, V22, P99, DOI 10.1002/jmv.1890220202; MORREY JD, 2008, ANTIVIRAL R IN PRESS; MURPHY FA, 1977, LAB INVEST, V37, P502; *NIAID, 2002, COUNT BIOT RES AG NA; REED L. J., 1938, AMER JOUR HYG, V27, P493; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; Sidwell RW, 2007, ANTIMICROB AGENTS CH, V51, P845, DOI 10.1128/AAC.01051-06; SMEE DF, 1993, ANTIVIR RES, V20, P57, DOI 10.1016/0166-3542(93)90059-R; Takahashi Kazumi, 2003, Antiviral Chemistry & Chemotherapy, V14, P235; 2007, FDANEWS DRUG PIPELIN	27	68	71	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3725	10.1371/journal.pone.0003725	http://dx.doi.org/10.1371/journal.pone.0003725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19008960	Green Published, gold			2022-12-25	WOS:000265166400004
J	Poussin, C; Hall, D; Minehira, K; Galzin, AM; Tarussio, D; Thorens, B				Poussin, Carine; Hall, Diana; Minehira, Kaori; Galzin, Anne-Marie; Tarussio, David; Thorens, Bernard			Different Transcriptional Control of Metabolism and Extracellular Matrix in Visceral and Subcutaneous Fat of Obese and Rimonabant Treated Mice	PLOS ONE			English	Article							CB1 RECEPTOR ANTAGONIST; DIET-INDUCED OBESITY; ADIPOSE-TISSUE DEVELOPMENT; NECROSIS-FACTOR-ALPHA; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; GENE-EXPRESSION; OXIDATIVE-PHOSPHORYLATION; 3T3-L1 ADIPOGENESIS; CARDIOVASCULAR RISK	Background: The visceral (VAT) and subcutaneous (SCAT) adipose tissues play different roles in physiology and obesity. The molecular mechanisms underlying their expansion in obesity and following body weight reduction are poorly defined. Methodology: C57Bl/6 mice fed a high fat diet (HFD) for 6 months developed low, medium, or high body weight as compared to normal chow fed mice. Mice from each groups were then treated with the cannabinoid receptor 1 antagonist rimonabant or vehicle for 24 days to normalize their body weight. Transcriptomic data for visceral and subcutaneous adipose tissues from each group of mice were obtained and analyzed to identify: i) genes regulated by HFD irrespective of body weight, ii) genes whose expression correlated with body weight, iii) the biological processes activated in each tissue using gene set enrichment analysis (GSEA), iv) the transcriptional programs affected by rimonabant. Principal Findings: In VAT, "metabolic'' genes encoding enzymes for lipid and steroid biosynthesis and glucose catabolism were down-regulated irrespective of body weight whereas "structure'' genes controlling cell architecture and tissue remodeling had expression levels correlated with body weight. In SCAT, the identified "metabolic'' and "structure'' genes were mostly different from those identified in VAT and were regulated irrespective of body weight. GSEA indicated active adipogenesis in both tissues but a more prominent involvement of tissue stroma in VAT than in SCAT. Rimonabant treatment normalized most gene expression but further reduced oxidative phosphorylation gene expression in SCAT but not in VAT. Conclusion: VAT and SCAT show strikingly different gene expression programs in response to high fat diet and rimonabant treatment. Our results may lead to identification of therapeutic targets acting on specific fat depots to control obesity.	[Poussin, Carine; Hall, Diana; Minehira, Kaori; Tarussio, David; Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, Lausanna, Switzerland; [Galzin, Anne-Marie] Sanofi Aventis, Rueil Malmaison, France	University of Lausanne; Sanofi-Aventis	Poussin, C (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanna, Switzerland.	Bernard.Thorens@unil.ch			Sanofi-Aventis; French MINEFI - Ministere de l'Industrie et des Finances; European Union Sixth Framework Programme on Hepatic and Adipose tissue and functions in the Metabolic Syndrome (EU-FP6 HEPADIP)	Sanofi-Aventis(Sanofi-Aventis); French MINEFI - Ministere de l'Industrie et des Finances; European Union Sixth Framework Programme on Hepatic and Adipose tissue and functions in the Metabolic Syndrome (EU-FP6 HEPADIP)	This work was supported by grants from Sanofi-Aventis and the the French MINEFI - Ministere de l'Industrie et des Finances - through the project 'Integrated Genomic approaches for the molecular dissection of Cannabinoid receptor 1 signalling and of CB1 antagonist effects in Obesity and in the Metabolic Syndrome'GenObeCB1 and from the European Union Sixth Framework Programme on Hepatic and Adipose tissue and functions in the Metabolic Syndrome (EU-FP6 HEPADIP). The funder (Sanofi-Aventis) had no role in study data collection and analysis. Study design and decision to publish were taken with the funder. The funder agreed to publish the manuscript that was drafted only by the investigators at the University of Lausanne.	Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Aronne LJ, 2007, AM J MED, V120, pS29, DOI 10.1016/j.amjmed.2006.11.015; Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; BERTRAND HA, 1984, J NUTR, V114, P127, DOI 10.1093/jn/114.1.127; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chiellini C, 2003, J CELL PHYSIOL, V195, P309, DOI 10.1002/jcp.10253; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; Cohen B, 2001, J BIOL CHEM, V276, P7697, DOI 10.1074/jbc.C000634200; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; de Fourmestraux V, 2004, J BIOL CHEM, V279, P50743, DOI 10.1074/jbc.M408014200; DEFOURMESTRAUX V, 2004, J BIOL CHEM; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Engelman JA, 1999, J BIOL CHEM, V274, P35630, DOI 10.1074/jbc.274.50.35630; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Gary-Bobo M, 2006, MOL PHARMACOL, V69, P471, DOI 10.1124/mol.105.015040; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hildebrandt AL, 2003, EUR J PHARMACOL, V462, P125, DOI 10.1016/S0014-2999(03)01343-8; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Marin P, 1996, J CLIN ENDOCR METAB, V81, P1018, DOI 10.1210/jc.81.3.1018; MATIAS I, 2007, NEUROPHARMACOLOGY; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Prunet-Marcassus B, 2006, EXP CELL RES, V312, P727, DOI 10.1016/j.yexcr.2005.11.021; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Taleb S, 2005, FASEB J, V19, P1540, DOI 10.1096/fj.05-3673fje; Tan Siok Hwee, 2006, Functional & Integrative Genomics, V6, P235, DOI 10.1007/s10142-005-0016-x; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; van Harmelen V, 2002, DIABETES, V51, P2029, DOI 10.2337/diabetes.51.7.2029; Verty ANA, 2004, ENDOCRINOLOGY, V145, P3224, DOI 10.1210/en.2004-0059; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Voros G, 2006, BBA-GEN SUBJECTS, V1760, P1837, DOI 10.1016/j.bbagen.2006.08.016; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187	63	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3385	10.1371/journal.pone.0003385	http://dx.doi.org/10.1371/journal.pone.0003385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	19030233	Green Published, Green Submitted, gold			2022-12-25	WOS:000265121600009
J	van Boven, M; Klinkenberg, D; Pen, I; Weissing, FJ; Heesterbeek, H				van Boven, Michiel; Klinkenberg, Don; Pen, Ido; Weissing, Franz J.; Heesterbeek, Hans			Self-Interest versus Group-Interest in Antiviral Control	PLOS ONE			English	Article							INFLUENZA; VACCINATION; STRATEGIES; DYNAMICS	Antiviral agents have been hailed to hold considerable promise for the treatment and prevention of emerging viral diseases like H5N1 avian influenza and SARS. However, antiviral drugs are not completely harmless, and the conditions under which individuals are willing to participate in a large-scale antiviral drug treatment program are as yet unknown. We provide population dynamical and game theoretical analyses of large-scale prophylactic antiviral treatment programs. Throughout we compare the antiviral control strategy that is optimal from the public health perspective with the control strategy that would evolve if individuals make their own, rational decisions. To this end we investigate the conditions under which a large-scale antiviral control program can prevent an epidemic, and we analyze at what point in an unfolding epidemic the risk of infection starts to outweigh the cost of antiviral treatment. This enables investigation of how the optimal control strategy is moulded by the efficacy of antiviral drugs, the risk of mortality by antiviral prophylaxis, and the transmissibility of the pathogen. Our analyses show that there can be a strong incentive for an individual to take less antiviral drugs than is optimal from the public health perspective. In particular, when public health asks for early and aggressive control to prevent or curb an emerging pathogen, for the individual antiviral drug treatment is attractive only when the risk of infection has become non-negligible. It is even possible that from a public health perspective a situation in which everybody takes antiviral drugs is optimal, while the process of individual choice leads to a situation where nobody is willing to take antiviral drugs.	[van Boven, Michiel; Klinkenberg, Don; Heesterbeek, Hans] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van Boven, Michiel] Wageningen Univ, Res Ctr, Animal Sci Grp, Lelystad, Netherlands; [van Boven, Michiel; Pen, Ido; Weissing, Franz J.] Univ Groningen, Ctr Ecol & Evol Stud, Haren, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; University of Groningen	van Boven, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	michiel.van.boven@rivm.nl	Pen, Ido/F-2478-2010	Weissing, Franz J./0000-0003-3281-663X; Klinkenberg, Don/0000-0002-9449-6873; Heesterbeek, Hans/0000-0001-8537-6418	EU Sixth Framework Programme [SP22-CT-2004-511066]; Netherlands Organisation for Scientific Research [918.56.620]	EU Sixth Framework Programme(European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The research of MvB and DK is supported by the EU Sixth Framework Programme for research for policy support (contract SP22-CT-2004-511066). The research of JAPH is supported by the Netherlands Organisation for Scientific Research (NWO grant 918.56.620).	[Anonymous], 2007, NATURE, V446, P358, DOI 10.1038/446358a; Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Cinatl J, 2005, ANTIVIR RES, V66, P81, DOI 10.1016/j.antiviral.2005.03.002; Cojocaru MG, 2007, B MATH BIOL, V69, P1453, DOI 10.1007/s11538-006-9173-x; De Clercq E, 2004, NAT REV MICROBIOL, V2, P704, DOI 10.1038/nrmicro975; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; *EUR MED AG, 2006, SCI DISC EUR MED EV; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Groneberg DA, 2005, LANCET INFECT DIS, V5, P147, DOI 10.1016/S1473-3099(05)70022-0; Hayden FG, 2006, ANTIVIR RES, V71, P372, DOI 10.1016/j.antiviral.2006.05.016; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Maxwell SRJ, 2007, BRIT MED J, V334, P1232, DOI 10.1136/bmj.39240.497025.80; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Reluga TC, 2006, MATH BIOSCI, V204, P185, DOI 10.1016/j.mbs.2006.08.015; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x	22	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1558	10.1371/journal.pone.0001558	http://dx.doi.org/10.1371/journal.pone.0001558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	19050769	Green Published, Green Submitted, gold			2022-12-25	WOS:000260535900003
J	Halle, M; Gomez, MA; Stuible, M; Shimizu, H; McMaster, WR; Olivier, M; Tremblay, ML				Halle, Maxime; Gomez, Maria Adelaida; Stuible, Matthew; Shimizu, Hidehisa; McMaster, W. Robert; Olivier, Martin; Tremblay, Michel L.			The Leishmania Surface Protease GP63 Cleaves Multiple Intracellular Proteins and Actively Participates in p38 Mitogen-activated Protein Kinase Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE-1/2; TYROSINE-PHOSPHATASE-PEST; TARGETED GENE DELETION; NF-KAPPA-B; PTP-PEST; DONOVANI PROMASTIGOTES; AMAZONENSIS PROMASTIGOTES; EXTRACELLULAR RELEASE; PARASITIC PROTOZOAN; ACTIN CYTOSKELETON	The Leishmania parasite is a widespread disease threat in tropical areas, causing symptoms ranging from skin lesions to death. Leishmania parasites typically invade macrophages but are also capable of infecting fibroblasts, which may serve as a reservoir for recurrent infection. Invasion by intracellular pathogens often involves exploitation of the host cell cytoskeletal and signaling machinery. Here we have observed a dramatic rearrangement of the actin cytoskeleton and marked modifications in the profile of protein tyrosine phosphorylation in fibroblasts infected with Leishmania major. Correspondingly, exposure to L. major resulted in degradation of the phosphorylated adaptor protein p130Cas and the protein-tyrosine phosphatase-PEST. Cellular and in vitro assays using pharmacological protease inhibitors, recombinant enzyme, and genetically modified strains of L. major identified the parasite protease GP63 as the principal catalyst of proteolysis during infection. A number of additional signaling proteins were screened for degradation during L. major infection as follows: a small subset was cleaved, including cortactin, T-cell protein-tyrosine phosphatase, and caspase-3, but the majority remained unaffected. Protein degradation occurred in cells incubated with Leishmania extracts in the absence of intact parasites, suggesting a mechanism permitting transfer of functional GP63 into the intracellular space. Finally, we evaluated the impact of Leishmania on MAPK signaling; unlike p44/42 and JNK, p38 was in activated upon infection in a GP63 and protein degradation-dependent manner, which likely involves cleavage of the upstream adaptor TAB1. Our results establish that GP63 plays a central role in a number of host cell molecular events that likely contribute to the infectivity of Leishmania.	[Gomez, Maria Adelaida; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Halle, Maxime; Stuible, Matthew; Shimizu, Hidehisa; Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Halle, Maxime; Stuible, Matthew; Shimizu, Hidehisa; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [McMaster, W. Robert] Univ British Columbia, Dept Med Genet, Jack Bell Res Ctr, Vancouver, BC V6H 3Z6, Canada; [McMaster, W. Robert] Vancouver Hosp, Immun & Infect Res Ctr, Vancouver, BC V6H 3Z6, Canada	McGill University; McGill University; McGill University; University of British Columbia; University of British Columbia	Olivier, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg,3775 Univ St,Rm 600, Montreal, PQ H3A 2B4, Canada.	martin.olivier@mcgill.ca; michel.tremblay@mcgill.ca		Gomez, Maria Adelaida/0000-0001-8792-1563; Shimizu, Hidehisa/0000-0002-0939-0098				Aga E, 2002, J IMMUNOL, V169, P898, DOI 10.4049/jimmunol.169.2.898; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Awasthi A, 2003, J EXP MED, V197, P1037, DOI 10.1084/jem.20022033; Balaraman S, 2005, MOL BIOCHEM PARASIT, V139, P117, DOI 10.1016/j.molbiopara.2004.10.006; BELLE E A, 1958, Can Med Assoc J, V79, P726; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; BOUVIER J, 1985, J BIOL CHEM, V260, P5504; Brittingham A, 1999, INFECT IMMUN, V67, P4477, DOI 10.1128/IAI.67.9.4477-4484.1999; BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102; BUTTON LL, 1993, GENE, V134, P75, DOI 10.1016/0378-1119(93)90176-4; CAMPBELL DA, 1992, FEMS MICROBIOL LETT, V96, P89, DOI 10.1111/j.1574-6968.1992.tb05398.x; Carmen JC, 2007, MOL MICROBIOL, V64, P904, DOI 10.1111/j.1365-2958.2007.05714.x; CHAUDHURI G, 1988, MOL BIOCHEM PARASIT, V27, P43, DOI 10.1016/0166-6851(88)90023-0; CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483; Chen DQ, 2000, INFECT IMMUN, V68, P80, DOI 10.1128/IAI.68.1.80-86.2000; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; COOL DE, 1990, P NATL ACAD SCI USA, V87, P7280, DOI 10.1073/pnas.87.18.7280; Corradin S, 1999, J BIOL CHEM, V274, P25411, DOI 10.1074/jbc.274.36.25411; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Ellis M, 2002, J BIOL CHEM, V277, P27968, DOI 10.1074/jbc.M202047200; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Ghosh D, 2002, BIOSCIENCE REP, V22, P395, DOI 10.1023/A:1020914024544; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gregory DJ, 2008, EUR J IMMUNOL, V38, P1071, DOI 10.1002/eji.200737586; Halle M, 2007, CELL CYCLE, V6, P2773, DOI 10.4161/cc.6.22.4926; Halle M, 2007, MOL CELL BIOL, V27, P1172, DOI 10.1128/MCB.02462-05; Hao LN, 1997, J BIOL CHEM, V272, P29322, DOI 10.1074/jbc.272.46.29322; Hepburn NC, 2000, CLIN EXP DERMATOL, V25, P363, DOI 10.1046/j.1365-2230.2000.00664.x; Hespanhol RC, 2005, J HISTOCHEM CYTOCHEM, V53, P35, DOI 10.1369/jhc.4A6384.2005; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hsiao CHC, 2008, MOL BIOCHEM PARASIT, V157, P148, DOI 10.1016/j.molbiopara.2007.10.008; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Jaffe CL, 2003, PARASITOL RES, V91, P229, DOI 10.1007/s00436-003-0960-0; Jamieson JS, 2005, J CELL SCI, V118, P5835, DOI 10.1242/jcs.02693; Joshi PB, 1998, MOL MICROBIOL, V27, P519, DOI 10.1046/j.1365-2958.1998.00689.x; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Junghae M, 2002, INFECT IMMUN, V70, P5026, DOI 10.1128/IAI.70.9.5026-5035.2002; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Kima PE, 2007, INT J PARASITOL, V37, P1087, DOI 10.1016/j.ijpara.2007.04.007; Kook S, 2000, MOL BIOL CELL, V11, P929, DOI 10.1091/mbc.11.3.929; Kulkarni MM, 2008, INFECT IMMUN, V76, P1738, DOI 10.1128/IAI.01274-07; Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x; Kyaw M, 2004, MOL PHARMACOL, V65, P832, DOI 10.1124/mol.65.4.832; Lerm M, 2006, INFECT IMMUN, V74, P2613, DOI 10.1128/IAI.74.5.2613-2618.2006; Liu LM, 2006, PARASITOL RES, V99, P189, DOI 10.1007/s00436-006-0168-1; Lodge R, 2005, CELL MICROBIOL, V7, P1647, DOI 10.1111/j.1462-5822.2005.00582.x; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; McGwire BS, 2003, INFECT IMMUN, V71, P1008, DOI 10.1128/IAI.71.2.1008-1010.2003; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Morehead J, 2002, INFECT IMMUN, V70, P4571, DOI 10.1128/IAI.70.8.4571-4580.2002; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Oliveira SHP, 1998, PARASITE IMMUNOL, V20, P405, DOI 10.1046/j.1365-3024.1998.00159.x; Prive C, 2000, EUR J IMMUNOL, V30, P2235, DOI 10.1002/1521-4141(2000)30:8&lt;2235::AID-IMMU2235&gt;3.0.CO;2-9; RIZVI FS, 1988, EUR J IMMUNOL, V18, P473, DOI 10.1002/eji.1830180323; ROBERTS LS, 2000, GD SCHMIDT LS ROBERT, P61; Rottner K, 2004, J PATHOL, V204, P396, DOI 10.1002/path.1638; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Seay MB, 1996, INFECT IMMUN, V64, P5129, DOI 10.1128/IAI.64.12.5129-5137.1996; Selbach M, 2005, TRENDS MICROBIOL, V13, P181, DOI 10.1016/j.tim.2005.02.007; Shi J, 2006, MOL BIOL CELL, V17, P4698, DOI 10.1091/mbc.E06-06-0492; Shim SR, 2001, BIOCHEM BIOPH RES CO, V286, P601, DOI 10.1006/bbrc.2001.5441; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Stuart LM, 2007, J BIOL CHEM, V282, P27392, DOI 10.1074/jbc.M702887200; Thiakaki M, 2006, MICROBES INFECT, V8, P1455, DOI 10.1016/j.micinf.2006.01.006; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; Victoir K, 2005, PARASITOLOGY, V131, P207, DOI 10.1017/S0031182005007535; Voth BR, 1998, MOL BIOCHEM PARASIT, V93, P31, DOI 10.1016/S0166-6851(98)00013-9; Woelbing F, 2006, J EXP MED, V203, P177, DOI 10.1084/jem.20052288; Yao CQ, 2007, EUKARYOT CELL, V6, P1905, DOI 10.1128/EC.00073-07; Yao CQ, 2004, MOL BIOCHEM PARASIT, V135, P171, DOI 10.1016/j.molbiopara.2004.03.010; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Yao CQ, 2002, MOL BIOCHEM PARASIT, V121, P119, DOI 10.1016/S0166-6851(02)00030-0; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; ZHAO ZZ, 1992, ANAL BIOCHEM, V202, P361, DOI 10.1016/0003-2697(92)90119-R	87	89	92	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6893	6908		10.1074/jbc.M805861200	http://dx.doi.org/10.1074/jbc.M805861200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19064994	Green Published, hybrid			2022-12-25	WOS:000263919000037
J	Desplats, C; Mus, F; Cuine, S; Billon, E; Cournac, L; Peltier, G				Desplats, Carine; Mus, Florence; Cuine, Stephan; Billon, Emmanuelle; Cournac, Laurent; Peltier, Gilles			Characterization of Nda2, a Plastoquinone-reducing Type II NAD(P)H Dehydrogenase in Chlamydomonas Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH DEHYDROGENASE; RESPIRATORY-CHAIN; ACIDIANUS-AMBIVALENS; HYDROGEN-PRODUCTION; ARABIDOPSIS; REINHARDTII; IDENTIFICATION; REDUCTASE; PROTEINS; MITOCHONDRIA	Electron transfer pathways associated to oxygenic photosynthesis, including cyclic electron flow around photosystem I and chlororespiration, rely on non-photochemical reduction of plastoquinones (PQs). In higher plant chloroplasts, a bacterial-like NDH complex homologous to complex I is involved in PQ reduction, but such a complex is absent from Chlamydomonas plastids where a type II NAD(P) H dehydrogenase activity has been proposed to operate. With the aim to elucidate the nature of the enzyme-supporting non-photochemical reduction of PQs, one of the type II NAD( P) H dehydrogenases identified in the Chlamydomonas reinhardtii genome (Nda2) was produced as a recombinant protein in Escherichia coli and further characterized. As many type II NAD( P) H dehydrogenases, Nda2 uses NADH as a preferential substrate, but in contrast to the eukaryotic enzymes described so far, contains non-covalently bound FMN as a cofactor. When expressed at a low level, Nda2 complements growth of an E. coli lacking both NDH-1 and NDH-2, but is toxic at high expression levels. Using an antibody raised against the recombinant protein and based on its mass spectrometric identification, we show that Nda2 is localized in thylakoid membranes. Chlorophyll fluorescence measurements performed on thylakoid membranes show that Nda2 is able to interact with thylakoid membranes of C. reinhardtii by reducing PQs from exogenous NADH or NADPH. We discuss the possible involvement of Nda2 in cyclic electron flow around PSI, chlororespiration, and hydrogen production.	[Desplats, Carine; Mus, Florence; Cuine, Stephan; Billon, Emmanuelle; Cournac, Laurent; Peltier, Gilles] Aix Marseille Univ,CEA,CEA Cadarache, Direct Sci Vivant,UMR Biol Vegetale & Microbiol E, Lab Bioenerget & Biotechnol Bacteries & Microalgu, Inst Biol Environm & Biotechnol,CNRS, F-13108 St Paul Les Durance, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Peltier, G (corresponding author), Aix Marseille Univ,CEA,CEA Cadarache, Direct Sci Vivant,UMR Biol Vegetale & Microbiol E, Lab Bioenerget & Biotechnol Bacteries & Microalgu, Inst Biol Environm & Biotechnol,CNRS, Batiment 161, F-13108 St Paul Les Durance, France.	gilles.peltier@cea.fr	PELTIER, Gilles/ABD-4484-2021; Cournac, Laurent/G-2564-2010	Cournac, Laurent/0000-0003-0371-938X; Peltier, Gilles/0000-0002-2226-3931; Mus, Florence/0000-0002-1655-1267	French "Agence Nationale pour la Recherche"; European FP7-Energy-RTD program [212508]	French "Agence Nationale pour la Recherche"(French National Research Agency (ANR)); European FP7-Energy-RTD program	This work was supported by the French "Agence Nationale pour la Recherche" (PHOTOBIOH2 project) and by the European FP7-Energy-RTD program (SOLARH2 project n degrees 212508). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; ATTEIA A, 1992, J BIOL CHEM, V267, P226; Bandeiras TM, 2003, BBA-BIOENERGETICS, V1557, P13, DOI 10.1016/S0005-2728(02)00374-2; Bandeiras TM, 2002, FEBS LETT, V531, P273, DOI 10.1016/S0014-5793(02)03514-7; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; Bernard L, 2006, FEBS J, V273, P3625, DOI 10.1111/j.1742-4658.2006.05370.x; Birch OM, 2000, J BIOL CHEM, V275, P32277, DOI 10.1074/jbc.M004497200; Bollivar DW, 1996, PLANT PHYSIOL, V112, P105, DOI 10.1104/pp.112.1.105; Brito JA, 2006, BBA-PROTEINS PROTEOM, V1764, P842, DOI 10.1016/j.bbapap.2005.09.015; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Cardol P, 2005, PLANT PHYSIOL, V137, P447, DOI 10.1104/pp.104.054148; Carneiro P, 2004, BBA-BIOENERGETICS, V1608, P45, DOI 10.1016/j.bbabio.2003.10.004; Carrie C, 2008, FEBS LETT, V582, P3073, DOI 10.1016/j.febslet.2008.07.061; Chen HC, 2004, PLANTA, V220, P198, DOI 10.1007/s00425-004-1331-5; CORRELL CC, 1993, PROTEIN SCI, V2, P2112, DOI 10.1002/pro.5560021212; Cournac L, 2002, INT J HYDROGEN ENERG, V27, P1229, DOI 10.1016/S0360-3199(02)00105-2; Dai SD, 1996, J MOL BIOL, V264, P1044, DOI 10.1006/jmbi.1996.0695; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Desplats C, 2007, FEBS LETT, V581, P4017, DOI 10.1016/j.febslet.2007.07.035; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Elhafez D, 2006, PLANT CELL PHYSIOL, V47, P43, DOI 10.1093/pcp/pci221; ERIKSSON M, 1995, PLANT PHYSIOL, V107, P479, DOI 10.1104/pp.107.2.479; Fang J, 2002, BIOCHEMISTRY-US, V41, P3065, DOI 10.1021/bi015989w; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fouchard S, 2005, APPL ENVIRON MICROB, V71, P6199, DOI 10.1128/AEM.71.10.6199-6205.2005; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GANS P, 1990, BIOCHIM BIOPHYS ACTA, V1015, P150, DOI 10.1016/0005-2728(90)90226-T; Geisler DA, 2007, J BIOL CHEM, V282, P28455, DOI 10.1074/jbc.M704674200; GODDE D, 1980, ARCH MICROBIOL, V127, P245, DOI 10.1007/BF00427200; Gomes CM, 2001, J BIOENERG BIOMEMBR, V33, P1, DOI 10.1023/A:1005630221892; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mechin V, 2003, PROTEOMICS, V3, P1299, DOI 10.1002/pmic.200300450; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Melis A, 2007, PLANTA, V226, P1075, DOI 10.1007/s00425-007-0609-9; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Melo AMP, 2001, J BIOL CHEM, V276, P3947, DOI 10.1074/jbc.M008199200; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Michalecka AM, 2004, PLANT J, V37, P415, DOI 10.1046/j.1365-313X.2003.01970.x; Michalecka AM, 2003, PLANT PHYSIOL, V133, P642, DOI 10.1104/pp.103.024208; Mus F, 2005, BBA-BIOENERGETICS, V1708, P322, DOI 10.1016/j.bbabio.2005.05.003; PATEL AM, 1995, J BACTERIOL, V177, P3917, DOI 10.1128/jb.177.14.3917-3922.1995; PELTIER G, 1991, P NATL ACAD SCI USA, V88, P4791, DOI 10.1073/pnas.88.11.4791; PELTIER G, 1987, BIOCHIM BIOPHYS ACTA, V893, P83, DOI 10.1016/0005-2728(87)90151-4; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Rasmusson AG, 1999, PLANT J, V20, P79, DOI 10.1046/j.1365-313X.1999.00576.x; RAVENEL J, 1994, PLANTA, V193, P251; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarrio N, 2006, BBA-BIOENERGETICS, V1757, P1476, DOI 10.1016/j.bbabio.2006.09.002; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Wagner V, 2008, PLANT PHYSIOL, V146, P772, DOI 10.1104/pp.107.109645; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083	59	111	114	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4148	4157		10.1074/jbc.M804546200	http://dx.doi.org/10.1074/jbc.M804546200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19056727	hybrid			2022-12-25	WOS:000263134400012
J	Luo, BH; Karanicolas, J; Harmacek, LD; Baker, D; Springer, TA				Luo, Bing-Hao; Karanicolas, John; Harmacek, Laura D.; Baker, David; Springer, Timothy A.			Rationally Designed Integrin beta 3 Mutants Stabilized in the High Affinity Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE MONOCLONAL-ANTIBODY; CD11B A-DOMAIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; I-DOMAIN; EXTRACELLULAR SEGMENT; GLYCOPROTEIN-IIIA; HYBRID DOMAIN; OUTSIDE-IN; PROTEIN	Integrins are important cell surface receptors that transmit bidirectional signals across the membrane. It has been shown that a conformational change of the integrin beta-subunit head-piece (i.e. the beta I domain and the hybrid domain) plays a critical role in regulating integrin ligand binding affinity and function. Previous studies have used coarse methods (a glycan wedge, mutations in transmembrane contacts) to force the beta-subunit into either the open or closed conformation. Here, we demonstrate a detailed understanding of this conformational change by applying computational design techniques to select five amino acid side chains that play an important role in the energetic balance between the open and closed conformations of alpha(IIb)beta(3). Eight single-point mutants were designed at these sites, of which five bound ligands much better than wild type. Further, these mutants were found to be in a more extended conformation than wild type, suggesting that the conformational change at the ligand binding headpiece was propagated to the legs of the integrin. This detailed understanding of the conformational change will assist in the development of allosteric drugs that either stabilize or destabilize specific integrin conformations without occluding the ligand-binding site.	[Luo, Bing-Hao; Harmacek, Laura D.; Springer, Timothy A.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Luo, Bing-Hao; Harmacek, Laura D.; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Luo, Bing-Hao] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Karanicolas, John; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Karanicolas, John; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Louisiana State University System; Louisiana State University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Springer, TA (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 200 Longwood Ave, Boston, MA 02115 USA.	SpringerOffice@idi.harvard.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217	National Institutes of Health [HL48675]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant HL48675 (to T.A.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ambroggio XI, 2006, CURR OPIN STRUC BIOL, V16, P525, DOI 10.1016/j.sbi.2006.05.014; Bennett JS, 2001, ANNU REV MED, V52, P161, DOI 10.1146/annurev.med.52.1.161; Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; DELANO WL, 2004, PYMOL; Giorgetti A, 2005, BIOINFORMATICS, V21, P72, DOI 10.1093/bioinformatics/bti1112; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; Ireton GC, 2003, STRUCTURE, V11, P961, DOI 10.1016/S0969-2126(03)00153-9; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; KOUNS WC, 1990, J BIOL CHEM, V265, P20594; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; McCleverty CJ, 2003, BIOCHEM J, V372, P121, DOI 10.1042/BJ20021273; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	37	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3917	3924		10.1074/jbc.M806312200	http://dx.doi.org/10.1074/jbc.M806312200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19019827	Green Published, hybrid			2022-12-25	WOS:000262872500060
J	Struchholz, S; Elfrink, K; Pieper, U; Kalhammer, G; Honnert, U; Gruetzner, A; Linke, WA; Liao, WQ; Bahler, M				Struchholz, Sandra; Elfrink, Kerstin; Pieper, Uwe; Kalhammer, Georg; Honnert, Ulrike; Gruetzner, Anika; Linke, Wolfgang A.; Liao, Wanqin; Baehler, Martin			Functional Role of the Extended Loop 2 in the Myosin 9b Head for Binding F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTOMYOSIN ADENOSINE-TRIPHOSPHATASE; MAXIMUM ATPASE ACTIVITY; PROCESSIVE MOVEMENT; ELECTRON CRYOMICROSCOPY; MOTOR DOMAIN; PROTEIN; MECHANISM; MUSCLE; IXB; AFFINITY	The mammalian class IX myosin Myo9b can move considerable distances along actin filaments before it dissociates. This is remarkable, because it is single headed and because the rate-limiting step in its ATPase cycle is ATP hydrolysis. Thus, it spends most of its cycling time in the ATP-bound state that has a weak affinity for F-actin in other myosins. It has been speculated that the very extended loop 2 in the Myo9b head domain comprises an additional actin-binding site that prevents it from dissociation in the weak binding states. Here we show that two regions in the loop 2 determine the F-actin concentrations needed to maximally activate the steady-state ATPase activity. Together these two regions regulate the amount capable of binding F-actin and the affinity of the nucleotide-free state. The isolated loop 2 behaved like an entropic spring and bound stoichiometrically and with high affinity to F-actin. Subfragment 1 from skeletal muscle myosin II bound to F-actin simultaneously with the isolated loop 2 of Myo9b and could not displace it. Furthermore, the present results imply also a regulatory role for the tail region. Taken together, the results demonstrate that the extended loop 2 in Myo9b binds F-actin and influences the binding of the conventional stereo-specific actin-binding site.	[Struchholz, Sandra; Elfrink, Kerstin; Pieper, Uwe; Kalhammer, Georg; Honnert, Ulrike; Gruetzner, Anika; Linke, Wolfgang A.; Liao, Wanqin; Baehler, Martin] Univ Munster, Inst Allgemeine Zool & Genet, D-48149 Munster, Germany	University of Munster	Bahler, M (corresponding author), Univ Munster, Inst Allgemeine Zool & Genet, Schlosspl 5, D-48149 Munster, Germany.	baehler@uni-muenster.de	Linke, Wolfgang A/E-8662-2012	Linke, Wolfgang/0000-0003-0801-3773	Deutsche Forschungsgemeinschaft [BA 1354/9-1, SFB 629]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants BA 1354/9-1 and SFB 629. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALISSANO P, 1978, P NATL ACAD SCI USA, V75, P2210, DOI 10.1073/pnas.75.5.2210; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; FOWLER WE, 1982, J CELL BIOL, V93, P452, DOI 10.1083/jcb.93.2.452; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; GOA J, 1953, SCAND J CLIN LAB INV, V5, P218, DOI 10.3109/00365515309094189; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Inoue A, 2002, NAT CELL BIOL, V4, P302, DOI 10.1038/ncb774; JAHN R, 1984, P NATL ACAD SCI-BIOL, V81, P1684, DOI 10.1073/pnas.81.6.1684; Joel PB, 2003, BIOCHEMISTRY-US, V42, P9160, DOI 10.1021/bi034415j; Kambara T, 2006, J BIOL CHEM, V281, P4949, DOI 10.1074/jbc.M509141200; Kempler K, 2007, BIOCHEMISTRY-US, V46, P4280, DOI 10.1021/bi062112u; Krementsova EB, 2006, J BIOL CHEM, V281, P6079, DOI 10.1074/jbc.M510041200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKATOS S, 1991, J BIOL CHEM, V266, P18707; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Linke WA, 2008, PFLUG ARCH EUR J PHY, V456, P101, DOI 10.1007/s00424-007-0389-x; MAGRI E, 1978, BIOCHEM BIOPH RES CO, V82, P1207, DOI 10.1016/0006-291X(78)90315-7; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; Murphy CT, 1999, BIOCHEMISTRY-US, V38, P3785, DOI 10.1021/bi9826815; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Nishikawa M, 2006, BIOCHEM BIOPH RES CO, V343, P1159, DOI 10.1016/j.bbrc.2006.03.057; OKAMOTO Y, 1985, J BIOCHEM-TOKYO, V98, P1143, DOI 10.1093/oxfordjournals.jbchem.a135365; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Sweeney HL, 2007, EMBO J, V26, P2682, DOI 10.1038/sj.emboj.7601720; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v	40	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3663	3671		10.1074/jbc.M808338200	http://dx.doi.org/10.1074/jbc.M808338200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19059909	hybrid			2022-12-25	WOS:000262872500034
J	Snijders, AM; Huey, B; Connelly, ST; Roy, R; Jordan, RCK; Schmidt, BL; Albertson, DG				Snijders, A. M.; Huey, B.; Connelly, S. T.; Roy, R.; Jordan, R. C. K.; Schmidt, B. L.; Albertson, D. G.			Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene	ONCOGENE			English	Article						GLI2; organotypic culture; transdifferentiation; invasion	GENE AMPLIFICATION; GENOMIC INSTABILITY; D1 OVEREXPRESSION; CARCINOMA-CELLS; TUMOR; DIFFERENTIATION; GROWTH; TISSUE; TRANSCRIPTION; INHIBITION	Hedgehog signaling is often activated in tumors, yet it remains unclear how GLI2, a transcription factor activated by this pathway, acts as an oncogene. We show that GLI2 is a pleiotropic oncogene. The overexpression induces genomic instability and blocks differentiation, likely mediated in part by enhanced expression of the stem cell gene SOX2. GLI2 also induces transforming growth factor (TGF) B1-dependent transdifferentiation of foreskin and tongue, but not gingival. broblasts into myofibroblasts, creating an environment permissive for invasion by keratinocytes, which are in various stages of differentiation having downregulated GLI2. Thus, upregulated GLI2 expression is sufficient to induce a number of the acquired characteristics of tumor cells; however, the stroma, in a tissue-specific manner, determines whether certain GLI2 oncogenic traits are expressed.	[Albertson, D. G.] Univ Calif San Francisco, Canc Res Inst, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Snijders, A. M.; Huey, B.; Roy, R.; Jordan, R. C. K.; Schmidt, B. L.; Albertson, D. G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Huey, B.; Albertson, D. G.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Connelly, S. T.; Jordan, R. C. K.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Schmidt, B. L.] Univ Calif San Francisco, Dept Oral & Maxillofacial Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Albertson, DG (corresponding author), Univ Calif San Francisco, Canc Res Inst, Ctr Comprehens Canc, 2340 Sutter St,Box 0808, San Francisco, CA 94143 USA.	albertson@cc.ucsf.edu		Schmidt, Brian/0000-0002-2409-8984	NIH [CA118323]; California Tobacco-Related Disease Research [14FT-0011]; NCI-sponsored Tumor Microenvironment Training Program; Western Oral Research Consortium (NIH) [K12 DE14609]; NATIONAL CANCER INSTITUTE [R01CA118323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K12DE014609] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Tobacco-Related Disease Research; NCI-sponsored Tumor Microenvironment Training Program; Western Oral Research Consortium (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Drs Gillian Hall and Richard Shaw, University of Liverpool for providing oral SCC 1300C2, Dr Fritz Aberger, University of Salzburg for providing the HaCaT Tet cells, HaCaT GLI2 cells and the 6xHis-GLI2DN pcDNA4/TO vector construct and Dr Rosemary Akhurst, UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC) and Dr J Yingling (Eli Lilly and Company, Indianapolis, IN) for providing the transforming growth factor beta receptor kinase inhibitor, LY2109761. The UCSF HDFCCC Microarray, Tissue, Immunohistochemistry/Molecular Pathology and Genome Analysis Shared Resources provided assistance. This work was supported by NIH Grant CA118323. AMS was the recipient of a postdoctoral fellowship from the California Tobacco-Related Disease Research Program (14FT-0011) and a trainee of the NCI-sponsored Tumor Microenvironment Training Program: Techniques in the Establishment and Manipulation of Organotypic Model Systems. BLS is an appointee of the Western Oral Research Consortium (NIH K12 DE14609).	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bigelow RLH, 2005, J INVEST DERMATOL, V124, P457, DOI 10.1111/j.0022-202X.2004.23590.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burnworth B, 2006, ONCOGENE, V25, P4399, DOI 10.1038/sj.onc.1209474; Cerezo A, 2003, J INVEST DERMATOL, V121, P110, DOI 10.1046/j.1523-1747.2003.12304.x; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Delehedde M, 2001, J INVEST DERMATOL, V116, P366, DOI 10.1046/j.1523-1747.2001.01260.x; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Grachtchouk V, 2003, EMBO J, V22, P2741, DOI 10.1093/emboj/cdg271; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Izzo JG, 1998, ONCOGENE, V17, P2313, DOI 10.1038/sj.onc.1202153; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kellermann MG, 2008, ORAL ONCOL, V44, P509, DOI 10.1016/j.oraloncology.2007.07.001; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lacher MD, 2006, CANCER RES, V66, P1648, DOI 10.1158/0008-5472.CAN-05-2328; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lewis MP, 2004, BRIT J CANCER, V90, P822, DOI 10.1038/sj.bjc.6601611; Marsh D, 2008, CANCER RES, V68, P3295, DOI 10.1158/0008-5472.CAN-08-0174; MIELE M, 1989, MUTAT RES, V219, P171, DOI 10.1016/0921-8734(89)90012-X; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Murnane JP, 2004, BIOESSAYS, V26, P1164, DOI 10.1002/bies.20125; Neill GW, 2008, CARCINOGENESIS, V29, P738, DOI 10.1093/carcin/bgn037; Nelsen CJ, 2005, J BIOL CHEM, V280, P768, DOI 10.1074/jbc.M407105200; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Paulson TG, 1998, MOL CELL BIOL, V18, P3089, DOI 10.1128/MCB.18.5.3089; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Riobo NA, 2006, CELL CYCLE, V5, P1612, DOI 10.4161/cc.5.15.3130; Roh HJ, 2000, CANCER RES, V60, P6496; Roth JR, 2004, RES MICROBIOL, V155, P342, DOI 10.1016/j.resmic.2004.01.016; Schmidt BL, 2004, J ORAL MAXIL SURG, V62, P1055, DOI 10.1016/j.joms.2004.03.010; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Snijders AM, 2003, ONCOGENE, V22, P4370, DOI 10.1038/sj.onc.1206482; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Snijders AM, 2008, GENE CHROMOSOME CANC, V47, P71, DOI 10.1002/gcc.20509; Svensson S, 2003, CANCER RES, V63, P1737; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Verona EV, 2007, CANCER RES, V67, P5737, DOI 10.1158/0008-5472.CAN-07-0444; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zhou P, 1996, CANCER RES, V56, P36	52	17	17	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					625	637		10.1038/onc.2008.421	http://dx.doi.org/10.1038/onc.2008.421			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	19015636	Green Accepted, Green Submitted			2022-12-25	WOS:000263076400001
J	Tanuma, N; Nomura, M; Ikeda, M; Kasugai, I; Tsubaki, Y; Takagaki, K; Kawamura, T; Yamashita, Y; Sato, I; Sato, M; Katakura, R; Kikuchi, K; Shima, H				Tanuma, N.; Nomura, M.; Ikeda, M.; Kasugai, I.; Tsubaki, Y.; Takagaki, K.; Kawamura, T.; Yamashita, Y.; Sato, I.; Sato, M.; Katakura, R.; Kikuchi, K.; Shima, H.			Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion	ONCOGENE			English	Article						DUSP; cadherin; KIF3	LEFT-RIGHT ASYMMETRY; DUAL-SPECIFICITY PHOSPHATASES; TYROSINE PHOSPHATASES; KINESIN SUPERFAMILY; KINASE; COMPLEX; FAMILY	Recent studies have demonstrated essential functions for KIF3, a microtubule-directed protein motor, in subcellular transport of several cancer-relatedproteins, including the beta-catenin-cadherin(s) complex. In this study, we report identification of the protein-phosphatase Dusp26 as a novel regulator of the KIF3 motor. Here we undertake yeast two-hybridscreening and identify Kif3a, a motor subunit of the KIF3 heterotrimeric complex, as a novel Dusp26-binding protein. Co-immunoprecipitation and colocalization experiments revealed that Dusp26 associates not only with Kif3a, but also with Kap3, another subunit of the KIF3 complex. Dephosphorylation experiments in vitro and analysis using mutant forms of Dusp26 in intact cells strongly suggested that Dusp26 is recruited to the KIF3 motor mainly by interaction with Kif3a, and thereby dephosphorylates Kap3. Forced expression of Dusp26, but not its catalytically inactive mutant, promotedd istribution of beta-catenin/N-cadherin, an established KIF3 cargo, to cell-cell junction sites, resulting in increased cell-cell adhesiveness. We also showed that Dusp26 mRNA expression was downregulated in human glioblastoma samples. These results suggest previously unidentified functions of Dusp26 in intracellular transport and cell-cell adhesion. Downregulation of Dusp26 may contribute to malignant phenotypes of glioma.	[Tanuma, N.; Nomura, M.; Kasugai, I.; Shima, H.] Miyagi Canc Ctr, Res Inst, Div Canc Chemotherapy, Natori, Miyagi 9811293, Japan; [Tanuma, N.; Ikeda, M.; Tsubaki, Y.; Takagaki, K.; Kikuchi, K.] Hokkaido Univ, Inst Med Genet, Div Biochem Oncol & Immunol, Sapporo, Hokkaido, Japan; [Kawamura, T.] Univ Tokyo, RCAST, Lab Syst Biol & Med, Tokyo, Japan; [Yamashita, Y.; Katakura, R.] Miyagi Canc Ctr, Div Neurosurg, Natori, Miyagi 9811293, Japan; [Sato, I.] Miyagi Canc Ctr, Res Inst, Sect Clin Res, Natori, Miyagi 9811293, Japan; [Sato, M.] Miyagi Canc Ctr, Div Thorac Surg, Natori, Miyagi 9811293, Japan	Miyagi Cancer Center; Hokkaido University; University of Tokyo; Miyagi Cancer Center; Miyagi Cancer Center; Miyagi Cancer Center	Shima, H (corresponding author), Miyagi Canc Ctr, Res Inst, Div Canc Chemotherapy, 47-1 Nodayama, Natori, Miyagi 9811293, Japan.	shima-hi632@pref.miyagi.jp		Takagaki, Kentaro/0000-0001-8085-6201	Japan Society for the Promotion of Science of Japan	Japan Society for the Promotion of Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We acknowledge Dr Konomi Kamada (Hokkaido University, Japan) for kindly providing the plasmid pBTM116-HA, the L40 yeast strain and E. coli HB101, and Dr Toshio Kitamura (University of Tokyo, Japan) for the pMX-puro plasmid and PLAT-E cells. Thanks are also due to E Yoshida for secretarial assistance. This work was supported in part by Grants-in-Aid for Scientific Research (B) and Grants-in-Aid for Scientific Research (C) provided by the Japan Society for the Promotion of Science of Japan.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Guillaud L, 2008, NAT CELL BIOL, V10, P19, DOI 10.1038/ncb1665; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Hirokawa N, 2000, TRAFFIC, V1, P29, DOI 10.1034/j.1600-0854.2000.010105.x; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hirokawa N, 2000, NEWS PHYSIOL SCI, V15, P56; Hu YZ, 2006, MOL CELL BIOL, V26, P3282, DOI 10.1128/MCB.26.8.3282-3294.2006; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pulido R, 2008, FEBS J, V275, P848, DOI 10.1111/j.1742-4658.2008.06250.x; Takagaki K, 2007, MOL CELL BIOCHEM, V296, P177, DOI 10.1007/s11010-006-9313-5; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Vasudevan SA, 2005, BIOCHEM BIOPH RES CO, V330, P511, DOI 10.1016/j.bbrc.2005.03.028; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; Yu W, 2007, ONCOGENE, V26, P1178, DOI 10.1038/sj.onc.1209899	22	40	41	2	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					752	761		10.1038/onc.2008.431	http://dx.doi.org/10.1038/onc.2008.431			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	19043453				2022-12-25	WOS:000263076400012
J	Mileykovskaya, E; Ryan, AC; Mo, X; Lin, CC; Khalaf, KI; Dowhan, W; Garrett, TA				Mileykovskaya, Eugenia; Ryan, Andrea C.; Mo, Xi; Lin, Chun-Chieh; Khalaf, Khaled I.; Dowhan, William; Garrett, Teresa A.			Phosphatidic Acid and N-Acylphosphatidylethanolamine Form Membrane Domains in Escherichia coli Mutant Lacking Cardiolipin and Phosphatidylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION-SITE SELECTION; OSMOSENSORY TRANSPORTER PROP; TANDEM MASS-SPECTROMETRY; PGSA NULL MUTANT; ACYL-PHOSPHATIDYLETHANOLAMINE; ELECTROSPRAY-IONIZATION; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; ACRIDINE-ORANGE; CELL-DIVISION	The pgsA null Escherichia coli strain, UE54, lacks the major anionic phospholipids phosphatidylglycerol and cardiolipin. Despite these alterations the strain exhibits relatively normal cell division. Analysis of the UE54 phospholipids using negativeion electrospray ionization mass spectrometry resulted in identification of a new anionic phospholipid, N-acylphosphatidylethanolamine. Staining with the fluorescent dye 10-N-nonyl acridine orange revealed anionic phospholipid membrane domains at the septal and polar regions. Making UE54 null in minCDE resulted in budding off of minicells from polar domains. Analysis of lipid composition by mass spectrometry revealed that minicells relative to parent cells were significantly enriched in phosphatidic acid and N-acylphosphatidylethanolamine. Thus despite the absence of cardiolipin, which forms membrane domains at the cell pole and division sites in wildtype cells, the mutant cells still maintain polar/septal localization of anionic phospholipids. These three anionic phospholipids share common physical properties that favor polar/septal domain formation. The findings support the proposed role for anionic phospholipids in organizing amphitropic cell division proteins at specific sites on the membrane surface.	[Mileykovskaya, Eugenia; Mo, Xi; Lin, Chun-Chieh; Khalaf, Khaled I.; Dowhan, William] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ryan, Andrea C.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Garrett, Teresa A.] Vassar Coll, Dept Chem, Poughkeepsie, NY 12604 USA	University of Texas System; University of Texas Health Science Center Houston; Duke University; Vassar College	Mileykovskaya, E (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	Eugenia.Mileykovskaya@uth.tmc.edu; William.Dowhan@uth.tmc.edu; tegarrett@vassar.edu		Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health [GM R37-20478]; LIPID MAPS Large Scale Collaborative [GM-069338]; Johns Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478, U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LIPID MAPS Large Scale Collaborative; Johns Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM R37-20478 (to W. D.). This work was also supported by the LIPID MAPS Large Scale Collaborative (Grant GM-069338) and by funds from the Johns Dunn Research Foundation (to W. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bernal P, 2007, ENVIRON MICROBIOL, V9, P1135, DOI 10.1111/j.1462-2920.2006.01236.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chapman KD, 2000, CHEM PHYS LIPIDS, V108, P221, DOI 10.1016/S0009-3084(00)00198-5; Corbin BD, 2002, EMBO J, V21, P1998, DOI 10.1093/emboj/21.8.1998; Cravatt BF, 2004, J NEUROBIOL, V61, P149, DOI 10.1002/neu.20080; Cytrynbaum EN, 2007, BIOPHYS J, V93, P1134, DOI 10.1529/biophysj.106.097162; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Dowhan W, 2004, BBA-BIOMEMBRANES, V1666, P19, DOI 10.1016/j.bbamem.2004.04.010; Drew DA, 2005, P NATL ACAD SCI USA, V102, P6114, DOI 10.1073/pnas.0502037102; Garrett TA, 2007, METHOD ENZYMOL, V432, P117, DOI 10.1016/S0076-6879(07)32005-3; Ghosh AS, 2005, J BACTERIOL, V187, P1913, DOI 10.1128/JB.187.6.1913-1922.2005; Hansen HS, 1998, BIOCHEM PHARMACOL, V55, P719, DOI 10.1016/S0006-2952(97)00396-1; Helmy FM, 2002, JPC-J PLANAR CHROMAT, V15, P23, DOI 10.1556/JPC.15.2002.1.4; Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P1, DOI 10.1016/j.jasms.2003.08.006; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12865, DOI 10.1074/jbc.M513864200; KATES M, 1993, LIPIDS, V28, P877, DOI 10.1007/BF02537494; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Kikuchi S, 2000, J BACTERIOL, V182, P371, DOI 10.1128/JB.182.2.371-376.2000; Koivusalo M, 2001, J LIPID RES, V42, P663; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Koppelman CM, 2001, J BACTERIOL, V183, P6144, DOI 10.1128/JB.183.20.6144-6147.2001; Lai EM, 2004, MOL MICROBIOL, V52, P1029, DOI 10.1111/j.1365-2958.2004.04040.x; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Matsumoto K, 2001, MOL MICROBIOL, V39, P1427, DOI 10.1046/j.1365-2958.2001.02320.x; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Merkel O, 2005, BBA-MOL CELL BIOL L, V1734, P215, DOI 10.1016/j.bbalip.2005.03.004; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Mileykovskaya E, 2005, BIOCHEMISTRY-MOSCOW+, V70, P154, DOI 10.1007/s10541-005-0095-2; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2001, FEBS LETT, V507, P187, DOI 10.1016/S0014-5793(01)02948-9; Mileykovskaya E, 2007, MOL MICROBIOL, V64, P1419, DOI 10.1111/j.1365-2958.2007.05766.x; Nagahama H, 2006, J GEN APPL MICROBIOL, V52, P91, DOI 10.2323/jgam.52.91; Norris V, 2004, FEBS LETT, V561, P3, DOI 10.1016/S0014-5793(04)00135-8; OKUYAMA H, 1976, J BIOL CHEM, V251, P2487; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Rahman MM, 2000, MICROBIOL-UK, V146, P1901, DOI 10.1099/00221287-146-8-1901; Rawyler AJ, 2001, PLANT PHYSIOL, V127, P240, DOI 10.1104/pp.127.1.240; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Rosch JW, 2007, J BACTERIOL, V189, P801, DOI 10.1128/JB.01549-06; Schaaf G, 2006, ACTA CRYSTALLOGR F, V62, P1156, DOI 10.1107/S1744309106041728; Shangguan T, 1998, BBA-BIOMEMBRANES, V1368, P171, DOI 10.1016/S0005-2736(97)00151-X; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; SNIDER MD, 1977, J BACTERIOL, V130, P1072, DOI 10.1128/JB.130.3.1072-1083.1977; Suzuki M, 2002, J BACTERIOL, V184, P5418, DOI 10.1128/JB.184.19.5418-5425.2002; TEATHER RM, 1974, J BACTERIOL, V118, P407, DOI 10.1128/JB.118.2.407-413.1974; Vermehren C, 2003, INT J PHARMACEUT, V254, P49, DOI 10.1016/S0378-5173(02)00681-6; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999	54	60	61	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2990	3000		10.1074/jbc.M805189200	http://dx.doi.org/10.1074/jbc.M805189200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049984	Green Published, hybrid			2022-12-25	WOS:000262700900043
J	Hui, DW; Kumar, KN; Mach, JR; Srinivasan, A; Pal, R; Bao, XD; Agbas, A; Hoefner, G; Wanner, KT; Michaelis, EK				Hui, Dongwei; Kumar, Keshava N.; Mach, Julie R.; Srinivasan, Ashik; Pal, Ranu; Bao, Xiaodong; Agbas, Abdulbaki; Hoefner, Georg; Wanner, Klaus T.; Michaelis, Elias K.			A Rat Brain Bicistronic Gene with an Internal Ribosome Entry Site Codes for a Phencyclidine-binding Protein with Cytotoxic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-D-ASPARTATE; RNA SECONDARY STRUCTURE; NMDA RECEPTOR COMPLEX; GLUTAMATE-BINDING; SYNAPTIC-MEMBRANES; MESSENGER-RNA; IMMUNOCHEMICAL CHARACTERIZATION; GLYCINE-BINDING; PURIFICATION; EXPRESSION	The cloning and characterization of the gene for the fourth subunit of a glutamate-binding protein complex in rat brain synaptic membranes are described. The cloned rat brain cDNA contained two open reading frames (ORFs) encoding 8.9-(PRO1) and 9.5kDa (PRO2) proteins. The cDNA sequence matched contiguous genomic DNA sequences in rat chromosome 17. Both ORFs were expressed within the structure of a single brain mRNA and antibodies against unique sequences in PRO1- and PRO2-labeled brain neurons in situ, indicative of bicistronic gene expression. Dicistronic vectors in which ORF1 and ORF2 were substituted by either two different fluorescent proteins or two luciferases indicated concurrent, yet independent translation of the two ORFs. Transfection with noncapped mRNA led to cap-independent translation of only ORF2 through an internal ribosome entry sequence preceding ORF2. In vitro or cell expression of the cloned cDNA led to the formation of multimeric protein complexes containing both PRO1 and PRO2. These complexes had low affinity (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (MK-801)-sensitive phencyclidine-binding sites. Overexpression of PRO1 and PRO2 in CHO cells, but not neuroblastoma cells, caused cell death within 24 -48 h. The cytotoxicity was blocked by concurrent treatment with MK-801 or by two tetrahydroisoquinolines that bind to phencyclidine sites in neuronal membranes. Co-expression of two of the other subunits of the protein complex together with PRO1/PRO2 abrogated the cytotoxic effect without altering PRO1/PRO2 protein levels. Thus, this rare mammalian bicistronic gene coded for two tightly interacting brain proteins forming a low affinity phencyclidine-binding entity in a synaptic membrane complex.	[Hui, Dongwei; Kumar, Keshava N.; Mach, Julie R.; Srinivasan, Ashik; Pal, Ranu; Bao, Xiaodong; Agbas, Abdulbaki; Michaelis, Elias K.] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66047 USA; [Kumar, Keshava N.; Hoefner, Georg; Michaelis, Elias K.] Univ Kansas, Ctr Neurobiol & Immunol Res, Lawrence, KS 66047 USA; [Wanner, Klaus T.] Univ Munich, Dept Pharm, Zentrum Pharmaforsch, D-81377 Munich, Germany	University of Kansas; University of Kansas; University of Munich	Michaelis, EK (corresponding author), Univ Kansas, Dept Pharmacol & Toxicol, 5064 Malott Hall,1251 Wescoe Dr, Lawrence, KS 66045 USA.	emichaelis@ku.edu			National Institutes of Health [AA11419, AA04732]; National Institute on Alcohol Abuse and Aging [AG12993, HD02528]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG012993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA004732, R01AA011419, R37AA004732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA11419 and AA04732 (National Institute on Alcohol Abuse and Aging), AG12993 (NICHD), and HD02528 (NIA). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agbas A, 2005, BRAIN RES, V1059, P59, DOI 10.1016/j.brainres.2005.08.008; Agbas A, 2002, FREE RADICAL BIO MED, V32, P512, DOI 10.1016/S0891-5849(01)00818-8; Aistrup GL, 1996, FEBS LETT, V394, P141, DOI 10.1016/0014-5793(96)00938-6; ATKINS JF, 1990, CELL, V62, P413, DOI 10.1016/0092-8674(90)90007-2; Babcock KK, 1996, NEUROCHEM INT, V29, P507, DOI 10.1016/0197-0186(96)00019-8; Bonaglia MC, 2005, EUR J HUM GENET, V13, P586, DOI 10.1038/sj.ejhg.5201369; CHEN JW, 1988, J BIOL CHEM, V263, P417; CUNNINGHAM MD, 1990, J BIOL CHEM, V265, P7768; EATON MJ, 1990, J BIOL CHEM, V265, P16195; EGGEMAN KT, 1993, NEUROSCI LETT, V158, P173, DOI 10.1016/0304-3940(93)90257-L; Hirbec H, 2002, J NEUROSCI RES, V68, P305, DOI 10.1002/jnr.10203; Hofner G, 1996, J RECEPT SIGNAL TR R, V16, P297, DOI 10.3109/10799899609039953; IKIN AF, 1990, BIOCHEMISTRY-US, V29, P2290, DOI 10.1021/bi00461a012; JACKSON RJ, 1994, MOL BIOL REP, V19, P147, DOI 10.1007/BF00986957; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KUMAR KN, 1991, NATURE, V354, P70, DOI 10.1038/354070a0; KUMAR KN, 1994, J BIOL CHEM, V269, P27384; Kumar KN, 1998, BIOCHEM BIOPH RES CO, V253, P463, DOI 10.1006/bbrc.1998.9800; KUMAR KN, 1995, BIOCHEM BIOPH RES CO, V216, P390, DOI 10.1006/bbrc.1995.2636; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Ludwig M, 2003, HETEROCYCLES, V61, P299; LUDWIG M, 1998, THESIS LUDWIGMAXIMIL; Ludwig M, 2006, EUR J MED CHEM, V41, P1003, DOI 10.1016/j.ejmech.2006.03.005; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Michaelis EK, 1996, J NEUROCHEM, V67, P201; Pal R, 2003, BRAIN RES, V994, P1, DOI 10.1016/j.brainres.2003.08.046; Pal R, 1999, NEUROSCIENCE, V94, P1291, DOI 10.1016/S0306-4522(99)00386-3; Palecek J, 1999, EUR J NEUROSCI, V11, P827, DOI 10.1046/j.1460-9568.1999.00489.x; PELLEGRINIGIAMPIETRO DE, 1991, P NATL ACAD SCI USA, V88, P4157, DOI 10.1073/pnas.88.10.4157; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; SHERRIFFS HJ, 1993, EUR J PHARM-MOLEC PH, V247, P319, DOI 10.1016/0922-4106(93)90201-J; STERN P, 1992, P ROY SOC B-BIOL SCI, V250, P271, DOI 10.1098/rspb.1992.0159; Tsuchida H, 2001, BIOCHEM BIOPH RES CO, V280, P1189, DOI 10.1006/bbrc.2001.4255; WANG H, 1992, NEUROSCIENCE, V46, P793, DOI 10.1016/0306-4522(92)90186-6; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; XIA Y, 1995, NEUROCHEM RES, V20, P617, DOI 10.1007/BF01694545; Zhao H, 2006, GENES GENET SYST, V81, P41, DOI 10.1266/ggs.81.41	40	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2245	2257		10.1074/jbc.M807063200	http://dx.doi.org/10.1074/jbc.M807063200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028684	Green Published, hybrid			2022-12-25	WOS:000262545600034
J	Kummer, MP; Maruyama, H; Huelsmann, C; Baches, S; Weggen, S; Koo, EH				Kummer, Markus P.; Maruyama, Hiroko; Huelsmann, Claudia; Baches, Sandra; Weggen, Sascha; Koo, Edward H.			Formation of Pmel17 Amyloid Is Regulated by Juxtamembrane Metalloproteinase Cleavage, and the Resulting C-terminal Fragment Is a Substrate for gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; MATRIX PROTEIN PMEL17/GP100; PRECURSOR PROTEIN; INTRAMEMBRANE PROTEOLYSIS; CONVERTING ENZYME; SILVER; MELANOCYTES; ACTIVATION; PRESENILIN; DOMAIN	The formation of insoluble cross beta-sheet amyloid is pathologically associated with disorders such as Alzheimer, Parkinson, and Huntington diseases. One exception is the nonpathological amyloid derived from the protein Pmel17 within melanosomes to generate melanin pigment. Here we show that the formation of insoluble M alpha C intracellular fragments of Pmel17, which are the direct precursors to Pmel17 amyloid, depends on a novel juxtamembrane cleavage at amino acid position 583 between the furin-like proprotein convertase cleavage site and the transmembrane domain. The resulting Pmel17 C-terminal fragment is then processed by the gamma-secretase complex to release a shortlived intracellular domain fragment. Thus, by analogy to the Notch receptor, we designate this cleavage the S2 cleavage site, whereas gamma-secretase mediates proteolysis at the intramembrane S3 site. Substitutions or deletions at this S2 cleavage site, the use of the metalloproteinase inhibitor TAPI-2, as well as small interfering RNA-mediated knock-down of the metalloproteinases ADAM10 and 17 reduced the formation of insoluble Pmel17 fragments. These results demonstrate that the release of the Pmel17 ectodomain, which is critical for melanin amyloidogenesis, is initiated by S2 cleavage at a juxtamembrane position.	[Kummer, Markus P.; Maruyama, Hiroko; Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Baches, Sandra; Weggen, Sascha] Univ Dusseldorf, Mol Neuropathol Grp, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Kummer, Markus P.; Huelsmann, Claudia] Univ Bonn, Clin Neurosci Grp, Dept Neurol, D-53127 Bonn, Germany	University of California System; University of California San Diego; Heinrich Heine University Dusseldorf; University of Bonn	Koo, EH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	edkoo@ucsd.edu	Kummer, Markus/A-3860-2009	Kummer, Markus P./0000-0002-0993-2918	National Institutes of Health [AG12376]; Deutsche Forschungsgemeinschaft Emmy Noether Program [WE 2561/1-3]; NATIONAL INSTITUTE ON AGING [R01AG012376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Emmy Noether Program(German Research Foundation (DFG)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG12376 (to E. H. K.). This work was also supported by Deutsche Forschungsgemeinschaft Emmy Noether Program Grant WE 2561/1-3 (to S. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADEMA GJ, 1994, J BIOL CHEM, V269, P20126; ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; Canet-Aviles RM, 2002, MOL BRAIN RES, V102, P62, DOI 10.1016/S0169-328X(02)00184-5; Chen CD, 2001, EMBO J, V20, P6277, DOI 10.1093/emboj/20.22.6277; Cheng QC, 2003, J BIOL CHEM, V278, P38421, DOI 10.1074/jbc.M302111200; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Hu DN, 1997, EXP EYE RES, V64, P397, DOI 10.1006/exer.1996.0223; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Hwang EM, 2006, BIOCHEM BIOPH RES CO, V349, P654, DOI 10.1016/j.bbrc.2006.08.077; Kang TB, 2002, J BIOL CHEM, V277, P25583, DOI 10.1074/jbc.M203532200; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; KWON BS, 1995, NUCLEIC ACIDS RES, V23, P154, DOI 10.1093/nar/23.1.154; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; MARESH GA, 1994, ARCH BIOCHEM BIOPHYS, V311, P95, DOI 10.1006/abbi.1994.1213; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Page LJ, 2005, EMBO J, V24, P4124, DOI 10.1038/sj.emboj.7600872; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SPANAKIS E, 1992, DEVELOPMENT, V114, P675; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Yang HQ, 2007, EUR J NEUROSCI, V26, P381, DOI 10.1111/j.1460-9568.2007.05648.x; Yasumoto K, 2004, J BIOL CHEM, V279, P28330, DOI 10.1074/jbc.M401269200	48	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2296	2306		10.1074/jbc.M808904200	http://dx.doi.org/10.1074/jbc.M808904200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047044	hybrid, Green Published			2022-12-25	WOS:000262545600039
J	Lima, WF; Murray, H; Nichols, JG; Wu, HJ; Sun, H; Prakash, TP; Berdeja, AR; Gaus, HJ; Crooke, ST				Lima, Walt F.; Murray, Heather; Nichols, Josh G.; Wu, Hongjiang; Sun, Hong; Prakash, Thazha P.; Berdeja, Andres R.; Gaus, Hans J.; Crooke, Stanley T.			Human Dicer Binds Short Single-strand and Double-strand RNA with High Affinity and Interacts with Different Regions of the Nucleic Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGONAUTE2 PAZ DOMAIN; OLIGONUCLEOTIDE DUPLEXES; CAENORHABDITIS-ELEGANS; MAMMALIAN-CELLS; INTERFERING-RNA; C-ELEGANS; EXPRESSION; RIBONUCLEASE; SPECIFICITY; COMPLEXES	Human Dicer is an integral component of the RNA interference pathway. Dicer processes premicro-RNA and double-strand RNA to, respectively, mature micro-RNA and short interfering RNA (siRNA) and transfers the processed products to the RNA-induced silencing complex. To better understand the factors that are important for the binding, translocation, and selective recognition of the siRNA strands, we determined the binding affinities of human Dicer for processed products (siRNA) and short single-strand RNAs (ssRNA). siRNAs and ssRNAs competitively inhibited human Dicer activity, suggesting that they are interacting with the active site of the enzyme. The dissociation constants (K-d) for unmodified siRNAs were 5-11-fold weaker compared with a 27-nucleotide double-strand RNA substrate. Chemically modified siRNAs exhibited binding affinities for Dicer comparable with the substrate. 3'-Dinucleotide overhangs in the siRNA affected the binding affinity of human Dicer for the siRNA and biased strand loading into RNA-induced silencing complex. The K-d values for the ssRNAs ranged from 3- to 40-fold weaker than the K-d for the substrate. Sequence composition of the 3'-terminal nucleotides of the ssRNAs exhibited the greatest effect on Dicer binding. Dicer cleaved substrates containing short siRNA-like double-strand regions and extended 3' or 5' ssRNA overhangs in the adjacent ssRNA regions. Remarkably, cleavage sites were observed consistent with the enzyme entering the substrate from the extended 3' ssRNA terminus. These data suggest that the siRNAs and ssRNAs interact predominantly with the PAZ domain of the enzyme. Finally, the tightest binding siRNAs were also more potent inhibitors of gene expression.	[Lima, Walt F.; Murray, Heather; Nichols, Josh G.; Wu, Hongjiang; Sun, Hong; Prakash, Thazha P.; Berdeja, Andres R.; Gaus, Hans J.; Crooke, Stanley T.] ISIS Pharmaceut, Dept Mol & Struct Biol, Carlsbad, CA 92008 USA	Isis Pharmaceuticals Inc	Lima, WF (corresponding author), ISIS Pharmaceut, Dept Mol & Struct Biol, 1896 Rutherford Rd, Carlsbad, CA 92008 USA.	wlima@isisph.com	Murray, Heather/GQY-8016-2022	Gaus, Hans/0000-0002-7471-8619				Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; BOULTA A, 2003, OLIGONUCLEOTIDES, V13, P295; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hohjoh H, 2002, FEBS LETT, V521, P195, DOI 10.1016/S0014-5793(02)02860-0; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee HS, 2007, J MOL GRAPH MODEL, V25, P784, DOI 10.1016/j.jmgm.2006.07.002; Lima WF, 1997, BIOCHEMISTRY-US, V36, P390, DOI 10.1021/bi962230p; Lima WF, 1997, J BIOL CHEM, V272, P27513, DOI 10.1074/jbc.272.44.27513; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Vickers TA, 2007, NUCLEIC ACIDS RES, V35, P6598, DOI 10.1093/nar/gkm663; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	34	35	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2535	2548		10.1074/jbc.M803748200	http://dx.doi.org/10.1074/jbc.M803748200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017633	hybrid			2022-12-25	WOS:000262545600059
J	Moore, TI; Chou, CS; Nie, Q; Jeon, NL; Yi, TM				Moore, Travis I.; Chou, Ching-Shan; Nie, Qing; Jeon, Noo Li; Yi, Tau-Mu			Robust Spatial Sensing of Mating Pheromone Gradients by Yeast Cells	PLOS ONE			English	Article								Projecting or moving up a chemical gradient is a universal behavior of living organisms. We tested the ability of S. cerevisiae a-cells to sense and respond to spatial gradients of the mating pheromone alpha-factor produced in a microfluidics chamber; the focus was on bar1 Delta strains, which do not degrade the pheromone input. The yeast cells exhibited good accuracy with the mating projection typically pointing in the correct direction up the gradient (similar to 80% under certain conditions), excellent sensitivity to shallow gradients, and broad dynamic range so that gradient-sensing was relatively robust over a 1000-fold range of average alpha-factor concentrations. Optimal directional sensing occurred at lower concentrations (5 nM) close to the K-d of the receptor and with steeper gradient slopes. Pheromone supersensitive mutations (sst2 Delta and ste2(300 Delta)) that disrupt the down-regulation of heterotrimeric G-protein signaling caused defects in both sensing and response. Interestingly, yeast cells employed adaptive mechanisms to increase the robustness of the process including filamentous growth (i. e. directional distal budding) up the gradient at low pheromone concentrations, bending of the projection to be more aligned with the gradient, and forming a more accurate second projection when the first projection was in the wrong direction. Finally, the cells were able to amplify a shallow external gradient signal of alpha-factor to produce a dramatic polarization of signaling proteins at the front of the cell. Mathematical modeling revealed insights into the mechanism of this amplification and how the supersensitive mutants can disrupt accurate polarization. Together, these data help to specify and elucidate the abilities of yeast cells to sense and respond to spatial gradients of pheromone.	[Yi, Tau-Mu] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Moore, Travis I.; Chou, Ching-Shan; Nie, Qing; Jeon, Noo Li; Yi, Tau-Mu] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92717 USA; [Chou, Ching-Shan; Nie, Qing] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Jeon, Noo Li] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Moore, TI (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	tmy@uci.edu	Shu, Chi-Wang/A-3216-2013; Moore, Travis/C-7963-2009	Shu, Chi-Wang/0000-0001-7720-9564; Moore, Travis/0000-0002-8503-6023	NIH [R01GM75309, P50GM76516]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516, R01GM075309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH grants R01GM75309 (through the joint NSF/NIGMS initiative to support research in the area of mathematical biology) to QN and TMY, and P50GM76516 to QN and TMY.	Arkowitz RA, 1997, J CELL BIOL, V138, P17, DOI 10.1083/jcb.138.1.17; Ash J, 2003, GENETICS, V163, P9; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022; BERG JM, 2007, BIOCHEMISTRY; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Dosil M, 2000, MOL CELL BIOL, V20, P5321, DOI 10.1128/MCB.20.14.5321-5329.2000; Erdman S, 2001, GENETICS, V159, P919; Gilman AG, 2002, NATURE, V420, P703, DOI 10.1038/nature01304; Giot L, 1997, MOL BIOL CELL, V8, P987, DOI 10.1091/mbc.8.6.987; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Guthrie C, 1991, GUIDE YEAST GENETICS; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hardman J. G., 1996, GOODMAN GILMANS PHAR; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; JACKSON CL, 1990, CELL, V63, P1039, DOI 10.1016/0092-8674(90)90507-B; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; KONOPKA JB, 1995, MOL CELL BIOL, V15, P723; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Manahan CL, 2000, MOL BIOL CELL, V11, P957, DOI 10.1091/mbc.11.3.957; Metodiev MV, 2002, SCIENCE, V296, P1483, DOI 10.1126/science.1070540; Moukadiri I, 1999, J BACTERIOL, V181, P4741, DOI 10.1128/JB.181.16.4741-4745.1999; Nern A, 2000, MOL CELL, V5, P853, DOI 10.1016/S1097-2765(00)80325-1; Nern A, 1998, NATURE, V391, P195, DOI 10.1038/34458; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pruyne D, 2000, J CELL SCI, V113, P365; Rasband W., 2006, IMAGEJ; Rodiek R.W., 1998, 1 STEPS SEEING; ROHRER J, 1993, MOL BIOL CELL, V4, P511, DOI 10.1091/mbc.4.5.511; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SNYDER M, 1989, J CELL BIOL, V108, P1419, DOI 10.1083/jcb.108.4.1419; SPRAGUE GF, 1992, PHEROMONE RESPONSE S, P657; Stefan CJ, 1999, J BIOL CHEM, V274, P1835, DOI 10.1074/jbc.274.3.1835; Vallier LG, 2002, CELL MOTIL CYTOSKEL, V53, P251, DOI 10.1002/cm.10073; Yi TM, 2007, J STAT PHYS, V128, P193, DOI 10.1007/s10955-007-9285-1; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100	41	83	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3865	10.1371/journal.pone.0003865	http://dx.doi.org/10.1371/journal.pone.0003865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052645	Green Published, gold			2022-12-25	WOS:000265452200011
J	Panagiotou, G; Andersen, MR; Grotkjaer, T; Regueira, TB; Hofmann, G; Nielsen, J; Olsson, L				Panagiotou, Gianni; Andersen, Mikael R.; Grotkjaer, Thomas; Regueira, Torsten B.; Hofmann, Gerald; Nielsen, Jens; Olsson, Lisbeth			Systems Analysis Unfolds the Relationship between the Phosphoketolase Pathway and Growth in Aspergillus nidulans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CDNA MICROARRAYS; METABOLIC FLUXES; WILD-TYPE; GLUCOSE; IDENTIFICATION; NORMALIZATION; ENZYMES; XYLOSE; FLAVUS	Background: Aspergillus nidulans is an important model organism for studies on fundamental eukaryotic cell biology and on industrial processes due to its close relation to A. niger and A. oryzae. Here we identified the gene coding for a novel metabolic pathway in A. nidulans, namely the phosphoketolase pathway, and investigated the role of an increased phosphoketolase activity. Methodology/Principal Findings: Over-expression of the phosphoketolase gene (phk) improved the specific growth rate on xylose, glycerol and ethanol. Transcriptome analysis showed that a total of 1,222 genes were significantly affected by overexpression of the phk, while more than half of the affected genes were carbon source specific. During growth on glucose medium, the transcriptome analysis showed that the response to phk over-expression is targeted to neutralize the effect of the over-expression by regulating the acetate metabolism and initiate a growth dampening response. Conclusions/Significance: Metabolic flux analysis using C-13-labelled glucose, showed that over-expression of phosphoketolase added flexibility to the central metabolism. Our findings further suggests that A. nidulans is not optimized for growth on xylose, glycerol or ethanol as the sole carbon sources.	[Panagiotou, Gianni; Andersen, Mikael R.; Regueira, Torsten B.; Hofmann, Gerald; Nielsen, Jens; Olsson, Lisbeth] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Grotkjaer, Thomas] Fluxome Sci AS, Lyngby, Denmark	Technical University of Denmark	Panagiotou, G (corresponding author), Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark.	lo@bio.dtu.dk	Panagiotou, Ioannis/B-7083-2013; Andersen, Mikael R/F-9377-2013; Andersen, Mikael Rørdam/P-6743-2019; Nielsen, Jens/Q-1347-2017	Andersen, Mikael R/0000-0003-4794-6808; Andersen, Mikael Rørdam/0000-0003-4794-6808; /0000-0002-0827-5442; Nielsen, Jens/0000-0002-9955-6003	Villum Kann Rasmussen and Lundbeck foundations; Danish Research Agency for Technology and Production	Villum Kann Rasmussen and Lundbeck foundations; Danish Research Agency for Technology and Production	This study was partly financed by the Villum Kann Rasmussen and Lundbeck foundations (GP) and the Danish Research Agency for Technology and Production (MRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; *AFF, 2007, PN702232; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Andersen MR, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.12; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Christensen B, 2000, BIOTECHNOL BIOENG, V68, P652, DOI 10.1002/(SICI)1097-0290(20000620)68:6<652::AID-BIT8>3.3.CO;2-A; David H, 2005, MICROBIOL-SGM, V151, P2209, DOI 10.1099/mic.0.27787-0; David H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r108; Guo BZ, 2003, J TOXICOL-TOXIN REV, V22, P287, DOI 10.1081/TXR-120024095; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JOHNSTONE IL, 1985, EMBO J, V4, P1307, DOI 10.1002/j.1460-2075.1985.tb03777.x; Maeda H, 2004, APPL MICROBIOL BIOT, V65, P74, DOI 10.1007/s00253-004-1608-4; Mogensen J, 2006, FUNGAL GENET BIOL, V43, P593, DOI 10.1016/j.fgb.2006.03.003; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; OBrian GR, 2003, FUNGAL GENET BIOL, V39, P118, DOI 10.1016/S1087-1845(03)00014-8; OLIVEIRA AP, 2008, BMC BIOINFO IN PRESS; Panagiotou G, 2007, METABOLOMICS, V3, P503, DOI 10.1007/s11306-007-0061-7; PANAGIOTOU G, 2008, METABOLIC E IN PRESS; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Pedersen H, 1999, APPL ENVIRON MICROB, V65, P11; RATLEDGE C, 1985, APPL MICROBIOL BIOT, V22, P217; ROHR LM, 2005, APPL MICROBIOL BIOT, V68, P567; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; Sambrook J., 2001, MOL CLONING; Scheidegger KA, 2003, J TOXICOL-TOXIN REV, V22, P423, DOI 10.1081/TXR-120024100; SENAC T, 1990, APPL ENVIRON MICROB, V56, P120, DOI 10.1128/AEM.56.1.120-126.1990; Sims AH, 2004, FUNGAL GENET BIOL, V41, P199, DOI 10.1016/j.fgb.2003.11.005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Thykaer J, 2007, PROCESS BIOCHEM, V42, P1050, DOI 10.1016/j.procbio.2007.04.004; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187	31	33	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3847	10.1371/journal.pone.0003847	http://dx.doi.org/10.1371/journal.pone.0003847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052639	Green Published, Green Submitted, gold			2022-12-25	WOS:000265452200004
J	Shaw, LN; Lindholm, C; Prajsnar, TK; Miller, HK; Brown, MC; Golonka, E; Stewart, GC; Tarkowski, A; Potempa, J				Shaw, Lindsey N.; Lindholm, Catharina; Prajsnar, Tomasz K.; Miller, Halie K.; Brown, Melanie C.; Golonka, Ewa; Stewart, George C.; Tarkowski, Andrej; Potempa, Jan			Identification and Characterization of sigma(S), a Novel Component of the Staphylococcus aureus Stress and Virulence Responses	PLOS ONE			English	Article								S. aureus is a highly successful pathogen that is speculated to be the most common cause of human disease. The progression of disease in S. aureus is subject to multi-factorial regulation, in response to the environments encountered during growth. This adaptive nature is thought to be central to pathogenesis, and is the result of multiple regulatory mechanisms employed in gene regulation. In this work we describe the existence of a novel S. aureus regulator, an as yet uncharacterized ECF-sigma factor (sigma(S)), that appears to be an important component of the stress and pathogenic responses of this organism. Using biochemical approaches we have shown that sigma(S) is able to associates with core-RNAP, and initiate transcription from its own coding region. Using a mutant strain we determined that sigma(S) is important for S. aureus survival during starvation, extended exposure to elevated growth temperatures, and Triton X-100 induced lysis. Coculture studies reveal that a sigma(S) mutant is significantly outcompeted by its parental strain, which is only exacerbated during prolonged growth (7 days), or in the presence of stressor compounds. Interestingly, transcriptional analysis determined that under standard conditions, S. aureus SH1000 does not initiate expression of sigS. Assays performed hourly for 72h revealed expression in typically background ranges. Analysis of a potential anti-sigma factor, encoded downstream of sigS, revealed it to have no obvious role in the upregulation of sigS expression. Using a murine model of septic arthritis, sigS-mutant infected animals lost significantly less weight, developed septic arthritis at significantly lower levels, and had increased survival rates. Studies of mounted immune responses reveal that sigS-mutant infected animals had significantly lower levels of IL-6, indicating only a weak immunological response. Finally, strains of S. aureus lacking sigS were far less able to undergo systemic dissemination, as determined by bacterial loads in the kidneys of infected animals. These results establish that sigma(S) is an important component in S. aureus fitness, and in its adaptation to stress. Additionally it appears to have a significant role in its pathogenic nature, and likely represents a key component in the S. aureus regulatory network.	[Shaw, Lindsey N.; Miller, Halie K.] Univ S Florida, Dept Biol, Tampa, FL 33620 USA; [Lindholm, Catharina; Golonka, Ewa] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Prajsnar, Tomasz K.; Tarkowski, Andrej; Potempa, Jan] Jagiellonian Univ, Fac Biotechnol, Dept Microbiol, PL-31007 Krakow, Poland; [Brown, Melanie C.; Potempa, Jan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Stewart, George C.] Univ Missouri, Bond Life Sci Ctr, Dept Vet Pathobiol, Columbia, MO 65211 USA	State University System of Florida; University of South Florida; University of Gothenburg; Jagiellonian University; University System of Georgia; University of Georgia; University of Missouri System; University of Missouri Columbia	Shaw, LN (corresponding author), Univ S Florida, Dept Biol, Tampa, FL 33620 USA.	lshaw@cas.usf.edu	Potempa, Jan/AAA-6850-2021; Shaw, Lindsey/AAI-1741-2020	Shaw, Lindsey/0000-0002-0629-8990; Prajsnar, Tomasz/0000-0001-6562-8630; Miller, Halie/0000-0001-5004-0789; Golonka, Ewa/0000-0002-4013-8616; Potempa, Jan/0000-0002-3600-7461	University of South Florida; Swedish Medical Research Council	University of South Florida; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	The financial support for this project was provided by start up funds from the University of South Florida (LNS) and the Swedish Medical Research Council (AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai K, 2003, FEMS MICROBIOL LETT, V220, P155, DOI 10.1016/S0378-1097(03)00093-4; Bae JB, 2004, J MOL BIOL, V335, P425, DOI 10.1016/j.jmb.2003.10.065; Bashyam MD, 2004, INFECT GENET EVOL, V4, P301, DOI 10.1016/j.meegid.2004.04.003; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Cheung AL, 2002, FRONT BIOSCI-LANDMRK, V7, pD1825, DOI 10.2741/cheung; CHI E, 1995, MOL MICROBIOL, V17, P713, DOI 10.1111/j.1365-2958.1995.mmi_17040713.x; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; DEORA R, 1995, BIOCHEM BIOPH RES CO, V208, P610, DOI 10.1006/bbrc.1995.1382; Doherty N, 2006, J BACTERIOL, V188, P2885, DOI 10.1128/JB.188.8.2885-2897.2006; Fernandes ND, 1999, J BACTERIOL, V181, P4266, DOI 10.1128/JB.181.14.4266-4274.1999; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Fujimoto DF, 1998, J BACTERIOL, V180, P3724, DOI 10.1128/JB.180.14.3724-3726.1998; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; GIRAUDO AT, 1994, CAN J MICROBIOL, V40, P677, DOI 10.1139/m94-107; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Heinrich J, 2006, MOL MICROBIOL, V62, P566, DOI 10.1111/j.1365-2958.2006.05391.x; HELLE M, 1988, EUR J IMMUNOL, V18, P1535, DOI 10.1002/eji.1830181010; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Horsburgh MJ, 1999, MOL MICROBIOL, V32, P41, DOI 10.1046/j.1365-2958.1999.01323.x; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Horsburgh MJ, 2001, MICROBIOL-SGM, V147, P2933, DOI 10.1099/00221287-147-11-2933; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; Huang XJ, 1997, J BACTERIOL, V179, P2915, DOI 10.1128/jb.179.9.2915-2921.1997; JANZON L, 1989, MOL GEN GENET, V219, P480, DOI 10.1007/BF00259623; Jonsson IM, 2004, INFECT IMMUN, V72, P6106, DOI 10.1128/IAI.72.10.6106-6111.2004; Keith LMW, 1999, J BACTERIOL, V181, P7176, DOI 10.1128/JB.181.23.7176-7184.1999; KEMP EH, 1991, J BACTERIOL, V173, P4646, DOI 10.1128/jb.173.15.4646-4652.1991; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Koide K, 2007, J BIOL CHEM, V282, P4553, DOI 10.1074/jbc.M607339200; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Makinoshima H, 2006, MICROBES INFECT, V8, P1882, DOI 10.1016/j.micinf.2006.02.021; Matsumoto T, 2005, GENES GENET SYST, V80, P385, DOI 10.1266/ggs.80.385; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Moon JL, 2006, BIOL CHEM, V387, P985, DOI 10.1515/BC.2006.122; Morikawa K, 2003, GENES CELLS, V8, P699, DOI 10.1046/j.1365-2443.2003.00668.x; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; NOVICK RP, 2006, GRAM POSITIVE PATHOG, P496; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Paget MSB, 2001, MOL MICROBIOL, V39, P1036, DOI 10.1046/j.1365-2958.2001.02298.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Qiu DR, 2007, P NATL ACAD SCI USA, V104, P8107, DOI 10.1073/pnas.0702660104; Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000; Resto-Ruiz SI, 2000, INFECT IMMUN, V68, P5970, DOI 10.1128/IAI.68.10.5970-5978.2000; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schmidt KA, 2001, INFECT IMMUN, V69, P4749, DOI 10.1128/IAI.69.8.4749-4758.2001; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Shaw LN, 2007, INFECT IMMUN, V75, P4519, DOI 10.1128/IAI.00491-07; Shaw LN, 2006, J BACTERIOL, V188, P6070, DOI 10.1128/JB.00551-06; Shaw LN, 2005, J BACTERIOL, V187, P1751, DOI 10.1128/JB.187.5.1751-1762.2005; Singh VK, 2007, MICROBIOL-SGM, V153, P3162, DOI 10.1099/mic.0.2007/009506-0; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; Tiwari HK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-156; Torres VJ, 2007, CELL HOST MICROBE, V1, P109, DOI 10.1016/j.chom.2007.03.001; Turner MS, 2000, J BACTERIOL, V182, P5202, DOI 10.1128/JB.182.18.5202-5210.2000; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; WEI ZM, 1995, J BACTERIOL, V177, P6201, DOI 10.1128/jb.177.21.6201-6210.1995; Weigel LM, 2007, ANTIMICROB AGENTS CH, V51, P231, DOI 10.1128/AAC.00576-06; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wu QL, 1997, J BACTERIOL, V179, P2922, DOI 10.1128/jb.179.9.2922-2929.1997; Wu SW, 1996, J BACTERIOL, V178, P6036, DOI 10.1128/jb.178.20.6036-6042.1996; XIAO YX, 1994, J BACTERIOL, V176, P1025, DOI 10.1128/JB.176.4.1025-1036.1994; Yarwood JM, 2001, J BACTERIOL, V183, P1113, DOI 10.1128/JB.183.4.1113-1123.2001; 2002, MMWR MORB MORTAL WKL, V51, P565; 2002, MMWR MORB MORTAL WKL, V51, P902	84	48	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3844	10.1371/journal.pone.0003844	http://dx.doi.org/10.1371/journal.pone.0003844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050758	Green Published, Green Submitted, gold			2022-12-25	WOS:000265452100005
J	Larsen, KS; Xu, J; Cermelli, S; Shu, ZY; Gross, SP				Larsen, Kristoffer S.; Xu, Jing; Cermelli, Silvia; Shu, Zhanyong; Gross, Steven P.			BicaudalD Actively Regulates Microtubule Motor Activity in Lipid Droplet Transport	PLOS ONE			English	Article								Background: A great deal of sub-cellular organelle positioning, and essentially all minus-ended organelle transport, depends on cytoplasmic dynein, but how dynein's function is regulated is not well understood. BicD is established to play a critical role in mediating dynein function-loss of BicD results in improperly localized nuclei, mRNA particles, and a dispersed Golgi apparatus-however exactly what BicD's role is remains unknown. Nonetheless, it is widely believed that BicD may act to tether dynein to cargos. Here we use a combination of biophysical and biochemical studies to investigate BicD's role in lipid droplet transport during Drosophila embryogenesis. Methodology/Principal Findings: Functional loss of BicD impairs the embryo's ability to control the net direction of droplet transport; the developmentally controlled reversal in transport is eliminated. We find that minimal BicD expression (near-BicD(null)) decreases the average run length of both plus and minus end directed microtubule (MT) based transport. A point mutation affecting the BicD N-terminus has very similar effects on transport during cellularization (phase II), but in phase III (gastrulation) motion actually appears better than in the wild-type. Conclusions/Significance: In contrast to a simple static tethering model of BicD function, or a role only in initial dynein recruitment to the cargo, our data uncovers a new dynamic role for BicD in actively regulating transport. Lipid droplets move bi-directionally, and our investigations demonstrate that BicD plays a critical-and temporally changing-role in balancing the relative contributions of plus-end and minus-end motors to control the net direction of transport. Our results suggest that while BicD might contribute to recruitment of dynein to the cargo it is not absolutely required for such dynein localization, and it clearly contributes to regulation, helping activation/inactivation of the motors.			Larsen, KS (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	sgross@uci.edu			NIGMS NIH HHS [GM-07311-29, GM64624, R01 GM064624, T32 GM007311] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064624, T32GM007311] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baens M, 1997, GENOMICS, V45, P601, DOI 10.1006/geno.1997.4971; Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Carter BC, 2005, PHYS BIOL, V2, P60, DOI 10.1088/1478-3967/2/1/008; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; FOE VE, 1983, J CELL SCI, V61, P31; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; MOHLER J, 1985, COLD SPRING HARB SYM, V50, P105, DOI 10.1101/SQB.1985.050.01.015; Oh J, 2000, GENETICS, V154, P713; Petrov DY, 2007, BIOPHYS J, V92, P2953, DOI 10.1529/biophysj.106.097253; SHUBEITA GT, 2008, CELL IN PRESS; Stuurman N, 1999, EUR J CELL BIOL, V78, P278, DOI 10.1016/S0171-9335(99)80061-2; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Swan A, 1996, DEVELOPMENT, V122, P3577; Vendra G, 2007, RNA, V13, P1860, DOI 10.1261/rna.509007; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9	29	44	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3763	10.1371/journal.pone.0003763	http://dx.doi.org/10.1371/journal.pone.0003763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018277	Green Published, gold			2022-12-25	WOS:000265448500010
J	Huffard, CL; Caldwell, RL; DeLoach, N; Gentry, DW; Humann, P; MacDonald, B; Moore, B; Ross, R; Uno, T; Wong, S				Huffard, Christine L.; Caldwell, Roy L.; DeLoach, Ned; Gentry, David Wayne; Humann, Paul; MacDonald, Bill; Moore, Bruce; Ross, Richard; Uno, Takako; Wong, Stephen			Individually Unique Body Color Patterns in Octopus (Wunderpus photogenicus) Allow for Photoidentification	PLOS ONE			English	Article								Studies on the longevity and migration patterns of wild animals rely heavily on the ability to track individual adults. Non-extractive sampling methods are particularly important when monitoring animals that are commercially important to ecotourism, and/or are rare. The use of unique body patterns to recognize and track individual vertebrates is well-established, but not common in ecological studies of invertebrates. Here we provide a method for identifying individual Wunderpus photogenicus using unique body color patterns. This charismatic tropical octopus is commercially important to the underwater photography, dive tourism, and home aquarium trades, but is yet to be monitored in the wild. Among the adults examined closely, the configurations of fixed white markings on the dorsal mantle were found to be unique. In two animals kept in aquaria, these fixed markings were found not to change over time. We believe another individual was photographed twice in the wild, two months apart. When presented with multiple images of W. photogenicus, volunteer observers reliably matched photographs of the same individuals. Given the popularity of W. photogenicus among underwater photographers, and the ease with which volunteers can correctly identify individuals, photo-identification appears to be a practical means to monitor individuals in the wild.	[Huffard, Christine L.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Caldwell, Roy L.] Univ Calif Berkeley, Dept Integrative Biol, Berkeley, CA 94720 USA; [DeLoach, Ned; Humann, Paul] New World Publications, Jacksonville, FL USA; [MacDonald, Bill] Bill Macdonald Productions, Venice, Italy; [Moore, Bruce] Black Sand Dive Retreat, Kasawari, Indonesia; [Ross, Richard] Steinhart Aquarium, San Francisco, CA USA; [Uno, Takako; Wong, Stephen] Homantin, Kowloon, Peoples R China	Monterey Bay Aquarium Research Institute; University of California System; University of California Berkeley	Huffard, CL (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA USA.	chuffard@berkeley.edu						Anderson TJ, 1999, MAR FRESHWATER RES, V50, P225, DOI 10.1071/MF98152; ARONSON RB, 1989, AM MALACOL BULL, V7, P47; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Boal JG, 2006, VIE MILIEU, V56, P69; Detto T, 2006, P ROY SOC B-BIOL SCI, V273, P1661, DOI 10.1098/rspb.2006.3503; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; FRICKE H, 1991, ENVIRON BIOL FISH, V32, P287, DOI 10.1007/BF00007462; HAMMOND PS, 1990, MAMMAL REV, V20, P17, DOI 10.1111/j.1365-2907.1990.tb00099.x; HANLON RT, 1989, AM MALACOL BULL, V7, P21; HANLON RT, 1988, MALACOLOGIA, V29, P247; Hochberg FG, 2006, MOLLUSCAN RES, V26, P128; Hochner B, 2006, BIOL BULL-US, V210, P308, DOI 10.2307/4134567; Huffard CL, 2008, MAR BIOL, V154, P353, DOI 10.1007/s00227-008-0930-2; Huffard CL, 2006, J EXP BIOL, V209, P3697, DOI 10.1242/jeb.02435; Kelly MJ, 2001, J MAMMAL, V82, P440, DOI 10.1644/1545-1542(2001)082<0440:CAPMIS>2.0.CO;2; KUCERA TE, 1978, J MAMMAL, V59, P463, DOI 10.2307/1380224; Messenger JB, 2001, BIOL REV, V76, P473, DOI 10.1017/S1464793101005772; Norman M.D., 2005, Phuket Marine Biological Center Research Bulletin, V66, P127; Packard A., 1977, Symposia of the Zoological Society of London, P191; Piatkowski U, 2001, FISH RES, V52, P5, DOI 10.1016/S0165-7836(01)00226-0; ROBINSON SMC, 1986, J ZOOL, V209, P559, DOI 10.1111/j.1469-7998.1986.tb03611.x; ROPER CFE, 1988, MALACOLOGIA, V29, P153; Semmens JM, 2007, REV FISH BIOL FISHER, V17, P401, DOI 10.1007/s11160-007-9048-8; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001	26	25	25	15	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3732	10.1371/journal.pone.0003732	http://dx.doi.org/10.1371/journal.pone.0003732			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19009019	Green Published, gold, Green Submitted			2022-12-25	WOS:000265166400010
J	De Proost, I; Pintelon, I; Wilkinson, WJ; Goethals, S; Brouns, I; Van Nassauw, L; Riccardi, D; Timmermans, JP; Kemp, PJ; Adriaensen, D				De Proost, Ian; Pintelon, Isabel; Wilkinson, William J.; Goethals, Sofie; Brouns, Inge; Van Nassauw, Luc; Riccardi, Daniela; Timmermans, Jean-Pierre; Kemp, Paul J.; Adriaensen, Dirk			Purinergic signaling in the pulmonary neuroepithelial body microenvironment unraveled by live cell imaging	FASEB JOURNAL			English	Article						ATP; NEB; Clara-like cells; mouse; lung	AIRWAY CHEMORECEPTORS; NADPH-OXIDASE; NEUROENDOCRINE CELLS; ATP RELEASE; STEM-CELLS; K+ CURRENT; BODIES; LUNG; RECEPTORS; ACTIVATION	Pulmonary neuroepithelial bodies (NEBs) are densely innervated groups of complex sensory airway receptors involved in the regulation of breathing. Together with their surrounding Clara-like cells, they exhibit stem cell potential through their capacity to regenerate depopulated areas of the epithelium following lung injury. We have employed confocal live cell imaging microscopy and novel electrophysiological techniques in a new ex vivo lung slice model to unravel potential purinergic signaling pathways within the NEB microenvironment. Quinacrine histochemistry indicated high amounts of vesicular ATP in NEB cells. Using a "reporter-patching" method adapted to create a uniquely sensitive and selective biosensor for the direct detection of ATP release from NEBs ex vivo, we demonstrated quantal ATP release from NEBs following their depolarization. Enhancing enzymatic extracellular ATP hydrolysis or inhibiting P2 receptors confirmed the central role of ATP in paracrine interactions between NEB cells and Clara-like cells. Combined calcium imaging, pharmacology, and immunohistochemistry showed that ligand-binding to functional P2Y(2) receptors underpins the activation of Clara-like cells. Hence, NEB cells communicate with their cellular neighbors in the NEB microenvironment by releasing ATP, which rapidly evokes purinergic activation of surrounding Clara-like cells. Besides ATP acting on the P2X(3) receptor expressing vagal sensory nerve terminals between NEB cells, local paracrine purinergic signaling within this potential stem cell niche may be important to both normal airway function, airway epithelial regeneration after injury, and/or the pathogenesis of small cell lung carcinomas.-De Proost, I., Pintelon, I., Wilkinson, W. J., Goethals, S., Brouns, I., Van Nassauw, L., Riccardi, D., Timmermans, J.-P., Kemp, P. J., Adriaensen, D. Purinergic signaling in the pulmonary neuroepithelial body microenvironment unraveled by live cell imaging. FASEB J. 23, 1153-1160 (2009)	[De Proost, Ian; Pintelon, Isabel; Goethals, Sofie; Brouns, Inge; Van Nassauw, Luc; Timmermans, Jean-Pierre; Adriaensen, Dirk] Univ Antwerp, Dept Vet Sci, Cell Biol & Histol Lab, B-2020 Antwerp, Belgium; [De Proost, Ian; Wilkinson, William J.; Riccardi, Daniela; Kemp, Paul J.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales	University of Antwerp; Cardiff University	Adriaensen, D (corresponding author), Univ Antwerp, Dept Vet Sci, Cell Biol & Histol Lab, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	dirk.adriaensen@ua.ac.be	Riccardi, Daniela/A-4674-2010; Wilkinson, William/A-1259-2011; Brouns, Inge/GZM-7277-2022; Kemp, Paul/A-4634-2010; van Nassauw, Luc/A-6735-2015	Riccardi, Daniela/0000-0002-7322-3163; Kemp, Paul/0000-0003-2773-973X; van Nassauw, Luc/0000-0001-7235-5730; Timmermans, Jean-Pierre/0000-0003-2506-6252	Fund for Scientific Research-Flanders [G.0085.04, G.0081.08]; University of Antwerp [NOI-BOF 2003, GOA-BOF 2007, KP-BOF 2006]; BBSRC; BHF; MRC; MRC [G0600821] Funding Source: UKRI; Medical Research Council [G0600821] Funding Source: researchfish	Fund for Scientific Research-Flanders(FWO); University of Antwerp; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BHF(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the following research grants: Fund for Scientific Research-Flanders (G.0085.04 and G.0081.08 to D. A.); NOI-BOF 2003 and GOA-BOF 2007 (to D. A.), and KP-BOF 2006 (to I. B.) from the University of Antwerp; BBSRC, BHF, and MRC grants (to D. R. and P. J. K.). We especially thank Profs. J.-M. Boeynaems and B. Robaye (Universite Libre de Bruxelles, Brussels, Belgium) for the stimulating discussions about purinergic signaling. We thank J. Van Daele and D. De Rijck for help with microscopy, imaging and illustrations, and S. Kockelberg and H. De Pauw for administrative help.	ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; ADRIAENSEN D, 1993, ANAT RECORD, V236, P70, DOI 10.1002/ar.1092360111; Adriaensen D, 2003, ANAT REC PART A, V270A, P25, DOI 10.1002/ar.a.10007; Adriaensen D, 2006, J APPL PHYSIOL, V101, P960, DOI 10.1152/japplphysiol.00267.2006; Allen TGJ, 1997, TRENDS NEUROSCI, V20, P192, DOI 10.1016/S0166-2236(96)01039-9; Aubrey KR, 2007, J NEUROSCI, V27, P6273, DOI 10.1523/JNEUROSCI.1024-07.2007; Bishop AE, 2004, CELL PROLIFERAT, V37, P89, DOI 10.1111/j.1365-2184.2004.00302.x; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Brouns I, 2000, AM J RESP CELL MOL, V23, P52, DOI 10.1165/ajrcmb.23.1.3936; Brouns I, 2009, HISTOCHEM CELL BIOL, V131, P55, DOI 10.1007/s00418-008-0495-7; Brown P, 2002, J PHYSIOL-LONDON, V540, P851; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Burnstock G., 1978, CELL MEMBRANE RECEPT, Vpp, P107; Cutz E, 1999, RESP PHYSIOL, V115, P201, DOI 10.1016/S0034-5687(99)00018-3; CUTZ F, 2003, LUNG OXYGEN SENSING, P567; De Proost I, 2008, AM J RESP CELL MOL, V39, P180, DOI 10.1165/rcmb.2008-0011OC; De Proost I, 2007, HISTOCHEM CELL BIOL, V128, P301, DOI 10.1007/s00418-007-0318-2; Fu XW, 2000, P NATL ACAD SCI USA, V97, P4374, DOI 10.1073/pnas.97.8.4374; Fu XW, 2004, BIOL CHEM, V385, P275, DOI 10.1515/BC.2004.022; Fu XW, 2002, J PHYSIOL-LONDON, V539, P503, DOI 10.1113/jphysiol.2001.013071; Giangreco A, 2007, AM J RESP CRIT CARE, V175, P547, DOI 10.1164/rccm.200607-984PP; HALLER CJ, 1994, MICRON, V25, P527, DOI 10.1016/0968-4328(94)90015-9; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; HUNG KS, 1982, ANAT RECORD, V203, P285, DOI 10.1002/ar.1092030210; Kemp PJ, 2003, ANAT REC PART A, V270A, P41, DOI 10.1002/ar.a.10008; Kishore BK, 2000, AM J PHYSIOL-RENAL, V278, pF43, DOI 10.1152/ajprenal.2000.278.1.F43; LAUWERYN.MJ, 1972, ANAT RECORD, V172, P471, DOI 10.1002/ar.1091720301; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; O'Kelly I, 1999, AM J PHYSIOL-LUNG C, V276, pL96, DOI 10.1152/ajplung.1999.276.1.L96; O'Kelly I, 2000, J BIOL CHEM, V275, P7684, DOI 10.1074/jbc.275.11.7684; PEARSALL AD, 1985, ANAT RECORD, V212, P132, DOI 10.1002/ar.1092120206; Pintelon I, 2005, CELL TISSUE RES, V321, P21, DOI 10.1007/s00441-005-1111-y; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Reynolds SD, 2000, AM J PHYSIOL-LUNG C, V278, pL1256, DOI 10.1152/ajplung.2000.278.6.L1256; SCHEUERMANN DW, 1987, INT REV CYTOL, V106, P35, DOI 10.1016/S0074-7696(08)61710-6; Silinsky EM, 1996, J PHYSIOL-LONDON, V492, P815, DOI 10.1113/jphysiol.1996.sp021348; Sorokin SP, 1989, LUNG CELL BIOL, P191; STAHLMAN MT, 1984, LAB INVEST, V51, P449; Taylor SC, 2000, J NEUROCHEM, V75, P1583, DOI 10.1046/j.1471-4159.2000.0751583.x; VANSCOTT MR, 1995, AM J PHYSIOL-LUNG C, V269, pL30, DOI 10.1152/ajplung.1995.269.1.L30; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Wang DS, 1996, P NATL ACAD SCI USA, V93, P13182, DOI 10.1073/pnas.93.23.13182; YOUNGSON C, 1993, NATURE, V365, P153, DOI 10.1038/365153a0; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104	45	32	33	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1153	1160		10.1096/fj.08-109579	http://dx.doi.org/10.1096/fj.08-109579			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19050048				2022-12-25	WOS:000266651600019
J	Lodyga, M; De Falco, V; Bai, XH; Kapus, A; Melillo, RM; Santoro, M; Liu, M				Lodyga, M.; De Falco, V.; Bai, X-H; Kapus, A.; Melillo, R. M.; Santoro, M.; Liu, M.			XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway	ONCOGENE			English	Article						adaptor protein; protein tyrosine phosphorylation; thyroid cancer; RET/PTC; phosphatidylinositol 3-kinase; PKB/AKT	THYROID PAPILLARY CARCINOMAS; TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; RET PROTOONCOGENE; SH2 DOMAINS; PHOSPHOINOSITIDE 3-KINASE; MAP KINASE; CELL LINE; RAS	XB130 is a recently cloned 130kDa-adaptor protein and Src kinase substrate, structurally similar to actin-filament-associated protein. Here we show that XB130 is predominantly expressed in the thyroid. Given that XB130 is a thyroid-specific tyrosine kinase substrate, we asked whether it is targeted by RET/PTC, a genetically rearranged, constitutively active, thyroid-specific tyrosine kinase that plays a pathogenic role in papillary thyroid cancer. RET/PTC induced robust tyrosine phosphorylation of XB130, which promoted its subsequent association with the p85 alpha subunit of phosphatidylinositol 3-kinase (PI 3-kinase). We identified tyrosine 54 of XB130 as the major target of RET/PTC-mediated phosphorylation and a critical binding site for the SH2 domains of p85 alpha. Importantly, downregulation of XB130 in TPC1 papillary thyroid cancer cells, harboring the RET/PTC1 kinase, strongly reduced Akt activity without altering ERK1/2 phosphorylation, and concomitantly inhibited cell-cycle progression and survival in suspension. In conclusion, XB130 is a novel substrate of the RET/PTC kinase that links RET/PTC signaling to PI 3-kinase activation, and thereby plays an important role in sustaining proliferation and survival of thyroid tumor cells.	[Lodyga, M.; Bai, X-H; Liu, M.] Univ Hlth Network, Toronto Gen Hosp, Div Cellular & Mol Biol, Toronto, ON M5G 1L7, Canada; [De Falco, V.; Melillo, R. M.; Santoro, M.] Inst Endocrinol & Oncol Sperimentale CNR G Salvat, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Kapus, A.; Liu, M.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Toronto	Liu, M (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Div Cellular & Mol Biol, TMDT 2-814,101 Coll St, Toronto, ON M5G 1L7, Canada.	masantor@unina.it; mingyao.liu@utoronto.ca	melillo, rosa marina/O-5255-2015; DE FALCO, VALENTINA/C-2061-2015	DE FALCO, VALENTINA/0000-0002-8972-7921; Liu, Mingyao/0000-0002-9188-8417; MELILLO, Rosa Marina/0000-0002-9233-5275	AstraZeneca [ZD6474]; Canadian Institutes of Health Research [MOP-13270, MOP-42546]; European Union [FP636495]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	AstraZeneca(AstraZeneca); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European Union(European Commission); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We are grateful to Dr B Han and Dr D Winer for technical assistance. We thank AJ Ryan, AstraZeneca for the ZD6474 inhibitor. We also thank Dr S Asa and JM Hershman for human thyroid cell lines, Dr G Pelicci for GST- fusion proteins and Dr M Chiariello for the Src mutant. This work was supported by operating grants (MOP-13270, MOP-42546) from Canadian Institutes of Health Research, a grant from the Italian Association for Cancer Research, MIUR, Alleanza contro iL Cancro and the European Union Contract FP636495 (GENRISK-T).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Carlomagno F, 2002, CANCER RES, V62, P7284; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; Castellone MD, 2003, ONCOGENE, V22, P246, DOI 10.1038/sj.onc.1206112; De Falco V, 2005, ONCOGENE, V24, P6303, DOI 10.1038/sj.onc.1208776; de Martimprey H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1094; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; FLYNN DC, 1993, MOL CELL BIOL, V13, P7892, DOI 10.1128/MCB.13.12.7892; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; Hemmings BA, 1997, SCIENCE, V277, P534, DOI 10.1126/science.277.5325.534; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Iwashita T, 1996, ONCOGENE, V12, P481; Jung HS, 2005, MOL ENDOCRINOL, V19, P2748, DOI 10.1210/me.2005-0122; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Knauf JA, 2003, ONCOGENE, V22, P4406, DOI 10.1038/sj.onc.1206602; Lodyga M, 2002, AM J PHYSIOL-LUNG C, V283, pL265, DOI 10.1152/ajplung.00492.2001; Maeda K, 2004, BIOCHEM BIOPH RES CO, V323, P345, DOI 10.1016/j.bbrc.2004.08.095; Mai KT, 2001, THYROID, V11, P859, DOI 10.1089/105072501316973118; Mariggio S, 2007, CANCER RES, V67, P11769, DOI 10.1158/0008-5472.CAN-07-1997; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Melillo RM, 2001, ONCOGENE, V20, P209, DOI 10.1038/sj.onc.1204049; Miyagi E, 2004, MOL CARCINOGEN, V41, P98, DOI 10.1002/mc.20042; Pelicci G, 2002, MOL CELL BIOL, V22, P7351, DOI 10.1128/MCB.22.20.7351-7363.2002; PIEROTTI MA, 1992, P NATL ACAD SCI USA, V89, P1616, DOI 10.1073/pnas.89.5.1616; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; SANTORO M, 1994, MOL CELL BIOL, V14, P663, DOI 10.1128/MCB.14.1.663; SANTORO M, 1993, CELL GROWTH DIFFER, V4, P77; SANTORO M, 1994, ONCOGENE, V9, P509; Santoro M, 1996, ONCOGENE, V12, P1821; TAKAHASHI M, 1988, ONCOGENE, V3, P571; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200	40	51	55	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 19	2009	28	7					937	949		10.1038/onc.2008.447	http://dx.doi.org/10.1038/onc.2008.447			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	408TH	19060924				2022-12-25	WOS:000263457400001
J	Egerer, M; Giesemann, T; Herrmann, C; Aktories, K				Egerer, Martina; Giesemann, Torsten; Herrmann, Christian; Aktories, Klaus			Autocatalytic Processing of Clostridium difficile Toxin B BINDING OF INOSITOL HEXAKISPHOSPHATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE DOMAIN; RTX TOXIN; CLEAVAGE; CELLS; GLYCOSYLTRANSFERASES; INTERNALIZATION; PROTEINS; COLITIS; SITE	Clostridium difficile toxins A and B are major virulence factors responsible for induction of pseudomembranous colitis and antibiotic-associated diarrhea in men. The toxins possess a multidomain structure and only the N-terminal glucosyl-transferase domain, which inactivates Rho GTPases by glucosylation, is translocated into the cytosol of target cells. Processing of the toxin occurs by autocatalytic cleavage and is activated by inositol hexakisphosphate (InsP(6)). Here we studied the inherent protease activity in fragments of toxin B and determined the site of toxin B that interacts with InsP(6). We report that a fragment of toxin B, comprised of residues 1-955, is cleaved in the presence of InsP(6). In contrast, mutants of the catalytic triad of the putative cysteine protease domain did not cleave this fragment. [H-3] InsP(6) bound to holotoxin B and to the fragment 1-955, but not to a fragment comprising residues 900-2366 or the glucosyltransferase domain (residues 1-544). Binding to the putative cysteine protease domain (residues 544-955) was also observed. InsP(6)-binding was specific and saturable. Isothermal titration calorimetry revealed a K-d value of 2.4 mu M for binding of InsP(6) to toxin fragment 544-955 with a stoichiometry factor of 0.86. Lysine 600 of toxin B was identified as essential amino acid for InsP(6) binding and for InsP(6)-dependent activation of the protease activity.	[Egerer, Martina; Giesemann, Torsten; Aktories, Klaus] Univ Freiburg, Inst Expt, D-79104 Freiburg, Germany; [Egerer, Martina; Giesemann, Torsten; Aktories, Klaus] Univ Freiburg, Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Egerer, Martina] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Herrmann, Christian] Ruhr Univ Bochum, Fak Chem & Biochem, D-44780 Bochum, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Ruhr University Bochum	Aktories, K (corresponding author), Univ Freiburg, Inst Expt, Albertstr 25, D-79104 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436	Deutsche Forschungsgemeinschaft Projects [GI684, AK6/16]; research group Klinische Infektiologie Freiburg, TP 1a	Deutsche Forschungsgemeinschaft Projects(German Research Foundation (DFG)); research group Klinische Infektiologie Freiburg, TP 1a	This work was supported by Deutsche Forschungsgemeinschaft Projects GI684 and AK6/16 and by the research group Klinische Infektiologie Freiburg, TP 1a. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; Datta SAK, 2007, J MOL BIOL, V365, P799, DOI 10.1016/j.jmb.2006.10.072; DOVE CH, 1990, INFECT IMMUN, V58, P480, DOI 10.1128/IAI.58.2.480-488.1990; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; FLORIN I, 1983, BIOCHIM BIOPHYS ACTA, V763, P383, DOI 10.1016/0167-4889(83)90100-3; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; HENRIQUES B, 1987, MICROB PATHOGENESIS, V2, P455, DOI 10.1016/0882-4010(87)90052-0; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Jank T, 2005, J BIOL CHEM, V280, P37833, DOI 10.1074/jbc.M506836200; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; JUST I, 1997, BACTERIAL TOXINS TOO; KRIVAN HC, 1987, INFECT IMMUN, V55, P1873, DOI 10.1128/IAI.55.8.1873-1877.1987; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; RIFKIN GD, 1977, LANCET, V2, P1103; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; VONEICHELSTREIBER C, 1990, GENE, V96, P107, DOI 10.1016/0378-1119(90)90348-U; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005	25	51	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3389	3395		10.1074/jbc.M806002200	http://dx.doi.org/10.1074/jbc.M806002200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19047051	hybrid			2022-12-25	WOS:000262872500004
J	Zhang, HD; Eoff, RL; Kozekov, ID; Rizzo, CJ; Egli, M; Guengerich, FP				Zhang, Huidong; Eoff, Robert L.; Kozekov, Ivan D.; Rizzo, Carmelo J.; Egli, Martin; Guengerich, F. Peter			Versatility of Y-family Sulfolobus solfataricus DNA Polymerase Dpo4 in Translesion Synthesis Past Bulky N-2-Alkylguanine Adducts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; NUCLEOTIDE INCORPORATION OPPOSITE; ERROR-FREE BYPASS; TANDEM MASS-SPECTROMETRY; INTERSTRAND CROSS-LINKS; STEADY-STATE KINETICS; RAY-DIFFRACTION DATA; REPLICATION FIDELITY; LESION-BYPASS; ELECTROSPRAY-IONIZATION	In contrast to replicative DNA polymerases, Sulfolobus solfataricus Dpo4 showed a limited decrease in catalytic efficiency (k(cat)/K-m) for insertion of dCTP opposite a series of N-2-alkylguanine templates of increasing size from (methyl (Me) to (9-anthracenyl)-Me (Anth)). Fidelity was maintained with increasing size up to (2-naphthyl)-Me (Naph). The catalytic efficiency increased slightly going from the N-2-NaphG to the N-2-AnthG substrate, at the cost of fidelity. Pre-steady-state kinetic bursts were observed for dCTP incorporation throughout the series (N-2-MeG to N-2-AnthG), with a decrease in the burst amplitude and k(pol), the rate of single-turnover incorporation. The pre-steady-state kinetic courses with G and all of the six N-2-alkyl G adducts could be fit to a general DNA polymerase scheme to which was added an inactive complex in equilibrium with the active ternary Dpo4.DNA.dNTP complex, and only the rates of equilibrium with the inactive complex and phosphodiester bond formation were altered. Two crystal structures of Dpo4 with a template N-2-NaphG (in a post-insertion register opposite a 3'-terminal C in the primer) were solved. One showed N-2-NaphG in a syn conformation, with the naphthyl group located between the template and the Dpo4 "little finger" domain. The Hoogsteen face was within hydrogen bonding distance of the N4 atoms of the cytosine opposite N-2-NaphG and the cytosine at the -2 position. The second structure showed N-2-Naph G in an anti conformation with the primer terminus largely disordered. Collectively these results explain the versatility of Dpo4 in bypassing bulky G lesions.	[Zhang, Huidong; Eoff, Robert L.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Zhang, Huidong; Eoff, Robert L.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Kozekov, Ivan D.; Rizzo, Carmelo J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Kozekov, Ivan D.; Rizzo, Carmelo J.] Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Zhang, Huidong/0000-0001-7845-3331	National Institutes of Health Grants [R01 ES010375, F32 CA119776, P01 ES05355, P30 ES000267]; U. S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355, R01ES010375, P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F. P. G.), F32 CA119776 (to R. L. E.), P01 ES05355 (to I. D. K., C. J. R., a nd M. E.), and P30 ES000267 (to F. P. G., C. J. R., and M. E.). Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bauer J, 2007, P NATL ACAD SCI USA, V104, P14905, DOI 10.1073/pnas.0700717104; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHENG SC, 1989, CHEM RES TOXICOL, V2, P334, DOI 10.1021/tx00011a011; Cheng TF, 2008, J BIOL CHEM, V283, P27820, DOI 10.1074/jbc.M804086200; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Choi JY, 2004, J BIOL CHEM, V279, P19217, DOI 10.1074/jbc.M313759200; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; EOFF RL, 2009, CHEM BIOL DNA DAMAGE; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; FANG JL, 1997, CARCINOGENESIS, V18, P632; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Forgacs E, 1997, J BIOL CHEM, V272, P8525, DOI 10.1074/jbc.272.13.8525; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Jia L, 2008, NUCLEIC ACIDS RES, V36, P6571, DOI 10.1093/nar/gkn719; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kornberg A., 1992, DNA REPLICATION; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lao YB, 2007, CHEM RES TOXICOL, V20, P246, DOI 10.1021/tx060208j; Lao YB, 2005, CHEM RES TOXICOL, V18, P711, DOI 10.1021/tx0497292; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lee HR, 2007, J BIOL CHEM, V282, P31982, DOI 10.1074/jbc.M705392200; Lemee F, 2007, ONCOGENE, V26, P3387, DOI 10.1038/sj.onc.1210116; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Liu X, 2006, BIOCHEMISTRY-US, V45, P12898, DOI 10.1021/bi060792v; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Matsuda T, 1999, BIOCHEMISTRY-US, V38, P929, DOI 10.1021/bi982134j; MEEHAN T, 1979, NATURE, V277, P410, DOI 10.1038/277410a0; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Ni JS, 1996, ANAL CHEM, V68, P1989, DOI 10.1021/ac960270t; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Perlow-Poehnelt RA, 2004, J BIOL CHEM, V279, P36951, DOI 10.1074/jbc.M404332200; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Searle C. F., 1984, CHEM CARCINOGENS; TAN HB, 1994, BIOCHEMISTRY-US, V33, P5335, DOI 10.1021/bi00183a042; Terashima I, 2001, BIOCHEMISTRY-US, V40, P4106, DOI 10.1021/bi002719p; Tissier A, 2000, GENE DEV, V14, P1642; Trincao J, 2004, NAT STRUCT MOL BIOL, V11, P457, DOI 10.1038/nsmb755; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; TURESKY RJ, 1992, CHEM RES TOXICOL, V5, P479, DOI 10.1021/tx00028a005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Vellieux FMD, 1997, J APPL CRYSTALLOGR, V30, P396, DOI 10.1107/S0021889896012551; Wang MY, 2007, CHEM RES TOXICOL, V20, P625, DOI 10.1021/tx600332p; Wang MY, 1997, CHEM RES TOXICOL, V10, P772, DOI 10.1021/tx960193x; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Yasui M, 2001, NUCLEIC ACIDS RES, V29, P1994, DOI 10.1093/nar/29.9.1994; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zang H, 2005, CHEM RES TOXICOL, V18, P389, DOI 10.1021/tx049683c; Zang H, 2005, J BIOL CHEM, V280, P1165, DOI 10.1074/jbc.M405996200; Zhang S, 2006, CHEM RES TOXICOL, V19, P1386, DOI 10.1021/tx060154d	82	53	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3563	3576		10.1074/jbc.M807778200	http://dx.doi.org/10.1074/jbc.M807778200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19059910	hybrid, Green Published			2022-12-25	WOS:000262872500024
J	Dar, AA; Belkhiri, A; El-Rifai, W				Dar, A. A.; Belkhiri, A.; El-Rifai, W.			The aurora kinase A regulates GSK-3 beta in gastric cancer cells	ONCOGENE			English	Article						AURKA; GSK-3 beta; beta-catenin; gastric cancer	BETA-CATENIN; FREQUENT OVEREXPRESSION; BARRETTS-ESOPHAGUS; OVARIAN-CANCER; CYCLIN D1; PATHWAY; CARCINOMA; TARGET; GENE; ACTIVATION	Aurora kinase A (AURKA) is located at 20q13, a region that is frequently amplified in gastric cancer. In this study, we have investigated the role of AURKA in regulating glycogen synthase kinase (GSK)-3 beta and beta-catenin/TCF complex in gastric cancer cells. Our results demonstrate a significant increase in the phosphorylation of GSK-3 beta at Ser 9 following the overexpression of AURKA in AGS cells. The immuno-precipitation with antibodies specific for AURKA and GSK-3 beta indicated that the two proteins coexist in the same protein complex. The recombinant human AURKA protein phosphorylated the GSK-3 beta protein at Ser 9 in a concentration-dependent manner, in vitro. The phosphorylation of beta-catenin (Ser33/37/Thr41) by GSK-3 beta is known to target beta-catenin towards degradation. In line with our findings, the increase in phospho-GSK-3 beta level was accompanied by a significant decrease in beta-catenin phosphorylation (Ser33/37/Thr41) and accumulation of beta-catenin protein. The knockdown of AURKA reversed the phosphorylation of GSK-3 beta and the beta-catenin protein levels. The immunofluorescence analysis demonstrated colocalization of AURKA and GSK-3 beta proteins and a significant increase in the nuclear beta-catenin levels in cells overexpressing AURKA. The beta-catenin/TCF transcription activity was measured using the pTopFlash and its mutant pFopFlash luciferase reporter vectors. Indeed, AURKA overexpression led to a significant increase in the pTopFlash reporter activity, whereas kinase dead AURKA mutant (D274A) had no effect. Consistent with these findings, we detected a significant mRNA up-regulation of several direct targets of the beta-catenin/TCF transcription complex (cyclin D1, c-MYC, c-MYC-binding protein, CLDN1, FGF18 and vascular endothelial growth factor), and a two-fold increase in the proliferation rate in AURKA overexpressing cells. We conclude that the AURKA/GSK-3 beta interaction is important in regulating beta-catenin, underscoring a novel oncogenic potential for AURKA in gastric tumorigenesis.	[El-Rifai, W.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Dar, A. A.; Belkhiri, A.; El-Rifai, W.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [El-Rifai, W.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	El-Rifai, W (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, 1255 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	wael.el-rifai@vanderbilt.edu			National Cancer Institute [CA95103]; Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE [R01CA131225, P50CA095103] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a pilot fund from the National Cancer Institute GI SPORE grant CA95103 and the Vanderbilt-Ingram Cancer Center support funds. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute or Vanderbilt University Medical Center.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Clements WM, 2002, CANCER RES, V62, P3503; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Damalas A, 1999, EMBO J, V18, P3054, DOI 10.1093/emboj/18.11.3054; Dar AA, 2008, CANCER-AM CANCER SOC, V112, P1688, DOI 10.1002/cncr.23371; Earle CC, 1999, EUR J CANCER, V35, P1059, DOI 10.1016/S0959-8049(99)00076-3; El-Rifai W, 2002, CANCER RES, V62, P6823; El-Rifai W, 2001, GASTROENTEROLOGY, V121, P592, DOI 10.1053/gast.2001.27215; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Giet R, 1999, J CELL SCI, V112, P3591; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hojilla CV, 2007, J CELL SCI, V120, P1050, DOI 10.1242/jcs.003335; Hu W, 2005, ONCOL RES, V15, P49, DOI 10.3727/096504005775082101; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kamada K, 2004, ONCOL REP, V12, P593; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NAKATSURU S, 1992, HUM MOL GENET, V1, P559, DOI 10.1093/hmg/1.8.559; Ogawa E, 2008, ANN SURG ONCOL, V15, P547, DOI 10.1245/s10434-007-9653-8; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sourbier C, 2006, CANCER RES, V66, P5130, DOI 10.1158/0008-5472.CAN-05-1469; Sparks AB, 1998, CANCER RES, V58, P1130; Tanaka T, 1999, CANCER RES, V59, P2041; Terris B, 1999, ONCOGENE, V18, P6583, DOI 10.1038/sj.onc.1203051; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Varis A, 2001, CANCER GENET CYTOGEN, V127, P53, DOI 10.1016/S0165-4608(00)00423-4; Voeller HJ, 1998, CANCER RES, V58, P2520; Wang Chenguang, 2004, Cancer Treat Res, V119, P217; Washington K, 1998, MODERN PATHOL, V11, P805; Yamada T, 2000, CANCER RES, V60, P4761; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; ZHANG YJ, 1993, BIOCHEM BIOPH RES CO, V196, P1010, DOI 10.1006/bbrc.1993.2350; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	49	106	108	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					866	875		10.1038/onc.2008.434	http://dx.doi.org/10.1038/onc.2008.434			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19060929	Green Accepted			2022-12-25	WOS:000263320000009
J	Lee, EK; Bae, GU; You, JS; Lee, JC; Jeon, YJ; Park, JW; Park, JH; Ahn, SH; Kim, YK; Choi, WS; Kang, JS; Han, G; Han, JW				Lee, Eun Kyung; Bae, Gyu-Un; You, Jueng Soo; Lee, Jae Cheol; Jeon, Yae Jee; Park, Jong Woo; Park, Jae Hyun; Ahn, Seong Hoon; Kim, Yong Kee; Choi, Wahn Soo; Kang, Jong-Sun; Han, Gyoonhee; Han, Jeung-Whan			Reversine Increases the Plasticity of Lineage-committed Cells toward Neuroectodermal Lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; MARROW STROMAL CELLS; IN-VITRO; NEURONAL PHENOTYPE; MAMMALIAN-CELLS; SOMATIC-CELLS; GERM-CELLS; DIFFERENTIATION; EXPRESSION; MYOBLASTS	Functional dedifferentiation of lineage-committed cells toward pluripotency may have a great potential in regenerative medicine. Reversine has been shown to induce dedifferentiation of multiple terminally differentiated mesodermal origin cells, which are capable of being directed to differentiate into other cell types within mesodermal lineages. However, the possibilities of these cells to give rise to other lineages have not been examined. Here we show that large scale gene expression profiling of reversine-treated C2C12 myoblasts identifies a subset of up-regulated genes involved in specification of neuroectodermal as well as mesodermal lineages. Reversine treatment leads to up-regulation of priming genes of neuroectodermal lineages, such as Ngn2, Nts, Irx3, Pax7, Hes1, and Hes6, through active histone modifications in the promoter regions of these genes. Additionally, reversine increases the expression of markers for other cell types of mesodermal lineages, Ogn and apoE, via inducing active histone modifications, while down-regulating the myogenic basic helix-loop-helix factor, MyoD, via repressive histone modifications. Consistent with up-regulation of these genes, reversine-treated C2C12 myoblasts redifferentiate into neural as well as mesodermal lineages, under appropriate stimuli. Taken together, these results indicate that reversine induces a multipotency of C2C12 myoblasts via inducing a specific combination of active histone modifications. Collectively, our findings provide a mechanistic rationale for the application of reversine to dedifferentiation of somatic cells.	[Lee, Eun Kyung; You, Jueng Soo; Lee, Jae Cheol; Jeon, Yae Jee; Park, Jong Woo; Park, Jae Hyun; Han, Jeung-Whan] Sungkyunkwan Univ, Coll Pharm, Dept Biochem & Mol Biol, Suwon 440746, South Korea; [Bae, Gyu-Un; Kang, Jong-Sun] Sungkyunkwan Univ, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Ahn, Seong Hoon] Hanyang Univ, Div Mol & Life Sci, Ansan 426791, South Korea; [Kim, Yong Kee] Kwandong Univ, Coll Med, Kangnung 210701, South Korea; [Choi, Wahn Soo] Konkuk Univ, Coll Med, Chungju 380701, South Korea; [Han, Gyoonhee] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Hanyang University; Catholic Kwandong University; Konkuk University; Konkuk University Medical Center; Yonsei University	Han, JW (corresponding author), Sungkyunkwan Univ, Coll Pharm, Dept Biochem & Mol Biol, Suwon 440746, South Korea.	jhhan551@skku.edu	lee, jaecheol/AAS-3747-2020	lee, jaecheol/0000-0002-2070-7463; Ahn, Seong-Hoon/0000-0002-9174-4966	Korea Food & Drug Administration in 2006 and 2007 [06122KFDA426, 07132KFDA688]	Korea Food & Drug Administration in 2006 and 2007(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This work was supported by Grants 06122KFDA426 and 07132KFDA688 from Korea Food & Drug Administration in 2006 and 2007. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.. S The on-line version of this article (availableathttp://www.jbc.org) contains supplemental Fig. S1 and Table S1.	Anastasia L, 2006, CELL DEATH DIFFER, V13, P2042, DOI 10.1038/sj.cdd.4401958; Chen SB, 2004, J AM CHEM SOC, V126, P410, DOI 10.1021/ja037390k; Chen SB, 2007, P NATL ACAD SCI USA, V104, P10482, DOI 10.1073/pnas.0704360104; Chen XP, 2005, MOL BIOL CELL, V16, P3140, DOI 10.1091/mbc.E05-03-0218; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Fairchild PJ, 2004, TRENDS IMMUNOL, V25, P465, DOI 10.1016/j.it.2004.07.005; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; KONIECZNY SF, 1988, MOL CELL BIOL, V29, P21; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lee JE, 1997, DEV NEUROSCI-BASEL, V19, P27, DOI 10.1159/000111182; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Pachernik J, 2005, PHYSIOL RES, V54, P115, DOI 10.33549/physiolres.930526; Pincus DW, 1998, ANN NEUROL, V43, P576, DOI 10.1002/ana.410430505; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Watanabe Y, 2004, GENE DEV, V18, P889, DOI 10.1101/gad.1179004; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WILMUT I, 1997, NATURE, V385, P813; Witusik M, 2007, BRAIN RES, V1186, P65, DOI 10.1016/j.brainres.2007.10.039; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang W, 2006, MOL CELL BIOL, V26, P3764, DOI 10.1128/MCB.26.10.3764-3772.2006	44	32	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2891	2901		10.1074/jbc.M804055200	http://dx.doi.org/10.1074/jbc.M804055200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19015271	hybrid			2022-12-25	WOS:000262700900033
J	Maresova, L; Muend, S; Zhang, YQ; Sychrova, H; Rao, R				Maresova, Lydie; Muend, Sabina; Zhang, Yong-Qiang; Sychrova, Hana; Rao, Rajini			Membrane Hyperpolarization Drives Cation Influx and Fungicidal Activity of Amiodarone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; INTRACELLULAR ACIDIFICATION; DIS-C-3(3) FLUORESCENCE; NEUROSPORA-CRASSA; POTENTIAL CHANGES; CA-2+ INFLUX; YEAST; CHANNEL; RESISTANT	Cationic amphipathic drugs, such as amiodarone, interact preferentially with lipid membranes to exert their biological effect. In the yeast Saccharomyces cerevisiae, toxic levels of amiodarone trigger a rapid influx of Ca2+ that can overwhelm cellular homeostasis and lead to cell death. To better understand the mechanistic basis of antifungal activity, we assessed the effect of the drug on membrane potential. We show that low concentrations of amiodarone (0.1-2 mu M) elicit an immediate, dose-dependent hyperpolarization of the membrane. At higher doses (>3 mu M), hyperpolarization is transient and is followed by depolarization, coincident with influx of Ca2+ and H+ and loss in cell viability. Proton and alkali metal cation transporters play reciprocal roles in membrane polarization, depending on the availability of glucose. Diminishment of membrane potential by glucose removal or addition of salts or in pma1, tok1 Delta, ena1-4 Delta, or nha1 Delta mutants protected against drug toxicity, suggesting that initial hyperpolarization was important in the mechanism of antifungal activity. Furthermore, we show that the link between membrane hyperpolarization and drug toxicity is pH-dependent. We propose the existence of pH- and hyperpolarization-activated Ca2+ channels in yeast, similar to those described in plant root hair and pollen tubes that are critical for cell elongation and growth. Our findings illustrate how membrane-active compounds can be effective microbicidals and may pave the way to developing membrane-selective agents.	[Muend, Sabina; Zhang, Yong-Qiang; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Maresova, Lydie; Sychrova, Hana] Acad Sci CR, Inst Physiol, Dept Membrane Transport, Prague, Czech Republic	Johns Hopkins University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	rrao@jhmi.edu	Sychrova, Hana/B-1350-2012	Sychrova, Hana/0000-0001-5967-5019	National Institutes of Health [R01AI065983]; Czech Grants [MSMTLC531, AV0Z 50110509]; GAAS CR [KJB500110701]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Czech Grants; GAAS CR(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI065983 (to R. R.). This work was also supported by Czech Grants MSMTLC531 and AV0Z 50110509 (to H. S.) and GAAS CR KJB500110701 (to L. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afeltra J, 2004, ANTIMICROB AGENTS CH, V48, P1335, DOI 10.1128/AAC.48.4.1335-1343.2004; BALLARINDENTI A, 1994, BBA-BIOMEMBRANES, V1190, P43, DOI 10.1016/0005-2736(94)90033-7; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Carmelo V, 1997, BBA-BIOMEMBRANES, V1325, P63, DOI 10.1016/S0005-2736(96)00245-3; CHATELAIN P, 1985, J PHARM SCI, V74, P783, DOI 10.1002/jps.2600740720; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; Courchesne WE, 2002, J PHARMACOL EXP THER, V300, P195, DOI 10.1124/jpet.300.1.195; Denksteinova B, 1997, FOLIA MICROBIOL, V42, P221, DOI 10.1007/BF02818983; EILAM Y, 1990, J GEN MICROBIOL, V136, P861, DOI 10.1099/00221287-136-5-861; EILAM Y, 1990, J GEN MICROBIOL, V136, P2537, DOI 10.1099/00221287-136-12-2537; EILAM Y, 1987, J GEN MICROBIOL, V133, P1641; GRADMANN D, 1978, J MEMBRANE BIOL, V39, P333, DOI 10.1007/BF01869898; Guo Q, 2008, J MED MICROBIOL, V57, P457, DOI 10.1099/jmm.0.47651-0; HERBETTE LG, 1988, J MOL CELL CARDIOL, V20, P373, DOI 10.1016/S0022-2828(88)80128-7; Kinclova-Zimmermannova O, 2005, J BIOL CHEM, V280, P30638, DOI 10.1074/jbc.M506341200; Malac J, 2005, INT J BIOCHEM CELL B, V37, P2536, DOI 10.1016/j.biocel.2005.06.005; Maresova L, 2007, BIOTECHNIQUES, V43, P667, DOI 10.2144/000112620; Maresova L, 2006, FEMS YEAST RES, V6, P1039, DOI 10.1111/j.1567-1364.2006.00140.x; Marx F, 2008, CELL MOL LIFE SCI, V65, P445, DOI 10.1007/s00018-007-7364-8; Matsumoto TK, 2002, J BIOL CHEM, V277, P33075, DOI 10.1074/jbc.M205037200; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Qu HY, 2007, NEW PHYTOL, V174, P524, DOI 10.1111/j.1469-8137.2007.02069.x; RAMOS S, 1989, J GEN MICROBIOL, V135, P2413; Roberts SK, 2003, EUKARYOT CELL, V2, P181, DOI 10.1128/EC.2.1.181-190.2003; Rosa SMLJ, 2000, BBA-MOL CELL BIOL L, V1487, P286, DOI 10.1016/S1388-1981(00)00122-0; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Shang ZL, 2005, PLANT CELL PHYSIOL, V46, P598, DOI 10.1093/pcp/pci063; Stevens HC, 2007, J BIOL CHEM, V282, P17563, DOI 10.1074/jbc.M700454200; TRUMBORE M, 1988, BIOPHYS J, V54, P535, DOI 10.1016/S0006-3495(88)82986-2; Vergani P, 1997, FEBS LETT, V405, P337, DOI 10.1016/S0014-5793(97)00211-1; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Zhang YQ, 2007, J BIOL CHEM, V282, P37844, DOI 10.1074/jbc.M707593200	35	67	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2795	2802		10.1074/jbc.M806693200	http://dx.doi.org/10.1074/jbc.M806693200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054772	Green Published, hybrid			2022-12-25	WOS:000262700900022
J	Zhang, H; Stavnezer, E				Zhang, Hong; Stavnezer, Ed			Ski Regulates Muscle Terminal Differentiation by Transcriptional Activation of Myog in a Complex with Six1 and Eya3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING-GROWTH-FACTOR; C-SKI; SKELETAL-MUSCLE; GENE-EXPRESSION; EYE DEVELOPMENT; POSITIVE AUTOREGULATION; ONCOPROTEIN INTERACTS; DROSOPHILA-DACHSHUND; MAMMALIAN-CELLS; SATELLITE CELLS	Overexpression of the Ski pro-oncogene has been shown to induce myogenesis in non-muscle cells, to promote muscle hypertrophy in postnatal mice, and to activate transcription of muscle-specific genes. However, the precise role of Ski in muscle cell differentiation and its underlying molecular mechanism are not fully understood. To elucidate the involvement of Ski in muscle terminal differentiation, two retroviral systems were used to achieve conditional overexpression or knockdown of Ski in satellite cell-derived C2C12 myoblasts. We found that enforced expression of Ski promoted differentiation, whereas loss of Ski severely impaired it. Compromised terminal differentiation in the absence of Ski was likely because of the failure to induce myogenin (Myog) and p21 despite normal expression of MyoD. Chromatin immunoprecipitation and transcriptional reporter experiments showed that Ski occupied the endogenous Myog regulatory region and activated transcription from the Myog regulatory region upon differentiation. Transactivation of Myog was largely dependent on a MEF3 site bound by Six1, not on the binding site of MyoD or MEF2. Activation of the MEF3 site required direct interaction of Ski with Six1 and Eya3 mediated by the evolutionarily conserved Dachshund homology domain of Ski. Our results indicate that Ski is necessary for muscle terminal differentiation and that it exerts this role, at least in part, through its association with Six1 and Eya3 to regulate the Myog transcription.	[Zhang, Hong; Stavnezer, Ed] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Stavnezer, E (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	ed.stavnezer@case.edu			National Institutes of Health Grant [CA43600]; NATIONAL CANCER INSTITUTE [R01CA043600] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA43600 (to E. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Arndt S, 2005, LAB INVEST, V85, P1330, DOI 10.1038/labinvest.3700344; Arndt S, 2007, MOL CELL NEUROSCI, V34, P603, DOI 10.1016/j.mcn.2007.01.002; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; Chen DH, 2003, CANCER RES, V63, P6626; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; CHENG TC, 1995, P NATL ACAD SCI USA, V92, P561, DOI 10.1073/pnas.92.2.561; Colmenares C, 1990, Semin Cancer Biol, V1, P383; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; COLMENARES C, 1991, J VIROL, V65, P4929, DOI 10.1128/JVI.65.9.4929-4935.1991; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; COLMENARES C, 1991, MOL CELL BIOL, V11, P1167, DOI 10.1128/MCB.11.2.1167; Dahl R, 1998, P NATL ACAD SCI USA, V95, P11187, DOI 10.1073/pnas.95.19.11187; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Davis RJ, 1999, DEV GENES EVOL, V209, P526, DOI 10.1007/s004270050285; Denissova NG, 2004, J BIOL CHEM, V279, P28143, DOI 10.1074/jbc.M404961200; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; ENGERT JC, 1995, NUCLEIC ACIDS RES, V23, P2988, DOI 10.1093/nar/23.15.2988; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Hammond KL, 1998, MECH DEVELOP, V74, P121, DOI 10.1016/S0925-4773(98)00071-9; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Heidt AB, 2007, MOL CELL BIOL, V27, P5910, DOI 10.1128/MCB.01700-06; HEYMAN HC, 1994, J BIOL CHEM, V269, P26996; Ichikawa K, 1997, BIOCHEM J, V328, P607, DOI 10.1042/bj3280607; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kobayashi N, 2007, GENES CELLS, V12, P375, DOI 10.1111/j.1365-2443.2007.01052.x; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Li X, 2002, SCIENCE, V297, P1180; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Mizuhara E, 2005, J BIOL CHEM, V280, P3645, DOI 10.1074/jbc.M411652200; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; MONAGHAN AP, 1991, DEVELOPMENT, V112, P1053; NAGASE T, 1990, NUCLEIC ACIDS RES, V18, P337, DOI 10.1093/nar/18.2.337; NAMCIU S, 1995, DEV DYNAM, V204, P291, DOI 10.1002/aja.1002040307; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Oliver G, 1995, DEVELOPMENT, V121, P4045; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Ozaki H, 2002, J HUM GENET, V47, P107, DOI 10.1007/s100380200011; PEARSONWHITE S, 1993, NUCLEIC ACIDS RES, V21, P4632, DOI 10.1093/nar/21.19.4632; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Prathapam T, 2001, NUCLEIC ACIDS RES, V29, P3469, DOI 10.1093/nar/29.17.3469; ROSENTHAL N, 1990, NUCLEIC ACIDS RES, V18, P6239, DOI 10.1093/nar/18.21.6239; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; STAVNEZER E, 1986, J VIROL, V57, P1073, DOI 10.1128/JVI.57.3.1073-1083.1986; STAVNEZER E, 1981, J VIROL, V39, P920, DOI 10.1128/JVI.39.3.920-934.1981; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Takeda M, 2004, MOL BIOL CELL, V15, P963, DOI 10.1091/mbc.E03-07-0478; Tokitou F, 1999, J BIOL CHEM, V274, P4485, DOI 10.1074/jbc.274.8.4485; WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242; Wilson JJ, 2004, STRUCTURE, V12, P785, DOI 10.1016/S0969-2126(04)00118-2; Xu PX, 1997, DEVELOPMENT, V124, P219; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Young DP, 2008, J IMMUNOL, V181, P2420, DOI 10.4049/jimmunol.181.4.2420; Zhang L, 2007, ONCOGENE, V26, P1595, DOI 10.1038/sj.onc.1209958; ZHENG G, 1990, ONCOGENE, V15, P459	81	34	36	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2867	2879		10.1074/jbc.M807526200	http://dx.doi.org/10.1074/jbc.M807526200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19008232	hybrid, Green Published			2022-12-25	WOS:000262700900031
J	Zhang, Y; Kobayashi, A; Yamamoto, M; Hayes, JD				Zhang, Yiguo; Kobayashi, Akira; Yamamoto, Masayuki; Hayes, John D.			The Nrf3 Transcription Factor Is a Membrane-bound Glycoprotein Targeted to the Endoplasmic Reticulum through Its N-terminal Homology Box 1 Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT-RESPONSE ELEMENT; NEGATIVE REGULATION; CONSENSUS SEQUENCE; OXIDATIVE STRESS; SIGNAL SEQUENCES; GENE-EXPRESSION; PHOSPHORYLATION; ACTIVATION; IDENTIFICATION; GLYCOSYLATION	Transcription factor Nrf3 (NF-E2 p45-related factor 3) is targeted to the endoplasmic reticulum ( ER). Mouse Nrf3 is subject to proteolysis, Asn glycosylation, and deglycosylation reactions. It is synthesized as a similar to 96-kDa protein that is subsequently converted into isoforms of similar to 90, 80, and 70 kDa. In the ER, the similar to 90kDa glycoprotein is predominant and gives rise to similar to 80- and similar to 70- kDa isoforms. The similar to 90- and similar to 80- kDa polypeptides were observed in the nuclear envelope, whereas the similar to 70- kDa isoform was detected primarily in the nucleoplasm. Our experiments showed the N-terminal homology box 1 (NHB1, residues 12-31) is part of a tripartite signal peptide sequence, comprising n, h, and c regions. The h region ( residues 12-23) was demonstrated to target Nrf3 to the ER and is necessary for its Asn glycosylation. The n region ( residues 1-11) controlled the abundance of the similar to 90- kDa glycoprotein. The c region ( residues 24-39) was found to contain a signal peptidase cleavage site that is responsible for production of the similar to 90- kDa mature Nrf3 glycoprotein from a similar to 96-kDa precursor. We have found that Nrf3 is activated by the ER stressors tunicamycin and brefeldin A, and that NHB1 is required for this response. Amino acids between the c region and NHB2 ( residues 76-100) controlled the proteolytic processing of mouse Nrf3 into cleavage products of similar to 80- kDa ( glycated) and similar to 70- kDa (non-glycated); by contrast, human Nrf3 lacked a signal peptidase cleavage site between its c region and NHB2. Lastly, data are presented suggesting that the NHB2 sequence in mouse Nrf3 may regulate the topology of the transcription factor within the ER membrane.	[Zhang, Yiguo; Hayes, John D.] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Zhang, Yiguo; Hayes, John D.] Univ Dundee, Sch Med, Dundee DD1 9SY, Scotland; [Kobayashi, Akira] Tohoku Univ, Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808577, Japan; [Yamamoto, Masayuki] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan	University of Dundee; University of Dundee; Tohoku University; Tohoku University; University of Tsukuba	Zhang, Y (corresponding author), Univ Dundee, Ninewells Hosp, Biomed Res Inst, Dundee DD1 9SY, Scotland.	y.z.zhang@dundee.ac.uk	Kobayashi, Akira/AAN-8003-2020; Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548; Kobayashi, Akira/0000-0001-9727-1218	Association for International Cancer Research [06-015]	Association for International Cancer Research	This work was supported by Association for International Cancer Research Grant 06-015. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Chenais B, 2005, MOL ENDOCRINOL, V19, P125, DOI 10.1210/me.2003-0379; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Derjuga A, 2004, MOL CELL BIOL, V24, P3286, DOI 10.1128/MCB.24.8.3286-3294.2004; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Etchevers HC, 2005, INT J DEV BIOL, V49, P363, DOI 10.1387/ijdb.041942he; Farley JR, 2005, CALCIFIED TISSUE INT, V76, P63, DOI 10.1007/s00223-004-0023-2; KAUFMANN SH, 1983, J BIOL CHEM, V258, P2710; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Liu H, 2005, BIOCHEM BIOPH RES CO, V338, P1005, DOI 10.1016/j.bbrc.2005.10.046; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Nouhi Z, 2007, FEBS LETT, V581, P5401, DOI 10.1016/j.febslet.2007.10.041; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sankaranarayanan K, 2004, J BIOL CHEM, V279, P50810, DOI 10.1074/jbc.M404984200; Schow SR, 1997, CELL IMMUNOL, V175, P199, DOI 10.1006/cimm.1996.1061; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zeghouf M, 2005, BIOCHEM SOC T, V33, P1265, DOI 10.1042/BST0331265; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200; Zhang YG, 2001, J BIOL CHEM, V276, P14572, DOI 10.1074/jbc.M004615200; Zhang YG, 2001, J BIOL CHEM, V276, P11775, DOI 10.1074/jbc.M006000200; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575	32	56	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3195	3210		10.1074/jbc.M805337200	http://dx.doi.org/10.1074/jbc.M805337200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047052	hybrid			2022-12-25	WOS:000262700900063
J	Jimeno, A; Chan, A; Cusatis, G; Zhang, X; Wheelhouse, J; Solomon, A; Chan, F; Zhao, M; Cosenza, SC; Reddy, MVR; Rudek, MA; Kulesza, P; Donehower, RC; Reddy, EP; Hidalgo, M				Jimeno, A.; Chan, A.; Cusatis, G.; Zhang, X.; Wheelhouse, J.; Solomon, A.; Chan, F.; Zhao, M.; Cosenza, S. C.; Reddy, M. V. Ramana; Rudek, M. A.; Kulesza, P.; Donehower, R. C.; Reddy, E. P.; Hidalgo, M.			Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay	ONCOGENE			English	Article						pancreatic cancer; xenograft model; biomarker; ex vivo; cyclin B1; mitotic modulator	POLO-LIKE KINASE-1; CELL-DIVISION; CYCLIN B1; CHEMOTHERAPY SENSITIVITY; RESISTANCE ASSAYS; IN-VIVO; ARREST; OVEREXPRESSION; LEADS	The pupose of this study was to evaluate the activity of ON 01910.Na, a mitotic inhibitor, in in vitro and in vivo models of pancreatic cancer and to discover biomarkers predictive of efficacy. Successive in vitro and in vivo models were used; these included cell line-derived and patient-derived tumors from our PancXenoBank, a live collection of freshly generated pancreatic cancer xeno-grafts. ON 01910.Na showed equivalent activity to gemcitabine against pancreatic cancer cell lines in vitro. The activity of the agent correlated with suppression of phospho-CDC25C and cyclin B1. These markers were optimized for a fine-needle aspirate ex vivo rapid assay. Cyclin B1 mRNA evaluation yielded the most optimal combination of accuracy and reproducibility. Next, nine patient-derived tumors from the PancXenoBank were pro. led using the assay developed in cell lines and treated with ON01910.Na for 28 days. Two cases were cataloged as potential responders and seven as resistants. There was a correlation between the ex vivo assay and sensitivity to the tested agent, as the two cases prospectively identified as sensitive met prespecified criteria for response. Of the seven tumors of predictive resistant, only one was found to be sensitive to ON 01910.Na. In addition, there was a good correlation between cyclin B1 downregulation ex vivo and changes in cyclin B1 protein post-treatment. The novel mitotic inhibitor, ON 01910.Na, showed activity in preclinical model of pancreatic cancer. A rapid assay was rationally developed that not only identified cases sensitive to ON 01910.Na, but also anticipated the pharmacodynamic events occurring after in vivo exposure.	[Jimeno, A.; Chan, A.; Cusatis, G.; Zhang, X.; Wheelhouse, J.; Solomon, A.; Chan, F.; Zhao, M.; Rudek, M. A.; Donehower, R. C.; Hidalgo, M.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Cosenza, S. C.; Reddy, M. V. Ramana; Reddy, E. P.] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Dept Biochem, Philadelphia, PA 19122 USA; [Kulesza, P.] Univ Alabama, Dept Pathol, Wallace Tumor Inst, Birmingham, AL 35294 USA	Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Alabama System; University of Alabama Birmingham	Hidalgo, M (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, 1650 Orleans St,Room 1M88, Baltimore, MD 21231 USA.	mhidalg1@jhmi.edu	Cusatis, Gianluca/G-2539-2011; HIDALGO, MANUEL/I-4995-2015; Reddy, E. Premkumar/F-6233-2011	HIDALGO, MANUEL/0000-0002-3765-3318; 	Viragh Foundation; Onconova Inc; NATIONAL CANCER INSTITUTE [R01CA116554, P30CA006973] Funding Source: NIH RePORTER	Viragh Foundation; Onconova Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the Viragh Foundation and Onconova Inc.	Budirahardja Y, 2008, DEVELOPMENT, V135, P1303, DOI 10.1242/dev.019075; Dvory-Sobol H, 2006, EUR J CANCER, V42, P422, DOI 10.1016/j.ejca.2005.11.009; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Hassan KA, 2002, CANCER RES, V62, P6414; Hidalgo M, 2006, MOL CANCER THER, V5, P1895, DOI 10.1158/1535-7163.MCT-05-0525; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jimeno A, 2006, CANCER RES, V66, P2385, DOI 10.1158/0008-5472.CAN-05-2882; Jimeno A, 2005, CANCER RES, V65, P3003, DOI 10.1158/0008-5472.CAN-04-3586; JIMENO A, 2008, J CLIN ONCOL; JIMENO A, 2008 ASCO ANN M OR P; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Korenaga D, 2002, SURGERY, V131, pS114, DOI 10.1067/msy.2002.119362; Li J, 2007, J CHROMATOGR B, V856, P198, DOI 10.1016/j.jchromb.2007.05.047; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Park M, 2000, CANCER RES, V60, P542; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Samson DJ, 2004, J CLIN ONCOL, V22, P3618, DOI 10.1200/JCO.2004.04.077; Schmidt M, 2006, MOL CANCER THER, V5, P809, DOI 10.1158/1535-7163.MCT-05-0455; Schrag D, 2004, J CLIN ONCOL, V22, P3631, DOI 10.1200/JCO.2004.05.065; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Yuan J, 2006, ONCOGENE, V25, P1753, DOI 10.1038/sj.onc.1209202	24	28	29	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					610	618		10.1038/onc.2008.424	http://dx.doi.org/10.1038/onc.2008.424			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	19029951	Green Accepted			2022-12-25	WOS:000262866500014
J	Ferguson, T; Soares, JA; Lienard, T; Gottschalk, G; Krzycki, JA				Ferguson, Tsuneo; Soares, Jitesh A.; Lienard, Tanja; Gottschalk, Gerhard; Krzycki, Joseph A.			RamA, a Protein Required for Reductive Activation of Corrinoid-dependent Methylamine Methyltransferase Reactions in Methanogenic Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-M METHYLTRANSFERASE; METHANOSARCINA-BARKERI; METHIONINE SYNTHASE; ACETOBACTERIUM-DEHALOGENANS; ACID METHYLTRANSFERASE; O-DEMETHYLASE; L-PYRROLYSINE; ISOENZYME-II; ACETIVORANS; METABOLISM	Archaeal methane formation from methylamines is initiated by distinct methyltransferases with specificity for monomethylamine, dimethylamine, or trimethylamine. Each methylamine methyltransferase methylates a cognate corrinoid protein, which is subsequently demethylated by a second methyltransferase to form methyl-coenzyme M, the direct methane precursor. Methylation of the corrinoid protein requires reduction of the central cobalt to the highly reducing and nucleophilic Co(I) state. RamA, a 60-kDa monomeric iron-sulfur protein, was isolated from Methanosarcina barkeri and is required for in vitro ATP-dependent reductive activation of methylamine: CoM methyl transfer from all three methylamines. In the absence of the methyltransferases, highly purified RamA was shown to mediate the ATP-dependent reductive activation of Co(II) corrinoid to the Co(I) state for the monomethylamine corrinoid protein, MtmC. The ramA gene is located near a cluster of genes required for monomethylamine methyltransferase activity, including MtbA, the methylamine-specific CoM methylase and the pyl operon required for co-translational insertion of pyrrolysine into the active site of methylamine methyltransferases. RamA possesses a C-terminal ferredoxinlike domain capable of binding two tetranuclear iron-sulfur proteins. Mutliple ramA homologs were identified in genomes of methanogenic Archaea, often encoded near methyltrophic methyltransferase genes. RamA homologs are also encoded in a diverse selection of bacterial genomes, often located near genes for corrinoid-dependent methyltransferases. These results suggest that RamA mediates reductive activation of corrinoid proteins and that it is the first functional archetype of COG3894, a family of redox proteins of unknown function.	[Ferguson, Tsuneo; Soares, Jitesh A.; Krzycki, Joseph A.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Krzycki, Joseph A.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Lienard, Tanja; Gottschalk, Gerhard] Univ Gottingen, Gottingen Gen Lab, Inst Microbiol & Genet, D-37077 Gottingen, Germany	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Gottingen	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 West,12th Ave, Columbus, OH 43210 USA.	Krzycki.1@osu.edu			National Institutes of Health [GM070663]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM070663 (to J. A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Boll M, 2005, BBA-BIOENERGETICS, V1707, P34, DOI 10.1016/j.bbabio.2004.01.009; Borodina E, 2004, APPL ENVIRON MICROB, V70, P4177, DOI 10.1128/AEM.70.7.4177-4186.2004; Bose A, 2008, J BACTERIOL, V190, P4017, DOI 10.1128/JB.00117-08; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; BURKE SA, 1995, J BACTERIOL, V177, P4410, DOI 10.1128/jb.177.15.4410-4416.1995; Daas PJH, 1996, J BIOL CHEM, V271, P22346, DOI 10.1074/jbc.271.37.22346; Daas PJH, 1996, J BIOL CHEM, V271, P22339, DOI 10.1074/jbc.271.37.22339; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Deppenmeier U, 2004, J BIOENERG BIOMEMBR, V36, P55, DOI 10.1023/B:JOBB.0000019598.64642.97; Deppenmeier U, 1999, FEBS LETT, V457, P291, DOI 10.1016/S0014-5793(99)01026-1; Di Luccio E, 2007, J MOL BIOL, V365, P783, DOI 10.1016/j.jmb.2006.10.068; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Engelmann T, 2001, ARCH MICROBIOL, V175, P376, DOI 10.1007/s002030100275; Ferguson DJ, 1997, J BACTERIOL, V179, P846, DOI 10.1128/jb.179.3.846-852.1997; Ferguson DJ, 1996, J BIOL CHEM, V271, P5189; Ferguson DJ, 2000, J BIOL CHEM, V275, P29053, DOI 10.1074/jbc.M910218199; Ferry JG, 1999, FEMS MICROBIOL REV, V23, P13, DOI 10.1016/S0168-6445(98)00029-1; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; GRAHAME DA, 1991, J BIOL CHEM, V266, P22227; Hagemeier CH, 2006, P NATL ACAD SCI USA, V103, P18917, DOI 10.1073/pnas.0603650103; Hao B, 2004, CHEM BIOL, V11, P1317, DOI 10.1016/j.chembiol.2004.07.011; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Heider J, 1997, EUR J BIOCHEM, V243, P577, DOI 10.1111/j.1432-1033.1997.00577.x; Jarrett JT, 1997, BIOCHEMISTRY-US, V36, P15739, DOI 10.1021/bi971987t; Krzycki JA, 2004, CURR OPIN CHEM BIOL, V8, P484, DOI 10.1016/j.cbpa.2004.08.012; Krzycki JA, 2005, CURR OPIN MICROBIOL, V8, P706, DOI 10.1016/j.mib.2005.10.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeClerc GM, 1996, J BIOL CHEM, V271, P18725, DOI 10.1074/jbc.271.31.18725; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Maeder DL, 2006, J BACTERIOL, V188, P7922, DOI 10.1128/JB.00810-06; Mahapatra A, 2006, MOL MICROBIOL, V59, P56, DOI 10.1111/j.1365-2958.2005.04927.x; Matthews RG, 2001, ACCOUNTS CHEM RES, V34, P681, DOI 10.1021/ar0000051; Naidu D, 2001, J BACTERIOL, V183, P3276, DOI 10.1128/JB.183.11.3276-3281.2001; NAUMANN E, 1984, ARCH MICROBIOL, V138, P79, DOI 10.1007/BF00425412; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Paul L, 1996, J BACTERIOL, V178, P6599, DOI 10.1128/jb.178.22.6599-6607.1996; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Sauer K, 1997, EUR J BIOCHEM, V243, P670, DOI 10.1111/j.1432-1033.1997.t01-1-00670.x; SEEFELDT LC, 1994, ANAL BIOCHEM, V221, P379, DOI 10.1006/abio.1994.1429; Siebert A, 2005, ARCH MICROBIOL, V183, P378, DOI 10.1007/s00203-005-0001-8; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soares JA, 2005, J BIOL CHEM, V280, P36962, DOI 10.1074/jbc.M506402200; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Tallant TC, 1997, J BACTERIOL, V179, P6902, DOI 10.1128/jb.179.22.6902-6911.1997; Tallant TC, 2001, J BIOL CHEM, V276, P4485, DOI 10.1074/jbc.M007514200; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; VANDERMEIJDEN P, 1983, ARCH MICROBIOL, V134, P238, DOI 10.1007/BF00407765; VANDERMEIJDEN P, 1983, J BACTERIOL, V153, P6, DOI 10.1128/JB.153.1.6-11.1983; Vannelli T, 1999, P NATL ACAD SCI USA, V96, P4615, DOI 10.1073/pnas.96.8.4615; Wassenaar RW, 1996, J BACTERIOL, V178, P6937, DOI 10.1128/jb.178.23.6937-6944.1996; YELISEEV A, 1993, ARCH MICROBIOL, V159, P530, DOI 10.1007/BF00249031	57	42	42	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2285	2295		10.1074/jbc.M807392200	http://dx.doi.org/10.1074/jbc.M807392200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19043046	Green Published, hybrid			2022-12-25	WOS:000262545600038
J	Jensen, ED; Gopalakrishnan, R; Westendorf, JJ				Jensen, Eric D.; Gopalakrishnan, Rajaram; Westendorf, Jennifer J.			Bone Morphogenic Protein 2 Activates Protein Kinase D to Regulate Histone Deacetylase 7 Localization and Repression of Runx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEF2 TRANSCRIPTION FACTOR; OSTEOBLASTIC CELL-DIFFERENTIATION; GENE-EXPRESSION; NUCLEAR EXPORT; MUSCLE DIFFERENTIATION; CARDIAC-HYPERTROPHY; SIGNAL-TRANSDUCTION; OSTEOCALCIN GENE; TGF-BETA; INDUCTION	The transcriptional activity of Runx2 is determined by associations with co-repressors including histone deacetylase 7 (HDAC7). We previously found that bone morphogenic protein 2 (BMP2) induces export of HDAC7 from the nucleus. In this study we demonstrate that BMP2 specifically stimulates redistribution of HDAC7 but not HDAC 4, 5, or 6. HDAC7 subcellular redistribution in mesenchymal cells requires Crm1-mediated nuclear export, is associated with increased HDAC7 serine phosphorylation, and requires conserved serines in the HDAC7 amino terminus. The protein kinase D (PKD) inhibitor Go6976 blocked both basal and BMP2-directed HDAC7 nuclear export. Protein kinase D1 (PKD1) associated with HDAC7 in a BMP2-enhanced manner, and a constitutively active form of PKD1 stimulated HDAC7 nuclear export. Furthermore, active PKD1 inhibited repression of Runx2-mediated transcription by HDAC7. Suppression of HDAC7 was not sufficient to rescue BMP2 induction of osteoblast marker genes in Go6976-treated cells, indicating that PKD-dependent factors beyond attenuation of HDAC7-repressive activity are required for osteoblast differentiation. These results establish a novel pathway by which BMP signaling regulates Runx2 activity via PKD-dependent inhibition of HDAC7 transcriptional repression.	[Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Jensen, Eric D.; Gopalakrishnan, Rajaram] Univ Minnesota, Sch Dent, Minneapolis, MN 55455 USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Westendorf, JJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 1s St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu			National Institutes of Health [AR48147, AR50074, AR50938]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048147, T32AR050938, R01AR050074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR48147, AR50074, and AR50938. This work was also supported by the V Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Harrison BC, 2004, MOL CELL BIOL, V24, P10636, DOI 10.1128/MCB.24.24.10636-10649.2004; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Huynh QK, 2006, ARCH BIOCHEM BIOPHYS, V450, P141, DOI 10.1016/j.abb.2006.02.014; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jensen ED, 2007, CRIT REV EUKAR GENE, V17, P187; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lemonnier J, 2004, J BIOL CHEM, V279, P259, DOI 10.1074/jbc.M308665200; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2004, TRENDS GENET, V20, P206, DOI 10.1016/j.tig.2004.02.002; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Medeiros RB, 2005, IMMUNITY, V23, P213, DOI 10.1016/j.immuni.2005.07.006; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Sucharov CC, 2006, AM J PHYSIOL-HEART C, V291, pH1299, DOI 10.1152/ajpheart.00017.2006; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Westendorf JJ, 2006, J CELL BIOCHEM, V98, P54, DOI 10.1002/jcb.20805; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zaidi SK, 2001, J CELL SCI, V114, P3093; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	66	55	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2225	2234		10.1074/jbc.M800586200	http://dx.doi.org/10.1074/jbc.M800586200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19029091	hybrid, Green Published			2022-12-25	WOS:000262545600032
J	Herrera, M; Hong, NJ; Ortiz, PA; Garvin, JL				Herrera, Marcela; Hong, Nancy J.; Ortiz, Pablo A.; Garvin, Jeffrey L.			Endothelin-1 Inhibits Thick Ascending Limb Transport via Akt-stimulated Nitric Oxide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY COLLECTING DUCT; NO PRODUCTION; HIGH-SALT; CHLORIDE ABSORPTION; NACL COTRANSPORT; ENOS ACTIVATION; ETB RECEPTORS; L-ARGININE; IN-VIVO; SYNTHASE	Endothelin-1 inhibits sodium reabsorption in the thick ascending limb (THAL) via stimulation of nitric oxide (NO) production. The mechanism whereby endothelin-1 stimulates THAL NO is unknown. We hypothesized that endothelin-1 stimulates THAL NO production by activating phosphatidylinositol 3-kinase(PI3K), stimulating Akt activity, and phosphorylating NOS3 at Ser(1177). This enhances NO production and inhibits sodium transport. We measured 1) NO production by fluorescence microscopy using DAF2-DA, 2) Akt activity using a fluorescence resonance energy transfer-based Akt reporter, 3) phosphorylated NOS3 and Akt by Western blotting, and 4) NKCC2 activity by fluorescence microscopy. In isolated THAL, endothelin-1 (1 nmol/liter) increased NO production from 0.23 +/- 0.24 to 2.81 +/- 0.32 fluorescence units/min (p < 0.001; n = 5) but failed to stimulate NO production in THALs isolated from NOS3(-/-) mice. Wortmannin (150 nmol/liter), a PI3K inhibitor, reduced endothelin-1-stimulated NO by 83% (0.49 +/- 0.13 versus 3.31 +/- 0.49 fluorescence units/min for endothelin-1 alone; p < 0.006; n = 5). Endothelin-1 stimulated Akt activity by 0.16 +/- 0.02 arbitrary units as measured by fluorescence resonance energy transfer (p < 0.001; n = 5) and increased phosphorylation of Akt at Ser(473) by 56 +/- 11% ( p < 0.002; n = 7). Dominant-negative Akt blocked endothelin-1- induced NO by 60 +/- 8% (p < 0.001 versus control; n = 6), and an Akt inhibitor had a similar effect. Endothelin-1 increased phosphorylation of NOS3 at Ser(1177) by 89 +/- 24% (p < 0.01; n = 7) but had no effect on Ser(633). Endothelin-1 inhibited NKCC2 activity, an effect that was blocked by dominant-negative Akt and NOS inhibition. We conclude that endothelin-1 stimulates THAL NO production by activating PI3K, stimulating Akt activity, and phosphorylating NOS3 at Ser(1177). This enhances NO production and inhibits sodium transport.	[Herrera, Marcela; Hong, Nancy J.; Ortiz, Pablo A.; Garvin, Jeffrey L.] Henry Ford Hosp, Hypertens & Vasc Res Div, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Garvin, JL (corresponding author), Henry Ford Hosp, Hypertens & Vasc Res Div, 2799 W Grand Blvd,E&R 7018, Detroit, MI 48202 USA.	jgarvin1@hfhs.org		Ortiz, Pablo/0000-0002-7512-7255	NHLBI [HL-28982, HL-70985]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070985, P01HL028982] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-28982 and HL-70985 from NHLBI (to J.L.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abassi ZA, 2001, NEWS PHYSIOL SCI, V16, P152; Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Boo YC, 2003, FREE RADICAL BIO MED, V35, P729, DOI 10.1016/S0891-5849(03)00397-6; Coffer PJ, 1998, BIOCHEM J, V335, P1; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Ferreira NCD, 1997, J PHYSIOL-LONDON, V505, P749, DOI 10.1111/j.1469-7793.1997.749ba.x; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcia NH, 1999, HYPERTENSION, V34, P508, DOI 10.1161/01.HYP.34.3.508; GARVIN J L, 1988, American Journal of Physiology, V255, pF57; Granger JP, 2006, CURR HYPERTENS REP, V8, P298, DOI 10.1007/s11906-006-0068-x; HEBERT SC, 1981, AM J PHYSIOL, V241, pF412, DOI 10.1152/ajprenal.1981.241.4.F412; HEBERT SC, 1981, AM J PHYSIOL, V241, pF432, DOI 10.1152/ajprenal.1981.241.4.F432; Herrera M, 2006, HYPERTENSION, V47, P95, DOI 10.1161/01.HYP.0000196274.78603.85; Herrera M, 2005, AM J PHYSIOL-RENAL, V288, pF58, DOI 10.1152/ajprenal.00209.2004; Herrera M, 2004, AM J PHYSIOL-RENAL, V287, pF231, DOI 10.1152/ajprenal.00413.2003; KOHAN DE, 1994, AM J PHYSIOL, V266, pF291, DOI 10.1152/ajprenal.1994.266.2.F291; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; NADLER SP, 1992, J CLIN INVEST, V90, P1458, DOI 10.1172/JCI116013; Nakano D, 2008, AM J PHYSIOL-RENAL, V294, pF1205, DOI 10.1152/ajprenal.00578.2007; Notenboom S, 2002, AM J PHYSIOL-RENAL, V282, pF458, DOI 10.1152/ajprenal.00173.2001; Ortiz PA, 2004, AM J PHYSIOL-RENAL, V287, pF274, DOI 10.1152/ajprenal.00382.2003; Ortiz PA, 2004, AM J PHYSIOL-RENAL, V287, pF281, DOI 10.1152/ajprenal.00383.2003; Ortiz PA, 2003, HYPERTENSION, V42, P674, DOI 10.1161/01.HYP.0000085561.00001.81; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Ortiz PA, 2002, HYPERTENSION, V39, P591, DOI 10.1161/hy0202.103287; Ortiz PA, 2001, AM J PHYSIOL-RENAL, V281, pF819, DOI 10.1152/ajprenal.0075.2001; Plato CF, 2000, HYPERTENSION, V35, P319, DOI 10.1161/01.HYP.35.1.319; Plato CF, 2000, AM J PHYSIOL-RENAL, V279, pF326, DOI 10.1152/ajprenal.2000.279.2.F326; Plato CF, 2001, AM J PHYSIOL-RENAL, V281, pF679, DOI 10.1152/ajprenal.2001.281.4.F679; Pollock DM, 2001, AM J PHYSIOL-RENAL, V281, pF144, DOI 10.1152/ajprenal.2001.281.1.F144; Pollock JS, 2006, HYPERTENSION, V47, P19, DOI 10.1161/01.HYP.0000196276.29211.6f; Scotland RS, 2002, CIRC RES, V90, P904, DOI 10.1161/01.RES.0000016506.04193.96; SHMIDT HHHW, 1992, CELL CALCIUM, V13, P427, DOI 10.1016/0143-4160(92)90055-W; Sorenson J, 2005, STROKE, V36, P158, DOI 10.1161/01.STR.0000150489.47080.67; Stricklett PK, 2006, AM J PHYSIOL-RENAL, V290, pF1315, DOI 10.1152/ajprenal.00450.2005; Vassileva I, 2003, HYPERTENSION, V41, P1359, DOI 10.1161/01.HYP.0000070958.39174.7E; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Zou AP, 1996, HYPERTENSION, V27, P631, DOI 10.1161/01.HYP.27.3.631	41	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1454	1460		10.1074/jbc.M804322200	http://dx.doi.org/10.1074/jbc.M804322200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19033447	hybrid, Green Published			2022-12-25	WOS:000262330100013
J	Baratt, A; Arkhipov, SN; Maly, IV				Baratt, Arie; Arkhipov, Sergey N.; Maly, Ivan V.			An Experimental and Computational Study of Effects of Microtubule Stabilization on T-Cell Polarity	PLOS ONE			English	Article								T-killer cells eliminate infected and cancerous cells with precision by positioning their centrosome near the interface (Immunological synapse) with the target cell. The mechanism of centrosome positioning has remained controversial, in particular the role of microtubule dynamics in it. We re-examined the issue in the experimental model of Jurkat cells presented with a T cell receptor-binding artificial substrate, which permits controlled stimulation and reproducible measurements. Neither 1-mu m taxol nor 100-nM nocodazole inhibited the centrosome positioning at the "synapse" with the biomimetic substrate. At the same time, in micromolar taxol but not in nanomolar nocodazole the centrosome adopted a distinct peripheral rather than the normally central position within the synapse. This effect was reproduced in a computational energy-minimization model that assumed no microtubule dynamics, but only a taxol-induced increase in the length of the microtubules. Together, the experimental and computational results indicate that microtubule dynamics are not essential for the centrosome positioning, but that the fit of the microtubule array in the deformed body of the conjugated T cell is a major factor. The possibility of modulating the T-cell centrosome position with well-studied drugs and of predicting their effects in silico appears attractive for designing anti-cancer and antiviral therapies.	[Baratt, Arie; Arkhipov, Sergey N.; Maly, Ivan V.] Univ Pittsburgh, Sch Med, Dept Computat Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Baratt, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat Biol, Pittsburgh, PA 15260 USA.	ivanmaly@pitt.edu	Arkhipov, Sergey/M-6858-2019; Arkhipov, Sergey/E-6293-2014	Arkhipov, Sergey/0000-0003-4707-902X	National Institutes of Health [GM078332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM078332 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHTBUEHLER G, 1979, EXP CELL RES, V120, P111, DOI 10.1016/0014-4827(79)90542-1; Arkhipov SN, 2006, PHYS BIOL, V3, P209, DOI 10.1088/1478-3975/3/3/006; Arkhipov SN, 2006, BIOPHYS J, V91, P4306, DOI 10.1529/biophysj.106.083204; Arkhipov SN, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016006; Arkhipov SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000633; Boal D. H., 2002, MECH CELL; Borroto A, 2000, EUR J IMMUNOL, V30, P3403, DOI 10.1002/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H; Boveri T, 2008, CONCERNING ORIGIN MA; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; BUNNELL SC, 2003, SCI STKE, pP18; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; BYKOVSKAJA SN, 1978, CELL IMMUNOL, V40, P164, DOI 10.1016/0008-8749(78)90324-6; Cytrynbaum EN, 2003, BIOPHYS J, V84, P757, DOI 10.1016/S0006-3495(03)74895-4; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; DYE RB, 1993, J BIOL CHEM, V268, P6847; Eddy RJ, 2002, MOL BIOL CELL, V13, P4470, DOI 10.1091/mbc.E02-04-0241; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; GUDIMA GO, 1988, J CELL SCI, V89, P225; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Holy TE, 1997, P NATL ACAD SCI USA, V94, P6228, DOI 10.1073/pnas.94.12.6228; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; JORDAN MA, 1992, J CELL SCI, V102, P401; Kikumoto M, 2006, BIOPHYS J, V90, P1687, DOI 10.1529/biophysj.104.055483; KNOX JD, 1993, CELL MOTIL CYTOSKEL, V24, P129, DOI 10.1002/cm.970240206; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Mullins DW, 1998, IMMUNOPHARM IMMUNOT, V20, P473, DOI 10.3109/08923979809031511; Pais-Correia Ana Monica, 2007, Current Immunology Reviews, V3, P170; PARSEY MV, 1993, J IMMUNOL, V151, P1881; PFEFFER TA, 1976, J CELL BIOL, V69, P599, DOI 10.1083/jcb.69.3.599; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Ratner S, 1997, J IMMUNOL, V159, P1063; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; SALMON ED, 1984, J CELL BIOL, V99, P2165, DOI 10.1083/jcb.99.6.2165; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Schmidt RF, 1989, HUMAN PHYSL; Smurova K. M., 2007, CELL TISSUE BIOL, V1, P225; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Verkhovsky AB, 2003, MOL BIOL CELL, V14, P4667, DOI 10.1091/mbc.E02-10-0630; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; ZHAI Y, 1994, J CELL SCI, V107, P881	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3861	10.1371/journal.pone.0003861	http://dx.doi.org/10.1371/journal.pone.0003861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060950	Green Accepted, Green Published, gold			2022-12-25	WOS:000265455100001
J	Leroux, A; Rokeach, LA				Leroux, Alexandre; Rokeach, Luis A.			Inter-Species Complementation of the Translocon Beta Subunit Requires Only Its Transmembrane Domain	PLOS ONE			English	Article								In eukaryotes, proteins enter the secretory pathway through the translocon pore of the endoplasmic reticulum. This protein translocation channel is composed of three major subunits, called Sec61 alpha, beta and gamma in mammals. Unlike the other subunits, the beta subunit is dispensable for translocation and cell viability in all organisms studied. Intriguingly, the knockout of the Sec61 beta encoding genes results in different phenotypes in different species. Nevertheless, the beta subunit shows a high level of sequence homology across species, suggesting the conservation of a biological function that remains ill-defined. To address its cellular roles, we characterized the homolog of Sec61 beta in the fission yeast Schizosaccharomyces pombe (Sbh1p). Here, we show that the knockout of sbh1(+) results in severe cold sensitivity, increased sensitivity to cell-wall stress, and reduced protein secretion at 23 degrees C. Sec61 beta homologs from Saccharomyces cerevisiae and human complement the knockout of sbh1(+) in S. pombe. As in S. cerevisiae, the transmembrane domain (TMD) of S. pombe Sec61 beta is sufficient to complement the phenotypes resulting from the knockout of the entire encoding gene. Remarkably, the TMD of Sec61 beta from S. cerevisiae and human also complement the gene knockouts in both yeasts. Together, these observations indicate that the TMD of Sec61 beta exerts a cellular function that is conserved across species.	[Leroux, Alexandre; Rokeach, Luis A.] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Leroux, A (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.	luis.rokeach@umontreal.ca			NSERC [171325]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a a NSERC grant (#171325) to Luis A. Rokeach and by a NSERC scholarship to Alexandre Leroux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFA C, 1993, EXPT FISSION YEASTS; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Boisrame A, 2002, J CELL SCI, V115, P4947, DOI 10.1242/jcs.00187; BRUNDAGE L, 1992, J BIOL CHEM, V267, P4166; Cao TB, 2003, BBA-BIOMEMBRANES, V1609, P115, DOI 10.1016/S0005-2736(02)00662-4; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Elbe R, 1992, BIOTECHNIQUES, V13, P18; ESNAULT Y, 1994, J BIOL CHEM, V269, P27478; Feng D, 2007, J BIOL CHEM, V282, P30618, DOI 10.1074/jbc.M701840200; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Flower AM, 2001, J BACTERIOL, V183, P2006, DOI 10.1128/JB.183.6.2006-2012.2001; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GUERIN R, 2008, MOL BIOL CELL; Hajjar F, 2007, YEAST, V24, P89, DOI 10.1002/yea.1440; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; Helmers J, 2003, J BIOL CHEM, V278, P23686, DOI 10.1074/jbc.C300180200; Hori O, 2006, MOL CELL BIOL, V26, P4257, DOI 10.1128/MCB.02055-05; JANNATIPOUR M, 1995, J BIOL CHEM, V270, P4845, DOI 10.1074/jbc.270.9.4845; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kinch LN, 2002, TRENDS BIOCHEM SCI, V27, P170, DOI 10.1016/S0968-0004(01)02055-2; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; Matsumoto G, 1998, P NATL ACAD SCI USA, V95, P13567, DOI 10.1073/pnas.95.23.13567; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Muller S, 1998, YEAST, V14, P1267, DOI 10.1002/(SICI)1097-0061(1998100)14:14<1267::AID-YEA327>3.0.CO;2-2; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; NISHIYAMA K, 1993, EMBO J, V12, P3409, DOI 10.1002/j.1460-2075.1993.tb06015.x; OSUMI M, 1989, J ELECTRON MICROSC, V38, P457; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; POGLIANO KJ, 1993, GENETICS, V133, P763; Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; ROITSCH T, 1988, EUR J BIOCHEM, V174, P699, DOI 10.1111/j.1432-1033.1988.tb14154.x; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Sherman F., 1981, METHODS YEAST GENETI; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Sirisattha S, 2004, WATER RES, V38, P61, DOI 10.1016/j.watres.2003.08.027; Slamovits CH, 2006, J MOL BIOL, V359, P1196, DOI 10.1016/j.jmb.2006.04.028; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; Toikkanen JH, 2004, YEAST, V21, P1045, DOI 10.1002/yea.1151; Toikkanen JH, 2003, J BIOL CHEM, V278, P20946, DOI 10.1074/jbc.M213111200; Turcotte C, 2007, FEMS YEAST RES, V7, P196, DOI 10.1111/j.1567-1364.2006.00145.x; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Valcarcel R, 1999, J CELL SCI, V112, P4389; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VEGA R, 1986, ARCH MICROBIOL, V144, P124, DOI 10.1007/BF00414721; VERGERES G, 1992, J BIOL CHEM, V267, P12583; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0; Wittke S, 2002, MOL BIOL CELL, V13, P2223, DOI 10.1091/mbc.01-10-0518; Yamaguchi A, 1999, J CELL BIOL, V147, P1195, DOI 10.1083/jcb.147.6.1195; Yang Zu-Jun, 2007, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V33, P354	70	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3880	10.1371/journal.pone.0003880	http://dx.doi.org/10.1371/journal.pone.0003880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057642	Green Submitted, Green Published, gold			2022-12-25	WOS:000265452300012
J	Jain, R; Dey, B; Dhar, N; Rao, V; Singh, R; Gupta, UD; Katoch, VM; Ramanathan, VD; Tyagi, AK				Jain, Ruchi; Dey, Bappaditya; Dhar, Neeraj; Rao, Vivek; Singh, Ramandeep; Gupta, Umesh D.; Katoch, V. M.; Ramanathan, V. D.; Tyagi, Anil K.			Enhanced and Enduring Protection against Tuberculosis by Recombinant BCG-Ag85C and Its Association with Modulation of Cytokine Profile in Lung	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; T-CELL EPITOPES; MYCOBACTERIUM-TUBERCULOSIS; GUINEA-PIG; CROSSED IMMUNOELECTROPHORESIS; PULMONARY GRANULOMAS; GLOBAL TRENDS; BCG VACCINE; ANTIGEN; EXPRESSION	Background: The variable efficacy (0-80%) of Mycobacterium bovis Bacille Calmette Gurein (BCG) vaccine against adult tuberculosis (TB) necessitates development of alternative vaccine candidates. Development of recombinant BCG (rBCG) over-expressing promising immunodominant antigens of M. tuberculosis represents one of the potential approaches for the development of vaccines against TB. Methods/Principal Findings: A recombinant strain of BCG - rBCG85C, over expressing the antigen 85C, a secretory immunodominant protein of M. tuberculosis, was evaluated for its protective efficacy in guinea pigs against M. tuberculosis challenge by aerosol route. Immunization with rBCG85C resulted in a substantial reduction in the lung (1.87 log(10), p<0.01) and spleen (2.36 log(10), p<0.001) bacillary load with a commensurate reduction in pathological damage, when compared to the animals immunized with the parent BCG strain at 10 weeks post-infection. rBCG85C continued to provide superior protection over BCG even when post-challenge period was prolonged to 16 weeks. The cytokine profile of pulmonary granulomas revealed that the superior protection imparted by rBCG85C was associated with the reduced levels of pro-inflammatory cytokines - interleukin (IL)-12, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, moderate levels of anti-inflammatory cytokine - transforming growth factor (TGF)-beta along with up-regulation of inducible nitric oxide synthase (iNOS). In addition, the rBCG85C vaccine induced modulation of the cytokine levels was found to be associated with reduced fibrosis and antigen load accompanied by the restoration of normal lung architecture. Conclusions/Significance: These results clearly indicate the superiority of rBCG85C over BCG as a promising prophylactic vaccine against TB. The enduring protection observed in this study gives enough reason to postulate that if an open-ended study is carried out with low dose of infection, rBCG85C vaccine in all likelihood would show enhanced survival of guinea pigs.	[Jain, Ruchi; Dey, Bappaditya; Dhar, Neeraj; Rao, Vivek; Singh, Ramandeep; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Gupta, Umesh D.; Katoch, V. M.] Natl JALMA Inst Leprosy & Other Mycobact Dis, Agra, Uttar Pradesh, India; [Ramanathan, V. D.] Tuberculosis Res Ctr, Dept Clin Pathol, Chennai, India; [Dhar, Neeraj] Ecole Polytech Fed Lausanne, Glob Hlth Inst, Lab Bacteriol, Lausanne, Switzerland; [Rao, Vivek] Ridgeweay Mill Hill, Natl Inst Med Res, Div Mycobacter Res, London, England; [Singh, Ramandeep] NIAID, NIH, Lab Clin Infect Dis, Tuberculosis Res Sect, Bethesda, MD USA	University of Delhi; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jain, R (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	aniltyagi@south.du.ac.in	Dey, Bappaditya/H-1831-2018; Dhar, Neeraj/K-8171-2013	Dey, Bappaditya/0000-0003-2728-4683; Dhar, Neeraj/0000-0002-5887-8137	Department of Biotechnology, Ministry of Science and Technology, India; Council of Scientific and Industrial Research, Government of India [research fellowship]	Department of Biotechnology, Ministry of Science and Technology, India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a research grant to AKT and VDR from the Department of Biotechnology, Ministry of Science and Technology, India. RJ and BD acknowledge Council of Scientific and Industrial Research, Government of India for research fellowship (CSIR JRF/SRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SS, 2003, INFECT IMMUN, V71, P4271, DOI 10.1128/IAI.71.8.4271-4277.2003; Basaraba RJ, 2006, VACCINE, V24, P280, DOI 10.1016/j.vaccine.2005.07.103; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; CLEMENS JD, 1983, JAMA-J AM MED ASSOC, V249, P2362, DOI 10.1001/jama.249.17.2362; CLOSS O, 1980, SCAND J IMMUNOL, V12, P249, DOI 10.1111/j.1365-3083.1980.tb00065.x; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; DasGupta SK, 1998, BIOCHEM BIOPH RES CO, V246, P797, DOI 10.1006/bbrc.1998.8724; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; Dhar N, 2004, MED MICROBIOL IMMUN, V193, P19, DOI 10.1007/s00430-002-0170-x; Dhar N, 2003, IMMUNOL LETT, V88, P175, DOI 10.1016/S0165-2478(03)00043-9; Dhar N, 2000, FEMS MICROBIOL LETT, V190, P309, DOI 10.1111/j.1574-6968.2000.tb09304.x; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Jain S, 1997, GENE, V190, P37, DOI 10.1016/S0378-1119(96)00746-9; Keane MP, 2001, RESP RES, V3; Kumar G, 2008, SCAND J IMMUNOL, V68, P177, DOI 10.1111/j.1365-3083.2008.02133.x; Lee BY, 1999, INFECT IMMUN, V67, P2665, DOI 10.1128/IAI.67.5.2665-2670.1999; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; Ly LH, 2008, EXPERT REV VACCINES, V7, P635, DOI 10.1586/14760584.7.5.635; Ly LH, 2007, CELL MICROBIOL, V9, P1127, DOI 10.1111/j.1462-5822.2006.00854.x; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mariani F, 2000, GENE, V253, P281, DOI 10.1016/S0378-1119(00)00249-3; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; MITCHISON D A, 1960, Tubercle, V41, P1, DOI 10.1016/S0041-3879(60)80019-0; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Shakila H, 1999, INDIAN J MED RES, V110, P4; SILVER RF, 1995, J IMMUNOL, V154, P4665; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; WIKER HG, 1988, SCAND J IMMUNOL, V27, P223, DOI 10.1111/j.1365-3083.1988.tb02342.x; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; World Health Organization, 2008, GLOB TUB CONTR SURV; Yamada H, 2005, EXP ANIM TOKYO, V54, P163, DOI 10.1538/expanim.54.163	46	47	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3869	10.1371/journal.pone.0003869	http://dx.doi.org/10.1371/journal.pone.0003869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052643	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000265452200013
J	Yiannoutsos, CT; An, MW; Frangakis, CE; Musick, BS; Braitstein, P; Wools-Kaloustian, K; Ochieng, D; Martin, JN; Bacon, MC; Ochieng, V; Kimaiyo, S				Yiannoutsos, Constantin T.; An, Ming-Wen; Frangakis, Constantine E.; Musick, Beverly S.; Braitstein, Paula; Wools-Kaloustian, Kara; Ochieng, Daniel; Martin, Jeffrey N.; Bacon, Melanie C.; Ochieng, Vincent; Kimaiyo, Sylvester			Sampling-Based Approaches to Improve Estimation of Mortality among Patient Dropouts: Experience from a Large PEPFAR-Funded Program in Western Kenya	PLOS ONE			English	Article								Background: Monitoring and evaluation (M&E) of HIV care and treatment programs is impacted by losses to follow-up (LTFU) in the patient population. The severity of this effect is undeniable but its extent unknown. Tracing all lost patients addresses this but census methods are not feasible in programs involving rapid scale-up of HIV treatment in the developing world. Sampling-based approaches and statistical adjustment are the only scaleable methods permitting accurate estimation of M&E indices. Methodology/Principal Findings: In a large antiretroviral therapy (ART) program in western Kenya, we assessed the impact of LTFU on estimating patient mortality among 8,977 adult clients of whom, 3,624 were LTFU. Overall, dropouts were more likely male (36.8% versus 33.7%; p = 0.003), and younger than non-dropouts (35.3 versus 35.7 years old; p = 0.020), with lower median CD4 count at enrollment (160 versus 189 cells/ml; p<0.001) and WHO stage 3-4 disease (47.5% versus 41.1%; p<0.001). Urban clinic clients were 75.0% of non-dropouts but 70.3% of dropouts (p<0.001). Of the 3,624 dropouts, 1,143 were sought and 621 had their vital status ascertained. Statistical techniques were used to adjust mortality estimates based on information obtained from located LTFU patients. Observed mortality estimates one year after enrollment were 1.7% (95% Cl 1.3%-2.0%), revised to 2.8% (2.3%-3.1%) when deaths discovered through outreach were added and adjusted to 9.2% (7.8%-10.6%) and 9.9% (8.4%-11.5%) through statistical modeling depending on the method used. The estimates 12 months after ART initiation were 1.7% (1.3%-2.2%), 3.4% (2.9%-4.0%), 10.5% (8.7%-12.3%) and 10.7% (8.9%-12.6%) respectively. Conclusions/Significance Abstract: Assessment of the impact of LTFU is critical in program M&E as estimated mortality based on passive monitoring may underestimate true mortality by up to 80%. This bias can be ameliorated by tracing a sample of dropouts and statistically adjust the mortality estimates to properly evaluate and guide large HIV care and treatment programs.	[Yiannoutsos, Constantin T.; Musick, Beverly S.] Indiana Univ, Div Biostat, Indianapolis, IN 46204 USA; [An, Ming-Wen] Vassar Coll, Dept Math, Poughkeepsie, NY 12601 USA; [Frangakis, Constantine E.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21218 USA; [Braitstein, Paula] Indiana Univ, Div Gen Internal Med & Geriat, Indianapolis, IN USA; [Wools-Kaloustian, Kara] Indiana Univ, Div Infect Dis, Indianapolis, IN USA; [Braitstein, Paula; Wools-Kaloustian, Kara; Ochieng, Daniel; Ochieng, Vincent; Kimaiyo, Sylvester] Acad Model Prevent & Treatment HIV AIDS AMPATH, Eldoret, Kenya; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bacon, Melanie C.] Natl Inst Allergies & Infect Dis (NIAID), Bethesda, MD USA; [Braitstein, Paula; Kimaiyo, Sylvester] Moi Univ, Sch Med, Eldoret, Kenya	Indiana University System; Indiana University-Purdue University Indianapolis; Vassar College; Johns Hopkins University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Moi University	Yiannoutsos, CT (corresponding author), Indiana Univ, Div Biostat, Indianapolis, IN 46204 USA.	cyiannou@iupui.edu			National Institutes of Health (NIAID) [U01-AI0669911]; President's Emergency Plan for AIDS Relief (PEPFAR); NIDA [R01-DA023879]; National Eye Institute [EY07127]; Clinical Trials Training Program in Vision Research; NATIONAL EYE INSTITUTE [T32EY007127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023879] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Clinical Trials Training Program in Vision Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded in part by the National Institutes of Health (NIAID) grant number U01-AI0669911 (East Africa IeDEA Regional Consortium), and a Targeted Evaluation supplement to this grant by the President's Emergency Plan for AIDS Relief (PEPFAR). This research was also supported in part by a grant to the USAID-AMPATH Partnership from PEPFAR. Dr. Frangakis' research was supported by NIDA grant R01-DA023879. Dr. An's research was also supported by the National Eye Institute Training Grant EY07127 and Clinical Trials Training Program in Vision Research.	ANGLARET XX, 2005, J ACQ IMMUN DEF SYND, V35, P320; BAKER SG, 1993, BIOMETRICS, V49, P379, DOI 10.2307/2532551; Bennett S, 2006, LANCET, V367, P79, DOI 10.1016/S0140-6736(06)67928-2; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Dabis F, 2005, INT J EPIDEMIOL, V34, P979, DOI 10.1093/ije/dyi164; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; EGGER M, 2007, OUTCOMES ART RESOURC; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Frangakis CE, 2001, BIOMETRICS, V57, P333, DOI 10.1111/j.0006-341X.2001.00333.x; *GLOB FUND, 2003, FRAM DOC GLOB FUND F; *I MED, 2007, PEPFAR IMPL PROGR PR; Mamlin Burke W, 2005, AMIA Annu Symp Proc, P490; [Organization WH World Health Organization Joint United Nations Programme on HIV/AIDS], 2003, TREAT 3 MILL 2005 MA; Raboud JM, 1996, J ACQ IMMUN DEF SYND, V12, P46, DOI 10.1097/00042560-199605010-00007; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Touloumi G, 2002, EPIDEMIOLOGY, V13, P347, DOI 10.1097/00001648-200205000-00017; *US 5 YEAR GLOB HI, 2004, PRES EM PLAN AIDS RE; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea	24	68	68	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3843	10.1371/journal.pone.0003843	http://dx.doi.org/10.1371/journal.pone.0003843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048109	gold, Green Published			2022-12-25	WOS:000265452000010
J	Irwin, AJ; Finkel, ZV				Irwin, Andrew J.; Finkel, Zoe V.			Mining a Sea of Data: Deducing the Environmental Controls of Ocean Chlorophyll	PLOS ONE			English	Article							NUMERICAL-SIMULATION; CLIMATE-CHANGE; SARGASSO SEA; UPPER WATERS; TEMPERATURE; CARBON; RATES; GROWTH; MODEL; CYCLE	Chlorophyll biomass in the surface ocean is regulated by a complex interaction of physiological, oceanographic, and ecological factors and in turn regulates the rates of primary production and export of organic carbon to the deep ocean. Mechanistic models of phytoplankton responses to climate change require the parameterization of many processes of which we have limited knowledge. We develop a statistical approach to estimate the response of remote-sensed ocean chlorophyll to a variety of physical and chemical variables. Irradiance over the mixed layer depth, surface nitrate, sea-surface temperature, and latitude and longitude together can predict 83% of the variation in log chlorophyll in the North Atlantic. Light and nitrate regulate biomass through an empirically determined minimum function explaining nearly 50% of the variation in log chlorophyll by themselves and confirming that either light or macronutrients are often limiting and that much of the variation in chlorophyll concentration is determined by bottom-up mechanisms. Assuming the dynamics of the future ocean are governed by the same processes at work today, we should be able to apply these response functions to future climate change scenarios, with changes in temperature, nutrient distributions, irradiance, and ocean physics.	[Irwin, Andrew J.] Mt Allison Univ, Dept Math & Comp Sci, Sackville, NB E0A 3C0, Canada; [Finkel, Zoe V.] Mt Allison Univ, Environm Sci Program, Sackville, NB, Canada	Mount Allison University; Mount Allison University	Irwin, AJ (corresponding author), Mt Allison Univ, Dept Math & Comp Sci, Sackville, NB E0A 3C0, Canada.	airwin@mta.ca	Irwin, Andrew/B-2245-2008; Finkel, Zoe V/B-9626-2008	Finkel, Zoe V/0000-0003-4212-3917; Irwin, Andrew/0000-0001-7784-2319	NSERC Canada	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	NSERC Canada contributed to the authors' research programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002620; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1479, DOI 10.4319/lo.1997.42.7.1479; Bissett WP, 1999, DEEP-SEA RES PT I, V46, P271, DOI 10.1016/S0967-0637(98)00063-6; Bissett WP, 1999, DEEP-SEA RES PT I, V46, P205, DOI 10.1016/S0967-0637(98)00062-4; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FELDMAN GC, 2007, MCCLAIN CR OCEAN COL; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Garcia H. E., 2006, WORLD OCEAN ATLAS 20, P396; Gregg WW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021808; GREGG WW, 2003, GEOPHYS RES LETT, V30, DOI DOI 10.1029/2003GL0116889; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hastie TJ, 2017, GEN ADDITIVE MODELS, DOI [10. 1201/9780203753781, DOI 10.1201/9780203753781]; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; KAMYKOWSKI D, 1986, DEEP-SEA RES, V33, P89, DOI 10.1016/0198-0149(86)90109-3; Kamykowski D, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001640; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Longhurst A, 1998, ECOLOGICAL GEOGRAPHY, P398; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Moore JK, 2001, DEEP-SEA RES PT II, V49, P403, DOI 10.1016/S0967-0645(01)00108-4; Oliver MJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034238; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; R Development Core Team, 2006, R LANG ENV STAT COMP; Ramsay J., 2005, FUNCTIONAL DATA ANAL, P430; Raven J, 2005, OCEAN ACIDIFICATION; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; RILEY GA, 1946, J MAR RES, V6, P54; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Siegel DA, 2002, SCIENCE, V296, P730, DOI 10.1126/science.1069174; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Uz BM, 2004, DEEP-SEA RES PT II, V51, P1001, DOI [10.1016/j.dsr2.2004.03.003, 10.1016/j.dsr2.2003.03.003]; Watson AJ, 1998, PHILOS T R SOC B, V353, P41, DOI 10.1098/rstb.1998.0189; Wilson C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002724; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Yoder JA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001942	48	38	39	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3836	10.1371/journal.pone.0003836	http://dx.doi.org/10.1371/journal.pone.0003836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043583	Green Published, Green Submitted, gold			2022-12-25	WOS:000265451500010
J	Li, ZY; Umeyama, T; Wang, CC				Li, Ziyin; Umeyama, Takashi; Wang, Ching C.			The Chromosomal Passenger Complex and a Mitotic Kinesin Interact with the Tousled-Like Kinase in Trypanosomes to Regulate Mitosis and Cytokinesis	PLOS ONE			English	Article								Aurora B kinase plays essential roles in mitosis and cytokinesis in eukaryotes. In the procyclic form of Trypanosoma brucei, the Aurora B homolog TbAUK1 regulates mitosis and cytokinesis, phosphorylates the Tousled-like kinase TbTLK1, interacts with two mitotic kinesins TbKIN-A and TbKIN-B and forms a novel chromosomal passenger complex (CPC) with two novel proteins TbCPC1 and TbCPC2. Here we show with time-lapse video microscopy the time course of CPC trans-localization from the spindle midzone in late anaphase to the dorsal side of the cell where the anterior end of daughter cell is tethered, and followed by a glide toward the posterior end to divide the cell, representing a novel mode of cytokinesis in eukaryotes. The three subunits of CPC, TbKIN-B and TbTLK1 interact with one another suggesting a close association among the five proteins. An ablation of TbTLK1 inhibited the subsequent trans-localization of CPC and TbKIN-B, whereas a knockdown of CPC or TbKIN-B disrupted the spindle pole localization of TbTLK1 during mitosis. In the bloodstream form of T. brucei, the five proteins also play essential roles in chromosome segregation and cytokinesis and display subcellular localization patterns similar to that in the procyclic form. The CPC in bloodstream form also undergoes a trans-localization during cytokinesis similar to that in the procyclic form. All together, our results indicate that the five-protein complex CPC-TbTLK1-TbKIN-B plays key roles in regulating chromosome segregation in the early phase of mitosis and that the highly unusual mode of cytokinesis mediated by CPC occurs in both forms of trypanosomes.	[Li, Ziyin; Umeyama, Takashi; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Li, ZY (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu	Umeyama, Takashi/R-6525-2019	Umeyama, Takashi/0000-0002-6635-4288; Li, Ziyin/0000-0002-3960-9716	NIH [AI-21786]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021786, R56AI021786] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH R01 grant AI-21786	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Carrera P, 2003, GENE DEV, V17, P2578, DOI 10.1101/gad.276703; CARRUTHERS VB, 1992, P NATL ACAD SCI USA, V89, P8818, DOI 10.1073/pnas.89.18.8818; Ehsan H, 2004, PLANT PHYSIOL, V134, P1488, DOI 10.1104/pp.103.038117; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gluenz E, 2008, MOL MICROBIOL, V69, P666, DOI 10.1111/j.1365-2958.2008.06320.x; Han ZB, 2005, CURR BIOL, V15, P894, DOI 10.1016/j.cub.2005.04.019; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li Z, 2007, J CELL SCI, V120, P3883, DOI 10.1242/jcs.007955; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Li ZY, 2002, J BIOL CHEM, V277, P42686, DOI 10.1074/jbc.M207183200; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Ploubidou A, 1999, J CELL SCI, V112, P4641; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; ROE JL, 1993, CELL, V75, P939, DOI 10.1016/0092-8674(93)90537-Z; SASSE R, 1988, J CELL SCI, V90, P577; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; Sillje HHW, 1999, EMBO J, V18, P5691, DOI 10.1093/emboj/18.20.5691; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Walczak CE, 1996, CELL, V85, P943, DOI 10.1016/S0092-8674(00)81295-7; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	33	42	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3814	10.1371/journal.pone.0003814	http://dx.doi.org/10.1371/journal.pone.0003814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043568	Green Published, gold			2022-12-25	WOS:000265451400006
J	Moulton, EA; Burstein, R; Tully, S; Hargreaves, R; Becerra, L; Borsook, D				Moulton, Eric A.; Burstein, Rami; Tully, Shannon; Hargreaves, Richard; Becerra, Lino; Borsook, David			Interictal Dysfunction of a Brainstem Descending Modulatory Center in Migraine Patients	PLOS ONE			English	Article								Background: The brainstem contains descending circuitry that can modulate nociceptive processing (neural signals associated with pain) in the dorsal horn of the spinal cord and the medullary dorsal horn. In migraineurs, abnormal brainstem function during attacks suggest that dysfunction of descending modulation may facilitate migraine attacks, either by reducing descending inhibition or increasing facilitation. To determine whether a brainstem dysfunction could play a role in facilitating migraine attacks, we measured brainstem function in migraineurs when they were not having an attack (i.e. the interictal phase). Methods and Findings: Using fMRI (functional magnetic resonance imaging), we mapped brainstem activity to heat stimuli in 12 episodic migraine patients during the interictal phase. Separate scans were collected to measure responses to 41 degrees C and noxious heat (pain threshold+1 degrees C). Stimuli were either applied to the forehead on the affected side (as reported during an attack) or the dorsum of the hand. This was repeated in 12 age-gender-matched control subjects, and the side tested corresponded to that in the matched migraine patients. Nucleus cuneiformis (NCF), a component of brainstem pain modulatory circuits, appears to be hypofunctional in migraineurs. 3 out of the 4 thermal stimulus conditions showed significantly greater NCF activation in control subjects than the migraine patients. Conclusions: Altered descending modulation has been postulated to contribute to migraine, leading to loss of inhibition or enhanced facilitation resulting in hyperexcitability of trigeminovascular neurons. NCF function could potentially serve as a diagnostic measure in migraine patients, even when not experiencing an attack. This has important implications for the evaluation of therapies for migraine.	[Moulton, Eric A.; Tully, Shannon; Becerra, Lino; Borsook, David] Harvard Univ, McLean Hosp, Sch Med, PAIN Grp,Brain Imaging Ctr, Belmont, MA 02178 USA; [Moulton, Eric A.; Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA; [Burstein, Rami] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Hargreaves, Richard] Merck & Co Inc, West Point, PA USA; [Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula Martinos Ctr Bioengn, Dept Radiol, Charlestown, MA USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Merck & Company; Harvard University; Massachusetts General Hospital	Moulton, EA (corresponding author), Harvard Univ, McLean Hosp, Sch Med, PAIN Grp,Brain Imaging Ctr, Belmont, MA 02178 USA.	dborsook@partners.org	Moulton, Eric/AAF-8225-2019; Moulton, Eric A/A-7908-2009	Moulton, Eric/0000-0002-7959-8441; 	NIH/NINDS [R01NS056195-02, R01NS051484-04]; Merck and Co; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056195, R01NS051484] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Merck and Co(Merck & Company); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was financially supported by NIH/NINDS grants to David Borsook (R01NS056195-02) and Rami Burstein (R01NS051484-04), and by an unrestricted grant from Merck and Co. These financial sponsors did not have a direct role in this study, and did not participate in the preparation of this manuscript.	Afridi SK, 2005, ARCH NEUROL-CHICAGO, V62, P1270, DOI 10.1001/archneur.62.8.1270; Bahra A, 2001, LANCET, V357, P1016, DOI 10.1016/S0140-6736(00)04250-1; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Becerra L, 2006, J NEUROSCI, V26, P10646, DOI 10.1523/JNEUROSCI.2305-06.2006; BEHBEHANI MM, 1986, BRAIN RES, V369, P110, DOI 10.1016/0006-8993(86)90518-4; BERNARD JF, 1989, BRAIN RES, V490, P181, DOI 10.1016/0006-8993(89)90449-6; Buchgreitz L, 2006, PAIN, V123, P19, DOI 10.1016/j.pain.2006.01.040; Burstein R, 2005, J COMP NEUROL, V493, P9, DOI 10.1002/cne.20688; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; Dunckley P, 2005, J NEUROSCI, V25, P7333, DOI 10.1523/JNEUROSCI.1100-05.2005; Duvernoy HM, 1995, HUMAN BRAIN STEM CER; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Fields H.L., 2006, WALL MELZACKS TXB PA; Hadjipavlou G, 2006, PAIN, V123, P169, DOI 10.1016/j.pain.2006.02.027; Haghparast A, 2008, NEUROSCI LETT, V438, P351, DOI 10.1016/j.neulet.2008.04.072; Haghparast A, 2007, NEUROSCI LETT, V427, P44, DOI 10.1016/j.neulet.2007.09.003; HAWS CM, 1989, BRAIN RES, V483, P272, DOI 10.1016/0006-8993(89)90171-6; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Knight YE, 2001, NEUROSCIENCE, V106, P793, DOI 10.1016/S0306-4522(01)00303-7; Kovelowski CJ, 2000, PAIN, V87, P265, DOI 10.1016/S0304-3959(00)00290-6; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Loder E, 2005, HEADACHE, V45, pS33, DOI 10.1111/j.1526-4610.2005.4501002.x; MCMAHON SB, 1985, BRAIN RES, V333, P19, DOI 10.1016/0006-8993(85)90119-2; MENETREY D, 1980, J NEUROPHYSIOL, V44, P862, DOI 10.1152/jn.1980.44.5.862; MOULTON EA, 2008, HUM BRAIN MAPP; Moulton EA, 2007, NEUROIMAGE, V35, P1586, DOI 10.1016/j.neuroimage.2007.02.001; Olausson HW, 2008, NEUROSCI LETT, V436, P128, DOI 10.1016/j.neulet.2008.03.015; OLESEN TS, 1987, ARCH NEUROL-CHICAGO, V44, P156; Ossipov MH, 2000, NEUROSCI LETT, V290, P129, DOI 10.1016/S0304-3940(00)01338-0; Pan ZZ, 1996, NEUROSCIENCE, V74, P855, DOI 10.1016/0306-4522(96)00179-0; RICHTER RC, 1991, BRAIN RES, V544, P279, DOI 10.1016/0006-8993(91)90065-4; Rocca MA, 2000, NEUROLOGY, V54, P507, DOI 10.1212/WNL.54.2.507; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Schoenen J, 2006, NEUROL SCI, V27, pS77, DOI 10.1007/s10072-006-0575-1; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tortorella P, 2006, J NEUROL SCI, V244, P137, DOI 10.1016/j.jns.2006.01.015; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; Welch KMA, 2001, HEADACHE, V41, P629, DOI 10.1046/j.1526-4610.2001.041007629.x; Welch KMA, 2003, NEUROLOGY, V61, pS2, DOI 10.1212/WNL.61.8_suppl_4.S2; WIBERG M, 1987, J COMP NEUROL, V264, P92, DOI 10.1002/cne.902640108; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; YEZIERSKI RP, 1984, PAIN S, V2, pS127; Zambreanu L, 2005, PAIN, V114, P397, DOI 10.1016/j.pain.2005.01.005; ZEMLAN FP, 1988, BRAIN RES, V453, P89, DOI 10.1016/0006-8993(88)90146-1; ZEMLAN FP, 1984, NEUROSCI LETT, V52, P103, DOI 10.1016/0304-3940(84)90358-6	46	161	162	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3799	10.1371/journal.pone.0003799	http://dx.doi.org/10.1371/journal.pone.0003799			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030105	gold, Green Submitted, Green Published			2022-12-25	WOS:000265450800009
J	Premi, S; Srivastava, J; Panneer, G; Ali, S				Premi, Sanjay; Srivastava, Jyoti; Panneer, Ganesan; Ali, Sher			Startling Mosaicism of the Y-Chromosome and Tandem Duplication of the SRY and DAZ Genes in Patients with Turner Syndrome	PLOS ONE			English	Article								Presence of the human Y-chromosome in females with Turner Syndrome (TS) enhances the risk of development of gonadoblastoma besides causing several other phenotypic abnormalities. In the present study, we have analyzed the Y chromosome in 15 clinically diagnosed Turner Syndrome (TS) patients and detected high level of mosaicisms ranging from 45, XO:46, XY = 100:0% in 4; 45, XO:46, XY:46XX = 4:94:2 in 8; and 45, XO:46, XY:46XX = 50:30:20 cells in 3 TS patients, unlike previous reports showing 5-8% cells with Y- material. Also, no ring, marker or di-centric Y was observed in any of the cases. of the two TS patients having intact Y chromosome in > 85% cells, one was exceptionally tall. Both the patients were positive for SRY, DAZ, CDY1, DBY, UTY and AZFa, b and c specific STSs. Real Time PCR and FISH demonstrated tandem duplication/multiplication of the SRY and DAZ genes. At sequence level, the SRY was normal in 8 TS patients while the remaining 7 showed either absence of this gene or known and novel mutations within and outside of the HMG box. SNV/SFV analysis showed normal four copies of the DAZ genes in these 8 patients. All the TS patients showed aplastic uterus with no ovaries and no symptom of gonadoblastoma. Present study demonstrates new types of polymorphisms indicating that no two TS patients have identical genotype-phenotype. Thus, a comprehensive analysis of more number of samples is warranted to uncover consensus on the loci affected, to be able to use them as potential diagnostic markers.	[Premi, Sanjay; Srivastava, Jyoti; Panneer, Ganesan; Ali, Sher] Natl Inst Immunol, Mol Genet Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Premi, S (corresponding author), Natl Inst Immunol, Mol Genet Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	alisher@nii.res.in	SRIVASTAVA, JYOTI/J-6065-2014; Premi, Sanjay/J-4351-2014; Premi, Sanjay/ABB-1423-2020; Srivastava, Jyoti/AAD-7610-2022	SRIVASTAVA, JYOTI/0000-0002-5727-741X; Premi, Sanjay/0000-0002-5492-5469; 	DBT [BT/PR2752/AAQ/01/113/2001, BT/PR8476/AAQ/01/315/2006]; Department of Biotechnology, Govt. of India; Council of Scientific and Industrial Research (CSIR), New Delhi [Senior Research Fellowship]	DBT(Department of Biotechnology (DBT) India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by DBT Grants No. BT/PR2752/AAQ/01/113/2001 and BT/PR8476/AAQ/01/315/2006 to SA and a core grant from the Department of Biotechnology, Govt. of India to the National Institute of Immunology, New Delhi. SP is thankful to Council of Scientific and Industrial Research (CSIR), New Delhi for the award of Senior Research Fellowship. This work has been seen and approved by all the authors and they do not have any conflict of personal communication or financial interests.	ALI S, 1986, HUM GENET, V74, P239; Bashamboo A, 2005, MOL HUM REPROD, V11, P117, DOI 10.1093/molehr/gah135; Gravholt CH, 2004, EUR J ENDOCRINOL, V151, P657, DOI 10.1530/eje.0.1510657; Gravholt CH, 2000, J CLIN ENDOCR METAB, V85, P3199, DOI 10.1210/jc.85.9.3199; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HOOK EB, 1977, AM J HUM GENET, V29, P94; HSU LYF, 1994, AM J MED GENET, V53, P108, DOI 10.1002/ajmg.1320530204; Jacobs P, 1997, ANN HUM GENET, V61, P471, DOI 10.1017/S0003480097006507; Kelly TE, 1998, J MED GENET, V35, P862, DOI 10.1136/jmg.35.10.862; Meng HY, 2005, J CLIN ENDOCR METAB, V90, P3419, DOI 10.1210/jc.2005-0544; Premi S, 2006, MOL HUM REPROD, V12, P113, DOI 10.1093/molehr/gal012; Premi S, 2007, HUM GENET, V121, P337, DOI 10.1007/s00439-006-0318-7; PROCTER SE, 1984, CLIN GENET, V25, P273; QUILTER CR, 2002, J MED GENET, V39, P80; Ranke MB, 2001, LANCET, V358, P309, DOI 10.1016/S0140-6736(01)05487-3; Reddy KS, 1998, CYTOGENET CELL GENET, V82, P52, DOI 10.1159/000015064; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Saenger P, 1997, Curr Ther Endocrinol Metab, V6, P239; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; TARAOKA M, 1998, AM J HUM GENET, V78, P424; TUCKMULLER CM, 1995, HUM GENET, V96, P119, DOI 10.1007/BF00214200; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1	23	11	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3796	10.1371/journal.pone.0003796	http://dx.doi.org/10.1371/journal.pone.0003796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030103	Green Published, Green Submitted, gold			2022-12-25	WOS:000265450800006
J	Wu, EX; Palmer, N; Tian, Z; Moseman, AP; Galdzicki, M; Wang, XT; Berger, B; Zhang, HB; Kohane, IS				Wu, Erxi; Palmer, Nathan; Tian, Ze; Moseman, Annie P.; Galdzicki, Michal; Wang, Xuetao; Berger, Bonnie; Zhang, Hongbing; Kohane, Isaac S.			Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells	PLOS ONE			English	Article								Despite the growing understanding of PDGF signaling, studies of PDGF function have encountered two major obstacles: the functional redundancy of PDGFR alpha and PDGFR beta in vitro and their distinct roles in vivo. Here we used wild-type mouse embryonic fibroblasts (MEF), MEF null for either PDGFR alpha, beta, or both to dissect PDGF-PDGFR signaling pathways. These four PDGFR genetically defined cells provided us a platform to study the relative contributions of the pathways triggered by the two PDGF receptors. They were treated with PDGF-BB and analyzed for differential gene expression, in vitro proliferation and differential response to pharmacological effects. No genes were differentially expressed in the double null cells, suggesting minimal receptor-independent signaling. Protean differentiation and proliferation pathways are commonly regulated by PDGFR alpha, PDGFR beta and PDGFR alpha/beta while each receptor is also responsible for regulating unique signaling pathways. Furthermore, some signaling is solely modulated through heterodimeric PDGFR alpha/beta.	[Wu, Erxi; Tian, Ze; Moseman, Annie P.; Galdzicki, Michal; Wang, Xuetao; Kohane, Isaac S.] Harvard Univ, Sch Med, Childrens Hosp Boston, Informat Program, Boston, MA 02115 USA; [Wu, Erxi; Kohane, Isaac S.] Harvard Univ, Div Hlth Sci & Technol, MIT, Cambridge, MA 02138 USA; [Palmer, Nathan; Berger, Bonnie] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Berger, Bonnie] MIT, Dept Math, Cambridge, MA 02139 USA; [Zhang, Hongbing] Tsinghua Univ, Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Hongbing] Chinese Acad Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Dept Physiol & Pathophysiol, Beijing 100864, Peoples R China	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Chinese Academy of Sciences	Wu, EX (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Informat Program, Boston, MA 02115 USA.	isaac_kohane@harvard.edu	tian, ze/HDM-4308-2022; Kohane, Isaac Kohane/K-3716-2012; Galdzicki, Michal/F-5682-2010	Kohane, Isaac Kohane/0000-0003-2192-5160; Galdzicki, Michal/0000-0002-8392-8183; Wu, Erxi/0000-0002-1680-3639	National Institutes of Health [LM 07092-11]; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health training grant 2 Ta5 LM 07092-11. The funder had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript	Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683; Antipova AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r47; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; El-Hashemite N, 2004, CANCER RES, V64, P3436, DOI 10.1158/0008-5472.CAN-03-3609; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hsu Hui-Chen, 2004, Current Drug Targets - Inflammation and Allergy, V3, P413, DOI 10.2174/1568010042634523; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Jones AV, 2004, CELL MOL LIFE SCI, V61, P2912, DOI 10.1007/s00018-004-4272-z; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Levitzki A, 2004, CYTOKINE GROWTH F R, V15, P229, DOI 10.1016/j.cytogfr.2004.03.010; Li L, 2006, J CELL BIOCHEM, V99, P1553, DOI 10.1002/jcb.20993; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; McGary EC, 2002, CLIN CANCER RES, V8, P3584; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Ohta S, 2005, INT J CANCER, V114, P139, DOI 10.1002/ijc.20670; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Shin KH, 2006, CLIN CANCER RES, V12, P3222, DOI 10.1158/1078-0432.CCR-05-2656; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vrekoussis T, 2007, ONCOL REP, V17, P1115; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984	39	88	100	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3794	10.1371/journal.pone.0003794	http://dx.doi.org/10.1371/journal.pone.0003794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030102	Green Published, Green Submitted, gold			2022-12-25	WOS:000265450800004
J	Yaghmur, A; Laggner, P; Almgren, M; Rappolt, M				Yaghmur, Anan; Laggner, Peter; Almgren, Mats; Rappolt, Michael			Self-Assembly in Monoelaidin Aqueous Dispersions: Direct Vesicles to Cubosomes Transition	PLOS ONE			English	Article							LIQUID-CRYSTALLINE PHASES; BICONTINUOUS CUBIC PHASES; LIPID-WATER PHASES; EMULSIFIED MICROEMULSIONS; GLYCERATE SURFACTANTS; ELECTRON-MICROSCOPY; CRYO-TRANSMISSION; SUSTAINED-RELEASE; MEMBRANE-FUSION; OLEIC-ACID	Background: In the present study, synchrotron small-angle X-ray scattering (SAXS) and Cryo-TEM were used to characterize the temperature-induced structural transitions of monoelaidin (ME) aqueous dispersion in the presence of the polymeric stabilizer F127. We prove that the direct transition from vesicles to cubosomes by heating this dispersion is possible. The obtained results were compared with the fully hydrated bulk ME phase. Methodology/Principal Findings: Our results indicate the formation of ME dispersion, which is less stable than that based on the congener monoolein (MO). In addition, the temperature-dependence behavior significantly differs from the fully hydrated bulk phase. SAXS findings indicate a direct L-alpha-V-2 internal transition in the dispersion. While the transition temperature is conserved in the dispersion, the formed cubosomes with internal Im3m symmetry clearly contain more water and this ordered interior is retained over a wider temperature range as compared to its fully hydrated bulk system. At 25 degrees C, Cryo-TEM observations reveal the formation of most likely closely packed onion-like vesicles. Above the lamellar to non-lamellar phase transition at 65 degrees C, flattened cubosomes with an internal nanostructure are observed. However, they have only arbitrary shapes and thus, their morphology is significantly different from that of the well-shaped analogous MO cubosome and hexosome particles. Conclusions/Significance: Our study reveals a direct liposomes-cubosomes transition in ME dispersion. The obtained results suggest that the polymeric stabilizer F127 especially plays a significant role in the membrane fusion processes. F127 incorporates in considerable amount into the internal nanostructure and leads to the formation of a highly swollen Im3m phase.	[Yaghmur, Anan; Laggner, Peter; Rappolt, Michael] Austrian Acad Sci, Inst Biophys & Nanosyst Res IBN, Graz, Austria; [Almgren, Mats] Uppsala Univ, Dept Phys Chem, S-75105 Uppsala, Sweden	Austrian Academy of Sciences; Uppsala University	Yaghmur, A (corresponding author), Austrian Acad Sci, Inst Biophys & Nanosyst Res IBN, Graz, Austria.	anan.yaghmur@oeaw.ac.at	Almgren, Mats/AAA-9284-2019; Yaghmur, Anan/AGU-9381-2022	Yaghmur, Anan/0000-0003-1608-773X; Rappolt, Michael/0000-0001-9942-3035				Abraham T, 2005, BIOTECHNOL PROGR, V21, P255, DOI 10.1021/bp0498544; Almgren M, 2000, COLLOID SURFACE A, V174, P3, DOI 10.1016/S0927-7757(00)00516-1; Almgren M, 2007, LANGMUIR, V23, P2768, DOI 10.1021/la062482j; Almgren M, 2007, J DISPER SCI TECHNOL, V28, P43, DOI 10.1080/01932690600992613; Almgren M, 2006, J DISPER SCI TECHNOL, V27, P599, DOI 10.1080/01932690600662513; Almsherqi ZA, 2006, J CELL BIOL, V173, P839, DOI 10.1083/jcb.200603055; Amenitsch H, 1998, J SYNCHROTRON RADIAT, V5, P506, DOI 10.1107/S090904959800137X; Angelova A, 2005, J PHYS CHEM B, V109, P3089, DOI 10.1021/jp044216p; Barauskas J, 2005, NANO LETT, V5, P1615, DOI 10.1021/nl050678i; Barauskas J, 2003, LANGMUIR, V19, P9562, DOI 10.1021/la0350812; Blijdenstein TBJ, 2004, FOOD HYDROCOLLOID, V18, P857, DOI 10.1016/j.foodhyd.2004.01.003; Boyd BJ, 2007, INT J PHARM, V340, P52, DOI 10.1016/j.ijpharm.2007.03.020; Boyd BJ, 2006, INT J PHARM, V318, P154, DOI 10.1016/j.ijpharm.2006.03.010; Boyd BJ, 2006, INT J PHARM, V309, P218, DOI 10.1016/j.ijpharm.2005.11.033; Caffrey M, 2003, J STRUCT BIOL, V142, P108, DOI 10.1016/S1047-8477(03)00043-1; Cherezov V, 2002, BIOPHYS J, V83, P3393, DOI 10.1016/S0006-3495(02)75339-3; Chung H, 2002, DIABETOLOGIA, V45, P448, DOI 10.1007/s00125-001-0751-z; Chung H, 1995, BIOPHYS J, V69, P1951, DOI 10.1016/S0006-3495(95)80065-2; Conn CE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108102; CZESLIK C, 1995, BIOPHYS J, V68, P1423, DOI 10.1016/S0006-3495(95)80315-2; de Campo L, 2004, LANGMUIR, V20, P5254, DOI 10.1021/la0499416; Dickinson E, 1997, J CHEM SOC FARADAY T, V93, P2297, DOI 10.1039/a701178d; Dong YD, 2006, LANGMUIR, V22, P9512, DOI 10.1021/la061706v; Esposito E, 2005, PHARM RES-DORDR, V22, P2163, DOI 10.1007/s11095-005-8176-x; Fainerman VB, 1999, LANGMUIR, V15, P1812, DOI 10.1021/la981180h; Fong C, 2005, AUST J CHEM, V58, P683, DOI 10.1071/CH05173; Funari SS, 2003, J LIPID RES, V44, P567, DOI 10.1194/jlr.M200356-JLR200; Gong XJ, 2008, INT J NANOTECHNOL, V5, P370, DOI 10.1504/IJNT.2008.016924; Guillot S, 2006, COLLOID SURFACE A, V291, P78, DOI 10.1016/j.colsurfa.2006.07.059; Gustafsson J, 1996, LANGMUIR, V12, P4611, DOI 10.1021/la960318y; Gustafsson J, 1997, LANGMUIR, V13, P6964, DOI 10.1021/la970566+; Hartley PG, 2007, BIOCONJUGATE CHEM, V18, P152, DOI 10.1021/bc060216b; HUI SW, 1981, SCIENCE, V212, P921, DOI 10.1126/science.7233185; HYDE S, 1997, ELSEVIER BOOK SERIES; Hyde ST, 1996, CURR OPIN SOLID ST M, V1, P653, DOI 10.1016/S1359-0286(96)80047-7; ISREALACHVILI J, 1991, INTERMOLECULAR SURFA; Johnsson M, 2005, J AM CHEM SOC, V127, P1076, DOI 10.1021/ja043331a; Johnsson M, 2006, J NANOSCI NANOTECHNO, V6, P3017, DOI 10.1166/jnn.2006.402; Kaasgaard T, 2006, PHYS CHEM CHEM PHYS, V8, P4957, DOI 10.1039/b609510k; Kraineva J, 2007, LANGMUIR, V23, P7118, DOI 10.1021/la700405y; Lam YM, 1999, PHYS CHEM CHEM PHYS, V1, P3331, DOI 10.1039/a902369k; LANDH T, 1994, J PHYS CHEM-US, V98, P8453, DOI 10.1021/j100085a028; Larsson K, 2000, CURR OPIN COLLOID IN, V5, P64, DOI 10.1016/S1359-0294(00)00040-6; LARSSON K, 1989, J PHYS CHEM-US, V93, P7304, DOI 10.1021/j100358a010; Larsson K, 2005, CURR OPIN COLLOID IN, V9, P365, DOI 10.1016/j.cocis.2004.12.002; LARSSON K, 1994, LIPIDS MOL ORG PHYS, V5; Leser ME, 2006, ADV COLLOID INTERFAC, V123, P125, DOI 10.1016/j.cis.2006.07.003; Lopes LB, 2006, PHARM RES-DORDR, V23, P1332, DOI 10.1007/s11095-006-0143-7; Luzzati V, 1997, CURR OPIN STRUC BIOL, V7, P661, DOI 10.1016/S0959-440X(97)80075-9; LUZZATI V, 1993, J MOL BIOL, V229, P540, DOI 10.1006/jmbi.1993.1053; Malmsten M, 2006, SOFT MATTER, V2, P760, DOI 10.1039/b608348j; Mezzenga R, 2005, NAT MATER, V4, P729, DOI 10.1038/nmat1496; Misquitta Y, 2001, BIOPHYS J, V81, P1047, DOI 10.1016/S0006-3495(01)75762-1; Nakano M, 2002, LANGMUIR, V18, P9283, DOI 10.1021/la026297r; PATTON JS, 1979, SCIENCE, V204, P145, DOI 10.1126/science.432636; Qiu H, 2000, BIOMATERIALS, V21, P223, DOI 10.1016/S0142-9612(99)00126-X; Rangelov S, 2005, J PHYS CHEM B, V109, P3921, DOI 10.1021/jp0447385; Rappolt M, 2003, BIOPHYS J, V84, P3111, DOI 10.1016/S0006-3495(03)70036-8; RAPPOLT M, 2006, ELSEVIER BOOK SERIES, V5, P253; Rizwan SB, 2007, MICRON, V38, P478, DOI 10.1016/j.micron.2006.08.003; Roach C, 2004, BIOCHEMISTRY-US, V43, P6344, DOI 10.1021/bi049917r; Sagalowicz L, 2006, J MICROSC-OXFORD, V221, P110, DOI 10.1111/j.1365-2818.2006.01544.x; Shah JC, 2001, ADV DRUG DELIVER REV, V47, P229, DOI 10.1016/S0169-409X(01)00108-9; Sharma PK, 2008, COLLOID SURFACE B, V61, P53, DOI 10.1016/j.colsurfb.2007.07.002; Shearman GC, 2007, LANGMUIR, V23, P7276, DOI 10.1021/la700355a; Siegel DP, 1999, BIOPHYS J, V76, P291, DOI 10.1016/S0006-3495(99)77197-3; Simidjiev I, 2000, P NATL ACAD SCI USA, V97, P1473, DOI 10.1073/pnas.97.4.1473; SINGLETON WS, 1953, J AM OIL CHEM SOC, V30, P592, DOI 10.1007/BF02640970; Takahashi H, 2002, PHYS CHEM CHEM PHYS, V4, P2365, DOI 10.1039/b110852b; WANKA G, 1994, MACROMOLECULES, V27, P4145, DOI 10.1021/ma00093a016; Yaghmur A, 2006, LANGMUIR, V22, P517, DOI 10.1021/la052109w; Yaghmur A, 2005, LANGMUIR, V21, P569, DOI 10.1021/la0482711; Yaghmur A, 2006, LANGMUIR, V22, P9919, DOI 10.1021/la061303v; Yaghmur A, 2009, ADV COLLOID INTERFAC, V147-48, P333, DOI 10.1016/j.cis.2008.07.007; Yaghmur A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000479; Yaghmur A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002072; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354	77	64	64	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3747	10.1371/journal.pone.0003747	http://dx.doi.org/10.1371/journal.pone.0003747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015726	Green Published, gold			2022-12-25	WOS:000265448400004
J	Carrasco-Lopez, C; Godoy, C; de las Rivas, B; Fernandez-Lorente, G; Palomo, JM; Guisan, JM; Fernandez-Lafuente, R; Martinez-Ripoll, M; Hermoso, JA				Carrasco-Lopez, Cesar; Godoy, Cesar; de las Rivas, Blanca; Fernandez-Lorente, Gloria; Palomo, Jose M.; Guisan, Jose M.; Fernandez-Lafuente, Roberto; Martinez-Ripoll, Martin; Hermoso, Juan A.			Activation of Bacterial Thermoalkalophilic Lipases Is Spurred by Dramatic Structural Rearrangements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-STEAROTHERMOPHILUS L1; ALPHA/BETA-HYDROLASE FOLD; CRYSTAL-STRUCTURE; GEOBACILLUS-STEAROTHERMOPHILUS; IMMOBILIZED LIPASES; THERMOPHILIC LIPASE; THERMOSTABLE LIPASE; THERMOCATENULATUS; CLONING; PURIFICATION	The bacterial thermoalkalophilic lipases that hydrolyze saturated fatty acids at 60-75 degrees C and pH 8-10 are grouped as the lipase family I.5. We report here the crystal structure of the lipase from Geobacillus thermocatenulatus, the first structure of a member of the lipase family I.5 showing an open configuration. Unexpectedly, enzyme activation involves large structural rearrangements of around 70 amino acids and the concerted movement of two lids, the alpha 6- and alpha 7-helices, unmasking the active site. Central in the restructuring process of the lids are both the transfer of bulky hydrophobic residues out of the N-terminal end of the alpha 6-helix and the incorporation of short side chain residues to the alpha 6 C-terminal end. All these structural changes are stabilized by the Zn2+-binding domain, which is characteristic of this family of lipases. Two detergent molecules are placed in the active site, mimicking chains of the triglyceride substrate, demonstrating the position of the oxyanion hole and the three pockets that accommodate the sn-1, sn-2, and sn-3 fatty acids chains. The combination of structural and biochemical studies indicate that the lid opening is not mediated by temperature but triggered by interaction with lipid substrate.	[Carrasco-Lopez, Cesar; Martinez-Ripoll, Martin; Hermoso, Juan A.] CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estruct, E-28006 Madrid, Spain; [Godoy, Cesar; de las Rivas, Blanca; Palomo, Jose M.; Guisan, Jose M.; Fernandez-Lafuente, Roberto] CSIC, Inst Catalisis, Dept Biocatalisis, E-28049 Madrid, Spain; [Fernandez-Lorente, Gloria] CSIC, Inst Fermentac Ind, Dept Microbiol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fermentaciones Industriales (IFI)	Hermoso, JA (corresponding author), CSIC, Inst Rocasolano, Grp Cristal Macromol & Biol Estruct, Serrano 119, E-28006 Madrid, Spain.	xjuan@iqfr.csic.es	Hermoso, Juan/J-3433-2012; Palomo, Jose M/AAA-8667-2020; Guisan, Jose M/K-4110-2016; Fernandez-Lorente, Gloria/M-8455-2013; Godoy, Cesar/GQY-8806-2022; de las Rivas, Blanca/K-3899-2014; Martinez-Ripoll, Martin/A-8313-2012	Hermoso, Juan/0000-0002-1862-8950; Guisan, Jose M/0000-0003-1627-6522; de las Rivas, Blanca/0000-0002-8357-5226; Martinez-Ripoll, Martin/0000-0002-4019-0529; Godoy Vargas, Cesar Alonso/0000-0003-4393-9889; Carrasco-Lopez, Cesar/0000-0002-3853-8776; Lorente, Fernandez/0000-0002-0756-439X	Direccion General de Investigacion [BFU2005-01645]; "Factoria de Cristalizacion," CONSOLIDER [INGENIO-NIO-2010]	Direccion General de Investigacion(Spanish Government); "Factoria de Cristalizacion," CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grant BFU2005-01645 from Direccion General de Investigacion and by "Factoria de Cristalizacion," CONSOLIDER INGENIO-NIO-2010.	[Anonymous], 1990, BIOCATAL BIOTRANSFOR; Bell PJL, 1999, BIOTECHNOL LETT, V21, P1003, DOI 10.1023/A:1005654701905; BJORKLING F, 1991, TRENDS BIOTECHNOL, V9, P360, DOI 10.1016/0167-7799(91)90119-3; BORNSCHEUER UT, 1995, ENZYME MICROB TECH, V17, P578, DOI 10.1016/0141-0229(94)00096-A; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrasco-Lopez C, 2008, ACTA CRYSTALLOGR F, V64, P1043, DOI 10.1107/S1744309108031928; Cho AR, 2000, FEMS MICROBIOL LETT, V186, P235, DOI 10.1016/S0378-1097(00)00150-6; Choi WC, 2005, FEBS LETT, V579, P3461, DOI 10.1016/j.febslet.2005.05.016; Cygler M, 1997, METHOD ENZYMOL, V284, P3; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; DEREWENDA ZS, 1993, TRENDS BIOCHEM SCI, V18, P20, DOI 10.1016/0968-0004(93)90082-X; Fernandez-Lorente G, 2008, BIOMACROMOLECULES, V9, P2553, DOI 10.1021/bm800609g; Fernandez-Lorente G, 2007, BIOTECHNOL BIOENG, V97, P242, DOI 10.1002/bit.21230; Fernandez-Lorente G, 2006, BIOMACROMOLECULES, V7, P2610, DOI 10.1021/bm060408+; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jeong ST, 2002, J BIOL CHEM, V277, P17041, DOI 10.1074/jbc.M200640200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim HK, 1998, BIOSCI BIOTECH BIOCH, V62, P66, DOI 10.1271/bbb.62.66; Matsumura H, 2008, PROTEINS, V70, P592, DOI 10.1002/prot.21799; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nardini M, 2000, J BIOL CHEM, V275, P31219, DOI 10.1074/jbc.M003903200; Nazina TN, 2001, INT J SYST EVOL MICR, V51, P433, DOI 10.1099/00207713-51-2-433; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Palomo JM, 2004, J CHROMATOGR A, V1038, P267, DOI 10.1016/j.chroma.2004.03.058; Palomo JM, 2003, BIOMACROMOLECULES, V4, P204, DOI 10.1021/bm020071l; Palomo JM, 2003, BIOMACROMOLECULES, V4, P1, DOI 10.1021/bm025729+; SARDA L, 1958, BIOCHIM BIOPHYS ACTA, V30, P513, DOI 10.1016/0006-3002(58)90097-0; SCHMIDTDANNERT C, 1994, BBA-LIPID LIPID MET, V1214, P43, DOI 10.1016/0005-2760(94)90008-6; SchmidtDannert C, 1996, BBA-LIPID LIPID MET, V1301, P105, DOI 10.1016/0005-2760(96)00027-6; SchmidtDannert C, 1997, METHOD ENZYMOL, V284, P194; STITES WE, 1991, J MOL BIOL, V221, P7, DOI 10.1016/0022-2836(91)90795-8; Tyndall JDA, 2002, J MOL BIOL, V323, P859, DOI 10.1016/S0022-2836(02)01004-5	34	169	175	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4365	4372		10.1074/jbc.M808268200	http://dx.doi.org/10.1074/jbc.M808268200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19056729	hybrid			2022-12-25	WOS:000263134400035
J	Zhong, M; Molday, LL; Molday, RS				Zhong, Ming; Molday, Laurie L.; Molday, Robert S.			Role of the C Terminus of the Photoreceptor ABCA4 Transporter in Protein Folding, Function, and Retinal Degenerative Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARGARDT MACULAR DYSTROPHY; CONE-ROD DYSTROPHY; GENE ABCR; RETINITIS-PIGMENTOSA; TANGIER-DISEASE; RIM PROTEIN; SYNTHETIC PEPTIDES; CHOLESTEROL EFFLUX; MEMBRANE TOPOLOGY; LOCALIZATION	ABCA4 is an ATP-binding cassette transporter that is expressed in rod and cone photoreceptor cells and implicated in the removal of retinal derivatives from outer segments following photoexcitation. Mutations in the ABCA4 gene are responsible for a number of related retinal degenerative diseases, including Stargardt macular degeneration, cone-rod dystrophy, retinitis pigmentosa, and age-related macular degeneration. In order to determine the role of the C terminus of ABCA4 in protein structure and function and understand mechanisms by which C-terminal mutations cause retinal degenerative diseases, we have expressed and purified a series of deletion and substitution mutants of ABCA4 and ABCA1 in HEK 293T cells for analysis of their cellular localization and biochemical properties. Removal of the C-terminal 30 amino acids of ABCA4, including a conserved VFVNFA motif, resulted in a loss in N-retinylidene-phosphatidylethanolamine substrate binding, ATP photoaffinity labeling, and retinal-stimulated ATPase activity. This mutant was also retained in the endoplasmic reticulum of cells. Replacement of the VFVNFA motif with alanine residues also resulted in loss in function and cellular mislocalization. In contrast, C-terminal deletion mutants that retain the VFVNFA motif were functionally active and localized to intracellular vesicles similar to wild-type ABCA4. Our studies indicated that the VFVNFA motif is required for the proper folding of ABCA4 into a functionally active protein. This motif also contributes to the efficient folding of ABCA1 into an active protein. Our results provide a molecular based rationale for the disease phenotype displayed by individuals with mutations in the C terminus of ABCA4.	[Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Ophthalmol & Visual Sci, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	molday@interchange.ubc.ca			Canadian Institutes for Health Research [MT5822]; University of British Columbia	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia	This work was supported by Canadian Institutes for Health Research Grant MT5822. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a University of British Columbia predoctoral studentship.	Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Ahn JH, 2003, J BIOL CHEM, V278, P39600, DOI 10.1074/jbc.M304236200; Allikmets R, 2000, AM J HUM GENET, V67, P793, DOI 10.1086/303100; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Attie AD, 2007, TRENDS BIOCHEM SCI, V32, P172, DOI 10.1016/j.tibs.2007.02.001; Azarian SM, 1997, FEBS LETT, V409, P247, DOI 10.1016/S0014-5793(97)00517-6; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brousseau ME, 2000, J LIPID RES, V41, P433; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; FISHMAN GA, 1991, OPHTHALMOLOGY, V98, P957; FISHMAN GA, 1987, OPHTHALMOLOGY, V94, P809, DOI 10.1016/s0161-6420(87)33533-x; Fishman GA, 2003, ARCH OPHTHALMOL-CHIC, V121, P851, DOI 10.1001/archopht.121.6.851; Fitzgerald MEC, 2001, VISUAL NEUROSCI, V18, P299, DOI 10.1017/S0952523801182143; Fitzgerald ML, 2004, J BIOL CHEM, V279, P48477, DOI 10.1074/jbc.M409848200; Fumagalli A, 2001, HUM GENET, V109, P326, DOI 10.1007/s004390100583; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; GELISKEN O, 1985, INT OPHTHALMOL, V8, P225, DOI 10.1007/BF00137651; GOLDBERG AFX, 1995, BIOCHEMISTRY-US, V34, P14213, DOI 10.1021/bi00043a028; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Loewen CJR, 2001, J BIOL CHEM, V276, P22388, DOI 10.1074/jbc.M011710200; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Moritz OL, 1996, INVEST OPHTH VIS SCI, V37, P352; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; PAPERMASTER DS, 1978, J CELL BIOL, V78, P415, DOI 10.1083/jcb.78.2.415; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Rozet JM, 1999, MOL GENET METAB, V68, P310, DOI 10.1006/mgme.1999.2925; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Stenirri S, 2006, CLIN CHEM LAB MED, V44, P533, DOI 10.1515/CCLM.2006.116; Sun H, 2000, NAT GENET, V26, P242, DOI 10.1038/79994; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Tamehiro N, 2008, BIOCHEMISTRY-US, V47, P6138, DOI 10.1021/bi800182t; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9	42	42	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3640	3649		10.1074/jbc.M806580200	http://dx.doi.org/10.1074/jbc.M806580200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19056738	hybrid, Green Accepted			2022-12-25	WOS:000262872500032
J	Hamanaka, RB; Bobrovnikova-Marjon, E; Ji, X; Liebhaber, SA; Diehl, JA				Hamanaka, R. B.; Bobrovnikova-Marjon, E.; Ji, X.; Liebhaber, S. A.; Diehl, J. A.			PERK-dependent regulation of IAP translation during ER stress	ONCOGENE			English	Article						PERK; ER stress; apoptosis; IAP	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; INDUCED CELL-DEATH; MESSENGER-RNA TRANSLATION; RIBOSOME ENTRY SITE; INDUCED APOPTOSIS; MITOCHONDRIAL APOPTOSIS; MAMMALIAN-CELLS; TUMOR-GROWTH	Exposure of cells to endoplasmic reticulum (ER) stress leads to activation of phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway and transcriptional induction of the inhibitor of apoptosis family of proteins. One of the proximal effectors of the ER stress response, the PKR-like ER kinase (PERK), leads to cellular adaptation to stress by multiple mechanisms, including attenuation of protein synthesis and transcriptional induction of prosurvival genes. Although PERK activity leads to cellular adaptation to ER stress, we now demonstrate that PERK activity also inhibits the ER stress-induced apoptotic program through the induction of cellular inhibitor of apoptosis (cIAP1 and cIAP2) proteins. This induction of IAPs occurs through both transcriptional and translational responses that are PERK dependent. Reintroduction of cIAP1 or cIAP2 expression into PERK-/- murine embryonic fibroblasts during ER stress delays the early onset of ER stress-induced caspase activation and apoptosis observed in these cells. Furthermore, we demonstrate that the activation of the PI3K-Akt pathway by ER stress is dependent on PERK, suggesting additional ways in which PERK activity protects cells from ER stress-induced apoptosis.	[Hamanaka, R. B.; Bobrovnikova-Marjon, E.; Diehl, J. A.] Univ Penn, Leonard & Madlyn Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Hamanaka, R. B.; Bobrovnikova-Marjon, E.; Diehl, J. A.] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; [Hamanaka, R. B.; Bobrovnikova-Marjon, E.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Ji, X.; Liebhaber, S. A.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Diehl, JA (corresponding author), Abramson Family Canc Res Inst, 454 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	adiehl@mail.med.upenn.edu			National Institutes of Health [F32CA1238252, P01 CA104838]; Leukemia & Lymphoma Scholar award; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [P01CA104838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Scholar award(Leukemia and Lymphoma Society); Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M Romero for technical assistance and X Yang for providing IAP expression vectors. This study was supported by a grant from the National Institutes of Health F32CA1238252 (EBM); P01 CA104838, a Leukemia & Lymphoma Scholar award and the Abramson Family Cancer Research Institute (JAD).	Bellacosa A, 2004, CANCER BIOL THER, V3, P268, DOI 10.4161/cbt.3.3.703; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Clem RJ, 2001, J BIOL CHEM, V276, P7602, DOI 10.1074/jbc.M010259200; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Di Sano F, 2006, J BIOL CHEM, V281, P2693, DOI 10.1074/jbc.M509110200; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Fernandez J, 2002, J BIOL CHEM, V277, P11780, DOI 10.1074/jbc.M110778200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Jamora C, 1996, P NATL ACAD SCI USA, V93, P7690, DOI 10.1073/pnas.93.15.7690; Ji XJ, 2003, MOL CELL BIOL, V23, P899, DOI 10.1128/MCB.23.3.899-907.2003; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004; Kaufman RJ, 2004, TRENDS BIOCHEM SCI, V29, P152, DOI 10.1016/j.tibs.2004.01.004; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Morishima N, 2004, J BIOL CHEM, V279, P50375, DOI 10.1074/jbc.M408493200; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Orth R, 1997, J BIOL CHEM, V272, P8841; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Shiraishi H, 2006, J CELL SCI, V119, P3958, DOI 10.1242/jcs.03160; Simons M, 1999, J NEUROCHEM, V72, P292, DOI 10.1046/j.1471-4159.1999.0720292.x; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vucic D, 2007, CLIN CANCER RES, V13, P5995, DOI 10.1158/1078-0432.CCR-07-0729; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Warnakulasuriyarachchi D, 2004, J BIOL CHEM, V279, P17148, DOI 10.1074/jbc.M308737200	63	70	74	4	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					910	920		10.1038/onc.2008.428	http://dx.doi.org/10.1038/onc.2008.428			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19029953	Green Accepted			2022-12-25	WOS:000263320000013
J	Bourguignon, LYW; Xia, WL; Wong, G				Bourguignon, Lilly Y. W.; Xia, Weiliang; Wong, Gabriel			Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates beta-Catenin Signaling and NF kappa B-specific Transcription Activity Leading to MDR1 and Bcl-x(L) Gene Expression and Chemoresistance in Breast Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MULTIDRUG-RESISTANCE GENE; GROWTH-FACTOR RECEPTOR; CANCER-CELLS; E-CADHERIN; CYTOSKELETON FUNCTION; TOPOISOMERASE-II; HOMING RECEPTOR; OVARIAN; ACTIVATION; CHEMOTHERAPY	In this study we have investigated hyaluronan (HA)-mediated CD44 (an HA receptor) interactions with p300 (a histone acetyltransferase) and SIRT1 (a histone deacetylase) in human breast tumor cells (MCF-7 cells). Specifically, our results indicate that HA binding to CD44 up-regulates p300 expression and its acetyltransferase activity that, in turn, promotes acetylation of beta-catenin and NF kappa B-p65 leading to activation of beta-catenin-associated T-cell factor/lymphocyte enhancer factor transcriptional co-activation and NF kappa B-specific transcriptional up-regulation, respectively. These changes then cause the expression of the MDR1 (P-glycoprotein/P-gp) gene and the anti-apoptotic gene Bcl-x(L) resulting in chemoresistance in MCF-7 cells. Our data also show that down-regulation of p300, beta-catenin, or NF kappa B-p65 in MCF-7 cells (by transfecting cells with p300-, beta-catenin-, or NF kappa B-p65-specific small interfering RNA) inhibits the HA/CD44-mediated beta-catenin/NF kappa B-p65 acetylation and abrogates the aforementioned transcriptional activities. Subsequently, there is a significant decrease in both MDR1 and Bcl-x(L) gene expression and an enhancement in caspase-3 activity and chemosensitivity in the breast tumor cells. Further analyses indicate that activation of SIRT1 (deacetylase) by resveratrol (a natural antioxidant) induces SIRT1-p300 association and acetyltransferase inactivation, leading to deacetylation of HA/CD44-induced beta-catenin and NF kappa B-p65, inhibition of beta-catenin-T-cell factor/lymphocyte enhancer factor and NF kappa B-specific transcriptional activation, and the impairment of MDR1 and Bcl-x(L) gene expression. All these multiple effects lead to an activation of caspase-3 and a reduction of chemoresistance. Together, these findings suggest that the interactions between HA/CD44-stimulated p300 (acetyltransferase) and resveratrol-activated SIRT1 (deacetylase) play pivotal roles in regulating the balance between cell survival versus apoptosis, and multidrug resistance versus sensitivity in breast tumor cells.	[Bourguignon, Lilly Y. W.] Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu	Xia, Weiliang/C-2650-2008; XIA, WEILIANG/AEA-0835-2022	Xia, Weiliang/0000-0002-0256-4219; XIA, WEILIANG/0000-0002-0256-4219	National Institutes of Health [R01 CA66163, R01 CA 78633, P01 AR39448]; Veterans Affairs merit review grant; Department of Defense grant; NATIONAL CANCER INSTITUTE [R01CA066163, R01CA078633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit review grant(US Department of Veterans Affairs); Department of Defense grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA66163, R01 CA 78633, and P01 AR39448 ( USPHS). This work was also supported by a Veterans Affairs merit review grant and a Department of Defense grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006; Auvinen P, 2005, HISTOPATHOLOGY, V47, P420, DOI 10.1111/j.1365-2559.2005.02220.x; Baker EK, 2004, CANCER BIOL THER, V3, P819, DOI 10.4161/cbt.3.9.1101; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; Cal C., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P77, DOI 10.2174/1568011033353443; Chan HM, 2001, J CELL SCI, V114, P2363; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Chuthapisith S, 2006, SURG-J R COLL SURG E, V4, P211, DOI 10.1016/S1479-666X(06)80062-4; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Debatin KM, 2002, ONCOGENE, V21, P8786, DOI 10.1038/sj.onc.1206039; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; DELPECH B, 1990, INT J CANCER, V46, P388, DOI 10.1002/ijc.2910460309; Engel N, 2008, INT J MOL MED, V21, P223; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Graham B, 2005, CELL CYCLE, V4, P1342, DOI 10.4161/cc.4.10.2047; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hill A, 2006, ONCOGENE, V25, P6079, DOI 10.1038/sj.onc.1209628; Hoei-Hansen CE, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-12; Iida N, 1997, J CELL PHYSIOL, V171, P152, DOI 10.1002/(SICI)1097-4652(199705)171:2<152::AID-JCP5>3.3.CO;2-6; IIDA N, 1995, J CELL PHYSIOL, V162, P127, DOI 10.1002/jcp.1041620115; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; JABNKNECHT R, 1996, CURR BIOL, V6, P22; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Li NX, 2000, METHOD ENZYMOL, V319, P273; Lonning PE, 2003, LANCET ONCOL, V4, P177; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Muggia FM, 1997, DRUGS, V54, P22, DOI 10.2165/00003495-199700544-00006; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ohashi R, 2007, CANCER LETT, V252, P225, DOI 10.1016/j.canlet.2006.12.025; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Peifer M, 1997, SCIENCE, V275, P1752, DOI 10.1126/science.275.5307.1752; Pervaiz S, 2004, DRUG RESIST UPDATE, V7, P333, DOI 10.1016/j.drup.2004.11.001; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Porter ACG, 2004, CHROMOSOME RES, V12, P569, DOI 10.1023/B:CHRO.0000036608.91085.d1; Pumfery A, 2003, CURR HIV RES, V1, P343, DOI 10.2174/1570162033485186; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Russo RIC, 2008, INT J CANCER, V122, P1012, DOI 10.1002/ijc.23122; Schultz J, 2004, J NATL CANCER I, V96, P1497, DOI 10.1093/jnci/96.20.1497; SCREATON GR, 1993, J BIOL CHEM, V268, P12235; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Shibata T, 1996, ONCOGENE, V13, P883; Smith H S, 1991, Basic Life Sci, V57, P329; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; UNDERHILL C, 1992, J CELL SCI, V103, P293; Van Beekum Olivier, 2007, Subcell Biochem, V41, P233; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vincent T, 2003, BRIT J HAEMATOL, V121, P259, DOI 10.1046/j.1365-2141.2003.04282.x; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P19, DOI 10.1001/archotol.132.1.19; Wang SJ, 2007, ARCH OTOLARYNGOL, V133, P281, DOI 10.1001/archotol.133.3.281; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Yang XH, 2001, CANCER RES, V61, P348; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhu D, 1998, CELL MOTIL CYTOSKEL, V39, P209, DOI 10.1002/(SICI)1097-0169(1998)39:3<209::AID-CM4>3.0.CO;2-#	110	144	148	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2657	2671		10.1074/jbc.M806708200	http://dx.doi.org/10.1074/jbc.M806708200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047049	Green Published, hybrid			2022-12-25	WOS:000262700900008
J	Du, L; Hickey, RW; Bayir, H; Watkins, SC; Tyurin, VA; Guo, FL; Kochanek, PM; Jenkins, LW; Ren, J; Gibson, G; Chu, CT; Kagan, VE; Clark, RSB				Du, Lina; Hickey, Robert W.; Bayir, Huelya; Watkins, Simon C.; Tyurin, Vladimir A.; Guo, Fengli; Kochanek, Patrick M.; Jenkins, Larry W.; Ren, Jin; Gibson, Greg; Chu, Charleen T.; Kagan, Valerian E.; Clark, Robert S. B.			Starving Neurons Show Sex Difference in Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; FATTY-ACIDS; CELL-DEATH; LIPID DROPLETS; GENDER; MICE; 3-METHYLADENINE; METABOLISM; INHIBITION; SURVIVAL	Sex-dependent differences in adaptation to famine have long been appreciated, thought to hinge on female versus male preferences for fat versus protein sources, respectively. However, whether these differences can be reduced to neurons, independent of typical nutrient depots, such as adipose tissue, skeletal muscle, and liver, was heretofore unknown. A vital adaptation to starvation is autophagy, a mechanism for recycling amino acids from organelles and proteins. Here we show that segregated neurons from males in culture are more vulnerable to starvation than neurons from females. Nutrient deprivation decreased mitochondrial respiration, increased autophagosome formation, and produced cell death more profoundly in neurons from males versus females. Starvation-induced neuronal death was attenuated by 3-methyladenine, an inhibitor of autophagy; Atg7 knockdown using small interfering RNA; or L-carnitine, essential for transport of fatty acids into mitochondria, all more effective in neurons from males versus females. Relative tolerance to nutrient deprivation in neurons from females was associated with a marked increase in triglyceride and free fatty acid content and a cytosolic phospholipase A2-dependent increase in formation of lipid droplets. Similar sex differences in sensitivity to nutrient deprivation were seen in fibroblasts. However, although inhibition of autophagy using Atg7 small interfering RNA inhibited cell death during starvation in neurons, it increased cell death in fibroblasts, implying that the role of autophagy during starvation is both sex-and tissue-dependent. Thus, during starvation, neurons from males more readily undergo autophagy and die, whereas neurons from females mobilize fatty acids, accumulate triglycerides, form lipid droplets, and survive longer.	[Du, Lina; Bayir, Huelya; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Du, Lina; Bayir, Huelya; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Hickey, Robert W.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; [Bayir, Huelya; Tyurin, Vladimir A.; Ren, Jin; Kagan, Valerian E.] Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Watkins, Simon C.; Guo, Fengli; Gibson, Greg] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; [Jenkins, Larry W.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Hickey, Robert W.; Bayir, Huelya; Clark, Robert S. B.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015; Chu, Charleen T/B-1601-2008; Watkins, Simon/ABG-2590-2021	Kochanek, Patrick M/0000-0002-2627-913X; Chu, Charleen T/0000-0002-5052-8271; Watkins, Simon/0000-0003-4092-1552; Tyurin, Vladimir/0000-0002-3474-1697; Kagan, Valerian E./0000-0002-7245-1885	National Institutes of Health [NS38620, NS30318, HD045968, NS061817, AG026389]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P20NS030318, P50NS030318, R01NS038620, P01NS030318, R01NS061817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS38620, NS30318, HD045968, NS061817, and AG026389. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Baker RR, 1999, BBA-MOL CELL BIOL L, V1438, P253, DOI 10.1016/S1388-1981(99)00057-8; Bakewell L, 2006, BRIT J NUTR, V96, P93, DOI 10.1079/BJN20061801; BALLOU LR, 1985, P NATL ACAD SCI USA, V82, P371, DOI 10.1073/pnas.82.2.371; Basoglu M, 2006, EUR J NEUROL, V13, P1089, DOI 10.1111/j.1468-1331.2006.01531.x; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Connan F, 2006, PSYCHIAT RES-NEUROIM, V146, P117, DOI 10.1016/j.pscychresns.2005.10.006; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fujimoto T, 2006, ANN NY ACAD SCI, V1086, P104, DOI 10.1196/annals.1377.010; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; HILL JO, 1984, AM J PHYSIOL, V247, pR318, DOI 10.1152/ajpregu.1984.247.2.R318; Hopkins RO, 2007, CURR OPIN CRIT CARE, V13, P497, DOI 10.1097/MCC.0b013e3282efd19c; HOYENGA KB, 1982, PHYSIOL BEHAV, V28, P545, DOI 10.1016/0031-9384(82)90153-6; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Katzman D K, 2001, Semin Clin Neuropsychiatry, V6, P146, DOI 10.1053/scnp.2001.22263; Kim HY, 2003, LIPIDS, V38, P453, DOI 10.1007/s11745-003-1083-z; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lamont LS, 2003, J APPL PHYSIOL, V95, P1259, DOI 10.1152/japplphysiol.01028.2002; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; LUXON BA, 1993, AM J PHYSIOL, V265, pG831, DOI 10.1152/ajpgi.1993.265.5.G831; McAnoy AM, 2005, J AM SOC MASS SPECTR, V16, P1498, DOI 10.1016/j.jasms.2005.04.017; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; NEELY N, 1974, BIOCHEM BIOPH RES CO, V59, P680, DOI 10.1016/S0006-291X(74)80033-1; Niskanen LK, 1997, EUR J ENDOCRINOL, V137, P61, DOI 10.1530/eje.0.1370061; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Patil S, 2005, NEUROSCI LETT, V384, P288, DOI 10.1016/j.neulet.2005.05.003; Rodriguez-Rodriguez RA, 2004, J NEUROCHEM, V88, P1041, DOI 10.1046/j.1471-4159.2003.02262.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Ulloth JE, 2003, J NEUROCHEM, V84, P655, DOI 10.1046/j.1471-4159.2003.01571.x; WIDDOWSON EM, 1976, P NUTR SOC, V35, P175, DOI 10.1079/PNS19760030; Wolf I, 2006, CANCER-AM CANCER SOC, V106, P966, DOI 10.1002/cncr.21690; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	42	155	157	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2383	2396		10.1074/jbc.M804396200	http://dx.doi.org/10.1074/jbc.M804396200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19036730	Green Published, hybrid			2022-12-25	WOS:000262545600047
J	Ezezika, OC; Younger, NS; Lu, J; Kaiser, DA; Corbin, ZA; Nolen, BJ; Kovar, DR; Pollard, TD				Ezezika, Obidimma C.; Younger, Noah S.; Lu, Jia; Kaiser, Donald A.; Corbin, Zachary A.; Nolen, Bradley J.; Kovar, David R.; Pollard, Thomas D.			Incompatibility with Formin Cdc12p Prevents Human Profilin from Substituting for Fission Yeast Profilin INSIGHTS FROM CRYSTAL STRUCTURES OF FISSION YEAST PROFILIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY-L-PROLINE; ACTIN-FILAMENT ELONGATION; NUCLEOTIDE EXCHANGE; BINDING-SITE; CHICK-EMBRYOS; ADP-ACTIN; MODEL; CYTOKINESIS; REFINEMENT; NUCLEATION	Expression of human profilin-I does not complement the temperature-sensitive cdc3-124 mutation of the single profilin gene in fission yeast Schizosaccharomyces pombe, resulting in death from cytokinesis defects. Human profilin-I and S. pombe profilin have similar affinities for actin monomers, the FH1 domain of fission yeast formin Cdc12p and poly-L-proline (Lu, J., and Pollard, T. D. ( 2001) Mol. Biol. Cell 12, 1161-1175), but human profilin-I does not stimulate actin filament elongation by formin Cdc12p like S. pombe profilin. Two crystal structures of S. pombe profilin and homology models of S. pombe profilin bound to actin show how the two profilins bind to identical surfaces on animal and yeast actins even though 75% of the residues on the profilin side of the interaction differ in the two profilins. Overexpression of human profilin-I in fission yeast expressing native profilin also causes cytokinesis defects incompatible with viability. Human profilin-I with the R88E mutation has no detectable affinity for actin and does not have this dominant overexpression phenotype. The Y6D mutation reduces the affinity of human profilin-I for poly-L-proline by 1000-fold, but overexpression of Y6D profilin in fission yeast is lethal. The most likely hypotheses to explain the incompatibility of human profilin-I with Cdc12p are differences in interactions with the proline-rich sequences in the FH1 domain of Cdc12p and wider "wings" that interact with actin.	[Ezezika, Obidimma C.; Corbin, Zachary A.; Nolen, Bradley J.; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Younger, Noah S.; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Younger, Noah S.; Kovar, David R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Lu, Jia; Kaiser, Donald A.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Yale University; Yale University; Yale University; University of Chicago; University of Chicago; Salk Institute	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu		Ezezika, Obidimma/0000-0001-7832-0483	National Institutes of Health [GM-026338, GM-066311, GM-079265]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066311, R01GM026338, R01GM079265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-026338 and GM-066311 ( to T. D. P.) and GM-079265 ( to D. R. K.).	ALMO SC, 1994, J MOL BIOL, V236, P950, DOI 10.1006/jmbi.1994.1200; ARCHER SJ, 1994, FEBS LETT, V337, P145, DOI 10.1016/0014-5793(94)80262-9; BALASUBRAMANIAN MK, 1994, J CELL BIOL, V125, P1289, DOI 10.1083/jcb.125.6.1289; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Christensen HEM, 1996, PLANT J, V10, P269, DOI 10.1046/j.1365-313X.1996.10020269.x; DeLano W, 2002, PYMOL 0 99; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu SP, 1998, J STRUCT BIOL, V123, P22, DOI 10.1006/jsbi.1998.4009; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Mahoney NM, 1999, NAT STRUCT BIOL, V6, P666, DOI 10.1038/10722; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; METZLER WJ, 1994, J BIOL CHEM, V269, P4620; Mimuro H, 2000, J BIOL CHEM, V275, P28893, DOI 10.1074/jbc.M003882200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ostrander DB, 1999, EUR J BIOCHEM, V262, P26, DOI 10.1046/j.1432-1327.1999.00354.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; PERELROIZEN I, 1995, J BIOL CHEM, V270, P1501, DOI 10.1074/jbc.270.4.1501; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; TANAKA M, 1985, EUR J BIOCHEM, V151, P291, DOI 10.1111/j.1432-1033.1985.tb09099.x; TUDERMAN L, 1975, EUR J BIOCHEM, V52, P9, DOI 10.1111/j.1432-1033.1975.tb03967.x; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873	47	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2088	2097		10.1074/jbc.M807073200	http://dx.doi.org/10.1074/jbc.M807073200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028693	Green Published, hybrid			2022-12-25	WOS:000262545600017
J	Jessop, CE; Tavender, TJ; Watkins, RH; Chambers, JE; Bulleid, NJ				Jessop, Catherine E.; Tavender, Timothy J.; Watkins, Rachel H.; Chambers, Joseph E.; Bulleid, Neil J.			Substrate Specificity of the Oxidoreductase ERp57 Is Determined Primarily by Its Interaction with Calnexin and Calreticulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; PEPTIDE-LOADING COMPLEX; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; SECRETORY PATHWAY; BINDING SITE; ER; TAPASIN; CELLS; GLYCOPROTEINS	The formation of disulfides within proteins entering the secretory pathway is catalyzed by the protein disulfide isomerase family of endoplasmic reticulum localized oxidoreductases. One such enzyme, ERp57, is thought to catalyze the isomerization of non-native disulfide bonds formed in glycoproteins with unstructured disulfide-rich domains. Here we investigated the mechanism underlying ERp57 specificity toward glycoprotein substrates and the interdependence of ERp57 and the calnexin cycle for their correct folding. Our results clearly show that ERp57 must be physically associated with the calnexin cycle to catalyze isomerization reactions with most of its substrates. In addition, some glycoproteins only require ERp57 for correct disulfide formation if they enter the calnexin cycle. Hence, the specificity of ER oxidoreductases is not only determined by the physical association of enzyme and substrate but also by accessory factors, such as calnexin and calreticulin in the case of ERp57. These conclusions suggest that the calnexin cycle has evolved with a specialized oxidoreductase to facilitate native disulfide formation in complex glycoproteins.	[Jessop, Catherine E.; Tavender, Timothy J.; Watkins, Rachel H.; Chambers, Joseph E.; Bulleid, Neil J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Bulleid, NJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	neil.bulleid@manchester.ac.uk	Chambers, Joseph/Z-5212-2019	Chambers, Joseph/0000-0003-4675-0053; Bulleid, Neil/0000-0002-9839-5279	Wellcome Trust [074081]; Biotechnology and Biological Sciences Research Council [D00764]; Biotechnology and Biological Sciences Research Council [BB/D00764X/1] Funding Source: researchfish; BBSRC [BB/D00764X/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by grants from the Wellcome Trust (Reference 074081) and the Biotechnology and Biological Sciences Research Council (Reference D00764). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen S, 1997, BIOCHEM J, V328, P113, DOI 10.1042/bj3280113; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Bulleid NJ, 1996, BIOCHEM J, V317, P195, DOI 10.1042/bj3170195; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chambers JE, 2008, J BIOL CHEM, V283, P1862, DOI 10.1074/jbc.M708196200; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Maggioni MC, 2005, NAT STRUCT MOL BIOL, V12, P258, DOI 10.1038/nsmb897; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; ROBERTS PC, 1993, J VIROL, V67, P3048, DOI 10.1128/JVI.67.6.3048-3060.1993; Russell SJ, 2004, J BIOL CHEM, V279, P18861, DOI 10.1074/jbc.M400575200; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Simons JF, 1998, EMBO J, V17, P396, DOI 10.1093/emboj/17.2.396; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009	28	65	69	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2194	2202		10.1074/jbc.M808054200	http://dx.doi.org/10.1074/jbc.M808054200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19054761	Green Published, hybrid			2022-12-25	WOS:000262545600029
J	Chenal, A; Guijarro, JI; Raynal, B; Delepierre, M; Ladant, D				Chenal, Alexandre; Guijarro, J. Inaki; Raynal, Bertrand; Delepierre, Muriel; Ladant, Daniel			RTX Calcium Binding Motifs Are Intrinsically Disordered in the Absence of Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HEMOLYSIN; ADENYLATE-CYCLASE TOXIN; SERRATIA-MARCESCENS; CRYSTAL-STRUCTURE; ABC-TRANSPORTER; SECB CHAPERONE; REPEAT DOMAIN; SECRETION; PROTEIN; HLYA	The Repeat in Toxin (RTX) motif is a tandemly repeated calcium-binding nonapeptide sequence present in proteins that are secreted by the type I secretion system (T1SS) of Gram-negative bacteria. Here, we have characterized the structural and hydrodynamic properties of the RTX Repeat Domain (RD) of the CyaA toxin from Bordetella pertussis. This 701-amino acid long domain contains about 40 RTX motifs. We showed that, in the absence of calcium, RD was natively disordered, weakly stable, and highly hydrated. Calcium binding induced compaction and dehydration of RD, along with the formation of stable secondary and tertiary structures. The calcium-induced conformational switch between unfolded conformations of apo-RD and stable structures of holo-RD is likely to be a key property for the biological function of the CyaA toxin: in the low calcium environment of the bacterial cytosol, the intrinsically disordered character of the protein may facilitate its secretion through the secretion machinery. In the extracellular medium, calcium binding can then trigger the folding of the polypeptide into its functional state. The intrinsic disorder of RTX-containing proteins in the absence of calcium may thus be directly involved in the efficient secretion of proteins through T1SS.	[Chenal, Alexandre] Inst Pasteur, Unite Biochim Interact Macromol, CNRS URA 2185, F-75724 Paris 15, France; [Guijarro, J. Inaki; Delepierre, Muriel] Inst Pasteur, Unite RMN Biomol, F-75724 Paris 15, France; [Raynal, Bertrand] Inst Pasteur, Dept Biol Struct & Chim, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chenal, A (corresponding author), Inst Pasteur, Unite Biochim Interact Macromol, CNRS URA 2185, 28 Rue Dr Roux, F-75724 Paris 15, France.	alexandre.chenal@pasteur.fr; daniel.ladant@pasteur.fr	Guijarro, J. Inaki/E-6438-2019; Chenal, Alexandre/C-2240-2009	Guijarro, J. Inaki/0000-0002-3826-5245; Chenal, Alexandre/0000-0002-4959-1003; raynal, Bertrand/0000-0001-5634-0408; LADANT, Daniel/0000-0003-1955-548X	Institut Pasteur; Centre National de la Recherche Scientifique [CNRS URA 2185]; European Union 6th Framework Programme [LSHB-CT-2004-503582]; Region Ile de France	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Union 6th Framework Programme(European Commission); Region Ile de France(Region Ile-de-France)	This work was supported by Institut Pasteur, the Centre National de la Recherche Scientifique (CNRS URA 2185, Biologie Structurale et Agents Infectieux), and the European Union 6th Framework Programme contract LSHB-CT-2004-503582 (Theravac). The 600 MHz spectrometer was funded by the Region Ile de France and the Institut Pasteur. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BOEHM DF, 1990, INFECT IMMUN, V58, P1959, DOI 10.1128/IAI.58.6.1959-1964.1990; Dalvit C, 1999, MAGN RESON CHEM, V37, P7, DOI 10.1002/(SICI)1097-458X(199901)37:1<7::AID-MRC398>3.0.CO;2-F; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Delepelaire P, 1998, EMBO J, V17, P936, DOI 10.1093/emboj/17.4.936; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; FELMLEE T, 1988, P NATL ACAD SCI USA, V85, P5269, DOI 10.1073/pnas.85.14.5269; FELMLEE T, 1985, J BACTERIOL, V163, P88, DOI 10.1128/JB.163.1.88-93.1985; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Harding SE, 1997, PROG BIOPHYS MOL BIO, V68, P207, DOI 10.1016/S0079-6107(97)00027-8; HARDING SE, 1995, ANAL BIOCHEM, V228, P131, DOI 10.1006/abio.1995.1324; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LETOFFE S, 1992, J BACTERIOL, V174, P4920; LUDWIG A, 1988, MOL GEN GENET, V214, P553, DOI 10.1007/BF00330494; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; NICAUD JM, 1986, FEBS LETT, V204, P331, DOI 10.1016/0014-5793(86)80838-9; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; Sanchez-Magraner L, 2007, J BIOL CHEM, V282, P11827, DOI 10.1074/jbc.M700547200; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; Wolff N, 2003, J BIOL CHEM, V278, P38247, DOI 10.1074/jbc.M302322200	31	104	107	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1781	1789		10.1074/jbc.M807312200	http://dx.doi.org/10.1074/jbc.M807312200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015266	hybrid			2022-12-25	WOS:000262330100049
J	Park, Y; Yoon, SK; Yoon, JB				Park, Yoon; Yoon, Sungjoo Kim; Yoon, Jong-Bok			The HECT Domain of TRIP12 Ubiquitinates Substrates of the Ubiquitin Fusion Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN UBIQUITINATION; POLYUBIQUITIN CHAINS; MULTIUBIQUITIN CHAIN; CONJUGATING ENZYME; CRYSTAL-STRUCTURE; PROTEOLYSIS; MECHANISMS; ALZHEIMERS; DISEASE; COMPLEX	The ubiquitin fusion degradation (UFD) pathway is a proteolytic system conserved in yeast and mammals in which an uncleavable ubiquitin moiety linked to the N terminus of a protein functions as a degradation signal of the fusion protein. Although key components of the UFD pathway in yeast have been identified, the E3 enzyme of the human UFD pathway has not been studied. In this work, we show that TRIP12 is the E3 enzyme of the human UFD pathway. Thus, TRIP12 catalyzes in vitro ubiquitination of UFD substrates in conjunction with E1, E2, and E4 enzymes. Knockdown of TRIP12 stabilizes not only artificial UFD substrates but a physiological substrate UBB+1. Moreover, TRIP12 knockdown reduces UBB+1-induced cell death in human neuroblastoma cells. Surprisingly, complementation of TRIP12 knockdown cells with the TRIP12 HECT domain mostly restores efficient degradation of UFD substrates, indicating that the TRIP12 HECT domain can act as the E3 enzyme for the UFD pathway in human cells. The TRIP12 HECT domain directs ubiquitination of UFD substrates in vitro and can be specifically cross-linked to the ubiquitin moiety of the substrates in vivo, suggesting that the TRIP12 HECT domain possesses a noncovalent ubiquitin-binding site. In addition, we demonstrate that Ub Delta GG, a mutant ubiquitin that cannot be conjugated to other proteins, is a substrate of the TRIP12 HECT domain both in vivo and in vitro, indicating that the C-terminal extension fused to the uncleavable ubiquitin is not required for substrate recognition in the UFD pathway. These results provide new insights into the mechanism of the mammalian UFD pathway and the functional nonequivalence of different HECT domains.	[Park, Yoon; Yoon, Jong-Bok] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Park, Yoon; Yoon, Jong-Bok] Yonsei Univ, Prot Network Res Ctr, Seoul 120749, South Korea; [Yoon, Sungjoo Kim] Catholic Univ Korea, Dept Biomed Sci, Seoul 137040, South Korea	Yonsei University; Yonsei University; Catholic University of Korea	Yoon, JB (corresponding author), Yonsei Univ, Dept Biochem, 134 Shinchon Dong, Seoul 120749, South Korea.	yoonj@yonsei.ac.kr		Yoon, Jong-Bok/0000-0002-3563-0702	Korean Ministry of Science and Technology; Korea Science and Engineering Foundation through the Protein Network Research Center at Yonsei University; Seoul RBD Program [10527]	Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Korea Science and Engineering Foundation through the Protein Network Research Center at Yonsei University(Korea Science and Engineering Foundation); Seoul RBD Program(Seoul RBD program)	This work was supported in part by grants from the Korean Ministry of Science and Technology through the Studies on Ubiquitome Functions Project, the Korea Science and Engineering Foundation through the Protein Network Research Center at Yonsei University, and Seoul R&BD Program Grant 10527. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; De Vrij FMS, 2001, FASEB J, V15, P2680, DOI 10.1096/fj.01-0438com; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DH, 2007, FEBS LETT, V581, P265, DOI 10.1016/j.febslet.2006.12.024; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200	27	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1540	1549		10.1074/jbc.M807554200	http://dx.doi.org/10.1074/jbc.M807554200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028681	hybrid			2022-12-25	WOS:000262330100022
J	Mozziconacci, J; Sandblad, L; Wachsmuth, M; Brunner, D; Karsenti, E				Mozziconacci, Julien; Sandblad, Linda; Wachsmuth, Malte; Brunner, Damian; Karsenti, Eric			Tubulin Dimers Oligomerize before Their Incorporation into Microtubules	PLOS ONE			English	Article								In the presence of GTP, purified dimers of alpha- and beta- tubulin will interact longitudinally and laterally to self-assemble into microtubules (MTs). This property provides a powerful in vitro experimental system to describe MT dynamic behavior at the micrometer scale and to study effects and functioning of a large variety of microtubule associated proteins (MAPs). Despite the plethora of such data produced, the molecular mechanisms of MT assembly remain disputed. Electron microscopy (EM) studies suggested that tubulin dimers interact longitudinally to form short oligomers which form a tube by lateral interaction and which contribute to MT elongation. This idea is however challenged: Based on estimated association constants it was proposed that single dimers represent the major fraction of free tubulin. This view was recently supported by measurements suggesting that MTs elongate by addition of single tubulin dimers. To solve this discrepancy, we performed a direct measurement of the longitudinal interaction energy for tubulin dimers. We quantified the size distribution of tubulin oligomers using EM and fluorescence correlation spectroscopy (FCS). From the distribution we derived the longitudinal interaction energy in the presence of GDP and the non-hydrolysable GTP analog GMPCPP. Our data suggest that MT elongation and nucleation involves interactions of short tubulin oligomers rather than dimers. Our approach provides a solid experimental framework to better understand the role of MAPs in MT nucleation and growth.	[Mozziconacci, Julien] Univ Paris 06, LPTMC, UMR 7600, Paris, France; [Mozziconacci, Julien; Sandblad, Linda; Wachsmuth, Malte; Brunner, Damian; Karsenti, Eric] EMBL, Cell Biol & Biophys Unit, Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; European Molecular Biology Laboratory (EMBL)	Mozziconacci, J (corresponding author), Univ Paris 06, LPTMC, UMR 7600, Paris, France.	brunner@embl.de; karsenti@embl.de	Mozziconacci, Julien/M-4731-2019; Brunner, Damian/F-2024-2011	Brunner, Damian/0000-0001-5250-492X	HFSPO [RGP11/2005]	HFSPO(Human Frontier Science Program)	This work was supported in part by the HFSPO grant RGP11/2005.	Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Beuron F, 2001, METH MOL B, V164, P235; Carlier MF, 1997, BIOPHYS J, V73, P418, DOI 10.1016/S0006-3495(97)78081-0; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; ERICKSON HP, 1981, BIOPHYS J, V34, P293, DOI 10.1016/S0006-3495(81)84850-3; Flory P. J, 1953, PRINCIPLES POLYM CHE; FRIGON RP, 1975, BIOCHEMISTRY-US, V14, P4567, DOI 10.1021/bi00692a002; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Hoenger A, 1996, J MOL BIOL, V263, P114, DOI 10.1006/jmbi.1996.0561; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Krouglova T, 2004, BIOPHYS J, V87, P2635, DOI 10.1529/biophysj.104.040717; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Oosawa F., 1975, THERMODYNAMICS POLYM; Peloquin J, 2005, NAT METHODS, V2, P299, DOI 10.1038/nmeth0405-299; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	25	48	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3821	10.1371/journal.pone.0003821	http://dx.doi.org/10.1371/journal.pone.0003821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043587	Green Published, gold, Green Submitted			2022-12-25	WOS:000265451500004
J	van Schothorst, EM; Bunschoten, A; Schrauwen, P; Mensink, RP; Keijer, J				van Schothorst, Evert M.; Bunschoten, Annelies; Schrauwen, Patrick; Mensink, Ronald P.; Keijer, Jaap			Effects of a high-fat, low- versus high-glycemic index diet: retardation of insulin resistance involves adipose tissue modulation	FASEB JOURNAL			English	Article						carbohydrate; adipokines; glucose tolerance	LIPID-METABOLISM; STARCH PROMOTES; GLUCOSE; OBESITY; CARBOHYDRATE; PROTEIN; LEPTIN; RAT; ADIPONECTIN; ADIPOCYTES	Beneficial effects of low glycemic index (GI) diets in rodents have been studied using healthy low-fat diets, while the effects might be different on high-fat diets inducing progression of insulin resistance. We fed C57BL/6J male mice high-fat low/high-GI (LGI/HGI) diets for 13 wk. Glucose and insulin tolerance and serum substrates, including adipokines, were measured longitudinally. The LGI group showed a significantly higher glucose tolerance from wk 2 onwards, which was supported by lower serum insulin and free fatty acids levels at 8 wk, and a tendency for lower leptin levels, while resistin levels remained similar. At 11 wk, when differences in serum resistin started to increase, differences in serum insulin were diminished. Although food intake was similar throughout the study, body weights and epididymal adipose tissue mass became significantly lower in the LGI group at necropsy. Several serum substrates and adipose tissue leptin mRNA levels, as analyzed by Q-PCR, were, again, significantly lower, whereas adiponectin mRNA levels were higher. Taken together, an LGI high-fat diet maintains higher glucose tolerance and insulin sensitivity via adipose tissue modulation solely because of a difference in the type of carbohydrate, supporting a nutritional approach in the fight against insulin resistance.-Van Schothorst, E. M., Bunschoten, A., Schrauwen, P., Mensink, R. P., Keijer, J. Effects of a high-fat, low versus high glycemic index diet: retardation of insulin resistance involves adipose tissue modulation. FASEB J. 23, 1092-1101 (2009)	[van Schothorst, Evert M.; Bunschoten, Annelies; Keijer, Jaap] Wageningen Univ, NL-6700 AH Wageningen, Netherlands; [van Schothorst, Evert M.; Bunschoten, Annelies; Schrauwen, Patrick; Mensink, Ronald P.; Keijer, Jaap] Top Inst Food & Nutr, Wageningen, Netherlands; [van Schothorst, Evert M.; Bunschoten, Annelies; Keijer, Jaap] Univ Wageningen & Res Ctr, RIKILT, Inst Food Safety, Wageningen, Netherlands; [Schrauwen, Patrick; Mensink, Ronald P.] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands	Wageningen University & Research; Top Institute Food & Nutrition; Wageningen University & Research; Maastricht University	van Schothorst, EM (corresponding author), Wageningen Univ, Marijkeweg 40,POB 338, NL-6700 AH Wageningen, Netherlands.	evert.vanschothorst@wur.nl	Keijer, Jaap/J-8089-2013	Keijer, Jaap/0000-0002-9720-7491; van Schothorst, Evert/0000-0002-3036-5903; schrauwen, patrick/0000-0002-0973-847X				Anderwald C, 2007, EUR J CLIN INVEST, V37, P774, DOI 10.1111/j.1365-2362.2007.01858.x; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Brand-Miller JC, 2003, DIABETES CARE, V26, P3363, DOI 10.2337/diacare.26.12.3363; Browning LM, 2006, DIABETES TECHNOL THE, V8, P45, DOI 10.1089/dia.2006.8.45; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; BYRNES SE, 1995, J NUTR, V125, P1430; de Boer VCJ, 2006, CELL MOL LIFE SCI, V63, P2847, DOI 10.1007/s00018-006-6316-z; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Herrmann TS, 2001, EXP BIOL MED, V226, P1037, DOI 10.1177/153537020122601111; Higgins JA, 1996, J NUTR, V126, P596, DOI 10.1093/jn/126.3.596; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; JENKINS DJA, 1978, BRIT MED J, V1, P1392, DOI 10.1136/bmj.1.6124.1392; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Jensen L, 2008, AM J CLIN NUTR, V87, P97, DOI 10.1093/ajcn/87.1.97; Kabir M, 1998, J NUTR, V128, P1878, DOI 10.1093/jn/128.11.1878; Kabir M, 1998, J NUTR, V128, P35, DOI 10.1093/jn/128.1.35; Kabir M, 2000, METABOLISM, V49, P764, DOI 10.1053/meta.2000.6258; Keijer J, 2008, CURR OPIN LIPIDOL, V19, P4, DOI 10.1097/MOL.0b013e3282f39f95; Kiens B, 1996, AM J CLIN NUTR, V63, P47, DOI 10.1093/ajcn/63.1.47; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; KREIJL CFK, 2004, OUR FOOD OUR HLTH HL; Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897; Lee JH, 2005, AM J PHYSIOL-ENDOC M, V288, pE625, DOI 10.1152/ajpendo.00184.2004; LererMetzger M, 1996, BRIT J NUTR, V75, P723, DOI 10.1079/BJN19960176; Lockridge JB, 2008, J LIPID RES, V49, P1395, DOI 10.1194/jlr.M700517-JLR200; Ludwig DS, 2007, LANCET, V369, P890, DOI 10.1016/S0140-6736(07)60427-9; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Muurling M, 2003, J NUTR, V133, P3350, DOI 10.1093/jn/133.11.3350; Pawlak DB, 2004, LANCET, V364, P778, DOI 10.1016/S0140-6736(04)16937-7; Pawlak DB, 2001, J NUTR, V131, P99, DOI 10.1093/jn/131.1.99; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; Pravenec M, 2003, J BIOL CHEM, V278, P45209, DOI 10.1074/jbc.M304869200; Rocca AS, 2001, ENDOCRINOLOGY, V142, P1148, DOI 10.1210/en.142.3.1148; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Scribner KB, 2007, OBESITY, V15, P2190, DOI 10.1038/oby.2007.260; Stienstra R, 2007, ENDOCRINOLOGY, V148, P2753, DOI 10.1210/en.2007-0014; Taketani Yutaka, 2007, J Med Invest, V54, P359, DOI 10.2152/jmi.54.359; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Van Schothorst EM, 2005, OBES RES, V13, P1031, DOI 10.1038/oby.2005.121; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Walker CG, 2002, HORM METAB RES, V34, P176, DOI 10.1055/s-2002-26707; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386; WRIGHT JD, 2003, ADV DATA VITAL HLTH, V334; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	51	41	41	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1092	1101		10.1096/fj.08-117119	http://dx.doi.org/10.1096/fj.08-117119			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19029198	Green Submitted			2022-12-25	WOS:000266651600013
J	Youm, YH; Yang, HW; Sun, YX; Smith, RG; Manley, NR; Vandanmagsar, B; Dixit, VD				Youm, Yun-Hee; Yang, Hyunwon; Sun, Yuxiang; Smith, Roy G.; Manley, Nancy R.; Vandanmagsar, Bolormaa; Dixit, Vishwa Deep			Deficient Ghrelin Receptor-mediated Signaling Compromises Thymic Stromal Cell Microenvironment by Accelerating Thymic Adiposity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; AGE; EXPRESSION; THYMOPOIESIS; PROGENITORS; MECHANISMS; CAPACITY; DEFECTS; OBESITY; MICE	With progressive aging, adipocytes are the major cell types that constitute the bulk of thymic microenvironment. Understanding the origin of thymic adipocytes and mechanisms responsible for age-related thymic adiposity is thus germane for the design of long lasting thymic rejuvenation strategies. We have recently identified that ghrelin, an orexigenic anti-inflammatory peptide, can partially reverse age-related thymic involution. Here we demonstrate that Ghrl and ghrelin receptor (growth hormone secretagogue receptor (GHSR)) are expressed in thymic stromal cells and that their expression declines with physiological aging. Genetic ablation of ghrelin and GHSR leads to loss of thymic epithelial cells (TEC) and an increase in adipogenic fibroblasts in the thymus, suggesting potential cellular transitions. Using FoxN1Cre; R26RstopLacZ double transgenic mice, we provide qualitative evidence that thymic epithelial cells can transition to mesenchymal cells that express proadipogenic regulators in the thymus. We found that loss of functional Ghrl-GHSR interactions facilitates EMT and induces thymic adipogenesis with age. In addition, the compromised thymic stromal microenvironment due to lack of Ghrl-GHSR interactions is associated with reduced number of naive T cells. These data suggest that Ghrl may be a novel regulator of EMT and preserves thymic stromal cell microenvironment by controlling age-related adipocyte development within the thymus.	[Youm, Yun-Hee; Yang, Hyunwon; Vandanmagsar, Bolormaa; Dixit, Vishwa Deep] Louisiana State Univ, Pennington Biomed Res Ctr, Lab Neuroendocrine Immunol, Baton Rouge, LA 70808 USA; [Manley, Nancy R.] Univ Georgia, Coverdell Ctr Biomed & Hlth Sci, Dept Genet, Athens, GA 30602 USA; [Sun, Yuxiang; Smith, Roy G.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University System of Georgia; University of Georgia; Baylor College of Medicine	Dixit, VD (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Lab Neuroendocrine Immunol, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	Vishwa.Dixit@pbrc.edu	Vandanmagsar, Bolormaa/R-4565-2018	Youm, Yun-Hee/0000-0002-8098-8527	COYPU; Pennington Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	COYPU; Pennington Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the COYPU and Pennington Foundation grants (to V. D. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson M, 2000, INT IMMUNOL, V12, P1105, DOI 10.1093/intimm/12.7.1105; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Clise-Dwyer K, 2007, J IMMUNOL, V178, P1321, DOI 10.4049/jimmunol.178.3.1321; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; FRIEDENSTEIN A, 1962, NATURE, V194, P698, DOI 10.1038/194698a0; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gonzalez-Rey E, 2006, GASTROENTEROLOGY, V130, P1707, DOI 10.1053/j.gastro.2006.01.041; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Gray DHD, 2007, J IMMUNOL, V178, P4956, DOI 10.4049/jimmunol.178.8.4956; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Gui JG, 2007, INT IMMUNOL, V19, P1201, DOI 10.1093/intimm/dxm095; Hale LP, 2001, DEV COMP IMMUNOL, V25, P509, DOI 10.1016/S0145-305X(00)00071-9; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kenins L, 2008, J EXP MED, V205, P523, DOI 10.1084/jem.20072065; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Mackall CL, 1998, EUR J IMMUNOL, V28, P1886, DOI 10.1002/(SICI)1521-4141(199806)28:06<1886::AID-IMMU1886>3.0.CO;2-M; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Min H, 2004, J IMMUNOL, V173, P245, DOI 10.4049/jimmunol.173.1.245; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rossi S, 2002, BLOOD, V100, P682, DOI 10.1182/blood.V100.2.682; Steinmann G G, 1986, Curr Top Pathol, V75, P43; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; Zediak VP, 2007, BLOOD, V110, P1161, DOI 10.1182/blood-2007-01-071605	35	64	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7068	7077		10.1074/jbc.M808302200	http://dx.doi.org/10.1074/jbc.M808302200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19054770	Green Published, hybrid			2022-12-25	WOS:000263919000055
J	Chanoux, RA; Yin, B; Urtishak, KA; Asare, A; Bassing, CH; Brown, EJ				Chanoux, Rebecca A.; Yin, Bu; Urtishak, Karen A.; Asare, Amma; Bassing, Craig H.; Brown, Eric J.			ATR and H2AX Cooperate in Maintaining Genome Stability under Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE-RESPONSE; HOMOLOGOUS RECOMBINATION REPAIR; S-PHASE ARREST; HISTONE H2AX; FUNCTIONAL INTERACTION; IONIZING-RADIATION; FORK PROGRESSION; BLM HELICASE; CHECKPOINT	Chromosomal abnormalities are frequently caused by problems encountered during DNA replication. Although the ATR-Chk1 pathway has previously been implicated in preventing the collapse of stalled replication forks into double-strand breaks (DSB), the importance of the response to fork collapse in ATR-deficient cells has not been well characterized. Herein, we demonstrate that, upon stalled replication, ATR deficiency leads to the phosphorylation of H2AX by ATM and DNA-PKcs and to the focal accumulation of Rad51, a marker of homologous recombination and fork restart. Because H2AX has been shown to play a facilitative role in homologous recombination, we hypothesized that H2AX participates in Rad51-mediated suppression of DSBs generated in the absence of ATR. Consistent with this model, increased Rad51 focal accumulation in ATR-deficient cells is largely dependent on H2AX, and dual deficiencies in ATR and H2AX lead to synergistic increases in chromatid breaks and translocations. Importantly, the ATM and DNA-PK phosphorylation site on H2AX (Ser(139)) is required for genome stabilization in the absence of ATR; therefore, phosphorylation of H2AX by ATM and DNA-PKcs plays a pivotal role in suppressing DSBs during DNA synthesis in instances of ATR pathway failure. These results imply that ATR-dependent fork stabilization and H2AX/ATM/DNA-PKcs-dependent restart pathways cooperatively suppress double-strand breaks as a layered response network when replication stalls.	[Chanoux, Rebecca A.; Yin, Bu; Urtishak, Karen A.; Asare, Amma; Bassing, Craig H.; Brown, Eric J.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Chanoux, Rebecca A.; Urtishak, Karen A.; Asare, Amma; Brown, Eric J.] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Yin, Bu; Bassing, Craig H.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Brown, EJ (corresponding author), 514 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	brownej@mail.med.upenn.edu	Yin, Bu/A-2327-2011	Asare, Amma/0000-0002-4865-6864	National Institutes of Health NIA [R01AG027376]; Pennsylvania Department of Health; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA125195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027376] Funding Source: NIH RePORTER	National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pennsylvania Department of Health; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health NIA Grant R01AG027376. This work was also supported by the Pennsylvania Department of Health and the Abramson Family Cancer Research Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Davalos AR, 2004, CELL CYCLE, V3, P1579, DOI 10.4161/cc.3.12.1286; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Durkin SG, 2006, ONCOGENE, V25, P4381, DOI 10.1038/sj.onc.1209466; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Lewis KA, 2005, CANCER RES, V65, P7091, DOI 10.1158/0008-5472.CAN-05-1019; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Marians KJ, 2000, CURR OPIN GENET DEV, V10, P151, DOI 10.1016/S0959-437X(00)00059-9; Meister P, 2005, J CELL BIOL, V168, P537, DOI 10.1083/jcb.200410006; Menoyo A, 2001, CANCER RES, V61, P7727; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Sonoda E, 2007, DNA REPAIR, V6, P280, DOI 10.1016/j.dnarep.2006.10.025; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Veuger SJ, 2003, CANCER RES, V63, P6008; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zhu M, 2007, MOL BIOL CELL, V18, P1044, DOI 10.1091/mbc.E06-10-0957; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	62	93	96	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5994	6003		10.1074/jbc.M806739200	http://dx.doi.org/10.1074/jbc.M806739200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19049966	Green Published, hybrid			2022-12-25	WOS:000263560600063
J	Qin, KF; Zhao, LL; Ash, RD; McDonough, WF; Zhao, RY				Qin, Kefeng; Zhao, Lili; Ash, Richard D.; McDonough, William F.; Zhao, Richard Y.			ATM-mediated Transcriptional Elevation of Prion in Response to Copper-induced Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; BINDING-SITES; REPEAT REGION; PROTEIN GENE; FULL-LENGTH; CELL; RECOMBINANT; CHAPERONE; PRP; COORDINATION	Increasing evidence suggests that the cellular prion protein (PrPC) plays a protective role in response to oxidative stress, but the molecular mechanism is unclear. Here, we demonstrate that murine neuro-2a and human HeLa cells rapidly respond to an increase of intracellular copper concentration by up-regulating ataxia-telangiectasia mutated (ATM)-mediated transcription of PrPC. Copper stimulation activates ATM by phosphorylation at Ser-1981, which leads to phosphorylation of p53 at Ser-15 and the initiation of the mitogen-activated protein kinase kinase/extracellular-related kinases/extracellular-related kinases (MEK/ERK)/Sp1 pathway. As results, Sp1 and p53 bind to the PrP promoter, leading to increase PrPC expression. Elevated PrPC correlates with reduction of intracellular copper concentration and suppression of Cu(II)-induced accumulation of reactive oxygen species and cell death. Depletion of PrPC, ATM, p53, and/or Sp1 further demonstrates that ATM is a key regulatory protein to promote activation of p53 and Sp1 leading to PrPC elevation, which is required to reduce Cu(II) toxic effects and may play an important role in modulation of intracellular copper concentration.	[Qin, Kefeng; Zhao, Lili; Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Microbiol Immunol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Ash, Richard D.; McDonough, William F.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park	Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Pathol, 10 S Pine St,MSTF 700A, Baltimore, MD 21201 USA.	RZhao@som.umaryland.edu	Ash, Richard/AAD-4888-2021; McDonough, William F/I-7720-2012; McDonough, William F/C-4791-2009	Ash, Richard/0000-0003-2144-5917; McDonough, William F/0000-0001-9154-3673; McDonough, William F/0000-0001-9154-3673; Zhao, Richard Y./0000-0003-3424-2852	University of Maryland Medical Center; University of Maryland School of Medicine	University of Maryland Medical Center; University of Maryland School of Medicine	This work was supported in part by funding from the University of Maryland Medical Center (to R.Y.Z.) and an intramural award from the University of Maryland School of Medicine (to K. Q.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1998, J NEUROCHEM, V70, P1686; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Burns CS, 2002, BIOCHEMISTRY-US, V41, P3991, DOI 10.1021/bi011922x; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; Choi CJ, 2007, TOXICOL SCI, V98, P495, DOI 10.1093/toxsci/kfm099; Desoize B, 2003, IN VIVO, V17, P529; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371; Haigh CL, 2006, J NEUROCHEM, V98, P677, DOI 10.1111/j.1471-4159.2006.03906.x; Harada K, 2000, ORAL ONCOL, V36, P3, DOI 10.1016/S1368-8375(99)00049-4; Harrison MD, 1999, J BIOL INORG CHEM, V4, P145, DOI 10.1007/s007750050297; HOFFMAN PW, 1995, NUCLEIC ACIDS RES, V23, P2229, DOI 10.1093/nar/23.12.2229; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Ischiropoulos H, 1999, METHOD ENZYMOL, V301, P367; Jones CE, 2004, J BIOL CHEM, V279, P32018, DOI 10.1074/jbc.M403467200; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Leclerc E, 2006, ARCH VIROL, V151, P2103, DOI 10.1007/s00705-006-0804-1; Liang J, 2006, TUMOR BIOL, V27, P84, DOI 10.1159/000092488; Mahal SP, 2001, GENE, V268, P105, DOI 10.1016/S0378-1119(01)00424-3; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Manzl C, 2004, TOXICOLOGY, V196, P57, DOI 10.1016/j.tox.2003.11.001; Miura T, 2005, BIOCHEMISTRY-US, V44, P8712, DOI 10.1021/bi0501784; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Nordstrom EK, 2005, J NEUROSCI, V25, P8451, DOI 10.1523/JNEUROSCI.2349-05.2005; Paitel E, 2003, J BIOL CHEM, V278, P10061, DOI 10.1074/jbc.M211580200; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Possel H, 1997, FEBS LETT, V416, P175, DOI 10.1016/S0014-5793(97)01197-6; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Qin K, 2006, NEUROSCIENCE, V141, P1375, DOI 10.1016/j.neuroscience.2006.04.068; Qin K, 2006, NEUROSCIENCE, V141, P1, DOI 10.1016/j.neuroscience.2006.04.057; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Qin KF, 2002, J BIOL CHEM, V277, P1981, DOI 10.1074/jbc.M108744200; Radisky D, 1999, J BIOL CHEM, V274, P4481, DOI 10.1074/jbc.274.8.4481; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Rosenzweig AC, 2000, CURR OPIN CHEM BIOL, V4, P140, DOI 10.1016/S1367-5931(99)00066-6; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Shiraishi N, 2006, J BIOL CHEM, V281, P34880, DOI 10.1074/jbc.M606581200; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Varela-Nallar L, 2006, AM J PHYSIOL-CELL PH, V290, pC271, DOI 10.1152/ajpcell.00160.2005; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang VC, 2005, BIOCHEM BIOPH RES CO, V333, P95, DOI 10.1016/j.bbrc.2005.05.091; Wells MA, 2006, BIOCHEM J, V399, P435, DOI 10.1042/BJ20060458; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; Whittal RM, 2000, PROTEIN SCI, V9, P332; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhang Y, 2006, BIOCHEM BIOPH RES CO, V349, P759, DOI 10.1016/j.bbrc.2006.08.116	59	32	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4582	4593		10.1074/jbc.M808410200	http://dx.doi.org/10.1074/jbc.M808410200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19064990	hybrid			2022-12-25	WOS:000263134400058
J	Hoskins, EE; Morris, TA; Higginbotham, JM; Spardy, N; Cha, E; Kelly, P; Williams, DA; Wikenheiser-Brokamp, KA; Duensing, S; Wells, SI				Hoskins, E. E.; Morris, T. A.; Higginbotham, J. M.; Spardy, N.; Cha, E.; Kelly, P.; Williams, D. A.; Wikenheiser-Brokamp, K. A.; Duensing, S.; Wells, S. I.			Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture	ONCOGENE			English	Article						Fanconi anemia; human papillomavirus; keratinocyte; organotypic raft culture	GENE-EXPRESSION; DNA; PROTEIN; RADIOSENSITIVITY; IDENTIFICATION; CANCER; SUSCEPTIBILITY; PATHOGENESIS; INSTABILITY; PATHWAY	Fanconi anemia (FA) is a recessive genome instability syndrome characterized by heightened cellular sensitivity to DNA damage, aplastic anemia and cancer susceptibility. Leukemias and squamous cell carcinomas (SCCs) are the most predominant FA-associated cancers, with the latter exhibiting markedly early disease onset and aggressiveness. Although studies of hematopoietic cells derived from FA patients have provided much insight into bone marrow deficiencies and leukemogenesis, molecular transforming events in FA-deficient keratinocytes, which are the cell type of origin for SCC, are poorly understood. We describe here the growth and molecular properties of FANCA-deficient versus FANCA-corrected HPV E6/E7 immortalized keratinocytes in monolayer and organotypic epithelial raft culture. In response to DNA damage, FANCA-deficient patient-derived keratinocyte cultures displayed a G2/M phase arrest, senescence and apoptosis. Organotypic raft cultures exhibited DNA repair-associated defects with more 53BP1 foci and TdT-mediated dNTP nick end labeling-positive cells over their corrected counterparts. Interestingly, together with reduced rates of DNA damage, FA correction resulted in a marked decrease in epithelial thickness and the presence of fewer cell layers. The observed FANCA-mediated suppression of hyperplasia correlated with the detection of fewer cells transiting through the cell cycle in the absence of gross differentiation abnormalities or apoptotic differences. Importantly, the knockdown of either FANCA or FANCD2 in HPV-positive keratinocytes was sufficient for increasing epithelial hyperplasia. Our findings support a new role for FA pathways in the maintenance of differentiation-dependent cell cycle exit, with the implication that FA deficiencies may contribute to the high risk of FA patients for developing HPV-associated SCC.	[Hoskins, E. E.; Morris, T. A.; Higginbotham, J. M.; Wells, S. I.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat,Div Hematol Oncol, Cincinnati, OH 45229 USA; [Spardy, N.; Cha, E.; Duensing, S.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Kelly, P.] Wyeth Pharmaceut, Cambridge, MA USA; [Williams, D. A.] Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA; [Wikenheiser-Brokamp, K. A.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat,Div Pathol & Lab Med & Pulm Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pfizer; Harvard University; Boston Children's Hospital; Harvard Medical School; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Wells, SI (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat,Div Hematol Oncol, TCHRF Room S7-206,MLC 7013,3333 Burnet Ave, Cincinnati, OH 45229 USA.	susanne.wells@cchmc.org			Public Health Service [CA102357, HL081499]; Translational Research Initiative at CCHMC; Fanconi Anemia Research Fund; NIH/NCI [R01 CA112598]; KAW-B [HL079193]; NATIONAL CANCER INSTITUTE [R01CA112598, R01CA102357] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081499, R01HL079193] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Translational Research Initiative at CCHMC; Fanconi Anemia Research Fund; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); KAW-B; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Paul Andreassen, Ruhikanta Meetei, Qishen Pang, James Mulloy, Harmut Geiger, Yi Zheng and Stella Davies for helpful discussions and critical comments on the manuscript. We thank members of the Fanconi Anemia Comprehensive Care Center (FACCC), particularly Lars Wagner, Richard Harris and Robin Mueller for human tissue samples, as well as Susan Radtke for regulatory support. We thank the patients of the FACCC for samples. We are grateful to Denis Lee and Paul Lambert for expert advice on the organotypic raft system, as well as to Maureen Hoatlin for the FANCA and to James Lessard for the monoclonal actin antibody. We thank Christopher Baum for the retroviral SF91 expression vector, and Neeraj Singh for generation of the SF91-18E6/E7 retroviral construct. We thank the flow cytometry core facility and Dan Marmer for assistance with flow sorting. Vector supernatant was provided by the CCHMC Viral Vector Core and Translational Trials Development and Support Lab. This research was supported by Public Health Service Grant CA102357, a grant from the Translational Research Initiative at CCHMC and a grant from the Fanconi Anemia Research Fund to SIW. SD and NS are supported by NIH/NCI R01 CA112598. DAW was supported by Public Health Service Grant HL081499. KAW-B was supported by HL079193.	Alter BP, 2003, CANCER-AM CANCER SOC, V97, P425, DOI 10.1002/cncr.11046; Alter BP, 2002, RADIOTHER ONCOL, V62, P345, DOI 10.1016/S0167-8140(01)00474-1; Bagby GC, 2006, SEMIN HEMATOL, V43, P147, DOI 10.1053/j.seminhematol.2006.04.005; Bremer M, 2003, STRAHLENTHER ONKOL, V179, P748, DOI 10.1007/s00066-003-1099-8; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Chandra S, 2005, MOL THER, V12, P976, DOI 10.1016/j.ymthe.2005.04.021; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dorsman JC, 2007, CELL ONCOL, V29, P211; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Guardiola P, 2004, BLOOD, V103, P73, DOI 10.1182/blood-2003-06-2146; Hanenberg H, 2002, EXP HEMATOL, V30, P410, DOI 10.1016/S0301-472X(02)00782-8; Hoskins EE, 2008, ONCOGENE, V27, P4798, DOI 10.1038/onc.2008.121; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Kutler DI, 2003, J NATL CANCER I, V95, P1718, DOI 10.1093/jnci/djg091; Kutler DI, 2003, ARCH OTOLARYNGOL, V129, P106, DOI 10.1001/archotol.129.1.106; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Marcou Y, 2001, RADIOTHER ONCOL, V60, P75, DOI 10.1016/S0167-8140(01)00370-X; Mathew CG, 2006, ONCOGENE, V25, P5875, DOI 10.1038/sj.onc.1209878; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Nakahara T, 2005, J VIROL, V79, P13150, DOI 10.1128/JVI.79.20.13150-13165.2005; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Pagano G, 2005, EUR J HAEMATOL, V75, P93, DOI 10.1111/j.1600-0609.2005.00507.x; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Schambach A, 2000, MOL THER, V2, P435, DOI 10.1006/mthe.2000.0191; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Spardy N, 2007, J VIROL, V81, P13265, DOI 10.1128/JVI.01121-07; Tamary H, 2007, PEDIATR HEMAT ONCOL, V24, P87, DOI 10.1080/08880010601123240; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; van Zeeburg HJT, 2005, CANCER RES, V65, P1271, DOI 10.1158/0008-5472.CAN-04-3665; van Zeeburg HJT, 2004, JNCI-J NATL CANCER I, V96, P968, DOI 10.1093/jnci/djh178; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159	41	51	53	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					674	685		10.1038/onc.2008.416	http://dx.doi.org/10.1038/onc.2008.416			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	19015634	Green Accepted			2022-12-25	WOS:000263076400005
J	Sui, X; Shin, S; Zhang, R; Firozi, PF; Yang, L; Abbruzzese, JL; Reddy, SAG				Sui, X.; Shin, S.; Zhang, R.; Firozi, P. F.; Yang, L.; Abbruzzese, J. L.; Reddy, S. A. G.			Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells	ONCOGENE			English	Article						pancreatic cancer; hdm2; K-Ras; c-Jun; cyclin D1; c-Myc	MDM2 SPLICE VARIANTS; NF-KAPPA-B; C-MYC; MESSENGER-RNA; MUTANT P53; DUCTAL ADENOCARCINOMA; INDUCED APOPTOSIS; DOWN-REGULATION; EXPRESSION; ACTIVATION	There is emerging evidence that the oncogenic potential of hdm2 (human and/or murine double minute-2 protein) stems not only from its ability to counteract tumor suppressor p53 but also from its less understood p53-independent functions. Surprisingly, little is known about the role and regulation of hdm2 in pancreatic tumors, a large proportion (50-75%) of which contain mutant p53. In this study, we determined that hdm2 was expressed in a Ras-signaling-dependent manner in various pancreatic cancer cell lines. As p53 was mutated and inactive in these cells, the expression of hdm2 was seemingly redundant. Indeed, the proliferation and survival of cell lines such as Panc-1 and Panc-28 could be inhibited by PRIMA-1 (mutant p53 activator) but not by Nutlin-3 (inhibitor of the hdm2-p53 interaction). Unexpectedly, however, the proliferation of both cell lines was strongly inhibited by hdm2-specific RNAi. Our data also revealed cyclin D1, c-Jun and c-Myc to be novel targets of hdm2 and suggested that they might mediate hdm2's role in cellular proliferation and/or survival. We conclude from our results that hdm2 is expressed in pancreatic cancer cells as a result of activated Ras signaling, and that it regulates cellular proliferation and the expression of three novel target genes by p53-independent mechanisms.	[Reddy, S. A. G.] Univ Texas MD Anderson Canc Ctr, Unit 426, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Reddy, SAG (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 426, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	sa08366@odin.mdacc.tmc.edu	qiao, zhixin/I-3408-2012		Lustgarten Foundation for Pancreatic Cancer Research (SAGR); Topfer Fund for Pancreatic Cancer Research (SAGR); University Cancer Foundation at The University of Texas M. D. Anderson Cancer Center (SAGR), NCI SPORE [CA101936]; NCI [CA016672]; University of Texas M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P20CA101936, P30CA016672] Funding Source: NIH RePORTER	Lustgarten Foundation for Pancreatic Cancer Research (SAGR); Topfer Fund for Pancreatic Cancer Research (SAGR); University Cancer Foundation at The University of Texas M. D. Anderson Cancer Center (SAGR), NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Drs Frank McCormick and Martin McMahon (University of California, San Francisco, CA, USA) for the hdm2 P2 promoter reporter constructs, Johannes Bos (Utrecht University) for the Raf1 GST-RBD plasmid and Gigi Lozano (M. D. Anderson Cancer Center, Houston, TX, USA) for the p53 and pCMV-hdm2 expression vectors. We also thank P. zer (CI-1040), Dr Bryant Darnay (pMX-BGD vector) and Dr F-X Claret (pSRa-c-Jun) for other reagents; Dr Baoan Ji for assistance with the qPCR assays and Beth L Notzon and Angelique L Geehan (M. D. Anderson Cancer Center) for editorial assistance. This work was supported by the Lustgarten Foundation for Pancreatic Cancer Research (SAGR), the Topfer Fund for Pancreatic Cancer Research (SAGR), the University Cancer Foundation at The University of Texas M. D. Anderson Cancer Center (SAGR), NCI SPORE CA101936 in Pancreatic Cancer (JLA) and NCI Grant CA016672 (DNA sequencing and media preparation facilities, The University of Texas M. D. Anderson Cancer Center).	Agrawal S, 2001, INT J ONCOL, V18, P1061; Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; Asano T, 2004, ONCOGENE, V23, P8571, DOI 10.1038/sj.onc.1207902; Bai JX, 2006, J PHARMACOL EXP THER, V319, P1435, DOI 10.1124/jpet.106.110007; Bartel F, 2002, CANCER CELL, V2, P9, DOI 10.1016/S1535-6108(02)00091-0; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brunner TB, 2005, CANCER RES, V65, P8433, DOI 10.1158/0008-5472.CAN-05-0158; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Carroll VA, 2008, CANCER RES, V68, P545, DOI 10.1158/0008-5472.CAN-06-4738; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Daujat S, 2001, TRENDS GENET, V17, P459, DOI 10.1016/S0168-9525(01)02369-1; Deb SP, 2003, MOL CANCER RES, V1, P1009; EBERT M, 1994, INT J ONCOL, V5, P1279; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Fridman JS, 2003, CANCER RES, V63, P5703; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Harris LC, 2005, CURR CANCER DRUG TAR, V5, P21, DOI 10.2174/1568009053332654; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jackson P, 2003, PROSTATE CANCER P D, V6, P174, DOI 10.1038/sj.pcan.4500634; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Konnikova L, 2005, CANCER RES, V65, P6516, DOI 10.1158/0008-5472.CAN-05-0924; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; LaRusch GA, 2007, CANCER RES, V67, P450, DOI 10.1158/0008-5472.CAN-06-2710; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Levav-Cohen Y, 2005, GROWTH FACTORS, V23, P183, DOI 10.1080/08977190500196218; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Natsume A, 2005, CANCER RES, V65, P7573, DOI 10.1158/0008-5472.CAN-05-0036; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Phelps M, 2005, J BIOL CHEM, V280, P16651, DOI 10.1074/jbc.M412334200; Phelps M, 2003, CANCER RES, V63, P2616; Phillips A, 2006, FEBS LETT, V580, P300, DOI 10.1016/j.febslet.2005.12.026; Prives C, 1999, J PATHOL, V187, P112; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Ruggeri BA, 1997, CANCER, V79, P700, DOI 10.1002/(SICI)1097-0142(19970215)79:4<700::AID-CNCR7>3.0.CO;2-H; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 1997, ONCOGENE, V15, P2717, DOI 10.1038/sj.onc.1201453; Shmueli A, 2007, MOL CELL, V25, P794, DOI 10.1016/j.molcel.2007.03.006; Sigalas I, 1996, NAT MED, V2, P912, DOI 10.1038/nm0896-912; Steinman HA, 2004, J BIOL CHEM, V279, P4877, DOI 10.1074/jbc.M305966200; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Walker SR, 2007, ONCOGENE, V26, P224, DOI 10.1038/sj.onc.1209775; Weis B, 1999, ONCOGENE, V18, P2579, DOI 10.1038/sj.onc.1202602; Zhang Z, 2004, CLIN CANCER RES, V10, P1263, DOI 10.1158/1078-0432.CCR-0245-03; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814	53	18	18	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					709	720		10.1038/onc.2008.423	http://dx.doi.org/10.1038/onc.2008.423			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	19029954				2022-12-25	WOS:000263076400008
J	Barros, SA; Srimaroeng, C; Perry, JL; Walden, R; Dembla-Rajpal, N; Sweet, DH; Pritchard, JB				Barros, Scott A.; Srimaroeng, Chutima; Perry, Jennifer L.; Walden, Ramsey; Dembla-Rajpal, Neetu; Sweet, Douglas H.; Pritchard, John B.			Activation of Protein Kinase C zeta Increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORT; BREAST-CANCER CELLS; SUBSTRATE-SPECIFICITY; CELLULAR PHYSIOLOGY; SULFATE TRANSPORT; PROXIMAL TUBULES; LLC-PK1 CELLS; PDZ; KIDNEY; MEMBRANE	Organic anion transporters (OATs) play a pivotal role in the clearance of small organic anions by the kidney, yet little is known about how their activity is regulated. A yeast two-hybrid assay was used to identify putative OAT3-associated proteins in the kidney. Atypical protein kinase C zeta(PKC zeta) was shown to bind to OAT3. Binding was confirmed in immunoprecipitation assays. The OAT3/PKC zeta interaction was investigated in rodent renal cortical slices from fasted animals. Insulin, an upstream activator of PKC zeta, increased both OAT3-mediated uptake of estrone sulfate (ES) and PKC zeta activity. Both effects were abolished by a PKC zeta-specific pseudosubstrate inhibitor. Increased ES transport was not observed in renal slices from OAT3-null mice. Transport of the shared OAT1/OAT3 substrate, p-aminohippurate, behaved similarly, except that stimulation was reduced, not abolished, in the OAT3-null mice. This suggested that OAT1 activity was also modified by PKC zeta, subsequently confirmed using an OAT1-specific substrate, adefovir. Inhibition of PKC zeta also blocked the increase in ES uptake seen in response to epidermal growth factor and to activation of protein kinase A. Thus, PKC zeta acted downstream of the epidermal growth factor to protein kinase A signaling pathway. Activation of transport was accompanied by an increase in V-max and was blocked by microtubule disruption, indicating that activation may result from trafficking of OAT3 into the plasma membrane. These data demonstrate that PKC zeta activation up-regulates OAT1 and OAT3 function, and that protein-protein interactions play a central role controlling these two important renal drug transporters.	[Barros, Scott A.; Srimaroeng, Chutima; Perry, Jennifer L.; Walden, Ramsey; Dembla-Rajpal, Neetu; Pritchard, John B.] NIEHS, NIH, Pharmacol Lab, Res Triangle Pk, NC 27709 USA; [Sweet, Douglas H.] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Medical University of South Carolina	Pritchard, JB (corresponding author), 111 TW Alexander Dr,MD F1-03, Res Triangle Pk, NC 27709 USA.	pritcha3@niehs.nih.gov	Cecile, Jennifer/H-4245-2012; Sweet, Douglas H/H-7914-2013	Cecile, Jennifer/0000-0002-2149-2222; Sweet, Douglas H/0000-0002-8911-9184; Srimaroeng, Chutima/0000-0002-5537-1023	National Institutes of Health Intramural Research Program from the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES080031, ZIAES080031] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program from the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program from the NIEHS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both authors contributed equally to this study.	Anzai N, 2005, J PHARMACOL SCI, V97, p120P; Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; Aslamkhan AG, 2006, AM J PHYSIOL-REG I, V291, pR1773, DOI 10.1152/ajpregu.00326.2006; Banan A, 2003, J PHARMACOL EXP THER, V307, P53, DOI 10.1124/jpet.103.053835; Biber J, 2005, J MEMBRANE BIOL, V203, P111, DOI 10.1007/s00232-005-0738-7; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Cihlar T, 1999, MOL PHARMACOL, V56, P570, DOI 10.1124/mol.56.3.570; Dantzler WH, 2003, BBA-BIOMEMBRANES, V1618, P185, DOI 10.1016/j.bbamem.2003.08.015; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Honegger KJ, 2006, P NATL ACAD SCI USA, V103, P803, DOI 10.1073/pnas.0503562103; Kato Y, 2005, MOL PHARMACOL, V67, P734, DOI 10.1124/mol.104.002212; Lu R, 1999, AM J PHYSIOL-RENAL, V276, pF295, DOI 10.1152/ajprenal.1999.276.2.F295; Mikkaichi T, 2004, P NATL ACAD SCI USA, V101, P3569, DOI 10.1073/pnas.0304987101; Miller DS, 1998, AM J PHYSIOL-RENAL, V274, pF156, DOI 10.1152/ajprenal.1998.274.1.F156; Miyazaki H, 2005, J AM SOC NEPHROL, V16, P3498, DOI 10.1681/ASN.2005030306; Mulato AS, 2000, J PHARMACOL EXP THER, V295, P10; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nozawa T, 2005, PHARM RES-DORDR, V22, P1634, DOI 10.1007/s11095-005-7096-0; PRITCHARD JB, 1983, P NATL ACAD SCI-BIOL, V80, P2603, DOI 10.1073/pnas.80.9.2603; Soodvilai S, 2004, AM J PHYSIOL-RENAL, V287, pF1021, DOI 10.1152/ajprenal.00080.2004; Spears KJ, 2005, BIOCHEM PHARMACOL, V69, P415, DOI 10.1016/j.bcp.2004.09.026; STANDAERT ML, 2001, BIOCHEMISTRY-US, V40, P1; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Sweet DH, 2003, AM J PHYSIOL-RENAL, V284, pF763, DOI 10.1152/ajprenal.00405.2002; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Takano M, 1996, AM J PHYSIOL-RENAL, V271, pF469, DOI 10.1152/ajprenal.1996.271.2.F469; Wolff NA, 2003, J AM SOC NEPHROL, V14, P1959, DOI 10.1097/01.ASN.0000079040.55124.25; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003; You GF, 2000, J BIOL CHEM, V275, P10278, DOI 10.1074/jbc.275.14.10278	30	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2672	2679		10.1074/jbc.M808078200	http://dx.doi.org/10.1074/jbc.M808078200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19028678	Green Published, hybrid			2022-12-25	WOS:000262700900009
J	Chen, LA; Li, J; Silva, SR; Jackson, LN; Zhou, YN; Watanabe, H; Ives, KL; Hellmich, MR; Evers, BM				Chen, L. Andy; Li, Jing; Silva, Scott R.; Jackson, Lindsey N.; Zhou, Yuning; Watanabe, Hiroaki; Ives, Kirk L.; Hellmich, Mark R.; Evers, B. Mark			PKD3 Is the Predominant Protein Kinase D Isoform in Mouse Exocrine Pancreas and Promotes Hormone-induced Amylase Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; ACINAR-CELLS; C-MU; PLASMA-MEMBRANE; DNA-SYNTHESIS; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; INDEPENDENT ACTIVATION; NEUROTENSIN SECRETION; SWISS 3T3-CELLS	The protein kinase D (PKD) family of serine/threonine kinases, which can be activated by gastrointestinal hormones, consists of three distinct isoforms that modulate a variety of cellular processes including intracellular protein transport as well as constitutive and regulated secretion. Although isoform-specific functions have been identified in a variety of cell lines, the expression and function of PKD isoforms in normal, differentiated secretory tissues is unknown. Here, we demonstrate that PKD isoforms are differentially expressed in the exocrine and endocrine cells of the pancreas. Specifically, PKD3 is the predominant isoform expressed in exocrine cells of the mouse and human pancreas, whereas PKD1 and PKD2 are more abundantly expressed in the pancreatic islets. Within isolated mouse pancreatic acinar cells, PKD3 undergoes rapid membrane translocation, trans-activating phosphorylation, and kinase activation after gastrointestinal hormone or cholinergic stimulation. PKD phosphorylation in pancreatic acinar cells occurs via a Ca2+-independent, diacylglycerol-and protein kinase C-dependent mechanism. PKD phosphorylation can also be induced by physiologic concentrations of secretagogues and by in vivo stimulation of the pancreas. Furthermore, activation of PKD3 potentiates MEK/ERK/RSK (RSK, ribosomal S6 kinase) signaling and significantly enhances cholecystokinin-mediated pancreatic amylase secretion. These findings reveal a novel distinction between the exocrine and endocrine cells of the pancreas and further identify PKD3 as a signaling molecule that promotes hormone-stimulated amylase secretion.	[Chen, L. Andy; Li, Jing; Silva, Scott R.; Jackson, Lindsey N.; Zhou, Yuning; Watanabe, Hiroaki; Ives, Kirk L.; Hellmich, Mark R.; Evers, B. Mark] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Li, Jing; Hellmich, Mark R.; Evers, B. Mark] Univ Texas Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Evers, BM (corresponding author), Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA.	mevers@utmb.edu	Li, Jing/B-7206-2011; WATANABE, HIROAKI/I-1094-2019	Watanabe, Hiroaki/0000-0001-6065-3925	National Institutes of Health;  [PO1 DK35608];  [RO1 DK48489];  [T32 DK007639]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007639, P01DK035608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 DK35608, RO1 DK48489, and T32 DK007639. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.. S The on-line version of this article (available at http://www.jbc.org)	Anderson G, 2005, CELL SIGNAL, V17, P1397, DOI 10.1016/j.cellsig.2005.02.007; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Berna MJ, 2007, BBA-MOL CELL RES, V1773, P483, DOI 10.1016/j.bbamcr.2006.12.008; Brandlin I, 2002, J BIOL CHEM, V277, P45451, DOI 10.1074/jbc.M205299200; BURGOYNE RD, 1993, BIOCHEM J, V293, P305, DOI 10.1042/bj2930305; CASE RM, 1978, BIOL REV, V53, P211, DOI 10.1111/j.1469-185X.1978.tb01437.x; Chen J, 2005, MOL PHARMACOL, V67, P152, DOI 10.1124/mol.104.004200; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Chiu T, 2001, FEBS LETT, V489, P101, DOI 10.1016/S0014-5793(01)02076-2; Chung OW, 2004, GASTROENTEROLOGY, V127, P957, DOI 10.1053/j.gastro.2004.05.002; Cosen-Binker LI, 2007, J BIOL CHEM, V282, P13047, DOI 10.1074/jbc.M611132200; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Ellwanger K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-47; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Ethridge RT, 2002, GASTROENTEROLOGY, V123, P1311, DOI 10.1053/gast.2002.35951; Gautam D, 2005, J PHARMACOL EXP THER, V313, P995, DOI 10.1124/jpet.105.084855; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guha S, 2002, CANCER RES, V62, P1632; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2001, FEBS LETT, V492, P39, DOI 10.1016/S0014-5793(01)02219-0; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Jackson LN, 2006, BIOCHEM BIOPH RES CO, V348, P945, DOI 10.1016/j.bbrc.2006.07.142; Jaggi M, 2005, CANCER RES, V65, P483; Ji B, 2001, GASTROENTEROLOGY, V121, P1380, DOI 10.1053/gast.2001.29557; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Lemonnier J, 2004, J BIOL CHEM, V279, P259, DOI 10.1074/jbc.M308665200; Li CW, 2004, AM J PHYSIOL-GASTR L, V287, pG764, DOI 10.1152/ajpgi.00111.2004; Li J, 2004, J BIOL CHEM, V279, P28466, DOI 10.1074/jbc.M314307200; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Lu GW, 2007, CELL SIGNAL, V19, P867, DOI 10.1016/j.cellsig.2006.10.012; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Maier D, 2006, GENE EXPR PATTERNS, V6, P849, DOI 10.1016/j.modgep.2006.03.007; Marklund U, 2003, IMMUNITY, V19, P491, DOI 10.1016/S1074-7613(03)00260-7; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; McKay C, 1996, ENDOCRINOLOGY, V137, P2473, DOI 10.1210/en.137.6.2473; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Olszewska-Pazdrak B, 2004, J BIOL CHEM, V279, P40400, DOI 10.1074/jbc.C400208200; Oster H, 2006, GENE EXPR PATTERNS, V6, P400, DOI 10.1016/j.modgep.2005.09.006; Papazyan R, 2006, BIOCHEM BIOPH RES CO, V342, P685, DOI 10.1016/j.bbrc.2006.02.013; Pickett JA, 2005, J BIOL CHEM, V280, P1506, DOI 10.1074/jbc.M411967200; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Rey O, 2006, J BIOL CHEM, V281, P5149, DOI 10.1074/jbc.M508014200; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sabbatini MAE, 2007, AM J PHYSIOL-GASTR L, V293, pG987, DOI 10.1152/ajpgi.00268.2007; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; SCHEELE GA, 1978, J CELL BIOL, V78, P110, DOI 10.1083/jcb.78.1.110; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; Song SY, 1999, GASTROENTEROLOGY, V117, P1416, DOI 10.1016/S0016-5085(99)70292-1; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Tapia JA, 2003, J BIOL CHEM, V278, P35220, DOI 10.1074/jbc.M303119200; Thomas RP, 2003, ENDOCR REV, V24, P571, DOI 10.1210/er.2002-0028; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TSIEN RY, 1990, CELL CALCIUM, V11, P93, DOI 10.1016/0143-4160(90)90063-Z; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Wang BJ, 2007, AM J PHYSIOL-REG I, V292, pR666, DOI 10.1152/ajpregu.00131.2006; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; WANK SA, 1995, AM J PHYSIOL-GASTR L, V269, pG628, DOI 10.1152/ajpgi.1995.269.5.G628; Watanabe H, 2005, GASTROENTEROLOGY, V128, P1391, DOI 10.1053/j.gastro.2005.03.016; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; WERNER MH, 1992, MOL PHARMACOL, V41, P382; Williams JA, 2001, ANNU REV PHYSIOL, V63, P77, DOI 10.1146/annurev.physiol.63.1.77; Williams JA, 2006, CURR OPIN GASTROEN, V22, P498, DOI 10.1097/01.mog.0000239863.96833.c0; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	73	26	26	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2459	2471		10.1074/jbc.M801697200	http://dx.doi.org/10.1074/jbc.M801697200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028687	Green Published, hybrid			2022-12-25	WOS:000262545600053
J	Young, JE; Martinez, RA; La Spada, AR				Young, Jessica E.; Martinez, Refugio A.; La Spada, Albert R.			Nutrient Deprivation Induces Neuronal Autophagy and Implicates Reduced Insulin Signaling in Neuroprotective Autophagy Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BULBAR MUSCULAR-ATROPHY; EXPANDED ANDROGEN RECEPTOR; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; PROTEIN-DEGRADATION; HUNTINGTONS-DISEASE; DEPENDENT MANNER; CELLS	Although autophagy maintains normal neural function by degrading misfolded proteins, little is known about how neurons activate this integral response. Furthermore, classical methods of autophagy induction used with nonneural cells, such as starvation, simply result in neuron death. To study neuronal autophagy, we cultured primary cortical neurons from transgenic mice that ubiquitously express green fluorescent protein-tagged LC3 and monitored LC3-I to LC3-II conversion by immunohistochemistry and immunoblotting. Evaluation of different culture media led us to discover that culturing primary neurons in Dulbecco's modified Eagle's medium without B27 supplementation robustly activates autophagy. We validated this nutrient-limited media approach for inducing autophagy by showing that 3-methyl-adenine treatment and Atg5 RNA interference knockdown each inhibits LC3-I to LC3-II conversion. Evaluation of B27 supplement components yielded insulin as the factor whose absence induced autophagy in primary neurons, and this activation was mammalian target of rapamycin-dependent. When we tested if nutrient-limited media could protect neurons expressing polyglutamine-expanded proteins against cell death, we observed a strong protective effect, probably due to autophagy activation. Our results indicate that nutrient deprivation can be used to understand the regulatory basis of neuronal autophagy and implicate diminished insulin signaling in the activation of neuronal autophagy.	[Young, Jessica E.; Martinez, Refugio A.; La Spada, Albert R.] Univ Washington, Dept Lab Med, Med Ctr, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Washington, Dept Med Med Genet, Med Ctr, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Washington, Dept Neurol, Med Ctr, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Washington, Ctr Neurogenet & Neurotherapeut, Med Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	La Spada, AR (corresponding author), Univ Washington, Dept Lab Med, Med Ctr, Box 357110,Rm NW 120, Seattle, WA 98195 USA.	laspada@u.washington.edu	La Spada, Albert/AAG-8809-2020		National Institutes of Health [NS41648, EY14997, T32-AG00057]; Muscular Dystrophy Association; NATIONAL EYE INSTITUTE [R01EY014997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS41648 (to A. R. L.), EY14997 (to A. R. L.), and T32-AG00057 (to J. E. Y.). This work was also supported by a grant from the Muscular Dystrophy Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Darrington RS, 2002, NEUROREPORT, V13, P2117, DOI 10.1097/00001756-200211150-00025; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kobayashi Y, 1998, BIOCHEM BIOPH RES CO, V252, P145, DOI 10.1006/bbrc.1998.9624; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; LA SA, 1991, NATURE, V352, P77; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Ryu BR, 1999, J NEUROBIOL, V39, P536, DOI 10.1002/(SICI)1097-4695(19990615)39:4<536::AID-NEU7>3.0.CO;2-J; Sale EM, 2008, CELL MOL LIFE SCI, V65, P113, DOI 10.1007/s00018-007-7274-9; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; van der Heide LP, 2003, J NEUROCHEM, V86, P86, DOI 10.1046/j.1471-4159.2003.01828.x; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065	50	99	99	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2363	2373		10.1074/jbc.M806088200	http://dx.doi.org/10.1074/jbc.M806088200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017649	hybrid, Green Published			2022-12-25	WOS:000262545600045
J	Cavanaugh, NA; Kuchta, RD				Cavanaugh, Nisha A.; Kuchta, Robert D.			Initiation of New DNA Strands by the Herpes Simplex Virus-1 Primase-Helicase Complex and Either Herpes DNA Polymerase or Human DNA Polymerase alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; PRIMER SYNTHESIS; UL8 SUBUNIT; REPLICATION PROTEINS; HYBRID DUPLEXES; INFECTED CELLS; GENE-PRODUCTS; UL42; TEMPLATE; UL52	A key set of reactions for the initiation of new DNA strands during herpes simplex virus-1 replication consists of the primase-catalyzed synthesis of short RNA primers followed by polymerase-catalyzed DNA synthesis (i.e. primase-coupled polymerase activity). Herpes primase (UL5-UL52-UL8) synthesizes products from 2 to similar to 13 nucleotides long. However, the herpes polymerase (UL30 or UL30-UL42) only elongates those at least 8 nucleotides long. Surprisingly, coupled activity was remarkably inefficient, even considering only those primers at least 8 nucleotides long, and herpes polymerase typically elongated <2% of the primase-synthesized primers. Of those primers elongated, only 4-26% of the primers were passed directly from the primase to the polymerase (UL30-UL42) without dissociating into solution. Comparing RNA primer-templates and DNA primer-templates of identical sequence showed that herpes polymerase greatly preferred to elongate the DNA primer by 650-26,000-fold, thus accounting for the extremely low efficiency with which herpes polymerase elongated primase-synthesized primers. Curiously, one of the DNA polymerases of the host cell, polymerase alpha (p70-p180 or p49-p58-p70-p180 complex), extended herpes primase-synthesized RNA primers much more efficiently than the viral polymerase, raising the possibility that the viral polymerase may not be the only one involved in herpes DNA replication.	[Cavanaugh, Nisha A.; Kuchta, Robert D.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Kuchta, RD (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 215, Boulder, CO 80309 USA.	kuchta@colorado.edu			National Institutes of Health [AI59764, GM073832]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073832, T32GM008759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI59764 and GM073832. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arana ME, 2004, DNA REPAIR, V3, P659, DOI 10.1016/j.dnarep.2004.02.006; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Biswas N, 1999, J BIOL CHEM, V274, P8068, DOI 10.1074/jbc.274.12.8068; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; CALDER JM, 1990, NUCLEIC ACIDS RES, V18, P3573, DOI 10.1093/nar/18.12.3573; CARMICHAEL EP, 1989, J VIROL, V63, P591, DOI 10.1128/JVI.63.2.591-599.1989; Chaudhuri M, 2003, J BIOL CHEM, V278, P8996, DOI 10.1074/jbc.M210023200; Chen Y, 2005, J VIROL, V79, P9088, DOI 10.1128/JVI.79.14.9088-9096.2005; CHOW CS, 1995, J VIROL, V69, P6965, DOI 10.1128/JVI.69.11.6965-6971.1995; Coll JM, 1997, ONCOL RES, V9, P629; CRUTE JJ, 1991, J BIOL CHEM, V266, P4484; CRUTE JJ, 1989, P NATL ACAD SCI USA, V86, P2186, DOI 10.1073/pnas.86.7.2186; DODSON MS, 1989, J BIOL CHEM, V264, P20835; DODSON MS, 1991, P NATL ACAD SCI USA, V88, P1105, DOI 10.1073/pnas.88.4.1105; Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766; GALLO ML, 1988, J VIROL, V62, P2874, DOI 10.1128/JVI.62.8.2874-2883.1988; GALLO ML, 1989, J VIROL, V63, P5023, DOI 10.1128/JVI.63.12.5023-5029.1989; GOTTLIEB J, 1994, J VIROL, V68, P4937, DOI 10.1128/JVI.68.8.4937-4945.1994; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; GravesWoodward KL, 1997, J BIOL CHEM, V272, P4623, DOI 10.1074/jbc.272.7.4623; HALL JD, 1989, NUCLEIC ACIDS RES, V17, P9231, DOI 10.1093/nar/17.22.9231; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; HU SZ, 1984, J BIOL CHEM, V259, P2602; Jiang HY, 2002, J CELL BIOCHEM, V85, P762, DOI 10.1002/jcb.10182; KAGUNI LS, 1983, P NATL ACAD SCI-BIOL, V80, P2221, DOI 10.1073/pnas.80.8.2221; Keller KE, 2008, BIOCHEMISTRY-US, V47, P8977, DOI 10.1021/bi8008467; Kim DK, 1996, J BIOL CHEM, V271, P15124, DOI 10.1074/jbc.271.25.15124; Kincaid K, 2005, NUCLEIC ACIDS RES, V33, P2620, DOI 10.1093/nar/gki563; KITANI T, 1985, J MOL BIOL, V184, P45, DOI 10.1016/0022-2836(85)90042-7; KUNKEL TA, 1985, J BIOL CHEM, V260, P2866; Kusakabe T, 1998, EMBO J, V17, P1542, DOI 10.1093/emboj/17.5.1542; LEE SSK, 1995, P NATL ACAD SCI USA, V92, P7882, DOI 10.1073/pnas.92.17.7882; LeGac NT, 1996, J BIOL CHEM, V271, P21645; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; LESNIK EA, 1995, BIOCHEMISTRY-US, V34, P10807, DOI 10.1021/bi00034a013; Marsden HS, 1996, J GEN VIROL, V77, P2241, DOI 10.1099/0022-1317-77-9-2241; Marsden HS, 1997, J VIROL, V71, P6390, DOI 10.1128/JVI.71.9.6390-6397.1997; Nimonkar AV, 2003, P NATL ACAD SCI USA, V100, P10201, DOI 10.1073/pnas.1534569100; Okorokov AL, 1997, PROTEIN ENG, V10, P273, DOI 10.1093/protein/10.3.273; PODUST VN, 1993, NUCLEIC ACIDS RES, V21, P841, DOI 10.1093/nar/21.4.841; Ramirez-Aguilar KA, 2004, BIOCHEMISTRY-US, V43, P1754, DOI 10.1021/bi035519x; Ramirez-Aguilar KA, 2002, BIOCHEMISTRY-US, V41, P14569, DOI 10.1021/bi026680v; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SHEAFF RJ, 1994, BIOCHEMISTRY-US, V33, P2247, DOI 10.1021/bi00174a035; SHERMAN G, 1992, J VIROL, V66, P4884, DOI 10.1128/JVI.66.8.4884-4892.1992; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; TENNEY DJ, 1994, J BIOL CHEM, V269, P5030; TENNEY DJ, 1993, J VIROL, V67, P1959, DOI 10.1128/JVI.67.4.1959-1966.1993; THOMPSON HC, 1995, NUCLEIC ACIDS RES, V23, P4109, DOI 10.1093/nar/23.20.4109; TSURUMI T, 1987, J VIROL, V61, P388, DOI 10.1128/JVI.61.2.388-394.1987; VISHWANATHA JK, 1986, NUCLEIC ACIDS RES, V14, P7305, DOI 10.1093/nar/14.18.7305; Weisshart K, 1999, J VIROL, V73, P55, DOI 10.1128/JVI.73.1.55-66.1999; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; YODA KY, 1988, NUCLEIC ACIDS RES, V16, P6531, DOI 10.1093/nar/16.14.6531	54	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1523	1532		10.1074/jbc.M805476200	http://dx.doi.org/10.1074/jbc.M805476200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028696	Green Published, hybrid			2022-12-25	WOS:000262330100020
J	Dybas, JM; Madrid-Aliste, CJ; Che, FY; Nieves, E; Rykunov, D; Angeletti, RH; Weiss, LM; Kim, K; Fiser, A				Dybas, Joseph M.; Madrid-Aliste, Carlos J.; Che, Fa-Yun; Nieves, Edward; Rykunov, Dmitry; Angeletti, Ruth Hogue; Weiss, Louis M.; Kim, Kami; Fiser, Andras			Computational Analysis and Experimental Validation of Gene Predictions in Toxoplasma gondii	PLOS ONE			English	Article							PROTEIN IDENTIFICATION; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; REVEALS; EXPRESSION	Background: Toxoplasma gondii is an obligate intracellular protozoan that infects 20 to 90% of the population. It can cause both acute and chronic infections, many of which are asymptomatic, and, in immunocompromized hosts, can cause fatal infection due to reactivation from an asymptomatic chronic infection. An essential step towards understanding molecular mechanisms controlling transitions between the various life stages and identifying candidate drug targets is to accurately characterize the T. gondii proteome. Methodology/Principal Findings: We have explored the proteome of T. gondii tachyzoites with high throughput proteomics experiments and by comparison to publicly available cDNA sequence data. Mass spectrometry analysis validated 2,477 gene coding regions with 6,438 possible alternative gene predictions; approximately one third of the T. gondii proteome. The proteomics survey identified 609 proteins that are unique to Toxoplasma as compared to any known species including other Apicomplexan. Computational analysis identified 787 cases of possible gene duplication events and located at least 6,089 gene coding regions. Commonly used gene prediction algorithms produce very disparate sets of protein sequences, with pairwise overlaps ranging from 1.4% to 12%. Through this experimental and computational exercise we benchmarked gene prediction methods and observed false negative rates of 31 to 43%. Conclusions/Significance: This study not only provides the largest proteomics exploration of the T. gondii proteome, but illustrates how high throughput proteomics experiments can elucidate correct gene structures in genomes.	[Dybas, Joseph M.; Madrid-Aliste, Carlos J.; Che, Fa-Yun; Nieves, Edward; Rykunov, Dmitry; Angeletti, Ruth Hogue; Weiss, Louis M.; Kim, Kami; Fiser, Andras] Albert Einstein Coll Med, Biodef Prote Res Ctr, Bronx, NY 10467 USA; [Dybas, Joseph M.; Madrid-Aliste, Carlos J.; Rykunov, Dmitry; Fiser, Andras] Albert Einstein Coll Med, Dept Syst & Comput Biol, Bronx, NY USA; [Dybas, Joseph M.; Madrid-Aliste, Carlos J.; Rykunov, Dmitry; Angeletti, Ruth Hogue; Fiser, Andras] Albert Einstein Coll Med, Dept Biochem, Bronx, NY USA; [Weiss, Louis M.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY USA; [Che, Fa-Yun; Nieves, Edward; Angeletti, Ruth Hogue] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY USA; [Weiss, Louis M.; Kim, Kami] Albert Einstein Coll Med, Dept Med, Bronx, NY USA; [Kim, Kami] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA; [Che, Fa-Yun; Nieves, Edward; Angeletti, Ruth Hogue] Albert Einstein Coll Med, Lab Macromol Anal & Proteom, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Dybas, JM (corresponding author), Albert Einstein Coll Med, Biodef Prote Res Ctr, Bronx, NY 10467 USA.	afiser@aecom.yu.edu		Kim, Kami/0000-0003-3384-152X	NIH-NIAID [HHSN266200400054C]; NATIONAL CANCER INSTITUTE [R33CA101150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019891, S10RR019352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039454, R01AI060496] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by NIH-NIAID HHSN266200400054C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Carruthers Vern B., 1999, Parasitology International, V48, P1; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Fauquenoy S, 2008, MOL CELL PROTEOMICS, V7, P891, DOI 10.1074/mcp.M700391-MCP200; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Jungblut PR, 2001, INFECT IMMUN, V69, P5905, DOI 10.1128/IAI.69.9.5905-5907.2001; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Karlin S, 2001, NATURE, V411, P259, DOI 10.1038/35077152; Khan A, 2006, GENOME RES, V16, P1119, DOI 10.1101/gr.5318106; Khan Asis, 2007, P193; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kissinger Jessica C., 2007, P209; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lu FL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-255; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mularoni L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r33; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Roos David S., 1999, Novartis Foundation Symposium, V226, P176; Sanderson SJ, 2008, PROTEOMICS, V8, P1398, DOI 10.1002/pmic.200700804; SOUSA OE, 1988, AM J TROP MED HYG, V38, P315, DOI 10.4269/ajtmh.1988.38.315; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Wang R, 2005, GENOME RES, V15, P1118, DOI 10.1101/gr.3994105; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Xia D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r116; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	34	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3899	10.1371/journal.pone.0003899	http://dx.doi.org/10.1371/journal.pone.0003899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065262	gold, Green Published, Green Submitted			2022-12-25	WOS:000265455200011
J	Marchi, M; D'Antoni, A; Formentini, I; Parra, R; Brambilla, R; Ratto, GM; Costa, M				Marchi, Matilde; D'Antoni, Angela; Formentini, Ivan; Parra, Riccardo; Brambilla, Riccardo; Ratto, Gian Michele; Costa, Mario			The N-Terminal Domain of ERK1 Accounts for the Functional Differences with ERK2	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; NUCLEAR TRANSLOCATION; SYNAPTIC PLASTICITY; GENE-EXPRESSION; SIGNAL; LOCALIZATION; GROWTH; IDENTIFICATION; CASCADE	The Extracellular Regulated Kinase 1 and 2 transduce a variety of extracellular stimuli regulating processes as diverse as proliferation, differentiation and synaptic plasticity. Once activated in the cytoplasm, ERK1 and ERK2 translocate into the nucleus and interact with nuclear substrates to induce specific programs of gene expression. ERK1/2 share 85% of aminoacid identity and all known functional domains and thence they have been considered functionally equivalent until recent studies found that the ablation of either ERK1 or ERK2 causes dramatically different phenotypes. To search a molecular justification of this dichotomy we investigated whether the different functions of ERK1 and 2 might depend on the properties of their cytoplasmic-nuclear trafficking. Since in the nucleus ERK1/2 is predominantly inactivated, the maintenance of a constant level of nuclear activity requires continuous shuttling of activated protein from the cytoplasm. For this reason, different nuclear-cytoplasmic trafficking of ERK1 and 2 would cause a differential signalling capability. We have characterised the trafficking of fluorescently tagged ERK1 and ERK2 by means of time-lapse imaging in living cells. Surprisingly, we found that ERK1 shuttles between the nucleus and cytoplasm at a much slower rate than ERK2. This difference is caused by a domain of ERK1 located at its N-terminus since the progressive deletion of these residues converted the shuttling features of ERK1 into those of ERK2. Conversely, the fusion of this ERK1 sequence at the N-terminus of ERK2 slowed down its shuttling to a similar value found for ERK1. Finally, computational, biochemical and cellular studies indicated that the reduced nuclear shuttling of ERK1 causes a strong reduction of its nuclear phosphorylation compared to ERK2, leading to a reduced capability of ERK1 to carry proliferative signals to the nucleus. This mechanism significantly contributes to the differential ability of ERK1 and 2 to generate an overall signalling output.	[Ratto, Gian Michele] Scuola Normale Superiore, NEST INFM, I-56100 Pisa, Italy; [Ratto, Gian Michele; Costa, Mario] CNR, Inst Neurosci, Pisa, Italy; [D'Antoni, Angela; Formentini, Ivan; Brambilla, Riccardo] San Raffele Sci Inst, Milan, Italy; [Parra, Riccardo] Scuola Normale Superiore, Pisa, Italy; [Marchi, Matilde] Italian Inst Technol IIT, Pisa, Italy; [D'Antoni, Angela] Univ Stud Milano, Milan, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; Istituto Italiano di Tecnologia - IIT	Marchi, M (corresponding author), Scuola Normale Superiore, NEST INFM, I-56100 Pisa, Italy.	gimmi@in.cnr.it; costa@in.cnr.it	Costa, Mario/AAC-2362-2022; Ratto, Gian Michele/AAB-8719-2021; Brambilla, Riccardo/A-6082-2010; Ratto, Gian Michele/AAX-8514-2020	Ratto, Gian Michele/0000-0001-9632-7769; Brambilla, Riccardo/0000-0003-3569-5706; Parra, Riccardo/0000-0003-1421-2832; COSTA, Mario/0000-0001-5821-9871	International Foundation for Paraplegia [239]; Italian Ministry of Health	International Foundation for Paraplegia; Italian Ministry of Health(Ministry of Health, Italy)	The study has been supported by a grant of the International Foundation for Paraplegia (grant 239) to GMR, and by a grant from the Italian Ministry of Health to RB.	Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Bessard A, 2008, ONCOGENE, V27, P5315, DOI 10.1038/onc.2008.163; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Chambard JC, 2006, BIOCH BIOPHYS ACTA; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Guha A, 1997, ONCOGENE, V15, P2755, DOI 10.1038/sj.onc.1201455; Kim-Kaneyama JR, 2000, J BIOL CHEM, V275, P20685, DOI 10.1074/jbc.M908723199; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Kopito RB, 2007, P NATL ACAD SCI USA, V104, P12743, DOI 10.1073/pnas.0702690104; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Ranganathan A, 2006, J BIOL CHEM, V281, P15645, DOI 10.1074/jbc.M513866200; Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Volmat V, 2001, J CELL SCI, V114, P3433; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZHENG CF, 1994, J BIOL CHEM, V269, P19947	51	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3873	10.1371/journal.pone.0003873	http://dx.doi.org/10.1371/journal.pone.0003873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052640	gold, Green Published			2022-12-25	WOS:000265452200014
J	Beck, C; Ognibeni, T; Neumann, H				Beck, Cornelia; Ognibeni, Thilo; Neumann, Heiko			Object Segmentation from Motion Discontinuities and Temporal Occlusions-A Biologically Inspired Model	PLOS ONE			English	Article							NEURAL MECHANISMS; VISION; DEPTH	Background: Optic flow is an important cue for object detection. Humans are able to perceive objects in a scene using only kinetic boundaries, and can perform the task even when other shape cues are not provided. These kinetic boundaries are characterized by the presence of motion discontinuities in a local neighbourhood. In addition, temporal occlusions appear along the boundaries as the object in front covers the background and the objects that are spatially behind it. Methodology/Principal Findings: From a technical point of view, the detection of motion boundaries for segmentation based on optic flow is a difficult task. This is due to the problem that flow detected along such boundaries is generally not reliable. We propose a model derived from mechanisms found in visual areas V1, MT, and MSTl of human and primate cortex that achieves robust detection along motion boundaries. It includes two separate mechanisms for both the detection of motion discontinuities and of occlusion regions based on how neurons respond to spatial and temporal contrast, respectively. The mechanisms are embedded in a biologically inspired architecture that integrates information of different model components of the visual processing due to feedback connections. In particular, mutual interactions between the detection of motion discontinuities and temporal occlusions allow a considerable improvement of the kinetic boundary detection. Conclusions/Significance: A new model is proposed that uses optic flow cues to detect motion discontinuities and object occlusion. We suggest that by combining these results for motion discontinuities and object occlusion, object segmentation within the model can be improved. This idea could also be applied in other models for object segmentation. In addition, we discuss how this model is related to neurophysiological findings. The model was successfully tested both with artificial and real sequences including self and object motion.	[Beck, Cornelia; Ognibeni, Thilo; Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, Ulm, Germany	Ulm University	Beck, C (corresponding author), Univ Ulm, Inst Neural Informat Proc, Ulm, Germany.	cornelia.beck@uni-ulm.de			European Union [027198]; ICT [215866-SEARISE]	European Union(European Commission); ICT	This work was supported by grants from the European Union for STREP project no. 027198-Decisions-In-Motion and ICT project no. 215866-SEARISE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayerl P, 2004, NEURAL COMPUT, V16, P2041, DOI 10.1162/0899766041732404; Bayerl P, 2007, IEEE T PATTERN ANAL, V29, P246, DOI 10.1109/TPAMI.2007.24; Beck C, 2007, LECT NOTES COMPUT SC, V4673, P53; Black MJ, 2000, INT J COMPUT VISION, V38, P231, DOI 10.1023/A:1008195307933; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Chen CC, 2005, NEUROIMAGE, V24, P802, DOI 10.1016/j.neuroimage.2004.09.021; CHOU GT, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P1050, DOI 10.1109/ICCV.1995.466818; Eckhorn R, 1990, NEURAL COMPUT, V2, P293, DOI 10.1162/neco.1990.2.3.293; Eifuku S, 1999, J NEUROPHYSIOL, V82, P2462, DOI 10.1152/jn.1999.82.5.2462; Eifuku S, 1998, J NEUROPHYSIOL, V80, P282, DOI 10.1152/jn.1998.80.1.282; Feldman D, 2008, IEEE T PATTERN ANAL, V30, P1171, DOI 10.1109/TPAMI.2007.70766; Hansen GH, 2008, J ECON GEOGR, V8, P1, DOI 10.1093/jeg/lbm043; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Ke QF, 2001, PROC CVPR IEEE, P255; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Movshon A, 1985, PATTERN RECOGN, V54, P117; NAKAYAMA K, 1990, VISION RES, V30, P1811, DOI 10.1016/0042-6989(90)90161-D; Neumann H, 2007, PHYS LIFE REV, V4, P189, DOI 10.1016/j.plrev.2007.09.001; NIYOGI SA, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P1044, DOI 10.1109/ICCV.1995.466819; Ogale AS, 2005, IEEE T PATTERN ANAL, V27, P988, DOI 10.1109/TPAMI.2005.123; OGALE AS, 2007, IJCV, V71, P9; Qiu FTT, 2007, NAT NEUROSCI, V10, P1492, DOI 10.1038/nn1989; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; SPORNS O, 1991, P NATL ACAD SCI USA, V88, P129, DOI 10.1073/pnas.88.1.129; Stein F, 2004, LECT NOTES COMPUT SC, V3175, P79; Thielscher A, 2005, SPATIAL VISION, V18, P227, DOI 10.1163/1568568053320594; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WANG JYA, 1994, IEEE T IMAGE PROCESS, V3, P625, DOI 10.1109/83.334981; Weiss Y, 1996, PROC CVPR IEEE, P321, DOI 10.1109/CVPR.1996.517092	31	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3807	10.1371/journal.pone.0003807	http://dx.doi.org/10.1371/journal.pone.0003807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043613	Green Published, gold			2022-12-25	WOS:000265451500001
J	Khorsand, P; Chance, F				Khorsand, Peyman; Chance, Frances			Transient Responses to Rapid Changes in Mean and Variance in Spiking Models	PLOS ONE			English	Article							FIRING RATE; ASYNCHRONOUS STATES; DYNAMICS; POPULATION; NEURONS; NOISE; VARIABILITY; NETWORKS; INFORMATION; DISCHARGE	The mean input and variance of the total synaptic input to a neuron can vary independently, suggesting two distinct information channels. Here we examine the impact of rapidly varying signals, delivered via these two information conduits, on the temporal dynamics of neuronal firing rate responses. We examine the responses of model neurons to step functions in either the mean or the variance of the input current. Our results show that the temporal dynamics governing response onset depends on the choice of model. Specifically, the existence of a hard threshold introduces an instantaneous component into the response onset of a leaky-integrate-and-fire model that is not present in other models studied here. Other response features, for example a decaying oscillatory approach to a new steady-state firing rate, appear to be more universal among neuronal models. The decay time constant of this approach is a power-law function of noise magnitude over a wide range of input parameters. Understanding how specific model properties underlie these response features is important for understanding how neurons will respond to rapidly varying signals, as the temporal dynamics of the response onset and response decay to new steady-state determine what range of signal frequencies a population of neurons can respond to and faithfully encode.	[Khorsand, Peyman; Chance, Frances] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine	Khorsand, P (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	peyman.khorsand@gmail.com		Chance, Frances/0000-0003-1420-4664	NSF [NSF-IOB-0446129]; Alfred P. Sloan Foundation; University of California Irvine	NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); University of California Irvine(University of California System)	NSF-IOB-0446129, Alfred P. Sloan Foundation, University of California Irvine	ABBOTT LF, 1993, PHYS REV E, V48, P1483, DOI 10.1103/PhysRevE.48.1483; Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Brunel N, 2003, NEURAL COMPUT, V15, P2281, DOI 10.1162/089976603322362365; Brunel N, 2001, PHYS REV LETT, V86, P2186, DOI 10.1103/PhysRevLett.86.2186; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; CONNOR JA, 1977, BIOPHYS J, V18, P81, DOI 10.1016/S0006-3495(77)85598-7; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; ERMENTROUT GB, 1986, SIAM J APPL MATH, V46, P233, DOI 10.1137/0146017; Fourcaud N, 2002, NEURAL COMPUT, V14, P2057, DOI 10.1162/089976602320264015; Fourcaud-Trocme N, 2005, J COMPUT NEUROSCI, V18, P311, DOI 10.1007/s10827-005-0337-8; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; FOX RF, 1986, PHYS REV A, V33, P467, DOI 10.1103/PhysRevA.33.467; Gerstner W, 2000, NEURAL COMPUT, V12, P43, DOI 10.1162/089976600300015899; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; HOPPENSTEADT FC, 1997, WEAKLY CONNECTED NEU, P428; Knight BW, 2000, NEURAL COMPUT, V12, P1045, DOI 10.1162/089976600300015493; Knight BW, 2000, NEURAL COMPUT, V12, P473, DOI 10.1162/089976600300015673; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Lindner B, 2003, NEURAL COMPUT, V15, P1761, DOI 10.1162/08997660360675035; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Manwani A, 1999, NEURAL COMPUT, V11, P1797, DOI 10.1162/089976699300015972; MATSUMURA M, 1988, EXP BRAIN RES, V70, P463; Moreno E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.236801; Naundorf B, 2005, NEUROCOMPUTING, V65, P421, DOI 10.1016/j.neucom.2004.10.040; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Silberberg G, 2004, J NEUROPHYSIOL, V91, P704, DOI 10.1152/jn.00415.2003; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; TUCKWELL HC, 1998, INTRO THEORETICAL NE, P265; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724	42	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3786	10.1371/journal.pone.0003786	http://dx.doi.org/10.1371/journal.pone.0003786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023442	gold, Green Published			2022-12-25	WOS:000265448800007
J	Wenzel, K; Haase, H; Wallukat, G; Derer, W; Bartel, S; Homuth, V; Herse, F; Hubner, N; Schulz, H; Janczikowski, M; Lindschau, C; Schroeder, C; Verlohren, S; Morano, I; Muller, DN; Luft, FC; Dietz, R; Dechend, R; Karczewski, P				Wenzel, Katrin; Haase, Hannelore; Wallukat, Gerd; Derer, Wolfgang; Bartel, Sabine; Homuth, Volker; Herse, Florian; Hubner, Norbert; Schulz, Herbert; Janczikowski, Marion; Lindschau, Carsten; Schroeder, Christoph; Verlohren, Stefan; Morano, Ingo; Muller, Dominik N.; Luft, Friedrich C.; Dietz, Rainer; Dechend, Ralf; Karczewski, Peter			Potential Relevance of alpha(1)-Adrenergic Receptor Autoantibodies in Refractory Hypertension	PLOS ONE			English	Article								Background: Agonistic autoantibodies directed at the alpha(1)-adrenergic receptor (alpha(1)-AAB) have been described in patients with hypertension. We implied earlier that alpha(1)-AAB might have a mechanistic role and could represent a therapeutic target. Methodology/Principal Findings: To pursue the issue, we performed clinical and basic studies. We observed that 41 of 81 patients with refractory hypertension had alpha(1)-AAB; after immunoadsorption blood pressure was significantly reduced in these patients. Rabbits were immunized to generate alpha(1)-adrenergic receptor antibodies (alpha(1)-AB). Patient alpha(1)-AAB and rabbit alpha(1)-AB were purified using affinity chromatography and characterized both by epitope mapping and surface plasmon resonance measurements. Neonatal rat cardiomyocytes, rat vascular smooth muscle cells (VSMC), and Chinese hamster ovary cells transfected with the human alpha(1A)-adrenergic receptor were incubated with patient alpha(1)-AAB and rabbit alpha(1)-AB and the activation of signal transduction pathways was investigated by Western blot, confocal laser scanning microscopy, and gene expression. We found that phospholipase A2 group IIA (PLA2-IIA) and L-type calcium channel (Cacna1c) genes were upregulated in cardiomyocytes and VSMC after stimulation with both purified antibodies. We showed that patient alpha(1)-AAB and rabbit alpha(1)-AB result in protein kinase C alpha activation and transient extracellular-related kinase (EKR1/2) phosphorylation. Finally, we showed that the antibodies exert acute effects on intracellular Ca2+ in cardiomyocytes and induce mesentery artery segment contraction. Conclusions/Significance: Patient alpha(1)-AAB and rabbit alpha(1)-AB can induce signaling pathways important for hypertension and cardiac remodeling. Our data provide evidence for a potential clinical relevance for alpha(1)-AAB in hypertensive patients, and the notion of immunity as a possible cause of hypertension.	[Wenzel, Katrin; Derer, Wolfgang; Homuth, Volker; Herse, Florian; Janczikowski, Marion; Schroeder, Christoph; Verlohren, Stefan; Luft, Friedrich C.; Dietz, Rainer; Dechend, Ralf] Franz Volhard Clin, Charite, Fac Med, Berlin, Germany; [Haase, Hannelore; Wallukat, Gerd; Bartel, Sabine; Hubner, Norbert; Schulz, Herbert; Morano, Ingo; Muller, Dominik N.; Luft, Friedrich C.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Lindschau, Carsten] Leibniz Univ Hannover, Sch Med, Dept Nephrol, D-30167 Hannover, Germany; [Karczewski, Peter] ERDE eV, Berlin, Germany	Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz University Hannover	Wenzel, K (corresponding author), Franz Volhard Clin, Charite, Fac Med, Berlin, Germany.	ralf.dechend@charite.de	Lindschau, Carsten/G-1798-2011; Lindschau, Carsten/AAE-6721-2020	Lindschau, Carsten/0000-0003-1960-099X; Verlohren, Stefan/0000-0003-3507-8636; Muller, Dominik N/0000-0003-3650-5644; Herse, Florian/0000-0002-9305-8134; Luft, Friedrich/0000-0002-8635-1199	Deutsche Forschungsgemeinschaft; ProFIT initiative of the European Community	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ProFIT initiative of the European Community	The Deutsche Forschungsgemeinschaft supported RD, DNM, and FCL with separate grants-in-aid. Part of this work was supported by the ProFIT initiative of the European Community.	Antonelli A, 2001, DIABETES, V50, P985, DOI 10.2337/diabetes.50.5.985; Barzilay Joshua I, 2004, J Clin Hypertens (Greenwich), V6, P116, DOI 10.1111/j.1524-6175.2004.03216.x; BOIVIN V, 2007, EUR HEART J S1, V27; BOIVIN V, 2007, EUR HEART J S1, V24; Dragun D, 2005, NEW ENGL J MED, V352, P558, DOI 10.1056/NEJMoa035717; FU MLX, 1994, LANCET, V344, P1660, DOI 10.1016/S0140-6736(94)90456-1; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Kugiyama K, 2000, CARDIOVASC RES, V47, P159, DOI 10.1016/S0008-6363(00)00060-2; Levick S, 2006, J IMMUNOL, V176, P7000, DOI 10.4049/jimmunol.176.11.7000; Liao YH, 2002, HYPERTENS RES, V25, P641; LUFT FC, 2008, J AM SOC HYPERTENSIO, V1, P571; Luther HP, 1997, HYPERTENSION, V29, P678, DOI 10.1161/01.HYP.29.2.678; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Michelotti GA, 2000, PHARMACOL THERAPEUT, V88, P281, DOI 10.1016/S0163-7258(00)00092-9; Nevalainen TJ, 2000, BBA-MOL CELL BIOL L, V1488, P83, DOI 10.1016/S1388-1981(00)00112-8; O-Uchi J, 2005, P NATL ACAD SCI USA, V102, P9400, DOI 10.1073/pnas.0503569102; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Porela P, 2000, BASIC RES CARDIOL, V95, P413, DOI 10.1007/s003950070041; Rapoport B, 2007, THYROID, V17, P911, DOI 10.1089/thy.2007.0170; Shannon R, 2006, AM HEART J, V152, P842, DOI 10.1016/j.ahj.2006.05.017; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; Zhou ZH, 2005, CLIN IMMUNOL, V114, P164, DOI 10.1016/j.clim.2004.09.011	25	82	89	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3742	10.1371/journal.pone.0003742	http://dx.doi.org/10.1371/journal.pone.0003742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011682	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000265448300010
J	Magnusson, SE; Pejler, G; Kleinau, S; Abrink, M				Magnusson, Sofia E.; Pejler, Gunnar; Kleinau, Sandra; Abrink, Magnus			Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis	FASEB JOURNAL			English	Article						protease and knockout mice; innate immune cell	COLLAGEN-INDUCED ARTHRITIS; FC-GAMMA RECEPTORS; RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; ANGIOTENSIN-II; BETA-CHYMASES; C5A RECEPTOR; KEY ROLE; ACTIVATION; MICE	Mast cells are implicated in rheumatoid arthritis, but the mechanism by which they contribute to disease progression is not clarified. Here we investigated whether mouse mast cell protease-4 (mMCP-4), a chymase present in the mast cell secretory granule, contributes to experimental arthritis. Two models of arthritis were investigated in mMCP-4(+/+) and mMCP-4(-/-) DBA/1 mice: collagen-induced arthritis ( CIA) was induced by immunization with collagen II (CII) in Freund's complete adjuvant, and a passive model of arthritis was induced by administration of anti-CII antibodies. The clinical scores were significantly reduced in the mMCP-4(-/-) animals as compared to mMCP-4(+/+) controls in both arthritis models. In CIA, the number of affected paws was lower in the CII-immunized mMCP-4(-/-) mice, with less cartilage destruction, pannus formation, and mononuclear cell and mast cell influx in the mMCP-4(-/-) joints. Interestingly, the lower clinical scores in the CII-immunized mMCP-4(-/-) mice coincided with lower serum levels of immunoglobulin G anti-CII antibodies. Our findings identify a pathogenic role of mMCP-4 in autoimmune arthritis.-Magnusson, S. E., Pejler, G., Kleinau, S., Abrink, M. Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis. FASEB J. 23, 875-882 (2009)	[Kleinau, Sandra] Uppsala Univ, Dept Cell & Mol Biol, Program Mol Immunol, Biomed Ctr, SE-75124 Uppsala, Sweden; [Abrink, Magnus] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden	Uppsala University; Uppsala University; Swedish University of Agricultural Sciences	Kleinau, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Program Mol Immunol, Biomed Ctr, Box 596, SE-75124 Uppsala, Sweden.	sandra.kleinau@icm.uu.se; magnus.abrink@imbim.uu.se	Kleinau, Sandra/C-9545-2013; Åbrink, Magnus/AAK-8346-2020	Abrink, Magnus/0000-0002-1335-3927; Kleinau, Sandra/0000-0002-9729-2286	Swedish Research Council; King Gustaf V 80-Year Foundation; Swedish Rheumatism Association; Goran Gustafsson Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V 80-Year Foundation; Swedish Rheumatism Association; Goran Gustafsson Foundation	This study was supported by the Swedish Research Council, King Gustaf V 80-Year Foundation, The Swedish Rheumatism Association, and the Goran Gustafsson Foundation.	Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; DIAZ DS, 2002, EUR J IMMUNOL, V32, P2915; Fang KC, 1997, J BIOL CHEM, V272, P25628, DOI 10.1074/jbc.272.41.25628; Fang KC, 1996, J CLIN INVEST, V97, P1589, DOI 10.1172/JCI118583; Grant EP, 2002, J EXP MED, V196, P1461, DOI 10.1084/jem.20020205; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; He SH, 1998, BRIT J PHARMACOL, V125, P1491, DOI 10.1038/sj.bjp.0702223; Itoh T, 2002, J IMMUNOL, V169, P2643, DOI 10.4049/jimmunol.169.5.2643; Johnston B, 1998, AM J PATHOL, V152, P555; Kakizoe E, 1999, INFLAMM RES, V48, P318, DOI 10.1007/s000110050467; KIDO H, 1985, BIOCHEM INT, V10, P863; Kleinau S, 2000, J EXP MED, V191, P1611, DOI 10.1084/jem.191.9.1611; Kleinau S, 1999, J IMMUNOL, V162, P4266; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lundequist A, 2004, J BIOL CHEM, V279, P32339, DOI 10.1074/jbc.M405576200; Maruotti N, 2007, CLIN RHEUMATOL, V26, P1, DOI 10.1007/s10067-006-0305-3; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; Nandakumar KS, 2003, EUR J IMMUNOL, V33, P2269, DOI 10.1002/eji.200323810; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Paniagua RT, 2006, J CLIN INVEST, V116, P2633, DOI 10.1172/JCI28546; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Rioja I, 2008, ARTHRITIS RHEUM-US, V58, P2257, DOI 10.1002/art.23667; SCHICK B, 1984, J IMMUNOL, V132, P2571; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Shin K, 2006, ARTHRITIS RHEUM-US, V54, P2863, DOI 10.1002/art.22058; Soruri A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-29; Sylvestre DL, 1996, IMMUNITY, V5, P387, DOI 10.1016/S1074-7613(00)80264-2; Tani K, 2000, J LEUKOCYTE BIOL, V67, P585, DOI 10.1002/jlb.67.4.585; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Terakawa M, 2006, EUR J PHARMACOL, V538, P175, DOI 10.1016/j.ejphar.2006.03.053; Tkaczyk C, 2004, INT ARCH ALLERGY IMM, V133, P305, DOI 10.1159/000077213; Wang HW, 1998, J CLIN INVEST, V102, P1617, DOI 10.1172/JCI3704; Yoshikawa T, 2001, IMMUNOLOGY, V104, P333, DOI 10.1046/j.1365-2567.2001.01320.x	37	45	46	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					875	882		10.1096/fj.08-120394	http://dx.doi.org/10.1096/fj.08-120394			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19010978				2022-12-25	WOS:000265506300023
J	Harmey, D; Smith, A; Simanski, S; Moussa, CZ; Ayad, NG				Harmey, Dympna; Smith, Anthony; Simanski, Scott; Moussa, Carole Zaki; Ayad, Nagi G.			The Anaphase Promoting Complex Induces Substrate Degradation during Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE EXIT; S-PHASE ENTRY; UBIQUITIN LIGASE; POSTMITOTIC NEURONS; AXONAL GROWTH; MITOSIS; ACCUMULATION; PROTEOLYSIS; PROTEIN; SKP2	The anaphase promoting complex (APC) is an E3 ubiquitin ligase required for the metaphase-to-anaphase transition and mitotic exit. However, APC also plays roles in G(1), where it is regulated by Cdh1, and APC activity has also been detected in differentiated and non-proliferating cells, suggesting that it may play roles outside the cell cycle. Here, we report that disrupting APC(Cdh1) activity inhibits neurite outgrowth of both PC12 pheochromocytoma cells and primary cerebellar granule cells. APC(Cdh1) activity dramatically increases as PC12 cells differentiate in response to nerve growth factor. Furthermore, a key target degraded by APC(Cdh1) following nerve growth factor treatment is the F-box protein Skp2, and APC(Cdh1)-mediated destruction of Skp2 is essential for proper terminal differentiation of neuronal precursors.	[Harmey, Dympna; Smith, Anthony; Simanski, Scott; Moussa, Carole Zaki; Ayad, Nagi G.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA	Scripps Research Institute	Ayad, NG (corresponding author), Scripps Res Inst, Dept Canc Biol, 5353 Parkside Dr, Jupiter, FL 33458 USA.	nayad@scripps.edu		Simanski, Scott/0000-0002-7594-5952	Landenberger Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067289] Funding Source: NIH RePORTER	Landenberger Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Landenberger Foundation.	Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Araki M, 2003, EMBO J, V22, P6115, DOI 10.1093/emboj/cdg573; Ayad NG, 2005, METHOD ENZYMOL, V399, P404, DOI 10.1016/S0076-6879(05)99028-9; Bai S, 2007, J BIOL CHEM, V282, P27171, DOI 10.1074/jbc.M700691200; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cuende J, 2008, ONCOGENE, V27, P3339, DOI 10.1038/sj.onc.1210987; Durand B, 1998, CURR BIOL, V8, P431, DOI 10.1016/S0960-9822(98)70177-0; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Vernon AE, 2003, DEVELOPMENT, V130, P85, DOI 10.1242/dev.00193; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wu G, 2007, MOL BIOL CELL, V18, P1018, DOI 10.1091/mbc.E06-09-0809	35	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4317	4323		10.1074/jbc.M804944200	http://dx.doi.org/10.1074/jbc.M804944200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19047054	hybrid			2022-12-25	WOS:000263134400030
J	Ni, HM; Chen, XY; Shi, YH; Liao, Y; Beg, AA; Fan, J; Yin, XM				Ni, Hong-Min; Chen, Xiaoyun; Shi, Ying-Hong; Liao, Yong; Beg, Amer A.; Fan, Jia; Yin, Xiao-Ming			Genetic Delineation of the Pathways Mediated by Bid and JNK in Tumor Necrosis Factor-alpha-induced Liver Injury in Adult and Embryonic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; TNF-ALPHA; INTRACELLULAR PATHWAYS; HEPATOCYTE APOPTOSIS; DEFICIENT MICE; ACTIVATION; DEATH; MITOCHONDRIA; INHIBITION	Tumor necrosis factor-alpha (TNF alpha)-induced hepatocyte death and liver injury can be mediated by multiple mechanisms, which could be evaluated by different animal models. Previous studies have defined the importance of Bid in mitochondrial apoptosis activation in adult mice treated with lipopolysaccharides in the presence of galactosamine (GalN), which suppresses NF-kappa B activation, but not in embryonic mice in which NF-kappa B activation is suppressed by genetic deletion of p65RelA. JNK has also been found important in TNF alpha-induced mitochondria activation and liver injury in the lipopolysaccharide/GalN and concanavalin A (ConA)/GalN models, but not in a ConA-only model in which NF-kappa B activation was not suppressed. To determine the mechanistic relationship of pathways mediated by Bid and JNK, we investigated these two molecules in TNF alpha injury models that had not been previously examined. Most importantly, we created and studied mice deficient in both Bid and JNK. We found that, like JNK, Bid was also required for TNF alpha-induced injury induced by concanavalin A/GalN but not by ConA alone. Furthermore, our results indicate that these two molecules function in a largely overlapped manner, with Bid being downstream of JNK in the adult livers. However, JNK, but not Bid, was able to contribute to the TNF alpha-induced liver apoptosis in RelA-deficient embryos. The Bid-independent role of JNK was also observed in the adult mice, mainly in the promotion of the lethal progression of the TNF alpha injury. This work defined both linear and parallel relationships of Bid and JNK in TNF alpha-induced hepatocyte apoptosis and liver injury.	[Ni, Hong-Min; Chen, Xiaoyun; Liao, Yong; Yin, Xiao-Ming] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15261 USA; [Shi, Ying-Hong; Fan, Jia] Fudan Univ, Zhongshan Hosp, Dept Liver Surg, Liver Canc Inst, Shanghai 200032, Peoples R China; [Beg, Amer A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University; H Lee Moffitt Cancer Center & Research Institute	Yin, XM (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, 3550 Terrace St, Pittsburgh, PA 15261 USA.	xmyin@pitt.edu	Chen, Xiaoyun/K-4786-2019; Shi, Ying-Hong/B-7063-2017; Fan, Jia/C-6689-2017		National Institutes of Health [R01CA 83817]; NATIONAL CANCER INSTITUTE [R01CA083817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA 83817 (to X.-M. Y.).	BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen XY, 2007, MOL CELL BIOL, V27, P541, DOI 10.1128/MCB.01166-06; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Gantner F, 1997, J PHARMACOL EXP THER, V280, P53; GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1002/hep.1840210131; GANTNER F, 1995, GASTROENTEROLOGY, V109, P166, DOI 10.1016/0016-5085(95)90282-1; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Gugasyan R, 2006, CELL DEATH DIFFER, V13, P1235, DOI 10.1038/sj.cdd.4401858; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kaufmann T, 2007, CELL DEATH DIFFER, V14, P637, DOI 10.1038/sj.cdd.4402061; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Kunstle G, 1999, HEPATOLOGY, V30, P1241, DOI 10.1002/hep.510300517; Kusters S, 1997, EUR J IMMUNOL, V27, P2870, DOI 10.1002/eji.1830271119; Lawson JA, 1998, HEPATOLOGY, V28, P761, DOI 10.1002/hep.510280324; Li SC, 2002, J BIOL CHEM, V277, P26912, DOI 10.1074/jbc.M200726200; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Ni HM, 2008, AM J PATHOL, V173, P962, DOI 10.2353/ajpath.2008.080358; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Streetz K, 2001, J IMMUNOL, V167, P514, DOI 10.4049/jimmunol.167.1.514; Trautwein C, 1998, GASTROENTEROLOGY, V114, P1035, DOI 10.1016/S0016-5085(98)70324-5; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Van Molle W, 1999, J IMMUNOL, V163, P5235; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yin XM, 2003, CURR MOL MED, V3, P491, DOI 10.2174/1566524033479555; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhao YG, 2003, GASTROENTEROLOGY, V125, P854, DOI 10.1016/S0016-5085(03)01066-7; Zhao YG, 2001, J BIOL CHEM, V276, P27432, DOI 10.1074/jbc.M102465200	40	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4373	4382		10.1074/jbc.M807259200	http://dx.doi.org/10.1074/jbc.M807259200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19060338	Green Published, hybrid			2022-12-25	WOS:000263134400036
J	Delisle, BP; Underkofler, HAS; Moungey, BM; Slind, JK; Kilby, JA; Best, JM; Foell, JD; Balijepalli, RC; Kamp, TJ; January, CT				Delisle, Brian P.; Underkofler, Heather A. S.; Moungey, Brooke M.; Slind, Jessica K.; Kilby, Jennifer A.; Best, Jabe M.; Foell, Jason D.; Balijepalli, Ravi C.; Kamp, Timothy J.; January, Craig T.			Small GTPase Determinants for the Golgi Processing and Plasmalemmal Expression of Human Ether-a-go-go Related (hERG) K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; ENDOPLASMIC-RETICULUM; BETA-COP; POTASSIUM CHANNEL; MUTANT CHANNELS; TRANSPORT; TRAFFICKING; PROTEIN; ER; RAB6	The pro-arrhythmic Long QT syndrome (LQT) is linked to 10 different genes (LQT1-10). Approximately 40% of genotype-positive LQT patients have LQT2, which is characterized by mutations in the human ether-a-go-go related gene (hERG). hERG encodes the voltage-gated K+ channel alpha-subunits that form the pore of the rapidly activating delayed rectifier K+ current in the heart. The purpose of this study was to elucidate the mechanisms that regulate the intracellular transport or trafficking of hERG, because trafficking is impaired for about 90% of LQT2 missense mutations. Protein trafficking is regulated by small GTPases. To identify the small GTPases that are critical for hERG trafficking, we coexpressed hERG and dominant negative (DN) GTPase mutations in HEK293 cells. The GTPases Sar1 and ARF1 regulate the endoplasmic reticulum (ER) export of proteins in COPII and COPI vesicles, respectively. Expression of DN Sar1 inhibited the Golgi processing of hERG, decreased hERG current (I-hERG) by 85%(n >= 8 cells per group, *, p< 0.01), and reduced the plasmalemmal staining of hERG. The coexpression of DNARF1 had relatively small effects on hERG trafficking. Surprisingly, the coexpression of DN Rab11B, which regulates the endosomal recycling, inhibited the Golgi processing of hERG, decreased I-hERG by 79% (n >= 8 cells per group; *, p < 0.01), and reduced the plasmalemmal staining of hERG. These data suggest that hERG undergoes ER export in COPII vesicles and endosomal recycling prior to being processed in the Golgi. We conclude that hERG trafficking involves a pathway between the ER and endosomal compartments that influences expression in the plasmalemma.	[Delisle, Brian P.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Underkofler, Heather A. S.; Moungey, Brooke M.; Slind, Jessica K.; Kilby, Jennifer A.; Best, Jabe M.; Foell, Jason D.; Balijepalli, Ravi C.; Kamp, Timothy J.; January, Craig T.] Univ Wisconsin, Cellular & Mol Arrhythmia Res Program, Dept Med, Madison, WI 53706 USA; [Underkofler, Heather A. S.; Moungey, Brooke M.; Slind, Jessica K.; Kilby, Jennifer A.; Best, Jabe M.; Foell, Jason D.; Balijepalli, Ravi C.; Kamp, Timothy J.; January, Craig T.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Kentucky; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Delisle, BP (corresponding author), Univ Kentucky, Dept Physiol, 800 Rose St MS508, Lexington, KY 40536 USA.	brian.delisle@uky.edu	Kamp, Timothy/ABD-1343-2020	Kamp, Timothy/0000-0003-2103-7876; Delisle, Brian/0000-0002-2146-327X	NHLBI, National Institutes of Health [R01 HL087039, R01 HL60723]; Scientist Development [0535068N, 0730010N]; American Heart Association; Mabel Lent Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060723, R01HL087039] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Scientist Development; American Heart Association(American Heart Association); Mabel Lent Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant R01 HL087039 (to B. P. D.) and Grant R01 HL60723 (to C. T. J.). This work was also supported by the Scientist Development Grants 0535068N and 0730010N from the American Heart Association (to B. P. D. and to R. C. B., respectively) and the Mabel Lent Foundation (to C. T. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 To whom correspondence may be addressed: Dept. of Physiology, University of Kentucky, 800 Rose St. MS508, Lexington, KY 40536. Tel.: 859-3232797; Fax: 859-323-1070; E-mail: brian.delisle@uky.edu.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; BARLOWE C, 1993, J BIOL CHEM, V268, P873; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Delisle BP, 2005, MOL PHARMACOL, V68, P233, DOI 10.1124/mol.105.012914; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Eckhardt LL, 2007, HEART RHYTHM, V4, P323, DOI 10.1016/j.hrthm.2006.10.025; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; GOUD B, 1994, ANN NY ACAD SCI, V710, P192, DOI 10.1111/j.1749-6632.1994.tb26627.x; GRIFFITHS G, 1995, J CELL SCI, V108, P2839; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; PETER F, 1993, J CELL BIOL, V122, P1155, DOI 10.1083/jcb.122.6.1155; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rajamani S, 2006, AM J PHYSIOL-HEART C, V290, pH1278, DOI 10.1152/ajpheart.00777.2005; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Trudeau MC, 1996, SCIENCE, V272, P1087; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	42	38	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2844	2853		10.1074/jbc.M807289200	http://dx.doi.org/10.1074/jbc.M807289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029296	Green Published, hybrid			2022-12-25	WOS:000262700900028
J	Luther, KB; Schindelin, H; Haltiwanger, RS				Luther, Kelvin B.; Schindelin, Hermann; Haltiwanger, Robert S.			Structural and Mechanistic Insights into Lunatic Fringe from a Kinetic Analysis of Enzyme Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAUSES SPONDYLOCOSTAL DYSOSTOSIS; FACTOR-LIKE REPEATS; CRYSTAL-STRUCTURE; GLYCOSYLTRANSFERASE FRINGE; URIDINE DIPHOSPHOGLUCOSE; BETA-GLUCOSYLTRANSFERASE; CATALYTIC MECHANISM; NOTCH-GENE; DROSOPHILA; GLYCOSYLATION	The Notch receptor is critical for proper development where it orchestrates numerous cell fate decisions. The Fringe family of beta 1,3-N-acetylglucosaminyltransferases are regulators of this pathway. Fringe enzymes add N-acetylglucosamine to O-linked fucose on the epidermal growth factor repeats of Notch. Here we have analyzed the reaction catalyzed by Lunatic Fringe (Lfng) in detail. A mutagenesis strategy for Lfng was guided by a multiple sequence alignment of Fringe proteins and solutions from docking an epidermal growth factor-like O-fucose acceptor substrate onto a homology model of Lfng. We targeted three main areas as follows: residues that could help resolve where the fucose binds, residues in two conserved loops not observed in the published structure of Manic Fringe, and residues predicted to be involved in UDP-N-acetylglucosamine (UDP-GlcNAc) donor specificity. We utilized a kinetic analysis of mutant enzyme activity toward the small molecule acceptor substrate 4-nitrophenyl-alpha-L-fucopyranoside to judge their effect on Lfng activity. Our results support the positioning of O-fucose in a specific orientation to the catalytic residue. We also found evidence that one loop closes off the active site coincident with, or subsequent to, substrate binding. We propose a mechanism whereby the ordering of this short loop may alter the conformation of the catalytic aspartate. Finally, we identify several residues near the UDP-GlcNAc-binding site, which are specifically permissive toward UDP-GlcNAc utilization.	[Luther, Kelvin B.; Schindelin, Hermann; Haltiwanger, Robert S.] SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Haltiwanger, RS (corresponding author), SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	rhaltiwanger@ms.cc.sunysb.edu	Schindelin, Hermann/Q-2697-2019	Luther, Kelvin/0000-0001-9438-9675	National Institutes of Health [GM061126, DK54835]; Deutsche Forschungsgemeinschaft [FZ82]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM061126 ( to R. S. H.) and DK54835 ( to H. S.). This work was also supported by Deutsche Forschungsgemeinschaft Grant FZ82 ( to H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Correia T, 2003, P NATL ACAD SCI USA, V100, P6404, DOI 10.1073/pnas.1131007100; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Eswar N., 2007, CURR PROTOC PROTEIN; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Jinek M, 2006, NAT STRUCT MOL BIOL, V13, P945, DOI 10.1038/nsmb1144; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kleywegt GJ, 2003, STRUCTURE, V11, P1051, DOI 10.1016/S0969-2126(03)00186-2; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MIYAMOTO Y, 1990, BIOCHEM BIOPH RES CO, V168, P1149, DOI 10.1016/0006-291X(90)91149-M; Moloney DJ, 1999, GLYCOBIOLOGY, V9, P679, DOI 10.1093/glycob/9.7.679; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; NOVIKOFF AB, 1961, P NATL ACAD SCI USA, V47, P802, DOI 10.1073/pnas.47.6.802; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Ritchie DW, 2003, PROTEINS, V52, P98, DOI 10.1002/prot.10379; ROBBINS J, 1992, J VIROL, V66, P2594, DOI 10.1128/JVI.66.4.2594-2599.1992; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sparrow DB, 2006, AM J HUM GENET, V78, P28, DOI 10.1086/498879; Sparrow Duncan B., 2007, Birth Defects Research, V81, P93, DOI 10.1002/bdrc.20093; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; VRIELINK A, 1994, EMBO J, V13, P3413, DOI 10.1002/j.1460-2075.1994.tb06646.x; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Yuan YQ, 2007, P NATL ACAD SCI USA, V104, P5348, DOI 10.1073/pnas.0701160104; Zhang N, 2002, GENESIS, V33, P21, DOI 10.1002/gene.10081; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	52	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3294	3305		10.1074/jbc.M805502200	http://dx.doi.org/10.1074/jbc.M805502200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19028689	Green Published, hybrid			2022-12-25	WOS:000262700900072
J	Tang, Z; Jiang, S; Du, R; Petri, ET; El-Telbany, A; Chan, PSO; Kijima, T; Dietrich, S; Matsui, K; Kobayashi, M; Sasada, S; Okamoto, N; Suzuki, H; Kawahara, K; Iwasaki, T; Nakagawa, K; Kawase, I; Christensen, JG; Hirashima, T; Halmos, B; Salgia, R; Boggon, TJ; Kern, JA; Ma, PC				Tang, Z.; Jiang, S.; Du, R.; Petri, E. T.; El-Telbany, A.; Chan, P. S. O.; Kijima, T.; Dietrich, S.; Matsui, K.; Kobayashi, M.; Sasada, S.; Okamoto, N.; Suzuki, H.; Kawahara, K.; Iwasaki, T.; Nakagawa, K.; Kawase, I.; Christensen, J. G.; Hirashima, T.; Halmos, B.; Salgia, R.; Boggon, T. J.; Kern, J. A.; Ma, P. C.			Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity	ONCOGENE			English	Article						EGFR; MET; mutation; tyrosine kinase inhibitor; structure; kinome	GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; C-MET; KINASE DOMAIN; THERAPEUTIC INHIBITION; SOMATIC MUTATIONS; TYROSINE KINASE; GEFITINIB; PATHWAY; COMPLEX	Targeted therapy against epidermal growth factor receptor (EGFR) represents a major therapeutic advance in lung cancer treatment. Somatic mutations of the EGFR gene, most commonly L858R (exon 21) and short in-frame exon 19 deletions, have been found to confer enhanced sensitivity toward the inhibitors gefitinib and erlotinib. We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib. The somatic E884K substitution appears to be relatively infrequent and resulted in a mutant lysine residue that disrupts an ion pair with residue R958 in the EGFR kinase domain C-lobe, an interaction that is highly conserved within the human kinome as demonstrated by our sequence analysis and structure analysis. Our studies here, using COS-7 transfection model system, show that E884K works in concert with L858R in-cis, in a dominant manner, to change downstream signaling, differentially induce Mitogen-activated protein kinase (extracellular signaling-regulated kinase 1/2) signaling and associated cell proliferation and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor-specific manner. Mutations of the conserved ion pair E884-R958 may result in conformational changes that alter kinase substrate recognition. The analogous E1271K-MET mutation conferred differential sensitivity toward preclinical MET inhibitors SU11274 (unchanged) and PHA665752 (more sensitive). Systematic bioinformatics analysis of the mutation catalog in the human kinome revealed the presence of cancer-associated mutations involving the conserved E884 homologous residue, and adjacent residues at the ion pair, in known proto-oncogenes (KIT, RET, MET and FAK) and tumor-suppressor gene (LKB1). Targeted therapy using small-molecule inhibitors should take into account potential cooperative effects of multiple kinase mutations, and their specific effects on downstream signaling and inhibitor sensitivity. Improved efficacy of targeted kinase inhibitors may be achieved by targeting the dominant activating mutations present.	[Tang, Z.; Jiang, S.; Du, R.; El-Telbany, A.; Dietrich, S.; Halmos, B.; Ma, P. C.] Case Western Reserve Univ, Sch Med, Univ Hosp Case Med Ctr, Div Hematol Oncol, Cleveland, OH 44106 USA; [Tang, Z.; Jiang, S.; Du, R.; El-Telbany, A.; Dietrich, S.; Halmos, B.; Kern, J. A.; Ma, P. C.] Case Comprehens Canc Ctr, Ireland Canc Ctr, Cleveland, OH USA; [Petri, E. T.; Boggon, T. J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Chan, P. S. O.] Elpidex Biosci Inc, Los Angeles, CA USA; [Kijima, T.; Kawase, I.] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Osaka, Japan; [Matsui, K.; Kobayashi, M.; Sasada, S.; Okamoto, N.; Suzuki, H.; Hirashima, T.] Osaka Prefecture Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, Osaka, Japan; [Kawahara, K.] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Pathol, Osaka, Japan; [Iwasaki, T.; Nakagawa, K.] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Surg, Osaka, Japan; [Christensen, J. G.] Pfizer Inc, Global Res & Dev, San Diego, CA USA; [Salgia, R.] Univ Chicago, Pritzker Sch Med, Canc Res Ctr, Hematol Oncol Sect, Chicago, IL 60637 USA; [Kern, J. A.] Case Western Reserve Univ, Sch Med, Univ Hosp Case Med Ctr, Div Pulm, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Yale University; Osaka University; Osaka Prefectural Medical Center Respiratory & Allergic Diseases; Osaka Prefectural Medical Center Respiratory & Allergic Diseases; Osaka Prefectural Medical Center Respiratory & Allergic Diseases; Pfizer; University of Chicago; Case Western Reserve University; Case Western Reserve University Hospital	Ma, PC (corresponding author), Case Western Reserve Univ, Sch Med, Univ Hosp Case Med Ctr, Div Hematol Oncol, 10900 Euclid Ave,WRB 2-123, Cleveland, OH 44106 USA.	patrick.ma@case.edu	Dietrich, Sascha/J-2562-2015	Dietrich, Sascha/0000-0002-0648-1832; Kern, Jeffrey/0000-0001-9709-9622; Petri, Edward/0000-0002-3650-1523	NIH; National Cancer Institute [K08, 5K08CA102545-04, 5T32CA009085-32]; American Cancer Society (Ohio) [IRG-91-022]; Case Comprehensive Cancer Center; Ohio Cancer Research Associates; NATIONAL CANCER INSTITUTE [T32CA009085, R01CA100750, R01CA125541, K08CA102545, R01CA129501] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society (Ohio)(American Cancer Society); Case Comprehensive Cancer Center; Ohio Cancer Research Associates; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Patrick C Ma is supported by NIH/National Cancer Institute-K08 Career Development Award (5K08CA102545-04), American Cancer Society (Ohio)-Institutional Research Grant (IRG-91-022, Case Comprehensive Cancer Center) and Ohio Cancer Research Associates (Give New Ideas A Chance) Grant Award. Titus J Boggon is an American Society of Hematology Junior Faculty Scholar. Edward T Petri is supported by an NIH/National Cancer Institute T32 training Grant (5T32CA009085-32). We thank Dr Zhenghe J Wang (Department of Genetics, Case Western Reserve University) for critically reading the manuscript and for helpful suggestions.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; BRODSKY LI, 1992, DIMACS SERIES DISCRE, V8, P127; Chen Z, 2008, ONCOGENE, V27, P4336, DOI 10.1038/onc.2008.71; Choong NW, 2006, NAT CLIN PRACT ONCOL, V3, P50, DOI 10.1038/ncponc0400; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Jackman DM, 2006, J CLIN ONCOL, V24, P4517, DOI 10.1200/JCO.2006.06.6126; Jagadeeswaran R, 2006, CANCER RES, V66, P352, DOI 10.1158/0008-5472.CAN-04-4567; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jin L, 2004, J BIOL CHEM, V279, P42818, DOI 10.1074/jbc.M407096200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma PC, 2007, BRIT J CANCER, V97, P368, DOI 10.1038/sj.bjc.6603884; Ma PC, 2005, CLIN CANCER RES, V11, P2312, DOI 10.1158/1078-0432.CCR-04-1708; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Ma PC, 2003, CANCER RES, V63, P6272; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Pevarello P, 2004, J MED CHEM, V47, P3367, DOI 10.1021/jm031145u; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Scapin G, 2003, CHEM BIOL, V10, P705, DOI 10.1016/S1074-5521(03)00159-5; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shinomiya N, 2004, CANCER RES, V64, P7962, DOI 10.1158/0008-5472.CAN-04-1043; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Tang Z, 2008, BRIT J CANCER, V99, P911, DOI 10.1038/sj.bjc.6604559; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	41	15	16	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					518	533		10.1038/onc.2008.411	http://dx.doi.org/10.1038/onc.2008.411			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	19015641	Green Accepted, Bronze			2022-12-25	WOS:000262866500006
J	Farver, O; Vitu, E; Wherland, S; Fass, D; Pecht, I				Farver, Ole; Vitu, Elvira; Wherland, Scot; Fass, Deborah; Pecht, Israel			Electron Transfer Reactivity of the Arabidopsis thaliana Sulfhydryl Oxidase AtErv1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-BOND FORMATION; ENDOPLASMIC-RETICULUM; INTERMEMBRANE SPACE; LIVER-REGENERATION; PROTEIN FAMILY; CYTOCHROME-C; RELAY SYSTEM; MITOCHONDRIA; ERO1P; AUGMENTOR	The redox reactivity of the three disulfide bridges and the flavin present in each protomer of the wild-type Arabidopsis thaliana mitochondrial sulfhydryl oxidase (AtErv1) homodimer has been investigated. Pulse radiolytically produced CO2- radical ions were found to reduce the disulfide bridges to yield disulfide radicals, RSS*R-. Rates and absorption changes due to formation or decay of RSS*R- and the flavin quinone, semiquinone, and hydroquinone were measured and analyzed. During the first 100 mu s following the pulse, the flavin was reduced to the semiquinone by intramolecular electron transfer from the active site disulfide radical. The semiquinone and the remaining disulfide radicals then reacted by much slower, 40 ms to 40 s, inter-homodimer electron transfer reactions, culminating in reduced flavin and dithiols. The dithiols were then subject to oxidation by enzyme molecules via their intrinsic enzymatic activity, at a rate comparable to the slower intermolecular processes in the 10-s time regime. Mutants of AtErv1 lacking each of the three individual cysteine pairs were studied to determine the involvement of the respective disulfide groups in these reactions. Elimination of the active site disulfide bridge increased the stability of the flavin semiquinone making it a long-lived product. Relevance of these observations to the design and function of the sulfhydryl oxidases is discussed.	[Vitu, Elvira; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Pecht, Israel] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Farver, Ole] Univ Copenhagen, Inst Analyt Chem, DK-2100 Copenhagen, Denmark; [Wherland, Scot] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Weizmann Institute of Science; Weizmann Institute of Science; University of Copenhagen; Washington State University	Fass, D (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	Deborah.Fass@weizmann.ac.il; Israel.Pecht@weizmann.ac.il	Vitu, Elvira/V-8201-2017	Wherland, Scot/0000-0003-1699-5594; Pecht, Israel/0000-0002-1883-9547	Kimmelman Center for Macromolecular Assemblies	Kimmelman Center for Macromolecular Assemblies	This work was supported by the Kimmelman Center for Macromolecular Assemblies ( to D. F.).	Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; FARVER O, 1992, J AM CHEM SOC, V114, P5764, DOI 10.1021/ja00040a043; Farver O, 1999, J BIOL CHEM, V274, P26135, DOI 10.1074/jbc.274.37.26135; Farver O, 2007, PROG INORG CHEM, V55, P1, DOI 10.1002/9780470144428.ch1; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Gerber J, 2001, J BIOL CHEM, V276, P23486, DOI 10.1074/jbc.M100134200; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; HERRMANN JM, 2009, BIOCH BIOPHYS ACTA M, P71; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; HILLE R, 1991, J BIOL CHEM, V266, P5608; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Mairet-Coello G, 2004, J COMP NEUROL, V473, P334, DOI 10.1002/cne.20126; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; OSTROWSKI MC, 1980, BIOCHEMISTRY-US, V19, P2639, DOI 10.1021/bi00553a016; Raje S, 2003, BIOCHEMISTRY-US, V42, P4560, DOI 10.1021/bi030003z; Rodriguez I, 2006, J VIROL, V80, P3157, DOI 10.1128/JVI.80.7.3157-3166.2006; Senkevich TG, 2000, P NATL ACAD SCI USA, V97, P12068, DOI 10.1073/pnas.210397997; Senkevich TG, 2002, P NATL ACAD SCI USA, V99, P6667, DOI 10.1073/pnas.062163799; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Su HP, 2005, P NATL ACAD SCI USA, V102, P4240, DOI 10.1073/pnas.0501103102; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070	28	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2098	2105		10.1074/jbc.M806316200	http://dx.doi.org/10.1074/jbc.M806316200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017646	hybrid			2022-12-25	WOS:000262545600018
J	Halaszovich, CR; Schreiber, DN; Oliver, D				Halaszovich, Christian R.; Schreiber, Daniela N.; Oliver, Dominik			Ci-VSP Is a Depolarization-activated Phosphatidylinositol-4,5-bisphosphate and Phosphatidylinositol-3,4,5-trisphosphate 5 '-Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PLASMA-MEMBRANE; LIVING CELLS; PHOSPHOINOSITIDE 3-KINASE; PH DOMAINS; PROTEIN; 4,5-BISPHOSPHATE; PHOSPHATASE; BINDING; KINASE	Phosphoinositides are membrane-delimited regulators of protein function and control many different cellular targets. The differentially phosphorylated isoforms have distinct concentrations in various subcellular membranes, which can change dynamically in response to cellular signaling events. Maintenance and dynamics of phosphoinositide levels involve a complex set of enzymes, among them phospholipases and lipid kinases and phosphatases. Recently, a novel type of phosphoinositide-converting protein ( termed Ci-VSP) that contains a voltage sensor domain was isolated. It was already shown that Ci-VSP can alter phosphoinositide levels in a voltage-dependent manner. However, the exact enzymatic reaction catalyzed by Ci-VSP is not known. We used fluorescent phosphoinositide-binding probes and total internal reflection microscopy together with patch-clamp measurements from living cells to delineate substrates and products of Ci-VSP. Upon activation of Ci-VSP by membrane depolarization, membrane association of phosphatidylinositol ( PI) (4,5)P-2- and PI( 3,4,5)P-3-specific binding domains decreased, revealing consumption of these phosphoinositides by Ci-VSP. Depletion of PI(4,5)P-2 was coincident with an increase in membrane PI(4)P. Similarly, PI(3,4)P-2 was generated during depletion of PI(3,4,5)P-3. These results suggest that Ci-VSP acts as a 5'-phosphatase of PI(4,5)P-2 and PI(3,4,5)P-3.	[Halaszovich, Christian R.; Schreiber, Daniela N.; Oliver, Dominik] Univ Marburg, Inst Physiol & Pathophysiol, Dept Neurophysiol, D-35037 Marburg, Germany	Philipps University Marburg	Oliver, D (corresponding author), Univ Marburg, Inst Physiol & Pathophysiol, Dept Neurophysiol, Deutschhausstr 2, D-35037 Marburg, Germany.	oliverd@staff.uni-marburg.de	Oliver, Dominik/F-5845-2013; Halaszovich, Christian/I-7231-2012	Oliver, Dominik/0000-0002-8368-0923; 	Deutsche Forschungsgemeinschaft [OI 240/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant OI 240/2 (to D.O.).	Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla T, 2001, CURR PHARM DESIGN, V7, P475, DOI 10.2174/1381612013397906; Bartlett PJ, 2005, J BIOL CHEM, V280, P21837, DOI 10.1074/jbc.M411843200; BAZENET CE, 1990, J BIOL CHEM, V265, P18012; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cheung SMS, 2007, CELL SIGNAL, V19, P902, DOI 10.1016/j.cellsig.2006.10.013; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kimber WA, 2002, BIOCHEM J, V361, P525, DOI 10.1042/0264-6021:3610525; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Manna D, 2007, J BIOL CHEM, V282, P32093, DOI 10.1074/jbc.M703517200; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Weixel KM, 2007, J BIOL CHEM, V282, P36534, DOI 10.1074/jbc.M703970200; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467	42	80	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2106	2113		10.1074/jbc.M803543200	http://dx.doi.org/10.1074/jbc.M803543200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047057	hybrid			2022-12-25	WOS:000262545600019
J	Lin, HY; Underhill, C; Gardill, BR; Muller, YA; Hammond, GL				Lin, Hai-Yan; Underhill, Caroline; Gardill, Bernd R.; Muller, Yves A.; Hammond, Geoffrey L.			Residues in the Human Corticosteroid-binding Globulin Reactive Center Loop That Influence Steroid Binding before and after Elastase Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERPIN CONFORMATIONAL CHANGE; SERINE-PROTEASE INHIBITORS; POLYMERASE CHAIN-REACTION; AMINO-ACID SUBSTITUTION; HINGE REGION MUTATIONS; HEPARIN-COFACTOR-II; ALPHA-1-PROTEINASE INHIBITOR; HORMONE-RELEASE; BETA-SHEET; CORTISOL	Corticosteroid-binding globulin (CBG) is a non-inhibitory serine proteinase inhibitor (serpin) that transports cortisol and progesterone in blood. Crystal structures of rat CBG and a thrombin-cleaved human CBG: anti-trypsin (Pittsburgh) chimera show how structural transitions after proteolytic cleavage of the CBG reactive center loop (RCL) could disrupt steroid binding. This ligand release mechanism is assumed to involve insertion of the cleaved RCL into the beta-sheet A of the serpin structure. We have, therefore, examined how amino acid substitutions in the human CBG RCL influence steroid binding before and after its cleavage by neutrophil elastase. Elastase-cleaved wild-type CBG or variants with substitutions at P15 and/or P16 (E334G/G335N or E334A) lost steroid binding completely, whereas deletion of Glu-334 resulted in no loss of steroid binding after RCL cleavage, presumably because this prevents its insertion into beta-sheet A. Similarly, the steroid binding properties of CBG variants with substitutions at P15 (G335P), P14 (V336R), or P12 (T338P) in the RCL hinge were largely unaffected after elastase cleavage, most likely because the re-orientation and/or insertion of the cleaved RCL was blocked. Substitutions at P10 (G340P, G340S) or P8 (T342P, T342N) resulted in a partial loss of steroid binding after proteolysis which we attribute to incomplete insertion of the cleaved RCL. Remarkably, several substitutions (E334A, V336R, G340S, and T342P) increased the steroid binding affinities of human CBG even before elastase cleavage, consistent with the concept that CBG normally toggles between a high affinity ligand binding state where the RCL is fully exposed and a lower affinity state in which the RCL is partly inserted into beta-sheet A.	[Lin, Hai-Yan; Underhill, Caroline; Hammond, Geoffrey L.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Lin, Hai-Yan; Underhill, Caroline; Hammond, Geoffrey L.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 4H4, Canada; [Gardill, Bernd R.; Muller, Yves A.] Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biotech, D-91052 Erlangen, Germany	Child & Family Research Institute; University of British Columbia; University of British Columbia; University of Erlangen Nuremberg	Hammond, GL (corresponding author), Univ British Columbia, Child & Family Res Inst, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	ghammond@cw.bc.ca	Muller, Yves A/R-5397-2016	Muller, Yves A/0000-0003-0519-8928; Hammond, Geoffrey/0000-0002-4639-7336	Canadian Institutes of Health Research [MOP 77586]; Deutsche Forschungsgemeinschaft [Mu1477-5]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Canadian Institutes of Health Research Grant MOP 77586 ( to G. L. H.) and in part by Deutsche Forschungsgemeinschaft Grant Mu1477-5. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AULAK KS, 1993, J BIOL CHEM, V268, P18088; AVVAKUMOV GV, 1993, J BIOL CHEM, V268, P862; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; BANDA MJ, 1987, J CLIN INVEST, V79, P1314, DOI 10.1172/JCI112955; Breuner CW, 2002, J ENDOCRINOL, V175, P99, DOI 10.1677/joe.0.1750099; CASO R, 1991, BRIT J HAEMATOL, V77, P87, DOI 10.1111/j.1365-2141.1991.tb07953.x; Corral J, 2004, CIRCULATION, V110, P1303, DOI 10.1161/01.CIR.0000140763.51679.D9; DAVIS AE, 1992, NAT GENET, V1, P354, DOI 10.1038/ng0892-354; Emptoz-Bonneton A, 2000, J CLIN ENDOCR METAB, V85, P361, DOI 10.1210/jc.85.1.361; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Grasberger H, 2002, BIOCHEM J, V365, P311, DOI 10.1042/BJ20020014; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; Hammond GL, 2002, OBSTET GYN CLIN N AM, V29, P411, DOI 10.1016/S0889-8545(02)00008-6; HAMMOND GL, 1990, BIOCHEM BIOPH RES CO, V172, P172, DOI 10.1016/S0006-291X(05)80189-5; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HAMMOND GL, 1991, J STEROID BIOCHEM, V40, P755, DOI 10.1016/0960-0760(91)90300-T; HAMMOND GL, 1990, ENDOCR REV, V11, P65, DOI 10.1210/edrv-11-1-65; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; Huntington JA, 1997, BIOCHEMISTRY-US, V36, P5432, DOI 10.1021/bi9702142; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Janssen OE, 2002, J CLIN ENDOCR METAB, V87, P1217, DOI 10.1210/jc.87.3.1217; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Jirasakuldech B, 2000, J CLIN ENDOCR METAB, V85, P3996, DOI 10.1210/jc.85.11.3996; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lawrence DA, 2000, J BIOL CHEM, V275, P5839, DOI 10.1074/jbc.275.8.5839; Lukacs CM, 1996, NAT STRUCT BIOL, V3, P888, DOI 10.1038/nsb1096-888; MOLHOSABATIER P, 1989, J CLIN INVEST, V84, P1236, DOI 10.1172/JCI114290; ORAVA M, 1994, GENE, V144, P259, DOI 10.1016/0378-1119(94)90387-5; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; PERRY DJ, 1989, FEBS LETT, V254, P174, DOI 10.1016/0014-5793(89)81033-6; ROBINSON PA, 1985, J ENDOCRINOL, V104, P259, DOI 10.1677/joe.0.1040259; SKRIVER K, 1991, J BIOL CHEM, V266, P9216; SMITH CL, 1991, J BIOL CHEM, V266, P18555; SMITH CL, 1992, J STEROID BIOCHEM, V42, P671, DOI 10.1016/0960-0760(92)90107-T; STEINBERGER D, 1995, HUM GENET, V96, P113, DOI 10.1007/BF00214198; VANBAELEN H, 1993, STEROIDS, V58, P275, DOI 10.1016/0039-128X(93)90072-U; Whisstock JC, 2000, J MOL BIOL, V296, P685, DOI 10.1006/jmbi.1999.3520; WRIGHT HT, 1990, J MOL BIOL, V213, P513; Yamasaki M, 2002, J MOL BIOL, V315, P113, DOI 10.1006/jmbi.2001.5056; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103	45	39	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					884	896		10.1074/jbc.M807376200	http://dx.doi.org/10.1074/jbc.M807376200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19011238	hybrid			2022-12-25	WOS:000262122900023
J	Tam, SP; Kisilevsky, R; Ancsin, JB				Tam, Shui-Pang; Kisilevsky, Robert; Ancsin, John B.			Acute-Phase-HDL Remodeling by Heparan Sulfate Generates a Novel Lipoprotein with Exceptional Cholesterol Efflux Activity from Macrophages	PLOS ONE			English	Article								During episodes of acute-inflammation high-density lipoproteins (HDL), the carrier of so-called good cholesterol, experiences a major change in apolipoprotein composition and becomes acute-phase HDL (AP-HDL). This altered, but physiologically important, HDL has an increased binding affinity for macrophages that is dependent on cell surface heparan sulfate (HS). While exploring the properties of AP-HDL: HS interactions we discovered that HS caused significant remodeling of AP-HDL. The physical nature of this change in structure and its potential importance for cholesterol efflux from cholesterol-loaded macrophages was therefore investigated. In the presence of heparin, or HS, AP-HDL solutions at pH 5.2 became turbid within minutes. Analysis by centrifugation and gel electrophoresis indicated that AP-HDL was remodeled generating novel lipid poor particles composed only of apolipoprotein AI, which we designate beta 2. This remodeling is dependent on pH, glycosaminoglycan type, is promoted by Ca2+ and is independent of protease or lipase activity. Compared to HDL and AP-HDL, remodeled AP-HDL (S-HDL-SAA), containing beta 2 particles, demonstrated a 3-fold greater cholesterol efflux activity from cholesterol-loaded macrophage. Because the identified conditions causing this change in AP-HDL structure and function can exist physiologically at the surface of the macrophage, or in its endosomes, we postulate that AP-HDL contains latent functionalities that become apparent and active when it associates with macrophage cell surface/endosomal HS. In this way initial steps in the reverse cholesterol transport pathway are focused at sites of injury to mobilize cholesterol from macrophages that are actively participating in the phagocytosis of damaged membranes rich in cholesterol. The mechanism may also be of relevance to aspects of atherogenesis.	[Tam, Shui-Pang; Kisilevsky, Robert; Ancsin, John B.] Queens Univ, Kingston Gen Hosp, Syl & Molly Apps Res Ctr, Dept Pathol & Mol Med, Kingston, ON, Canada; [Kisilevsky, Robert] Queens Univ, Dept Biochem, Syl & Molly Apps Res Ctr, Kingston Gen Hosp, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada; Queens University - Canada	Tam, SP (corresponding author), Queens Univ, Kingston Gen Hosp, Syl & Molly Apps Res Ctr, Dept Pathol & Mol Med, Kingston, ON, Canada.	3jba1@queensu.ca	Eckhardt, Erik/G-1567-2010		Canadian Institutes of Health Research [MOP-3153]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grant MOP-3153 from the Canadian Institutes of Health Research. The granting agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; AXELRAD MA, 1982, LAB INVEST, V47, P139; BANKA CL, 1995, J LIPID RES, V36, P1058; Barter PJ, 2006, CURR OPIN LIPIDOL, V17, P399, DOI 10.1097/01.mol.0000236365.40969.af; BENDITT EP, 1971, FEBS LETT, V19, P169, DOI 10.1016/0014-5793(71)80506-9; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; BENDITT EP, 1982, ANN NY ACAD SCI, V389, P183, DOI 10.1111/j.1749-6632.1982.tb22136.x; Benjwal S, 2005, BIOCHEMISTRY-US, V44, P10218, DOI 10.1021/bi050781m; Cabana VG, 1996, J LIPID RES, V37, P2662; CABANA VG, 1989, J LIPID RES, V30, P39; CEVC G, 1990, BIOCHIM BIOPHYS ACTA, V1031, P311, DOI 10.1016/0304-4157(90)90015-5; CLIFTON PM, 1985, J LIPID RES, V26, P1389; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Ely S, 2001, AMYLOID, V8, P169, DOI 10.3109/13506120109007360; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GEISOW MJ, 1984, EXP CELL RES, V150, P36, DOI 10.1016/0014-4827(84)90699-2; Graversen JH, 2008, LIPIDS, V43, P467, DOI 10.1007/s11745-008-3169-2; Han CY, 2006, ARTERIOSCL THROM VAS, V26, P1806, DOI 10.1161/01.ATV.0000227472.70734.ad; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hayat S, 1997, BIOCHEM SOC T, V25, pS348, DOI 10.1042/bst025348s; Hayat S, 2000, SCAND J IMMUNOL, V51, P141; Jayaraman S, 2006, BIOCHEMISTRY-US, V45, P4620, DOI 10.1021/bi0524565; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Kinkley SM, 2006, AMYLOID, V13, P123, DOI 10.1080/13506120600877201; Kisilevsky R, 2003, J LIPID RES, V44, P2257, DOI 10.1194/jlr.M300133-JLR200; KISILEVSKY R, 1992, LAB INVEST, V66, P778; Kisilevsky R, 2008, CURR OPIN INVEST DR, V9, P265; Kluve-Beckerman B, 2001, SCAND J IMMUNOL, V53, P393, DOI 10.1046/j.1365-3083.2001.00879.x; LEVIN M, 1972, J CLIN INVEST, V51, P2773, DOI 10.1172/JCI107098; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lindahl B, 1997, J BIOL CHEM, V272, P26091, DOI 10.1074/jbc.272.42.26091; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; Manley PN, 2006, MED HYPOTHESES, V66, P784, DOI 10.1016/j.mehy.2005.10.018; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Navarro MA, 2005, CYTOKINE, V31, P52, DOI 10.1016/j.cyto.2005.03.002; Rader DJ, 2007, NAT CLIN PRACT CARD, V4, P102, DOI 10.1038/ncpcardio0768; Rocken C, 1997, AMYLOID, V4, P259, DOI 10.3109/13506129709003837; Tam SP, 2005, J LIPID RES, V46, P2091, DOI 10.1194/jlr.M500191-JLR200; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; TAPE C, 1990, BIOCHIM BIOPHYS ACTA, V1043, P295, DOI 10.1016/0005-2760(90)90030-2; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737; YOKOYAMA S, 1982, J BIOCHEM, V91, P1267, DOI 10.1093/oxfordjournals.jbchem.a133811	48	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3867	10.1371/journal.pone.0003867	http://dx.doi.org/10.1371/journal.pone.0003867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057652	Green Published, gold, Green Submitted			2022-12-25	WOS:000265452300007
J	Tian, C; Kosoy, R; Lee, A; Ransom, M; Belmont, JW; Gregersen, PK; Seldin, MF				Tian, Chao; Kosoy, Roman; Lee, Annette; Ransom, Michael; Belmont, John W.; Gregersen, Peter K.; Seldin, Michael F.			Analysis of East Asia Genetic Substructure Using Genome-Wide SNP Arrays	PLOS ONE			English	Article								Accounting for population genetic substructure is important in reducing type 1 errors in genetic studies of complex disease. As efforts to understand complex genetic disease are expanded to different continental populations the understanding of genetic substructure within these continents will be useful in design and execution of association tests. In this study, population differentiation (Fst) and Principal Components Analyses (PCA) are examined using >200 K genotypes from multiple populations of East Asian ancestry. The population groups included those from the Human Genome Diversity Panel [Cambodian, Yi, Daur, Mongolian, Lahu, Dai, Hezhen, Miaozu, Naxi, Oroqen, She, Tu, Tujia, Naxi, Xibo, and Yakut], HapMap [ Han Chinese (CHB) and Japanese (JPT)], and East Asian or East Asian American subjects of Vietnamese, Korean, Filipino and Chinese ancestry. Paired Fst (Wei and Cockerham) showed close relationships between CHB and several large East Asian population groups (CHB/Korean, 0.0019; CHB/JPT, 00651; CHB/Vietnamese, 0.0065) with larger separation with Filipino (CHB/Filipino, 0.014). Low levels of differentiation were also observed between Dai and Vietnamese (0.0045) and between Vietnamese and Cambodian (0.0062). Similarly, small Fst's were observed among different presumed Han Chinese populations originating in different regions of mainland of China and Taiwan (Fst's <0.0025 with CHB). For PCA, the first two PC's showed a pattern of relationships that closely followed the geographic distribution of the different East Asian populations. PCA showed substructure both between different East Asian groups and within the Han Chinese population. These studies have also identified a subset of East Asian substructure ancestry informative markers (EASTASAIMS) that may be useful for future complex genetic disease association studies in reducing type 1 errors and in identifying homogeneous groups that may increase the power of such studies.	[Tian, Chao; Kosoy, Roman; Ransom, Michael; Seldin, Michael F.] Univ Calif Davis, Dept Biochem, Rowe Program Human Genet, Davis, CA 95616 USA; [Lee, Annette; Gregersen, Peter K.] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; [Belmont, John W.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX USA	University of California System; University of California Davis; Northwell Health; Baylor College of Medicine	Tian, C (corresponding author), Univ Calif Davis, Dept Biochem, Rowe Program Human Genet, Davis, CA 95616 USA.	mfseldin@ucdavis.edu	Belmont, John/AAH-6084-2021; Belmont, John W/AAI-2494-2019	Belmont, John W/0000-0001-7409-3578	NIH [DK071185, AR050267, AR44422]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050267, R01AR044422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK071185, AR050267, and AR44422.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2003, NATURE, V426, P789; BALLINGER SW, 1992, GENETICS, V130, P139; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Belkhir K, 2001, 5000 CNRS UMR U MONT; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; CAVALLISFORZA LL, 1996, HIST GEOGRAPHY HUMAN, pR13; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Ding YC, 2000, P NATL ACAD SCI USA, V97, P14003, DOI 10.1073/pnas.240441297; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Falush D, 2003, GENETICS, V164, P1567; Hellenthal G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000078; Hollander M., 1973, NONPARAMETRIC STAT M, P115; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kobayashi S, 2008, ARTHRITIS RHEUM, V58, P1940, DOI 10.1002/art.23494; KOSOY R, HUMAN MUTAT IN PRESS; Lee HS, 2007, MOL MED, V13, P455, DOI 10.2119/2007-00072.Lee; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lin YJ, 2007, GENES IMMUN, V8, P302, DOI 10.1038/sj.gene.6364387; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; NEI M, 1993, MOL BIOL EVOL, V10, P927; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Seldin MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040005; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shin HD, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2152; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zhang F, 2007, PHILOS T R SOC B, V362, P987, DOI 10.1098/rstb.2007.2028	39	93	94	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3862	10.1371/journal.pone.0003862	http://dx.doi.org/10.1371/journal.pone.0003862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057645	Green Published, gold, Green Submitted			2022-12-25	WOS:000265452300004
J	Lu, H; Patil, P; Van Sluys, MA; White, FF; Ryan, RP; Dow, JM; Rabinowicz, P; Salzberg, SL; Leach, JE; Sonti, R; Brendel, V; Bogdanove, AJ				Lu, Hong; Patil, Prabhu; Van Sluys, Marie-Anne; White, Frank F.; Ryan, Robert P.; Dow, J. Maxwell; Rabinowicz, Pablo; Salzberg, Steven L.; Leach, Jan E.; Sonti, Ramesh; Brendel, Volker; Bogdanove, Adam J.			Acquisition and Evolution of Plant Pathogenesis-Associated Gene Clusters and Candidate Determinants of Tissue-Specificity in Xanthomonas	PLOS ONE			English	Article							ORYZAE PV.-ORYZAE; EXTRACELLULAR POLYSACCHARIDE PRODUCTION; PATHOGENICITY FACTOR PRODUCTION; CAMPESTRIS PATHOVAR CAMPESTRIS; OUTER-MEMBRANE PROTEIN; GYP DOMAIN PROTEIN; GENOME SEQUENCE; XANTHAN PRODUCTION; ESCHERICHIA-COLI; II SECRETION	Background: Xanthomonas is a large genus of plant-associated and plant-pathogenic bacteria. Collectively, members cause diseases on over 392 plant species. Individually, they exhibit marked host- and tissue-specificity. The determinants of this specificity are unknown. Methodology/Principal Findings: To assess potential contributions to host- and tissue-specificity, pathogenesis-associated gene clusters were compared across genomes of eight Xanthomonas strains representing vascular or non-vascular pathogens of rice, brassicas, pepper and tomato, and citrus. The gum cluster for extracellular polysaccharide is conserved except for gumN and sequences downstream. The xcs and xps clusters for type II secretion are conserved, except in the rice pathogens, in which xcs is missing. In the otherwise conserved hrp cluster, sequences flanking the core genes for type III secretion vary with respect to insertion sequence element and putative effector gene content. Variation at the rpf (regulation of pathogenicity factors) cluster is more pronounced, though genes with established functional relevance are conserved. A cluster for synthesis of lipopolysaccharide varies highly, suggesting multiple horizontal gene transfers and reassortments, but this variation does not correlate with host- or tissue-specificity. Phylogenetic trees based on amino acid alignments of gum, xps, xcs, hrp, and rpf cluster products generally reflect strain phylogeny. However, amino acid residues at four positions correlate with tissue specificity, revealing hpaA and xpsD as candidate determinants. Examination of genome sequences of xanthomonads Xylella fastidiosa and Stenotrophomonas maltophilia revealed that the hrp, gum, and xcs clusters are recent acquisitions in the Xanthomonas lineage. Conclusions/Significance: Our results provide insight into the ancestral Xanthomonas genome and indicate that differentiation with respect to host- and tissue-specificity involved not major modifications or wholesale exchange of clusters, but subtle changes in a small number of genes or in non-coding sequences, and/or differences outside the clusters, potentially among regulatory targets or secretory substrates.	[Lu, Hong; Brendel, Volker] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Patil, Prabhu; Sonti, Ramesh] Council Sci & Indust Res, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Van Sluys, Marie-Anne] IB USP, Dept Bot, Sao Paulo, Brazil; [White, Frank F.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Ryan, Robert P.; Dow, J. Maxwell] Univ Coll Cork, BioSci Inst, BIOMERIT Res Ctr, Cork, Ireland; [Rabinowicz, Pablo] Inst Genom Res, Rockville, MD USA; [Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Van Sluys, Marie-Anne; Leach, Jan E.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Brendel, Volker] Iowa State Univ, Dept Stat, Ames, IA 50011 USA; [Bogdanove, Adam J.] Iowa State Univ, Dept Plant Pathol, Ames, IA 50011 USA	Iowa State University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Kansas State University; University College Cork; J. Craig Venter Institute; University System of Maryland; University of Maryland College Park; Colorado State University; Iowa State University; Iowa State University	Lu, H (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	ajbog@iastate.edu	Patil, Prabhu/B-4070-2010; Bogdanove, Adam/ABE-6252-2020; Lu, Hong/F-2744-2015; Salzberg, Steven/Q-6514-2019; Van Sluys, Marie-Anne/A-8483-2012; Hong, LU/HDM-0673-2022; Salzberg, Steven L/F-6162-2011	Lu, Hong/0000-0002-4026-4292; Salzberg, Steven/0000-0002-8859-7432; Van Sluys, Marie-Anne/0000-0002-6506-2734; Salzberg, Steven L/0000-0002-8859-7432; Dow, Max/0000-0001-8245-2294; Ryan, Rober/0000-0002-7353-0913	U.S. Department of Agriculture-National Science Foundation Microbial Genome Sequencing Program [20043560015022]; Science Foundation of Ireland [Principal Investigator Award]; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	U.S. Department of Agriculture-National Science Foundation Microbial Genome Sequencing Program; Science Foundation of Ireland(Science Foundation Ireland); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Support for this study was provided by the U.S. Department of Agriculture-National Science Foundation Microbial Genome Sequencing Program (20043560015022 to AB, JL, SS, and FW) and through a Principal Investigator Award from the Science Foundation of Ireland to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLAT M, 1991, MOL PLANT MICROBE IN, V4, P593, DOI 10.1094/MPMI-4-593; Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; Bedini E, 2005, J AM CHEM SOC, V127, P2414, DOI 10.1021/ja0452166; Berg G, 1999, J CLIN MICROBIOL, V37, P3594, DOI 10.1128/JCM.37.11.3594-3600.1999; Bhattacharyya A, 2002, P NATL ACAD SCI USA, V99, P12403, DOI 10.1073/pnas.132393999; BIRCH RG, 1987, PHYSIOL MOL PLANT P, V30, P199, DOI 10.1016/0885-5765(87)90033-6; BIRCH RG, 1987, PHYSIOL MOL PLANT P, V30, P207, DOI 10.1016/0885-5765(87)90034-8; Blanch M, 2008, J PLANT PHYSIOL, V165, P366, DOI 10.1016/j.jplph.2007.03.008; Bogdanove AJ, 1996, MOL MICROBIOL, V20, P681, DOI 10.1046/j.1365-2958.1996.5731077.x; Boon C, 2008, ISME J, V2, P27, DOI 10.1038/ISMEJ.2007.76; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Brosch R, 2001, TRENDS MICROBIOL, V9, P452, DOI 10.1016/S0966-842X(01)02131-X; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buttner D, 2006, MOL MICROBIOL, V59, P513, DOI 10.1111/j.1365-2958.2005.04924.x; Champoiseau P, 2006, PHYTOPATHOLOGY, V96, P1081, DOI 10.1094/PHYTO-96-1081; Chatterjee S, 2002, MOL PLANT MICROBE IN, V15, P463, DOI 10.1094/MPMI.2002.15.5.463; Chen LY, 1996, J BIOL CHEM, V271, P2703, DOI 10.1074/jbc.271.5.2703; Chen Y, 2005, J BIOL CHEM, V280, P42356, DOI 10.1074/jbc.M506843200; Simionato AVC, 2007, J MASS SPECTROM, V42, P490, DOI 10.1002/jms.1181; Comas I, 2006, MOL BIOL EVOL, V23, P2049, DOI 10.1093/molbev/msl075; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; da Silva FR, 2001, FEMS MICROBIOL LETT, V203, P165, DOI 10.1111/j.1574-6968.2001.tb10836.x; DANIELS MJ, 1989, GENETICS BACTERIAL D, P353; DENFERT C, 1987, EMBO J, V6, P3531, DOI 10.1002/j.1460-2075.1987.tb02679.x; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Dharmapuri S, 2001, MOL PLANT MICROBE IN, V14, P1335, DOI 10.1094/MPMI.2001.14.11.1335; Dharmapuri S, 1999, FEMS MICROBIOL LETT, V179, P53, DOI 10.1111/j.1574-6968.1999.tb08707.x; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dow JM, 2000, MICROBIOL-SGM, V146, P885, DOI 10.1099/00221287-146-4-885; DOW JM, 1989, J CELL SCI, P59; Dow JM, 2000, YEAST, V17, P263, DOI 10.1002/1097-0061(200012)17:4&lt;263::AID-YEA44&gt;3.0.CO;2-G; DUMS F, 1991, MOL GEN GENET, V229, P357, DOI 10.1007/BF00267456; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; FELSENSTEIN J, 2007, PHYLIP PHYLOGENY INF; Fontaniella B, 2002, J CHROMATOGR B, V770, P275, DOI 10.1016/S1570-0232(01)00579-7; Fouhy Y, 2007, J BACTERIOL, V189, P4964, DOI 10.1128/JB.00310-07; Goncalves ER, 2002, INT J SYST EVOL MICR, V52, P355, DOI 10.1099/00207713-52-2-355; Gupta RS, 2007, J MOL EVOL, V64, P90, DOI 10.1007/s00239-006-0082-2; HARDING NE, 1987, J BACTERIOL, V169, P2854, DOI 10.1128/jb.169.6.2854-2861.1987; Hayward A. C., 1993, Xanthomonas., P1; Huguet E, 1998, MOL MICROBIOL, V29, P1379, DOI 10.1046/j.1365-2958.1998.01019.x; KAMOUN S, 1990, APPL ENVIRON MICROB, V56, P3855, DOI 10.1128/AEM.56.12.3855-3860.1990; Katzen F, 1998, J BACTERIOL, V180, P1607, DOI 10.1128/JB.180.7.1607-1617.1998; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Kiraly Z, 1997, J PHYTOPATHOL, V145, P59, DOI 10.1111/j.1439-0434.1997.tb00365.x; KOPLIN R, 1992, J BACTERIOL, V174, P191; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; LEITE RP, 1994, APPL ENVIRON MICROB, V60, P1068, DOI 10.1128/AEM.60.4.1068-1077.1994; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Lima WC, 2008, FEMS MICROBIOL LETT, V281, P87, DOI 10.1111/j.1574-6968.2008.01083.x; LIMA WC, 2005, J INTEGRATIVE BIOL, V9, P160; Lindeberg M, 1996, MOL MICROBIOL, V20, P175, DOI 10.1111/j.1365-2958.1996.tb02499.x; Lorenz C, 2008, MOL MICROBIOL, V69, P344, DOI 10.1111/j.1365-2958.2008.06280.x; Mackey D, 2006, MOL MICROBIOL, V61, P1365, DOI 10.1111/j.1365-2958.2006.05311.x; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mooi FR, 1997, TRENDS MICROBIOL, V5, P161, DOI 10.1016/S0966-842X(96)10086-X; Moore ERB, 1997, FEMS MICROBIOL LETT, V151, P145, DOI 10.1016/S0378-1097(97)00152-3; Moreira LM, 2004, ANNU REV PHYTOPATHOL, V42, P163, DOI 10.1146/annurev.phyto.42.040803.140310; Newman MA, 2001, EUR J PLANT PATHOL, V107, P95, DOI 10.1023/A:1008738817551; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275, DOI 10.6090/jarq.39.275; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Patil PB, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-40; Patil PB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-243; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; POSSOT O, 1992, MOL MICROBIOL, V6, P95, DOI 10.1111/j.1365-2958.1992.tb00841.x; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rademaker JLW, 2005, PHYTOPATHOLOGY, V95, P1098, DOI 10.1094/PHYTO-95-1098; Rademaker JLW, 2000, INT J SYST EVOL MICR, V50, P665, DOI 10.1099/00207713-50-2-665; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Ray SK, 2002, MOL MICROBIOL, V46, P637, DOI 10.1046/j.1365-2958.2002.03188.x; Raymundo A. K., 1993, Philippine Journal of Biotechnology, V4, P29; Reeves PP, 2002, CURR TOP MICROBIOL, V264, P109; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Scarpari LM, 2003, FEMS MICROBIOL LETT, V222, P83, DOI 10.1016/S0378-1097(03)00251-9; Siciliano F, 2006, ELECTRON J BIOTECHN, V9, P199, DOI 10.2225/vol9-issue3-fulltext-20; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Steinmann D, 1997, ARCH MICROBIOL, V168, P441, DOI 10.1007/s002030050520; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Sugio A, 2005, MOL PLANT MICROBE IN, V18, P546, DOI 10.1094/MPMI-18-0546; Sun QH, 2005, PLANT PATHOL, V54, P15, DOI 10.1111/j.1365-3059.2004.01101.x; Tang JL, 1996, MOL PLANT MICROBE IN, V9, P664, DOI 10.1094/MPMI-9-0664; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toth IK, 2006, ANNU REV PHYTOPATHOL, V44, P305, DOI 10.1146/annurev.phyto.44.070505.143444; Tsuge S, 2005, J BACTERIOL, V187, P2308, DOI 10.1128/JB.187.7.2308-2314.2005; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; VANDERSLICE RW, 1989, BIOMEDICAL AND BIOTECHNOLOGICAL ADVANCES IN INDUSTRIAL POLYSACCHARIDES, P145; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vorhoelter FJ, 2008, J BIOTECHNOL, V134, P33, DOI 10.1016/j.jbiotec.2007.12.013; Vorholter FJ, 2001, MOL GENET GENOMICS, V266, P79, DOI 10.1007/s004380100521; Wang LH, 2004, MOL MICROBIOL, V51, P903, DOI 10.1046/j.1365-2958.2003.03883.x; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Weber E, 2005, J BACTERIOL, V187, P6175, DOI 10.1128/JB.187.17.6175-6186.2005; Wilson TJG, 1998, MOL MICROBIOL, V28, P961, DOI 10.1046/j.1365-2958.1998.00852.x; Yoon KH, 2007, BIOTECHNOL LETT, V29, P95, DOI 10.1007/s10529-006-9217-1	112	72	77	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3828	10.1371/journal.pone.0003828	http://dx.doi.org/10.1371/journal.pone.0003828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043590	Green Published, gold, Green Submitted			2022-12-25	WOS:000265451500008
J	Saenz, A; Azpitarte, M; Armananzas, R; Leturcq, F; Alzualde, A; Inza, I; Garcia-Bragado, F; De la Herran, G; Corcuera, J; Cabello, A; Navarro, C; De la Torre, C; Gallardo, E; Illa, I; de Munain, AL				Saenz, Amets; Azpitarte, Margarita; Armananzas, Ruben; Leturcq, France; Alzualde, Ainhoa; Inza, Inaki; Garcia-Bragado, Federico; De la Herran, Gaspar; Corcuera, Julian; Cabello, Ana; Navarro, Carmen; De la Torre, Carolina; Gallardo, Eduard; Illa, Isabel; Lopez de Munain, Adolfo			Gene Expression Profiling in Limb-Girdle Muscular Dystrophy 2A	PLOS ONE			English	Article								Limb-girdle muscular dystrophy type 2A (LGMD2A) is a recessive genetic disorder caused by mutations in calpain 3 (CAPN3). Calpain 3 plays different roles in muscular cells, but little is known about its functions or in vivo substrates. The aim of this study was to identify the genes showing an altered expression in LGMD2A patients and the possible pathways they are implicated in. Ten muscle samples from LGMD2A patients with in which molecular diagnosis was ascertained were investigated using array technology to analyze gene expression profiling as compared to ten normal muscle samples. Upregulated genes were mostly those related to extracellular matrix (different collagens), cell adhesion (fibronectin), muscle development (myosins and melusin) and signal transduction. It is therefore suggested that different proteins located or participating in the costameric region are implicated in processes regulated by calpain 3 during skeletal muscle development. Genes participating in the ubiquitin proteasome degradation pathway were found to be deregulated in LGMD2A patients, suggesting that regulation of this pathway may be under the control of calpain 3 activity. As frizzled-related protein (FRZB) is upregulated in LGMD2A muscle samples, it could be hypothesized that beta-catenin regulation is also altered at the Wnt signaling pathway, leading to an incorrect myogenesis. Conversely, expression of most transcription factor genes was downregulated (MYC, FOS and EGR1). Finally, the upregulation of IL-32 and immunoglobulin genes may induce the eosinophil chemoattraction explaining the inflammatory findings observed in presymptomatic stages. The obtained results try to shed some light on identification of novel therapeutic targets for limb-girdle muscular dystrophies.	[Saenz, Amets; Azpitarte, Margarita; Alzualde, Ainhoa] Hosp Donostia, Expt Unit, Donostia San Sebastian, Basque Country, Spain; [Armananzas, Ruben; Inza, Inaki] Univ Basque Country, Comp Sci Fac, Department of Comp Sci & Artificial Intelligence, San Sebastian, Spain; [Leturcq, France] Hop Cochin, Groupe Hosp Pitie Salpetriere, Lab Biochim Genet Mol, Paris, France; [Garcia-Bragado, Federico] Hosp Virgen Camino, Dept Pathol, Pamplona, Spain; [De la Herran, Gaspar; Corcuera, Julian] Hosp Donostia, Dept Orthoped Surg, San Sebastian, Spain; [Cabello, Ana] Hosp 12 Octubre, Dept Pathol, Madrid, Spain; [Navarro, Carmen] Hosp Meixoeiro, Dept Pathol, Vigo, Spain; [De la Torre, Carolina; Gallardo, Eduard] Hosp Santa Creu & Sant Pau, Lab Expt Neurol, Barcelona, Spain; [Illa, Isabel] Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona, Spain; [Lopez de Munain, Adolfo] Hosp Donostia, Dept Neurol, San Sebastian, Spain	University Hospital Donostia; University of Basque Country; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; University Hospital Donostia; Hospital Universitario 12 de Octubre; Complexo Hospitalario Universitario de Vigo; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; University Hospital Donostia	Saenz, A (corresponding author), Hosp Donostia, Expt Unit, Donostia San Sebastian, Basque Country, Spain.	amets.saenzpena@osakidetza.net	ILLA, Isabel/AAD-1816-2019; Sáenz, Amets/E-4761-2019; Armañanzas, Rubén/C-2735-2013; De La Torre Gómez, Carolina/AAP-1738-2020; Armañanzas, Rubén/O-7403-2019; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Navarro, Carmen/A-9210-2012	Sáenz, Amets/0000-0002-0704-1150; Armañanzas, Rubén/0000-0003-4049-0000; De La Torre Gómez, Carolina/0000-0001-9363-291X; Armañanzas, Rubén/0000-0003-4049-0000; INZA CANO, INAKI/0000-0003-4674-1755; Gallardo, Eduard/0000-0002-3942-3436; /0000-0002-9509-4032	Health Research Fund of the Spanish Ministry of Health [FIS CP06/00099]; Gipuzkoako Foru Aldundia (Berrikuntzarako eta Jakintzaren Gizarterako Departamentua [76/06]; European Union; Instituto de Salud Carlos III; Basque Foundation for Health Innovation and Research (BIOEF); Basque Government [AE-BFI-05/430]	Health Research Fund of the Spanish Ministry of Health(Instituto de Salud Carlos III); Gipuzkoako Foru Aldundia (Berrikuntzarako eta Jakintzaren Gizarterako Departamentua; European Union(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Basque Foundation for Health Innovation and Research (BIOEF); Basque Government(Basque Government)	Health Research Fund of the Spanish Ministry of Health (FIS CP06/00099); Gipuzkoako Foru Aldundia (Berrikuntzarako eta Jakintzaren Gizarterako Departamentua, 76/06); European Union (FEDER Funds and CIBERNED); Instituto de Salud Carlos III. AS: Spanish Ministry of Health (FIS) and Basque Foundation for Health Innovation and Research (BIOEF) promoted by the Basque Government Department of Health. RA: Basque Government (AE-BFI-05/430).	ARAHATA K, 1995, MUSCLE NERVE, pS56; Baghdiguian S, 2001, J MOL MED, V79, P254, DOI 10.1007/s001090100225; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Bakay M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-4; Baldwin KM, 2002, AM J PHYS MED REHAB, V81, pS40, DOI 10.1097/00002060-200211001-00006; Belkin AM, 1996, J CELL BIOL, V132, P211, DOI 10.1083/jcb.132.1.211; Benayoun B, 2008, FASEB J, V22, P1521, DOI 10.1096/fj.07-8701com; Bolstad B, 2005, BIOINFORMATICS COMPU; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brancaccio M, 1999, J BIOL CHEM, V274, P29282, DOI 10.1074/jbc.274.41.29282; Cai BY, 2000, AM J PATHOL, V156, P1789, DOI 10.1016/S0002-9440(10)65050-X; Campanaro S, 2002, HUM MOL GENET, V11, P3283, DOI 10.1093/hmg/11.26.3283; Campbell KP, 2003, J BIOL CHEM, V278, P12599, DOI 10.1074/jbc.R300005200; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Diaz BEG, 2006, BIOCHEMISTRY-US, V45, P3714, DOI 10.1021/bi051917j; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Duda R.O., 2000, PATTERN CLASSIFICATI; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Figarella-Branger D, 2002, NEUROMUSCULAR DISORD, V12, P4, DOI 10.1016/S0960-8966(01)00245-0; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Gallardo E, 2001, NEUROLOGY, V57, P2136, DOI 10.1212/WNL.57.11.2136; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Guyon JR, 2003, MUSCLE NERVE, V28, P472, DOI 10.1002/mus.10465; Hall MA, 1997, P 4 INT C NEUR INF P, P855; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; Hayashi C, 2008, J BIOL CHEM, V283, P14801, DOI 10.1074/jbc.M708262200; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kang PB, 2005, MUSCLE NERVE, V32, P483, DOI 10.1002/mus.20356; KARSCHMIZRACHI I, 1989, NUCLEIC ACIDS RES, V17, P6167, DOI 10.1093/nar/17.15.6167; Keira Y, 2007, NEUROSCI RES, V57, P513, DOI 10.1016/j.neures.2006.12.010; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kinbara K, 1998, BIOCHEM PHARMACOL, V56, P415; Krahn M, 2006, ANN NEUROL, V59, P905, DOI 10.1002/ana.20833; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2006, MOL CELL BIOL, V26, P8437, DOI 10.1128/MCB.01296-06; Marotta M, 2007, NEUROMUSCULAR DISORD, V17, P707, DOI 10.1016/j.nmd.2007.05.007; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Noguchi S, 2003, HUM MOL GENET, V12, P595, DOI 10.1093/hmg/ddg065; Olive M, 1997, NEUROPATH APPL NEURO, V23, P475, DOI 10.1111/j.1365-2990.1997.tb01324.x; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Saenz A, 2005, BRAIN, V128, P732, DOI 10.1093/brain/awh408; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Taniguchi M, 2006, BIOCHEM BIOPH RES CO, V342, P489, DOI 10.1016/j.bbrc.2005.12.224; von der Hagen M, 2005, NEUROMUSCULAR DISORD, V15, P863, DOI 10.1016/j.nmd.2005.09.002; Wang Y, 2005, COMPUT BIOL CHEM, V29, P37, DOI 10.1016/j.compbiolchem.2004.11.001; Weinstock A, 1997, J CHILD NEUROL, V12, P146, DOI 10.1177/088307389701200214; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Wu G, 2004, MOL CELL, V13, P451, DOI 10.1016/S1097-2765(04)00090-5; Zhou XD, 2006, ARTHRITIS RHEUM-US, V54, P2626, DOI 10.1002/art.21973	60	35	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3750	10.1371/journal.pone.0003750	http://dx.doi.org/10.1371/journal.pone.0003750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015733	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000265448400007
J	Fustin, JM; Dardente, H; Wagner, GC; Carter, DA; Johnston, JD; Lincoln, GA; Hazlerigg, DG				Fustin, J. M.; Dardente, H.; Wagner, G. C.; Carter, D. A.; Johnston, J. D.; Lincoln, G. A.; Hazlerigg, D. G.			Egr1 involvement in evening gene regulation by melatonin	FASEB JOURNAL			English	Article						pars tuberalis; clock gene; cryptochrome; photoperiod; circadian	HORMONE-BETA-GENE; DECODING PHOTOPERIODIC TIME; EARLY GROWTH RESPONSE-1; STEROIDOGENIC FACTOR-I; OVINE PARS TUBERALIS; PITUITARY HOMEOBOX 1; NGFI-A; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION FACTORS; BINDING-SITES	Seasonal photoperiodic responses in mammals depend on the pineal hormone melatonin. The pars tuberalis (PT) region of the anterior pituitary has emerged as a principal melatonin target tissue, controlling endocrine responses. Rising melatonin levels acutely influence the expression of a small cluster of genes either positively (exemplified by cryptochrome-1, cry1) or negatively (exemplified by the type 1 melatonin receptor, mt1). The purpose of this study was to characterize the pathways through which these evening actions of melatonin are mediated. In vitro experiments showed that cAMP signaling in the PT directly influences mt1 but not cry1 expression. Analysis of nuclear extracts from sheep PT tissue collected 90 min after melatonin or saline control injections highlighted the response element for the immediate early gene egr1 (EGR1-RE) as a candidate for acute melatonin-dependent transcriptional regulation. We identified putative EGR1-RE's in the proximal promoter regions of the ovine cry1 and mt1 genes, and confirmed their functionality in luciferase reporter assays. Egr1 expression is suppressed by melatonin in PT cell cultures, and is rhythmic in the ovine PT with a nadir in the early night. We propose that melatonin-dependent effects on EGR1-RE's contribute to evening gene expression profiles in this pituitary melatonin target tissue.-Fustin J. M., Dardente H., Wagner G. C., Carter D. A., Johnston J. D., Lincoln G. A., Hazlerigg D. G. Egr1 involvement in evening gene regulation by melatonin. FASEB J. 23, 764-773 (2009)	[Fustin, J. M.; Dardente, H.; Wagner, G. C.; Hazlerigg, D. G.] Univ Aberdeen, Sch Biol Sci, Dept Zool, Aberdeen AB24 2TZ, Scotland; [Johnston, J. D.] Univ Surrey, Guildford GU2 5XH, Surrey, England; [Lincoln, G. A.] Univ Edinburgh, Ctr Reprod Biol, Queens Med Res Inst, Edinburgh EH3 9EW, Midlothian, Scotland	University of Aberdeen; University of Surrey; University of Edinburgh	Hazlerigg, DG (corresponding author), Univ Aberdeen, Sch Biol Sci, Dept Zool, Tillydrone Ave, Aberdeen AB24 2TZ, Scotland.	d.hazlerigg@abdn.ac.uk	Fustin, Jean-Michel/R-6621-2019; DARDENTE, Hugues/ABI-5590-2020; Carter, David/A-4479-2010; Johnston, Jonathan D/H-6363-2011; Johnston, Jonathan/AAS-6969-2021	Fustin, Jean-Michel/0000-0002-6200-6075; DARDENTE, Hugues/0000-0001-7209-5940; Carter, David/0000-0002-8419-3975; Johnston, Jonathan D/0000-0001-8083-9794; 	Aberdeen University College of Life Science and Medicine; UK Biotechnology and Biological Sciences Research Council; MRC [G0600678, G9724886] Funding Source: UKRI; Medical Research Council [G0600678, G9724886] Funding Source: researchfish	Aberdeen University College of Life Science and Medicine; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the Aberdeen University College of Life Science and Medicine and the UK Biotechnology and Biological Sciences Research Council for financial support, and Jacques Tremblay (Laval University, Quebec, QC, Canada) for the PITX1 expression vector. The authors thank the Marshall Building animal care staff and Mr. M. Birnie for excellent technical support.	Barrett P, 1997, BBA-MOL CELL RES, V1356, P299, DOI 10.1016/S0167-4889(96)00179-6; Barrett P, 2003, J PINEAL RES, V35, P221, DOI 10.1034/j.1600-079X.2003.00090.x; Barrett P, 1996, MOL ENDOCRINOL, V10, P892, DOI 10.1210/me.10.7.892; Dardente H, 2003, MOL BRAIN RES, V114, P101, DOI 10.1016/S0169-328X(03)00134-7; Donovan MJ, 1999, DEV GENET, V24, P252, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<252::AID-DVG8>3.0.CO;2-K; Dorn C, 1999, J BIOL CHEM, V274, P13870, DOI 10.1074/jbc.274.20.13870; Drouin J, 1998, MOL CELL ENDOCRINOL, V140, P31, DOI 10.1016/S0303-7207(98)00026-4; Dupre SM, 2008, ENDOCRINOLOGY, V149, P5527, DOI 10.1210/en.2008-0834; Esumi N, 2007, J BIOL CHEM, V282, P1838, DOI 10.1074/jbc.M609517200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Halvorson LM, 1998, J BIOL CHEM, V273, P14712, DOI 10.1074/jbc.273.24.14712; Hazlerigg DG, 2001, J BIOL RHYTHM, V16, P326, DOI 10.1177/074873001129002042; HAZLERIGG DG, 1993, ENDOCRINOLOGY, V132, P285, DOI 10.1210/en.132.1.285; Johnston JD, 2006, ENDOCRINOLOGY, V147, P959, DOI 10.1210/en.2005-1100; Johnston JD, 2003, P NATL ACAD SCI USA, V100, P2831, DOI 10.1073/pnas.0436184100; Johnston JD, 2007, MOL CELL ENDOCRINOL, V268, P59, DOI 10.1016/j.mce.2007.01.015; Kaiser UB, 2000, MOL ENDOCRINOL, V14, P1235, DOI 10.1210/me.14.8.1235; Kilduff TS, 1998, J BIOL RHYTHM, V13, P347, DOI 10.1177/074873098129000174; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Lanctot C, 1999, ENDOCRINOLOGY, V140, P1416, DOI 10.1210/en.140.3.1416; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Lin JT, 1997, MOL BRAIN RES, V46, P303, DOI 10.1016/S0169-328X(97)00005-3; Lincoln G, 2002, P NATL ACAD SCI USA, V99, P13890, DOI 10.1073/pnas.212517599; Lincoln GA, 2006, SCIENCE, V314, P1941, DOI 10.1126/science.1132009; Messager S, 2001, NEUROREPORT, V12, P579, DOI 10.1097/00001756-200103050-00029; Messager S, 1999, P NATL ACAD SCI USA, V96, P9938, DOI 10.1073/pnas.96.17.9938; Morgan PJ, 1998, J NEUROENDOCRINOL, V10, P319, DOI 10.1046/j.1365-2826.1998.00232.x; MORGAN PJ, 1995, J NEUROENDOCRINOL, V7, P361, DOI 10.1111/j.1365-2826.1995.tb00770.x; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Tanaka M, 1999, EUR J NEUROSCI, V11, P3178, DOI 10.1046/j.1460-9568.1999.00739.x; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; Wagner GC, 2008, ENDOCRINOLOGY, V149, P32, DOI 10.1210/en.2007-0658	36	25	26	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					764	773		10.1096/fj.08-121467	http://dx.doi.org/10.1096/fj.08-121467			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19019852				2022-12-25	WOS:000265506300012
J	Nightingale, TD; Frayne, MEF; Clasper, S; Banerji, S; Jackson, DG				Nightingale, Thomas D.; Frayne, Matthew E. F.; Clasper, Steven; Banerji, Suneale; Jackson, David G.			A Mechanism of Sialylation Functionally Silences the Hyaluronan Receptor LYVE-1 in Lymphatic Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLATION MUTANTS; ADHESION MOLECULES; N-GLYCOSYLATION; BINDING DOMAIN; CELL-SURFACE; CD44; INFLAMMATION; LYMPHANGIOGENESIS; EXPRESSION; MUTATIONS	The major lymphatic endothelial hyaluronan receptor LYVE-1, a Link superfamily glycoprotein similar to the hyaluronan-binding/inflammatory leukocyte homing receptor CD44, was initially implicated in hyaluronan (HA)-mediated cell adhesion and lymph-borne hyaluronan metabolism. However, the apparently normal phenotype of Lyve-1 knock-out mice and the recent demonstration that the receptor undergoes cytokine-induced endocytosis independent of HA uptake have cast doubt on such functions. Here we present new data that reconcile these anomalies by showing that LYVE-1 is functionally "silenced" in a cell-specific fashion by autoinhibitory glycosylation. We demonstrate that LYVE-1 transfected in HEK 293T fibroblasts and Jurkat T cells is competent to bind HA, whereas the endogenous receptor in cultured lymphatic endothelial cells or the receptor transfected in Chinese hamster ovary and HeLa cells is not. Moreover, through a combination of mutagenesis and functional analysis in HEK 293T fibroblasts and glycosylation-defective Chinese hamster ovary cell lines, we reveal that the inhibitory mechanism is reversible and is exerted by terminal sialylation, most likely through alpha 2-3 or alpha 2-6 linkage to O-glycans. Finally, we provide evidence that the mechanism operates in vivo by showing that native LYVE-1 in primary lymphatic endothelial cells is extensively sialylated and that HA binding can be reactivated by neuraminidase treatment of the soluble ectodomain. These results reveal unexpected complexity in the regulation of LYVE-1 function and raise the possibility that this receptor, like CD44, may become active after appropriate unmasking in vivo.	[Nightingale, Thomas D.; Frayne, Matthew E. F.; Clasper, Steven; Banerji, Suneale; Jackson, David G.] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford	Jackson, DG (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England.	djackson@hammer.imm.ox.ac.uk		, david/0000-0002-4133-9364; Nightingale, Thomas/0000-0002-3429-0988	United Kingdom Medical Research Council (MRC); MRC; Medical Research Council [MC_U137884182] Funding Source: researchfish; MRC [MC_U137884182] Funding Source: UKRI	United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the United Kingdom Medical Research Council (MRC) (to D. G. J.) and by MRC D. Phil studentships (to T. D. N. and M. E. F. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 1998, PROTEIN EXPRES PURIF, V14, P371, DOI 10.1006/prep.1998.0971; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Carreira CM, 2001, CANCER RES, V61, P8079; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; English NM, 1998, CANCER RES, V58, P3736; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; Gale NW, 2007, MOL CELL BIOL, V27, P595, DOI 10.1128/MCB.01503-06; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; Hong YJ, 2003, J BIOL CHEM, V278, P53045, DOI 10.1074/jbc.M309967200; Huang SS, 2006, FEBS LETT, V580, P6259, DOI 10.1016/j.febslet.2006.10.028; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Jackson DG, 2007, CANCER TREAT RES, P39; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Katoh S, 1999, J IMMUNOL, V162, P5058; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Kincade PW, 1997, CURR OPIN CELL BIOL, V9, P635, DOI 10.1016/S0955-0674(97)80116-0; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; TENGBLAD A, 1986, BIOCHEM J, V236, P521, DOI 10.1042/bj2360521; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Witte MH, 2006, CANCER METAST REV, V25, P159, DOI 10.1007/s10555-006-8496-2; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; YU Q, 1995, BIOTECHNIQUES, V19, P122	45	44	47	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3935	3945		10.1074/jbc.M805105200	http://dx.doi.org/10.1074/jbc.M805105200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19033446	hybrid			2022-12-25	WOS:000262872500062
J	Bugni, JM; Meira, LB; Samson, LD				Bugni, J. M.; Meira, L. B.; Samson, L. D.			Alkylation-induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteins	ONCOGENE			English	Article						colorectal cancer; Mgmt; Msh6; mismatch repair; azoxymethane	INVITRO DNA-REPLICATION; MISMATCH-REPAIR; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; INTESTINAL TUMORIGENESIS; METHYLTRANSFERASE GENE; MUTATION FREQUENCY; KNOCKOUT MICE; APOPTOSIS; CANCER; DAMAGE	O-6-methylguanine DNA methyltransferase (MGMT) suppresses mutations and cell death that result from alkylation damage. MGMT expression is lost by epigenetic silencing in a variety of human cancers including nearly half of sporadic colorectal cancers, suggesting that this loss maybe causal. Using mice with a targeted disruption of the Mgmt gene, we tested whether Mgmt protects against azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF), against AOM and dextran sulfate sodium (DSS)-induced colorectal adenomas and against spontaneous intestinal adenomas in Apc(Min) mice. We also examined the genetic interaction of the Mgmt null gene with a DNA mismatch repair null gene, namely Msh6. Both Mgmt and Msh6 independently suppress AOM-induced ACF, and combination of the two mutant alleles had a multiplicative effect. This synergism can be explained entirely by the suppression of alkylationinduced apoptosis when Msh6 is absent. In addition, following AOM_DSS treatment Mgmt protected against adenoma formation to the same degree as it protected against AOM-induced ACF formation. Finally, Mgmt de. ciency did not affect spontaneous intestinal adenoma development in Apc(Min/+) mice, suggesting that Mgmt suppresses intestinal cancer associated with exogenous alkylating agents, and that endogenous alkylation does not contribute to the rapid tumor development seen in Apc(Min/+) mice.	MIT, Biol Engn Dept, Cambridge, MA 02139 USA; MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Samson, LD (corresponding author), MIT, Dept Environm Hlth Sci, Bldg 56-235, Cambridge, MA 02139 USA.	lsamson@mit.edu	Meira, Lisiane/AAA-4326-2020	Meira, Lisiane/0000-0003-4289-2986	NIH [ES02109, CA75576]; NCI [CA14051]; NATIONAL CANCER INSTITUTE [R01CA075576, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by NIH Grants ES02109 and CA75576. We acknowledge the MIT CCR Histology facility (NCI Grant: CA14051), especially Alicia Caron. LDS is an American Cancer Society Research Professor.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; AQUILINA G, 1992, CANCER RES, V52, P6471; Baker SM, 1998, CANCER RES, V58, P1087; Edelmann W, 1999, CANCER RES, V59, P1301; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Esteller M, 2001, CANCER RES, V61, P3225; Fang QM, 2005, BIOCHEMISTRY-US, V44, P15396, DOI 10.1021/bi051460d; Fox EJ, 2006, J MOL DIAGN, V8, P68, DOI 10.2353/jmoldx.2006.050084; Glassner BJ, 1999, MUTAGENESIS, V14, P339, DOI 10.1093/mutage/14.3.339; Haigis KM, 2002, P NATL ACAD SCI USA, V99, P8927, DOI 10.1073/pnas.132275099; HARRIS LC, 1991, NUCLEIC ACIDS RES, V19, P6163, DOI 10.1093/nar/19.22.6163; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Hickman MJ, 1999, P NATL ACAD SCI USA, V96, P10764, DOI 10.1073/pnas.96.19.10764; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kaina B, 1997, MUTAT RES-FUND MOL M, V381, P227, DOI 10.1016/S0027-5107(97)00187-5; KARRAN P, 1992, NUCLEIC ACIDS RES, V20, P2933, DOI 10.1093/nar/20.12.2933; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kawate H, 1998, P NATL ACAD SCI USA, V95, P5116, DOI 10.1073/pnas.95.9.5116; Kellett M, 1992, Epithelial Cell Biol, V1, P147; Kohonen-Corish MRJ, 2002, CANCER RES, V62, P2092; Kuraguchi M, 2001, CANCER RES, V61, P7934; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; MYRNES B, 1984, CARCINOGENESIS, V5, P1061, DOI 10.1093/carcin/5.8.1061; Nagasaka T, 2008, INT J CANCER, V122, P2429, DOI 10.1002/ijc.23398; Reitmair AH, 1996, CANCER RES, V56, P2922; Sakumi K, 1997, CANCER RES, V57, P2415; Sandercock LE, 2004, ONCOGENE, V23, P5931, DOI 10.1038/sj.onc.1207791; Sedgwick B, 1997, CARCINOGENESIS, V18, P1561, DOI 10.1093/carcin/18.8.1561; Sieber OM, 2004, CANCER RES, V64, P8876, DOI 10.1158/0008-5472.CAN-04-2958; SNOW ET, 1984, J BIOL CHEM, V259, P8095; Sohn OS, 2001, CANCER RES, V61, P8435; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Taniguchi K, 2006, ONCOLOGY-BASEL, V71, P124, DOI 10.1159/000100522; Toft NJ, 2000, CARCINOGENESIS, V21, P593, DOI 10.1093/carcin/21.4.593; Toft NJ, 1999, P NATL ACAD SCI USA, V96, P3911, DOI 10.1073/pnas.96.7.3911; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Wali RK, 1999, CARCINOGENESIS, V20, P2355, DOI 10.1093/carcin/20.12.2355; WEI X, 1993, P NATL ACAD SCI USA, V90, P2117, DOI 10.1073/pnas.90.6.2117; Xu-Welliver M, 2002, CARCINOGENESIS, V23, P823, DOI 10.1093/carcin/23.5.823; ZAIDI NH, 1995, CARCINOGENESIS, V16, P451, DOI 10.1093/carcin/16.3.451	43	39	40	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					734	741		10.1038/onc.2008.426	http://dx.doi.org/10.1038/onc.2008.426			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	19029948	Green Submitted, Green Accepted			2022-12-25	WOS:000263076400010
J	Goodwin, JS; Larson, GA; Swant, J; Sen, N; Javitch, JA; Zahniser, NR; De Felice, LJ; Khoshbouei, H				Goodwin, J. Shawn; Larson, Gaynor A.; Swant, Jarod; Sen, Namita; Javitch, Jonathan A.; Zahniser, Nancy R.; De Felice, Louis J.; Khoshbouei, Habibeh			Amphetamine and Methamphetamine Differentially Affect Dopamine Transporters in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NUCLEUS-ACCUMBENS; PLASMA-MEMBRANE; MONOAMINE TRANSPORTERS; BEHAVIORAL-RESPONSES; LOCOMOTOR-ACTIVITY; UPTAKE INHIBITORS; CROSS-LINKING; CELL LINES; RELEASE	The psychostimulants D-amphetamine (AMPH) and methamphetamine (METH) release excess dopamine (DA) into the synaptic clefts of dopaminergic neurons. Abnormal DA release is thought to occur by reverse transport through the DA transporter (DAT), and it is believed to underlie the severe behavioral effects of these drugs. Here we compare structurally similar AMPH and METH on DAT function in a heterologous expression system and in an animal model. In the in vitro expression system, DAT-mediated whole-cell currents were greater for METH stimulation than for AMPH. At the same voltage and concentration, METH released five times more DA than AMPH and did so at physiological membrane potentials. At maximally effective concentrations, METH released twice as much [Ca2+](i) from internal stores compared with AMPH. [Ca2+](i) responses to both drugs were independent of membrane voltage but inhibited by DAT antagonists. Intact phosphorylation sites in the N-terminal domain of DAT were required for the AMPH-and METH-induced increase in [Ca2+](i) and for the enhanced effects of METH on [Ca2+](i) elevation. Calmodulin-dependent protein kinase II and protein kinase C inhibitors alone or in combination also blocked AMPH-or METH-induced Ca2+ responses. Finally, in the rat nucleus accumbens, in vivo voltammetry showed that systemic application of METH inhibited DAT-mediated DA clearance more efficiently than AMPH, resulting in excess external DA. Together these data demonstrate that METH has a stronger effect on DAT-mediated cell physiology than AMPH, which may contribute to the euphoric and addictive properties of METH compared with AMPH.	[Swant, Jarod; Khoshbouei, Habibeh] Meharry Med Coll, Dept Neurobiol & Neurotoxicol, Nashville, TN 37208 USA; [Goodwin, J. Shawn; De Felice, Louis J.] Meharry Med Coll, Dept Canc Biol, Nashville, TN 37208 USA; [Larson, Gaynor A.; Zahniser, Nancy R.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [De Felice, Louis J.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; [De Felice, Louis J.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Ctr Mol Recognit, Dept Pharmacol, New York, NY 10027 USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, New York, NY 10027 USA	Meharry Medical College; Meharry Medical College; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University; Vanderbilt University; Columbia University; Columbia University	Khoshbouei, H (corresponding author), Meharry Med Coll, Dept Neurobiol & Neurotoxicol, 3244 W Basic Sci Bldg,1005 Dr B Todd Jr Blvd, Nashville, TN 37208 USA.			Khoshbouei, Habibeh/0000-0002-1533-8771; Javitch, Jonathan/0000-0001-7395-2967; De Felice, Louis/0000-0002-4594-3171	National Institutes of Health [HL076133, DA021471, NS034075, DA06338, DA012408, DA022413, DA004216, DA015050, U54NS041071, G12RR03032, U54CA91408, U54RR019192]; National Science Foundation [IOS-0642188]; Meharry Medical College Morphology Core; NATIONAL CANCER INSTITUTE [U54CA091408] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019192, G12RR003032] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034075, U54NS041071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, R37DA004216, P01DA012408, R01DA004216, K05DA015050, R24DA021471, R01DA026947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Meharry Medical College Morphology Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL076133 (to J.S.), DA021471 (to H. K.), NS034075 and DA06338 (to L. J. D. F.), DA012408 and DA022413 (to J. A. J.), and DA004216 and DA015050 (to N.R.Z.). This work was also supported by National Science Foundation Award IOS-0642188 (to H. K.). Microscopy experiments and data analysis were performed through the use of the Meharry Medical College Morphology Core, which is supported in part by National Institutes of Health Grants U54NS041071, G12RR03032, U54CA91408, and U54RR019192. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Broom SL, 2005, PSYCHOPHARMACOLOGY, V181, P467, DOI 10.1007/s00213-005-0007-6; Browman KE, 1998, BRAIN RES, V814, P112, DOI 10.1016/S0006-8993(98)01040-3; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; CASS WA, 1993, J NEUROCHEM, V61, P273, DOI 10.1111/j.1471-4159.1993.tb03565.x; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chan SL, 2006, J BIOL CHEM, V281, P37391, DOI 10.1074/jbc.M605552200; Colliver J. D., 2006, MISUSE PRESCRIPTION; COX RH, 1972, J PHARMACOL-PARIS, V181, P1; Doolen S, 2002, FEBS LETT, V516, P187, DOI 10.1016/S0014-5793(02)02554-1; Doolen S, 2001, J PHARMACOL EXP THER, V296, P931; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; FISCHER JF, 1976, P W PHARMACOL SOC, V19, P179; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Foster JD, 2003, MOL BRAIN RES, V110, P100, DOI 10.1016/S0169-328X(02)00645-9; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Fujimoto Y, 2007, EXP ANIM TOKYO, V56, P119, DOI 10.1538/expanim.56.119; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; GIAMBALVO CT, 1989, BIOCHEM PHARMACOL, V38, P4445, DOI 10.1016/0006-2952(89)90655-2; GIAMBALVO CT, 1988, BIOCHEM PHARMACOL, V37, P4009, DOI 10.1016/0006-2952(88)90087-1; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; Gorentla BK, 2005, NEUROPHARMACOLOGY, V49, P759, DOI 10.1016/j.neuropharm.2005.08.011; Gulley JM, 2007, BRAIN RES, V1151, P32, DOI 10.1016/j.brainres.2007.03.009; Hall DA, 2008, PSYCHOPHARMACOLOGY, V195, P469, DOI 10.1007/s00213-007-0923-8; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Hanson GR, 2004, NEUROPHARMACOLOGY, V47, P92, DOI 10.1016/j.neuropharm.2004.06.004; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Huff RA, 1997, J NEUROCHEM, V68, P225; John CE, 2007, NEUROPHARMACOLOGY, V52, P1596, DOI 10.1016/j.neuropharm.2007.03.004; Johnson RA, 1998, SYNAPSE, V30, P97, DOI 10.1002/(SICI)1098-2396(199809)30:1<97::AID-SYN12>3.0.CO;2-M; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1998, J NEUROSCI, V18, P1979; Joyce BM, 2007, PSYCHOPHARMACOLOGY, V191, P669, DOI 10.1007/s00213-006-0550-9; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Kahlig KM, 2003, EUR J PHARMACOL, V479, P153, DOI 10.1016/j.ejphar.2003.08.065; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kantor L, 1998, J PHARMACOL EXP THER, V284, P592; Kantor L, 2001, J PHARMACOL EXP THER, V297, P1016; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; Kitaichi K, 2003, EUR J PHARMACOL, V464, P39, DOI 10.1016/S0014-2999(03)01321-9; KUCZENSKI R, 1995, J NEUROSCI, V15, P1308; LUCAJ Z, 1994, BRAIN RES, V660, P1, DOI 10.1016/0006-8993(94)90832-X; LYTTON J, 1991, J BIOL CHEM, V266, P17067; National Toxicology Program, 2006, Natl Toxicol Program Tech Rep Ser, P1; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PEACHEY JE, 1977, PSYCHOPHARMACOLOGY, V51, P137, DOI 10.1007/BF00431729; Rees S, 1996, BIOTECHNIQUES, V20, P102; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Rothman RB, 2003, EUR J PHARMACOL, V479, P23, DOI 10.1016/j.ejphar.2003.08.054; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Sandoval V, 2001, J NEUROSCI, V21, P1413; Segal DS, 1997, J PHARMACOL EXP THER, V282, P561; Shoblock JR, 2003, PSYCHOPHARMACOLOGY, V165, P359, DOI 10.1007/s00213-002-1288-7; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Vaughan RA, 2004, J PHARMACOL EXP THER, V310, P1, DOI 10.1124/jpet.103.052423; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; WALL SC, 1995, MOL PHARMACOL, V47, P544; Zahniser NR, 1998, METHOD ENZYMOL, V296, P708; Zahniser NR, 1999, ALCOHOL CLIN EXP RES, V23, P1721, DOI 10.1111/j.1530-0277.1999.tb04066.x	69	131	132	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2978	2989		10.1074/jbc.M805298200	http://dx.doi.org/10.1074/jbc.M805298200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047053	Green Published, hybrid			2022-12-25	WOS:000262700900042
J	Liu, CL; Wu, J; Zhu, J; Kuei, C; Yu, JX; Shelton, J; Sutton, SW; Li, X; Yun, SJ; Mirzadegan, T; Mazur, C; Kamme, F; Lovenberg, TW				Liu, Changlu; Wu, Jiejun; Zhu, Jessica; Kuei, Chester; Yu, Jingxue; Shelton, Jonathan; Sutton, Steven W.; Li, Xiaorong; Yun, Su Jin; Mirzadegan, Taraneh; Mazur, Curt; Kamme, Fredrik; Lovenberg, Timothy W.			Lactate Inhibits Lipolysis in Fat Cells through Activation of an Orphan G-protein-coupled Receptor, GPR81	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL LACTIC-ACIDOSIS; NICOTINIC-ACID; GAMMA-HYDROXYBUTYRATE; ADIPOSE-TISSUE; SELECTIVE LIGAND; BLOOD LACTATE; CANCER-CELLS; PUMA-G; DICHLOROACETATE; METABOLISM	Lactic acid is a well known metabolic by-product of intense exercise, particularly under anaerobic conditions. Lactate is also a key source of energy and an important metabolic substrate, and it has also been hypothesized to be a signaling molecule directing metabolic activity. Here we show that GPR81, an orphan G-protein-coupled receptor highly expressed in fat, is in fact a sensor for lactate. Lactate activates GPR81 in its physiological concentration range of 1-20 mM and suppresses lipolysis in mouse, rat, and human adipocytes as well as in differentiated 3T3-L1 cells. Adipocytes from GPR81-deficient mice lack an antilipolytic response to lactate but are responsive to other antilipolytic agents. Lactate specifically induces internalization of GPR81 after receptor activation. Site-directed mutagenesis of GPR81 coupled with homology modeling demonstrates that classically conserved key residues in the transmembrane binding domains are responsible for interacting with lactate. Our results indicate that lactate suppresses lipolysis in adipose tissue through a direct activation of GPR81. GPR81 may thus be an attractive target for the treatment of dyslipidemia and other metabolic disorders.	[Liu, Changlu; Wu, Jiejun; Zhu, Jessica; Kuei, Chester; Yu, Jingxue; Shelton, Jonathan; Sutton, Steven W.; Li, Xiaorong; Yun, Su Jin; Mirzadegan, Taraneh; Mazur, Curt; Kamme, Fredrik; Lovenberg, Timothy W.] Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA	Liu, CL (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, 3210 Merryfield Row, San Diego, CA 92121 USA.	cliu9@its.jnj.com						Achten J, 2004, INT J SPORTS MED, V25, P32, DOI 10.1055/s-2003-45231; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; BJORNTORP P, 1965, ACTA MED SCAND, V178, P253; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Borgen LA, 2004, J CLIN PHARMACOL, V44, P253, DOI 10.1177/0091270003262795; BOYD AE, 1974, METABOLISM, V23, P531, DOI 10.1016/0026-0495(74)90081-X; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; CHEETHAM ME, 1986, J APPL PHYSIOL, V61, P54, DOI 10.1152/jappl.1986.61.1.54; Cheng K, 2006, P NATL ACAD SCI USA, V103, P6682, DOI 10.1073/pnas.0601574103; CLARK AS, 1987, J CLIN INVEST, V79, P588, DOI 10.1172/JCI112851; DEPERGOLA G, 1989, HORM METAB RES, V21, P210, DOI 10.1055/s-2007-1009193; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; Elliott SP, 2004, THER DRUG MONIT, V26, P432, DOI 10.1097/00007691-200408000-00014; FAIN JN, 1976, J LIPID RES, V17, P377; FERRANNINI E, 1993, AM J PHYSIOL, V265, pE504, DOI 10.1152/ajpendo.1993.265.3.E504; GARG A, 1990, JAMA-J AM MED ASSOC, V264, P723, DOI 10.1001/jama.264.6.723; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Ge H, 2008, J LIPID RES, V49, P797, DOI 10.1194/jlr.M700513-JLR200; Gonzalez A, 2005, J PSYCHOPHARMACOL, V19, P195, DOI 10.1177/0269881105049041; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; HAGSTROM E, 1990, AM J PHYSIOL, V258, pE888, DOI 10.1152/ajpendo.1990.258.5.E888; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hosoi T, 2002, J BIOL CHEM, V277, P31459, DOI 10.1074/jbc.M203194200; HUGHSON RL, 1987, J APPL PHYSIOL, V62, P1975, DOI 10.1152/jappl.1987.62.5.1975; Kamijo Y, 2000, J APPL PHYSIOL, V89, P2196, DOI 10.1152/jappl.2000.89.6.2196; Kato-Weinstein J, 1998, TOXICOLOGY, V130, P141, DOI 10.1016/S0300-483X(98)00106-1; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; LeBeau MA, 2006, J ANAL TOXICOL, V30, P98, DOI 10.1093/jat/30.2.98; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Lingohr MK, 2002, TOXICOL SCI, V68, P508, DOI 10.1093/toxsci/68.2.508; Liu CL, 2005, J BIOL CHEM, V280, P292, DOI 10.1074/jbc.M409916200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Maitre M, 1997, PROG NEUROBIOL, V51, P337, DOI 10.1016/S0301-0082(96)00064-0; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; OHKUWA T, 1984, EUR J APPL PHYSIOL O, V53, P213, DOI 10.1007/BF00776592; SHUMATE JS, 1979, RES COMMUN CHEM PATH, V25, P241; SOLAPENNA M, 2008, IUBMB LIFE, V49, P797; Stacpoole PW, 2008, PEDIATRICS, V121, pE1223, DOI 10.1542/peds.2007-2062; Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226; Stacpoole PW, 2003, J CLIN PHARMACOL, V43, P683, DOI 10.1177/0091270003254637; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wong CGT, 2004, TRENDS PHARMACOL SCI, V25, P29, DOI 10.1016/j.tips.2003.11.001; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038	53	304	318	4	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2811	2822		10.1074/jbc.M806409200	http://dx.doi.org/10.1074/jbc.M806409200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047060	hybrid			2022-12-25	WOS:000262700900024
J	Wang, S; Alimi, Y; Tong, A; Nichols, CG; Enkvetchakul, D				Wang, Shizhen; Alimi, Yewande; Tong, Ailing; Nichols, Colin G.; Enkvetchakul, Decha			Differential Roles of Blocking Ions in KirBac1.1 Tetramer Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CHANNELS; RECTIFYING POTASSIUM CHANNELS; INWARD-RECTIFIER; SELECTIVITY FILTER; CRYSTAL-STRUCTURE; KIR CHANNEL; FUNCTIONAL-CHARACTERIZATION; 2.0-ANGSTROM RESOLUTION; KCSA; PORE	Potassium channels are tetrameric proteins that mediate K+-selective transmembrane diffusion. For KcsA, tetramer stability depends on interactions between permeant ions and the channel pore. We have examined the role of pore blockers on the tetramer stability of KirBac1.1. In 150 mM KCl, purified KirBac1.1 protein migrates as a monomer (similar to 40 kDa) on SDS-PAGE. Addition of Ba2+ (K-1/2 similar to 50 mu M) prior to loading results in an additional tetramer band (similar to 160 kDa). Mutation A109C, at a residue located near the expected Ba2+-binding site, decreased tetramer stabilization by Ba2+ (K-1/2 similar to 300 mu M), whereas I131C, located nearby, stabilized tetramers in the absence of Ba2+. Neither mutation affected Ba2+ block of channel activity (using Rb-86(+) flux assay). In contrast to Ba2+, Mg2+ had no effect on tetramer stability (even though Mg2+ was a potent blocker). Many studies have shown Cd2+ block of K+ channels as a result of cysteine substitution of cavity-lining M2 (S6) residues, with the implicit interpretation that coordination of a single ion by cysteine side chains along the central axis effectively blocks the pore. We examined blocking and tetramer-stabilizing effects of Cd2+ on KirBac1.1 with cysteine substitutions in M2. Cd2+ block potency followed an alpha-helical pattern consistent with the crystal structure. Significantly, Cd2+ strongly stabilized tetramers of I138C, located in the center of the inner cavity. This stabilization was additive with the effect of Ba2+, consistent with both ions simultaneously occupying the channel: Ba2+ at the selectivity filter entrance and Cd2+ coordinated by I138C side chains in the inner cavity.	[Wang, Shizhen; Alimi, Yewande; Enkvetchakul, Decha] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Wang, Shizhen; Tong, Ailing; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Saint Louis University; Washington University (WUSTL)	Enkvetchakul, D (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	denkvetc@slu.edu	Nichols, Colin/D-6336-2012; Wang, Shizhen/N-6577-2017	Wang, Shizhen/0000-0003-1065-4756; Alimi, Yewande/0000-0002-7318-7158	National Institutes of Health [DK069424, DK069424-02S1, HL54171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK069424 and DK069424-02S1 (to D. E.) and HL54171 (to C. G. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; ChauhanPatel R, 1997, J MEMBRANE BIOL, V158, P265, DOI 10.1007/s002329900263; Compoint M, 2004, BBA-BIOMEMBRANES, V1661, P26, DOI 10.1016/j.bbamem.2003.11.019; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-14; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; FAKLER B, 1994, FEBS LETT, V356, P199, DOI 10.1016/0014-5793(94)01258-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Fujiwara Y, 2002, J GEN PHYSIOL, V120, P677, DOI 10.1085/jgp.20028663; Irizarry SN, 2002, BIOCHEMISTRY-US, V41, P13653, DOI 10.1021/bi026393r; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; Krishnan MN, 2008, BIOCHEMISTRY-US, V47, P5354, DOI 10.1021/bi702281p; Krishnan MN, 2005, J GEN PHYSIOL, V126, P271, DOI 10.1085/jgp.200509323; Kubo Y, 2005, PHARMACOL REV, V57, P509, DOI 10.1124/pr.57.4.11; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Leung YM, 2000, CAN J PHYSIOL PHARM, V78, P751, DOI 10.1139/cjpp-78-9-751; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Loboda A, 2001, BIOPHYS J, V80, P2704, DOI 10.1016/S0006-3495(01)76239-X; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Loussouarn G, 2000, J BIOL CHEM, V275, P1137, DOI 10.1074/jbc.275.2.1137; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Melishchuk A, 1998, BIOPHYS J, V75, P1828, DOI 10.1016/S0006-3495(98)77624-6; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Neamtu A, 2004, Rom J Physiol, V41, P69; Nichols CG, 1996, CIRC RES, V78, P1, DOI 10.1161/01.RES.78.1.1; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; RANSOM CB, 1995, J NEUROPHYSIOL, V73, P333, DOI 10.1152/jn.1995.73.1.333; REES DC, 1989, ANNU REV BIOCHEM, V58, P607; Renart ML, 2006, J BIOL CHEM, V281, P29905, DOI 10.1074/jbc.M602636200; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; Sun S, 2006, PHYSIOL GENOMICS, V26, P1, DOI 10.1152/physiolgenomics.00026.2006; Szendroedi J, 2007, BIOPHYS J, V93, P4209, DOI 10.1529/biophysj.107.104794; van Dalen A, 2002, FEBS LETT, V525, P33, DOI 10.1016/S0014-5793(02)03061-2; van den Brink-van der Laan E, 2004, BIOCHEMISTRY-US, V43, P4240, DOI 10.1021/bi036129d; WISCHMEYER E, 1995, PFLUG ARCH EUR J PHY, V429, P809, DOI 10.1007/BF00374805; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Zhou Y, 2004, BIOCHEMISTRY-US, V43, P4978, DOI 10.1021/bi049876z; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	52	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2854	2860		10.1074/jbc.M807474200	http://dx.doi.org/10.1074/jbc.M807474200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19033439	hybrid, Green Published			2022-12-25	WOS:000262700900029
J	Gayer, CP; Chaturvedi, LS; Wang, SY; Craig, DH; Flanigan, T; Basson, MD				Gayer, Christopher P.; Chaturvedi, Lakshmi S.; Wang, Shouye; Craig, David H.; Flanigan, Thomas; Basson, Marc D.			Strain-induced Proliferation Requires the Phosphatidylinositol 3-Kinase/AKT/Glycogen Synthase Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; INTESTINAL EPITHELIAL PROLIFERATION; SIGNAL-REGULATED KINASE; CYCLIC STRAIN; CELL-SURVIVAL; BACTERIAL TRANSLOCATION; REPETITIVE DEFORMATION; MECHANICAL STRAIN; MUSCLE-CELLS; SMALL-BOWEL	The intestinal epithelium is repetitively deformed by shear, peristalsis, and villous motility. Such repetitive deformation stimulates the proliferation of intestinal epithelial cells on collagen or laminin substrates via ERK, but the upstream mediators of this effect are poorly understood. We hypothesized that the phosphatidylinositol 3-kinase (PI3K)/AKT cascade mediates this mitogenic effect. PI3K, AKT, and glycogen synthase kinase-3 beta (GSK-3 beta) were phosphorylated by 10 cycles/min strain at an average 10% deformation, and pharmacologic blockade of these molecules or reduction by small interfering RNA ( siRNA) prevented the mitogenic effect of strain in Caco-2 or IEC-6 intestinal epithelial cells. Strain MAPK activation required PI3K but not AKT. AKT isoform-specific siRNA transfection demonstrated that AKT2 but not AKT1 is required for GSK-3 beta phosphorylation and the strain mitogenic effect. Furthermore, overexpression of AKT1 or an AKT chimera including the PH domain and hinge region of AKT2 and the catalytic domain and C-tail of AKT1 prevented strain activation of GSK-3 beta, but overexpression of AKT2 or a chimera including the PH domain and hinge region of AKT1 and the catalytic domain and C-tail of AKT2 did not. These data delineate a role for PI3K, AKT2, and GSK-3 beta in the mitogenic effect of strain. PI3K is required for both ERK and AKT2 activation, whereas AKT2 is sequentially required for GSK-3 beta. Furthermore, AKT2 specificity requires its catalytic domain and tail region. Manipulating this pathway may prevent mucosal atrophy and maintain the mucosal barrier in conditions such as ileus, sepsis, and prolonged fasting when peristalsis and villous motility are decreased and the mucosal barrier fails.	[Gayer, Christopher P.; Chaturvedi, Lakshmi S.; Wang, Shouye; Craig, David H.; Flanigan, Thomas; Basson, Marc D.] John Dingell VAMC, Surg Serv 11S, Dept Surg, Detroit, MI 48301 USA; [Gayer, Christopher P.; Flanigan, Thomas; Basson, Marc D.] Detroit Med Ctr, Detroit, MI 48301 USA; [Gayer, Christopher P.; Flanigan, Thomas; Basson, Marc D.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Detroit Medical Center; Wayne State University	Basson, MD (corresponding author), John Dingell VAMC, Surg Serv 11S, Dept Surg, 4646 John R St, Detroit, MI 48301 USA.	mdbasson@gmail.com	Wang, Shouye/B-1992-2008		National Institutes of Health [RO1 DK067257, 2 T32 GM008420]; Veterans Affairs Merit Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK067257 ( to M. D. B.) and by 2 T32 GM008420 ( to M. D. B. and C. P. G.). This work was also supported in part by a Veterans Affairs Merit Award.	Basson MD, 1996, J CELL PHYSIOL, V168, P476, DOI 10.1002/(SICI)1097-4652(199608)168:2<476::AID-JCP26>3.0.CO;2-#; Basson MD, 2003, DIGESTION, V68, P217, DOI 10.1159/000076385; Basson MD, 2002, METABOLISM, V51, P1525, DOI 10.1053/meta.2002.36303; Basson MD, 1996, CANCER LETT, V99, P155, DOI 10.1016/0304-3835(95)04058-7; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; CARR KE, 1991, J SUBMICR CYTOL PATH, V23, P569; Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200; Chen AL, 2005, SURGERY, V138, P382, DOI 10.1016/j.surg.2005.04.012; Chen B, 2005, MOL ENDOCRINOL, V19, P1978, DOI 10.1210/me.2004-0274; Chen QH, 2003, J VASC SURG, V37, P660, DOI 10.1067/mva.2003.95; Cheng HL, 2000, J BIOL CHEM, V275, P27197; Chess PR, 2000, AM J PHYSIOL-LUNG C, V279, pL43; Chess PR, 2005, J APPL PHYSIOL, V99, P1226, DOI 10.1152/japplphysiol.01105.2004; Chong ZZ, 2007, CELL SIGNAL, V19, P1150, DOI 10.1016/j.cellsig.2006.12.009; Dufour G, 2004, J BIOL CHEM, V279, P44113, DOI 10.1074/jbc.M405323200; Fenton JI, 2005, CANCER EPIDEM BIOMAR, V14, P1646, DOI 10.1158/1055-9965.EPI-04-0916; Ferrand A, 2005, CANCER RES, V65, P2770, DOI 10.1158/0008-5472.CAN-04-0978; Flanigan TL, 2008, AM J SURG, V196, P683, DOI 10.1016/j.amjsurg.2008.07.016; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gu J, 2008, EXP EYE RES, V86, P322, DOI 10.1016/j.exer.2007.11.004; Han EKH, 2008, ANTICANCER RES, V28, P957; Han OH, 1998, AM J PHYSIOL-GASTR L, V275, pG534, DOI 10.1152/ajpgi.1998.275.3.G534; Hasaneen NA, 2007, AM J PHYSIOL-LUNG C, V293, pL1059, DOI 10.1152/ajplung.00480.2006; Hennig GW, 1999, J PHYSIOL-LONDON, V517, P575, DOI 10.1111/j.1469-7793.1999.0575t.x; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Hsiung SC, 2005, J NEUROCHEM, V95, P1653, DOI 10.1111/j.1471-4159.2005.03496.x; Jakubikova J, 2005, BIOCHEM PHARMACOL, V69, P1543, DOI 10.1016/j.bcp.2005.03.015; Johnson FE, 2000, INT J ONCOL, V16, P617; JONES WG, 1990, ANN SURG, V211, P399, DOI 10.1097/00000658-199004000-00004; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Kim Y, 2004, MOL CELLS, V18, P353; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Koyama M, 2007, MOL CANCER THER, V6, P1579, DOI 10.1158/1535-7163.MCT-06-0814; Li W, 2005, AM J PHYSIOL-HEART C, V288, pH1591, DOI 10.1152/ajpheart.00382.2004; Li W, 2001, AM J PHYSIOL-GASTR L, V280, P75; Litovchick L, 2004, MOL CELL BIOL, V24, P8970, DOI 10.1128/MCB.24.20.8970-8980.2004; Liu LL, 2008, MOL BIOL+, V42, P403, DOI 10.1134/S0026893308030084; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Masure S, 1999, EUR J BIOCHEM, V265, P353, DOI 10.1046/j.1432-1327.1999.00774.x; MCNEIL PL, 1990, J CELL SCI, V96, P549; MCNEIL PL, 1989, GASTROENTEROLOGY, V96, P1238, DOI 10.1016/S0016-5085(89)80010-1; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; Mettler SE, 2007, AM J PHYSIOL-GASTR L, V293, pG532, DOI 10.1152/ajpgi.00138.2007; MIFTAKHOV R, 1994, BIORHEOLOGY, V31, P309; MOORE R, 1989, AM J PHYSIOL, V257, pG274, DOI 10.1152/ajpgi.1989.257.2.G274; Murnin M, 2000, J GASTROINTEST SURG, V4, P435, DOI 10.1016/S1091-255X(00)80025-6; Ngan ESW, 2007, BBA-MOL CELL RES, V1773, P536, DOI 10.1016/j.bbamcr.2007.01.013; Nguyen T, 2007, AM J PATHOL, V170, P1219, DOI 10.2353/ajpath.2007.060745; Nishimura K, 2006, AM J PHYSIOL-CELL PH, V290, pC812, DOI 10.1152/ajpcell.00347.2005; Osada T, 1999, GUT, V45, P508, DOI 10.1136/gut.45.4.508; Palanivel R, 2006, DIABETOLOGIA, V49, P183, DOI 10.1007/s00125-005-0060-z; Palma-Nicolas JP, 2008, BIOSCIENCE REP, V28, P307, DOI 10.1042/BSR20080083; PETERSON MD, 1993, J CELL SCI, V105, P461; PETERSON MD, 1992, J CELL SCI, V102, P581; Potoka DA, 2003, AM J PHYSIOL-GASTR L, V285, pG861, DOI 10.1152/ajpgi.00412.2002; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Shen XL, 2007, REGUL PEPTIDES, V141, P61, DOI 10.1016/j.regpep.2006.12.017; Sheng H, 2003, GUT, V52, P1472, DOI 10.1136/gut.52.10.1472; Shimizu N, 2008, J APPL PHYSIOL, V104, P766, DOI 10.1152/japplphysiol.00870.2007; Shiratsuchi H, 2007, J CELL BIOCHEM, V102, P353, DOI 10.1002/jcb.21295; Song Guanbin, 2007, Molecular & Cellular Biomechanics, V4, P201; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; Spencer AU, 2006, SURGERY, V140, P212, DOI 10.1016/j.surg.2006.03.005; Tanaka M, 1999, BIOCHEM BIOPH RES CO, V255, P169, DOI 10.1006/bbrc.1999.0162; Thamilselvan V, 2007, FASEB J, V21, P1730, DOI 10.1096/fj.06-6545com; Tian Q, 2005, CELL CYCLE, V4, P215; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Wang' S, 2008, EXP CELL RES, V314, P286, DOI 10.1016/j.yexcr.2007.08.005; WOMACK WA, 1987, AM J PHYSIOL, V252, pG250, DOI 10.1152/ajpgi.1987.252.2.G250; Yanagihara M, 2005, CANCER SCI, V96, P620, DOI 10.1111/j.1349-7006.2005.00088.x; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yu P, 2000, CRIT CARE MED, V28, P2573, DOI 10.1097/00003246-200007000-00065; Zhai H, 2005, EUR J PHARMACOL, V516, P112, DOI 10.1016/j.ejphar.2005.04.035; Zhang JH, 2003, FASEB J, V17, P926, DOI 10.1096/fj.02-0663fje; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	76	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2001	2011		10.1074/jbc.M804576200	http://dx.doi.org/10.1074/jbc.M804576200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047055	Green Published, hybrid			2022-12-25	WOS:000262545600007
J	Jobling, AI; Gentle, A; Metlapally, R; McGowan, BJ; McBrien, NA				Jobling, Andrew I.; Gentle, Alex; Metlapally, Ravikanth; McGowan, Bryan J.; McBrien, Neville A.			Regulation of Scleral Cell Contraction by Transforming Growth Factor-beta and Stress COMPETING ROLES IN MYOPIC EYE GROWTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX SYNTHESIS; TREE SHREW SCLERA; FIBROBLAST CONTRACTION; MECHANICAL STRETCH; GENE-EXPRESSION; COLLAGEN GELS; AXIAL MYOPIA; IN-VITRO; MYOFIBROBLASTS; MODULATION	Reduced extracellular matrix accumulation in the sclera of myopic eyes leads to increased ocular extensibility and is related to reduced levels of scleral transforming growth factor-beta(TGF-beta). The current study investigated the impact of this extracellular environment on scleral cell phenotype and cellular biomechanical characteristics. Scleral cell phenotype was investigated in vivo in a mammalian model of myopia using the myofibroblast marker, alpha-smooth muscle actin (alpha-SMA). In eyes developing myopia alpha-SMA levels were increased, suggesting increased numbers of contractile myofibroblasts, and decreased in eyes recovering from myopia. To understand the factors regulating this change in scleral phenotype, the competing roles of TGF-beta and mechanical stress were investigated in scleral cells cultured in three-dimensional collagen gels. All three mammalian isoforms of TGF-beta altered scleral cell phenotype to produce highly contractile, alpha-SMA-expressing myofibroblasts (TGF-beta 3 > TGF-beta 2 > TGF-beta 1). Exposure of cells to the reduced levels of TGF-beta found in the sclera in myopia produced decreased cell-mediated contraction and reduced alpha-SMA expression. These findings are contrary to the in vivo gene expression data. However, when cells were exposed to both the increased stress and the reduced levels of TGF-beta found in myopia, increased alpha-SMA expression was observed, replicating in vivo findings. These results show that although reduced scleral TGF-beta is a major contributor to the extracellular matrix remodeling in the myopic eye, it is the resulting increase in scleral stress that dominates the competing TGF-beta effect, inducing increased alpha-SMA expression and, hence, producing a larger population of contractile cells in the myopic eye.	[Jobling, Andrew I.; Gentle, Alex; Metlapally, Ravikanth; McGowan, Bryan J.; McBrien, Neville A.] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic 3010, Australia	University of Melbourne	McBrien, NA (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic 3010, Australia.	nmcbrien@unimelb.edu.au	Jobling, Andrew/C-8221-2015	Jobling, Andrew/0000-0002-7827-3135	National Health and Medical Research Council of Australia [251557, 454602]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by National Health and Medical Research Council of Australia Grants 251557 and 454602.	AVETISOV ES, 1984, METAB PEDIATR SYST O, V7, P183; Bellezza AJ, 2000, INVEST OPHTH VIS SCI, V41, P2991; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Cordeiro MF, 2000, INVEST OPHTH VIS SCI, V41, P756; Cui W, 2004, EXP EYE RES, V78, P275, DOI 10.1016/j.exer.2003.10.007; Curtin BJ, 1985, MYOPIAS BASIC SCI CL; Ehrlich HP, 2000, J CELL PHYSIOL, V185, P432, DOI 10.1002/1097-4652(200012)185:3<432::AID-JCP14>3.0.CO;2-R; Fujikura H, 2002, JPN J OPHTHALMOL, V46, P24, DOI 10.1016/S0021-5155(01)00451-8; Gentle A, 1999, EXP EYE RES, V68, P155, DOI 10.1006/exer.1998.0587; Gentle A, 2003, J BIOL CHEM, V278, P16587, DOI 10.1074/jbc.M300970200; HE YJ, 1994, J CELL BIOL, V126, P457, DOI 10.1083/jcb.126.2.457; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Jobling AI, 2004, J BIOL CHEM, V279, P18121, DOI 10.1074/jbc.M400381200; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; MacKenna D, 2000, CARDIOVASC RES, V46, P257, DOI 10.1016/S0008-6363(00)00030-4; McBrien NA, 2000, INVEST OPHTH VIS SCI, V41, P3713; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; MCBRIEN NA, 1992, VISION RES, V32, P843, DOI 10.1016/0042-6989(92)90027-G; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Moring AG, 2007, INVEST OPHTH VIS SCI, V48, P2947, DOI 10.1167/iovs.06-0906; NORTON TT, 1995, INVESTIG OPHTHALMOL, V3517, P760; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Phillips JR, 2004, INVEST OPHTH VIS SCI, V45, P758, DOI 10.1167/iovs.03-0732; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; Poukens V, 1998, INVEST OPHTH VIS SCI, V39, P1765; Redden RA, 2006, IN VITRO CELL DEV-AN, V42, P70; SCHMIDT MB, 1990, J ORTHOPAED RES, V8, P353, DOI 10.1002/jor.1100080307; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; SHAH M, 1995, J CELL SCI, V108, P985; Shelton L, 2007, EXP EYE RES, V84, P314, DOI 10.1016/j.exer.2006.10.004; Siegwart JT, 1999, VISION RES, V39, P387, DOI 10.1016/S0042-6989(98)00150-3; SIEGWART JT, 1994, LAB ANIM SCI, V44, P213; TOMASEK JJ, 1992, ANAT REC, V232, P359, DOI 10.1002/ar.1092320305; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; ZORN N, 1992, INVESTIG OPHTHALMOL, V1811, P1053	39	34	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2072	2079		10.1074/jbc.M807521200	http://dx.doi.org/10.1074/jbc.M807521200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19011237	hybrid, Green Submitted			2022-12-25	WOS:000262545600015
J	Vercauteren, K; Gleyzer, N; Scarpulla, RC				Vercauteren, Kristel; Gleyzer, Natalie; Scarpulla, Richard C.			Short Hairpin RNA-mediated Silencing of PRC (PGC-1-related Coactivator) Results in a Severe Respiratory Chain Deficiency Associated with the Proliferation of Aberrant Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-PHOSPHORYLATION; INDUCIBLE COACTIVATOR; PGC-1 FAMILY; TRANSCRIPTION; PGC-1-ALPHA; BIOGENESIS; METABOLISM; EXPRESSION; CELLS; THERMOGENESIS	PRC, a member of the PGC-1 coactivator family, is responsive to serum growth factors and up-regulated in proliferating cells. Here, we investigated its in vivo role by stably silencing PRC expression with two different short hairpin RNAs (shRNA1 and shRNA4) that were lentivirally introduced into U2OS cells. shRNA1 transductants exhibited nearly complete knockdown of PRC protein, whereas shRNA4 transductants expressed PRC protein at similar to 15% of the control level. Complete PRC silencing by shRNA1 resulted in a severe inhibition of respiratory growth; reduced expression of respiratory protein subunits from complexes I, II, III, and IV; markedly lower complex I and IV respiratory enzyme levels; and diminished mitochondrial ATP production. Surprisingly, shRNA1 transductants exhibited a striking proliferation of abnormal mitochondria that were devoid of organized cristae and displayed severe membrane abnormalities. Although shRNA4 transductants had normal respiratory subunit expression and a moderately diminished respiratory growth rate, both transductants showed markedly reduced growth on glucose accompanied by inhibition of G(1)/S cell cycle progression. Microarray analysis revealed striking overlaps in the genes affected by PRC silencing in the two transductants, and the functional identities of these overlapping genes were consistent with the observed mitochondrial and cell growth phenotypes. The consistency between phenotype and PRC expression levels in the two independent transductant lines argues that the defects result from PRC silencing and not from off target effects. These results support a role for PRC in the integration of pathways directing mitochondrial respiratory function and cell growth.	[Vercauteren, Kristel; Gleyzer, Natalie; Scarpulla, Richard C.] NW Med Sch, Dept Cell & Mol Biol, Chicago, IL 60611 USA		Scarpulla, RC (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	rsc248@northwestern.edu			National Institutes of Health [GM32525-26]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032525, R56GM032525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32525-26. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adan C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; BALABAN RS, 1990, AM J PHYSIOL, V258, pC377, DOI 10.1152/ajpcell.1990.258.3.C377; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200; DOENCH JG, 2008, GENE DEV, V17, P438; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Metivier D, 1998, IMMUNOL LETT, V61, P157, DOI 10.1016/S0165-2478(98)00013-3; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Robinson B H, 1996, Methods Enzymol, V264, P454, DOI 10.1016/S0076-6879(96)64041-5; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; SEPTINUS M, 1985, HISTOCHEMISTRY, V82, P51, DOI 10.1007/BF00502091; Sledz CA, 2004, BIOCHEM SOC T, V32, P952, DOI 10.1042/BST0320952; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Vogel JL, 2000, EMBO J, V19, P683, DOI 10.1093/emboj/19.4.683; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	55	53	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2307	2319		10.1074/jbc.M806434200	http://dx.doi.org/10.1074/jbc.M806434200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19036724	Green Published, hybrid			2022-12-25	WOS:000262545600040
J	Spender, LC; Inman, GJ				Spender, Lindsay C.; Inman, Gareth J.			TGF-beta Induces Growth Arrest in Burkitt Lymphoma Cells via Transcriptional Repression of E2F-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK INHIBITOR P15(INK4B); EPSTEIN-BARR-VIRUS; HUMAN B-CELLS; C-MYC; UP-REGULATION; CYCLE ARREST; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; CANCER-CELLS; G(1) ARREST	Transforming growth factor-beta(TGF-beta) is a potent regulator of tissue homeostasis and can act as both a tumor suppressor and a tumor promoter. The ability to induce cell cycle arrest is a major component of the tumor suppressor function of TGF-beta. Lung, mammary, and skin epithelial cells exhibit a common minimal cytostatic program in response to TGF-beta signaling involving the repression of the growth-promoting factors c-MYC, Id1, Id2, and Id3. Loss of c-MYC expression is a pivotal event in this process, resulting in derepression of the cyclin-dependent kinase inhibitors CDKN1A (p21) and CDKN2B (p15) and ultimately leading to growth arrest. It is not clear, however, which responses are necessary for TGF-beta-mediated growth arrest in other cell types. Here, in human Burkitt lymphoma cells transformed by deregulated c-MYC expression, we demonstrate that efficient TGF-beta-induced cytostasis can occur despite both maintenance of c-MYC levels and a lack of p21 and p15 induction. TGF-beta treatment also results in induction, rather than repression, of Id1 and Id2 expression. In this context, growth arrest correlates with transcriptional repression of E2F-1, and overexpression of E2F-1 in Burkitt lymphoma cells largely overcomes the TGF-beta-mediated G(1) arrest phenotype. These data indicate that deregulation of c-MYC in lymphoma cells does not overcome the tumor suppressor function of TGF-beta and that repression of E2F-1 transcription is sufficient for the efficient induction of cytostasis.	[Spender, Lindsay C.; Inman, Gareth J.] Beatson Inst Canc Res, Growth Factor Signalling Lab, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Inman, GJ (corresponding author), Beatson Inst Canc Res, Growth Factor Signalling Lab, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	g.inman@beatson.gla.ac.uk		Inman, Gareth/0000-0002-6264-4253	Cancer Research UK; International Cancer Research	Cancer Research UK(Cancer Research UK); International Cancer Research	This work was supported by Cancer Research UK and an Association for International Cancer Research fellowship (to G.J.I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Cherney BW, 1997, CANCER RES, V57, P2508; Depoortere F, 2000, MOL BIOL CELL, V11, P1061, DOI 10.1091/mbc.11.3.1061; Doucet JP, 2004, LEUKEMIA LYMPHOMA, V45, P357, DOI 10.1080/10428190310001595713; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Iavarone A, 1997, NATURE, V387, P417; Inman GJ, 2000, J GEN VIROL, V81, P1567, DOI 10.1099/0022-1317-81-6-1567; Kamesaki H, 1998, J IMMUNOL, V160, P770; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kee BL, 2005, J IMMUNOL, V175, P4518, DOI 10.4049/jimmunol.175.7.4518; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kersten C, 2006, EXP HEMATOL, V34, P72, DOI 10.1016/j.exphem.2005.09.010; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Li JM, 1997, P NATL ACAD SCI USA, V94, P4948, DOI 10.1073/pnas.94.10.4948; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Rotzer D, 2006, ONCOGENE, V25, P2070, DOI 10.1038/sj.onc.1209230; Santoni-Rugiu E, 2002, ONCOGENE, V21, P6498, DOI 10.1038/sj.onc.1205828; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; SCHWARZ JK, 1995, P NATL ACAD SCI USA, V92, P483, DOI 10.1073/pnas.92.2.483; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siegel PM, 2003, J BIOL CHEM, V278, P35444, DOI 10.1074/jbc.M301413200; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Spender LC, 1999, J VIROL, V73, P4678, DOI 10.1128/JVI.73.6.4678-4688.1999; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100	43	28	30	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1435	1442		10.1074/jbc.M808080200	http://dx.doi.org/10.1074/jbc.M808080200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19022773	hybrid			2022-12-25	WOS:000262330100011
J	Waldo, J; Scherrer, M				Waldo, Jennifer; Scherrer, Michael			Production and Initial Characterization of Dad1p, a Component of the Dam1-DASH Kinetochore Complex	PLOS ONE			English	Article							DASH COMPLEX; MICROTUBULE INTERFACE; DAM1 COMPLEX; RING; DEPOLYMERIZATION; ARCHITECTURE; ATTACHMENT	In all dividing eukaryotic cells, the mitotic spindle (composed primarily of microtubules) must interact with chromosomes through a complex protein assembly called the kinetochore. In Saccharomyces cerevisiae, the Dam1-DASH complex plays an important role in promoting attachment between the kinetochore and the mitotic spindle. It also actively participates in the physical separation of sister chromatids in anaphase. Understanding the biochemical mechanisms used by Dam1-DASH has been facilitated by bacterial co-expression of the ten Dam1-DASH genes, which results in the production of a heterodecameric protein complex that can be studied in vitro. However, individual protein subunits are not soluble when expressed in E. coli, thus precluding analysis of the nature of the interaction between subunits and an examination of the assembly of the functional complex. In this paper, we describe the expression, solubilization, purification and refolding of Dad1p, one of the Dam1-DASH complex subunits. In addition, we show that Dad1p, when isolated in this manner forms dimers and/or tetramers, dependent upon protein concentration. This work provides an important tool for studying the Dam1-DASH complex that was previously unavailable, and provides an avenue of investigation for understanding how the individual heterodecamers associate with each other to facilitate chromosome segregation.	[Scherrer, Michael] SUNY Coll New Paltz, Dept Biol, New Paltz, NY USA	State University of New York (SUNY) System; SUNY New Paltz	Waldo, J (corresponding author), SUNY Coll New Paltz, Dept Biol, New Paltz, NY USA.	waldoj@newpaltz.edu			SUNY New Paltz [Provost's Research Award]; SUNY New Paltz Summer Undergraduate Research Experience program	SUNY New Paltz; SUNY New Paltz Summer Undergraduate Research Experience program	This work was supported by the Provost's Research Award of SUNY New Paltz, and by the SUNY New Paltz Summer Undergraduate Research Experience program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P6918, DOI 10.1073/pnas.0801811105; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Li J, 2005, MOL CELL BIOL, V25, P767, DOI 10.1128/MCB.25.2.767-778.2005; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Miranda JJL, 2007, MOL BIOL CELL, V18, P2503, DOI 10.1091/mbc.E07-02-0135; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	18	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3888	10.1371/journal.pone.0003888	http://dx.doi.org/10.1371/journal.pone.0003888			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065263	Green Published, Green Submitted, gold			2022-12-25	WOS:000265455200006
J	Van't Hof, AE; Marec, F; Saccheri, IJ; Brakefield, PM; Zwaan, BJ				Van't Hof, Arjen E.; Marec, Frantisek; Saccheri, Ilik J.; Brakefield, Paul M.; Zwaan, Bas J.			Cytogenetic Characterization and AFLP-Based Genetic Linkage Mapping for the Butterfly Bicyclus anynana, Covering All 28 Karyotyped Chromosomes	PLOS ONE			English	Article							EPHESTIA-KUEHNIELLA INSECTA; IN-SITU HYBRIDIZATION; BOMBYX-MORI; SEX-CHROMOSOME; W-CHROMOSOME; EVO-DEVO; MOLECULAR DIFFERENTIATION; CODLING MOTH; GENOME SIZE; MAP	Background: The chromosome characteristics of the butterfly Bicyclus anynana, have received little attention, despite the scientific importance of this species. This study presents the characterization of chromosomes in this species by means of cytogenetic analysis and linkage mapping. Methodology/Principal Findings: Physical genomic features in the butterfly B. anynana were examined by karyotype analysis and construction of a linkage map. Lepidoptera possess a female heterogametic W-Z sex chromosome system. The WZ-bivalent in pachytene oocytes of B. anynana consists of an abnormally small, heterochromatic W-chromosome with the Z-chromosome wrapped around it. Accordingly, the W-body in interphase nuclei is much smaller than usual in Lepidoptera. This suggests an intermediate stage in the process of secondary loss of the W-chromosome to a ZZ/Z sex determination system. Two nucleoli are present in the pachytene stage associated with an autosome and the WZ-bivalent respectively. Chromosome counts confirmed a haploid number of n = 28. Linkage mapping had to take account of absence of crossing-over in females, and of our use of a full-sib crossing design. We developed a new method to determine and exclude the non-recombinant uninformative female inherited component in offspring. The linkage map was constructed using a novel approach that uses exclusively JOINMAP-software for Lepidoptera linkage mapping. This approach simplifies the mapping procedure, avoids over-estimation of mapping distance and increases the reliability of relative marker positions. A total of 347 AFLP markers, 9 microsatellites and one single-copy nuclear gene covered all 28 chromosomes, with a mapping distance of 1354 cM. Conserved synteny of Tpi on the Z-chromosome in Lepidoptera was confirmed for B. anynana. The results are discussed in relation to other mapping studies in Lepidoptera. Conclusions/Significance: This study adds to the knowledge of chromosome structure and evolution of an intensively studied organism. On a broader scale it provides an insight in Lepidoptera sex chromosome evolution and it proposes a simpler and more reliable method of linkage mapping than used for Lepidoptera to date.	[Van't Hof, Arjen E.; Brakefield, Paul M.; Zwaan, Bas J.] Leiden Univ, Inst Biol, Dept Evolut Biol, NL-2300 RA Leiden, Netherlands; [Marec, Frantisek] Univ S Bohemia, Fac Biol Sci, Ceske Budejovice, Czech Republic; [Saccheri, Ilik J.] Univ S Bohemia, Inst Entomol, ASCR, Biol Ctr, Ceske Budejovice, Czech Republic; Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	Leiden University; Leiden University - Excl LUMC; Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Liverpool	Van't Hof, AE (corresponding author), Univ Liverpool, Sch Biol Sci, Biosci Bldg, Liverpool L69 3BX, Merseyside, England.	b.j.zwaan@biology.leidenuniv.nl	Marec, Frantisek/G-7943-2014; Zwaan, Bas J/D-8721-2015; Van 't Hof, Arjen/AAE-8044-2022	Marec, Frantisek/0000-0002-6745-5603; Zwaan, Bas J/0000-0002-8221-4998; 	Grant Agency of the Czech Republic (Prague) [206/06/1860]; Entomology Institute [Z50070508]	Grant Agency of the Czech Republic (Prague)(Grant Agency of the Czech Republic); Entomology Institute	The financing of the cytogenetic experiments was covered by grant 206/06/1860 of the Grant Agency of the Czech Republic (Prague) and from the Entomology Institute project Z50070508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2005, CYTOGENET GENOME RES, V110, P144, DOI 10.1159/000084946; Beldade P, 2005, EVOL DEV, V7, P101, DOI 10.1111/j.1525-142X.2005.05011.x; Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Blake T., 1999, J AGR GENOMICS, V4; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; BROWN KS, 1992, HEREDITAS, V117, P109, DOI 10.1111/j.1601-5223.1992.tb00165.x; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; DELESSE H, 1968, ANN SOC ENTOMOL FR, V4, P581; DELESSE H, 1962, B IFAN, V24, P464; DELESSE H, 1965, B IFAN, V27, P1089; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Fischer K, 2003, P ROY SOC B-BIOL SCI, V270, P2051, DOI 10.1098/rspb.2003.2470; Fukova I, 2005, GENOME, V48, P1083, DOI 10.1139/G05-063; Fukova I, 2007, CHROMOSOMA, V116, P135, DOI 10.1007/s00412-006-0086-0; Gawlowska M., 2005, Pisum Genetics, V37, P19; Gregory TR, 2003, CAN J ZOOL, V81, P1399, DOI 10.1139/Z03-126; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; HIRAI H, 1994, CHROMOSOMA, V103, P171, DOI 10.1007/s004120050021; Jiggins CD, 2005, GENETICS, V171, P557, DOI 10.1534/genetics.104.034686; Kandul NR, 2007, EVOLUTION, V61, P546, DOI 10.1111/j.1558-5646.2007.00046.x; Kapan DD, 2006, GENETICS, V173, P735, DOI 10.1534/genetics.106.057166; KING M, 1990, GENETICA, V80, P17, DOI 10.1007/BF00120116; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Marcus JM, 2004, P ROY SOC B-BIOL SCI, V271, pS263, DOI 10.1098/rsbl.2004.0175; Marec F, 2001, HEREDITY, V87, P659, DOI 10.1046/j.1365-2540.2001.00958.x; MAREC F, 1994, GENOME, V37, P426, DOI 10.1139/g94-060; Mediouni J, 2004, CARYOLOGIA, V57, P184, DOI 10.1080/00087114.2004.10589391; Miao XX, 2005, P NATL ACAD SCI USA, V102, P16303, DOI 10.1073/pnas.0507794102; Muranty H, 1997, GENET RES, V70, P259, DOI 10.1017/S0016672397003030; Pijpe J, 2008, AM NAT, V171, P81, DOI 10.1086/524200; PROMBOON A, 1995, GENET RES, V66, P1, DOI 10.1017/S0016672300034339; Prowell DP, 1998, ENDLESS FORMS, P309; REGIER JC, 2005, PROTOCOLS CONCEPTS R; Robinson R, 1971, LEPIDOPTERA GENETICS; Sahara K, 2003, CHROMOSOMA, V112, P48, DOI 10.1007/s00412-003-0245-5; Sewell MM, 1999, GENETICS, V151, P321; SHI JR, 1995, GENET RES, V66, P109, DOI 10.1017/S0016672300034467; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; SUOMALAINEN E, 1984, CHROMOSOMA, V90, P170, DOI 10.1007/BF00292393; Suomalainen E., 1969, CHROMOSOMES TODAY, V2, P132; Tan YD, 2001, GENETICS, V157, P1277; Tanaka N, 2000, HEREDITAS, V133, P95, DOI 10.1111/j.1601-5223.2000.t01-1-00095.x; Tobler A, 2005, HEREDITY, V94, P408, DOI 10.1038/sj.hdy.6800619; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Traut W, 1999, CHROMOSOMA, V108, P173, DOI 10.1007/s004120050366; Traut W, 1996, Q REV BIOL, V71, P239, DOI 10.1086/419371; TRAUT W, 1986, GENETICA, V70, P69, DOI 10.1007/BF00123216; TRAUT W, 1976, CHROMOSOMA, V58, P275, DOI 10.1007/BF00292094; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Van't Hof AE, 2007, HEREDITY, V98, P320, DOI 10.1038/sj.hdy.6800944; van't Hof AE, 2005, MOL ECOL NOTES, V5, P169, DOI 10.1111/j.1471-8286.2004.00870.x; Vitkova M, 2007, CHROMOSOME RES, V15, P917, DOI 10.1007/s10577-007-1173-7; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang BQ, 2004, GENETICS, V168, P215, DOI 10.1534/genetics.104.028118; WEITH A, 1986, CHROMOSOMA, V94, P125, DOI 10.1007/BF00286990; WHITE MJD, 1973, CHROMOSOMES; Wijngaarden PJ, 2000, HEREDITY, V85, P471, DOI 10.1046/j.1365-2540.2000.00786.x; Wolf KW, 1996, INT J INSECT MORPHOL, V25, P37, DOI 10.1016/0020-7322(95)00021-6; Yamamoto K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r21; Yamamoto K, 2006, GENETICS, V173, P151, DOI 10.1534/genetics.105.053801; Yasukochi Y, 1998, GENETICS, V150, P1513; Yasukochi Y, 2006, GENETICS, V173, P1319, DOI 10.1534/genetics.106.055541; Yoshido A, 2005, CHROMOSOMA, V114, P193, DOI 10.1007/s00412-005-0013-9; Yoshido A, 2005, GENETICS, V170, P675, DOI 10.1534/genetics.104.040352; Yoshido Atsuo, 2006, Journal of Insect Biotechnology and Sericology, V75, P147; Zijlstra WG, 2003, EVOLUTION, V57, P1852	69	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3882	10.1371/journal.pone.0003882	http://dx.doi.org/10.1371/journal.pone.0003882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060955	Green Published, gold			2022-12-25	WOS:000265455100005
J	Magalhaes, I; Sizemore, DR; Ahmed, RK; Mueller, S; Wehlin, L; Scanga, C; Weichold, F; Schirru, G; Pau, MG; Goudsmit, J; Kuhlmann-Berenzon, S; Spangberg, M; Andersson, J; Gaines, H; Thorstensson, R; Skeiky, YAW; Sadoff, J; Maeurer, M				Magalhaes, Isabelle; Sizemore, Donata R.; Ahmed, Raija K.; Mueller, Stefanie; Wehlin, Lena; Scanga, Charles; Weichold, Frank; Schirru, Giulia; Pau, Maria Grazia; Goudsmit, Jaap; Kuhlmann-Berenzon, Sharon; Spangberg, Mats; Andersson, Jan; Gaines, Hans; Thorstensson, Rigmor; Skeiky, Yasir A. W.; Sadoff, Jerry; Maeurer, Markus			rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector	PLOS ONE			English	Article								Background: BCG vaccination, combined with adenoviral-delivered boosts, represents a reasonable strategy to augment, broaden and prolong immune protection against tuberculosis (TB). We tested BCG (SSI1331) (in 6 animals, delivered intradermally) and a recombinant (rBCG) AFRO-1 expressing perfringolysin (in 6 animals) followed by two boosts (delivered intramuscullary) with non-replicating adenovirus 35 (rAd35) expressing a fusion protein composed of Ag85A, Ag85B and TB10.4, for the capacity to induce antigen-specific cellular immune responses in rhesus macaques (Macaca mulatta). Control animals received diluent (3 animals). Methods and Findings: Cellular immune responses were analyzed longitudinally (12 blood draws for each animal) using intracellular cytokine staining (TNF-alpha, IL-2 and IFN-gamma), T cell proliferation was measured in CD4(+), CD8alpha/beta(+), and CD8alpha/alpha(+) T cell subsets and IFN-gamma production was tested in 7 day PBMC cultures (whole blood cell assay, WBA) using Ag85A, Ag85B, TB10.4 recombinant proteins, PPD or BCG as stimuli. Animals primed with AFRO-1 showed i) increased Ag85B-specific IFN-gamma production in the WBA assay (median >400 pg/ml for 6 animals) one week after the first boost with adenoviral-delivered TB-antigens as compared to animals primed with BCG (< 200 pg/ml), ii) stronger T cell proliferation in the CD8alpha/alpha(+) T cell subset (proliferative index 17%) as compared to BCG-primed animals (proliferative index 5% in CD8alpha/alpha(+) T cells). Polyfunctional T cells, defined by IFN-gamma, TNF-alpha and IL-2 production were detected in 2/6 animals primed with AFRO-1 directed against Ag85A/b and TB10.4; 4/6 animals primed with BCG showed a Ag85A/b responses, yet only a single animal exhibited Ag85A/b and TB10.4 reactivity. Conclusion: AFRO-1 induces qualitatively and quantitatively different cellular immune responses as compared with BCG in rhesus macaques. Increased IFN-gamma-responses and antigen-specific T cell proliferation in the CD8alpha/alpha(+) T cell subset represents a valuable marker for vaccine-take in BCG-based TB vaccine trials	[Magalhaes, Isabelle; Maeurer, Markus] Karolinska Inst, Microbiol Tumor & Cell Biol Ctr, Solna, Sweden; [Magalhaes, Isabelle; Ahmed, Raija K.; Wehlin, Lena; Kuhlmann-Berenzon, Sharon; Spangberg, Mats; Gaines, Hans; Thorstensson, Rigmor; Maeurer, Markus] Swedish Inst Infect Dis Control, Solna, Sweden; [Sizemore, Donata R.; Mueller, Stefanie; Scanga, Charles; Weichold, Frank; Skeiky, Yasir A. W.; Sadoff, Jerry] Aeras Glob TB Vaccine Fdn, Rockville, MD USA; [Schirru, Giulia; Pau, Maria Grazia; Goudsmit, Jaap] Crucell Holland BV, Leiden, Netherlands; [Andersson, Jan] Karolinska Univ, Hosp Huddinge, Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Johnson & Johnson; Karolinska Institutet; Karolinska University Hospital	Magalhaes, I (corresponding author), Karolinska Inst, Microbiol Tumor & Cell Biol Ctr, Solna, Sweden.	markus.maeurer@ki.se	Magalhaes, Isabelle/AAC-7898-2020; Kühlmann-Berenzon, Sharon/J-1554-2019; Scanga, Charles/L-2353-2019	Magalhaes, Isabelle/0000-0003-0440-6924; Kühlmann-Berenzon, Sharon/0000-0002-8138-1196; Scanga, Charles/0000-0003-3654-5603; Maeurer, Markus/0000-0002-8436-8077	Aeras Foundation; Vetenskapsradet; Soderberg foundation; Karolinska Institutet; Marie Curie Host Fellowship for Early Stage Researchers Training	Aeras Foundation; Vetenskapsradet(Swedish Research Council); Soderberg foundation; Karolinska Institutet(Karolinska Institutet); Marie Curie Host Fellowship for Early Stage Researchers Training(European Commission)	This work was supported by the Aeras Foundation, Vetenskapsradet, the Soderberg foundation and Karolinska Institutet. IM is supported by a Marie Curie Host Fellowship for Early Stage Researchers Training. The authors state that they have a financial interest.	Allers K, 2008, J IMMUNOTHER, V31, P334, DOI 10.1097/CJI.0b013e3181635e7f; Barouch DH, 2005, HUM GENE THER, V16, P149, DOI 10.1089/hum.2005.16.149; Caruso AM, 1999, J IMMUNOL, V162, P5407; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dillon DC, 1999, INFECT IMMUN, V67, P2941, DOI 10.1128/IAI.67.6.2941-2950.1999; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Gaines H, 2000, METH MOL B, V134, P243; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Havenga M, 2006, J GEN VIROL, V87, P2135, DOI 10.1099/vir.0.81956-0; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; Konno A, 2002, BLOOD, V100, P4090, DOI 10.1182/blood-2002-04-1136; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Lacabaratz-Porret C, 2003, J INFECT DIS, V187, P748, DOI 10.1086/368333; Lagrelius M, 2006, CYTOKINE, V33, P156, DOI 10.1016/j.cyto.2006.01.005; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Magalhaes I, 2008, J IMMUNOTHER, V31, P840, DOI 10.1097/CJI.0b013e31818883a1; Majlessi L, 2006, INFECT IMMUN, V74, P2128, DOI 10.1128/IAI.74.4.2128-2137.2006; McMurray DN, 2000, CLIN INFECT DIS, V30, pS210, DOI 10.1086/313885; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Nanda A, 2005, J VIROL, V79, P14161, DOI 10.1128/JVI.79.22.14161-14168.2005; PORTNOY DA, 1992, INFECT IMMUN, V60, P2710, DOI 10.1128/IAI.60.7.2710-2717.1992; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Weichold FF, 2007, GENES IMMUN, V8, P334, DOI 10.1038/sj.gene.6364392; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992	34	75	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3790	10.1371/journal.pone.0003790	http://dx.doi.org/10.1371/journal.pone.0003790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023426	Green Submitted, gold, Green Published			2022-12-25	WOS:000265448800011
J	Zhou, T; Enyeart, PJ; Wilke, CO				Zhou, Tong; Enyeart, Peter J.; Wilke, Claus O.			Detecting Clusters of Mutations	PLOS ONE			English	Article							AMINO-ACID SITES; RELATIVE SOLVENT ACCESSIBILITY; ADAPTIVE PROTEIN EVOLUTION; SYNONYMOUS CODON USAGE; POSITIVE SELECTION; ESCHERICHIA-COLI; SECONDARY STRUCTURE; NATURAL-SELECTION; CRYSTAL-STRUCTURE; DROSOPHILA-MELANOGASTER	Positive selection for protein function can lead to multiple mutations within a small stretch of DNA, i.e., to a cluster of mutations. Recently, Wagner proposed a method to detect such mutation clusters. His method, however, did not take into account that residues with high solvent accessibility are inherently more variable than residues with low solvent accessibility. Here, we propose a new algorithm to detect clustered evolution. Our algorithm controls for different substitution probabilities at buried and exposed sites in the tertiary protein structure, and uses random permutations to calculate accurate P values for inferred clusters. We apply the algorithm to genomes of bacteria, fly, and mammals, and find several clusters of mutations in functionally important regions of proteins. Surprisingly, clustered evolution is a relatively rare phenomenon. Only between 2% and 10% of the genes we analyze contain a statistically significant mutation cluster. We also find that not controlling for solvent accessibility leads to an excess of clusters in terminal and solvent-exposed regions of proteins. Our algorithm provides a novel method to identify functionally relevant divergence between groups of species. Moreover, it could also be useful to detect artifacts in automatically assembled genomes.	[Zhou, Tong; Wilke, Claus O.] Univ Texas Austin, Sect Integrat Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Enyeart, Peter J.; Wilke, Claus O.] Univ Texas, Inst Cell & Mol Biol, Austin, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Zhou, T (corresponding author), Univ Texas Austin, Sect Integrat Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.	cwilke@mail.utexas.edu	Wilke, Claus O./B-4643-2008	Enyeart, Peter/0000-0002-1740-2570; Wilke, Claus/0000-0002-7470-9261	NIH [R01 AI065960]; Reeder Centennial Fellowship in Systematic and Evolutionary Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reeder Centennial Fellowship in Systematic and Evolutionary Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R01 AI065960 and by a Reeder Centennial Fellowship in Systematic and Evolutionary Biology to C.O.W.	Abramowitz M., 1965, HDB MATH FUNCTIONS; Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; AKASHI H, 1994, GENETICS, V136, P927; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berglund AC, 2005, J MOL EVOL, V60, P499, DOI 10.1007/s00239-004-0223-4; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Choi SC, 2007, MOL BIOL EVOL, V24, P1769, DOI 10.1093/molbev/msm097; CHRISTOPHER JA, 1996, P NATL ACAD SCI USA, V102, P1053; Chung JJ, 2002, TRENDS CELL BIOL, V12, P146, DOI 10.1016/S0962-8924(01)02241-3; Creighton T.E., 1992, PROTEINS STRUCTURES; Dagan T, 2002, MOL BIOL EVOL, V19, P1022, DOI 10.1093/oxfordjournals.molbev.a004161; Dean AM, 2002, MOL BIOL EVOL, V19, P1846, DOI 10.1093/oxfordjournals.molbev.a004009; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Eames M, 2007, STRUCTURE, V15, P1442, DOI 10.1016/j.str.2007.09.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fu YX, 1996, GENETICS, V143, P557; Fukushima M, 2002, J CLIN MICROBIOL, V40, P2779, DOI 10.1128/JCM.40.8.2779-2785.2002; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Ghosh D, 2001, J BIOL CHEM, V276, P18457, DOI 10.1074/jbc.M100538200; Giordani R, 2004, EUR J BIOCHEM, V271, P2400, DOI 10.1111/j.1432-1033.2004.04159.x; Goldman N, 1998, GENETICS, V149, P445; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hanada K, 2006, GENE, V385, P83, DOI 10.1016/j.gene.2006.06.029; Hirsh AE, 2005, MOL BIOL EVOL, V22, P174, DOI 10.1093/molbev/msh265; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; Hughes AL, 2008, P NATL ACAD SCI USA, V105, P13193, DOI 10.1073/pnas.0807440105; Hughes AL, 2008, IMMUNOGENETICS, V60, P495, DOI 10.1007/s00251-008-0304-4; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; JORNVALL H, 1993, FEBS LETT, V322, P240, DOI 10.1016/0014-5793(93)81578-N; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawabata T, 2002, NUCLEIC ACIDS RES, V30, P294, DOI 10.1093/nar/30.1.294; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; KOSHI JM, 1995, PROTEIN ENG, V8, P641; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liang H, 2006, NUCLEIC ACIDS RES, V34, pW382, DOI 10.1093/nar/gkl272; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Nguyen MN, 2005, PROTEINS, V59, P30, DOI 10.1002/prot.20404; Nickel GC, 2008, NUCLEIC ACIDS RES, V36, pD800, DOI 10.1093/nar/gkm764; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Nielsen R, 1998, GENETICS, V148, P929; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Oppermann U, 2007, ANNU REV PHARMACOL, V47, P293, DOI 10.1146/annurev.pharmtox.47.120505.105316; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Rao-Naik C, 1998, J BIOL CHEM, V273, P34976, DOI 10.1074/jbc.273.52.34976; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; RUIZHERRERA J, 1969, J BACTERIOL, V99, P720, DOI 10.1128/JB.99.3.720-729.1969; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sawicki MW, 1999, P NATL ACAD SCI USA, V96, P840, DOI 10.1073/pnas.96.3.840; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Smith NGC, 2003, J MOL EVOL, V57, P467, DOI 10.1007/s00239-003-2500-z; STENICO M, 1994, NUCLEIC ACIDS RES, V22, P2437, DOI 10.1093/nar/22.13.2437; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; SUKHWINDER SL, 2005, DRUG METAB DISPOS, V33, P254; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Suzuki Y, 2004, MOL BIOL EVOL, V21, P2352, DOI 10.1093/molbev/msh249; TAJIMA F, 1989, GENETICS, V123, P585; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Thompson MJ, 1996, PROTEINS, V25, P38, DOI 10.1002/(SICI)1097-0134(199605)25:1<38::AID-PROT4>3.3.CO;2-H; Wagner A, 2007, GENETICS, V176, P2451, DOI 10.1534/genetics.107.074732; Wall JD, 2000, GENETICS, V155, P1865; Xia XH, 1998, J MOL EVOL, V47, P557, DOI 10.1007/PL00006412; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	80	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3765	10.1371/journal.pone.0003765	http://dx.doi.org/10.1371/journal.pone.0003765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018282	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448500012
J	Rothmeier, AS; Ischenko, I; Joore, J; Garczarczyk, D; Furst, R; Bruns, CJ; Vollmar, AM; Zahler, S				Rothmeier, Andrea S.; Ischenko, Ivan; Joore, Jos; Garczarczyk, Dorota; Fuerst, Robert; Bruns, Christiane J.; Vollmar, Angelika M.; Zahler, Stefan			Investigation of the marine compound spongistatin 1 links the inhibition of PKC alpha translocation to nonmitotic effects of tubulin antagonism in angiogenesis	FASEB JOURNAL			English	Article						angiogenesis; microtubules; chemotaxis; protein kinase C	PROTEIN-KINASE-C; ENDOTHELIAL GROWTH-FACTOR; MICROTUBULE-TARGETING AGENTS; VASCULAR DISRUPTING AGENTS; CANCER-TREATMENT; CELLS; DRUGS; ACTIVATION; MECHANISMS; MIGRATION	The aims of the study were to meet the demand of new tubulin antagonists with fewer side effects by characterizing the antiangiogenic properties of the experimental compound spongistatin 1, and to elucidate nonmitotic mechanisms by which tubulin antagonists inhibit angiogenesis. Although tubulin-inhibiting drugs and their antiangiogenic properties have been investigated for a long time, surprisingly little is known about their underlying mechanisms of action. Antiangiogenic effects of spongistatin 1 were investigated in endothelial cells in vitro, including functional cell-based assays, live-cell imaging, and a kinome array, and in the mouse cornea pocket assay in vivo. Spongistatin 1 inhibited angiogenesis at nanomolar concentrations (IC50: cytotoxicity > 50 nM, proliferation 100 pM, migration 1.0 nM, tube formation 1.0 nM, chemotaxis 1.0 nM, aortic ring sprouting 500 pM, neovascularization in vivo 10 mu g/kg). Further, a kinome array and validating data showed that spongistatin 1 inhibits the phosphorylation activity of protein kinase C alpha (PKC alpha), an essential kinase in angiogenesis, and its translocation to the membrane. Thus, we conclude that PKC alpha might be an important target for the antiangiogenic effects of tubulin antagonism. In addition, the data from the kinase array suggest that different tubulin antagonists might have individual intracellular actions.-Rothmeier, A. S., Ischenko, I., Joore, J., Garczarczyk, D., Furst, R., Bruns, C. J., Vollmar, A. M., Zahler, S. Investigation of the marine compound spongistatin 1 links the inhibition of PKC alpha translocation to nonmitotic effects of tubulin antagonism in angiogenesis. FASEB J. 23, 1127-1137 (2009)	[Rothmeier, Andrea S.; Fuerst, Robert; Vollmar, Angelika M.; Zahler, Stefan] Univ Munich, Dept Pharm, Ctr Drug Res, D-81377 Munich, Germany; [Ischenko, Ivan; Bruns, Christiane J.] Univ Munich, Dept Surg, Klinikum Grosshadern, D-81377 Munich, Germany; [Joore, Jos] Pepscan Syst BV, Lelystad, Netherlands; [Garczarczyk, Dorota] Innsbruck Med Univ, Div Med Biochem, Innsbruck, Austria	University of Munich; University of Munich; Pepscan Therapeutics B.V.; Medical University of Innsbruck	Zahler, S (corresponding author), Univ Munich, Dept Pharm, Ctr Drug Res, Butenandtstr 5-13, D-81377 Munich, Germany.	stefan.zahler@cup.uni-muenchen.de	Fuerst, Robert/B-5815-2011; Ischenko, Ivan/A-4591-2011	Zahler, Stefan/0000-0002-5140-7287; Furst, Robert/0000-0002-9926-7578; Joore, Jos/0000-0002-2744-4862	European Community [LSHB-CT-2004-503467]	European Community(European Commission)	This work has been partially supported by the European Community (FP6-2002-Life Science & Health, Prokinase Research Project, project no. LSHB-CT-2004-503467).	Attard G, 2006, PATHOL BIOL, V54, P72, DOI 10.1016/j.patbio.2005.03.003; BAI RL, 1995, BIOCHEMISTRY-US, V34, P9714, DOI 10.1021/bi00030a009; BAI RL, 1993, MOL PHARMACOL, V44, P757; Battistella-Patterson AS, 2000, ACTA PHYSIOL SCAND, V170, P87, DOI 10.1046/j.1365-201x.2000.00755.x; Bijman MNA, 2006, MOL CANCER THER, V5, P2348, DOI 10.1158/1535-7163.MCT-06-0242; Broxterman HJ, 2005, DRUG RESIST UPDATE, V8, P183, DOI 10.1016/j.drup.2005.07.002; Cai SX, 2007, RECENT PAT ANTI-CANC, V2, P79, DOI 10.2174/157489207779561462; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gliki G, 2002, CELL BIOL INT, V26, P751, DOI 10.1016/S1065-6995(02)90926-1; Harrington EO, 1997, J BIOL CHEM, V272, P7390, DOI 10.1074/jbc.272.11.7390; Hinnen P, 2007, BRIT J CANCER, V96, P1159, DOI 10.1038/sj.bjc.6603694; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; KOBAYASHI M, 1993, TETRAHEDRON LETT, V34, P2795, DOI 10.1016/S0040-4039(00)73564-7; Li HG, 1998, MOL PHARMACOL, V53, P630, DOI 10.1124/mol.53.4.630; Meissner M, 2008, J INVEST DERMATOL, V128, P2084, DOI 10.1038/jid.2008.37; Mwanjewe J, 2001, BIOCHEM J, V359, P211, DOI 10.1042/0264-6021:3590211; Nakhost A, 2002, J BIOL CHEM, V277, P40633, DOI 10.1074/jbc.M205099200; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Omelchenko T, 2002, P NATL ACAD SCI USA, V99, P10452, DOI 10.1073/pnas.152339899; Pasquier E, 2007, CURR CANCER DRUG TAR, V7, P566, DOI 10.2174/156800907781662266; Pasquier E, 2006, DRUG RESIST UPDATE, V9, P74, DOI 10.1016/j.drup.2006.04.003; PETTIT GR, 1993, J ORG CHEM, V58, P1302, DOI 10.1021/jo00058a004; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; Schyschka L, 2008, LEUKEMIA, V22, P1737, DOI 10.1038/leu.2008.146; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Taylor Caroline J., 2006, Angiogenesis, V9, P39, DOI 10.1007/s10456-006-9028-y; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; UEDA M, 1994, J CELL SCI, V107, P2071; van Baal JWPM, 2006, CANCER RES, V66, P11605, DOI 10.1158/0008-5472.CAN-06-1370; Vincent L, 2005, J CLIN INVEST, V115, P2992, DOI 10.1172/JCI24586; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Wellner M, 1999, ARTERIOSCL THROM VAS, V19, P178, DOI 10.1161/01.ATV.19.1.178; Xu H, 2008, CARDIOVASC RES, V78, P349, DOI 10.1093/cvr/cvm085	36	28	28	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1127	1137		10.1096/fj.08-117127	http://dx.doi.org/10.1096/fj.08-117127			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19056838	Green Submitted			2022-12-25	WOS:000266651600016
J	Hohensinner, PJ; Kaun, C; Rychli, K; Niessner, A; Pfaffenberger, S; Rega, G; Furnkranz, A; Uhrin, P; Zaujec, J; Afonyushkin, T; Bochkov, VN; Maurer, G; Huber, K; Wojta, J				Hohensinner, P. J.; Kaun, C.; Rychli, K.; Niessner, A.; Pfaffenberger, S.; Rega, G.; Furnkranz, A.; Uhrin, P.; Zaujec, J.; Afonyushkin, T.; Bochkov, V. N.; Maurer, G.; Huber, K.; Wojta, J.			The inflammatory mediator oncostatin M induces stromal derived factor-1 in human adult cardiac cells	FASEB JOURNAL			English	Article						cytokine; heart	ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; MYOCARDIAL-INFARCTION; FACTOR EXPRESSION; TISSUE INHIBITOR; UP-REGULATION; STEM-CELLS; HEART; FIBROBLASTS; MYOCYTES	Stromal derived factor 1 (SDF-1) is a CXC chemokine important in the homing process of stem cells to injured tissue. It has been implicated in healing and tissue repair. Growing evidence suggests that the glycoprotein-130 (gp130) ligand family is involved in repair processes in the heart. The aim of our study was to determine whether gp130 ligands could affect SDF-1 expression in cardiac cells. Human adult cardiac myocytes (HACMs) and fibroblasts (HACFs) were treated with gp130 ligands. Protein and mRNA levels of SDF-1 were determined using ELISA and RT-PCR, respectively. mRNA levels of SDF-1 were determined in human and mouse heart samples by RT-PCR. HACMs and HACFs constitutively express SDF-1, which was significantly up-regulated by the gp130 ligand oncostatin M (OSM). This effect was counteracted by a p38 inhibitor and to a lesser extent by a PI3K inhibitor. mRNA expression of SDF-1 in hearts of mice injected with OSM increased significantly. Levels of OSM and SDF-1 mRNA correlated significantly in human failing hearts. Our data, showing that OSM induces SDF-1 protein secretion in human cardiac cells in vitro and murine hearts in vivo, suggest that OSM via the induction of SDF-1 might play a key role in repair and tissue regeneration.-Hohensinner, P. J., Kaun, C., Rychli, K., Niessner, A., Pfaffenberger, S., Rega, G., Furnkranz, A., Uhrin, P., Zaujec, J., Afonyushkin, T., Bochkov, V. N., Maurer, G., Huber, K., Wojta, J. The inflammatory mediator oncostatin M induces stromal derived factor-1 in human adult cardiac cells. FASEB J. 23, 774-782 (2009)	[Hohensinner, P. J.; Kaun, C.; Rychli, K.; Niessner, A.; Pfaffenberger, S.; Rega, G.; Maurer, G.; Wojta, J.] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria; [Uhrin, P.; Zaujec, J.; Afonyushkin, T.; Bochkov, V. N.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Vienna, Austria; [Hohensinner, P. J.; Wojta, J.] Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria; [Furnkranz, A.; Huber, K.] Wilhelminenhosp, Dept Med 3, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute; Wilhelminenspital	Wojta, J (corresponding author), Med Univ Vienna, Dept Internal Med 2, Waehringer Guertel 18-20, Vienna, Austria.	johann.wojta@meduniwien.ac.at	Kaun, Christoph/L-7543-2015; Wojta, Johann/AAC-8433-2020	Kaun, Christoph/0000-0003-3873-7246; Wojta, Johann/0000-0002-1282-9276; Maurer, Gerald/0000-0002-9043-7657; Kober-Rychli, Kathrin/0000-0001-6147-577X; Hohensinner, Philipp/0000-0003-4819-3190; Rega-Kaun, Gersina/0000-0002-3110-481X; Uhrin, Pavel/0000-0002-9792-3420	Fund for the Promotion of Scientific Research [S9409-B11]; Association for the Promotion of Research in Arteriosclerosis, Thrombosis, and Vascular Biology; Austrian Cardiologic Society	Fund for the Promotion of Scientific Research(Austrian Science Fund (FWF)); Association for the Promotion of Research in Arteriosclerosis, Thrombosis, and Vascular Biology; Austrian Cardiologic Society	This work was supported by the Fund for the Promotion of Scientific Research ( grant S9409-B11) and by the Association for the Promotion of Research in Arteriosclerosis, Thrombosis, and Vascular Biology. P.J.H. received a scholarship from the Austrian Cardiologic Society.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Amin MA, 2007, ARTHRITIS RHEUM-US, V56, P1787, DOI 10.1002/art.22705; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; Brar BK, 2001, CYTOKINE, V16, P93, DOI 10.1006/cyto.2001.0951; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cohen EBT, 2007, BIOCHEM PHARMACOL, V73, P77, DOI 10.1016/j.bcp.2006.09.007; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Demyanets S, 2006, THROMB HAEMOSTASIS, V95, P107, DOI 10.1160/TH05-05-0333; Demyanets S, 2007, AM J PHYSIOL-HEART C, V293, pH1962, DOI 10.1152/ajpheart.01366.2006; Ebelt H, 2007, STEM CELLS, V25, P236, DOI 10.1634/stemcells.2006-0374; Elmadbouh I, 2007, J MOL CELL CARDIOL, V42, P792, DOI 10.1016/j.yjmcc.2007.02.001; Fedyk ER, 2001, J IMMUNOL, V166, P5749, DOI 10.4049/jimmunol.166.9.5749; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Freed DH, 2003, MOL CELL BIOCHEM, V254, P247, DOI 10.1023/A:1027332504861; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Guan K, 2007, J MOL CELL CARDIOL, V43, P377, DOI 10.1016/j.yjmcc.2007.07.056; Gwechenberger M, 1999, CIRCULATION, V99, P546, DOI 10.1161/01.CIR.99.4.546; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Hohensinner PJ, 2007, J THROMB HAEMOST, V5, P2520, DOI 10.1111/j.1538-7836.2007.02784.x; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Kim KW, 2007, ARTHRITIS RHEUM-US, V56, P1076, DOI 10.1002/art.22439; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lafontant PJ, 2006, AM J PHYSIOL-CELL PH, V291, pC18, DOI 10.1152/ajpcell.00322.2005; Lee MJ, 2007, INT J BIOCHEM CELL B, V39, P650, DOI 10.1016/j.biocel.2006.11.003; Leone AM, 2006, INT J CARDIOL, V111, P202, DOI 10.1016/j.ijcard.2005.06.043; Ma N, 2005, CARDIOVASC RES, V66, P45, DOI 10.1016/j.cardiores.2004.12.013; Macfelda K, 2002, J MOL CELL CARDIOL, V34, P1681, DOI 10.1006/jmcc.2002.2117; Minehata K, 2006, INT J HEMATOL, V84, P319, DOI 10.1532/IJH97.06090; Modur V, 1997, J CLIN INVEST, V100, P158, DOI 10.1172/JCI119508; Ono K, 1998, CIRCULATION, V98, P149, DOI 10.1161/01.CIR.98.2.149; Pillarisetti K, 2001, INFLAMMATION, V25, P293, DOI 10.1023/A:1012808525370; Salvucci O, 2004, J LEUKOCYTE BIOL, V76, P217, DOI 10.1189/jlb.1203609; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Segret A, 2007, J HISTOCHEM CYTOCHEM, V55, P141, DOI 10.1369/jhc.6A7050.2006; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Sohara N, 2002, J HEPATOL, V36, P191, DOI 10.1016/S0168-8278(01)00265-3; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Tong L, 2004, CELL SIGNAL, V16, P1123, DOI 10.1016/j.cellsig.2004.03.003; Vandervelde S, 2005, J MOL CELL CARDIOL, V39, P363, DOI 10.1016/j.yjmcc.2005.05.012; Wang F, 2002, J MOL CELL CARDIOL, V34, P1309, DOI 10.1006/jmcc.2002.2059; Weiss TW, 2005, J MOL CELL CARDIOL, V39, P545, DOI 10.1016/j.yjmcc.2005.03.015; Weiss TW, 2004, J MOL CELL CARDIOL, V36, P539, DOI 10.1016/j.yjmcc.2004.02.001; Weiss TW, 2003, CARDIOVASC RES, V59, P628, DOI 10.1016/S0008-6363(03)00463-2; Yamani MH, 2005, J AM COLL CARDIOL, V46, P1029, DOI 10.1016/j.jacc.2005.04.059; Yue P, 1998, AM J PHYSIOL-HEART C, V275, pH250, DOI 10.1152/ajpheart.1998.275.1.H250; Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com	51	28	29	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					774	782		10.1096/fj.08-108035	http://dx.doi.org/10.1096/fj.08-108035			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19019853				2022-12-25	WOS:000265506300013
J	Arzoine, L; Zilberberg, N; Ben-Romano, R; Shoshan-Barmatz, V				Arzoine, Laetitia; Zilberberg, Noam; Ben-Romano, Ronit; Shoshan-Barmatz, Varda			Voltage-dependent Anion Channel 1-based Peptides Interact with Hexokinase to Prevent Its Anti-apoptotic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN HEXOKINASE; CYTOCHROME-C; CELL LIFE; MITOCHONDRIA; ACTIVATION; BINDING; VDAC; GLYCOLYSIS; CANCERS; DOMAIN	In brain and tumor cells, the hexokinase isoforms, HK-I and HK-II, bind to the voltage-dependent anion channel (VDAC) in the outer mitochondrial membrane. The VDAC domains interacting with these anti-apoptotic proteins were recently defined using site-directed mutagenesis. Now, we demonstrate that synthetic peptides corresponding to the VDAC1 N-terminal region and selected sequences bound specifically, in a concentration- and time-dependent manner, to immobilized HK-I, as revealed by real time surface plasmon resonance technology. The same VDAC1-based peptides also detached HK bound to brain or tumor-derived mitochondria. Moreover, expression of the VDAC1-based peptides in cells overexpressing HK-I or HK-II prevented HK-mediated protection against staurosporine-induced release of cytochrome c and subsequent cell death. One loop-shaped VDAC1-based peptide corresponding to a selected sequence and fused to a cell-penetrating peptide entered the cell and prevented the anti-apoptotic effects of HK-I and HK-II. This peptide detached mitochondrial-bound HK better than did the same peptide in its linear form. Both cell-expressed and exogenously added cell-penetrating peptide detached mitochondrial-bound HK-I-GFP. These results point to HK-I and HK-II as promoting tumor cell survival through binding to VDAC1, thereby inhibiting cytochrome c release and apoptotic cell death. Moreover, VDAC1-based peptides interfering with HK-mediated anti-apoptotic activity may potentiate the efficacy of conventional chemotherapeutic agents.	[Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, POB 653, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il	Zilberberg, Noam/F-2005-2012	Zilberberg, Noam/0000-0002-7848-2391	Israel Science Foundation; Johnson and Johnson Corporate Office of Science and Technology	Israel Science Foundation(Israel Science Foundation); Johnson and Johnson Corporate Office of Science and Technology(Johnson & JohnsonJohnson & Johnson USA)	This work was supported, in part, by grants from the Israel Science Foundation and the Johnson and Johnson Corporate Office of Science and Technology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Al jamal JA, 2005, PROTEIN J, V24, P1, DOI 10.1007/s10930-004-0600-2; ARORA KK, 1990, J BIOL CHEM, V265, P6481; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Beutner G, 1998, BBA-BIOMEMBRANES, V1368, P7, DOI 10.1016/S0005-2736(97)00175-2; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; De Pinto Vito, 2003, Ital J Biochem, V52, P17; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; Dinnen RD, 2007, J BIOL CHEM, V282, P26675, DOI 10.1074/jbc.M701864200; FANCIULLI M, 1994, ONCOL RES, V6, P405; GELB BD, 1992, P NATL ACAD SCI USA, V89, P202, DOI 10.1073/pnas.89.1.202; Geschwind JFH, 2002, CANCER RES, V62, P3909; Goldin N, 2008, ONCOGENE, V27, P4636, DOI 10.1038/onc.2008.108; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Holinger EP, 1999, J BIOL CHEM, V274, P13298, DOI 10.1074/jbc.274.19.13298; Jarver P, 2004, DRUG DISCOV TODAY, V9, P395, DOI 10.1016/S1359-6446(04)03042-9; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Moin SM, 2007, J BIOL CHEM, V282, P21124, DOI 10.1074/jbc.M701696200; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; Oudard Stephane, 2004, Bull Cancer, V91, pE184; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P1, DOI 10.1007/s10863-007-9070-5; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; POLAKIS PG, 1985, ARCH BIOCHEM BIOPHYS, V236, P328, DOI 10.1016/0003-9861(85)90633-2; Robey RB, 2005, CELL CYCLE, V4, P654, DOI 10.4161/cc.4.5.1678; Rotem R, 2005, CANCER RES, V65, P1984, DOI 10.1158/0008-5472.CAN-04-3091; Sade H, 2004, EUR J IMMUNOL, V34, P119, DOI 10.1002/eji.200324650; Schimmer AD, 2001, CELL DEATH DIFFER, V8, P725, DOI 10.1038/sj.cdd.4400870; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shinohara Y, 2000, EUR J BIOCHEM, V267, P6067, DOI 10.1046/j.1432-1327.2000.01687.x; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; Vyssokikh M, 2004, MOL CELL BIOCHEM, V256, P117, DOI 10.1023/B:MCBI.0000009863.69249.d9; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; WILSON JE, 1989, ARCH BIOCHEM BIOPHYS, V269, P517, DOI 10.1016/0003-9861(89)90135-5; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599	50	136	143	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3946	3955		10.1074/jbc.M803614200	http://dx.doi.org/10.1074/jbc.M803614200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19049977	hybrid			2022-12-25	WOS:000262872500063
J	Omura, A; Matsuzaki, T; Mio, K; Ogura, T; Yamamoto, M; Fujita, A; Okawa, K; Kitayama, H; Takahashi, C; Sato, C; Noda, M				Omura, Akira; Matsuzaki, Tomoko; Mio, Kazuhiro; Ogura, Toshihiko; Yamamoto, Mako; Fujita, Akiko; Okawa, Katsuya; Kitayama, Hitoshi; Takahashi, Chiaki; Sato, Chikara; Noda, Makoto			RECK Forms Cowbell-shaped Dimers and Inhibits Matrix Metalloproteinase-catalyzed Cleavage of Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MMP-REGULATOR RECK; AUTOMATIC PARTICLE PICKUP; FAS LIGAND; MATRILYSIN; METASTASIS; PROTEIN; ANGIOGENESIS; INVASION; RECONSTRUCTION; IDENTIFICATION	The membrane-anchored protease regulator RECK plays important roles in mammalian development and tumor suppression. The biochemical bases of these bioactivities, however, remain poorly understood. Here we report on the properties of a recombinant RECK protein expressed in mouse fibroblasts and purified to near homogeneity. Multiple lines of evidence indicate that RECK forms dimers. Single particle reconstruction using transmission electron microscopy revealed a unique cowbell-like shaped RECK dimer. RECK is cleaved by MMP-2 and MMP-7 and competitively inhibits MMP-7-catalyzed cleavage of fibronectin. Forced RECK expression in HT1080 cells, whose endogenous RECK expression is minimal, leads to an increase in the amount of fibronectin associated with the cell. Our data demonstrate the ability of RECK to protect fibronectin from MMP-mediated degradation.	[Omura, Akira; Matsuzaki, Tomoko; Yamamoto, Mako; Fujita, Akiko; Kitayama, Hitoshi; Takahashi, Chiaki; Noda, Makoto] Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 6068501, Japan; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Sakyo Ku, Kyoto 6068501, Japan; [Takahashi, Chiaki] Kyoto Univ, Grad Sch Med, Century COE Format 21st, Sakyo Ku, Kyoto 6068501, Japan; [Ogura, Toshihiko; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba 3058568, Japan; [Mio, Kazuhiro; Ogura, Toshihiko; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba 3058568, Japan; [Ogura, Toshihiko] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Kyoto University; Kyoto University; Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Noda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 6068501, Japan.	mnoda@virus.kyoto-u.ac.jp	Mio, Kazuhiro/L-7488-2018; Sato, Chikara/M-7183-2016; Ogura, Toshihiko/M-4089-2018	Mio, Kazuhiro/0000-0002-1655-8231; Sato, Chikara/0000-0001-5543-4496; Matsuzaki, Tomoko/0000-0002-9878-0433	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, and Science and Technology; New Energy and Industrial Technology Development Organization; Japan Science and Technology Agency	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, and Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant-in-aid for creative scientific research from Japan Society for the Promotion of Science, a grant-in-aid for priority areas (Structure of Biological Macromolecular Assemblies) from Ministry of Education, Culture, Sports, and Science and Technology, a grant from New Energy and Industrial Technology Development Organization, and a PRESTO grant from Japan Science and Technology Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Barilla ML, 2000, SEMIN ARTHRITIS RHEU, V29, P252, DOI 10.1016/S0049-0172(00)80012-8; Echizenya M, 2005, ONCOGENE, V24, P5850, DOI 10.1038/sj.onc.1208733; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Frank J, 2006, 3 DIMENSIONAL ELECT; FUKAI F, 1995, BIOCHEMISTRY-US, V34, P11453, DOI 10.1021/bi00036a018; Fukui N, 2002, J BIOL CHEM, V277, P2193, DOI 10.1074/jbc.M105485200; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; HARAUZ G, 1986, OPTIK, V73, P146; Itoh T, 1998, CANCER RES, V58, P1048; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Kawashima S, 2008, J NEUROCHEM, V104, P376, DOI 10.1111/j.1471-4159.2007.04977.x; Kondo S, 2007, J CELL SCI, V120, P849, DOI 10.1242/jcs.03388; Kozaki T, 2003, J BIOL CHEM, V278, P50546, DOI 10.1074/jbc.M307432200; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Miki T, 2007, J BIOL CHEM, V282, P12341, DOI 10.1074/jbc.M610948200; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MILLER AD, 1989, BIOTECHNIQUES, V7, P984; MILLER AD, 1989, BIOTECHNIQUES, V7, P989; Miyamoto S, 2004, CANCER RES, V64, P665, DOI 10.1158/0008-5472.CAN-03-1916; MIYAZAKI K, 1990, CANCER RES, V50, P7758; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Noda M, 2007, CANCER SCI, V98, P1659, DOI 10.1111/j.1349-7006.2007.00588.x; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; OLDEN K, 1977, CELL, V11, P957, DOI 10.1016/0092-8674(77)90307-5; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Sasahara RM, 1999, BIOCHEM BIOPH RES CO, V264, P668, DOI 10.1006/bbrc.1999.1552; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Simizu S, 2005, CANCER RES, V65, P7455, DOI 10.1158/0008-5472.CAN-04-4446; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620	48	47	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3461	3469		10.1074/jbc.M806212200	http://dx.doi.org/10.1074/jbc.M806212200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19022775	hybrid			2022-12-25	WOS:000262872500012
J	Scarselli, M; Donaldson, JG				Scarselli, Marco; Donaldson, Julie G.			Constitutive Internalization of G Protein-coupled Receptors and G Proteins via Clathrin-independent Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; BETA-ARRESTINS; MEDIATED ENDOCYTOSIS; DOWN-REGULATION; TRAFFICKING; ACTIVATION; ENDOSOMES; PATHWAYS; SEQUESTRATION; BINDING	Although agonist-dependent endocytosis of G protein-coupled receptors (GPCRs) as a means to modulate receptor signaling has been widely studied, the constitutive endocytosis of GPCRs has received little attention. Here we show that two prototypical class I GPCRs, the beta 2 adrenergic and M3 muscarinic receptors, enter cells constitutively by clathrin-independent endocytosis and colocalize with markers of this endosomal pathway on recycling tubular endosomes, indicating that these receptors can subsequently recycle back to the plasma membrane (PM). This constitutive endocytosis of these receptors was not blocked by antagonists, indicating that receptor signaling was not required. Interestingly, the G proteins that these receptors couple to, G alpha(s) and G alpha(q), localized together with their receptors at the plasma membrane and on tubular recycling endosomes. Upon agonist stimulation, G alpha(s) and G alpha(q) remained associated with the PM and these endosomal membranes, whereas beta 2 and M3 receptors now entered cells via clathrin-dependent endocytosis. Deletion of the third intracellular loop (i3 loop), which is thought to play a role in agonist-dependent endocytosis of the M3 receptor, had no effect on the constitutive internalization of the receptor. Surprisingly, with agonist, the mutated M3 receptor still internalized and accumulated in cells but through clathrin-independent and not clathrin-dependent endocytosis. These findings demonstrate that GPCRs are versatile PM proteins that can utilize different mechanisms of internalization depending upon ligand activation.	[Scarselli, Marco; Donaldson, Julie G.] NHLBI, NIH, Cell Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Donaldson, JG (corresponding author), NHLBI, NIH, Cell Biol Lab, Bldg 50,Rm 2503, Bethesda, MD 20892 USA.	jdonalds@helix.nih.gov		Scarselli, Marco/0000-0001-5087-3182	Intramural Research Program of the NHLBI; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000517, Z01HL000517] Funding Source: NIH RePORTER	Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of the NHLBI, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bohn LM, 2007, MOL PHARMACOL, V71, P957, DOI 10.1124/mol.107.034223; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Delaney KA, 2002, J BIOL CHEM, V277, P33439, DOI 10.1074/jbc.M205293200; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; LAMEH J, 1992, J BIOL CHEM, V267, P13406; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Maggio R, 1996, J BIOL CHEM, V271, P31055, DOI 10.1074/jbc.271.49.31055; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; MORO O, 1993, J BIOL CHEM, V268, P6862; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Nathanson NM, 2008, PHARMACOL THERAPEUT, V119, P33, DOI 10.1016/j.pharmthera.2008.04.006; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Novi F, 2005, J BIOL CHEM, V280, P19768, DOI 10.1074/jbc.M411281200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Popova JS, 2004, J BIOL CHEM, V279, P30410, DOI 10.1074/jbc.M402871200; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Roseberry AG, 1999, J BIOL CHEM, V274, P33671, DOI 10.1074/jbc.274.47.33671; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Vogler O, 1999, J BIOL CHEM, V274, P12333, DOI 10.1074/jbc.274.18.12333; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154	55	73	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3577	3585		10.1074/jbc.M806819200	http://dx.doi.org/10.1074/jbc.M806819200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19033440	hybrid, Green Published			2022-12-25	WOS:000262872500025
J	Menigatti, M; Truninger, K; Gebbers, JO; Marbet, U; Marra, G; Schar, P				Menigatti, M.; Truninger, K.; Gebbers, J-O; Marbet, U.; Marra, G.; Schaer, P.			Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters	ONCOGENE			English	Article						hMLH1; MGMT; promoter methylation; colorectal mucosa; colorectal cancer	NORMAL COLONIC-MUCOSA; CPG ISLAND METHYLATION; ABERRANT CRYPT FOCI; MICROSATELLITE INSTABILITY; GENE-EXPRESSION; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; PROXIMAL COLON; MLH1 PROMOTER; K-RAS; CANCER	Silencing of gene expression by aberrant cytosine methylation is a prominent feature of human tumors, including colorectal cancers. Epigenetic changes of this type play undisputed roles in cell transformation when they involve genes that safeguard genome stability, and they can also be detected in precancerous lesions and seemingly normal peritumoral tissues. We explored physiological conditions associated with aberrant promoter methylation involving two DNA-repair genes in normal colorectal mucosa. Samples of cecal, transverse colon, sigmoid and rectal mucosa collected from 100 healthy individuals undergoing screening colonoscopy were analysed for hMLH1 and MGMT promoter methylation with a quantitative PCR assay. Positivity in at least one colon segment was common in both sexes, with methylation involving 0.1-18.8% of the alleles (median = 0.49%). Samples from males showed no consistent patterns for either promoter, but there were striking age- and colon segment-specific differences in the female subgroup. Here, the prevalence of hMLH1 and MGMT methylation increased significantly with age, particularly in the right colon, where there was also an age- related increase in the percentage of alleles showing hMLH1 methylation. Concomitant methylation of both promoters was also significantly more common in the right colon of women. These findings paralleled immunohistochemical patterns of hMLH1 and MGMT protein loss in an independent series of 231 colorectal cancers and were consistent with current epigenetic profiles of colorectal cancer subsets. They suggest the intriguing possibility that the epigenetic signatures of cancers may have early-stage, normal-tissue counterparts that reflect potentially important aspects of the initial carcinogenetic process.	[Marra, G.] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Menigatti, M.; Schaer, P.] Univ Basel, Dept Biomed, Basel, Switzerland; [Truninger, K.] SRO Hosp Langenthal, Langenthal, Switzerland; [Gebbers, J-O] Cantonal Hosp Lucerne, Dept Pathol, Luzern, Switzerland; [Marbet, U.] Cantonal Hosp Altdorf, Clin Internal Med, Altdorf, Switzerland	University of Zurich; University of Basel; Lucerne Cantonal Hospital	Marra, G (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	marra@imcr.uzh.ch	Schär, Primo/G-5967-2012	Schär, Primo/0000-0003-1843-6147	Swiss National Science Foundation; Krebsliga Zentralschweiz; Krebsliga Beider Basel; Julius-Muller Stiftung, Zurich; Hanne-Liebermann Stiftung, Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Krebsliga Zentralschweiz; Krebsliga Beider Basel; Julius-Muller Stiftung, Zurich; Hanne-Liebermann Stiftung, Zurich	We thank Josef Jiricny at the Institute of Molecular Cancer Research of the University of Zurich and our colleagues at the Department of Biomedicine of the University of Basel for helpful discussions and support throughout the project. We are also grateful to Patric Urfer and Christophe Kunz for critical reading of the manuscript, Ritva Haider for technical assistance, and Marian E Kent for editorial assistance. The study was supported by the Swiss National Science Foundation (to GM), the Krebsliga Zentralschweiz (to GM), the Krebsliga Beider Basel (to PS), Julius-Muller Stiftung, Zurich (to KT) and the Hanne-Liebermann Stiftung, Zurich (to KT).	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Ahuja N, 1998, CANCER RES, V58, P5489; Al-Ghnaniem R, 2007, AM J CLIN NUTR, V86, P1064, DOI 10.1093/ajcn/86.4.1064; Anacleto C, 2005, NEOPLASIA, V7, P331, DOI 10.1593/neo.04502; Capel E, 2007, ONCOGENE, V26, P7596, DOI 10.1038/sj.onc.1210581; Chan AOO, 2002, AM J PATHOL, V160, P1823, DOI 10.1016/S0002-9440(10)61128-5; Deng GR, 1999, CANCER RES, V59, P2029; Esteller M, 2000, CANCER RES, V60, P2368; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fox EJ, 2006, J MOL DIAGN, V8, P68, DOI 10.2353/jmoldx.2006.050084; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Giovannucci E, 2005, JNCI-J NATL CANCER I, V97, P1317, DOI 10.1093/jnci/dji305; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Greenspan EJ, 2007, CARCINOGENESIS, V28, P769, DOI 10.1093/carcin/bgl209; Hiraoka S, 2006, GASTROENTEROLOGY, V131, P379, DOI 10.1053/j.gastro.2006.04.027; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JPJ, 2001, CANCER RES, V61, P3573; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; Kane MF, 1997, CANCER RES, V57, P808; Kawakami K, 2006, BRIT J CANCER, V94, P593, DOI 10.1038/sj.bjc.6602940; Kim SH, 2003, MOL CARCINOGEN, V37, P32, DOI 10.1002/mc.10116; Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661; Lindblom A, 2001, CURR OPIN ONCOL, V13, P63, DOI 10.1097/00001622-200101000-00013; Malkhosyan SR, 2000, GASTROENTEROLOGY, V119, P598, DOI 10.1053/gast.2000.16154; Menigatti M, 2001, GENE CHROMOSOME CANC, V31, P357, DOI 10.1002/gcc.1154; Menigatti M, 2007, ONCOL REP, V17, P1421; Minoo P, 2006, GUT, V55, DOI 10.1136/gut.2005.082859; Miyakura Y, 2001, GASTROENTEROLOGY, V121, P1300, DOI 10.1053/gast.2001.29616; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Nakagawa H, 2001, CANCER RES, V61, P6991; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Ogino S, 2007, GUT, V56, P1564, DOI 10.1136/gut.2007.119750; Percesepe A, 2001, J CLIN ONCOL, V19, P3944, DOI 10.1200/JCO.2001.19.19.3944; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Slattery ML, 2001, CANCER RES, V61, P126; Soetikno RM, 2008, JAMA-J AM MED ASSOC, V299, P1027, DOI 10.1001/jama.299.9.1027; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Truninger K, 2005, GASTROENTEROLOGY, V128, P1160, DOI 10.1053/j.gastro.2005.01.056; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Whitehall VLJ, 2001, CANCER RES, V61, P827; Xiong ZG, 2001, CANCER EPIDEM BIOMAR, V10, P799; Ye CZ, 2006, ONCOL REP, V16, P429	49	59	60	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					899	909		10.1038/onc.2008.444	http://dx.doi.org/10.1038/onc.2008.444			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19060925				2022-12-25	WOS:000263320000012
J	Maki, RA; Tyurin, VA; Lyon, RC; Hamilton, RL; DeKosky, ST; Kagan, VE; Reynolds, WF				Maki, Richard A.; Tyurin, Vladimir A.; Lyon, Robert C.; Hamilton, Ronald L.; DeKosky, Steven T.; Kagan, Valerian E.; Reynolds, Wanda F.			Aberrant Expression of Myeloperoxidase in Astrocytes Promotes Phospholipid Oxidation and Memory Deficits in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MILD COGNITIVE IMPAIRMENT; CORONARY-ARTERY-DISEASE; ACID RESPONSE ELEMENT; LIPID-PEROXIDATION; BREAST-CANCER; REDUCED RISK; POLYMORPHISM; PROTEIN; BRAIN; GENE	Myeloperoxidase (MPO) is expressed in Alzheimer disease ( AD) but not normal aged brain. A functional -463G/A MPO promoter polymorphism has been associated with AD risk through as yet unidentified mechanisms. Here we report that human MPO-463G allele, but not MPO-463A or mouse MPO, is strongly expressed in astrocytes and deposited in plaques in huMPO transgenic mice crossed to the APP23 model. MPO is similarly expressed in astrocytes in human AD tissue. In cortical homogenates of the MPOG-APP23 model, MPO expression correlated with increased levels of a lipid peroxidation product, 4-hydroxynonenal. Fluorescence high-performance liquid chromatography and electrospray ionization mass spectroscopy identified selective accumulation of phospholipid hydroperoxides in two classes of anionic phospholipids, phosphatidylserine (PS-OOH) and phosphatidylinositol (PI-OOH). The same molecular species of PS-OOH and PI-OOH were elevated in human AD brains as compared with non-demented controls. Augmented lipid peroxidation in MPOG-APP23 mice correlated with greater memory deficits. We suggest that aberrant huMPO expression in astrocytes leads to a specific pattern of phospholipid peroxidation and neuronal dysfunction contributing to AD.	[Maki, Richard A.; Lyon, Robert C.; Reynolds, Wanda F.] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; [Tyurin, Vladimir A.; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15219 USA; [Hamilton, Ronald L.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [DeKosky, Steven T.] Univ Pittsburgh, Dept Pathol & Neurol, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reynolds, WF (corresponding author), Sidney Kimmel Canc Ctr, 10905 Rd Cure, San Diego, CA 92121 USA.	wreynolds@skcc.org		DeKosky, Steven/0000-0003-3743-2758; Tyurin, Vladimir/0000-0002-3474-1697; Kagan, Valerian E./0000-0002-7245-1885	National Institutes of Health [AG-017879, HL088428, AG026539]; Pennsylvania Dept. of Health [4100027294]; PHS [R24-MH068855]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG026539, R01AG017879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Dept. of Health; PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG-017879, HL088428 ( to W. R.), and AG026539 ( to V. K.). This work was also supported by the Pennsylvania Dept. of Health ( Grant SAP 4100027294 to V. K.). Human brain tissue samples were generously provided by the Harvard Brain Repository, which is supported by PHS Grant R24-MH068855, and also by Douglas Walker ( Sun Health Research Institute), Eliezer Masliah, and Lawrence Hansen ( University of California at San Diego). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahn J, 2006, CLIN CANCER RES, V12, P7063, DOI 10.1158/1078-0432.CCR-06-0039; Ahn JY, 2004, CANCER RES, V64, P7634, DOI 10.1158/0008-5472.CAN-04-1843; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Ando Y, 1998, J NEUROL SCI, V156, P172, DOI 10.1016/S0022-510X(98)00042-2; Annangudi SP, 2008, CHEM RES TOXICOL, V21, P1384, DOI 10.1021/tx8000303; Asselbergs FW, 2004, AM J MED, V116, P429, DOI 10.1016/j.amjmed.2003.10.025; Astern JM, 2007, AM J PATHOL, V171, P349, DOI 10.2353/ajpath.2007.060831; Baldus S, 2001, J CLIN INVEST, V108, P1759; BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X; Borisenko GG, 2003, ARCH BIOCHEM BIOPHYS, V413, P41, DOI 10.1016/S0003-9861(03)00083-3; Bush AI, 2008, EUR BIOPHYS J BIOPHY, V37, P241, DOI 10.1007/s00249-007-0228-1; Butterfield DA, 2006, NEUROBIOL DIS, V22, P223, DOI 10.1016/j.nbd.2005.11.002; Butterfield DA, 2006, NEUROSCI LETT, V397, P170, DOI 10.1016/j.neulet.2005.12.017; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Cascorbi I, 2000, CANCER RES, V60, P644; Castellani LW, 2006, J LIPID RES, V47, P1366, DOI 10.1194/jlr.M600005-JLR200; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Choi DK, 2005, J NEUROSCI, V25, P6594, DOI 10.1523/JNEUROSCI.0970-05.2005; Crawford FC, 2001, EXP NEUROL, V167, P456, DOI 10.1006/exnr.2000.7560; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; FOLCH J, 1957, J BIOL CHEM, V226, P497; Green PS, 2004, J NEUROCHEM, V90, P724, DOI 10.1111/j.1471-4159.2004.02527.x; Heinecke JW, 2002, TOXICOLOGY, V177, P11, DOI 10.1016/S0300-483X(02)00192-0; Hoy A, 2002, CLIN CHEM LAB MED, V40, P2, DOI 10.1515/CCLM.2002.002; Kagan V E, 1998, Methods Mol Biol, V108, P71; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koudinov AR, 2001, FASEB J, V15, P1858, DOI 10.1096/fj.00-0815fje; Kumar AP, 2005, NITRIC OXIDE-BIOL CH, V13, P42, DOI 10.1016/j.niox.2005.04.002; Kumar AP, 2005, BIOCHEM BIOPH RES CO, V331, P442, DOI 10.1016/j.bbrc.2005.03.204; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; Lange MLB, 2008, NEUROBIOL DIS, V29, P456, DOI 10.1016/j.nbd.2007.11.004; Lebig J, 2007, APOPTOSIS, V12, P1803, DOI 10.1007/s10495-007-0113-5; Leininger-Muller B, 2003, NEUROSCI LETT, V349, P95, DOI 10.1016/S0304-3940(03)00795-X; Lovell MA, 2008, NEUROBIOL DIS, V29, P169, DOI 10.1016/j.nbd.2007.07.030; Lovell MA, 2007, J NEUROSCI RES, V85, P3036, DOI 10.1002/jnr.21346; Makela R, 2003, LAB INVEST, V83, P919, DOI 10.1097/01.LAB.0000077981.49367.46; Markesbery WR, 2007, ARCH NEUROL-CHICAGO, V64, P954, DOI 10.1001/archneur.64.7.954; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; Markesbery WR, 2005, ANN NEUROL, V58, P730, DOI 10.1002/ana.20629; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; McGrath LT, 2001, QJM-MON J ASSOC PHYS, V94, P485, DOI 10.1093/qjmed/94.9.485; Modi HR, 2008, J MEMBRANE BIOL, V221, P51, DOI 10.1007/s00232-007-9086-0; Moreira Paula I, 2005, Curr Alzheimer Res, V2, P403; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nikpoor B, 2001, AM HEART J, V142, P336, DOI 10.1067/mhj.2001.116769; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Picklo MJ, 2002, TOXICOL APPL PHARM, V184, P187, DOI 10.1006/taap.2002.9506; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Pope SK, 2006, AM J EPIDEMIOL, V163, P1084, DOI 10.1093/aje/kwj146; Reynolds WF, 2006, BIOCHEM BIOPH RES CO, V349, P846, DOI 10.1016/j.bbrc.2006.08.119; Reynolds WF, 2000, NEUROLOGY, V55, P1284, DOI 10.1212/WNL.55.9.1284; Reynolds WF, 1999, EXP NEUROL, V155, P31, DOI 10.1006/exnr.1998.6977; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Schabath MB, 2002, LUNG CANCER-J IASLC, V37, P35, DOI 10.1016/S0169-5002(02)00034-X; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sompol P, 2008, NEUROSCIENCE, V153, P120, DOI 10.1016/j.neuroscience.2008.01.044; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sultana R, 2006, NEUROBIOL AGING, V27, P1564, DOI 10.1016/j.neurobiolaging.2005.09.021; VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Williams TI, 2006, NEUROBIOL AGING, V27, P1094, DOI 10.1016/j.neurobiolaging.2005.06.004; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Yang JJ, 2001, AM J PATHOL, V158, P581, DOI 10.1016/S0002-9440(10)64000-X; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zappia M, 2004, ARCH NEUROL-CHICAGO, V61, P341, DOI 10.1001/archneur.61.3.341; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	76	91	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3158	3169		10.1074/jbc.M807731200	http://dx.doi.org/10.1074/jbc.M807731200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19059911	Green Published, hybrid			2022-12-25	WOS:000262700900060
J	Xiong, WF; Knispel, R; MacTaggart, J; Greiner, TC; Weiss, SJ; Baxter, T				Xiong, Wanfen; Knispel, Rebecca; MacTaggart, Jason; Greiner, Timothy C.; Weiss, Stephen J.; Baxter, Timothy			Membrane-type 1 Matrix Metalloproteinase Regulates Macrophage-dependent Elastolytic Activity and Aneurysm Formation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABDOMINAL AORTIC-ANEURYSMS; EXTRACELLULAR-MATRIX; 1-MATRIX METALLOPROTEINASE; ATHEROSCLEROTIC PLAQUES; MMP-2 ACTIVITY; MURINE MODEL; CELLS; EXPRESSION; MICE; LOCALIZATION	During arterial aneurysm formation, levels of the membrane-anchored matrix metalloproteinase, MT1-MMP, are elevated dramatically. Although MT1-MMP is expressed predominately by infiltrating macrophages, the roles played by the proteinase in abdominal aortic aneurysm (AAA) formation in vivo remain undefined. Using a newly developed chimeric mouse model of AAA, we now demonstrate that macrophage-derived MT1MMP plays a dominant role in disease progression. In wild-type mice transplanted with MT1-MMP-null marrow, aneurysm formation induced by the application of CaCl2 to the aortic surface was almost completely ablated. Macrophage infiltration into the aortic media was unaffected by MT1-MMP deletion, and AAA formation could be reconstituted when MT1-MMP+/+ macrophages, but not MT1-MMP+/+ lymphocytes, were infused into MT1-MMP-null marrow recipients. In vitro studies using macrophages isolated from either WT/MT1-MMP-/- chimeric mice, MMP-2-null mice, or MMP-9-null mice demonstrate that MT1-MMP alone plays a dominant role in macrophage-mediated elastolysis. These studies demonstrate that destruction of the elastin fiber network during AAA formation is dependent on macrophage-derived MT1-MMP, which unexpectedly serves as a direct-acting regulator of macrophage proteolytic activity.	[Xiong, Wanfen; Knispel, Rebecca; MacTaggart, Jason; Baxter, Timothy] Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68198 USA; [Greiner, Timothy C.; Baxter, Timothy] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Baxter, Timothy] Univ Nebraska, Med Ctr, Dept Cell Biol & Anat, Omaha, NE 68198 USA; [Weiss, Stephen J.] Univ Michigan, Dept Internal Med, Inst Life Sci, Div Mol Med & Genet, Ann Arbor, MI 48109 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Michigan System; University of Michigan	Xiong, WF (corresponding author), 987690 Nebraska Med Ctr, Omaha, NE 68198 USA.	wxiong@unmc.edu			National Institutes of Health [5RO1HL62400-02, RO1 CA088308]; American Heart Association [974015N]; NATIONAL CANCER INSTITUTE [R01CA088308] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1HL62400-02 ( to B. T. B.) and RO1 CA088308 ( to S. J. W.). This work was also supported by American Heart Association Grant 974015N ( to B. T. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BANDA MJ, 1987, METHOD ENZYMOL, V144, P288; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Chute JP, 2004, EXP HEMATOL, V32, P308, DOI 10.1016/j.exphem.2003.12.002; Crowther M, 2000, BRIT J SURG, V87, P1391, DOI 10.1046/j.1365-2168.2000.01554.x; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625, DOI 10.1161/01.ATV.18.10.1625; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Filippov S, 2003, J EXP MED, V198, P925, DOI 10.1084/jem.20030626; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Hayashi K, 2000, J PATHOL, V191, P299, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH637>3.0.CO;2-L; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Ichiyasu H, 2004, AM J RESP CELL MOL, V30, P761, DOI 10.1165/rcmb.2003-0370OC; Isenburg JC, 2007, CIRCULATION, V115, P1729, DOI 10.1161/CIRCULATIONAHA.106.672873; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kelleher CM, 2004, CURR TOP DEV BIOL, V62, P153; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Matias-Roman S, 2005, BLOOD, V105, P3956, DOI 10.1182/blood-2004-06-2382; Nollendorfs A, 2001, J VASC SURG, V34, P316, DOI 10.1067/mva.2001.115962; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rajavashisth TB, 1999, CIRCULATION, V99, P3103, DOI 10.1161/01.CIR.99.24.3103; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; Sinha I, 2004, SURGERY, V136, P176, DOI 10.1016/j.surg.2004.04.010; Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Xiong WF, 2004, J IMMUNOL, V172, P2607, DOI 10.4049/jimmunol.172.4.2607; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	34	72	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1765	1771		10.1074/jbc.M806239200	http://dx.doi.org/10.1074/jbc.M806239200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19010778	Green Published, hybrid			2022-12-25	WOS:000262330100047
J	van Rossum, DB; Oberdick, D; Rbaibi, Y; Bhardwaj, G; Barrow, RK; Nikolaidis, N; Snyder, SH; Kiselyov, K; Patterson, RL				van Rossum, Damian B.; Oberdick, Daniel; Rbaibi, Youssef; Bhardwaj, Gaurav; Barrow, Roxanne K.; Nikolaidis, Nikolas; Snyder, Solomon H.; Kiselyov, Kirill; Patterson, Randen L.			TRP_2, a Lipid/Trafficking Domain That Mediates Diacylglycerol-induced Vesicle Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH CONES; PROTEIN-KINASE-C; TRPC3 CHANNELS; CA2+ ENTRY; ACTIVATION; RECEPTOR; CELLS; REQUIREMENT; GUIDANCE; MUTATION	We recently modeled transient receptor potential (TRP) channels using the Gestalt Domain Detection Algorithm-Basic Local Alignment Tool (GDDA-BLAST), which derives structural, functional, and evolutionary information from primary amino acid sequences using phylogenetic profiles (Ko, K. D., Hong, Y., Chang, G. S., Bhardwaj, G., van Rossum, D. B., and Patterson, R. L. (2008) Physics Arch. Quant. Methods arXiv:0806.2394v1). Herein we test our functional predictions for the TRP_2 domain of TRPC3; a domain of unknown function that is conserved in all TRPC channels. Our functional models of this domain identify both lipid binding and trafficking activities. In this study, we reveal: (i) a novel structural determinant of ion channel sensitivity to lipids, (ii) a molecular mechanism for the difference between diacylglycerol (DAG)-sensitive and DAG-insensitive TRPC subfamilies, and (iii) evidence that TRPC3 can comprise part of the vesicle fusion machinery. Indeed, the TRPC3 TRP_2 domain mediates channel trafficking to the plasma membrane and binds to plasma membrane lipids. Further, mutations in TRP_2, which alter lipid binding, also disrupt the DAG-mediated fusion of TRPC3-containing vesicles with the plasma membrane without disrupting SNARE interactions. Importantly, these data agree with the known role of DAG in membrane destabilization, which facilitates SNARE-dependent synaptic vesicle fusion (Villar, A. V., Goni, F. M., and Alonso, A. (2001) FEBS Lett. 494, 117-120 and Goni, F. M., and Alonso, A. (1999) Prog. Lipid Res. 38, 1-48). Taken together, functional models generated by GDDA-BLAST provide a computational platform for deriving domain functionality, which can have in vivo and mechanistic relevance.	[van Rossum, Damian B.; Bhardwaj, Gaurav; Patterson, Randen L.] Penn State Univ, Ctr Computat Prote, University Pk, PA 16802 USA; [van Rossum, Damian B.; Bhardwaj, Gaurav; Nikolaidis, Nikolas; Patterson, Randen L.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Oberdick, Daniel; Rbaibi, Youssef; Kiselyov, Kirill] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Barrow, Roxanne K.; Snyder, Solomon H.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kiselyov, K (corresponding author), 519 Langley Hall,4249 5th Ave, Pittsburgh, PA 15260 USA.	kiselyov@pitt.edu; rlp25@psu.edu	Bhardwaj, Gaurav/H-7609-2016	Kiselyov, Kirill/0000-0001-6683-2895; van Rossum, Damian/0000-0003-1011-2586; Bhardwaj, Gaurav/0000-0001-6554-2335	Searle Young Investigators Award; NCSA [MCB070027N]; T. O. Magnetti Fund; ML4 Foundation [MH18501]; Research Scientist Award [DA00074]; Eberly College of Sciences; Huck Institutes of the Life Sciences; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074] Funding Source: NIH RePORTER	Searle Young Investigators Award; NCSA; T. O. Magnetti Fund; ML4 Foundation; Research Scientist Award; Eberly College of Sciences; Huck Institutes of the Life Sciences; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the Searle Young Investigators Award and start-up funds from PSU (to R. L. P.), NCSA Grant TG-MCB070027N (to R. L. P. and D. V. R.), the T. O. Magnetti Fund (to R. L. P. and D. V. R.), a grant from the ML4 Foundation (to K. K.), Grant MH18501, and Research Scientist Award DA00074 (to S. H. S.). This project was also funded by a fellowship from the Eberly College of Sciences and the Huck Institutes of the Life Sciences (to D. V. R.) and a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds (to D. V. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Chahl LA, 2007, BBA-MOL BASIS DIS, V1772, P968, DOI 10.1016/j.bbadis.2007.05.003; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Cozier GE, 2000, J BIOL CHEM, V275, P28261; Dietrich A, 2007, CELL CALCIUM, V42, P233, DOI 10.1016/j.ceca.2007.02.009; EKENA K, 1993, CIBA F SYMP, V176, P198; Firth AL, 2007, BBA-MOL BASIS DIS, V1772, P895, DOI 10.1016/j.bbadis.2007.02.009; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jordt S. E., 2007, V45, P253; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 2007, J PHYSIOL-LONDON, V578, P641, DOI 10.1113/jphysiol.2006.119024; KO KD, 2008, PHYS ARCH QUANT METH; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Kwan HY, 2006, J CELL PHYSIOL, V207, P315, DOI 10.1002/jcp.20567; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Soboloff J., 2007, V179, P575; Tabuchi K, 2005, NEUROSCI LETT, V382, P304, DOI 10.1016/j.neulet.2005.03.035; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Villar AV, 2001, FEBS LETT, V494, P117, DOI 10.1016/S0014-5793(01)02333-X; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	38	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34384	34392		10.1074/jbc.M804707200	http://dx.doi.org/10.1074/jbc.M804707200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	19043047	Green Published, hybrid			2022-12-25	WOS:000261277700066
J	Bishop, KL; Pai, AK; Schmitt, D				Bishop, Kristin L.; Pai, Anita K.; Schmitt, Daniel			Whole Body Mechanics of Stealthy Walking in Cats	PLOS ONE			English	Article							SYMMETRICAL GAITS; LOCOMOTION; DYNAMICS; PATTERNS	The metabolic cost associated with locomotion represents a significant part of an animal's metabolic energy budget. Therefore understanding the ways in which animals manage the energy required for locomotion by controlling muscular effort is critical to understanding limb design and the evolution of locomotor behavior. The assumption that energetic economy is the most important target of natural selection underlies many analyses of steady animal locomotion, leading to the prediction that animals will choose gaits and postures that maximize energetic efficiency. Many quadrupedal animals, particularly those that specialize in long distance steady locomotion, do in fact reduce the muscular contribution required for walking by adopting pendulum-like center of mass movements that facilitate exchange between kinetic energy (KE) and potential energy (PE) [1-4]. However, animals that are not specialized for long distance steady locomotion may face a more complex set of requirements, some of which may conflict with the efficient exchange of mechanical energy. For example, the "stealthy'' walking style of cats may demand slow movements performed with the center of mass close to the ground. Force plate and video data show that domestic cats (Felis catus, Linnaeus, 1758) have lower mechanical energy recovery than mammals specialized for distance. A strong negative correlation was found between mechanical energy recovery and diagonality in the footfalls and there was also a negative correlation between limb compression and diagonality of footfalls such that more crouched postures tended to have greater diagonality. These data show a previously unrecognized mechanical relationship in which crouched postures are associated with changes in footfall pattern which are in turn related to reduced mechanical energy recovery. Low energy recovery was not associated with decreased vertical oscillations of the center of mass as theoretically predicted, but rather with posture and footfall pattern on the phase relationship between potential and kinetic energy. An important implication of these results is the possibility of a tradeoff between stealthy walking and economy of locomotion. This potential tradeoff highlights the complex and conflicting pressures that may govern the locomotor choices that animals make.	[Bishop, Kristin L.] Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA; [Pai, Anita K.; Schmitt, Daniel] Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27706 USA	University of California System; University of California Davis; Duke University	Bishop, KL (corresponding author), Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA.	kvwbishop@ucdavis.edu			NSF [DBI-0630670, BCS-0452217]	NSF(National Science Foundation (NSF))	This work was supported by NSF awards DBI-0630670 to KLB and BCS-0452217 to DS.	Ahn AN, 2004, J EXP BIOL, V207, P399, DOI 10.1242/jeb.00761; Biewener AA, 2006, J EXP ZOOL PART A, V305A, P899, DOI 10.1002/jez.a.334; Biknevicius AR, 2007, J MORPHOL, V268, P1049; Biknevicius AR, 2006, J EXP ZOOL PART A, V305A, P923, DOI 10.1002/jez.a.332; Cartmill M, 2002, ZOOL J LINN SOC-LOND, V136, P401, DOI 10.1046/j.1096-3642.2002.00038.x; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; DEMES B, 1994, J HUM EVOL, V26, P353, DOI 10.1006/jhev.1994.1023; Farley CT, 1997, J EXP BIOL, V200, P2177; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Griffin TM, 2004, J EXP BIOL, V207, P3545, DOI 10.1242/jeb.01177; HEDRICK TL, 2005, DLT DATA VIEWER 2; Manter JT, 1938, J EXP BIOL, V15, P522; Parchman AJ, 2003, J EXP BIOL, V206, P1379, DOI 10.1242/jeb.00267; Reilly SM, 2007, ZOOLOGY, V110, P271, DOI 10.1016/j.zool.2007.01.003; Usherwood JR, 2007, J EXP BIOL, V210, P533, DOI 10.1242/jeb.02647; Zani PA, 2005, J EXP BIOL, V208, P1489, DOI 10.1242/jeb.01554	16	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3808	10.1371/journal.pone.0003808	http://dx.doi.org/10.1371/journal.pone.0003808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043580	Green Published, gold, Green Submitted			2022-12-25	WOS:000265451400001
J	Foller, M; Sopjani, M; Koka, S; Gu, SC; Mahmud, H; Wang, K; Floride, E; Schleicher, E; Schulz, E; Munzel, T; Lang, F				Foeller, Michael; Sopjani, Mentor; Koka, Saisudha; Gu, Shuchen; Mahmud, Hasan; Wang, Kan; Floride, Elisa; Schleicher, Erwin; Schulz, Eberhard; Muenzel, Thomas; Lang, Florian			Regulation of erythrocyte survival by AMP-activated protein kinase	FASEB JOURNAL			English	Article						cell volume; annexin; eryptosis; calcium; phosphatidylserine	PROGRAMMED CELL-DEATH; PHOSPHATIDYLSERINE EXPOSURE; CATION CONDUCTANCE; INHIBITION; STIMULATION; MECHANISMS; APOPTOSIS; ADHESION; CHANNELS; RECEPTOR	AMP-activated protein kinase (AMPK), an energy-sensing enzyme, counteracts energy depletion by stimulation of energy production and limitation of energy utilization. On energy depletion, erythrocytes undergo suicidal death or eryptosis, triggered by an increase in cytosolic Ca2+ activity ([Ca2+](i)) and characterized by cell shrinkage and phosphatidylserine (PS) exposure at the erythrocyte surface. The present study explored whether AMPK participates in the regulation of eryptosis. Western blotting and confocal microscopy disclosed AMPK expression in erythrocytes. [Ca2+](i) (Fluo3 fluorescence), cell volume (forward scatter), and PS exposure (annexin V binding) were determined by fluorescence-activated cell sorting (FACS) analysis. Glucose removal increased [Ca2+](i), decreased cell volume, and increased PS exposure. The AMPK-inhibitor compound C (20 mu M) did not significantly modify eryptosis under glucose-replete conditions but significantly augmented the eryptotic effect of glucose withdrawal. An increase in [Ca2+](i) by Ca2+ ionophore ionomycin triggered eryptosis, an effect blunted by the AMPK activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR; 1 mM). As compared with erythrocytes from wild-type littermates (ampk(+/+)), erythrocytes from AMPK alpha 1-deficient mice (ampk(-/-)) were significantly more susceptible to the eryptotic effect of energy depletion. The ampk(-/-) mice were anemic despite excessive reticulocytosis, and they suffered from severe splenomegaly, again pointing to enhanced erythrocyte turnover. The observations disclose a critical role of AMPK in the survival of circulating erythrocytes.-Foller, M., Sopjani, M., Koka, S., Gu, S., Mahmud, H., Wang, K., Floride, E., Schleicher, E., Schulz, E., Munzel, T., Lang, F. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J. 23, 1072-1080 (2009)	[Foeller, Michael] Univ Tubingen, Inst Physiol, Dept Physiol, D-72076 Tubingen, Germany; [Schleicher, Erwin] Univ Tubingen, Dept Endocrinol Diabet Vasc Med Nephrol & Clin Ch, D-72076 Tubingen, Germany; [Schulz, Eberhard; Muenzel, Thomas] Johannes Gutenberg Univ Mainz, Dept Cardiol, Mainz, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Johannes Gutenberg University of Mainz	Foller, M (corresponding author), Univ Tubingen, Inst Physiol, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de	Munzel, Thomas/A-2912-2014; koka, Saisudha/F-2381-2012	Munzel, Thomas/0000-0001-5503-4150; Sopjani, Mentor/0000-0002-4187-7218	Carl-Zeiss-Stiftung; Deutsche Forschungsgemeinschaft [GRK 1302, SFB 773, LA 315/13-3]	Carl-Zeiss-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We acknowledge the technical assistance of Vanessa Schnorr and Alejandro Hernandez Garcia and the meticulous preparation of the manuscript by Tanja Loch. We further thank Albrecht Pfafflin for helping to determine vitamins in murine plasma and Ulf Scheurlen for providing the animal blood counter. This study was supported by the Carl-Zeiss-Stiftung, and the Deutsche Forschungsgemeinschaft, GRK 1302, SFB 773, LA 315/13-3.	Andrews D A, 1999, Curr Opin Hematol, V6, P76, DOI 10.1097/00062752-199903000-00004; Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Bookchin R M, 1987, Prog Clin Biol Res, V240, P193; Brand VB, 2003, CELL PHYSIOL BIOCHEM, V13, P347, DOI 10.1159/000075122; Bratosin D, 2001, CELL DEATH DIFFER, V8, P1143, DOI 10.1038/sj.cdd.4400946; BRUGNARA C, 1993, J CLIN INVEST, V92, P520, DOI 10.1172/JCI116597; Carling David, 2007, Novartis Found Symp, V286, P72; CASKIN FS, 2007, AM J PHYSIOL-HEART C, V292, pH326; Chuang De-Maw, 2004, Critical Reviews in Neurobiology, V16, P83, DOI 10.1615/CritRevNeurobiol.v16.i12.90; Chung SM, 2007, ARTERIOSCL THROM VAS, V27, P414, DOI 10.1161/01.ATV.0000252898.48084.6a; Closse C, 1999, BRIT J HAEMATOL, V107, P300, DOI 10.1046/j.1365-2141.1999.01718.x; Daugas E, 2001, CELL DEATH DIFFER, V8, P1131, DOI 10.1038/sj.cdd.4400953; Duranton C, 2003, CELL PHYSIOL BIOCHEM, V13, P189, DOI 10.1159/000072421; Duranton C, 2002, J PHYSIOL-LONDON, V539, P847, DOI 10.1113/jphysiol.2001.013040; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Foller M, 2007, CELL PHYSIOL BIOCHEM, V20, P1051, DOI 10.1159/000110715; Gallagher PG, 2003, BLOOD, V101, P4625, DOI 10.1182/blood-2001-12-0329; Gulbins E, 2003, PHARMACOL RES, V47, P393, DOI 10.1016/S1043-6618(03)00052-5; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Horie T, 2008, J CELL PHYSIOL, V215, P733, DOI 10.1002/jcp.21353; Huber SM, 2001, PFLUG ARCH EUR J PHY, V441, P551, DOI 10.1007/s004240000456; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V293, pE286, DOI 10.1152/ajpendo.00693.2006; Kaestner L, 2004, THROMB HAEMOSTASIS, V92, P1269, DOI 10.1160/TH04-06-0338; Kempe DS, 2006, FASEB J, V20, P368, DOI 10.1096/fj.05-4872fje; Klarl BA, 2006, AM J PHYSIOL-CELL PH, V290, pC244, DOI 10.1152/ajpcell.00283.2005; Kohno D, 2008, BIOCHEM BIOPH RES CO, V366, P388, DOI 10.1016/j.bbrc.2007.11.166; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; Lang KS, 2004, AM J PHYSIOL-RENAL, V286, pF1046, DOI 10.1152/ajprenal.00263.2003; Lang KS, 2004, CELL DEATH DIFFER, V11, P231, DOI 10.1038/sj.cdd.4401311; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lang PA, 2003, CELL PHYSIOL BIOCHEM, V13, P337, DOI 10.1159/000075121; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Lang PA, 2006, CELL PHYSIOL BIOCHEM, V18, P151, DOI 10.1159/000095190; Lira VA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1062, DOI 10.1152/ajpendo.00045.2007; LOW PS, 1993, J BIOL CHEM, V268, P14627; Mayer A, 2008, EUR J IMMUNOL, V38, P948, DOI 10.1002/eji.200738045; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; Nicolay JP, 2008, PFLUG ARCH EUR J PHY, V456, P293, DOI 10.1007/s00424-007-0393-1; Nicolay JP, 2006, CELL PHYSIOL BIOCHEM, V18, P223, DOI 10.1159/000097669; Nicolay JP, 2007, CELL PHYSIOL BIOCHEM, V19, P175, DOI 10.1159/000099205; Pandolfi A, 2007, J CELL PHYSIOL, V213, P699, DOI 10.1002/jcp.21138; Schneider J, 2007, CELL PHYSIOL BIOCHEM, V20, P35, DOI 10.1159/000104151; Sell H, 2006, BIOCHEM BIOPH RES CO, V343, P700, DOI 10.1016/j.bbrc.2006.03.010; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Winder WW, 2007, CELL BIOCHEM BIOPHYS, V47, P332, DOI 10.1007/s12013-007-0008-7; Wood BL, 1996, BLOOD, V88, P1873; Zappulla Donatella, 2008, J Cardiometab Syndr, V3, P30, DOI 10.1111/j.1559-4572.2008.07263.x; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	51	173	175	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1072	1080		10.1096/fj.08-121772	http://dx.doi.org/10.1096/fj.08-121772			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19050047				2022-12-25	WOS:000266651600011
J	Chomel, C; Cazes, A; Faye, C; Bignon, M; Gomez, E; Ardidie-Robouant, C; Barret, A; Ricard-Blum, S; Muller, L; Germain, S; Monnot, C				Chomel, Clemence; Cazes, Aurelie; Faye, Clement; Bignon, Marine; Gomez, Elisa; Ardidie-Robouant, Corinne; Barret, Alain; Ricard-Blum, Sylvie; Muller, Laurent; Germain, Stephane; Monnot, Catherine			Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity	FASEB JOURNAL			English	Article						angiogenesis; extracellular matrix; endothelial cell; hypoxia	PROPROTEIN CONVERTASES; EXTRACELLULAR-MATRIX; TUMOR ANGIOGENESIS; CELL-SURFACE; PROTEIN-4; INHIBITION; METASTASIS; METABOLISM; OLIGOMERIZATION; ACTIVATION	Angiopoietin-like 4 (ANGPTL4) is involved in angiogenesis and lipid metabolism. It is secreted by liver and adipose tissues and cleaved to generate circulating coiled-coil domain (CCD) and fibrinogen-like domain (FLD) fragments. The full-length ANGPTL4 produced by hypoxic endothelial cells interacts with the extracellular matrix (ECM). The ECM-bound and soluble forms of ANGPTL4 have antiangiogenic properties. We carried out a structure-function analysis to investigate the regulation of ANGPTL4 bioactivity in endothelial cells. We found that the recombinant CCD binds to the ECM, whereas the FLD is released into the medium. The CCD, like the full-length ANGPTL4, binds to heparan and dermatan sulfates in surface plasmon resonance assays and inhibits endothelial cell adhesion, motility, and tubule-like formation. In endothelial cells, ANGPTL4 is processed in the secretion medium after release from the ECM. This processing is altered by the proprotein convertases inhibitor alpha 1-PDX and abolished by the mutation of the 161RRKR164 cleavage site without modification of the ECM binding and release. These data suggest that the full-length form, which interacts with heparan sulfate proteoglycans via its CCD, is protected from proteolysis by proprotein convertases and constitutes the major active pool of ANGPTL4 in hypoxic endothelial cells.-Chomel, C., Cazes, A., Faye, C., Bignon, M., Gomez, E., Ardidie-Robouant, C., Barret, A., Ricard-Blum, S., Muller, L., Germain, S., Monnot, C. Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity. FASEB J. 23, 940-949 (2009)	[Monnot, Catherine] Coll France, INSERM, U833, F-75005 Paris, France; [Chomel, Clemence; Bignon, Marine; Gomez, Elisa; Ardidie-Robouant, Corinne; Barret, Alain; Muller, Laurent; Germain, Stephane; Monnot, Catherine] Coll France, Expt Med Unit, F-75005 Paris, France; [Cazes, Aurelie] Hop Europeen Georges Pompidou, Serv Anat Pathol, Paris, France; [Germain, Stephane] Hop Europeen Georges Pompidou, Serv Hematol Biol A, Paris, France; [Faye, Clement; Ricard-Blum, Sylvie] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69365 Lyon, France; [Cazes, Aurelie] Fac Med Paris Descartes, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Paris Cite	Monnot, C (corresponding author), Coll France, INSERM, U833, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	catherine.monnot@college-de-france.fr	Perdiguero, Elisa Gomez/U-2120-2018; Germain, Stephane/E-2301-2016; muller, laurent/S-1990-2016; Monnot, Catherine/E-5861-2017	Perdiguero, Elisa Gomez/0000-0002-7717-7897; Germain, Stephane/0000-0001-5992-1275; muller, laurent/0000-0001-9634-4323; Monnot, Catherine/0000-0003-1334-7348; RICARD-BLUM, Sylvie/0000-0001-9263-1851	European Vascular Genomics Network [LSHMCT-2003503254]; Agence Nationale de la Recherche [ANR-06-JCJC-0160]	European Vascular Genomics Network; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the European Vascular Genomics Network (http:// www. evgn. org; contract LSHMCT-2003503254) and by a grant from the Agence Nationale de la Recherche (ANR-06-JCJC-0160). We thank Eric Etienne for technical help in confocal microscopy, videomicroscopy, and cell tracking.	Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hermann LM, 2005, CLIN IMMUNOL, V115, P93, DOI 10.1016/j.clim.2004.12.002; Ito Y, 2003, CANCER RES, V63, P6651; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kelly T, 2003, CANCER RES, V63, P8749; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Ricard-Blum S, 2006, J BIOL CHEM, V281, P25195, DOI 10.1074/jbc.M603096200; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Tsuji A, 2003, BBA-PROTEINS PROTEOM, V1645, P95, DOI 10.1016/S1570-9639(02)00532-0; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Xu Y, 2004, CANCER RES, V64, P6119, DOI 10.1158/0008-5472.CAN-04-1054; Xu Y, 2004, J BIOL CHEM, V279, P41179, DOI 10.1074/jbc.M400292200; Xu Y, 2001, J BIOL CHEM, V276, P34990, DOI 10.1074/jbc.M103661200; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776	28	71	73	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					940	949		10.1096/fj.08-115170	http://dx.doi.org/10.1096/fj.08-115170			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19019854				2022-12-25	WOS:000265506300029
J	Russo, S; Schweitzer, JE; Polen, T; Bott, M; Pohl, E				Russo, Santina; Schweitzer, Jens-Eric; Polen, Tino; Bott, Michael; Pohl, Ehmke			Crystal Structure of the Caseinolytic Protease Gene Regulator, a Transcriptional Activator in Actinomycetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; HEAT-SHOCK RESPONSE; BACILLUS-SUBTILIS; MACROMOLECULAR CRYSTALLOGRAPHY; CORYNEBACTERIUM-GLUTAMICUM; STREPTOMYCES-LIVIDANS; STRUCTURE VALIDATION; DIFFRACTION DATA; HIGH-RESOLUTION; CLGR	Human pathogens of the genera Corynebacterium and Mycobacterium possess the transcriptional activator ClgR (clp gene regulator) which in Corynebacterium glutamicum has been shown to regulate the expression of the ClpCP protease genes. ClgR specifically binds to pseudo-palindromic operator regions upstream of clpC and clpP1P2. Here, we present the first crystal structure of a ClgR protein from C. glutamicum. The structure was determined from two different crystal forms to resolutions of 1.75 and 2.05 angstrom, respectively. ClgR folds into a five-helix bundle with a helix-turn-helix motif typical for DNA-binding proteins. Upon dimerization the two DNA-recognition helices are arranged opposite to each other at the protein surface in a distance of similar to 30 angstrom, which suggests that they bind into two adjacent major grooves of B-DNA in an anti-parallel manner. A binding pocket is situated at a strategic position in the dimer interface and could possess a regulatory role altering the positions of the DNA-binding helices.	[Schweitzer, Jens-Eric; Polen, Tino; Bott, Michael] Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany; [Russo, Santina] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Pohl, Ehmke] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Pohl, Ehmke] Univ Durham, Sch Biol & Biomed Sci, Univ Sci Labs, Durham DH1 3LE, England	Helmholtz Association; Research Center Julich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Durham University; Durham University	Bott, M (corresponding author), Forschungszentrum Julich, Inst Biotechnol 1, Postfach 1913, D-52425 Julich, Germany.	m.bott@fz-juelich.de; ehmke.pohl@durham.ac.uk	Polen, Tino/G-4017-2016; Pohl, Ehmke/I-2408-2012; Bott, Michael/E-8004-2011	Polen, Tino/0000-0002-0065-3007; Pohl, Ehmke/0000-0002-9949-4471; Bott, Michael/0000-0002-4701-8254				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Albright RA, 1998, J MOL BIOL, V280, P137, DOI 10.1006/jmbi.1998.1848; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Bellier A, 2006, MICROBIOL-SGM, V152, P1021, DOI 10.1099/mic.0.28564-0; Bellier A, 2004, J BACTERIOL, V186, P3238, DOI 10.1128/JB.186.10.3238-3248.2004; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Derre I, 1999, MOL MICROBIOL, V32, P581, DOI 10.1046/j.1365-2958.1999.01374.x; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diederichs K, 2003, ACTA CRYSTALLOGR D, V59, P903, DOI 10.1107/S0907444903006516; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engels S, 2005, MOL MICROBIOL, V57, P576, DOI 10.1111/j.1365-2958.2005.04710.x; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kruger E, 1998, J BACTERIOL, V180, P6681; Kruger E, 2001, EMBO J, V20, P852, DOI 10.1093/emboj/20.4.852; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeehan JE, 2005, J MOL BIOL, V346, P689, DOI 10.1016/j.jmb.2004.12.025; MONDRAGON A, 1991, J MOL BIOL, V219, P321, DOI 10.1016/0022-2836(91)90568-Q; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Pohl E., 2006, SYNCHROTRON RAD NEWS, V19, P24; Sawaya MR, 2005, STRUCTURE, V13, P1837, DOI 10.1016/j.str.2005.08.017; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHIMON LJW, 1993, J MOL BIOL, V232, P826, DOI 10.1006/jmbi.1993.1434; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turgay K, 1998, EMBO J, V17, P6730; Ventura M, 2005, J BACTERIOL, V187, P8411, DOI 10.1128/JB.187.24.8411-8426.2005; Viala J, 2002, MOL MICROBIOL, V44, P633, DOI 10.1046/j.1365-2958.2002.02907.x; Wennerhold J, 2005, J BIOL CHEM, V280, P40500, DOI 10.1074/jbc.M508693200; WOLBERGER C, 1988, NATURE, V335, P789, DOI 10.1038/335789a0	42	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5208	5216		10.1074/jbc.M806591200	http://dx.doi.org/10.1074/jbc.M806591200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19019826	Green Published, hybrid			2022-12-25	WOS:000263416600051
J	Lara, E; Mai, A; Calvanese, V; Altucci, L; Lopez-Nieva, P; Martinez-Chantar, ML; Varela-Rey, M; Rotili, D; Nebbioso, A; Ropero, S; Montoya, G; Oyarzabal, J; Velasco, S; Serrano, M; Witt, M; Villar-Garea, A; Inhof, A; Mato, JM; Esteller, M; Fraga, MF				Lara, E.; Mai, A.; Calvanese, V.; Altucci, L.; Lopez-Nieva, P.; Martinez-Chantar, M. L.; Varela-Rey, M.; Rotili, D.; Nebbioso, A.; Ropero, S.; Montoya, G.; Oyarzabal, J.; Velasco, S.; Serrano, M.; Witt, M.; Villar-Garea, A.; Inhof, A.; Mato, J. M.; Esteller, M.; Fraga, M. F.			Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect	ONCOGENE			English	Article						HDACs inhibitors; Sirtuins; cancer; apoptosis	HISTONE DEACETYLASE INHIBITORS; SMALL-MOLECULE INHIBITOR; DNA-DAMAGE; SIR2; P53; DISCOVERY; IDENTIFICATION; NICOTINAMIDE; MECHANISM; SURVIVAL	Sirtuin 1 (Sirt1) and Sirtuin 2 (Sirt2) belong to the family of NAD+(nicotinamide adenine dinucleotide-positive)dependent class III histone deacetylases and are involved in regulating lifespan. As cancer is a disease of ageing, targeting Sirtuins is emerging as a promising antitumour strategy. Here we present Salermide (N-{3-[(2-hydroxynaphthalen-1-ylmethylene)-amino]-phenyl}-2-phenyl-propionamide), a reverse amide with a strong in vitro inhibitory effect on Sirt1 and Sirt2. Salermide was well tolerated by mice at concentrations up to 100 mu M and prompted tumour-specific cell death in a wide range of human cancer cell lines. The antitumour activity of Salermide was primarily because of a massive induction of apoptosis. This was independent of global tubulin and K16H4 acetylation, which ruled out a putative Sirt2-mediated apoptotic pathway and suggested an in vivo mechanism of action through Sirt1. Consistently with this, RNA interference-mediated knockdown of Sirt1, but not Sirt2, induced apoptosis in cancer cells. Although p53 has been reported to be a target of Sirt1, genetic p53 knockdowns showed that the Sirt1-dependent proapoptotic effect of Salermide is p53-independent. We were finally able to ascribe the apoptotic effect of Salermide to the reactivation of proapoptotic genes epigenetically repressed exclusively in cancer cells by Sirt1. Taken together, our results underline Salermide's promise as an anticancer drug and provide evidence for the molecular mechanism through which Sirt1 is involved in human tumorigenesis.	[Lara, E.; Calvanese, V.; Lopez-Nieva, P.; Ropero, S.; Fraga, M. F.] CNIO, Spanish Natl Canc Res Ctr, Canc Epigenet Lab, E-28029 Madrid, Spain; [Mai, A.; Rotili, D.] Univ Roma La Sapienza, Dipartimento Studi Farmaceut, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Altucci, L.; Nebbioso, A.] Univ Naples 2, Dipartimento Patol Gen, Naples, Italy; [Martinez-Chantar, M. L.; Varela-Rey, M.; Mato, J. M.] CIC BioGUNE, CIBERehd, Bizkaia, Spain; [Montoya, G.] CNIO, Spanish Natl Canc Res Ctr, Ctr Macromol Crystallog, E-28029 Madrid, Spain; [Oyarzabal, J.] CNIO, Spanish Natl Canc Res Ctr, Computat Chem Grp, E-28029 Madrid, Spain; [Velasco, S.; Serrano, M.] CNIO, Spanish Natl Canc Res Ctr, Tumour Suppress Grp, E-28029 Madrid, Spain; [Witt, M.] Bruker Daltonik GmbH, Bremen, Germany; [Villar-Garea, A.; Inhof, A.] Univ Munich, Histone Modificat Grp, Adolf Butenandt Inst, Munich, Germany; [Esteller, M.] ICO, PEBC, Barcelona, Spain; [Fraga, M. F.] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Fondazione Cenci Bolognetti; Sapienza University Rome; Universita della Campania Vanvitelli; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Bruker Corporation; Bruker Daltonik GmbH; University of Munich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Fraga, MF (corresponding author), CNIO, Spanish Natl Canc Ctr, Canc Epigenet Lab, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mesteller@cnio.es; mffraga@cnio.es	Calvanese, Vincenzo/AAO-4311-2020; NEBBIOSO, ANGELA/GVS-1294-2022; Varela-Rey, Marta/C-5460-2019; Fraga, Mario F/H-7824-2017; Altucci, Lucia/S-8031-2019; Oyarzabal, Julen/K-7393-2017; MATO, JOSE/A-5187-2011; Chantar, Maria Luz Martinez/F-5190-2011; Rotili, Dante/J-9157-2016; Mai, Antonello/AAC-2144-2019; Nieva, Pilar López/R-9516-2019; Calvanese, Vincenzo/E-1145-2016; Serrano, Manuel/H-2634-2015; Esteller, Manel/L-5956-2014; NEBBIOSO, Angela/C-3566-2016	Calvanese, Vincenzo/0000-0002-7937-1511; Fraga, Mario F/0000-0001-8450-2603; Oyarzabal, Julen/0000-0003-1941-7255; MATO, JOSE/0000-0003-1264-3153; Chantar, Maria Luz Martinez/0000-0002-6446-9911; Nieva, Pilar López/0000-0001-6369-2444; Calvanese, Vincenzo/0000-0002-7937-1511; Serrano, Manuel/0000-0001-7177-9312; Esteller, Manel/0000-0003-4490-6093; altucci, lucia/0000-0002-7312-5387; NEBBIOSO, Angela/0000-0001-5374-3527; Villar Garea, Ana/0000-0001-8960-1635; Rotili, Dante/0000-0002-8428-8763; Varela-Rey, Marta/0000-0002-2413-8659; Mai, Antonello/0000-0001-9176-2382	European Union [LSHG-CT-2006-037415]; Spanish Ramon & Cajal Programme; Health Department of the Spanish Government [PI061267]; Health and Education and Science Departments of the Spanish Government [FIS01-04, I+D+I MCYT08-03, FU2004-02073/BMC, MEC09-05]; European Grant [TRANSFOG LSHC-CT-2004-503438, EPITRON LSHC-CT2005- 518417, APO-SYS HEALTH-F4-2007-200767]; Spanish Association Against Cancer; FIS Spanish Research Program; FPU Spanish Research Program;  [PRIN2006];  [AICR2007]	European Union(European Commission); Spanish Ramon & Cajal Programme(Spanish Government); Health Department of the Spanish Government; Health and Education and Science Departments of the Spanish Government; European Grant; Spanish Association Against Cancer; FIS Spanish Research Program; FPU Spanish Research Program(Spanish Government); ; 	This work was primarily supported by the European Union (LSHG-CT-2006-037415). MFF is funded by the Spanish Ramon & Cajal Programme and the Health Department of the Spanish Government (PI061267). Thanks are due to PRIN2006 (AM) and AICR2007 (AM) for grants. The Cancer Epigenetics group at the CNIO is supported by the Health (FIS01-04) and Education and Science (I+D+I MCYT08-03, FU2004-02073/BMC and Consolider MEC09-05) Departments of the Spanish Government, the European Grant TRANSFOG LSHC-CT-2004-503438, EPITRON LSHC-CT2005- 518417, APO-SYS HEALTH-F4-2007-200767 and the Spanish Association Against Cancer (AECC). EL is a recipient of a fellowship from the FIS Spanish Research Program. VC is a recipient of a Fellowship from the FPU Spanish Research Program.	Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Clark AM, 2006, J CHEM INF MODEL, V46, P1107, DOI 10.1021/ci050550m; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Herranz M, 2006, BLOOD, V107, P1174, DOI 10.1182/blood-2005-05-2033; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huhtiniemi T, 2006, J COMPUT AID MOL DES, V20, P589, DOI 10.1007/s10822-006-9084-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kamel C, 2006, AGING CELL, V5, P81, DOI 10.1111/j.1474-9726.2006.00191.x; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mai A, 2005, J MED CHEM, V48, P7789, DOI 10.1021/jm050100l; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Olaharski AJ, 2005, PLOS GENET, V1, P689, DOI 10.1371/journal.pgen.0010077; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Parks BA, 2007, ANAL CHEM, V79, P7984, DOI 10.1021/ac070553t; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Ropero S, 2004, BREAST CANCER RES TR, V86, P125, DOI 10.1023/B:BREA.0000032981.20384.c6; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Sun YN, 2007, LUNG CANCER, V58, P21, DOI 10.1016/j.lungcan.2007.05.013; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Villar-Garea A, 2008, CURR PROTOC PROTEIN; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	46	203	207	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					781	791		10.1038/onc.2008.436	http://dx.doi.org/10.1038/onc.2008.436			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19060927				2022-12-25	WOS:000263320000001
J	Bergbrede, T; Chuky, N; Schoebel, S; Blankenfeldt, W; Geyer, M; Fuchs, E; Goody, RS; Barr, F; Alexandrov, K				Bergbrede, Tim; Chuky, Nam; Schoebel, Stefan; Blankenfeldt, Wulf; Geyer, Matthias; Fuchs, Evelyn; Goody, Roger S.; Barr, Francis; Alexandrov, Kirill			Biophysical Analysis of the Interaction of Rab6a GTPase with Its Effector Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; GOLGI-APPARATUS; PROTEINS; FAMILY; RECRUITMENT; TRANSPORT	Rab GTPases are key regulators of intracellular vesicular transport that control vesicle budding, cargo sorting, transport, tethering, and fusion. In the inactive (GDP-bound) conformation, Rab GTPases are targeted to intracellular compartments where they are converted into the active GTP-bound form and recruit effector domain containing proteins. Rab6a has been implicated in dynein-mediated vesicle movement at the Golgi apparatus and shown to interact with a plethora of effector proteins. In this study, we identify minimal Rab6a binding domains of three Rab6a effector proteins: PIST, BicaudalD2, and p150(glued). All three domains are >15-kDa fragments predicted to form coiled-coil structures that display no sequence homology to each other. Complex formation with BicaudalD2 and p150 has a moderate inhibitory effect on the intrinsic GTPase activity of Rab6a, while interaction with PIST has no influence on the hydrolysis rate. The effectors bind activated Rab6a with comparable affinities with K-d values ranging from high nanomolar to low micromolar. Transient kinetic analysis revealed that effectors bind to Rab6a in an apparent single-step reaction characterized by relatively rapid on- and off-rates. We propose that the high off-rates of Rab6.effector complexes enable GTPase-activating protein-mediated net dissociation, which would not be possible if the off-rate were significantly slower.	[Bergbrede, Tim; Chuky, Nam; Schoebel, Stefan; Blankenfeldt, Wulf; Geyer, Matthias; Goody, Roger S.; Alexandrov, Kirill] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Fuchs, Evelyn; Barr, Francis] Univ Liverpool, Canc Res Ctr, Liverpool L3 9TA, Merseyside, England	Max Planck Society; University of Queensland; University of Liverpool	Alexandrov, K (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, Otto Hahn Str 11, D-44227 Dortmund, Germany.	k.alexandrov@imb.uq.edu.au	Alexandrov, Kirill/A-5830-2013; Chu, Nam/AAY-8247-2021; Goody, Roger S/J-8845-2014; Blankenfeldt, Wulf/F-8877-2010	Alexandrov, Kirill/0000-0002-0957-6511; Goody, Roger S/0000-0002-0772-0444; Blankenfeldt, Wulf/0000-0001-9886-9668; Geyer, Matthias/0000-0002-7718-5002; Barr, Francis/0000-0001-7518-253X; Chu, Nam/0000-0001-9717-5007; Bergbrede, Tim/0000-0002-0930-1884	DFG [AL 484/7-2]; SFB [642]	DFG(German Research Foundation (DFG)); SFB(Austrian Science Fund (FWF))	This work was supported in part by DFG Grant AL 484/7-2 (to K. A.) and Grant SFB 642 (to K. A. and R. S. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILLY E, 1991, NATURE, V350, P715, DOI 10.1038/350715a0; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Bergbrede T, 2005, J STRUCT BIOL, V152, P235, DOI 10.1016/j.jsb.2005.10.001; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Indyk L, 1998, METHOD ENZYMOL, V295, P350; KISHIDA S, 1993, J BIOL CHEM, V268, P22259; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Miserey-Lenkei S, 2006, EMBO J, V25, P278, DOI 10.1038/sj.emboj.7600929; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Monier S, 2002, TRAFFIC, V3, P289, DOI 10.1034/j.1600-0854.2002.030406.x; Nagelkerken B, 2000, BIOCHEM J, V346, P593, DOI 10.1042/0264-6021:3460593; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Teber I, 2005, BIOL CHEM, V386, P671, DOI 10.1515/BC.2005.078; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	21	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2628	2635		10.1074/jbc.M806003200	http://dx.doi.org/10.1074/jbc.M806003200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19019823	hybrid			2022-12-25	WOS:000262700900005
J	Jin, L; Yoshida, T; Ho, RY; Owens, GK; Somlyo, AV				Jin, Li; Yoshida, Tadashi; Ho, Ruoya; Owens, Gary K.; Somlyo, Avril V.			The Actin-associated Protein Palladin Is Required for Development of Normal Contractile Properties of Smooth Muscle Cells Derived from Embryoid Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; STEM-CELLS; SIGNAL-TRANSDUCTION; NONMUSCLE MYOSIN; BINDING PARTNER; GENE-EXPRESSION; MARKER GENES; DIFFERENTIATION; MYOCARDIN; KINASE	Palladin is a widely expressed actin-associated protein localized at stress fibers, focal adhesions, and other actin-based structures, playing a significant role in cell adhesion and cell motility. Knockout of Palladin in mice is embryonic lethal, demonstrating the importance of Palladin in development yet its role in the vasculature is not known. In the present study, smooth muscle cell (SMC) markers, such as myosin, actin, caldesmon, calponin, and LPP, were down-regulated in embryoid bodies (EBs) derived from embryonic stem cells lacking Palladin. Transgenic embryonic stem cell lines were generated that stably expressed a puromycin-resistance gene under the control of a SM alpha-actin (SMA) promoter. Negative selection was then used to purify SMCs from EBs. Purified SMCs expressing multiple SMC markers were designated APSCs (SMA-puromycin-selected cells). Palladin null APSCs express significantly less myosin, actin, calponin, and h-caldesmon. The filamentous ( F) to globular ( G) actin ratio, known to regulate myocardin family transcription factors, was also decreased. Palladin null APSCs showed increased cell adhesion and decreased cell motility. Importantly, Palladin null APSCs within collagen gels generated less maximum contractile force when stimulated with endothelin-1, sphingosine 1-phosphate (S1P), and thrombin. Myosin light chains (MLC20) were phosphorylated by lysophosphatidic acid to the same extent in Palladin null and wild type APSCs but myosin content/total protein was reduced by >50%, consistent with the observed decreases in contractility. All together, these results suggest that Palladin is essential for expression of the full complement of contractile proteins necessary for optimal force development of SMCs derived from EBs.	[Jin, Li; Yoshida, Tadashi; Ho, Ruoya; Owens, Gary K.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia	Somlyo, AV (corresponding author), 415 Jordan Hall,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	avs5u@virginia.edu			National Institutes of Health [PO1 HL48807, PO1 HL 19242]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL019242, P01HL048807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL48807 ( to A. V. S.) and PO1 HL 19242 ( to A. V. S. and G. K. O.).	BOND M, 1982, J CELL BIOL, V95, P403, DOI 10.1083/jcb.95.2.403; Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Gailly P, 1997, J PHYSIOL-LONDON, V500, P95, DOI 10.1113/jphysiol.1997.sp022002; Gammill LS, 2002, DEVELOPMENT, V129, P5731, DOI 10.1242/dev.00175; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Gorenne I, 2006, CIRC RES, V98, P378, DOI 10.1161/01.RES.0000202802.34727.fd; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hoofnagle MH, 2006, ARTERIOSCL THROM VAS, V26, P2579, DOI 10.1161/01.ATV.0000249623.79871.bc; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Jin L, 2007, CIRC RES, V100, P817, DOI 10.1161/01.RES.0000261351.54147.de; Jones PL, 2007, CIRC RES, V100, P757, DOI 10.1161/01.RES.0000263446.33849.ed; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; Liu XS, 2007, BLOOD, V110, P870, DOI 10.1182/blood-2007-01-068528; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Matthew JD, 2000, J PHYSIOL-LONDON, V529, P811, DOI 10.1111/j.1469-7793.2000.00811.x; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Ogut O, 2007, J MUSCLE RES CELL M, V28, P409, DOI 10.1007/s10974-008-9132-2; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Ryu B, 2001, CANCER RES, V61, P1833; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Somlyo AP, 2004, J MUSCLE RES CELL M, V25, P613; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Woodsome TP, 2006, J CELL SCI, V119, P1769, DOI 10.1242/jcs.02805; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006	43	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2121	2130		10.1074/jbc.M806095200	http://dx.doi.org/10.1074/jbc.M806095200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19015263	hybrid, Green Published			2022-12-25	WOS:000262545600021
J	Park, S; Guo, JP; Kim, D; Cheng, JQ				Park, Sungman; Guo, Jianping; Kim, Donghwa; Cheng, Jin Q.			Identification of 24p3 as a Direct Target of Foxo3a Regulated by Interleukin-3 through the Phosphoinositide 3-Kinase/Akt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC-CELLS; APOPTOSIS; SURVIVAL; DEATH; GENE; SUPPRESSION; EXPRESSION; INDUCTION; RECEPTOR; SIGNALS	Pro-apoptotic protein 24p3, a member of lipocalin family, is induced upon interleukin-3 (IL-3) deprivation and plays a pivotal role in induction of apoptosis in hematopoietic cells. However, the molecular mechanism by which IL-3 regulates 24p3 expression remains largely unknown. Here, we show that 24p3 is a direct target of Foxo3a and that phosphoinositide 3-kinase (PI3K)/Akt mediates IL-3-repressed 24p3 through regulation of Foxo3a. Inhibition of the PI3K/Akt (but not MAPK) pathway induced 24p3 expression and programmed cell death in FL5.12 cells. Furthermore, constitutively active Akt largely attenuated 24p3 expression and apoptosis in response to IL-3 withdrawal. Foxo3a directly bound to the 24p3 promoter and induced promoter activity. Akt abrogated wild-type Foxo3a-induced (but notAkt-non-phosphorylatable Foxo3a(3A)-induced) 24p3expression and promoter activity. Therefore, these data indicate for the first time that 24p3 is a Foxo3a target gene and that PI3K/Akt (but not MAPK) mediates IL-3-regulated 24p3 expression in hematopoietic cells.	[Park, Sungman; Guo, Jianping; Kim, Donghwa; Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Cheng, JQ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	jin.cheng@moffitt.org			National Institutes of Health [R01CA107098]; United States Department of Defense; NATIONAL CANCER INSTITUTE [R01CA107098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA107098 (to J.Q.C.). This work was also supported by the United States Department of Defense (to J.Q.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GOLD MR, 1994, J BIOL CHEM, V269, P5403; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; Lin H, 2005, ONCOGENE, V24, P3246, DOI 10.1038/sj.onc.1208500; MCCUBREY J, 1989, ONCOGENE RES, V4, P97; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SCHEID MP, 1995, BIOCHEM J, V312, P159, DOI 10.1042/bj3120159; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000	26	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2187	2193		10.1074/jbc.M806131200	http://dx.doi.org/10.1074/jbc.M806131200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19056725	Green Published, hybrid			2022-12-25	WOS:000262545600028
J	Utreras, E; Futatsugi, A; Rudrabhatla, P; Keller, J; Iadarola, MJ; Pant, HC; Kulkarni, AB				Utreras, Elias; Futatsugi, Akira; Rudrabhatla, Parvathi; Keller, Jason; Iadarola, Michael J.; Pant, Harish C.; Kulkarni, Ashok B.			Tumor Necrosis Factor-alpha Regulates Cyclin-dependent Kinase 5 Activity during Pain Signaling through Transcriptional Activation of p35	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; MESSENGER-RNA; UP-REGULATION; SPINAL-CORD; PC12 CELLS; PHOSPHORYLATION; EXPRESSION; CDK5; ERK; NEURONS	Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/ threonine kinase. We have previously reported that Cdk5 participates in the regulation of nociceptive signaling, and the expression of Cdk5 and its activator, p35, are up-regulated in nociceptive neurons during peripheral inflammation. The aim of our current study was to identify the proinflammatory molecules that regulate Cdk5/p35 activity in response to inflammation. We constructed a vector that contains the mouse p35 promoter driving luciferase expression. We transiently transfected this vector in PC12 cells to test the effect of several cytokines on p35 transcriptional activity and Cdk5 activity. Our results indicate that tumor necrosis factor-alpha (TNF-alpha) activates p35 promoter activity in a dose- and time-dependent manner and concomitantly up-regulates Cdk5 activity. Because TNF-alpha is known to activate ERK1/2, p38 MAPK, JNK, and NF-kappa B signaling pathways, we examined their involvement in the activation of p35 promoter activity. MEK inhibitor, which inhibits ERK activation, decreased p35 promoter activity, whereas the inhibitors of p38 MAPK, JNK, and NF-kappa B increased p35 promoter activity, indicating that these pathways regulate p35 expression differently. The mRNA and protein levels of Egr-1, a transcription factor, were increased by TNF-alpha treatment, and this increase was dependent on ERK signaling. In a mouse model of inflammation-induced pain in which carrageenan injection into the hind paw causes hypersensitivity to heat stimuli, TNF-alpha mRNA was increased at the site of injection. These findings suggest that TNF-alpha-mediated regulation of Cdk5 activity plays an important role in inflammation-induced pain signaling.	[Kulkarni, Ashok B.] NIH, LCDB, NIDCR, Funct Gen Sect, Bethesda, MD 20892 USA; [Keller, Jason; Iadarola, Michael J.] NIH, Neurobiol & Pain Therapeut Sect, NIDCR, Bethesda, MD 20892 USA; [Rudrabhatla, Parvathi; Pant, Harish C.] NIH, Neurochem Lab, NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kulkarni, AB (corresponding author), NIH, LCDB, NIDCR, Funct Gen Sect, 30 Convent Dr,Bldg 30,Rm 130,MSC 4395, Bethesda, MD 20892 USA.	ak40m@nih.gov	Utreras, Elias/I-1038-2013	Utreras, Elias/0000-0002-1004-0466; Rudrabhatla, Parvathi/0000-0002-7537-3130	National Institutes of Health; Division of Intramural Research of NIDCR; NINDS; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000688, ZIADE000664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000688, Z01DE000664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Health, Division of Intramural Research of NIDCR and NINDS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arruda JL, 1998, MOL BRAIN RES, V62, P228, DOI 10.1016/S0169-328X(98)00257-5; Barbin G, 2001, NEUROCHEM RES, V26, P107, DOI 10.1023/A:1011086426652; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DeLeo JA, 2000, NEUROREPORT, V11, P599, DOI 10.1097/00001756-200002280-00033; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Friedrichsen S, 2006, ENDOCRINOLOGY, V147, P773, DOI 10.1210/en.2005-0967; Glicksman MA, 2007, CURR ALZHEIMER RES, V4, P547, DOI 10.2174/156720507783018181; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Humbert S, 2000, NEUROREPORT, V11, P2213, DOI 10.1097/00001756-200007140-00030; Lee HJ, 2006, CYTOKINE, V35, P67, DOI 10.1016/j.cyto.2006.07.009; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Loram LC, 2007, J PAIN, V8, P127, DOI 10.1016/j.jpain.2006.06.010; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Marz P, 1996, BRAIN RES, V706, P71, DOI 10.1016/0006-8993(95)01210-9; Mielke K, 2002, MOL CELL NEUROSCI, V20, P211, DOI 10.1006/mcne.2002.1132; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 1996, GENOMICS, V35, P372, DOI 10.1006/geno.1996.0370; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pareek TK, 2007, P NATL ACAD SCI USA, V104, P660, DOI 10.1073/pnas.0609916104; Pareek TK, 2006, CELL CYCLE, V5, P585, DOI 10.4161/cc.5.6.2578; Pareek Tej K., 2008, P211, DOI 10.1007/978-0-387-78887-6_15; Pareek TK, 2006, P NATL ACAD SCI USA, V103, P791, DOI 10.1073/pnas.0510405103; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Rocha ACC, 2006, BRIT J PHARMACOL, V148, P688, DOI 10.1038/sj.bjp.0706775; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Saikkonen B, 2008, CELL CYCLE, V7, P750, DOI 10.4161/cc.7.6.5494; Schafers M, 2003, NEUROSCI LETT, V347, P179, DOI 10.1016/S0304-3940(03)00695-5; Shu HF, 2007, RESP PHYSIOL NEUROBI, V157, P187, DOI 10.1016/j.resp.2007.01.010; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Takahashi N, 2006, SPINE, V31, P523, DOI 10.1097/01.brs.0000201305.01522.17; Takahashi S, 2005, P NATL ACAD SCI USA, V102, P1737, DOI 10.1073/pnas.0409456102; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Ulfhammer E, 2006, J THROMB HAEMOST, V4, P1781, DOI 10.1111/j.1538-7836.2006.02035.x; Yang HYT, 2007, J NEUROCHEM, V103, P1628, DOI 10.1111/j.1471-4159.2007.04874.x; Yang YR, 2007, PAIN, V127, P109, DOI 10.1016/j.pain.2006.08.008; Zhang JH, 2006, CHINESE MED J-PEKING, V119, P930, DOI 10.1097/00029330-200606010-00009	46	76	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2275	2284		10.1074/jbc.M805052200	http://dx.doi.org/10.1074/jbc.M805052200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19049962	Green Published, hybrid			2022-12-25	WOS:000262545600037
J	Wang, YQ; Feechan, A; Yun, BW; Shafiei, R; Hofmann, A; Taylor, P; Xue, P; Yang, FQ; Xie, ZS; Pallas, JA; Chu, CC; Loake, GJ				Wang, Yi-Qin; Feechan, Angela; Yun, Byung-Wook; Shafiei, Reza; Hofmann, Andreas; Taylor, Paul; Xue, Peng; Yang, Fu-Quan; Xie, Zhen-Sheng; Pallas, Jacqueline A.; Chu, Cheng-Cai; Loake, Gary J.			S-Nitrosylation of AtSABP3 Antagonizes the Expression of Plant Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; CARBONIC-ANHYDRASE; ARABIDOPSIS-THALIANA; RESISTANCE GENE; TOBACCO; SIGNAL; IDENTIFICATION; SPECIFICITY; AVIRULENCE; INHIBITION	Changes in cellular redox status are a well established response across phyla following pathogen challenge. In this context, the synthesis of nitric oxide ( NO) is a conspicuous feature of plants responding to attempted microbial infection and this redox-based regulator underpins the development of plant immunity. However, the associated molecular mechanism(s) have not been defined. Here we show that NO accretion during the nitrosative burst promotes increasing S-nitrosylation of the Arabidopsis thaliana salicylic acid-binding protein 3 (AtSABP3) at cysteine (Cys) 280, suppressing both binding of the immune activator, salicylic acid ( SA), and the carbonic anhydrase ( CA) activity of this protein. The CA function of AtSABP3 is required for the expression of resistance in the host against attempted pathogen infection. Therefore, inhibition of AtSBAP3 CA function by S-nitrosylation could contribute to a negative feedback loop that modulates the plant defense response. Thus, AtSABP3 is one of the first targets for S-nitrosylation in plants for which the biological function of this redox-based post-translational modification has been uncovered. These data provide a molecular connection between the changes in NO levels triggered by attempted pathogen infection and the expression of disease resistance.	[Wang, Yi-Qin; Feechan, Angela; Yun, Byung-Wook; Shafiei, Reza; Loake, Gary J.] Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Hofmann, Andreas; Taylor, Paul] Univ Edinburgh, Sch Biol Sci, Inst Struct & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Wang, Yi-Qin; Chu, Cheng-Cai] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Xue, Peng; Yang, Fu-Quan; Xie, Zhen-Sheng] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Pallas, Jacqueline A.] Syngenta, Trait Res, Bracknell RG42 6EY, Berks, England	University of Edinburgh; University of Edinburgh; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Syngenta	Loake, GJ (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	gloake@ed.ac.uk	Chu, Chengcai/AAF-6083-2019; Wang, Yiqin/AAJ-8144-2020; Feechan, Angela/A-1296-2010; Hofmann, Andreas/B-9515-2008; Hofmann, Andreas/M-9870-2019; Pallas, Jacqueline A/C-2994-2008; Shafiei, Reza/ABE-2427-2020	Chu, Chengcai/0000-0001-8097-6115; Hofmann, Andreas/0000-0003-4408-5467; Hofmann, Andreas/0000-0003-4408-5467; Shafiei, Reza/0000-0003-0891-0730; Pallas, Jacqueline/0000-0002-2207-3185; Feechan, Angela/0000-0002-4954-5613; Taylor, Paul/0000-0002-8213-0380; Loake, Gary/0000-0002-7989-9180	Biological Sciences Research Council [BB/D011809/1]; BBSRC [BB/D011809/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011809/1] Funding Source: researchfish	Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biological Sciences Research Council Grant BB/D011809/1.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chandra-Shekara AC, 2007, P NATL ACAD SCI USA, V104, P7277, DOI 10.1073/pnas.0609259104; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hess DT, 2001, NAT CELL BIOL, V3, pE46, DOI 10.1038/35055152; Hoang CV, 2002, PLANT PHYSIOL, V128, P1417, DOI 10.1104/pp.010879; Hong JK, 2008, J EXP BOT, V59, P147, DOI 10.1093/jxb/erm244; INGARRO LJ, 2000, NITRIC OXIDE BIOL PA; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kimber MS, 2000, EMBO J, V19, P1407, DOI 10.1093/emboj/19.7.1407; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Lindermayr C, 2006, J BIOL CHEM, V281, P4285, DOI 10.1074/jbc.M511635200; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Marshall HE, 2004, P NATL ACAD SCI USA, V101, P8841, DOI 10.1073/pnas.0403034101; Miles Allen M., 1995, Methods (Orlando), V7, P40, DOI 10.1006/meth.1995.1006; Nandi A, 2004, PLANT CELL, V16, P465, DOI 10.1105/tpc.016907; Polverari A, 2003, MOL PLANT MICROBE IN, V16, P1094, DOI 10.1094/MPMI.2003.16.12.1094; Restrepo S, 2005, MOL PLANT MICROBE IN, V18, P913, DOI 10.1094/MPMI-18-0913; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Wang YQ, 2006, J EXP BOT, V57, P1777, DOI 10.1093/jxb/erj211; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; WILBUR KM, 1948, J BIOL CHEM, V176, P147	40	175	184	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2131	2137		10.1074/jbc.M806782200	http://dx.doi.org/10.1074/jbc.M806782200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017644	Green Submitted, hybrid			2022-12-25	WOS:000262545600022
J	Li, H; Jogl, G				Li, Hua; Jogl, Gerwald			Structural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOGLYCERATE MUTASE HOMOLOG; BROAD-SPECIFICITY PHOSPHATASE; BACILLUS-STEAROTHERMOPHILUS; FRUCTOSE 2,6-BISPHOSPHATE; CRYSTAL-STRUCTURE; BIFUNCTIONAL ENZYME; METABOLISM; PROTEIN; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; FRUCTOSE-2,6-BISPHOSPHATASE	Activation of the p53 tumor suppressor by cellular stress leads to variable responses ranging from growth inhibition to apoptosis. TIGAR is a novel p53-inducible gene that inhibits glycolysis by reducing cellular levels of fructose-2,6-bisphosphate, an activator of glycolysis and inhibitor of gluconeogenesis. Here we describe structural and biochemical studies of TIGAR from Danio rerio. The overall structure forms a histidine phosphatase fold with a phosphate molecule coordinated to the catalytic histidine residue and a second phosphate molecule in a position not observed in other phosphatases. The recombinant human and zebra fish enzymes hydrolyze fructose-2,6-bisphosphate as well as fructose-1,6-bisphosphate but not fructose 6-phosphate in vitro. The TIGAR active site is open and positively charged, consistent with its enzymatic function as bisphosphatase. The closest related structures are the bacterial broad specificity phosphatase PhoE and the fructose-2,6-bisphosphatase domain of the bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. The structural comparison shows that TIGAR combines an accessible active site as observed in PhoE with a charged substrate-binding pocket as seen in the fructose-2,6-bisphosphatase domain of the bifunctional enzyme.	[Li, Hua; Jogl, Gerwald] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA	Brown University	Jogl, G (corresponding author), Brown Univ, Dept Biochem Mol Biol & Cell Biol, Box G-E129, Providence, RI 02912 USA.	Gerwald_Jogl@brown.edu	Jogl, Gerwald/AAJ-5783-2021; Li, Hua/ABH-1613-2021	Jogl, Gerwald/0000-0002-5465-5315; Li, Hua/0000-0003-1903-836X	National Institutes of Health [P20RR15578]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR15578. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hasemann CA, 1996, STRUCTURE, V4, P1017, DOI 10.1016/S0969-2126(96)00109-8; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Michels PAM, 2006, IUBMB LIFE, V58, P133, DOI 10.1080/15216540600688280; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Mizuguchi H, 1999, J BIOL CHEM, V274, P2166, DOI 10.1074/jbc.274.4.2166; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Muller P, 2005, ACTA CRYSTALLOGR D, V61, P309, DOI 10.1107/S0907444904033190; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PILKIS SJ, 1982, METHOD ENZYMOL, V89, P101; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2001, PROTEIN SCI, V10, P1835, DOI 10.1110/ps.15701; Rigden DJ, 2002, J MOL BIOL, V315, P1129, DOI 10.1006/jmbi.2001.5290; Rigden DJ, 2003, J MOL BIOL, V325, P411, DOI 10.1016/S0022-2836(02)01229-9; Rigden DJ, 1999, J MOL BIOL, V289, P691, DOI 10.1006/jmbi.1999.2848; TAULER A, 1990, J BIOL CHEM, V265, P15617; TEDOKON M, 1992, CLIN CHEM, V38, P512; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANSCHAFTINGEN E, 1981, EUR J BIOCHEM, V117, P319, DOI 10.1111/j.1432-1033.1981.tb06339.x; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wu CD, 2006, ADV ENZYME REGUL, V46, P72, DOI 10.1016/j.advenzreg.2006.01.010; Yuen MH, 1999, J BIOL CHEM, V274, P2176, DOI 10.1074/jbc.274.4.2176	38	88	96	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1748	1754		10.1074/jbc.M807821200	http://dx.doi.org/10.1074/jbc.M807821200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015259	Green Published, hybrid			2022-12-25	WOS:000262330100045
J	Gaseitsiwe, S; Valentini, D; Mahdavifar, S; Magalhaes, I; Hoft, DF; Zerweck, J; Schutkowski, M; Andersson, J; Reilly, M; Maeurer, MJ				Gaseitsiwe, Simani; Valentini, Davide; Mahdavifar, Shahnaz; Magalhaes, Isabelle; Hoft, Daniel F.; Zerweck, Johannes; Schutkowski, Mike; Andersson, Jan; Reilly, Marie; Maeurer, Markus J.			Pattern Recognition in Pulmonary Tuberculosis Defined by High Content Peptide Microarray Chip Analysis Representing 61 Proteins from M. tuberculosis	PLOS ONE			English	Article							T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; DIAGNOSIS; ANTIGEN; GENE; IDENTIFICATION; EXPRESSION; INFECTION; VACCINE; CD4(+)	Background: Serum antibody-based target identification has been used to identify tumor-associated antigens (TAAs) for development of anti-cancer vaccines. A similar approach can be helpful to identify biologically relevant and clinically meaningful targets in M. tuberculosis (MTB) infection for diagnosis or TB vaccine development in clinically well defined populations. Method: We constructed a high-content peptide microarray with 61 M. tuberculosis proteins as linear 15 aa peptide stretches with 12 aa overlaps resulting in 7446 individual peptide epitopes. Antibody profiling was carried with serum from 34 individuals with active pulmonary TB and 35 healthy individuals in order to obtain an unbiased view of the MTB epitope pattern recognition pattern. Quality data extraction was performed, data sets were analyzed for significant differences and patterns predictive of TB+/-. Findings: Three distinct patterns of IgG reactivity were identified: 89/7446 peptides were differentially recognized (in 34/34 TB+ patients and in 35/35 healthy individuals) and are highly predictive of the division into TB+ and TB-, other targets were exclusively recognized in all patients with TB (e. g. sigmaF) but not in any of the healthy individuals, and a third peptide set was recognized exclusively in healthy individuals (35/35) but no in TB+ patients. The segregation between TB+ and TB- does not cluster into specific recognition of distinct MTB proteins, but into specific peptide epitope 'hotspots' at different locations within the same protein. Antigen recognition pattern profiles in serum from TB+ patients from Armenia vs. patients recruited in Sweden showed that IgG-defined MTB epitopes are very similar in individuals with different genetic background. Conclusions: A uniform target MTB IgG-epitope recognition pattern exists in pulmonary tuberculosis. Unbiased, high-content peptide microarray chip-based testing of clinically well-defined populations allows to visualize biologically relevant targets useful for development of novel TB diagnostics and vaccines.	[Magalhaes, Isabelle; Maeurer, Markus J.] Karolinska Inst Stockholm, Dept Microbiol, Tumor & Cell Biol Ctr MTC, Stockholm, Sweden; [Valentini, Davide; Reilly, Marie] Karolinska Inst, Dept Med Epidemiol & Biostat, S-10401 Stockholm, Sweden; [Gaseitsiwe, Simani; Mahdavifar, Shahnaz; Magalhaes, Isabelle; Maeurer, Markus J.] Swedish Inst Infect Dis Control SMI, Stockholm, Sweden; [Hoft, Daniel F.] St Louis Univ, Med Ctr, Dept Internal Med & Mol Microbiol, Div Immunobiol, St Louis, MO USA; [Zerweck, Johannes; Schutkowski, Mike] JPT, Berlin, Germany; [Andersson, Jan] Karolinska Univ, Hosp Huddinge, Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Saint Louis University; Karolinska Institutet; Karolinska University Hospital	Gaseitsiwe, S (corresponding author), Karolinska Inst Stockholm, Dept Microbiol, Tumor & Cell Biol Ctr MTC, Stockholm, Sweden.	markus.maeurer@ki.se	Magalhaes, Isabelle/AAC-7898-2020	Magalhaes, Isabelle/0000-0003-0440-6924; Schutkowski, MIke/0000-0003-0919-7076; Maeurer, Markus/0000-0002-8436-8077	EU Curie; Vetenskapradet; SIDA/SAREC; Soderberg-Foundation; Karolinska Institutet	EU Curie; Vetenskapradet; SIDA/SAREC; Soderberg-Foundation; Karolinska Institutet(Karolinska Institutet)	EU Curie Grant to SG; Vetenskapradet, SIDA/SAREC, Soderberg-Foundation and Karolinska Institutet Support to MM.	Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Banerjee S, 2004, P NATL ACAD SCI USA, V101, P12652, DOI 10.1073/pnas.0404347101; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Blythe Martin J, 2007, Immunome Res, V3, P10, DOI 10.1186/1745-7580-3-10; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; Jager Dirk, 2005, Cancer Immun, V5, P11; Kaufmann SHE, 2006, INT J TUBERC LUNG D, V10, P1068; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Lee JH, 2008, J BACTERIOL, V190, P1128, DOI 10.1128/JB.00511-07; Lee JH, 2008, J BACTERIOL, V190, P699, DOI 10.1128/JB.01273-07; Lee SY, 2007, J MICROBIOL BIOTECHN, V17, P879; Lyashchenko K, 1998, INFECT IMMUN, V66, P3606, DOI 10.1128/IAI.66.8.3606-3610.1998; Meena LS, 2002, J CLIN LAB ANAL, V16, P151, DOI 10.1002/jcla.10031; Michaud GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/nbt910; Michele TM, 1999, ANTIMICROB AGENTS CH, V43, P218, DOI 10.1128/AAC.43.2.218; MUELLER H, 2008, CYTOKINE; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Nahtman T, 2007, J IMMUNOL METHODS, V328, P1, DOI 10.1016/j.jim.2007.07.015; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Odunsi Kunle, 2007, Cancer Immun, V7, P3; Pottumarthy S, 2000, J CLIN MICROBIOL, V38, P2227; Predki Paul F, 2005, Hum Antibodies, V14, P7; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tully G, 2005, J IMMUNOL, V174, P2174, DOI 10.4049/jimmunol.174.4.2174; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059	31	60	68	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3840	10.1371/journal.pone.0003840	http://dx.doi.org/10.1371/journal.pone.0003840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065269	gold, Green Published, Green Submitted			2022-12-25	WOS:000265455200001
J	Mietchen, D; Manz, B; Volke, F; Storey, K				Mietchen, Daniel; Manz, Bertram; Volke, Frank; Storey, Kenneth			In Vivo Assessment of Cold Adaptation in Insect Larvae by Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy	PLOS ONE			English	Article							FAT-BODY CELLS; FREEZE TOLERANCE; GALL FLY; MOTION CORRECTION; ICE NUCLEATION; SELF-DIFFUSION; NMR; WATER; MICROSCOPY; VISUALIZATION	Background: Temperatures below the freezing point of water and the ensuing ice crystal formation pose serious challenges to cell structure and function. Consequently, species living in seasonally cold environments have evolved a multitude of strategies to reorganize their cellular architecture and metabolism, and the underlying mechanisms are crucial to our understanding of life. In multicellular organisms, and poikilotherm animals in particular, our knowledge about these processes is almost exclusively due to invasive studies, thereby limiting the range of conclusions that can be drawn about intact living systems. Methodology: Given that non-destructive techniques like 1 H Magnetic Resonance (MR) imaging and spectroscopy have proven useful for in vivo investigations of a wide range of biological systems, we aimed at evaluating their potential to observe cold adaptations in living insect larvae. Specifically, we chose two cold-hardy insect species that frequently serve as cryobiological model systems-the freeze-avoiding gall moth Epiblema scudderiana and the freeze-tolerant gall fly Eurosta solidaginis. Results: In vivo MR images were acquired from autumn-collected larvae at temperatures between 0 degrees C and about -70 degrees C and at spatial resolutions down to 27 mm. These images revealed three-dimensional (3D) larval anatomy at a level of detail currently not in reach of other in vivo techniques. Furthermore, they allowed visualization of the 3D distribution of the remaining liquid water and of the endogenous cryoprotectants at subzero temperatures, and temperature-weighted images of these distributions could be derived. Finally, individual fat body cells and their nuclei could be identified in intact frozen Eurosta larvae. Conclusions: These findings suggest that high resolution MR techniques provide for interesting methodological options in comparative cryobiological investigations, especially in vivo.	[Mietchen, Daniel; Manz, Bertram; Volke, Frank] Fraunhofer Inst Biomed Engn IBMT, Magnet Resonance Grp, St Ingbert, Germany; [Mietchen, Daniel] Univ Saarland, Fac Phys & Mechatron, Saarbrucken, Germany; [Mietchen, Daniel] Univ Jena, Dept Psychiat, D-6900 Jena, Germany; [Storey, Kenneth] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada	Fraunhofer Gesellschaft; Saarland University; Friedrich Schiller University of Jena; Carleton University	Mietchen, D (corresponding author), Fraunhofer Inst Biomed Engn IBMT, Magnet Resonance Grp, St Ingbert, Germany.	daniel.mietchen@uni-jena.de	Mietchen, Daniel/A-7748-2009	Mietchen, Daniel/0000-0001-9488-1870; Storey, Kenneth/0000-0002-7363-1853	IBMT	IBMT(International Business Machines (IBM))	The study was supported by an IBMT-internal grant.	Abragam A., 1961, PRINCIPLES NUCL MAGN; AGUAYO JB, 1986, NATURE, V322, P190, DOI 10.1038/322190a0; Bhattacharya P, 2005, MAGN RESON MATER PHY, V18, P245, DOI 10.1007/s10334-005-0007-x; Bliimich B., 1992, MAGNETIC RESONANCE M; BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679; Boesch Chris, 1999, Molecular Aspects of Medicine, V20, P185, DOI 10.1016/S0098-2997(99)00007-2; Bonnet N, 2004, MICRON, V35, P635, DOI 10.1016/j.micron.2004.04.006; Boppart SA, 1996, DEV BIOL, V177, P54, DOI 10.1006/dbio.1996.0144; Borah B, 2001, ANAT RECORD, V265, P101, DOI 10.1002/ar.1060; Borgia GC, 2000, J CULT HERIT, V1, P127, DOI 10.1016/S1296-2074(00)00156-4; BOTTOMLEY PA, 1984, P NATL ACAD SCI-BIOL, V81, P6856, DOI 10.1073/pnas.81.21.6856; BRATEMAN L, 1986, AM J ROENTGENOL, V146, P971, DOI 10.2214/ajr.146.5.971; BUCHANAN GW, 1983, CAN J BIOCHEM CELL B, V61, P1260, DOI 10.1139/o83-162; BURT CT, 1982, LIFE SCI, V31, P2793; Callaghan P., 1991, PRINCIPLES NUCL MAGN; Callaghan PT, 1997, REV SCI INSTRUM, V68, P4263, DOI 10.1063/1.1148340; Catana C, 2008, P NATL ACAD SCI USA, V105, P3705, DOI 10.1073/pnas.0711622105; Ciobanu L, 2003, PROG NUCL MAG RES SP, V42, P69, DOI 10.1016/S0079-6565(03)00004-9; Clarke CJ, 2002, CRYOLETTERS, V23, P89; Collins S.D., 1996, Problemy Kriobiologii, V1, P3; Concha ML, 1998, DEVELOPMENT, V125, P983; Dabos KJ, 2002, NMR BIOMED, V15, P241, DOI 10.1002/nbm.765; Daniel BL, 1999, MAGNET RESON MED, V41, P627, DOI 10.1002/(SICI)1522-2594(199903)41:3<627::AID-MRM28>3.0.CO;2-Q; Danks HV, 2000, J INSECT PHYSIOL, V46, P837, DOI 10.1016/S0022-1910(99)00204-8; Darrasse L, 2003, BIOCHIMIE, V85, P915, DOI 10.1016/j.biochi.2003.09.016; Davis DJ, 2001, ARCH INSECT BIOCHEM, V48, P199, DOI 10.1002/arch.1072; de Swiet TM, 1998, J MAGN RESON, V133, P385, DOI 10.1006/jmre.1998.1459; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; EDELSTEIN WA, 1991, J GLACIOL, V37, P177; Eicken H, 2000, COLD REG SCI TECHNOL, V31, P207, DOI 10.1016/S0165-232X(00)00016-1; Eisenreich W, 2007, PHYTOCHEMISTRY, V68, P2799, DOI 10.1016/j.phytochem.2007.09.028; FOSTER FS, 1993, IEEE T ULTRASON FERR, V40, P608, DOI 10.1109/58.238115; Ganguly A, 2005, ACAD RADIOL, V12, P1167, DOI 10.1016/j.acra.2005.03.076; GEORGE MF, 1974, PLANT PHYSIOL, V54, P29, DOI 10.1104/pp.54.1.29; Glover P, 2002, REP PROG PHYS, V65, P1489, DOI 10.1088/0034-4885/65/10/203; Goldman LW, 2007, J NUCL MED TECHNOL, V35, DOI 10.2967/jnmt.106.037846; GOODMAN BA, 1995, J INSECT PHYSIOL, V41, P419, DOI 10.1016/0022-1910(94)00115-W; Gowland PA, 2005, PROG BIOPHYS MOL BIO, V87, P175, DOI 10.1016/j.pbiomolbio.2004.08.006; Han SI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.144501; Hart A. G., 2003, Journal of Insect Science (Tucson), V3, P1; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Hindmarsh JP, 2004, CHEM ENG SCI, V59, P2113, DOI 10.1016/j.ces.2003.12.031; Hsieh CH, 1996, BIOPHYS J, V71, P3278, DOI 10.1016/S0006-3495(96)79520-6; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Izumi Y, 2006, J INSECT PHYSIOL, V52, P215, DOI 10.1016/j.jinsphys.2005.11.001; Katscher U, 2006, NMR BIOMED, V19, P393, DOI 10.1002/nbm.1049; KELLER RE, 1978, J MORPHOL, V157, P223, DOI 10.1002/jmor.1051570209; Kerr WL, 1998, FOOD SCI TECHNOL-LEB, V31, P215; Kleinberg RL, 2005, COLD REG SCI TECHNOL, V42, P63, DOI 10.1016/j.coldregions.2004.12.002; Koop T, 2004, Z PHYS CHEM, V218, P1231, DOI 10.1524/zpch.218.11.1231.50812; Koptyug IV, 2007, APPL MAGN RESON, V32, P321, DOI 10.1007/s00723-007-0017-0; Lacey ME, 2001, J CHROMATOGR A, V922, P139, DOI 10.1016/S0021-9673(01)00912-8; Lambert JB, 2000, CHEM SOC REV, V29, P175, DOI 10.1039/a908378b; Larkman DJ, 2007, PHYS MED BIOL, V52, pR15, DOI 10.1088/0031-9155/52/7/R01; Lazovic J, 2005, MAGN RESON MED, V53, P1150, DOI 10.1002/mrm.20459; Ledbetter MP, 2008, P NATL ACAD SCI USA, V105, P2286, DOI 10.1073/pnas.0711505105; LEE AP, 1995, J ARCHAEOL SCI, V22, P257, DOI 10.1006/jasc.1995.0027; Lee CC, 1996, MAGNET RESON MED, V36, P436, DOI 10.1002/mrm.1910360316; Lee R., 1991, INSECTS LOW TEMPERAT; Lee Richard E. Jr., 1995, P257; Lee SC, 2006, BIOPHYS J, V90, P1797, DOI 10.1529/biophysj.105.073502; Lee SC, 2007, DIFFERENTIATION, V75, P84, DOI 10.1111/j.1432-0436.2006.00114.x; Lemor RM, 2004, ACOUST IMAG, V27, P563; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Ludeke K M, 1985, Magn Reson Imaging, V3, P329, DOI 10.1016/0730-725X(85)90397-2; Manz B, 2003, BIOTECHNOL BIOENG, V84, P424, DOI 10.1002/bit.10782; Mariette F, 2005, J AGR FOOD CHEM, V53, P1317, DOI 10.1021/jf049294o; Mazur P, 2008, BIOL REPROD, V78, P2, DOI 10.1095/biolreprod.107.064113; Mel'nichenko N. A., 1979, Oceanology, V19, P535; Menzel MI, 2000, J MAGN RESON, V143, P376, DOI 10.1006/jmre.1999.1999; Mietchen D, 2008, BIOGEOSCIENCES, V5, P25, DOI 10.5194/bg-5-25-2008; Mietchen D, 2005, BIOGEOSCIENCES, V2, P133, DOI 10.5194/bg-2-133-2005; Mietchen Daniel, 2005, Biomagn Res Technol, V3, P2, DOI 10.1186/1477-044X-3-2; Moritz C, 2008, CRYOBIOLOGY, V56, P181, DOI 10.1016/j.cryobiol.2008.02.003; Muller WEG, 2006, J STRUCT BIOL, V153, P31, DOI 10.1016/j.jsb.2005.09.008; Nayak KS, 2000, MAGNET RESON MED, V43, P251, DOI 10.1002/(SICI)1522-2594(200002)43:2<251::AID-MRM12>3.0.CO;2-#; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ouwerkerk Ronald, 2007, J Am Coll Radiol, V4, P739, DOI 10.1016/j.jacr.2007.07.001; Peh WCG, 2001, SKELETAL RADIOL, V30, P179, DOI 10.1007/s002560100341; Philip BN, 2008, J EXP BIOL, V211, P1114, DOI 10.1242/jeb.016758; Price WS, 1997, AUST J PLANT PHYSIOL, V24, P599, DOI 10.1071/PP97049; Purea A, 2004, CONCEPT MAGN RESON B, V22B, P7, DOI 10.1002/cmr.b.20015; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; RAIFORD DS, 1979, ANAL CHEM, V51, P2050, DOI 10.1021/ac50048a040; Richardson C., 1966, J GLACIOL, V6, P89; RICKARDS J, 1987, J INSECT PHYSIOL, V33, P443, DOI 10.1016/0022-1910(87)90024-2; Rovnyak D, 2004, J BIOMOL NMR, V30, P1, DOI 10.1023/B:JNMR.0000042946.04002.19; Rubinsky B., 1994, American Journal of Physiology, V267, pR1078; Rubinsky B., 1994, American Journal of Physiology, V266, pR1771; Rueden C, 2004, TRAFFIC, V5, P411, DOI 10.1111/j.1600-0854.2004.00189.x; SALT RW, 1959, NATURE, V184, P1426, DOI 10.1038/1841426a0; Samset E, 2005, COMPUT MED IMAG GRAP, V29, P499, DOI 10.1016/j.compmedimag.2005.02.008; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Schenck JF, 2005, PROG BIOPHYS MOL BIO, V87, P185, DOI 10.1016/j.pbiomolbio.2004.08.009; Schneider H, 2003, NEW PHYTOL, V159, P487, DOI 10.1046/j.1469-8137.2003.00814.x; Schwarzbauer C, 2006, NEUROIMAGE, V29, P774, DOI 10.1016/j.neuroimage.2005.08.025; Silva AKA, 2006, RADIAT ENVIRON BIOPH, V45, P245, DOI 10.1007/s00411-006-0065-0; Sinclair BJ, 2003, TRENDS ECOL EVOL, V18, P257, DOI 10.1016/S0169-5347(03)00014-4; SLICHTER CP, 1978, PRINCIPLES MAGNETIC; Still BM, 2007, CHEM SOC REV, V36, P665, DOI 10.1039/b606190g; Storey KB, 1997, COMP BIOCHEM PHYS A, V117, P319, DOI 10.1016/S0300-9629(96)00270-8; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; STOREY KB, 1984, EUR J BIOCHEM, V142, P591, DOI 10.1111/j.1432-1033.1984.tb08327.x; Storey Kenneth B., 1992, V1, P101; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Tsuchihashi Toshio, 2003, Nihon Hoshasen Gijutsu Gakkai Zasshi, V59, P1370; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Tyszka JM, 2005, CURR OPIN BIOTECH, V16, P93, DOI 10.1016/j.copbio.2004.11.004; Van As H, 2007, J EXP BOT, V58, P743, DOI 10.1093/jxb/erl157; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; van Zijl PCM, 2007, P NATL ACAD SCI USA, V104, P4359, DOI 10.1073/pnas.0700281104; VANZIJL PCM, 1991, P NATL ACAD SCI USA, V88, P3228, DOI 10.1073/pnas.88.8.3228; Volke F, 1996, CHEM PHYS LETT, V262, P374, DOI 10.1016/0009-2614(96)01062-7; VOLKE F, 1995, BIOPHYS J, V68, P1960, DOI 10.1016/S0006-3495(95)80373-5; Watson P., 2001, CRYOBANKING GENETIC; WHARTON DA, 1995, J EXP BIOL, V198, P1381; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Wind RA, 2000, J MAGN RESON, V147, P371, DOI 10.1006/jmre.2000.2212; Wu DH, 1997, JMRI-J MAGN RESON IM, V7, P365, DOI 10.1002/jmri.1880070219; Wuthrich K, 1996, FARADAY DISCUSS, V103, P245, DOI 10.1039/fd9960300245; Yi SX, 2003, J INSECT PHYSIOL, V49, P999, DOI 10.1016/S0022-1910(03)00168-9; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289; Zimmermann H, 2004, IEE Proc Nanobiotechnol, V151, P134, DOI 10.1049/ip-nbt:20040908; [No title captured]; [No title captured]; [No title captured]	126	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3826	10.1371/journal.pone.0003826	http://dx.doi.org/10.1371/journal.pone.0003826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057644	gold, Green Published, Green Submitted			2022-12-25	WOS:000265452300002
J	Lopez-Vidal, Y; Ponce-de-Leon, S; Castillo-Rojas, G; Barreto-Zuniga, R; Torre-Delgadillo, A				Lopez-Vidal, Yolanda; Ponce-de-Leon, Sergio; Castillo-Rojas, Gonzalo; Barreto-Zuniga, Rafael; Torre-Delgadillo, Aldo			High Diversity of vacA and cagA Helicobacter pylori Genotypes in Patients with and without Gastric Cancer	PLOS ONE			English	Article								Background: Helicobacter pylori is associated with chronic gastritis, peptic ulcers, and gastric cancer. The aim of this study was to assess the topographical distribution of H. pylori in the stomach as well as the vacA and cagA genotypes in patients with and without gastric cancer. Methodology/Principal Findings: Three gastric biopsies, from predetermined regions, were evaluated in 16 patients with gastric cancer and 14 patients with dyspeptic symptoms. From cancer patients, additional biopsy specimens were obtained from tumor centers and margins; among these samples, the presence of H. pylori vacA and cagA genotypes was evaluated. Positive H. pylori was 38% and 26% in biopsies obtained from the gastric cancer and non-cancer groups, respectively (p = 0.008), and 36% in tumor sites. In cancer patients, we found a preferential distribution of H. pylori in the fundus and corpus, whereas, in the non-cancer group, the distribution was uniform (p = 0.003). A majority of the biopsies were simultaneously cagA gene-positive and-negative. The fundus and corpus demonstrated a higher positivity rate for the cagA gene in the non-cancer group (p = 0.036). A mixture of cagA gene sizes was also significantly more frequent in this group (p = 0.003). Ninety-two percent of all the subjects showed more than one vacA gene genotype; s1b and m1 vacA genotypes were predominantly found in the gastric cancer group. The highest vacA-genotype signal-sequence diversity was found in the corpus and 5 cm from tumor margins. Conclusion/Significance: High H. pylori colonization diversity, along with the cagA gene, was found predominantly in the fundus and corpus of patients with gastric cancer. The genotype diversity observed across systematic whole-organ and tumor sampling was remarkable. We find that there is insufficient evidence to support the association of one isolate with a specific disease, due to the multistrain nature of H. pylori infection shown in this work.	[Lopez-Vidal, Yolanda; Castillo-Rojas, Gonzalo] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Programa Inmunol Mol Microbiana, Mexico City 04510, DF, Mexico; [Ponce-de-Leon, Sergio] INCMNSZ, Unidad Epidemiol Clin, Mexico City, DF, Mexico; [Barreto-Zuniga, Rafael; Torre-Delgadillo, Aldo] INCMNSZ, Dept Endoscop Gastroenterol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Lopez-Vidal, Y (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Programa Inmunol Mol Microbiana, Mexico City 04510, DF, Mexico.	lvidal@servidor.unam.mx	Torre, Aldo/AAC-1774-2021; Barreto, Rafael/ABC-1959-2020; López-Vidal, Yolanda/ABE-9501-2021	López-Vidal, Yolanda/0000-0001-7111-8813; Barreto Zuniga, Rafael/0000-0001-9683-4154	Universidad Nacional Autonoma de Mexico (UNAM) [DGAPA PAPIIT-IN207302]; UC-MEXUS; CONACyT-Mexico [47749-M]	Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); UC-MEXUS; CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was funded by grant DGAPA PAPIIT-IN207302 from the Universidad Nacional Autonoma de Mexico (UNAM), UC-MEXUS, and CONACyT-Mexico 47749-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arents NLA, 2001, AM J GASTROENTEROL, V96, P2603, DOI 10.1111/j.1572-0241.2001.04104.x; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Blaser MJ, 2001, J CLIN INVEST, V107, P767, DOI 10.1172/JCI12672; Borrmann R., 1926, HDB SPEZIELLEN PATHO, P864; Camargo MC, 2004, HELICOBACTER, V9, P262, DOI 10.1111/j.1083-4389.2004.00221.x; Castillo-Rojas G, 2002, EUR J GASTROEN HEPAT, V14, P1113, DOI 10.1097/00042737-200210000-00012; Everhart JE, 2000, GASTROENTEROL CLIN N, V29, P559, DOI 10.1016/S0889-8553(05)70130-8; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Go MF, 2002, ALIMENT PHARM THER, V16, P3, DOI 10.1046/j.1365-2036.2002.0160s1003.x; Israel DA, 2001, ALIMENT PHARM THER, V15, P1271, DOI 10.1046/j.1365-2036.2001.01052.x; Japanese Research Society for Gastric Cancer Committee on Histologic Classification of Gastric Cancer, 1981, JPN J SURG, V11, P140; KAJITANI T, 1981, JPN J SURG, V11, P127; Karita M, 2003, MICROBIOL IMMUNOL, V47, P619, DOI 10.1111/j.1348-0421.2003.tb03425.x; Kidd M, 1999, GUT, V45, P499, DOI 10.1136/gut.45.4.499; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lin HJ, 2004, WORLD J GASTROENTERO, V10, P2493, DOI 10.3748/wjg.v10.i17.2493; Morales-Espinosa R, 1999, J CLIN MICROBIOL, V37, P3001, DOI 10.1128/JCM.37.9.3001-3004.1999; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Rozen P, 2004, EUR J CANCER PREV, V13, P71, DOI 10.1097/00008469-200402000-00011; Semino-Mora C, 2003, J INFECT DIS, V187, P1165, DOI 10.1086/368133; Tang YL, 2005, WORLD J GASTROENTERO, V11, P1387, DOI 10.3748/wjg.v11.i9.1387; van Doorn LJ, 1999, GASTROENTEROLOGY, V116, P823, DOI 10.1016/S0016-5085(99)70065-X; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Zhang C, 2005, WORLD J GASTROENTERO, V11, P791, DOI 10.3748/wjg.v11.i6.791	24	35	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2008	3	12							e3849	10.1371/journal.pone.0003849	http://dx.doi.org/10.1371/journal.pone.0003849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YN	19050763	Green Published, Green Submitted, gold			2022-12-25	WOS:000265452100008
J	Li, YL; Wu, GZ; Dawe, GS; Zeng, L; Cui, SS; Loers, G; Tilling, T; Sun, L; Schachner, M; Xiao, ZC				Li, Ya-li; Wu, Guang-zhi; Dawe, Gavin S.; Zeng, Li; Cui, Shu-sen; Loers, Gabriele; Tilling, Thomas; Sun, Li; Schachner, Melitta; Xiao, Zhi-Cheng			Cell Surface Sialylation and Fucosylation Are Regulated by L1 via Phospholipase C gamma and Cooperate to Modulate Neurite Outgrowth, Cell Survival and Migration	PLOS ONE			English	Article							RECOGNITION MOLECULE L1; SIALIC-ACID; ADHESION; GLYCOSYLATION; PROLIFERATION; INHIBITION; GLYCANS; LECTIN; L5	Background: Cell surface glycosylation patterns are markers of cell type and status. However, the mechanisms regulating surface glycosylation patterns remain unknown. Methodology/Principal Findings: Using a panel of carbohydrate surface markers, we have shown that cell surface sialylation and fucosylation were downregulated in L1(-/y) neurons versus L1(+/y) neurons. Consistently, mRNA levels of sialyltransferase ST6Gal1, and fucosyltransferase FUT9 were significantly reduced in L1(-/y) neurons. Moreover, treatment of L1(+/y) neurons with L1 antibodies, triggering signal transduction downstream of L1, led to an increase in cell surface sialylation and fucosylation compared to rat IgG-treated cells. ShRNAs for both ST6Gal1 and FUT9 blocked L1 antibody-mediated enhancement of neurite outgrowth, cell survival and migration. A phospholipase C gamma (PLC gamma) inhibitor and shRNA, as well as an Erk inhibitor, reduced ST6Gal1 and FUT9 mRNA levels and inhibited effects of L1 on neurite outgrowth and cell survival. Conclusions: Neuronal surface sialylation and fucosylation are regulated via PLC gamma by L1, modulating neurite outgrowth, cell survival and migration.	[Li, Ya-li; Wu, Guang-zhi; Xiao, Zhi-Cheng] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Li, Ya-li; Sun, Li; Xiao, Zhi-Cheng] Singapore Gen Hosp, Dept Clin Res, Singapore, Singapore; [Li, Ya-li; Dawe, Gavin S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117548, Singapore; [Wu, Guang-zhi; Cui, Shu-sen] Jilin Univ, China Japan Union Hosp, Surg Dept, Changchun, Peoples R China; [Zeng, Li; Xiao, Zhi-Cheng] Inst Mol & Cell Biol, Dev Biol Div, Singapore, Singapore; [Zeng, Li] Natl Neurosci Inst, Dev Biol Div, Singapore, Singapore; [Loers, Gabriele; Tilling, Thomas; Schachner, Melitta] Univ Hamburg, Zent Mol Neurobiol, Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborative Neurosci, Piscataway, NJ USA	University of Hong Kong; Singapore General Hospital; National University of Singapore; Jilin University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National Neuroscience Institute (NNI); University of Hamburg; Rutgers State University New Brunswick	Li, YL (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China.	xiaozc@hku.hk	xiao, zhicheng/A-1529-2011	xiao, zhicheng/0000-0001-5172-762X; Dawe, Gavin/0000-0001-6119-701X; Tilling, Thomas/0000-0002-4774-3384	University of Hong Kong; National Medical Research Council of Singapore; Singapore Health Services Pte Ltd; Department of Clinical Research, Singapore General Hospital; Institute of Molecular and Cell Biology, A*STAR, Singapore	University of Hong Kong(University of Hong Kong); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Singapore Health Services Pte Ltd; Department of Clinical Research, Singapore General Hospital; Institute of Molecular and Cell Biology, A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grants to Z.C. Xiao from the University of Hong Kong, the National Medical Research Council of Singapore, Singapore Health Services Pte Ltd, Department of Clinical Research, Singapore General Hospital and Institute of Molecular and Cell Biology, A*STAR, Singapore, and a grant to G.S. Dawe from the National Medical Research Council of Singapore.	APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Bosques CJ, 2004, J AM CHEM SOC, V126, P8421, DOI 10.1021/ja0496266; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Courel M, 2008, J BIOL CHEM, V283, P11807, DOI 10.1074/jbc.M709832200; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Deryugina EI, 1996, J CELL SCI, V109, P643; Dong L, 2003, MOL CELL NEUROSCI, V22, P234, DOI 10.1016/S1044-7431(02)00033-7; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FAHRIG T, 1990, EUR J NEUROSCI, V2, P153, DOI 10.1111/j.1460-9568.1990.tb00407.x; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Goldstein IJ, 2002, J AGR FOOD CHEM, V50, P6583, DOI 10.1021/jf0201879; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; KUCHERER A, 1987, J CELL BIOL, V104, P1597, DOI 10.1083/jcb.104.6.1597; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Lowe JB, 2002, BIOCHEM SOC SYMP, V69, P33; Ma YX, 2006, MOL ENDOCRINOL, V20, P14, DOI 10.1210/me.2004-0488; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Orczyk-Pawilowicz M, 2006, CLIN CHIM ACTA, V367, P86, DOI 10.1016/j.cca.2005.11.025; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Rabinovich GA, 2002, J LEUKOCYTE BIOL, V71, P741; Schwarz M, 2004, AM J HUM GENET, V74, P472, DOI 10.1086/382492; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; STREIT A, 1990, J NEUROCHEM, V55, P1494, DOI 10.1111/j.1471-4159.1990.tb04931.x; Streit A, 1996, J NEUROCHEM, V66, P834; Sun HZ, 2004, ENDOCRINOLOGY, V145, P5332, DOI 10.1210/en.2004-0668; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wang ZG, 1996, CARBOHYD RES, V295, P25, DOI 10.1016/S0008-6215(96)90116-0; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0	41	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3841	10.1371/journal.pone.0003841	http://dx.doi.org/10.1371/journal.pone.0003841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048108	Green Published, gold, Green Submitted			2022-12-25	WOS:000265452000009
J	Gilestro, GF				Gilestro, Giorgio F.			Redundant Mechanisms for Regulation of Midline Crossing in Drosophila	PLOS ONE			English	Article								During development, all neurons have to decide on whether to cross the longitudinal midline to project on the contralateral side of the body. In vertebrates and invertebrates regulation of crossing is achieved by interfering with Robo signalling either through sorting and degradation of the receptor, in flies, or through silencing of its repulsive activity, in vertebrates. Here I show that in Drosophila a second mechanism of regulation exists that is independent from sorting. Using in vitro and in vivo assays I mapped the region of Robo that is sufficient and required for its interaction with Comm, its sorting receptor. By modifying that region, I generated new forms of Robo that are insensitive to Comm sorting in vitro and in vivo, yet still able to normally translate repulsive activity in vivo. Using gene targeting by homologous recombination I created new conditional alleles of robo that are sorting defective (robo(SD)). Surprisingly, expression of these modified proteins results in phenotypically normal flies, unveiling a sorting independent mechanism of regulation.	[Gilestro, Giorgio F.] Res Inst Mol Pathol IMP, Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Gilestro, GF (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.	gilestro@wisc.edu	Gilestro, Giorgio/A-8721-2010	Gilestro, Giorgio/0000-0001-7512-8541	Boehringer Ingelheim; Austrian Academy of Sciences	Boehringer Ingelheim(Boehringer Ingelheim); Austrian Academy of Sciences	This work was supported by funding from Boehringer Ingelheim and the Austrian Academy of Sciences. The funding agencies had no role in the collection, analysis, and interpretation of the data, nor in the preparation, review, or approval of the manuscript.	Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 2001, J CELL BIOL, V155, P1117, DOI 10.1083/jcb.200110077; Boyan G, 2003, ARTHROPOD STRUCT DEV, V32, P61, DOI 10.1016/S1467-8039(03)00037-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chang C, 2004, SCIENCE, V305, P103, DOI 10.1126/science.1096983; CHOI Y, 2003, THESIS OHIO STATE U; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dumstrei K, 2002, DEVELOPMENT, V129, P3983; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Georgiou M, 2003, MECH DEVELOP, V120, P1009, DOI 10.1016/S0925-4773(03)00179-5; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Ghose A, 2002, BIOESSAYS, V24, P401, DOI 10.1002/bies.10080; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Newsome TP, 2000, DEVELOPMENT, V127, P851; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Schimmelpfeng K, 2001, MECH DEVELOP, V106, P25, DOI 10.1016/S0925-4773(01)00402-6; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wolf B, 1998, DEVELOPMENT, V125, P3853; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	41	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2008	3	11							e3798	10.1371/journal.pone.0003798	http://dx.doi.org/10.1371/journal.pone.0003798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YA	19030109	Green Published, gold, Green Submitted			2022-12-25	WOS:000265450800008
J	Grutzmann, R; Molnar, B; Pilarsky, C; Habermann, JK; Schlag, PM; Saeger, HD; Miehlke, S; Stolz, T; Model, F; Roblick, UJ; Bruch, HP; Koch, R; Liebenberg, V; deVos, T; Song, XL; Day, RH; Sledziewski, AZ; Lofton-Day, C				Gruetzmann, Robert; Molnar, Bela; Pilarsky, Christian; Habermann, Jens K.; Schlag, Peter M.; Saeger, Hans D.; Miehlke, Stephan; Stolz, Thomas; Model, Fabian; Roblick, Uwe J.; Bruch, Hans-Peter; Koch, Rainer; Liebenberg, Volker; deVos, Theo; Song, Xiaoling; Day, Robert H.; Sledziewski, Andrew Z.; Lofton-Day, Catherine			Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay	PLOS ONE			English	Article								Background: Colorectal cancer (CRC) is the second leading cause of cancer deaths despite the fact that detection of this cancer in early stages results in over 90% survival rate. Currently less than 45% of at-risk individuals in the US are screened regularly, exposing a need for better screening tests. We performed two case-control studies to validate a blood-based test that identifies methylated DNA in plasma from all stages of CRC. Methodology/Principal Findings: Using a PCR assay for analysis of Septin 9 (SEPT9) hypermethylation in DNA extracted from plasma, clinical performance was optimized on 354 samples (252 CRC, 102 controls) and validated in a blinded, independent study of 309 samples (126 CRC, 183 controls). 168 polyps and 411 additional disease controls were also evaluated. Based on the training study SEPT9-based classification detected 120/252 CRCs (48%) and 7/ 102 controls (7%). In the test study 73/126 CRCs (58%) and 18/183 control samples (10%) were positive for SEPT9 validating the training set results. Inclusion of an additional measurement replicate increased the sensitivity of the assay in the testing set to 72% (90/125 CRCs detected) while maintaining 90% specificity (19/183 for controls). Positive rates for plasmas from the other cancers (11/96) and non-cancerous conditions (41/315) were low. The rate of polyp detection (> 1 cm) was similar to 20%. Conclusions/Significance: Analysis of SEPT9 DNA methylation in plasma represents a straightforward, minimally invasive method to detect all stages of CRC with potential to satisfy unmet needs for increased compliance in the screening population. Further clinical testing is warranted.	[Gruetzmann, Robert; Pilarsky, Christian; Saeger, Hans D.] Univ Hosp Carl Gustav Carus Dresden, Dept Visceral Thorac & Vasc Surg, Dresden, Germany; [Molnar, Bela] Semmelweis Univ, H-1085 Budapest, Hungary; [Habermann, Jens K.; Roblick, Uwe J.; Bruch, Hans-Peter] Univ Hosp Schleswig Holstein, Dept Surg, Lubeck, Germany; [Schlag, Peter M.] Robert Rossle Klin, Dept Surg & Surg Oncol, Charite Campus Berlin Buch, Berlin, Germany; [Miehlke, Stephan] Univ Hosp Carl Gustav Carus Dresden, Dept Gastroenterol, Dresden, Germany; [Stolz, Thomas] Volklingen Clin, Volklingen, Germany; [Model, Fabian; Liebenberg, Volker] Epigenom AG, Berlin, Germany; [Koch, Rainer] Tech Univ Dresden, Inst Med Informat & Biomet, Dresden, Germany; [deVos, Theo; Song, Xiaoling; Day, Robert H.; Sledziewski, Andrew Z.; Lofton-Day, Catherine] Epigenom Inc, Seattle, WA USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Semmelweis University; University of Kiel; Schleswig Holstein University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Grutzmann, R (corresponding author), Univ Hosp Carl Gustav Carus Dresden, Dept Visceral Thorac & Vasc Surg, Dresden, Germany.	Robert.Gruetzmann@uniklinikum-dresden.de	Bruch, Hans-Peter/E-7731-2010; Habermann, Jens/AAA-5149-2020; Roblick, Uwe J/F-5906-2011; Liebenberg, Volker/AAY-7687-2021	Pilarsky, Christian/0000-0002-7968-3283; deVos, Theo/0000-0003-2085-2844; Liebenberg, Volker/0000-0003-1936-1247	Epigenomics AG, Berlin	Epigenomics AG, Berlin	The study was sponsored by Epigenomics AG, Berlin. The study sponsor participated in study design and the analysis of the samples. Interpretation of data and writing of the paper as well as the decision to submit it for publication was performed by the all authors including the authors employed by the sponsor.	*AM CANC S, 2005, BEH RISK FACT SURV S; Arnir S, 2007, CANCER BIOL THER, V6, P1926, DOI 10.4161/cbt.6.12.4971; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Bennett KL, 2008, CANCER RES, V68, P4494, DOI 10.1158/0008-5472.CAN-07-6509; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Chen WD, 2005, JNCI-J NATL CANCER I, V97, P1124, DOI 10.1093/jnci/dji204; Davis KC, 1998, PUBLIC HEALTH REP, V113, P346; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Ebert MPA, 2005, NEOPLASIA, V7, P771, DOI 10.1593/neo.05235; Fisher JA, 2006, CANCER EPIDEM BIOMAR, V15, P108, DOI 10.1158/1055-9965.EPI-05-0198; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kurosu T, 2008, INT J HEMATOL, V88, P192, DOI 10.1007/s12185-008-0133-0; Leung WK, 2005, AM J GASTROENTEROL, V100, P2274, DOI 10.1111/j.1572-0241.2005.50412.x; Li SR, 2006, INT J CANCER, V118, P3078, DOI 10.1002/ijc.21774; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; McDade SS, 2007, HUM MOL GENET, V16, P742, DOI 10.1093/hmg/ddm003; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Nakayama H, 2002, CANCER LETT, V188, P115, DOI 10.1016/S0304-3835(01)00839-4; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Osborn NK, 2006, CLIN GASTROENTEROL H, V4, P212, DOI 10.1016/j.cgh.2005.11.009; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Regueiro CR, 2005, GASTROENTEROLOGY, V129, P1083, DOI 10.1053/j.gastro.2005.06.012; Russell SEH, 2000, CANCER RES, V60, P4729; Russell SEH, 2005, BRIT J CANCER, V93, P499, DOI 10.1038/sj.bjc.6602753; Scott M, 2005, ONCOGENE, V24, P4688, DOI 10.1038/sj.onc.1208574; Tetzner R, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl955; Toyooka S, 2002, CANCER RES, V62, P3382; Toyota M, 2000, CANCER RES, V60, P4044; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Zitt M, 2007, DIS MARKERS, V23, P51, DOI 10.1155/2007/891967; Zou HZ, 2002, CLIN CANCER RES, V8, P188	35	287	364	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3759	10.1371/journal.pone.0003759	http://dx.doi.org/10.1371/journal.pone.0003759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018278	Green Published, Green Accepted, gold			2022-12-25	WOS:000265448500006
J	Norman, JP; Perry, SW; Reynolds, HM; Kiebala, M; Bentley, KLD; Trejo, M; Volsky, DJ; Maggirwar, SB; Dewhurst, S; Masliah, E; Gelbard, HA				Norman, John P.; Perry, Seth W.; Reynolds, Holly M.; Kiebala, Michelle; Bentley, Karen L. De Mesy; Trejo, Margarita; Volsky, David J.; Maggirwar, Sanjay B.; Dewhurst, Stephen; Masliah, Eliezer; Gelbard, Harris A.			HIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial Hyperpolarization	PLOS ONE			English	Article								Neurologic disease caused by human immunodeficiency virus type 1 (HIV-1) is ultimately refractory to highly active antiretroviral therapy (HAART) because of failure of complete virus eradication in the central nervous system (CNS), and disruption of normal neural signaling events by virally induced chronic neuroinflammation. We have previously reported that HIV-1 Tat can induce mitochondrial hyperpolarization in cortical neurons, thus compromising the ability of the neuron to buffer calcium and sustain energy production for normal synaptic communication. In this report, we demonstrate that Tat induces rapid loss of ER calcium mediated by the ryanodine receptor (RyR), followed by the unfolded protein response (UPR) and pathologic dilatation of the ER in cortical neurons in vitro. RyR antagonism attenuated both Tat-mediated mitochondrial hyperpolarization and UPR induction. Delivery of Tat to murine CNS in vivo also leads to long-lasting pathologic ER dilatation and mitochondrial morphologic abnormalities. Finally, we performed ultrastructural studies that demonstrated mitochondria with abnormal morphology and dilated endoplasmic reticulum (ER) in brain tissue of patients with HIV-1 inflammation and neurodegeneration. Collectively, these data suggest that abnormal RyR signaling mediates the neuronal UPR with failure of mitochondrial energy metabolism, and is a critical locus for the neuropathogenesis of HIV-1 in the CNS.	[Norman, John P.; Perry, Seth W.; Reynolds, Holly M.; Gelbard, Harris A.] Univ Rochester, Sch Med & Dent, Ctr Neural Dev & Dis, Rochester, NY 14627 USA; [Norman, John P.; Perry, Seth W.; Reynolds, Holly M.; Gelbard, Harris A.] Univ Rochester, Sch Med & Dent, Dept Neurol, Child Neurol Div, Rochester, NY 14627 USA; [Bentley, Karen L. De Mesy] Univ Rochester, Sch Med & Dent, Dept Lab Med & Pathol, Rochester, NY 14627 USA; [Kiebala, Michelle; Maggirwar, Sanjay B.; Dewhurst, Stephen; Gelbard, Harris A.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14627 USA; [Volsky, David J.] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Mol Virol Div, New York, NY 10027 USA; [Trejo, Margarita; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, Dept Neurosci, La Jolla, CA 92093 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; University of California System; University of California San Diego	Norman, JP (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Neural Dev & Dis, Rochester, NY 14627 USA.	harris_gelbard@urmc.rochester.edu	Gelbard, Harris/M-9260-2019	Dewhurst, Stephen/0000-0001-7729-7920; Perry, Seth W/0000-0002-1503-6634; Gelbard, Harris/0000-0001-5095-7976	Geoffrey Waasdorp Pediatric Neurology Fund; NIH [T32ES07026, T32 AI49105, PO1MH64570, R01MH56838, R01MH078989, RO1 NS054578, PO1NS31492, MH62962, MH59745, MH62512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062962, P01MH064570, P30MH062512, R24MH059745, R01MH056838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054578, P01NS031492] Funding Source: NIH RePORTER	Geoffrey Waasdorp Pediatric Neurology Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Geoffrey Waasdorp Pediatric Neurology Fund, and NIH grants T32ES07026 (to J.P.N.), T32 AI49105 (to M.K. and H.M.R.), PO1MH64570, R01MH56838 and R01MH078989 (to J.N.P, S.W.P., S.B.M., S.D. and H.A.G.); RO1 NS054578 (to S.B.M. and H.A.G.); PO1NS31492 (to D.J.V. and H.A.G.); and MH62962, MH59745, and MH62512 to E.M. No funding sponsor played a role in this research.	ADLEBIASSETTE H, 1995, NEUROPATH APPL NEURO, V21, P218, DOI 10.1111/j.1365-2990.1995.tb01053.x; Altschafl BA, 2007, BBA-BIOMEMBRANES, V1768, P1784, DOI 10.1016/j.bbamem.2007.04.011; An SF, 1997, J NEUROPATH EXP NEUR, V56, P1262, DOI 10.1097/00005072-199711000-00011; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Bellizzi MJ, 2005, J CLIN INVEST, V115, P3185, DOI 10.1172/JCI25444; Beutner G, 2005, BBA-BIOMEMBRANES, V1717, P1, DOI 10.1016/j.bbamem.2005.09.016; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brigati C, 2003, FEMS MICROBIOL LETT, V220, P57, DOI 10.1016/S0378-1097(03)00067-3; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Buriani A, 1999, J NeuroAIDS, V2, P1, DOI 10.1300/J128v02n02_01; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Del Gaizo V, 2003, MOL GENET METAB, V80, P170, DOI 10.1016/j.ymgme.2003.08.017; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; GELBARD HA, 1995, NEUROPATH APPL NEURO, V21, P208, DOI 10.1111/j.1365-2990.1995.tb01052.x; GENDELMAN HE, 2002, AIDS OTHER MANIFESTA, P86; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Haughey NJ, 1999, J NEUROCHEM, V73, P1363, DOI 10.1046/j.1471-4159.1999.0731363.x; Haughey NJ, 2002, JAIDS-J ACQ IMM DEF, V31, pS55, DOI 10.1097/00126334-200210012-00005; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Iwawaki T, 2006, BIOCHEM BIOPH RES CO, V350, P709, DOI 10.1016/j.bbrc.2006.09.100; JENSEN KLD, 1983, MASSON MONOGRAPHS DI, V4, P194; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Masliah E, 1996, J NEUROSCI, V16, P5795; Matarrese P, 2003, J IMMUNOL, V170, P6006, DOI 10.4049/jimmunol.170.12.6006; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Murakami T, 2007, NEUROSCIENCE, V146, P1, DOI 10.1016/j.neuroscience.2007.01.069; Nagy G, 2003, J IMMUNOL, V171, P5188, DOI 10.4049/jimmunol.171.10.5188; Nath A, 1998, PROG NEUROBIOL, V54, P19, DOI 10.1016/S0301-0082(97)00053-1; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Norman JP, 2007, J IMMUNOL, V178, P869, DOI 10.4049/jimmunol.178.2.869; Ozdener H, 2005, J BIOSCIENCES, V30, P391, DOI 10.1007/BF02703676; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Perry SW, 2005, J IMMUNOL, V174, P4333, DOI 10.4049/jimmunol.174.7.4333; Perry SW, 1998, J BIOL CHEM, V273, P17660, DOI 10.1074/jbc.273.28.17660; Petito CK, 1999, J NEUROVIROL, V5, P327, DOI 10.3109/13550289909029474; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Porcheray F, 2006, AM J PHYSIOL-CELL PH, V291, pC618, DOI 10.1152/ajpcell.00021.2006; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Solovyova N, 2002, J NEUROSCI METH, V122, P1, DOI 10.1016/S0165-0270(02)00300-X; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; TARDIEU M, 1992, ANN NEUROL, V32, P11, DOI 10.1002/ana.410320104; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van de Bovenkamp M, 2002, EUR J CLIN INVEST, V32, P619, DOI 10.1046/j.1365-2362.2002.01029.x; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8; Weis S, 1996, CLIN NEUROPATHOL, V15, P361; Williams BL, 2006, J VIROL, V80, P8613, DOI 10.1128/JVI.00836-06; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848	65	85	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2008	3	11							e3731	10.1371/journal.pone.0003731	http://dx.doi.org/10.1371/journal.pone.0003731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432XA	19009018	gold, Green Published, Green Submitted			2022-12-25	WOS:000265166400009
J	Fan, SJ; Meng, QH; Laterra, JJ; Rosen, EM				Fan, Saijun; Meng, Qinghui; Laterra, John J.; Rosen, Eliot M.			Role of Src Signal Transduction Pathways in Scatter Factor-mediated Cellular Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HEPATOCYTE GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; MAMMARY-CARCINOMA CELLS; C-SRC; BREAST-CANCER; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; FACTOR/SCATTER FACTOR; GENE-EXPRESSION	Scatter factor (SF) (hepatocyte growth factor) is a pleiotrophic cytokine that accumulates in tumors, where it may induce invasion, angiogenesis, and chemoresistance. We have studied the mechanisms by which SF and its receptor (c-Met) protect cells against the DNA-damaging agent adriamycin (ADR) as a model for chemoresistance of SF/c-Met-overexpressing tumors. Previous studies identified a phosphatidylinositol 3-kinase/c-Akt/Pak1/NF-kappa B cell survival pathway in DU-145 prostate cancer and Madin-Darby canine kidney epithelial cells. Here we studied Src signaling pathways involved in SF cell protection. Src enhanced basal and SF stimulated NF-kappa B activity and SF protection against ADR, in a manner dependent upon its kinase and Src homology 3 domains; and endogenous Src was required for SF stimulation of NF-kappa B activity and cell protection. The ability of Src to enhance SF stimulation of NF-kappa B activity was due, in part, to its ability to stimulate Akt and I kappa B kinase activity; and Src-mediated stimulation of NF-kappa B was due, in part, to a Rac1/MKK3/6/p38 pathway and was Akt-dependent. SF caused the activation of Src and the Rac1 effector Pak1. Furthermore, SF induced activating phosphorylations of MKK3, MKK6, and p38 within the c-Met signalsome in an Src-dependent manner. The NF-kappa B-inducing kinase was found to act downstream of TAK1 (transforming growth factor-beta-activated kinase 1) as a mediator of SF- and Src-stimulated NF-kappa B activity. Finally, the Src/Rac1/MKK3/6/p38 and Src/TAK1/NF-kappa B-inducing kinase pathways exhibited cross-talk at the level of MKK3. These findings delineate some novel signaling pathways for SF- mediated resistance to ADR.	[Fan, Saijun; Meng, Qinghui; Rosen, Eliot M.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Laterra, John J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Georgetown University; Johns Hopkins University	Rosen, EM (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, 3970 Reservoir Rd,NW,Box 571469, Washington, DC 20057 USA.	emr36@georgetown.edu	Meng, Q./GSI-6185-2022		National Institutes of Health [RO1-ES09169, RO1-NS43987]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032148, R01NS043987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-ES09169 (to E.M.R.) and RO1-NS43987	Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; ALLEY MC, 1988, CANCER RES, V48, P589; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Bardelli A, 1996, EMBO J, V15, P6205, DOI 10.1002/j.1460-2075.1996.tb01009.x; Bottero V, 2001, CANCER RES, V61, P7785; Bowers DC, 2000, CANCER RES, V60, P4277; Chini CCS, 2000, EUR J IMMUNOL, V30, P2791, DOI 10.1002/1521-4141(200010)30:10<2791::AID-IMMU2791>3.0.CO;2-D; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Ding JB, 1996, J BIOL CHEM, V271, P24869, DOI 10.1074/jbc.271.40.24869; Fan S, 2007, ONCOGENE, V26, P4774, DOI 10.1038/sj.onc.1210271; Fan SJ, 2000, ONCOGENE, V19, P2212, DOI 10.1038/sj.onc.1203566; Fan SJ, 2005, ONCOGENE, V24, P1749, DOI 10.1038/sj.onc.1208327; Fan SJ, 2001, MOL CELL BIOL, V21, P4968, DOI 10.1128/MCB.21.15.4968-4984.2001; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Funakoshi-Tago M, 2005, J BIOCHEM, V137, P189, DOI 10.1093/jb/mvi018; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; Han QW, 2002, J BIOL CHEM, V277, P48379, DOI 10.1074/jbc.M209542200; Higashio K, 1993, EXS, V65, P351; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Hurle RA, 2005, HISTOL HISTOPATHOL, V20, P1339, DOI 10.14670/HH-20.1339; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x; Kaminska B, 2005, ACTA BIOCHIM POL, V52, P329; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kang JY, 2003, CANCER RES, V63, P1101; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Levin Victor A, 2004, Cancer Treat Res, V119, P89; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Liu AX, 1998, CANCER RES, V58, P2973; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mikami F, 2005, J BIOL CHEM, V280, P36185, DOI 10.1074/jbc.M503941200; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ozes ON, 1999, NATURE, V401, P82; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Popsueva A, 2003, J CELL BIOL, V161, P119, DOI 10.1083/jcb.200212174; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; REDDY S, 1990, J VIROL, V64, P3545, DOI 10.1128/JVI.64.7.3545-3550.1990; Rosen EM, 1997, CIBA F SYMP, V212, P215; ROSEN EM, 1994, J CELL BIOL, V127, P1783, DOI 10.1083/jcb.127.6.1783; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Siegfried JM, 1997, CANCER RES, V57, P433; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tsukinoki K, 2004, ONCOL REP, V12, P1017; WENG ZG, 1995, MOL CELL BIOL, V15, P5627; Wojcik EJ, 2006, ONCOGENE, V25, P2773, DOI 10.1038/sj.onc.1209306; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; YAMASHITA J, 1994, CANCER RES, V54, P1630; Yamauchi J, 2001, J BIOL CHEM, V276, P23362, DOI 10.1074/jbc.M011752200; Yang XH, 2004, J BIOL CHEM, V279, P38099, DOI 10.1074/jbc.C400318200; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zeng QH, 2002, J BIOL CHEM, V277, P50137, DOI 10.1074/jbc.M208952200; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949	62	23	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7561	7577		10.1074/jbc.M807497200	http://dx.doi.org/10.1074/jbc.M807497200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19047046	Green Published, hybrid			2022-12-25	WOS:000264195600019
J	Ding, W; Liu, WL; Cooper, KL; Qin, XJ; Bergo, PLD; Hudson, LG; Liu, KJ				Ding, Wei; Liu, Wenlan; Cooper, Karen L.; Qin, Xu-Jun; Bergo, Patricia L. de Souza; Hudson, Laurie G.; Liu, Ke Jian			Inhibition of Poly(ADP-ribose) Polymerase-1 by Arsenite Interferes with Repair of Oxidative DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULTRAVIOLET-RADIATION; MAMMALIAN-CELLS; METAL-COMPOUNDS; NITRIC-OXIDE; ZINC-FINGER; MOUSE SKIN; CANCER; EXPRESSION; GENERATION; INDUCTION	Arsenic enhances skin tumor formation when combined with other carcinogens, including UV radiation (UVR). In this study we report that low micromolar concentrations of arsenite synergistically increases UVR-induced oxidative DNA damage in human keratinocytes as detected by 8-hydroxyl-2'-deoxyguanine (8-OHdG) formation. Poly(ADP-ribose) polymerase-1 (PARP-1) is involved in base excision repair, a process that repairs 8-OHdG lesions. Arsenite suppresses UVR-induced PARP-1 activation in a concentration-dependent manner. Inhibition of PARP-1 activity by 3-aminobenzamide or small interfering RNA silencing of PARP-1 expression significantly increases UVR-induced 8-OHdG formation, suggesting that inhibition of PARP-1 activity by arsenite contributes to oxidative DNA damage. PARP-1 is a zinc finger protein, and mass spectrometry analysis reveals that arsenite can occupy a synthetic apopeptide representing the first zinc finger of PARP-1 (PARPzf). When the PARPzf peptide is preincubated with Zn(II) followed by incubation with increasing concentrations of arsenite, the ZnPARPzf signal is decreased while the AsPARPzf signal intensity is increased as a function of arsenite dose, suggesting a competition between zinc and arsenite for the same binding site. Addition of Zn(II) abolished arsenite enhancement of UVR-stimulated 8-OHdG generation and restored PARP-1 activity. Our findings demonstrate that arsenite inhibits oxidative DNA damage repair and suggest that interaction of arsenite with the PARP-1 zinc finger domain contributes to the inhibition of PARP-1 activity by arsenite. Arsenite inhibition of poly( ADP-ribosyl)ation is one likely mechanism for the reported co-carcinogenic activities of arsenic in UVR-induced skin carcinogenesis.	[Hudson, Laurie G.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	University of New Mexico	Hudson, LG (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, MSC 09 5360, Albuquerque, NM 87131 USA.	lhudson@salud.unm.edu	Ding, Wei/L-1503-2014	de Souza Bergo, Patricia Luisa/0000-0002-4288-4903	NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015826, P30ES012072, R01ES012938] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA118100] Funding Source: Medline; NIEHS NIH HHS [R01 ES15826, P30 ES-012072, R01 ES012938] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Ahmed NU, 1999, BRIT J DERMATOL, V140, P226, DOI 10.1111/j.1365-2133.1999.02653.x; Asmuss M, 2000, CARCINOGENESIS, V21, P2097, DOI 10.1093/carcin/21.11.2097; Bal W, 2002, TOXICOL LETT, V127, P55, DOI 10.1016/S0378-4274(01)00483-0; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Begley TJ, 2004, DNA REPAIR, V3, P1123, DOI 10.1016/j.dnarep.2004.03.013; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; De Blasio A, 2003, INT J ONCOL, V23, P1521; Ding W, 2005, MOL CELL BIOCHEM, V279, P105, DOI 10.1007/s11010-005-8227-y; Ding W, 2008, FREE RADICAL BIO MED, V45, P1065, DOI 10.1016/j.freeradbiomed.2008.06.022; Evans CD, 2004, CARCINOGENESIS, V25, P493, DOI 10.1093/carcin/bgg199; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Fischer JM, 2005, MUTAT RES-GEN TOX EN, V588, P35, DOI 10.1016/j.mrgentox.2005.09.003; Germolec DR, 1998, AM J PATHOL, V153, P1775, DOI 10.1016/S0002-9440(10)65692-1; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Hartwig A, 2002, ENVIRON HEALTH PERSP, V110, P797, DOI 10.1289/ehp.02110s5797; Hartwig A, 2003, TOXICOLOGY, V193, P161, DOI 10.1016/j.tox.2003.08.004; Hartwig A, 2002, TOXICOL LETT, V127, P47, DOI 10.1016/S0378-4274(01)00482-9; Hartwig A, 2003, INT J CANCER, V104, P1, DOI 10.1002/ijc.10911; Hei TK, 1998, P NATL ACAD SCI USA, V95, P8103, DOI 10.1073/pnas.95.14.8103; KAWAMITSU H, 1984, BIOCHEMISTRY-US, V23, P3771, DOI 10.1021/bi00311a032; Kessel M, 2002, MOL CELL BIOCHEM, V234, P301, DOI 10.1023/A:1015927406142; Kitchin KT, 2008, J INORG BIOCHEM, V102, P532, DOI 10.1016/j.jinorgbio.2007.10.021; Kitchin KT, 2005, TOXICOL APPL PHARM, V206, P66, DOI 10.1016/j.taap.2004.12.010; Le Rhun Y, 1998, BIOCHEM BIOPH RES CO, V245, P1; Liao XY, 2005, ENVIRON INT, V31, P791, DOI 10.1016/j.envint.2005.05.030; Liu F, 2000, FREE RADICAL BIO MED, V28, P55, DOI 10.1016/S0891-5849(99)00196-3; Liu WL, 2006, J NEUROSCI RES, V84, P360, DOI 10.1002/jnr.20895; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Matsui M, 1999, J INVEST DERMATOL, V113, P26, DOI 10.1046/j.1523-1747.1999.00630.x; Patel KS, 2005, ENVIRON GEOCHEM HLTH, V27, P131, DOI 10.1007/s10653-005-0120-9; PERSHAGEN G, 1981, ENVIRON HEALTH PERSP, V40, P93, DOI 10.2307/3429223; Piatek K, 2008, CHEM RES TOXICOL, V21, P600, DOI 10.1021/tx7003135; Poonepalli A, 2005, CANCER RES, V65, P10977, DOI 10.1158/0008-5472.CAN-05-2336; Qin XJ, 2008, TOXICOL APPL PHARM, V232, P41, DOI 10.1016/j.taap.2008.05.019; Qin XJ, 2008, CHEM RES TOXICOL, V21, P1806, DOI 10.1021/tx8001548; Ramirez P, 2000, CARCINOGENESIS, V21, P701, DOI 10.1093/carcin/21.4.701; Rossman TG, 2004, TOXICOL APPL PHARM, V198, P394, DOI 10.1016/j.taap.2003.10.016; Rossman TG, 2001, TOXICOL APPL PHARM, V176, P64, DOI 10.1006/taap.2001.9277; Schwerdtle T, 2003, DNA REPAIR, V2, P1449, DOI 10.1016/j.dnarep.2003.09.001; Shi HL, 2004, CHEM RES TOXICOL, V17, P871, DOI 10.1021/tx049939e; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Walter I, 2007, DNA REPAIR, V6, P61, DOI 10.1016/j.dnarep.2006.08.008; Yager JW, 1997, MUTAT RES-REV MUTAT, V386, P345, DOI 10.1016/S1383-5742(97)00011-2; YAMAMOTO S, 1995, CANCER RES, V55, P1271; Yarborough A, 1996, CANCER RES, V56, P683	48	119	120	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6809	6817		10.1074/jbc.M805566200	http://dx.doi.org/10.1074/jbc.M805566200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19056730	hybrid, Green Published			2022-12-25	WOS:000263919000026
J	Zhang, JH; Ge, RS; Matte-Martone, C; Goodwin, J; Shlomchik, WD; Mamula, MJ; Kooshkabadi, A; Hardy, MP; Geller, D				Zhang, Junhui; Ge, Renshang; Matte-Martone, Catherine; Goodwin, Julie; Shlomchik, Warren D.; Mamula, Mark J.; Kooshkabadi, Ali; Hardy, Matthew P.; Geller, David			Characterization of a Novel Gain of Function Glucocorticoid Receptor Knock-in Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT LEYDIG-CELLS; FOLLICLE-STIMULATING-HORMONE; ADRENAL AXIS REGULATION; LUTEINIZING-HORMONE; BINDING DOMAIN; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; MINERALOCORTICOID RECEPTORS; CUSHINGS-SYNDROME; GENE; SENSITIVITY	Glucocorticoids (GCs) exert profound influences on many physiologic functions by virtue of their diverse roles in growth, development, and maintenance of homeostasis. We previously created a novel gain of function in the human glucocorticoid receptor (hGR), hGR(M604L), which is active at GC concentrations 5-10-fold lower than wild-type GR. To gain a greater insight into GC physiology in vivo, we inserted this mutant GR (GR(M610L) in mice) into mice via homologous recombination. Mice expressing the allele are phenotypically normal with respect to GC function. However, corticosterone levels, ACTH levels, and adrenocortical size are markedly reduced, suggesting they are phenotypically normal because the mutant GR alters the basal regulation of the hypothalamic-pituitary-adrenal axis. We demonstrate via physiologic and immunologic studies that GR(M610L) mice have increased sensitivity to GCs in vivo. Sensitivity to the actions of endogenous GCs may be an important factor underlying the development of many human diseases including hypertension, obesity, and diabetes. Our model may provide a new and powerful tool for the study of GC physiological and pathological processes in vivo.	[Matte-Martone, Catherine; Shlomchik, Warren D.; Mamula, Mark J.; Kooshkabadi, Ali; Geller, David] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Zhang, Junhui] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Goodwin, Julie] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Ge, Renshang; Hardy, Matthew P.] Rockefeller Univ, New York, NY 10065 USA; [Ge, Renshang; Hardy, Matthew P.] Populat Council, New York, NY 10065 USA	Yale University; Yale University; Yale University; Rockefeller University; Population Council	Geller, D (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA.		Goodwin, Julie/AAF-5754-2020		National Institutes of Health [R03-DK064907]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK064907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R03-DK064907 (to D.S.G.) from the NIDDK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; AGULAR BM, 1995, J STEROID BIOCHEM, V54, P75, DOI 10.1016/0960-0760(95)00058-8; AGULAR BM, 1992, J STEROID BIOCHEM, V43, P565, DOI 10.1016/0960-0760(92)90245-E; AXELROD L, 1976, MEDICINE, V55, P39, DOI 10.1097/00005792-197601000-00003; BAIN PA, 1991, P NATL ACAD SCI USA, V88, P8870, DOI 10.1073/pnas.88.20.8870; BALDWIN BA, 1979, J NEUROSCI METH, V1, P243, DOI 10.1016/0165-0270(79)90035-9; BAMBINO TH, 1981, ENDOCRINOLOGY, V108, P2142, DOI 10.1210/endo-108-6-2142; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Buemann B, 2005, OBES RES, V13, P862, DOI 10.1038/oby.2005.99; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Charmandari E, 2005, J CLIN ENDOCR METAB, V90, P3696, DOI 10.1210/jc.2004-1920; COCHRAN RC, 1981, INVEST UROL, V19, P142; de Kloet ER, 2000, KIDNEY INT, V57, P1329, DOI 10.1046/j.1523-1755.2000.00971.x; Deschepper CF, 2004, J APPL PHYSIOL, V97, P369, DOI 10.1152/japplphysiol.00073.2004; Eremina V, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133788; Feng JO, 2000, AM J MED GENET, V96, P412, DOI 10.1002/1096-8628(20000612)96:3<412::AID-AJMG33>3.0.CO;2-C; Funder JW, 1997, ANNU REV MED, V48, P231, DOI 10.1146/annurev.med.48.1.231; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Ge RS, 1997, ENDOCRINOLOGY, V138, P5089, DOI 10.1210/en.138.12.5089; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; Giordano R, 2005, J CLIN ENDOCR METAB, V90, P5656, DOI 10.1210/jc.2005-0105; Gomez F, 1998, AM J PHYSIOL-REG I, V274, pR420, DOI 10.1152/ajpregu.1998.274.2.R420; HALES DB, 1989, ENDOCRINOLOGY, V124, P2099, DOI 10.1210/endo-124-5-2099; Howell MP, 2006, FRONT NEUROENDOCRIN, V27, P275, DOI 10.1016/j.yfrne.2006.05.001; Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P144, DOI 10.1210/jc.83.1.144; IIDA S, 1990, J CLIN ENDOCR METAB, V70, P729, DOI 10.1210/jcem-70-3-729; Irving JAE, 2005, CANCER RES, V65, P9712, DOI 10.1158/0008-5472.CAN-05-1227; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Juruena MF, 2006, PSYCHOPHARMACOLOGY, V189, P225, DOI 10.1007/s00213-006-0555-4; KARL M, 1993, J CLIN ENDOCR METAB, V76, P683, DOI 10.1210/jc.76.3.683; Kelly JJ, 1998, CLIN EXP PHARMACOL P, V25, pS51, DOI 10.1111/j.1440-1681.1998.tb02301.x; LAKSHMI V, 1985, J STEROID BIOCHEM, V22, P331, DOI 10.1016/0022-4731(85)90435-2; Lamberts SWJ, 1996, STEROIDS, V61, P157, DOI 10.1016/0039-128X(96)00005-0; LAMBERTS SWJ, 1986, J CLIN ENDOCR METAB, V63, P1328, DOI 10.1210/jcem-63-6-1328; MANTERO F, 1992, J STEROID BIOCHEM, V43, P409, DOI 10.1016/0960-0760(92)90077-V; Matte CC, 2004, NAT MED, V10, P987, DOI 10.1038/nm1089; MONDER C, 1992, SERONO SYM, V86, P145; MONDER C, 1994, ENDOCRINOLOGY, V134, P1193, DOI 10.1210/en.134.3.1193; Nagano M, 2002, CANCER LETT, V181, P109, DOI 10.1016/S0304-3835(02)00042-3; ORR TE, 1994, J ANDROL, V15, P302; Paust HJ, 2006, EXP CLIN ENDOCR DIAB, V114, P6, DOI 10.1055/s-2005-873007; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SUTER DE, 1985, ENDOCRINOLOGY, V117, P855, DOI 10.1210/endo-117-3-855; SVEC F, 1985, LIFE SCI, V36, P2359, DOI 10.1016/0024-3205(85)90339-X; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; TROSTEL KA, 1992, AM J PHYSIOL, V263, pR1265, DOI 10.1152/ajpregu.1992.263.6.R1265; van Winsen LLM, 2005, J NEUROIMMUNOL, V167, P150, DOI 10.1016/j.jneuroim.2005.06.010; VINGERHOEDS ACM, 1976, J CLIN ENDOCR METAB, V43, P1128, DOI 10.1210/jcem-43-5-1128; Walker BR, 1996, HYPERTENSION, V27, P190, DOI 10.1161/01.HYP.27.2.190; WARRIAR N, 1994, J BIOL CHEM, V269, P29010; YU CY, 1995, BIOCHEMISTRY-US, V34, P14163, DOI 10.1021/bi00043a022; Zhang JH, 2005, P NATL ACAD SCI USA, V102, P2707, DOI 10.1073/pnas.0409663102; Zhang JH, 2006, J MOL ENDOCRINOL, V37, P163, DOI 10.1677/jme.1.02089	56	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6249	6259		10.1074/jbc.M807997200	http://dx.doi.org/10.1074/jbc.M807997200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19017639	Green Published, hybrid			2022-12-25	WOS:000263742700028
J	Ikonomov, OC; Fligger, J; Sbrissa, D; Dondapati, R; Mlak, K; Deeb, R; Shisheva, A				Ikonomov, Ognian C.; Fligger, Jason; Sbrissa, Diego; Dondapati, Rajeswari; Mlak, Krzysztof; Deeb, Robert; Shisheva, Assia			Kinesin Adapter JLP Links PIKfyve to Microtubule-based Endosome-to-Trans-Golgi Network Traffic of Furin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC RECYCLING COMPARTMENT; SCAFFOLD PROTEIN JLP; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; MAMMALIAN ORTHOLOG; SIGNALING MODULES; AXONAL-TRANSPORT; KINASE; MEMBRANE; PROGRESSION; ACTIVATION	JIPs (c-Jun N-terminal kinase interacting proteins), which scaffold JNK/p38 MAP kinase signaling modules, also bind conventional kinesins and are implicated in microtubule-based membrane trafficking in neuronal cells. Here we have identified a novel splice variant of the Jip4 gene product JLP(L) (JNK-interacting leucine zipper protein) in yeast-two hybrid screens with the phosphoinositide kinase PIKfyve. The interaction was confirmed by pulldown and coimmunoprecipitation assays in native cells. It engages the PIKfyve cpn60_TCP1 consensus sequence and the last 75 residues of the JLP C terminus. Subpopulations of both proteins cofractionated and populated similar structures at the cell perinuclear region. Because PIKfyve is essential in endosome-to-trans-Golgi network (TGN) cargo transport, we tested whether JLP is a PIKfyve functional partner in this trafficking pathway. Short interfering RNA (siRNA)-mediated depletion of endogenous JLP or PIKfyve profoundly delayed the microtubule-based transport of chimeric furin (Tac-furin) from endosomes to the TGN in a CHO cell line, which was rescued upon ectopic expression of siRNA-resistant JLP or PIKfyve constructs. Peptides from the contact sites in PIKfyve and JLP, or a dominant-negative PIKfyve mutant introduced into cells by ectopic expression or microinjection, induced a similar defect. Because Tac-TGN38 delivery from endosomes to the TGN, unlike that of Tac-furin, does not require intact microtubules, we monitored the effect of JLP and PIKfyve depletion or the interacting peptides administration on Tac-TGN38 trafficking. Remarkably, neither maneuver altered the Tac-TGN38 delivery to the TGN. Our data indicate that JLP interacts with PIKfyve and that both proteins and their association are required in microtubule-based, but not in microtubule-independent, endosome-to-TGN cargo transport.	[Ikonomov, Ognian C.; Fligger, Jason; Sbrissa, Diego; Dondapati, Rajeswari; Mlak, Krzysztof; Deeb, Robert; Shisheva, Assia] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA	Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.	ashishev@med.wayne.edu			National Institutes of Health Research [DK58058]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Research Grant DK58058. This work was also supported by a grant from the American Diabetes Association (to A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; HARLOW E, 1988, ANTIBODIES LAB MANUA, P271; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Horiuchi D, 2005, CURR BIOL, V15, P2137, DOI 10.1016/j.cub.2005.10.047; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2003, J BIOL CHEM, V278, P50863, DOI 10.1074/jbc.M307260200; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Iwanaga A, 2008, TRANSGENIC RES, V17, P1045, DOI 10.1007/s11248-008-9191-6; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; Kashef K, 2005, BIOCHEMISTRY-US, V44, P14090, DOI 10.1021/bi050604l; Kashef K, 2006, J CELL BIOCHEM, V98, P715, DOI 10.1002/jcb.20930; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2004, ENDOCRINOLOGY, V145, P4853, DOI 10.1210/en.2004-0489; Sbrissa D, 2001, MOL CELL ENDOCRINOL, V181, P35, DOI 10.1016/S0303-7207(01)00539-1; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Schapiro FB, 2004, MOL BIOL CELL, V15, P2884, DOI 10.1091/mbc.E03-09-0653; Schnapp BJ, 2003, J CELL SCI, V116, P2125, DOI 10.1242/jcs.00488; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wolins N, 1997, J CELL BIOL, V139, P1735, DOI 10.1083/jcb.139.7.1735; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	55	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3750	3761		10.1074/jbc.M806539200	http://dx.doi.org/10.1074/jbc.M806539200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19056739	Green Published, hybrid			2022-12-25	WOS:000262872500043
J	Thiriet, C; Hayes, JJ				Thiriet, Christophe; Hayes, Jeffrey J.			Linker Histone Phosphorylation Regulates Global Timing of Replication Origin Firing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACT; IN-VIVO; PHYSARUM-POLYCEPHALUM; GENE-EXPRESSION; CHROMATIN-STRUCTURE; H1 PHOSPHORYLATION; MOUSE DEVELOPMENT; DNA-REPLICATION; CELL-CYCLE; SITES	Despite the presence of linker histone in all eukaryotes, the primary function(s) of this histone have been difficult to clarify. Knock-out experiments indicate that H1s play a role in regulation of only a small subset of genes but are an essential component in mouse development. Here, we show that linker histone (H1) is involved in the global regulation of DNA replication in Physarum polycephalum. We find that genomic DNA of H1 knock-down cells is more rapidly replicated, an effect due at least in part to disruption of the native timing of replication fork firing. Immunoprecipitation experiments demonstrate that H1 is transiently lost from replicating chromatin via a process facilitated by phosphorylation. Our results suggest that linker histones generate a chromatin environment refractory to replication and that their transient removal via protein phosphorylation during S phase is a critical step in the epigenetic regulation of replication timing.	[Hayes, Jeffrey J.] Univ Nantes, CNRS, UMR 1 6204 U3B, F-44322 Nantes, France; [Hayes, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	Centre National de la Recherche Scientifique (CNRS); Nantes Universite; University of Rochester	Thiriet, C (corresponding author), Univ Nantes, CNRS, UMR 1 6204 U3B, F-44322 Nantes, France.	christophe.thiriet@univ-nantes.fr; Jeffrey_Hayes@urmc.rochester.edu			National Institutes of Health [GM052426]; Action The matique et Incitative sur Programme from Centre National de la Recherche Scientifique; Foridation pour la Recherche Medicale; National Science Foundation [MCB0317935]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Action The matique et Incitative sur Programme from Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Foridation pour la Recherche Medicale; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM052426 (to J.J.H.). This work was also supported by an Action The matique et Incitative sur Programme from Centre National de la Recherche Scientifique and a Foridation pour la Recherche Medicale grant (to C. T.) and National Science Foundation Grant MCB0317935. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Dou YL, 2002, P NATL ACAD SCI USA, V99, P6142, DOI 10.1073/pnas.092029599; Downs JA, 2007, ONCOGENE, V26, P7765, DOI 10.1038/sj.onc.1210874; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; FISCHER SG, 1980, BIOCHEMISTRY-US, V19, P2240, DOI 10.1021/bi00551a038; Folco HD, 2003, EUKARYOT CELL, V2, P341, DOI 10.1128/EC.2.2.341-350.2003; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Hellauer K, 2001, J BIOL CHEM, V276, P13587, DOI 10.1074/jbc.M011196200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Lu ZH, 1998, MOL BIOL CELL, V9, P1163, DOI 10.1091/mbc.9.5.1163; Lu ZH, 1997, J CELL SCI, V110, P2745; Maric C, 2003, EMBO REP, V4, P474, DOI 10.1038/sj.embor.embor822; MUELLER RD, 1985, J BIOL CHEM, V260, P5081; PIERRON G, 1989, NUCLEIC ACIDS RES, V17, P553, DOI 10.1093/nar/17.2.553; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; SMITH RC, 1988, GENE DEV, V2, P1284, DOI 10.1101/gad.2.10.1284; Steinbach OC, 1997, NATURE, V389, P395, DOI 10.1038/38755; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Thiriet C, 2004, METHODS, V33, P86, DOI 10.1016/j.ymeth.2003.10.023; Thiriet C, 1997, J BIOL CHEM, V272, P18740, DOI 10.1074/jbc.272.30.18740; Thiriet C, 2001, J CELL SCI, V114, P965; Thiriet C, 2001, GENE DEV, V15, P2048, DOI 10.1101/gad.910201; van Holde KE., 1989, SPRINGER SERIES MOL; VASSILEV L, 1988, NUCLEIC ACIDS RES, V16, P10397, DOI 10.1093/nar/16.21.10397; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311	35	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2823	2829		10.1074/jbc.M805617200	http://dx.doi.org/10.1074/jbc.M805617200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19015270	hybrid, Green Published			2022-12-25	WOS:000262700900025
J	Tateishi, Y; Ariyoshi, M; Igarashi, R; Hara, H; Mizuguchi, K; Seto, A; Nakai, A; Kokubo, T; Tochio, H; Shirakawa, M				Tateishi, Yukihiro; Ariyoshi, Mariko; Igarashi, Ryuji; Hara, Hideyuki; Mizuguchi, Kenji; Seto, Azusa; Nakai, Akira; Kokubo, Tetsuro; Tochio, Hidehito; Shirakawa, Masahiro			Molecular Basis for SUMOylation-dependent Regulation of DNA Binding Activity of Heat Shock Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUANTUM COHERENCE ESR; SUMO MODIFICATION; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; E3 LIGASE; UBIQUITIN; PROTEIN; NUCLEAR; HSF2; STRESS	Heat shock factor 2 (HSF2) is a member of a vertebrate transcription factor family for genes of heat shock proteins and is involved in the regulation of development and cellular differentiation. The DNA binding property of HSF2 is modulated by the post-translational modification of a specific lysine residue in its DNA binding domain by small ubiquitin-like modifier (SUMO), but the consequences of SUMOylation and its underlying molecular mechanism remain unclear. Here we show the inhibitory effect of SUMOylation on the interaction between HSF2 and DNA based on biochemical analysis using isolated recombinant HSF2. NMR study of the SUMOylated DNA binding domain of HSF2 indicates that the SUMO moiety is flexible with respect to the DNA binding domain and has neither a noncovalent interface with nor a structural effect on the domain. Combined with data from double electron-electron resonance and paramagnetic NMR relaxation enhancement experiments, these results suggest that SUMO attachment negatively modulates the formation of the protein-DNA complex through a randomly distributed steric interference.	[Tateishi, Yukihiro; Ariyoshi, Mariko; Igarashi, Ryuji; Seto, Azusa; Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Tateishi, Yukihiro; Kokubo, Tetsuro] Yokohama City Univ, Int Grad Sch Arts & Sci, Kanagawa 2300045, Japan; [Hara, Hideyuki] Bruker Bioispin KK, ESR Applicat, Ibaraki 3050051, Japan; [Mizuguchi, Kenji] Natl Inst Biomed Innovat, Ibaraki, Osaka 5670085, Japan; [Nakai, Akira] Yamaguchi Univ, Sch Med, Dept Biochem & Mol Biol, Ube, Yamaguchi 7668505, Japan	Kyoto University; Yokohama City University; National Institute of Health Sciences - Japan; Yamaguchi University	Ariyoshi, M (corresponding author), Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	ma4@eng.mbox.kyoto-u.ac.jp; shirakawa@moleng.kyoto-u.a.cjp	Tochio, Hidehito/GWV-0429-2022; Igarashi, Ryuji/GON-5988-2022; Mizuguchi, Kenji/GVS-5857-2022; Tochio, Hidehito/F-6109-2011	Tochio, Hidehito/0000-0003-3843-3330; Mizuguchi, Kenji/0000-0003-3021-7078; Ariyoshi, Mariko/0000-0002-1361-2642; Igarashi, Ryuji/0000-0003-4415-9702	Ministry of Education, Culture, Sports, Science and Technology of Japan; Global COE Program	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants (to M. S. and H. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and in part by the Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" the Ministry of Education, Culture, Sports, Science and Technology of Japan, administrated by the Japan Society for the Promotion of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Alastalo TP, 2003, J CELL SCI, V116, P3557, DOI 10.1242/jcs.00671; Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; BLOEMBERGEN N, 1961, J CHEM PHYS, V34, P842, DOI 10.1063/1.1731684; BONNER JJ, 1994, MOL CELL BIOL, V14, P501, DOI 10.1128/MCB.14.1.501; Borbat PP, 2002, J AM CHEM SOC, V124, P5304, DOI 10.1021/ja020040y; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chou CC, 2007, J BIOL CHEM, V282, P27239, DOI 10.1074/jbc.M700351200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Goddard T.D, 2002, SPARKY3; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Hara H, 2007, J MAGN RESON, V184, P78, DOI 10.1016/j.jmr.2006.09.017; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hilgarth RS, 2004, CELL STRESS CHAPERON, V9, P214, DOI 10.1379/CSC-8R.1; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Loison F, 2006, BIOCHEM J, V395, P223, DOI 10.1042/BJ20051190; Loones MT, 1997, CELL MOL LIFE SCI, V53, P179, DOI 10.1007/PL00000590; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Morimoto RI, 2002, CELL, V110, P281, DOI 10.1016/S0092-8674(02)00860-7; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; VUISTER GW, 1994, J AM CHEM SOC, V116, P9206, DOI 10.1021/ja00099a041; VUISTER GW, 1994, NAT STRUCT BIOL, V1, P605, DOI 10.1038/nsb0994-605; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Zhang J, 2008, J BIOL CHEM, V283, P7464, DOI 10.1074/jbc.M707122200	55	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2435	2447		10.1074/jbc.M806392200	http://dx.doi.org/10.1074/jbc.M806392200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017645	hybrid			2022-12-25	WOS:000262545600051
J	Cheng, HP; Vetrivel, KS; Drisdel, RC; Meckler, X; Gong, P; Leem, JY; Li, T; Carter, M; Chen, Y; Nguyen, P; Iwatsubo, T; Tomita, T; Wong, PC; Green, WN; Kounnas, MZ; Thinakaran, G				Cheng, Haipeng; Vetrivel, Kulandaivelu S.; Drisdel, Renaldo C.; Meckler, Xavier; Gong, Ping; Leem, Jae Yoon; Li, Tong; Carter, Meghan; Chen, Ying; Nguyen, Phuong; Iwatsubo, Takeshi; Tomita, Taisuke; Wong, Philip C.; Green, William N.; Kounnas, Maria Z.; Thinakaran, Gopal			S-Palmitoylation of gamma-Secretase Subunits Nicastrin and APH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; LIPID RAFTS; A-BETA; PROTEIN PALMITOYLATION; PRESENILIN; COMPLEX; APP; ASSOCIATION; ACCUMULATION; DEGRADATION	Proteolytic processing of amyloid precursor protein (APP) by beta- and gamma-secretases generates beta-amyloid (A beta) peptides, which accumulate in the brains of individuals affected by Alzheimer disease. Detergent-resistant membrane microdomains (DRM) rich in cholesterol and sphingolipid, termed lipid rafts, have been implicated in A beta production. Previously, we and others reported that the four integral subunits of the gamma-secretase associate with DRM. In this study we investigated the mechanisms underlying DRM association of gamma-secretase subunits. We report that in cultured cells and in brain the gamma-secretase subunits nicastrin and APH-1 undergo S-palmitoylation, the post-translational covalent attachment of the long chain fatty acid palmitate common in lipid raft-associated proteins. By mutagenesis we show that nicastrin is S-palmitoylated at Cys(689), and APH-1 is S-palmitoylated at Cys(182) and Cys(245). S-Palmitoylation-defective nicastrin and APH-1 form stable gamma-secretase complexes when expressed in knock-out fibroblasts lacking wild type subunits, suggesting that S-palmitoylation is not essential for gamma-secretase assembly. Nevertheless, fractionation studies show that S-palmitoylation contributes to DRM association of nicastrin and APH-1. Moreover, pulse-chase analyses reveal that S-palmitoylation is important for nascent polypeptide stability of both proteins. Co-expression of S-palmitoylation- deficient nicastrin and APH-1 in cultured cells neither affects A beta 40, A beta 42, and AICD production, nor intramembrane processing of Notch and N-cadherin. Our findings suggest that S-palmitoylation plays a role in stability and raft localization of nicastrin and APH-1, but does not directly modulate gamma-secretase processing of APP and other substrates.	[Cheng, Haipeng; Vetrivel, Kulandaivelu S.; Drisdel, Renaldo C.; Meckler, Xavier; Gong, Ping; Leem, Jae Yoon; Carter, Meghan; Chen, Ying; Green, William N.; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Nguyen, Phuong; Kounnas, Maria Z.] TorreyPines Therapeut Inc, La Jolla, CA 92037 USA; [Iwatsubo, Takeshi; Tomita, Taisuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; [Iwatsubo, Takeshi; Tomita, Taisuke] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Bunkyo Ku, Tokyo 1130033, Japan	University of Chicago; University of Chicago; University of Chicago; Johns Hopkins University; University of Tokyo; Japan Science & Technology Agency (JST)	Thinakaran, G (corresponding author), Univ Chicago, Dept Neurobiol, Knapp R212,924 E 57th St, Chicago, IL 60637 USA.	gopal@uchicago.edu	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943	National Institutes of Health [AG021495, AG019070, NS45150, P01 NS047308]; Alzheimer Association; American Health Assistance Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047308, R01NS045150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019070, R01AG021495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); American Health Assistance Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021495 (to G.T.), AG019070 (to G.T.), NS45150 (to P.C.W.), and P01 NS047308 (to P.C.W.). This work was also supported by grants from the Alzheimer Association (to G.T. and K.S.V.) and American Health Assistance Foundation (to G.T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Breuer P, 1998, J BIOL CHEM, V273, P33254, DOI 10.1074/jbc.273.50.33254; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Cheng HP, 2007, NAT CLIN PRACT NEURO, V3, P374, DOI 10.1038/ncpneuro0549; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; DE SB, 1999, NATURE, V398, P518; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Salaun C, 2005, J BIOL CHEM, V280, P19449, DOI 10.1074/jbc.M501923200; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tanimura N, 2006, BIOCHEM BIOPH RES CO, V341, P1177, DOI 10.1016/j.bbrc.2006.01.076; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Tsvetkov P, 2008, PROTEINS, V70, P1357, DOI 10.1002/prot.21614; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Veit M, 2000, MOL CELL NEUROSCI, V15, P408, DOI 10.1006/mcne.1999.0830; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100	57	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1373	1384		10.1074/jbc.M806380200	http://dx.doi.org/10.1074/jbc.M806380200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028695	hybrid, Green Published			2022-12-25	WOS:000262330100005
J	van Horssen, R; Janssen, E; Peters, W; Van de Pasch, L; Lindert, MMT; van Dommelen, MMT; Linssen, PC; ten Hagen, TLM; Fransen, JAM; Wieringa, B				van Horssen, Remco; Janssen, Edwin; Peters, Wilma; Van de Pasch, Loes; Lindert, Mariska M. te; van Dommelen, Michiel M. T.; Linssen, Peter C.; ten Hagen, Timo L. M.; Fransen, Jack A. M.; Wieringa, Be			Modulation of Cell Motility by Spatial Repositioning of Enzymatic ATP/ADP Exchange Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE KINASE; NEUTROPHIL CHEMOTAXIS; ATP HYDROLYSIS; RHO-GTPASES; ACTIN; MIGRATION; DYNAMICS; GENE; EXPRESSION; ISOFORM	ATP is the "principal energy currency" in metabolism and the most versatile small molecular regulator of cellular activities. Although already much is known about the role of ATP in fundamental processes of living systems, data about its compartmentalization are rather scarce, and we still have only very limited understanding of whether patterns in the distribution of intracellular ATP concentration ("ATP inhomogeneity") do exist and have a regulatory role. Here we report on the analysis of coupling of local ATP supply to regulation of actomyosin behavior, a widespread and dynamic process with conspicuous high ATP dependence, which is central to cell shape changes and cell motility. As an experimental model, we use embryonic fibroblasts from knock-out mice without major ATP-ADP exchange enzymes, in which we (re) introduce the ATP/ADP exchange enzyme adenylate kinase-1 (AK1) and deliberately manipulate its spatial positioning by coupling to different artificial location tags. By transfection-complementation of AK1 variants and comparison with yellow fluorescent protein controls, we found that motility and spreading were enhanced in cells with AK1 with a focal contact guidance tag. Intermediary enhancement was observed in cells with membrane-targeted or cytosolic AK1. Use of a heterodimer-inducing approach for transient translocation of AK1 to focal contacts under conditions of constant global AK1 activity in the cell corroborated these results. Based on our findings with these model systems, we propose that local ATP supply in the cell periphery and "on site" fuelling of the actomyosin machinery, when maintained via enzymes involved in phosphoryl transfer, are codetermining factors in the control of cell motility.	[van Horssen, Remco; Janssen, Edwin; Peters, Wilma; Van de Pasch, Loes; Lindert, Mariska M. te; van Dommelen, Michiel M. T.; Fransen, Jack A. M.; Wieringa, Be] Radboud Univ Nijmegen, Dept Cell Biol, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Linssen, Peter C.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6500 HB Nijmegen, Netherlands; [ten Hagen, Timo L. M.] Erasmus MC, Dept Surg Oncol, NL-3000 DR Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Wieringa, B (corresponding author), Radboud Univ Nijmegen, Dept Cell Biol, Nijmegen Ctr Mol Life Sci, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	b.wieringa@ncmls.ru.nl	Wieringa, Berend/A-5346-2011; Fransen, Jack/E-8924-2010	Wieringa, Berend/0000-0001-9192-8020; Fransen, Jack/0000-0002-0571-7639	Dutch Cancer Society [KUN 2002-1763]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by Dutch Cancer Society Grant KUN 2002-1763. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BALABAN RS, 1990, AM J PHYSIOL, V258, pC377, DOI 10.1152/ajpcell.1990.258.3.C377; BEREITERHAHN J, 1990, J CELL SCI, V96, P171; Bernstein BW, 2003, J NEUROSCI, V23, P1; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Collavin L, 1999, ONCOGENE, V18, P5879, DOI 10.1038/sj.onc.1202970; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Cuppen E, 1999, J CELL SCI, V112, P3299; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Ginger ML, 2005, J BIOL CHEM, V280, P11781, DOI 10.1074/jbc.M413821200; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Janssen E, 2004, MOL CELL BIOCHEM, V256, P59, DOI 10.1023/B:MCBI.0000009859.15267.db; Krooshoop DJEB, 2003, J IMMUNOL METHODS, V280, P89, DOI 10.1016/S0022-1759(03)00262-X; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Michiels F, 2000, METHOD ENZYMOL, V325, P295; NODA LH, 1973, ENZYMES, P297; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Ruan QQ, 2002, BIOPHYS J, V83, P3177, DOI 10.1016/S0006-3495(02)75320-4; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; UEDA T, 1987, EXP CELL RES, V169, P191, DOI 10.1016/0014-4827(87)90237-0; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; Volkmann N, 2000, CURR OPIN CELL BIOL, V12, P26, DOI 10.1016/S0955-0674(99)00053-8; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Willemse M, 2007, NAT BIOTECHNOL, V25, P170, DOI 10.1038/nbt0207-170; Yegutkin GG, 2006, MOL BIOL CELL, V17, P3378, DOI 10.1091/mbc.E05-10-0993	34	51	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1620	1627		10.1074/jbc.M806974200	http://dx.doi.org/10.1074/jbc.M806974200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19008233	Green Published, hybrid			2022-12-25	WOS:000262330100030
J	Oshiumi, H; Matsumoto, M; Hatakeyama, S; Seya, T				Oshiumi, Hiroyuki; Matsumoto, Misako; Hatakeyama, Shigetsugu; Seya, Tsukasa			Riplet/RNF135, a RING Finger Protein, Ubiquitinates RIG-I to Promote Interferon-beta Induction during the Early Phase of Viral Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA HELICASE LGP2; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; NF-KAPPA-B; ANTIVIRAL RESPONSES; ISG15 CONJUGATION; INNATE IMMUNITY; NEGATIVE REGULATION; ADAPTER PROTEIN	RIG-I (retinoic acid-inducible gene-I), a cytoplasmic RNA helicase, interacts with IPS-1/MAVS/Cardif/VISA, a protein on the outer membrane of mitochondria, to signal the presence of virus-derived RNA and induce type I interferon production. Activation of RIG-I requires the ubiquitin ligase, TRIM25, which mediates lysine 63-linked polyubiquitination of the RIG-I N-terminal CARD-like region. However, how this modification proceeds for activation of IPS-1 by RIG-I remains unclear. Here we identify an alternative factor, Riplet/RNF135, that promotes RIG-I activation independent of TRIM25. The Riplet/RNF135 protein consists of an N- terminal RING finger domain, C-terminal SPRY and PRY motifs, and shows sequence similarity to TRIM25. Immunoprecipitation analyses demonstrated that the C-terminal helicase and repressor domains of RIG-I interact with the Riplet/RNF135 C-terminal region, whereas the CARD-like region of RIG-I is dispensable for this interaction. Riplet/RNF135 promotes lysine 63-linked polyubiquitination of the C-terminal region of RIG-I, modification of which differs from the N- terminal ubiquitination by TRIM25. Overexpression and knockdown analyses revealed that Riplet/RNF135 promotes RIGI-mediated interferon-beta promoter activation and inhibits propagation of the negative-strand RNA virus, vesicular stomatitis virus. Our data suggest that Riplet/RNF135 is a novel factor of the RIG-I pathway that is involved in the evoking of human innate immunity against RNA virus infection, and activates RIG-I through ubiquitination of its C-terminal region. We infer that a variety of RIG-I-ubiquitinating molecular complexes sustain RIG-I activation to modulate RNA virus replication in the cytoplasm.	[Oshiumi, Hiroyuki; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Hatakeyama, Shigetsugu] Hokkaido Univ, Grad Sch Med, Dept Biochem, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Hokkaido University; Hokkaido University	Seya, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	seya-tu@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Oshiumi, Hiroyuki/G-1645-2012; Hatakeyama, Shigetsugu/C-8333-2012; Seya, Tsukasa/A-4336-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979; Oshiumi, Hiroyuki/0000-0003-1567-8722	Ministry of Education, Science and Culture of Japan; Ministry of Health, Labour, and Welfare; Mitsubishi Foundation; Mochida Memorial Foundation	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Mitsubishi Foundation; Mochida Memorial Foundation	This work was supported in part by grants-in-aid from the Ministry of Education, Science and Culture of Japan, Ministry of Health, Labour, and Welfare, The Mitsubishi Foundation, and The Mochida Memorial Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arimoto KI, 2008, MOL IMMUNOL, V45, P1078, DOI 10.1016/j.molimm.2007.07.021; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Douglas J, 2007, NAT GENET, V39, P963, DOI 10.1038/ng2083; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tanabe M, 2003, BIOCHEM BIOPH RES CO, V311, P39, DOI 10.1016/j.bbrc.2003.09.159; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	34	259	279	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					807	817		10.1074/jbc.M804259200	http://dx.doi.org/10.1074/jbc.M804259200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19017631	hybrid			2022-12-25	WOS:000262122900015
J	Bille, E; Ure, R; Gray, SJ; Kaczmarski, EB; McCarthy, ND; Nassif, X; Maiden, MCJ; Tinsley, CR				Bille, Emmanuelle; Ure, Roisin; Gray, Stephen J.; Kaczmarski, Edward B.; McCarthy, Noel D.; Nassif, Xavier; Maiden, Martin C. J.; Tinsley, Colin R.			Association of a Bacteriophage with Meningococcal Disease in Young Adults	PLOS ONE			English	Article								Despite being the agent of life-threatening meningitis, Neisseria meningitidis is usually carried asymptomatically in the nasopharynx of humans and only occasionally causes disease. The genetic bases for virulence have not been entirely elucidated and the search for new virulence factors in this species is hampered by the lack of an animal model representative of the human disease. As an alternative strategy we employ a molecular epidemiological approach to establish a statistical association of a candidate virulence gene with disease in the human population. We examine the distribution of a previously-identified genetic element, a temperate bacteriophage, in 1288 meningococci isolated from cases of disease and asymptomatic carriage. The phage was over-represented in disease isolates from young adults indicating that it may contribute to invasive disease in this age group. Further statistical analysis indicated that between 20% and 45% of the pathogenic potential of the five most common disease-causing meningococcal groups was linked to the presence of the phage. In the absence of an animal model of human disease, this molecular epidemiological approach permitted the estimation of the influence of the candidate virulence factor. Such an approach is particularly valuable in the investigation of exclusively human diseases.	[Nassif, Xavier; Tinsley, Colin R.] INSERM, Paris, France; [Bille, Emmanuelle; Nassif, Xavier; Tinsley, Colin R.] Univ Paris 05, Fac Med, Unite Pathogen Infect Syst, Paris, France; [Bille, Emmanuelle; Nassif, Xavier] Hop Necker Enfants Malad, AP HP, Lab Microbiol, Paris, France; [Ure, Roisin; McCarthy, Noel D.; Maiden, Martin C. J.] Peter Medawar Building Pathogen Res, Dept Zool, Oxford, England; [Gray, Stephen J.; Kaczmarski, Edward B.] Manchester Roy Infirmary, Hlth Protect Agcy, Meningococcal Reference Unit, Manchester, Lancs, England; [Tinsley, Colin R.] AgroParis Tech, Ctr Grignon, CNRS 2585, INRA 1238, Lab Microbiol Genet Mol, Thiverval Grignon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Health Protection Agency; AgroParisTech; INRAE	Bille, E (corresponding author), INSERM, Paris, France.	tinsley@grignon.inra.fr	Maiden, Martin/N-6805-2019; Maiden, Martin C J/C-5055-2014; McCarthy, Noel D/K-3314-2012	Maiden, Martin/0000-0001-6321-5138; Maiden, Martin C J/0000-0001-6321-5138; /0000-0001-9172-0510; McCarthy, Noel/0000-0003-1113-1017; Nassif, Xavier/0000-0003-2855-3240	Institut National de la Sante et de la Recherche Medicale (France); Universite Paris Descartes (France); Wellcome Trust (UK); Health Protection Agency (UK); AgroParisTech (France); Institut National de Recherche Agrnonomique (France); Centre Nationale pour la Recherche Scientifique (France)	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Descartes (France); Wellcome Trust (UK)(Wellcome Trust); Health Protection Agency (UK); AgroParisTech (France); Institut National de Recherche Agrnonomique (France); Centre Nationale pour la Recherche Scientifique (France)	Parts of this study were supported by the Institut National de la Sante et de la Recherche Medicale (France), by the Universite Paris Descartes (France), by the Wellcome Trust (UK), by the Health Protection Agency (UK), by AgroParisTech (France), by the Institut National de Recherche Agrnonomique (France), and by the Centre Nationale pour la Recherche Scientifique (France). The funding agencies did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; CAUGANT DA, 1986, J GEN MICROBIOL, V132, P641; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; DENSEN P, 1989, CLIN MICROBIOL REV, V2, pS11, DOI 10.1128/CMR.2.Suppl.S11-S17.1989; GOLD R, 1978, J INFECT DIS, V137, P112, DOI 10.1093/infdis/137.2.112; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; GOTSCHLICH EC, 1990, MICROBIOLOGY, P551; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Holmes EC, 1999, MOL BIOL EVOL, V16, P741, DOI 10.1093/oxfordjournals.molbev.a026159; Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000; Kawai M, 2006, GENE, V383, P52, DOI 10.1016/j.gene.2006.07.013; KRIZOVA P, 1997, CTR EUR J PUBLIC HLT, V4, P214; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; Tinsley CR, 2006, MICROBES INFECT, V8, P1365, DOI 10.1016/j.micinf.2005.12.013; Tonjum T, 1997, GENE, V192, P155, DOI 10.1016/S0378-1119(97)00018-8; WHO, 1998, CONTR EP MEN DIS WHO, V2nd ed.	21	52	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3885	10.1371/journal.pone.0003885	http://dx.doi.org/10.1371/journal.pone.0003885			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065260	Green Submitted, Green Published, gold			2022-12-25	WOS:000265455200005
J	Abramson, T; Kedem, H; Relman, DA				Abramson, Tzvia; Kedem, Hassya; Relman, David A.			Modulation of the NF-kappa B Pathway by Bordetella pertussis Filamentous Hemagglutinin	PLOS ONE			English	Article								Background: Filamentous hemagglutinin (FHA) is a cell-associated and secreted adhesin produced by Bordetella pertussis with pro-apoptotic and pro-inflammatory activity in host cells. Given the importance of the NF-kappa B transcription factor family in these host cell responses, we examined the effect of FHA on NF-kappa B activation in macrophages and bronchial epithelial cells, both of which are relevant cell types during natural infection. Methodology/Principal Findings: Exposure to FHA of primary human monocytes and transformed U-937 macrophages, but not BEAS-2B epithelial cells, resulted in early activation of the NF-kappa B pathway, as manifested by the degradation of cytosolic I kappa B alpha, by NF-kappa B DNA binding, and by the subsequent secretion of NF-kappa B-regulated inflammatory cytokines. However, exposure of macrophages and human monocytes to FHA for two hours or more resulted in the accumulation of cytosolic I kappa B alpha, and the failure of TNF-alpha to activate NF-kappa B. Proteasome activity was attenuated following exposure of cells to FHA for 2 hours, as was the nuclear translocation of RelA in BEAS-2B cells. Conclusions: These results reveal a complex temporal dynamic, and suggest that despite short term effects to the contrary, longer exposures of host cells to this secreted adhesin may block NF-kappa B activation, and perhaps lead to a compromised immune response to this bacterial pathogen.	[Abramson, Tzvia; Kedem, Hassya; Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Veterans Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Abramson, Tzvia] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA	Stanford University; Stanford University; California State University System; San Jose State University	Abramson, T (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354	NIH/NIAID [R01 AI39587, R21/33 AI057188]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039587, R33AI057188, R21AI057188] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from NIH/NIAID (R01 AI39587, R21/33 AI057188) to DAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson T, 2001, INFECT IMMUN, V69, P2650, DOI 10.1128/IAI.69.4.2650-2658.2001; Belcher CE, 2000, P NATL ACAD SCI USA, V97, P13847, DOI 10.1073/pnas.230262797; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; ISHIBASHI Y, 1994, J EXP MED, V180, P1225, DOI 10.1084/jem.180.4.1225; Ishibashi Y, 2003, MICROB PATHOGENESIS, V35, P169, DOI 10.1016/S0882-4010(03)00113-X; Ishibashi Y, 2001, MICROB PATHOGENESIS, V30, P279, DOI 10.1006/mpat.2001.0432; Jacob-Dubuisson F, 2000, MICROBIOL-SGM, V146, P1211, DOI 10.1099/00221287-146-5-1211; Jana NR, 2004, J BIOL CHEM, V279, P11680, DOI 10.1074/jbc.M310369200; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kettritz R, 2004, J BIOL CHEM, V279, P2657, DOI 10.1074/jbc.M309778200; Legarda D, 2005, CELL MICROBIOL, V7, P489, DOI 10.1111/j.1462-5822.2004.00473.x; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McGuirk P, 2000, EUR J IMMUNOL, V30, P415, DOI 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.3.CO;2-O; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Neish AS, 2004, IMMUNOL RES, V29, P175, DOI 10.1385/IR:29:1-3:175; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; RELMAN D, 1990, CELL, V61, P1375, DOI 10.1016/0092-8674(90)90701-F; RELMAN DA, 1989, P NATL ACAD SCI USA, V86, P2637, DOI 10.1073/pnas.86.8.2637; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; SCHULZELUEHRMAN.J, 2006, B IMMUNITY, V25, P701; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Ward PA, 2002, MOL CELL BIOCHEM, V234, P225, DOI 10.1023/A:1015944709177; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; Yuk MH, 2000, MOL MICROBIOL, V35, P991, DOI 10.1046/j.1365-2958.2000.01785.x	28	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3825	10.1371/journal.pone.0003825	http://dx.doi.org/10.1371/journal.pone.0003825			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043589	gold, Green Submitted, Green Published			2022-12-25	WOS:000265451500006
J	Nilsson, C; Skoglund, A; Moran, AP; Annuk, H; Engstrand, L; Normark, S				Nilsson, Christina; Skoglund, Anna; Moran, Anthony P.; Annuk, Heidi; Engstrand, Lars; Normark, Staffan			Lipopolysaccharide Diversity Evolving in Helicobacter pylori Communities through Genetic Modifications in Fucosyltransferases	PLOS ONE			English	Article							LEWIS ANTIGEN-EXPRESSION; BLOOD GROUP ANTIGENS; CARBOXYL-TERMINUS; STRAIN VARIATION; PHASE VARIATION; MOUSE MODEL; SINGLE; INFECTION; ULCER; DIVERSIFICATION	Helicobacter pylori persistently colonizes the gastric mucosa of half the human population. It is one of the most genetically diverse bacterial organisms and subvariants are continuously emerging within an H. pylori population. In this study we characterized a number of single-colony isolates from H. pylori communities in various environmental settings, namely persistent human gastric infection, in vitro bacterial subcultures on agar medium, and experimental in vivo infection in mice. The lipopolysaccharide (LPS) O-antigen chain revealed considerable phenotypic diversity between individual cells in the studied bacterial communities, as demonstrated by size variable O-antigen chains and different levels of Lewis glycosylation. Absence of high-molecular-weight O-antigen chains was notable in a number of experimentally passaged isolates in vitro and in vivo. This phenotype was not evident in bacteria obtained from a human gastric biopsy, where all cells expressed high-molecular-weight O-antigen chains, which thus may be the preferred phenotype for H. pylori colonizing human gastric mucosa. Genotypic variability was monitored in the two genes encoding alpha 1,3-fucosyltransferases, futA and futB, that are involved in Lewis antigen expression. Genetic modifications that could be attributable to recombination events within and between the two genes were commonly detected and created a diversity, which together with phase variation, contributed to divergent LPS expression. Our data suggest that the surrounding environment imposes a selective pressure on H. pylori to express certain LPS phenotypes. Thus, the milieu in a host will select for bacterial variants with particular characteristics that facilitate adaptation and survival in the gastric mucosa of that individual, and will shape the bacterial community structure.	[Nilsson, Christina; Skoglund, Anna; Engstrand, Lars; Normark, Staffan] Karolinska Inst, Dept Microbiol, Tumor & Cell Biol, Stockholm, Sweden; [Nilsson, Christina; Skoglund, Anna; Engstrand, Lars; Normark, Staffan] Swedish Inst Infect Dis Control, Solna, Sweden; [Moran, Anthony P.; Annuk, Heidi] Natl Univ Ireland, Sch Nat Sci, Dept Microbiol, Galway, Ireland; [Moran, Anthony P.] Griffith Univ, Inst Glycom, Nathan, Qld 4111, Australia	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Ollscoil na Gaillimhe-University of Galway; Griffith University	Nilsson, C (corresponding author), Genome Inst Singapore, Singapore, Singapore.	Christina.Nilsson@mtc.ki.se			European Union [LSHC-CT-2005-018704]; Swedish Foundation for Strategic Research; Swedish Cancer Society; Swedish Research Council; Irish Health Research Board; Griffith University	European Union(European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Irish Health Research Board; Griffith University(Griffith University)	This work was financially supported by grants from the Sixth Research Framework Programme of the European Union, project INCA (LSHC-CT-2005-018704), the Swedish Foundation for Strategic Research, the Swedish Cancer Society, the Swedish Research Council, the Irish Health Research Board and Griffith University.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P6221, DOI 10.1093/nar/20.23.6221; Alvi A, 2007, J CLIN MICROBIOL, V45, P4039, DOI 10.1128/JCM.01631-07; Appelmelk BJ, 1999, INFECT IMMUN, V67, P5361, DOI 10.1128/IAI.67.10.5361-5366.1999; Appelmelk BJ, 1998, INFECT IMMUN, V66, P70, DOI 10.1128/IAI.66.1.70-76.1998; ASPINALL GO, 1994, CARBOHYDR LETT, V0001; Aspinall GO, 1996, BIOCHEMISTRY-US, V35, P2489, DOI 10.1021/bi951852s; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bjorkholm B, 2001, INFECT IMMUN, V69, P7832, DOI 10.1128/IAI.69.12.7832-7838.2001; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Bourzac KM, 2005, CELL MICROBIOL, V7, P911, DOI 10.1111/j.1462-5822.2005.00541.x; Broutet N, 2002, J INFECT DIS, V185, P503, DOI 10.1086/339016; Cooke CL, 2005, FEMS IMMUNOL MED MIC, V45, P11, DOI 10.1016/j.femsim.2005.04.002; Enroth H, 1999, DIGEST DIS SCI, V44, P102, DOI 10.1023/A:1026658301825; Enroth H, 2000, CANCER EPIDEM BIOMAR, V9, P981; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; FALK PG, 1995, P NATL ACAD SCI USA, V92, P1515, DOI 10.1073/pnas.92.5.1515; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Gibson JR, 1998, LETT APPL MICROBIOL, V26, P399, DOI 10.1046/j.1472-765X.1998.00361.x; Granstrom M, 1997, J CLIN MICROBIOL, V35, P468; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Heneghan MA, 2000, INFECT IMMUN, V68, P937, DOI 10.1128/IAI.68.2.937-941.2000; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; Khamri W, 2005, INFECT IMMUN, V73, P7677, DOI 10.1128/IAI.73.11.7677-7686.2005; Kim N, 2007, DNA REPAIR, V6, P1285, DOI 10.1016/j.dnarep.2007.02.023; Kraft C, 2006, J BACTERIOL, V188, P249, DOI 10.1128/JB.188.1.249-254.2006; Kuipers EJ, 2000, J INFECT DIS, V181, P273, DOI 10.1086/315173; Levine SM, 2007, FASEB J, V21, P3458, DOI 10.1096/fj.07-8501com; Lin SW, 2006, BIOCHEMISTRY-US, V45, P8108, DOI 10.1021/bi0601297; Lundin A, 2005, INFECT IMMUN, V73, P4818, DOI 10.1128/IAI.73.8.4818-4822.2005; Ma B, 2006, J BIOL CHEM, V281, P6385, DOI 10.1074/jbc.M511320200; Ma B, 2005, J BIOL CHEM, V280, P36848, DOI 10.1074/jbc.M504415200; Ma B, 2003, J BIOL CHEM, V278, P21893, DOI 10.1074/jbc.M301704200; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Marshall DG, 1999, FEMS IMMUNOL MED MIC, V24, P79, DOI 10.1111/j.1574-695X.1999.tb01268.x; MITCHELL HM, 1992, J INFECT DIS, V166, P149, DOI 10.1093/infdis/166.1.149; Monteiro MA, 2000, EUR J BIOCHEM, V267, P305, DOI 10.1046/j.1432-1327.2000.01007.x; Monteiro MA, 2001, ADV CARBOHYD CHEM BI, V57, P99, DOI 10.1016/S0065-2318(01)57016-X; Monteiro MA, 2000, GLYCOBIOLOGY, V10, P701, DOI 10.1093/glycob/10.7.701; Moran AP, 2008, CARBOHYD RES, V343, P1952, DOI 10.1016/j.carres.2007.12.012; Moran AP, 2007, INT J MED MICROBIOL, V297, P307, DOI 10.1016/j.ijmm.2007.03.008; MORAN AP, 1992, J BACTERIOL, V174, P1370, DOI 10.1128/jb.174.4.1370-1377.1992; MORAN AP, 1995, FEMS IMMUNOL MED MIC, V10, P271; Nilsson C, 2006, P NATL ACAD SCI USA, V103, P2863, DOI 10.1073/pnas.0511119103; Nilsson C, 2003, INFECT IMMUN, V71, P6573, DOI 10.1128/IAI.71.11.6573-6581.2003; Prouzet-Mauleon V, 2005, J CLIN MICROBIOL, V43, P4237, DOI 10.1128/JCM.43.8.4237-4241.2005; Rasko DA, 2000, J BIOL CHEM, V275, P4988, DOI 10.1074/jbc.275.7.4988; Rasko DA, 2000, J INFECT DIS, V181, P1089, DOI 10.1086/315354; Rasko DA, 2001, J INFECT DIS, V184, P315, DOI 10.1086/322025; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; SALAMA SM, 1995, J CLIN MICROBIOL, V33, P2496, DOI 10.1128/JCM.33.9.2496-2497.1995; Salaun L, 2004, MICROBIOL-SGM, V150, P817, DOI 10.1099/mic.0.26993-0; SimoonsSmit IM, 1996, J CLIN MICROBIOL, V34, P2196, DOI 10.1128/JCM.34.9.2196-2200.1996; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Taylor DE, 1998, GASTROENTEROLOGY, V115, P1113, DOI 10.1016/S0016-5085(98)70082-4; TAYLOR NS, 1995, J CLIN MICROBIOL, V33, P918, DOI 10.1128/JCM.33.4.918-923.1995; Walsh EJ, 1997, J APPL MICROBIOL, V83, P67, DOI 10.1046/j.1365-2672.1997.00164.x; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; Wirth HP, 2006, FASEB J, V20, P1534, DOI 10.1096/fj.05-5529fje; Wirth HP, 1997, GASTROENTEROLOGY, V113, P1091, DOI 10.1053/gast.1997.v113.pm9322503; Wirth HP, 1996, INFECT IMMUN, V64, P4598, DOI 10.1128/IAI.64.11.4598-4605.1996; Wirth HP, 1999, J LAB CLIN MED, V133, P488, DOI 10.1016/S0022-2143(99)90026-4; Wong BCY, 2001, ALIMENT PHARM THERAP, V15, P493, DOI 10.1046/j.1365-2036.2001.00949.x	68	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3811	10.1371/journal.pone.0003811	http://dx.doi.org/10.1371/journal.pone.0003811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043574	gold, Green Published, Green Submitted			2022-12-25	WOS:000265451400003
J	Sugatani, T; Hruska, KA				Sugatani, Toshifumi; Hruska, Keith A.			Impaired Micro-RNA Pathways Diminish Osteoclast Differentiation and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PU.1; NF-KAPPA-B; GENE-EXPRESSION; NUCLEAR-FACTOR; T-CELLS; NFATC1; PROMOTER; MITF; IDENTIFICATION; PROLIFERATION	Micro-RNAs (miRNAs) are important in regulating cell fate determination because many of their target mRNA transcripts are engaged in cell proliferation, differentiation, and apoptosis. DGCR8, Dicer, and Ago2 are essential factors for miRNA homeostasis. Here we show that these three factors have critical roles in osteoclast differentiation and function. Gene silencing of DGCR8, Dicer, or Ago2 by small interfering RNA revealed global inhibition of osteoclast transcription factor expression and function, decreased osteoclastogenesis, and decreased bone resorption in vitro. In vivo, CD11b(+)-cre/Dicer-null mice had mild osteopetrosis caused by decreased osteoclast number and bone resorption. These results suggest that miRNAs play important roles in differentiation and function of osteoclasts in vitro and in vivo. We found a novel mechanism mediating these results in which PU.1, miRNA-223, NFI-A, and the macrophage colony-stimulating factor receptor (M-CSFR) are closely linked through a positive feedback loop. PU.1 stimulates miRNA-223 expression, and this up-regulation is implicated in stimulating differentiation and function of osteoclasts through negative regulation of NFI-A levels. Down-regulation of NFI-A levels is important for expression of the M-CSFR, which is critical for osteoclast differentiation and function. NFI-A overexpression decreased osteoclast formation and function with down-regulation of M-CSFR levels. Forced expression of the M-CSFR in M-CSF-dependent bone marrow macrophages from Dicer-deficient mice rescued osteoclast differentiation with up-regulation of PU.1 levels. Our studies provide new molecular mechanisms controlling osteoclast differentiation and function by the miRNA system and specifically by miRNA-223, which regulates NFI-A and the M-CSFR levels.	[Sugatani, Toshifumi; Hruska, Keith A.] Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Hruska, KA (corresponding author), McDonnell Pediatr, Res Bldg,Campus Box 8208,660 S Euclid Ave, St Louis, MO 63110 USA.	hruska_k@kids.wustl.edu			National Institutes of Health [DK070790, AR41677]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK070790 and AR41677 (to K. A. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Crotti TN, 2006, GENE, V372, P92, DOI 10.1016/j.gene.2005.12.012; DEL FA, 2008, ARCH BIOCHEM BIOPHYS, V473, P147; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kwon OH, 2005, BIOCHEM BIOPH RES CO, V335, P437, DOI 10.1016/j.bbrc.2005.07.092; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Pang M, 2007, GENE, V403, P151, DOI 10.1016/j.gene.2007.08.007; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Shen Z, 2007, BBA-GENE STRUCT EXPR, V1769, P659, DOI 10.1016/j.bbaexp.2007.08.005; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	49	171	192	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4667	4678		10.1074/jbc.M805777200	http://dx.doi.org/10.1074/jbc.M805777200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19059913	Green Published, hybrid			2022-12-25	WOS:000263134400066
J	Mullins, LJ; Peter, A; Wrobel, N; McNeilly, JR; McNeilly, AS; Al-Dujaili, EAS; Brownstein, DG; Mullins, JJ; Kenyon, CJ				Mullins, Linda J.; Peter, Audrey; Wrobel, Nicola; McNeilly, Judith R.; McNeilly, Alan S.; Al-Dujaili, Emad A. S.; Brownstein, David G.; Mullins, John J.; Kenyon, Christopher J.			Cyp11b1 Null Mouse, a Model of Congenital Adrenal Hyperplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							11-BETA-HYDROXYLASE DEFICIENCY; 21-HYDROXYLASE DEFICIENCY; PRIMARY ALDOSTERONISM; PRENATAL-DIAGNOSIS; METABOLIC SYNDROME; INSULIN-SECRETION; GLUCOSE-TOLERANCE; BLOOD-PRESSURE; MICE; CELLS	Patients with congenital adrenal hyperplasia arising from mutations of 11 beta-hydroxylase, the final enzyme in the glucocorticoid biosynthetic pathway, exhibit glucocorticoid deficiency, adrenal hyperplasia driven by unsuppressed hypothalamo-pituitary-adrenal activity, and excess mineralocorticoid activity caused by the accumulation of deoxycorticosterone. A mouse model, in which exons 3-7 of Cyp11b1 (the gene encoding 11 beta-hydroxylase) were replaced with cDNA encoding enhanced cyan fluorescent protein, was generated to investigate the underlying disease mechanisms. Enhanced cyan fluorescent protein was expressed appropriately in the zona fasciculata of the adrenal gland, and targeted knock-out was confirmed by urinary steroid profiles and, immunocytochemically, by the absence of 11 beta-hydroxylase. The null mice exhibited glucocorticoid deficiency, mineralocorticoid excess, adrenal hyperplasia, mild hypertension, and hypokalemia. They also displayed glucose intolerance. Because rodents do not synthesize adrenal androgens, changes in reproductive function such as genital virilization of females were not anticipated. However, adult homozygote females were infertile, their ovaries showing an absence of corpora lutea and a central proliferation of disorganized steroidogenic tissue. Null females responded normally to superovulation, suggesting that raised systemic progesterone levels also contribute to infertility problems. The model reveals previously unrecognized phenotypic subtleties of congenital adrenal hyperplasia.	[Kenyon, Christopher J.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [McNeilly, Judith R.; McNeilly, Alan S.] Univ Edinburgh, Ctr Reprod Biol, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Kenyon, CJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	chris.kenyon@ed.ac.uk		Mullins, Linda/0000-0002-6743-8707	Medical Research Council (United Kingdom); Medical Research Council [G0500026, G9900991B, MC_U127685843] Funding Source: researchfish; MRC [G0500026, MC_U127685843] Funding Source: UKRI	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (United Kingdom). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Al-Dujaili EAS, 2006, CLIN CHIM ACTA, V364, P172, DOI 10.1016/j.cccn.2005.06.019; ALDUJAILI EAS, 1984, J STEROID BIOCHEM, V20, P849, DOI 10.1016/0022-4731(84)90394-7; ALDUJAILI EAS, 1981, CLIN CHIM ACTA, V116, P277, DOI 10.1016/0009-8981(81)90047-4; ALDUJAILI EAS, 1981, STEROIDS, V37, P157, DOI 10.1016/S0039-128X(81)80015-3; Barr M, 2006, CLIN ENDOCRINOL, V65, P816, DOI 10.1111/j.1365-2265.2006.02673.x; Boini KM, 2006, DIABETES, V55, P2059, DOI 10.2337/db05-1038; Catena C, 2006, J CLIN ENDOCR METAB, V91, P3457, DOI 10.1210/jc.2006-0736; Cerame BI, 1999, J CLIN ENDOCR METAB, V84, P3129, DOI 10.1210/jc.84.9.3129; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Claahsen-van der Grinten HL, 2006, J PEDIATR ENDOCR MET, V19, P677; Coll AP, 2005, DIABETES, V54, P2269, DOI 10.2337/diabetes.54.8.2269; CONN JW, 1965, NEW ENGL J MED, V273, P1135, DOI 10.1056/NEJM196511182732106; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; De Geyter C, 2002, HUM REPROD, V17, P933, DOI 10.1093/humrep/17.4.933; DOMALIK LJ, 1991, MOL ENDOCRINOL, V5, P1853, DOI 10.1210/mend-5-12-1853; EVANS AL, 1994, MED BIOL ENG COMPUT, V32, P101, DOI 10.1007/BF02512487; FEEK CM, 1989, J STEROID BIOCHEM, V32, P573, DOI 10.1016/0022-4731(89)90392-0; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; GOTOH H, 1988, ENDOCRINOLOGY, V123, P1923, DOI 10.1210/endo-123-4-1923; Greaves P, 2006, BEST PRACT RES CL OB, V20, P503, DOI 10.1016/j.bpobgyn.2006.01.003; Grosse SD, 2007, HORM RES, V67, P284, DOI 10.1159/000098400; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kotelevtsev Y, 1999, J CLIN INVEST, V103, P683, DOI 10.1172/JCI4445; Krone N, 2005, J CLIN ENDOCR METAB, V90, P3724, DOI 10.1210/jc.2005-0089; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lin HY, 2005, DIABETES, V54, P1717, DOI 10.2337/diabetes.54.6.1717; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MARSHALL E, 2003, END ABSTR, V5, pP231; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; McNeilly JR, 2000, ENDOCRINOLOGY, V141, P4284, DOI 10.1210/en.141.11.4284; Michael AE, 2003, REPRODUCTION, V126, P425, DOI 10.1530/rep.0.1260425; Michailidou Z, 2007, J ENDOCRINOL, V194, P161, DOI 10.1677/JOE-07-0090; Morton NM, 2005, DIABETES, V54, P3371, DOI 10.2337/diabetes.54.12.3371; Motaghedi R, 2005, J PEDIATR ENDOCR MET, V18, P133; Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283; Ortiz LA, 2001, KIDNEY INT, V59, P1663, DOI 10.1046/j.1523-1755.2001.0590051663.x; ORTMANN O, 1994, J STEROID BIOCHEM, V48, P47, DOI 10.1016/0960-0760(94)90249-6; Paperna T, 2005, J CLIN ENDOCR METAB, V90, P5463, DOI 10.1210/jc.2005-1145; PAULA FJA, 1994, HORM METAB RES, V26, P552, DOI 10.1055/s-2007-1001755; Peeke PM, 1995, ANN NY ACAD SCI, V771, P665, DOI 10.1111/j.1749-6632.1995.tb44719.x; PHILIPPE J, 1992, J CLIN INVEST, V90, P2228, DOI 10.1172/JCI116108; QUARMBY VE, 1984, ENDOCRINOLOGY, V114, P108, DOI 10.1210/endo-114-1-108; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Rae MT, 2004, J CLIN ENDOCR METAB, V89, P4538, DOI 10.1210/jc.2003-032225; Riepe FG, 2005, ENDOCRINOLOGY, V146, P2563, DOI 10.1210/en.2004-1563; RODRIGUEZSARGEN.C, 1990, HYPERTENSION S1, V15, P112; SALICIONI AM, 1993, J ENDOCRINOL, V139, P253, DOI 10.1677/joe.0.1390253; SHIMAMOTO K, 1994, J HUM HYPERTENS, V8, P755; Simm PJ, 2007, HORM RES, V68, P294, DOI 10.1159/000107651; Speiser PW, 2003, NEW ENGL J MED, V349, P776, DOI 10.1056/NEJMra021561; Stubbe J, 2006, AM J PHYSIOL-RENAL, V291, pF812, DOI 10.1152/ajprenal.00477.2005; Takeda K, 2003, J ENDOCRINOL, V176, P237, DOI 10.1677/joe.0.1760237; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; Ullrich S, 2007, BIOCHEM BIOPH RES CO, V352, P662, DOI 10.1016/j.bbrc.2006.11.065; Wang Q, 2005, HYPERTENSION, V46, P547, DOI 10.1161/01.HYP.0000178572.63064.73; Wulff C, 2001, J CLIN ENDOCR METAB, V86, P3377, DOI 10.1210/jc.86.7.3377; Yazawa T, 2008, ENDOCRINOLOGY, V149, P1786, DOI 10.1210/en.2007-1015	59	27	27	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3925	3934		10.1074/jbc.M805081200	http://dx.doi.org/10.1074/jbc.M805081200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19029289	hybrid			2022-12-25	WOS:000262872500061
J	Soeda, T; Nogami, K; Nishiya, K; Takeyama, M; Ogiwara, K; Sakata, Y; Yoshioka, A; Shima, M				Soeda, Tetsuhiro; Nogami, Keiji; Nishiya, Katsumi; Takeyama, Masahiro; Ogiwara, Kenichi; Sakata, Yoichi; Yoshioka, Akira; Shima, Midori			The Factor VIIIa C2 Domain (Residues 2228-2240) Interacts with the Factor IXa Gla Domain in the Factor Xase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	49th Annual Meeting of the American-Society-of-Hematology	DEC 08-11, 2007	Atlanta, GA	Amer Soc Hematol			VON-WILLEBRAND-FACTOR; COAGULATION-FACTOR-VIII; GAMMA-CARBOXYGLUTAMIC ACID; BINDING-SITE; INHIBITOR ALLOANTIBODIES; CRYSTAL-STRUCTURE; LIGHT-CHAIN; A2 SUBUNIT; FACTOR-X; SEQUENCE	Factor VIIIa functions as a cofactor for factor IXa in the phospholipid surface-dependent activation of factor X. Both the C2 domain of factor VIIIa and the Gla domain of factor IXa are involved in phospholipid binding and are required for the activation of factor X. In this study, we have examined the close relationship between these domains in the factor Xase complex. Enzyme-linked immunosorbent assay-based and surface plasmon resonance-based assays in the absence of phospholipid showed that Glu-Gly-Arg active site-modified factor IXa bound to immobilized recombinant C2 domain (rC2) dose-dependently (K-d = 108 nM). This binding ability was optimal under physiological conditions. A monoclonal antibody against the Gla domain of factor IXa inhibited binding by similar to 95%, and Gla domainless factor IXa failed to bind to rC2. The addition of monoclonal antibody or rC2 with factor VIIIa inhibited factor IXa-catalyzed factor X activation in the absence of phospholipid. Inhibition was not evident, however, in similar experiments in the absence of factor VIIIa, indicating that the C2 domain interacted with the Gla domain of factor IXa. A fragment designated C2-(2182-2259), derived from V8 proteasecleaved rC2, bound to Glu-Gly-Arg active site-modified factor IXa. Competitive assays, using overlapping synthetic peptides encompassing residues 2182-2259, demonstrated that peptide 2228-2240 significantly inhibited both this binding and factor Xa generation, independently of phospholipid. Our results indicated that residues 2228-2240 in the factor VIIIa C2 domain constitutes an interactive site for the Gla domain of factor IXa. The findings provide the first evidence for an essential role for this interaction in factor Xase assembly.	[Soeda, Tetsuhiro; Nogami, Keiji; Nishiya, Katsumi; Takeyama, Masahiro; Ogiwara, Kenichi; Yoshioka, Akira; Shima, Midori] Nara Med Univ, Dept Pediat, Nara 6348522, Japan	Nara Medical University	Shima, M (corresponding author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Nara 6348522, Japan.	roc-noga@naramed-u.ac.jp	Ogiwara, Kenichi/ABD-7067-2021	Ogiwara, Kenichi/0000-0002-3046-6915				Bajaj SP, 2001, J BIOL CHEM, V276, P16302, DOI 10.1074/jbc.M011680200; Barrow RT, 2001, BLOOD, V97, P169, DOI 10.1182/blood.V97.1.169; Blostein MD, 2003, J BIOL CHEM, V278, P31297, DOI 10.1074/jbc.M302840200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cameron C, 1998, THROMB HAEMOSTASIS, V79, P317, DOI 10.1055/s-0037-1614984; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; ELDER B, 1993, GENOMICS, V16, P374, DOI 10.1006/geno.1993.1200; Fay PJ, 1999, J BIOL CHEM, V274, P29826, DOI 10.1074/jbc.274.42.29826; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; FAY PJ, 1994, J BIOL CHEM, V269, P20522; FOSTER PA, 1990, BLOOD, V75, P1999; Freedman SJ, 1996, J BIOL CHEM, V271, P16227, DOI 10.1074/jbc.271.27.16227; GERSTEIN M, 1992, ACTA CRYSTALLOGR A, V48, P271, DOI 10.1107/S0108767391012680; Hay CRM, 1998, HAEMOPHILIA, V4, P558, DOI 10.1046/j.1365-2516.1998.440558.x; Healey JF, 1998, BLOOD, V92, P3701, DOI 10.1182/blood.V92.10.3701.422k22_3701_3709; Healey JF, 1996, BLOOD, V88, P4209; Jenkins PV, 2004, BIOCHEMISTRY-US, V43, P5094, DOI 10.1021/bi036289p; KARLSSON R, 1994, ANAL BIOCHEM, V221, P142, DOI 10.1006/abio.1994.1390; Larson PJ, 1996, J BIOL CHEM, V271, P3869; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Liu ML, 2000, BLOOD, V96, P979, DOI 10.1182/blood.V96.3.979.015k42a_979_987; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Mimuro J, 2004, J THROMB HAEMOST, V2, P275, DOI 10.1046/j.1538-7933.2003.00572.x; MORITA T, 1985, BIOCHEM BIOPH RES CO, V130, P841, DOI 10.1016/0006-291X(85)90493-0; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Nogami K, 2004, J BIOL CHEM, V279, P33104, DOI 10.1074/jbc.M405537200; Nogami K, 2000, J BIOL CHEM, V275, P25774, DOI 10.1074/jbc.M002007200; Nogami K, 1999, J BIOL CHEM, V274, P31000, DOI 10.1074/jbc.274.43.31000; Nogami K, 1999, BRIT J HAEMATOL, V107, P196, DOI 10.1046/j.1365-2141.1999.01673.x; Nogami K, 2007, INT J HEMATOL, V85, P317, DOI 10.1532/IJH97.06192; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Saenko EL, 1997, J BIOL CHEM, V272, P18007, DOI 10.1074/jbc.272.29.18007; Saenko EL, 1998, J BIOL CHEM, V273, P27918, DOI 10.1074/jbc.273.43.27918; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Schmidt AE, 2005, J MOL BIOL, V350, P78, DOI 10.1016/j.jmb.2005.04.052; Schmidt AE, 2003, TRENDS CARDIOVAS MED, V13, P39, DOI 10.1016/S1050-1738(02)00210-4; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; SHIMA M, 1995, BRIT J HAEMATOL, V91, P714, DOI 10.1111/j.1365-2141.1995.tb05374.x; SHIMA M, 1993, THROMB HAEMOSTASIS, V69, P240; Stoilova-McPhie S, 2002, BLOOD, V99, P1215, DOI 10.1182/blood.V99.4.1215; SUGO T, 1990, THROMB RES, V58, P603, DOI 10.1016/0049-3848(90)90306-W; Takeshima K, 2003, THROMB HAEMOSTASIS, V89, P788, DOI 10.1055/s-0037-1613463; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	48	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3379	3388		10.1074/jbc.M804955200	http://dx.doi.org/10.1074/jbc.M804955200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	400MO	19047063	hybrid, Green Submitted			2022-12-25	WOS:000262872500003
J	Hu, GD; Barnes, BJ				Hu, Guodong; Barnes, Betsy J.			IRF-5 Is a Mediator of the Death Receptor-induced Apoptotic Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR; TRAIL-INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; GENE INDUCTION; CASPASE-8 GENE; CELL-CYCLE; EXPRESSION; ACTIVATION; FADD; DR5	The efficient and regulated response to cellular stress is coordinated by a genetic regulatory network in which a given transcription factor controls the expression of diverse target genes depending on the cell type and/or nature of the stimuli. The tumor suppressor p53 is thought to preferentially regulate the balance between cell survival and death. The interferon regulatory factor 5 (IRF-5), known to be involved in the innate immune response to pathogens, is also a critical regulator of DNA damage-induced apoptosis. Here, we provide direct evidence that IRF-5 promotes apoptosis upon signaling through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptors (DR). We report that IRF-5 sensitizes tumor cells to TRAIL-induced apoptosis and cell death that is further enhanced by type I interferons. Cells deficient of IRF-5 gave a significantly diminished response to these agents. IRF-5 is involved in DR signaling upstream of caspase 8, in part because of an IRF-5-dependent increase in caspase 8 activation. We provide evidence that TRAIL induces a signaling cascade that leads to the phosphorylation and nuclear localization of IRF-5, resulting in transactivation of key DR signaling components. The results presented here identify IRF-5 as a new mediator of DR signaling and provides molecular insight into the mechanism of TRAIL-induced IRF-5 signaling.	[Hu, Guodong; Barnes, Betsy J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Univ Hosp, Ctr Canc, Newark, NJ 07103 USA; [Barnes, Betsy J.] Univ Med & Dent New Jersey, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Hu, Guodong; Barnes, Betsy J.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; Johns Hopkins Medicine	Barnes, BJ (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Univ Hosp, Ctr Canc, G1224,205 S Orange Ave, Newark, NJ 07103 USA.	barnesbe@umdnj.edu	hu, guodong/B-4794-2010		Flight Attendant Medical Research Institute; New Jersey Medical School-University Hospital Cancer Center	Flight Attendant Medical Research Institute; New Jersey Medical School-University Hospital Cancer Center	This work was supported in part by the Flight Attendant Medical Research Institute and the New Jersey Medical School-University Hospital Cancer Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Casciano I, 2004, CELL DEATH DIFFER, V11, P131, DOI 10.1038/sj.cdd.4401327; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Finnberg N, 2005, MOL CELL BIOL, V25, P2000, DOI 10.1128/MCB.25.5.2000-2013.2005; Horak P, 2005, MOL CANCER RES, V3, P335, DOI 10.1158/1541-7786.MCR-04-0136; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Izeradjene K, 2005, ONCOGENE, V24, P2050, DOI 10.1038/sj.onc.1208397; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Korz C, 2002, BLOOD, V99, P4554, DOI 10.1182/blood.V99.12.4554; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Ren YG, 2004, MOL BIOL CELL, V15, P5064, DOI 10.1091/mbc.e04-03-0184; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Shigeno M, 2003, ONCOGENE, V22, P1653, DOI 10.1038/sj.onc.1206139; Stang MT, 2007, ONCOGENE, V26, P6420, DOI 10.1038/sj.onc.1210470; Suliman A, 2001, ONCOGENE, V20, P2122, DOI 10.1038/sj.onc.1204282; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Van Valen F, 2003, INT J CANCER, V107, P929, DOI 10.1002/ijc.11503; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yang P, 2007, INVEST OPHTH VIS SCI, V48, P3341, DOI 10.1167/iovs.06-1340; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7	39	60	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2767	2777		10.1074/jbc.M804744200	http://dx.doi.org/10.1074/jbc.M804744200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19028697	hybrid			2022-12-25	WOS:000262700900019
J	Pattingre, S; Bauvy, C; Carpentier, S; Levade, T; Levine, B; Codogno, P				Pattingre, Sophie; Bauvy, Chantal; Carpentier, Stephane; Levade, Thierry; Levine, Beth; Codogno, Patrice			Role of JNK1-dependent Bcl-2 Phosphorylation in Ceramide-induced Macroautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR FUNCTION; JUN NH2-TERMINAL KINASE; AUTOPHAGIC CELL-DEATH; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; SELF-DIGESTION; FAMILY-MEMBERS; APOPTOSIS; BECLIN-1; PROTEIN	Macroautophagy is a vacuolar lysosomal catabolic pathway that is stimulated during periods of nutrient starvation to preserve cell integrity. Ceramide is a bioactive sphingolipid associated with a large range of cell processes. Here we show that short-chain ceramides (C-2-ceramide and C-6-ceramide) and stimulation of the de novo ceramide synthesis by tamoxifen induce the dissociation of the complex formed between the autophagy protein Beclin 1 and the anti-apoptotic protein Bcl-2. This dissociation is required for macroautophagy to be induced either in response to ceramide or to starvation. Three potential phosphorylation sites, Thr(69), Ser(70), and Ser(87), located in the non-structural N-terminal loop of Bcl-2, play major roles in the dissociation of Bcl-2 from Beclin 1. We further show that activation of c-Jun N-terminal protein kinase 1 by ceramide is required both to phosphorylate Bcl-2 and to stimulate macroautophagy. These findings reveal a new aspect of sphingolipid signaling in up-regulating a major cell process involved in cell adaptation to stress.	[Pattingre, Sophie; Bauvy, Chantal; Codogno, Patrice] INSERM U756, F-92296 Chatenay Malabry, France; [Pattingre, Sophie; Bauvy, Chantal; Codogno, Patrice] Univ Paris 11, Fac Pharm, F-92296 Chatenay Malabry, France; [Carpentier, Stephane] Univ Toulouse 3, INSERM U858, F-31000 Toulouse, France; [Carpentier, Stephane; Levade, Thierry] Univ Toulouse 3, Inst Med Mol Rangueil, F-31000 Toulouse, France; [Levine, Beth] Howard Hughes Med Inst, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Codogno, P (corresponding author), INSERM U756, 5 Rue Jean Baptiste Clement, F-92296 Chatenay Malabry, France.	patrice.codogno@u-psud.fr	Levade, Thierry/O-8948-2014; Codogno, Patrice/G-1384-2013	Codogno, Patrice/0000-0002-5492-3180; Pattingre, Sophie/0000-0001-6284-6050	National Institutes of Health [R01 CA109618]; INSERM; University Paris-Sud 11; Association pour la Recherche sur le Cancer [3503, 4006]; NATIONAL CANCER INSTITUTE [R01CA109618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris-Sud 11; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA109618 ( to B. L.). This work was also supported by institutional funding from INSERM, from University Paris-Sud 11, and from the Association pour la Recherche sur le Cancer ( Grant 3503 to P. C. and Grant 4006 to S. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Basu S, 1998, ONCOGENE, V17, P3277, DOI 10.1038/sj.onc.1202570; BAUVY C, 2008, METHODS ENZ IN PRESS; Bielawska A, 2001, ANAL BIOCHEM, V298, P141, DOI 10.1006/abio.2001.5342; Birbes H, 2002, ADV ENZYME REGUL, V42, P113, DOI 10.1016/S0065-2571(01)00026-7; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Bleicher RJ, 2002, BBA-MOL CELL BIOL L, V1585, P172, DOI 10.1016/S1388-1981(02)00338-4; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chaumorcel M, 2008, AUTOPHAGY, V4, P46, DOI 10.4161/auto.5184; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kurinna SM, 2004, CANCER RES, V64, P7852, DOI 10.1158/0008-5472.CAN-04-1552; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lavieu G, 2007, AUTOPHAGY, V3, P45, DOI 10.4161/auto.3416; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Liang CG, 2008, AUTOPHAGY, V4, P268, DOI 10.4161/auto.5210; Liang XH, 2001, CANCER RES, V61, P3443; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; SASLOWSKY DE, 2008, FASEB J IN PRESS; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	78	214	222	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2719	2728		10.1074/jbc.M805920200	http://dx.doi.org/10.1074/jbc.M805920200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029119	Green Published, hybrid			2022-12-25	WOS:000262700900014
J	Wakatsuki, S; Yumoto, N; Komatsu, K; Araki, T; Sehara-Fujisawa, A				Wakatsuki, Shuji; Yumoto, Norihiro; Komatsu, Koji; Araki, Toshiyuki; Sehara-Fujisawa, Atsuko			Roles of Meltrin-beta/ADAM19 in Progression of Schwann Cell Differentiation and Myelination during Sciatic Nerve Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; MELTRIN-BETA ADAM19; AXONAL REGULATION; PERIPHERAL-NERVE; SYSTEM; EXPRESSION; NEUREGULIN-1; CLEAVAGE; INJURY; HEART	Remyelination is an important aspect of nerve regeneration after nerve injury, but the underlying mechanisms are not fully understood. Here, we show that meltrin-beta(ADAM19), a member of the ADAM (a disintegrin and metalloprotease) family, plays crucial roles in nerve regeneration after a crush injury to the sciatic nerves. The expression of meltrin-beta was up-regulated in neurons after the crush injury. Morphometrical analysis revealed a delay in remyelination in meltrin-beta-deficient nerves, whereas no significant defects were observed in their axon elongation. The activation of Krox-20, an indispensable transcription factor for myelination, was delayed in meltrin-beta-deficient nerves and was accompanied by the retarded expression of myelin-related proteins. Expression of Krox-20 in Schwann cells was mediated by Akt. Phosphorylation of Akt but not that of Erks was reduced in regenerating nerves of meltrin-beta-deficient mice. The cell membrane fraction prepared from meltrin-beta-deficient nerves showed a defective activation of Akt in the membrane-loaded Schwann cells. Meltrin-beta-deficient mice exhibited delayed sciatic functional recovery after the nerve crush. Altogether, these results reveal a role of meltrin-beta in Schwann cell differentiation and re-myelination in nerve regeneration. Moreover, this study suggests that meltrin-beta functions as a modulator of juxtacrine signaling from axons that activate the Akt pathway and the Krox-20 expression, which is the prerequisite for Schwann cell differentiation.	[Wakatsuki, Shuji; Yumoto, Norihiro; Komatsu, Koji; Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto 6068507, Japan; [Wakatsuki, Shuji; Araki, Toshiyuki] Natl Ctr Neurol & Psychiat, Dept Peripheral Nervous Syst Res, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan	Kyoto University; National Center for Neurology & Psychiatry - Japan	Sehara-Fujisawa, A (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kawahara Cho 53, Kyoto 6068507, Japan.	asehara@frontier.kyoto-u.ac.jp	Messier, Claude/A-2322-2008; Araki, Toshiyuki/H-4289-2019	Messier, Claude/0000-0002-4791-1763; Araki, Toshiyuki/0000-0003-3625-2042	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare; Research for Evolutional Science and Technology; Japan Science and Technology Corporation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST))	This work was funded in part by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, a Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare, and a Research Grant from Core Research for Evolutional Science and Technology, the Japan Science and Technology Corporation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068; CONTRERAS PC, 1995, J PHARMACOL EXP THER, V274, P1443; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Holmes FE, 2003, P NATL ACAD SCI USA, V100, P6180, DOI 10.1073/pnas.0937087100; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; Inoue D, 1998, J BIOL CHEM, V273, P4180, DOI 10.1074/jbc.273.7.4180; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kim JE, 2003, MOL CELL NEUROSCI, V23, P451, DOI 10.1016/S1044-7431(03)00076-9; Komatsu K, 2007, DEV BIOL, V303, P82, DOI 10.1016/j.ydbio.2006.10.037; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kurohara K, 2004, DEV BIOL, V267, P14, DOI 10.1016/j.ydbio.2003.10.021; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Pot C, 2002, J CELL BIOL, V159, P29, DOI 10.1083/jcb.200206068; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Salzer JL, 2008, J CELL BIOL, V181, P575, DOI 10.1083/jcb.200804136; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Wakatsuki S, 2004, J NEUROCHEM, V89, P119, DOI 10.1046/j.1471-4159.2003.02303.x; Waller Augustus, 1851, Edinb Med Surg J, V76, P369; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; Yin X, 2000, J CELL BIOL, V148, P1009, DOI 10.1083/jcb.148.5.1009; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	43	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2957	2966		10.1074/jbc.M803191200	http://dx.doi.org/10.1074/jbc.M803191200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049978	hybrid			2022-12-25	WOS:000262700900040
J	Lee, YH; Chatani, E; Sasahara, K; Naiki, H; Goto, Y				Lee, Young-Ho; Chatani, Eri; Sasahara, Kenji; Naiki, Hironobu; Goto, Yuji			A Comprehensive Model for Packing and Hydration for Amyloid Fibrils of beta(2)-Microglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEEDING-DEPENDENT PROPAGATION; SOLID-STATE NMR; GLOBULAR-PROTEINS; HIGH-PRESSURE; H/D-EXCHANGE; 3D STRUCTURE; VOLUME; COMPRESSIBILITY; CONFORMATION; CORE	Volume can provide informative structural descriptions of macromolecules such as proteins in solution because a final volumetric outcome accompanies the exquisite equipoise of packing effects between residues, and residues and waters inside and outside proteins. Here we performed systematic investigations on the volumetric nature of the amyloidogenic conformations of beta(2)-microglobulin (beta 2-m) and its amyloidogenic core peptide, K3, using a high precision densitometer. The transition from the acid-denatured beta 2-m to the mature amyloid fibrils was accompanied by a positive change in the partial specific volume, which was larger than that observed for the transition from the acid-denatured beta(2)-m to the native structure. The data imply that the mature amyloid fibrils are more voluminous than the native structure because of a sparse packing density of side chains. In contrast, the formation of the mature amyloid-like fibrils of the K3 from the random coil was followed by a considerable decrease in the partial specific volume, suggesting a highly compact core structure. Interestingly, the immature amyloid-like fibrils of beta(2)-m exhibited a volume intermediate between those of the mature fibrils of beta(2)- m and K3, because of the core structure at their center and the relatively noncompact region around the core with much hydration. These volumetric differences would result from the nature of main-chain-dominated fibrillogenesis. We suggest comprehensive models for these three types of fibrils illustrating packing and hydrational states.	[Lee, Young-Ho; Chatani, Eri; Sasahara, Kenji; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Lee, Young-Ho; Chatani, Eri; Sasahara, Kenji; Goto, Yuji] Japan Sci & Technol Agcy, CREST, Suita, Osaka 5650871, Japan; [Naiki, Hironobu] Univ Fukui, Fac Med Sci, Fukui 9101193, Japan; [Naiki, Hironobu] Japan Sci & Technol Agcy, CREST, Fukui 9101193, Japan	Osaka University; Japan Science & Technology Agency (JST); University of Fukui; Japan Science & Technology Agency (JST)	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Naiki, Hironobu/G-5599-2014		Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for Promotion of Science postdoctoral fellowship	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to Y. G.) and by the Japan Society for Promotion of Science postdoctoral fellowship (to Y.- H. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akasaka K, 2007, BIOCHEMISTRY-US, V46, P10444, DOI 10.1021/bi700648b; Chalikian TV, 2003, ANNU REV BIOPH BIOM, V32, P207, DOI 10.1146/annurev.biophys.32.110601.141709; Chalikian TV, 1996, J MOL BIOL, V260, P588, DOI 10.1006/jmbi.1996.0423; Chalikian TV, 1997, J MOL BIOL, V274, P237, DOI 10.1006/jmbi.1997.1394; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chatani E, 2006, J MOL BIOL, V359, P1086, DOI 10.1016/j.jmb.2006.04.023; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DILL KA, 1995, PROTEIN SCI, V4, P561; Dirix C, 2005, J MOL BIOL, V347, P903, DOI 10.1016/j.jmb.2005.01.073; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; Gekko K, 2003, BIOCHEMISTRY-US, V42, P13746, DOI 10.1021/bi030115q; GEKKO K, 1979, J PHYS CHEM-US, V83, P2706, DOI 10.1021/j100484a006; Hiramatsu H, 2004, J AM CHEM SOC, V126, P3008, DOI 10.1021/ja0383017; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; Kihara M, 2006, J BIOL CHEM, V281, P31061, DOI 10.1074/jbc.M605358200; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Plattt GW, 2005, J MOL BIOL, V346, P279, DOI 10.1016/j.jmb.2004.11.035; Royer CA, 2002, BBA-PROTEIN STRUCT M, V1595, P201, DOI 10.1016/S0167-4838(01)00344-2; Sasahara K, 2005, J MOL BIOL, V352, P700, DOI 10.1016/j.jmb.2005.07.033; Sasahara K, 1999, J MOL BIOL, V291, P693, DOI 10.1006/jmbi.1999.2982; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Silva JL, 2002, BBA-PROTEIN STRUCT M, V1595, P250, DOI 10.1016/S0167-4838(01)00348-X; Smirnovas V, 2005, J PHYS CHEM B, V109, P19043, DOI 10.1021/jp053283w; Smirnovas V, 2006, CHEMPHYSCHEM, V7, P1046, DOI 10.1002/cphc.200500717; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067; Yamazaki T, 2008, BIOPHYS J, V95, P4540, DOI 10.1529/biophysj.107.123000	38	46	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2169	2175		10.1074/jbc.M806939200	http://dx.doi.org/10.1074/jbc.M806939200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017634	hybrid, Green Published			2022-12-25	WOS:000262545600026
J	Radyuk, SN; Rebrin, I; Luchak, JM; Michalak, K; Klichko, VI; Sohal, RS; Orr, WC				Radyuk, Svetlana N.; Rebrin, Igor; Luchak, James M.; Michalak, Katarzyna; Klichko, Vladimir I.; Sohal, Rajindar S.; Orr, William C.			The Catalytic Subunit of Drosophila Glutamate-Cysteine Ligase Is a Nucleocytoplasmic Shuttling Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; GLUTATHIONE REDOX STATE; NUCLEAR-LOCALIZATION; MODIFIER SUBUNIT; MELANOGASTER; CELLS; CADMIUM; OVEREXPRESSION; TRAFFICKING; MECHANISMS	GSH concentration is considerably lower in the nucleus than in the cytoplasm; however, it is significantly elevated during active cell proliferation. The main purpose of this study was to understand the mechanism underlying these variations in nuclear/cytoplasmic distribution of GSH. The rate-limiting step in the de novo GSH biosynthesis pathway is catalyzed by glutamate cysteine ligase (GCL), a heterodimer, composed of a catalytic subunit (GCLc) and a modulatory subunit (GCLm). In Drosophila, GCLc, but not GCLm, contains a nuclear localization signal (NLS). Drosophila S2 cells, constitutively expressing regular GCLc protein or expressing GCLc protein with a mutated NLS motif, were generated by transfection. In quiescent S2 cells, GCLc is aggregated in the perinuclear cytosol and the nucleus, whereas GLCm resides solely in the cytosol. In actively proliferating S2 cells, expressing the normal NLS motif, GCLc migrates from the perinuclear cytoplasm into the nucleus, and the nuclear GSH level becomes elevated; in contrast, in proliferating cells, expressing the mutated NLS motif, neither does the GCLc migrate into the nucleus nor does the nuclear GSH amount rise. In S2 cells expressing wild type GCLc, perturbation of cellular redox state by exposure to cadmium resulted in the migration of GCLc into the nucleus but not in cells expressing GCLc with the mutated NLS motif. Overall, results indicated that GSH biosynthesis in the nucleus is associated with migration of only the GCLc subunit from the cytoplasm into the nucleus, and this migration requires the presence of an intact NLS.	[Radyuk, Svetlana N.; Luchak, James M.; Michalak, Katarzyna; Klichko, Vladimir I.; Orr, William C.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; [Rebrin, Igor; Sohal, Rajindar S.] Univ So Calif, Dept Mol Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA	Southern Methodist University; University of Southern California	Orr, WC (corresponding author), Dedman Life Sci Bldg,6105 Airline Rd, Dallas, TX 75275 USA.	borr@smu.edu		Radyuk, Svetlana/0000-0002-3467-5255	National Institutes of Health; NIA [RO1-AG15122]; NATIONAL INSTITUTE ON AGING [R01AG015122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, Grant RO1-AG15122 from NIA. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BELLOMO G, 1992, P NATL ACAD SCI USA, V89, P4412, DOI 10.1073/pnas.89.10.4412; Chen ZF, 1998, J PHARMACOL EXP THER, V285, P608; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Daniel S, 2008, BBA-MOL CELL RES, V1783, P1003, DOI 10.1016/j.bbamcr.2008.01.014; Das GC, 2006, MOL CARCINOGEN, V45, P635, DOI 10.1002/mc.20184; Dixon BM, 2008, ANTIOXID REDOX SIGN, V10, P963, DOI 10.1089/ars.2007.1869; Engel R, 2004, EXP CELL RES, V295, P421, DOI 10.1016/j.yexcr.2004.01.012; Fraser JA, 2003, J BIOL CHEM, V278, P46369, DOI 10.1074/jbc.M308035200; Fraser JA, 2002, J BIOL CHEM, V277, P1158, DOI 10.1074/jbc.M106683200; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Hasbold J, 2000, CYTOMETRY, V40, P230, DOI 10.1002/1097-0320(20000701)40:3<230::AID-CYTO8>3.0.CO;2-E; Ho Y.F., 1994, TOXICOLOGIST, V14, P178; HUANG CS, 1993, J BIOL CHEM, V268, P20578; Katti MV, 2000, PROTEIN SCI, V9, P1203, DOI 10.1110/ps.9.6.1203; LASH LH, 1993, PHARMACOLOGIST, V35, P148; Lu Q, 2007, J CELL PHYSIOL, V212, P827, DOI 10.1002/jcp.21079; Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Patrick Lyn, 2003, Altern Med Rev, V8, P106; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; Rebrin I, 2004, BIOCHEM J, V382, P131, DOI 10.1042/BJ20040506; RIZZINO A, 1978, IN VITRO CELL DEV B, V14, P437; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Rodriguez JA, 2004, ONCOGENE, V23, P1809, DOI 10.1038/sj.onc.1207302; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Shi S, 2007, CYTOM PART A, V71A, P686, DOI 10.1002/cyto.a.20434; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Yang PM, 2004, CHEM-BIOL INTERACT, V149, P125, DOI 10.1016/j.cbi.2004.08.001; Zegura B, 2006, MUTAT RES-GEN TOX EN, V611, P25, DOI 10.1016/j.mrgentox.2006.06.038; Zhou T, 2004, TOXICOL LETT, V154, P191, DOI 10.1016/j.toxlet.2004.07.015	35	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2266	2274		10.1074/jbc.M805913200	http://dx.doi.org/10.1074/jbc.M805913200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19036725	Green Published, hybrid			2022-12-25	WOS:000262545600036
J	Tate, JJ; Georis, I; Feller, A; Dubois, E; Cooper, TG				Tate, Jennifer J.; Georis, Isabelle; Feller, Andre; Dubois, Evelyne; Cooper, Terrance G.			Rapamycin-induced Gln3 Dephosphorylation Is Insufficient for Nuclear Localization Sit4 AND PP2A PHOSPHATASES ARE REGULATED AND FUNCTION DIFFERENTLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROGEN CATABOLITE REPRESSION; METHIONINE SULFOXIMINE TREATMENT; RETROGRADE GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TOR PROTEINS; CARBON STARVATION; CELL-GROWTH; PHOSPHORYLATION; TRANSCRIPTION; TAP42	Gln3, the major activator of nitrogen catabolite repression (NCR)-sensitive transcription, is often used as an assay of Tor pathway regulation in Saccharomyces cerevisiae. Gln3 is cytoplasmic in cells cultured with repressive nitrogen sources (Gln) and nuclear with derepressive ones (Pro) or after treating Gln-grown cells with the Tor inhibitor, rapamycin (Rap). In Rap-treated or Pro-grown cells, Sit4 is posited to dephosphorylate Gln3, which then dissociates from a Gln3-Ure2 complex and enters the nucleus. However, in contrast with this view, Sit4-dependent Gln3 dephosphorylation is greater in Gln than Pro. Investigating this paradox, we show that PP2A (another Tor pathway phosphatase)-dependent Gln3 dephosphorylation is regulated oppositely to that of Sit4, being greatest in Pro-and least in Gln-grown cells. It thus parallels nuclear Gln3 localization and NCR-sensitive transcription. However, because PP2A is not required for nuclear Gln3 localization in Pro, PP2A-dependent Gln3 dephosphorylation and nuclear localization are likely parallel responses to derepressive nitrogen sources. In contrast, Rap-induced nuclear Gln3 localization absolutely requires all four PP2A components (Pph21/22, Tpd3, Cdc55, and Rts1). In pph21 Delta 22 Delta, tpd3 Delta, or cdc55 Delta cells, however, Gln3 is dephosphorylated to the same level as in Rap-treated wildtype cells, indicating Rap-induced Gln3 dephosphorylation is insufficient to achieve nuclear localization. Finally, PP2A-dependent Gln3 dephosphorylation parallels conditions where Gln3 is mostly nuclear, while Sit4-dependent and Rap-induced dephosphorylation parallels those where Gln3 is mostly cytoplasmic, suggesting the effects of these phosphatases on Gln3 may occur in different cellular compartments.	[Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA; [Georis, Isabelle; Feller, Andre; Dubois, Evelyne] Univ Libre Bruxelles, Microbiol Lab, Inst Rech Microbiol JM Wiame, B-1070 Brussels, Belgium	University of Tennessee System; University of Tennessee Health Science Center; Universite Libre de Bruxelles	Cooper, TG (corresponding author), Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA.	tcooper@utmem.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health [GM-35642]; National Science Foundation [DMS-0443901]; COCOF (Commission de la Communaute francaise); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); COCOF (Commission de la Communaute francaise); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM-35642 from the National Institutes of Health. This work was also supported by the National Science Foundation (DMS-0443901) (to T. C.) and COCOF (Commission de la Communaute francaise) (to E. D. and I. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, MYCOTA, V3, P81; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Puria R, 2008, P NATL ACAD SCI USA, V105, P7194, DOI 10.1073/pnas.0801087105; Rohde JR, 2003, CURR TOP MICROBIOL, V279, P53; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2006, J BIOL CHEM, V281, P28460, DOI 10.1074/jbc.M604171200; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; Tate JJ, 2003, J BIOL CHEM, V278, P36924, DOI 10.1074/jbc.M301829200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	42	44	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2522	2534		10.1074/jbc.M806162200	http://dx.doi.org/10.1074/jbc.M806162200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19015262	Green Published, hybrid			2022-12-25	WOS:000262545600058
J	Daniels, RL; Takashima, Y; McKemy, DD				Daniels, Richard L.; Takashima, Yoshio; McKemy, David D.			Activity of the Neuronal Cold Sensor TRPM8 Is Regulated by Phospholipase C via the Phospholipid Phosphoinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; RECEPTOR POTENTIAL MELASTATIN-8; PROTEIN-KINASE-C; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ION CHANNELS; CAPSAICIN RECEPTOR; CATION CHANNEL; LIVING CELLS; K+ CHANNEL; MENTHOL	Cold temperatures robustly activate a small cohort of somatosensory nerves, yet during a prolonged cold stimulus their activity will decrease, or adapt, over time. This process allows for the discrimination of subtle changes in temperature. At the molecular level, cold is detected by transient receptor potential melastatin 8 (TRPM8), a nonselective cation channel expressed on a subset of peripheral afferent fibers. We and others have reported that TRPM8 channels also adapt in a calcium-dependent manner when activated by the cooling compound menthol. Additionally, TRPM8 activity is sensitive to the phospholipid phosphoinositol 4,5-bisphosphate (PIP2), a substrate for the enzyme phospholipase C (PLC). These results suggest an adaptation model whereby TRPM8-mediated Ca2+ influx activates PLC, thereby decreasing PIP2 levels and resulting in reduced TRPM8 activity. Here we tested this model using pharmacological activation of PLC and by manipulating PIP2 levels independent of both PLC and Ca2+. PLC activation leads to adaptation-like reductions in cold- or menthol-evoked TRPM8 currents in both heterologous and native cells. Moreover, PLC-independent reductions in PIP2 had a similar effect on cold- and menthol-evoked currents. Mechanistically, either form of adaptation does not alter temperature sensitivity of TRPM8 but does lead to a change in channel gating. Our results show that adaptation is a shift in voltage dependence toward more positive potentials, reversing the trend toward negative potentials caused by agonist. These data suggest that PLC activity not only mediates adaptation to thermal stimuli, but likely underlies a more general mechanism that establishes the temperature sensitivity of somatosensory neurons.	[Daniels, Richard L.; Takashima, Yoshio; McKemy, David D.] Univ So Calif, Dept Biol Sci, Grad Program Neurosci, Los Angeles, CA 90089 USA; [McKemy, David D.] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	McKemy, DD (corresponding author), 3641 Watt Way,HNB228, Los Angeles, CA 90089 USA.	mckemy@usc.edu		Daniels, Richard/0000-0003-2477-6025	National Institutes of Health (NINDS) [R01 NS054069]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054069] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS054069 (NINDS) (to D.D.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abe J, 2006, NEUROSCI LETT, V397, P140, DOI 10.1016/j.neulet.2005.12.005; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; BYERS MR, 2002, DENT PULP, V3, P151; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Daniels RL, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-23; DARIANSMITH I, 1973, J NEUROPHYSIOL, V36, P325, DOI 10.1152/jn.1973.36.2.325; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hui KY, 2005, BIOCHEM BIOPH RES CO, V333, P374, DOI 10.1016/j.bbrc.2005.05.123; Jajoo S, 2008, NEUROSCIENCE, V151, P525, DOI 10.1016/j.neuroscience.2007.11.010; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KENSHALO DR, 1977, J NEUROPHYSIOL, V40, P319, DOI 10.1152/jn.1977.40.2.319; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Linte RM, 2007, EXP BRAIN RES, V178, P89, DOI 10.1007/s00221-006-0712-3; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nam JH, 2007, J PHYSIOL-LONDON, V582, P977, DOI 10.1113/jphysiol.2007.128413; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Premkumar LS, 2005, J NEUROSCI, V25, P11322, DOI 10.1523/JNEUROSCI.3006-05.2005; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Reid G, 2002, NEUROSCI LETT, V324, P164, DOI 10.1016/S0304-3940(02)00181-7; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2008, MOL NEUROBIOL, V37, P153, DOI 10.1007/s12035-008-8027-y; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V455, P157, DOI 10.1007/s00424-007-0275-6; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V453, P753, DOI 10.1007/s00424-006-0153-7; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Xing H, 2006, J NEUROPHYSIOL, V95, P1221, DOI 10.1152/jn.01035.2005; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	60	103	110	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1570	1582		10.1074/jbc.M807270200	http://dx.doi.org/10.1074/jbc.M807270200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19019830	Green Published, hybrid			2022-12-25	WOS:000262330100025
J	Singh, M; Gonzales, FA; Cascio, D; Heckmann, N; Chanfreau, G; Feigon, J				Singh, Mahavir; Gonzales, Fernando A.; Cascio, Duilio; Heckmann, Nathanael; Chanfreau, Guillaume; Feigon, Juli			Structure and Functional Studies of the CS Domain of the Essential H/ACA Ribonucleoparticle Assembly Protein SHQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; HUMAN TELOMERASE RNA; HEAT-SHOCK-PROTEIN; CRYSTAL-STRUCTURE; YEAST; P23; LOCALIZATION; SGT1; PSEUDOURIDYLATION; NAF1P	H/ACA ribonucleoprotein particles are essential for ribosomal RNA and telomerase RNA processing and metabolism. Shq1p has been identified as an essential eukaryotic H/ACA small nucleolar (sno) ribonucleoparticle (snoRNP) biogenesis and assembly factor. Shq1p is postulated to be involved in the early biogenesis steps of H/ACA snoRNP complexes, and Shq1p depletion leads to a specific decrease in H/ACA small nucleolar RNA levels and to defects in ribosomal RNA processing. Shq1p contains two predicted domains as follows: an N-terminal CS (named after CHORD-containing proteins and SGT1) or HSP20-like domain, and a C-terminal region of high sequence homology called the Shq1 domain. Here we report the crystal structure and functional studies of the Saccharomyces cerevisiae Shq1p CS domain. The structure consists of a compact anti-parallel beta-sandwich fold that is composed of two beta-sheets containing four and three beta-strands, respectively, and a short alpha-helix. Deletion studies showed that the CS domain is required for the essential functions of Shq1p. Point mutations in residues Phe-6, Gln-10, and Lys-80 destabilize Shq1p in vivo and induce a temperature-sensitive phenotype with depletion of H/ACA small nucleolar RNAs and defects in rRNA processing. Although CS domains are frequently found in co-chaperones of the Hsp90 molecular chaperone, no interaction was detected between the Shq1p CS domain and yeast Hsp90 in vitro. These results show that the CS domain is essential for Shq1p function in H/ACA snoRNP biogenesis in vivo, possibly in an Hsp90-independent manner.	[Singh, Mahavir; Gonzales, Fernando A.; Heckmann, Nathanael; Chanfreau, Guillaume; Feigon, Juli] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cascio, Duilio; Chanfreau, Guillaume; Feigon, Juli] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Feigon, J (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, POB 951569, Los Angeles, CA 90095 USA.	feigon@mbi.ucla.edu	Chanfreau, Guillaume/S-7421-2019; Gonzales-Zubiate, Fernando A/O-2709-2014; Heckmann, Nathanael/GXV-2765-2022	Gonzales-Zubiate, Fernando A/0000-0001-9519-4079; 	National Institutes of Health [GM37254, GM48123]; American Cancer Society Research Scholar [RSG-06-040]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048123, R01GM037254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM37254 and GM48123 (to J.F.). This work was also supported by American Cancer Society Research Scholar Grant RSG-06-040 ( to G. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker DL, 2005, GENE DEV, V19, P1238, DOI 10.1101/gad.1309605; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; Boter M, 2007, PLANT CELL, V19, P3791, DOI 10.1105/tpc.107.050427; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237; Charpentier B, 2005, NUCLEIC ACIDS RES, V33, P3133, DOI 10.1093/nar/gki630; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; Dez C, 2002, MOL CELL BIOL, V22, P7053, DOI 10.1128/MCB.22.20.7053-7065.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fatica A, 2002, RNA, V8, P1502, DOI 10.1017/S1355838202022094; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldwasser E, 1966, Prog Nucleic Acid Res Mol Biol, V5, P399, DOI 10.1016/S0079-6603(08)60241-X; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Haslbeck Martin, 2002, Prog Mol Subcell Biol, V28, P37; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Henras A, 1998, EMBO J, V17, P7078, DOI 10.1093/emboj/17.23.7078; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Jin H, 2007, MOL CELL, V26, P205, DOI 10.1016/j.molcel.2007.03.014; Kadota Y, 2008, EMBO REP, V9, P1209, DOI 10.1038/embor.2008.185; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; KOLODRUBETZ D, 1991, YEAST, V7, P79, DOI 10.1002/yea.320070202; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Leulliot N, 2007, J MOL BIOL, V371, P1338, DOI 10.1016/j.jmb.2007.06.031; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez-Yamout MA, 2006, J BIOL CHEM, V281, P14457, DOI 10.1074/jbc.M601759200; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; MORRISSEY JP, 1993, MOL CELL BIOL, V13, P2469, DOI 10.1128/MCB.13.4.2469; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Rozhdestvensky TS, 2003, NUCLEIC ACIDS RES, V31, P869, DOI 10.1093/nar/gkg175; Sambrook J., 2001, MOL CLONING; Sherman F., 1974, METHODS YEAST GENETI; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Theimer CA, 2007, MOL CELL, V27, P869, DOI 10.1016/j.molcel.2007.07.017; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; Toogun OA, 2008, MOL CELL BIOL, V28, P457, DOI 10.1128/MCB.01417-07; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Wu HH, 2007, P NATL ACAD SCI USA, V104, P6655, DOI 10.1073/pnas.0701534104; Yang PK, 2002, J BIOL CHEM, V277, P45235, DOI 10.1074/jbc.M207669200; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461; Zhang MH, 2008, EMBO J, V27, P2789, DOI 10.1038/emboj.2008.190; Zhu SY, 2004, FASEB J, V18, P940, DOI 10.1096/fj.04-1570hyp; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	66	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1906	1916		10.1074/jbc.M807337200	http://dx.doi.org/10.1074/jbc.M807337200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19019820	Green Published, hybrid			2022-12-25	WOS:000262330100061
J	Crabtree, MJ; Tatham, AL; Al-Wakeel, Y; Warrick, N; Hale, AB; Cai, S; Channon, KM; Alp, NJ				Crabtree, Mark J.; Tatham, Amy L.; Al-Wakeel, Yasir; Warrick, Nicholas; Hale, Ashley B.; Cai, Shijie; Channon, Keith M.; Alp, Nicholas J.			Quantitative Regulation of Intracellular Endothelial Nitric-oxide Synthase (eNOS) Coupling by Both Tetrahydrobiopterin-eNOS Stoichiometry and Biopterin Redox Status INSIGHTS FROM CELLS WITH TET-REGULATED GTP CYCLOHYDROLASE I EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT VASODILATION; SUPEROXIDE-PRODUCTION; DIABETES-MELLITUS; HYPERCHOLESTEROLEMIA; MICE; OVEREXPRESSION; PEROXYNITRITE; NO; 5,6,7,8-TETRAHYDROBIOPTERIN; ATHEROSCLEROSIS	Tetrahydrobiopterin (BH4) is a critical determinant of endothelial nitric-oxide synthase (eNOS) activity. In the absence of BH4, eNOS becomes "uncoupled" and generates superoxide rather than NO. However, the stoichiometry of intracellular BH4/eNOS interactions is not well defined, and it is unclear whether intracellular BH4 deficiency alone is sufficient to induce eNOS uncoupling. To address these questions, we developed novel cell lines with tet-regulated expression of human GTP cyclohydrolase I (GTPCH), the rate-limiting enzyme in BH4 synthesis, to selectively induce intracellular BH4 deficiency by incubation with doxycycline. These cells were stably co-transfected to express a human eNOS-green fluorescent protein fusion protein, selecting clones expressing either low (GCH/eNOS-LOW) or high (GCH/eNOS-HIGH) levels. Doxycycline abolished GTPCH mRNA expression and GTPCH protein, leading to markedly diminished total biopterin levels and a decreased ratio of BH4 to oxidized biopterins in cells expressing eNOS. Intracellular BH4 deficiency induced superoxide generation from eNOS, as assessed by N-nitro-L-arginine methyl ester inhibitable 2-hydroxyethidium generation, and attenuated NO production. Quantitative analysis of cellular BH4 versus superoxide production between GCH/eNOS-LOW and GCH/eNOS-HIGH cells revealed a striking linear relationship between eNOS protein and cellular BH4 stoichiometry, with eNOS uncoupling at eNOS: BH4 molar ratio >1. Furthermore, increasing the intracellular BH2 concentration in the presence of a constant eNOS: BH4 ratio was sufficient to induce eNOS-dependent superoxide production. This specific, reductionist approach in a cell-based system reveals that eNOS: BH4 reaction stoichiometry together with the intracellular BH4:BH2 ratio, rather than absolute concentrations of BH4, are the key determinants of eNOS uncoupling, even in the absence of exogenous oxidative stress.	[Crabtree, Mark J.; Tatham, Amy L.; Al-Wakeel, Yasir; Warrick, Nicholas; Hale, Ashley B.; Cai, Shijie; Channon, Keith M.; Alp, Nicholas J.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Oxford	Alp, NJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	nicholas.alp@well.ox.ac.uk		Crabtree, Mark/0000-0003-3298-2697; channon, keith/0000-0002-1043-4342	British Heart Foundation [PG/05/141/20098, RG/02/006]; Wellcome Trust Clinician Scientist Fellowship [GR074428/Z/04/Z]; British Heart Foundation [RG/07/003/23133] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust Clinician Scientist Fellowship(Wellcome Trust); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Project Grant PG/05/141/20098, British Heart Foundation Programme Grant RG/02/006, and Wellcome Trust Clinician Scientist Fellowship GR074428/Z/04/Z. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Antoniades C, 2006, CIRCULATION, V114, P1193, DOI 10.1161/CIRCULATIONAHA.106.612325; Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; Cai S, 2005, DIABETOLOGIA, V48, P1933, DOI 10.1007/s00125-005-1857-5; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; de Bono JP, 2007, NITRIC OXIDE-BIOL CH, V16, P1, DOI 10.1016/j.niox.2006.03.008; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Fukuda Y, 2002, HEART, V87, P264, DOI 10.1136/heart.87.3.264; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; HEALES S, 1989, J CHROMATOGR-BIOMED, V494, P77, DOI 10.1016/S0378-4347(00)82658-4; Heitzer T, 2000, CIRC RES, V86, pE36, DOI 10.1161/01.RES.86.2.e36; Heitzer T, 2000, DIABETOLOGIA, V43, P1435, DOI 10.1007/s001250051551; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; KOJIMA S, 1995, FREE RADICAL RES, V23, P419, DOI 10.3109/10715769509065263; Kuzkaya N, 2003, J BIOL CHEM, V278, P22546, DOI 10.1074/jbc.M302227200; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; McDonald DM, 2004, PHARMACOGENETICS, V14, P831, DOI 10.1097/00008571-200412000-00006; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Ozaki M, 2002, J CLIN INVEST, V110, P331, DOI 10.1172/JCI200215215; PANZA JA, 1995, CIRCULATION, V91, P1732, DOI 10.1161/01.CIR.91.6.1732; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; Schmidt PP, 2001, J BIOL INORG CHEM, V6, P151, DOI 10.1007/s007750000185; Stroes E, 1998, FEBS LETT, V438, P161, DOI 10.1016/S0014-5793(98)01292-7; Stroes E, 1997, J CLIN INVEST, V99, P41, DOI 10.1172/JCI119131; Timimi FK, 1998, J AM COLL CARDIOL, V31, P552, DOI 10.1016/S0735-1097(97)00536-6; Ting HH, 1997, CIRCULATION, V95, P2617, DOI 10.1161/01.CIR.95.12.2617; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vasquez-Vivar J, 2003, FREE RADICAL RES, V37, P121, DOI 10.1080/1071576021000040655; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Vasquez-Vivar J, 2001, FREE RADICAL BIO MED, V31, P975, DOI 10.1016/S0891-5849(01)00680-3; Vasquez-Vivar J., 2004, BIOL MAGN RESON, P75; Werner-Felmayer G, 1996, METHODS NITRIC OXIDE, P271; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	40	146	154	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1136	1144		10.1074/jbc.M805403200	http://dx.doi.org/10.1074/jbc.M805403200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19011239	hybrid			2022-12-25	WOS:000262122900050
J	Roland, JT; Lapierre, LA; Goldenring, JR				Roland, Joseph T.; Lapierre, Lynne A.; Goldenring, James R.			Alternative Splicing in Class V Myosins Determines Association with Rab10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; UNCONVENTIONAL MYOSIN; INTERACTING PROTEIN-2; FLUORESCENT PROTEIN; AMPA RECEPTORS; EXON-B; TRANSPORT; EXPRESSION; FAMILY; IDENTIFICATION	Rab proteins influence vesicle trafficking pathways through the assembly of regulatory protein complexes. Previous investigations have documented that Rab11a and Rab8a can interact with the tail region of myosin Vb and regulate distinct trafficking pathways. We have now determined that a related Rab protein, Rab10, can interact with myosin Va, myosin Vb, and myosin Vc. Rab10 localized to a system of tubules and vesicles that have partially overlapping localization with Rab8a. Both Rab8a and Rab10 were mislocalized by the expression of dominant-negative myosin V tails. Interaction with Rab10 was dependent on the presence of the alternatively spliced exon D in myosin Va and myosin Vb and the homologous region in myosin Vc. Yeast two-hybrid assays and fluorescence resonance energy transfer studies confirmed that Rab10 binding to myosin V tails in vivo required the alternatively spliced exon D. In contrast to our previous work, we found that Rab11a can interact with both myosin Va and myosin Vb tails independent of their splice isoform. These results indicate that Rab GTPases regulate diverse endocytic trafficking pathways through recruitment of multiple myosin V isoforms.	[Goldenring, James R.] Vanderbilt Univ, Sch Med, Dept Surg, Epithelial Biol Program, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Nashville Vet Affairs Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Goldenring, JR (corresponding author), Vanderbilt Univ, Sch Med, Dept Surg, Epithelial Biol Program, 4160A MRB III,465 21st St S, Nashville, TN 37232 USA.	jim.goldenring@vanderbilt.edu	Roland, Joseph/C-9592-2013		National Institutes of Health [R01 DK070856, R01 DK48370, F32 DK072789]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK072789, R01DK048370, P30DK020593, U2CDK059637, P60DK020593, P30DK058404, U24DK059637, R01DK070856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK070856 ( NIDDK) and R01 DK48370 ( to J. R. G.) and F32 DK072789 ( to J. T. R.).	Au JSY, 2002, CELL MOTIL CYTOSKEL, V53, P89, DOI 10.1002/cm.10061; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P6549, DOI 10.1073/pnas.91.14.6549; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Casavola EC, 2008, MOL MICROBIOL, V67, P1051, DOI 10.1111/j.1365-2958.2008.06106.x; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; CHEN YT, 1993, P NATL ACAD SCI USA, V90, P6508, DOI 10.1073/pnas.90.14.6508; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; ESPINDOLA FS, 1992, J CELL BIOL, V118, P359, DOI 10.1083/jcb.118.2.359; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Futter CE, 2006, PIGM CELL RES, V19, P104, DOI 10.1111/j.1600-0749.2006.00303.x; Goldenring JR, 1996, AM J PHYSIOL-GASTR L, V270, pG515, DOI 10.1152/ajpgi.1996.270.3.G515; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hobdy-Henderson KC, 2003, TRAFFIC, V4, P681, DOI 10.1034/j.1600-0854.2003.00124.x; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; Huang JD, 1998, GENETICS, V148, P1963; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Lambert J, 1998, BIOCHEM BIOPH RES CO, V252, P329, DOI 10.1006/bbrc.1998.9644; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lapierre LA, 2007, AM J PHYSIOL-GASTR L, V292, pG1249, DOI 10.1152/ajpgi.00505.2006; Lindsay AJ, 2002, J BIOL CHEM, V277, P27193, DOI 10.1074/jbc.M200757200; Lipatova Z, 2008, MOL BIOL CELL, V19, P4177, DOI 10.1091/mbc.E08-02-0220; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NAGATA K, 1990, FEBS LETT, V275, P29, DOI 10.1016/0014-5793(90)81431-M; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Provance DW, 2002, TRAFFIC, V3, P124, DOI 10.1034/j.1600-0854.2002.030205.x; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Schuck S, 2007, TRAFFIC, V8, P47, DOI 10.1111/j.1600-0854.2006.00506.x; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Westbroek W, 2003, J INVEST DERMATOL, V120, P465, DOI 10.1046/j.1523-1747.2003.12068.x; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760	55	80	83	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1213	1223		10.1074/jbc.M805957200	http://dx.doi.org/10.1074/jbc.M805957200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008234	hybrid, Green Published			2022-12-25	WOS:000262122900057
J	Horiguchi, K; Shirakihara, T; Nakano, A; Imamura, T; Miyazono, K; Saitoh, M				Horiguchi, Kana; Shirakihara, Takuya; Nakano, Ayako; Imamura, Takeshi; Miyazono, Kohei; Saitoh, Masao			Role of Ras Signaling in the Induction of Snail by Transforming Growth Factor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TGF-BETA; CANCER PROGRESSION; TUMOR SUPPRESSION; H-RAS; CELLS; PATHWAYS; METASTASIS; PANCREAS; ADENOCARCINOMA	The epithelial-mesenchymal transition (EMT) is a crucial morphological event that occurs during the progression of epithelial tumors. EMT can be induced by transforming growth factor (TGF)-beta in some tumor cells. Here, we demonstrate the molecular mechanism whereby Snail, a key regulator of EMT, is induced by TGF-beta in tumor cells. Snail induction by TGF-beta was highly dependent on cooperation with active Ras signals, and silencing of Ras abolished Snail induction by TGF-beta in pancreatic cancer Panc-1 cells. Transfection of constitutively active Ras into HeLa cells led to induction of Snail by TGF-beta, while representative direct targets of TGF-beta, including Smad7 and PAI-1, were not affected by Ras signaling. Using mitogen-activated protein kinase inhibitors or Smad3 or Smad2 mutants, we found that phosphorylation at the linker region of Smad2/3 was not required for the induction of Snail by TGF-beta. Taken together, these findings indicate that Ras and TGF-beta-Smad signaling selectively cooperate in the induction of Snail, which occurs in a Smad-dependent manner, but independently of phosphorylation at the linker region of R-Smads by Ras signaling.	[Horiguchi, Kana; Shirakihara, Takuya; Miyazono, Kohei; Saitoh, Masao] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Nakano, Ayako; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, Tokyo 1358550, Japan	University of Tokyo; Japanese Foundation for Cancer Research	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp		Shirakihara, Takuya/0000-0002-6222-0143	KAKENHI; Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by KAKENHI (Grants-in-Aid for Scientific Research) and the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges.	Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; EHATA S, 2006, CANCER SCI, V67, P9694; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Filmus Jorge, 1993, Current Opinion in Oncology, V5, P123; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; HOUCK KA, 1989, ONCOGENE, V4, P19; HOWE PH, 1993, J BIOL CHEM, V268, P21448; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kawasaki K, 2008, J CELL BIOL, V181, P131, DOI 10.1083/jcb.200709127; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; LONGSTREET M, 1992, ONCOGENE, V7, P1549; MITCHELL CE, 1995, ANAL BIOCHEM, V224, P148, DOI 10.1006/abio.1995.1020; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Rajesh D, 1999, MOL PHARMACOL, V56, P515, DOI 10.1124/mol.56.3.515; Sakorafas GH, 2000, CANCER TREAT REV, V26, P29, DOI 10.1053/ctrv.1999.0144; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; SCHWARZ LC, 1988, CANCER RES, V48, P6999; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; VALVERIUS EM, 1989, CANCER RES, V49, P6269; Watanabe M, 1996, INT J CANCER, V67, P264, DOI 10.1002/(SICI)1097-0215(19960717)67:2<264::AID-IJC18>3.0.CO;2-B; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	40	170	173	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					245	253		10.1074/jbc.M804777200	http://dx.doi.org/10.1074/jbc.M804777200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19010789	hybrid			2022-12-25	WOS:000261974800028
J	Vamosi, JC; Vamosi, SM				Vamosi, Jana C.; Vamosi, Steven M.			Extinction Risk Escalates in the Tropics	PLOS ONE			English	Article							SPECIES RICHNESS; NONRANDOM EXTINCTION; SPECIATION; EVOLUTION; RATES; SIZE; GRADIENT	The latitudinal biodiversity gradient remains one of the most widely recognized yet puzzling patterns in nature [ 1]. Presently, the high level of extinction of tropical species, referred to as the "tropical biodiversity crisis", has the potential to erode this pattern. While the connection between species richness, extinction, and speciation has long intrigued biologists [2,3], these interactions have experienced increased poignancy due to their relevancy to where we should concentrate our conservation efforts. Natural extinction is a phenomenon thought to have its own latitudinal gradient, with lower extinction rates in the tropics being reported in beetles, birds, mammals, and bivalves [4-7]. Processes that have buffered ecosystems from high extinction rates in the past may also buffer ecosystems against disturbance of anthropogenic origin. While potential parallels between historical and present-day extinction patterns have been acknowledged, they remain only superficially explored and plant extinction patterns have been particularly neglected. Studies on the disappearances of animal species have reached conflicting conclusions, with the rate of extinction appearing either higher [ 8] or lower [ 9] in species richness hotspots. Our global study of extinction risk in vascular plants finds disproportionately higher extinction risk in tropical countries, even when indicators of human pressure (GDP, population density, forest cover change) are taken into account. Our results are at odds with the notion that the tropics represent a museum of plant biodiversity ( places of historically lowered extinction) and we discuss mechanisms that may reconcile this apparent contradiction.	[Vamosi, Steven M.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Vamosi, JC (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	jvamosi@ucalgary.ca	Vamosi, Steven/C-8126-2009	Vamosi, Steven/0000-0003-3903-5000; Vamosi, Jana/0000-0002-2376-0729	Natural Sciences and Engineering Research Council (Canada) [Discovery Grants]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by Discovery Grants from the Natural Sciences and Engineering Research Council (Canada) to JCV and SMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Crawley MJ, 2005, STAT INTRO USING R; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Davies RG, 2006, P ROY SOC B-BIOL SCI, V273, P2127, DOI 10.1098/rspb.2006.3551; Dobzhansky T., 1950, American Scientist, V38, P209; Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x; Gaston K.J, 1996, BIODIVERSITY BIOL NU; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Ives AR, 2000, ECOL LETT, V3, P399, DOI 10.1046/j.1461-0248.2000.00144.x; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jamieson IG, 2007, ANIM CONSERV, V10, P139, DOI 10.1111/j.1469-1795.2006.00095.x; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Jansson R, 2008, ECOL LETT, V11, P173, DOI 10.1111/j.1461-0248.2007.01138.x; Martin PR, 2004, EVOLUTION, V58, P938; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Niklas KJ, 2003, ECOL LETT, V6, P631, DOI 10.1046/j.1461-0248.2003.00473.x; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Payne JL, 2007, P NATL ACAD SCI USA, V104, P10506, DOI 10.1073/pnas.0701257104; Pitman NCA, 2002, SCIENCE, V298, P989, DOI 10.1126/science.298.5595.989; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Qian H, 2007, ECOLOGY, V88, P1440, DOI 10.1890/06-0916; R Core Development Team, 2008, R LANG ENV STAT COMP; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rode AL, 2005, J PALEONTOL, V79, P267, DOI 10.1666/0022-3360(2005)079<0267:IEABAC>2.0.CO;2; STEBBINS G L, 1971, Taxon, V20, P3, DOI 10.2307/1218529; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; Vamosi JC, 2005, DIVERS DISTRIB, V11, P25, DOI 10.1111/j.1366-9516.2005.00119.x; Vamosi SM, 2007, CAN J ZOOL, V85, P443, DOI 10.1139/Z07-021; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Wright S, 2006, P NATL ACAD SCI USA, V103, P7718, DOI 10.1073/pnas.0510383103; [No title captured]; [No title captured]; [No title captured]	38	40	42	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2008	3	12							e3886	10.1371/journal.pone.0003886	http://dx.doi.org/10.1371/journal.pone.0003886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZS	19066623	gold, Green Submitted, Green Published			2022-12-25	WOS:000265455700004
J	Polymenidou, M; Moos, R; Scott, M; Sigurdson, C; Shi, YZ; Yajima, B; Hafner-Bratkovic, I; Jerala, R; Hornemann, S; Wuthrich, K; Bellon, A; Vey, M; Garen, G; James, MNG; Kav, N; Aguzzi, A				Polymenidou, Magdalini; Moos, Rita; Scott, Mike; Sigurdson, Christina; Shi, Yong-zhong; Yajima, Bill; Hafner-Bratkovic, Iva; Jerala, Roman; Hornemann, Simone; Wuthrich, Kurt; Bellon, Anne; Vey, Martin; Garen, Graciela; James, Michael N. G.; Kav, Nat; Aguzzi, Adriano			The POM Monoclonals: A Comprehensive Set of Antibodies to Non-Overlapping Prion Protein Epitopes	PLOS ONE			English	Article								PrP(Sc), a misfolded and aggregated form of the cellular prion protein PrP(C), is the only defined constituent of the transmissible agent causing prion diseases. Expression of PrP(C) in the host organism is necessary for prion replication and for prion neurotoxicity. Understanding prion diseases necessitates detailed structural insights into PrP(C) and PrP(Sc). Towards this goal, we have developed a comprehensive collection of monoclonal antibodies denoted POM1 to POM19 and directed against many different epitopes of mouse PrP(C). Three epitopes are located within the N-terminal octarepeat region, one is situated within the central unstructured region, and four epitopes are discontinuous within the globular C-proximal domain of PrP(C). Some of these antibodies recognize epitopes that are resilient to protease digestion in PrP(Sc). Other antibodies immunoprecipitate PrP(C), but not PrP(Sc). A third group was found to immunoprecipitate both PrP isoforms. Some of the latter antibodies could be blocked with epitope-mimicking peptides, and incubation with an excess of these peptides allowed for immunochromatography of PrP(C) and PrP(Sc). Amino-proximal antibodies were found to react with repetitive PrP(C) epitopes, thereby vastly increasing their avidity. We have also created functional single-chain miniantibodies from selected POMs, which retained the binding characteristics despite their low molecular mass. The POM collection, thus, represents a unique set of reagents allowing for studies with a variety of techniques, including western blotting, ELISA, immunoprecipitation, conformation-dependent immunoassays, and plasmon surface plasmon resonance-based assays.	[Polymenidou, Magdalini; Moos, Rita; Sigurdson, Christina; Aguzzi, Adriano] Univ Hosp Zurich, Inst Neuropathol, Zurich, Switzerland; [Scott, Mike] Univ Zurich, ETH, Funct Genom Ctr Zurich, CH-8006 Zurich, Switzerland; [Yajima, Bill; Garen, Graciela; Kav, Nat] Univ Alberta, Dept Agr, Food & Nutr Sci, Edmonton, AB T6G 2M7, Canada; [Garen, Graciela; James, Michael N. G.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2M7, Canada; [Shi, Yong-zhong] Alberta Res Council, Edmonton, AB, Canada; [Hafner-Bratkovic, Iva; Jerala, Roman] Univ Ljubljana, Natl Inst Chem, Dept Biotechnol, Ljubljana 61000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 61000, Slovenia; [Hornemann, Simone; Wuthrich, Kurt] Swiss Fed Inst Technol, Inst Molekularbiol & Biophys, Zurich, Switzerland; [Wuthrich, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA USA; [Bellon, Anne; Vey, Martin] ZLB Behring, Marburg, Germany	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Alberta; University of Alberta; Alberta Innovates; National Institute of Chemistry - Slovenia; University of Ljubljana; University of Ljubljana; Swiss Federal Institutes of Technology Domain; ETH Zurich; Scripps Research Institute	Polymenidou, M (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	adriano.aguzzi@usz.ch	Polymenidou, Magdalini/D-2254-2014; Aguzzi, Adriano/A-3351-2008; Jerala, Roman/H-9850-2015	Jerala, Roman/0000-0002-6337-5251; Aguzzi, Adriano/0000-0002-0344-6708	Bundesamt fur Bildung und Wissenschaft; Ernst-Jung-Foundation; Stammbach foundation; European Union; Swiss National Science Foundation; NCCR; ETH Zurich; University of Zurich [career development award]; Alberta Prion Research Institute; Slovenian Research Agency	Bundesamt fur Bildung und Wissenschaft; Ernst-Jung-Foundation; Stammbach foundation; European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich); University of Zurich; Alberta Prion Research Institute; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants of the Bundesamt fur Bildung und Wissenschaft (AA), the Ernst-Jung-Foundation (AA), the Stammbach foundation (AA), the European Union (ImmunoPrion and TSEUR to AA and UPMAN to KW), the Swiss National Science Foundation (AA), the NCCR on Neural Plasticity and Repair (AA) and of Structural Biology (KW), the ETH Zurich (KW), and a career development award of the University of Zurich (MP). Financial assistance from the Alberta Prion Research Institute (NK and AA) is gratefully acknowledged. IHB and RJ are supported by grants from the Slovenian Research Agency.	BARRY RA, 1986, J INFECT DIS, V154, P518, DOI 10.1093/infdis/154.3.518; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Burmester J, 2001, J MOL BIOL, V309, P671, DOI 10.1006/jmbi.2001.4663; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Krasemann S, 1999, J BIOTECHNOL, V73, P119, DOI 10.1016/S0168-1656(99)00115-7; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Neri D, 1997, NAT BIOTECHNOL, V15, P1271, DOI 10.1038/nbt1197-1271; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; ROGERS M, 1991, J IMMUNOL, V147, P3568; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; WESTAWAY D, 1986, NUCLEIC ACIDS RES, V14, P2035, DOI 10.1093/nar/14.5.2035; Williamson RA, 1996, P NATL ACAD SCI USA, V93, P7279, DOI 10.1073/pnas.93.14.7279; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	27	135	137	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2008	3	12							e3872	10.1371/journal.pone.0003872	http://dx.doi.org/10.1371/journal.pone.0003872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZO	19060956	Green Published, gold, Green Accepted			2022-12-25	WOS:000265455100002
J	Wimberly, MC; Hildreth, MB; Boyte, SP; Lindquist, E; Kightlinger, L				Wimberly, Michael C.; Hildreth, Michael B.; Boyte, Stephen P.; Lindquist, Erik; Kightlinger, Lon			Ecological Niche of the 2003 West Nile Virus Epidemic in the Northern Great Plains of the United States	PLOS ONE			English	Article								Background: The incidence of West Nile virus(WNv) has remained high in the northern Great Plains compared to the rest of the United States. However, the reasons for the sustained high risk of WNv transmission in the regions have not been determined. To assess the environmental drivers of WNv in the northern Great Plains, we analyzed the county-level spatial pattern of human cases during the 2003 epidemic across a seven-state region. Methodology/Principal Findings: County-level data on WNv cases were examined using spatial cluster analysis, and were used to fit statistical models with weather, climate, and land use variables as predictors. In 2003 there was a single large cluster of elevated WNv risk encompassing North Dakota, South Dakota, and Nebraska along with portions of eastern Montana and Wyoming. The relative risk of WNv remained high within the boundaries of this cluster from 2004-2007. WNv incidence during the 2003 epidemic was found to have a stronger relationship with long-term climate patterns than with annual weather in either 2002 or 2003. WNv incidence increased with May-July temperature and had a unimodal relationship with total May-July precipitation. WNv incidence also increased with the percentage of irrigated cropland and with the percentage of the human population living in rural areas. Conclusion/Significance: The spatial pattern of WNv cases during the 2003 epidemic in the northern Great Plains was associated with both climatic gradients and land use patterns. These results were interpreted as evidence that environmental conditions across much of the northern Great Plains created a favorable ecological niche for Culex tarsalis, a particularly efficient vector of WNv. Further research is needed to determine the proximal causes of sustained WNv transmission and to enhance strategies for disease prevention.	[Wimberly, Michael C.; Boyte, Stephen P.; Lindquist, Erik] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA; [Hildreth, Michael B.] S Dakota State Univ, Dept Biol, Brookings, SD USA; [Kightlinger, Lon] S Dakota Dept Hlth, Pierre, SD USA	South Dakota State University; South Dakota State University	Wimberly, MC (corresponding author), S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA.	michael.wimberly@sdstate.edu		Boyte, Stephen/0000-0002-5462-3225; Wimberly, Michael/0000-0003-1549-3891	South Dakota State University; National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01-AI079411]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079411] Funding Source: NIH RePORTER	South Dakota State University; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this research was provided by South Dakota State University. This study was supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (grant R01-AI079411 to MCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bell JA, 2005, VECTOR-BORNE ZOONOT, V5, P373, DOI 10.1089/vbz.2005.5.373; Bell JA, 2006, EMERG INFECT DIS, V12, P1245, DOI 10.3201/eid1708.060129; Bolling BG, 2005, J VECTOR ECOL, V30, P186; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; Cleveland W.S., 1993, STAT METHODS S, P309; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; DALY G, 2004, AMS C APPL CLIM 84 A; DeGroote John P, 2008, Int J Health Geogr, V7, P19, DOI 10.1186/1476-072X-7-19; Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283; Eisen L, 2007, EMERG INFECT DIS, V13, P1816, DOI 10.3201/eid1312.070211; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P73, DOI 10.1089/vbz.2006.6.73; Gomez A, 2008, EMERG INFECT DIS, V14, P962, DOI 10.3201/eid1406.070352; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; KULLDORF M, 2006, SATSCAN V7 0 3 SOFTW; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kunkel KE, 2006, AM J TROP MED HYG, V74, P168, DOI 10.4269/ajtmh.2006.74.168; Landesman WJ, 2007, VECTOR-BORNE ZOONOT, V7, P337, DOI 10.1089/vbz.2006.0590; Lawson A. B., 2003, DIS MAPPING WINBUGS; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lindsey NP, 2008, VECTOR-BORNE ZOONOT, V8, P35, DOI 10.1089/vbz.2007.0137; LUNGSTROM LEON, 1954, TRANS KANSAS ACAD SCI, V57, P86, DOI 10.2307/3625649; Miramontes R, 2006, AM J PREV MED, V30, P160, DOI 10.1016/j.amepre.2005.10.008; Nielsen CF, 2008, AM J TROP MED HYG, V78, P53, DOI 10.4269/ajtmh.2008.78.53; Pecoraro HL, 2007, J VECTOR ECOL, V32, P22, DOI 10.3376/1081-1710(2007)32[22:CALCFP]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Ruiz Marilyn O, 2004, Int J Health Geogr, V3, P8, DOI 10.1186/1476-072X-3-8; SPIEGELHALTER D, 2004, WINBUGS USERS MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Takeda T, 2003, J AM MOSQUITO CONTR, V19, P179; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Waller L.A., 2004, APPL SPATIAL STAT PU; Wimberly MC, 2008, GLOBAL ECOL BIOGEOGR, V17, P189, DOI 10.1111/j.1466-8238.2007.00353.x; Wimberly MC, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-15; Yiannakoulias NW, 2007, ANN NY ACAD SCI, V1102, P135, DOI 10.1196/annals.1408.010; Zou L, 2006, J MED ENTOMOL, V43, P1034, DOI 10.1603/0022-2585(2006)43[1034:MLHMUR]2.0.CO;2	41	48	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2008	3	12							e3744	10.1371/journal.pone.0003744	http://dx.doi.org/10.1371/journal.pone.0003744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YP	19057643	Green Published, gold			2022-12-25	WOS:000265452300001
J	Albrecht-Buehler, G				Albrecht-Buehler, Guenter			Properties and Distribution of Pure GA-Sequences of Mammalian Genomes	PLOS ONE			English	Article							BINDING; ACTIVATION; DNA	The article describes DNA sequences of mammalian genomes that are longer than 50 bases, but consist exclusively of G's and A's ('pure GA-sequences'). Although their frequency of incidence should be 10 216 or smaller, the chromosomes of human, chimpanzee, dog, cat, rat, and mouse contained many tens of thousands of them ubiquitously located along the chromosomes with a species-dependent density, reaching sizes of up to 1300 [b]. With the exception of a small number of poly-A-, poly-G-, poly-GA-, and poly-GAAA-sequences (combined <0.5%), all pure GA-sequences of the mammals tested were unique individuals, contained several repeated short GA-containing motifs, and shared a common hexa-nucleotide spectrum. At most 2% of the human GA-sequences were transcribed into mRNAs; all others were not coding for proteins. Although this could have made them less subject to natural selection, they contained 160 times fewer point mutations than one should expect from the genome at large. As to the presence of other sequences with similarly restricted base contents, there were approximately as many pure TC-sequences as pure GA-sequences, but many fewer pure AC-, TA, and TG-sequences. There were practically no pure GC-sequences. The functions of pure GA-sequences are not known. Supported by a number of observations related to heat shock phenomena, the article speculates that they serve as genomic sign posts which may help guide polymerases and transcription factors to their proper targets, and/or as spatial linkers that help generate the 3-dimensional organization of chromatin.	[Albrecht-Buehler, Guenter] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Albrecht-Buehler, G (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	g-buehler@northwestern.edu			Robert Laughlin Rea endowed Chair	Robert Laughlin Rea endowed Chair	The work was supported by the Robert Laughlin Rea endowed Chair held by the author. Funds from the Chair provided part of the author's salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht-Buehler G, 2007, GENOMICS, V89, P596, DOI 10.1016/j.ygeno.2006.12.009; Albrecht-Buehler G, 2006, P NATL ACAD SCI USA, V103, P17828, DOI 10.1073/pnas.0605553103; ALBRECHTBUEHLER G, 2009, BIOESSAYS IN PRESS; CALLADINE CR, 1982, J MOL BIOL, V161, P343, DOI 10.1016/0022-2836(82)90157-7; Jolly C, 2002, J CELL BIOL, V156, P775, DOI 10.1083/jcb.200109018; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; LU Q, 1993, MOL CELL BIOL, V13, P2802, DOI 10.1128/MCB.13.5.2802; Luchowski R, 2005, CHEM PHYS, V314, P309, DOI 10.1016/j.chemphys.2005.03.012; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Saenger W., 1984, PRINCIPLES NUCLEIC A, P253; Wilkins RC, 1998, NUCLEIC ACIDS RES, V26, P2672, DOI 10.1093/nar/26.11.2672; PARETO DISTRIBUTION	14	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3818	10.1371/journal.pone.0003818	http://dx.doi.org/10.1371/journal.pone.0003818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043592	Green Published, gold, Green Submitted			2022-12-25	WOS:000265451500003
J	Edwards, AO; Fridley, BL; James, KM; Sharma, AS; Cunningham, JM; Tosakulwong, N				Edwards, Albert O.; Fridley, Brooke L.; James, Katherine M.; Sharma, Anil S.; Cunningham, Julie M.; Tosakulwong, Nirubol			Evaluation of Clustering and Genotype Distribution for Replication in Genome Wide Association Studies: The Age-Related Eye Disease Study	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; MACULAR DEGENERATION; SUSCEPTIBILITY GENES; RISK; VARIANT; POLYMORPHISMS; HAPLOTYPES; LOC387715; ALLOTYPES; TESTS	Genome-wide association studies (GWASs) assess correlation between traits and DNA sequence variation using large numbers of genetic variants such as single nucleotide polymorphisms (SNPs) distributed across the genome. A GWAS produces many trait-SNP associations with low p-values, but few are replicated in subsequent studies. We sought to determine if characteristics of the genomic loci associated with a trait could be used to identify initial associations with a higher chance of replication in a second cohort. Data from the age-related eye disease study (AREDS) of 100,000 SNPs on 395 subjects with and 198 without age-related macular degeneration (AMD) were employed. Loci highly associated with AMD were characterized based on the distribution of genotypes, level of significance, and clustering of adjacent SNPs also associated with AMD suggesting linkage disequilibrium or multiple effects. Forty nine loci were highly associated with AMD, including 3 loci (CFH, C2/BF, LOC387715/HTRA1) already known to contain important genetic risks for AMD. One additional locus (C3) reported during the course of this study was identified and replicated in an additional study group. Tag-SNPs and haplotypes for each locus were evaluated for association with AMD in additional cohorts to account for population differences between discovery and replication subjects, but no additional clearly significant associations were identified. Relying on a significant genotype tests using a log-additive model would have excluded 57% of the non-replicated and none of the replicated loci, while use of other SNP features and clustering might have missed true associations.	[Edwards, Albert O.; James, Katherine M.; Sharma, Anil S.; Tosakulwong, Nirubol] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA; [Fridley, Brooke L.] Mayo Clin, Div Biostat, Rochester, MN USA; [Cunningham, Julie M.] Mayo Clin, Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Edwards, AO (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	edwardslab@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956; Sharma, Anil/0000-0002-4471-7172	Foundation Fighting Blindness, Owing Mills, MD; American Health Assistance Foundation, Clarksburg, MD; Research to Prevent Blindness, New York, NY; Mayo Clinic Foundation;  [EY014467]; NATIONAL EYE INSTITUTE [R01EY014467] Funding Source: NIH RePORTER	Foundation Fighting Blindness, Owing Mills, MD; American Health Assistance Foundation, Clarksburg, MD; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Mayo Clinic Foundation; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by EY014467, the Foundation Fighting Blindness, Owing Mills, MD, the American Health Assistance Foundation, Clarksburg, MD, unrestricted departmental grants from Research to Prevent Blindness, New York, NY, and the Mayo Clinic Foundation. The sponsors had no role in the design or conduct of the study.	Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Conti DV, 2003, HUM HERED, V56, P83, DOI 10.1159/000073736; Edwards AO, 2008, INVEST OPHTH VIS SCI, V49, P1652, DOI 10.1167/iovs.07-1378; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; EDWARDS AO, 2007, ANGIOGENESI IN PRESS; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; FINN JE, 1993, CLIN EXP IMMUNOL, V91, P410; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; HAGEMAN GS, 2005, P NATL ACAD SCI US; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Messias-Reason IJ, 2003, TISSUE ANTIGENS, V62, P308, DOI 10.1034/j.1399-0039.2003.00101.x; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Slager SL, 2007, BRIT J HAEMATOL, V139, P762, DOI 10.1111/j.1365-2141.2007.06872.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teo YY, 2008, CURR OPIN LIPIDOL, V19, P133, DOI 10.1097/MOL.0b013e3282f5dd77; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zhang H, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-51; ARCH OPHTHALMOL, V119, P1417; NATURE, V447, P661	36	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3813	10.1371/journal.pone.0003813	http://dx.doi.org/10.1371/journal.pone.0003813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043567	Green Published, gold, Green Submitted			2022-12-25	WOS:000265451400005
J	Jiang, SG; Bailey, AS; Goldman, DC; Swain, JR; Wong, MH; Streeter, PR; Fleming, WH				Jiang, Shuguang; Bailey, Alexis S.; Goldman, Devorah C.; Swain, John R.; Wong, Melissa H.; Streeter, Philip R.; Fleming, William H.			Hematopoietic Stem Cells Contribute to Lymphatic Endothelium	PLOS ONE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; MARROW-DERIVED CELLS; TUMOR ANGIOGENESIS; PROGENITOR CELLS; VASCULAR ENDOTHELIUM; VESSEL FORMATION; PERICYTE PROGENITORS; PRECURSOR CELLS; MYELOID CELLS; IN-VIVO	Background: Although the lymphatic system arises as an extension of venous vessels in the embryo, little is known about the role of circulating progenitors in the maintenance or development of lymphatic endothelium. Here, we investigated whether hematopoietic stem cells (HSCs) have the potential to give rise to lymphatic endothelial cells (LEC). Methodology/Principal Findings: Following the transfer of marked HSCs into irradiated recipients, donor-derived LEC that co-express the lymphatic endothelial markers Lyve-1 and VEGFR-3 were identified in several tissues. HSC-derived LEC persisted for more than 12 months and contributed to similar to 3-4% of lymphatic vessels. Donor-derived LECs were not detected in mice transplanted with common myeloid progenitors and granulocyte/ macrophage progenitors, suggesting that myeloid lineage commitment is not a requisite step in HSC contribution to lymphatic endothelium. Analysis of parabiotic mice revealed direct evidence for the existence of functional, circulating lymphatic progenitors in the absence of acute injury. Furthermore, the transplantation of HSCs into Apc(Min/+) mice resulted in the incorporation of donor-derived LEC into the lymphatic vessels of spontaneously arising intestinal tumors. Conclusions/Significance: Our results indicate that HSCs can contribute to normal and tumor associated lymphatic endothelium. These findings suggest that the modification of HSCs may be a novel approach for targeting tumor metastasis and attenuating diseases of the lymphatic system.	[Jiang, Shuguang; Bailey, Alexis S.; Goldman, Devorah C.; Streeter, Philip R.; Fleming, William H.] Oregon Hlth & Sci Univ, Dept Med, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Swain, John R.; Wong, Melissa H.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA; [Jiang, Shuguang; Bailey, Alexis S.; Goldman, Devorah C.; Swain, John R.; Wong, Melissa H.; Streeter, Philip R.; Fleming, William H.] Oregon Hlth & Sci Univ, Oregon Canc Inst, Oregon Stem Cell Ctr, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Jiang, SG (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Hematol & Med Oncol, Portland, OR 97201 USA.	flemingw@ohsu.edu			NIH [HL077818, HL069133, CA118235]; NATIONAL CANCER INSTITUTE [R01CA118235] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077818, R01HL069133] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants HL077818 and HL069133 (WHF) and CA118235 (MHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Achen MG, 2006, INT J CANCER, V119, P1755, DOI 10.1002/ijc.21899; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Bailey AS, 2004, BLOOD, V103, P13, DOI 10.1182/blood-2003-05-1684; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Crosby JR, 2000, CIRC RES, V87, P728, DOI 10.1161/01.RES.87.9.728; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Dudas J, 2004, ANAT EMBRYOL, V208, P359, DOI 10.1007/s00429-004-0403-4; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; He YL, 2004, CANCER RES, V64, P3737, DOI 10.1158/0008-5472.CAN-04-0088; Ji RC, 2007, CURR MED CHEM, V14, P2359, DOI 10.2174/092986707781745541; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Larrivee B, 2005, J IMMUNOL, V175, P2890, DOI 10.4049/jimmunol.175.5.2890; Liersch R, 2007, THROMB HAEMOSTASIS, V98, P304, DOI 10.1160/TH07-04-0238; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Montfort MJ, 2002, EXP HEMATOL, V30, P950, DOI 10.1016/S0301-472X(02)00813-5; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Ribatti D, 2007, LEUKEMIA RES, V31, P439, DOI 10.1016/j.leukres.2006.10.014; Roy HK, 2005, CANCER EPIDEM BIOMAR, V14, P1639, DOI 10.1158/1055-9965.EPI-04-0837; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Shojaei F, 2008, TRENDS CELL BIOL, V18, P372, DOI 10.1016/j.tcb.2008.06.003; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Sundar SS, 2007, J CLIN ONCOL, V25, P4298, DOI 10.1200/JCO.2006.07.1092; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	46	52	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2008	3	11							e3812	10.1371/journal.pone.0003812	http://dx.doi.org/10.1371/journal.pone.0003812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YG	19043576	Green Submitted, Green Published, gold			2022-12-25	WOS:000265451400004
J	Leal, WS; Ishida, Y				Leal, Walter S.; Ishida, Yuko			GP-9s Are Ubiquitous Proteins Unlikely Involved in Olfactory Mediation of Social Organization in the Red Imported Fire Ant, Solenopsis invicta	PLOS ONE			English	Article								The red imported fire ant (RIFA), Solenopsis invicta, is an invasive species, accidentally introduced in the United States that can cause painful (sometimes life-threatening) stings to human, pets, and livestock. Their colonies have two social forms: monogyne and polygyne that have a single and multiple functional queens, respectively. A major gene (Gp-9), identified as a putative pheromone-binding protein on the basis of a modest amino acid sequence identity, has been suggested to influence the expression of colony social organization. Monogyne queens are reported to possess only the GP-9B alleles, whereas polygyne queens possess both GP-9B and GP-9b. Thus, both social forms are reported to express GP-9B, with GP-9b being a marker expressed in polygynes but it is absent in monogynes. Here, we report two types of polygyne colonies, one that does not express GP-9b (monogyne-like) and the other expressing both proteins, GP-9B and GP-9b. Given their expression pattern, GP-9s are hemolymph proteins, which are more likely to be involved in the transport of lipids and small ligands within the homocoel. GP-9B existed in two forms, one of them is phosphorylated. The helical-rich content of the protein resembles the secondary structures of a beetle hemolymph protein and moth pheromone-binding proteins. An olfactory role is unlikely given the lack of specific expression in the sensillar lymph. In marked contrast to GP-9s, a chemosensory protein, SinvCSP, is demonstrated to be specifically expressed in the antennae. Within the antennae, expression of SinvCSP is restricted to the last two segments, which are known to house olfactory sensilla.	[Leal, Walter S.; Ishida, Yuko] Univ Calif Davis, Dept Entomol, Honorary Maeda Duffey Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Leal, WS (corresponding author), Univ Calif Davis, Dept Entomol, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240	National Institutes of Health [1U01AI05826-01]; Bedoukian Research Inc; National Research Initiative of the U.S. Department of Agriculture [2003-35302-13648]; National Science Foundation [0234769]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bedoukian Research Inc; National Research Initiative of the U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the National Institutes of Health (1U01AI05826-01), a research agreement with Bedoukian Research Inc., the National Research Initiative of the U.S. Department of Agriculture (USDA-CSREES 2003-35302-13648) and National Science Foundation (0234769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FLETCHER DJC, 1983, SCIENCE, V219, P312, DOI 10.1126/science.219.4582.312; Gotzek D, 2008, J INSECT BEHAV, V21, P337, DOI 10.1007/s10905-008-9130-7; Ishida Y, 2002, NATURWISSENSCHAFTEN, V89, P505, DOI 10.1007/s00114-002-0368-1; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Leal Walter S., 2003, P447, DOI 10.1016/B978-012107151-6/50017-7; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; LENNARTZ FE, 1973, THESIS U FLORIDA GAI; Renthal R, 2003, MICRON, V34, P405, DOI 10.1016/S0968-4328(03)00050-7; Ross KG, 1997, GENETICS, V145, P961; Rothemund S, 1999, STRUCT FOLD DES, V7, P1325, DOI 10.1016/S0969-2126(00)80022-2; Rothemund S, 1997, BIOCHEMISTRY-US, V36, P13791, DOI 10.1021/bi971529k; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; SHOEMAKER DD, 1992, HEREDITY, V69, P573, DOI 10.1038/hdy.1992.173; Steinbrecht Rudolf Alexander, 1999, P155; Taber SW, 2000, FIRE ANTS; Vander Meer RK, 2002, BEHAV ECOL SOCIOBIOL, V51, P122, DOI 10.1007/s002650100417; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950	17	25	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3762	10.1371/journal.pone.0003762	http://dx.doi.org/10.1371/journal.pone.0003762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018280	Green Submitted, Green Published, gold			2022-12-25	WOS:000265448500009
J	Mourier, T; Willerslev, E				Mourier, Tobias; Willerslev, Eske			Does Selection against Transcriptional Interference Shape Retroelement-Free Regions in Mammalian Genomes?	PLOS ONE			English	Article							TRANSPOSON-FREE REGIONS; L1 RETROTRANSPOSITION; EMBRYONIC-DEVELOPMENT; ANTISENSE PROMOTER; HOX GENES; ELEMENTS; EXPRESSION; MECHANISM; BROWSER; REPEATS	Background: Eukaryotic genomes are scattered with retroelements that proliferate through retrotransposition. Although retroelements make up around 40 percent of the human genome, large regions are found to be completely devoid of retroelements. This has been hypothesised to be a result of genomic regions being intolerant to insertions of retroelements. The inadvertent transcriptional activity of retroelements may affect neighbouring genes, which in turn could be detrimental to an organism. We speculate that such retroelement transcription, or transcriptional interference, is a contributing factor in generating and maintaining retroelement-free regions in the human genome. Methodology/Principal Findings: Based on the known transcriptional properties of retroelements, we expect long interspersed elements (LINEs) to be able to display a high degree of transcriptional interference. In contrast, we expect short interspersed elements (SINEs) to display very low levels of transcriptional interference. We find that genomic regions devoid of long interspersed elements (LINEs) are enriched for protein-coding genes, but that this is not the case for regions devoid of short interspersed elements (SINEs). This is expected if genes are subject to selection against transcriptional interference. We do not find microRNAs to be associated with genomic regions devoid of either SINEs or LINEs. We further observe an increased relative activity of genes overlapping LINE-free regions during early embryogenesis, where activity of LINEs has been identified previously. Conclusions/Significance: Our observations are consistent with the notion that selection against transcriptional interference has contributed to the maintenance and/or generation of retroelement-free regions in the human genome.	[Mourier, Tobias; Willerslev, Eske] Univ Copenhagen, Dept Biol, Ancient DNA & Evolut Grp, Copenhagen, Denmark	University of Copenhagen	Mourier, T (corresponding author), Univ Copenhagen, Dept Biol, Ancient DNA & Evolut Grp, Copenhagen, Denmark.	tmourier@bi.ku.dk	Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Mourier, Tobias/C-1164-2015	Willerslev, Eske/0000-0002-7081-6748; Mourier, Tobias/0000-0003-2727-1903	Lundbeck Foundation; Villum Kann Rasmussen Foundation; Danish Natural Science Research Council; Danish National Research Foundation	Lundbeck Foundation(Lundbeckfonden); Villum Kann Rasmussen Foundation(Villum Fonden); Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond)	TM is supported by a grant from the Lundbeck Foundation. Work at the Ancient DNA and Evolution group is funded by the Villum Kann Rasmussen Foundation, the Danish Natural Science Research Council and the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipova I, 2000, P NATL ACAD SCI USA, V97, P14473, DOI 10.1073/pnas.97.26.14473; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; CHESNOKOV IN, 1995, J BIOL CHEM, V270, P18539, DOI 10.1074/jbc.270.31.18539; CHU WM, 1995, NUCLEIC ACIDS RES, V23, P1750, DOI 10.1093/nar/23.10.1750; Conte C, 2002, EMBO J, V21, P3908, DOI 10.1093/emboj/cdf367; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Eppig Janan T, 2007, Toxicol Pathol, V35, P456, DOI 10.1080/01926230701310536; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Evsikov AV, 2004, CYTOGENET GENOME RES, V105, P240, DOI 10.1159/000078195; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Medstrand P, 2005, CYTOGENET GENOME RES, V110, P342, DOI 10.1159/000084966; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; Meunier J, 2005, P NATL ACAD SCI USA, V102, P5471, DOI 10.1073/pnas.0408986102; Morgan R, 2006, TRENDS GENET, V22, P67, DOI 10.1016/j.tig.2005.11.004; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Pittoggi C, 2003, MOL REPROD DEV, V66, P225, DOI 10.1002/mrd.10349; Poethig RS, 2006, COLD SPRING HARB SYM, V71, P165, DOI 10.1101/sqb.2006.71.030; Prak ETL, 2003, P NATL ACAD SCI USA, V100, P1832, DOI 10.1073/pnas.0337627100; Rizzon C, 2002, GENOME RES, V12, P400, DOI 10.1101/gr.210802; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; Simons C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-470; Sironi M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r120; Smit A, 1996, REPEATMASKER OPEN 30; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Szucsik JC, 1997, DEV BIOL, V191, P230, DOI 10.1006/dbio.1997.8733; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Tribioli C, 1999, DEVELOPMENT, V126, P5699; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	52	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3760	10.1371/journal.pone.0003760	http://dx.doi.org/10.1371/journal.pone.0003760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	19018283	Green Submitted, Green Published, gold			2022-12-25	WOS:000265448500007
J	Hong, SK; Dawid, IB				Hong, Sung-Kook; Dawid, Igor B.			Alpha2 Macroglobulin-Like Is Essential for Liver Development in Zebrafish	PLOS ONE			English	Article							BETA-AMYLOID PEPTIDE; ENDODERM FORMATION; GENE-EXPRESSION; ALPHA(2)-MACROGLOBULIN; ALPHA-2-MACROGLOBULIN; PROTEIN; DOMAIN; DIFFERENTIATION	Background: Alpha 2 Macroglobulin family members have been studied extensively with respect to their roles in physiology and human disease including innate immunity and Alzheimer's disease, but little is known about a possible role in liver development loss-of-function in model systems. Principal Findings: We report the isolation of the zebrafish alpha 2 macroglobulin-like (A2ML) gene and its specific expression in the liver during differentiation. Morpholino-based knock-down of A2ML did not block the initial formation of the liver primordium, but inhibited liver growth and differentiation. Significance: This report on A2ML function in zebrafish development provides the first evidence for a specific role of an A2M family gene in liver formation during early embryogenesis in a vertebrate.	[Hong, Sung-Kook; Dawid, Igor B.] Eunice Kennedy Shriver NICHHD, Mol Genet Lab, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hong, SK (corresponding author), Eunice Kennedy Shriver NICHHD, Mol Genet Lab, NIH, Bethesda, MD USA.	idawid@nih.gov			NICHD, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008809] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008809] Funding Source: NIH RePORTER	NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the NICHD, NIH.	Armstrong PB, 2006, IMMUNOBIOLOGY, V211, P263, DOI 10.1016/j.imbio.2006.01.002; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Du YS, 1997, J NEUROCHEM, V69, P299; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Galliano MF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002729; Galliano MF, 2006, J BIOL CHEM, V281, P5780, DOI 10.1074/jbc.M508017200; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Ho CY, 1999, CURR BIOL, V9, P1131, DOI 10.1016/S0960-9822(99)80485-0; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Huang W, 2000, J BIOL CHEM, V275, P1089, DOI 10.1074/jbc.275.2.1089; Kawahara A, 2000, GENESIS, V28, P58, DOI 10.1002/1526-968X(200010)28:2<58::AID-GENE30>3.0.CO;2-N; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Manfroid I, 2007, DEVELOPMENT, V134, P4011, DOI 10.1242/dev.007823; Melby AE, 2000, DEV BIOL, V224, P275, DOI 10.1006/dbio.2000.9780; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Narita M, 1997, J NEUROCHEM, V69, P1904; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Pack M, 1996, DEVELOPMENT, V123, P321; Pineda-Salgado L, 2005, GENE EXPR PATTERNS, V6, P3, DOI 10.1016/j.modgep.2005.09.001; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Tayade C, 2005, MOL CELL ENDOCRINOL, V245, P60, DOI 10.1016/j.mce.2005.10.004; Umans L, 1999, AM J PATHOL, V155, P983, DOI 10.1016/S0002-9440(10)65198-X; UMANS L, 1995, J BIOL CHEM, V270, P19778, DOI 10.1074/jbc.270.34.19778; VANLEUVEN F, 1988, J BIOL CHEM, V263, P468; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009	33	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2008	3	11							e3736	10.1371/journal.pone.0003736	http://dx.doi.org/10.1371/journal.pone.0003736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XB	19011686	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448300004
J	Stone, SJ; Levin, MC; Zhou, P; Han, JY; Walther, TC; Farese, RV				Stone, Scot J.; Levin, Malin C.; Zhou, Ping; Han, Jiayi; Walther, Tobias C.; Farese, Robert V., Jr.			The Endoplasmic Reticulum Enzyme DGAT2 Is Found in Mitochondria-associated Membranes and Has a Mitochondrial Targeting Signal That Promotes Its Association with Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE ACTIVITY; RED FLUORESCENT PROTEIN; RAT-LIVER; TRIACYLGLYCEROL SYNTHESIS; LIPID DROPLETS; ACYL-COA; SACCHAROMYCES-CEREVISIAE; CONTACT SITES; MONOMERIC RED; BIOSYNTHESIS	The synthesis and storage of neutral lipids in lipid droplets is a fundamental property of eukaryotic cells, but the spatial organization of this process is poorly understood. Here we examined the intracellular localization of acyl-CoA: diacylglycerol acyltransferase 2 (DGAT2), an enzyme that catalyzes the final step of triacylglycerol (TG) synthesis in eukaryotes. We found that DGAT2 expressed in cultured cells localizes to the endoplasmic reticulum (ER) under basal conditions. After providing oleate to drive TG synthesis, DGAT2 also localized to near the surface of lipid droplets, where it co-localized with mitochondria. Biochemical fractionation revealed that DGAT2 is present in mitochondria-associated membranes, specialized domains of the ER that are highly enriched in lipid synthetic enzymes and interact tightly with mitochondria. The interaction of DGAT2 with mitochondria depended on 67 N-terminal amino acids of DGAT2, which are not conserved in family members that have different catalytic functions. This targeting signal was sufficient to localize a red fluorescent protein to mitochondria. A highly conserved, positively charged, putative mitochondrial targeting signal was identified in murine DGAT2 between amino acids 61 and 66. Thus, DGAT2, an ER-resident transmembrane domain-containing enzyme, is also found in mitochondria-associated membranes, where its N terminus may promote its association with mitochondria.	[Stone, Scot J.; Han, Jiayi] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Levin, Malin C.; Zhou, Ping; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Levin, Malin C.; Farese, Robert V., Jr.] Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Walther, Tobias C.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	University of Saskatchewan; University of California System; University of California San Francisco; The J David Gladstone Institutes; Max Planck Society; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Farese, RV (corresponding author), J David Gladstone Inst, 1650 Owens St, San Francisco, CA 94158 USA.	bfarese@gladstone.ucsf.edu		Levin, Malin/0000-0003-1069-5275; Walther, Tobias/0000-0003-1442-1327	National Institutes of Health [5R01-DK065599]; American Heart Association scientist development grant; Hillblom postdoctoral fellowship;  [CO6RR018928]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association scientist development grant(American Heart Association); Hillblom postdoctoral fellowship; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01-DK065599 ( to R. V. F.). This work was also supported by an American Heart Association scientist development grant ( to S. S.), a Hillblom postdoctoral fellowship ( to M. L.), and the J. David Gladstone Institutes and National Institutes of Health/NCRR Grant CO6RR018928 to the J. David Gladstone Institutes.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ANDERSSON M, 1994, J LIPID RES, V35, P535; ARDAIL D, 1993, J BIOL CHEM, V268, P25985; ARDAIL D, 1991, J BIOL CHEM, V266, P7978; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brindley D. N, 1991, BIOCH LIPIDS LIPOPRO, P171; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; COLEMAN R, 1976, J BIOL CHEM, V251, P4537; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; CUI Z, 1993, J BIOL CHEM, V268, P16655; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; GUNSTONE FD, 1994, LIPID HDB, P646; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; STEMBERGER BH, 1984, CELL TISSUE RES, V236, P471, DOI 10.1007/BF00214252; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Sturmey RG, 2006, REPRODUCTION, V132, P829, DOI 10.1530/REP-06-0073; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wakimoto K, 2003, BIOCHEM BIOPH RES CO, V310, P296, DOI 10.1016/j.bbrc.2003.09.015; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; WILGRAM GF, 1963, J BIOL CHEM, V238, P2615; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200	55	254	263	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5352	5361		10.1074/jbc.M805768200	http://dx.doi.org/10.1074/jbc.M805768200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19049983	Green Published, hybrid			2022-12-25	WOS:000263416600065
J	Frost, B; Ollesch, J; Wille, H; Diamond, MI				Frost, Bess; Ollesch, Julian; Wille, Holger; Diamond, Marc I.			Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE PRION PROTEIN; MUTANT-TAU; PEPTIDES; DEMENTIA; POLYMERIZATION; PROPAGATION; PHENOTYPES; FILAMENTS; ISOFORMS; FTDP-17	Tauopathies are sporadic and genetic neurodegenerative diseases characterized by aggregation of the microtubule-associated protein Tau. Tau pathology occurs in over 20 phenotypically distinct neurodegenerative diseases, including Alzheimer disease and frontotemporal dementia. The molecular basis of this diversity among sporadic tauopathies is unknown, but distinct fibrillar wild-type (WT) Tau conformations could play a role. Using Fourier transform infrared spectroscopy, circular dichroism, and electron microscopy, we show that WT Tau fibrils and P301L/V337M Tau fibrils have distinct secondary structures, fragilities, and morphologies. Furthermore, P301L/V337M fibrillar seeds induce WT Tau monomer to form a novel fibrillar conformation, termed WT*, that is maintained over multiple seeding reactions. WT* has secondary structure, fragility, and morphology that are similar to P301L/V337M fibrils and distinct from WT fibrils. WT Tau is thus capable of conformational diversity that arises via templated conformation change, as has been described for amyloid beta, beta(2)-microglobulin, and prion proteins.	[Frost, Bess; Wille, Holger; Diamond, Marc I.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Frost, Bess; Diamond, Marc I.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Frost, Bess; Diamond, Marc I.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [Ollesch, Julian; Wille, Holger; Diamond, Marc I.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Diamond, MI (corresponding author), Univ Calif San Francisco, GH S572B 600 16th St, San Francisco, CA 94143 USA.	marc.diamond@ucsf.edu	Wille, Holger/C-2280-2008	Wille, Holger/0000-0001-5102-8706; Frost, Bess/0000-0002-1212-8138	National Institutes of Health Grant [R01 NS50284-03]; National Institutes of Health Training Grant for Neurodegenerative Diseases; Sandler Family Supporting Foundation; Taube Family Foundation Program in Huntington's Disease Research, and the Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050284] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant for Neurodegenerative Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Supporting Foundation; Taube Family Foundation Program in Huntington's Disease Research, and the Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or part, by National Institutes of Health Grant R01 NS50284-03 from NINDS (to M. I. D.) and a National Institutes of Health Training Grant for Neurodegenerative Diseases (to B. F.). This work was also supported by the Sandler Family Supporting Foundation, the Taube Family Foundation Program in Huntington's Disease Research, and the Muscular Dystrophy Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi R, 2007, J BIOL CHEM, V282, P8978, DOI 10.1074/jbc.M611738200; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Hofmann MW, 2004, P NATL ACAD SCI USA, V101, P14776, DOI 10.1073/pnas.0405175101; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872, DOI 10.1093/jnen/60.9.872; Ollesch J, 2008, EUR BIOPHYS J BIOPHY, V37, P435, DOI 10.1007/s00249-007-0233-4; Ollesch J, 2007, APPL SPECTROSC, V61, P1025, DOI 10.1366/000370207782217680; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wille H, 2007, ARCH BIOCHEM BIOPHYS, V467, P239, DOI 10.1016/j.abb.2007.08.010; WILSON DM, 1995, J BIOL CHEM, V270, P24306, DOI 10.1074/jbc.270.41.24306; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061	25	161	164	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3546	3551		10.1074/jbc.M805627200	http://dx.doi.org/10.1074/jbc.M805627200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19010781	Green Published, hybrid			2022-12-25	WOS:000262872500022
J	Pal, A; Kraetzner, R; Gruene, T; Grapp, M; Schreiber, K; Gronborg, M; Urlaub, H; Becker, S; Asif, AR; Gartner, J; Sheldrick, GM; Steinfeld, R				Pal, Aritra; Kraetzner, Ralph; Gruene, Tim; Grapp, Marcel; Schreiber, Kathrin; Gronborg, Mads; Urlaub, Henning; Becker, Stefan; Asif, Abdul R.; Gaertner, Jutta; Sheldrick, George M.; Steinfeld, Robert			Structure of Tripeptidyl-peptidase I Provides Insight into the Molecular Basis of Late Infantile Neuronal Ceroid Lipofuscinosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; CARBOXYL PROTEINASE; CLN2; AMINOPEPTIDASE; KUMAMOLISIN; INHIBITOR; MUTATIONS; PROTEASE; RAT	Late infantile neuronal ceroid lipofuscinosis, a fatal neurodegenerative disease of childhood, is caused by mutations in the TPP1 gene that encodes tripeptidyl-peptidase I. We show that purified TPP1 requires at least partial glycosylation for in vitro autoprocessing and proteolytic activity. We crystallized the fully glycosylated TPP1 precursor under conditions that implied partial autocatalytic cleavage between the prosegment and the catalytic domain. X-ray crystallographic analysis at 2.35 angstrom resolution reveals a globular structure with a subtilisin-like fold, a Ser(475) -Glu(272) -Asp(360) catalytic triad, and an octahedrally coordinated Ca2+ -binding site that are characteristic features of the S53 sedolisin family of peptidases. In contrast to other S53 peptidases, the TPP1 structure revealed steric constraints on the P4 substrate pocket explaining its preferential cleavage of tripeptides from the unsubstituted N terminus of proteins. Two alternative conformations of the catalytic Asp(276) are associated with the activation status of TPP1. 28 disease-causing missense mutations are analyzed in the light of the TPP1 structure providing insight into the molecular basis of late infantile neuronal ceroid lipofuscinosis.	[Kraetzner, Ralph; Grapp, Marcel; Schreiber, Kathrin; Gaertner, Jutta; Steinfeld, Robert] Univ Gottingen, Dept Pediat & Pediat Neurol, D-37075 Gottingen, Germany; [Pal, Aritra; Gruene, Tim; Sheldrick, George M.] Univ Gottingen, Dept Struct Chem, D-34077 Gottingen, Germany; [Gronborg, Mads; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Becker, Stefan] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Asif, Abdul R.] Univ Gottingen, Dept Clin Chem, Proteom & Mass Spectrometry Facil, D-37075 Gottingen, Germany	University of Gottingen; University of Gottingen; Max Planck Society; Max Planck Society; University of Gottingen	Steinfeld, R (corresponding author), Univ Gottingen, Dept Pediat & Pediat Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany.	rsteinfeld@med.uni-goettingen.de	Asif, Abdul Rahman/G-7924-2011; Asif, Abdul R./A-9432-2016	Asif, Abdul R./0000-0002-8581-3187; Steinfeld, Robert/0000-0003-0956-6601	Fonds der Chemischen Industrie	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; Comellas-Bigler M, 2004, STRUCTURE, V12, P1313, DOI 10.1016/j.str.2004.04.013; Comellas-Bigler M, 2002, STRUCTURE, V10, P865, DOI 10.1016/S0969-2126(02)00772-4; DOEBBER TW, 1978, ENDOCRINOLOGY, V103, P1794, DOI 10.1210/endo-103-5-1794; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezaki J, 2000, BIOCHEM BIOPH RES CO, V268, P904, DOI 10.1006/bbrc.2000.2207; Golabek AA, 2004, J BIOL CHEM, V279, P31058, DOI 10.1074/jbc.M400700200; Golabek AA, 2008, J BIOL CHEM, V283, P16497, DOI 10.1074/jbc.M800458200; GUHANIYOGI J, 2009, J BIOL CHEM IN PRESS, V284; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyama H, 2005, J BIOCHEM, V138, P127, DOI 10.1093/jb/mvi110; Rawlings ND, 1999, BBA-PROTEIN STRUCT M, V1429, P496, DOI 10.1016/S0167-4838(98)00238-6; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sleat DE, 1999, AM J HUM GENET, V64, P1511, DOI 10.1086/302427; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Steinfeld R, 2004, HUM MOL GENET, V13, P2483, DOI 10.1093/hmg/ddh264; Tian Y, 2006, J BIOL CHEM, V281, P6559, DOI 10.1074/jbc.M507336200; Tsiakas K, 2004, GLYCOBIOLOGY, V14, p1C, DOI 10.1093/glycob/cwh054; Vines D, 1998, BBA-PROTEIN STRUCT M, V1384, P233, DOI 10.1016/S0167-4838(98)00012-0; Warburton MJ, 2001, FEBS LETT, V500, P145, DOI 10.1016/S0014-5793(01)02608-4; Wlodawer A, 2004, J BIOL CHEM, V279, P21500, DOI 10.1074/jbc.M401141200; Wlodawer A, 2001, NAT STRUCT BIOL, V8, P442, DOI 10.1038/87610; Wlodawer Alexander, 2003, BMC Struct Biol, V3, P8, DOI 10.1186/1472-6807-3-8; Wujek P, 2004, J BIOL CHEM, V279, P12827, DOI 10.1074/jbc.M313173200	28	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3976	3984		10.1074/jbc.M806947200	http://dx.doi.org/10.1074/jbc.M806947200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19038966	hybrid, Green Published			2022-12-25	WOS:000262872500066
J	Summers, DW; Douglas, PM; Ren, HY; Cyr, DM				Summers, Daniel W.; Douglas, Peter M.; Ren, Hong-Yu; Cyr, Douglas M.			The Type I Hsp40 Ydj1 Utilizes a Farnesyl Moiety and Zinc Finger-like Region to Suppress Prion Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE; CO-CHAPERONE; PEPTIDE SUBSTRATE; CRYSTAL-STRUCTURE; HSP70 CHAPERONES; YEAST HSP40; PIN+ PRION; PROTEIN; DNAJ; BINDING	Type I Hsp40s are molecular chaperones that protect neurons from degeneration by modulating the aggregation state of amyloid-forming proteins. How Type I Hsp40s recognize beta-rich, amyloid-like substrates is currently unknown. Thus, we examined the mechanism for binding between the Type I Hsp40 Ydj1 and the yeast prion [RNQ(+)]. Ydj1 recognized the Gln/Asn-rich prion domain from Rnq1 specifically when it assembled into the amyloid-like [RNQ(+)] prion state. Upon deletion of YDJ1, overexpression of the Rnq1 prion domain killed yeast. Surprisingly, binding and suppression of prion domain toxicity by Ydj1 was dependent upon farnesylation of its C-terminal CAAX box and action of a zinc finger-like region. In contrast, folding of luciferase was independent of farnesylation, yet required the zinc finger-like region of Ydj1 and a conserved hydrophobic peptide-binding pocket. Type I Hsp40s contain at least three different domains that work in concert to bind different protein conformers. The combined action of a farnesyl moiety and zinc finger-like region enable Type I Hsp40s to recognize amyloid-like substrates and prevent formation of cytotoxic protein species.	[Summers, Daniel W.; Douglas, Peter M.; Ren, Hong-Yu; Cyr, Douglas M.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Cyr, DM (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	dmcyr@med.unc.edu		Cyr, Douglas/0000-0002-4928-3414; Summers, Daniel/0000-0001-7228-8849	National Institutes of Health Pre-doctoral Training [5T32GM008581-09, 5R01GM067785-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008581, R01GM067785] Funding Source: NIH RePORTER	National Institutes of Health Pre-doctoral Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Pre-doctoral Training Grant 5T32GM008581-09 (to D. W. S.) and Grant 5R01GM067785-06 (to D. M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aron R, 2007, EMBO J, V26, P3794, DOI 10.1038/sj.emboj.7601811; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; Chai YH, 1999, J NEUROSCI, V19, P10338; Chapple JP, 2003, J BIOL CHEM, V278, P19087, DOI 10.1074/jbc.M212349200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; Cyr DM, 2008, CELL, V133, P945, DOI 10.1016/j.cell.2008.05.036; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Kurahashi H, 2008, MOL CELL BIOL, V28, P3313, DOI 10.1128/MCB.01900-07; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li JZ, 2005, BIOCHEM J, V386, P453, DOI 10.1042/BJ20041050; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; Lopez N, 2003, MOL BIOL CELL, V14, P1172, DOI 10.1091/mbc.E02-09-0593; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Pylypenko O, 2008, J MOL BIOL, V377, P1334, DOI 10.1016/j.jmb.2008.01.099; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; Tkach JM, 2008, TRAFFIC, V9, P39, DOI 10.1111/j.1600-0854.2007.00666.x; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Vitrenko YA, 2007, CURR GENET, V51, P309, DOI 10.1007/s00294-007-0127-0; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065	53	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3628	3639		10.1074/jbc.M807369200	http://dx.doi.org/10.1074/jbc.M807369200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19056735	Green Published, hybrid			2022-12-25	WOS:000262872500031
J	Cai, CX; Masumiya, H; Weisleder, N; Pan, Z; Nishi, MK; Komazaki, SJ; Takeshima, H; Ma, JJ				Cai, Chuanxi; Masumiya, Haruko; Weisleder, Noah; Pan, Zui; Nishi, Miyuki; Komazaki, Shinji; Takeshima, Hiroshi; Ma, Jianjie			MG53 Regulates Membrane Budding and Exocytosis in Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE-MUSCULAR-DYSTROPHY; RING-FINGER PROTEIN; SKELETAL-MUSCLE; RYANODINE RECEPTORS; MONKEY TRIM5-ALPHA; SARCOPLASMIC-RETICULUM; TRIAD JUNCTION; CAVEOLIN-3; RESTRICTION; DOMAINS	Membrane recycling and remodeling contribute to multiple cellular functions, including cell fusion events during myogenesis. We have identified a tripartite motif (TRIM72) family member protein named MG53 and defined its role in mediating the dynamic process of membrane fusion and exocytosis in striated muscle. MG53 is a muscle-specific protein that contains a TRIM motif at the amino terminus and a SPRY motif at the carboxyl terminus. Live cell imaging of green fluorescent protein-MG53 fusion construct in cultured myoblasts showed that although MG53 contains no trans-membrane segment it is tightly associated with intracellular vesicles and sarcolemmal membrane. RNA interference-mediated knockdown of MG53 expression impeded myoblast differentiation, whereas overexpression of MG53 enhanced vesicle trafficking to and budding from sarcolemmal membrane. Co-expression studies indicated that MG53 activity is regulated by a functional interaction with caveolin-3. Our data reveal a new function for TRIM family proteins in regulating membrane trafficking and fusion in striated muscles.	[Masumiya, Haruko; Nishi, Miyuki; Takeshima, Hiroshi] Tohoku Univ, Grad Sch Med, Dept Med Chem, Sendai, Miyagi 9808575, Japan; [Cai, Chuanxi; Weisleder, Noah; Pan, Zui; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA; [Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan; [Komazaki, Shinji] Saitama Med Univ, Dept Anat, Saitama 3500495, Japan	Tohoku University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Kyoto University; Saitama Medical University	Takeshima, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Chem, Sendai, Miyagi 9808575, Japan.	takeshim@pharm.kyoto-u.ac.jp; maj2@umdnj.edu	Cai, Chuanxi/AAW-1488-2020; Weisleder, Noah L/A-7098-2013; Liu, FL/D-1795-2009	Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088; Takeshima, Hiroshi/0000-0003-4525-3725; Pan, Zui/0000-0003-4105-901X	National Institutes of Health; Chinese Natural Science Foundation; Ministry of Education, Science, Sports and Culture of Japan	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in whole or in part, by National Institutes of Health grants ( to J.M. and N.W.). This work was also supported by grants from the Chinese Natural Science Foundation ( to J.M.) and the Ministry of Education, Science, Sports and Culture of Japan ( to H. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bolanos-Jimenez F, 2001, GENE, V274, P217, DOI 10.1016/S0378-1119(01)00606-0; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chakrabarty T, 2002, P NATL ACAD SCI USA, V99, P6011, DOI 10.1073/pnas.082024299; Fiori MG, 1996, CLIN NEUROPATHOL, V15, P240; FLUCHER BE, 1992, DEV BIOL, V150, P266, DOI 10.1016/0012-1606(92)90241-8; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Galbiati F, 2000, P NATL ACAD SCI USA, V97, P9689, DOI 10.1073/pnas.160249097; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Komazaki S, 1999, DEV DYNAM, V215, P87, DOI 10.1002/(SICI)1097-0177(199906)215:2<87::AID-DVDY1>3.0.CO;2-Y; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Li YK, 2001, J BIOL CHEM, V276, P40824, DOI 10.1074/jbc.M106141200; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; Nakayama EE, 2005, J VIROL, V79, P8870, DOI 10.1128/JVI.79.14.8870-8877.2005; Nishi M, 1999, J CELL BIOL, V147, P1473, DOI 10.1083/jcb.147.7.1473; Oshikawa J, 2004, P NATL ACAD SCI USA, V101, P12670, DOI 10.1073/pnas.0402053101; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Scriven DRL, 2005, BIOPHYS J, V89, P1893, DOI 10.1529/biophysj.105.064212; Smith RD, 2005, AM J PHYSIOL-CELL PH, V288, pC982, DOI 10.1152/ajpcell.00120.2004; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H, 1998, BIOCHEM J, V331, P317, DOI 10.1042/bj3310317; VALENTINE BA, 1990, J NEUROL SCI, V97, P1, DOI 10.1016/0022-510X(90)90095-5; van Diepen MT, 2005, MOL CELL NEUROSCI, V29, P74, DOI 10.1016/j.mcn.2005.01.005; Vichi A, 2005, P NATL ACAD SCI USA, V102, P1945, DOI 10.1073/pnas.0409800102; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V323, P9, DOI 10.1016/j.bbrc.2004.08.048; Ward NL, 2004, BIOCHEM BIOPH RES CO, V323, P937, DOI 10.1016/j.bbrc.2004.08.185; Wei XL, 2003, J BIOL CHEM, V278, P29288, DOI 10.1074/jbc.M212215200; Weisleder N, 2008, CELL CALCIUM, V43, P1, DOI 10.1016/j.ceca.2007.10.006	44	90	100	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3314	3322		10.1074/jbc.M808866200	http://dx.doi.org/10.1074/jbc.M808866200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029292	Green Published, hybrid			2022-12-25	WOS:000262700900074
J	Granneman, JG; Moore, HPH; Mottillo, EP; Zhu, ZX				Granneman, James G.; Moore, Hsiao-Ping H.; Mottillo, Emilio P.; Zhu, Zhengxian			Functional Interactions between Mldp (LSDP5) and Abhd5 in the Control of Intracellular Lipid Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANARIN-DORFMAN-SYNDROME; TRIGLYCERIDE LIPASE PNPLA2; FATTY-ACID; PROTEIN TRAFFICKING; DROPLET PROTEINS; STORAGE DISEASE; ACYL-COA; PERILIPIN; LIPOLYSIS; CGI-58	Cellular lipid metabolism is regulated in part by protein-protein interactions near the surface of intracellular lipid droplets. This work investigated functional interactions between Abhd5, a protein activator of the lipase Atgl, and Mldp, a lipid droplet scaffold protein that is highly expressed in oxidative tissues. Abhd5 was highly targeted to individual lipid droplets containing Mldp in microdissected cardiac muscle fibers. Mldp bound Abhd5 in transfected fibroblasts and directed it to lipid droplets in proportion to Mldp concentration. Analysis of protein-protein interactions in situ demonstrated that the interaction of Abhd5 and Mldp occurs mainly, if not exclusively, on the surface of lipid droplets. Oleic acid treatment rapidly increased the interaction between Abhd5 and Mldp, and this effect was suppressed by pharmacological inhibition of triglyceride synthesis. The functional role of the Abhd5-Mldp interaction was explored using a mutant of mouse Abhd5 (E262K) that has greatly reduced binding to Mldp. Mldp promoted the subcellular colocalization and interaction of Atgl with wild type, but not mutant, Abhd5. This differential interaction was reflected in cellular assays of Atgl activity. In the absence of Mldp, wild type and mutant Abhd5 were equally effective in reducing lipid droplet formation. In contrast, mutant Abhd5 was unable to prevent lipid droplet accumulation in cells expressing Mldp despite considerable targeting of Atgl to lipid droplets containing Mldp. These results indicate that the interaction between Abhd5 and Mldp is dynamic and essential for regulating the activity of Atgl at lipid droplets containing Mldp.	[Granneman, James G.; Moore, Hsiao-Ping H.; Mottillo, Emilio P.; Zhu, Zhengxian] Wayne State Univ, Sch Med, CIMER, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA	Wayne State University	Granneman, JG (corresponding author), Wayne State Univ, Sch Med, CIMER, Dept Psychiat & Behav Neurosci, 550 E Canfield, Detroit, MI 48201 USA.	jgranne@med.wayne.edu			National Institutes of Health [DK062292, NS061634]; American Diabetes Association [07-06-RA-50]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062292, R56DK062292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK062292 and NS061634. This work was also provided by American Diabetes Association Grant 07-06-RA-50) and the Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama M, 2007, MUSCLE NERVE, V36, P856, DOI 10.1002/mus.20869; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Caux F, 2004, AM J MED GENET A, V129A, P214, DOI 10.1002/ajmg.a.30228; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Dickie R, 2006, MICROVASC RES, V72, P20, DOI 10.1016/j.mvr.2006.05.003; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Michnick SW, 2003, CURR OPIN BIOTECH, V14, P610, DOI 10.1016/j.copbio.2003.10.014; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; NEGOESCU A, 1994, J HISTOCHEM CYTOCHEM, V42, P433, DOI 10.1177/42.3.7508473; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200	29	111	115	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3049	3057		10.1074/jbc.M808251200	http://dx.doi.org/10.1074/jbc.M808251200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19064991	hybrid, Green Published			2022-12-25	WOS:000262700900049
J	Pan, MR; Chang, HC; Wu, YC; Huang, CC; Hung, WC				Pan, Mei-Ren; Chang, Hui-Chiu; Wu, Yang-Chang; Huang, Chao-Cheng; Hung, Wen-Chun			Tubocapsanolide A Inhibits Transforming Growth Factor-beta-activating Kinase 1 to Suppress NF-kappa B-induced CCR7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPH-NODE METASTASIS; CHEMOKINE RECEPTOR CCR7; WITHANIA-SOMNIFERA LEAVES; CELL LUNG-CANCER; BREAST-CANCER; TUMOR-CELLS; LEUKEMIA-CELLS; WITHAFERIN-A; EXPRESSION; WITHANOLIDES	Withanolides are C-28 steroidal lactones isolated from plants that exhibit potent anti-cancer activity. The chemokine receptor CCR7 is important for lymphatic invasion of cancer cells and is overexpressed in metastatic breast cancer cells. A bioactive withanolide tubocapsanolide A (Tubo A) suppressed NF-kappa B-mediated CCR7 expression in breast cancer cells and attenuated their migration toward lymphatic endothelial cells. Chromatin immunoprecipitation assay confirmed that binding of NF-kappa B to the consensus site localized at the -398/-389 of human CCR7 promoter was repressed by Tubo A. Tubo A inhibited I kappa B kinase (IKK) and p38 kinase and downstream mitogen and stress-activated protein kinase 1 (MSK1) activity to reduce I kappa B degradation and to suppress NF-kappa B activation. Co-expression of IKK and MSK1 fully rescued Tubo A-induced inhibition. In addition, ectopic expression of transforming growth factor-beta-activating kinase (TAK1), the common upstream kinase of IKK and MSK1, also completely reversed the inhibition by Tubo A. Most importantly, Tubo A reduced NF-kappa B activation, CCR7 expression, and lymph node metastasis of breast cancer in vivo. We conclude that Tubo A inhibits TAK1 to repress NF-kappa B-induced CCR7 expression in breast cancer cells and suggest that Tubo A may be useful for the prevention of lymphatic invasion of breast cancer cells.	[Wu, Yang-Chang; Hung, Wen-Chun] Kaohsiung Med Univ, Natl Sun Yat Sen Univ, Joint Res Ctr, Kaohsiung 804, Taiwan; [Pan, Mei-Ren; Chang, Hui-Chiu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan; [Wu, Yang-Chang] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung 807, Taiwan; [Hung, Wen-Chun] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan; [Huang, Chao-Cheng] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Pathol, Kaohsiung 833, Taiwan; [Hung, Wen-Chun] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 701, Taiwan	Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Chang Gung Memorial Hospital; Chang Gung University; National Cheng Kung University	Hung, WC (corresponding author), Kaohsiung Med Univ, Natl Sun Yat Sen Univ, Joint Res Ctr, Kaohsiung 804, Taiwan.	hung1228@ms10.hinet.net	Hung, Wen-Chun/F-4846-2011; Wu, Yang-Chang/C-5682-2009; Wu, Yang-Chang/D-1471-2011; Pan, Mei-Ren/I-2021-2013	Wu, Yang-Chang/0000-0001-7815-2686; 	National Sun Yat-Sen University; Kaohsiung Medical University Joint Research Center and Center for Gene Regulation and Signal Transduction Research, National Cheng Kung University	National Sun Yat-Sen University; Kaohsiung Medical University Joint Research Center and Center for Gene Regulation and Signal Transduction Research, National Cheng Kung University	This study was supported by the National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center and Center for Gene Regulation and Signal Transduction Research, National Cheng Kung University (to W.-C. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Chang HC, 2007, MOL CANCER THER, V6, P1572, DOI 10.1158/1535-7163.MCT-06-0812; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Chen X, 2005, BLOOD, V106, P2409, DOI 10.1182/blood-2005-03-0854; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Devi P. Uma, 2000, Indian Journal of Experimental Biology, V38, P432; Ding YZ, 2003, CLIN CANCER RES, V9, P3406; Fattal E, 2006, ADV DRUG DELIVER REV, V58, P1203, DOI 10.1016/j.addr.2006.07.020; FUSKA J, 1984, NEOPLASMA, V31, P31; Hasegawa H, 2000, BLOOD, V95, P30; Hopken UE, 2002, BLOOD, V99, P1109, DOI 10.1182/blood.V99.4.1109; Hsieh PW, 2007, J NAT PROD, V70, P747, DOI 10.1021/np0605541; Hsu MC, 2006, J BIOL CHEM, V281, P4718, DOI 10.1074/jbc.M510937200; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Izbicki JR, 1997, NEW ENGL J MED, V337, P1188, DOI 10.1056/NEJM199710233371702; Jayaprakasam B, 2003, TETRAHEDRON, V59, P841, DOI 10.1016/S0040-4020(02)01601-0; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kubuschok B, 1999, J CLIN ONCOL, V17, P19, DOI 10.1200/JCO.1999.17.1.19; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; LEE YC, 1995, J CELL BIOCHEM, V57, P150, DOI 10.1002/jcb.240570115; Leyon PV, 2004, PHYTOTHER RES, V18, P118, DOI 10.1002/ptr.1378; LINNENBACH AJ, 1989, P NATL ACAD SCI USA, V86, P27, DOI 10.1073/pnas.86.1.27; Mashino K, 2002, CANCER RES, V62, P2937; Mathur R, 2006, J ETHNOPHARMACOL, V105, P336, DOI 10.1016/j.jep.2005.11.020; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 2004, J DERMATOL SCI, V36, P71, DOI 10.1016/j.jdermsci.2004.03.002; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Pan MR, 2008, J BIOL CHEM, V283, P11155, DOI 10.1074/jbc.M710038200; Prang N, 2005, BRIT J CANCER, V92, P342, DOI 10.1038/sj.bjc.6602310; Qin W Z, 1983, J Tradit Chin Med, V3, P131; Schimanski CC, 2005, CLIN CANCER RES, V11, P1743, DOI 10.1158/1078-0432.CCR-04-1195; Taichman RS, 2002, CANCER RES, V62, P1832; Takanami I, 2003, INT J CANCER, V105, P186, DOI 10.1002/ijc.11063; Takeuchi H, 2004, CLIN CANCER RES, V10, P2351, DOI 10.1158/1078-0432.CCR-03-0195; TAO XL, 1989, CHINESE MED J-PEKING, V102, P327; THAUKUR RS, 1989, MAJOR MED PLANTS IND, P531; Till KJ, 2002, BLOOD, V99, P2977, DOI 10.1182/blood.V99.8.2977; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769	47	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2746	2754		10.1074/jbc.M806223200	http://dx.doi.org/10.1074/jbc.M806223200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049961	hybrid			2022-12-25	WOS:000262700900017
J	Kamiya, T; Tanaka, M; Mitani, N; Ma, JF; Maeshima, M; Fujiwara, T				Kamiya, Takehiro; Tanaka, Mayuki; Mitani, Namiki; Ma, Jian Feng; Maeshima, Masayoshi; Fujiwara, Toru			NIP1;1, an Aquaporin Homolog, Determines the Arsenite Sensitivity of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICE; TRANSPORTERS; EXPRESSION; ANTIMONITE; TOLERANCE; PROTEINS; GROWTH; GENES; SET	Arsenite [As(III)] is highly toxic to organisms, including plants. Very recently, transporters in rice responsible for As(III) transport have been described (Ma, J. F., Yamaji, N., Mitani, N., Xu, X. Y., Su, Y. H., McGrath, S. P., and Zhao, F. J. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 9931-9935), but little is known about As(III) tolerance. In this study, three independent As(III)-tolerant mutants were isolated from ethyl methanesulfonate-mutagenized M2 seeds of Arabidopsis thaliana. All three mutants carried independent mutations in Nodulin 26-like intrinsic protein 1;1 (NIP1;1), a homolog of an aquaporin. Two independent transgenic lines carrying T-DNA in NIP1; 1 were highly tolerant to As(III), establishing that NIP1;1 is the causal gene of As(III) tolerance. Because an aquaglyceroporin is able to transport As(III), we measured As(III) transport activity. When expressed in Xenopus oocytes, NIP1; 1 was capable of transporting As(III). As content in the mutant plants was 30% lower than in wild-type plants. Promoter beta-glucuronidase and real-time PCR analysis showed that NIP1; 1 is highly expressed in roots, and GFP-NIP1;1 is localized to the plasma membrane. These data show that NIP1; 1 is involved in As(III) uptake into roots and that disruption of NIP1; 1 function confers As(III) tolerance to plants. NIP1;2 and NIP5;1, closely related homologs of NIP1;1, were also permeable to As(III). Although the disruption of these genes reduced the As content in plants, As(III) tolerance was not observed in nip1;2 and nip5;1 mutants. This indicates that As(III) tolerance cannot be simply explained by decreased As contents in plants.	[Kamiya, Takehiro; Tanaka, Mayuki; Fujiwara, Toru] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Mitani, Namiki; Ma, Jian Feng] Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan; [Maeshima, Masayoshi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Fujiwara, Toru] Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Chuo Ku, Tokyo 1030027, Japan	University of Tokyo; Okayama University; Nagoya University; Japan Science & Technology Agency (JST)	Fujiwara, T (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	atorufu@mail.ecc.u-tokyo.ac.jp	FUJIWARA, Toru/A-4119-2011; Ma, Jianfeng/GZB-0110-2022; Kamiya, Takehiro/AAU-1703-2020; Tanaka, Mayuki/GQB-2552-2022; Feng, Jian/C-7213-2009; Maeshima, Masayoshi/D-3073-2013	Kamiya, Takehiro/0000-0003-3790-7119; Feng, Jian/0000-0003-3411-827X; Maeshima, Masayoshi/0000-0002-1611-5481	Japanese Society for the Promotion of Science; Ministry of Agriculture, Forestry, and Fisheries of Japan [IPG-0005]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; PROBRAIN; Grants-in-Aid for Scientific Research [21228002] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PROBRAIN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Japanese Society for the Promotion of Science ( to T. K.), from the Ministry of Agriculture, Forestry, and Fisheries of Japan ( Genomics for Agricultural Innovation Grant IPG-0005 ( to T. F.), a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ( to T. F.), and PROBRAIN ( to M. M.).	Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Figarella K, 2007, MOL MICROBIOL, V65, P1006, DOI 10.1111/j.1365-2958.2007.05845.x; Isayenkov SV, 2008, FEBS LETT, V582, P1625, DOI 10.1016/j.febslet.2008.04.022; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Kamiya T, 2006, PLANT CELL PHYSIOL, V47, P96, DOI 10.1093/pcp/pci227; Kataoka T, 2004, PLANT CELL, V16, P2693, DOI 10.1105/tpc.104.023960; Kinniburgh DG, 2001, ARSENIC CONTAMINATIO; Liu ZJ, 2004, J BIOL CHEM, V279, P17312, DOI 10.1074/jbc.M314006200; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; MARIN AR, 1992, PLANT SOIL, V139, P175, DOI 10.1007/BF00009308; Meharg AA, 2004, TRENDS PLANT SCI, V9, P415, DOI 10.1016/j.tplants.2004.07.002; Meharg AA, 2003, NEW PHYTOL, V157, P39, DOI 10.1046/j.1469-8137.2003.00655.x; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raab A, 2004, PLANT PHYSIOL, V134, P1113, DOI 10.1104/pp.103.033506; Rahman MA, 2007, CHEMOSPHERE, V67, P1072, DOI 10.1016/j.chemosphere.2006.11.061; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Sanders OI, 1997, J BACTERIOL, V179, P3365, DOI 10.1128/jb.179.10.3365-3367.1997; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tripathi RD, 2007, TRENDS BIOTECHNOL, V25, P158, DOI 10.1016/j.tibtech.2007.02.003; *US EPA, 1992, METH DET MET ENV SAM; Weig AR, 2000, FEBS LETT, V481, P293, DOI 10.1016/S0014-5793(00)02027-5; Wysocki R, 2001, MOL MICROBIOL, V40, P1391, DOI 10.1046/j.1365-2958.2001.02485.x; Zardoya R, 2002, P NATL ACAD SCI USA, V99, P14893, DOI 10.1073/pnas.192573799	32	149	158	2	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2114	2120		10.1074/jbc.M806881200	http://dx.doi.org/10.1074/jbc.M806881200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19029297	hybrid			2022-12-25	WOS:000262545600020
J	Pankratz, SL; Tan, EY; Fine, Y; Mercurio, AM; Shaw, LM				Pankratz, Shannon L.; Tan, Ernest Y.; Fine, Yumiko; Mercurio, Arthur M.; Shaw, Leslie M.			Insulin Receptor Substrate-2 Regulates Aerobic Glycolysis in Mouse Mammary Tumor Cells via Glucose Transporter 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; GLUCOSE-UPTAKE; GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; GROWTH; EXPRESSION; METASTASIS; KINASE; TRAFFICKING; ACTIVATION	The insulin receptor substrate (IRS) proteins are cytoplasmic adaptor molecules that function as signaling intermediates downstream of activated cell surface receptors. Based on data implicating IRS-2 but not IRS-1 in breast cancer invasion, survival, and metastasis, we assessed the contribution of IRS-1 and IRS-2 to aerobic glycolysis, which is known to impact tumor growth and progression. For this purpose, we used tumor cell lines derived from transgenic mice that express the polyoma virus middle T antigen (PyV-MT) in the mammary gland and that are wild-type (WT) or null for either Irs-1 (Irs-1(-/-)) or Irs-2 (Irs-2(-/-)). Aerobic glycolysis, as assessed by the rate of lactic acid production and glucose consumption, was diminished significantly in Irs-2(-/-) cells when compared with WT and Irs-1(-/-) cells. Expression of exogenous Irs-2 in Irs-2(-/-) cells restored the rate of glycolysis to that observed in WT cells. The transcription factor FoxO1 does not appear to be involved in Irs-2-mediated glycolysis. However, Irs-2 does regulate the surface expression of glucose transporter 1 (Glut1) as assessed by flow cytometry using a Glut1-specific ligand. Suppression of Glut1 expression inhibits Irs-2-dependent invasion, which links glycolysis to mammary tumor progression. Irs-2 was shown to be important for mammalian target of rapamycin (mTor) activation, and Irs-2-dependent regulation of Glut1 surface expression is rapamycin-sensitive. Collectively, our data indicate that Irs-2, but not Irs-1, promotes invasion by sustaining the aerobic glycolysis of mouse mammary tumor cells and that it does so by regulating the mTor-dependent surface expression of Glut1.	[Shaw, Leslie M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Shaw, LM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB 409,364 Plantat St, Worcester, MA 01605 USA.	leslie.shaw@umassmed.edu			National Institutes of Health [CA090583]; Susan G. Komen Foundation [BCTR0706837]; NATIONAL CANCER INSTITUTE [R01CA090583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA090583 ( to L. M. S.). This work was also supported by Grant BCTR0706837 from the Susan G. Komen Foundation ( to A. M. M. and L. M. S.).	Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Byron SA, 2006, BRIT J CANCER, V95, P1220, DOI 10.1038/sj.bjc.6603354; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cui XJ, 2006, CANCER RES, V66, P5304, DOI 10.1158/0008-5472.CAN-05-2858; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dunn SE, 1998, CANCER RES, V58, P3353; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guo SD, 2006, MOL ENDOCRINOL, V20, P3389, DOI 10.1210/me.2006-0092; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; Jackson JG, 2001, ONCOGENE, V20, P7318, DOI 10.1038/sj.onc.1204920; Jiang XY, 2008, AM J PATHOL, V172, P1748, DOI 10.2353/ajpath.2008.070958; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; Kang SS, 2002, JPN J CANCER RES, V93, P1123, DOI 10.1111/j.1349-7006.2002.tb01214.x; Kim Felix J, 2004, Retrovirology, V1, P41, DOI 10.1186/1742-4690-1-41; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Moadel RM, 2005, CANCER RES, V65, P698; Morelli C, 2004, ONCOGENE, V23, P7517, DOI 10.1038/sj.onc.1208014; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; QUON MJ, 1994, J BIOL CHEM, V269, P27920; Sachdev D, 2004, J BIOL CHEM, V279, P5017, DOI 10.1074/jbc.M305403200; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Sisci D, 2007, J CLIN PATHOL, V60, P633, DOI 10.1136/jcp.2006.039107; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Trojanek J, 2003, MOL CELL BIOL, V23, P7510, DOI 10.1128/MCB.23.21.7510-7524.2003; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang XH, 2004, BREAST CANCER RES TR, V83, P161, DOI 10.1023/B:BREA.0000010709.31256.c6; Zhou QL, 2008, BIOCHEM J, V411, P647, DOI 10.1042/BJ20071084	40	33	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2031	2037		10.1074/jbc.M804776200	http://dx.doi.org/10.1074/jbc.M804776200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19056742	hybrid, Green Published			2022-12-25	WOS:000262545600010
J	Jung, S; Dingley, AJ; Augustin, R; Anton-Erxleben, F; Stanisak, M; Gelhaus, C; Gutsmann, T; Hammer, MU; Podschun, R; Bonvin, AMJJ; Leippe, M; Bosch, TCG; Grotzinger, J				Jung, Sascha; Dingley, Andrew J.; Augustin, Rene; Anton-Erxleben, Friederike; Stanisak, Mareike; Gelhaus, Christoph; Gutsmann, Thomas; Hammer, Malte U.; Podschun, Rainer; Bonvin, Alexandre M. J. J.; Leippe, Matthias; Bosch, Thomas C. G.; Groetzinger, Joachim			Hydramacin-1, Structure and Antibacterial Activity of a Protein from the Basal Metazoan Hydra	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; DEFENSIN; ANTIBIOTICS; CHALLENGE; SYSTEM; BONDS; LEECH	Hydramacin-1 is a novel antimicrobial protein recently discovered during investigations of the epithelial defense of the ancient metazoan Hydra. The amino acid sequence of hydramacin-1 shows no sequence homology to any known antimicrobial proteins. Determination of the solution structure revealed that hydramacin-1 possesses a disulfide bridge-stabilized alpha beta motif. This motif is the common scaffold of the knottin protein fold. The structurally closest relatives are the scorpion oxin-like superfamily. Within this superfamily hydramacin-1 establishes a new family of proteins that all share antimicrobial activity. Hydramacin-1 is potently active against Gram-positive and Gram-negative bacteria including multi-resistant human pathogenic strains. It leads to aggregation of bacteria as an initial step of its bactericidal mechanism. Aggregated cells are connected via electron-dense contacts and adopt a thorn apple-like morphology. Analysis of the hydramacin-1 structure revealed an unusual distribution of amino acid side chains on the surface. Abelt of positively charged residues is sandwiched by two hydrophobic areas. Based on this characteristic surface feature and on biophysical analysis of protein-membrane interactions, we propose a model that describes the aggregation effect exhibited by hydramacin-1.	[Jung, Sascha; Groetzinger, Joachim] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Stanisak, Mareike; Gelhaus, Christoph; Leippe, Matthias] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Dingley, Andrew J.] Univ Auckland, Dept Chem, Auckland 1142, New Zealand; [Dingley, Andrew J.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Augustin, Rene; Anton-Erxleben, Friederike; Bosch, Thomas C. G.] Univ Kiel, Inst Zool Cell & Dev Biol, D-24118 Kiel, Germany; [Gutsmann, Thomas; Hammer, Malte U.] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Podschun, Rainer] Univ Hosp Schleswig Holstein, Inst Infect Med, D-24105 Kiel, Germany; [Bonvin, Alexandre M. J. J.] Univ Utrecht, Bijvoet Ctr Biomol Res, Fac Sci, NL-3584 CH Utrecht, Netherlands	University of Kiel; University of Kiel; University of Auckland; University of Auckland; University of Kiel; Forschungszentrum Borstel; University of Kiel; Schleswig Holstein University Hospital; Utrecht University	Grotzinger, J (corresponding author), Univ Kiel, Inst Biochem, Olshaussenstr 40, D-24098 Kiel, Germany.	jgroetzinger@biochem.uni-kiel.de	Gutsmann, Thomas/E-6100-2011; Bonvin, Alexandre M.J.J./A-5420-2009; Gelhaus, Christoph/D-8050-2011; Bosch, Thomas C. G./D-5218-2011; Dingley, Andrew/G-6427-2013; Leippe, Matthias/AAP-1677-2020	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Dingley, Andrew/0000-0002-6838-5803; Jung, Sascha/0000-0003-4970-6904	Deutsche Forschungsgemeinschaft [SFB 617: A1, A9, A17, and A18]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 617: A1, A9, A17, and A18). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Blanc E, 1998, BIOCHEMISTRY-US, V37, P12412, DOI 10.1021/bi9809371; BOSCH TCG, 2008, DEV COMP IM IN PRESS; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P946; Cook WJ, 2002, PROTEIN SCI, V11, P479, DOI 10.1110/ps.39202; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dingley Andrew J., 2008, V451, P441, DOI 10.1007/978-1-59745-102-4_30; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Errington J, 2003, NAT CELL BIOL, V5, P175, DOI 10.1038/ncb0303-175; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herbst R, 2002, J BIOL CHEM, V277, P22353, DOI 10.1074/jbc.M201475200; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Lamberty M, 2001, BIOCHEMISTRY-US, V40, P11995, DOI 10.1021/bi0103563; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; LENGUYEN D, 1990, BIOCHIMIE, V72, P431, DOI 10.1016/0300-9084(90)90067-Q; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Marshall SH, 2003, ELECTRON J BIOTECHN, V6, P271, DOI 10.4067/S0717-34582003000300011; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PICK U, 1981, ARCH BIOCHEM BIOPHYS, V212, P186, DOI 10.1016/0003-9861(81)90358-1; REES DC, 1982, J MOL BIOL, V160, P475, DOI 10.1016/0022-2836(82)90309-6; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Sahly H, 2003, ANTIMICROB AGENTS CH, V47, P1739, DOI 10.1128/AAC.47.5.1739-1741.2003; Schikorski D, 2008, J IMMUNOL, V181, P1083, DOI 10.4049/jimmunol.181.2.1083; Tasiemski A, 2004, J BIOL CHEM, V279, P30973, DOI 10.1074/jbc.M312156200; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	35	87	94	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1896	1905		10.1074/jbc.M804713200	http://dx.doi.org/10.1074/jbc.M804713200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19019828	Green Published, hybrid			2022-12-25	WOS:000262330100060
J	Salazar, G; Zlatic, S; Craige, B; Peden, AA; Pohl, J; Faundez, V				Salazar, Gloria; Zlatic, Stephanie; Craige, Branch; Peden, Andrew A.; Pohl, Jan; Faundez, Victor			Hermansky-Pudlak Syndrome Protein Complexes Associate with Phosphatidylinositol 4-Kinase Type II alpha in Neuronal and Non-neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOME-RELATED ORGANELLES; CLATHRIN-COATED VESICLES; SORTING MACHINERY; AP-3 ADAPTER; TRAFFICKING; MELANOSOMES; TYROSINASE; ENDOSOMES; BLOC-1; TRANSPORT	The Hermansky-Pudlak syndrome is a disorder affecting endosome sorting. Disease is triggered by defects in any of 15 mouse gene products, which are part of five distinct cytosolic molecular complexes: AP-3, homotypic fusion and vacuole protein sorting, and BLOC-1, -2, and -3. To identify molecular associations of these complexes, we used in vivo cross-linking followed by purification of cross-linked AP-3 complexes and mass spectrometric identification of associated proteins. AP-3 was co-isolated with BLOC-1, BLOC-2, and homotypic fusion and vacuole protein sorting complex subunits; clathrin; and phosphatidylinositol-4- kinase type II alpha ( PI4KII alpha). We previously reported that this membrane-anchored enzyme is a regulator of AP-3 recruitment to membranes and a cargo of AP-3 (Craige, B., Salazar, G., and Faundez, V. (2008) Mol. Biol. Cell 19, 1415 1426). Using cells deficient in different Hermansky-Pudlak syndrome complexes, we identified that BLOC-1, but not BLOC-2 or BLOC-3, deficiencies affect PI4KII alpha inclusion into AP-3 complexes. BLOC-1, PI4KII alpha, and AP-3 belong to a tripartite complex, and down-regulation of either PI4KII alpha, BLOC-1, or AP-3 complexes led to similar LAMP1 phenotypes. Our analysis indicates that BLOC-1 complex modulates the association of PI4KII alpha with AP-3. These results suggest that AP-3 and BLOC-1 act, either in concert or sequentially, to specify sorting of PI4KII alpha along the endocytic route.	[Zlatic, Stephanie; Craige, Branch; Faundez, Victor] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Zlatic, Stephanie; Craige, Branch; Faundez, Victor] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Salazar, Gloria] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Zlatic, Stephanie; Craige, Branch] Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA; [Faundez, Victor] Emory Univ, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Pohl, Jan] Emory Univ, Microchem Facil, Atlanta, GA 30322 USA; [Peden, Andrew A.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; University of Cambridge	Faundez, V (corresponding author), Emory Univ, Dept Cell Biol, 615 Michael St,Rm 446, Atlanta, GA 30322 USA.	faundez@cellbio.emory.edu		Peden, Andrew/0000-0003-0144-7712; Faundez, Victor/0000-0002-2114-5271; Zlatic, Stephanie/0000-0003-0758-9500	National Institutes of Health [NS42599, GM 077569]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042599, R56NS042599] Funding Source: NIH RePORTER; Medical Research Council [G120/952] Funding Source: researchfish; MRC [G120/952] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants NS42599 and GM 077569 (to V. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alloza I, 2004, ANAL BIOCHEM, V324, P137, DOI 10.1016/j.ab.2003.09.017; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Craige B, 2008, MOL BIOL CELL, V19, P1415, DOI 10.1091/mbc.E07-12-1239; Danglot L, 2007, BIOL CELL, V99, P349, DOI 10.1042/BC20070029; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; GIRARD M, 2004, CURRENT PROTOCOLS CE; Helip-Wooley A, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-33; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Khwaja FW, 2007, J PROTEOME RES, V6, P559, DOI 10.1021/pr060240z; Li G, 1997, ELECTROPHORESIS, V18, P391, DOI 10.1002/elps.1150180313; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; LOMANT AJ, 1976, J MOL BIOL, V104, P243, DOI 10.1016/0022-2836(76)90011-5; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Newell-Litwa K, 2007, J CELL SCI, V120, P531, DOI 10.1242/jcs.03365; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Salazar G, 2005, MOL BIOL CELL, V16, P3692, DOI 10.1091/mbc.E05-01-0020; Salazar G, 2004, MOL BIOL CELL, V15, P575, DOI 10.1091/mbc.E03-06-0401; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Xiang CC, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh185	46	71	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1790	1802		10.1074/jbc.M805991200	http://dx.doi.org/10.1074/jbc.M805991200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19010779	Green Published, hybrid			2022-12-25	WOS:000262330100050
J	Shan, L; Yu, XC; Liu, ZY; Hu, Y; Sturgis, LT; Miranda, ML; Liu, QY				Shan, Lu; Yu, Xuan-Chuan; Liu, Ziye; Hu, Yi; Sturgis, Lydia T.; Miranda, Maricar L.; Liu, Qingyun			The Angiopoietin-like Proteins ANGPTL3 and ANGPTL4 Inhibit Lipoprotein Lipase Activity through Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-LIPID LEVELS; ADIPOSE-TISSUE; SARCOPLASMIC-RETICULUM; METABOLISM; MICE; ENZYME; OLIGOMERIZATION; CHYLOMICRONS; INACTIVATION; CHOLESTEROL	Two members of the angiopoietin-like family of proteins, ANGPTL3 and ANGPTL4, have been shown to play important roles in modulating lipoprotein metabolism in the body. Both proteins were found to suppress lipoprotein lipase (LPL) activity in vitro as well as in vivo. However, their mechanisms of inhibition remained poorly understood. Using enzyme kinetic analysis with purified recombinant proteins, we have found key mechanistic differences between ANGPTL3 and ANGPTL4. ANGPTL3 reduced LPL catalytic activity but did not significantly alter its self-inactivation rate. In contrast, ANGPTL4 suppressed LPL by accelerating the irreversible inactivation of LPL. Furthermore, heparin was able to overcome the inhibitory effect of ANGPTL3 on LPL but not that of ANGPTL4. Site-directed mutagenesis demonstrated the critical function of Glu(40) in ANGPTL4. In contrast, when cysteine residues involved in disulfide bond formation were mutated to serines, ANGPTL4 retained its activity. Taken together, our data provide a more detailed view of the structure and mechanisms of these proteins. The finding that ANGPTL3 and ANGPTL4 inhibit LPL activity through distinct mechanisms indicates that the two proteins play unique roles in modulation of lipid metabolism in vivo.	[Shan, Lu; Yu, Xuan-Chuan; Liu, Ziye; Sturgis, Lydia T.; Miranda, Maricar L.; Liu, Qingyun] Lexicon Pharmaceut, Dept Pharmaceut Discovery, The Woodlands, TX 77381 USA; [Hu, Yi] Lexicon Pharmaceut, Dept Mol Biol, The Woodlands, TX 77381 USA	Lexicon Pharmaceuticals; Lexicon Pharmaceuticals	Shan, L (corresponding author), Lexicon Pharmaceut, Dept Pharmaceut Discovery, 8800 Technol Forest Pl, The Woodlands, TX 77381 USA.	lshan@lexpharma.com		Shan, Lu/0000-0003-2334-9216	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073837] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM073837] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ando Y, 2003, J LIPID RES, V44, P1216, DOI 10.1194/jlr.M300031-JLR200; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Bergo M, 2002, J BIOL CHEM, V277, P11927, DOI 10.1074/jbc.M200325200; BRAUN JEA, 1992, BIOCHEM J, V287, P337, DOI 10.1042/bj2870337; Copeland R. A., 2005, EVALUATION ENZYME IN; CORBALANGARCIA S, 1993, BIOCHIM BIOPHYS ACTA, V1203, P45, DOI 10.1016/0167-4838(93)90034-O; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; EMMERICH J, 1992, J BIOL CHEM, V267, P4161; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Goldberg IJ, 1996, J LIPID RES, V37, P693; Graca R, 2005, VET CLIN PATH, V34, P39, DOI 10.1111/j.1939-165X.2005.tb00007.x; Hatsuda S, 2007, J VASC RES, V44, P61, DOI 10.1159/000098153; Kobayashi Y, 2002, EUR J BIOCHEM, V269, P4701, DOI 10.1046/j.1432-1033.2002.03179.x; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Li C, 2007, CURR OPIN LIPIDOL, V18, P597, DOI 10.1097/MOL.0b013e3282efa4e1; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Lookene A, 2004, J BIOL CHEM, V279, P49964, DOI 10.1074/jbc.M407419200; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Nordestgaard BG, 1997, CIRCULATION, V96, P1737, DOI 10.1161/01.CIR.96.6.1737; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; OSBORNE JC, 1985, BIOCHEMISTRY-US, V24, P5606, DOI 10.1021/bi00341a048; Panteghini M, 2001, ANN CLIN BIOCHEM, V38, P365, DOI 10.1258/0004563011900876; Potenz R, 1996, METHOD ENZYMOL, V263, P319; Rip J, 2006, ARTERIOSCL THROM VAS, V26, P1236, DOI 10.1161/01.ATV.0000219283.10832.43; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; TERUEL JA, 1986, BIOCHIM BIOPHYS ACTA, V869, P8, DOI 10.1016/0167-4838(86)90303-1; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; Wong H, 1997, P NATL ACAD SCI USA, V94, P5594, DOI 10.1073/pnas.94.11.5594; Wu GS, 2003, J BIOL CHEM, V278, P11925, DOI 10.1074/jbc.M212736200; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Young SG, 2007, CURR OPIN LIPIDOL, V18, P389, DOI 10.1097/MOL.0b013e3281527914	38	106	112	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1419	1424		10.1074/jbc.M808477200	http://dx.doi.org/10.1074/jbc.M808477200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028676	Green Published, hybrid			2022-12-25	WOS:000262330100009
J	Ranjith-Kumar, CT; Murali, A; Dong, W; Srisathiyanarayanan, D; Vaughan, R; Ortiz-Alacantara, J; Bhardwaj, K; Li, XJ; Li, PW; Kao, CC				Ranjith-Kumar, C. T.; Murali, Ayaluru; Dong, Wen; Srisathiyanarayanan, Dharmaiah; Vaughan, Robert; Ortiz-Alacantara, Joanna; Bhardwaj, Kanchan; Li, Xiaojun; Li, Pingwei; Kao, Cheng C.			Agonist and Antagonist Recognition by RIG-I, a Cytoplasmic Innate Immunity Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; ANTIVIRAL RESPONSES; FUNCTIONAL ANALYSES; STRUCTURAL BASIS; ADAPTER PROTEIN; IDENTIFICATION; HELICASE	Cytoplasmic RNA receptors are important in the detection of and response to viral infections. We analyzed ligand recognition by the retinoic acid-inducible protein I (RIG-I) protein in biochemical assays and in transiently transfected cells and characterized the requirements for both single- and double-stranded RNA agonists for RIG-I activation of signaling. RIG-I mutants such as K270A and T409A/S411A that were defective in signaling with triphosphorylated single-stranded RNAs were perfectly capable of signaling with dsRNAs. Furthermore, phosphorothioated oligodeoxynucleotides were found to antagonize RIG-I signaling. Both agonists and antagonist bind purified RIG-I protein and a truncated RIG-I protein that lacked the signaling domain. The agonists were necessary to activate RIG-I ATPase activity in vitro, whereas antagonist inhibited ATPase activity. Differential scanning fluorometry showed that RIG-I bound to agonists, and antagonists have different denaturation properties, suggesting a difference in protein conformations. Last, single particle reconstruction was used to generate three-dimensional models of the RIG-I dimers in complex with an agonist and an antagonist. The two complexes exhibited dramatically different structures.	[Ranjith-Kumar, C. T.; Murali, Ayaluru; Dong, Wen; Srisathiyanarayanan, Dharmaiah; Vaughan, Robert; Ortiz-Alacantara, Joanna; Bhardwaj, Kanchan; Li, Xiaojun; Li, Pingwei; Kao, Cheng C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Ranjith-Kumar, CT (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	ctrkumar@gmail.com	Bhardwaj, Kanchan/CAH-2291-2022; Kumar CT, Ranjith/J-5701-2016; Dharmaiah, Srisathiyanarayanan/B-2887-2009; Li, Xiaojun/J-4460-2012; Murali, Ayaluru/G-3401-2014	Bhardwaj, Kanchan/0000-0002-7331-7717; Li, Xiaojun/0000-0001-8528-8258; Murali, Ayaluru/0000-0001-6406-6840; Dharmaiah, Srisathiyanarayanan/0000-0001-7630-3962; Ortiz-Alcantara, Joanna Maria/0000-0003-2894-3652	National Institutes of Health [1RO1AI073335]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1AI073335 (NIAID; to C. K.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bhardwaj K, 2008, J BIOL CHEM, V283, P3655, DOI 10.1074/jbc.M708375200; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; Gaspari AA, 2006, J AM ACAD DERMATOL, V54, pS67, DOI 10.1016/j.jaad.2005.10.057; Guarino LA, 2005, J MOL BIOL, V353, P1106, DOI 10.1016/j.jmb.2005.09.007; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim YC, 2005, J BIOL CHEM, V280, P38011, DOI 10.1074/jbc.M508145200; Kobayashi T, 2006, NAT IMMUNOL, V7, P123, DOI 10.1038/ni0206-123; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SHINOZUKA K, 1991, NUCL ACIDS S SER, V25, P101; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Underhill DM, 2004, CURR OPIN IMMUNOL, V16, P483, DOI 10.1016/j.coi.2004.05.012; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	37	46	51	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1155	1165		10.1074/jbc.M806219200	http://dx.doi.org/10.1074/jbc.M806219200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19019822	Green Published, hybrid			2022-12-25	WOS:000262122900052
J	Hartmann, S; Missimer, JH; Stoeckel, C; Abela, E; Shah, J; Seitz, RJ; Weder, BJ				Hartmann, Susanne; Missimer, John H.; Stoeckel, Cornelia; Abela, Eugenio; Shah, Jon; Seitz, Ruediger J.; Weder, Bruno J.			Functional Connectivity in Tactile Object Discrimination-A Principal Component Analysis of an Event Related fMRI-Study	PLOS ONE			English	Article								Background: Tactile object discrimination is an essential human skill that relies on functional connectivity between the neural substrates of motor, somatosensory and supramodal areas. From a theoretical point of view, such distributed networks elude categorical analysis because subtraction methods are univariate. Thus, the aim of this study was to identify the neural networks involved in somatosensory object discrimination using a voxel-based principal component analysis (PCA) of event-related functional magnetic resonance images. Methodology/Principal Findings: Seven healthy, right-handed subjects aged between 22 and 44 years were required to discriminate with their dominant hand the length differences between otherwise identical parallelepipeds in a two-alternative forced-choice paradigm. Of the 34 principal components retained for analysis according to the 'bootstrapped' Kaiser-Guttman criterion, t-tests applied to the subject-condition expression coefficients showed significant mean differences between the object presentation and inter-stimulus phases in PC 1, 3, 26 and 32. Specifically, PC 1 reflected object exploration or manipulation, PC 3 somatosensory and short-term memory processes. PC 26 evinced the perception that certain parallelepipeds could not be distinguished, while PC 32 emerged in those choices when they could be. Among the cerebral regions evident in the PCs are the left posterior parietal lobe and premotor cortex in PC 1, the left superior parietal lobule (SPL) and the right cuneus in PC 3, the medial frontal and orbitofrontal cortex bilaterally in PC 26, and the right intraparietal sulcus, anterior SPL and dorsolateral prefrontal cortex in PC 32. Conclusions/Significance: The analysis provides evidence for the concerted action of large-scale cortico-subcortical networks mediating tactile object discrimination. Parallel to activity in nodes processing object-related impulses we found activity in key cerebral regions responsible for subjective assessment and validation.	[Hartmann, Susanne; Abela, Eugenio; Weder, Bruno J.] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland; [Missimer, John H.] Paul Scherrer Inst, Villigen, Switzerland; [Stoeckel, Cornelia] Univ Oxford, Dept Clin Neurol, FMRIB Ctr, Oxford OX1 2JD, England; [Shah, Jon; Seitz, Ruediger J.] Univ Hosp Dusseldorf, Dept Neurol, Dusseldorf, Germany; [Seitz, Ruediger J.] Res Ctr Julich, Brain Imaging Ctr W, Julich, Germany; [Weder, Bruno J.] Univ Bern, CH-3012 Bern, Switzerland	Kantonsspital St. Gallen; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Oxford; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; Research Center Julich; University of Bern	Hartmann, S (corresponding author), Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland.	bruno.weder@kssg.ch	Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Abela, Eugenio/0000-0002-9356-1450; Weder, Bruno/0000-0002-8106-9899	Deutsche Forschungsgemeinschaft [SFB 194]; Swiss National Foundation [3200B0-118018/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by the Deutsche Forschungsgemeinschaft (SFB 194) and the Swiss National Foundation (SNF 3200B0-118018/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Gene E., 1994, Human Brain Mapping, V2, P79, DOI 10.1002/hbm.460020108; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Bernard FA, 2004, NEUROIMAGE, V22, P1704, DOI 10.1016/j.neuroimage.2004.03.036; Binkofski F, 2001, BRAIN, V124, P132, DOI 10.1093/brain/124.1.132; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Binkofski F, 1999, EXP BRAIN RES, V128, P210, DOI 10.1007/s002210050838; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Bohlhalter S, 2002, BRAIN, V125, P2537, DOI 10.1093/brain/awf245; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; CASELLI RJ, 1993, NEUROLOGY, V43, P762, DOI 10.1212/WNL.43.4.762; Choi HJ, 2006, J COMP NEUROL, V495, P53, DOI 10.1002/cne.20849; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Ehrsson HH, 2000, EUR J NEUROSCI, V12, P3385, DOI 10.1046/j.1460-9568.2000.00209.x; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Floyer-Lea A, 2004, J NEUROPHYSIOL, V92, P2405, DOI 10.1152/jn.01092.2003; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gottwald B, 2004, J NEUROL NEUROSUR PS, V75, P1524, DOI 10.1136/jnnp.2003.018093; Gray JR, 2001, J COMP PHYSIOL A, V187, P115, DOI 10.1007/s003590100182; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Habeck C, 2005, COGNITIVE BRAIN RES, V23, P207, DOI 10.1016/j.cogbrainres.2004.10.010; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; Hermsdorfer J, 2001, NEUROIMAGE, V14, P149, DOI 10.1006/nimg.2001.0796; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Horwitz Barry, 1994, Human Brain Mapping, V2, P112, DOI 10.1002/hbm.460020111; Iidaka T, 2000, COGNITIVE BRAIN RES, V9, P73, DOI 10.1016/S0926-6410(99)00047-6; Iwamura Y, 1998, CURR OPIN NEUROBIOL, V8, P522, DOI 10.1016/S0959-4388(98)80041-X; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Kaas AL, 2007, CEREB CORTEX, V17, P1637, DOI 10.1093/cercor/bhl074; KOOB GF, 1988, ANN N Y ACAD SCI, V537, P216; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Lau HC, 2004, NEUROIMAGE, V21, P1407, DOI 10.1016/j.neuroimage.2003.10.034; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McIntosh AR, 2004, NEUROIMAGE, V23, P764, DOI 10.1016/j.neuroimage.2004.05.018; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; MOELLER JR, 1987, J CEREBR BLOOD F MET, V7, P649, DOI 10.1038/jcbfm.1987.118; MOELLER JR, 2006, INT J BIOMED IMAG, P1; Molenberghs P, 2007, CEREB CORTEX, V17, P2703, DOI 10.1093/cercor/bhl179; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; Picard N, 1997, J NEUROPHYSIOL, V77, P2197, DOI 10.1152/jn.1997.77.4.2197; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; ROLAND PE, 1987, BRAIN RES REV, V12, P1, DOI 10.1016/0165-0173(87)90017-8; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; ROLAND PE, 1993, BRAIN ACTIVATION, P83; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; Seitz RJ, 2001, BRAIN RES BULL, V54, P299, DOI 10.1016/S0361-9230(00)00438-X; SEITZ RJ, 1991, EUR J NEUROSCI, V3, P481, DOI 10.1111/j.1460-9568.1991.tb00835.x; Seitz RJ, 2000, EXP BRAIN RES, V133, P71, DOI 10.1007/s002210000402; Seitz Rudiger J, 2003, Adv Neurol, V93, P281; Seitz RJ, 2006, NEUROPSYCHOLOGY, V20, P743, DOI 10.1037/0894-4105.20.6.743; Smith JF, 2006, NEUROIMAGE, V32, P325, DOI 10.1016/j.neuroimage.2005.12.010; Stoeckel MC, 2004, EUR J NEUROSCI, V19, P1067, DOI 10.1111/j.0953-816X.2004.03185.x; Stoeckel MC, 2003, NEUROIMAGE, V19, P1103, DOI 10.1016/S1053-8119(03)00182-4; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Talairach J., 1998, COPLANAR STEREOTAXIC; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Weder B, 1998, EXP BRAIN RES, V120, P104, DOI 10.1007/s002210050382; Weder B, 2000, HUM BRAIN MAPP, V11, P131, DOI 10.1002/1097-0193(200011)11:3<131::AID-HBM10>3.3.CO;2-D; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499; Zysset S, 2006, NEUROIMAGE, V31, P1380, DOI 10.1016/j.neuroimage.2006.01.017	70	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3831	10.1371/journal.pone.0003831	http://dx.doi.org/10.1371/journal.pone.0003831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048104	gold, Green Submitted, Green Published			2022-12-25	WOS:000265452000005
J	Managbanag, JR; Witten, TM; Bonchev, D; Fox, LA; Tsuchiya, M; Kennedy, BK; Kaeberlein, M				Managbanag, J. R.; Witten, Tarynn M.; Bonchev, Danail; Fox, Lindsay A.; Tsuchiya, Mitsuhiro; Kennedy, Brian K.; Kaeberlein, Matt			Shortest-Path Network Analysis Is a Useful Approach toward Identifying Genetic Determinants of Longevity	PLOS ONE			English	Article							REPLICATIVE LIFE-SPAN; YEAST; CELLS; IDENTIFICATION; PROTEINS; SYSTEMS; RETURN; TIME; TOR	Background: Identification of genes that modulate longevity is a major focus of aging-related research and an area of intense public interest. In addition to facilitating an improved understanding of the basic mechanisms of aging, such genes represent potential targets for therapeutic intervention in multiple age-associated diseases, including cancer, heart disease, diabetes, and neurodegenerative disorders. To date, however, targeted efforts at identifying longevity-associated genes have been limited by a lack of predictive power, and useful algorithms for candidate gene-identification have also been lacking. Methodology/Principal Findings: We have utilized a shortest-path network analysis to identify novel genes that modulate longevity in Saccharomyces cerevisiae. Based on a set of previously reported genes associated with increased life span, we applied a shortest-path network algorithm to a pre-existing protein-protein interaction dataset in order to construct a shortest-path longevity network. To validate this network, the replicative aging potential of 88 single-gene deletion strains corresponding to predicted components of the shortest-path longevity network was determined. Here we report that the single-gene deletion strains identified by our shortest-path longevity analysis are significantly enriched for mutations conferring either increased or decreased replicative life span, relative to a randomly selected set of 564 single-gene deletion strains or to the current data set available for the entire haploid deletion collection. Further, we report the identification of previously unknown longevity genes, several of which function in a conserved longevity pathway believed to mediate life span extension in response to dietary restriction. Conclusions/Significance: This work demonstrates that shortest-path network analysis is a useful approach toward identifying genetic determinants of longevity and represents the first application of network analysis of aging to be extensively validated in a biological system. The novel longevity genes identified in this study are likely to yield further insight into the molecular mechanisms of aging and age-associated disease.	[Managbanag, J. R.; Witten, Tarynn M.; Bonchev, Danail] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA; [Bonchev, Danail] Virginia Commonwealth Univ, Dept Math & Applied Math, Richmond, VA 23284 USA; [Fox, Lindsay A.; Tsuchiya, Mitsuhiro; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Managbanag, JR (corresponding author), Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA.	tmwitten@vcu.edu; kaeber@u.washington.edu		Kennedy, Brian/0000-0002-5754-1874; Kaeberlein, Matt/0000-0002-1311-3421	University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging; NIH [5P30 AG013280, RO1 AG025549]; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [P30AG013280, R01AG025549, P50AG005136] Funding Source: NIH RePORTER	University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by a pilot award to M.K. from the University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging NIH Grant 5P30 AG013280, an award from the Ellison Medical Foundation to B.K.K. and M.K. and by National Institutes of Health Grant RO1 AG025549 to B.K.K. M.K. is an Ellison Medical Foundation New Scholar in Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bonchev D, 2004, CHEM BIODIVERS, V1, P312, DOI 10.1002/cbdv.200490028; de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2005, MECH AGEING DEV, V126, P17, DOI 10.1016/j.mad.2004.09.013; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2002, MECH AGEING DEV, V123, P1115, DOI 10.1016/S0047-6374(02)00011-8; Kaeberlein M, 2006, HDB MODELS HUMAN AGI, P109; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kaeberlein M, 2006, SCIENCE, V312, DOI 10.1126/science.1124608; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith ED, 2008, GENOME RES, V18, P564, DOI 10.1101/gr.074724.107; STEFFAN KK, 2008, CELL; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; STEINKRAUS KA, 2008, AGING CELL; Tsuchiya M, 2006, AGING CELL, V5, P505, DOI 10.1111/j.1474-9726.2006.00240.x; WARD MP, 1994, MOL CELL BIOL, V14, P5619, DOI 10.1128/MCB.14.9.5619; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WITTEN M, 1984, MECH AGEING DEV, V27, P323, DOI 10.1016/0047-6374(84)90056-3; WITTEN M, 1985, MECH AGEING DEV, V32, P141, DOI 10.1016/0047-6374(85)90077-6; Witten TM, 2007, CHEM BIODIVERS, V4, P2639, DOI 10.1002/cbdv.200790216; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; ZHANG LV, 2005, J BIOL LONDON, V4, pNIL1	32	90	91	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2008	3	11							e3802	10.1371/journal.pone.0003802	http://dx.doi.org/10.1371/journal.pone.0003802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YD	19030232	Green Published, gold, Green Submitted			2022-12-25	WOS:000265451100002
J	Kantor, L; Pinchasi, D; Mintz, M; Hathout, Y; Vanderver, A; Elroy-Stein, O				Kantor, Liraz; Pinchasi, Dalia; Mintz, Michelle; Hathout, Yetrib; Vanderver, Adeline; Elroy-Stein, Orna			A Point Mutation in Translation Initiation Factor 2B Leads to a Continuous Hyper Stress State in Oligodendroglial-Derived Cells	PLOS ONE			English	Article								Background: Mutations in eukaryotic translation initiation factor 2B (eIF2B) cause Childhood Ataxia with CNS Hypomyelination (CACH), also known as Vanishing White Matter disease (VWM). The disease is manifested by loss of brain myelin upon physiological stress. In a previous study, we showed that fibroblasts isolated from CACH/VWM patients are hypersensitive to pharmacologically-induced endoplasmic reticulum (ER) stress. Since brain cells from affected individuals are not available for research, we wished to assess the effect of eIF2B mutation on oligodendroglial-derived cells. Methodology/Principal Findings: A rat oligodendroglial-derived cell line was used for a stable knock-down of eIF2B5 followed by stable expression of mutated eIF2B5(R195H) cDNA. In response to a pharmacological ER-stress agent, eIF2B5(R195H) expressing cells exhibited heightened ER-stress response demonstrated by hyper induction of ATF4, GADD34, Bip, PDIA1, PDIA3, PDIA4 and PDIA6 proteins. Moreover, even in the absence of a pharmacological stress agent, eIF2B5(R195H)-expressing cells exhibited high basal levels of ATF4, GADD34 and ER-associated Bip, PDIA1 and PDIA3. Significance: The data provide evidence that oligodendroglial-derived cells expressing a mutated eIF2B constantly use their stress response mechanism as an adaptation mean in order to survive. The current study is the first to demonstrate the effects of eIF2B5 mutation on ER homeostasis in oligodendroglial-derived cells.	[Kantor, Liraz; Pinchasi, Dalia; Elroy-Stein, Orna] Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; [Mintz, Michelle; Hathout, Yetrib; Vanderver, Adeline] Childrens Natl Med Ctr, Ctr Genet Med, Washington, DC USA	Tel Aviv University; Children's National Health System	Kantor, L (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel.	ornaes@tauex.tau.ac.il	Vanderver, Adeline/CAG-5072-2022	Vanderver, Adeline/0000-0002-6290-6751; Elroy-Stein, Orna/0000-0002-3716-1540	European Leukodystrophy Association; Adams Super Center; USA-Israel Bi-National Science Foundation [2003364]; NIH [IDDRC 1P30HD40677, 5R24 HD050846]; Parson family foundation; Children's Health Research Center at Children's National Medical Center [K12HD001399]; American Academy of Neurology Foundation; Postdoctoral Training in Developmental Disabilities Research [5T32HD046388]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846, T32HD046388, K12HD001399, P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060695] Funding Source: NIH RePORTER	European Leukodystrophy Association; Adams Super Center; USA-Israel Bi-National Science Foundation(US-Israel Binational Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parson family foundation; Children's Health Research Center at Children's National Medical Center; American Academy of Neurology Foundation; Postdoctoral Training in Developmental Disabilities Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the European Leukodystrophy Association, Adams Super Center and the USA-Israel Bi-National Science Foundation grant #2003364 (to OES), NIH grants: IDDRC 1P30HD40677 and 5R24 HD050846, Parson family foundation (to YH), the Children's Health Research Center at Children's National Medical Center (#K12HD001399) and the American Academy of Neurology Foundation (to AV), and Postdoctoral Training in Developmental Disabilities Research #5T32HD046388 (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; EIZENBERG O, 1995, EMBO J, V14, P1136, DOI 10.1002/j.1460-2075.1995.tb07097.x; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Gerlitz G, 2002, EUR J BIOCHEM, V269, P2810, DOI 10.1046/j.1432-1033.2002.02974.x; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P949, DOI 10.1097/01.WCB.0000077641.41248.EA; Hendershot LM, 2004, MT SINAI J MED, V71, P289; HENSEL G, 1994, EUR J CELL BIOL, V63, P208; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Kimball SR, 1996, PROG NUCLEIC ACID RE, V54, P165, DOI 10.1016/S0079-6603(08)60363-3; KIMBALL SR, 1994, BBA-GEN SUBJECTS, V1201, P473, DOI 10.1016/0304-4165(94)90079-5; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lin WS, 2007, J CLIN INVEST, V117, P448, DOI 10.1172/JCI29571; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mintz M, 2008, J PROTEOME RES, V7, P2435, DOI 10.1021/pr700842m; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Paschen W, 2004, J NEUROCHEM, V90, P694, DOI 10.1111/j.1471-4159.2004.02555.x; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schiffmann R, 2006, MOL GENET METAB, V88, P7, DOI 10.1016/j.ymgme.2005.10.019; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; van der Voorn JP, 2005, J NEUROPATH EXP NEUR, V64, P770, DOI 10.1097/01.jnen.0000178446.41595.3a; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620	31	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3783	10.1371/journal.pone.0003783	http://dx.doi.org/10.1371/journal.pone.0003783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023445	Green Submitted, Green Published			2022-12-25	WOS:000265448800004
J	Kalaitzidis, D; Neel, BG				Kalaitzidis, Demetrios; Neel, Benjamin G.			Flow-Cytometric Phosphoprotein Analysis Reveals Agonist and Temporal Differences in Responses of Murine Hematopoietic Stem/Progenitor Cells	PLOS ONE			English	Article							SELF-RENEWAL; BONE-MARROW; STEM-CELLS; THROMBOPOIETIN; EXPRESSION; PROGENITOR; PROLIFERATION	Hematopoietic stem cells (HSCs) are probably the best-studied adult tissue-restricted stem cells. Although methods for flow cytometric detection of phosphoproteins in hematopoeitic progenitors and mature cells are available, analogous protocols for HSC are lacking. We present a robust method to study intracellular signaling in immunophenotypically-defined murine HSC/progenitor cell (HPC)-enriched populations. Using this method, we uncover differences in the response dynamics of several phosphoproteins representative of the Ras/MAP-Kinase(K), PI3K, mTOR and Jak/STAT pathways in HSC/HPCs stimulated by Scf, Thpo, as well as several other important HSC/HPC agonists.	[Kalaitzidis, Demetrios; Neel, Benjamin G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Canc Biol Program, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kalaitzidis, D (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA.	dkalaitzidis@partners.org			NIH [5T32-HL07623-20];  [RO1 CA114945];  [R37 CA49152]; NATIONAL CANCER INSTITUTE [R37CA049152, R01CA114945] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	D.K. was supported by an NIH postdoctoral institutional training grant in Hematology (5T32-HL07623-20). This work was supported by RO1 CA114945 and R37 CA49152 awarded to B.G.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; CHRISTENSEN JL, 2001, P NATL ACAD SCI USA, V198, P305; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Gilner JB, 2007, STEM CELLS, V25, P279, DOI 10.1634/stemcells.2006-0076; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krutzik PO, 2005, J IMMUNOL, V175, P2366, DOI 10.4049/jimmunol.175.4.2366; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Ku H, 1996, BLOOD, V87, P4544, DOI 10.1182/blood.V87.11.4544.bloodjournal87114544; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Sharma Y, 2007, EXP HEMATOL, V35, P214, DOI 10.1016/j.exphem.2006.10.001; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Snow JW, 2002, BLOOD, V99, P95, DOI 10.1182/blood.V99.1.95; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418	28	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3776	10.1371/journal.pone.0003776	http://dx.doi.org/10.1371/journal.pone.0003776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020663	Green Submitted, Green Published, gold			2022-12-25	WOS:000265448600009
J	Kovacheva, VP; Davison, JM; Mellott, TJ; Rogers, AE; Yang, S; O'Brien, MJ; Blusztajn, JK				Kovacheva, Vesela P.; Davison, Jessica M.; Mellott, Tiffany J.; Rogers, Adrianne E.; Yang, Shi; O'Brien, Michael J.; Blusztajn, Jan Krzysztof			Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival	FASEB JOURNAL			English	Article						DNA methylation; epigenetic; diet; breast cancer; nutrition; pregnancy	BREAST-CANCER CELLS; ANTIESTROGEN RESISTANCE; EPIGENETIC REGULATION; GLAND CARCINOGENESIS; COLORECTAL-CANCER; DNA METHYLATION; MESSENGER-RNA; RATS; IDENTIFICATION; HYPERMETHYLATION	Choline is an essential nutrient that serves as a donor of metabolic methyl groups used during gestation to establish the epigenetic DNA methylation patterns that modulate tissue-specific gene expression. Because the mammary gland begins its development prenatally, we hypothesized that choline availability in utero may affect the gland's susceptibility to cancer. During gestational days 11-17, pregnant rats were fed a control, choline-supplemented, or choline-deficient diet (8, 36, and 0 mmol/kg of choline, respectively). On postnatal day 65, the female offspring received 25 mg/kg of a carcinogen 7,12-dimethylbenz[alpha]anthracene. Approximately 70% of the rats developed mammary adenocarcinomas; prenatal diet did not affect tumor latency, incidence, size, and multiplicity. Tumor growth rate was inversely related to choline content in the prenatal diet, resulting in 50% longer survival until euthanasia, determined by tumor size, of the prenatally choline-supplemented rats compared with the prenatally choline-deficient rats. This was accompanied by distinct expression patterns of similar to 70 genes in tumors derived from the three dietary groups. Tumors from the prenatally choline-supplemented rats overexpressed genes that confer favorable prognosis in human cancers (Klf6, Klf9, Nid2, Ntn4, Per1, and Txnip) and underexpressed those associated with aggressive disease (Bcar3, Cldn12, Csf1, Jag1, Lgals3, Lypd3, Nme1, Ptges2, Ptgs1, and Smarcb1). DNA methylation within the tumor suppressor gene, stratifin (Sfn, 14-3-3 sigma), was proportional to the prenatal choline supply and correlated inversely with the expression of its mRNA and protein in tumors, suggesting that an epigenetic mechanism may underlie the altered molecular phenotype and tumor growth. Our results suggest a role for adequate maternal choline nutrition during pregnancy in prevention/alleviation of breast cancer in daughters.-Kovacheva, V. P., Davison, J. M., Mellott, T. J., Rogers, A. E., Yang, S., O'Brien, M. J., Blusztajn, J. K. Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival. (2009) FASEB J. 23, 1054-1063 (2009)	[Kovacheva, Vesela P.; Davison, Jessica M.; Mellott, Tiffany J.; Rogers, Adrianne E.; Yang, Shi; O'Brien, Michael J.; Blusztajn, Jan Krzysztof] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University	Blusztajn, JK (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, 72 E Concord St,L804, Boston, MA 02118 USA.	jbluszta@bu.edu	O'Brien, Michael J/R-7179-2019	/0000-0001-8438-3122; Mellott, Tiffany/0000-0003-3287-9374; Yang, Shi/0000-0001-8316-6484; O'Brien, Michael J/0000-0003-1124-3537	National Institute of Health [CA120488, AG009525]; NATIONAL CANCER INSTITUTE [R21CA120488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Adam Lerner for the anti-BCAR3 antibody and Patrick Hogan and Bethany Shade for assistance. The Molecular Genetics Core Facility at Children's Hospital Boston performed the microarray analysis. These studies were supported by National Institute of Health grants CA120488 and AG009525.	Alshafie GA, 2000, ONCOL REP, V7, P1377; [Anonymous], 2000, METHODS MAMMARY GLAN; Bertagnolo V, 2006, INT J ONCOL, V28, P863; Blusztajn JK, 1998, SCIENCE, V281, P794, DOI 10.1126/science.281.5378.794; Buendia MA, 2007, J HEPATOL, V46, P546, DOI 10.1016/j.jhep.2007.01.005; Cai DP, 2003, CANCER RES, V63, P6802; Crawford NPS, 2008, CLIN EXP METASTAS, V25, P357, DOI 10.1007/s10585-008-9146-6; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esseghir S, 2007, CLIN CANCER RES, V13, P3164, DOI 10.1158/1078-0432.CCR-07-0224; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Food andNutrition Board Institute of Medicine, 1998, DIET REF INT THIAM R, DOI 10.17226/6015; Friess H, 2003, CELL MOL LIFE SCI, V60, P1180, DOI 10.1007/s00018-003-3036-5; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Grone J, 2007, INT J COLORECTAL DIS, V22, P651, DOI 10.1007/s00384-006-0197-3; Heimann R, 2000, EUR J CANCER, V36, P1631, DOI 10.1016/S0959-8049(00)00151-9; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hilakivi-Clarke L, 2006, TRENDS ENDOCRIN MET, V17, P340, DOI 10.1016/j.tem.2006.09.002; HilakiviClarke L, 1996, JNCI-J NATL CANCER I, V88, P1821, DOI 10.1093/jnci/88.24.1821; HilakiviClarke L, 1997, P NATL ACAD SCI USA, V94, P9372, DOI 10.1073/pnas.94.17.9372; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jeronimo C, 2008, BREAST CANCER RES TR, V109, P27, DOI 10.1007/s10549-007-9620-x; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Korkola JE, 2003, CANCER RES, V63, P7167; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Kuramoto T, 2002, CANCER RES, V62, P3592; LEONE A, 1993, ONCOGENE, V8, P855; Lewis EM, 2002, DRUG CHEM TOXICOL, V25, P437, DOI 10.1081/DCT-120014794; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin JF, 2007, INT J CANCER, V121, P2596, DOI 10.1002/ijc.23016; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; Maffini MV, 2004, J CELL SCI, V117, P1495, DOI 10.1242/jcs.01000; Mayoral MA, 2008, CANCER INVEST, V26, P615, DOI 10.1080/07357900701837051; McCann JC, 2006, NEUROSCI BIOBEHAV R, V30, P696, DOI 10.1016/j.neubiorev.2005.12.003; Meck WH, 2008, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.007.2007; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; Meck WH, 1999, DEV BRAIN RES, V118, P51, DOI 10.1016/S0165-3806(99)00105-4; Medina D, 2005, J CELL SCI, V118, P123, DOI 10.1242/jcs.01597; Mellott TJ, 2007, FASEB J, V21, P1311, DOI 10.1096/fj.06-6597com; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Oshiro MM, 2005, NEOPLASIA, V7, P799, DOI 10.1593/neo.05274; Ouatas T, 2003, J BIOENERG BIOMEMBR, V35, P73, DOI 10.1023/A:1023497924277; Papaconstantinou AD, 2006, INT J CANCER, V118, P17, DOI 10.1002/ijc.21247; Paret C, 2007, BRIT J CANCER, V97, P1146, DOI 10.1038/sj.bjc.6604012; Resseguie M, 2007, FASEB J, V21, P2622, DOI 10.1096/fj.07-8227com; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Russo J., 1987, The mammary gland. Development, regulation, and function., P67; RUSSO J, 1990, LAB INVEST, V62, P244; Sapi E, 2004, EXP BIOL MED, V229, P1; Shan L, 2005, TOXICOL PATHOL, V33, P768, DOI 10.1080/01926230500437027; Shan L, 2005, CARCINOGENESIS, V26, P503, DOI 10.1093/carcin/bgh330; Shan L, 2004, AM J PATHOL, V165, P191, DOI 10.1016/S0002-9440(10)63288-9; Shan L, 2002, CARCINOGENESIS, V23, P1561, DOI 10.1093/carcin/23.10.1561; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Smalley MJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1834; Stark AH, 2003, NUTR CANCER, V46, P59, DOI 10.1207/S15327914NC4601_08; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Thorat MA, 2008, MODERN PATHOL, V21, P15, DOI 10.1038/modpathol.3800970; Thornton S, 2003, J MOL MED, V81, P536, DOI 10.1007/s00109-003-0461-8; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulazzi L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-17; Umbricht CB, 2001, ONCOGENE, V20, P3348, DOI 10.1038/sj.onc.1204438; van Agthoven T, 1998, EMBO J, V17, P2799, DOI 10.1093/emboj/17.10.2799; Velarde MC, 2007, MOL ENDOCRINOL, V21, P2988, DOI 10.1210/me.2007-0242; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Winter SL, 2007, NEOPLASIA, V9, P797, DOI 10.1593/neo.07595; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; Xue F, 2007, LANCET ONCOL, V8, P1088, DOI 10.1016/S1470-2045(07)70377-7; Yu Y, 2002, ONCOGENE, V21, P7557, DOI 10.1038/sj.onc.1205961; ZEISEL SH, 1995, J NUTR, V125, P3049; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	83	38	40	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2009	23	4					1054	1063		10.1096/fj.08-122168	http://dx.doi.org/10.1096/fj.08-122168			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZO	19047067	Green Published			2022-12-25	WOS:000266651600009
J	Chastre, E; Abdessamad, M; Kruglov, A; Bruyneel, E; Bracke, M; Di Gioia, Y; Beckerle, MC; van Roy, F; Kotelevets, L				Chastre, Eric; Abdessamad, Mahmoud; Kruglov, Alexey; Bruyneel, Erik; Bracke, Marc; Di Gioia, Yolande; Beckerle, Mary C.; van Roy, Frans; Kotelevets, Larissa			TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness	FASEB JOURNAL			English	Article						PTEN; PDZ domain; NF-kappa B; E-cadherins; PI3-kinase; Akt	NF-KAPPA-B; ZYXIN-RELATED PROTEIN; LIM-DOMAIN PROTEIN; CADHERIN EXPRESSION; UP-REGULATION; ACTIVATION; JUNCTIONS; INTERACTS; FAMILY; ZRP-1	We recently established the critical role of the PTEN/MAGI-1b signalosome in stabilization of cell-cell contacts and suppression of invasiveness. The PTEN tumor suppressor is recruited to E-cadherin junctional complexes through the binding to the second PDZ domain of the MAGI-1b scaffolding molecule, whereas beta-catenin interacts with the fifth PDZ domain. To identify additional effectors of this signalosome, we used yeast 2-hybrid screening. Among the clones identified, we focused on TRIP6, which belongs to the zyxin family of proteins. We demonstrated that TRIP6 interacted directly with MAGI-1b by binding to its fifth PDZ domain. Ectopic expression of TRIP6 induced invasiveness in the epithelial MDCK and MDCKts-src cells in a PI3-kinase-and a NF-kappa B-dependent manner and impaired cell-cell aggregation at least in part by uncoupling adherens junctional complexes from the cytoskeleton. The TRIP6Stop473 mutant, which lacks the PDZ binding motif, was still able to increase NF-kappa B and Akt activities but did not promote invasiveness or interfere with cell-cell aggregation. Intracellular delivery of competing peptides corresponding to TRIP6 or beta-catenin C terminus restored invasive properties in MDCKts-src TRIP6Stop473 cells, highlighting the requirement of PDZ scaffolds in junctional complexes activity. TRIP6 overexpression in colon tumors suggest its critical role in cancer progression.-Chastre, E., Abdessamad, M., Kruglov, A., Bruyneel, E., Bracke, M., Di Gioia, Y., Beckerle, M. C., van Roy, F., Kotelevets, L. TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness. FASEB J. 23, 916-928 (2009)	[Chastre, Eric] Univ Paris 07, INSERM, Ctr Rech Biomed Bichat Beaujon CRB3, Fac Med Bichat,U773, F-75018 Paris, France; [Kruglov, Alexey] Russian Acad Sci, Inst Theoret & Expt Biophys, Moscow, Russia; [Bruyneel, Erik; Bracke, Marc] Ghent Univ Hosp, Expt Cancerol Lab, B-9000 Ghent, Belgium; [Beckerle, Mary C.] Univ Utah, Dept Biol, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Beckerle, Mary C.] Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT USA; [van Roy, Frans] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [van Roy, Frans] Univ Ghent VIB, Dept Mol Biol, Ghent, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; Ghent University; Ghent University Hospital; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Chastre, E (corresponding author), Univ Paris 07, INSERM, Ctr Rech Biomed Bichat Beaujon CRB3, Fac Med Bichat,U773, 16 Rue Henri Huchard, F-75018 Paris, France.	eric.chastre@inserm.fr; larissa.kotelevets@inserm.fr	van Roy, Frans M/C-6123-2009; CHASTRE, Eric/L-8446-2018; Kruglov, Alexey/A-6057-2014	van Roy, Frans M/0000-0003-4358-1039; CHASTRE, Eric/0000-0002-8993-1228; Kruglov, Alexey/0000-0001-9215-7387	INSERM; Association pour la Recherche contre le Cancer (ARC, France); INSERM/DGRSRT (Tunisia); Interuniversity Attraction Pools 5 of the Federal Science Policy (Belgium); European Union (BRECOSM); ARC and INSERM; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche contre le Cancer (ARC, France)(Fondation ARC pour la Recherche sur le Cancer); INSERM/DGRSRT (Tunisia)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Interuniversity Attraction Pools 5 of the Federal Science Policy (Belgium); European Union (BRECOSM)(European Commission); ARC and INSERM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully thank Dr. I. Dobrosotskaya (University of Texas, Dallas, TX, USA) for providing the MAGI-1b expression vector. We thank S. Benadda (IFR02, Paris, France) for her assistance in confocal microscopy. This work was supported by INSERM, the Association pour la Recherche contre le Cancer (ARC, France), the partnership INSERM/DGRSRT (Tunisia), the Fund for Scientific ResearchFlanders, the Interuniversity Attraction Pools 5 of the Federal Science Policy (Belgium), Brussels, and FP6 of the European Union (BRECOSM). L. K. was a recipient of a FEBS fellowship and was supported by the ARC and INSERM.	Andre T, 2000, INT J CANCER, V86, P174, DOI 10.1002/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.3.CO;2-5; Bai CY, 2007, J CELL SCI, V120, P2828, DOI 10.1242/jcs.03477; Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104; Boterberg T, 2001, Methods Mol Med, V58, P33, DOI 10.1385/1-59259-137-X:033; Bracke M E, 2001, Methods Mol Med, V58, P81, DOI 10.1385/1-59259-137-X:081; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; Cuppen E, 2000, EUR J CELL BIOL, V79, P283, DOI 10.1078/S0171-9335(04)70031-X; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Guryanova OA, 2005, MOL BIOL+, V39, P905; Hansen MDH, 2006, J BIOL CHEM, V281, P16178, DOI 10.1074/jbc.M512771200; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kassel O, 2004, GENE DEV, V18, P2518, DOI 10.1101/gad.322404; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Kotelevets L, 1998, J BIOL CHEM, V273, P14138, DOI 10.1074/jbc.273.23.14138; Kotelevets L, 2001, J CELL BIOL, V155, P1129, DOI 10.1083/jcb.200105109; Lai YJ, 2005, MOL CELL BIOL, V25, P5859, DOI 10.1128/MCB.25.14.5859-5868.2005; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; Murthy KK, 1999, J BIOL CHEM, V274, P20679, DOI 10.1074/jbc.274.29.20679; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Petit MMR, 2005, FEBS LETT, V579, P5061, DOI 10.1016/j.febslet.2005.08.012; Petit MMR, 1996, GENOMICS, V36, P118, DOI 10.1006/geno.1996.0432; Pratt SJ, 2005, J CELL BIOL, V168, P813, DOI 10.1083/jcb.200406083; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Rahmani M, 2001, ONCOGENE, V20, P5132, DOI 10.1038/sj.onc.1204678; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Williams G, 1998, INDEX CENSORSHIP, V27, P186, DOI 10.1080/03064229808536405; Xu J, 2004, J BIOL CHEM, V279, P10459, DOI 10.1074/jbc.M311891200; Yi JS, 2002, J BIOL CHEM, V277, P9580, DOI 10.1074/jbc.M106922200; Yi JS, 1998, GENOMICS, V49, P314, DOI 10.1006/geno.1998.5248	35	49	51	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					916	928		10.1096/fj.08-106344	http://dx.doi.org/10.1096/fj.08-106344			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19017743				2022-12-25	WOS:000265506300027
J	Tan, YW; Chan, SL; Ong, TC; Yit, LY; Tiong, YS; Chew, FT; Sivaraman, J; Mok, YK				Tan, Yih Wan; Chan, Siew Leong; Ong, Tan Ching; Yit, Le Yau; Tiong, Yuen Sung; Chew, Fook Tim; Sivaraman, J.; Mok, Yu Keung			Structures of Two Major Allergens, Bla g 4 and Per a 4, from Cockroaches and Their IgE Binding Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOCALIN PROTEIN FAMILY; BOVINE BETA-LACTOGLOBULIN; CRYSTAL-STRUCTURE; MOLECULAR-STRUCTURE; STRUCTURE ALIGNMENT; APOLIPOPROTEIN-D; RESOLUTION; ANTIBODY; CLONING; SITE	Inhalant allergens from cockroaches are an important cause of asthma to millions of individuals worldwide. Here we report for the first time the structures of two major cockroach allergens, Bla g 4 and Per a 4, that adopt a typical lipocalin fold but with distinct structural features as compared with other known lipocalin allergens. Both Bla g 4 and Per a 4 contain two long-range disulfide bonds linking the N and C termini to a beta-barrel. The C-terminal helix of Bla g 4 is bent and greatly extended toward the N terminus. Bla g 4 is found to be a monomer, whereas Per a 4 exists as a dimer in solution with a novel dimeric interface involving residues from loops at the top and bottom of the beta-barrel. Putative ligand binding sites of both allergens are determined by docking of the juvenile hormone III inside the beta-barrel and found to interact with the ligand using non-conserved residues. Bla g 4 and Per a 4 are found to be cross-reactive in sera IgE binding, at least in the Singaporean Chinese population tested. A major IgE binding epitope unique to Per a 4 is found on the loops at the bottom of the beta-barrel that may aid the development of hypoallergens for immunotherapy.	[Tan, Yih Wan; Chan, Siew Leong; Ong, Tan Ching; Yit, Le Yau; Tiong, Yuen Sung; Chew, Fook Tim; Sivaraman, J.; Mok, Yu Keung] Natl Univ Singapore, Dept Biol Sci, Singapore 17543, Singapore	National University of Singapore	Sivaraman, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 17543, Singapore.	dbsjayar@dbs.nus.edu.sg; dbsmokh@nus.edu.sg	Sivaraman, J/H-8028-2012; Chew, Fook Tim/E-7259-2010; Mok, Yu Keung/H-8019-2012	Chew, Fook Tim/0000-0003-1337-5146; Mok, Yu Keung/0000-0002-2829-4878; J, Sivaraman/0000-0001-9781-5326	Academic Research Fund; National University of Singapore [R-154-000-349-112, R-154-000-245112]; Biomedical Research Council [04/1/21/19/315]; Agency for Science Technology and Research (A*STAR)	Academic Research Fund(Ministry of Education, Singapore); National University of Singapore(National University of Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by Academic Research Fund, National University of Singapore Grants R-154-000-349-112 ( to Y. K. M.) and R-154-000-245112 ( to J.S.) and Biomedical Research Council Grant 04/1/21/19/315 from the Agency for Science Technology and Research (A*STAR), Singapore ( to F. T. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arruda LK, 1995, J BIOL CHEM, V270, P31196, DOI 10.1074/jbc.270.52.31196; ARRUDA LK, 1995, J BIOL CHEM, V270, P19563, DOI 10.1074/jbc.270.33.19563; BERNTON HS, 1964, J ALLERGY, V35, P506, DOI 10.1016/0021-8707(64)90082-6; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Breustedt DA, 2006, BBA-PROTEINS PROTEOM, V1764, P161, DOI 10.1016/j.bbapap.2005.12.006; Brownlow S, 1997, STRUCTURE, V5, P481, DOI 10.1016/S0969-2126(97)00205-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calderone V, 2003, J MOL BIOL, V329, P841, DOI 10.1016/S0022-2836(03)00468-6; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Chaudhuri BN, 1999, ACTA CRYSTALLOGR D, V55, P753, DOI 10.1107/S0907444998017211; Chew FT, 1999, ALLERGY, V54, P1150, DOI 10.1034/j.1398-9995.1999.00050.x; DeLano W, 2002, PYMOL 0 99; Eggleston PA, 1998, J ALLERGY CLIN IMMUN, V102, P563, DOI 10.1016/S0091-6749(98)70272-6; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan Y, 2005, INSECT MOL BIOL, V14, P45, DOI 10.1111/j.1365-2583.2004.00530.x; FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Gao YF, 2007, J ALLERGY CLIN IMMUN, V120, P105, DOI 10.1016/j.jaci.2007.02.032; Gore JC, 2007, ANNU REV ENTOMOL, V52, P439, DOI 10.1146/annurev.ento.52.110405.091313; HOLDEN HM, 1987, EMBO J, V6, P1565, DOI 10.1002/j.1460-2075.1987.tb02401.x; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Kauppinen J, 1999, CLIN EXP ALLERGY, V29, P989; Kontopidis G, 2002, J MOL BIOL, V318, P1043, DOI 10.1016/S0022-2836(02)00017-7; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Lucke C, 1999, EUR J BIOCHEM, V266, P1210, DOI 10.1046/j.1432-1327.1999.00984.x; Melen E, 1999, J ALLERGY CLIN IMMUN, V103, P859, DOI 10.1016/S0091-6749(99)70430-6; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Ortlund E, 2002, BIOCHEMISTRY-US, V41, P7030, DOI 10.1021/bi025696i; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pomes A, 2007, PROTEIN PEPTIDE LETT, V14, P960, DOI 10.2174/092986607782541178; Pomes A, 2002, AM J RESP CRIT CARE, V165, P391, DOI 10.1164/ajrccm.165.3.2104027; REDDY BMMMK, 1992, MOL IMMUNOL, V29, P511, DOI 10.1016/0161-5890(92)90008-L; Rouvinen J, 1999, J BIOL CHEM, V274, P2337, DOI 10.1074/jbc.274.4.2337; Shimamoto S, 2007, J BIOL CHEM, V282, P31373, DOI 10.1074/jbc.M700123200; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Smith W, 2004, CLIN EXP ALLERGY, V34, P1732, DOI 10.1111/j.1365-2222.2004.02090.x; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; YANG CY, 1994, BIOCHEMISTRY-US, V33, P12451, DOI 10.1021/bi00207a011	50	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3148	3157		10.1074/jbc.M807209200	http://dx.doi.org/10.1074/jbc.M807209200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19056737	hybrid			2022-12-25	WOS:000262700900059
J	Kruger, WA; Yun, CC; Monteith, GR; Poronnik, P				Kruger, Wade A.; Yun, C. Chris; Monteith, Gregory R.; Poronnik, Philip			Muscarinic-induced Recruitment of Plasma Membrane Ca2+-ATPase Involves PSD-95/Dlg/Zo-1-mediated Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-MEDIATED INHIBITION; PROTEIN-KINASE-A; EXCHANGER REGULATORY FACTOR-2; INTACT EPITHELIAL-CELLS; PDZ SCAFFOLD NHERF-2; ILEAL BRUSH-BORDER; NA+-H+ EXCHANGER; CALCIUM-PUMP; CA2+ PUMP; ADAPTER PROTEINS	Efflux of cytosolic Ca2+ mediated by plasma membrane Ca2+-ATPases (PMCA) plays a key role in fine tuning the magnitude and duration of Ca2+ signaling following activation of G-protein-coupled receptors. However, the molecular mechanisms that underpin the trafficking of PMCA to the membrane during Ca2+ signaling remain largely unexplored in native cell models. One potential mechanism for the recruitment of proteins to the plasma membrane involves PDZ interactions. In this context, we investigated the role of PMCA interactions with the Na+/H+ exchanger regulatory factor 2 (NHERF-2) during muscarinic-induced Ca2+ mobilization in the HT-29 epithelial cell line. GST pull-downs in HT-29 cell lysates showed that the PDZ2 module of NHERF-2 bound to the PDZ binding motif on the C terminus of PMCA. Co-immunoprecipitations confirmed that PMCA1b and NHERF-2 associated under normal conditions in HT-29 cells. Cell surface biotinylations revealed significant increases in membrane-associated NHERF-2 and PMCA within 60 s following muscarinic activation, accompanied by increased association of the two proteins as seen by confocal microscopy. The recruitment of NHERF-2 to the membrane preceded that of PMCA, suggesting that NHERF-2 was involved in nucleating an efflux complex at the membrane. The muscarinic-mediated translocation of PMCA was abolished when NHERF-2 was silenced, and the rate of relative Ca2+ efflux was also reduced. These experiments also uncovered a NHERF-2-independent PMCA retrieval mechanism. Our findings describe rapid agonist-induced translocation of PMCA in a native cell model and suggest that NHERF-2 plays a key role in scaffolding and maintaining PMCA at the cell membrane.	[Kruger, Wade A.; Poronnik, Philip] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia; [Yun, C. Chris] Emory Univ, Dept Med, Atlanta, GA 30322 USA	University of Queensland; University of Queensland; Emory University	Poronnik, P (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.	p.poronnik@uq.edu.au	Monteith, Gregory/B-1626-2008	Monteith, Gregory/0000-0002-4345-530X; Poronnik, Philip/0000-0002-6246-528X	National Institutes of Health [DK061418]; Australian Research Council; National Health and Medical Research Council of Australia; University of Queensland Development Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Development Grant(University of Queensland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grant DK061418 from the National Institutes of Health ( to C. C. Y.). This work was also supported by grants from the Australian Research Council and National Health and Medical Research Council of Australia ( to P. P.) and a University of Queensland Development Grant ( to P. P. and G. R. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambudkar IS, 2007, PFLUG ARCH EUR J PHY, V455, P187, DOI 10.1007/s00424-007-0252-0; Ambudkar IS, 2006, TRENDS PHARMACOL SCI, V27, P25, DOI 10.1016/j.tips.2005.11.008; Aung CS, 2007, BIOCHEM BIOPH RES CO, V355, P932, DOI 10.1016/j.bbrc.2007.02.050; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Bruce JIE, 2002, J BIOL CHEM, V277, P48172, DOI 10.1074/jbc.M208393200; Carafoli E, 2003, NAT REV MOL CELL BIO, V4, P326, DOI 10.1038/nrm1073; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; Cummins MM, 2000, IMMUNOL CELL BIOL, V78, P375, DOI 10.1046/j.1440-1711.2000.00932.x; Cummins MM, 2002, PFLUG ARCH EUR J PHY, V444, P644, DOI 10.1007/s00424-002-0856-3; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; DeMarco SJ, 2002, J BIOL CHEM, V277, P10506, DOI 10.1074/jbc.M111616200; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Duman JG, 2008, J GEN PHYSIOL, V131, P307, DOI 10.1085/jgp.200709915; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Goellner GM, 2003, ANN NY ACAD SCI, V986, P461, DOI 10.1111/j.1749-6632.2003.tb07230.x; Guerini D, 2003, J BIOL CHEM, V278, P38141, DOI 10.1074/jbc.M302400200; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Ingraffea J, 2002, EUR J CELL BIOL, V81, P61, DOI 10.1078/0171-9335-00218; KESSLER F, 1990, J BIOL CHEM, V265, P16012; Kim JY, 2006, J BIOL CHEM, V281, P32540, DOI 10.1074/jbc.M602496200; KOPP R, 1989, EUR J PHARM-MOLEC PH, V172, P397, DOI 10.1016/0922-4106(89)90021-7; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lee WJ, 2005, J BIOL CHEM, V280, P27076, DOI 10.1074/jbc.M414142200; Lee-Kwon W, 2005, AM J PHYSIOL-CELL PH, V288, pC942, DOI 10.1152/ajpcell.00417.2004; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; MONTEITH GR, 1995, CELL CALCIUM, V18, P459, DOI 10.1016/0143-4160(95)90009-8; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Oceandy D, 2007, BIOCHEM SOC T, V35, P927, DOI 10.1042/BST0350927; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Padanyi R, 2003, J BIOL CHEM, V278, P35798, DOI 10.1074/jbc.M305794200; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paquet M, 2006, J COMP NEUROL, V494, P752, DOI 10.1002/cne.20854; Paquet M, 2006, J BIOL CHEM, V281, P29949, DOI 10.1074/jbc.M602262200; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Poronnik P, 2002, CELL BIOCHEM BIOPHYS, V36, P221, DOI 10.1385/CBB:36:2-3:221; SCHATZMANN HJ, 1966, EXPERIENTIA, V22, P364, DOI 10.1007/BF01901136; Schuh K, 2003, J BIOL CHEM, V278, P9778, DOI 10.1074/jbc.M212507200; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Stauffer TP, 1997, BRAIN RES, V748, P21, DOI 10.1016/S0006-8993(96)01282-6; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Wanaverbecq N, 2003, J PHYSIOL-LONDON, V550, P83, DOI 10.1113/jphysiol.2002.035782; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zabe M, 2001, J BIOL CHEM, V276, P14704, DOI 10.1074/jbc.M009850200; Zylinska L, 1998, BBA-MOL CELL RES, V1448, P99, DOI 10.1016/S0167-4889(98)00128-1; Zylinska L, 2002, CELL MOL BIOL LETT, V7, P1037	66	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1820	1830		10.1074/jbc.M804590200	http://dx.doi.org/10.1074/jbc.M804590200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017653	Green Published, hybrid			2022-12-25	WOS:000262330100053
J	Du, XY; Zabel, BA; Myles, T; Allen, SJ; Handel, TM; Lee, PP; Butcher, EC; Leung, LL				Du, Xiao-Yan; Zabel, Brian A.; Myles, Timothy; Allen, Samantha J.; Handel, Tracy M.; Lee, Peter P.; Butcher, Eugene C.; Leung, Lawrence L.			Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (Activated Thrombin-activable Fibrinolysis Inhibitor), and Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; PROCARBOXYPEPTIDASE-B; IN-VIVO; PLASMINOGEN; EXPRESSION; CELLS; INFLAMMATION; CHEMOKINES; RECEPTORS; COAGULATION	Chemerin is a potent chemoattractant for cells expressing the serpentine receptor CMKLR1(chemokine- like receptor 1), such as plasmacytoid dendritic cells and tissue macrophages. The bioactivity of chemerin is post-translationally regulated; the attractant circulates in blood in a relatively inactive form (prochemerin) and is activated by carboxyl-terminal proteolytic cleavage. We discovered that plasma carboxypeptidase N (CPN) and B (CPB or activated thrombin-activable fibrinolysis inhibitor, TAFIa) enhanced the bioactivity of 10-mer chemerin peptide NH2-YFPGQFAFSK-COOH by removing the carboxyl-terminal lysine ( K). Sequential cleavages of either a prochemerin peptide (NH2-YFPGQFAFSKALPRS-COOH) or recombinant full-length prochemerin by plasmin and CPN/CPB substantially increased their chemotactic activities. Endogenous CPN present in circulating plasma enhanced the activity of plasmin-cleaved prochemerin. In addition, we discovered that platelets store chemerin protein and release it upon stimulation. Thus circulating CPN/CPB and platelets may potentially contribute to regulating the bioactivity of leukocyte chemoattractant chemerin, and further extend the molecular link between blood coagulation/fibrinolysis and CMKLR1-mediated immune responses.	[Zabel, Brian A.; Butcher, Eugene C.; Leung, Lawrence L.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Du, Xiao-Yan; Myles, Timothy; Lee, Peter P.; Leung, Lawrence L.] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Zabel, Brian A.; Butcher, Eugene C.; Leung, Lawrence L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Allen, Samantha J.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; University of California System; University of California San Diego	Leung, LL (corresponding author), VA Palo Alto Hlth Care Syst, 3801 Miranda Ave 11, Palo Alto, CA 94304 USA.	lawrence.leung@stanford.edu		Lee, Peter P./0000-0002-2660-4377	National Institutes of Health [RO1 HL57530, AI59625, AI057229, DK56339]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, R21AI059625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL57530 ( to L. L.) and AI59625, AI057229, and DK56339 ( to E. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Boehlen F, 2001, TRANSFUSION MED, V11, P403, DOI 10.1046/j.1365-3148.2001.00340.x; Brandt E, 2000, IMMUNOL REV, V177, P204, DOI 10.1034/j.1600-065X.2000.17705.x; Ceresa E, 2006, J BIOL CHEM, V281, P15878, DOI 10.1074/jbc.M509839200; Cines DB, 2007, J CLIN APHERESIS, V22, P31, DOI 10.1002/jca.20109; Clemetson KJ, 2007, CURR PHARM DESIGN, V13, P2673, DOI 10.2174/138161207781662894; Clemetson KJ, 2000, BLOOD, V96, P4046; Du XY, 2006, BLOOD CELL MOL DIS, V36, P414, DOI 10.1016/j.bcmd.2006.03.001; Du XY, 2002, J BIOL CHEM, V277, P35124, DOI 10.1074/jbc.M204372200; Gonzalez-Gronow M, 2008, FRONT BIOSCI-LANDMRK, V13, P1610, DOI 10.2741/2785; Hildebrandt M, 2008, FRONT BIOSCI-LANDMRK, V13, P1774, DOI 10.2741/2798; Kulig P, 2007, J IMMUNOL, V178, P3713, DOI 10.4049/jimmunol.178.6.3713; Lenich C, 1997, BLOOD, V90, P3579, DOI 10.1182/blood.V90.9.3579; Matthews KW, 2004, MOL IMMUNOL, V40, P785, DOI 10.1016/j.molimm.2003.10.002; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; MILES LA, 1985, J BIOL CHEM, V260, P4303; MILES LA, 1986, J CLIN INVEST, V77, P2001, DOI 10.1172/JCI112529; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Myles T, 2008, J BIOL CHEM, V283, P17789, DOI 10.1074/jbc.M708629200; Nishimura T, 2007, BLOOD, V109, P1992, DOI 10.1182/blood-2006-03-012567; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; PLOW EF, 1981, BLOOD, V58, P1069; POWER CA, 1995, CYTOKINE, V7, P479, DOI 10.1006/cyto.1995.0065; REDLITZ A, 1995, J CLIN INVEST, V96, P2534, DOI 10.1172/JCI118315; Stellos K, 2007, THROMB HAEMOSTASIS, V98, P922, DOI 10.1160/TH07-02-0147; von Hundelshausen P, 2007, THROMB HAEMOSTASIS, V97, P704, DOI 10.1160/TH07-01-0066; Warkentin TE, 1998, THROMB HAEMOSTASIS, V79, P1; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011; Zhang Z, 2005, CELL MOL IMMUNOL, V2, P411	36	91	103	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					751	758		10.1074/jbc.M805000200	http://dx.doi.org/10.1074/jbc.M805000200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010784	Green Published, hybrid			2022-12-25	WOS:000262122900008
J	Mcintyre, GJ; Groneman, JL; Tran, A; Applegate, TL				Mcintyre, Glen John; Groneman, Jennifer Lynne; Tran, Anna; Applegate, Tanya Lynn			An Infinitely Expandable Cloning Strategy plus Repeat-Proof PCR for Working with Multiple shRNA	PLOS ONE			English	Article								Vector construction with restriction enzymes (REs) typically involves the ligation of a digested donor fragment (insert) to a reciprocally digested recipient fragment (vector backbone). Creating a suitable cloning plan becomes increasingly difficult for complex strategies requiring repeated insertions such as constructing multiple short hairpin RNA (shRNA) expression vectors for RNA interference (RNAi) studies. The problem lies in the reduced availability of suitable RE recognition sites with an increasing number of cloning events and or vector size. This report details a technically simple, directional cloning solution using REs with compatible cohesive ends that are repeatedly destroyed and simultaneously re-introduced with each round of cloning. Donor fragments can be made by PCR or sub-cloned from pre-existing vectors and inserted ad infinitum in any combination. The design incorporates several cloning cores in order to be compatible with as many donor sequences as possible. We show that joining sub-combinations made in parallel is more time-efficient than sequential construction (of one cassette at a time) for any combination of 4 or more insertions. Screening for the successful construction of combinations using Taq polymerase based PCR became increasingly difficult with increasing number of repeated sequence elements. A Pfu polymerase based PCR was developed and successfully used to amplify combinations of up to eleven consecutive hairpin expression cassettes. The identified PCR conditions can be beneficial to others working with multiple shRNA or other repeated sequences, and the infinitely expandable cloning strategy serves as a general solution applicable to many cloning scenarios.	[Mcintyre, Glen John; Groneman, Jennifer Lynne; Tran, Anna; Applegate, Tanya Lynn] Johnson & Johnson Res Pty Ltd, Eveleigh, NSW, Australia	Johnson & Johnson	Mcintyre, GJ (corresponding author), Johnson & Johnson Res Pty Ltd, Australian Technol Pk, Eveleigh, NSW, Australia.	glen@madebyglen.com		Applegate, Tanya/0000-0002-8657-4261	Johnson and Johnson Research	Johnson and Johnson Research	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Johnson and Johnson Research was the company for which the three authors were working for at the time of the research. JJR also funded the open access payment fee. There is no advantage to be gained by the company in publishing this work.	Anderson JC, 2005, AM J GASTROENTEROL, V100, P2049, DOI 10.1111/j.1572-0241.2005.41832.x; DARDEL F, 1988, NUCLEIC ACIDS RES, V16, P1767, DOI 10.1093/nar/16.5.1767; Gonzalez S, 2005, MOL THER, V11, P811, DOI 10.1016/j.ymthe.2004.12.023; GOU, 2007, J GENE MED, P751; HENRY, 2006, MOL THER, P485; HINTON TM, 2008, ANTIVIR RES, DOI DOI 10.1016/J.ANTIVIRAL.2008.1005.1009; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Jazag A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni130; McIntyre GJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-1; SHENG Y, 1995, NUCLEIC ACIDS RES, V23, P1990, DOI 10.1093/nar/23.11.1990; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SONG J, 2008, BMB REPORTS, P358; Tao QZ, 1998, NUCLEIC ACIDS RES, V26, P4901, DOI 10.1093/nar/26.21.4901; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Truong K, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-8; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98	17	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3827	10.1371/journal.pone.0003827	http://dx.doi.org/10.1371/journal.pone.0003827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043584	Green Published, Green Submitted, gold			2022-12-25	WOS:000265451500007
J	Esposito, A; Tiffert, T; Mauritz, JMA; Schlachter, S; Bannister, LH; Kaminski, CF; Lew, VL				Esposito, Alessandro; Tiffert, Teresa; Mauritz, Jakob M. A.; Schlachter, Simon; Bannister, Lawrence H.; Kaminski, Clemens F.; Lew, Virgilio L.			FRET Imaging of Hemoglobin Concentration in Plasmodium falciparum-Infected Red Cells	PLOS ONE			English	Article							CALCIUM-CHELATOR ESTERS; MALARIA PARASITES; ENERGY-TRANSFER; MAURERS CLEFTS; GENERATION; DIGESTION; ERYTHROCYTES; FORMALDEHYDE; TRANSPORT; VOLUME	Background: During its intraerythrocytic asexual reproduction cycle Plasmodium falciparum consumes up to 80% of the host cell hemoglobin, in large excess over its metabolic needs. A model of the homeostasis of falciparum-infected red blood cells suggested an explanation based on the need to reduce the colloid-osmotic pressure within the host cell to prevent its premature lysis. Critical for this hypothesis was that the hemoglobin concentration within the host cell be progressively reduced from the trophozoite stage onwards. Methodology/Principal Findings: The experiments reported here were designed to test this hypothesis by direct measurements of the hemoglobin concentration in live, infected red cells. We developed a novel, non-invasive method to quantify the hemoglobin concentration in single cells, based on Forster resonance energy transfer between hemoglobin molecules and the fluorophore calcein. Fluorescence lifetime imaging allowed the quantitative mapping of the hemoglobin concentration within the cells. The average fluorescence lifetimes of uninfected cohorts was 270 +/- 30 ps (mean +/- SD; N = 45). In the cytoplasm of infected cells the fluorescence lifetime of calcein ranged from 290 +/- 20 ps for cells with ring stage parasites to 590 +/- 13 ps and 1050 +/- 60 ps for cells with young trophozoites and late stage trophozoite/early schizonts, respectively. This was equivalent to reductions in hemoglobin concentration spanning the range from 7.3 to 2.3 mM, in line with the model predictions. An unexpected ancillary finding was the existence of a microdomain under the host cell membrane with reduced calcein quenching by hemoglobin in cells with mature trophozoite stage parasites. Conclusions/Significance: The results support the predictions of the colloid-osmotic hypothesis and provide a better understanding of the homeostasis of malaria-infected red cells. In addition, they revealed the existence of a distinct peripheral microdomain in the host cell with limited access to hemoglobin molecules indicating the concentration of substantial amounts of parasite-exported material.	[Esposito, Alessandro; Mauritz, Jakob M. A.; Schlachter, Simon; Kaminski, Clemens F.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Esposito, Alessandro; Tiffert, Teresa; Mauritz, Jakob M. A.; Lew, Virgilio L.] Univ Cambridge, Dept Physiol, Dev & Neurosci, Cambridge CB2 1TN, England; [Bannister, Lawrence H.] Kings Coll London, Ctr Ultrastruct Imaging, London WC2R 2LS, England; [Kaminski, Clemens F.] Univ Erlangen Nurnberg, Div 3, Max Planck Res Grp, Sch Advanced Optical Technol, D-8520 Erlangen, Germany	University of Cambridge; University of Cambridge; University of London; King's College London; Max Planck Society; University of Erlangen Nuremberg	Esposito, A (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.	aesposito@quantitative-microscopy.org	Esposito, Alessandro/A-8536-2008; Kaminski, Clemens/G-7488-2016	Esposito, Alessandro/0000-0002-5051-091X; Kaminski, Clemens/0000-0002-5194-0962	EPSRC [EP/E059384]; BBSRC [BB/E008542/1]; Biotechnology and Biological Sciences Research Council [BB/E008542/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funds from the EPSRC (EP/E059384) and BBSRC (BB/E008542/1).	AWAYA T, 1979, NUCL INSTRUM METHODS, V165, P317, DOI 10.1016/0029-554X(79)90287-8; BARBER PR, 2005, SPIE, P171; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Beghetto C, 2000, EUR J BIOCHEM, V267, P5585, DOI 10.1046/j.1432-1327.2000.01625.x; BENNETT RG, 1964, J CHEM PHYS, V41, P3037, DOI 10.1063/1.1725670; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Cooke BM, 2004, TRENDS PARASITOL, V20, P581, DOI 10.1016/j.pt.2004.09.008; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Esposito A., 2007, STANDARDIZATION FLUO; ESPOSITO A, 2004, FLUORESCENCE LIFETIM; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; FRANK JH, 2007, J MICROSCOPY; Frischknecht F, 2008, MOL MICROBIOL, V67, P687, DOI 10.1111/j.1365-2958.2007.06095.x; GARCIASANCHO J, 1985, BIOCHIM BIOPHYS ACTA, V813, P148, DOI 10.1016/0005-2736(85)90357-8; GINSBURG H, 1983, MOL BIOCHEM PARASIT, V8, P177, DOI 10.1016/0166-6851(83)90008-7; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x; HARRISON DG, 1968, J PHYSIOL-LONDON, V199, P367, DOI 10.1113/jphysiol.1968.sp008658; Horecker BL, 1943, J BIOL CHEM, V148, P173; Kaestner L, 2006, CELL CALCIUM, V39, P13, DOI 10.1016/j.ceca.2005.09.004; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lew VL, 2004, BLOOD CELL MOL DIS, V32, P353, DOI 10.1016/j.bcmd.2004.01.006; Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654; LEW VL, 1993, BIOCHIM BIOPHYS ACTA, V1148, P152, DOI 10.1016/0005-2736(93)90172-V; LEW VL, 1995, BLOOD, V86, P334, DOI 10.1182/blood.V86.1.334.bloodjournal861334; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; Pelet S, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2203664; Przyborski JM, 2008, TRENDS PARASITOL, V24, P285, DOI 10.1016/j.pt.2008.04.002; Roberts KE, 2003, J FLUORESC, V13, P513, DOI 10.1023/B:JOFL.0000008062.85865.c6; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Staines HM, 2001, AM J PHYSIOL-CELL PH, V280, pC1576, DOI 10.1152/ajpcell.2001.280.6.C1576; Taraschi TF, 2003, BLOOD, V102, P3420, DOI 10.1182/blood-2003-05-1448; TIFFERT T, 1984, BIOCHIM BIOPHYS ACTA, V773, P143, DOI 10.1016/0005-2736(84)90559-5; Tiffert T, 2000, J PHYSIOL-LONDON, V525, P125, DOI 10.1111/j.1469-7793.2000.00125.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wouters FS, 2008, HFSP J, V2, P7, DOI 10.2976/1.2833600; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1	41	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3780	10.1371/journal.pone.0003780	http://dx.doi.org/10.1371/journal.pone.0003780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023444	gold, Green Published, Green Submitted			2022-12-25	WOS:000265448800001
J	Zhang, CL; Qiu, CF; Hu, FB; David, RM; van Dam, RM; Bralley, A; Williams, MA				Zhang, Cuilin; Qiu, Chunfang; Hu, Frank B.; David, Robert M.; van Dam, Rob M.; Bralley, Alexander; Williams, Michelle A.			Maternal Plasma 25-Hydroxyvitamin D Concentrations and the Risk for Gestational Diabetes Mellitus	PLOS ONE			English	Article								Background: Evidence is accumulating for a role of vitamin D in maintaining normal glucose homeostasis. However, studies that prospectively examined circulating concentrations of 25-hydroxyvitamin D ( 25-[OH] D) in relation to diabetes risk are limited. Our objective is to determine the association between maternal plasma 25-[OH] D concentrations in early pregnancy and the risk for gestational diabetes mellitus (GDM). Methods: A nested case-control study was conducted among a prospective cohort of 953 pregnant women. Among them, 57 incident GDM cases were ascertained and 114 women who were not diagnosed with GDM were selected as controls. Controls were frequency matched to cases for the estimated season of conception of the index pregnancy. Results: Among women who developed GDM, maternal plasma 25-[OH] D concentrations at an average of 16 weeks of gestation were significantly lower than controls (24.2 vs. 30.1 ng/ml, P < 0.001). This difference remained significant (3.62 ng/ml lower on average in GDM cases than controls (P value = 0.018)) after the adjustment for maternal age, race, family history of diabetes, and pre-pregnancy BMI. Approximately 33% of GDM cases, compared with 14% of controls (P < 0.001), had maternal plasma 25-[OH] D concentrations consistent with a pre-specified diagnosis of vitamin D deficiency (<20 ng/ml). After adjustment for the aforementioned covariates including BMI, vitamin D deficiency was associated with a 2.66-fold (OR (95% CI): 2.66 (1.01-7.02)) increased GDM risk. Moreover, each 5 ng/ml decrease in 25-[OH] D concentrations was related to a 1.29-fold increase in GDM risk (OR (95% CI): 1.29 (1.05-1.60)). Additional adjustment for season and physical activity did not change findings substantially. Conclusions: Findings from the present study suggest that maternal vitamin D deficiency in early pregnancy is significantly associated with an elevated risk for GDM.	[Zhang, Cuilin] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD USA; [Qiu, Chunfang; Williams, Michelle A.] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hu, Frank B.; van Dam, Rob M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Hu, Frank B.; van Dam, Rob M.] Harvard Univ, Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [David, Robert M.; Bralley, Alexander] Metametrix Clin Lab, Norcross, GA USA; [Williams, Michelle A.] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Swedish Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle	Zhang, CL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD USA.	zhangcu@mail.nih.gov	van Dam, Rob M/F-9674-2010	van Dam, Rob M/0000-0002-7354-8734; Zhang, Cuilin/0000-0002-8014-2708	National Institutes of Health [HD/HL 32562]; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008889, ZIAHD008888] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by award (HD/HL 32562) from the National Institutes of Health. Dr. Cuilin Zhang was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health.	[Anonymous], DIABETES; Baynes KCR, 1997, DIABETOLOGIA, V40, P344, DOI 10.1007/s001250050685; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; BOUCHER BJ, 1995, DIABETOLOGIA, V38, P1239, DOI 10.1007/BF00422375; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; CADE C, 1987, ENDOCRINOLOGY, V120, P1490, DOI 10.1210/endo-120-4-1490; CHERTOW BS, 1983, ENDOCRINOLOGY, V113, P1511, DOI 10.1210/endo-113-4-1511; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Clifton-Bligh RJ, 2008, DIABETIC MED, V25, P678, DOI 10.1111/j.1464-5491.2008.02422.x; de Boer IH, 2008, DIABETES CARE, V31, P701, DOI 10.2337/dc07-1829; Dempsey JC, 2004, AM J EPIDEMIOL, V159, P663, DOI 10.1093/aje/kwh091; DENT CE, 1975, LANCET, V2, P1057; DEVLIN JT, 1992, DIABETES CARE, V15, P1690, DOI 10.2337/diacare.15.11.1690; DRAZNIN B, 1988, J CLIN INVEST, V82, P1848, DOI 10.1172/JCI113801; FARRANT HJ, 2008, EUR J CLIN NUTR 0220; GEDIK O, 1986, DIABETOLOGIA, V29, P142, DOI 10.1007/BF02427083; GIOVANNUCCI E, 2008, ANN EPIDEMIOL; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2006, CAN MED ASSOC J, V174, P1287, DOI 10.1503/cmaj.060149; Isaia G, 2001, DIABETES CARE, V24, P1496, DOI 10.2337/diacare.24.8.1496; KristalBoneh E, 1997, HYPERTENSION, V30, P1289, DOI 10.1161/01.HYP.30.5.1289; LIND L, 1995, AM J HYPERTENS, V8, P894, DOI 10.1016/0895-7061(95)00154-H; LIND L, 1989, DIABETES RES CLIN EX, V11, P141; Maghbooli Z, 2008, DIABETES-METAB RES, V24, P27, DOI 10.1002/dmrr.737; MAK RHK, 1992, KIDNEY INT, V41, P1049, DOI 10.1038/ki.1992.159; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; ORWOLL E, 1994, AM J CLIN NUTR, V59, P1083, DOI 10.1093/ajcn/59.5.1083; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1; SCRAGG R, 1990, INT J EPIDEMIOL, V19, P559, DOI 10.1093/ije/19.3.559; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Sooy K, 1999, J BIOL CHEM, V274, P34343, DOI 10.1074/jbc.274.48.34343; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Zhang CL, 2006, ARCH INTERN MED, V166, P543, DOI 10.1001/archinte.166.5.543; Zhang CL, 2004, EPIDEMIOLOGY, V15, P597, DOI 10.1097/01.ede.0000134864.90563.fa; Zittermann A, 2003, J AM COLL CARDIOL, V41, P105, DOI 10.1016/S0735-1097(02)02624-4; 2004, DIABETES CARE S1, V27, P88	40	249	281	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2008	3	11							e3753	10.1371/journal.pone.0003753	http://dx.doi.org/10.1371/journal.pone.0003753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XC	19015731	Green Published, Green Submitted, gold			2022-12-25	WOS:000265448400010
J	Almulki, L; Noda, K; Amini, R; Schering, A; Garland, RC; Nakao, S; Nakazawa, T; Hisatomi, T; Thomas, KL; Masli, S; Hafezi-Moghadam, A				Almulki, Lama; Noda, Kousuke; Amini, Reza; Schering, Alexander; Garland, Rebecca C.; Nakao, Shintaro; Nakazawa, Toru; Hisatomi, Toshio; Thomas, Kennard L.; Masli, Sharmila; Hafezi-Moghadam, Ali			Surprising up-regulation of P-selectin glycoprotein ligand-1 (PSGL-1) in endotoxin-induced uveitis	FASEB JOURNAL			English	Article						leukocyte rolling velocity; autoperfused micro-flow chamber; lipopolysaccharides; adhesion molecules; acute immune response	IN-VIVO; ISCHEMIA/REPERFUSION INJURY; ENDOTHELIAL INTERACTIONS; MONOCLONAL-ANTIBODIES; OCULAR INFLAMMATION; ADHESION MOLECULES; RAT-KIDNEY; LEUKOCYTE; INHIBITION; NEUTROPHILS	P-selectin glycoprotein ligand-1 (PSGL-1) is constitutively expressed on leukocytes and was thought to be down-regulated with cell activation. However, this work shows the surprising finding of functional PSGL-1 up-regulation during acute inflammation. PSGL-1 function was studied in our autoperfusion assay, in which blood from a mouse carotid flows through a microchamber coated with a fixed density of P-selectin. Under the inflammatory conditions-uveitis induced by systemic lipopolysaccharide injection-we recorded significantly reduced leukocyte rolling velocity, which suggests PSGL-1 up-regulation; however, flow cytometry showed reduced PSGL-1. When bound leukocytes were released from the vasculature by PSGL-1 blockade, a large peripheral blood leukocyte (PBL) population showed elevated PSGL-1, which could account for the reduced PSGL-1 in the remaining unbound population. In the eye, systemic blockade of PSGL-1 with a monoclonal antibody or recombinant soluble PSGL-1 drastically reduced the severe manifestations of uveitis. Furthermore, PSGL-1 blockade was significantly more effective in reducing retinal leukostasis than was P-selectin blockade. Our results provide surprising evidence for functional PSGL-1 up-regulation in PBLs during acute inflammation. The temporal overlap between PSGL-1 and P-selectin up-regulation reveals an as yet unrecognized collaboration between this receptor-ligand pair, increasing efficiency of the first steps of the leukocyte recruitment cascade.-Almulki, L., Noda, K., Amini, R., Schering, A., Garland, R. C., Nakao, S., Nakazawa, T., Hisatomi, T., Thomas, K. L., Masli, S., Hafezi-Moghadam, A. Surprising up-regulation of P-selectin glycoprotein ligand-1 (PSGL-1) in endotoxin-induced uveitis. FASEB J. 23, 929-939 (2009)	[Almulki, Lama; Noda, Kousuke; Amini, Reza; Schering, Alexander; Garland, Rebecca C.; Nakao, Shintaro; Nakazawa, Toru; Hisatomi, Toshio; Thomas, Kennard L.; Hafezi-Moghadam, Ali] Massachusetts Eye & Ear Infirm, Angiogenesis Lab, Boston, MA 02114 USA; [Almulki, Lama; Noda, Kousuke; Amini, Reza; Schering, Alexander; Garland, Rebecca C.; Nakao, Shintaro; Nakazawa, Toru; Hisatomi, Toshio; Thomas, Kennard L.; Masli, Sharmila; Hafezi-Moghadam, Ali] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Masli, Sharmila] Schepens Eye Res Inst, Boston, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Schepens Eye Research Institute	Hafezi-Moghadam, A (corresponding author), Massachusetts Eye & Ear Infirm, Angiogenesis Lab, 325 Cambridge St,3rd Floor, Boston, MA 02114 USA.	ali_hafezi-moghadam@meei.harvard.edu		Hisatomi, Toshio/0000-0003-2552-9595; Hafezi-Moghadam, Ali/0000-0002-5336-0697	U. S. National Institue of Health [HL086933, AI050775]; National Eye Institute [EY14104]; NATIONAL EYE INSTITUTE [P30EY014104] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050775] Funding Source: NIH RePORTER	U. S. National Institue of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Dr. P. Cheung, Director of Preclinical Research and Discovery at Y's Therapeutics for graciously providing research- grade YSPSL (recombinant soluble Pselectin glycoprotein ligand IgG fusion protein, rPSGL-Ig). The authors thank Dr. S. E. Leeman for a critical review of the manuscript and R. Huang for his assistance with flow cytometry. This work was supported by U. S. National Institue of Health grants (HL086933, AI050775) and a National Eye Institute core grant (EY14104). We are indebted to the Massachusetts Lions Foundation for generous funds provided for laboratory equipment used in this project. We thank Research to Prevent Blindness for unrestricted funds awarded to the Department of Ophthalmology at Harvard Medical School. We are grateful to the Marion W. and Edward F. Knight Fund for support of A. H.-M.'s research.	BAATZ H, 1995, INVEST OPHTH VIS SCI, V36, P1960; Becker MD, 2001, INVEST OPHTH VIS SCI, V42, P2563; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Davenpeck KL, 2000, J IMMUNOL, V165, P2764, DOI 10.4049/jimmunol.165.5.2764; Dulkanchainun TS, 1998, ANN SURG, V227, P832, DOI 10.1097/00000658-199806000-00006; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; Fuller TF, 2001, TRANSPLANTATION, V72, P216, DOI 10.1097/00007890-200107270-00008; GABER AO, 2007, AM TRANSPL C; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; Hafezi-Moghadam A, 2007, FASEB J, V21, P464, DOI 10.1096/fj.06-6390com; Hafezi-Moghadam A, 2004, AM J PHYSIOL-CELL PH, V286, pC876, DOI 10.1152/ajpcell.00500.2003; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; Hafezi-Moghadam A, 1999, J EXP MED, V189, P939, DOI 10.1084/jem.189.6.939; Hicks AER, 2003, BLOOD, V101, P3249, DOI 10.1182/blood-2002-07-2329; Hirata T, 2000, J EXP MED, V192, P1669, DOI 10.1084/jem.192.11.1669; Khor SP, 2000, J PHARMACOL EXP THER, V293, P618; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Marie O, 1999, INVEST OPHTH VIS SCI, V40, P2275; Marsik C, 2004, J CLIN IMMUNOL, V24, P62, DOI 10.1023/B:JOCI.0000018064.13793.83; Mertens P, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.04.020; Miyamoto K, 1996, INVEST OPHTH VIS SCI, V37, P2708; Miyamoto K, 1998, MICROVASC RES, V55, P230, DOI 10.1006/mvre.1998.2084; Moore KL, 1998, LEUKEMIA LYMPHOMA, V29, P1, DOI 10.3109/10428199809058377; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417; Planck SR, 1998, CURR EYE RES, V17, P941, DOI 10.1076/ceyr.17.9.941.5139; ROSENBAUM JT, 1993, CURR EYE RES, V12, P827, DOI 10.3109/02713689309020387; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Smith JR, 1998, IMMUNOL CELL BIOL, V76, P497, DOI 10.1046/j.1440-1711.1998.00783.x; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; Strauss EC, 1999, INVEST OPHTH VIS SCI, V40, P1336; Suzuma K, 1997, INVEST OPHTH VIS SCI, V38, P1610; Takada M, 1997, J CLIN INVEST, V99, P2682, DOI 10.1172/JCI119457; Tamesis RR, 1996, OPHTHALMOLOGY, V103, P768; Thadani Sunil M, 2004, Paediatr Drugs, V6, P289, DOI 10.2165/00148581-200406050-00003; Tsuchihashi S, 2006, J IMMUNOL, V176, P616, DOI 10.4049/jimmunol.176.1.616; WHITCUP SM, 1993, CLIN IMMUNOL IMMUNOP, V67, P143, DOI 10.1006/clin.1993.1057; WHITCUP SM, 1995, EXP EYE RES, V60, P597, DOI 10.1016/S0014-4835(05)80001-6; Whitcup SM, 1997, CLIN IMMUNOL IMMUNOP, V83, P45, DOI 10.1006/clin.1996.4324; Yang Y, 2003, AM J RESP CELL MOL, V29, P583, DOI 10.1165/rcmb.2002-0315OC	43	17	18	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					929	939		10.1096/fj.08-118760	http://dx.doi.org/10.1096/fj.08-118760			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19050046	Green Published			2022-12-25	WOS:000265506300028
J	Mukhopadhyay, A; Saddoughi, SA; Song, PF; Sultan, I; Ponnusamy, S; Senkal, CE; Snook, CF; Arnold, HK; Sears, RC; Hannun, YA; Ogretmen, B				Mukhopadhyay, Archana; Saddoughi, Sahar A.; Song, Pengfei; Sultan, Iyad; Ponnusamy, Suriyan; Senkal, Can E.; Snook, Christopher F.; Arnold, Hugh K.; Sears, Rosalie C.; Hannun, Yusuf A.; Ogretmen, Besim			Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling	FASEB JOURNAL			English	Article						bioactive lipids; c-Myc degradation	LONGEVITY ASSURANCE GENE-1; SQUAMOUS-CELL CARCINOMAS; REVERSE-TRANSCRIPTASE PROMOTER; HUMAN HEAD; C-MYC; NONVESICULAR TRAFFICKING; SET; ACTIVATION; MECHANISMS; GROWTH	In this study, the inhibitor 2 of protein phosphatase 2A (I2PP2A) was identified in vitro and in situ as a ceramide-binding protein, which exhibits stereoisomer specificity and fatty acid chain length preference. Site-directed mutagenesis coupled with structural details of I2PP2A suggested that VIK 207-209 residues localized on helix 7 are important for ceramide binding and single mutation of K209D altered this interaction. Notably, I2PP2A-ceramide binding decreased the association between PP2A and the inhibitor, preventing the inhibition of PP2A activity in vitro. In addition, studies in A549 human lung cancer cells revealed that ceramide mediates c-Myc degradation via its PP2A-dependent dephosphorylation at S62, and treatment with okadaic acid and expression of c-Myc mutants with S62A or S62D conversions resulted in resistance to ceramide-mediated degradation. Importantly, whereas down-regulation of I2PP2A enhanced PP2A-mediated c-Myc degradation in response to ceramide, ectopic expression of wild-type I2PP2A but not of its K209D mutant protected this degradation in A549 cells. Moreover, expression of wild-type I2PP2A prevented the growth-inhibitory effects of ceramide both against A549 cells and xenograft-driven tumors in situ and in vivo compared with that in controls. Thus, these results suggest that direct interaction of I2PP2A with ceramide plays important biological roles via the regulation of PP2A activity and signaling, which in turn control ceramide-mediated degradation of c-Myc and antiproliferation.-Mukhopadhyay, A., Saddoughi, S. A., Song, P., Sultan, I., Ponnusamy, S., Senkal, C. E., Snook, C. F., Arnold, H. K., Sears, R. C., Hannun, Y. A., Ogretmen, B. Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling. FASEB J. 23, 751-763 (2009)	[Mukhopadhyay, Archana; Saddoughi, Sahar A.; Song, Pengfei; Sultan, Iyad; Ponnusamy, Suriyan; Senkal, Can E.; Hannun, Yusuf A.; Ogretmen, Besim] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Mukhopadhyay, Archana; Saddoughi, Sahar A.; Song, Pengfei; Sultan, Iyad; Ponnusamy, Suriyan; Senkal, Can E.; Snook, Christopher F.; Hannun, Yusuf A.; Ogretmen, Besim] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Arnold, Hugh K.; Sears, Rosalie C.] Oregon Hlth & Sci Univ, Dept Mol Med Genet, Portland, OR 97201 USA	Medical University of South Carolina; Medical University of South Carolina; Oregon Health & Science University	Ogretmen, B (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	ogretmen@musc.edu			U.S. National Institutes of Health [CA-088932, CA-097132]; Abney and Wachovia Foundations; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA088932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abney and Wachovia Foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr. J.G. Schnellmann for critically reviewing the manuscript. This work was supported by research grants from the U.S. National Institutes of Health (CA-088932 and CA-097132). S.A.S. was supported by scholarships obtained from they Abney and Wachovia Foundations.	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Faustino RS, 2008, J LIPID RES, V49, P654, DOI 10.1194/jlr.M700464-JLR200; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; Guo HB, 2007, P NATL ACAD SCI USA, V104, P8797, DOI 10.1073/pnas.0702981104; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Ledeen RW, 2008, J LIPID RES, V49, P1176, DOI 10.1194/jlr.R800009-JLR200; Ledeen RW, 2006, BBA-MOL CELL BIOL L, V1761, P588, DOI 10.1016/j.bbalip.2006.04.010; Li M, 1998, METH MOL B, V93, P59; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Ogretmen B, 2001, J BIOL CHEM, V276, P32506, DOI 10.1074/jbc.M101350200; Ogretmen B, 2001, J BIOL CHEM, V276, P24901, DOI 10.1074/jbc.M100314200; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Senkal CE, 2006, J PHARMACOL EXP THER, V317, P1188, DOI 10.1124/jpet.106.101949; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Snook CF, 2006, BBA-MOL CELL BIOL L, V1761, P927, DOI 10.1016/j.bbalip.2006.06.004; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Szulc ZM, 2006, BIOORGAN MED CHEM, V14, P7083, DOI 10.1016/j.bmc.2006.07.016; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang GH, 2005, J BIOL CHEM, V280, P26415, DOI 10.1074/jbc.M501492200; Wooten LG, 2005, J BIOL CHEM, V280, P28867, DOI 10.1074/jbc.M413444200; Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	43	160	161	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					751	763		10.1096/fj.08-120550	http://dx.doi.org/10.1096/fj.08-120550			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19028839	Green Published			2022-12-25	WOS:000265506300011
J	Gevorkyan-Airapetov, L; Zohary, K; Popov-Celeketic, D; Mapa, K; Hell, K; Neupert, W; Azem, A; Mokranjac, D				Gevorkyan-Airapetov, Lada; Zohary, Keren; Popov-Celeketic, Dusan; Mapa, Koyeli; Hell, Kai; Neupert, Walter; Azem, Abdussalam; Mokranjac, Dejana			Interaction of Tim23 with Tim50 Is Essential for Protein Translocation by the Mitochondrial TIM23 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; PRESEQUENCE TRANSLOCASE; IMPORT MOTOR; PREPROTEIN TRANSLOCASE; PRECURSOR PROTEINS; HSP70; OUTER; COCHAPERONE; EXPRESSION; COMPONENT	The TIM23 complex is the major translocase of the mitochondrial inner membrane responsible for the import of essentially all matrix proteins and a number of inner membrane proteins. Tim23 and Tim50, two essential proteins of the complex, expose conserved domains into the intermembrane space that interact with each other. Here, we describe in vitro reconstitution of this interaction using recombinantly expressed and purified intermembrane space domains of Tim50 and Tim23. We established two independent methods, chemical cross-linking and surface plasmon resonance, to track their interaction. In addition, we identified mutations in Tim23 that abolish its interaction with Tim50 in vitro. These mutations also destabilized the interaction between the two proteins in vivo, leading to defective import of preproteins via the TIM23 complex and to cell death at higher temperatures. This is the first study to describe the reconstitution of the Tim50-Tim23 interaction in vitro and to identify specific residues of Tim23 that are vital for the interaction with Tim50.	[Gevorkyan-Airapetov, Lada; Zohary, Keren; Azem, Abdussalam] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel; [Popov-Celeketic, Dusan; Mapa, Koyeli; Hell, Kai; Neupert, Walter; Mokranjac, Dejana] Univ Munich, Inst Physiol Chem, Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany	Tel Aviv University; University of Munich	Azem, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel.	azema@tauex.tau.ac.il	Popov-Celeketic, Dusan/O-2371-2016	Popov-Celeketic, Dusan/0000-0002-0512-6900; Mokranjac, Dejana/0000-0002-4005-6979	German-Israeli Foundation for Scientific Research and Development [753/181]; German-Israeli Project Cooperation [F5.1]	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); German-Israeli Project Cooperation	This work was supported by German-Israeli Foundation for Scientific Research and Development Grant 753/181 and German-Israeli Project Cooperation Grant F5.1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alder NN, 2008, MOL BIOL CELL, V19, P159, DOI 10.1091/mbc.E07-07-0669; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; KRONIDOU NG, 1994, P NATL ACAD SCI USA, V91, P12818, DOI 10.1073/pnas.91.26.12818; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; SIKORSKI RS, 1989, GENETICS, V122, P19; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	31	50	50	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4865	4872		10.1074/jbc.M807041200	http://dx.doi.org/10.1074/jbc.M807041200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19017642	hybrid			2022-12-25	WOS:000263416600015
J	Demidova, AR; Aau, MY; Zhuang, L; Yu, Q				Demidova, Anastasia R.; Aau, Mei Yee; Zhuang, Li; Yu, Qiang			Dual Regulation of Cdc25A by Chk1 and p53-ATF3 in DNA Replication Checkpoint Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINTS; S-PHASE CHECKPOINT; TRANSCRIPTIONAL REPRESSOR ATF3; INDUCED DOWN-REGULATION; G(2) CHECKPOINT; CANCER-CELLS; INDUCED APOPTOSIS; GENOTOXIC STRESS; G2 CHECKPOINT; P53	Eukaryotic cells respond to DNA damage and stalled replication forks by activating signaling pathways that promote cell cycle arrest and DNA repair. A systematic screening of the protein kinase small interfering RNA library reveals that Chk1 and ataxia telangiectasia-mutated (ATM) and Rad3-related (ATR) are the main kinases responsible for intra-S-phase checkpoint upon topoisomerase I inhibitor camptothecin-induced DNA damage. It is well known that ATR-Chk1-mediated protein degradation of Cdc25A protein phosphatase is a crucial mechanism conferring this checkpoint activation. Here we describe another mechanism underlying Cdc25A down-regulation in response to DNA damage that occurs at the transcriptional level. We show that activation of tumor suppressor p53 by DNA damage results in inhibition of Cdc25A transcription as a result of activation of transcriptional repressor ATF3 that directly binds to the Cdc25A promoter. In cells deficient in both Chk1 and p53, Cdc25A down-regulation upon camptothecin-induced DNA damage is completely abolished, leading to severe defects in cell cycle checkpoints and remarkable cell death in mitosis. Our findings reveal two independent mechanisms acting in concert in regulation of Cdc25A in DNA damage response. Although Chk1 affects Cdc25A via rapid phosphorylation and protein turnover, inhibition of Cdc25A transcription by p53-ATF3 is required for the maintenance of cell cycle arrest.	ASTAR, Canc Biol & Pharmacol Genome Inst Singapore, Singapore 138672, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Demidova, AR (corresponding author), ASTAR, Canc Biol & Pharmacol Genome Inst Singapore, 02-01 Genome Bldg,60 Biopolis St, Singapore 138672, Singapore.	demidovaa@gis.a-star.edu.sg; yuq@gis.a-star.edu.sg	Goloudina, Anastasia/T-4989-2019; Goloudina, Anastasia/T-4985-2019	Yu, Qiang/0000-0003-2132-8278	Agency for Science, Technology and Research of Singapore	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grants from the Agency for Science, Technology and Research of Singapore. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; Fuchs C, 2006, CANCER TREAT REV, V32, P491, DOI 10.1016/j.ctrv.2006.07.001; Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Gupta M, 1997, CLIN CANCER RES, V3, P1653; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Jurvansuu J, 2007, J MOL BIOL, V372, P397, DOI 10.1016/j.jmb.2007.06.077; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawabe T, 2004, MOL CANCER THER, V3, P513; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Koniaras K, 2001, ONCOGENE, V20, P7453, DOI 10.1038/sj.onc.1204942; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Le Gac G, 2006, J BIOL CHEM, V281, P24161, DOI 10.1074/jbc.M603724200; LEE KAW, 1987, P NATL ACAD SCI USA, V84, P8355, DOI 10.1073/pnas.84.23.8355; Legarza K, 2006, ANTICANCER RES, V26, P3301; Levesque AA, 2005, ONCOGENE, V24, P3786, DOI 10.1038/sj.onc.1208451; Levesque AA, 2008, MOL CANCER THER, V7, P252, DOI 10.1158/1535-7163.MCT-07-2066; Luo Y, 2001, ANTICANCER RES, V21, P23; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mashima T, 2001, J CELL PHYSIOL, V188, P352, DOI 10.1002/jcp.1130; Matthew EM, 2007, CELL CYCLE, V6, P2571, DOI 10.4161/cc.6.20.5079; Mukhopadhyay UK, 2005, CANCER RES, V65, P2872, DOI 10.1158/0008-5472.CAN-04-2502; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Playle LC, 2002, BRIT J CANCER, V87, P352, DOI 10.1038/sj.bjc.6600492; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Rother K, 2007, ONCOGENE, V26, P1949, DOI 10.1038/sj.onc.1209989; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shao RG, 1997, CANCER RES, V57, P4029; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Srivastava V, 2005, BIOORGAN MED CHEM, V13, P5892, DOI 10.1016/j.bmc.2005.05.066; St Clair S, 2004, MOL CELL, V16, P725; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Tse AN, 2007, CLIN CANCER RES, V13, P591, DOI 10.1158/1078-0432.CCR-06-1424; Wang YL, 2004, CANCER BIOL THER, V3, P305, DOI 10.4161/cbt.3.3.697; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhang C, 2002, BIOCHEM BIOPH RES CO, V297, P1302, DOI 10.1016/S0006-291X(02)02382-3; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	54	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4132	4139		10.1074/jbc.M808118200	http://dx.doi.org/10.1074/jbc.M808118200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19060337	hybrid			2022-12-25	WOS:000263134400010
J	Matsubara, E; Sakai, I; Yamanouchi, J; Fujiwara, H; Yakushijin, Y; Hato, T; Shigemoto, K; Yasukawa, M				Matsubara, Etsuko; Sakai, Ikuya; Yamanouchi, Jun; Fujiwara, Hiroshi; Yakushijin, Yoshihiro; Hato, Takaaki; Shigemoto, Kazuhiro; Yasukawa, Masaki			The Role of Zinc Finger Protein 521/Early Hematopoietic Zinc Finger Protein in Erythroid Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; FUNCTIONAL-CHARACTERIZATION; RETROVIRAL INTEGRATION; GENE; REPRESSION; EXPRESSION; INDUCTION; CLONING; REGULATOR; RECRUITS	ZNF521 (zinc finger protein 521) is a transcription factor with an N-terminal transcriptional repressor motif and 30 zinc finger domains. Although a high expression level of ZNF521 in human CD34(+) progenitors and hematopoietic malignancies has been demonstrated, the functional role of ZNF521 in hematopoietic cell differentiation has not been clarified. In this study, we analyzed the role of ZNF521 in erythroid cell differentiation using the short hairpin RNA (shRNA)-mediated gene silencing method. Down-regulation of ZNF521 mediated by transient expression of shRNA for ZNF521 resulted in increased synthesis of hemoglobin in K562 and HEL cell lines as compared with control cells. K562-derived clones in which ZNF521 was constitutively silenced by shRNA also showed marked synthesis of hemoglobin and an increased expression level of glycophorin A. Since GATA-1 is the key regulator of erythroid differentiation, the effect of ZNF521 on transcription activity of GATA-1 was analyzed using a luciferase assay. GATA-1 activity was markedly inhibited by ZNF521 in a dose-dependent manner. Deletion analysis of ZNF521 showed that the repressive effect requires an N-terminal repression motif. Furthermore, the direct interaction of ZNF521 with GATA-1 was demonstrated. These results indicate that ZNF521 modulates erythroid cell differentiation through direct binding with GATA-1.	[Sakai, Ikuya] Matsuyama Univ, Sch Clin Pharm, Coll Pharmaceut Sci, Dept Pathophysiol, Matsuyama, Ehime 7908578, Japan; [Matsubara, Etsuko; Yamanouchi, Jun; Fujiwara, Hiroshi; Yakushijin, Yoshihiro; Yasukawa, Masaki] Ehime Univ, Grad Sch Med, Dept Bioregulatory Med, Toon, Ehime 7910295, Japan; [Hato, Takaaki] Ehime Univ, Grad Sch Med, Div Blood Transfus & Cell Therapy, Toon, Ehime 7910295, Japan; [Shigemoto, Kazuhiro] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan	Ehime University; Ehime University; Tokyo Metropolitan Institute of Gerontology	Sakai, I (corresponding author), Matsuyama Univ, Sch Clin Pharm, Coll Pharmaceut Sci, Dept Pathophysiol, Matsuyama, Ehime 7908578, Japan.	isakai@cc.matsuyama-u.ac.jp; yasukawa@m.ehime-u.ac.jp	Hato, Takaaki/AAH-8356-2021		Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Dalgin G, 2007, DEV BIOL, V310, P454, DOI 10.1016/j.ydbio.2007.08.012; Eisbacher M, 2003, MOL CELL BIOL, V23, P3427, DOI 10.1128/MCB.23.10.3427-3441.2003; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Fox AH, 1998, J BIOL CHEM, V273, P33595, DOI 10.1074/jbc.273.50.33595; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hentges KE, 2005, ONCOGENE, V24, P1220, DOI 10.1038/sj.onc.1208243; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; JUSTICE MJ, 1994, J VIROL, V68, P1293, DOI 10.1128/JVI.68.3.1293-1300.1994; Ku MC, 2006, J BIOL CHEM, V281, P5277, DOI 10.1074/jbc.M510004200; LABBAYE C, 1995, J CLIN INVEST, V95, P2346, DOI 10.1172/JCI117927; Laricchia-Robbio L, 2006, MOL CELL BIOL, V26, P7658, DOI 10.1128/MCB.00363-06; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Maeno M, 1996, BLOOD, V88, P1965, DOI 10.1182/blood.V88.6.1965.bloodjournal8861965; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; OTTMANN OG, 1988, J IMMUNOL, V140, P2661; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Sitnicka E, 1996, BLOOD, V88, P82; Soderholm J, 1997, LEUKEMIA, V11, P352, DOI 10.1038/sj.leu.2400584; Takahashi T, 2000, ONCOGENE, V19, P134, DOI 10.1038/sj.onc.1203228; Tsai RYL, 1997, J NEUROSCI, V17, P4159; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Warming S, 2004, ONCOGENE, V23, P2727, DOI 10.1038/sj.onc.1207452	41	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3480	3487		10.1074/jbc.M805874200	http://dx.doi.org/10.1074/jbc.M805874200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19049973	hybrid			2022-12-25	WOS:000262872500014
J	Agrawal, G; Dighe, RR				Agrawal, Gaurav; Dighe, Rajan R.			Critical Involvement of the Hinge Region of the Follicle-stimulating Hormone Receptor in the Activation of the Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE; THYROTROPIN RECEPTOR; EXTRACELLULAR DOMAIN; MONOCLONAL-ANTIBODIES; GLYCOPROTEIN HORMONES; SIGNAL-TRANSDUCTION; FSH RECEPTOR; TSH RECEPTOR; STRUCTURAL BIOLOGY; LIGAND-BINDING	The follicle-stimulating hormone receptor (FSHR) is a G-protein-coupled receptor with a large hormone-specific extracellular domain (amino acids (aa) 1-366) and a characteristic seven-transmembrane domain (TMD; aa 367-695). The extracellular domain is composed of leucine-rich repeats (LRRs; aa 18-259) connected to TMD by a hinge region (HinR; aa 260-366), whose role in the hormone action is not clearly understood. We generated a novel polyclonal HinR antibody that specifically stimulates cAMP production by HEK 293 cells expressing FSHR in a hormone-independent manner. The monovalent antibody retained the stimulatory potential. The segment of aa 296-331 in HinR was identified as the binding site for the stimulatory antibody. Deletions of this entire segment or any 10 amino acids within this segment from FSHR led to complete loss of antibody response and, surprisingly, response to the hormone as well despite all mutants exhibiting cell surface receptor density and affinity comparable with the wild type receptor. Interestingly, these mutants exhibited higher basal cAMP production. The mutant lacking LRRs with the intact HinR (Delta 18-259) showed suppressed basal activity, which increased significantly with deletions extending to aa 331. These data suggest that the segment 296-331 acts as a tethered inverse agonist of the TMD and plays a very critical role in the hormonal activation of FSHR. The mutants lacking LRRs failed to bind FSH, whereas deletions in HinR had no effect on hormone binding, indicating that the LRRs constitute the primary high affinity binding site, whereas HinR may not play a significant role in FSH binding.	[Dighe, Rajan R.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Dighe, RR (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	rdighe@mrdg.iisc.ernet.in			Department of Biotechnology, Department of Science and Technology; University Grants Commission; Indian Council for Medical Research, Government of India, New Delhi; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, Department of Science and Technology(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India); Indian Council for Medical Research, Government of India, New Delhi(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The work presented in this study was supported by grants from the Department of Biotechnology, Department of Science and Technology, University Grants Commission, and Indian Council for Medical Research, Government of India, New Delhi. This work was reported in abstract form ( 49). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.. S The on-line version of this article ( available at http://www.jbc.org) contains supplemental Figs. 1-3.; 1 Supported by a fellowship from the Council of Scientific and Industrial Research, New Delhi.	AGRAWAL G, 2008, 90 ANN M END SOC END; Ahda Y, 2005, J ANDROL, V26, P494, DOI 10.2164/jandrol.04186; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Bruysters M, 2008, J BIOL CHEM, V283, P25821, DOI 10.1074/jbc.M804395200; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Dias JA, 2001, ARCH MED RES, V32, P510, DOI 10.1016/S0188-4409(01)00333-2; DIGHE RR, 1990, J IMMUNOL METHODS, V131, P229, DOI 10.1016/0022-1759(90)90194-Z; DIGHE RR, 1983, ARCH BIOCHEM BIOPHYS, V225, P490, DOI 10.1016/0003-9861(83)90058-9; DIGHE RR, 1990, MOL CELL ENDOCRINOL, V72, P63, DOI 10.1016/0303-7207(90)90240-9; Doherty E, 2002, J CLIN ENDOCR METAB, V87, P1151, DOI 10.1210/jc.87.3.1151; Fan QR, 2005, ENDOCRINE, V26, P179, DOI 10.1385/ENDO:26:3:179; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gadkari R, 2003, PROTEIN EXPRES PURIF, V32, P175, DOI 10.1016/S1046-5928(03)00231-6; Gadkari RA, 2007, MOL CELL ENDOCRINOL, V260, P23, DOI 10.1016/j.mce.2006.07.006; Ghosalkar JD, 2007, J REPROD IMMUNOL, V74, P24, DOI 10.1016/j.jri.2007.01.004; Gromoll J, 1996, J CLIN ENDOCR METAB, V81, P1367, DOI 10.1210/jc.81.4.1367; Gruters A, 1998, J CLIN ENDOCR METAB, V83, P1431, DOI 10.1210/jc.83.5.1431; Karges B, 2005, MOL ENDOCRINOL, V19, P2086, DOI 10.1210/me.2004-0378; Kene PS, 2005, AM J REPROD IMMUNOL, V54, P38, DOI 10.1111/j.1600-0897.2005.00285.x; Kene PS, 2004, J ENDOCRINOL, V182, P501, DOI 10.1677/joe.0.1820501; Khoo TK, 2007, THYROID, V17, P1013, DOI 10.1089/thy.2007.0185; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Moyle WR, 2005, ENDOCRINE, V26, P189, DOI 10.1385/ENDO:26:3:189; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; NALAWADI V, 1999, THESIS INDIAN I SCI; Nishi S, 2002, J BIOL CHEM, V277, P3958, DOI 10.1074/jbc.M109617200; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Rannikko A, 2002, MOL HUM REPROD, V8, P311, DOI 10.1093/molehr/8.4.311; Rapoport B, 2007, THYROID, V17, P911, DOI 10.1089/thy.2007.0170; Sambrook J., 2002, MOL CLONING LAB MANU; Sanders J, 2005, THYROID, V15, P672, DOI 10.1089/thy.2005.15.672; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Schmidt A, 2001, J BIOL CHEM, V276, P23373, DOI 10.1074/jbc.M100057200; SHARMA SC, 1995, MOL CELL ENDOCRINOL, V115, P87, DOI 10.1016/0303-7207(95)03673-U; Shenoy AR, 2003, FEBS LETT, V545, P253, DOI 10.1016/S0014-5793(03)00580-5; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Touraine P, 1999, MOL ENDOCRINOL, V13, P1844, DOI 10.1210/me.13.11.1844; VanSande J, 1996, MOL CELL ENDOCRINOL, V119, P161, DOI 10.1016/0303-7207(96)03804-X; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514; ZHANG ML, 1995, BIOCHEM BIOPH RES CO, V211, P205, DOI 10.1006/bbrc.1995.1797	49	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2636	2647		10.1074/jbc.M808199200	http://dx.doi.org/10.1074/jbc.M808199200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029293	hybrid			2022-12-25	WOS:000262700900006
J	Sun, FY; Xie, QL; Ma, J; Yang, SH; Chen, QY; Hong, A				Sun, Fenyong; Xie, Qiuling; Ma, Ji; Yang, Songhai; Chen, Qiongyu; Hong, An			Nuclear Factor Y Is Required for Basal Activation and Chromatin Accessibility of Fibroblast Growth Factor Receptor 2 Promoter in Osteoblast-like Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-Y; TRANSCRIPTION FACTOR; HISTONE ACETYLTRANSFERASES; BONE-FORMATION; BINDING; GENE; MUTATIONS; REGION; EXPRESSION; DOMAINS	Fibroblast growth factor receptor 2 (FGFR2) plays an important regulatory role in bone development. However, the regulatory mechanisms controlling FGFR2 expression remain poorly understood. Here we have identified a role for the nuclear factor Y (NF-Y) in constitutive activation of FGFR2. A unique DNase I hypersensitive site was detected in the region encompassing nucleotides -270 to +230 after scanning a large range covering 33.3 kilobases around the transcription start site of FGFR2. Using a PCR-based chromatin accessibility assay, an open chromatin conformation was detected around the proximal 5' fragment of FGFR2 gene. Deletion constructs of the 5'-flanking region of FGFR2 were fused to a luciferase reporter gene. After transient transfection in C3H10T1/2, ME3T3-E1, and C2C12 as well as primary osteoblasts, a minimal region -86/ +139 that is highly homologous to the human sequence and bears a CCAAT box was identified as the core promoter. Electrophoretic mobility shift assay supershift and chromatin immunoprecipitation demonstrated that the CCAAT box was the binding site for NF-Y. Deletion of NF-Y consensus sequence resulted in the total loss of NF-Y promoter activity. Overexpression of NF-Y protein and transfection of NF-Y small interfering RNAs in the cells substantially changed the promoter activity. Moreover, NF-Y small interfering RNAs greatly inhibited the endogenous FGFR2 transcription level and the chromatin accessibility and H3 acetylation across the promoter. Taken together, our results demonstrate that interaction of NF-Y at the CCAAT box is pivotal to FGFR2 gene transcription partly through the construction of a local open chromatin configuration across the promoter.	[Sun, Fenyong; Xie, Qiuling; Ma, Ji; Chen, Qiongyu; Hong, An] Jinan Univ, Inst Genet Engn, Natl Engn Res Ctr Genet Med, Key Lab Genet Med Guangdong Prov, Guangzhou 510632, Guangdong, Peoples R China; [Yang, Songhai] Shaoguan Tielu Hosp, Shaoguan 512023, Guangdong, Peoples R China	Jinan University	Hong, A (corresponding author), Jinan Univ, Inst Genet Engn, Natl Engn Res Ctr Genet Med, Key Lab Genet Med Guangdong Prov, Guangzhou 510632, Guangdong, Peoples R China.	tha@jnu.edu.cn	MA, Ji/GXG-9194-2022	MA, Ji/0000-0001-6904-5360	National Natural Science Foundation of China [30400270,]; National 973 program [2001CB510106]; Science and Technology program of Guangzhou [2006Z1-E0031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 program(National Basic Research Program of China); Science and Technology program of Guangzhou	The work was supported by 211 project, National Natural Science Foundation of China Grant 30400270, National 973 program Grant 2001CB510106, and Science and Technology program of Guangzhou Grant 2006Z1-E0031. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; AVIVI A, 1992, ONCOGENE, V7, P1957; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; Bellorini M, 1997, NUCLEIC ACIDS RES, V25, P2174, DOI 10.1093/nar/25.11.2174; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Brettingham-Moore KH, 2005, NUCLEIC ACIDS RES, V33, P225, DOI 10.1093/nar/gki161; Caretti G, 1999, MOL CELL BIOL, V19, P8591; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Coustry F, 1998, BIOCHEM J, V331, P291, DOI 10.1042/bj3310291; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430; DENNIG J, 1995, J BIOL CHEM, V270, P12737, DOI 10.1074/jbc.270.21.12737; Duan ZJ, 2001, MOL CELL BIOL, V21, P3083, DOI 10.1128/MCB.21.9.3083-3095.2001; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Evers R, 1998, J CLIN INVEST, V101, P1310, DOI 10.1172/JCI119886; FRAMSON P, 1993, J BIOL CHEM, V268, P4989; Francis J, 2006, MOL ENDOCRINOL, V20, P3133, DOI 10.1210/me.2006-0126; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; GORZOWSKI JJ, 1995, J BIOL CHEM, V270, P26940, DOI 10.1074/jbc.270.45.26940; Gui CY, 2001, MOL CELL BIOL, V21, P1155, DOI 10.1128/MCB.21.4.1155-1163.2001; KOLLMAR R, 1994, J BIOL CHEM, V269, P2252; Kubota K, 2002, BONE, V31, P465, DOI 10.1016/S8756-3282(02)00852-9; LANDSBERGER N, 1995, MOL CELL BIOL, V15, P6013; Lemonnier J, 2001, J BONE MINER RES, V16, P832, DOI 10.1359/jbmr.2001.16.5.832; Lemonnier J, 2000, EXP CELL RES, V256, P158, DOI 10.1006/excr.2000.4820; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Motta MC, 1999, J BIOL CHEM, V274, P1326, DOI 10.1074/jbc.274.3.1326; NAKAMURA T, 1995, ENDOCRINOLOGY, V136, P1276, DOI 10.1210/en.136.3.1276; Nakamura T, 1998, J BONE MINER RES, V13, P942, DOI 10.1359/jbmr.1998.13.6.942; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; NODA M, 1989, J CELL BIOL, V109, P2529, DOI 10.1083/jcb.109.5.2529; Radomsky ML, 1998, CLIN ORTHOP RELAT R, pS283; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; RAZ V, 1991, ONCOGENE, V6, P753; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Sinha S, 1996, MOL CELL BIOL, V16, P328; Su L, 2004, J IMMUNOL, V173, P4994, DOI 10.4049/jimmunol.173.8.4994; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Xu XL, 1999, CELL TISSUE RES, V296, P33, DOI 10.1007/s004410051264; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; ZWICKER J, 1995, NUCLEIC ACIDS RES, V23, P3822, DOI 10.1093/nar/23.19.3822	48	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3136	3147		10.1074/jbc.M808992200	http://dx.doi.org/10.1074/jbc.M808992200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047043	hybrid, Green Published			2022-12-25	WOS:000262700900058
J	Takahashi, Y; Moiseyev, G; Ablonczy, Z; Chen, Y; Crouch, RK; Ma, JX				Takahashi, Yusuke; Moiseyev, Gennadiy; Ablonczy, Zsolt; Chen, Ying; Crouch, Rosalie K.; Ma, Jian-Xing			Identification of a Novel Palmitylation Site Essential for Membrane Association and Isomerohydrolase Activity of RPE65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; 2 POINT MUTATIONS; VISUAL CYCLE; PROTEIN PALMITOYLATION; KEY RESIDUES; IN-VITRO; ISOMERASE; PHOTORECEPTORS; EXPRESSION; STABILITY	RPE65 is a membrane-associated protein abundantly expressed in the retinal pigment epithelium, which converts all-trans-retinyl ester to 11-cis-retinol, a key step in the retinoid visual cycle. Although three cysteine residues (Cys-231, Cys-329, and Cys-330) were identified to be palmitylated in RPE65, recent studies showed that a triple mutant, with all three Cys replaced by an alanine residue, was still palmitylated and remained membrane-associated, suggesting that there are other yet to be identified palmitylated Cys residues in RPE65. Here we mapped the entire RPE65 using mass spectrometry analysis and demonstrated that a trypsin-digested RPE65 fragment ( residues 98-118), which contains two Cys residues (Cys-106 and Cys-112), was singly palmitylated in both native bovine and recombinant human RPE65. To determine whether Cys-106 or Cys-112 is the palmitylation site, these Cys were separately replaced by alanine. Mass spectrometry analysis of purified wild-type RPE65 and C106A and C112A mutants showed that mutation of Cys-106 did not affect the palmitylation status of the fragment 98-118, whereas mutation of Cys-112 abolished palmitylation in this fragment. Subcellular fractionation and immunocytochemistry analyses both showed that mutation of Cys-112 dissociated RPE65 from the membrane, whereas the C106A mutant remained associated with the membrane. In vitro isomerohydrolase activity assay showed that C106A has an intact enzymatic activity similar to that of wtRPE65, whereas C112A lost its enzymatic activity. These results indicate that the newly identified Cys-112 palmitylation site is essential for the membrane association and activity of RPE65.	[Takahashi, Yusuke; Moiseyev, Gennadiy; Chen, Ying; Ma, Jian-Xing] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Dept Med Endocrinol, Oklahoma City, OK 73104 USA; [Ablonczy, Zsolt; Crouch, Rosalie K.] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Medical University of South Carolina	Ma, JX (corresponding author), 941 Stanton L Young Blvd,BSEB 328B, Oklahoma City, OK 73104 USA.	jian-xing-ma@ouhsc.edu			National Institutes of Health [EY012231, EY015650, EY004939, P20RR024215]; OCAST, Foundation Fighting Blindness, and Research for Prevention of Blindness.; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R33EY015650, R21EY015650, R01EY004939, R01EY012231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OCAST, Foundation Fighting Blindness, and Research for Prevention of Blindness.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012231, EY015650, EY004939, and P20RR024215 (NCRR). This work was also supported by grants from OCAST, Foundation Fighting Blindness, and Research for Prevention of Blindness. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ablonczy Z, 2002, J BIOL CHEM, V277, P40491, DOI 10.1074/jbc.M205507200; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; BERNSTEIN PS, 1987, J BIOL CHEM, V262, P16848; BERNSTEIN PS, 1987, P NATL ACAD SCI USA, V84, P1849, DOI 10.1073/pnas.84.7.1849; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIDGES CDB, 1972, RHODOPSIN PORPHYROPS, P417; Chen Y, 2006, FEBS LETT, V580, P4200, DOI 10.1016/j.febslet.2006.06.078; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Ma JX, 2001, INVEST OPHTH VIS SCI, V42, P1429; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Rando RR, 2001, CHEM REV, V101, P1881, DOI 10.1021/cr960141c; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; SEFTON BM, 1987, J CELL BIOL, V104, P1449, DOI 10.1083/jcb.104.6.1449; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Takahashi Y, 2006, INVEST OPHTH VIS SCI, V47, P5191, DOI 10.1167/iovs.06-0614; Takahashi Y, 2006, J BIOL CHEM, V281, P21820, DOI 10.1074/jbc.M603725200; Trudel E, 2006, BIOCHEMISTRY-US, V45, P3337, DOI 10.1021/bi0519405; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016	29	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3211	3218		10.1074/jbc.M807248200	http://dx.doi.org/10.1074/jbc.M807248200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049981	Green Published, hybrid			2022-12-25	WOS:000262700900064
J	Cai, QS; Li, J; Gao, TY; Xie, JW; Evers, BM				Cai, Qingsong; Li, Jing; Gao, Tianyan; Xie, Jingwu; Evers, B. Mark			Protein Kinase C delta Negatively Regulates Hedgehog Signaling by Inhibition of Gli1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; PKC-DELTA; PHORBOL ESTER; TYROSINE PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVITY; NEUROTENSIN SECRETION; BREAST-CANCER; KAPPA-B; PATHWAY; ACTIVATION	Constitutive activation of the hedgehog pathway is implicated in the development of many human malignancies; hedgehog targets, PTCH1 and Gli1, are markers of hedgehog signaling activation and are expressed in most hedgehog-associated tumors. Protein kinase C delta (PKC delta) generally slows proliferation and induces cell cycle arrest of various cell lines. In this study, we show that activated PKC delta (wild-type PKC delta stimulated by phorbol 12-myristate 13-acetate or constitutively active PKC delta) decreased Gli-luciferase reporter activity in NIH/3T3 cells, as well as the endogenous hedgehog-responsive gene PTCH1. In human hepatoma (i.e. Hep3B) cells, wild-type PKC delta and constitutively active PKC delta decreased the expression levels of endogenous Gli1 and PTCH1. In contrast, PKC delta siRNA increased the expression levels of these target genes. Silencing of PKC delta by siRNA rescued the inhibition of cell growth by KAAD-cyclopamine, an antagonist of hedgehog signaling element Smoothened, suggesting that PKC delta acts downstream of Smoothened. The biological relevance of our study is shown in hepatocellular carcinoma where we found that hepatocellular carcinoma with detectable hedgehog signaling had weak or no detectable expression of PKC delta, whereas PKC delta highly expressing tumors had no detectable hedgehog signaling. Our results demonstrate that PKC delta alters hedgehog signaling by inhibition of Gli protein transcriptional activity. Furthermore, our findings suggest that, in certain cancers, PKC delta plays a role as a negative regulator of tumorigenesis by regulating hedgehog signaling.	[Cai, Qingsong; Li, Jing; Evers, B. Mark] Univ Texas Galveston, Dept Surg, Med Branch, Galveston, TX 77555 USA; [Cai, Qingsong; Li, Jing; Gao, Tianyan; Xie, Jingwu; Evers, B. Mark] Univ Texas Galveston, Sealy Ctr Canc Cell Biol, Med Branch, Galveston, TX 77555 USA; [Gao, Tianyan; Xie, Jingwu] Univ Texas Galveston, Dept Pharmacol & Toxicol, Med Branch, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Evers, BM (corresponding author), Univ Texas Galveston, Dept Surg, Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.	mevers@utmb.edu	Li, Jing/B-7206-2011; Cai, Qingsong/J-6428-2012		National Institutes of Health [R01 CA104748, R01 DK48489, R01 DK35608, R01 CA94160]; NATIONAL CANCER INSTITUTE [R01CA094160, R01CA104748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA104748, R01 DK48489, R01 DK35608, and R01 CA94160.	Ashton AW, 1999, J BIOL CHEM, V274, P20805, DOI 10.1074/jbc.274.30.20805; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Braun MU, 2003, J MOL CELL CARDIOL, V35, P895, DOI 10.1016/S0022-2828(03)00142-1; Brodie C, 2004, MOL PHARMACOL, V66, P76, DOI 10.1124/mol.66.1.76; Choi SY, 2006, J BIOL CHEM, V281, P7049, DOI 10.1074/jbc.M512000200; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; FlorinChristensen J, 1996, BIOCHEM J, V315, P513, DOI 10.1042/bj3150513; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Hsu SL, 1998, BIOCHEM J, V333, P57, DOI 10.1042/bj3330057; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; King LB, 1999, J IMMUNOL, V162, P2655; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Kubo Makoto, 2007, Nihon Rinsho, V65 Suppl 6, P142; Lasfer M, 2006, FEBS LETT, V580, P2547, DOI 10.1016/j.febslet.2006.03.089; Leitges M, 2001, LAB INVEST, V81, P1087, DOI 10.1038/labinvest.3780321; Li J, 2005, J BIOL CHEM, V280, P8351, DOI 10.1074/jbc.M409431200; Li J, 2002, AM J PHYSIOL-GASTR L, V283, pG1197, DOI 10.1152/ajpgi.00177.2002; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; Ma XL, 2005, CARCINOGENESIS, V26, P1698, DOI 10.1093/carcin/bgi130; Mackay K, 2001, J MOL CELL CARDIOL, V33, P1301, DOI 10.1006/jmcc.2001.1400; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Neill GW, 2003, CANCER RES, V63, P4692; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; Sanchez P, 2005, CANCER RES, V65, P2990, DOI 10.1158/0008-5472.CAN-05-0439; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wang QD, 2001, GASTROENTEROLOGY, V120, P1381, DOI 10.1053/gast.2001.24044; Wang QD, 2006, INT J CANCER, V118, P326, DOI 10.1002/ijc.21373; Wang QD, 2003, J BIOL CHEM, V278, P51091, DOI 10.1074/jbc.M306541200; Wang XF, 2004, ONCOGENE, V23, P1885, DOI 10.1038/sj.onc.1207312; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	52	34	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2150	2158		10.1074/jbc.M803235200	http://dx.doi.org/10.1074/jbc.M803235200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19015273	Green Published, hybrid			2022-12-25	WOS:000262545600024
J	Lu, WB; Ma, H; Sheng, ZH; Mochida, S				Lu, Wenbo; Ma, Huan; Sheng, Zu-Hang; Mochida, Sumiko			Dynamin and Activity Regulate Synaptic Vesicle Recycling in Sympathetic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMITTER RELEASE; DROSOPHILA MUTANT; ENDOCYTOSIS; MEMBRANE; SYNAPSES; AMPHIPHYSIN; CA2+; GTP; REQUIREMENT; INHIBITION	Neurotransmission in central neuronal synapses is supported by the recycling of synaptic vesicles via endocytosis at different time scales during and after transmitter release. Here, we examine the kinetics and molecular determinants of different modes of synaptic vesicle recycling at a peripheral neuronal synapse formed between superior cervical ganglion neurons in culture, via acute disruption of endocytosis with Dynasore, an inhibitor of dynamin activation, or a dynamin peptide (P4) that perturbs linkage of dynamin to clathrin coats through amphiphysin. When paired action potentials are generated to produce excitatory postsynaptic potential responses, the second response was reduced after application of Dynasore but not P4. In addition, graded reduction in synaptic transmission during a train of action potentials was accelerated by Dynasore but enhanced by P4. After full depletion of releasable vesicles, P4 delayed the recovery of synaptic transmission while Dynasore limited recovery to 10%. In control neurons, synaptic transmission is stable for more than 1 h under low frequency presynaptic stimulation (0.2 Hz), but was reduced gradually by P4 and rapidly but incompletely blocked by Dynasore at a much lower stimulation frequency. These results suggest two essential modes of dynamin-mediated synaptic vesicle recycling, one activity-dependent and the other activity-independent. Our findings extend the current understanding of synaptic vesicle recycling to sympathetic nerve terminals and provide evidence for a physiological and molecular heterogeneity in endocytosis, a key cellular process for efficient replenishment of the vesicle pool, and thus for synaptic plasticity.	[Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Shinjuku Ku, Tokyo 1608402, Japan; [Lu, Wenbo; Ma, Huan; Mochida, Sumiko] Shanghai Jiao Tong Univ, Dept Neurobiol, Sch Med, Shanghai 200025, Peoples R China; [Sheng, Zu-Hang] NINDS, Synapt Funct Sect, NIH, Bethesda, MD 20892 USA	Tokyo Medical University; Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Mochida, S (corresponding author), Tokyo Med Univ, Dept Physiol, Shinjuku Ku, 1-1 Shinjuku 6 Chome, Tokyo 1608402, Japan.	mochida@tokyo-med.ac.jp	Ma, Huan/A-1379-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002946, Z01NS002946, ZIANS003029] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BIRKS RI, 1957, BRIT MED BULL, V13, P157, DOI 10.1093/oxfordjournals.bmb.a069605; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Ertunc M, 2007, J NEUROSCI, V27, P341, DOI 10.1523/JNEUROSCI.4051-06.2007; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JANIG W, 1970, PFLUG ARCH EUR J PHY, V314, P199, DOI 10.1007/BF00592246; Kavalali ET, 2007, J PHYSIOL-LONDON, V585, P669, DOI 10.1113/jphysiol.2007.137745; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klingauf J, 2007, NEURON, V54, P857, DOI 10.1016/j.neuron.2007.06.010; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LoGiudice L, 2006, NEURON, V51, P676, DOI 10.1016/j.neuron.2006.09.004; Ma H, 2007, NEUROSCI RES, V57, P491, DOI 10.1016/j.neures.2006.12.015; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; MOCHIDA S, 1995, J PHYSIOLOGY-PARIS, V89, P83, DOI 10.1016/0928-4257(96)80555-9; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wu LG, 2004, TRENDS NEUROSCI, V27, P548, DOI 10.1016/j.tins.2004.07.001; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Zhang C, 2004, NEURON, V42, P225, DOI 10.1016/S0896-6273(04)00189-8	46	28	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1930	1937		10.1074/jbc.M803691200	http://dx.doi.org/10.1074/jbc.M803691200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19010787	hybrid			2022-12-25	WOS:000262330100063
J	Stathopulos, PB; Zheng, L; Ikura, M				Stathopulos, Peter B.; Zheng, Le; Ikura, Mitsuhiko			Stromal Interaction Molecule (STIM) 1 and STIM2 Calcium Sensing Regions Exhibit Distinct Unfolding and Oligomerization Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; CRAC CHANNEL; STORE; ORAI1; SENSOR; ACTIVATION; DEPLETION; PROTEIN; IDENTIFICATION; INITIATION	Stromal interaction molecules (STIM) 1 and STIM2 are regulators of store-operated calcium (Ca2+) entry as well as basal cytoplasmic Ca2+ levels in human cells. Despite a high sequence similarity (>65%) and analogous sequence-based domain architectures, STIM1 and STIM2 differentially influence these phenomena. Among all eukaryotes, the endoplasmic reticulum luminal portion of STIM proteins minimally encode EF-hand and sterile alpha-motif (SAM) domains (EF-SAM), which are responsible for sensing changes in Ca2+ levels and initiating oligomerization. STIM oligomerization is a key induction step in the activation of Ca2+ permeable channels on the plasma membrane. Here, we show that the kinetic half-time of conversion from a monomeric to a steady oligomeric state is > 70 x shorter for STIM1 EF-SAM than STIM2 under similar conditions. Urea-induced rates of unfolding for STIM1 EF-SAM are > 3 x quicker when compared with STIM2, coherent with partial unfolding-coupled aggregation. Additionally, we demonstrate that the isoform-specific N-terminal residues beyond EF-SAM can influence the stability of this region. We postulate that distinct oligomerization dynamics of STIM isoforms have evolved to adapt to differential roles in Ca2+ homeostasis and signaling.	[Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ikura, M (corresponding author), MaRS Toronto Med Discovery Tower, Rm 4-804,101 Coll St, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca		Stathopulos, Peter B./0000-0002-0536-6656; Ikura, Mitsuhiko/0000-0002-9524-1303	Canadian Institutes of Health Research; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by a Canadian Institutes of Health Research operating grant and by Canadian Foundation for Innovation funding for 800 and 600 MHz NMR spectrometers. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cai XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000609; Chen LH, 2007, CARCINOGENESIS, V28, P2328, DOI 10.1093/carcin/bgm173; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GAO S, 2008, CELL CALCIU IN PRESS; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yan XH, 2006, J GEN PHYSIOL, V128, P443, DOI 10.1085/jgp.200609611; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129	35	139	143	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					728	732		10.1074/jbc.C800178200	http://dx.doi.org/10.1074/jbc.C800178200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19019825	hybrid			2022-12-25	WOS:000262122900005
J	Townsend, PD; Holliday, PM; Fenyk, S; Hess, KC; Gray, MA; Hodgson, DRW; Cann, MJ				Townsend, Philip D.; Holliday, Phillip M.; Fenyk, Stepan; Hess, Kenneth C.; Gray, Michael A.; Hodgson, David R. W.; Cann, Martin J.			Stimulation of Mammalian G-protein-responsive Adenylyl Cyclases by Carbon Dioxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CAMP PRODUCTION; NUCLEOTIDE PHOSPHODIESTERASE; CO2; EXPRESSION; PH; AVOIDANCE; MICROTI; SITES; SAC	Carbon dioxide is fundamental to the physiology of all organisms. There is considerable interest in the precise molecular mechanisms that organisms use to directly sense CO2. Here we demonstrate that a mammalian recombinant G-protein-activated adenylyl cyclase and the related Rv1625c adenylyl cyclase of Mycobacterium tuberculosis are specifically stimulated by CO2. Stimulation occurred at physiological concentrations of CO2 through increased kcat.CO2 increased the affinity of enzyme for metal co-factor, but contact with metal was not necessary as CO2 interacted directly with apoenzyme. CO2 stimulated the activity of both G-protein-regulated adenylyl cyclases and Rv1625c in vivo. Activation of G-protein regulated adenylyl cyclases by CO2 gave a corresponding increase in cAMP-response element-binding protein ( CREB) phosphorylation. Comparison of the responses of the G-protein regulated adenylyl cyclases and the molecularly, and biochemically distinct mammalian soluble adenylyl cyclase revealed that whereas G-protein- regulated enzymes are responsive to CO2, the soluble adenylyl cyclase is responsive to both CO2 and bicarbonate ion. We have, thus, identified a signaling enzyme by which eukaryotes can directly detect and respond to fluctuating CO2.	[Townsend, Philip D.; Holliday, Phillip M.; Fenyk, Stepan; Cann, Martin J.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Holliday, Phillip M.; Hodgson, David R. W.] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Hess, Kenneth C.] Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Gray, Michael A.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Durham University; Durham University; Cornell University; Newcastle University - UK	Cann, MJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	m.j.cann@durham.ac.uk	Cann, Martin/G-2864-2012; Hodgson, David/F-7174-2011; Townsend, Phiip/J-3761-2018; Hess, Kenneth/K-6546-2019	Cann, Martin/0000-0001-6305-8769; Hodgson, David/0000-0003-4517-9166; Townsend, Phiip/0000-0001-9235-3492; Hess, Kenneth/0000-0003-1377-6070; GRAY, MICHAEL/0000-0002-6774-6283	Wellcome Trust; Leverhulme Trust; Biotechnology and Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust, the Leverhulme Trust, and the Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bahn YS, 2006, CURR OPIN MICROBIOL, V9, P572, DOI 10.1016/j.mib.2006.09.003; Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Cann MJ, 2003, J BIOL CHEM, V278, P35033, DOI 10.1074/jbc.M303025200; Chen J, 1997, J APPL PHYSIOL, V82, P1771, DOI 10.1152/jappl.1997.82.6.1771; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Clarke LL, 1998, GASTROENTEROLOGY, V114, pA94, DOI 10.1016/S0016-5085(98)80378-8; COOPER TG, 1969, J BIOL CHEM, V244, P1081; Cotelesage JJH, 2007, INT J BIOCHEM CELL B, V39, P1204, DOI 10.1016/j.biocel.2007.03.015; Dessauer CW, 1996, J BIOL CHEM, V271, P16967, DOI 10.1074/jbc.271.28.16967; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES, P156; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Hall PR, 2004, EMBO J, V23, P3621, DOI 10.1038/sj.emboj.7600373; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hammer A, 2006, BIOCHEM J, V396, P215, DOI 10.1042/BJ20060372; Hegyi P, 2004, PANCREAS, V28, P427, DOI 10.1097/00006676-200405000-00012; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; HOPPE A, 1982, AM J PHYSIOL, V243, pF471, DOI 10.1152/ajprenal.1982.243.5.F471; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Inada T, 1996, MOL GEN GENET, V253, P198, DOI 10.1007/s004380050313; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kobayashi M, 2004, DEV GENES EVOL, V214, P503, DOI 10.1007/s00427-004-0432-2; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; LEE E, 1994, METHOD ENZYMOL, V237, P146; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; LORIMER GH, 1979, J BIOL CHEM, V254, P5599; LORIMER GH, 1983, TRENDS BIOCHEM SCI, V8, P65, DOI 10.1016/0968-0004(83)90393-6; LOWRIE DB, 1979, J GEN MICROBIOL, V110, P431, DOI 10.1099/00221287-110-2-431; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Morollo AA, 1999, BIOCHEMISTRY-US, V38, P3293, DOI 10.1021/bi9822729; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Raven John A, 2006, Biochem J, V396, pe5; Reddy SK, 2001, J BIOL CHEM, V276, P35141, DOI 10.1074/jbc.M104108200; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Summers BA, 2002, J NEUROPHYSIOL, V88, P604, DOI 10.1152/jn.2002.88.2.604; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Willoughby D, 2005, J BIOL CHEM, V280, P30864, DOI 10.1074/jbc.M414355200; Xie F, 2004, DEV BIOL, V265, P196, DOI 10.1016/j.ydbio.2003.09.020; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Yan SZ, 2002, METHOD ENZYMOL, V345, P231	55	36	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					784	791		10.1074/jbc.M807239200	http://dx.doi.org/10.1074/jbc.M807239200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008230	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000262122900012
J	Silva, M; Pereira, HS; Bento, M; Santos, AP; Shaw, P; Delgado, M; Neves, N; Viegas, W				Silva, Manuela; Pereira, H. Sofia; Bento, Miguel; Santos, Ana Paula; Shaw, Peter; Delgado, Margarida; Neves, Nuno; Viegas, Wanda			Interplay of Ribosomal DNA Loci in Nucleolar Dominance: Dominant NORs Are Up-Regulated by Chromatin Dynamics in the Wheat-Rye System	PLOS ONE			English	Article							RNA GENES; NUCLEAR ARCHITECTURE; ORGANIZATION; HETEROCHROMATIN; CHROMOSOMES; METHYLATION; GENOME; TRANSCRIPTION; INTERPHASE	Background: Chromatin organizational and topological plasticity, and its functions in gene expression regulation, have been strongly revealed by the analysis of nucleolar dominance in hybrids and polyploids where one parental set of ribosomal RNA ( rDNA) genes that are clustered in nucleolar organizing regions (NORs), is rendered silent by epigenetic pathways and heterochromatization. However, information on the behaviour of dominant NORs is very sparse and needed for an integrative knowledge of differential gene transcription levels and chromatin specific domain interactions. Methodology/Principal Findings: Using molecular and cytological approaches in a wheat-rye addition line (wheat genome plus the rye nucleolar chromosome pair 1R), we investigated transcriptional activity and chromatin topology of the wheat dominant NORs in a nucleolar dominance situation. Herein we report dominant NORs up-regulation in the addition line through quantitative real-time PCR and silver-staining technique. Accompanying this modification in wheat rDNA trascription level, we also disclose that perinucleolar knobs of ribosomal chromatin are almost transcriptionally silent due to the residual detection of BrUTP incorporation in these domains, contrary to the marked labelling of intranucleolar condensed rDNA. Further, by comparative confocal analysis of nuclei probed to wheat and rye NORs, we found that in the wheat-rye addition line there is a significant decrease in the number of wheat-origin perinucleolar rDNA knobs, corresponding to a diminution of the rDNA heterochromatic fraction of the dominant (wheat) NORs. Conclusions/Significance: We demonstrate that inter-specific interactions leading to wheat-origin NOR dominance results not only on the silencing of rye origin NOR loci, but dominant NORs are also modified in their transcriptional activity and interphase organization. The results show a cross-talk between wheat and rye NORs, mediated by ribosomal chromatin dynamics, revealing a conceptual shift from differential amphiplasty to 'mutual amphiplasty' in the nucleolar dominance process.	[Silva, Manuela; Pereira, H. Sofia; Bento, Miguel; Santos, Ana Paula; Delgado, Margarida; Neves, Nuno; Viegas, Wanda] Univ Tecn Lisboa, Inst Super Agron, Ctr Bot Aplicada Agricultura, Lisbon, Portugal; [Santos, Ana Paula; Shaw, Peter] John Innes Ctr, Norwich, Norfolk, England; [Delgado, Margarida] Univ Lusofona Humanidades Tecnol, Lisbon, Portugal; [Neves, Nuno] Univ Nova Lisboa, Fac Ciencias Tecnol, Dept Ciencias Vida, Monte De Caparica, Portugal	Universidade de Lisboa; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Lusofona University; Universidade Nova de Lisboa	Silva, M (corresponding author), Univ Tecn Lisboa, Inst Super Agron, Ctr Bot Aplicada Agricultura, Lisbon, Portugal.	manuelasilva@isa.utl.pt	Santos, Ana Paula/D-3154-2012; Delgado, Margarida/E-2764-2014; Silva, Manuela/ABF-7085-2020; shaw, peter j/E-5511-2011; Silva, Manuela/GSN-4031-2022	Santos, Ana Paula/0000-0002-8108-1863; Silva, Manuela/0000-0003-4677-870X; shaw, peter j/0000-0003-1076-2669; Pereira, H. Sofia/0000-0002-7933-6097; Bento, Miguel/0000-0002-7545-8943; Delgado, Margarida/0000-0003-3132-3278; Viegas, Wanda/0000-0003-4660-1226	Fundacao para a Ciencia e Tecnologia [POCI/BIA-BDE/57575/2004, POCI/BIA-BCM/59389/2004]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Fundacao para a Ciencia e Tecnologia (projects POCI/BIA-BDE/57575/2004 to M.S. and POCI/BIA-BCM/59389/2004 to N.N.).	Abranches R, 1998, J CELL BIOL, V143, P5, DOI 10.1083/jcb.143.1.5; Akhmanova A, 2000, J CELL SCI, V113, P4463; Caperta AD, 2002, J CELL SCI, V115, P2839; Caperta AD, 2007, PROTOPLASMA, V232, P55, DOI 10.1007/s00709-007-0277-4; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Carvalho C, 2001, MOL BIOL CELL, V12, P3563, DOI 10.1091/mbc.12.11.3563; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Cheutin T, 2002, J CELL SCI, V115, P3297; DURICA DS, 1977, DEV BIOL, V59, P62, DOI 10.1016/0012-1606(77)90240-8; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; FLAVELL RB, 1976, HEREDITY, V37, P377, DOI 10.1038/hdy.1976.102; Fransz P, 2006, CHROMOSOME RES, V14, P71, DOI 10.1007/s10577-005-1022-5; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hasterok R, 2000, GENOME, V43, P574, DOI 10.1139/gen-43-3-574; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Houchins K, 1997, MOL GEN GENET, V255, P294, DOI 10.1007/s004380050500; LACADENA JR, 1984, THEOR APPL GENET, V67, P207, DOI 10.1007/BF00317037; LEITCH AR, 1992, J CELL SCI, V101, P751; Lewis MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000815; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Morais-Cecilio L, 2000, CHROMOSOME RES, V8, P341, DOI 10.1023/A:1009291714371; MUKAI Y, 1991, CHROMOSOMA, V100, P71, DOI 10.1007/BF00418239; NAVASHIN M., 1934, CYTOLOGIA, V5, P169, DOI 10.1508/cytologia.5.169; Neves N, 1997, CHROMOSOME RES, V5, P125, DOI 10.1023/A:1018470208730; Neves N, 2005, CYTOGENET GENOME RES, V109, P104, DOI 10.1159/000082388; Pecinka A, 2004, CHROMOSOMA, V113, P258, DOI 10.1007/s00412-004-0316-2; Pikaard CS, 2007, CHROMOSOME RES, V15, P18; Pikaard CS, 2001, TRENDS GENET, V17, P675, DOI 10.1016/S0168-9525(01)02545-8; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; Santos AP, 2002, J CELL SCI, V115, P4597, DOI 10.1242/jcs.00160; Savino TM, 2001, J CELL BIOL, V153, P1097, DOI 10.1083/jcb.153.5.1097; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Viegas W., 2002, Current Genomics, V3, P563, DOI 10.2174/1389202023350237	39	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2008	3	12							e3824	10.1371/journal.pone.0003824	http://dx.doi.org/10.1371/journal.pone.0003824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YM	19048103	gold, Green Published			2022-12-25	WOS:000265452000004
J	Bain, MB; Singkran, N; Mills, KE				Bain, Mark B.; Singkran, Nuanchan; Mills, Katherine E.			Integrated Ecosystem Assessment: Lake Ontario Water Management	PLOS ONE			English	Article							GREAT-LAKES; COASTAL WETLANDS; BLACK TERN; NEARSHORE; EROSION; MACROPHYTES; ECOLOGY; IMPACT; DEPTH; INDEX	Background: Ecosystem management requires organizing, synthesizing, and projecting information at a large scale while simultaneously addressing public interests, dynamic ecological properties, and a continuum of physicochemical conditions. We compared the impacts of seven water level management plans for Lake Ontario on a set of environmental attributes of public relevance. Methodology and Findings: Our assessment method was developed with a set of established impact assessment tools (checklists, classifications, matrices, simulations, representative taxa, and performance relations) and the concept of archetypal geomorphic shoreline classes. We considered each environmental attribute and shoreline class in its typical and essential form and predicted how water level change would interact with defining properties. The analysis indicated that about half the shoreline of Lake Ontario is potentially sensitive to water level change with a small portion being highly sensitive. The current water management plan may be best for maintaining the environmental resources. In contrast, a natural water regime plan designed for greatest environmental benefits most often had adverse impacts, impacted most shoreline classes, and the largest portion of the lake coast. Plans that balanced multiple objectives and avoided hydrologic extremes were found to be similar relative to the environment, low on adverse impacts, and had many minor impacts across many shoreline classes. Significance: The Lake Ontario ecosystem assessment provided information that can inform decisions about water management and the environment. No approach and set of methods will perfectly and unarguably accomplish integrated ecosystem assessment. For managing water levels in Lake Ontario, we found that there are no uniformly good and bad options for environmental conservation. The scientific challenge was selecting a set of tools and practices to present broad, relevant, unbiased, and accessible information to guide decision-making on a set of management options.	[Bain, Mark B.; Singkran, Nuanchan; Mills, Katherine E.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA	Cornell University	Bain, MB (corresponding author), Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA.	Mark.Bain@Cornell.edu			US Army Corps of Engineers; International Joint Commission; National Science Foundation [OCE-0083625]; Great Lakes Commission; US Environmental Protection Agency	US Army Corps of Engineers(United States Department of DefenseUnited States Army); International Joint Commission; National Science Foundation(National Science Foundation (NSF)); Great Lakes Commission; US Environmental Protection Agency(United States Environmental Protection Agency)	Our approach was developed under a grant to MBB from the US Army Corps of Engineers and the International Joint Commission. These sponsors did not specify or influence the study design, findings, and interpretations. They were not aware of the conclusions prior to publication, and our findings are independent of agency policies. Field studies of the Lake Ontario coastal zone were supported by grants from the National Science Foundation (OCE-0083625), the Great Lakes Commission, and the US Environmental Protection Agency.	Allen A.W., 1983, HABITAT SUITABILITY; ALSOP FJ, 2001, BIRDS N AM; Amin SMN, 1997, J COASTAL RES, V13, P1093; BARTON D R, 1978, Journal of Great Lakes Research, V4, P27; BARTON DR, 1984, J GREAT LAKES RES, V10, P407, DOI 10.1016/S0380-1330(84)71857-0; BEDFORD KW, 1992, J GREAT LAKES RES, V18, P571, DOI 10.1016/S0380-1330(92)71323-9; Brewer R, 1991, ATLAS BREEDING BIRDS; *CAN WILDL SERV, 2008, BIRD FACT SHEETS KIL; Carpenter SR, 2002, ECOLOGY, V83, P2069, DOI 10.2307/3072038; Casselman JM, 1996, CAN J FISH AQUAT SCI, V53, P161, DOI 10.1139/cjfas-53-S1-161; CHAMBERS PA, 1985, CAN J FISH AQUAT SCI, V42, P701, DOI 10.1139/f85-090; *CHES BAY PROGR, 2007, 903R07001 EPA; *CJ STEW CONS, 2001, REV POT DAT SOURC US; CLARK CF, 1950, COPEIA, P285; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Curnutt JL, 2000, ECOL APPL, V10, P1849, DOI 10.2307/2641243; CURRIER CL, 2000, SPEC AN ABSTR CHLID; DAVIDSONARNOTT RGD, 1995, MAR GEOL, V122, P349, DOI 10.1016/0025-3227(94)00115-2; Davies SP, 2006, ECOL APPL, V16, P1251, DOI 10.1890/1051-0761(2006)016[1251:TBCGAD]2.0.CO;2; *ENV CAN, 2008, PIP PLOV E CAN; *ENV CAN, 2007, SPEC RISK PUBL REG; FABRICIUS E, 1950, I FRESHWATER RES DRO, V29, P57; Fitz C, 2003, MODEL DYN SYST, P143; *FUNCT GROUP 2, 1989, LIV LAK CHALL OPP AN; Great Lakes Commission, 2003, WAT RES MAN DEC SUPP; Hall SR, 2003, J GREAT LAKES RES, V29, P54, DOI 10.1016/S0380-1330(03)70415-8; HARRIS SW, 1963, ECOLOGY, V44, P331, DOI 10.2307/1932180; Harrison H.H, 1979, FIELD GUIDE W BIRDS; HAUG PT, 1984, J ENVIRON MANAGE, V18, P15; HERDENDORF CE, 1992, J GREAT LAKES RES, V18, P533, DOI 10.1016/S0380-1330(92)71321-5; Hickey JM, 1997, COLON WATERBIRD, V20, P582, DOI 10.2307/1521614; *HIGH PERF SYST IN, 2003, STELLA RES VERS 8 0; Hudon C, 2000, CAN J FISH AQUAT SCI, V57, P31, DOI 10.1139/f99-232; JOHNSGARD PA, 1956, ECOLOGY, V37, P689, DOI 10.2307/1933059; JUDE DJ, 1992, J GREAT LAKES RES, V18, P651, DOI 10.1016/S0380-1330(92)71328-8; KEAST A, 1977, Environmental Biology of Fishes, V2, P235, DOI 10.1007/BF00005992; KEDDY PA, 1982, AM J BOT, V69, P13, DOI 10.2307/2442827; KEDDY PA, 1985, VEGETATION DYNAMICS, P38; KRIEGER KA, 1992, J GREAT LAKES RES, V18, P525, DOI 10.1016/S0380-1330(92)71319-7; *LAK ONT BIOC PROJ, 2007, LAK ONT BIOC STUD PH; *LAK ONT STL RIV S, 2006, OPT MAN LAK ONT ST L; LAWRENCE PL, 1994, GEOMORPHOLOGY, V10, P65, DOI 10.1016/0169-555X(94)90008-6; LISTER R, 2008, BIRD FACT SHEETS MAL; Lund J., 2007, ENVISIONING FUTURES; *MAN MUS MAN NAT, 2008, MARSH WREN CIST PAL; Mazzocchi IM, 1997, COLON WATERBIRD, V20, P596, DOI 10.2307/1521615; MEANLEY B, 1969, NATURAL HIST KING RA, P67; Mortsch LD, 1998, CLIMATIC CHANGE, V40, P391, DOI 10.1023/A:1005445709728; MUMFORD RE, 2000, BIRDS INDIANA; *NAT BIOL INF INFR, 2006, US FISH WILDL SERV F; National Research Council, 2001, INL NAV SYST PLANN U; National Research Council, 2002, MISS RIV EC EXPL PRO, P176, DOI [10.17226/10277, DOI 10.17226/10277]; *NY DEP ENV CONS, 2008, PIP PLOV FACT SHEET; *NY DEP ENV CONS, 2007, LIST END THREAT SPEC; Palmer R.S., 1962, HDB N AM BIRDS, V1; PARKER B, 2003, ENV TECHNICAL WORK G, P6; Randall RG, 1996, CAN J FISH AQUAT SCI, V53, P35, DOI 10.1139/cjfas-53-S1-35; ROBEL ROBERT J., 1962, JOUR WILDLIFE MANAGEMENT, V26, P221, DOI 10.2307/3798611; Scott WB., 1973, FRESHWATER FISHES CA; SHOPLEY JB, 1984, J ENVIRON MANAGE, V18, P25; Smith C.L., 1985, INLAND FISHES NEW YO; STEWART CJ, 1993, EROSION PROCESSES TA; *STILLW SCI, 2006, SACR RIV EC FLOWS ST; *STLAWR RIV LAK ON, 1999, PLAN STUD CRIT REV O; Taft OW, 2002, J APPL ECOL, V39, P987, DOI 10.1046/j.1365-2664.2002.00763.x; Tufts R.W., 1986, BIRDS NOVA SCOTIA; *US ARM CORPS ENG, 2004, 2004 REP C; *US EPA, 1987, GREAT LAK ENV ATL RE; *US FISH WILDL SER, 2008, PIP PLOV; WESTMAN WE, 1985, ECOLOGY IMPACT ASSES; Wilcox D.A., 2007, LAKE LEVEL VARIABILI, P1311; WILCOX DA, 1992, WETLANDS, V12, P192; WILCOX DA, 1995, NAT AREA J, V15, P240; WILLIAMS DC, 1995, THESIS U MICHIGAN MI; WILLIAMSON LO, 1942, WISCONSIN CONSERVATI, V7, P10	75	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2008	3	11							e3806	10.1371/journal.pone.0003806	http://dx.doi.org/10.1371/journal.pone.0003806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YD	19030230	Green Published, Green Submitted, gold			2022-12-25	WOS:000265451100006
J	Sussan, TE; Jun, J; Thimmulappa, R; Bedja, D; Antero, M; Gabrielson, KL; Polotsky, VY; Biswal, S				Sussan, Thomas E.; Jun, Jonathan; Thimmulappa, Rajesh; Bedja, Djahida; Antero, Maria; Gabrielson, Kathleen L.; Polotsky, Vsevolod Y.; Biswal, Shyam			Disruption of Nrf2, a Key Inducer of Antioxidant Defenses, Attenuates ApoE-Mediated Atherosclerosis in Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ENHANCES SUSCEPTIBILITY; OXIDATIVE STRESS; LDL; GLUTATHIONE; PROGRESSION; DEFICIENT; INDUCTION; RESPONSES; CD36	Background: Oxidative stress and inflammation are two critical factors that drive the formation of plaques in atherosclerosis. Nrf2 is a redox-sensitive transcription factor that upregulates a battery of antioxidative genes and cytoprotective enzymes that constitute the cellular response to oxidative stress. Our previous studies have shown that disruption of Nrf2 in mice (Nrf2(-/-)) causes increased susceptibility to pulmonary emphysema, asthma and sepsis due to increased oxidative stress and inflammation. Here we have tested the hypothesis that disruption of Nrf2 in mice causes increased atherosclerosis. Principal Findings: To investigate the role of Nrf2 in the development of atherosclerosis, we crossed Nrf2(-/-) mice with apoliporotein E-deficient (ApoE(-/-)) mice. ApoE(-/-) and ApoE(-/-) Nrf2(-/-) mice were fed an atherogenic diet for 20 weeks, and plaque area was assessed in the aortas. Surprisingly, ApoE(-/-) Nrf2(-/-) mice exhibited significantly smaller plaque area than ApoE(-/-) controls (11.5% vs 29.5%). This decrease in plaque area observed in ApoE(-/-) Nrf2(-/-) mice was associated with a significant decrease in uptake of modified low density lipoproteins (AcLDL) by isolated macrophages from ApoE(-/-) Nrf2(-/-) mice. Furthermore, atherosclerotic plaques and isolated macrophages from ApoE(-/-) Nrf2(-/-) mice exhibited decreased expression of the scavenger receptor CD36. Conclusions: Nrf2 is pro-atherogenic in mice, despite its antioxidative function. The net pro-atherogenic effect of Nrf2 may be mediated via positive regulation of CD36. Our data demonstrates that the potential effects of Nrf2-targeted therapies on cardiovascular disease need to be investigated.	[Sussan, Thomas E.; Thimmulappa, Rajesh; Antero, Maria; Biswal, Shyam] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Jun, Jonathan; Polotsky, Vsevolod Y.; Biswal, Shyam] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulmonary & Critical Care Med, Baltimore, MD 21218 USA; [Bedja, Djahida; Gabrielson, Kathleen L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparative Pathobiol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Sussan, TE (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	sbiswal@jhsph.edu	Thimmulappa, Rajesh/AAW-5013-2021	Thimmulappa, Rajesh/0000-0001-6050-1323; Sussan, Thomas/0000-0002-5240-4299	NIH [HL081205, HL080105]; NHLBI SCCOR [P50HL084945, HL07534]; NIEHS [P50ES015903, ES07141]; Maryland Cigarette Restitution Fund; FAMRI Clinical Innovator award; AHA [0765293U]; National Sleep Foundation [SF-78568-N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081205, R01HL080105, P50HL084945, T32HL007534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141, P50ES015903] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI SCCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Maryland Cigarette Restitution Fund; FAMRI Clinical Innovator award; AHA(American Heart Association); National Sleep Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIH grant HL081205, NHLBI SCCOR grant P50HL084945 (SB and VYP), NIEHS grant P50ES015903, Maryland Cigarette Restitution Fund research grant, and FAMRI Clinical Innovator award to SB, and NIH grant HL080105 and AHA grant 0765293U to VYP. TES is supported by the NIEHS training grant ES07141. JJ is supported by the NHLBI T32 training grant HL07534 and National Sleep Foundation grant SF-78568-N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI11927; Bea F, 2003, CIRC RES, V92, P386, DOI 10.1161/01.RES.0000059561.65545.16; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; BJORKHEM I, 1991, ARTERIOSCLER THROMB, V11, P15, DOI 10.1161/01.ATV.11.1.15; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hartley CJ, 2000, AM J PHYSIOL-HEART C, V279, pH2326, DOI 10.1152/ajpheart.2000.279.5.H2326; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Hsich E, 2000, CIRCULATION, V101, P1234, DOI 10.1161/01.CIR.101.11.1234; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kirk EA, 2000, ARTERIOSCL THROM VAS, V20, P1529, DOI 10.1161/01.ATV.20.6.1529; MARUYAMA A, 2008, ARCH BIOCH BIOPHYS; Minuz Pietro, 2006, Pharmacol Rep, V58 Suppl, P57; Morrison JA, 1999, CIRCULATION, V100, P2244, DOI 10.1161/01.CIR.100.22.2244; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Rosenblat M, 2002, ATHEROSCLEROSIS, V163, P17, DOI 10.1016/S0021-9150(01)00744-4; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SPARROW CP, 1992, J CLIN INVEST, V89, P1885, DOI 10.1172/JCI115793; STEINBERG D, 1995, ADV EXP MED BIOL, V369, P39; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tomasian D, 2000, CARDIOVASC RES, V47, P426, DOI 10.1016/S0008-6363(00)00103-6; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Yang H, 2004, CIRC RES, V95, P1075, DOI 10.1161/01.RES.0000149564.49410.0d; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje; Zhao L, 2005, PROSTAG OTH LIPID M, V78, P185, DOI 10.1016/j.prostaglandins.2005.07.003; Zureik M, 2004, ARTERIOSCL THROM VAS, V24, P1485, DOI 10.1161/01.ATV.0000136648.62973.c8	36	128	143	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2008	3	11							e3791	10.1371/journal.pone.0003791	http://dx.doi.org/10.1371/journal.pone.0003791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XG	19023427	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448800012
J	Wang, JL; Wang, H; Li, ZZ; Wu, QL; Lathia, JD; McLendon, RE; Hjelmeland, AB; Rich, JN				Wang, Jialiang; Wang, Hui; Li, Zhizhong; Wu, Qiulian; Lathia, Justin D.; McLendon, Roger E.; Hjelmeland, Anita B.; Rich, Jeremy N.			c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells	PLOS ONE			English	Article								Background: Malignant gliomas rank among the most lethal cancers. Gliomas display a striking cellular heterogeneity with a hierarchy of differentiation states. Recent studies support the existence of cancer stem cells in gliomas that are functionally defined by their capacity for extensive self-renewal and formation of secondary tumors that phenocopy the original tumors. As the c-Myc oncoprotein has recognized roles in normal stem cell biology, we hypothesized that c-Myc may contribute to cancer stem cell biology as these cells share characteristics with normal stem cells. Methodology/Principal Findings: Based on previous methods that we and others have employed, tumor cell populations were enriched or depleted for cancer stem cells using the stem cell marker CD133 (Prominin-1). We characterized c-Myc expression in matched tumor cell populations using real time PCR, immunoblotting, immunofluorescence and flow cytometry. Here we report that c-Myc is highly expressed in glioma cancer stem cells relative to non-stem glioma cells. To interrogate the significance of c-Myc expression in glioma cancer stem cells, we targeted its expression using lentivirally transduced short hairpin RNA (shRNA). Knockdown of c-Myc in glioma cancer stem cells reduced proliferation with concomitant cell cycle arrest in the G(0)/G(1) phase and increased apoptosis. Non-stem glioma cells displayed limited dependence on c-Myc expression for survival and proliferation. Further, glioma cancer stem cells with decreased c-Myc levels failed to form neurospheres in vitro or tumors when xenotransplanted into the brains of immunocompromised mice. Conclusions/Significance: These findings support a central role of c-Myc in regulating proliferation and survival of glioma cancer stem cells. Targeting core stem cell pathways may offer improved therapeutic approaches for advanced cancers.	[Wang, Jialiang; Wu, Qiulian; Lathia, Justin D.; Hjelmeland, Anita B.; Rich, Jeremy N.] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Wang, Hui; Li, Zhizhong; Rich, Jeremy N.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA; [McLendon, Roger E.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Rich, Jeremy N.] Duke Univ, Dept Med, Durham, NC 27706 USA; [Wang, Jialiang; Wang, Hui; Li, Zhizhong; Wu, Qiulian; Lathia, Justin D.; McLendon, Roger E.; Hjelmeland, Anita B.; Rich, Jeremy N.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27706 USA; [Rich, Jeremy N.] Cleveland Clin, Dept Stem Cell Biol & Regen Biol, Cleveland, OH USA	Duke University; Duke University; Duke University; Duke University; Duke University; Cleveland Clinic Foundation	Wang, JL (corresponding author), Duke Univ, Dept Surg, Durham, NC 27710 USA.	richj@ccf.org	Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022		American Brain Tumor Association Basic Research Fellowship; Childhood Brain Tumor Foundation; Pediatric Brain Tumor Foundation of the United States; Accelerate Brain Cancer Cure; Alexander and Margaret Stewart Trust; Brain Tumor Society; Goldhirsh Foundation; Duke Comprehensive Cancer Center Stem Cell Initiative; NIH [NS047409, NS054276, CA116659]; Damon Runyon Cancer Research Foundation [Damon Runyon-Lilly Clinical Investigator]; Sidney Kimmel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA116659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054276, K02NS047409] Funding Source: NIH RePORTER	American Brain Tumor Association Basic Research Fellowship; Childhood Brain Tumor Foundation; Pediatric Brain Tumor Foundation of the United States; Accelerate Brain Cancer Cure; Alexander and Margaret Stewart Trust; Brain Tumor Society; Goldhirsh Foundation; Duke Comprehensive Cancer Center Stem Cell Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Sidney Kimmel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Jialiang Wang is a recipient of the American Brain Tumor Association Basic Research Fellowship. Other financial support was provided by the Childhood Brain Tumor Foundation, the Pediatric Brain Tumor Foundation of the United States, Accelerate Brain Cancer Cure, Alexander and Margaret Stewart Trust, Brain Tumor Society, Goldhirsh Foundation, Duke Comprehensive Cancer Center Stem Cell Initiative Grant (J.R.), NIH grants NS047409, NS054276, and CA116659 (J.R.). J.R. is a Damon Runyon-Lilly Clinical Investigator supported by the Damon Runyon Cancer Research Foundation and a Sidney Kimmel Foundation for Cancer Research Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; BAO S, 2008, CANC RES IN PRESS; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bouchard C, 1998, TRENDS CELL BIOL, V8, P202, DOI 10.1016/S0962-8924(98)01251-3; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DAKSIS JI, 1994, ONCOGENE, V9, P3635; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Flores I, 2004, ONCOGENE, V23, P5923, DOI 10.1038/sj.onc.1207796; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Herms JW, 1999, SURG NEUROL, V51, P536, DOI 10.1016/S0090-3019(98)00028-7; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Jensen NA, 2003, J BIOL CHEM, V278, P8300, DOI 10.1074/jbc.M211195200; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kaptein JS, 1996, J BIOL CHEM, V271, P18875, DOI 10.1074/jbc.271.31.18875; Karlsson A, 2003, BLOOD, V101, P2797, DOI 10.1182/blood-2002-10-3091; Knezevic D, 2004, CELL CYCLE, V3, P729; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Mitchell KO, 1999, CELL GROWTH DIFFER, V10, P223; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thompson EB, 1998, ANNU REV PHYSIOL, V60, P575, DOI 10.1146/annurev.physiol.60.1.575; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	63	313	322	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2008	3	11							e3769	10.1371/journal.pone.0003769	http://dx.doi.org/10.1371/journal.pone.0003769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XE	19020659	Green Published, gold, Green Submitted			2022-12-25	WOS:000265448600002
J	Shimwell, NJ; Martin, A; Bruton, RK; Blackford, AN; Sedgwick, GG; Gallimore, PH; Turnell, AS; Grand, RJA				Shimwell, N. J.; Martin, A.; Bruton, R. K.; Blackford, A. N.; Sedgwick, G. G.; Gallimore, P. H.; Turnell, A. S.; Grand, R. J. A.			Adenovirus 5 E1A is responsible for increased expression of insulin receptor substrate 4 in established adenovirus 5-transformed cell lines and interacts with IRS components activating the PI3 kinase/Akt signalling pathway	ONCOGENE			English	Article						Ad5E1A; IRS-1; IRS-2; IRS-4; Akt	GROWTH-FACTOR-I; LARGE T-ANTIGEN; GENE-EXPRESSION; BINDING PROTEIN; DNA-REPAIR; TRANSCRIPTIONAL ADAPTER; SIMIAN ADENOVIRUSES; GLUCOSE-HOMEOSTASIS; SEQUENCE-ANALYSIS; MEDIATOR COMPLEX	Using mass spectrometric analysis insulin receptor substrate 4 (IRS-4) has been identified as a novel adenovirus 5 early region 1A (Ad5E1A)-binding protein. IRS-4 interacts with both the transcriptional activation domain (conserved region 3) and the N-terminal region of Ad5E1A13S. Prolonged expression of Ad5E1A13S is required for the observed dramatic increase in the levels of IRS-4 mRNA and protein in Ad5E1-transformed human cell lines. Once expressed, as well as binding to E1A and the insulin receptor, IRS-4 remains tyrosine phosphorylated and constitutively associates with the regulatory p85 subunit of phosphoinositide 3 kinase, resulting in the phosphorylation of Akt (causing activation) and GSK-3 beta (causing inhibition). Reducing IRS-4 expression using small interfering RNA (siRNA) in established Ad5E1A-expressing cell lines decreases the activation of Akt and cellular proliferation. During Ad5 infection, IRS-4 is not expressed. However, Ad5E1A associates with IRS-1, increasing Akt and GSK-3 beta phosphorylation and tyrosine phosphorylation of IRS-1 itself. We conclude that the association and altered regulation of IRS proteins by Ad5E1A contribute to the adenovirus-transformed phenotype and modulates viral infection in an Akt-dependent manner.	[Grand, R. J. A.] Univ Birmingham, Inst Canc Studies, Sch Canc Sci, Canc Res UK, Birmingham B15 2TT, W Midlands, England	Cancer Research UK; University of Birmingham	Grand, RJA (corresponding author), Univ Birmingham, Inst Canc Studies, Sch Canc Sci, Canc Res UK, Birmingham B15 2TT, W Midlands, England.	R.J.A.Grand@bham.ac.uk	Blackford, Andrew N/H-6575-2019	Blackford, Andrew N/0000-0003-1979-021X	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We are most grateful to Dr Joe Mymryk (University of Western Ontario) for the gift of various AdE1A constructs, Professor Thomas Dobner (University of Hamburg) for a gift of the Ad5-transformed rat cell lines, Professor Derek Leroith (Mount Sinai School of Medicine) for IRS-4 cDNA and Cancer Research UK for their financial support.	ARAKI E, 1995, MOL ENDOCRINOL, V9, P1367, DOI 10.1210/me.9.10.1367; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Avvakumov N, 2004, VIROLOGY, V329, P477, DOI 10.1016/j.virol.2004.08.007; Avvakumov N, 2002, J VIROL, V76, P7968, DOI 10.1128/JVI.76.16.7968-7975.2002; Barral PM, 2005, FEBS LETT, V579, P2752, DOI 10.1016/j.febslet.2005.03.095; Bartholomeusz C, 2006, ONCOGENE, V25, P79, DOI 10.1038/sj.onc.1209014; BAYLEY ST, 1994, INT J ONCOL, V5, P425; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Bruton RK, 2007, ONCOGENE, V26, P7467, DOI 10.1038/sj.onc.1210551; Cai DS, 2003, J BIOL CHEM, V278, P25323, DOI 10.1074/jbc.M212430200; Cuevas EP, 2007, J HEPATOL, V46, P1089, DOI 10.1016/j.jhep.2007.01.031; DeAngelis T, 2006, ONCOGENE, V25, P32, DOI 10.1038/sj.onc.1209013; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; DYSON N, 1992, J VIROL, V66, P6893, DOI 10.1128/JVI.66.12.6893-6902.1992; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Endter C, 2004, CURR TOP MICROBIOL, V273, P163; Fantin VR, 1998, J BIOL CHEM, V273, P10726, DOI 10.1074/jbc.273.17.10726; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Fantin VR, 1999, BIOCHEM BIOPH RES CO, V260, P718, DOI 10.1006/bbrc.1999.0967; FEI ZL, 1995, MOL CELL BIOL, V15, P4232; Flaherty DM, 2004, AM J PHYSIOL-LUNG C, V287, pL393, DOI 10.1152/ajplung.00359.2003; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Gallimore PH, 2001, ONCOGENE, V20, P7824, DOI 10.1038/sj.onc.1204913; GEISBERG JV, 1995, MOL CELL BIOL, V15, P6283; GEISBERG JV, 1994, P NATL ACAD SCI USA, V91, P2488, DOI 10.1073/pnas.91.7.2488; Giovannone B, 2000, DIABETES-METAB RES, V16, P434, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR159>3.0.CO;2-8; Honma M, 2006, GENES CELLS, V11, P143, DOI 10.1111/j.1365-2443.2006.00926.x; KELEKAR A, 1987, MOL CELL BIOL, V7, P3899, DOI 10.1128/MCB.7.11.3899; KIM HS, 1995, MOL ENDOCRINOL, V9, P178, DOI 10.1210/me.9.2.178; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; LIU F, 1994, NATURE, V368, P520, DOI 10.1038/368520a0; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; Liu SCH, 1999, J BIOL CHEM, V274, P18093, DOI 10.1074/jbc.274.25.18093; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Qu BH, 1999, J BIOL CHEM, V274, P31179, DOI 10.1074/jbc.274.44.31179; Rasti M, 2005, J VIROL, V79, P5594, DOI 10.1128/JVI.79.9.5594-5605.2005; Rasti M, 2006, EMBO J, V25, P2710, DOI 10.1038/sj.emboj.7601169; Reiss K, 2006, J CELL PHYSIOL, V206, P295, DOI 10.1002/jcp.20455; STEIN RW, 1987, MOL CELL BIOL, V7, P1164, DOI 10.1128/MCB.7.3.1164; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TIMMERS HTM, 1988, J BIOL CHEM, V263, P1329; Trojanek J, 2006, J CELL PHYSIOL, V206, P35, DOI 10.1002/jcp.20425; Trojanek J, 2003, MOL CELL BIOL, V23, P7510, DOI 10.1128/MCB.23.21.7510-7524.2003; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tsuruzoe K, 2001, MOL CELL BIOL, V21, P26, DOI 10.1128/MCB.21.1.26-38.2001; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Wang G, 2002, J VIROL, V76, P9186, DOI 10.1128/JVI.76.18.9186-9193.2002; Ward DG, 2006, BRIT J CANCER, V94, P1898, DOI 10.1038/sj.bjc.6603188; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Zhou-Li Fei, 1995, Molecular and Cellular Biology, V15, P4232	60	17	17	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					686	697		10.1038/onc.2008.417	http://dx.doi.org/10.1038/onc.2008.417			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	19029952				2022-12-25	WOS:000263076400006
J	Scaltriti, M; Verma, C; Guzman, M; Jimenez, J; Parra, JL; Pedersen, K; Smith, DJ; Landolfi, S; Cajal, SRY; Arribas, J; Baselga, J				Scaltriti, M.; Verma, C.; Guzman, M.; Jimenez, J.; Parra, J. L.; Pedersen, K.; Smith, D. J.; Landolfi, S.; Ramon y Cajal, S.; Arribas, J.; Baselga, J.			Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity	ONCOGENE			English	Article						ErbB receptor; trastuzumab; tyrosine kinase inhibitor; antibody-dependent cell cytotoxicity (ADCC); breast cancer	FACTOR RECEPTOR EGFR; METASTATIC BREAST-CANCER; MONOCLONAL-ANTIBODY; ADJUVANT CHEMOTHERAPY; DOWN-REGULATION; PHASE-II; GROWTH; ERBB2; HERCEPTIN; EXPRESSION	Lapatinib is a human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitor (TKI) that has clinical activity in HER2-amplified breast cancer. In vitro studies have shown that lapatinib enhances the effects of the monoclonal antibody trastuzumab suggesting partially non-overlapping mechanisms of action. To dissect these mechanisms, we have studied the effects of lapatinib and trastuzumab on receptor expression and receptor signaling and have identified a new potential mechanism for the enhanced antitumor activity of the combination. Lapatinib, given alone or in combination with trastuzumab to HER2-overexpressing breast cancer cells SKBR3 and MCF7-HER2, inhibited HER2 phosphorylation, prevented receptor ubiquitination and resulted in a marked accumulation of inactive receptors at the cell surface. By contrast, trastuzumab alone caused enhanced HER2 phosphorylation, ubiquitination and degradation of the receptor. By immunoprecipitation and computational protein modeling techniques we have shown that the lapatinib-induced HER2 accumulation at the cell surface also results in the stabilization of inactive HER2 homo- (HER2/HER2) and hetero- (HER2/EGFR and HER2/HER3) dimers. Lapatinib-induced accumulation of HER2 and trastuzumab-mediated downregulation of HER2 was also observed in vivo, where the combination of the two agents triggered complete tumor remissions in all cases after 10 days of treatment. Accumulation of HER2 at the cell surface by lapatinib enhanced immune-mediated trastuzumab-dependent cytotoxicity. We propose that this is a novel mechanism of action of the combination that may be clinically relevant and exploitable in the therapy of patients with HER2-positive tumors.	[Scaltriti, M.; Guzman, M.; Parra, J. L.; Pedersen, K.; Arribas, J.; Baselga, J.] Vall Hebron Univ Hosp, Dept Med Oncol, Vall Hebron Res Inst, Barcelona 08035, Spain; [Verma, C.; Smith, D. J.] Bioinformat Inst, Biomol Modeling & Design Grp, Singapore, Singapore; [Jimenez, J.; Landolfi, S.; Ramon y Cajal, S.] Vall Hebron Univ Hosp, Dept Pathol, Barcelona 08035, Spain; [Baselga, J.] Univ Autonoma Barcelona, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Baselga, J (corresponding author), Vall Hebron Univ Hosp, Dept Med Oncol, Vall Hebron Res Inst, Paseo Vall Hebron 119-129, Barcelona 08035, Spain.	jbaselga@vhebron.net	Ramon y Cajal, Santiago/H-4955-2016; 高, 雨莉/HGU-8187-2022; Arribas, Joaquin/M-4482-2014	Ramon y Cajal, Santiago/0000-0002-3867-1390; Arribas, Joaquin/0000-0002-0504-0664; Jimenez, Jose/0000-0002-2576-1776; Landolfi, Stefania/0000-0002-1059-635X	Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in full by a grant of the Breast Cancer Research Foundation.	Anido J, 2003, CLIN CANCER RES, V9, P1274; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Baselga J, 1998, CANCER RES, V58, P2825; Baselga J., 2006, J CLIN ONCOL, V24, P3006; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Bleeker WK, 2004, J IMMUNOL, V173, P4699, DOI 10.4049/jimmunol.173.7.4699; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chu I, 2005, CANCER RES, V65, P18; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cuello M, 2001, CANCER RES, V61, P4892; Diermeier S, 2005, EXP CELL RES, V304, P604, DOI 10.1016/j.yexcr.2004.12.008; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Gennari R, 2004, CLIN CANCER RES, V10, P5650, DOI 10.1158/1078-0432.CCR-04-0225; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Hommelgaard AM, 2004, MOL BIOL CELL, V15, P1557, DOI 10.1091/mbc.E03-08-0596; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Izumi Y, 2002, NATURE, V416, P279, DOI 10.1038/416279b; Johns TG, 2003, P NATL ACAD SCI USA, V100, P15871, DOI 10.1073/pnas.2036503100; Kim JY, 2003, J NEUROSCI, V23, P5561; Klapper LN, 2000, CANCER RES, V60, P3384; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Li X, 2007, CANCER RES, V67, P8716, DOI 10.1158/0008-5472.CAN-06-3731; Lichtner RB, 2001, CANCER RES, V61, P5790; Longva KE, 2005, INT J CANCER, V116, P359, DOI 10.1002/ijc.21015; Lu Y, 2007, CANCER RES, V67, P8240, DOI 10.1158/0008-5472.CAN-07-0589; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Matar P, 2004, CLIN CANCER RES, V10, P6487, DOI 10.1158/1078-0432.CCR-04-0870; Milella M, 2004, CLIN CANCER RES, V10, P7747, DOI 10.1158/1078-0432.CCR-04-0908; Mimura K, 2005, CLIN CANCER RES, V11, P4898, DOI 10.1158/1078-0432.CCR-04-2476; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; OSHAUGHNESSY J, 2008, J CLIN ONCOL S, V26; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Perera RM, 2005, CLIN CANCER RES, V11, P6390, DOI 10.1158/1078-0432.CCR-04-2653; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Rusnak DW, 2001, MOL CANCER THER, V1, P85; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; SLAMON D, 2005, 28 ANN SAN ANT BREAS; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Tseng PH, 2006, MOL PHARMACOL, V70, P1534, DOI 10.1124/mol.106.023911; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Valabrega G, 2005, ONCOGENE, V24, P3002, DOI 10.1038/sj.onc.1208478; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Wolpoe ME, 2003, J IMMUNOL, V171, P2161, DOI 10.4049/jimmunol.171.4.2161; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xia WL, 2005, ONCOGENE, V24, P6213, DOI 10.1038/sj.onc.1208774; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yuste L, 2005, CANCER RES, V65, P6801, DOI 10.1158/0008-5472.CAN-04-4023; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	62	305	314	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2009	28	6					803	814		10.1038/onc.2008.432	http://dx.doi.org/10.1038/onc.2008.432			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	406UI	19060928				2022-12-25	WOS:000263320000003
J	Guallar, V; Lu, CY; Borrelli, K; Egawa, TY; Yeh, SR				Guallar, Victor; Lu, Changyuan; Borrelli, Kenneth; Egawa, Tsuyoshi; Yeh, Syun-Ru			Ligand Migration in the Truncated Hemoglobin-II from Mycobacterium tuberculosis THE ROLE OF G8 TRYPTOPHAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; HYDROGEN-BOND NETWORK; HEME DISTAL SITE; FUNCTIONAL-PROPERTIES; CARBON-MONOXIDE; STRUCTURAL DETERMINANTS; GEMINATE RECOMBINATION; CAMPYLOBACTER-JEJUNI; MOLECULAR-DYNAMICS; ENERGY LANDSCAPE	Resonance Raman studies show that the heme-bound CO in trHbO, a truncated-II hemoglobin from Mycobacterium tuberculosis, is exposed to an environment with a positive electrostatic potential. The mutation of Trp(G8), an absolutely conserved residue in group II and III truncated hemoglobins, to Phe introduces two new Fe-CO conformers, both of which exhibit reduced electrostatic potentials. Computer simulations reveal that the structural perturbation is a result of the increased flexibility of the Tyr(CD1) and Leu(E11) side chains due to the reduction of the size of the G8 residue. Laser flash photolysis studies show that the G8 mutation induces 1) the presence of two new geminate recombination phases, one with a rate faster than the time resolution of our instrument and the other with a rate 13-fold slower than that of the wild type protein, and 2) the reduction of the total geminate recombination yield from 86 to 62% and the increase in the bimolecular recombination rate by a factor of 530. Computer simulations uncover that the photodissociated ligand migrates between three distal temporary docking sites before it subsequently rebinds to the heme iron or ultimately escapes into the solvent via a hydrophobic tunnel. The calculated energy profiles associated with the ligand migration processes are in good agreement with the experimental observations. The results highlight the importance of the Trp( G8) in regulating ligand migration in trHbO, underscoring its pivotal role in the structural and functional properties of the group II and III truncated hemoglobins.	[Guallar, Victor; Borrelli, Kenneth] Barcelona Supercomp Ctr, Life Sci Program, Catalan Inst Res & Adv Studies, Barcelona 08028, Spain; [Lu, Changyuan; Egawa, Tsuyoshi; Yeh, Syun-Ru] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	ICREA; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Yeshiva University; Albert Einstein College of Medicine	Guallar, V (corresponding author), Barcelona Supercomp Ctr, Life Sci Program, Catalan Inst Res & Adv Studies, Edificio Nexus 2, Barcelona 08028, Spain.	victor.guallar@bsc.es; syeh@aecom.yu.edu	Guallar, Victor/B-1579-2013	Guallar, Victor/0000-0002-4580-1114; Yeh, Syun-Ru/0000-0002-9858-386X	Spanish Ministry of Education and Science [CTQ2007-62122/BQU]; ICREA Funding Source: Custom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065465] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); ICREA(ICREA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Spanish Ministry of Education and Science ( to V. G.) through Project CTQ2007-62122/BQU. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alcantara RE, 2007, P NATL ACAD SCI USA, V104, P18451, DOI 10.1073/pnas.0706026104; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Boechi L, 2008, PROTEINS, V73, P372, DOI 10.1002/prot.22072; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; CARVER TE, 1990, J BIOL CHEM, V265, P20007; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Das TK, 2000, BIOCHEMISTRY-US, V39, P837, DOI 10.1021/bi9922087; Das TK, 1999, J BIOL CHEM, V274, P4207, DOI 10.1074/jbc.274.7.4207; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; ELBER R, 1990, J AM CHEM SOC, V112, P9161, DOI 10.1021/ja00181a020; Feis A, 1998, BIOCHEMISTRY-US, V37, P13575, DOI 10.1021/bi981399v; Feis A, 2008, BIOCHEMISTRY-US, V47, P902, DOI 10.1021/bi701297f; Friesner RA, 2005, ANNU REV PHYS CHEM, V56, P389, DOI 10.1146/annurev.physchem.55.091602.094410; Guallar V, 2006, J AM CHEM SOC, V128, P5427, DOI 10.1021/ja057318h; Guallar V, 2005, P NATL ACAD SCI USA, V102, P3954, DOI 10.1073/pnas.0500888102; HENRY ER, 1983, J MOL BIOL, V166, P443, DOI 10.1016/S0022-2836(83)80094-1; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; Lu CY, 2008, METHOD ENZYMOL, V437, P255, DOI 10.1016/S0076-6879(07)37014-6; Lu CY, 2007, J BIOL CHEM, V282, P25917, DOI 10.1074/jbc.M704415200; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; Ludemann SK, 2000, J MOL BIOL, V303, P797, DOI 10.1006/jmbi.2000.4154; Marti MA, 2008, J AM CHEM SOC, V130, P1688, DOI 10.1021/ja076853+; Milani M, 2005, J INORG BIOCHEM, V99, P97, DOI 10.1016/j.jinorgbio.2004.10.035; Milani M, 2003, P NATL ACAD SCI USA, V100, P5766, DOI 10.1073/pnas.1037676100; Mukai M, 2002, BIOCHEMISTRY-US, V41, P3897, DOI 10.1021/bi0156409; Mukai M, 2001, J BIOL CHEM, V276, P7272, DOI 10.1074/jbc.M009280200; Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337; Ouellet H, 2007, BIOCHEMISTRY-US, V46, P11440, DOI 10.1021/bi7010288; Samuni U, 2004, J AM CHEM SOC, V126, P2682, DOI 10.1021/ja038093i; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; TILTON RF, 1988, J MOL BIOL, V199, P195, DOI 10.1016/0022-2836(88)90389-0; Vogel KM, 2000, INORG CHIM ACTA, V297, P11, DOI 10.1016/S0020-1693(99)00253-4; WARSHEL A, 1977, P NATL ACAD SCI USA, V74, P1789, DOI 10.1073/pnas.74.5.1789; Wei GH, 2002, J CHEM PHYS, V117, P11379, DOI 10.1063/1.1522373; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Wu GH, 2003, ADV MICROB PHYSIOL, V47, P255, DOI 10.1016/S0065-2911(03)47005-7; Yu N.-T., 1988, BIOL APPLICATIONS RA, V3, P39	40	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3106	3116		10.1074/jbc.M806183200	http://dx.doi.org/10.1074/jbc.M806183200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19019831	hybrid, Green Accepted			2022-12-25	WOS:000262700900055
J	Hoffhines, AJ; Jen, CH; Leary, JA; Moore, KL				Hoffhines, Adam J.; Jen, Constance H.; Leary, Julie A.; Moore, Kevin L.			Tyrosylprotein Sulfotransferase-2 Expression Is Required for Sulfation of RNase 9 and Mfge8 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-O-SULFATION; MOLECULAR CHARACTERIZATION; MASS-SPECTROMETRY; APOPTOTIC CELLS; A SUPERFAMILY; PROTEIN; MOUSE; IDENTIFICATION; MFG-E8; MICE	Protein-tyrosine sulfation is mediated by two Golgi tyrosylprotein sulfotransferases (TPST-1 and TPST-2) that are widely expressed in vivo. However, the full substrate repertoire of this enzyme system is unknown and thus, our understanding of the biological role(s) of tyrosine sulfation is limited. We reported that whereas Tpst1(-/-) male mice have normal fertility, Tpst2(-/-) males are infertile despite normal spermatogenesis. However, Tpst2(-/-) sperm are severely defective in their motility in viscous media and in their ability to fertilize eggs. These findings suggest that sulfation of unidentified substrate( s) is crucial for normal sperm function. We therefore sought to identify tyrosine-sulfated proteins in the male genital tract using affinity chromatography on PSG2, an anti-sulfotyrosine monoclonal antibody, followed by mass spectrometry. Among the several candidate tyrosine-sulfated proteins identified, RNase 9 and Mfge8 were examined in detail. RNase 9, a catalytically inactive RNase A family member of unknown function, is expressed only in the epididymis after onset of sexual maturity. Mfge8 is expressed on mouse sperm and Mfge8(-/-) male mice are subfertile. Metabolic labeling coupled with sulfoamino acid analysis confirmed that both proteins are tyrosine-sulfated and both proteins are expressed at comparable levels in wild type, Tpst1(-/-), and Tpst2(-/-) epididymides. However, we demonstrate that RNase 9 and Mfge8 are tyrosine-sulfated in wild type and Tpst1(-/-), but not in Tpst2(-/-) mice. These findings suggest that lack of sulfation of one or both of these proteins may contribute mechanistically to the infertility of Tpst2(-/-) males.	[Hoffhines, Adam J.; Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Jen, Constance H.; Leary, Julie A.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 94616 USA; [Leary, Julie A.] Univ Calif Davis, Dept Chem, Davis, CA 94616 USA; [Moore, Kevin L.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Moore, Kevin L.] Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California Davis; University of California System; University of California Davis; Oklahoma Medical Research Foundation	Moore, KL (corresponding author), 825 NE 13th St, Oklahoma City, OK 73104 USA.	kevin-moore@omrf.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056022] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD056022-01A1, HD 056022, R01 HD056022] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Araki Y, 2002, J ANDROL, V23, P854; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; BETTELHEIM FR, 1954, J AM CHEM SOC, V76, P2838, DOI 10.1021/ja01639a073; Borghei A, 2006, J BIOL CHEM, V281, P9423, DOI 10.1074/jbc.M513768200; Bu HF, 2007, J CLIN INVEST, V117, P3673, DOI 10.1172/JCI31841; Burgess B, 2006, MOL VIS, V12, P1437; Cho S, 2005, GENOMICS, V85, P208, DOI 10.1016/j.ygeno.2004.10.008; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Devor EJ, 2004, HUM BIOL, V76, P921, DOI 10.1353/hub.2005.0016; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Goettsch S, 2006, J MOL BIOL, V361, P436, DOI 10.1016/j.jmb.2006.06.023; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; HUTTNER WB, 1984, METHOD ENZYMOL, V107, P200; Huttner WB, 1988, MODERN CELL BIOL, V6, P97; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KRAJEWSKI T, 1968, ACTA CHEM SCAND, V22, P1339, DOI 10.3891/acta.chem.scand.22-1339; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Oshima K, 1999, BIOCHEM BIOPH RES CO, V254, P522, DOI 10.1006/bbrc.1998.0107; Ouyang YB, 1998, J BIOL CHEM, V273, P24770, DOI 10.1074/jbc.273.38.24770; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; Ouyang YB, 2002, J BIOL CHEM, V277, P23781, DOI 10.1074/jbc.M202420200; PAULSSON M, 1985, BIOCHEM J, V231, P571, DOI 10.1042/bj2310571; Penttinen J, 2003, MOL ENDOCRINOL, V17, P2138, DOI 10.1210/me.2003-0008; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; ROSA P, 1992, J BIOL CHEM, V267, P12227; Salek M, 2004, ANAL CHEM, V76, P5136, DOI 10.1021/ac0400414; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Yu YH, 2007, NAT METHODS, V4, P583, DOI 10.1038/NMETH1056; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	40	17	20	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3096	3105		10.1074/jbc.M808434200	http://dx.doi.org/10.1074/jbc.M808434200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047058	hybrid, Green Published			2022-12-25	WOS:000262700900054
J	Kida, Y; Morimoto, F; Sakaguchi, M				Kida, Yuichiro; Morimoto, Fumiko; Sakaguchi, Masao			Signal Anchor Sequence Provides Motive Force for Polypeptide Chain Translocation through the Endoplasmic Reticulum Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; ER MEMBRANE; RECOGNITION; TOPOGENESIS; CHANNEL	Many proteins are translocated across and integrated into the endoplasmic reticulum membrane. The type I signal anchor sequence mediates the translocation of its preceding region through the endoplasmic reticulum membrane, but the source of the motive force has been unclear. Here, we characterized the motive force for N-terminal domain translocation using two probes. First, an Ig-like domain of the muscle protein titin (I27 domain) or its mutants were fused to the N termini, and translocation was examined in a cell-free translation system supplemented with rough microsomal membrane. The N-terminal translocation efficiencies correlated with the mechanical instabilities of the I27 mutants. When the I27 domain was separated from the signal anchor sequence by inserting a spacer, even the most unstable mutant stalled on the cytoplasmic side, whereas its downstream portion spanned the membrane. Proline insertion into the signal anchor sequence also caused a large translocation defect. Second, a streptavidin-binding peptide tag was fused to the N terminus. Titration of streptavidin in the translation system allowed us to estimate the translocation motive force operative on the tag. The motive force was decreased by the proline insertion into the signal anchor sequence as well as by separation from the signal anchor sequence. When the streptavidin-binding peptide tag was separated from the signal anchor, the proline insertion did not induce further deficits in the motive force for the tag. On the basis of the findings obtained by using these two independent techniques, we conclude that the signal sequence itself provides the motive force for N-terminal domain translocation within a limited upstream region.	[Kida, Yuichiro; Morimoto, Fumiko; Sakaguchi, Masao] Univ Hyogo, Grad Sch Life Sci, Ako, Hyogo 6781297, Japan; [Kida, Yuichiro; Sakaguchi, Masao] Univ Hyogo, Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Ako, Hyogo 6781297, Japan	University of Hyogo; Japan Science & Technology Agency (JST); University of Hyogo	Sakaguchi, M (corresponding author), Univ Hyogo, Grad Sch Life Sci, Ako, Hyogo 6781297, Japan.	sakag@sci.u-hyogo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Sumitomo Foundation; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Sumitomo Foundation, and the Uehara Memorial Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Belin D, 1996, EMBO J, V15, P468, DOI 10.1002/j.1460-2075.1996.tb00379.x; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kida Y, 2000, J CELL BIOL, V150, P719, DOI 10.1083/jcb.150.4.719; Kida Y, 2005, EMBO J, V24, P3202, DOI 10.1038/sj.emboj.7600788; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Sato T, 2005, P NATL ACAD SCI USA, V102, P17999, DOI 10.1073/pnas.0504495102; Skach WR, 2007, J CELL BIOL, V179, P1333, DOI 10.1083/jcb.200711107; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218	15	18	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2861	2866		10.1074/jbc.M808020200	http://dx.doi.org/10.1074/jbc.M808020200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19010775	hybrid			2022-12-25	WOS:000262700900030
J	Radziszewska, A; Choi, D; Nguyen, KTT; Schroer, SA; Tajmir, P; Wang, L; Suzuki, A; Mak, TW; Evan, GI; Woo, M				Radziszewska, Anna; Choi, Diana; Nguyen, Kinh-Tung T.; Schroer, Stephanie A.; Tajmir, Panteha; Wang, Linyuan; Suzuki, Akira; Mak, Tak W.; Evan, Gerard I.; Woo, Minna			PTEN Deletion and Concomitant c-Myc Activation Do Not Lead to Tumor Formation in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; GENE; BINDING; BAD; SUPPRESSOR; RESISTANCE; DOMAIN; LIVE	Phosphatase and tensin homologue (PTEN) deleted on chromosome 10 is a dual-specific phosphatase and a potent antagonist of the phosphoinositide 3-kinase signaling pathway. Although first discovered as a tumor suppressor, emerging evidence supports PTEN as a potential therapeutic target for diabetes. PTEN deletion in beta cells leads to increased beta cell mass and protection from streptozotocin-induced diabetes. Importantly, PTEN deletion does not lead to tumor formation in beta cells. To further assess the potential tumorigenic role of PTEN, we tested the biological role of PTEN in the context of activation of the proto-oncogene c-Myc. We generated and characterized beta cell-specific PTEN knock-out mice expressing an inducible c-Myc transgene in beta cells. Surprisingly, we found that PTEN loss did not confer protection from the overwhelming apoptosis and diabetes development seen with c-Myc activation. Importantly, despite the combined effect of the loss of a tumor suppressor and activation of an oncogene in beta cells, there was no evidence of tumor development with sustained c-Myc activation.	[Radziszewska, Anna; Schroer, Stephanie A.; Tajmir, Panteha; Wang, Linyuan; Mak, Tak W.; Woo, Minna] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Choi, Diana; Nguyen, Kinh-Tung T.; Woo, Minna] Univ Toronto, Inst Med Sci, Toronto, ON M5G 2M9, Canada; [Suzuki, Akira] Akita Univ, Sch Med, Dept Mol Biol, Akita 0108543, Japan; [Mak, Tak W.] Univ Toronto, Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada; [Evan, Gerard I.] Univ Calif San Francisco, Ctr Comprehens Canc, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Evan, Gerard I.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Woo, Minna] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Woo, Minna] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; Akita University; University of Toronto; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Woo, M (corresponding author), Ontario Canc Inst, 610 Univ Ave Rm 8-113, Toronto, ON M5G 2M9, Canada.	mwoo@uhnresearch.ca	Suzuki, Akira/GYD-6697-2022	Suzuki, Akira/0000-0002-5950-8808; Radziszewska, Ania/0000-0002-3885-3477	Canadian Institutes for Health Research; Canadian Diabetes Association; Banting and Best Diabetes Centre-Yom Kam-Yuen Studentship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Banting and Best Diabetes Centre-Yom Kam-Yuen Studentship	This work was supported by grants from the Canadian Institutes for Health Research and the Canadian Diabetes Association (to M. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Supported by the Banting and Best Diabetes Centre-Yom Kam-Yuen Studentship.	Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Gajewski TF, 1996, CELL, V87, P589, DOI 10.1016/S0092-8674(00)81377-X; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Klefstrom J, 2002, J BIOL CHEM, V277, P43224, DOI 10.1074/jbc.M206967200; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Lazar DF, 2006, NAT REV DRUG DISCOV, V5, P333, DOI 10.1038/nrd2007; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	25	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2917	2922		10.1074/jbc.M805183200	http://dx.doi.org/10.1074/jbc.M805183200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19056726	hybrid			2022-12-25	WOS:000262700900036
J	Shao, CL; Cobb, MH				Shao, Chunli; Cobb, Melanie H.			Sumoylation Regulates the Transcriptional Activity of MafA in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE-TRANSCRIPTION; BINDING PROTEIN-BETA; NUCLEAR-LOCALIZATION; DIABETES-MELLITUS; KEY REGULATOR; EXPRESSION; SUMO; REPRESSION; GLUCOSE; PHOSPHORYLATION	MafA is a transcriptional regulator expressed primarily in pancreatic beta cells. It binds to the RIPE3b/C1-binding site within the ins gene promoter, which plays a critical role in regulating ins gene expression in response to glucose. Here, we show that MafA is post-translationally modified by the small ubiquitin-related modifiers SUMO-1 and -2. Mutation of a single site in MafA, Lys(32), blocks its sumoylation in beta cells. Incubation of beta cells in low glucose ( 2 mM) or exposure to hydrogen peroxide increases sumoylation of endogenous MafA. Forced sumoylation of MafA results in reduced transcriptional activity toward the ins gene promoter and increased suppression of the CHOP-10 gene promoter. Sumoylation of MafA has no apparent effect on either its nuclear localization in beta cells or its ubiquitin-dependent degradation. This study suggests that modification of MafA by SUMO modulates gene transcription and thereby beta cell function.	[Shao, Chunli; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Melanie.Cobb@UTSouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [DK55310]; Robert A. Welch Foundation [I1243]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55310. This work was also supported by Robert A. Welch Foundation Grant I1243. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aramata S, 2007, ENDOCR J, V54, P659, DOI 10.1507/endocrj.KR-101; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2007, P NATL ACAD SCI USA, V104, P11518, DOI 10.1073/pnas.0704618104; Malecki MT, 2005, DIABETES RES CLIN PR, V68, pS10, DOI 10.1016/j.diabres.2005.03.003; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Seufert J, 1998, J CLIN INVEST, V101, P2528, DOI 10.1172/JCI2401; Sii-Felice K, 2005, FEBS LETT, V579, P3547, DOI 10.1016/j.febslet.2005.04.086; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Tillmanns S, 2007, MOL CELL BIOL, V27, P5554, DOI 10.1128/MCB.01811-06; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Ye DZ, 2006, DIABETES, V55, P742, DOI 10.2337/diabetes.55.03.06.db05-0653; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	37	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3117	3124		10.1074/jbc.M806286200	http://dx.doi.org/10.1074/jbc.M806286200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029092	Green Published, hybrid			2022-12-25	WOS:000262700900056
J	Pauchet, Y; Freitak, D; Heidel-Fischer, HM; Heckel, DG; Vogel, H				Pauchet, Yannick; Freitak, Dalial; Heidel-Fischer, Hanna M.; Heckel, David G.; Vogel, Heiko			GLUCANASE ACTIVITY IN A GLUCAN-BINDING PROTEIN FAMILY FROM LEPIDOPTERA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,3-GLUCAN RECOGNITION PROTEIN; MANDUCA-SEXTA; MOLECULAR-CLONING; PROPHENOLOXIDASE ACTIVATION; HELICOVERPA-ARMIGERA; ANOPHELES-GAMBIAE; MASS-SPECTROMETRY; IMMUNE-RESPONSES; COTTON BOLLWORM; INNATE IMMUNITY	The cell surfaces of microorganisms display distinct molecular patterns formed from lipopolysaccharides, peptidoglycans, or beta 1,3-glucans. Binding of these surfaces by pattern recognition proteins such as beta 1,3-glucan recognition proteins (beta GRPs) activates the immune response in arthropods. We identified a 40-kDa beta 1,3-glucan-binding protein with sequence similarity to previously characterized lepidopteran beta GRPs from hemolymph, but unlike these it is secreted into the larval gut lumen and is an active beta 1,3-glucanase. This glucanase was not detected in hemolymph. Its mRNA is constitutively and predominantly expressed in the midgut and is induced there when larvae feed on a diet containing bacteria. Homologs of this predominantly midgut-expressed gene from many Lepidoptera possess key residues shown to be part of the active site of other glucanases, and form a cluster that is distinct from previously described beta GRPs. In addition, this group includes proteins from insects such as the Anopheles gambiae GNBP subgroup B for which a catalytic role has not been previously suspected. The current domain classification does not distinguish between the catalytic and noncatalytic clades, and should be revised. The noncatalytic beta GRPs may be evolutionarily derived from this newly described enzyme family that continues to function catalytically in digestion and/or pathogen defense.	[Pauchet, Yannick; Freitak, Dalial; Heidel-Fischer, Hanna M.; Heckel, David G.; Vogel, Heiko] Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany	Max Planck Society	Pauchet, Y (corresponding author), Univ Exeter, Sch Biosci, Penryn TR10 9EZ, Cornwall, England.	Y.Pauchet@exeter.ac.uk	Heckel, David G/K-2138-2013; Pauchet, Yannick/AAU-9751-2021; Freitak, Dalial/H-4904-2012	Heckel, David G/0000-0001-8991-2150; Pauchet, Yannick/0000-0002-2918-8946; Freitak, Dalial/0000-0001-8574-0531	MaxPlanck Society	MaxPlanck Society(Max Planck Society)	This work was supported by the MaxPlanck Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ao JQ, 2008, MOL IMMUNOL, V45, P543, DOI 10.1016/j.molimm.2007.05.019; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chai LQ, 2008, DEV COMP IMMUNOL, V32, P71, DOI 10.1016/j.dci.2007.04.006; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Fabrick JA, 2004, J BIOL CHEM, V279, P26605, DOI 10.1074/jbc.M403382200; Fabrick JA, 2003, INSECT BIOCHEM MOLEC, V33, P579, DOI 10.1016/S0965-1748(03)00029-8; Fischer HM, 2008, MOL BIOL EVOL, V25, P809, DOI 10.1093/molbev/msn014; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Genta FA, 2003, INSECT BIOCHEM MOLEC, V33, P1085, DOI 10.1016/S0965-1748(03)00121-8; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; HALL M, 1995, P NATL ACAD SCI USA, V92, P7764, DOI 10.1073/pnas.92.17.7764; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; JUNCOSA M, 1994, J BIOL CHEM, V269, P14530; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; LAMB CJ, 1989, CELL, V56, P215, DOI 10.1016/0092-8674(89)90894-5; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; MAUCH F, 1988, PLANT PHYSIOL, V88, P936, DOI 10.1104/pp.88.3.936; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; Ping LY, 2007, ENVIRON MICROBIOL, V9, P1572, DOI 10.1111/j.1462-2920.2007.01279.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Shin SW, 1998, INSECT BIOCHEM MOLEC, V28, P827, DOI 10.1016/S0965-1748(98)00077-0; Simpson RM, 2007, INSECT MOL BIOL, V16, P675, DOI 10.1111/j.1365-2583.2007.00763.x; Spiteller D, 2000, BIOL CHEM, V381, P755, DOI 10.1515/BC.2000.096; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDERZANT ES, 1968, ANN ENTOMOL SOC AM, V61, P120, DOI 10.1093/aesa/61.1.120; Warr E, 2008, INSECT MOL BIOL, V17, P39, DOI 10.1111/j.1365-2583.2008.00778.x; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	39	71	77	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2214	2224		10.1074/jbc.M806204200	http://dx.doi.org/10.1074/jbc.M806204200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19033442	hybrid			2022-12-25	WOS:000262545600031
J	Jian, XY; Brown, P; Schuck, P; Gruschus, JM; Balbo, A; Hinshaw, JE; Randazzo, PA				Jian, Xiaoying; Brown, Patrick; Schuck, Peter; Gruschus, James M.; Balbo, Andrea; Hinshaw, Jenny E.; Randazzo, Paul A.			Autoinhibition of Arf GTPase-activating Protein Activity by the BAR Domain in ASAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE A2 ACTIVITY; MEMBRANE CURVATURE; RECYCLING ENDOSOME; ACTIN CYTOSKELETON; PH DOMAINS; GAPS; BINDING; FAMILY; ULTRACENTRIFUGATION; RECOGNITION	ASAP1 is an Arf GTPase-activating protein (GAP) that functions on membrane surfaces to catalyze the hydrolysis of GTP bound to Arf. ASAP1 contains a tandem of BAR, pleckstrin homology (PH), and Arf GAP domains and contributes to the formation of invadopodia and podosomes. The PH domain interacts with the catalytic domain influencing both the catalytic and Michaelis constants. Tandem BAR-PH domains have been found to fold into a functional unit. The results of sedimentation velocity studies were consistent with predictions from homology models in which the BAR and PH domains of ASAP1 fold together. We set out to test the hypothesis that the BAR domain of ASAP1 affects GAP activity by interacting with the PH and/or Arf GAP domains. Recombinant proteins composed of the BAR, PH, Arf GAP, and Ankyrin repeat domains (called BAR-PZA) and the PH, Arf GAP, and Ankyrin repeat domains (PZA) were compared. Catalytic power for the two proteins was determined using large unilamellar vesicles as a reaction surface. The catalytic power of PZA was greater than that of BAR-PZA. The effect of the BAR domain was dependent on the N-terminal loop of the BAR domain and was not the consequence of differential membrane association or changes in large unilamellar vesicle curvature. The K-m for BAR-PZA was greater and the k(cat) was smaller than for PZA determined by saturation kinetics. Analysis of single turnover kinetics revealed a transition state intermediate that was affected by the BAR domain. We conclude that BAR domains can affect enzymatic activity through intraprotein interactions.	[Randazzo, Paul A.] NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Brown, Patrick; Schuck, Peter; Balbo, Andrea] NIDDK, Sect Dynam Macromol Assembly, NIH, Bethesda, MD 20892 USA; [Gruschus, James M.] NIDDK, NHLBI, NIH, Bethesda, MD 20892 USA; [Hinshaw, Jenny E.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Randazzo, PA (corresponding author), NCI, Cellular & Mol Biol Lab, NIH, Bldg 37,Rm 2042, Bethesda, MD 20892 USA.	randazzo@helix.nih.gov	Schuck, Peter/AAA-6888-2020	Schuck, Peter/0000-0002-8859-6966	NCI; NIBIB; National Institutes of Health; Department of Health and Human Services; NATIONAL CANCER INSTITUTE [Z01BC007365, ZIABC007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000008, ZICEB000008, Z01EB000008] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by the intramural program at NCI and by the NIBIB, National Institutes of Health, Department of Health and Human Services. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Che MM, 2005, METHOD ENZYMOL, V404, P147, DOI 10.1016/S0076-6879(05)04015-2; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DENNIS EA, 1973, ARCH BIOCHEM BIOPHYS, V158, P485, DOI 10.1016/0003-9861(73)90540-7; DENNIS EA, 1973, J LIPID RES, V14, P152; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Itoh T, 2002, CELL SIGNAL, V14, P733, DOI 10.1016/S0898-6568(02)00028-1; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; Lee MCS, 2004, SCIENCE, V303, P479, DOI 10.1126/science.1094231; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; LIVESEY AK, 1986, J CHEM PHYS, V84, P5102, DOI 10.1063/1.450663; Luo R, 2008, CELL SIGNAL, V20, P1968, DOI 10.1016/j.cellsig.2008.07.007; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Randazzo PA, 2001, METHOD ENZYMOL, V329, P343; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	42	47	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1652	1663		10.1074/jbc.M804218200	http://dx.doi.org/10.1074/jbc.M804218200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017632	Green Published, hybrid			2022-12-25	WOS:000262330100034
J	McAllister, CS; Samuel, CE				McAllister, Christopher S.; Samuel, Charles E.			The RNA-activated Protein Kinase Enhances the Induction of Interferon-beta and Apoptosis Mediated by Cytoplasmic RNA Sensors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; TOLL-LIKE-RECEPTORS; INDUCIBLE GENE-I; ADAPTER PROTEIN; PKR; TRANSCRIPTION; RECOGNITION; MECHANISM; INFECTION	Detection of foreign RNA by the innate immune system can trigger the induction of type I interferon (IFN) and apoptosis. Important antiviral defense pathways that result in type I IFN production following the recognition of foreign doublestranded RNA (dsRNA) include the RIG-I family helicases and IPS-1 adaptor cytosolic pathway and the Toll-like receptor 3 and TIR domain-containing adaptor-inducing IFN-beta (TRIF) adaptor membrane-associated pathway, both of which activate IFN regulatory factor 3 (IRF3). In addition to triggering an innate immune response, dsRNAs are widely used to mediate geneselective silencing in mammalian cells by the RNA interference pathway. We investigated the ability of short interfering RNAs, including T7 phage polymerase-synthesized RNA (PRNA), which like some viral RNAs contains a 5'-triphosphate, to selectively silence gene expression and to cause induction of IFN-beta and apoptosis. We found that PRNA-mediated gene silencing and associated nonspecific pro-apoptotic and IFN-inducing effects were dependent on the cell line and RNA length. Double-stranded PRNAs 50 nucleotides long as well as polyinosinicpolycytidylic acid activated the RNA-dependent protein kinase (PKR) and induced significant levels of IFN-beta and apoptosis, whereas shorter PRNAs and chemically synthesized dsRNAs did not. Effector caspase activation and apoptosis following RNA transfection was enhanced by pretreatment with IFN, and removal of the 5'-phosphate from PRNAs decreased induction of both IFN-beta and apoptosis. PKR, in addition to IPS-1 and IRF3 but not TRIF, was required for maximal type I IFN-beta induction and the induction of apoptosis by both transfected PRNAs and polyinosinicpolycytidylic acid.	[McAllister, Christopher S.; Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			National Institutes of Health Grants [AI-12520, AI-20611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI012520, R01AI020611, R37AI012520] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-12520 and AI-20611. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; BISCHOFF JR, 1989, VIROLOGY, V172, P106, DOI 10.1016/0042-6822(89)90112-8; Bouxsein NF, 2007, BIOCHEMISTRY-US, V46, P4785, DOI 10.1021/bi062138l; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Das S, 2006, J BIOL CHEM, V281, P3244, DOI 10.1074/jbc.M510612200; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; GAROUFALIS E, 1994, J VIROL, V68, P4707, DOI 10.1128/JVI.68.8.4707-4715.1994; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Heylbroeck C, 2000, J VIROL, V74, P3781, DOI 10.1128/JVI.74.8.3781-3792.2000; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kang DC, 2004, ONCOGENE, V23, P1789, DOI 10.1038/sj.onc.1207300; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; LAMPSON GP, 1967, P NATL ACAD SCI USA, V58, P782, DOI 10.1073/pnas.58.2.782; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; Matsukura S, 1999, J IMMUNOL, V163, P6876; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MELLITS KH, 1990, NUCLEIC ACIDS RES, V18, P5401, DOI 10.1093/nar/18.18.5401; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Robbins MA, 2005, NAT MED, V11, P250, DOI 10.1038/nm0305-250; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Samuel CE, 2004, NAT BIOTECHNOL, V22, P280, DOI 10.1038/nbt0304-280; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sioud M, 2006, TRENDS MOL MED, V12, P167, DOI 10.1016/j.molmed.2006.02.004; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Ui-Tei K, 2000, FEBS LETT, V479, P79, DOI 10.1016/S0014-5793(00)01883-4; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	57	83	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1644	1651		10.1074/jbc.M807888200	http://dx.doi.org/10.1074/jbc.M807888200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028691	Green Published			2022-12-25	WOS:000262330100033
J	Wang, YB; Weiss, LM; Orlofsky, A				Wang, Yubao; Weiss, Louis M.; Orlofsky, Amos			Host Cell Autophagy Is Induced by Toxoplasma gondii and Contributes to Parasite Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID; APICOMPLEXAN PARASITES; PROTEIN LIPIDATION; AMINO-ACIDS; CALCIUM; MACROAUTOPHAGY; METABOLISM; COMPLEX; INNATE; BIOSYNTHESIS	Autophagy has been shown to contribute to defense against intracellular bacteria and parasites. In comparison, the ability of such pathogens to manipulate host cell autophagy to their advantage has not been examined. Here we present evidence that infection by Toxoplasma gondii, an intracellular protozoan parasite, induces host cell autophagy in both HeLa cells and primary fibroblasts, via a mechanism dependent on host Atg5 but independent of host mammalian target of rapamycin suppression. Infection led to the conversion of LC3 to the autophagosome-associated form LC3-II, to the accumulation of LC3-containing vesicles near the parasitophorous vacuole, and to the relocalization toward the vacuole of structures labeled by the phosphatidylinositol 3-phosphate indicator YFP-2xFYVE. The autophagy regulator beclin 1 was concentrated in the vicinity of the parasitophorous vacuole in infected cells. Inhibitor studies indicated that parasite-induced autophagy is dependent on calcium signaling and on abscisic acid. At physiologically relevant amino acid levels, parasite growth became defective in Atg5-deficient cells, indicating a role for host cell autophagy in parasite recovery of host cell nutrients. A flow cytometric analysis of cell size as a function of parasite content revealed that autophagy-dependent parasite growth correlates with autophagy-dependent consumption of host cell mass that is dependent on parasite progression. These findings indicate a new role for autophagy as a pathway by which parasites may effectively compete with the host cell for limiting anabolic resources.	[Wang, Yubao; Weiss, Louis M.; Orlofsky, Amos] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Weiss, Louis M.] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Orlofsky, A (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, G704,1300 Morris Pk Ave, Bronx, NY 10461 USA.	orlofsky@aecom.yu.edu	Wang, Yubao/L-3912-2014		National Institutes of Health [AI-55358, AI-39454]; Flow Cytometry Core of the Center for AIDS Research [AI-51519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055358, R01AI039454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Core of the Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-55358 (to A. O.) and AI-39454 (to L. M. W.). This work was also supported by the Flow Cytometry Core of the Center for AIDS Research Grant AI-51519. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; AOKI TT, 1975, AM J CLIN NUTR, V28, P507, DOI 10.1093/ajcn/28.5.507; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BRUZZONE S, 2008, J BIOL CHEM; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Calbet JAL, 2002, J NUTR, V132, P2174, DOI 10.1093/jn/132.8.2174; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Fox BA, 2004, INT J PARASITOL, V34, P323, DOI 10.1016/j.ijpara.2003.12.001; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Gherardi A, 2007, TRENDS PARASITOL, V23, P384, DOI 10.1016/j.pt.2007.06.003; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; PALOU A, 1981, HORM METAB RES, V13, P326, DOI 10.1055/s-2007-1019258; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Ravindran S, 2008, TRAFFIC, V9, P647, DOI 10.1111/j.1600-0854.2008.00723.x; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; SCHWARTZ A, 1994, P NATL ACAD SCI USA, V91, P4019, DOI 10.1073/pnas.91.9.4019; Shrestha SP, 2006, INT J PARASITOL, V36, P433, DOI 10.1016/j.ijpara.2006.01.006; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; YOKOGOSHI H, 1986, METABOLISM, V35, P837, DOI 10.1016/0026-0495(86)90225-8; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; ZOCCHI E, 2006, FLURIDONE ANTII 1006	49	90	94	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1694	1701		10.1074/jbc.M807890200	http://dx.doi.org/10.1074/jbc.M807890200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028680	hybrid, Green Published			2022-12-25	WOS:000262330100038
J	Carobbio, S; Frigerio, F; Rubi, B; Vetterli, L; Bloksgaard, M; Gjinovci, A; Pournourmohammadi, S; Herrera, PL; Reith, W; Mandrup, S; Maechler, P				Carobbio, Stefania; Frigerio, Francesca; Rubi, Blanca; Vetterli, Laurene; Bloksgaard, Maria; Gjinovci, Asllan; Pournourmohammadi, Shirin; Herrera, Pedro L.; Reith, Walter; Mandrup, Susanne; Maechler, Pierre			Deletion of Glutamate Dehydrogenase in beta-Cells Abolishes Part of the Insulin Secretory Response Not Required for Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELEASE; SIRT4; MICE; MITOCHONDRIA; DEFICIENCY; METABOLISM; RESISTANCE; PATHWAYS; LEUCINE; ISLETS	Insulin exocytosis is regulated in pancreatic beta-cells by a cascade of intracellular signals translating glucose levels into corresponding secretory responses. The mitochondrial enzyme glutamate dehydrogenase (GDH) is regarded as a major player in this process, although its abrogation has not been tested yet in animal models. Here, we generated transgenic mice, named beta Glud1(-/-), with beta-cell-specific GDH deletion. Our results show that GDH plays an essential role in the full development of the insulin secretory response. In situ pancreatic perfusion revealed that glucose-stimulated insulin secretion was reduced by 37% in beta Glud1(-/-). Furthermore, isolated islets with either constitutive or acute adenovirus-mediated knock-out of GDH showed a 49 and 38% reduction in glucose-induced insulin release, respectively. Adenovirus-mediated re-expression of GDH in beta Glud1(-/-) islets fully restored glucose-induced insulin release. Thus, GDH appears to account for about 40% of glucose-stimulated insulin secretion and to lack redundant mechanisms. In beta Glud1(-/-) mice, the reduced secretory capacity resulted in lower plasma insulin levels in response to both feeding and glucose load, while body weight gain was preserved. The results demonstrate that GDH is essential for the full development of the secretory response in beta-cells. However, maximal secretory capacity is not required for maintenance of glucose homeostasis in normo-caloric conditions.	[Carobbio, Stefania; Frigerio, Francesca; Rubi, Blanca; Vetterli, Laurene; Gjinovci, Asllan; Pournourmohammadi, Shirin; Maechler, Pierre] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Herrera, Pedro L.] Univ Geneva, Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Reith, Walter] Univ Geneva, Med Ctr, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; [Mandrup, Susanne] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Geneva; University of Geneva; University of Geneva; University of Southern Denmark	Maechler, P (corresponding author), Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Pierre.Maechler@medecine.unige.ch	carobbio, stefania/E-7095-2018; Mandrup, Susanne/B-6693-2008	Herrera Merino, Pedro Luis/0000-0003-0771-9504; Maechler, Pierre/0000-0002-2005-1433; Mandrup, Susanne/0000-0002-0961-5787; Bloksgaard, Maria/0000-0002-4474-9553	Swiss National Science Foundation; EFSD/Novo Nordisk research; Dr. Max Cloetta Foundation; Danish Natural Science Research Council and Health Science Research Council; Juvenile Diabetes Research Foundation; Fondation Romande pour la Recherche sur le Diabete	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EFSD/Novo Nordisk research; Dr. Max Cloetta Foundation; Danish Natural Science Research Council and Health Science Research Council; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Fondation Romande pour la Recherche sur le Diabete	This study was supported by the Swiss National Science Foundation (to P. M., W. R., and P. L. H.), an EFSD/Novo Nordisk research grant (to P. M.), the Dr. Max Cloetta Foundation (to P. M.), the Danish Natural Science Research Council and Health Science Research Council (to S. M.), the Juvenile Diabetes Research Foundation (to P. H.), and Fondation Romande pour la Recherche sur le Diabete (to P. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Argmann C, 2006, CELL, V126, P837, DOI 10.1016/j.cell.2006.08.031; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Carobbio S, 2004, DIABETOLOGIA, V47, P266, DOI 10.1007/s00125-003-1306-2; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; Frigerio F, 2008, BBA-BIOENERGETICS, V1777, P965, DOI 10.1016/j.bbabio.2008.04.031; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Gorogawa S, 2004, BIOCHEM BIOPH RES CO, V319, P1159, DOI 10.1016/j.bbrc.2004.05.095; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Konrad D, 2007, DIABETOLOGIA, V50, P833, DOI 10.1007/s00125-007-0596-1; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Li CH, 2006, J BIOL CHEM, V281, P15064, DOI 10.1074/jbc.M600994200; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2002, DIABETES, V51, pS99, DOI 10.2337/diabetes.51.2007.S99; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MICHAELIDIS TM, 1993, GENOMICS, V16, P150, DOI 10.1006/geno.1993.1152; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; ORCI L, 1975, LANCET, V2, P1243, DOI 10.1016/S0140-6736(75)92078-4; PANTEN U, 1984, BIOCHEM J, V219, P189, DOI 10.1042/bj2190189; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Produit-Zengaffinen N, 2007, DIABETOLOGIA, V50, P84, DOI 10.1007/s00125-006-0499-6; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; Xia Z, 2002, J BIOL CHEM, V277, P45874, DOI 10.1074/jbc.M207281200; Ye F, 2008, J BIOCHEM BIOPH METH, V70, P978, DOI 10.1016/j.jprot.2008.01.003	38	78	78	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					921	929		10.1074/jbc.M806295200	http://dx.doi.org/10.1074/jbc.M806295200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19015267	hybrid			2022-12-25	WOS:000262122900027
J	Verpooten, D; Ma, YJ; Hou, SW; Yan, ZP; He, B				Verpooten, Dustin; Ma, Yijie; Hou, Songwang; Yan, Zhipeng; He, Bin			Control of TANK-binding Kinase 1-mediated Signaling by the gamma(1)34.5 Protein of Herpes Simplex Virus 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERFERON ANTIVIRAL RESPONSE; INNATE IMMUNE-RESPONSE; TYPE-1 US11 PROTEIN; IKK-RELATED KINASE; VIRAL-INFECTION; REGULATORY SUBUNIT; STIMULATED GENES; ACTIVATION; CELLS	TANK-binding kinase 1 (TBK1) is a key component of Toll-like receptor-dependent and -independent signaling pathways. In response to microbial components, TBK1 activates interferon regulatory factor 3 (IRF3) and cytokine expression. Here we show that TBK1 is a novel target of the gamma(1)34.5 protein, a virulence factor whose expression is regulated in a temporal fashion. Remarkably, the gamma(1)34.5 protein is required to inhibit IRF3 phosphorylation, nuclear translocation, and the induction of antiviral genes in infected cells. When expressed in mammalian cells, the gamma(1)34.5 protein forms complexes with TBK1 and disrupts the interaction of TBK1 and IRF3, which prevents the induction of interferon and interferon-stimulated gene promoters. Down-regulation of TBK1 requires the amino-terminal domain. In addition, unlike wild type virus, a herpes simplex virus mutant lacking gamma(1)34.5 replicates efficiently in TBK1(-/-) cells but not in TBK1(+/+) cells. Addition of exogenous interferon restores the antiviral activity in both TBK1(-/-) and TBK+/+ cells. Hence, control of TBK1-mediated cell signaling by the gamma(1)34.5 protein contributes to herpes simplex virus infection. These results reveal that TBK1 plays a pivotal role in limiting replication of a DNA virus.	[Verpooten, Dustin; Ma, Yijie; Hou, Songwang; Yan, Zhipeng; He, Bin] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	He, B (corresponding author), 835 S Wolcott Ave, Chicago, IL 60612 USA.	tshuo@uic.edu	Yan, Zhipeng/AHC-7029-2022	Yan, Zhipeng/0000-0002-8463-1891	National Institutes of Health [AI46665]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046665, R56AI046665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI46665 (NIAID) (to B. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BROWN SM, 1994, J GEN VIROL, V75, P3679, DOI 10.1099/0022-1317-75-12-3679; Brown SM, 1997, J VIROL, V71, P9442, DOI 10.1128/JVI.71.12.9442-9449.1997; Chee AV, 2003, J VIROL, V77, P7101, DOI 10.1128/JVI.77.12.7101-7105.2003; Cheng GF, 2002, J VIROL, V76, P9434, DOI 10.1128/JVI.76.18.9434-9445.2002; Cheng GF, 2001, VIROLOGY, V290, P115, DOI 10.1006/viro.2001.1148; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; CHOU J, 1986, J VIROL, V57, P629, DOI 10.1128/JVI.57.2.629-637.1986; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; CHOU J, 1992, P NATL ACAD SCI USA, V89, P3266, DOI 10.1073/pnas.89.8.3266; CHOU J, 1990, J VIROL, V64, P1014, DOI 10.1128/JVI.64.3.1014-1020.1990; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Feng ZD, 2007, J VIROL, V81, P182, DOI 10.1128/JVI.01006-06; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Jing XH, 2004, J VIROL, V78, P7653, DOI 10.1128/JVI.78.14.7653-7666.2004; Johnson KE, 2008, VIROLOGY, V374, P487, DOI 10.1016/j.virol.2008.01.001; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Leib DA, 2000, P NATL ACAD SCI USA, V97, P6097, DOI 10.1073/pnas.100415697; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Mao HW, 2002, J BIOL CHEM, V277, P11423, DOI 10.1074/jbc.M111553200; MCKAY EM, 1993, J GEN VIROL, V74, P2493, DOI 10.1099/0022-1317-74-11-2493; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Melchjorsen J, 2006, J GEN VIROL, V87, P1099, DOI 10.1099/vir.0.81541-0; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Mohr I, 2001, J VIROL, V75, P5189, DOI 10.1128/JVI.75.11.5189-5196.2001; Mossman KL, 2000, J VIROL, V74, P2052, DOI 10.1128/JVI.74.4.2052-2056.2000; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Nicholl MJ, 2000, J GEN VIROL, V81, P2215, DOI 10.1099/0022-1317-81-9-2215; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Pasieka TJ, 2006, J VIROL, V80, P7600, DOI 10.1128/JVI.00333-06; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Poppers J, 2000, J VIROL, V74, P11215, DOI 10.1128/JVI.74.23.11215-11221.2000; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; Roizman B, 1999, ACTA VIROL, V43, P75; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sanchez R, 2007, J VIROL, V81, P3455, DOI 10.1128/JVI.02520-06; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Trgovcich J, 2002, J VIROL, V76, P6974, DOI 10.1128/JVI.76.14.6974-6986.2002; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	55	148	149	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1097	1105		10.1074/jbc.M805905200	http://dx.doi.org/10.1074/jbc.M805905200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010780	hybrid, Green Published			2022-12-25	WOS:000262122900046
J	Nguyen, HTT; Dalmasso, G; Yan, YT; Obertone, TS; Sitaraman, SV; Merlin, D				Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Obertone, Tracy S.; Sitaraman, Shanthi V.; Merlin, Didier			Ecto-Phosphorylation of CD98 Regulates Cell-Cell Interactions	PLOS ONE			English	Article								Ecto-phosphorylation plays an important role in many cellular functions. The transmembrane glycoprotein CD98 contains potential phosphorylation sites in its extracellular C-terminal tail. We hypothesized that extracellular signaling through ectoprotein kinases (ePKs) might lead to ecto-phosphorylation of CD98 and influence its multiple functions, including its role in cell-cell interactions. Our results show that recombinant CD98 was phosphorylated in vitro by ePKs from Jurkat cells and by the commercial casein kinase 2 (CK2). Alanine substitutions at serines-305/307/309 or serines-426/430 attenuated CK2-mediated CD98 phosphorylation, suggesting that these residues are the dominant phosphorylation sites for CK2. Furthermore, CD98 expressed in the basolateral membranes of intestinal epithelial Caco2-BBE cells was ecto-phosphorylated by Jurkat cell-derived ePKs and ecto-CK2 was involved in this process. Importantly, cell attachment studies showed that the ecto-phosphorylation of CD98 enhanced heterotypic cell-cell interactions and that the extracellular domain of CD98, which possesses the serine phosphorylation sites, was crucial for this effect. In addition, phosphorylation of recombinant CD98 increased its interactions with Jurkat and Caco2-BBE cells, and promoted cell attachment and spreading. In conclusion, here we demonstrated the ecto-phosphorylation of CD98 by ePKs and its functional importance in cell-cell interactions. Our findings reveal a novel mechanism involved in regulating the multiple functions of CD98 and raise CD98 as a promising target for therapeutic modulations of cell-cell interactions.	[Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Obertone, Tracy S.; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University	Nguyen, HTT (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	hnguye9@emory.edu	Nguyen, Hang/N-2441-2018; Dalmasso, Guillaume/N-2443-2018	Nguyen, Hang/0000-0001-7431-5126; Dalmasso, Guillaume/0000-0002-3433-870X	National Institutes of Health of Diabetes and Digestive and Kidney Diseases [RO1-DK-071594]; Crohn's and Colitis Foundation of America [research fellowship]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071594] Funding Source: NIH RePORTER	National Institutes of Health of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the National Institutes of Health of Diabetes and Digestive and Kidney Diseases by the grant RO1-DK-071594. G. Dalmasso and Y. Yan are recipients of a research fellowship award from the Crohn's and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; APASOV S, 1995, IMMUNOL REV, V146, P5, DOI 10.1111/j.1600-065X.1995.tb00680.x; Apasov SG, 1996, J BIOL CHEM, V271, P25677, DOI 10.1074/jbc.271.41.25677; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; FAIS S, 1989, GASTROENTEROLOGY, V97, P1435, DOI 10.1016/0016-5085(89)90387-9; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Fenczik CA, 2001, J BIOL CHEM, V276, P8746, DOI 10.1074/jbc.M011239200; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HAYNES BF, 1981, J IMMUNOL, V126, P1409; IMADA S, 1988, EXP CELL RES, V179, P554, DOI 10.1016/0014-4827(88)90293-5; KANG ES, 1984, CELL IMMUNOL, V87, P319, DOI 10.1016/0008-8749(84)90001-7; KUBLER D, 1983, P NATL ACAD SCI-BIOL, V80, P4021, DOI 10.1073/pnas.80.13.4021; Kucharzik T, 2005, LAB INVEST, V85, P932, DOI 10.1038/labinvest.3700289; LITCHFIELD DW, 1990, FEBS LETT, V261, P117, DOI 10.1016/0014-5793(90)80650-8; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu X, 2003, J BIOL CHEM, V278, P23672, DOI 10.1074/jbc.M302777200; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1991, FEBS LETT, V279, P307, DOI 10.1016/0014-5793(91)80174-2; MEGGIO F, 1992, BIOCHEM BIOPH RES CO, V182, P1460, DOI 10.1016/0006-291X(92)91898-Z; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Merlin D, 2001, J BIOL CHEM, V276, P39282, DOI 10.1074/jbc.M105077200; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; REDEGELD F, 1991, J IMMUNOL, V147, P3638; Redegeld FA, 1999, TRENDS PHARMACOL SCI, V20, P453, DOI 10.1016/S0165-6147(99)01399-1; Redegeld FA, 1997, BBA-BIOMEMBRANES, V1328, P151, DOI 10.1016/S0005-2736(97)00082-5; Sarno S, 2000, BIOCHEMISTRY-US, V39, P12324, DOI 10.1021/bi0011431; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; SCHREIBER S, 1991, GASTROENTEROLOGY, V101, P1020, DOI 10.1016/0016-5085(91)90729-5; Seger D, 2001, J BIOL CHEM, V276, P16998, DOI 10.1074/jbc.M003766200; SKUBITZ KM, 1991, J IMMUNOL, V147, P638; Stepanova V, 2002, J BIOL CHEM, V277, P10265, DOI 10.1074/jbc.M109057200; Teshima R, 1997, J IMMUNOL, V159, P964; Teshima R, 1999, IMMUNOL LETT, V68, P369, DOI 10.1016/S0165-2478(99)00086-3; Thu Nguyen HT, 2007, AM J PHYSIOL-GASTR L, V293, pG1155, DOI 10.1152/ajpgi.00334.2007; Trachana V, 2005, INT J BIOCHEM CELL B, V37, P478, DOI 10.1016/j.biocel.2004.08.001; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; YAN Y, 2008, BIOCH BIOPHYS ACTA; Yan Y, 2007, J MEMBRANE BIOL, V215, P15, DOI 10.1007/s00232-007-9001-8; Zien P, 2003, BIOCHEM BIOPH RES CO, V306, P129, DOI 10.1016/S0006-291X(03)00928-8; Zimina EP, 2007, J BIOL CHEM, V282, P22737, DOI 10.1074/jbc.M701937200	42	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3895	10.1371/journal.pone.0003895	http://dx.doi.org/10.1371/journal.pone.0003895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065266	Green Published, Green Submitted, gold			2022-12-25	WOS:000265455200009
J	Thomas, B; Holland, JD; Minot, EO				Thomas, Bindi; Holland, John D.; Minot, Edward O.			Elephant (Loxodonta africana) Home Ranges in Sabi Sand Reserve and Kruger National Park: A Five-Year Satellite Tracking Study	PLOS ONE			English	Article								During a five-year GPS satellite tracking study in Sabi Sand Reserve (SSR) and Kruger National Park (KNP) we monitored the daily movements of an elephant cow (Loxodonta africana) from September 2003 to August 2008. The study animal was confirmed to be part of a group of seven elephants therefore her position is representative of the matriarchal group. We found that the study animal did not use habitat randomly and confirmed strong seasonal fidelity to its summer and winter five-year home ranges. The cow's summer home range was in KNP in an area more than four times that of her SSR winter home range. She exhibited clear park habitation with up to three visits per year travelling via a well-defined northern or southern corridor. There was a positive correlation between the daily distance the elephant walked and minimum daily temperature and the elephant was significantly closer to rivers and artificial waterholes than would be expected if it were moving randomly in KNP and SSR. Transect lines established through the home ranges were surveyed to further understand the fine scale of the landscape and vegetation representative of the home ranges.	[Thomas, Bindi; Holland, John D.; Minot, Edward O.] Massey Univ, Inst Nat Resources, Ecol Grp, Palmerston North, New Zealand	Massey University	Thomas, B (corresponding author), Massey Univ, Inst Nat Resources, Ecol Grp, Palmerston North, New Zealand.	j.d.holland@massey.ac.nz			Institute of Natural Resources, Massey University	Institute of Natural Resources, Massey University	We gratefully acknowledge the financial support of the Institute of Natural Resources, Massey University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Codron J, 2006, J MAMMAL, V87, P27, DOI 10.1644/05-MAMM-A-017R1.1; de Beer Y, 2006, J ARID ENVIRON, V64, P412, DOI 10.1016/j.jaridenv.2005.06.015; DIXON KR, 1980, ECOLOGY, V61, P1040, DOI 10.2307/1936821; Dolmia NM, 2007, AFR J ECOL, V45, P594, DOI 10.1111/j.1365-2028.2007.00777.x; FAIRALL N, 1979, HDB BIOTELEMETRY RAD, P673; FYVIE C, 2008, TREES KRUGER NATL PA; HOOGE K, 1997, ANIMAL MOVEMENT EXTE; JduP Bothma, 2002, GAME RANCH MANAGEMEN; Kenward RE., 2000, MANUAL WILDLIFE RADI; LINDEQUE M, 1991, AFR J ECOL, V27, P198; NTUMI CP, 2005, GREAT ELEPHANT INDAB; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith N., 1988, MEGAHERBIVORES INFLU; Shannon G, 2006, AFR ZOOL, V41, P37, DOI 10.3377/1562-7020(2006)41[37:AEHRAH]2.0.CO;2; Smit IPJ, 2007, DIVERS DISTRIB, V13, P666, DOI 10.1111/j.1472-4642.2007.00403.x; Whyte I.J., 2007, RESULTS 2006 2007 CE; Whyte I, 1998, ANIM CONSERV, V1, P77, DOI 10.1111/j.1469-1795.1998.tb00014.x; WHYTE IJ, 2001, THESIS U PRETORIA PR; 2008, AFRICA WILDLIFE TRAC	19	25	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2008	3	12							e3902	10.1371/journal.pone.0003902	http://dx.doi.org/10.1371/journal.pone.0003902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436ZP	19065264	gold, Green Published, Green Submitted			2022-12-25	WOS:000265455200014
J	Dettman, EJ; Justice, MJ				Dettman, E. J.; Justice, Monica J.			The Zinc Finger SET Domain Gene Prdm14 Is Overexpressed in Lymphoblastic Lymphomas with Retroviral Insertions at Evi32	PLOS ONE			English	Article								Background: AKXD recombinant inbred strains of mice have proven to be very useful in the identification of potential oncogenes and tumor suppressors involved in the development of lymphoid and myeloid malignancies. In these tumors, the hematopoietic insertion of an active AKV murine leukemia virus (MuLV) is associated with the onset of disease. Common sites of retroviral insertion (CIS) identify genes causally associated with the development or initiation of lymphoma. Methodology: In the present study, we analyzed a previously uncharacterized CIS, Ecotropic Viral Integration Site 32 (Evi32), which is located on mouse chromosome 1. We analyzed candidate genes in the region to identify those involved in Evi32 mediated oncogenesis. Results: Here we show that proviral insertion at Evi32 correlates with significant overexpression of a putative transcription factor, PR-domain containing 14 (Prdm14). Tumors with insertions at Evi32 are consistently lymphoid in nature. Prdm14 is normally expressed early in embryonic development with the highest expression in undifferentiated embryonic stem (ES) cells. This study implicates Prdm14 as a proto-oncogene involved in lymphoblastic lymphoma formation.	[Dettman, E. J.; Justice, Monica J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Justice, Monica J.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Dettman, EJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	mjustice@bcm.edu		Dettman, E.J./0000-0002-0059-836X	NIH [R01 CA63229]; NATIONAL CANCER INSTITUTE [R01CA063229] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for the work in this manuscript was provided from NIH grant R01 CA63229 to MJJ. The funding agency had no role in study design, data collection and analysis, decision to publish or prepare the manuscript.	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carapeti M, 1998, BLOOD, V91, P3127, DOI 10.1182/blood.V91.9.3127.3127_3127_3133; CHATTOPADHYAY SK, 1980, P NATL ACAD SCI-BIOL, V77, P5774, DOI 10.1073/pnas.77.10.5774; Chen SL, 2000, GENE DEV, V14, P1209; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; GILBERT DJ, 1993, J VIROL, V67, P2083, DOI 10.1128/JVI.67.4.2083-2090.1993; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Hansen GM, 2000, GENOME RES, V10, P237, DOI 10.1101/gr.10.2.237; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; JUSTICE MJ, 1994, J VIROL, V68, P1293, DOI 10.1128/JVI.68.3.1293-1300.1994; LAZO PA, 1990, P NATL ACAD SCI USA, V87, P170, DOI 10.1073/pnas.87.1.170; Liang J, 1998, BLOOD, V92, P2118, DOI 10.1182/blood.V92.6.2118.418k09_2118_2122; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Modlich U, 2008, LEUKEMIA, V22, P1519, DOI 10.1038/leu.2008.118; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; Nishikawa N, 2007, CANCER RES, V67, P9649, DOI 10.1158/0008-5472.CAN-06-4111; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Sakai I, 2005, GENE CHROMOSOME CANC, V44, P265, DOI 10.1002/gcc.20241; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Sorensen KD, 2007, VIROLOGY, V362, P179, DOI 10.1016/j.virol.2006.12.016; Stevens-Kroef MJPL, 2006, LEUKEMIA, V20, P1187, DOI 10.1038/sj.leu.2404210; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Weiser KC, 2007, MAMM GENOME, V18, P709, DOI 10.1007/s00335-007-9060-2; Xiao ZJ, 2006, LEUKEMIA RES, V30, P332, DOI 10.1016/j.leukres.2005.07.002; Xinh PT, 2003, GENE CHROMOSOME CANC, V36, P313, DOI 10.1002/gcc.10176; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yamashita N, 2005, BRIT J HAEMATOL, V131, P495, DOI 10.1111/j.1365-2141.2005.05793.x	38	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2008	3	11							e3823	10.1371/journal.pone.0003823	http://dx.doi.org/10.1371/journal.pone.0003823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YH	19043588	Green Submitted, gold, Green Published			2022-12-25	WOS:000265451500005
J	Wang, X; Sun, Q; McGrath, SD; Mardis, ER; Soloway, PD; Clark, AG				Wang, Xu; Sun, Qi; McGrath, Sean D.; Mardis, Elaine R.; Soloway, Paul D.; Clark, Andrew G.			Transcriptome-Wide Identification of Novel Imprinted Genes in Neonatal Mouse Brain	PLOS ONE			English	Article								Imprinted genes display differential allelic expression in a manner that depends on the sex of the transmitting parent. The degree of imprinting is often tissue-specific and/or developmental stage-specific, and may be altered in some diseases including cancer. Here we applied Illumina/Solexa sequencing of the transcriptomes of reciprocal F1 mouse neonatal brains and identified 26 genes with parent-of-origin dependent differential allelic expression. Allele-specific Pyrosequencing verified 17 of them, including three novel imprinted genes. The known and novel imprinted genes all are found in proximity to previously reported differentially methylated regions (DMRs). Ten genes known to be imprinted in placenta had sufficient expression levels to attain a read depth that provided statistical power to detect imprinting, and yet all were consistent with non-imprinting in our transcript count data for neonatal brain. Three closely linked and reciprocally imprinted gene pairs were also discovered, and their pattern of expression suggests transcriptional interference. Despite the coverage of more than 5000 genes, this scan only identified three novel imprinted refseq genes in neonatal brain, suggesting that this tissue is nearly exhaustively characterized. This approach has the potential to yield an complete catalog of imprinted genes after application to multiple tissues and developmental stages, shedding light on the mechanism, bioinformatic prediction, and evolution of imprinted genes and diseases associated with genomic imprinting.	[Wang, Xu; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Sun, Qi] Cornell Univ, Life Sci Core Lab Ctr, Computat Biol Serv Unit, Ithaca, NY 14853 USA; [McGrath, Sean D.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63130 USA; [Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Washington University (WUSTL); Cornell University	Wang, X (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ac347@cornell.edu	Mardis, Elaine/W-2202-2019; McGrath, Sean David/AAT-3540-2020; Wang, Xu/B-4587-2008; Soloway, Paul/T-8243-2019; Tang, Shuang/F-9115-2014	McGrath, Sean David/0000-0001-9064-8449; Wang, Xu/0000-0002-7594-5004; Soloway, Paul/0000-0003-1967-0437; Tang, Shuang/0000-0002-3084-0903; Clark, Andrew/0000-0001-7159-8511; Zheng, Zhi-Ming/0000-0001-5547-7912	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA 95713, R01 CA095713, CA 79006, R01 CA094141, CA 94141] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BJORNSSON HT, 2008, GENOME RES; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Charalambous M, 2004, DEV BIOL, V271, P488, DOI 10.1016/j.ydbio.2004.04.022; Choi JD, 2005, MOL CELL BIOL, V25, P5514, DOI 10.1128/MCB.25.13.5514-5522.2005; Chrast R, 2000, GENOME RES, V10, P2006, DOI 10.1101/gr.10.12.2006; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.02.043; Davies W, 2004, GENE EXPR PATTERNS, V4, P741, DOI 10.1016/j.modgep.2004.03.008; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Evans HK, 2005, MOL BIOL EVOL, V22, P1740, DOI 10.1093/molbev/msi165; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gould TD, 1998, HUM MOL GENET, V7, P483, DOI 10.1093/hmg/7.3.483; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; Hemberger M, 1998, DEV GENES EVOL, V208, P393, DOI 10.1007/s004270050195; Hikichi T, 2003, NUCLEIC ACIDS RES, V31, P1398, DOI 10.1093/nar/gkg232; Hoshiya H, 2003, J HUM GENET, V48, P208, DOI 10.1007/s10038-003-0006-6; Hu JF, 1999, BIOCHEM BIOPH RES CO, V257, P604, DOI 10.1006/bbrc.1999.0380; Jones BK, 2001, HUM MOL GENET, V10, P807, DOI 10.1093/hmg/10.8.807; Jong MTC, 1999, HUM MOL GENET, V8, P795, DOI 10.1093/hmg/8.5.795; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Kikyo N, 1997, DEV BIOL, V190, P66, DOI 10.1006/dbio.1997.8681; Kim J, 2000, GENOME RES, V10, P1138, DOI 10.1101/gr.10.8.1138; Kim J, 2001, GENOMICS, V77, P91, DOI 10.1006/geno.2001.6621; Lee YJ, 2000, FEBS LETT, V472, P230, DOI 10.1016/S0014-5793(00)01461-7; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Lehmann EL, 2005, TESTING STAT HYPOTHE, pxiv; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Matoba R, 2000, GENE, V241, P125, DOI 10.1016/S0378-1119(99)00457-6; McLaughlin D, 2006, GENE EXPR PATTERNS, V6, P394, DOI 10.1016/j.modgep.2005.09.007; Mergenthaler S, 2001, AM J HUM GENET, V68, P543, DOI 10.1086/318192; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; Ogata T, 2008, EPIGENETICS-US, V3, P181, DOI 10.4161/epi.3.4.6550; OHLSSON R, 1994, DEVELOPMENT, V120, P361; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Paulsen M, 1998, HUM MOL GENET, V7, P1149, DOI 10.1093/hmg/7.7.1149; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Sado T, 2001, DEVELOPMENT, V128, P1275; Schmidt JV, 2000, GENE DEV, V14, P1997; Schulz R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl461; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2003, EMBO J, V22, P3696, DOI 10.1093/emboj/cdg341; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; STORER BE, 1990, J AM STAT ASSOC, V85, P146, DOI 10.2307/2289537; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Wang YD, 2004, MOL CELL BIOL, V24, P270, DOI 10.1128/MCB.24.1.270-279.2004; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Weinstein LS, 2000, AM J PHYSIOL-RENAL, V278, pF507, DOI 10.1152/ajprenal.2000.278.4.F507; Wilcox R.R., 2003, APPLYING CONT STAT T, DOI [10.1016/B978-012751541-0/50029-8, DOI 10.1016/B978-012751541-0/50029-8, DOI 10.1198/TECH.2004.S233]; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yamazawa K, 2008, AM J MED GENET A, V146A, P514, DOI 10.1002/ajmg.a.32125; Yevtodiyenko A, 2004, GENOMICS, V84, P277, DOI 10.1016/j.ygeno.2004.04.005; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	74	250	262	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3839	10.1371/journal.pone.0003839	http://dx.doi.org/10.1371/journal.pone.0003839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052635	Green Published, Green Submitted, gold			2022-12-25	WOS:000265452200001
